PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Daubeuf, F; Hachet-Haas, M; Gizzi, P; Gasparik, V; Bonnet, D; Utard, V; Hibert, M; Frossard, N; Galzi, JL				Daubeuf, Francois; Hachet-Haas, Muriel; Gizzi, Patrick; Gasparik, Vincent; Bonnet, Dominique; Utard, Valerie; Hibert, Marcel; Frossard, Nelly; Galzi, Jean-Luc			An Antedrug of the CXCL12 Neutraligand Blocks Experimental Allergic Asthma without Systemic Effect in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; HEMATOPOIETIC PROGENITOR CELLS; T-LYMPHOCYTES; WHIM SYNDROME; RAPID MOBILIZATION; ANTAGONIST AMD3100; IN-VITRO; G-CSF; EXPRESSION; CANCER	The chemokine receptor CXCR4 and its chemokine CXCL12 are involved in normal tissue patterning but also in tumor cell growth and survival as well as in the recruitment of immune and inflammatory cells, as successfully demonstrated using agents that block either CXCL12 or CXCR4. In order to achieve selectivity in drug action on the CXCR4/CXCL12 pair, in particular in the airways, drugs should be delivered as selectively as possible in the treated tissue and should not diffuse in the systemic circulation, where it may reach undesired organs. To this end, we used a previously unexploited Knoevenagel reaction to create a short lived drug, or soft drug, based on the CXCL12-neutralizing small molecule, chalcone 4, which blocks binding of CXCL12 to CXCR4. We show that the compound, carbonitrile-chalcone 4, blocks the recruitment of eosinophils to the airways in ovalbumin-sensitized and challenged mice in vivo when administered directly to the airways by the intranasal route, but not when administered systemically by the intraperitoneal route. We show that the lack of effect at a distant site is due to the rapid degradation of the molecule to inactive fragments. This approach allows selective action of the CXCL12 neutraligands although the target protein is widely distributed in the organism.	[Daubeuf, Francois; Gasparik, Vincent; Bonnet, Dominique; Hibert, Marcel; Frossard, Nelly] Univ Strasbourg, Lab Innovat Therapeut, Fac Pharm, UMR 7200,CNRS, F-67401 Illkirch Graffenstaden, France; [Hachet-Haas, Muriel; Gizzi, Patrick; Utard, Valerie; Galzi, Jean-Luc] Univ Strasbourg, Ecole Super Biotechnol, Lab Biotechnol & Signalisat Cellulaire, UMR 7242,CNRS,Ecole Biotechnol Strasbourg, F-67412 Illkirch Graffenstaden, France; [Daubeuf, Francois; Hachet-Haas, Muriel; Gizzi, Patrick; Gasparik, Vincent; Bonnet, Dominique; Utard, Valerie; Hibert, Marcel; Frossard, Nelly; Galzi, Jean-Luc] Univ Strasbourg, Lab Excellence MEDALIS, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Galzi, JL (corresponding author), Univ Strasbourg, Lab Excellence MEDALIS, F-67400 Illkirch Graffenstaden, France.	galzi@unistra.fr	Bonnet, Dominique/N-7275-2014; Frossard, Nelly/F-8301-2013	Bonnet, Dominique/0000-0002-8252-9199; 	CNRS; Institut National pour la Sante et la Recherche Medicale; Agence Nationale pour la Recherche (ANR); Fonds de Recherche en Sante Respiratoire from Societe de Pneumologie de langue francaise (SPLF); Region Alsace	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National pour la Sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Fonds de Recherche en Sante Respiratoire from Societe de Pneumologie de langue francaise (SPLF); Region Alsace(Region Grand-Est)	This work was supported by funds from CNRS, the Institut National pour la Sante et la Recherche Medicale, and the Agence Nationale pour la Recherche (ANR).; Supported by a fellowship from the Fonds de Recherche en Sante Respiratoire from Societe de Pneumologie de langue francaise (SPLF) and the Region Alsace.	Bachelerie F, 2010, DIS MARKERS, V29, P189, DOI [10.3233/DMA-2010-0736, 10.1155/2010/475104]; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balabanian K, 2012, BLOOD, V119, P5722, DOI 10.1182/blood-2012-01-403378; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bouchery T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034971; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chow KYC, 2010, CELL HOST MICROBE, V8, P523, DOI 10.1016/j.chom.2010.11.006; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Negrete-Garcia MC, 2010, CHEST, V138, P100, DOI 10.1378/chest.09-2104; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Devine SM, 2004, J CLIN ONCOL, V22, P1095, DOI 10.1200/JCO.2004.07.131; Eddleston J, 2002, J IMMUNOL, V169, P6445, DOI 10.4049/jimmunol.169.11.6445; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Flomenberg N, 2005, BLOOD, V106, P1867, DOI 10.1182/blood-2005-02-0468; Flomenberg N, 2005, ACTA HAEMATOL-BASEL, V114, P198, DOI 10.1159/000088410; Fulkerson PC, 2004, J IMMUNOL, V173, P7565, DOI 10.4049/jimmunol.173.12.7565; Galzi JL, 2010, PHARMACOL THERAPEUT, V126, P39, DOI 10.1016/j.pharmthera.2009.12.003; Gasparik V, 2012, ACS MED CHEM LETT, V3, P10, DOI 10.1021/ml200017d; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; GUTHRIE JP, 1983, CAN J CHEM, V61, P2621, DOI 10.1139/v83-449; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Johnson Z, 2005, TRENDS IMMUNOL, V26, P268, DOI 10.1016/j.it.2005.03.001; Jourdan P, 1998, J IMMUNOL, V160, P4153; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Khan MOF, 2008, CHEM REV, V108, P5131, DOI 10.1021/cr068203e; Khan MOF, 2005, CURR MED CHEM, V12, P2227, DOI 10.2174/0929867054864840; Kim HY, 2010, CANCER RES TREAT, V42, P225, DOI 10.4143/crt.2010.42.4.225; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liles WC, 2005, TRANSFUSION, V45, P295, DOI 10.1111/j.1537-2995.2005.04222.x; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Maillet EL, 2007, FASEB J, V21, P2124, DOI 10.1096/fj.06-7683com; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; McDermott DH, 2011, J CELL MOL MED, V15, P2071, DOI 10.1111/j.1582-4934.2010.01210.x; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagase H, 2000, J IMMUNOL, V164, P5935, DOI 10.4049/jimmunol.164.11.5935; Nagase H, 2000, J ALLERGY CLIN IMMUN, V106, P1132; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Rajasekaran K, 2008, J CHEM SCI, V120, P475, DOI 10.1007/s12039-008-0074-4; ROBERTS DL, 1962, J ORG CHEM, V27, P3989, DOI 10.1021/jo01058a056; Rusconi S, 2009, MOLECULES, V14, P1927, DOI 10.3390/molecules14051927; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Trent JO, 2003, J BIOL CHEM, V278, P47136, DOI 10.1074/jbc.M307850200; Waldhauser KM, 2008, BRIT J PHARMACOL, V155, P585, DOI 10.1038/bjp.2008.287; Wang JB, 1998, J LEUKOCYTE BIOL, V64, P642, DOI 10.1002/jlb.64.5.642; Wells TNC, 1999, INFLAMM RES, V48, P353, DOI 10.1007/s000110050472; WETZLER M, 1990, AM J MED, V89, P663, DOI 10.1016/0002-9343(90)90187-I; Xu JG, 2008, J HEART LUNG TRANSPL, V27, P1302, DOI 10.1016/j.healun.2008.08.010; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	67	29	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11865	11876		10.1074/jbc.M112.449348	http://dx.doi.org/10.1074/jbc.M112.449348			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23449983	Green Published, hybrid			2022-12-28	WOS:000318157600022
J	Fils-Aime, N; Dai, MO; Guo, JM; El-Mousawi, M; Kahramangil, B; Neel, JC; Lebrun, JJ				Fils-Aime, Nadege; Dai, Meiou; Guo, Jimin; El-Mousawi, Mayada; Kahramangil, Bora; Neel, Jean-Charles; Lebrun, Jean-Jacques			MicroRNA-584 and the Protein Phosphatase and Actin Regulator 1 (PHACTR1), a New Signaling Route through Which Transforming Growth Factor-beta Mediates the Migration and Actin Dynamics of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MESENCHYMAL TRANSITION; TUMOR-SUPPRESSION; BINDING-PROTEIN; TARGET GENES; IN-VITRO; METASTASIS; PROLIFERATION; INHIBITION; FAMILY	TGF-beta plays an important role in breast cancer progression as a prometastatic factor, notably through enhancement of cell migration. It is becoming clear that microRNAs, a new class of small regulatory molecules, also play crucial roles in mediating tumor formation and progression. We found TGF-beta to downregulate the expression of the microRNA miR-584 in breast cancer cells. Furthermore, we identified PHACTR1, an actin-binding protein, to be positively regulated by TGF-beta in a miR584- dependent manner. Moreover, we found TGF-beta-mediated down-regulation of miR-584 and increased expression of PHACTR1 to be required for TGF-beta-induced cell migration of breast cancer cells. Indeed, both overexpression of miR-584 and knockdown of PHACTR1 resulted in a drastic reorganization of the actin cytoskeleton and reduced TGF-beta-induced cell migration. Our data highlight a novel signaling route whereby TGF-beta silences the expression of miR-584, resulting in enhanced PHACTR1 expression, and further leading to actin rearrangement and breast cancer cell migration.	[Fils-Aime, Nadege; Dai, Meiou; Guo, Jimin; El-Mousawi, Mayada; Kahramangil, Bora; Neel, Jean-Charles; Lebrun, Jean-Jacques] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Med Oncol,Dept Med, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Lebrun, JJ (corresponding author), McGill Univ, Fac Med, Div Expt Med, 687 Pine Ave W,Rm H7-66, Montreal, PQ H3A 1A1, Canada.	jj.lebrun@mcgill.ca	Lebrun, Jean-Jacques/GNP-5222-2022	Guo, Jimin/0000-0003-4008-2285	Canadian Institutes of Health Research (CIHR) [MOP-114904]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant MOP-114904 (to J.J.L.).	Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen WJ, 1999, MICROBES INFECT, V1, P1367, DOI 10.1016/S1286-4579(99)00249-X; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Drummond A, 2006, REPRODUCTION, V132, P177, DOI 10.1530/rep.1.01238; Eisenmann KM, 2009, ONCOGENE, V28, P3429, DOI 10.1038/onc.2009.207; Enright AJ, 2004, GENOME BIOL, V5; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo JM, 2009, CELL SIGNAL, V21, P899, DOI 10.1016/j.cellsig.2009.01.037; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Humbert L, 2010, TRENDS CELL MOL BIOL, V5, P69; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; KONG FM, 1995, ANN SURG, V222, P155, DOI 10.1097/00000658-199508000-00007; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lebrun JJ, 2012, ISRN MOL BIOL, V2012, DOI [DOI 10.5402/2012/381428, 10.5402/2012/381428]; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lehmann S, 2007, LEUKEMIA, V21, P1931, DOI 10.1038/sj.leu.2404852; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutherborrow M, 2011, AM J HEMATOL, V86, P2, DOI 10.1002/ajh.21864; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Moore LD, 2008, CLIN CANCER RES, V14, P4961, DOI 10.1158/1078-0432.CCR-07-4604; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Neel J. C., 2012, MED SCI AM NUMERO GR, V1, P1; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rodriguez Luis G., 2004, V294, P23; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tobin SW, 2001, CELL GROWTH DIFFER, V12, P109; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zhang BX, 2009, CANCER LETT, V277, P114, DOI 10.1016/j.canlet.2008.11.035	81	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11807	11823		10.1074/jbc.M112.430934	http://dx.doi.org/10.1074/jbc.M112.430934			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479725	Green Published, hybrid			2022-12-28	WOS:000318157600017
J	Malmgren, S; Spegel, P; Danielsson, APH; Nagorny, CL; Andersson, LE; Nitert, MD; Ridderstrale, M; Mulder, H; Ling, C				Malmgren, Siri; Spegel, Peter; Danielsson, Anders P. H.; Nagorny, Cecilia L.; Andersson, Lotta E.; Nitert, Marloes Dekker; Ridderstrale, Martin; Mulder, Hindrik; Ling, Charlotte			Coordinate Changes in Histone Modifications, mRNA Levels, and Metabolite Profiles in Clonal INS-1 832/13 beta-Cells Accompany Functional Adaptations to Lipotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-SECRETION; RAT PANCREATIC-ISLETS; FREE FATTY-ACIDS; DNA METHYLATION; MITOCHONDRIAL DYSFUNCTION; CHROMATIN MODIFICATIONS; GLUCOSE-METABOLISM; MALONYL-COA; EXPRESSION; GENES	Lipotoxicity is a presumed pathogenetic process whereby elevated circulating and stored lipids in type 2 diabetes cause pancreatic beta-cell failure. To resolve the underlying molecular mechanisms, we exposed clonal INS-1 832/13 beta-cells to palmitate for 48 h. We observed elevated basal insulin secretion but impaired glucose-stimulated insulin secretion in palmitate-exposed cells. Glucose utilization was unchanged, palmitate oxidation was increased, and oxygen consumption was impaired. Halting exposure of the clonal INS-1 832/13 beta-cells to palmitate largely recovered all of the lipid-induced functional changes. Metabolite profiling revealed profound but reversible increases in cellular lipids. Glucose-induced increases in tricarboxylic acid cycle intermediates were attenuated by exposure to palmitate. Analysis of gene expression by microarray showed increased expression of 982 genes and decreased expression of 1032 genes after exposure to palmitate. Increases were seen in pathways for steroid biosynthesis, cell cycle, fatty acid metabolism, DNA replication, and biosynthesis of unsaturated fatty acids; decreases occurred in the aminoacyl-tRNA synthesis pathway. The activity of histone-modifying enzymes and histone modifications of differentially expressed genes were reversibly altered upon exposure to palmitate. Thus, Insig1, Lss, Peci, Idi1, Hmgcs1, and Casr were subject to epigenetic regulation. Our analyses demonstrate that coordinate changes in histone modifications, mRNA levels, and metabolite profiles accompanied functional adaptations of clonal beta-cells to lipotoxicity. It is highly likely that these changes are pathogenetic, accounting for loss of glucose responsiveness and perturbed insulin secretion.	[Malmgren, Siri; Spegel, Peter; Danielsson, Anders P. H.; Nagorny, Cecilia L.; Andersson, Lotta E.; Mulder, Hindrik] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden; [Malmgren, Siri; Ling, Charlotte] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Epigenet & Diabet,CRC, S-20502 Malmo, Sweden; [Danielsson, Anders P. H.; Ridderstrale, Martin] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Clin Obes,CRC, S-20502 Malmo, Sweden; [Nitert, Marloes Dekker] Univ Queensland, Sch Med, Clin Res Ctr, Herston, Qld 4029, Australia	Lund University; Lund University; Lund University; University of Queensland	Malmgren, S (corresponding author), Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden.	siri.malmgren@med.lu.se	Mulder, Hindrik/E-1045-2012; Nitert, Marloes D/A-8822-2011; Spégel, Peter/G-9947-2018; Ling, Charlotte/Q-2432-2015	Nitert, Marloes D/0000-0002-1909-8920; Spégel, Peter/0000-0002-6092-2387; Ling, Charlotte/0000-0003-0587-7154; Malmgren, Siri/0000-0002-4540-1102; Mulder, Hindrik/0000-0002-6593-8417	Magnus Bergvalls Foundation; Crafoordska Foundation; Direktor Albert Pahlssons Foundation; Fredrik och Ingrid Thurings Foundation; Ake Wibergs Foundation; O.E. och Edla Johanssons Foundation; Knut och Alice Wallenbergs Foundation; Lars Hiertas Minne; Swedish Research Council; Region Skane Foundation; Novo Nordisk Foundation; Soderberg; Diabetes Fonden; Linne Grant [B31 5631/2006]; Exodiab; Novo Nordisk Fonden [NNF11OC1014660] Funding Source: researchfish	Magnus Bergvalls Foundation; Crafoordska Foundation; Direktor Albert Pahlssons Foundation; Fredrik och Ingrid Thurings Foundation; Ake Wibergs Foundation; O.E. och Edla Johanssons Foundation; Knut och Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); Lars Hiertas Minne; Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Soderberg; Diabetes Fonden; Linne Grant; Exodiab; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Magnus Bergvalls, Crafoordska, Direktor Albert Pahlssons, Fredrik och Ingrid Thurings, Ake Wibergs, O.E. och Edla Johanssons, Knut och Alice Wallenbergs Foundations, Lars Hiertas Minne, the Swedish Research Council, Region Skane Foundation, Novo Nordisk Foundation, Soderberg, Diabetes Fonden, Linne Grant B31 5631/2006, and Exodiab.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen K, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-57; Danielsson APH, 2012, METABOLOMICS, V8, P50, DOI 10.1007/s11306-011-0283-6; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; Deering TG, 2009, DIABETES, V58, P185, DOI 10.2337/db08-1150; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; El-Osta A, 2012, CURR OPIN LIPIDOL, V23, P24, DOI 10.1097/MOL.0b013e32834f319d; Eto K, 2002, DIABETES, V51, pS414, DOI 10.2337/diabetes.51.2007.S414; Falchetti A, 2012, EUR J ENDOCRINOL, V166, P933, DOI 10.1530/EJE-11-0953; Ferrannini E, 2003, DIABETOLOGIA, V46, P1211, DOI 10.1007/s00125-003-1169-6; Fex M, 2004, ENDOCRINOLOGY, V145, P3746, DOI 10.1210/en.2003-1673; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; GILON P, 1991, ENDOCRINOLOGY, V129, P2521, DOI 10.1210/endo-129-5-2521; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Keating ST, 2012, J CARDIOVASC TRANSL, V5, P399, DOI 10.1007/s12265-012-9380-9; KELLY RP, 1991, J PHYSIOL-LONDON, V443, P175, DOI 10.1113/jphysiol.1991.sp018829; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; LeRoith D, 2005, DIABETES-METAB RES, V21, P85, DOI 10.1002/dmrr.530; Liang Y, 1997, DIABETOLOGIA, V40, P1018, DOI 10.1007/s001250050783; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Moran A, 1997, J CLIN INVEST, V99, P534, DOI 10.1172/JCI119190; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Ogihara T, 2009, ISLETS, V1, P269, DOI 10.4161/isl.1.3.9779; Olson LK, 1998, MOL ENDOCRINOL, V12, P207, DOI 10.1210/me.12.2.207; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Quintens R, 2008, BIOCHEM SOC T, V36, P300, DOI 10.1042/BST0360300; RANDLE PJ, 1963, LANCET, V1, P785; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; van Weeghel M, 2012, FASEB J, V26, P4316, DOI 10.1096/fj.12-206326; Vock C, 2008, CELL PHYSIOL BIOCHEM, V22, P515, DOI 10.1159/000185525; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Weishaupt H, 2010, BIOL PROCED ONLINE, V12, P1, DOI 10.1007/s12575-010-9031-y; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	79	51	53	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11973	11987		10.1074/jbc.M112.422527	http://dx.doi.org/10.1074/jbc.M112.422527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23476019	hybrid, Green Published			2022-12-28	WOS:000318157600032
J	Kay, NE; Bainbridge, TW; Condit, RC; Bubb, MR; Judd, RE; Venkatakrishnan, B; McKenna, R; D'Costa, SM				Kay, Nicole E.; Bainbridge, Travis W.; Condit, Richard C.; Bubb, Michael R.; Judd, Reuben E.; Venkatakrishnan, Balasubramanian; McKenna, Robert; D'Costa, Susan M.			Biochemical and Biophysical Properties of a Putative Hub Protein Expressed by Vaccinia Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANTS; TRANSCRIPTION TERMINATION FACTOR; TRIPHOSPHATE PHOSPHOHYDROLASE I; RNA-POLYMERASE; MESSENGER-RNA; REPLICATION COMPLEX; INTRINSIC DISORDER; ELONGATION-FACTOR; DNA-REPLICATION; A20R PROTEIN	H5 is a constitutively expressed, phosphorylated vaccinia virus protein that has been implicated in viral DNA replication, post-replicative gene expression, and virus assembly. For the purpose of understanding the role of H5 in vaccinia biology, we have characterized its biochemical and biophysical properties. Previously, we have demonstrated that H5 is associated with an endoribonucleolytic activity. In this study, we have shown that this cleavage results in a 3'-OH end suitable for polyadenylation of the nascent transcript, corroborating a role for H5 in vaccinia transcription termination. Furthermore, we have shown that H5 is intrinsically disordered, with an elongated rod-shaped structure that preferentially binds double-stranded nucleic acids in a sequence nonspecific manner. The dynamic phosphorylation status of H5 influences this structure and has implications for the role of H5 in multiple processes during virus replication.	[Kay, Nicole E.; Bainbridge, Travis W.; Condit, Richard C.; D'Costa, Susan M.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Bubb, Michael R.; Judd, Reuben E.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Venkatakrishnan, Balasubramanian; McKenna, Robert] Univ Florida, Dept Biochem, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	D'Costa, SM (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, J Hillis Miller Hlth Ctr, POB 100266, Gainesville, FL 32610 USA.	ihssd@ufl.edu			National Institutes of Health [RO1 18094]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RO1 18094 (to R. C. C.).	ANTCZAK JB, 1992, P NATL ACAD SCI USA, V89, P12033, DOI 10.1073/pnas.89.24.12033; BAYLISS CD, 1995, J BIOL CHEM, V270, P1550, DOI 10.1074/jbc.270.4.1550; BEAUD G, 1995, J VIROL, V69, P1819, DOI 10.1128/JVI.69.3.1819-1826.1995; Beaud G, 1997, J GEN VIROL, V78, P3297, DOI 10.1099/0022-1317-78-12-3297; Black EP, 1996, J VIROL, V70, P47, DOI 10.1128/JVI.70.1.47-54.1996; Black EP, 1998, VIROLOGY, V245, P313, DOI 10.1006/viro.1998.9166; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; BUBB MR, 1995, J BIOL CHEM, V270, P3463, DOI 10.1074/jbc.270.8.3463; BUBB MR, 1991, J BIOL CHEM, V266, P3820; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; Condit RC, 1996, VIROLOGY, V218, P169, DOI 10.1006/viro.1996.0177; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cresawn SG, 2007, VIROLOGY, V363, P333, DOI 10.1016/j.virol.2007.02.016; D'Costa SM, 2004, VIROLOGY, V319, P1, DOI 10.1016/j.virol.2003.09.041; D'Costa SM, 2008, J BIOL CHEM, V283, P5267, DOI 10.1074/jbc.M709258200; D'Costa SM, 2010, VIROLOGY, V401, P49, DOI 10.1016/j.virol.2010.01.020; De Silva FS, 2007, P NATL ACAD SCI USA, V104, P18724, DOI 10.1073/pnas.0709276104; Dellis S, 2004, VIROLOGY, V329, P328, DOI 10.1016/j.virol.2004.08.017; DeMasi J, 2000, J VIROL, V74, P2393, DOI 10.1128/JVI.74.5.2393-2405.2000; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Domi A, 2000, J GEN VIROL, V81, P1231, DOI 10.1099/0022-1317-81-5-1231; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Eckert D, 2005, J VIROL, V79, P15084, DOI 10.1128/JVI.79.24.15084-15090.2005; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; GORDON J, 1991, VIROLOGY, V181, P671, DOI 10.1016/0042-6822(91)90901-M; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kovacs GR, 1996, J VIROL, V70, P6796, DOI 10.1128/JVI.70.10.6796-6802.1996; Lackner CA, 2000, J BIOL CHEM, V275, P1485, DOI 10.1074/jbc.275.2.1485; Latner DR, 2000, VIROLOGY, V269, P345, DOI 10.1006/viro.2000.0243; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MAHR A, 1984, J VIROL, V49, P510, DOI 10.1128/JVI.49.2.510-520.1984; Mayer M, 2000, BIOCHEMISTRY-US, V39, P2096, DOI 10.1021/bi992253e; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Mohamed MR, 2000, J BIOL CHEM, V275, P25798, DOI 10.1074/jbc.M002250200; MOHANDAS AR, 1994, VIROLOGY, V200, P207, DOI 10.1006/viro.1994.1179; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Moss B, 2007, FIELDS VIROLOGY, P2906; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; NOWAKOWSKI M, 1978, VIROLOGY, V86, P217, DOI 10.1016/0042-6822(78)90022-3; PARSONS BL, 1990, VIROLOGY, V175, P69, DOI 10.1016/0042-6822(90)90187-V; PATEL DD, 1989, J VIROL, V63, P1076, DOI 10.1128/JVI.63.3.1076-1086.1989; PATEL DD, 1988, P NATL ACAD SCI USA, V85, P9431, DOI 10.1073/pnas.85.24.9431; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Silva MD, 2006, BIOINFORMATICS, V22, P2846, DOI 10.1093/bioinformatics/btl506; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI [10.1586/epr.10.36, 10.1586/EPR.10.36]; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; WINTERSBERGER U, 1990, PHARMACOL THERAPEUT, V48, P259, DOI 10.1016/0163-7258(90)90083-E; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang ZL, 2012, J BIOL CHEM, V287, P31050, DOI 10.1074/jbc.M112.390054; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	69	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11470	11481		10.1074/jbc.M112.442012	http://dx.doi.org/10.1074/jbc.M112.442012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476017	hybrid, Green Published			2022-12-28	WOS:000317915500048
J	Kulik, HJ; Drennan, CL				Kulik, Heather J.; Drennan, Catherine L.			Substrate Placement Influences Reactivity in Non-heme Fe(II) Halogenases and Hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; FATTY-ACID SYNTHASE; STRUCTURAL BASIS; IRON; BIOSYNTHESIS; ENZYMES; SYRB2; SYRINGOMYCIN; ACTIVATION	We employ error-corrected density functional theory methods to map out the dependence of reactivity on substrate position for SyrB2, a member of a family of non-heme iron halogenases and hydroxylases that are only reactive toward amino acid substrates delivered via prosthetic phosphopantetheine arms. For the initial hydrogen abstraction step, the inherent flexibility of the phosphopantetheine molecule weakens the position dependence for both the native substrate (threonine for SyrB2) and alternative substrates. Over a 5 angstrom window of substrate positions, the tethered hydrogen abstraction step proceeds with nearly identical activation energies and donor-acceptor distances in the transition state. The propensity of a particular substrate toward halogenation or hydroxylation is found to depend strongly on the substrate placement following hydrogen abstraction, with deeper substrate delivery into the active (for native substrates) site favoring halogenation and shallower substrate delivery favoring hydroxylation.	[Kulik, Heather J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Drennan, Catherine L.] MIT, Dept Biol & Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kulik, HJ (corresponding author), Stanford Univ, Dept Chem, 333 Campus Dr,Mudd Bldg,Rm 121, Stanford, CA 94305 USA.	hkulik@stanford.edu			Burroughs Wellcome Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund)	Recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Chemistry, Stanford University, 333 Campus Dr., Mudd Bldg., Rm. 121, Stanford, CA, 94305. E-mail: hkulik@stanford.edu.	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borowski T, 2010, J AM CHEM SOC, V132, P12887, DOI 10.1021/ja101877a; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Cho KB, 2012, CHEM COMMUN, V48, P2189, DOI 10.1039/c2cc17610f; Comba P, 2010, CHEM-EUR J, V16, P7293, DOI 10.1002/chem.201000092; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; de Visser SP, 2006, J AM CHEM SOC, V128, P9813, DOI 10.1021/ja061581g; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GRGURINA I, 1994, EXPERIENTIA, V50, P130, DOI 10.1007/BF01984950; Gribble GW, 2004, J CHEM EDUC, V81, P1441, DOI 10.1021/ed081p1441; Grzyska PK, 2007, J INORG BIOCHEM, V101, P797, DOI 10.1016/j.jinorgbio.2007.01.011; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Janardanan D, 2010, ANGEW CHEM INT EDIT, V49, P3342, DOI 10.1002/anie.201000004; Joshi AK, 2005, BIOCHEMISTRY-US, V44, P4100, DOI 10.1021/bi047856r; Klinker EJ, 2009, ANGEW CHEM INT EDIT, V48, P1291, DOI 10.1002/anie.200804029; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Kulik HJ, 2009, J AM CHEM SOC, V131, P14426, DOI 10.1021/ja905206k; Lai JR, 2006, P NATL ACAD SCI USA, V103, P5314, DOI 10.1073/pnas.0601038103; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Liu HN, 2009, J PHYS CHEM B, V113, P4887, DOI 10.1021/jp810715t; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Lowe JR, 2011, POLYM CHEM-UK, V2, P702, DOI 10.1039/c0py00283f; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; MCMILLEN DF, 1982, ANNU REV PHYS CHEM, V33, P493, DOI 10.1146/annurev.pc.33.100182.002425; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pandian S, 2009, DALTON T, P6201, DOI 10.1039/b906866j; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Seo MS, 2011, CHEM SCI, V2, P1039, DOI 10.1039/c1sc00062d; Shaik S, 2010, NAT CHEM, V2, P347, DOI 10.1038/nchem.638; Sheppard D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841941; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Tran L, 2010, CHEM BIOL, V17, P705, DOI 10.1016/j.chembiol.2010.05.017; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497	53	41	42	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11233	11241		10.1074/jbc.M112.415570	http://dx.doi.org/10.1074/jbc.M112.415570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449977	Green Published, hybrid			2022-12-28	WOS:000317915500026
J	Pozzi, N; Chen, ZW; Zapata, F; Niu, WL; Barranco-Medina, S; Pelc, LA; Di Cera, E				Pozzi, Nicola; Chen, Zhiwei; Zapata, Fatima; Niu, Weiling; Barranco-Medina, Sergio; Pelc, Leslie A.; Di Cera, Enrico			Autoactivation of Thrombin Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN ALPHA-THROMBIN; BOVINE TRYPSINOGEN; CONFORMATIONAL SELECTION; PROTEIN-C; ACTIVATION; BINDING; PROTHROMBIN; PROTEASES; PRETHROMBIN-2	Trypsin-like proteases are synthesized as inactive zymogens and convert to the mature form upon activation by specific enzymes, often assisted by cofactors. Central to this paradigm is that the zymogen does not convert spontaneously to the mature enzyme, which in turn does not feed back to activate its zymogen form. In the blood, the zymogens prothrombin and prethrombin-2 require the prothrombinase complex to be converted to the mature protease thrombin, which is unable to activate prothrombin or prethrombin-2. Here, we show that replacement of key residues within the activation domain causes these zymogens to spontaneously convert to thrombin. The conversion is started by the zymogen itself, which is capable of binding ligands at the active site, and is abrogated by inactivation of the catalytic residue Ser-195. The product of autoactivation is functionally and structurally equivalent to wild-type thrombin. Zymogen autoactivation is explained by conformational selection, a basic property of the trypsin fold uncovered by structural and rapid kinetics studies. Both the zymogen and protease undergo a preexisting equilibrium between active and inactive forms. The equilibrium regulates catalytic activity in the protease and has the potential to unleash activity in the zymogen to produce autoactivation. A new strategy emerges for the facile production of enzymes through zymogen autoactivation that is broadly applicable to trypsin-like proteases of biotechnological and clinical interest.	[Pozzi, Nicola; Chen, Zhiwei; Zapata, Fatima; Niu, Weiling; Barranco-Medina, Sergio; Pelc, Leslie A.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAV-4876-2021; Pozzi, Nicola/AAE-4910-2020	Pozzi, Nicola/0000-0003-2309-7100; 	National Institutes of Health [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049413, R29HL049413, U54HL112303, R01HL073813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Research Grants HL49413, HL73813, and HL112303 (to E.D.C.).	Aizawa P, 2008, THROMB RES, V122, P560, DOI 10.1016/j.thromres.2007.12.027; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAJAJ SP, 1973, J BIOL CHEM, V248, P7729; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1992, PROTEIN SCI, V1, P426; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; CLAESON G, 1994, BLOOD COAGUL FIBRIN, V5, P411; Craik CS, 2011, BIOCHEM J, V435, P1, DOI 10.1042/BJ20100965; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Di Cera E, 2011, PROG MOL BIOL TRANSL, V99, P145, DOI 10.1016/B978-0-12-385504-6.00004-X; DIBELLA EE, 1995, J BIOL CHEM, V270, P163, DOI 10.1074/jbc.270.1.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Fersht A.R., 1999, ENZYME STRUCTURE MEC; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heffernan JK, 2007, REGUL TOXICOL PHARM, V47, P48, DOI 10.1016/j.yrtph.2006.07.006; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NEURATH H, 1957, FED PROC, V16, P791; NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Virel A, 2012, ANAL CHEM, V84, P2380, DOI 10.1021/ac203138y; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; Yamamoto E, 2011, BIOSCI BIOTECH BIOCH, V75, P2070, DOI 10.1271/bbb.110515	55	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11601	11610		10.1074/jbc.M113.451542	http://dx.doi.org/10.1074/jbc.M113.451542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23467412	Green Published, hybrid			2022-12-28	WOS:000317915500065
J	Lu, M; Sarruf, DA; Li, PP; Osborn, O; Sanchez-Alavez, M; Talukdar, S; Chen, A; Bandyopadhyay, G; Xu, JF; Morinaga, H; Dines, K; Watkins, S; Kaiyala, K; Schwartz, MW; Olefsky, JM				Lu, Min; Sarruf, David A.; Li, Pingping; Osborn, Olivia; Sanchez-Alavez, Manuel; Talukdar, Saswata; Chen, Ai; Bandyopadhyay, Gautam; Xu, Jianfeng; Morinaga, Hidetaka; Dines, Kevin; Watkins, Steven; Kaiyala, Karl; Schwartz, Michael W.; Olefsky, Jerrold M.			Neuronal Sirt1 Deficiency Increases Insulin Sensitivity in Both Brain and Peripheral Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES FOOD-INTAKE; ADIPOSE-TISSUE; CELLULAR-METABOLISM; HYPOTHALAMIC SIRT1; ENERGY-BALANCE; AGRP NEURONS; PROTECTS; DEACETYLASE; EXPRESSION; DISEASE	Sirt1 is a NAD(+)-dependent class III deacetylase that functions as a cellular energy sensor. In addition to its well-characterized effects in peripheral tissues, emerging evidence suggests that neuronal Sirt1 activity plays a role in the central regulation of energy balance and glucose metabolism. To assess this idea, we generated Sirt1 neuron-specific knockout (SINKO) mice. On both standard chow and HFD, SINKO mice were more insulin sensitive than Sirt1(f/f) mice. Thus, SINKO mice had lower fasting insulin levels, improved glucose tolerance and insulin tolerance, and enhanced systemic insulin sensitivity during hyperinsuline-mic euglycemic clamp studies. Hypothalamic insulin sensitivity of SINKO mice was also increased over controls, as assessed by hypothalamic activation of PI3K, phosphorylation of Akt and FoxO1 following systemic insulin injection. Intracerebroventricular injection of insulin led to a greater systemic effect to improve glucose tolerance and insulin sensitivity in SINKO mice compared with controls. In line with the in vivo results, insulin-induced AKT and FoxO1 phosphorylation were potentiated by inhibition of Sirt1 in a cultured hypothalamic cell line. Mechanistically, this effect was traced to a reduced effect of Sirt1 to directly deacetylate and repress IRS-1 function. The enhanced central insulin signaling in SINKO mice was accompanied by increased insulin receptor signal transduction in liver, muscle, and adipose tissue. In summary, we conclude that neuronal Sirt1 negatively regulates hypothalamic insulin signaling, leading to systemic insulin resistance. Interventions that reduce neuronal Sirt1 activity have the potential to improve systemic insulin action and limit weight gain on an obesigenic diet.	[Lu, Min; Li, Pingping; Osborn, Olivia; Talukdar, Saswata; Chen, Ai; Bandyopadhyay, Gautam; Xu, Jianfeng; Morinaga, Hidetaka; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Sarruf, David A.; Kaiyala, Karl; Schwartz, Michael W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98104 USA; [Sanchez-Alavez, Manuel] Scripps Res Inst, La Jolla, CA 92037 USA; [Dines, Kevin] Tanabe Res Lab Inc, San Diego, CA 92121 USA; [Watkins, Steven] Lipom Technol, West Sacramento, CA 95691 USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Scripps Research Institute	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA.	jolefsky@ucsd.edu	Li, Pingping/F-1109-2019; osborn, olivia/R-1460-2018	Li, Pingping/0000-0003-0679-270X; osborn, olivia/0000-0003-0516-7937; Sanchez-Alavez, Manuel/0000-0002-8164-8452	National Institutes of Health (NIH) [DK033651, DK063491, DK074868, DK09062, DK068384, DK083042, DK052989]; Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH [U54 HD012303-25]; Ruth L. Kirschstein National Research Service Award Fellowship [F32DK080604-01]; Nutrition Obesity Research Center [DK035816]; Mouse Metabolic Phenotyping Center at the University of Washington [U24 DK076126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090320, F32DK009062, P01DK068384, R01DK083042, U24DK076126, R01DK033651, P01DK074868, R01DK052989, P30DK035816, R37DK033651, P30DK063491, F32DK080604] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ruth L. Kirschstein National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; Mouse Metabolic Phenotyping Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health (NIH) Grants DK033651, DK063491, DK074868, and DK09062 (to J. O.) and by the Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH through cooperative agreement of U54 HD012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by NIH Grants DK068384, DK083042, and DK052989 (to M. S.), by Ruth L. Kirschstein National Research Service Award Fellowship F32DK080604-01 (to D. S.), and by the Nutrition Obesity Research Center Grant DK035816 and the Mouse Metabolic Phenotyping Center (U24 DK076126) at the University of Washington.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Garcia-Serrano S, 2011, MOL MED, V17, P273, DOI 10.2119/molmed.2010.00078; Girard J, 2006, J CLIN INVEST, V116, P302, DOI 10.1172/JCI27743; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallschmid M, 2009, DIABETOLOGIA, V52, P2264, DOI 10.1007/s00125-009-1501-x; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Kaiser C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-23; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Knight CM, 2011, DIABETES, V60, P2691, DOI 10.2337/db10-0987; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanchez-Alavez M, 2011, J BIOL CHEM, V286, P14983, DOI 10.1074/jbc.M110.188540; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stefater MA, 2010, ANNU REV NUTR, V30, P219, DOI 10.1146/annurev.nutr.012809.104723; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Wu DS, 2011, ANN OPER RES, V185, P1, DOI 10.1007/s10479-010-0822-y; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	54	45	45	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10722	10735		10.1074/jbc.M112.443606	http://dx.doi.org/10.1074/jbc.M112.443606			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457303	hybrid, Green Published			2022-12-28	WOS:000317565000050
J	Tan, JHY; Ludeman, JP; Wedderburn, J; Canals, M; Hall, P; Butler, SJ; Taleski, D; Christopoulos, A; Hickey, MJ; Payne, RJ; Stone, MJ				Tan, Joshua H. Y.; Ludeman, Justin P.; Wedderburn, Jamie; Canals, Meritxell; Hall, Pam; Butler, Stephen J.; Taleski, Deni; Christopoulos, Arthur; Hickey, Michael J.; Payne, Richard J.; Stone, Martin J.			Tyrosine Sulfation of Chemokine Receptor CCR2 Enhances Interactions with Both Monomeric and Dimeric Forms of the Chemokine Monocyte Chemoattractant Protein-1 (MCP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTACTIC PROTEIN-1; CXCR4 SULFOTYROSINE; AMINO-TERMINUS; HIV-1 ENTRY; IN-VIVO; BINDING; RECOGNITION; INTERLEUKIN-8; RESIDUES; ATHEROSCLEROSIS	Chemokine receptors are commonly post-translationally sulfated on tyrosine residues in their N-terminal regions, the initial site of binding to chemokine ligands. We have investigated the effect of tyrosine sulfation of the chemokine receptor CCR2 on its interactions with the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2). Inhibition of CCR2 sulfation, by growth of expressing cells in the presence of sodium chlorate, significantly reduced the potency for MCP-1 activation of CCR2. MCP-1 exists in equilibrium between monomeric and dimeric forms. The obligate monomeric mutant MCP-1(P8A) was similar to wild type MCP-1 in its ability to induce leukocyte recruitment in vivo, whereas the obligate dimeric mutant MCP-1(T10C)was less effective at inducing leukocyte recruitment in vivo. In two-dimensional NMR experiments, sulfated peptides derived from the N-terminal region of CCR2 bound to both the monomeric and dimeric forms of wild type MCP-1 and shifted the equilibrium to favor the monomeric form. Similarly, MCP-1(P8A) bound more tightly than MCP-1(T10C) to the CCR2-derived sulfopeptides. NMR chemical shift mapping using the MCP-1 mutants showed that the sulfated N-terminal region of CCR2 binds to the same region (N-loop and beta 3-strand) of both monomeric and dimeric MCP-1 but that binding to the dimeric form also influences the environment of chemokine N-terminal residues, which are involved in dimer formation. We conclude that interaction with the sulfated N terminus of CCR2 destabilizes the dimerization interface of inactive dimeric MCP-1, thus inducing dissociation to the active monomeric state.	[Tan, Joshua H. Y.; Ludeman, Justin P.; Wedderburn, Jamie; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Canals, Meritxell; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Hall, Pam; Hickey, Michael J.] Monash Univ, Dept Med, Monash Med Ctr, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia; [Butler, Stephen J.; Taleski, Deni; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Monash University; Monash University; Monash University; University of Sydney	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Bldg 76,Wellington Rd, Clayton, Vic 3800, Australia.	martin.stone@monash.edu	Christopoulos, Arthur/B-6207-2013; Butler, Stephen/K-7050-2013; Payne, Richard/AAH-3666-2021; Hickey, Michael/A-5429-2012; Stone, Martin/C-2492-2012	Christopoulos, Arthur/0000-0003-4442-3294; Butler, Stephen/0000-0001-8109-3330; Hickey, Michael/0000-0003-2354-357X; Canals, Meritxell/0000-0002-7942-5006; Payne, Richard/0000-0002-3618-9226; Stone, Martin/0000-0002-6468-4427	Australian Research Council [DP0881570, LE0989504, DP1094884]; Australian National Health and Medical Research Council [519461]; Monash MNHS International Honours Scholarship; Australia Postgraduate Award	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash MNHS International Honours Scholarship; Australia Postgraduate Award	This work was supported by Australian Research Council Grants DP0881570 and LE0989504 (to M. J. S.) and DP1094884 (to R. J. P. and M. J. S.) and by Australian National Health and Medical Research Council Grant 519461 (to A. C.).; Supported by a Monash MNHS International Honours Scholarship.; Supported by an Australia Postgraduate Award.	Apostolopoulos J, 2008, J LEUKOCYTE BIOL, V83, P902, DOI 10.1189/jlb.0607353; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; CLUBB RT, 1994, FEBS LETT, V338, P93, DOI 10.1016/0014-5793(94)80123-1; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Fernando H, 2004, J BIOL CHEM, V279, P36175, DOI 10.1074/jbc.C400283200; Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gutierrez J, 2004, J BIOL CHEM, V279, P14726, DOI 10.1074/jbc.M309689200; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Preobrazhensky AA, 2000, J IMMUNOL, V165, P5295, DOI 10.4049/jimmunol.165.9.5295; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; ROBINSON EA, 1989, P NATL ACAD SCI USA, V86, P1850, DOI 10.1073/pnas.86.6.1850; Schmidt PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037779; Seibert C, 2008, BIOCHEMISTRY-US, V47, P11251, DOI 10.1021/bi800965m; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Taleski D, 2011, CHEM-ASIAN J, V6, P1316, DOI 10.1002/asia.201100232; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Ye JP, 2000, J BIOL CHEM, V275, P27250; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	41	67	71	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10024	10034		10.1074/jbc.M112.447359	http://dx.doi.org/10.1074/jbc.M112.447359			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408426	Green Published, hybrid			2022-12-28	WOS:000317114000041
J	Iglesias-Guimarais, V; Gil-Guinon, E; Sanchez-Osuna, M; Casanelles, E; Garcia-Belinchon, M; Comella, JX; Yuste, VJ				Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Sanchez-Osuna, Maria; Casanelles, Elisenda; Garcia-Belinchon, Merce; Comella, Joan X.; Yuste, Victor J.			Chromatin Collapse during Caspase-dependent Apoptotic Cell Death Requires DNA Fragmentation Factor, 40-kDa Subunit-/Caspase-activated Deoxyribonuclease-mediated 3 '-OH Single-strand DNA Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL TRANSFERASE; ENDONUCLEASE DFF40/CAD; MORPHOLOGICAL CHANGE; NEUROBLASTOMA-CELLS; INHIBITOR; CLEAVAGE; CAD; NUCLEASE; DIFFERENTIATION; CONDENSATION	Apoptotic nuclear morphology and oligonucleosomal double-strand DNA fragments (also known as DNA ladder) are considered the hallmarks of apoptotic cell death. From a classic point of view, these two processes occur concomitantly. Once activated, DNA fragmentation factor, 40-kDa subunit (DFF40)/caspase-activated DNase (CAD) endonuclease hydrolyzes the DNA into oligonucleosomal-size pieces, facilitating the chromatin package. However, the dogma that the apoptotic nuclear morphology depends on DNA fragmentation has been questioned. Here, we use different cellular models, including MEF CAD(-/-) cells, to unravel the mechanism by which DFF40/CAD influences chromatin condensation and nuclear collapse during apoptosis. Upon apoptotic insult, SK-N-AS cells display caspase-dependent apoptotic nuclear alterations in the absence of internucleosomal DNA degradation. The overexpression of a wild-type form of DFF40/CAD endonuclease, but not of different catalytic-null mutants, restores the cellular ability to degrade the chromatin into oligonucleosomal-length fragments. We show that apoptotic nuclear collapse requires a 3'-OH endonucleolytic activity even though the internucleosomal DNA degradation is impaired. Moreover, alkaline unwinding electrophoresis and In Situ End-Labeling (ISEL)/In Situ Nick Translation (ISNT) assays reveal that the apoptotic DNA damage observed in the DNA ladder-deficient SK-N-AS cells is characterized by the presence of single-strand nicks/breaks. Apoptotic single-strand breaks can be impaired by DFF40/CAD knockdown, abrogating nuclear collapse and disassembly. In conclusion, the highest order of chromatin compaction observed in the later steps of caspase-dependent apoptosis relies on DFF40/CAD-mediated DNA damage by generating 3'-OH ends in single-strand rather than double-strand DNA nicks/breaks.	[Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Sanchez-Osuna, Maria; Casanelles, Elisenda; Garcia-Belinchon, Merce; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Sanchez-Osuna, Maria; Casanelles, Elisenda; Garcia-Belinchon, Merce; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.] Vall dHebron Inst Recerca, Cell Signalling & Apoptosis Grp, Barcelona 08035, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.; Yuste, Victor J.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08035, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Gil, Estel/B-9786-2015; Yuste, Victor J./C-7071-2008; Comella, Joan/GQA-4279-2022; Comella, Joan X/D-7333-2012	Yuste, Victor J./0000-0001-5322-9261; Comella, Joan X/0000-0002-6218-0786; Gil, Estel/0000-0003-4502-4623	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) [SAF2011-24081, SAF2012-31485, SAF2010-19953]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Grant [CB06/05/0042]; Generalitat de Catalunya Grant [SGR2009-346]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya); Ministerio de Ciencia e Innovacion [TRA2009-0185, BES-2099-028572]; Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia)	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Grant; Generalitat de Catalunya Grant(Generalitat de Catalunya); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia)(German Research Foundation (DFG))	This work was supported by Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) Grants SAF2011-24081 and SAF2012-31485 (to V. J. Y.) and SAF2010-19953 (to J. X. C.), by Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Grant CB06/05/0042, and by Generalitat de Catalunya Grant SGR2009-346. This work was also supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya) (to V. I. G.), by Postdoctoral Contract TRA2009-0185 from the Ministerio de Ciencia e Innovacion (to E. G. G.), by Formacion de Personal Investigador (FPI) Fellowship BES-2099-028572 from the Ministerio de Ciencia e Innovacion (to M. G. B.), and by the Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia) (to V. J. Y.).	Ageichik AV, 2007, J BIOL CHEM, V282, P27374, DOI 10.1074/jbc.M704307200; Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Bayascas JR, 2002, CELL DEATH DIFFER, V9, P1078, DOI 10.1038/sj.cdd.4401075; Bayascas JR, 2004, FEBS LETT, V566, P234, DOI 10.1016/S0014-5793(04)00519-8; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Boulares AH, 2001, J BIOL CHEM, V276, P38185; Chalmers Claire R., 2006, Angiogenesis, V9, P193, DOI 10.1007/s10456-006-9050-0; Cho SG, 2003, J CELL BIOL, V163, P71, DOI 10.1083/jcb.200303003; COULTON GR, 1992, J CELL SCI, V102, P653; DAWSON BA, 1988, DEV BIOL, V127, P362, DOI 10.1016/0012-1606(88)90322-3; Dieker J, 2012, TRAFFIC, V13, P257, DOI 10.1111/j.1600-0854.2011.01307.x; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FARZANEH F, 1982, NATURE, V300, P362, DOI 10.1038/300362a0; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; FORNACE AJ, 1986, CARCINOGENESIS, V7, P927, DOI 10.1093/carcin/7.6.927; FOURNEL S, 1995, FEBS LETT, V367, P188, DOI 10.1016/0014-5793(95)00532-E; FRANKFURT OS, 1987, EXP CELL RES, V170, P369, DOI 10.1016/0014-4827(87)90314-4; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Iglesias-Guimarais V, 2012, J BIOL CHEM, V287, P7766, DOI 10.1074/jbc.M111.290718; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Korn C, 2002, NUCLEIC ACIDS RES, V30, P1325, DOI 10.1093/nar/30.6.1325; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Larsen BD, 2010, CELL CYCLE, V9, P2940, DOI 10.4161/cc.9.15.12335; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Lechardeur D, 2004, J CELL BIOL, V167, P851, DOI 10.1083/jcb.200404105; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MODAK SP, 1972, EXP CELL RES, V75, P307, DOI 10.1016/0014-4827(72)90434-X; Nagase H, 2003, CELL DEATH DIFFER, V10, P142, DOI 10.1038/sj.cdd.4401139; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; PEITSCH MC, 1993, NUCLEIC ACIDS RES, V21, P4206, DOI 10.1093/nar/21.18.4206; Perez-Alvarez S, 2011, PHARMACOL RES, V63, P352, DOI 10.1016/j.phrs.2010.12.001; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Sakahira H, 2001, ARCH BIOCHEM BIOPHYS, V388, P91, DOI 10.1006/abbi.2000.2266; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; SEN S, 1992, BIOL REV, V67, P287, DOI 10.1111/j.1469-185X.1992.tb00727.x; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Sjakste N, 2007, EUR J HISTOCHEM, V51, P81; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Takahashi M, 2007, ONCOGENE, V26, P5669, DOI 10.1038/sj.onc.1210352; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Widlak P, 2002, J BIOL CHEM, V277, P21683, DOI 10.1074/jbc.M201027200; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Widlak P, 2001, MOL CELL BIOCHEM, V218, P125, DOI 10.1023/A:1007231822086; Widlak P, 2006, APOPTOSIS, V11, P1331, DOI 10.1007/s10495-006-6983-0; WILLIAMS GT, 1983, BIOSCIENCE REP, V3, P815, DOI 10.1007/BF01133780; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Woo EJ, 2004, MOL CELL, V14, P531, DOI 10.1016/S1097-2765(04)00258-8; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yamaguchi K, 2004, BIOCHEM BIOPH RES CO, V318, P710, DOI 10.1016/j.bbrc.2004.04.086; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zamzami N, 1999, NATURE, V401, P127, DOI 10.1038/43591	68	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9200	9215		10.1074/jbc.M112.411371	http://dx.doi.org/10.1074/jbc.M112.411371			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430749	hybrid, Green Published			2022-12-28	WOS:000316862200039
J	Leto, D; Uhm, M; Williams, A; Chen, XW; Saltiel, AR				Leto, Dara; Uhm, Maeran; Williams, Anja; Chen, Xiao-wei; Saltiel, Alan R.			Negative Regulation of the RalGAP Complex by 14-3-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; MEDIATED PHOSPHORYLATION; GLUT4 TRANSLOCATION; TUMOR-SUPPRESSOR; PLASMA-MEMBRANE; INSULIN; RAS; RALA; TSC2; BINDING	RGC1 and RGC2 comprise a functional RalGAP complex (RGC) that suppresses RalA activity. The PI3-kinase/Akt signaling pathway activates RalA through phosphorylation-mediated inhibition of the RGC. Here we identify a novel phosphorylation-dependent interaction between 14-3-3 and the RGC. 14-3-3 binds to the complex through an Akt-phosphorylated residue, threonine 715, on RGC2. Interaction with 14-3-3 does not alter in vitro activity of the GTPase-activating protein complex. However, blocking the interaction between 14-3-3 and RGC2 in cells increases suppression of RalA activity by the RGC, suggesting that 14-3-3 inhibits the complex through a non-catalytic mechanism. Together, these data show that 14-3-3 negatively regulates the RGC downstream of the PI3-kinase/Akt signaling pathway.	[Uhm, Maeran; Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	saltiel@umich.edu	Chen, Xiaowei/F-7026-2014; Saltiel, Alan/L-3632-2019	Chen, Xiao-Wei/0000-0001-6466-6248; Saltiel, Alan/0000-0002-9726-9828	National Institutes of Health Grant [DK076906]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076906, P30DK020572, R01DK061618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076906 (to A.R.S.).	Alan JK, 2010, MOL CELL BIOL, V30, P4324, DOI 10.1128/MCB.01646-09; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chen S, 2011, TRENDS ENDOCRIN MET, V22, P429, DOI 10.1016/j.tem.2011.07.005; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, CELL CYCLE, V10, P2299, DOI 10.4161/cc.10.14.16524; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Csepanyi-Komi R, 2012, MOL CELL ENDOCRINOL, V353, P10, DOI 10.1016/j.mce.2011.11.005; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Gridley S, 2005, CELL SIGNAL, V17, P59, DOI 10.1016/j.cellsig.2004.05.013; Hernandez-Munoz I, 2000, ONCOGENE, V19, P2745, DOI 10.1038/sj.onc.1203586; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kishida S, 1997, ONCOGENE, V15, P2899, DOI 10.1038/sj.onc.1201473; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tian XJ, 2002, EMBO J, V21, P1327, DOI 10.1093/emboj/21.6.1327; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	52	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9272	9283		10.1074/jbc.M112.426106	http://dx.doi.org/10.1074/jbc.M112.426106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386617	Green Published, hybrid			2022-12-28	WOS:000316862200045
J	Phillips, DD; Fattah, RJ; Crown, D; Zhang, Y; Liu, SH; Moayeri, M; Fischer, ER; Hansen, BT; Ghirlando, R; Nestorovich, EM; Wein, AN; Simons, L; Leppla, SH; Leysath, CE				Phillips, Damilola D.; Fattah, Rasem J.; Crown, Devorah; Zhang, Yi; Liu, Shihui; Moayeri, Mahtab; Fischer, Elizabeth R.; Hansen, Bryan T.; Ghirlando, Rodolfo; Nestorovich, Ekaterina M.; Wein, Alexander N.; Simons, Lacy; Leppla, Stephen H.; Leysath, Clinton E.			Engineering Anthrax Toxin Variants That Exclusively Form Octamers and Their Application to Targeting Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; PROTECTIVE ANTIGEN; LETHAL FACTOR; SEDIMENTATION-VELOCITY; MAMMALIAN-CELLS; PORE FORMATION; KINASE-KINASE; OLIGOMERIZATION; ULTRACENTRIFUGATION; INTERNALIZATION	Anthrax toxin protective antigen (PA) delivers its effector proteins into the host cell cytosol through formation of an oligomeric pore, which can assume heptameric or octameric states. By screening a highly directed library of PA mutants, we identified variants that complement each other to exclusively form octamers. These PA variants were individually nontoxic and demonstrated toxicity only when combined with their complementary partner. We then engineered requirements for activation by matrix metalloproteases and urokinase plasminogen activator into two of these variants. The resulting therapeutic toxin specifically targeted cells expressing both tumor associated proteases and completely stopped tumor growth in mice when used at a dose far below that which caused toxicity. This scheme for obtaining intercomplementing subunits can be employed with other oligomeric proteins and potentially has wide application.	[Phillips, Damilola D.; Fattah, Rasem J.; Crown, Devorah; Zhang, Yi; Liu, Shihui; Moayeri, Mahtab; Wein, Alexander N.; Simons, Lacy; Leppla, Stephen H.; Leysath, Clinton E.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Fischer, Elizabeth R.; Hansen, Bryan T.] NIAID, Electron Microscopy Unit, Res Technol Branch, NIH, Hamilton, MT 59840 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Nestorovich, Ekaterina M.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Catholic University of America	Leysath, CE (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	leysathce@niaid.nih.gov		Moayeri, Mahtab/0000-0002-4448-8883; Wein, Alex/0000-0002-8813-3523; Phillips, Damilola/0000-0002-3643-7111; Liu, Shihui/0000-0003-3444-1069	Intramural Research Program of NIAID from the National Institutes of Health; Intramural Research Program of NIDDK from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031, ZICAI001052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	Intramural Research Program of NIAID from the National Institutes of Health; Intramural Research Program of NIDDK from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Programs of NIAID and NIDDK from the National Institutes of Health.	Ahuja N, 2001, BIOCHEM BIOPH RES CO, V287, P542, DOI 10.1006/bbrc.2001.5613; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Boukari H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098106; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Czajkowsky DM, 1998, J MOL BIOL, V276, P325, DOI 10.1006/jmbi.1997.1535; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Dumetz F, 2011, AM J PATHOL, V178, P2523, DOI 10.1016/j.ajpath.2011.02.027; Feld GK, 2012, J MOL BIOL, V415, P159, DOI 10.1016/j.jmb.2011.10.035; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kintzer AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013888; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2005, NAT BIOTECHNOL, V23, P725, DOI 10.1038/nbt1091; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mogridge J, 2001, J BACTERIOL, V183, P2111, DOI 10.1128/JB.183.6.2111-2116.2001; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Singh Y, 1999, INFECT IMMUN, V67, P1853; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Varughese M, 1998, MOL MED, V4, P87, DOI 10.1007/BF03401732; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	32	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9058	9065		10.1074/jbc.M113.452110	http://dx.doi.org/10.1074/jbc.M113.452110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393143	Green Published, hybrid			2022-12-28	WOS:000316862200025
J	Zhao, X; Yang, B; Solakylidirim, K; Joo, EJ; Toida, T; Higashi, K; Linhardt, RJ; Li, LY				Zhao, Xue; Yang, Bo; Solakylidirim, Kemal; Joo, Eun Ji; Toida, Toshihiko; Higashi, Kyohei; Linhardt, Robert J.; Li, Lingyun			Sequence Analysis and Domain Motifs in the Porcine Skin Decorin Glycosaminoglycan Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMATAN SULFATE; IDURONIC ACID; COLLAGEN FIBRILS; BIOSYNTHESIS; LYASES; OLIGOSACCHARIDES; PROTEOGLYCANS; BIKUNIN	Decorin proteoglycan is comprised of a core protein containing a single O-linked dermatan sulfate/chondroitin sulfate glycosaminoglycan (GAG) chain. Although the sequence of the decorin core protein is determined by the gene encoding its structure, the structure of its GAG chain is determined in the Golgi. The recent application of modern MS to bikunin, a far simpler chondroitin sulfate proteoglycans, suggests that it has a single or small number of defined sequences. On this basis, a similar approach to sequence the decorin of porcine skin much larger and more structurally complex dermatan sulfate/chondroitin sulfate GAG chain was undertaken. This approach resulted in information on the consistency/variability of its linkage region at the reducing end of the GAG chain, its iduronic acid-rich domain, glucuronic acid-rich domain, and non-reducing end. A general motif for the porcine skin decorin GAG chain was established. A single small decorin GAG chain was sequenced using MS/MS analysis. The data obtained in the study suggest that the decorin GAG chain has a small or a limited number of sequences.	[Zhao, Xue] Ocean Univ China, Coll Food Sci & Technol, Qingdao 266003, Peoples R China; [Zhao, Xue; Yang, Bo; Solakylidirim, Kemal; Joo, Eun Ji; Linhardt, Robert J.; Li, Lingyun] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Toida, Toshihiko; Higashi, Kyohei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Ocean University of China; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Chiba University	Li, LY (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Biotechnol Bldg 4211, Troy, NY 12180 USA.	lil12@rpi.edu		Higashi, Kyohei/0000-0002-2622-4825	National Institutes of Heath [GM38060, HL096972, ES 020903]; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Heath Grants GM38060, HL096972, and ES 020903 (to R.J.L.) and by a grant from the China Scholarship Council (to X.Z.).	Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; Fansson LA, 2000, MATRIX BIOL, V19, P367, DOI 10.1016/S0945-053X(00)00083-4; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; GU KN, 1995, BIOCHEM J, V312, P569, DOI 10.1042/bj3120569; GU KN, 1993, CARBOHYD RES, V244, P369, DOI 10.1016/0008-6215(83)85014-9; Guidetti GF, 2004, FEBS LETT, V574, P95, DOI 10.1016/j.febslet.2004.08.011; Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x; Hocking AM, 1998, MATRIX BIOL, V17, P1; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; JANDIK KA, 1994, GLYCOBIOLOGY, V4, P289, DOI 10.1093/glycob/4.3.289; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P1175, DOI 10.1093/glycob/7.8.1175; Laremore TN, 2010, BIOCHEM J, V431, P199, DOI 10.1042/BJ20100788; Laremore TN, 2010, ANAL BIOCHEM, V401, P236, DOI 10.1016/j.ab.2010.03.004; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; LINHARDT RJ, 1995, GEN PHARMACOL-VASC S, V26, P443, DOI 10.1016/0306-3623(94)00231-B; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Ly M, 2011, ANAL BIOANAL CHEM, V399, P737, DOI 10.1007/s00216-010-3679-7; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; Malmstrom A., 2012, J HISTOCHEM CYTOCHEM; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Matsuda N, 2006, J NUTR SCI VITAMINOL, V52, P211, DOI 10.3177/jnsv.52.211; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Seidler DG, 2007, THESCIENTIFICWORLDJO, V7, P233, DOI 10.1100/tsw.2007.63; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Seidler DG, 2012, CURR OPIN STRUC BIOL, V22, P578, DOI 10.1016/j.sbi.2012.07.012; Seo NS, 2005, J BIOL CHEM, V280, P42774, DOI 10.1074/jbc.M511531200; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Solakyildirim K, 2010, ANAL BIOCHEM, V397, P24, DOI 10.1016/j.ab.2009.09.031; Tollefsen DM, 2010, PROG MOL BIOL TRANSL, V93, P351, DOI 10.1016/S1877-1173(10)93015-9; Watanabe T, 2012, J ANAT, V220, P156, DOI 10.1111/j.1469-7580.2011.01456.x; Wheatley DN, 2004, J BIOMED BIOTECHNOL, P211; Zamfir A, 2003, GLYCOBIOLOGY, V13, P733, DOI 10.1093/glycob/cwg086; Zamfir AD, 2009, PROTEOMICS, V9, P3435, DOI 10.1002/pmic.200800440; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813	46	20	21	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9226	9237		10.1074/jbc.M112.437236	http://dx.doi.org/10.1074/jbc.M112.437236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23423381	Green Published, hybrid			2022-12-28	WOS:000316862200041
J	Baranovic, J; Ramanujan, CS; Kasai, N; Midgett, CR; Madden, DR; Torimitsu, K; Ryan, JF				Baranovic, Jelena; Ramanujan, Chandra S.; Kasai, Nahoko; Midgett, Charles R.; Madden, Dean R.; Torimitsu, Keiichi; Ryan, John F.			Reconstitution of Homomeric GluA2(flop) Receptors in Supported Lipid Membranes FUNCTIONAL AND STRUCTURAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; IONOTROPIC GLUTAMATE RECEPTORS; PERMEABLE AMPA RECEPTOR; ACETYLCHOLINE-RECEPTOR; PROTEIN RECONSTITUTION; POTASSIUM CHANNEL; SINGLE; SOLUBILIZATION; VISUALIZATION; ARCHITECTURE	AMPA receptors (AMPARs) are glutamate-gated ion channels ubiquitous in the vertebrate central nervous system, where they mediate fast excitatory neurotransmission and act as molecular determinants of memory formation and learning. Together with detailed analyses of individual AMPAR domains, structural studies of full-length AMPARs by electron microscopy and x-ray crystallography have provided important insights into channel assembly and function. However, the correlation between the structure and functional states of the channel remains ambiguous particularly because these functional states can be assessed only with the receptor bound within an intact lipid bilayer. To provide a basis for investigating AMPAR structure in a membrane environment, we developed an optimized reconstitution protocol using a receptor whose structure has previously been characterized by electron microscopy. Single-channel recordings of reconstituted homomeric GluA2(flop) receptors recapitulate key electrophysiological parameters of the channels expressed in native cellular membranes. Atomic force microscopy studies of the reconstituted samples provide high-resolution images of membrane-embedded full-length AMPARs at densities comparable to those in postsynaptic membranes. The data demonstrate the effect of protein density on conformational flexibility and dimensions of the receptors and provide the first structural characterization of functional membrane-embedded AMPARs, thus laying the foundation for correlated structure-function analyses of the predominant mediators of excitatory synaptic signals in the brain.	[Ryan, John F.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Kasai, Nahoko; Torimitsu, Keiichi] NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Midgett, Charles R.; Madden, Dean R.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	University of Oxford; Nippon Telegraph & Telephone Corporation; Dartmouth College	Baranovic, J (corresponding author), Leibniz Inst Mol Pharmacol FMP, Campus Berlin Buch,Robert Rossle Str 10, D-13125 Berlin, Germany.	baranovic@fmp-berlin.de	TORIMITSU, KEIICHI/GQR-2299-2022; Torimitsu, Keiichi/AAE-4333-2019; Torimitsu, Keiichi/A-3078-2011	Baranovic, Jelena/0000-0003-2310-960X	Hitchcock Foundation; Medical Research Council, United Kingdom	Hitchcock Foundation; Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Hitchcock Foundation (to D. R. M.) and the Medical Research Council, United Kingdom (to J. B.).	BAHR BA, 1992, J NEUROCHEM, V59, P1979, DOI 10.1111/j.1471-4159.1992.tb11038.x; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; CORONADO R, 1983, BIOPHYS J, V43, P231, DOI 10.1016/S0006-3495(83)84343-4; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Jaroslawski S, 2007, J MOL BIOL, V374, P500, DOI 10.1016/j.jmb.2007.09.043; Jespersen LK, 2000, EUR J BIOCHEM, V267, P1382, DOI 10.1046/j.1432-1327.2000.01137.x; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kasai N, 2010, BBA-GEN SUBJECTS, V1800, P655, DOI 10.1016/j.bbagen.2010.03.002; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Madden Dean R, 2007, Methods Mol Biol, V363, P39, DOI 10.1007/978-1-59745-209-0_3; Mari SA, 2011, P NATL ACAD SCI USA, V108, P20802, DOI 10.1073/pnas.1111149108; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Midgett CR, 2008, J MOL BIOL, V382, P578, DOI 10.1016/j.jmb.2008.07.021; Midgett CR, 2012, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmol.2011.00056, 10.3389/fnmo1.2011.00056]; Momiyama A, 2003, J PHYSIOL-LONDON, V549, P75, DOI 10.1113/jphysiol.2002.033472; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292; Muller DJ, 1997, J STRUCT BIOL, V119, P149, DOI 10.1006/jsbi.1997.3878; Nakagawa T, 2006, BIOL CHEM, V387, P179, DOI 10.1515/BC.2006.024; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Rasband W., 2006, IMAGEJ; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Scheuring S, 2005, BBA-BIOMEMBRANES, V1712, P109, DOI 10.1016/j.bbamem.2005.04.005; Schurholz T, 1996, BIOPHYS CHEM, V58, P87, DOI 10.1016/0301-4622(95)00088-7; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Smith TC, 2000, J NEUROSCI, V20, P2073; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Suhara W, 2006, NEUROSCI LETT, V391, P102, DOI 10.1016/j.neulet.2005.08.066; Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Vaithianathan H, 2005, CELL BIOCHEM BIOPHYS, V42, P75, DOI 10.1385/CBB:42:1:075; VODYANOY V, 1993, NEUROSCI LETT, V150, P80, DOI 10.1016/0304-3940(93)90113-Y; Vuong N, 2010, CHEM PHYS LIPIDS, V163, P117, DOI 10.1016/j.chemphyslip.2009.09.003; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	48	4	4	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8647	8657		10.1074/jbc.M112.422105	http://dx.doi.org/10.1074/jbc.M112.422105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382380	hybrid, Green Published			2022-12-28	WOS:000316564500065
J	Brinkmann, CR; Jensen, L; Dagnaes-Hansen, F; Holm, IE; Endo, Y; Fujita, T; Thiel, S; Jensenius, JC; Degn, SE				Brinkmann, Christel R.; Jensen, Lisbeth; Dagnaes-Hansen, Frederik; Holm, Ida E.; Endo, Yuichi; Fujita, Teizo; Thiel, Steffen; Jensenius, Jens C.; Degn, Soren E.			Mitochondria and the Lectin Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING LECTIN; SERINE-PROTEASE (MASP)-1; H-FICOLIN; LYSOSOMAL DEGRADATION; ALTERNATIVE PATHWAY; APOPTOTIC CELLS; ACTIVATION; PURIFICATION; ASSOCIATION; DEFICIENCY	Mitochondria, the powerhouses of our cells, are remnants of a eubacterial endosymbiont. Notwithstanding the evolutionary time that has passed since the initial endosymbiotic event, mitochondria have retained many hallmarks of their eubacterial origin. Recent studies have indicated that during perturbations of normal homeostasis, such as following acute trauma leading to massive necrosis and release of mitochondria, the immune system might mistake symbiont for enemy and initiate an inappropriate immune response. The innate immune system is the first line of defense against invading microbial pathogens, and as such is the primary suspect in the recognition of mitochondria-derived danger-associated molecular patterns and initiation of an aberrant response. Conversely, innate immune mechanisms are also central to noninflammatory clearance of innocuous agents. Here we investigated the role of a central humoral component of innate immunity, the lectin pathway of complement, in recognition of mitochondria in vitro and in vivo. We found that the soluble pattern recognition molecules, mannan-binding lectin (MBL), L-ficolin, and M-ficolin, were able to recognize mitochondria. Furthermore, MBL in complex with MBL-associated serine protease 2 (MASP-2) was able to activate the lectin pathway and deposit C4 onto mitochondria, suggesting that these molecules are involved either in homeostatic clearance of mitochondria or in induction of untoward inflammatory reactions. We found that following mitochondrial challenge, C3 was consumed in vivo in the absence of overt inflammation, indicating a potential role of complement in noninflammatory clearance of mitochondria. Thus, we report here the first indication of involvement of the lectin pathway in mitochondrial immune handling.	[Thiel, Steffen; Jensenius, Jens C.; Degn, Soren E.] Aarhus Univ, Dept Biomed, Fac Hlth Sci, DK-8000 Aarhus C, Denmark; [Holm, Ida E.] Aarhus Univ, Inst Clin Med, DK-8000 Aarhus C, Denmark; [Holm, Ida E.] Randers Cent Hosp, Expt Neuropathol Lab, Dept Pathol, DK-8930 Randers NO, Denmark; [Endo, Yuichi; Fujita, Teizo] Fukushima Med Univ, Dept Immunol, Fukushima 9601295, Japan	Aarhus University; Aarhus University; Fukushima Medical University	Degn, SE (corresponding author), Aarhus Univ, Dept Biomed, Bartholin Bldg,Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	sdegn@microbiology.au.dk	Degn, Søren E/G-7936-2017	Degn, Søren E/0000-0001-5409-045X; Thiel, Steffen/0000-0002-4817-155X; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	This work was supported by a postdoctoral grant from the Carlsberg Foundation (to S.E.D.).	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; COMIS A, 1985, FEBS LETT, V185, P105, DOI 10.1016/0014-5793(85)80749-3; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dodds AW, 2002, IMMUNOBIOLOGY, V205, P340, DOI 10.1078/0171-2985-00137; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GLAUMANN H, 1975, LAB INVEST, V33, P239; GLAUMANN H, 1975, LAB INVEST, V33, P262; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Hirano S, 1996, AM J PHYSIOL-LUNG C, V270, pL836, DOI 10.1152/ajplung.1996.270.5.L836; Jensenius JC, 2003, BIOCHEM SOC T, V31, P763, DOI 10.1042/BST0310763; Kolln J, 2007, PROTEIN PEPTIDE LETT, V14, P475, DOI 10.2174/092986607780782795; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Peterslund NA, 2001, LANCET, V358, P637, DOI 10.1016/S0140-6736(01)05785-3; PINCKARD RN, 1975, J CLIN INVEST, V56, P740, DOI 10.1172/JCI108145; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schlapbach LJ, 2011, GUT, V60, P1438, DOI 10.1136/gut.2010.226027; Schlapbach LJ, 2009, MOL IMMUNOL, V46, P2597, DOI 10.1016/j.molimm.2009.05.003; Schmid M, 2012, IMMUNOBIOLOGY, V217, P610, DOI 10.1016/j.imbio.2011.10.020; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THIEL S, 1995, PEDIATR ALLERGY IMMU, V6, P20, DOI 10.1111/j.1399-3038.1995.tb00252.x; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	46	32	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8016	8027		10.1074/jbc.M112.430249	http://dx.doi.org/10.1074/jbc.M112.430249			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378531	Green Published, hybrid			2022-12-28	WOS:000316564500003
J	Chen, L; Brown, JW; Mok, YF; Hatters, DM; McKnight, CJ				Chen, Lin; Brown, Jeffrey W.; Mok, Yee-Foong; Hatters, Danny M.; McKnight, C. James			The Allosteric Mechanism Induced by Protein Kinase A (PKA) Phosphorylation of Dematin (Band 4.9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNA HEREDITARY HYPOTRICHOSIS; HUMAN ERYTHROID DEMATIN; ACTIN-BINDING; F-ACTIN; HEADPIECE DOMAIN; MEMBRANE; REVEALS; VILLIN; VISUALIZATION; PURIFICATION	Dematin (band 4.9) is an F-actin binding and bundling protein best known for its role within red blood cells, where it both stabilizes as well as attaches the spectrin/actin cytoskeleton to the erythrocytic membrane. Here, we investigate the structural consequences of phosphorylating serine 381, a covalent modification that turns off F-actin bundling activity. In contrast to the canonical doctrine, in which phosphorylation of an intrinsically disordered region/protein confers affinity for another domain/protein, we found the converse to be true of dematin: phosphorylation of the well folded C-terminal villin-type headpiece confers affinity for its intrinsically disordered N-terminal core domain. We employed analytical ultracentrifugation to demonstrate that dematin is monomeric, in contrast to the prevailing view that it is trimeric. Next, using a series of truncation mutants, we verified that dematin has two F-actin binding sites, one in the core domain and the other in the headpiece domain. Although the phosphorylation-mimicking mutant, S381E, was incapable of bundling microfilaments, it retains the ability to bind F-actin. We found that a phosphorylation-mimicking mutant, S381E, eliminated the ability to bundle, but not bind F-actin filaments. Lastly, we show that the S381E point mutant caused the headpiece domain to associate with the core domain, leading us to the mechanism for cAMP-dependent kinase control of dematin's F-actin bundling activity: when unphosphorylated, dematin's two F-actin binding domains move independent of one another permitting them to bind different F-actin filaments. Phosphorylation causes these two domains to associate, forming a compact structure, and sterically eliminating one of these F-actin binding sites.	[Chen, Lin; Brown, Jeffrey W.; McKnight, C. James] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Mok, Yee-Foong; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 2010, Australia; [Mok, Yee-Foong; Hatters, Danny M.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 2010, Australia	Boston University; University of Melbourne; University of Melbourne	McKnight, CJ (corresponding author), 700 Albany St,W302, Boston, MA 02118 USA.	cjmck@bu.edu	Brown, Jeffrey Wade/ABA-7141-2021	Brown, Jeffrey Wade/0000-0002-3992-9613; Hatters, Danny/0000-0002-9965-2847; McKnight, Christopher/0000-0002-3237-0896	National Institutes of Health [GM62886]; Boston University graduate student research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University graduate student research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62886 (to C. J. M.). This work was also supported by a Boston University graduate student research fellowship (to J. W. B.).	[Anonymous], 2004, PERS VIS RAYTR VERS; AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; Brown JW, 2010, ANAL BIOCHEM, V398, P117, DOI 10.1016/j.ab.2009.11.023; Brown JW, 2009, J MOL BIOL, V393, P608, DOI 10.1016/j.jmb.2009.08.018; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; Chen L, 2009, PROTEIN SCI, V18, P629, DOI 10.1002/pro.59; DERICK LH, 1992, EUR J CELL BIOL, V57, P317; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FAQUIN WC, 1988, EUR J CELL BIOL, V46, P168; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Frank BS, 2004, J BIOL CHEM, V279, P7909, DOI 10.1074/jbc.M310524200; Hampton CM, 2008, STRUCTURE, V16, P1882, DOI 10.1016/j.str.2008.09.015; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; HUSAINCHISHTI A, 1989, J BIOL CHEM, V264, P8985; HUSAINCHISHTI A, 1988, NATURE, V334, P718, DOI 10.1038/334718a0; Jiang ZHG, 2006, STRUCTURE, V14, P379, DOI 10.1016/j.str.2005.11.007; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Kim AC, 1997, GENOMICS, V46, P291, DOI 10.1006/geno.1997.5029; Koshino I, 2012, J BIOL CHEM, V287, P35244, DOI 10.1074/jbc.M111.305441; Lalle M, 2011, J BIOL CHEM, V286, P1227, DOI 10.1074/jbc.M110.194613; Lutchman M, 1999, CANCER GENET CYTOGEN, V115, P65, DOI 10.1016/S0165-4608(99)00081-3; Lutchman M, 2002, EUR J BIOCHEM, V269, P638, DOI 10.1046/j.0014-2956.2001.02694.x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mohseni M, 2008, MOL CELL BIOL, V28, P4712, DOI 10.1128/MCB.00237-08; Mohseni M, 2008, AM J HEMATOL, V83, P430, DOI 10.1002/ajh.21153; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RANA AP, 1993, P NATL ACAD SCI USA, V90, P6651, DOI 10.1073/pnas.90.14.6651; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SIEGEL DL, 1985, J CELL BIOL, V100, P775, DOI 10.1083/jcb.100.3.775; Sreekumar GP, 2000, J INVEST DERMATOL, V114, P595, DOI 10.1046/j.1523-1747.2000.114003595.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vardar D, 2002, CELL MOTIL CYTOSKEL, V52, P9, DOI 10.1002/cm.10027; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vocke CD, 1996, CANCER RES, V56, P2411; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	44	13	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8313	8320		10.1074/jbc.M112.438861	http://dx.doi.org/10.1074/jbc.M112.438861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23355471	hybrid, Green Published			2022-12-28	WOS:000316564500031
J	Danielsen, AA; Parker, MD; Lee, S; Boron, WF; Aalkjaer, C; Boedtkjer, E				Danielsen, Andreas A.; Parker, Mark D.; Lee, Soojung; Boron, Walter F.; Aalkjaer, Christian; Boedtkjer, Ebbe			Splice Cassette II of Na+, HCO3- Cotransporter NBCn1 (slc4a7) Interacts with Calcineurin A IMPLICATIONS FOR TRANSPORTER ACTIVITY AND INTRACELLULAR pH CONTROL DURING RAT ARTERY CONTRACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; ELECTRONEUTRAL SODIUM/BICARBONATE COTRANSPORTER; FUNCTIONAL-CHARACTERIZATION; BICARBONATE TRANSPORT; HOMOLOGOUS PROTEIN; CALCIUM; CHANNELS; HYPERTENSION; CYCLOSPORINE; CA2+-ATPASE	Activation of Na+, HCO3- cotransport in vascular smooth muscle cells (VSMCs) contributes to intracellular pH (pH(i)) control during artery contraction, but the signaling pathways involved have been unknown. We investigated whether physical and functional interactions between the Na+, HCO3- cotransporter NBCn1 (slc4a7) and the Ca2+/calmodulin-activated serine/threonine phosphatase calcineurin exist and play a role for pH(i) control in VSMCs. Using a yeast two-hybrid screen, we found that splice cassette II from the N terminus of NBCn1 interacts with calcineuri A beta. When cassette II was truncated or mutated to disrupt the putative calcineurin binding motif PTV-VIH, the interaction was abolished. Native NBCn1 and calcineurin A beta co-immunoprecipitated from A7r5 rat VSMCs. A peptide (acetyl-DDIPTVVIH-amide), which mimics the putative calcineurin binding motif, inhibited the co-immunoprecipitation whereas a mutated peptide (acetyl-DDIATAVAA-amide) did not. Na+, HCO3- cotransport activity was investigated in VSMCs of mesenteric arteries after an NH4+ prepulse. During depolarization with 50mM extracellular K+ to raise intracellular [Ca2+], Na+, HCO3- cotransport activity was inhibited 20-30% by calcineurin inhibitors (FK506 and cyclosporine A). FK506 did not affect Na+, HCO3- cotransport activity in VSMCs when cytosolic [Ca2+] was lowered by buffering, nor did it disrupt binding between NBCn1 and calcineuri A beta. FK506 augmented the intracellular acidification of VSMCs during norepinephrine-induced artery contractions. No physical or functional interactions between calcineurin A beta and the Na+/H+ exchanger NHE1 were observed in VSMCs. In conclusion, we demonstrate a physical interaction between calcineurin A beta and cassette II of NBCn1. Intracellular Ca2+ activates Na+, HCO3- cotransport activity in VSMCs in a calcineurin-dependent manner which is important for protection against intracellular acidification.	[Danielsen, Andreas A.; Lee, Soojung; Aalkjaer, Christian; Boedtkjer, Ebbe] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Danielsen, Andreas A.; Lee, Soojung; Aalkjaer, Christian; Boedtkjer, Ebbe] Aarhus Univ, Water & Salt Res Ctr, DK-8000 Aarhus C, Denmark; [Parker, Mark D.; Boron, Walter F.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Aarhus University; Aarhus University; Case Western Reserve University	Boedtkjer, E (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	eb@fi.au.dk	Boron, Walter/ABI-1564-2020; Parker, Mark/AAH-5575-2020; Boedtkjer, Ebbe/O-8449-2019; Boedtkjer, Ebbe/B-7315-2008	Boedtkjer, Ebbe/0000-0002-5078-9279; Boedtkjer, Ebbe/0000-0002-5078-9279; Aalkjaer, Christian/0000-0003-2618-4015; Boron, Walter/0000-0003-4741-7287	National Institutes of Health [K01DK082646, NS18400]; Danish National Research Foundation; Danish Council for Independent Research Grants [10-094816, 09-066609]; Lundbeck Foundation [R93-A8859]; Novo Nordisk Foundation; Lundbeck Foundation [R93-2011-8859] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research Grants; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Harindarpal S. Gill (who was supported by National Institutes of Health Grant K01DK082646) for providing the cassette II clone that was used as a PCR template in the construction of the yeast two-hybrid expression vector. The Water and Salt Research Center at Aarhus University was established and supported by the Danish National Research Foundation.; This work was supported, in whole or in part, by National Institutes of Health Grant NS18400 (to W.F.B.). This work was also supported by the Danish Council for Independent Research Grants 10-094816 (to E.B.) and 09-066609 (to C.A.), the Lundbeck Foundation Grant R93-A8859 (to E.B.), and the Novo Nordisk Foundation (to E.B.).	AALKJAER C, 1991, AM J PHYSIOL, V261, pC1010, DOI 10.1152/ajpcell.1991.261.6.C1010; AALKJAER C, 1991, J PHYSIOL-LONDON, V436, P57, DOI 10.1113/jphysiol.1991.sp018539; Aalkjaer C, 1988, Prog Biochem Pharmacol, V23, P150; Aalkjaer C., 2012, TRENDS CARDIOVASC S, VS1050-1738, P00324; ABERCROMBIE RF, 1986, AM J PHYSIOL, V250, pC391, DOI 10.1152/ajpcell.1986.250.3.C391; AHN K, 1992, P NATL ACAD SCI USA, V89, P8606, DOI 10.1073/pnas.89.18.8606; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BATLLE DC, 1993, AM J PHYSIOL, V264, pC932, DOI 10.1152/ajpcell.1993.264.4.C932; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Boedtkjer E, 2006, CIRC RES, V98, P515, DOI 10.1161/01.RES.0000204750.04971.76; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; Boedtkjer E, 2008, AM J PHYSIOL-CELL PH, V294, pC591, DOI 10.1152/ajpcell.00281.2007; Boedtkjer E, 2012, J VASC RES, V49, P479, DOI 10.1159/000341235; Boedtkjer E, 2012, J PHYSIOL-LONDON, V590, P1895, DOI 10.1113/jphysiol.2011.227132; Boedtkjer E, 2011, CIRCULATION, V124, P1819, DOI 10.1161/CIRCULATIONAHA.110.015974; Boedtkjer E, 2009, AM J PHYSIOL-HEART C, V296, pH247, DOI 10.1152/ajpheart.00725.2008; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Cooper DS, 2006, J BIOMED SCI, V13, P593, DOI 10.1007/s11373-006-9078-6; Cooper DS, 2005, J BIOL CHEM, V280, P17823, DOI 10.1074/jbc.M408646200; Damkier HH, 2006, AM J PHYSIOL-HEART C, V290, pH172, DOI 10.1152/ajpheart.00713.2005; DAUGIRDAS JT, 1995, J CLIN INVEST, V95, P1480, DOI 10.1172/JCI117819; EISNER DA, 1989, PFLUG ARCH EUR J PHY, V413, P553, DOI 10.1007/BF00594188; Epstein A, 1998, SURGERY, V123, P456, DOI 10.1016/S0039-6060(98)70168-0; Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503; FLEMING I, 1994, CIRC RES, V74, P1220, DOI 10.1161/01.RES.74.6.1220; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; KLOCKNER U, 1994, J GEN PHYSIOL, V103, P647, DOI 10.1085/jgp.103.4.647; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Maier LS, 2011, HEART RHYTHM, V8, P474, DOI 10.1016/j.hrthm.2010.09.080; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Naderali EK, 1997, J PHYSIOL-LONDON, V505, P329, DOI 10.1111/j.1469-7793.1997.329bb.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Park M, 2002, J BIOL CHEM, V277, P50503, DOI 10.1074/jbc.M201862200; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schubert R, 2001, J VASC RES, V38, P30, DOI 10.1159/000051027; Schuhmann K, 1997, J GEN PHYSIOL, V110, P503, DOI 10.1085/jgp.110.5.503; Shing CM, 2012, TRANSPL INT, V25, P337, DOI 10.1111/j.1432-2277.2011.01420.x; Yu LY, 2008, AM J RESP CRIT CARE, V177, P1276, DOI 10.1164/rccm.200710-1522OC	50	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8146	8155		10.1074/jbc.M113.455386	http://dx.doi.org/10.1074/jbc.M113.455386			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382378	hybrid, Green Published			2022-12-28	WOS:000316564500015
J	Heatley, SL; Pietra, G; Lin, J; Widjaja, JML; Harpur, CM; Lester, S; Rossjohn, J; Szer, J; Schwarer, A; Bradstock, K; Bardy, PG; Mingari, MC; Moretta, L; Sullivan, LC; Brooks, AG				Heatley, Susan L.; Pietra, Gabriella; Lin, Jie; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Lester, Sue; Rossjohn, Jamie; Szer, Jeff; Schwarer, Anthony; Bradstock, Kenneth; Bardy, Peter G.; Mingari, Maria Cristina; Moretta, Lorenzo; Sullivan, Lucy C.; Brooks, Andrew G.			Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BINDING-SPECIFICITY; SURFACE EXPRESSION; DIFFERENTIAL EXPRESSION; CD94/NKG2 RECEPTORS; NK RECEPTORS; LIGANDS; VARIABILITY; AFFINITIES; PROTECTION; EXPANSION	Natural killer (NK) cell recognition of the nonclassical human leukocyte antigen (HLA) molecule HLA-E is dependent on the presentation of a nonamer peptide derived from the leader sequence of other HLA molecules to CD94-NKG2 receptors. However, human cytomegalovirus can manipulate this central innate interaction through the provision of a "mimic" of the HLA-encoded peptide derived from the immunomodulatory glycoprotein UL40. Here, we analyzed UL40 sequences isolated from 32 hematopoietic stem cell transplantation recipients experiencing cytomegalovirus reactivation. The UL40 protein showed a "polymorphic hot spot" within the region that encodes the HLA leader sequence mimic. Although all sequences that were identical to those encoded within HLA-I genes permitted the interaction between HLA-E and CD94-NKG2 receptors, other UL40 polymorphisms reduced the affinity of the interaction between HLA-E and CD94-NKG2 receptors. Furthermore, functional studies using NK cell clones expressing either the inhibitory receptor CD94-NKG2A or the activating receptor CD94-NKG2C identified UL40-encoded peptides that were capable of inhibiting target cell lysis via interaction with CD94-NKG2A, yet had little capacity to activate NK cells through CD94-NKG2C. The data suggest that UL40 polymorphisms may aid evasion of NK cell immunosurveillance by modulating the affinity of the interaction with CD94-NKG2 receptors.	[Heatley, Susan L.; Lin, Jie; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Sullivan, Lucy C.; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Pietra, Gabriella; Mingari, Maria Cristina] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Lester, Sue] Queen Elizabeth Hosp, Dept Rheumatol, Woodville, SA 5011, Australia; [Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Szer, Jeff] Royal Melbourne Hosp, Dept Clin Haematol, Melbourne, Vic 3050, Australia; [Szer, Jeff] Royal Melbourne Hosp, Bone Marrow Transplant Serv, Melbourne, Vic 3050, Australia; [Schwarer, Anthony] Alfred Hosp, Malignant Haematol & Stem Cell Transplantat Serv, Melbourne, Vic 3004, Australia; [Bradstock, Kenneth] Westmead Hosp, Dept Haematol, Westmead, NSW 2145, Australia; [Bardy, Peter G.] Royal Adelaide Hosp, Canc Serv, Adelaide, SA 5000, Australia; [Mingari, Maria Cristina] IRCCS AOU San Martino IST, I-16132 Genoa, Italy; [Moretta, Lorenzo] Ist Giannina Gaslini, I-16147 Genoa, Italy	University of Melbourne; University of Genoa; Monash University; Royal Melbourne Hospital; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; University of Sydney; Royal Adelaide Hospital; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini	Brooks, AG (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	agbrooks@unimelb.edu.au	Moretta, Lorenzo/AAA-7239-2020; pietra, gabriella/J-7204-2016; Mingari, Maria Cristina/AAB-1315-2019; Rossjohn, Jamie/F-9032-2013; Heatley, Susan/AGP-2179-2022	Moretta, Lorenzo/0000-0003-4658-1747; pietra, gabriella/0000-0002-7080-531X; Rossjohn, Jamie/0000-0002-2020-7522; Widjaja, Jacqueline/0000-0002-4946-5584; Sullivan, Lucy/0000-0003-2907-4989; Brooks, Andrew/0000-0002-4085-9683; Heatley, Susan/0000-0001-7497-6477; Szer, Jeff/0000-0001-6783-2301; Harpur, Chris/0000-0002-3238-9861	National Health and Medical Research Council; Australia fellowship from the National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australia fellowship from the National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council, a career development award from the National Health and Medical Research Council (to L. C. S.), and an Australia fellowship from the National Health and Medical Research Council (to J. R.).	Bland FA, 2003, J BIOL CHEM, V278, P33747, DOI 10.1074/jbc.M305593200; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1999, J IMMUNOL, V162, P305; Brostjan C, 2002, J IMMUNOL METHODS, V264, P109, DOI 10.1016/S0022-1759(02)00084-4; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Corte MFD, 2010, J CLIN VIROL, V47, P161, DOI 10.1016/j.jcv.2009.11.023; Garrigue I, 2008, TRANSPLANTATION, V86, P826, DOI 10.1097/TP.0b013e3181859edd; Garrigue I, 2007, J CLIN VIROL, V40, P120, DOI 10.1016/j.jcv.2007.06.015; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; Kaiser BK, 2005, J IMMUNOL, V174, P2878, DOI 10.4049/jimmunol.174.5.2878; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Magri G, 2011, BLOOD, V117, P848, DOI 10.1182/blood-2010-08-301374; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; Miyasaka T, 2013, TISSUE ANTIGENS, V81, P72, DOI 10.1111/tan.12041; Miyasaka T, 2011, GENE, V472, P42, DOI 10.1016/j.gene.2010.10.007; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; POGGI A, 1990, J EXP MED, V172, P1409, DOI 10.1084/jem.172.5.1409; Prod'homme V, 2012, J IMMUNOL, V188, P2794, DOI 10.4049/jimmunol.1102068; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Vales-Gomez M, 2000, HUM IMMUNOL, V61, P28, DOI 10.1016/S0198-8859(99)00159-7; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	36	74	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8679	8690		10.1074/jbc.M112.409672	http://dx.doi.org/10.1074/jbc.M112.409672			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23335510	Green Published, hybrid			2022-12-28	WOS:000316564500068
J	Scopelliti, AJ; Ryan, RM; Vandenberg, RJ				Scopelliti, Amanda J.; Ryan, Renae M.; Vandenberg, Robert J.			Molecular Determinants for Functional Differences between Alanine-Serine-Cysteine Transporter 1 and Other Glutamate Transporter Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; SUBSTRATE; EXPRESSION; BINDING; CLONING; MECHANISM; MUTATION; SYSTEM; ASCT1; SITE	The ASCTs (alanine, serine, and cysteine transporters) belong to the solute carrier family 1 (SLC1), which also includes the human glutamate transporters (excitatory amino acid transporters, EAATs) and the prokaryotic aspartate transporter Glt(Ph). Despite the high degree of amino acid sequence identity between family members, ASCTs function quite differently from the EAATs and GltPh. The aim of this study was to mutate ASCT1 to generate a transporter with functional properties of the EAATs and GltPh, to further our understanding of the structural basis for the different transport mechanisms of the SLC1 family. We have identified three key residues involved in determining differences between ASCT1, the EAATs and Glt(Ph). ASCT1 transporters containing the mutations A382T, T459R, and Q386E were expressed in Xenopus laevis oocytes, and their transport and anion channel functions were investigated. A382T and T459R altered the substrate selectivity of ASCT1 to allow the transport of acidic amino acids, particularly L-aspartate. The combination of A382T and T459R within ASCT1 generates a transporter with a similar profile to that of Glt(Ph), with preference for L-aspartate over L-glutamate. Interestingly, the amplitude of the anion conductance activated by the acidic amino acids does not correlate with rates of transport, highlighting the distinction between these two processes. Q386E impaired the ability of ASCT1 to bind acidic amino acids at pH 5.5; however, this was reversed by the additional mutation A382T. We propose that these residues differences in TM7 and TM8 combine to determine differences in substrate selectivity between members of the SLC1 family.	[Scopelliti, Amanda J.; Ryan, Renae M.; Vandenberg, Robert J.] Univ Sydney, Discipline Pharmacol, Bosch Inst, Sch Med Sci, Sydney, NSW 2006, Australia	University of Sydney	Vandenberg, RJ (corresponding author), Univ Sydney, Discipline Pharmacol, Bosch Inst, Sch Med Sci, Sydney, NSW 2006, Australia.	robert.vandenberg@sydney.edu.au	Ryan, Renae/AAC-3540-2021; Vandenberg, Robert John/E-6018-2016	Ryan, Renae/0000-0002-8680-4610; Vandenberg, Robert John/0000-0003-1523-4814	Australian Research Council [DP1092729]; University of Sydney; John Lamberton scholarship; National Health and Medical Research Council [571093]	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney); John Lamberton scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Discovery Grant DP1092729 from the Australian Research Council.; Supported by a University of Sydney postgraduate award and a John Lamberton scholarship.; Supported by a National Health and Medical Research Council Career Development Fellowship 571093.	ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Broer A, 1999, J NEUROCHEM, V73, P2184; CHRISTENSEN HN, 1967, J BIOL CHEM, V242, P5237; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CONRADT M, 1995, J BIOL CHEM, V270, P25207, DOI 10.1074/jbc.270.42.25207; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Howard A, 2004, J NUTR, V134, P2957, DOI 10.1093/jn/134.11.2957; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Poulsen MV, 2001, J PHYSIOL-LONDON, V534, P159, DOI 10.1111/j.1469-7793.2001.00159.x; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Sakai K, 2003, J NEUROSCI, V23, P550; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Tamarappoo BK, 1996, BBA-BIOMEMBRANES, V1279, P131, DOI 10.1016/0005-2736(95)00259-6; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	32	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8250	8257		10.1074/jbc.M112.441022	http://dx.doi.org/10.1074/jbc.M112.441022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23393130	hybrid, Green Published			2022-12-28	WOS:000316564500025
J	Tsutakawa, SE; Shin, DS; Mol, CD; Izumi, T; Arvai, AS; Mantha, AK; Szczesny, B; Ivanov, IN; Hosfield, DJ; Maiti, B; Pique, ME; Frankel, KA; Hitomi, K; Cunningham, RP; Mitra, S; Tainer, JA				Tsutakawa, Susan E.; Shin, David S.; Mol, Clifford D.; Izumi, Tadahide; Arvai, Andrew S.; Mantha, Anil K.; Szczesny, Bartosz; Ivanov, Ivaylo N.; Hosfield, David J.; Maiti, Buddhadev; Pique, Mike E.; Frankel, Kenneth A.; Hitomi, Kenichi; Cunningham, Richard P.; Mitra, Sankar; Tainer, John A.			Conserved Structural Chemistry for Incision Activity in Structurally Non-homologous Apurinic/Apyrimidinic Endonuclease APE1 and Endonuclease IV DNA Repair Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC ENDONUCLEASE; THERMOTOGA-MARITIMA; SUBSTRATE RECOGNITION; PERIPLASMIC NUCLEASE; ABASIC ENDONUCLEASE; DAMAGE RECOGNITION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; EXONUCLEASE-III; SINGLE-TURNOVER	Non-coding apurinic/apyrimidinic (AP) sites in DNA form spontaneously and as DNA base excision repair intermediates are the most common toxic and mutagenic in vivo DNA lesion. For repair, APsites must be processed by 5' AP endonucleases in initial stages of base repair. Human APE1 and bacterial Nfo represent the two conserved 5' AP endonuclease families in the biosphere; they both recognize AP sites and incise the phosphodiester backbone 5' to the lesion, yet they lack similar structures and metal ion requirements. Here, we determined and analyzed crystal structures of a 2.4 angstrom resolution APE1-DNA product complex with Mg2+ and a 0.92 angstrom Nfo with three metal ions. Structural and biochemical comparisons of these two evolutionarily distinct enzymes characterize keyAPE1catalytic residues that are potentially functionally similar to Nfo active site components, as further tested and supported by computational analyses. We observe a magnesium-water cluster in the APE1 active site, with only Glu-96 forming the direct protein coordination to the Mg2+. Despite differences in structure and metal requirements of APE1 and Nfo, comparison of their active site structures surprisingly reveals strong geometric conservation of the catalytic reaction, with APE1 catalytic side chains positioned analogously to Nfo metal positions, suggesting surprising functional equivalence between Nfo metal ions and APE1 residues. The finding that APE1 residues are positioned to substitute for Nfo metal ions is supported by the impact of mutations on activity. Collectively, the results illuminate the activities of residues, metal ions, and active site features for abasic site endonucleases.	[Tsutakawa, Susan E.; Frankel, Kenneth A.; Hitomi, Kenichi; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Shin, David S.; Mol, Clifford D.; Arvai, Andrew S.; Hosfield, David J.; Pique, Mike E.; Hitomi, Kenichi; Tainer, John A.] Scripps Res Inst, La Jolla, CA 92037 USA; [Izumi, Tadahide] Univ Kentucky, Lexington, KY 40536 USA; [Izumi, Tadahide; Mantha, Anil K.; Szczesny, Bartosz; Mitra, Sankar] Univ Texas Med Branch, Galveston, TX 77555 USA; [Ivanov, Ivaylo N.; Maiti, Buddhadev] Georgia State Univ, Atlanta, GA 30302 USA; [Hitomi, Kenichi] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Cunningham, Richard P.] SUNY Albany, Albany, NY 12222 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute; University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University System of Georgia; Georgia State University; Osaka University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Tainer, JA (corresponding author), Lawrence Berkeley Natl Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA USA.	JATainer@lbl.gov	Ivanov, Ivaylo/A-7613-2013; Mantha, Anil/AAM-5035-2021; Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Ivanov, Ivaylo/0000-0002-5306-1005; Tainer, John/0000-0003-1659-2429; Tsutakawa, Susan/0000-0002-4918-4571	National Institutes of Health (NIH), NCI [P01 CA92584]; NIH, NIGMS [GM046312, CA053791]; National Science Foundation Career Award [MCB-1149521]; Howard Hughes Medical Institute; Department of Energy [DE-AC02-05CH11231]; Department of Energy (Office of Biological and Environmental Research); NIH (National Center for Research Resources), Biomedical Technology Program; NIH (NIGMS); Japan Society for the Promotion of Science fellowship; Skaggs Institute for Chemical Biology; Direct For Biological Sciences [1149521] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA158910, P01CA092584, R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046312] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Career Award(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Energy(United States Department of Energy (DOE)); Department of Energy (Office of Biological and Environmental Research)(United States Department of Energy (DOE)); NIH (National Center for Research Resources), Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Japan Society for the Promotion of Science fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Skaggs Institute for Chemical Biology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant P01 CA92584 and NIH, NIGMS, Grants GM046312 and CA053791 (for work on APE1 and Nfo). Work on APE1 and Nfo was also supported by National Science Foundation Career Award MCB-1149521. The Berkeley Center for Structural Biology is supported in part by NIH, NIGMS, and the Howard Hughes Medical Institute none of the authors are hhmi. The Advanced Light Source is supported under Department of Energy Contract DE-AC02-05CH11231. The Stanford Synchrotron Radiation Laboratory is supported by the Department of Energy (Office of Biological and Environmental Research), NIH (National Center for Research Resources), Biomedical Technology Program, and NIH (NIGMS).; Supported in part by a Japan Society for the Promotion of Science fellowship and by the Skaggs Institute for Chemical Biology.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aramini JM, 2004, J MOL BIOL, V338, P77, DOI 10.1016/j.jmb.2004.02.035; Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; Barondeau DP, 2004, BIOCHEMISTRY-US, V43, P8038, DOI 10.1021/bi0496081; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Castillo-Acosta VM, 2009, NUCLEIC ACIDS RES, V37, P1829, DOI 10.1093/nar/gkp021; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Dupureur C.M, 2008, CURR CHEM BIOL, V2, P159; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Haas BJ, 1999, J BACTERIOL, V181, P2834, DOI 10.1128/JB.181.9.2834-2839.1999; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Ho MH, 2010, J AM CHEM SOC, V132, P13702, DOI 10.1021/ja102933y; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Horton NC, 1998, P NATL ACAD SCI USA, V95, P13489, DOI 10.1073/pnas.95.23.13489; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2005, MOL CELL BIOL, V25, P6380, DOI 10.1128/MCB.25.15.6380-6390.2005; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Ivanov I, 2007, P NATL ACAD SCI USA, V104, P1465, DOI 10.1073/pnas.0603468104; Izumi T, 1999, J MOL BIOL, V287, P47, DOI 10.1006/jmbi.1999.2573; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kerins SM, 2003, J BIOL CHEM, V278, P3048, DOI 10.1074/jbc.M210750200; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KUHN LA, 1992, J MOL BIOL, V228, P13, DOI 10.1016/0022-2836(92)90487-5; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; LEVIN JD, 1988, J BIOL CHEM, V263, P8066; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lipton AS, 2008, J AM CHEM SOC, V130, P9332, DOI 10.1021/ja0776881; LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6; Lowry DF, 2003, J MOL BIOL, V329, P311, DOI 10.1016/S0022-2836(03)00382-6; Lucas JA, 1999, BIOCHEMISTRY-US, V38, P4958, DOI 10.1021/bi982052v; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Malygin EG, 2001, MOL BIOL+, V35, P35, DOI 10.1023/A:1004846600495; Mantha AK, 2008, J MOL BIOL, V379, P28, DOI 10.1016/j.jmb.2008.03.052; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; McMurray CT, 2003, NAT GENET, V34, P239, DOI 10.1038/ng0703-239; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Mundle ST, 2009, BIOCHEMISTRY-US, V48, P19, DOI 10.1021/bi8016137; Mundle ST, 2004, DNA REPAIR, V3, P1447, DOI 10.1016/j.dnarep.2004.06.009; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NESTLE M, 1969, J BIOL CHEM, V244, P5219; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Oezguen N, 2011, BIOINFORMATION, V7, P184; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Rothwell DG, 1996, NUCLEIC ACIDS RES, V24, P4217, DOI 10.1093/nar/24.21.4217; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Tomanicek SJ, 2010, ACTA CRYSTALLOGR F, V66, P1003, DOI 10.1107/S1744309110028575; Tomlinson CG, 2011, J BIOL CHEM, V286, P30878, DOI 10.1074/jbc.M111.230391; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Tsutakawa SE, 1999, CELL, V99, P615, DOI 10.1016/S0092-8674(00)81550-0; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wu SI, 2001, APPL ENVIRON MICROB, V67, P82, DOI 10.1128/AEM.67.1.82-88.2001; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502	87	79	81	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8445	8455		10.1074/jbc.M112.422774	http://dx.doi.org/10.1074/jbc.M112.422774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23355472	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000316564500042
J	Xiao, XW; Guo, P; Chen, Z; El-Gohary, Y; Wiersch, J; Gaffar, I; Prasadan, K; Shiota, C; Gittes, GK				Xiao, Xiangwei; Guo, Ping; Chen, Zean; El-Gohary, Yousef; Wiersch, John; Gaffar, Iljana; Prasadan, Krishna; Shiota, Chiyo; Gittes, George K.			Hypoglycemia Reduces Vascular Endothelial Growth Factor A Production by Pancreatic Beta Cells as a Regulator of Beta Cell Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LASER CAPTURE MICRODISSECTION; VEGF-A; GENE-EXPRESSION; ISLETS; REVASCULARIZATION; DIFFERENTIATION; CONTRIBUTE; INDUCTION; LETHALITY; INCREASES	VEGF-A expression in beta cells is critical for pancreatic development, formation of islet-specific vasculature, and Insulin secretion. However, two key questions remain. First, is VEGF-A release from beta cells coupled to VEGF-A production in beta cells? Second, how is the VEGF-A response by beta cells affected by metabolic signals? Here, we show that VEGF-A secretion, but not gene transcription, in either cultured islets or purified pancreatic beta cells, was significantly reduced early on during low glucose conditions. In vivo, a sustained hypoglycemia in mice was induced with Insulin pellets, resulting in a significant reduction in beta cell mass. This loss of beta cell mass could be significantly rescued with continuous delivery of exogenous VEGF-A, which had no effect on beta cell mass in normoglycemic mice. In addition, an increase in apoptotic endothelial cells during hypoglycemia preceded an increase in apoptotic beta cells. Both endothelial and beta cell apoptosis were prevented by exogenous VEGF-A, suggesting a possible causative relationship between reduced VEGF-A and the loss of islet vasculature and beta cells. Furthermore, in none of these experimental groups did beta cell proliferation and islet vessel density change, suggesting a tightly regulated balance between these two cellular compartments. The average islet size decreased in hypoglycemia, which was also prevented by exogenous VEGF-A. Taken together, our data suggest that VEGF-A release in beta cells is independent of VEGF-A synthesis. Beta cell mass can be regulated through modulated release of VEGF-A from beta cells based on physiological need.	[Xiao, Xiangwei; Guo, Ping; Chen, Zean; El-Gohary, Yousef; Wiersch, John; Gaffar, Iljana; Prasadan, Krishna; Shiota, Chiyo; Gittes, George K.] Univ Pittsburgh, Div Pediat Surg, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gittes, GK (corresponding author), 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gittesgk@upmc.edu	xiao, xiangwei/K-1218-2012	El-Gohary, Yousef/0000-0002-8655-0948; Xiao, Xiangwei/0000-0003-0890-9203	National Institutes of Health [RO1 DK064952, R01 DK083541]; Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083541, R01DK064952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK064952 and R01 DK083541 (to G. K. G.) and the Children's Hospital of Pittsburgh.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Akirav EM, 2011, DIABETES, V60, P876, DOI 10.2337/db10-0793; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Cai Q, 2012, DEV BIOL, V367, P40, DOI 10.1016/j.ydbio.2012.04.022; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen Z., 2013, J CLIN INVE IN PRESS; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; CHRISTOFORI G, 1995, MOL ENDOCRINOL, V9, P1760, DOI 10.1210/me.9.12.1760; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Cleaver O, 2012, DEVELOPMENT, V139, P2833, DOI 10.1242/dev.065953; Darland DC, 2011, DEV BIOL, V358, P9, DOI 10.1016/j.ydbio.2011.06.045; Eichler W, 2000, NEUROREPORT, V11, P3533, DOI 10.1097/00001756-200011090-00026; El-Gohary Y, 2012, ANAT REC, V295, P1473, DOI 10.1002/ar.22530; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Magenheim J, 2011, DEVELOPMENT, V138, P4743, DOI 10.1242/dev.066548; Marselli L, 2009, METHODS MOL BIOL, V560, P87, DOI 10.1007/978-1-59745-448-3_8; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Vasir B, 1998, DIABETES, V47, P1894, DOI 10.2337/diabetes.47.12.1894; Wada T, 2006, J NEUROSCI, V26, P6803, DOI 10.1523/JNEUROSCI.0526-06.2006; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428	41	77	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8636	8646		10.1074/jbc.M112.422949	http://dx.doi.org/10.1074/jbc.M112.422949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378532	Green Published, hybrid			2022-12-28	WOS:000316564500064
J	Bowers, PM; Neben, TY; Tomlinson, GL; Dalton, JL; Altobell, L; Zhang, X; Macomber, JL; Wu, BF; Toobian, RM; McConnell, AD; Verdino, P; Chau, B; Horlick, RA; King, DJ				Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Dalton, Jennifer L.; Altobell, Larry; Zhang, Xue; Macomber, John L.; Wu, Betty F.; Toobian, Rachelle M.; McConnell, Audrey D.; Verdino, Petra; Chau, Betty; Horlick, Robert A.; King, David J.			Humanization of Antibodies Using Heavy Chain Complementarity-determining Region 3 Grafting Coupled with in Vitro Somatic Hypermutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; AFFINITY MATURATION; COMPUTATIONAL DESIGN; SURFACE DISPLAY; MOUSE; CELLS; GENERATION; SEQUENCES; SELECTION; PROTEINS	A method for simultaneous humanization and affinity maturation of monoclonal antibodies has been developed using heavy chain complementarity-determining region (CDR) 3 grafting combined with somatic hypermutation in vitro. To minimize the amount of murine antibody-derived antibody sequence used during humanization, only the CDR3 region from a murine antibody that recognizes the cytokine h beta NGF was grafted into a nonhomologous human germ line V region. The resulting CDR3-grafted HC was paired with a CDR-grafted light chain, displayed on the surface of HEK293 cells, and matured using in vitro somatic hypermutation. A high affinity humanized antibody was derived that was considerably more potent than the parental antibody, possessed a low pM dissociation constant, and demonstrated potent inhibition of h beta NGF activity in vitro. The resulting antibody contained half the heavy chain murine donor sequence compared with the same antibody humanized using traditional methods.	[Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Dalton, Jennifer L.; Altobell, Larry; Zhang, Xue; Macomber, John L.; Wu, Betty F.; Toobian, Rachelle M.; McConnell, Audrey D.; Verdino, Petra; Chau, Betty; Horlick, Robert A.; King, David J.] Anaptysbio Inc, San Diego, CA 92131 USA		Bowers, PM (corresponding author), AnaptysBio Inc, Prot Engn & Computat Biol, 10421 Pacific Ctr Ct,Ste 200, San Diego, CA 92121 USA.	pbowers@anaptysbio.com			Anaptysbio Inc.	Anaptysbio Inc.	All authors associated with this manuscript work for Anaptysbio Inc. and receive a salary, stock, and/or stock options as part of their employment. The scientific work presented in this paper is one part of the Anaptysbio platform and technology.	Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Baca M, 1997, J BIOL CHEM, V272, P10678; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; Cattaneo A, 2005, Patent, Patent No. [WO/2005/061540, 2005061540]; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Covaceuszach S, 2008, J MOL BIOL, V381, P881, DOI 10.1016/j.jmb.2008.06.008; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Lazar GA, 2007, MOL IMMUNOL, V44, P1986, DOI 10.1016/j.molimm.2006.09.029; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; McConnell AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049458; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; ROGERS J, 1981, CELL, V26, P19, DOI 10.1016/0092-8674(81)90029-5; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Tan P, 2002, J IMMUNOL, V169, P1119, DOI 10.4049/jimmunol.169.2.1119; Van den Brulle J, 2008, BIOTECHNIQUES, V45, P340, DOI 10.2144/000112953; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; Zheng NY, 2005, J EXP MED, V201, P1467, DOI 10.1084/jem.20042483	33	16	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7688	7696		10.1074/jbc.M112.445502	http://dx.doi.org/10.1074/jbc.M112.445502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355464	hybrid, Green Published			2022-12-28	WOS:000316455300025
J	Fu, HL; Valiathan, RR; Arkwright, R; Sohail, A; Mihai, C; Kumarasiri, M; Mahasenan, KV; Mobashery, S; Huang, P; Agarwal, G; Fridman, R				Fu, Hsueh-Liang; Valiathan, Rajeshwari R.; Arkwright, Richard; Sohail, Anjum; Mihai, Cosmin; Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar; Huang, Paul; Agarwal, Gunjan; Fridman, Rafael			Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MAMMARY-GLAND DEVELOPMENT; CELL-MIGRATION; ACTIVATION; DDR1; CANCER; BINDING; INHIBITION; PROTEIN; GROWTH; SRC	The discoidin domain receptors (DDRs) are receptor tyrosine kinases that recognize collagens as their ligands. DDRs display unique structural features and distinctive activation kinetics, which set them apart from other members of the kinase superfamily. DDRs regulate cell-collagen interactions in normal and pathological conditions and thus are emerging as major sensors of collagen matrices and potential novel therapeutic targets. New structural and biological information has shed light on the molecular mechanisms that regulate DDR signaling, turnover, and function. This minireview provides an overview of these areas of DDR research with the goal of fostering further investigation of these intriguing and unique receptors.	[Fu, Hsueh-Liang; Valiathan, Rajeshwari R.; Arkwright, Richard; Sohail, Anjum; Fridman, Rafael] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Mihai, Cosmin; Agarwal, Gunjan] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mihai, Cosmin; Agarwal, Gunjan] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Huang, Paul] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England	Wayne State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Notre Dame; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Fridman, R (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.	rfridman@med.wayne.edu	Huang, Paul H./H-8591-2015; Agarwal, Gunjan/E-2616-2011	Huang, Paul H./0000-0003-3972-5087; Sohail, Anjum/0000-0001-5567-9645; Agarwal, Gunjan/0000-0003-3731-2107	National Institutes of Health from NCI [CA61986]; NATIONAL CANCER INSTITUTE [R01CA061986] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I014276/1] Funding Source: researchfish; BBSRC [BB/I014276/1] Funding Source: UKRI	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant CA61986 from NCI (to R. F.).	Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; Abella JV, 2009, AM J PHYSIOL-ENDOC M, V296, pE973, DOI 10.1152/ajpendo.90857.2008; Agarwal G, 2002, BIOCHEMISTRY-US, V41, P11091, DOI 10.1021/bi020087w; Agarwal G, 2007, J MOL BIOL, V367, P443, DOI 10.1016/j.jmb.2006.12.073; ALVES F, 1995, ONCOGENE, V10, P609; Alves F, 2001, FASEB J, V15, P1321, DOI 10.1096/fj.00-0626fje; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bertrand T, 2012, J MOL BIOL, V423, P439, DOI 10.1016/j.jmb.2012.08.002; Bhadriraju K, 2009, BIOMATERIALS, V30, P6687, DOI 10.1016/j.biomaterials.2009.08.036; Bogdanovic O, 2012, DEV CELL, V23, P782, DOI 10.1016/j.devcel.2012.09.004; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Curat CA, 2002, J AM SOC NEPHROL, V13, P2648, DOI 10.1097/01.ASN.0000032419.13208.0C; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Dejmek J, 2003, INT J CANCER, V103, P344, DOI 10.1002/ijc.10752; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; DIMARCO E, 1993, J BIOL CHEM, V268, P24290; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Ferri N, 2004, AM J PATHOL, V164, P1575, DOI 10.1016/S0002-9440(10)63716-9; Flynn LA, 2010, J MOL BIOL, V395, P533, DOI 10.1016/j.jmb.2009.10.073; Foehr ED, 2000, FASEB J, V14, P973, DOI 10.1096/fasebj.14.7.973; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Huang PH, 2012, MOL BIOSYST, V8, P1100, DOI 10.1039/c1mb05327b; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Ikeda K, 2002, J BIOL CHEM, V277, P19206, DOI 10.1074/jbc.M201078200; Ith B, 2005, GENE EXPR PATTERNS, V5, P533, DOI 10.1016/j.modgep.2004.11.002; Iwai LK, 2013, CELL ADHES MIGR, V7, P161, DOI 10.4161/cam.22572; Jansson M, 2001, J CELL SCI, V114, P2043; Jin P, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2447; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P5677, DOI 10.1073/pnas.90.12.5677; Kano K, 2008, MOL ENDOCRINOL, V22, P1866, DOI 10.1210/me.2007-0310; Kano K, 2010, MOL REPROD DEV, V77, P29, DOI 10.1002/mrd.21093; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo DHH, 2006, FEBS LETT, V580, P15, DOI 10.1016/j.febslet.2005.11.035; L'hote CGML, 2001, FASEB J, V15, P234, DOI 10.1096/fj.01-0414fje; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; LAVAL S, 1994, CELL GROWTH DIFFER, V5, P1173; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lemeer S, 2012, J PROTEOMICS, V75, P3465, DOI 10.1016/j.jprot.2011.10.007; Lu KK, 2011, CARDIOVASC PATHOL, V20, P71, DOI 10.1016/j.carpath.2009.12.006; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Olaso E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-5; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Perez JL, 1996, ONCOGENE, V12, P1469; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; SANCHEZ MP, 1994, P NATL ACAD SCI USA, V91, P1819, DOI 10.1073/pnas.91.5.1819; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Sivakumar L, 2010, BIOMATERIALS, V31, P4802, DOI 10.1016/j.biomaterials.2010.02.070; Slack BE, 2006, J CELL BIOCHEM, V98, P672, DOI 10.1002/jcb.20812; Suh HN, 2011, J CELL PHYSIOL, V226, P3422, DOI 10.1002/jcp.22697; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2002, FEBS LETT, V514, P175, DOI 10.1016/S0014-5793(02)02360-8; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Wall SJ, 2005, J BIOL CHEM, V280, P40187, DOI 10.1074/jbc.M508226200; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Yang G, 2009, PROTEOMICS, V9, P4944, DOI 10.1002/pmic.200800762; Yang K, 2005, J BIOL CHEM, V280, P39058, DOI 10.1074/jbc.M506921200; Yeh YC, 2012, AM J PHYSIOL-CELL PH, V303, pC1207, DOI 10.1152/ajpcell.00253.2012; Yeh YC, 2009, J CELL PHYSIOL, V218, P146, DOI 10.1002/jcp.21578; ZERLIN M, 1993, ONCOGENE, V8, P2731; Zhang H, 2012, CELL SIGNAL, V24, P1173, DOI 10.1016/j.cellsig.2012.01.017; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	94	135	138	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7430	7437		10.1074/jbc.R112.444158	http://dx.doi.org/10.1074/jbc.R112.444158			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23335507	Green Published, hybrid			2022-12-28	WOS:000316455300001
J	Lolis, AA; Londhe, P; Beggs, BC; Byrum, SD; Tackett, AJ; Davie, JK				Lolis, Alexandra A.; Londhe, Priya; Beggs, Benjamin C.; Byrum, Stephanie D.; Tackett, Alan J.; Davie, Judith K.			Myogenin Recruits the Histone Chaperone Facilitates Chromatin Transcription (FACT) to Promote Nucleosome Disassembly at Muscle-specific Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GROUP BOX PROTEIN; MYOD; DNA; EXPRESSION; COMPLEX; BINDING; DIFFERENTIATION; ACTIVATION; SPT16	Facilitates chromatin transcription (FACT) functions to reorganize nucleosomes by acting as a histone chaperone that destabilizes and restores nucleosomal structure. The FACT complex is composed of two subunits: SSRP1 and SPT16. We have discovered that myogenin interacts with the FACT complex. Transfection of FACT subunits with myogenin is highly stimulatory for endogenous muscle gene expression in 10T1/2 cells. We have also found that FACT subunits do not associate with differentiation-specific genes while C2C12 cells are proliferating but are recruited to muscle-specific genes as differentiation initiates and then dissociate as differentiation proceeds. The recruitment is dependent on myogenin, as knockdowns of myogenin show no recruitment of the FACT complex. These data suggest that FACT is involved in the early steps of gene activation through its histone chaperone activities that serve to open the chromatin structure and facilitate transcription. Consistent with this hypothesis, we find that nucleosomes are depleted at muscle-specific promoters upon differentiation and that this activity is dependent on the presence of FACT. Our results show that the FACT complex promotes myogenin-dependent transcription and suggest that FACT plays an important role in the establishment of the appropriate transcription profile in a differentiated muscle cell.	[Lolis, Alexandra A.; Londhe, Priya; Beggs, Benjamin C.; Davie, Judith K.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; [Lolis, Alexandra A.; Londhe, Priya; Beggs, Benjamin C.; Davie, Judith K.] So Illinois Univ, Sch Med, Simmons Canc Inst, Carbondale, IL 62901 USA; [Byrum, Stephanie D.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Arkansas System; University of Arkansas Medical Sciences	Davie, JK (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	jdavie@siumed.edu			National Institute of Health [R01DA025755, F32GM093614, UL1RR029884, P30GM103450, P20GM103429]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR060017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450, F32GM093614, P20GM103429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025755] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute of Health Grants R01DA025755, F32GM093614, UL1RR029884, P30GM103450, and P20GM103429.	Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Byrum S, 2012, METHODS MOL BIOL, V833, P143, DOI 10.1007/978-1-61779-477-3_10; Byrum S, 2011, J CUTAN PATHOL, V38, P933, DOI 10.1111/j.1600-0560.2011.01761.x; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Garcia H, 2011, ONCOTARGET, V2, P783; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kihara T, 2008, EXP CELL RES, V314, P629, DOI 10.1016/j.yexcr.2007.10.004; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pollard JW, 1997, BASIC CELL CULTURE P; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Tai PWL, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-25; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Vethantham V, 2012, MOL CELL BIOL, V32, P1044, DOI 10.1128/MCB.06026-11; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200	50	22	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7676	7687		10.1074/jbc.M112.426718	http://dx.doi.org/10.1074/jbc.M112.426718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23364797	hybrid, Green Published			2022-12-28	WOS:000316455300024
J	Chae, M; Carman, GM				Chae, Minjung; Carman, George M.			Characterization of the Yeast Actin Patch Protein App1p Phosphatidate Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; CYTIDINE DIPHOSPHATE CHOLINE; PHOSPHOLIPASE-D ACTIVITY; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; TRITON X-100; KINETIC-ANALYSIS; ENZYMATIC-SYNTHESIS; MIXED MICELLES; KINASE-C	Yeast App1p is a phosphatidate phosphatase (PAP) that associates with endocytic proteins at cortical actin patches. App1p, which catalyzes the conversion of phosphatidate (PA) to diacylglycerol, is unique among Mg2+-dependent PAP enzymes in that its reaction is not involved with de novo lipid synthesis. Instead, App1p PAP is thought to play a role in endocytosis because its substrate and product facilitate membrane fission/fusion events and regulate enzymes that govern vesicular movement. App1p PAP was purified from yeast and characterized with respect to its enzymological, kinetic, and regulatory properties. Maximum PAP activity was dependent on Triton X-100 (20mM), PA (2mM), Mg2+ (0.5mM), and 2-mercaptoethanol (10 mM) at pH 7.5 and 30 degrees C. Analysis of surface dilution kinetics with Triton X-100/PA-mixed micelles yielded constants for surface binding (K-s(A) = 11mM), interfacialPAbinding (K-m(B) = 4.2 mol %), and catalytic efficiency (V-max = 557 mu mol/min/mg). The activation energy, turnover number, and equilibrium constant were 16.5 kcal/mol, 406 s(-1), and 16.2, respectively. PAP activity was stimulated by anionic lipids (cardiolipin, phosphatidylglycerol, phosphatidylserine, and CDP-diacylglycerol) and inhibited by zwitterionic (phosphatidylcholine and phosphatidyl-ethanolamine) and cationic (sphinganine) lipids, nucleotides (ATP and CTP), N-ethylmaleimide, propranolol, phenylglyoxal, and divalent cations (Ca2+, Mn2+, and Zn2+). App1p also utilized diacylglycerol pyrophosphate and lyso-PA as substrates with specificity constants 4- and 7-fold lower, respectively, when compared with PA.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health [GM-28140, NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140.; We thank Gil-Soo Han for helpful comments during the course of this work and in the preparation of the manuscript. The mass spectrometry data were obtained from an Orbitrap instrument funded in part by National Institutes of Health Grant NS046593, for the support of the University of Medicine and Dentistry of New Jersey Neuroproteomics Core Facility.	Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; BAELEE M, 1990, J BIOL CHEM, V265, P7221; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BHAT BG, 1994, J BIOL CHEM, V269, P13172; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BUXEDA RJ, 1991, J BIOL CHEM, V266, P13859; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1979, J BIOL CHEM, V254, P8391; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Das A, 2006, MOL BIOCHEM PARASIT, V150, P201, DOI 10.1016/j.molbiopara.2006.08.002; DAVIDSON JB, 1971, BIOCHEM BIOPH RES CO, V42, P1191, DOI 10.1016/0006-291X(71)90032-5; Dawson Rex M.C., 1986, DATA BIOCH RES; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HJELMSTAD RH, 1991, BIOCHEMISTRY-US, V30, P1731, DOI 10.1021/bi00221a001; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jain MR, 2012, J PROTEOME RES, V11, P1791, DOI 10.1021/pr201043u; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; JONES GA, 1993, J BIOL CHEM, V268, P20845; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KIYASU JY, 1963, J BIOL CHEM, V238, P2293; Kocsis MG, 1996, LIPIDS, V31, P785, DOI 10.1007/BF02522974; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; LIAO MJ, 1979, BIOCHIM BIOPHYS ACTA, V550, P157, DOI 10.1016/0005-2736(79)90204-9; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Mahuren JD, 2001, ANAL BIOCHEM, V298, P241, DOI 10.1006/abio.2001.5402; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016; MORITZ A, 1992, J BIOL CHEM, V267, P7207; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; MULLMANN TJ, 1991, J BIOL CHEM, V266, P2013; NICKELS JT, 1994, J BIOL CHEM, V269, P11018; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROBSON RJ, 1977, J PHYS CHEM-US, V81, P1075, DOI 10.1021/j100526a010; Rose MD., 1990, METHODS YEAST GENETI; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Sambrook J., 1989, MOL CLONING LAB MANU; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Singer-Kruger B, 1998, J CELL SCI, V111, P3347; SMITH SW, 1957, J BIOL CHEM, V228, P915; Stukey J, 1997, PROTEIN SCI, V6, P469; Sun Y., 2012, J CELL SCI IN PRESS; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; TALWALKAR RT, 1973, BIOCHIM BIOPHYS ACTA, V306, P412, DOI 10.1016/0005-2760(73)90180-X; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WALSH JP, 1986, J BIOL CHEM, V261, P5062; WALSH JP, 1986, J BIOL CHEM, V261, P6239; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WARNER TG, 1975, J BIOL CHEM, V250, P8004; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; WEISS SB, 1958, J BIOL CHEM, V231, P53; WEISS SB, 1960, J BIOL CHEM, V235, P40; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	121	15	18	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6427	6437		10.1074/jbc.M112.449629	http://dx.doi.org/10.1074/jbc.M112.449629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335564	Green Published, hybrid			2022-12-28	WOS:000315820700037
J	Serrano-Bueno, G; Hernandez, A; Lopez-Lluch, G; Perez-Castineira, JR; Navas, P; Serrano, A				Serrano-Bueno, Gloria; Hernandez, Agustin; Lopez-Lluch, Guillermo; Roman Perez-Castineira, Jose; Navas, Placido; Serrano, Aurelio			Inorganic Pyrophosphatase Defects Lead to Cell Cycle Arrest and Autophagic Cell Death through NAD(+) Depletion in Fermenting Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; ESCHERICHIA-COLI; EXPRESSION; APOPTOSIS; GLUCOSE; IDENTIFICATION; DEGRADATION; MECHANISMS; INHIBITORS	Inorganic pyrophosphatases are required for anabolism to take place in all living organisms. Defects in genes encoding these hydrolytic enzymes are considered inviable, although their exact nature has not been studied at the cellular and molecular physiology levels. Using a conditional mutant in IPP1, the Saccharomyces cerevisiae gene encoding the cytosolic soluble pyrophosphatase, we show that respiring cells arrest in S phase upon Ipp1p deficiency, but they remain viable and resume growth if accumulated pyrophosphate is removed. However, fermenting cells arrest in G(1)/G(0) phase and suffer massive vacuolization and eventual cell death by autophagy. Impaired NAD(+) metabolism is a major determinant of cell death in this scenario because demise can be avoided under conditions favoring accumulation of the oxidized pyridine coenzyme. These results posit that the mechanisms related to excess pyrophosphate toxicity in eukaryotes are dependent on the energy metabolism of the cell.	[Serrano-Bueno, Gloria; Hernandez, Agustin; Roman Perez-Castineira, Jose; Serrano, Aurelio] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; [Hernandez, Agustin] Univ Pablo de Olavide, Dept Physiol Anat & Cell Biol, Seville 41013, Spain; [Lopez-Lluch, Guillermo; Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Lopez-Lluch, Guillermo; Navas, Placido] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville 41013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Hernandez, A (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Avda Americo Vespucio 49, Seville 41092, Spain.	agustin.hernandez@ibvf.csic.es; aurelio@ibvf.csic.es	Lopez-Lluch, Guillermo/N-4742-2014; Serrano, Aurelio/K-3004-2014; Hernandez, Agustin/E-4544-2010; Pérez-Castiñeira, José R/F-2811-2010; NAVAS, PLACIDO/R-5943-2019	Lopez-Lluch, Guillermo/0000-0001-9830-8502; Serrano, Aurelio/0000-0002-8077-9098; Hernandez, Agustin/0000-0002-7884-8023; Pérez-Castiñeira, José R/0000-0002-4749-6897; NAVAS, PLACIDO/0000-0002-4115-7966; Serrano-Bueno, Gloria/0000-0002-8518-9038	Andalusian Regional Government; Spanish Ministries of Science and Innovation and of Health, Social Policies, and Equality [BIO-261, BIO-177, P07-CVI-3082, BFU2007-61887, BFU2010-15622, FIS-PI080500, P08-CTS-3988]; European Regional Development Fund program	Andalusian Regional Government; Spanish Ministries of Science and Innovation and of Health, Social Policies, and Equality; European Regional Development Fund program	This work was supported by grants from the Andalusian Regional Government and the Spanish Ministries of Science and Innovation and of Health, Social Policies, and Equality (to Plan Andaluz de Investigacion, Desarrollo e Innovacion Groups BIO-261 and BIO-177) and Grants P07-CVI-3082, BFU2007-61887, BFU2010-15622, FIS-PI080500, and P08-CTS-3988, all of them partially funded by European Regional Development Fund program.	Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Chen GA, 2002, CLIN CANCER RES, V8, P2298; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Drake R, 2010, BIOCHEM J, V426, P147, DOI 10.1042/BJ20091491; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; George GM, 2010, PLANT PHYSIOL, V154, P55, DOI 10.1104/pp.110.157776; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gomez-Garcia MR, 2006, BIOCHEM J, V395, P211, DOI 10.1042/BJ20051657; Heinonen J. K., 2001, BIOL ROLE INORGANIC; Hernandez A, 2009, GENE CHROMOSOME CANC, V48, P194, DOI 10.1002/gcc.20630; Jimenez-Hidalgo M, 2009, AGING CELL, V8, P140, DOI 10.1111/j.1474-9726.2009.00461.x; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Journo D, 2008, METHOD ENZYMOL, V451, P79, DOI 10.1016/S0076-6879(08)03207-2; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirkland JB, 2010, EXP BIOL MED, V235, P561, DOI 10.1258/ebm.2010.009280; KORNBERG A, 1950, J BIOL CHEM, V182, P763; KUKKOKALSKE E, 1989, J BACTERIOL, V171, P4498, DOI 10.1128/JB.171.8.4498-4500.1989; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Nakamura N, 1997, J BIOCHEM, V121, P338; Perez-Castineira Jose R., 2001, International Microbiology, V4, P135; Perez-Castineira JR, 2002, P NATL ACAD SCI USA, V99, P15914, DOI 10.1073/pnas.242625399; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; RATHBUN WB, 1969, ANAL BIOCHEM, V28, P436, DOI 10.1016/0003-2697(69)90198-5; Ruckenstuhl C, 2010, AGING-US, V2, P643, DOI 10.18632/aging.100223; SAZER S, 1990, J CELL SCI, V97, P509; Serrano A, 2007, IUBMB LIFE, V59, P76, DOI 10.1080/15216540701258132; SONNEWALD U, 1992, PLANT J, V2, P571; Takahashi R, 2010, J BIOCHEM, V147, P95, DOI 10.1093/jb/mvp152; Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321; Verstrepen KJ, 2004, TRENDS BIOTECHNOL, V22, P531, DOI 10.1016/j.tibtech.2004.08.001; Weissen-Plenz G, 2008, ADV CLIN CHEM, V46, P263, DOI 10.1016/S0065-2423(08)00407-1; Wilkinson S, 2010, CURR OPIN GENET DEV, V20, P57, DOI 10.1016/j.gde.2009.12.004; Wlodkowic D, 2009, METHODS MOL BIOL, V559, P19, DOI 10.1007/978-1-60327-017-5_2; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Zuin A, 2010, AGING-US, V2, P231, DOI 10.18632/aging.100133	46	28	30	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13082	13092		10.1074/jbc.M112.439349	http://dx.doi.org/10.1074/jbc.M112.439349			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23479727	hybrid, Green Published			2022-12-28	WOS:000318555100059
J	Kosaka, N; Iguchi, H; Hagiwara, K; Yoshioka, Y; Takeshita, F; Ochiya, T				Kosaka, Nobuyoshi; Iguchi, Haruhisa; Hagiwara, Keitaro; Yoshioka, Yusuke; Takeshita, Fumitaka; Ochiya, Takahiro			Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS; HYPOXIA; RNA	The release of humoral factors between cancer cells and the microenvironmental cells is critical for metastasis; however, the roles of secreted miRNAs in non-cell autonomous cancer progression against microenvironmental cells remain largely unknown. Here, we demonstrate that the neutral sphyngomyelinase 2 (nSMase2) regulates exosomal microRNA (miRNA) secretion and promotes angiogenesis within the tumor microenvironment as well as metastasis. We demonstrate a requirement for nSMase2-mediated cancer cell exosomal miRNAs in the regulation of metastasis through the induction of angiogenesis in inoculated tumors. In addition, miR-210, released by metastatic cancer cells, was shown to transport to endothelial cells and suppress the expression of specific target genes, which resulted in enhanced angiogenesis. These findings suggest that the horizontal transfer of exosomal miRNAs from cancer cells can dictate the microenviromental niche for the benefit of the cancer cell, like "on demand system" for cancer cells.	[Kosaka, Nobuyoshi; Iguchi, Haruhisa; Hagiwara, Keitaro; Yoshioka, Yusuke; Takeshita, Fumitaka; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Iguchi, Haruhisa] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Konohana Ku, Osaka 5540022, Japan; [Hagiwara, Keitaro] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	National Cancer Center - Japan; Dainippon Sumitomo Pharmaceutical Company; Tokyo Institute of Technology	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, 1-1 Tsukiji,5 Chome, Tokyo 1040045, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Education, Culture, Sports, Science, and Technology; National Institute of Biomedical Innovation (NiBio); Japan Society for the Promotion of Science initiated by the Council for Science and Technology Policy; Japanese Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science initiated by the Council for Science and Technology Policy(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for the third term comprehensive 10-year strategy for cancer control, a grant-in-aid for scientific research on priority areas cancer from the Ministry of Education, Culture, Sports, Science, and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), and the Japan Society for the Promotion of Science through the Funding Program for world leading innovative R&D on science and technology (FIRST Program) initiated by the Council for Science and Technology Policy, and a grant-in-aid for Scientific Research on Innovative Areas (functional machinery for non-coding RNAs) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; GALAND P, 1966, EXP CELL RES, V43, P391, DOI 10.1016/0014-4827(66)90066-8; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka Nobuyoshi, 2012, Frontiers in Genetics, V2, P97, DOI 10.3389/fgene.2011.00097; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Maupas-Schwalm F, 2009, CELL SIGNAL, V21, P1925, DOI 10.1016/j.cellsig.2009.08.010; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; STROUN M, 1978, CANCER RES, V38, P3546; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yamamoto Y, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-135; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717	31	501	530	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10849	10859		10.1074/jbc.M112.446831	http://dx.doi.org/10.1074/jbc.M112.446831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439645	hybrid, Green Published			2022-12-28	WOS:000317565000062
J	Walter, JD; Werther, RA; Polozova, MS; Pohlman, J; Healey, JF; Meeks, SL; Lollar, P; Spiegel, PC				Walter, Justin D.; Werther, Rachel A.; Polozova, Maria S.; Pohlman, Julie; Healey, John F.; Meeks, Shannon L.; Lollar, Pete; Spiegel, P. Clint, Jr.			Characterization and Solution Structure of the Factor VIII C2 Domain in a Ternary Complex with Classical and Non-classical Inhibitor Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; HEMOPHILIA-A PATIENTS; VONWILLEBRAND-FACTOR; MONOCLONAL-ANTIBODY; BINDING; MECHANISM; EFFICACY; SURFACE; SAFETY	The most significant complication for patients with severe cases of congenital or acquired hemophilia A is the development of inhibitor antibodies against coagulation factor VIII (fVIII). The C2 domain of fVIII is a significant antigenic target of anti-fVIII antibodies. Here, we have utilized small angle x-ray scattering (SAXS) and biochemical techniques to characterize interactions between two different classes of anti-C2 domain inhibitor antibodies and the isolated C2 domain. Multiple assays indicated that antibodies 3E6 and G99 bind independently to the fVIII C2 domain and can form a stable ternary complex. SAXS-derived numerical estimates of dimensional parameters for all studied complexes agree with the proportions of the constituent proteins. Ab initio modeling of the SAXS data results in a long kinked structure of the ternary complex, showing an angle centered at the C2 domain of similar to 130 degrees. Guided by biochemical data, rigid body modeling of subunits into the molecular envelope of the ternary complex suggests that antibody 3E6 recognizes a C2 domain epitope consisting of the Arg(2209)-Ser(2216) and Leu(2178)-Asp(2187) loops. In contrast, antibody G99 recognizes the C2 domain primarily through the Pro(2221)-Trp(2229) loop. These two epitopes are on opposing sides of the fVIII C2 domain, are consistent with the solvent accessibility in the context of the entire fVIII molecule, and provide further structural detail regarding the pathogenic immune response to fVIII.	[Walter, Justin D.; Werther, Rachel A.; Polozova, Maria S.; Pohlman, Julie; Spiegel, P. Clint, Jr.] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Healey, John F.; Meeks, Shannon L.; Lollar, Pete] Emory Univ, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Western Washington University; Emory University	Spiegel, PC (corresponding author), Western Washington Univ, Dept Chem, 516 High St, Bellingham, WA 98225 USA.	spiegep@chem.wwu.edu		Meeks, Shannon/0000-0002-3683-8644	National Institutes of Health [R15 HL103518, U54 HL112309, K08 HL102262, R01 HL082609, R01 HL040921]; National Science Foundation [CHE-1062722]; Western Washington University; Hemophilia of Georgia, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL103518, R01HL040921, K08HL102262, U54HL112309, R01HL082609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Western Washington University; Hemophilia of Georgia, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15 HL103518; Grant U54 HL112309 (to S. L. M. and to P. L.); Grant K08 HL102262 (to S. L. M.); and Grants R01 HL082609 and R01 HL040921 (to P. L.). This work was also supported by National Science Foundation Grant CHE-1062722, a project development award from Western Washington University (to P. C. S.), and Hemophilia of Georgia, Inc. (to S. L. M. and P. L.).	ANDERSSON LO, 1981, BIOCHEM J, V200, P161, DOI 10.1042/bj2000161; BRAY GL, 1994, BLOOD, V83, P2428; DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; Franchini M, 2008, BLOOD, V112, P250, DOI 10.1182/blood-2008-03-143586; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GAWRYL MS, 1982, BLOOD, V60, P1103; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GREENSPAN NS, 1989, FASEB J, V3, P2203, DOI 10.1096/fasebj.3.10.2666233; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; Hoots WK, 2001, HAEMOPHILIA, V7, P4, DOI 10.1046/j.1365-2516.2001.00099.x; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KANE WH, 1988, BLOOD, V71, P539; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kreuz W, 2002, SEMIN THROMB HEMOST, V28, P285, DOI 10.1055/s-2002-32664; LAJMANOVICH A, 1981, BIOCHIM BIOPHYS ACTA, V678, P132, DOI 10.1016/0304-4165(81)90056-8; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; Lusher JM, 2003, HAEMOPHILIA, V9, P38, DOI 10.1046/j.1365-2516.2003.00708.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Mauser-Bunschoten EP, 2001, HAEMOPHILIA, V7, P364, DOI 10.1046/j.1365-2516.2001.00513.x; Meeks SL, 2009, J THROMB HAEMOST, V7, P658, DOI 10.1111/j.1538-7836.2009.03299.x; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Nogami K, 2000, J BIOL CHEM, V275, P25774, DOI 10.1074/jbc.M002007200; Nogami K, 1999, J BIOL CHEM, V274, P31000, DOI 10.1074/jbc.274.43.31000; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; SAENKO EL, 1995, J BIOL CHEM, V270, P13826, DOI 10.1074/jbc.270.23.13826; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Scharrer I, 1999, HAEMOPHILIA, V5, P145; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; SHIMA M, 1995, BRIT J HAEMATOL, V91, P714, DOI 10.1111/j.1365-2141.1995.tb05374.x; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Spiegel PC, 2004, CHEM BIOL, V11, P1413, DOI 10.1016/j.chembiol.2004.08.006; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Spiegel PC, 2004, J BIOL CHEM, V279, P53691, DOI 10.1074/jbc.M409389200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	50	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9905	9914		10.1074/jbc.M112.424564	http://dx.doi.org/10.1074/jbc.M112.424564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417672	hybrid, Green Published			2022-12-28	WOS:000317114000030
J	Boiko, N; Kucher, V; Eaton, BA; Stockand, JD				Boiko, Nina; Kucher, Volodymyr; Eaton, Benjamin A.; Stockand, James D.			Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; GATED POTASSIUM CHANNELS; FUNCTIONAL EXPRESSION; SYMPTOMATIC TREATMENT; AXONAL DEGENERATION; K+ CHANNEL; ACID; BLOCK; RECEPTORS; ISCHEMIA	The voltage-gated K+ (Kv) channel blocker 4-aminopyridine (4-AP) is used to target symptoms of the neuroinflammatory disease multiple sclerosis (MS). By blocking Kv channels, 4-AP facilitates action potential conduction and neurotransmitter release in presynaptic neurons, lessening the effects of demyelination. Because they conduct inward Na+ and Ca2(+) currents that contribute to axonal degeneration in response to inflammatory conditions, acid-sensing ion channels (ASICs) contribute to the pathology of MS. Consequently, ASICs are emerging as disease-modifying targets in MS. Surprisingly, as first demonstrated here, 4-AP inhibits neuronal degenerin/epithelial Na+ (Deg/ENaC) channels, including ASIC and BLINaC. This effect is specific for 4-AP compared with its heterocyclic base, pyridine, and the related derivative, 4-methylpyridine; and akin to the actions of 4-AP on the structurally unrelated Kv channels, dose- and voltage-dependent. 4-AP has differential actions on distinct ASICs, strongly inhibiting ASIC1a channels expressed in central neurons but being without effect on ASIC3, which is enriched in peripheral sensory neurons. The voltage dependence of the 4-AP block and the single binding site for this inhibitor are consistent with 4-AP binding in the pore of Deg/ENaC channels as it does Kv channels, suggesting a similar mechanism of inhibition in these two classes of channels. These findings argue that effects on both Kv and Deg/ENaC channels should be considered when evaluating the actions of 4-AP. Importantly, the current results are consistent with 4-AP influencing the symptoms of MS as well as the course of the disease because of inhibitory actions on Kv and ASIC channels, respectively.	[Boiko, Nina; Kucher, Volodymyr; Eaton, Benjamin A.; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health Grant [R01 DK059594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062811] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK059594 (to J. D. S.).	Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; Berdiev BK, 2002, J BIOL CHEM, V277, P45734, DOI 10.1074/jbc.M208995200; Boiko N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411736; Bolshakov KV, 2002, NEUROSCIENCE, V110, P723, DOI 10.1016/S0306-4522(01)00582-6; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P603, DOI 10.1085/jgp.101.4.603; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Filippova N, 2001, J PHYSIOL-LONDON, V535, P145, DOI 10.1111/j.1469-7793.2001.00145.x; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HEINEMANN SH, 1988, BIOPHYS J, V54, P757, DOI 10.1016/S0006-3495(88)83013-3; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hunt T, 2012, BIOORG MED CHEM LETT, V22, P929, DOI 10.1016/j.bmcl.2011.12.016; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Kalia J, 2011, MOL PHARMACOL, V80, P1085, DOI 10.1124/mol.111.074989; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; KIRSCH GE, 1993, J GEN PHYSIOL, V102, P797, DOI 10.1085/jgp.102.5.797; Korenke AR, 2008, ANN PHARMACOTHER, V42, P1458, DOI 10.1345/aph.1L028; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Kucher V, 2011, BIOPHYS J, V100, P1930, DOI 10.1016/j.bpj.2011.02.046; Lassmann H, 2007, J NEUROL SCI, V259, P3, DOI 10.1016/j.jns.2006.08.016; Leng TD, 2013, ACTA PHARMACOL SIN, V34, P33, DOI 10.1038/aps.2012.81; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; O'Dowd D. K., 2007, JOVE-J VIS EXP, V5, P226, DOI [10.3791/226, DOI 10.3791/226]; Petrescu N, 2007, MUSCLE NERVE, V35, P451, DOI 10.1002/mus.20731; Pietra F, 2012, CHEM BIODIVERS, V9, P331, DOI 10.1002/cbdv.201100260; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Solari A, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001330; Staruschenko A, 2007, DEV NEUROBIOL, V67, P97, DOI 10.1002/dneu.20338; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; THOMPSON S, 1982, J GEN PHYSIOL, V80, P1, DOI 10.1085/jgp.80.1.1; VANDIEMEN HAM, 1993, CLIN NEUROPHARMACOL, V16, P195, DOI 10.1097/00002826-199306000-00002; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YELLEN G, 1984, J GEN PHYSIOL, V84, P157, DOI 10.1085/jgp.84.2.157; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	53	29	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9418	9427		10.1074/jbc.M112.449413	http://dx.doi.org/10.1074/jbc.M112.449413			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404498	Green Published, hybrid			2022-12-28	WOS:000316862200058
J	Higashi, S; Hirose, T; Takeuchi, T; Miyazaki, K				Higashi, Shouichi; Hirose, Tomokazu; Takeuchi, Tomoka; Miyazaki, Kaoru			Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; AMINO-ACID-RESIDUES; TISSUE INHIBITOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EXTRACELLULAR-MATRIX; IV COLLAGENASE; CELL-MIGRATION; BINDING; CANCER	Synthetic inhibitors of matrix metalloproteinases (MMPs), designed previously, as well as tissue inhibitors of metalloproteinases (TIMPs) lack enzyme selectivity, which has been a major obstacle for developing inhibitors into safe and effective MMP-targeted drugs. Here we designed a fusion protein named APP-IP-TIMP-2, in which the ten amino acid residue sequence of APP-derived MMP-2 selective inhibitory peptide (APP-IP) is added to the N terminus of TIMP-2. The APP-IP and TIMP-2 regions of the fusion protein are designed to interact with the active site and the hemopexin-like domain of MMP-2, respectively. The reactive site of the TIMP-2 region, which has broad specificity against MMPs, is blocked by the APP-IP adduct. The recombinant APP-IP-TIMP-2 showed strong inhibitory activity toward MMP-2 (K-i(app) = 0.68 pM), whereas its inhibitory activity toward MMP-1, MMP-3, MMP-7, MMP-8, MMP-9, or MT1-MMP was six orders of magnitude or more weaker (IC50 > 1 mu M). The fusion protein inhibited the activation of pro-MMP-2 in the concanavalin A-stimulated HT1080 cells, degradation of type IV collagen by the cells, and the migration of stimulated cells. Compared with the decapeptide APP-IP (t(1/2) = 30 min), APP-IP-TIMP-2 (t(1/2) >> 96 h) showed a much longer half-life in cultured tumor cells. Therefore, the fusion protein may be a useful tool to evaluate contributions of proteolytic activity of MMP-2 in various pathophysiological processes. It may also be developed as an effective anti-tumor drug with restricted side effects.	[Higashi, Shouichi; Hirose, Tomokazu; Takeuchi, Tomoka; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp			Strategic Research Promotion of Yokohama City University, Japan, JST (Research for Promoting Technological Seeds) [T2401]; Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University, Japan	Strategic Research Promotion of Yokohama City University, Japan, JST (Research for Promoting Technological Seeds); Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University, Japan	This work was supported in part by Grant No. T2401 (to S. H.) from the 2012 Strategic Research Promotion of Yokohama City University, Japan, JST (Research for Promoting Technological Seeds, to S. H.), and an Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University, Japan (to S. H.).	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Betz M, 1997, EUR J BIOCHEM, V247, P356, DOI 10.1111/j.1432-1033.1997.00356.x; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dublanchet AC, 2005, BIOORG MED CHEM LETT, V15, P3787, DOI 10.1016/j.bmcl.2005.05.079; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Finzel BC, 1998, PROTEIN SCI, V7, P2118, DOI 10.1002/pro.5560071008; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Gooyit M, 2011, J MED CHEM, V54, P6676, DOI 10.1021/jm200566e; Hashimoto H, 2011, J BIOL CHEM, V286, P33236, DOI 10.1074/jbc.M111.264176; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Jia MC, 2000, ADV EXP MED BIOL, V476, P181; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; LIOTTA LA, 1986, CANCER RES, V46, P1; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; MIYAZAKI K, 1990, CANCER RES, V50, P7758; Momi S, 2009, J EXP MED, V206, P2365, DOI 10.1084/jem.20090687; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murphy DJ, 2004, ANAL BIOCHEM, V327, P61, DOI 10.1016/j.ab.2003.12.018; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Rosenblum G, 2003, J BIOL CHEM, V278, P27009, DOI 10.1074/jbc.M301139200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shofuda K, 1998, J BIOCHEM-TOKYO, V124, P462, DOI 10.1093/oxfordjournals.jbchem.a022136; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takeda S, 2012, BBA-PROTEINS PROTEOM, V1824, P164, DOI 10.1016/j.bbapap.2011.04.009; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Williams J W, 1979, Methods Enzymol, V63, P437; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644	53	19	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9066	9076		10.1074/jbc.M112.441758	http://dx.doi.org/10.1074/jbc.M112.441758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395821	Green Published, hybrid			2022-12-28	WOS:000316862200026
J	Lee, CH; Lee, M; Kang, HJ; Kim, DH; Kang, YH; Bae, SH; Seo, YS				Lee, Chul-Hwan; Lee, Miju; Kang, Hyo-Jin; Kim, Do-Hyung; Kang, Young-Hoon; Bae, Sung-Ho; Seo, Yeon-Soo			The N-terminal 45-kDa Domain of Dna2 Endonuclease/Helicase Targets the Enzyme to Secondary Structure DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; STALLED REPLICATION FORKS; CELL NUCLEAR ANTIGEN; BREAK END RESECTION; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; S-PHASE; FISSION YEAST; FLAP ENDONUCLEASE-1	The removal of initiating primers from the 5'-ends of each Okazaki fragment, required for the generation of contiguous daughter strands, can be catalyzed by the combined action of DNA polymerase delta and Fen1. When the flaps generated by displacement of DNA synthesis activity of polymerase delta become long enough to bind replication protein A or form hairpin structures, the helicase/endonuclease enzyme, Dna2, becomes critical because of its ability to remove replication protein A-coated or secondary structure flaps. In this study, we show that the N-terminal 45-kDa domain of Dna2 binds hairpin structures, allowing the enzyme to target secondary structure flap DNA. We found that this activity was essential for the efficient removal of hairpin flaps by the endonuclease activity of Dna2 with the aid of its helicase activity. Thus, the efficient removal of hairpin structure flaps requires the coordinated action of all three functional domains of Dna2. We also found that deletion of the N-terminal 45-kDa domain of Dna2 led to a partial loss of the intra-S-phase checkpoint function and an increased rate of homologous recombination in yeast. We discuss the potential roles of the N-terminal domain of Dna2 in the maintenance of genomic stability.	[Lee, Chul-Hwan; Lee, Miju; Kang, Hyo-Jin; Kim, Do-Hyung; Kang, Young-Hoon; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Bae, Sung-Ho] Inha Univ, Dept Biol Sci, Inchon 402751, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Inha University	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011; Bae, Sung-Ho/AAK-7350-2020	Lee, Chul-Hwan/0000-0003-0643-0100	Korean Ministry of Education, Science and Technology	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korean Ministry of Education, Science and Technology (to Y.-S.S.).	Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Formosa T, 1998, MOL GEN GENET, V257, P461, DOI 10.1007/s004380050670; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kang HY, 2000, GENETICS, V155, P1055; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Onoda F, 2004, DNA REPAIR, V3, P429, DOI 10.1016/j.dnarep.2003.12.007; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Reynolds N, 2000, EMBO J, V19, P1108, DOI 10.1093/emboj/19.5.1108; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tanaka H, 2004, NUCLEIC ACIDS RES, V32, P6367, DOI 10.1093/nar/gkh963; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	55	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9468	9481		10.1074/jbc.M112.418715	http://dx.doi.org/10.1074/jbc.M112.418715			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23344960	Green Published, hybrid			2022-12-28	WOS:000316862200063
J	Wei, JJ; Zhang, Y; Ivanov, IP; Sachs, MS				Wei, Jiajie; Zhang, Ying; Ivanov, Ivaylo P.; Sachs, Matthew S.			The Stringency of Start Codon Selection in the Filamentous Fungus Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUG TRANSLATION INITIATION; MODULATES AUTOREGULATION; REGULATORY SEQUENCES; RNA-POLYMERASE; IN-VIVO; CONTEXT; RECOGNITION; GENES; ARABIDOPSIS; UPSTREAM	In eukaryotic cells initiation may occur from near-cognate codons that differ from AUG by a single nucleotide. The stringency of start codon selection impacts the efficiency of initiation at near-cognate codons and the efficiency of initiation at AUG codons in different contexts. We used a codon-optimized firefly luciferase reporter initiated with AUG or each of the nine near-cognate codons in preferred context to examine the stringency of start codon selection in the model filamentous fungus Neurospora crassa. In vivo results indicated that the hierarchy of initiation at start codons in N. crassa (AUG >> CUG > GUG > ACG > AUA approximate to UUG > AUU > AUC) is similar to that in human cells. Similar results were obtained by translating mRNAs in a homologous N. crassa in vitro translation system or in rabbit reticulocyte lysate. We next examined the efficiency of initiation at AUG, CUG, and UUG codons in different contexts in vitro. The preferred context was more important for efficient initiation from near-cognate codons than from AUG. These studies demonstrated that near-cognate codons are used for initiation in N. crassa. Such events could provide additional coding capacity or have regulatory functions. Analyses of the 5'-leader regions in the N. crassa transcriptome revealed examples of highly conserved near-cognate codons in preferred contexts that could extend the N termini of the predicted polypeptides.	[Wei, Jiajie; Zhang, Ying; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Ivanov, Ivaylo P.] Univ Coll Cork, Dept Biochem, Cork, Ireland	Texas A&M University System; Texas A&M University College Station; University College Cork	Sachs, MS (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	msachs@bio.tamu.edu		Ivanov, Ivaylo/0000-0002-4793-5466; Sachs, Matthew/0000-0001-9891-9223; Zhang, Ying/0000-0002-1238-0456; Ivanov, Ivaylo/0000-0002-6008-3261	National Institutes of Health [GM47498, GM068087]; Science Foundation Ireland Grant [08/IN.1/B1889]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM047498, R29GM047498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland Grant(Science Foundation Ireland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM47498 and GM068087 (to M. S. S.).; Supported by Science Foundation Ireland Grant 08/IN.1/B1889 to J.F. Atkins.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Chang CP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-188; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; Christensen AC, 2005, PLANT CELL, V17, P2805, DOI 10.1105/tpc.105.035287; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; Conlon H, 2001, MOL MICROBIOL, V40, P361, DOI 10.1046/j.1365-2958.2001.02399.x; Dementhon K, 2004, MOL MICROBIOL, V53, P1625, DOI 10.1111/j.1365-2958.2004.04235.x; DONAHUE TF, 1988, MOL CELL BIOL, V8, P2955, DOI 10.1128/MCB.8.7.2955; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Fang P, 2000, J BIOL CHEM, V275, P26710; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; GORDON K, 1992, PLANT J, V2, P809, DOI 10.1046/j.1365-313X.1992.t01-17-00999.x; Grundemann D, 1996, BIOTECHNIQUES, V21, P898; GUTIERREZ S, 1991, J BACTERIOL, V173, P2354; Hedtke B, 2002, PLANT J, V30, P625, DOI 10.1046/j.1365-313X.2002.01318.x; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Johansson MJO, 2010, GENE DEV, V24, P1491, DOI 10.1101/gad.1930710; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kobayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P57, DOI 10.1016/S0006-291X(02)02579-2; Kochetov AV, 2013, J BIOMOL STRUCT DYN, V31, P103, DOI 10.1080/07391102.2012.691367; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; Margolin B.S., 1997, FUNGAL GENET REP, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Martin-Marcos P, 2011, MOL CELL BIOL, V31, P4814, DOI 10.1128/MCB.05819-11; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; PORTIS JL, 1994, J VIROL, V68, P3879, DOI 10.1128/JVI.68.6.3879-3887.1994; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; SACHS MS, 1991, DEV BIOL, V148, P117, DOI 10.1016/0012-1606(91)90322-T; Simpson GG, 2010, PLANT CELL, V22, P3764, DOI 10.1105/tpc.110.077990; Singh CR, 2012, MOL CELL BIOL, V32, P3978, DOI 10.1128/MCB.00376-12; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Takahashi K, 2005, GENOMICS, V85, P360, DOI 10.1016/j.ygeno.2004.11.012; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Vaughn JN, 2012, RNA, V18, P368, DOI 10.1261/rna.031179.111; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang Z, 1998, MOL CELL BIOL, V18, P7528, DOI 10.1128/MCB.18.12.7528; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; Wilke CO, 2010, CURR OPIN STRUC BIOL, V20, P385, DOI 10.1016/j.sbi.2010.03.004; Wu C, 2007, METHOD ENZYMOL, V429, P203, DOI 10.1016/S0076-6879(07)29010-X; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Zhang A, 1997, CELL MOL LIFE SCI, V53, P69, DOI 10.1007/PL00000581; Zhang F, 2011, NUCLEIC ACIDS RES, V39, P3128, DOI 10.1093/nar/gkq1251; Zhou M., 2013, NATURE IN PRESS; [No title captured]	73	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9549	9562		10.1074/jbc.M112.447177	http://dx.doi.org/10.1074/jbc.M112.447177			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396971	Green Published, hybrid			2022-12-28	WOS:000316862200069
J	Musselman, LP; Fink, JL; Ramachandran, PV; Patterson, BW; Okunade, AL; Maier, E; Brent, MR; Turk, J; Baranski, TJ				Musselman, Laura Palanker; Fink, Jill L.; Ramachandran, Prasanna Venkatesh; Patterson, Bruce W.; Okunade, Adewole L.; Maier, Ezekiel; Brent, Michael R.; Turk, John; Baranski, Thomas J.			Role of Fat Body Lipogenesis in Protection against the Effects of Caloric Overload in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; METABOLIC SYNDROME; LITHIATED ADDUCTS; MASS-SPECTROMETRY; ACID ELONGASE; OBESITY; GENE; IDENTIFICATION; HOMEOSTASIS	The Drosophila fat body is a liver- and adipose-like tissue that stores fat and serves as a detoxifying and immune responsive organ. We have previously shown that a high sugar diet leads to elevated hemolymph glucose and systemic insulin resistance in developing larvae and adults. Here, we used stable isotope tracer feeding to demonstrate that rearing larvae on high sugar diets impaired the synthesis of esterified fatty acids from dietary glucose. Fat body lipid profiling revealed changes in both carbon chain length and degree of unsaturation of fatty acid substituents, particularly in stored triglycerides. We tested the role of the fat body in larval tolerance of caloric excess. Our experiments demonstrated that lipogenesis was necessary for animals to tolerate high sugar feeding as tissue-specific loss of orthologs of carbohydrate response element-binding protein or stearoyl-CoA desaturase 1 resulted in lethality on high sugar diets. By contrast, increasing the fat content of the fat body by knockdown of king-tubby was associated with reduced hyperglycemia and improved growth and tolerance of high sugar diets. Our work supports a critical role for the fat body and the Drosophila carbohydrate response element-binding protein ortholog in metabolic homeostasis in Drosophila.	[Musselman, Laura Palanker; Fink, Jill L.; Ramachandran, Prasanna Venkatesh; Turk, John; Baranski, Thomas J.] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Patterson, Bruce W.; Okunade, Adewole L.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; [Maier, Ezekiel; Brent, Michael R.] Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA; [Maier, Ezekiel; Brent, Michael R.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Baranski, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	tbaransk@dom.wustl.edu	Ramachandran, Prasanna/AAD-9824-2021; Brent, Michael/AAK-3702-2020; Musselman, Laura/K-4697-2019	Ramachandran, Prasanna/0000-0002-3439-6125; Brent, Michael/0000-0002-8689-0299; Musselman, Laura/0000-0002-8478-2526; Maier, Ezekiel/0000-0003-1216-6537; Patterson, Bruce W/0000-0001-9261-0233	National Institutes of Health through the Washington University Diabetes Research and Training Center [T32 GM007464, 5K12HD001459-12, P60 DK20579]; National Institutes of Health through the Nutrition Obesity Research Center [P20 RR020643, P30 DK56341]; National Institutes of Health through Biomedical Mass Spectrometry Resource [P41-RR00954]; Small Business Technology Transfer grant [1R41DK76338]; Children's Discovery Institute [MD-II-2010-41]; Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, P20RR020643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R41DK076338, P30DK056341, P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	National Institutes of Health through the Washington University Diabetes Research and Training Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the Nutrition Obesity Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through Biomedical Mass Spectrometry Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Small Business Technology Transfer grant; Children's Discovery Institute; Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM007464 (to L.P.M.), 5K12HD001459-12 (to L.P.M.), P60 DK20579 through the Washington University Diabetes Research and Training Center (to J.T. and T.J.B.), P20 RR020643 (to T.J.B.), P30 DK56341 through the Nutrition Obesity Research Center (to A.L.O., B.W.P., and J.T.), P41-RR00954 through the Biomedical Mass Spectrometry Resource (to J.T.), and 1R41DK76338, a Small Business Technology Transfer grant (to Medros, Inc.). This work was also supported by Children's Discovery Institute Grant MD-II-2010-41 (to M.R.B. and T.J.B.) and Washington University (to T.J.B.). T.J.B. is a co-founder of Medros, Inc.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohlin K, 2005, J LIPID RES, V46, P1257, DOI 10.1194/jlr.M400481-JLR200; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Ceriello Antonio, 2006, Curr Atheroscler Rep, V8, P472, DOI 10.1007/s11883-006-0022-z; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chinkes DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE373, DOI 10.1152/ajpendo.1996.271.2.E373; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clifton PM, 2008, NAT CLIN PRACT GASTR, V5, P672, DOI 10.1038/ncpgasthep1283; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Fay JR, 2009, CANCER PREV RES, V2, P301, DOI 10.1158/1940-6207.CAPR-08-0166; Fukuchi S, 2004, EXP BIOL MED, V229, P486, DOI 10.1177/153537020422900606; Gagliardi L, 2007, CURR DIABETES REV, V3, P95, DOI 10.2174/157339907780598207; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hammad LA, 2011, RAPID COMMUN MASS SP, V25, P2959, DOI 10.1002/rcm.5187; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Knight JA, 2011, ANN CLIN LAB SCI, V41, P107; KRITCHEVSKY D, 1995, EUR J CANCER PREV, V4, P445, DOI 10.1097/00008469-199512000-00002; Kuhnlein RP, 2011, PROG LIPID RES, V50, P348, DOI 10.1016/j.plipres.2011.04.001; Leclercq IA, 2008, CURR OPIN CLIN NUTR, V11, P766, DOI 10.1097/MCO.0b013e328312c353; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Magkos F, 2009, ANNU REV NUTR, V29, P223, DOI 10.1146/annurev-nutr-080508-141200; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Neuschwander-Tetri Brent A, 2010, Curr Gastroenterol Rep, V12, P49, DOI 10.1007/s11894-009-0083-6; Niswender K, 2010, DIABETES OBES METAB, V12, P267, DOI 10.1111/j.1463-1326.2009.01175.x; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Patterson BW, 1999, J LIPID RES, V40, P2118; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shiri-Sverdlov R, 2006, DIABETES, V55, P385, DOI 10.2337/diabetes.55.02.06.db05-0997; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Sorensen TIA, 2010, BBA-MOL CELL BIOL L, V1801, P400, DOI 10.1016/j.bbalip.2009.12.011; Sullivan S, 2010, CURR OPIN GASTROEN, V26, P160, DOI 10.1097/MOG.0b013e3283358a58; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Taubes G, 2009, SCIENCE, V325, P256, DOI 10.1126/science.325_256; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; van Vliet-Ostaptchouk JV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001405; Wang Y, 2006, PHYSIOL GENOMICS, V27, P131, DOI 10.1152/physiolgenomics.00239.2005; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200	72	78	79	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8028	8042		10.1074/jbc.M112.371047	http://dx.doi.org/10.1074/jbc.M112.371047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23355467	Green Published, hybrid			2022-12-28	WOS:000316564500004
J	Canning, P; Cooper, CDO; Krojer, T; Murray, JW; Pike, ACW; Chaikuad, A; Keates, T; Thangaratnarajah, C; Hojzan, V; Marsden, BD; Gileadi, O; Knapp, S; von Delft, F; Bullock, AN				Canning, Peter; Cooper, Christopher D. O.; Krojer, Tobias; Murray, James W.; Pike, Ashley C. W.; Chaikuad, Apirat; Keates, Tracy; Thangaratnarajah, Chancievan; Hojzan, Viktorija; Marsden, Brian D.; Gileadi, Opher; Knapp, Stefan; von Delft, Frank; Bullock, Alex N.			Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; PROTEASOMAL DEGRADATION; CRYSTAL-STRUCTURE; COMPLEX REVEALS; DLG MOTIFS; ACTIVATION; DOMAIN; KEAP1; SCF; MUTATIONS	Cullin-RING ligases are multisubunit E3 ubiquitin ligases that recruit substrate-specific adaptors to catalyze protein ubiquitylation. Cul3-based Cullin-RING ligases are uniquely associated with BTB adaptors that incorporate homodimerization, Cul3 assembly, and substrate recognition into a single multidomain protein, of which the best known are BTB-BACK-Kelch domain proteins, including KEAP1. Cul3 assembly requires a BTB protein "3-box" motif, analogous to the F-box and SOCS box motifs of other Cullin-based E3s. To define the molecular basis for this assembly and the overall architecture of the E3, we determined the crystal structures of the BTB-BACK domains of KLHL11 both alone and in complex with Cul3, along with the Kelch domain structures of KLHL2 (Mayven), KLHL7, KLHL12, and KBTBD5. We show that Cul3 interaction is dependent on a unique N-terminal extension sequence that packs against the 3-box in a hydrophobic groove centrally located between the BTB and BACK domains. Deletion of this N-terminal region results in a 30-fold loss in affinity. The presented data offer a model for the quaternary assembly of this E3 class that supports the bivalent capture of Nrf2 and reveals potential new sites for E3 inhibitor design.	[Canning, Peter; Cooper, Christopher D. O.; Krojer, Tobias; Murray, James W.; Pike, Ashley C. W.; Chaikuad, Apirat; Keates, Tracy; Thangaratnarajah, Chancievan; Hojzan, Viktorija; Marsden, Brian D.; Gileadi, Opher; Knapp, Stefan; von Delft, Frank; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	University of Oxford	Bullock, AN (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England.	alex.bullock@sgc.ox.ac.uk	Cooper, Christopher/E-8392-2013; Krojer, Tobias/ABE-3829-2021; Gileadi, Opher/F-1105-2013; Knapp, Stefan/AAG-2347-2019; Cooper, Chris/G-9982-2014	Gileadi, Opher/0000-0001-6886-898X; Knapp, Stefan/0000-0001-5995-6494; Cooper, Chris/0000-0002-9197-8041; Thangaratnarajah, Chancievan/0000-0002-0279-6642; von Delft, Frank/0000-0003-0378-0017; Krojer, Tobias/0000-0003-0661-0814; Chaikuad, Apirat/0000-0003-1120-2209; Canning, Peter/0000-0001-9678-4169; Murray, James/0000-0002-8897-0161	Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; AbbVie; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust [092809/Z/10/Z]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and Wellcome Trust Grant 092809/Z/10/Z.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Bricogne G., 2011, BUSTER VERSION 2 10; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buckley DL, 2012, ANGEW CHEM INT EDIT, V51, P11463, DOI 10.1002/anie.201206231; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Gray CH, 2009, J BIOL CHEM, V284, P30498, DOI 10.1074/jbc.M109.023259; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	68	175	185	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7803	7814		10.1074/jbc.M112.437996	http://dx.doi.org/10.1074/jbc.M112.437996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23349464	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000316455300035
J	Van Laer, K; Dziewulska, AM; Fislage, M; Wahni, K; Hbeddou, A; Collet, JF; Versees, W; Mateos, LM; Dufe, VT; Messens, J				Van Laer, Koen; Dziewulska, Aleksandra M.; Fislage, Marcus; Wahni, Khadija; Hbeddou, Abderahim; Collet, Jean-Francois; Versees, Wim; Mateos, Luis M.; Dufe, Veronica Tamu; Messens, Joris			NrdH-redoxin of Mycobacterium tuberculosis and Corynebacterium glutamicum Dimerizes at High Protein Concentration and Exclusively Receives Electrons from Thioredoxin Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I RIBONUCLEOTIDE REDUCTASE; STRUCTURAL BASIS; MECHANISM; ELECTROSTATICS; EXPRESSION; CATALYSIS; SYSTEM; GENES	NrdH-redoxins are small reductases with a high amino acid sequence similarity with glutaredoxins and mycoredoxins but with a thioredoxin-like activity. They function as the electron donor for class Ib ribonucleotide reductases, which convert ribonucleotides into deoxyribonucleotides. We solved the x-ray structure of oxidized NrdH-redoxin from Corynebacterium glutamicum (Cg) at 1.5 angstrom resolution. Based on this monomeric structure, we built a homology model of NrdH-redoxin from Mycobacterium tuberculosis (Mt). Both NrdH-redoxins have a typical thioredoxin fold with the active site CXXC motif located at the N terminus of the first alpha-helix. With size exclusion chromatography and small angle x-ray scattering, we show that Mt_NrdH-redoxin is a monomer in solution that has the tendency to form a non-swapped dimer at high protein concentration. Further, Cg_NrdH-redoxin and Mt_NrdH-redoxin catalytically reduce a disulfide with a specificity constant 1.9 x 10(6) and 5.6 x 10(6) M-1 min(-1), respectively. They use a thiol-disulfide exchange mechanism with an N-terminal cysteine pK(a) lower than 6.5 for nucleophilic attack, whereas the pK(a) of the C-terminal cysteine is similar to 10. They exclusively receive electrons from thioredoxin reductase (TrxR) and not from mycothiol, the low molecular weight thiol of actinomycetes. This specificity is shown in the structural model of the complex between NrdH-redoxin and TrxR, where the two surface-exposed phenylalanines of TrxR perfectly fit into the conserved hydrophobic pocket of the NrdH-redoxin. Moreover, nrdh gene deletion and disruption experiments seem to indicate that NrdH-redoxin is essential in C. glutamicum.	[Van Laer, Koen; Dziewulska, Aleksandra M.; Fislage, Marcus; Wahni, Khadija; Hbeddou, Abderahim; Versees, Wim; Dufe, Veronica Tamu; Messens, Joris] Vlaams Inst Biotechnol, Dept Biol Struct, B-1050 Brussels, Belgium; [Van Laer, Koen; Dziewulska, Aleksandra M.; Fislage, Marcus; Wahni, Khadija; Hbeddou, Abderahim; Versees, Wim; Dufe, Veronica Tamu; Messens, Joris] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Van Laer, Koen; Dziewulska, Aleksandra M.; Wahni, Khadija; Hbeddou, Abderahim; Collet, Jean-Francois; Dufe, Veronica Tamu; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Mateos, Luis M.] Univ Leon, Dept Mol Biol, Area Microbiol, E-24071 Leon, Spain; [Collet, Jean-Francois] Welbio, B-1200 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Catholique Louvain; Universidad de Leon; WELBIO	Messens, J (corresponding author), Vrije Univ Brussel, Vlaams Inst Biotechnol, Redox Biol Lab, Dept Biol Struct, Pleinlaan 2, B-1050 Brussels, Belgium.	joris.messens@vib-vub.be	Versées, Wim/H-5518-2015; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Messens, Joris/AAH-3008-2020	MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Messens, Joris/0000-0002-2128-8264; Fislage, Marcus/0000-0002-2527-2657; Collet, Jean-Francois/0000-0001-8069-7036; Versees, Wim/0000-0002-4695-696X	Agentschap voor Innovatie door Wetenschap en Technologie (IWT); Vlaams Instituut voor Biotechnologie (VIB); HOA-project of the Onderzoeksraad of Vrije Universiteit Brussel; IWT Ph.D. fellowship	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaams Instituut voor Biotechnologie (VIB); HOA-project of the Onderzoeksraad of Vrije Universiteit Brussel; IWT Ph.D. fellowship	This work was supported by Agentschap voor Innovatie door Wetenschap en Technologie (IWT), the Vlaams Instituut voor Biotechnologie (VIB), and the HOA-project of the Onderzoeksraad of Vrije Universiteit Brussel.; Supported by an IWT Ph.D. fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akif M, 2005, ACTA CRYSTALLOGR D, V61, P1603, DOI 10.1107/S0907444905030519; Akif M, 2008, J BACTERIOL, V190, P7087, DOI 10.1128/JB.00159-08; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; EKLUND H, 1992, J MOL BIOL, V228, P596, DOI 10.1016/0022-2836(92)90844-A; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FernandezGonzalez C, 1996, APPL MICROBIOL BIOT, V46, P554, DOI 10.1007/s002530050860; Garcia-Pino A, 2009, J MOL BIOL, V385, P1590, DOI 10.1016/j.jmb.2008.11.040; Guinier A., 1955, SMALL ANGLE SCATTERI; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JAGER W, 1992, J BACTERIOL, V174, P5462; Jensen KS, 2009, ANTIOXID REDOX SIGN, V11, P1047, DOI 10.1089/ARS.2008.2297; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Leiting WU, 2010, MICROB PATHOGENESIS, V48, P97, DOI 10.1016/j.micpath.2010.01.004; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Mowa MB, 2009, J BACTERIOL, V191, P985, DOI 10.1128/JB.01409-08; Newcomer ME, 2001, NAT STRUCT BIOL, V8, P282, DOI 10.1038/86134; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; NILSSON O, 1988, BIOCHEM SOC T, V16, P91, DOI 10.1042/bst0160091; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rabinovitch I, 2010, J BACTERIOL, V192, P4963, DOI 10.1128/JB.00539-10; REICHARD P, 1983, SCIENCE, V221, P514, DOI 10.1126/science.6306767; Roos G, 2006, J PHYS CHEM B, V110, P557, DOI 10.1021/jp0549780; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Stehr M, 2004, PROTEINS, V55, P613, DOI 10.1002/prot.20126; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	60	9	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7942	7955		10.1074/jbc.M112.392688	http://dx.doi.org/10.1074/jbc.M112.392688			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362277	Green Published, hybrid			2022-12-28	WOS:000316455300047
J	Shah, A; Xia, L; Goldberg, H; Lee, KW; Quaggin, SE; Fantus, IG				Shah, Anu; Xia, Ling; Goldberg, Howard; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George			Thioredoxin-interacting Protein Mediates High Glucose-induced Reactive Oxygen Species Generation by Mitochondria and the NADPH Oxidase, Nox4, in Mesangial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; DIABETIC-NEPHROPATHY; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; FIBRONECTIN EXPRESSION; FAMILY PROTEINS; UP-REGULATION; P38 MAPK; KAPPA-B	Thioredoxin-interacting protein (TxNIP) is up-regulated by high glucose and is associated with oxidative stress. It has been implicated in hyperglycemia-induced beta-cell dysfunction and apoptosis. As high glucose and oxidative stress mediate diabetic nephropathy (DN), the contribution of TxNIP was investigated in renal mesangial cell reactive oxygen species (ROS) generation and collagen synthesis. To determine the role of TxNIP, mouse mesangial cells (MC) cultured from wild-type C3H and TxNIP-deficient Hcb-19 mice were incubated in HG. Confocal microscopy was used to measure total and mitochondrial ROS production (DCF and MitoSOX) and collagen IV. Trx and NADPH oxidase activities were assayed and NADPH oxidase isoforms, Nox2 and Nox4, and antioxidant enzymes were determined by immunoblotting. C3H MC exposed to HG elicited a significant increase in cellular and mitochondrial ROS as well as Nox4 protein expression and NADPH oxidase activation, whereas Hcb-19MC showed no response. Trx activity was attenuated by HG only in C3H MC. These defects in Hcb-19 MC were not due to increased antioxidant enzymes or scavenging of ROS, but associated with decreased ROS generation. Adenovirus-mediated overexpression of TxNIP in Hcb-19MC and TxNIP knockdown with siRNA in C3H confirmed the specific role of TxNIP. Collagen IV accumulation in HG was markedly reduced in Hcb-19 cells. TxNIP is a critical component of the HG-ROS signaling pathway, required for the induction of mitochondrial and total cell ROS and the NADPH oxidase isoform, Nox4. TxNIP is a potential target to prevent DN.	[Shah, Anu; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Mt Sinai Hosp, Dept Med, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Xia, Ling; Goldberg, Howard; Lee, Ken W.; Fantus, I. George] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Univ Toronto, Dept Physiol, Toronto, ON M5T 3L9, Canada; [Shah, Anu; Xia, Ling; Goldberg, Howard; Lee, Ken W.; Quaggin, Susan E.; Fantus, I. George] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5T 3L9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Fantus, IG (corresponding author), Mt Sinai Hosp, 60 Murray St,Joseph & Wolfe Lebovic Bldg,Suite 5-, Toronto, ON M5T 3L9, Canada.	gfantus@mtsinai.on.ca	Johnson, Michael D. L./B-4352-2012	Shah, Anu/0000-0002-2407-0631	Canadian Institutes of Health Research [MOP 97979, PCN 49409]; Novo Nordisk Studentship from the Banting and Best Diabetes Centre; Canada Graduate Scholarship (NSERC); Ontario Graduate Scholarship; Canadian Diabetes Association [OG-3-10-2997-IF]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Novo Nordisk Studentship from the Banting and Best Diabetes Centre; Canada Graduate Scholarship (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Diabetes Association	This work was supported in part by Canadian Institutes of Health Research Grants MOP 97979 and PCN 49409 (to I. G. F.). Supported in part by a Novo Nordisk Studentship from the Banting and Best Diabetes Centre, a Canada Graduate Scholarship (NSERC), and an Ontario Graduate Scholarship. Supported in part by a Novo Nordisk Studentship from the Banting and Best Diabetes Centre and Canadian Diabetes Association Grant OG-3-10-2997-IF.	Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Cheng Davis W., 2006, Archives of Physiology and Biochemistry, V112, P189, DOI 10.1080/13813450601093518; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Fujita H, 2009, J AM SOC NEPHROL, V20, P1303, DOI 10.1681/ASN.2008080844; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Hamada Y, 2007, NEPHROL DIAL TRANSPL, V22, P1547, DOI 10.1093/ndt/gfm099; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Kakehi T, 2008, SEMIN IMMUNOPATHOL, V30, P301, DOI 10.1007/s00281-008-0122-7; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kitada M, 2003, DIABETES, V52, P2603, DOI 10.2337/diabetes.52.10.2603; Kobayashi T, 2003, KIDNEY INT, V64, P1632, DOI 10.1046/j.1523-1755.2003.00263.x; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lan T, 2011, MOL ENDOCRINOL, V25, P2094, DOI 10.1210/me.2011-0095; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Li H, 2011, CELL SIGNAL, V23, P1625, DOI 10.1016/j.cellsig.2011.05.016; Li JM, 2010, DIABETES, V59, P2033, DOI 10.2337/db09-1800; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Masson E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1251, DOI 10.1152/ajpendo.90619.2008; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Mene Paolo, 2009, V466, P3, DOI 10.1007/978-1-59745-352-3_1; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Pendyala S, 2011, FREE RADICAL BIO MED, V50, P1749, DOI 10.1016/j.freeradbiomed.2011.03.022; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Yang WS, 2008, AM J PHYSIOL-RENAL, V294, pF1065, DOI 10.1152/ajprenal.00381.2007; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zitman-Gal T, 2010, NEPHROL DIAL TRANSPL, V25, P2141, DOI 10.1093/ndt/gfp768	73	110	116	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6835	6848		10.1074/jbc.M112.419101	http://dx.doi.org/10.1074/jbc.M112.419101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329835	Green Published, hybrid			2022-12-28	WOS:000316002400006
J	Burlet, E; Jain, SK				Burlet, Elodie; Jain, Sushil K.			Manganese Supplementation Reduces High Glucose-induced Monocyte Adhesion to Endothelial Cells and Endothelial Dysfunction in Zucker Diabetic Fatty Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; CHEMOATTRACTANT PROTEIN-1; OXIDATIVE STRESS; VASCULAR-DISEASE; EXPRESSION; MAGNESIUM; MELLITUS; COPPER; ZINC	Endothelial dysfunction is a hallmark of increased vascular inflammation, dyslipidemia, and the development of atherosclerosis in diabetes. Previous studies have reported lower levels of Mn2+ in the plasma and lymphocytes of diabetic patients and in the heart and aortic tissue of patients with atherosclerosis. This study examines the hypothesis that Mn2+ supplementation can reduce the markers/risk factors of endothelial dysfunction in type 2 diabetes. Human umbilical vein endothelial cells (HUVECs) were cultured with or without Mn2+ supplementation and then exposed to high glucose (HG, 25 mM) to mimic diabetic conditions. Mn2+ supplementation caused a reduction in monocyte adhesion to HUVECs treated with HG or MCP-1. Mn2+ also inhibited ROS levels, MCP-1 secretion, and ICAM-1 up-regulation in HUVECs treated with HG. Silencing studies using siRNA against MnSOD showed that similar results were observed in MnSOD knockdown HUVECs following Mn2+ supplementation, suggesting that the effect of manganese on monocyte adhesion to endothelial cells is mediated by ROS and ICAM-1, but not MnSOD. To validate the relevance of our findings in vivo, Zucker diabetic fatty rats were gavaged daily with water (placebo) or MnCl2 (16 mg/kg of body weight) for 7 weeks. When compared with placebo, Mn2+-supplemented rats showed lower blood levels of ICAM-1 (17%, p < 0.04), cholesterol (25%, p < 0.05), and MCP-1 (28%, p = 0.25). These in vitro and in vivo studies demonstrate that Mn2+ supplementation can down-regulate ICAM-1 expression and ROS independently of MnSOD, leading to a decrease in monocyte adhesion to endothelial cells, and therefore can lower the risk of endothelial dysfunction in diabetes.	[Jain, Sushil K.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Shreveport, LA 71130 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, 1501 Kings Highway, Shreveport, LA 71130 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436	National Institutes of Health through the NIDDK [RO1 DK072433]; Office of Dietary Supplements; Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK072433 through the NIDDK and the Office of Dietary Supplements. This work was also supported by the Malcolm Feist Endowed Chair in Diabetes.	Anetor JI, 2007, BIOL TRACE ELEM RES, V120, P19, DOI 10.1007/s12011-007-0069-x; Bae YJ, 2011, BIOL TRACE ELEM RES, V141, P224, DOI 10.1007/s12011-010-8714-1; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bomb B S, 1988, J Assoc Physicians India, V36, P149; Bonazzi M, 2011, J CELL BIOL, V195, P348, DOI 10.1083/jcb.201106011; DAVIS CD, 1990, J NUTR, V120, P507, DOI 10.1093/jn/120.5.507; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Ekmekcioglu C, 2001, BIOL TRACE ELEM RES, V79, P205, DOI 10.1385/BTER:79:3:205; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; Forcheron F, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-16; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Golias C, 2011, CELL COMMUN ADHES, V18, P19, DOI 10.3109/15419061.2011.606381; Holm AM, 2004, EUR J ENDOCRINOL, V150, P893, DOI 10.1530/eje.0.1500893; Hussain S, 1999, NEUROSCI LETT, V261, P21, DOI 10.1016/S0304-3940(98)01005-2; Isaac AO, 2006, NEUROCHEM RES, V31, P1305, DOI 10.1007/s11064-006-9173-0; JAIN SK, 1989, J BIOL CHEM, V264, P21340; Jain SK, 1997, FREE RADICAL BIO MED, V22, P593, DOI 10.1016/S0891-5849(96)00377-2; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Khan AG, 2010, J VIROL, V84, P3984, DOI 10.1128/JVI.01693-09; Lefer DJ, 1999, CIRC RES, V84, P1353, DOI 10.1161/01.RES.84.11.1353; Malthankar GV, 2004, NEUROCHEM RES, V29, P709, DOI 10.1023/B:NERE.0000018841.98399.ce; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Metais C, 2008, METABOLISM, V57, P946, DOI 10.1016/j.metabol.2008.02.010; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Nahar Z, 2010, BIOL TRACE ELEM RES, V133, P284, DOI 10.1007/s12011-009-8441-7; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; PAYNTER DI, 1980, J NUTR, V110, P437, DOI 10.1093/jn/110.3.437; Peluso Ilaria, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P351; Rains JL, 2012, CAN J PHYSIOL PHARM, V90, P1642, DOI 10.1139/y2012-131; Rains JL, 2011, AM J PHYSIOL-ENDOC M, V301, pE298, DOI 10.1152/ajpendo.00038.2011; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Son EW, 2007, ARCH PHARM RES, V30, P743, DOI 10.1007/BF02977637; SUN Y, 1988, CLIN CHEM, V34, P497; VOLKOV NF, 1963, FED PROC, V22, pT897; WALTER RM, 1991, DIABETES CARE, V14, P1050, DOI 10.2337/diacare.14.11.1050; Xing L, 2007, ANTIOXID REDOX SIGN, V9, P1979, DOI 10.1089/ars.2007.1921; ZIDENBERGCHERR S, 1983, J NUTR, V113, P2498, DOI 10.1093/jn/113.12.2498	38	32	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6409	6416		10.1074/jbc.M112.447805	http://dx.doi.org/10.1074/jbc.M112.447805			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329836	Green Published, hybrid			2022-12-28	WOS:000315820700035
J	Yang, JW; Huang, HS; Yang, HP; He, XB; Jiang, X; Shi, Y; Alatangaole, D; Shi, LG; Zhou, NM				Yang, Jingwen; Huang, Haishan; Yang, Huipeng; He, Xiaobai; Jiang, Xue; Shi, Ying; Alatangaole, Damirin; Shi, Liangen; Zhou, Naiming			Specific Activation of the G Protein-coupled Receptor BNGR-A21 by the Neuropeptide Corazonin from the Silkworm, Bombyx mori, Dually Couples to the G(q) and G(s) Signaling Cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; FUNCTIONAL-CHARACTERIZATION; ADIPOKINETIC HORMONE; NONVISUAL ARRESTIN; DARK-COLOR; IDENTIFICATION; EXPRESSION; STIMULATION; GENE; NEUROHORMONE	Corazonin, an undecapeptide neurohormone sharing a highly conserved amino acid sequence across Insecta, plays different physiological roles in the regulation of heart contraction rates, silk spinning rates, the induction of dark color and morphometric phase changes, and ecdysis. Corazonin receptors have been identified in Drosophila melanogaster, Manduca sexta, and Musca domestica. However, detailed information on the signaling and major physiological functions of corazonin and its receptor is largely unknown. In the current study, using both the mammalian cell line HEK293 and insect cell lines BmN and Sf21, we paired the Bombyx corazonin neuropeptide as a specific endogenous ligand for the Bombyx neuropeptide G protein-coupled receptor A21 (BNGR-A21), and we therefore designated this receptor as BmCrzR. Further characterization indicated that synthetic BmCrz demonstrated a high affinity for and activated BmCrzR, resulting in intracellular cAMP accumulation, Ca2+ mobilization, and ERK1/2 phosphorylation via the G(q)- and G(s)-coupled signaling pathways. The direct interaction of BmCrzR with BmCrz was confirmed by a rhodamine-labeled BmCrz peptide. Moreover, experiments with double-stranded RNA and synthetic peptide injection suggested a possible role of BmCrz/BmCrzR in the regulation of larval growth and spinning rate. Our present results provide the first in-depth information on BmCrzR-mediated signaling for further elucidation of the BmCrz/BmCrzR system in the regulation of fundamental physiological processes.	[Yang, Jingwen; Jiang, Xue; Shi, Liangen] Zhejiang Univ, Coll Anim Sci, Dept Econ Zool, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Huipeng; He, Xiaobai; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Huang, Haishan] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Model Organisms, Wenzhou 325035, Zhejiang, Peoples R China; [Alatangaole, Damirin] Inner Mongolia Univ, Coll Life Sci, Dept Biochem & Mol Biol, Hohhot 010021, Inner Mongolia, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Inner Mongolia University	Shi, LG (corresponding author), Zhejiang Univ, Coll Anim Sci, Dept Econ Zool, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	slgsilk@zju.edu.cn; znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022		Ministry of Science and Technology of China [2012CB910402]; National Natural Science Foundation of China [31072090, 31272375]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2012CB910402 and the National Natural Science Foundation of China Grants 31072090 and 31272375.	Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Belmont M, 2006, BIOCHEM BIOPH RES CO, V344, P160, DOI 10.1016/j.bbrc.2006.03.117; Bergland AO, 2012, PLOS GENET, V8, P215, DOI 10.1371/journal.pgen.1002631; Boerjan B, 2010, GEN COMP ENDOCR, V166, P222, DOI 10.1016/j.ygcen.2009.09.004; Callaghan B, 2006, AM J PHYSIOL-HEART C, V291, pH2541, DOI 10.1152/ajpheart.00420.2006; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Choi SH, 2008, J COMP NEUROL, V507, P1184, DOI 10.1002/cne.21594; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Grach C, 2004, PHYSIOL ENTOMOL, V29, P97, DOI 10.1111/j.1365-3032.2004.00370.x; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hillyer JF, 2012, INSECT MOL BIOL, V21, P343, DOI 10.1111/j.1365-2583.2012.01140.x; HORIE K, 1995, MOL PHARMACOL, V48, P392; Hua YJ, 2000, J INSECT PHYSIOL, V46, P853, DOI 10.1016/S0022-1910(99)00173-0; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Johnson EC, 2008, INSECT BIOCHEM MOLEC, V38, P1016, DOI 10.1016/j.ibmb.2008.09.003; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Kaufmann C, 2009, INSECT BIOCHEM MOLEC, V39, P770, DOI 10.1016/j.ibmb.2009.09.002; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kuhn B, 1996, MOL ENDOCRINOL, V10, P1697, DOI 10.1210/me.10.12.1697; Lee G, 2008, CELL TISSUE RES, V331, P659, DOI 10.1007/s00441-007-0549-5; Li G, 2011, J BIOL CHEM, V286, P31199, DOI 10.1074/jbc.M111.241372; Maruko T, 2005, N-S ARCH PHARMACOL, V372, P153, DOI 10.1007/s00210-005-0001-x; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Predel R, 2007, PEPTIDES, V28, P3, DOI 10.1016/j.peptides.2006.10.011; Qi-Miao S, 2003, EUR J ENTOMOL, V100, P283, DOI 10.14411/eje.2003.044; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Roman G, 2000, GENETICS, V155, P1281; Roy SJ, 2010, EUR J PHARMACOL, V630, P10, DOI 10.1016/j.ejphar.2009.12.022; Rubovitch V, 2003, MOL BRAIN RES, V110, P261, DOI 10.1016/S0169-328X(02)00656-3; Sha K, 2012, GENE, V497, P191, DOI 10.1016/j.gene.2012.01.052; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shi Y, 2011, J BIOL CHEM, V286, P42390, DOI 10.1074/jbc.M111.275602; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Tanaka Y, 2003, PEPTIDES, V24, P837, DOI 10.1016/S0196-9781(03)00169-4; Tanaka Y, 2002, J INSECT PHYSIOL, V48, P707, DOI 10.1016/S0022-1910(02)00094-X; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Viard P, 2001, BRIT J PHARMACOL, V132, P669, DOI 10.1038/sj.bjp.0703864; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Wise S, 2002, J COMP NEUROL, V447, P366, DOI 10.1002/cne.10242; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yamaoka K, 2009, BIOCHEM BIOPH RES CO, V389, P678, DOI 10.1016/j.bbrc.2009.09.064; Yerushalmi Y., 2002, PHYSIOL ENTOMOL, V25, P127; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141; Zhu CG, 2009, FEBS LETT, V583, P1463, DOI 10.1016/j.febslet.2009.03.060	54	25	27	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11662	11675		10.1074/jbc.M112.441675	http://dx.doi.org/10.1074/jbc.M112.441675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23457297	hybrid, Green Published			2022-12-28	WOS:000318157600005
J	Deka, RK; Brautigam, CA; Liu, WZ; Tomchick, DR; Norgard, MV				Deka, Ranjit K.; Brautigam, Chad A.; Liu, Wei Z.; Tomchick, Diana R.; Norgard, Michael V.			The TP0796 Lipoprotein of Treponema pallidum Is a Bimetal-dependent FAD Pyrophosphatase with a Potential Role in Flavin Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; ADENINE GLYCOSYLASE MUTY; COMPLETE GENOME SEQUENCE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISMS; FMN PHOSPHOHYDROLASE; THIAMINE SYNTHESIS; CHORISMATE LYASE; MEMBRANE-PROTEIN; IN-VIVO	Treponema pallidum, an obligate parasite of humans and the causative agent of syphilis, has evolved the capacity to exploit host-derived metabolites for its survival. Flavin-containing compounds are essential cofactors that are required for metabolic processes in all living organisms, and riboflavin is a direct precursor of the cofactors FMN and FAD. Unlike many pathogenic bacteria, Treponema pallidum cannot synthesize riboflavin; we recently described a flavin-uptake mechanism composed of an ABC-type transporter. However, there is a paucity of information about flavin utilization in bacterial periplasms. Using a discovery-driven approach, we have identified the TP0796 lipoprotein as a previously uncharacterized Mg2+-dependent FAD pyrophosphatase within the ApbE superfamily. TP0796 probably plays a central role in flavin turnover by hydrolyzing exogenously acquired FAD, yielding AMP and FMN. Biochemical and structural investigations revealed that the enzyme has a unique bimetal Mg2+ catalytic center. Furthermore, the pyrophosphatase activity is product-inhibited by AMP, indicating a possible role for this molecule in modulating FMN and FAD levels in the treponemal periplasm. The ApbE superfamily was previously thought to be involved in thiamine biosynthesis, but our characterization of TP0796 prompts a renaming of this superfamily as a periplasmic flavin-trafficking protein (Ftp). TP0796 is the first structurally and biochemically characterized FAD pyrophosphate enzyme in bacteria. This new paradigm for a bacterial flavin utilization pathway may prove to be useful for future inhibitor design.	[Deka, Ranjit K.; Liu, Wei Z.; Norgard, Michael V.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Brautigam, Chad A.; Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tomchick, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Diana.Tomchick@UTSouthwestern.edu; Michael.Norgard@UTSouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643; Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [AI056305]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI056305 (to M. V. N.).; We thank Martin Goldberg for technical assistance and the scientists in the University of Texas Southwestern Protein Chemistry Core for protein sequence and mass analyses. The structures shown in this report are derived from work performed on beamline 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand A, 2012, J BACTERIOL, V194, P2321, DOI 10.1128/JB.00101-12; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; Beck BJ, 1999, J BACTERIOL, V181, P7285, DOI 10.1128/JB.181.23.7285-7290.1999; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; BRENNAN S, 1992, REV SCI INSTRUM, V63, P850, DOI 10.1063/1.1142625; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Covington ED, 2010, MOL MICROBIOL, V78, P519, DOI 10.1111/j.1365-2958.2010.07353.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; Deka RK, 2013, MBIO, V4, DOI 10.1128/mBio.00615-12; Deka RK, 2012, J MOL BIOL, V416, P678, DOI 10.1016/j.jmb.2012.01.015; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Deka RK, 2004, J BIOL CHEM, V279, P55644, DOI 10.1074/jbc.M409263200; Deka RK, 2004, J BACTERIOL, V186, P2303, DOI 10.1128/JB.186.8.2303-2308.2004; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORTI G, 1968, EUR J BIOCHEM, V3, P461, DOI 10.1111/j.1432-1033.1967.tb19553.x; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Gallagher DT, 2001, PROTEINS, V44, P304, DOI 10.1002/prot.1095; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gorelik M, 2006, PROTEIN SCI, V15, P1506, DOI 10.1110/ps.062146906; Han C, 2011, STAND GENOMIC SCI, V4, P361, DOI 10.4056/sigs.1984594; Han GW, 2006, PROTEINS, V64, P1083, DOI 10.1002/prot.20950; Herguedas B, 2010, J MOL BIOL, V400, P218, DOI 10.1016/j.jmb.2010.05.018; HINKSON JW, 1968, BIOCHEMISTRY-US, V7, P2666, DOI 10.1021/bi00847a033; Holden MJ, 2002, BBA-PROTEIN STRUCT M, V1594, P160, DOI 10.1016/S0167-4838(01)00302-8; Hustad S, 2002, CLIN CHEM, V48, P1571; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knapp K, 2012, STRUCTURE, V20, P2161, DOI 10.1016/j.str.2012.10.001; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE RSF, 1988, J BIOL CHEM, V263, P14878; Lee RSF, 1997, METHOD ENZYMOL, V280, P424; Luthra A, 2011, J BIOL CHEM, V286, P41656, DOI 10.1074/jbc.M111.305284; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Machius M, 2007, J MOL BIOL, V373, P681, DOI 10.1016/j.jmb.2007.08.018; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Maruta T, 2012, PLANT CELL PHYSIOL, V53, P1106, DOI 10.1093/pcp/pcs054; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Pallotta ML, 2011, YEAST, V28, P693, DOI 10.1002/yea.1897; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Reidl J, 2000, MOL MICROBIOL, V35, P1573, DOI 10.1046/j.1365-2958.2000.01829.x; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Robinson Jr W. N., 1993, SYPHILIS HIST, P334; Saier MH, 2000, J MOL MICROB BIOTECH, V2, P393; Sandoval FJ, 2008, J BIOL CHEM, V283, P30890, DOI 10.1074/jbc.M803416200; Schmidt-Brauns J, 2001, INT J MED MICROBIOL, V291, P219, DOI 10.1078/1438-4221-00122; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SELL S, 1983, INT REV EXP PATHOL, V24, P203; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; SKARE JT, 1993, J BIOL CHEM, V268, P16302; Strauss EJ, 1997, SCIENCE, V276, P707, DOI 10.1126/science.276.5313.707; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	80	21	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11106	11121		10.1074/jbc.M113.449975	http://dx.doi.org/10.1074/jbc.M113.449975			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23447540	Green Published, hybrid			2022-12-28	WOS:000317915500016
J	Matusica, D; Skeldal, S; Sykes, AM; Palstra, N; Sharma, A; Coulson, EJ				Matusica, Dusan; Skeldal, Sune; Sykes, Alex M.; Palstra, Nickless; Sharma, Aanchal; Coulson, Elizabeth J.			An Intracellular Domain Fragment of the p75 Neurotrophin Receptor (p75(NTR)) Enhances Tropomyosin Receptor Kinase A (TrkA) Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; PC12 CELL-DIFFERENTIATION; AFFINITY NGF RECEPTOR; SYMPATHETIC NEURONS; GAMMA-SECRETASE; SIGNAL-TRANSDUCTION; FACTOR BINDING; DEATH DOMAIN; MAP KINASE; IN-VIVO	Facilitation of nerve growth factor (NGF) signaling by the p75 neurotrophin receptor (p75(NTR)) is critical for neuronal survival and differentiation. However, the interaction between p75(NTR) and TrkA receptors required for this activity is not understood. Here, we report that a specific 29-amino acid peptide derived from the intracellular domain fragment of p75(NTR) interacts with and potentiates binding of NGF to TrkA-expressing cells, leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced Erk1/2 and Akt signaling. An endogenous intracellular domain fragment of p75(NTR) (p75(ICD)) containing these 29 amino acids is produced by regulated proteolysis of the full-length receptor. We demonstrate that generation of this fragment is a requirement for p75(NTR) to facilitate TrkA signaling in neurons and propose that the juxtamembrane region of p75(ICD) acts to cause a conformational change within the extracellular domain of TrkA. This finding provides new insight into the mechanism by which p75(NTR) and TrkA interact to enhance neurotrophic signaling.	[Matusica, Dusan; Skeldal, Sune; Sykes, Alex M.; Palstra, Nickless; Sharma, Aanchal; Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland	Coulson, EJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	e.coulson@uq.edu.au	Matusica, Dusan/G-8138-2011; Coulson, Elizabeth J./C-8766-2009	Matusica, Dusan/0000-0001-6472-7653; Coulson, Elizabeth J./0000-0003-3783-6197; Sykes, Alex/0000-0001-8981-6652	National Health and Medical Research Council of Australia (NHMRC) [10012610, 569507]; NHMRC [569601]; Australian Research Council [LP110100403]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grants 10012610 and 569507, NHMRC Career Development Fellowship 569601 (to E. J. C.), and Australian Research Council Grant LP110100403.	Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Barrett GL, 1996, J NEUROSCI RES, V45, P117, DOI 10.1002/(SICI)1097-4547(19960715)45:2<117::AID-JNR4>3.0.CO;2-D; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BLOCK T, 1983, J NEUROCHEM, V40, P1654, DOI 10.1111/j.1471-4159.1983.tb08139.x; Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Coulson EJ, 2004, PROG BRAIN RES, V146, P41, DOI 10.1016/S0079-6123(03)46003-2; Coulson EJ, 1999, J BIOL CHEM, V274, P16387, DOI 10.1074/jbc.274.23.16387; Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; FAY SP, 1991, BIOCHEMISTRY-US, V30, P5066, DOI 10.1021/bi00234a033; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; FUKUDA M, 1995, ONCOGENE, V11, P239; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; Ho A, 2001, CANCER RES, V61, P474; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; IBANEZ CF, 1994, J NEUROBIOL, V25, P1349, DOI 10.1002/neu.480251104; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kim Y, 2004, MOL CELLS, V18, P353; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, DEVELOPMENT, V120, P1027; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sklar LA, 2002, ANNU REV BIOPH BIOM, V31, P97, DOI 10.1146/annurev.biophys.31.082901.134406; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Weible MW, 2004, J NEUROSCI RES, V75, P771, DOI 10.1002/jnr.20021; Weible MW, 2001, CYTOMETRY, V43, P182, DOI 10.1002/1097-0320(20010301)43:3<182::AID-CYTO1047>3.0.CO;2-J; WOLF DE, 1995, J BIOL CHEM, V270, P2133, DOI 10.1074/jbc.270.5.2133; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zareen N, 2009, JOVE-J VIS EXP, V23, pe988	58	35	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11144	11154		10.1074/jbc.M112.436469	http://dx.doi.org/10.1074/jbc.M112.436469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23471969	Green Published, hybrid			2022-12-28	WOS:000317915500019
J	Filippova, EV; Weston, LA; Kuhn, ML; Geissler, B; Gehring, AM; Armoush, N; Adkins, CT; Minasov, G; Dubrovska, I; Shuvalova, L; Winsor, JR; Lavis, LD; Satchell, KJF; Becker, DP; Anderson, WF; Johnson, RJ				Filippova, Ekaterina V.; Weston, Leigh A.; Kuhn, Misty L.; Geissler, Brett; Gehring, Alexandra M.; Armoush, Nicola; Adkins, Chinessa T.; Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Winsor, James R.; Lavis, Luke D.; Satchell, Karla J. F.; Becker, Daniel P.; Anderson, Wayne F.; Johnson, R. Jeremy			Large Scale Structural Rearrangement of a Serine Hydrolase from Francisella tularensis Facilitates Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; ALPHA/BETA-HYDROLASE; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; SUBSTRATE-SPECIFICITY; OPEN CONFORMATION; PROTEIN; MODEL; CARBOXYLESTERASE; ESTERASE	Tularemia is a deadly, febrile disease caused by infection by the Gram-negative bacterium, Francisella tularensis. Members of the ubiquitous serine hydrolase protein family are among current targets to treat diverse bacterial infections. Herein we present a structural and functional study of a novel bacterial carboxylesterase (FTT258) from F. tularensis, a homologue of human acyl protein thioesterase (hAPT1). The structure of FTT258 has been determined in multiple forms, and unexpectedly large conformational changes of a peripheral flexible loop occur in the presence of a mechanistic cyclobutanone ligand. The concomitant changes in this hydrophobic loop and the newly exposed hydrophobic substrate binding pocket suggest that the observed structural changes are essential to the biological function and catalytic activity of FTT258. Using diverse substrate libraries, site-directed mutagenesis, and liposome binding assays, we determined the importance of these structural changes to the catalytic activity and membrane binding activity of FTT258. Residues within the newly exposed hydrophobic binding pocket and within the peripheral flexible loop proved essential to the hydrolytic activity of FTT258, indicating that structural rearrangement is required for catalytic activity. Both FTT258 and hAPT1 also showed significant association with liposomes designed to mimic bacterial or human membranes, respectively, even though similar structural rearrangements for hAPT1 have not been reported. The necessity for acyl protein thioesterases to have maximal catalytic activity near the membrane surface suggests that these conformational changes in the protein may dually regulate catalytic activity and membrane association in bacterial and human homologues.	[Weston, Leigh A.; Gehring, Alexandra M.; Johnson, R. Jeremy] Butler Univ, Dept Chem, Indianapolis, IN 46208 USA; [Filippova, Ekaterina V.; Kuhn, Misty L.; Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Winsor, James R.; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Filippova, Ekaterina V.; Kuhn, Misty L.; Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Winsor, James R.; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Geissler, Brett; Satchell, Karla J. F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Armoush, Nicola; Becker, Daniel P.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60660 USA; [Adkins, Chinessa T.; Lavis, Luke D.] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA	Butler University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Howard Hughes Medical Institute	Johnson, RJ (corresponding author), Butler Univ, Dept Chem, 4600 Sunset Ave, Indianapolis, IN 46208 USA.	rjjohns1@butler.edu	Satchell, Karla/GSN-3100-2022	Minasov, George/0000-0001-5460-3462; Lavis, Luke/0000-0002-0789-6343; Winsor, James/0000-0002-9673-4839	Department of Health and Human Services, NIAID, National Institutes of Health (NIH) [HHSN272200700058C]; NIH [AI051490]; Burroughs Wellcome Fund; Butler University; Howard Hughes Medical Institute; Indiana Academy of Sciences; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490] Funding Source: NIH RePORTER	Department of Health and Human Services, NIAID, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Butler University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Indiana Academy of Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Department of Health and Human Services, NIAID, National Institutes of Health (NIH) Contract HHSN272200700058C (to W. F. A.), NIH Grant AI051490 (to K. J. F. S.), and an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund (to K. J. F. S.).; Supported by a Holcomb grant from Butler University.; Supported by the Howard Hughes Medical Institute.; Supported by start-up funds and a Holcomb grant from Butler University and a Senior Research Grant from the Indiana Academy of Sciences. To whom correspondence should be addressed: Dept. of Chemistry, Butler University, 4600 Sunset Ave., Indianapolis, IN 46208. Tel.: 317-940-9062; Fax: 317-940-9519; E-mail: rjjohns1@butler.edu.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Armoush N, 2008, SYNTHETIC COMMUN, V38, P1679, DOI 10.1080/00397910801981110; Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Bisel P, 1998, EUR J ORG CHEM, V1998, P729, DOI 10.1002/(SICI)1099-0690(199804)1998:4<729::AID-EJOC729>3.0.CO;2-B; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Busto E, 2010, CHEM SOC REV, V39, P4504, DOI 10.1039/c003811c; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; DEREWENDA ZS, 1991, BIOCHEM CELL BIOL, V69, P842, DOI 10.1139/o91-125; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Drzewiecki K, 2010, MICROB BIOTECHNOL, V3, P84, DOI 10.1111/j.1751-7915.2009.00150.x; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forestal CA, 2008, MICROB PATHOGENESIS, V44, P512, DOI 10.1016/j.micpath.2008.01.003; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Heal WP, 2012, TOP CURR CHEM, V324, P115, DOI 10.1007/128_2011_299; Hedge MK, 2012, BBA-PROTEINS PROTEOM, V1824, P1024, DOI 10.1016/j.bbapap.2012.05.009; Hirano T, 2009, BBA-MOL CELL BIOL L, V1791, P797, DOI 10.1016/j.bbalip.2009.05.001; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Johnson JW, 2010, J AM CHEM SOC, V132, P2558, DOI 10.1021/ja9086374; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Kim S, 2004, BIOSCI BIOTECH BIOCH, V68, P2289, DOI 10.1271/bbb.68.2289; Kim Y, 2008, ADV PROTEIN CHEM, V75, P85, DOI 10.1016/S0065-3233(07)75003-9; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Lall MS, 2002, J ORG CHEM, V67, P1536, DOI 10.1021/jo0109016; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavis LD, 2011, CHEM SCI, V2, P521, DOI 10.1039/c0sc00466a; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Macarron R, 2011, MOL BIOTECHNOL, V47, P270, DOI 10.1007/s12033-010-9335-9; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parra MC, 2010, MICROBIOL RES, V165, P531, DOI 10.1016/j.micres.2009.11.004; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Pesaresi A, 2005, CURR MICROBIOL, V50, P102, DOI 10.1007/s00284-004-4414-4; Pesaresi A, 2010, BIOCHIMIE, V92, P1787, DOI 10.1016/j.biochi.2010.09.001; Pohanka M, 2009, FOLIA MICROBIOL, V54, P263, DOI 10.1007/s12223-009-0046-1; Qin AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024611; Rehm S, 2010, PROTEIN SCI, V19, P2122, DOI 10.1002/pro.493; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Tian L, 2012, P NATL ACAD SCI USA, V109, P4756, DOI 10.1073/pnas.1111943109; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; West NP, 2011, CHEM COMMUN, V47, P5166, DOI 10.1039/c0cc05635a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	63	23	23	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10522	10535		10.1074/jbc.M112.446625	http://dx.doi.org/10.1074/jbc.M112.446625			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430251	Green Published, hybrid			2022-12-28	WOS:000317565000032
J	Hertel, P; Daniel, J; Stegehake, D; Vaupel, H; Kailayangiri, S; Gruel, C; Woltersdorf, C; Liebau, E				Hertel, Patrick; Daniel, Jens; Stegehake, Dirk; Vaupel, Hannah; Kailayangiri, Sareetha; Gruel, Clio; Woltersdorf, Christian; Liebau, Eva			The Ubiquitin-fold Modifier 1 (Ufm1) Cascade of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CRYSTAL-STRUCTURE; C-ELEGANS; SYSTEM; ENZYME; CALCINEURIN; INTERACT; BINDING; LIGASE	Ufm1 (ubiquitin-fold modifier 1) is the most recently identified member of the ubiquitin-like protein family. We characterized the Ufm1 cascade of the model organism Caenorhabditis elegans in terms of function and analyzed interactions of the involved proteins in vitro and in vivo. Furthermore, we investigated the phenotypes of the deletion mutants uba5(ok3364) (activating enzyme of Ufm1) and ufc1(tm4888) (conjugating enzyme of Ufm1). The viable deletion mutants showed a decrease in reproduction, development, life span, and a reduced survival under heavy metal stress. However, an increased survival rate under pathogenic, oxidative, heat, and endoplasmic reticulum stress was observed. We propose that the Ufm1 cascade negatively regulates the IRE1-mediated unfolded protein response.	[Hertel, Patrick; Daniel, Jens; Stegehake, Dirk; Vaupel, Hannah; Kailayangiri, Sareetha; Gruel, Clio; Woltersdorf, Christian; Liebau, Eva] Univ Munster, Dept Mol Physiol, Inst Anim Physiol, D-48143 Munster, Germany	University of Munster	Liebau, E (corresponding author), Univ Munster, Dept Mol Physiol, Inst Anim Physiol, Schlosspl 8, D-48143 Munster, Germany.	liebaue@uni-muenster.de						Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; BRENNER S, 1974, GENETICS, V77, P71; CARDENAS ME, 1994, EMBO J, V13, P5944, DOI 10.1002/j.1460-2075.1994.tb06940.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Einarson M. B., 2007, CSH PROTOC, V2007; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Ha BH, 2011, J BIOL CHEM, V286, P10248, DOI 10.1074/jbc.M110.172171; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Kim SS, 1997, J MOL NEUROSCI, V9, P49, DOI 10.1007/BF02789394; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Mizushima T, 2007, BIOCHEM BIOPH RES CO, V362, P1079, DOI 10.1016/j.bbrc.2007.08.129; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Nam S, 2009, J BIOL CHEM, V284, P8192, DOI 10.1074/jbc.M808230200; Neziri D, 2010, BBA-GEN SUBJECTS, V1800, P430, DOI 10.1016/j.bbagen.2009.12.004; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Zhang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048587	44	25	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10661	10671		10.1074/jbc.M113.458000	http://dx.doi.org/10.1074/jbc.M113.458000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23449979	hybrid, Green Published			2022-12-28	WOS:000317565000044
J	Yu, ZH; Xu, J; Walls, CD; Chen, L; Zhang, S; Zhang, RY; Wu, L; Wang, LN; Liu, SJ; Zhang, ZY				Yu, Zhi-Hong; Xu, Jie; Walls, Chad D.; Chen, Lan; Zhang, Sheng; Zhang, Ruoyu; Wu, Li; Wang, Lina; Liu, Sijiu; Zhang, Zhong-Yin			Structural and Mechanistic Insights into LEOPARD Syndrome-Associated SHP2 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; NOONAN-SYNDROME; GERMLINE MUTATIONS; KINASE ACTIVATION; PTPN11 MUTATIONS; MOUSE MODEL; BINDING; SH-PTP2; KRAS	SHP2 is an allosteric phosphatase essential for growth factor-mediated Ras activation. Germ-line mutations in SHP2 cause clinically similar LEOPARD and Noonan syndromes, two of several autosomal-dominant conditions characterized by gain-of-function mutations in the Ras pathway. Interestingly, Noonan syndrome SHP2 mutants are constitutively active, whereas LEOPARD syndrome SHP2 mutants exhibit reduced phosphatase activity. How do catalytically impaired LEOPARD syndrome mutants engender gain-of-function phenotypes? Our study reveals that LEOPARD syndrome mutations weaken the intramolecular interaction between the N-SH2 and phosphatase domains, leading to a change in SHP2 molecular switching mechanism. Consequently, LEOPARD syndrome SHP2 mutants bind upstream activators preferentially and are hypersensitive to growth factor stimulation. They also stay longer with scaffolding adapters, thus prolonging substrate turnover, which compensates for the reduced phosphatase activity. The study provides a solid framework for understanding how individual SHP2 mutations cause diseases.	[Yu, Zhi-Hong; Xu, Jie; Walls, Chad D.; Chen, Lan; Zhang, Sheng; Zhang, Ruoyu; Wu, Li; Wang, Lina; Liu, Sijiu; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Lan; Wu, Li] Indiana Univ Sch Med, Chem Genom Core Facil, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iu.edu			National Institutes of Health [CA69202]; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA69202.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Hanna N, 2006, FEBS LETT, V580, P2477, DOI 10.1016/j.febslet.2006.03.088; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Oishi K, 2006, HUM MOL GENET, V15, P543, DOI 10.1093/hmg/ddi471; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025	47	76	80	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10472	10482		10.1074/jbc.M113.450023	http://dx.doi.org/10.1074/jbc.M113.450023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457302	hybrid, Green Published			2022-12-28	WOS:000317565000027
J	Ahn, KH; Mahmoud, MM; Shim, JY; Kendall, DA				Ahn, Kwang H.; Mahmoud, Mariam M.; Shim, Joong-Youn; Kendall, Debra A.			Distinct Roles of beta-Arrestin 1 and beta-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ALLOSTERIC MODULATION; KINASE ACTIVATION; REGULATED KINASES; DOWN-REGULATION; 7TM RECEPTORS; HELIX 8; AGONIST; MECHANISM; PATHWAY	The cannabinoid receptor 1 (CB1) is a G protein-coupled receptor primarily expressed in brain tissue that has been implicated in several disease states. CB1 allosteric compounds, such as ORG27569, offer enormous potential as drugs over orthosteric ligands, but their mechanistic, structural, and downstream effects upon receptor binding have not been established. Previously, we showed that ORG27569 enhances agonist binding affinity to CB1 but inhibits G protein-dependent agonist signaling efficacy in HEK293 cells and rat brain expressing the CB1 receptor (Ahn, K. H., Mahmoud, M. M., and Kendall, D. A. (2012) J. Biol. Chem. 287, 12070-12082). Here, we identify the mediators of CB1 receptor internalization and ORG27569-induced G protein-independent signaling. Using siRNA technology, we elucidate an ORG27569-induced signaling mechanism for CB1 wherein beta-arrestin 1 mediates short term signaling to ERK1/2 with a peak at 5 min and other upstream kinase components including MEK1/2 and c-Src. Consistent with these findings, we demonstrate co-localization of CB1-GFP with red fluorescent protein-beta-arrestin 1 upon ORG27569 treatment using confocal microscopy. In contrast, we show the critical role of beta-arrestin 2 in CB1 receptor internalization upon treatment with CP55940 (agonist) or treatment with ORG27569. These results demonstrate for the first time the involvement of beta-arrestin in CB1-biased signaling by a CB1 allosteric modulator and also define the differential role of the two beta-arrestin isoforms in CB1 signaling and internalization.	[Ahn, Kwang H.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Mahmoud, Mariam M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	University of Connecticut; University of Connecticut; University of North Carolina; North Carolina Central University	Kendall, DA (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, 69 N Eagleville Rd, Storrs, CT 06269 USA.	debra.kendall@uconn.edu		Mahmoud, Mariam/0000-0002-0491-1544	National Institutes of Health [DA020763]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA020763 (to D. A. K.).	Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Baillie GL, 2013, MOL PHARMACOL, V83, P322, DOI 10.1124/mol.112.080879; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Davis AA, 2010, ACS CHEM NEUROSCI, V1, P542, DOI 10.1021/cn100011e; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Klaasse EC, 2005, EUR J PHARMACOL, V522, P1, DOI 10.1016/j.ejphar.2005.08.052; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Langmead CJ, 2006, MOL PHARMACOL, V69, P236, DOI 10.1124/mol.105.017814; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Navarro HA, 2009, BRIT J PHARMACOL, V156, P1178, DOI 10.1111/j.1476-5381.2009.00124.x; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Perez DM, 1996, MOL PHARMACOL, V49, P112; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Zhang YQ, 2005, J PHARMACOL EXP THER, V315, P1212, DOI 10.1124/jpet.105.090308	57	100	101	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9790	9800		10.1074/jbc.M112.438804	http://dx.doi.org/10.1074/jbc.M112.438804			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23449980	Green Published, hybrid			2022-12-28	WOS:000317114000020
J	Bhattacharyya, S; Singh, P; Rathore, U; Purwar, M; Wagner, D; Arendt, H; DeStefano, J; LaBranche, CC; Montefiori, DC; Phogat, S; Varadarajan, R				Bhattacharyya, Sanchari; Singh, Pranveer; Rathore, Ujjwal; Purwar, Mansi; Wagner, Denise; Arendt, Heather; DeStefano, Joanne; LaBranche, Celia C.; Montefiori, David C.; Phogat, Sanjay; Varadarajan, Raghavan			Design of an Escherichia coli Expressed HIV-1 gp120 Fragment Immunogen That Binds to b12 and Induces Broad and Potent Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; CD4-BINDING SITE; CD4 BINDING; COMPUTATIONAL DESIGN; STRUCTURAL BASIS; RATIONAL DESIGN; CD4-BOUND STATE; MONOMERIC GP120	b12, one of the few broadly neutralizing antibodies against HIV-1, binds to the CD4 binding site (CD4bs) on the gp120 subunit of HIV-1 Env. Two small fragments of HIV-1 gp120, b121a and b122a, which display about 70% of the b12 epitope and include solubility-enhancing mutations, were designed. Bacterially expressed b121a/b122a were partially folded and could bind b12 but not the CD4bs-directed non-neutralizing antibody b6. Sera from rabbits primed with b121a or b122a protein fragments and boosted with full-length gp120 showed broad neutralizing activity in a TZM-bl assay against a 16-virus panel that included nine Tier 2 and 3 viruses as well as in a five-virus panel previously designed to screen for broad neutralization. Using a mean IC50 cut-off of 50, sera from control rabbits immunized with gp120 alone neutralized only one virus of the 14 non-Tier 1 viruses tested (7%), whereas sera from b121a- and b122a-immunized rabbits neutralized seven (50%) and twelve (86%) viruses, respectively. Serum depletion studies confirmed that neutralization was gp120-directed and that sera from animals immunized with gp120 contained lower amounts of CD4bs-directed antibodies than corresponding sera from animals immunized with b121a/b122a. Competition binding assays with b12 also showed that b121a/2a sera contained significantly higher amounts of antibodies directed toward the CD4 binding site than the gp120 sera. The data demonstrate that it is possible to elicit broadly neutralizing sera against HIV-1 in small animals.	[Bhattacharyya, Sanchari; Singh, Pranveer; Rathore, Ujjwal; Purwar, Mansi; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jakkur, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India; [Wagner, Denise; Arendt, Heather; DeStefano, Joanne; Phogat, Sanjay; Varadarajan, Raghavan] Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, New York, NY 11220 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Dept Surg, Durham, NC 27705 USA	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); International AIDS Vaccine Initiative; Duke University	Phogat, S (corresponding author), Sanofi Pasteur, 1 Discovery Dr, Swiftwater, PA 18370 USA.	sanjay.phogat@sanofipasteur.com; varadar@mbu.iisc.ernet.in	Bhattacharyya, Sanchari/L-4344-2019; Rathore, Ujjwal/AAD-9974-2021	Bhattacharyya, Sanchari/0000-0003-3421-4755; Rathore, Ujjwal/0000-0002-0329-7431	Council of Scientific and Industrial Research, Government of India; D. S. Kothari fellowship	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); D. S. Kothari fellowship	Recipient of a fellowship from the Council of Scientific and Industrial Research, Government of India.; Supported by a D. S. Kothari fellowship.	Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cohen J, 2011, SCIENCE, V333, P1560, DOI 10.1126/science.333.6049.1560; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Korber B, 2011, EXPERT REV VACCINES, V10, P929, DOI [10.1586/ERV.11.81, 10.1586/erv.11.81]; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; Murad W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S12; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Roehr B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5880; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Saha P, 2011, BIOCHEMISTRY-US, V50, P7891, DOI 10.1021/bi200870r; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2009, J MOL BIOL, V389, P365, DOI 10.1016/j.jmb.2009.04.019; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Willey R, 2010, AIDS RES HUM RETROV, V26, P89, DOI 10.1089/aid.2009.0144; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	62	22	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9815	9825		10.1074/jbc.M112.425959	http://dx.doi.org/10.1074/jbc.M112.425959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430741	hybrid, Green Published			2022-12-28	WOS:000317114000022
J	Cebula, M; Moolla, N; Capovilla, A; Arner, ESJ				Cebula, Marcus; Moolla, Naazneen; Capovilla, Alexio; Arner, Elias S. J.			The Rare TXNRD1_v3 ("v3") Splice Variant of Human Thioredoxin Reductase 1 Protein Is Targeted to Membrane Rafts by N-Acylation and Induces Filopodia Independently of Its Redox Active Site Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY EMBRYONIC LETHALITY; LIPID RAFTS; PLASMA-MEMBRANE; CHOLERA-TOXIN; ANCHORED PROTEINS; MYRISTOYL-COA; CELLS; PALMITOYLATION; EXPRESSION; COMPLEX	The human selenoprotein thioredoxin reductase 1 (TrxR1), encoded by the TXNRD1 gene, is a key player in redox regulation. Alternative splicing generates several TrxR1 variants, one of which is v3 that carries an atypical N-terminal glutaredoxin domain. When overexpressed, v3 associates with membranes and triggers formation of filopodia. Here we found that membrane targeting of v3 is mediated by myristoylation and palmitoylation of its N-terminal MGC motif, through which v3 specifically targets membrane rafts. This was suggested by its localization in cholera toxin subunit B-stained membrane areas and also shown using lipid fractionation experiments. Utilizing site-directed mutant variants, we also found that v3-mediated generation of filopodia is independent of the Cys residues in its redox active site, but dependent upon its membrane raft targeting. These results identify v3 as an intricately regulated protein that expands TXNRD1-derived protein functions to the membrane raft compartment.	[Cebula, Marcus; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Moolla, Naazneen; Capovilla, Alexio] Univ Witwatersrand, Sch Med, Dept Mol Med & Haematol, ZA-2193 Johannesburg, South Africa	Karolinska Institutet; University of Witwatersrand	Arner, ESJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.	Elias.Arner@ki.se	Arnér, Elias/K-6737-2019; Arnér, Elias S.J./J-5832-2012	Arnér, Elias/0000-0002-4807-6114; Arnér, Elias S.J./0000-0002-4807-6114; Cebula, Marcus/0000-0002-0149-1580	Swedish Research Council (Medicine); Swedish Cancer Society; Wallenberg Foundations; Karolinska Institutet; Medical Research Council (MRC); Polio Research Foundation (PRF) of South Africa	Swedish Research Council (Medicine)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Wallenberg Foundations; Karolinska Institutet(Karolinska Institutet); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Polio Research Foundation (PRF) of South Africa	This work was supported by the Swedish Research Council (Medicine), the Swedish Cancer Society, The Wallenberg Foundations, and the Karolinska Institutet. This work was also supported in part by the Medical Research Council (MRC) and Polio Research Foundation (PRF) of South Africa (to A. C. and N. M.).	Alexander M, 2004, J VIROL, V78, P1685, DOI 10.1128/JVI.78.4.1685-1696.2004; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arstikaitis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016998; Bhatnagar RS, 1999, BBA-MOL CELL BIOL L, V1441, P162, DOI 10.1016/S1388-1981(99)00155-9; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; GRASSIE MA, 1994, BIOCHEM J, V302, P913, DOI 10.1042/bj3020913; Gri G, 2004, IMMUNOL LETT, V94, P247, DOI 10.1016/j.imlet.2004.05.012; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Hara T, 2007, ANTIOXID REDOX SIGN, V9, P1427, DOI 10.1089/ars.2007.1661; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Hintze KJ, 2003, J NUTR, V133, P2721, DOI 10.1093/jn/133.9.2721; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Kondo N, 2007, ANTIOXID REDOX SIGN, V9, P1439, DOI 10.1089/ars.2007.1665; Larive RM, 2010, BBA-BIOMEMBRANES, V1798, P389, DOI 10.1016/j.bbamem.2009.11.016; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; NADLER MJS, 1993, BIOCHEMISTRY-US, V32, P9250, DOI 10.1021/bi00086a034; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Osborne S A, 2001, BMC Genomics, V2, P10, DOI 10.1186/1471-2164-2-10; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rundlof AK, 2000, BIOCHEM J, V347, P661, DOI 10.1042/0264-6021:3470661; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Rundlof AK, 2001, J BIOL CHEM, V276, P30542, DOI 10.1074/jbc.M101452200; Rundlof AK, 2007, DIFFERENTIATION, V75, P123, DOI 10.1111/j.1432-0436.2006.00121.x; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Scorticati C, 2011, J NEUROCHEM, V119, P521, DOI 10.1111/j.1471-4159.2011.07252.x; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Su D, 2004, BIOCHEMISTRY-US, V43, P12177, DOI 10.1021/bi048478t; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Van't Hof W, 2000, METHOD ENZYMOL, V327, P317, DOI 10.1016/S0076-6879(00)27287-X; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	66	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10002	10011		10.1074/jbc.M112.445932	http://dx.doi.org/10.1074/jbc.M112.445932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413027	Green Published, hybrid			2022-12-28	WOS:000317114000039
J	Zhang, J; Chen, C; Hou, XX; Gao, YY; Lin, F; Yang, J; Gao, ZM; Pan, LN; Tao, LQ; Wen, CJ; Yao, ZJ; Tsun, A; Shi, GC; Li, B				Zhang, Jing; Chen, Chen; Hou, Xiaoxia; Gao, Yayi; Lin, Fang; Yang, Jing; Gao, Zhimei; Pan, Lina; Tao, Lianqin; Wen, Chijun; Yao, Zhengju; Tsun, Andy; Shi, Guochao; Li, Bin			Identification of the E3 Deubiquitinase Ubiquitin-specific Peptidase 21 (USP21) as a Positive Regulator of the Transcription Factor GATA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELLS; TGF-BETA; HISTONE ACETYLTRANSFERASE; FOXP3 EXPRESSION; DIFFERENTIATION; PROGRAMS; IL-4	The expression of the transcription factor GATA 3 in FOXP3(+) regulatory T (Treg) cells is crucial for their physiological function in limiting inflammatory responses. Although other studies have shown how T cell receptor (TcR) signals induce the up-regulation of GATA3 expression in Treg cells, the underlying mechanism that maintains GATA3 expression in Treg cells remains unclear. Here, we show how USP21 interacts with and stabilizes GATA3 by mediating its deubiquitination. In a T cell line model, we found that TcR stimulation promoted USP21 expression, which was further up-regulated in the presence of FOXP3. The USP21 mutant C221A reduced its capacity to stabilize GATA3 expression, and its knockdown led to the down-regulation of GATA3 protein expression in Treg cells. Furthermore, we found that FOXP3 could directly bind to the USP21 gene promoter and activated its transcription upon TcR stimulation. Finally, USP21, GATA3, and FOXP3 were found up-regulated in Treg cells that were isolated from asthmatic subjects. In summary, we have identified a USP21-mediated pathway that promotes GATA3 stabilization and expression at the post-translational level. We propose that this pathway forms an important signaling loop that stabilizes the expression of GATA3 in Treg cells.	[Zhang, Jing; Chen, Chen; Gao, Yayi; Lin, Fang; Yang, Jing; Gao, Zhimei; Yao, Zhengju; Tsun, Andy; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, Shanghai 200025, Peoples R China; [Hou, Xiaoxia; Pan, Lina; Tao, Lianqin; Shi, Guochao] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pneumol, Shanghai 200025, Peoples R China; [Wen, Chijun] Shanghai Second Peoples Hosp, Dept Resp Med, Shanghai 200011, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University	Shi, GC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pneumol Med, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	shiguochao@hotmail.com; binli@sibs.ac.cn	lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884	National Natural Science Foundation of China, NSFC [30972702, 31170825, 81270083, 31150110337, 31200647, 81271835]; National Institutes of Health-NSFC Collaborative Grant [81161120417]; Shanghai "Rising Star" Program Grant [10QA1407900]; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2010KIP205, 2012KIP204]	National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); National Institutes of Health-NSFC Collaborative Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai "Rising Star" Program Grant; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by (National Natural Science Foundation of China, NSFC) Grants 30972702, 31170825, 81270083, 31150110337, 31200647, and 81271835; National Institutes of Health-NSFC Collaborative Grant 81161120417; Shanghai "Rising Star" Program Grant 10QA1407900; and the Novo Nordisk-Chinese Academy of Sciences Foundation. This work was also supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grants 2010KIP205 and 2012KIP204.	Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wang YQ, 2010, J IMMUNOL, V185, P5983, DOI 10.4049/jimmunol.1001255; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	35	55	58	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9373	9382		10.1074/jbc.M112.374744	http://dx.doi.org/10.1074/jbc.M112.374744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395819	Green Published, hybrid			2022-12-28	WOS:000316862200054
J	Vu, NT; Park, MA; Shultz, JC; Goehe, RW; Hoeferlin, LA; Shultz, MD; Smith, SA; Lynch, KW; Chalfant, CE				Vu, Ngoc T.; Park, Margaret A.; Shultz, Jacqueline C.; Goehe, Rachel W.; Hoeferlin, L. Alexis; Shultz, Michael D.; Smith, Sarah A.; Lynch, Kristen W.; Chalfant, Charles E.			hnRNP U Enhances Caspase-9 Splicing and Is Modulated by AKT-dependent Phosphorylation of hnRNP L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEAR-MATRIX PROTEIN; DOUBLE-STRAND BREAKS; PRE-MESSENGER-RNA; CELL LUNG-CANCER; U/SAF-A; SAF-A; APOPTOSIS; DNA; TRANSCRIPTION	Caspase-9 has two splice variants, pro-apoptotic caspase-9a and anti-apoptotic caspase-9b, which are regulated by RNA trans-factors associated with exon 3 of caspase-9 pre-mRNA (C9/E3). In this study, we identified hnRNP U as an RNA trans-factor associated with C9/E3. Down-regulation of hnRNP U led to a decrease in the caspase-9a/9bmRNAratio, demonstrating a novel enhancing function. Importantly, hnRNP U bound specifically to C9/E3 at an RNA cis-element previously reported as the binding site for the splicing repressor, hnRNP L. Phosphorylated hnRNP L interfered with hnRNP U binding to C9/E3, and our results demonstrate the importance of the phosphoinositide 3-kinase/AKT pathway in modulating the association of hnRNP U to C9/E3. Taken together, these findings show that hnRNP U competes with hnRNP L for binding to C9/E3 to enhance the inclusion of the four-exon cassette, and this splice-enhancing function is blocked by the AKT pathway via phosphorylation of hnRNP L.	[Vu, Ngoc T.; Park, Margaret A.; Shultz, Jacqueline C.; Goehe, Rachel W.; Hoeferlin, L. Alexis; Shultz, Michael D.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Vu, Ngoc T.] Vietnam Educ Fdn, Arlington, VA 22201 USA; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Smith, Sarah A.; Lynch, Kristen W.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; University of Pennsylvania	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Sanger Hall,Rm 2-016,1101 E Marshall St, Richmond, VA 23298 USA.	cechalfant@vcu.edu		Hoeferlin, L. Alexis/0000-0001-7569-8712	National Institutes of Health [CA154314, R01 GM067719]; Department of Veterans Affairs; Vietnam Education Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA154314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067719] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Vietnam Education Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants CA154314 (to C. E. C.) and R01 GM067719 (to K. W. L.). This work was also supported by a merit review and research career scientist award from the Department of Veterans Affairs (to C. E. C.), a fellowship from the Vietnam Education Foundation (to N. T. V.), and a fellowship from the American Heart Association (to S. A. S.).	Berglund FM, 2009, BIOCHEM BIOPH RES CO, V381, P59, DOI 10.1016/j.bbrc.2009.02.019; Britton S, 2009, CELL CYCLE, V8, P3717, DOI 10.4161/cc.8.22.10025; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Eggert M, 1997, J BIOL CHEM, V272, P28471, DOI 10.1074/jbc.272.45.28471; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Helbig R, 2003, CHROMOSOMA, V112, P173, DOI 10.1007/s00412-003-0258-0; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; Seol DW, 1999, J BIOL CHEM, V274, P2072, DOI 10.1074/jbc.274.4.2072; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Srinivasula SM, 1999, CANCER RES, V59, P999; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062	24	55	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8575	8584		10.1074/jbc.M112.443333	http://dx.doi.org/10.1074/jbc.M112.443333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23396972	Green Published, hybrid			2022-12-28	WOS:000316564500058
J	Fu, XB; Koller, S; Abd Alla, J; Quitterer, U				Fu, Xuebin; Koller, Samuel; Abd Alla, Joshua; Quitterer, Ursula			Inhibition of G-protein-coupled Receptor Kinase 2 (GRK2) Triggers the Growth-promoting Mitogen-activated Protein Kinase (MAPK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; CARDIAC DYSFUNCTION; BETA; HEART; ERK1/2; RAF; G-PROTEIN-COUPLED-RECEPTOR-KINASE-2; PHOSPHORYLATION; OVEREXPRESSION; SELECTIVITY	Inhibition of G-protein-coupled receptor kinase 2 (GRK2) is an emerging treatment option for heart failure. Because GRK2 is also indispensable for growth and development, we analyzed the impact of GRK2 inhibition on cell growth and proliferation. Inhibition of GRK2 by the dominant-negative GRK2-K220R did not affect the proliferation of cultured cells. In contrast, upon xenograft transplantation of cells into immunodeficient mice, the dominant-negative GRK2-K220R or a GRK2-specific peptide inhibitor increased tumor mass. The enhanced tumor growth upon GRK2 inhibition was attributed to the growth-promoting MAPK pathway because dual inhibition of the GRK2 and RAF-MAPK axis by the Raf kinase inhibitor protein (RKIP) did not increase tumor mass. The MAPK cascade contributed to the cardioprotective profile of GRK2 inhibition by preventing cardiomyocyte death, whereas dual inhibition of RAF/MAPK and GRK2 by RKIP induced cardiomyocyte apoptosis, cardiac dysfunction, and signs of heart failure. Thus, cardioprotective signaling induced by GRK2 inhibition is overlapping with tumor growth promotion.	[Fu, Xuebin; Koller, Samuel; Abd Alla, Joshua; Quitterer, Ursula] Swiss Fed Inst Technol ETH Zuerich, Dept Chem & Appl Biosci, Mol Pharmacol Unit, CH-8057 Zurich, Switzerland; [Quitterer, Ursula] Univ Zurich, Dept Med, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Zurich	Quitterer, U (corresponding author), Swiss Fed Inst Technol ETH Zuerich, Dept Chem & Appl Biosci, Mol Pharmacol Unit, Rm Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch	Fu, Xuebin/B-6591-2018; Fu, Xuebin/AAH-9622-2019	Fu, Xuebin/0000-0002-7232-3576; Koller, Samuel/0000-0003-0965-0539; Fu, Xuebin/0000-0002-1281-2466	Swiss National Science Foundation [31-140679]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by Swiss National Science Foundation Grant 31-140679 (to U. Q.).	Abd Alla J, 2010, J BIOL CHEM, V285, P23494, DOI 10.1074/jbc.M110.117481; Abd Alla J, 2010, INTEGR BIOL-UK, V2, P209, DOI 10.1039/b922592g; AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla Said, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P190; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Agwa S. H., 2011, FORUM IMMUNOPATHOL D, V2, P71; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Cheng H, 2011, CIRC RES, V109, P1401, DOI 10.1161/CIRCRESAHA.111.255695; Conner DA, 1997, CIRC RES, V81, P1021; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Esposito G, 2001, CIRCULATION, V103, P1453, DOI 10.1161/01.CIR.103.10.1453; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; GULICK J, 1991, J BIOL CHEM, V266, P9180; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KONG GH, 1994, J BIOL CHEM, V269, P13084; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Metaye T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nagy A., 2003, MANIPULATING MOUSE E; Oka Y., 2010, REGEN MED, V6, P149; Osborne JK, 2012, CELL RES, V22, P14, DOI 10.1038/cr.2011.193; Philipp M, 2008, MOL BIOL CELL, V19, P5478, DOI 10.1091/mbc.E08-05-0448; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Quitterer U, 2011, BIOCHEM BIOPH RES CO, V409, P544, DOI 10.1016/j.bbrc.2011.05.041; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Tachibana H, 2005, CIRCULATION, V111, P591, DOI 10.1161/01.CIR.0000142291.70954.DF; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Volkers M, 2011, CIRC RES, V108, P27, DOI 10.1161/CIRCRESAHA.110.225201; Wei ZY, 2012, J CELL PHYSIOL, V227, P2371, DOI 10.1002/jcp.22972; Winstel R, 2005, BIOCHEM PHARMACOL, V70, P1001, DOI 10.1016/j.bcp.2005.06.015; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109	52	33	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7738	7755		10.1074/jbc.M112.428078	http://dx.doi.org/10.1074/jbc.M112.428078			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362259	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000316455300030
J	Meitzler, JL; Hinde, S; Banfi, B; Nauseef, WM; de Montellano, PRO				Meitzler, Jennifer L.; Hinde, Sara; Banfi, Botond; Nauseef, William M.; de Montellano, Paul R. Ortiz			Conserved Cysteine Residues Provide a Protein-Protein Interaction Surface in Dual Oxidase (DUOX) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; CONGENITAL GOITER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MYELOPEROXIDASE; PEROXIDASE; ACTIVATION; STABILITY; DOMAIN; MODEL	Intramolecular disulfide bond formation is promoted in oxidizing extracellular and endoplasmic reticulum compartments and often contributes to protein stability and function. DUOX1 and DUOX2 are distinguished from other members of the NOX protein family by the presence of a unique extracellular N-terminal region. These peroxidase-like domains lack the conserved cysteines that confer structural stability to mammalian peroxidases. Sequence-based structure predictions suggest that the thiol groups present are solvent-exposed on a single protein surface and are too distant to support intramolecular disulfide bond formation. To investigate the role of these thiol residues, we introduced four individual cysteine to glycine mutations in the peroxidase-like domains of both human DUOXs and purified the recombinant proteins. The mutations caused little change in the stabilities of the monomeric proteins, supporting the hypothesis that the thiol residues are solvent-exposed and not involved in disulfide bonds that are critical for structural integrity. However, the ability of the isolated hDUOX1 peroxidase-like domain to dimerize was altered, suggesting a role for these cysteines in protein-protein interactions that could facilitate homodimerization of the peroxidase-like domain or, in the full-length protein, heterodimeric interactions with a maturation protein. When full-length hDUOX1 was expressed in HEK293 cells, the mutations resulted in decreased H2O2 production that correlated with a decreased amount of the enzyme localized to the membrane surface rather than with a loss of activity or with a failure to synthesize the mutant proteins. These results support a role for the cysteine residues in intermolecular disulfide bond formation with the DUOX maturation factor DUOXA1.	[Meitzler, Jennifer L.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hinde, Sara; Banfi, Botond; Nauseef, William M.] Univ Iowa, Inflammat Program, Dept Med, Iowa City, IA 52240 USA; [Banfi, Botond] Univ Iowa, Dept Anat & Cell Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52240 USA; [Banfi, Botond] Vet Adm Med Ctr, Iowa City, IA 52240 USA; [de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Genentech Hall GH N572D,600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu		Banfi, Botond/0000-0001-9273-1318; Nauseef, William/0000-0003-4032-757X	National Institutes of Health [DK 30297, HL 090830, AI 70958, AI 044642]; National Center for Research Resources Grant [P41RR001614]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070958, P01AI044642, R56AI070958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants DK 30297 (to P. R. O. M.), HL 090830 (to B. B.), and AI 70958 and AI 044642 (to W. M. N.). This work was also supported by the resources and use of facilities at the Iowa City Department of Veterans Affairs Medical Center, Iowa City, IA (to W. M. N.).; We thank Karine Reiter and the Narum laboratory for the use of their JASCO J-815 spectropolarimeter. Mass spectrometric proteomic analyses were carried out by Bio-Organic Bio-medical Mass Spectrometry Resource at the University of California (director, A. L. Burlingame) supported by National Center for Research Resources Grant P41RR001614.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DeLeo FR, 1998, J CLIN INVEST, V101, P2900, DOI 10.1172/JCI2649; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fortunato RS, 2010, J CLIN ENDOCR METAB, V95, P5403, DOI 10.1210/jc.2010-1085; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Gunther V, 2012, BBA-MOL CELL RES, V1823, P476, DOI 10.1016/j.bbamcr.2011.10.006; Hanggi E, 2006, MOL PHARMACOL, V70, P806, DOI 10.1124/mol.105.019547; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Hishinuma A, 1999, J CLIN ENDOCR METAB, V84, P1438, DOI 10.1210/jc.84.4.1438; Kang DC, 2011, BIOCHEMISTRY-US, V50, P8445, DOI 10.1021/bi201175y; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koo BH, 2012, J BIOL CHEM, V287, P22643, DOI 10.1074/jbc.M111.337949; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Loughran NB, 2012, MOL BIOL EVOL, V29, P2039, DOI 10.1093/molbev/mss073; Luxen S, 2009, J CELL SCI, V122, P1238, DOI 10.1242/jcs.044123; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meitzler JL, 2011, ARCH BIOCHEM BIOPHYS, V512, P197, DOI 10.1016/j.abb.2011.05.021; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Morand S, 2004, J BIOL CHEM, V279, P30244, DOI 10.1074/jbc.M405406200; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Singh M, 2011, J STRUCT BIOL, V174, P374, DOI 10.1016/j.jsb.2011.01.013; Song Y, 2010, J CLIN ENDOCR METAB, V95, P375, DOI 10.1210/jc.2009-1727; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200; Tiedge M, 1997, BBA-PROTEIN STRUCT M, V1337, P175, DOI 10.1016/S0167-4838(96)00162-8; Tiedge M, 2000, ARCH BIOCHEM BIOPHYS, V375, P251, DOI 10.1006/abbi.1999.1666; Wolf SM, 2000, J MASS SPECTROM, V35, P210, DOI 10.1002/(SICI)1096-9888(200002)35:2<210::AID-JMS931>3.0.CO;2-Z; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	42	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7147	7157		10.1074/jbc.M112.414797	http://dx.doi.org/10.1074/jbc.M112.414797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23362256	Green Published, hybrid			2022-12-28	WOS:000316002400036
J	Zhou, W; Cao, H; Yang, XH; Cong, K; Wang, W; Chen, TR; Yin, HB; Wu, ZP; Cai, XP; Liu, TL; Xiao, JR				Zhou, Wang; Cao, Hao; Yang, Xinghai; Cong, Kan; Wang, Wei; Chen, Tianrui; Yin, Huabin; Wu, Zhipeng; Cai, Xiaopan; Liu, Tielong; Xiao, Jianru			Characterization of Nuclear Localization Signal in the N Terminus of Integrin-linked Kinase-associated Phosphatase (ILKAP) and Its Essential Role in the Down-regulation of RSK2 Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTIN-ALPHA; CELL-SURVIVAL; STRUCTURAL BASIS; DOCKING; COMPLEX; RECOGNITION; APOPTOSIS; SEQUENCES; DOMAINS; BINDING	Integrin-linked kinase-associated phosphatase (ILKAP) is a serine/threonine (S/T) phosphatase that belongs to the protein phosphatase 2C (PP2C) family. Many previous studies have demonstrated that ILKAP plays key roles in the regulation of cell survival and apoptosis. Researchers have thus far considered ILKAP a cytoplasmic protein that negatively regulates integrin signaling by interacting with and phosphorylating integrin-linked kinase 1 (ILK1). In this study, we found that both endogenous and tagged ILKAP mainly localize to the nucleus and that the nuclear transport of ILKAP is nuclear localization signal (NLS) importin-mediated. The ILKAP protein interacts directly with importin alpha 1, alpha 3, and alpha 5. The NLS in ILKAP is located in the N-terminal region between amino acids 71 and 86, and the NLS-deleted ILKAP protein was distributed in the cytoplasm. In addition, we show that Lys-78 and Arg-79 are critical for the binding of ILKAP to importin alpha. We also found that nuclear ILKAP interacts with ribosomal protein S6 kinase-2 (RSK2) and induces apoptosis by inhibiting RSK2 activity and down-regulating the expression level of the RSK2 downstream substrate cyclin D1. These results indicate that ILKAP is a nuclear protein that regulates cell survival and apoptosis through the regulation of RSK2 signaling.	[Zhou, Wang; Yang, Xinghai; Yin, Huabin; Wu, Zhipeng; Cai, Xiaopan; Liu, Tielong; Xiao, Jianru] Second Mil Med Univ, Changzheng Hosp, Shanghai 200433, Peoples R China; [Cao, Hao] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China; [Cong, Kan] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Wang, Wei] Ctr Dis Control & Prevent CDC ONDIEH NCEH, Off Noncommunicable Dis Injury & Environm Hlth, Natl Ctr Environm Hlth, Doraville, GA 30340 USA; [Chen, Tianrui] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA	Naval Medical University; Jilin University; California State University System; California State University Long Beach; Centers for Disease Control & Prevention - USA; Duke University	Liu, TL (corresponding author), Second Mil Med Univ, Changzheng Hosp, 415 Feng Yang Rd, Shanghai 200433, Peoples R China.	cztielongliu@163.com; jianruxiao83@163.com	Xiao, Jian/GYU-4351-2022		National Natural Science Foundation of China [81201556]; Department of Health of the National Natural Science Foundation of China [2012159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 81201556) and the Department of Health of the National Natural Science Foundation of China (Grant 2012159).	CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kang SM, 2011, EXPERT OPIN THER TAR, V15, P11, DOI 10.1517/14728222.2010.531013; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leung-Hagesteijn C, 2001, EMBO J, V20, P2160, DOI 10.1093/emboj/20.9.2160; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tong Y, 1998, J BIOL CHEM, V273, P35282, DOI 10.1074/jbc.273.52.35282; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1	31	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6259	6271		10.1074/jbc.M112.432195	http://dx.doi.org/10.1074/jbc.M112.432195			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329845	hybrid, Green Published			2022-12-28	WOS:000315820700021
J	Chen, CC; Liou, SW; Chen, CC; Chen, WC; Hu, FR; Wang, IJ; Lin, SJ				Chen, Chun-Chen; Liou, Shiow-Wen; Chen, Chi-Chih; Chen, Wen-Chung; Hu, Fung-Rong; Wang, I-Jong; Lin, Shing-Jong			Coenzyme Q(10) Rescues Ethanol-induced Corneal Fibroblast Apoptosis through the Inhibition of Caspase-2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED APOPTOSIS; MITOCHONDRIAL PERMEABILITY TRANSITION; CYTOCHROME-C RELEASE; OXIDATIVE DNA-DAMAGE; CELL-DEATH; CAENORHABDITIS-ELEGANS; IN-VITRO; ALCOHOL; UBIQUINONE; PATHWAYS	Recent studies indicate that caspase-2 is involved in the early stages of apoptosis, particularly before the occurrence of mitochondrial damage. Here we report the important role of the coenzyme Q(10) (CoQ(10)) on the activity of caspase-2 upstream of mitochondria in ethanol (EtOH)-treated corneal fibroblasts. After EtOH exposure, cells produce excessive reactive oxygen species formation, p53 expression, and most importantly, caspase-2 activation. After the activation of the caspase-2, the cells exhibited hallmarks of apoptotic pathway, such as mitochondrial damage and translocation of Bax and cytochrome c, which were then followed by caspase-3 activation. By pretreating the cells with a cell-permeable, biotinylated pan-caspase inhibitor, we identified caspase-2 as an initiator caspase in EtOH-treated corneal fibroblasts. Loss of caspase-2 inhibited EtOH-induced apoptosis. We further found that caspase-2 acts upstream of mitochondria to mediate EtOH-induced apoptosis. The loss of caspase-2 significantly inhibited EtOH-induced mitochondrial dysfunction, Bax translocation, and cytochrome c release from mitochondria. The pretreatment of CoQ(10) prevented EtOH-induced caspase-2 activation and mitochondria-mediated apoptosis. Our data demonstrated that by blocking caspase-2 activity, CoQ(10) can protect the cells from mitochondrial membrane change, apoptotic protein translocation, and apoptosis. Taken together, EtOH-induced mitochondria-mediated apoptosis is initiated by caspase-2 activation, which is regulated by CoQ(10).	[Chen, Chun-Chen; Liou, Shiow-Wen] Taipei City Hosp Renai Branch, Dept Ophthalmol, Taipei 106, Taiwan; [Chen, Chun-Chen; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Chi-Chih; Chen, Wen-Chung] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei 112, Taiwan; [Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Liou, Shiow-Wen; Hu, Fung-Rong; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 100, Taiwan; [Liou, Shiow-Wen] Taipei Med Univ, Taipei 110, Taiwan; [Wang, I-Jong] China Med Univ, Grad Inst Clin Med Sci, Taichung 404, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; China Medical University Taiwan	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, 7 Chung Shan S Rd, Taipei 100, Taiwan.	ijong@ms8.hinet.net; sjlin@vghtpe.gov.tw		Wang, I-Jong/0000-0002-3045-0614; HU, FUNG-RONG/0000-0002-2102-5317	Taiwan National Science Council [NSC95-2314-B002-149-MY3, NSC96-2627-B002-011, NSC97-2627-B002-007, NSC98-2627-B002-004, NSC98-3112-B002-040, NSC99-3112-B002-029, NSC99-2314-B002-039-MY3, NSC99-2314-B002-040-MY3, NSC100-2314-B002-061-MY3]; Department of Health, Executive Yuan, R.O.C. (Taiwan) [DOH100-TD-PB-111-TM005]; National Taiwan University Hospital [NTUH.98-S1105, NTUH.99-MSN 01, NTUH.100-001637, NTUH.VN101-06]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, R.O.C. (Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported in part by Taiwan National Science Council Grants NSC95-2314-B002-149-MY3, NSC96-2627-B002-011, NSC97-2627-B002-007, NSC98-2627-B002-004, NSC98-3112-B002-040, NSC99-3112-B002-029, NSC99-2314-B002-039-MY3, NSC99-2314-B002-040-MY3, NSC100-2314-B002-061-MY3, Department of Health, Executive Yuan, R.O.C. (Taiwan), DOH100-TD-PB-111-TM005, and National Taiwan University Hospital NTUH.98-S1105, NTUH.99-MSN 01, NTUH.100-001637, and NTUH.VN101-06.	Abad JC, 1997, OPHTHALMOLOGY, V104, P1566, DOI 10.1016/S0161-6420(97)30095-5; Alleva R, 2001, FEBS LETT, V503, P46, DOI 10.1016/S0014-5793(01)02694-1; Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Brancato R, 2000, EUR J OPHTHALMOL, V10, P32, DOI 10.1177/112067210001000106; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chan KM, 2010, TOXICOL SCI, V116, P533, DOI 10.1093/toxsci/kfq151; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Chen CC, 2002, INVEST OPHTH VIS SCI, V43, P2593; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019111; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Chen Y, 2008, PHARM RES-DORDR, V25, P72, DOI 10.1007/s11095-007-9504-0; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Gutierrez-Mariscal FM, 2012, AGE, V34, P389, DOI 10.1007/s11357-011-9229-1; Higuchi H, 2001, HEPATOLOGY, V34, P320, DOI 10.1053/jhep.2001.26380; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Kanno S, 2006, TOXICOL LETT, V166, P131, DOI 10.1016/j.toxlet.2006.06.005; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim TI, 2004, INVEST OPHTH VIS SCI, V45, P86, DOI 10.1167/iovs.03-0520; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kumar S, 2002, SCIENCE, V297, P1290, DOI 10.1126/science.1076118; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; LENAZ G, 1993, CLIN INVESTIGATOR, V71, pS66; Lopez-Lluch G, 1999, BIOFACTORS, V9, P171, DOI 10.1002/biof.5520090212; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mancuso M, 2010, CURR DRUG TARGETS, V11, P111, DOI 10.2174/138945010790031018; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Nair VD, 2006, APOPTOSIS, V11, P955, DOI 10.1007/s10495-006-6316-3; Nanji AA, 1998, SEMIN LIVER DIS, V18, P187, DOI 10.1055/s-2007-1007154; Olsson M, 2009, ONCOGENE, V28, P1949, DOI 10.1038/onc.2009.36; Papucci L, 2003, J BIOL CHEM, V278, P28220, DOI 10.1074/jbc.M302297200; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Pepper C, 1998, LEUKEMIA RES, V22, P439, DOI 10.1016/S0145-2126(98)00013-7; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rutjes SK, 1999, J BIOL CHEM, V274, P24799, DOI 10.1074/jbc.274.35.24799; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Shim HY, 2007, MOL CELLS, V24, P95; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Stein HA, 1997, J CATARACT REFR SURG, V23, P1160, DOI 10.1016/S0886-3350(97)80309-4; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Tomasetti M, 2001, FASEB J, V15, P1425, DOI 10.1096/fj.00-0694fje; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Zhang FX, 1998, J NEUROCHEM, V71, P196, DOI 10.1046/j.1471-4159.1998.71010196.x; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	71	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11689	11704		10.1074/jbc.M112.401844	http://dx.doi.org/10.1074/jbc.M112.401844			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23430247	hybrid, Green Published			2022-12-28	WOS:000318157600007
J	Kan, CY; Petti, C; Bracken, L; Maritz, M; Xu, N; O'Brien, R; Yang, C; Liu, T; Yuan, J; Lock, RB; MacKenzie, KL				Kan, Chin-Yi; Petti, Carlotta; Bracken, Lauryn; Maritz, Michelle; Xu, Ning; O'Brien, Rosemary; Yang, Chen; Liu, Tao; Yuan, Jun; Lock, Richard B.; MacKenzie, Karen L.			Up-regulation of Survivin during Immortalization of Human Myofibroblasts Is Linked to Repression of Tumor Suppressor p16(INK4a) Protein and Confers Resistance to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERASE ACTIVITY; HUMAN-CELLS; DNA-DAMAGE; LIFE-SPAN; MALIGNANT-TRANSFORMATION; HYDROGEN-PEROXIDE; GROWTH ARREST; SENESCENCE; FIBROBLASTS; APOPTOSIS	Survivin is an essential component of the chromosomal passenger complex and a member of the inhibitor of apoptosis family. It is expressed at high levels in a large variety of malignancies, where it has been implicated in drug resistance. It was also shown previously that survivin is up-regulated during telomerase-mediated immortalization, which occurs at a relatively early stage during carcinogenesis. This study shows that up-regulation of survivin during immortalization of human myofibroblasts is an indirect consequence of the repression of p16(INK4a). Survivin and p16(INK4a) were functionally linked by assays that showed that either the up-regulation of survivin or repression of p16(INK4a) rendered telomerase-transduced MRC-5 myofibroblasts resistant to oxidative stress. Conversely, siRNA-mediated down-regulation of survivin activated caspases and enhanced the sensitivity of immortal MRC-5 cells to oxidative stress. The E2F1 transcription factor, which is negatively regulated by the pRB/p16(INK4a) tumor suppressor pathway, was implicated in the up-regulation of survivin. Using the ChIP assay, it was shown that E2F1 directly interacted with the survivin gene (BIRC5) promoter in cells that spontaneously silenced p16(INK4a) during telomerase-mediated immortalization. E2F1 binding to the BIRC5 was also enhanced in telomerase-transduced cells subjected to shRNA-mediated repression of p16(INK4a). Together, these data show that repression of p16(INK4a) contributes to the up-regulation of survivin and thereby provides a survival advantage to cells exposed to oxidative stress during immortalization. The up-regulation of survivin during immortalization likely contributes to the vulnerability of immortal cells to transformation by oncogenes that alter intracellular redox state.	[Kan, Chin-Yi; Petti, Carlotta; Bracken, Lauryn; Maritz, Michelle; O'Brien, Rosemary; Yang, Chen; Yuan, Jun; MacKenzie, Karen L.] Univ New S Wales, Canc Cell Dev Grp, Childrens Canc Inst Australia, Lowy Canc Res Ctr, Randwick, NSW 2031, Australia; [Xu, Ning; Liu, Tao] Univ New S Wales, Histone Modificat Grp, Childrens Canc Inst Australia, Lowy Canc Res Ctr, Randwick, NSW 2031, Australia; [Lock, Richard B.] Univ New S Wales, Leukaemia Biol Program, Childrens Canc Inst Australia, Lowy Canc Res Ctr, Randwick, NSW 2031, Australia	Children's Cancer Institute; University of New South Wales Sydney; Children's Cancer Institute; University of New South Wales Sydney; Children's Cancer Institute; University of New South Wales Sydney	MacKenzie, KL (corresponding author), Childrens Canc Inst Australia Med Res, POB 81, Randwick, NSW 2031, Australia.	k.mackenzie@unsw.edu.au	MacKenzie, Karen/N-5849-2019; Mackenzie, Karen/F-1310-2011; Lock, Richard/G-4253-2013; Liu, Tao/A-3922-2015	Liu, Tao/0000-0001-6244-7316; Lock, Richard/0000-0002-3436-9071; Maritz, Michelle Frances/0000-0001-6345-4446; MacKenzie, Karen/0000-0003-2996-1617	National Health and Medical Research Council (NHMRC) [510378, 568704]; Cancer Institute New South Wales Career Development and Support Fellowship [07-CDF-1/23]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development and Support Fellowship	This work was supported by National Health and Medical Research Council (NHMRC) Career Development Award 510378 (to K. L. M.), by a senior research fellowship (to R. B. L.), by NHMRC Project Grant 568704, and by Cancer Institute New South Wales Career Development and Support Fellowship 07-CDF-1/23 (to K. L. M.).	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ausserlechner MJ, 2001, J BIOL CHEM, V276, P10984, DOI 10.1074/jbc.M008188200; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Duan JM, 2001, J BIOL CHEM, V276, P48325, DOI 10.1074/jbc.M104814200; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Franco S, 2001, EXP CELL RES, V268, P14, DOI 10.1006/excr.2001.5264; Frost M, 2002, AM J CLIN PATHOL, V117, P738; Gianani R, 2001, HUM PATHOL, V32, P119, DOI 10.1053/hupa.2001.21897; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Guidarelli A, 1997, FREE RADICAL RES, V26, P537, DOI 10.3109/10715769709097825; Guidarelli A, 1997, EXP CELL RES, V237, P176, DOI 10.1006/excr.1997.3779; Gurbuxani S, 2005, P NATL ACAD SCI USA, V102, P11480, DOI 10.1073/pnas.0500303102; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huschtscha LI, 1998, CANCER RES, V58, P3508; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kan CY, 2012, ONCOGENE, V31, P4815, DOI 10.1038/onc.2011.645; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Ksiazek K, 2007, BIOCHEM BIOPH RES CO, V362, P707, DOI 10.1016/j.bbrc.2007.08.047; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; MacKenzie KL, 2002, ONCOGENE, V21, P4200, DOI 10.1038/sj.onc.1205425; MacKenzie KL, 2000, EXP CELL RES, V259, P336, DOI 10.1006/excr.2000.4982; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Milyavsky M, 2003, CANCER RES, V63, P7147; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Napier CE, 2010, BBA-MOL CELL RES, V1803, P1142, DOI 10.1016/j.bbamcr.2010.06.010; Obexer P, 2009, J BIOL CHEM, V284, P30933, DOI 10.1074/jbc.M109.051441; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; RICEEVANS C, 1985, BIOCHIM BIOPHYS ACTA, V815, P426, DOI 10.1016/0005-2736(85)90370-0; Rincheval V, 2012, CELL BIOL TOXICOL, V28, P239, DOI 10.1007/s10565-012-9219-9; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taylor LM, 2004, J BIOL CHEM, V279, P43634, DOI 10.1074/jbc.M402388200; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vaziri SAJ, 2005, MOL CANCER THER, V4, P1880, DOI 10.1158/1535-7163.MCT-05-0222; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; WHITAKER NJ, 1995, ONCOGENE, V11, P971; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572; Xu JH, 2009, ONCOL RES, V18, P377, DOI 10.3727/096504010X12644422320663; Yuan J, 2009, ONCOGENE, V28, P2678, DOI 10.1038/onc.2009.136	61	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12032	12041		10.1074/jbc.M112.447821	http://dx.doi.org/10.1074/jbc.M112.447821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23449974	Green Published, hybrid			2022-12-28	WOS:000318157600037
J	Lo, YY; Hsu, SH; Ko, YC; Hung, CC; Chang, MY; Hsu, HH; Pan, MJ; Chen, YW; Lee, CH; Tseng, FG; Sun, YJ; Yang, CW; Pan, RL				Lo, Yueh-Yu; Hsu, Shen-Hsing; Ko, Yi-Ching; Hung, Cheng-Chieh; Chang, Ming-Yang; Hsu, Hsiang-Hao; Pan, Ming-Jeng; Chen, Yen-Wei; Lee, Ching-Hung; Tseng, Fan-Gang; Sun, Yuh-Ju; Yang, Chih-Wei; Pan, Rong-Long			Essential Calcium-binding Cluster of Leptospira LipL32 Protein for Inflammatory Responses through the Toll-like Receptor 2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATES FIBRONECTIN-BINDING; ATOMIC-FORCE MICROSCOPE; OUTER-MEMBRANE PROTEINS; TUBULE EPITHELIAL-CELLS; PATHOGENIC LEPTOSPIRA; RENAL-DISEASE; SURFACE; LIPOPROTEIN; ANTIGEN; GENES	Leptospirosis is the most widespread zoonosis caused by the pathogenic Leptospira worldwide. LipL32, a 32-kDa lipoprotein, is the most abundant protein on the outer membrane of Leptospira and has an atypical poly(Asp) motif ((161)DDDDDGDD(168)). The x-ray crystallographic structure of LipL32 revealed that the calcium-binding cluster of LipL32 includes several essential residues Asp(132), Thr(133), Asp(164), Asp(165), and Tyr(178). The goals of this study were to determine possible roles of the Ca2+-binding cluster for the interaction of LipL32 and Toll-like receptor 2 (TLR2) in induced inflammatory responses of human kidney cells. Site-directed mutagenesis was employed to individually mutate Ca2+-binding residues of LipL32 to Ala, and their effects subsequently were observed. These mutations abolished primarily the structural integrity of the calcium-binding cluster in LipL32. The binding assay and atomic force microscopy analysis further demonstrated the decreased binding capability of LipL32 mutants to TLR2. Inflammatory responses induced by LipL32 variants, as determined by TLR2 pathway intermediates hCXCL8/IL-8, hCCL2/MCP-1, hMMP7, and hTNF-alpha, were also lessened. In conclusion, the calcium-binding cluster of LipL32 plays essential roles in presumably sustaining LipL32 conformation for its proper association with TLR2 to elicit inflammatory responses in human renal cells.	[Lo, Yueh-Yu; Chen, Yen-Wei; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30013, Taiwan; [Lo, Yueh-Yu; Chen, Yen-Wei; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Hsu, Shen-Hsing; Ko, Yi-Ching; Hung, Cheng-Chieh; Chang, Ming-Yang; Hsu, Hsiang-Hao; Yang, Chih-Wei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Tao Yuan 33333, Taiwan; [Pan, Ming-Jeng] Cent Taiwan Univ Sci & Technol, Coll Hlth Sci, Inst Biotechnol, Taichung 40601, Taiwan; [Tseng, Fan-Gang] Natl Tsing Hua Univ, Coll Nucl Sci, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University; Central Taiwan University Science & Technology; National Tsing Hua University	Yang, CW (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Tao Yuan 33333, Taiwan.	cwyang@ms1.hinet.net; rlpan@life.nthu.edu.tw	Chang, Ming-Yang/AGH-5397-2022	Chang, Ming-Yang/0000-0001-8899-0376; Tseng, Fan-Gang/0000-0001-7654-6905	Chang Gung Memorial Hospital-National Tsing Hua University [101N2748E1]; National Science Council, Republic of China [NSC 101-2627-M-007-008, NSC 100-2311-B-007-001-MY3, NSC100-2314-B-182-031-MY3, NSC 101-2120-M-007-001, NSC 101-2627-M-007-009]	Chang Gung Memorial Hospital-National Tsing Hua University(Chang Gung Memorial Hospital); National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grant 101N2748E1 (to R.-L. P.) and National Science Council, Republic of China, Grants NSC 101-2627-M-007-008 and NSC 100-2311-B-007-001-MY3 (to R.-L. P.), NSC100-2314-B-182-031-MY3 (to C.-W. Y.), and NSC 101-2120-M-007-001 and NSC 101-2627-M-007-009 (to F.-G. T.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Hsu SH, 2010, BIOCHEMISTRY-US, V49, P5408, DOI 10.1021/bi100058w; Hsu SH, 2009, BOT STUD, V50, P291; Hung CC, 2006, KIDNEY INT, V69, P1814, DOI 10.1038/sj.ki.5000362; Hung CC, 2006, NEPHROL DIAL TRANSPL, V21, P898, DOI 10.1093/ndt/gfi316; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kim H, 2006, ULTRAMICROSCOPY, V106, P652, DOI 10.1016/j.ultramic.2005.12.007; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Lee SH, 2000, GENE, V254, P19, DOI 10.1016/S0378-1119(00)00293-6; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Stroh C, 2004, P NATL ACAD SCI USA, V101, P12503, DOI 10.1073/pnas.0403538101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; Yang CW, 2000, J AM SOC NEPHROL, V11, P2017, DOI 10.1681/ASN.V11112017; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73	37	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12335	12344		10.1074/jbc.M112.418699	http://dx.doi.org/10.1074/jbc.M112.418699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486465	Green Published, hybrid			2022-12-28	WOS:000318157600064
J	Zhuang, Q; Qing, XB; Ying, Y; Wu, HT; Benda, C; Lin, J; Huang, ZJ; Liu, LQ; Xu, Y; Bao, XC; Qin, BM; Pei, DQ; Esteban, MA				Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.			Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2 Proteins Regulate the Mesenchymal-to-Epithelial Transition of Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; MOUSE FIBROBLASTS; DEFINED FACTORS; DIFFERENTIATION; CARDIOMYOCYTES; HYPERTROPHY; GENERATION; EFFICIENT; MEF2; MYC	Class IIa histone deacetylases (HDACs) and myocyte enhancer factor 2 (MEF2) proteins compose a signaling module that orchestrates lineage specification during embryogenesis. We show here that this module also regulates the generation of mouse induced pluripotent stem cells by defined transcription factors. Class IIa HDACs and MEF2 proteins rise steadily during fibroblast reprogramming to induced pluripotent stem cells. MEF2 proteins tend to block the process by inducing the expression of Tgf beta cytokines, which impairs the necessary phase of mesenchymal-to-epithelial transition (MET). Conversely, class IIa HDACs endeavor to suppress the activity of MEF2 proteins, thus enhancing the MET and colony formation efficiency. Our work highlights an unexpected role for a developmental axis in somatic cell reprogramming and provides new insight into how the MET is regulated in this context.	[Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Guangzhou Inst Biomed, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zhuang, Qiang; Qing, Xiaobing; Ying, Yue; Wu, Haitao; Benda, Christina; Lin, Jiao; Huang, Zhijian; Liu, Longqi; Xu, Yan; Bao, Xichen; Qin, Baoming; Pei, Duanqing; Esteban, Miguel A.] Guangzhou Inst Hlth, Guangdong Prov Key Lab Stem Cells & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Qing, Xiaobing] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Esteban, MA (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org	Qin, Baoming/G-1553-2015; Qing, Xiaobing/ABF-5539-2020	Qin, Baoming/0000-0001-7652-161X; Xu, Yan/0000-0001-5653-291X	Chinese Academy of Sciences [XDA01020106]; Ministry of Science and Technology of China 973 Program Grants [2011CB965200]; National Natural Science Foundation of China [31071309]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China 973 Program Grants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01020106, by Ministry of Science and Technology of China 973 Program Grants 2011CB965200, and by National Natural Science Foundation of China Grant 31071309.	Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Quinn ZA, 2001, NUCLEIC ACIDS RES, V29, P732, DOI 10.1093/nar/29.3.732; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	41	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12022	12031		10.1074/jbc.M113.460766	http://dx.doi.org/10.1074/jbc.M113.460766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467414	hybrid, Green Published			2022-12-28	WOS:000318157600036
J	Diab, HI; Kane, PM				Diab, Heba I.; Kane, Patricia M.			Loss of Vacuolar H+-ATPase (V-ATPase) Activity in Yeast Generates an Iron Deprivation Signal That Is Moderated by Induction of the Peroxiredoxin TSA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXIN; PH HOMEOSTASIS; TRANSCRIPTION; RECEPTOR; REVEALS; PEROXIDASE; OXIDASE; REGULON	Vacuolar H+-ATPases (V-ATPases) acidify intracellular organelles and help to regulate overall cellular pH. Yeast vma mutants lack V-ATPase activity and allow exploration of connections between cellular pH, iron, and redox homeostasis common to all eukaryotes. A previous microarray study in a vma mutant demonstrated up-regulation of multiple iron uptake genes under control of Aft1p (the iron regulon) and only one antioxidant gene, the peroxiredoxin TSA2 (Milgrom, E., Diab, H., Middleton, F., and Kane, P. M. (2007) Loss of vacuolar proton-translocating ATPase activity in yeast results in chronic oxidative stress. J. Biol. Chem. 282, 7125-7136). Fluorescent biosensors placing GFP under transcriptional control of either an Aft1-dependent promoter (P-FIT2-GFP) or the TSA2 promoter (P-TSA2-GFP) were constructed to monitor transcriptional signaling. Both biosensors were up-regulated in the vma2 Delta mutant, and acute V-ATPase inhibition with concanamycin A induced coordinate up-regulation from both promoters. P-TSA2-GFP induction was Yap1p-dependent, indicating an oxidative stress signal. Total cell iron measurements indicate that the vma2 Delta mutant is iron-replete, despite up-regulation of the iron regulon. Acetic acid up-regulated P-FIT2-GFP expression in wildtype cells, suggesting that loss of pH control contributes to an iron deficiency signal in the mutant. Iron supplementation significantly decreased P-FIT2-GFP expression and, surprisingly, restored P-TSA2-GFP to wild-type levels. A tsa2 Delta mutation induced both nuclear localization of Aft1p and P-FIT2-GFP expression. The data suggest a novel function for Tsa2p as a negative regulator of Aft1p-driven transcription, which is induced in V-ATPase mutants to limit transcription of the iron regulon. This represents a new mechanism bridging the antioxidant and iron-regulatory pathways that is intimately linked to pH homeostasis.	[Diab, Heba I.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu			National Institutes of Health [R01 GM50322]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM50322 (to P. M. K.).	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; BALI PK, 1992, BIOCHEMISTRY-US, V31, P3963, DOI 10.1021/bi00131a011; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; Berggren MI, 2001, ARCH BIOCHEM BIOPHYS, V392, P103, DOI 10.1006/abbi.2001.2435; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Brombacher K, 2006, YEAST, V23, P741, DOI 10.1002/yea.1392; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cockrell AL, 2011, BIOCHEMISTRY-US, V50, P10275, DOI 10.1021/bi2014954; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Follmann M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-621; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Iraqui I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000524; Irazusta V, 2008, FREE RADICAL BIO MED, V44, P1712, DOI 10.1016/j.freeradbiomed.2008.01.014; Iwai K, 2010, J BIOL CHEM, V285, P10597, DOI 10.1074/jbc.M109.090142; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1992, J BIOL CHEM, V267, P447; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Spizzo T, 1997, MOL GEN GENET, V256, P547; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; Williamson WR, 2010, J CELL BIOL, V189, P885, DOI 10.1083/jcb.201003062; Wong CM, 2003, FREE RADICAL BIO MED, V34, P585, DOI 10.1016/S0891-5849(02)01354-0; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	65	34	37	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11366	11377		10.1074/jbc.M112.419259	http://dx.doi.org/10.1074/jbc.M112.419259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457300	Green Published, hybrid			2022-12-28	WOS:000317915500039
J	Li, Y; Wong, K; Walsh, K; Gao, B; Zang, MW				Li, Yu; Wong, Kimberly; Walsh, Kenneth; Gao, Bin; Zang, Mengwei			Retinoic Acid Receptor beta Stimulates Hepatic Induction of Fibroblast Growth Factor 21 to Promote Fatty Acid Oxidation and Control Whole-body Energy Homeostasis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; IMPROVES INSULIN SENSITIVITY; ADAPTIVE THERMOGENESIS; LIPID-METABOLISM; TRANSGENIC MICE; HEPG2 CELLS; PPAR-ALPHA; ALL-TRANS; EXPRESSION; OBESITY	Activation of retinoic acid receptor (RAR) with all-trans-retinoic acid (RA) ameliorates glucose intolerance and insulin resistance in obese mice. The recently discovered fibroblast growth factor 21 (FGF21) is a hepatocyte-derived hormone that restores glucose and lipid homeostasis in obesity-induced diabetes. However, whether hepatic RAR is linked to FGF21 in the control of lipid metabolism and energy homeostasis remains elusive. Here we identify FGF21 as a direct target gene of RAR beta. The gene transcription of Fgf21 is increased by the RAR agonist RA and by overexpression of RAR alpha and RAR beta, but it is unaffected by RAR gamma in HepG2 cells. Promoter deletion analysis characterizes a putative RA-responsive element (RARE) primarily located in the 5'-flanking region of the Fgf21 gene. Disruption of the RARE sequence abolishes RA responsiveness. In vivo adenoviral overexpression of RAR beta in the liver enhances production and secretion of FGF21, which in turn promotes hepatic fatty acid oxidation and ketogenesis and ultimately leads to increased energy expenditure in mice. The metabolic effects of RA or RAR beta are mimicked by FGF21 overexpression and largely abolished by FGF21 knockdown. Moreover, hepatic RAR beta is bound to the putative RAREs of the Fgf21 promoter in a fasting-inducible manner in vivo, which contributes to FGF21 induction and the metabolic adaptation to prolonged fasting. In addition to other nuclear receptors, such as peroxisome proliferator-activated receptor alpha and retinoic acid receptor-related receptor alpha, RAR may act as a novel component to induce hepatic FGF21 in the regulation of lipid metabolism. The hepatic RAR-FGF21 pathway may represent a potential drug target for treating metabolic disorders.	[Li, Yu; Wong, Kimberly; Walsh, Kenneth; Zang, Mengwei] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Gao, Bin] NIAAA, Lab Liver Dis, Bethesda, MD 20892 USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Li, Y (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, X725,650 Albany St, Boston, MA 02118 USA.	leonli@bu.edu; mwzang1@bu.edu		Zang, Mengwei/0000-0002-2502-2586; Li, Yu/0000-0001-6910-5933; Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [DK076942]; Robert Dawson Evans Junior Faculty Merit Award; Wing Tat Lee Award; Boston University CTSI subsidy fund [UL1RR025771]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Dawson Evans Junior Faculty Merit Award; Wing Tat Lee Award; Boston University CTSI subsidy fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076942. This work was also supported by the Robert Dawson Evans Junior Faculty Merit Award, the Wing Tat Lee Award (to M. Z.), and Boston University CTSI subsidy fund Grant UL1RR025771 (to Y. L.).	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085; Ashla AA, 2010, HEPATOL RES, V40, P594, DOI 10.1111/j.1872-034X.2010.00646.x; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bonilla S, 2000, BRIT J NUTR, V83, P665, DOI 10.1017/S0007114500000842; Cai SY, 2010, J LIPID RES, V51, P2265, DOI 10.1194/jlr.M005546; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; ROCHETTEEGLY C, 1995, MOL ENDOCRINOL, V9, P860, DOI 10.1210/me.9.7.860; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tay S, 2010, MOL PHARMACOL, V77, P218, DOI 10.1124/mol.109.059071; Tsuchiya H, 2012, HEPATOLOGY, V56, P1319, DOI 10.1002/hep.25798; VALERA A, 1994, J BIOL CHEM, V269, P6267; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0	50	72	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10490	10504		10.1074/jbc.M112.429852	http://dx.doi.org/10.1074/jbc.M112.429852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430257	hybrid, Green Published			2022-12-28	WOS:000317565000029
J	Musumeci, MA; Hug, I; Scott, NE; Ielmini, MV; Foster, LJ; Wang, PG; Feldman, MF				Musumeci, Matias A.; Hug, Isabelle; Scott, Nichollas E.; Ielmini, M. Veronica; Foster, Leonard J.; Wang, Peng G.; Feldman, Mario F.			In Vitro Activity of Neisseria meningitidis PglL O-Oligosaccharyltransferase with Diverse Synthetic Lipid Donors and a UDP-activated Sugar	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; BACTERIAL OLIGOSACCHARYLTRANSFERASES; ANTIGEN BIOSYNTHESIS; PILIN GLYCOSYLATION; GLYCAN; SYSTEM; IDENTIFICATION; FRACTIONATION; SPECIFICITY	Oligosaccharyltransferases (OTases) are enzymes that catalyze the transfer of an oligosaccharide from a lipid carrier to an acceptor molecule, commonly a protein. OTases are classified as N-OTases and O-OTases, depending on the nature of the glycosylation reaction. The N-OTases catalyze the glycan transfer to amide groups in asparagines in a reaction named N-linked glycosylation. The O-OTases are responsible for protein O-linked glycosylation, which involves the attachment of glycans to hydroxyl groups of serine or threonine residues. These enzymes exhibit a relaxed specificity and are able to transfer a variety of glycan structures to different protein acceptors. This property confers OTases with great biotechnological potential as these enzymes can produce glycoconjugates relevant to the pharmaceutical industry. Furthermore, OTases are thought to be involved in pathogenesis mechanisms. Several aspects of the functionality of OTases are not fully understood. In this work, we developed a novel approach to perform kinetic studies on PglL, the O-OTase from Neisseria meningitidis. We investigated the importance of the acyl moiety of the lipid glycan donor substrate on the functionality of PglL by testing the efficiency of glycosylation reactions using synthetic substrates carrying the same glycan structure but different acyl moieties. We found that PglL can function with many lipids as glycan donors, although the length and the conformation of the lipid moiety significantly influenced the catalytic efficiency. Interestingly, PglL was also able to transfer a monosaccharide employing its nucleotide-activated form, acting as a Leloir glycosyltransferase. These results provide new insights on the function and the evolution of oligosaccharyltransferases.	[Musumeci, Matias A.; Hug, Isabelle; Ielmini, M. Veronica; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB T6G 2E9, Canada; [Scott, Nichollas E.; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 14, Canada; [Scott, Nichollas E.; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 14, Canada; [Wang, Peng G.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University of Alberta; University of British Columbia; University of British Columbia; University System of Georgia; Georgia State University	Feldman, MF (corresponding author), Univ Alberta, CW 405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Feldman, Mario/A-2637-2014; WANG, Peng/GSN-5263-2022	Feldman, Mario/0000-0003-4497-0976; Scott, Nichollas/0000-0003-2556-8316; Musumeci, Matias/0000-0003-2358-1365; Hug, Isabelle/0000-0002-4524-9569	Natural Sciences and Engineering Research Council of Canada; Alberta Glycomics Center; National Health and Medical Research Council of Australia Overseas Biomedical Fellowship [APP1037373]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Glycomics Center; National Health and Medical Research Council of Australia Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada and the Alberta Glycomics Center (to M. F. F.).; Supported by National Health and Medical Research Council of Australia Overseas Biomedical Fellowship APP1037373.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; Borud B, 2010, J BACTERIOL, V192, P2816, DOI 10.1128/JB.00101-10; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; Cristobal A, 2012, ANALYST, V137, P3541, DOI 10.1039/c2an35445d; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Feldman MF, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P903; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Gebhart C, 2012, GLYCOBIOLOGY, V22, P962, DOI 10.1093/glycob/cws059; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Han WQ, 2012, J BIOL CHEM, V287, P5357, DOI 10.1074/jbc.M111.308486; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Jennings MP, 2011, CELL MICROBIOL, V13, P885, DOI 10.1111/j.1462-5822.2011.01586.x; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Langdon RH, 2009, FUTURE MICROBIOL, V4, P401, DOI 10.2217/FMB.09.10; LAUGHLIN MR, 1988, J BIOL CHEM, V263, P2285; Li M, 2008, BIOCHEMISTRY-US, V47, P11590, DOI 10.1021/bi801067s; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Markovic D, 2008, MOL ENDOCRINOL, V22, P689, DOI 10.1210/me.2007-0136; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Power PM, 2006, BIOCHEM BIOPH RES CO, V347, P904, DOI 10.1016/j.bbrc.2006.06.182; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Thomas RM, 2011, J BACTERIOL, V193, P5498, DOI 10.1128/JB.00438-11; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	49	19	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10578	10587		10.1074/jbc.M112.432815	http://dx.doi.org/10.1074/jbc.M112.432815			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23460642	Green Published, hybrid			2022-12-28	WOS:000317565000037
J	Patron, M; Raffaello, A; Granatiero, V; Tosatto, A; Merli, G; De Stefani, D; Wright, L; Pallafacchina, G; Terrin, A; Mammucari, C; Rizzuto, R				Patron, Maria; Raffaello, Anna; Granatiero, Veronica; Tosatto, Anna; Merli, Giulia; De Stefani, Diego; Wright, Lauren; Pallafacchina, Giorgia; Terrin, Anna; Mammucari, Cristina; Rizzuto, Rosario			The Mitochondrial Calcium Uniporter (MCU): Molecular Identity and Physiological Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENDOPLASMIC-RETICULUM CA2+; RAT-LIVER MITOCHONDRIA; SIGNAL TRANSMISSION; ESSENTIAL COMPONENT; INTRACELLULAR CA2+; RYANODINE RECEPTOR; STORE; TRANSPORT; HEART; MICRODOMAINS	The direct measurement of mitochondrial [Ca2+] with highly specific probes demonstrated that major swings in organellar [Ca2+] parallel the changes occurring in the cytosol and regulate processes as diverse as aerobic metabolism and cell death by necrosis and apoptosis. Despite great biological relevance, insight was limited by the complete lack of molecular understanding. The situation has changed, and new perspectives have emerged following the very recent identification of the mitochondrial Ca2+ uniporter, the channel allowing rapid Ca2+ accumulation across the inner mitochondrial membrane.	[Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; CNR, Inst Neurosci, I-35131 Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Rizzuto, R (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.	rosario.rizzuto@unipd.it	Raffaello, Anna/K-7052-2016; Granatiero, Veronica/AAX-9044-2020; Merli, Giulia/E-4717-2019; Pallafacchina, Giorgia/K-4056-2016; De Stefani, Diego/I-7715-2015	Granatiero, Veronica/0000-0003-2440-5144; Merli, Giulia/0000-0001-7895-5606; Pallafacchina, Giorgia/0000-0001-9766-5970; De Stefani, Diego/0000-0003-3796-8907; RAFFAELLO, ANNA/0000-0002-8344-6459; Rizzuto, Rosario/0000-0001-7044-5097	National Institutes of Health [1P01 AG025532-01A1]; Italian Ministries of Health (Ricerca Finalizzata); Education, University and Research (PRIN and FIRB); European Union ERC mitoCalcium Project [294777, 223576]; Cariparo Foundation (Padua, Italy); Italian Association for Cancer Research (AIRC),; Telethon-Italy Grant [GPP10005A]; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministries of Health (Ricerca Finalizzata); Education, University and Research (PRIN and FIRB); European Union ERC mitoCalcium Project; Cariparo Foundation (Padua, Italy)(Fondazione Cariparo); Italian Association for Cancer Research (AIRC),(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy Grant(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01 AG025532-01A1. This work was also supported by grants from the Italian Ministries of Health (Ricerca Finalizzata) and of Education, University and Research (PRIN and FIRB), European Union ERC mitoCalcium Project Grant 294777 and FP7 "MyoAGE" Project Grant 223576, the Cariparo Foundation (Padua, Italy), the Italian Association for Cancer Research (AIRC), and Telethon-Italy Grant GPP10005A. This article is part of the Thematic Minireview Series on the Ins and Outs of Calcium Transport.	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BECKER GL, 1980, J BIOL CHEM, V255, P9009; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1984, BIOCHEMISTRY-US, V23, P1645, DOI 10.1021/bi00303a010; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; BRAGADIN M, 1979, FEBS LETT, V104, P347, DOI 10.1016/0014-5793(79)80849-2; BRAND MD, 1985, BIOCHEM J, V229, P161, DOI 10.1042/bj2290161; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CARAFOLI E, 1967, J GEN PHYSIOL, V50, P1849, DOI 10.1085/jgp.50.7.1849; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; CARAFOLI E, 1970, BIOCHIM BIOPHYS ACTA, V205, P18, DOI 10.1016/0005-2728(70)90057-5; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen G, 2006, NEUROSCIENCE, V142, P97, DOI 10.1016/j.neuroscience.2006.06.008; Cobbold P H, 1990, Semin Cell Biol, V1, P311; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MELA L, 1969, BIOCHEMISTRY-US, V8, P2481, DOI 10.1021/bi00834a034; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; O'Rourke B, 2000, J PHYSIOL-LONDON, V529, P23, DOI 10.1111/j.1469-7793.2000.00023.x; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; PANFILI E, 1976, NATURE, V264, P185, DOI 10.1038/264185a0; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Pivovarova NB, 1999, J NEUROSCI, V19, P6372; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Ringer S, 1883, J Physiol, V4, P222; RIZZUTO R, 1987, BIOCHEM J, V246, P271, DOI 10.1042/bj2460271; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rudolf R, 2003, NAT REV MOL CELL BIO, V4, P579, DOI 10.1038/nrm1153; Ryu SY, 2011, J BIOL CHEM, V286, P21324, DOI 10.1074/jbc.C111.245597; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Szabadkai G, 2003, J BIOL CHEM, V278, P15153, DOI 10.1074/jbc.M300180200; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Young KW, 2008, CELL CALCIUM, V43, P296, DOI 10.1016/j.ceca.2007.06.007	88	104	108	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10750	10758		10.1074/jbc.R112.420752	http://dx.doi.org/10.1074/jbc.R112.420752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23400777	Green Published, hybrid			2022-12-28	WOS:000317565000053
J	Ritter, E; Piwowarski, P; Hegemann, P; Bartl, FJ				Ritter, Eglof; Piwowarski, Patrick; Hegemann, Peter; Bartl, Franz J.			Light-dark Adaptation of Channelrhodopsin C128T Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; METARHODOPSIN-II; RESONANCE RAMAN; BACTERIORHODOPSIN; RHODOPSIN; SPECTROSCOPY; PHOTOCYCLES; CHROMOPHORE; MEMBRANE; PEPTIDES	Channelrhodopsins are microbial type rhodopsins that operate as light-gated ion channels. Largely prolonged lifetimes of the conducting state of channelrhodopsin-2 may be achieved by mutations of crucial single amino acids, i.e. cysteine 128. Such mutants are of great scientific interest in the field of neurophysiology because they allow neurons to be switched on and off on demand (step function rhodopsins). Due to their slow photocycle, structural alterations of these proteins can be studied by vibrational spectroscopy in more detail than possible with wild type. Here, we present spectroscopic evidence that the photocycle of the C128T mutant involves three different dark-adapted states that are populated according to the wavelength and duration of the preceding illumination. Our results suggest an important role of multiphoton reactions and the previously described side reaction for dark state regeneration. Structural changes that cause formation and depletion of the assumed ion conducting state P520 are only small and follow larger changes that occur early and late in the photocycle, respectively. They require only minor structural rearrangements of amino acids near the retinal binding pocket and are triggered by all-trans/13-cis retinal isomerization, although additional isomerizations are also involved in the photocycle. We will discuss an extended photocycle model of this mutant on the basis of spectroscopic and electrophysiological data.	[Ritter, Eglof; Piwowarski, Patrick; Bartl, Franz J.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Hegemann, Peter] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Ritter, E (corresponding author), Charite, Inst Med Phys & Biophys, Charitepl 1, D-10117 Berlin, Germany.	eglof.ritter@charite.de; franz.bartl@charite.de			Deutsche Forschungsgemeinschaft [BA 2242/2-1, SFB 1078]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants BA 2242/2-1 (to F. J. B.) and SFB 1078.	ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; MARCUS MA, 1978, BIOCHEMISTRY-US, V17, P4722, DOI 10.1021/bi00615a019; MARRERO H, 1987, BIOPHYS J, V52, P629, DOI 10.1016/S0006-3495(87)83254-X; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nack M, 2009, FEBS LETT, V583, P3676, DOI 10.1016/j.febslet.2009.10.052; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Patzelt H, 2002, P NATL ACAD SCI USA, V99, P9765, DOI 10.1073/pnas.132253899; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; SCHERRER P, 1989, BIOCHEMISTRY-US, V28, P829, DOI 10.1021/bi00428a063; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	30	42	44	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10451	10458		10.1074/jbc.M112.446427	http://dx.doi.org/10.1074/jbc.M112.446427			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439646	Green Published, hybrid			2022-12-28	WOS:000317565000025
J	Vandevenne, M; Jacques, DA; Artuz, C; Nguyen, CD; Kwan, AHY; Segal, DJ; Matthews, JM; Crossley, M; Guss, JM; Mackay, JP				Vandevenne, Marylene; Jacques, David A.; Artuz, Crisbel; Cuong Dinh Nguyen; Kwan, Ann H. Y.; Segal, David J.; Matthews, Jacqueline M.; Crossley, Merlin; Guss, J. Mitchell; Mackay, Joel P.			New Insights into DNA Recognition by Zinc Fingers Revealed by Structural Analysis of the Oncoprotein ZNF217	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTIFICIAL TRANSCRIPTION FACTORS; SINGLE-STRANDED RNA; CRYSTAL-STRUCTURE; BINDING PROTEINS; NONSPECIFIC DNA; DOMAINS; COMPLEX; SEQUENCES; SITE; PLASTOCYANIN	Classical zinc fingers (ZFs) are one of the most abundant and best characterized DNA-binding domains. Typically, tandem arrays of three or more ZFs bind DNA target sequences with high affinity and specificity, and the mode of DNA recognition is sufficiently well understood that tailor-made ZF-based DNA-binding proteins can be engineered. We have shown previously that a two-zinc finger unit found in the transcriptional coregulator ZNF217 recognizes DNA but with an affinity and specificity that is lower than other ZF arrays. To investigate the basis for these differences, we determined the structure of a ZNF217-DNA complex. We show that although the overall position of the ZFs on the DNA closely resembles that observed for other ZFs, the side-chain interaction pattern differs substantially from the canonical model. The structure also reveals the presence of two methyl-pi interactions, each featuring a tyrosine contacting a thymine methyl group. To our knowledge, interactions of this type have not previously been described in classical ZF-DNA complexes. Finally, we investigated the sequence specificity of this two-ZF unit and discuss how ZNF217 might discriminate its target DNA sites in the cell.	[Vandevenne, Marylene; Jacques, David A.; Cuong Dinh Nguyen; Kwan, Ann H. Y.; Matthews, Jacqueline M.; Guss, J. Mitchell; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Artuz, Crisbel; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Segal, David J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Segal, David J.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of Sydney; University of New South Wales Sydney; University of California System; University of California Davis; University of California System; University of California Davis	Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Butlin Ave & Maze Crescent,Darlington Campus, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au	Crossley, Merlin/D-7888-2011; Segal, David/V-9126-2019; Guss, Jules Mitchell/N-1387-2019; Mackay, Joel/D-6834-2011	Crossley, Merlin/0000-0003-2057-3642; Segal, David/0000-0001-8962-3105; Guss, Jules Mitchell/0000-0003-4259-6079; Matthews, Jacqueline/0000-0001-8518-3472; Vandevenne, Marylene/0000-0002-4492-2635; Mackay, Joel/0000-0001-7508-8033; Jacques, David/0000-0002-6426-4510; Kwan, Ann/0000-0002-1506-2226	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council and the Australian Research Council (to J. P. M.).	Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bond CS, 1999, ACTA CRYSTALLOGR D, V55, P414, DOI 10.1107/S0907444998012074; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Choo Y, 1998, NAT STRUCT BIOL, V5, P264, DOI 10.1038/nsb0498-264; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dahlquist FW, 2006, NAT CHEM BIOL, V2, P353, DOI 10.1038/nchembio0706-353; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; de la Rosa MAD, 2010, BIOPHYS J, V98, P2943, DOI 10.1016/j.bpj.2010.02.055; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Dreyer AK, 2011, METHODS MOL BIOL, V813, P145, DOI 10.1007/978-1-61779-412-4_8; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000341; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; Goddard T. D, 2007, SPARKY 3; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HANSEN A, 1991, BIOCHEM BIOPH RES CO, V175, P492, DOI 10.1016/0006-291X(91)91591-Y; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; JOHNSTON M, 1987, NATURE, V328, P353, DOI 10.1038/328353a0; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lee S, 2010, J MOL BIOL, V397, P1055, DOI 10.1016/j.jmb.2010.02.006; Lefrancois P, 2010, METHOD ENZYMOL, V470, P77, DOI 10.1016/S0076-6879(10)70004-5; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Lowry JA, 2009, J BIOL CHEM, V284, P5827, DOI 10.1074/jbc.M808712200; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; Nonet GH, 2001, CANCER RES, V61, P1250; Nunez N, 2011, J BIOL CHEM, V286, P38190, DOI 10.1074/jbc.M111.301234; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Peterson SN, 2007, J MOL BIOL, V369, P1307, DOI 10.1016/j.jmb.2007.04.023; Pingoud A, 2007, STRUCTURE, V15, P391, DOI 10.1016/j.str.2007.04.001; Plevin MJ, 2010, NAT CHEM, V2, P466, DOI [10.1038/NCHEM.650, 10.1038/nchem.650]; Riley LG, 1996, PROTEIN ENG, V9, P223, DOI 10.1093/protein/9.2.223; Roberts MAJ, 2012, P NATL ACAD SCI USA, V109, P6698, DOI 10.1073/pnas.1114000109; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; Schmidt L, 2006, ACTA CRYSTALLOGR D, V62, P1022, DOI 10.1107/S0907444906023638; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Shibata N, 1999, J BIOL CHEM, V274, P4225, DOI 10.1074/jbc.274.7.4225; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Umezawa Y, 2002, NUCLEIC ACIDS RES, V30, P2183, DOI 10.1093/nar/30.10.2183; Vendrell JA, 2012, CANCER RES, V72, P3593, DOI 10.1158/0008-5472.CAN-11-3095; VONHIPPE PH, 1972, ANNU REV BIOCHEM, V41, P231, DOI 10.1146/annurev.bi.41.070172.001311; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8; Zandarashvili L, 2012, P NATL ACAD SCI USA, V109, pE1724, DOI 10.1073/pnas.1121500109	73	32	32	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10616	10627		10.1074/jbc.M112.441451	http://dx.doi.org/10.1074/jbc.M112.441451			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23436653	hybrid, Green Published			2022-12-28	WOS:000317565000040
J	Zierler, KA; Jaeger, D; Pollak, NM; Eder, S; Rechberger, GN; Radner, FPW; Woelkart, G; Kolb, D; Schmidt, A; Kumari, M; Preiss-Landl, K; Pieske, B; Mayer, B; Zimmermann, R; Lass, A; Zechner, R; Haemmerle, G				Zierler, Kathrin A.; Jaeger, Doris; Pollak, Nina M.; Eder, Sandra; Rechberger, Gerald N.; Radner, Franz P. W.; Woelkart, Gerald; Kolb, Dagmar; Schmidt, Albrecht; Kumari, Manju; Preiss-Landl, Karina; Pieske, Burkert; Mayer, Bernd; Zimmermann, Robert; Lass, Achim; Zechner, Rudolf; Haemmerle, Guenter			Functional Cardiac Lipolysis in Mice Critically Depends on Comparative Gene Identification-58	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; LIPID STORAGE DISEASE; CELLULAR FAT STORES; ENERGY-METABOLISM; SKELETAL-MUSCLE; LYSOPHOSPHATIDIC ACID; INSULIN SENSITIVITY; PPAR-ALPHA; CGI-58	Efficient catabolism of cellular triacylglycerol (TG) stores requires the TG hydrolytic activity of adipose triglyceride lipase (ATGL). The presence of comparative gene identification-58 (CGI-58) strongly increased ATGL-mediated TG catabolism in cell culture experiments. Mutations in the genes coding for ATGL or CGI-58 in humans cause neutral lipid storage disease characterized by TG accumulation in multiple tissues. ATGL gene mutations cause a severe phenotype especially in cardiac muscle leading to cardiomyopathy that can be lethal. In contrast, CGI-58 gene mutations provoke severe ichthyosis and hepatosteatosis in humans and mice, whereas the role of CGI-58 in muscle energy metabolism is less understood. Here we show that mice lacking CGI-58 exclusively in muscle (CGI-58KOM) developed severe cardiac steatosis and cardiomyopathy linked to impaired TG catabolism and mitochondrial fatty acid oxidation. The marked increase in ATGL protein levels in cardiac muscle of CGI-58KOM mice was unable to compensate the lack of CGI-58. The addition of recombinant CGI-58 to cardiac lysates of CGI-58KOM mice completely reconstituted TG hydrolytic activities. In skeletal muscle, the lack of CGI-58 similarly provoked TG accumulation. The addition of recombinant CGI-58 increased TG hydrolytic activities in control and CGI-58KOM tissue lysates, elucidating the limiting role of CGI-58 in skeletal muscle TG catabolism. Finally, muscle CGI-58 deficiency affected whole body energy homeostasis, which is caused by impaired muscle TG catabolism and increased cardiac glucose uptake. In summary, this study demonstrates that functional muscle lipolysis depends on both CGI-58 and ATGL.	[Zierler, Kathrin A.; Jaeger, Doris; Pollak, Nina M.; Eder, Sandra; Rechberger, Gerald N.; Radner, Franz P. W.; Kumari, Manju; Preiss-Landl, Karina; Zimmermann, Robert; Lass, Achim; Zechner, Rudolf; Haemmerle, Guenter] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Woelkart, Gerald; Mayer, Bernd] Graz Univ, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Med Res Ctr, A-8036 Graz, Austria; [Schmidt, Albrecht; Pieske, Burkert] Med Univ Graz, Dept Cardiol, Dept Internal Med, A-8036 Graz, Austria	University of Graz; University of Graz; Medical University of Graz; Medical University of Graz	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.	guenter.haemmerle@uni-graz.at	Lass, Achim/C-3332-2008; Pollak, Nina M./L-3308-2018; Pieske, Burkert/M-8089-2016	Lass, Achim/0000-0002-8190-7151; Pollak, Nina M./0000-0001-8437-3303; Zechner, Rudolf/0000-0001-5483-1182; Radner, Franz/0000-0003-3466-0181; Schmidt, Albrecht/0000-0003-4783-4603; Pieske, Burkert/0000-0002-6466-5306; Mayer, Bernd/0000-0002-2921-3494; Woelkart, Gerald/0000-0003-2552-1999; Kumari, Meena/0000-0001-9716-1035; Zimmermann, Robert/0000-0002-7354-870X; Rechberger, Gerald N./0000-0002-0071-317X; Haemmerle, Guenter/0000-0001-9900-5896	Austrian Ministry for Science and Research; Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P20602-B05, DK-MCD W1226, SFB LIPOTOX F30-B05]; Austrian Science Fund (FWF) [Z 136, P 24005, P 20602, F 3002, W 901] Funding Source: researchfish	Austrian Ministry for Science and Research; Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Ministry for Science and Research and Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung (FWF)) Project Grants P20602-B05, DK-MCD W1226, and SFB LIPOTOX F30-B05.	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Badin PM, 2012, J LIPID RES, V53, P839, DOI 10.1194/jlr.M019182; Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Bieber L L, 1981, Methods Enzymol, V71 Pt C, P351; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Moro C, 2008, AM J PHYSIOL-ENDOC M, V294, pE203, DOI 10.1152/ajpendo.00624.2007; Nunes PM, 2012, AM J PHYSIOL-ENDOC M, V303, pE71, DOI 10.1152/ajpendo.00597.2011; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; RANDLE PJ, 1963, LANCET, V1, P785; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Song QJ, 2003, J CLIN INVEST, V111, P859, DOI 10.1172/JCI200316738; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	42	59	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9892	9904		10.1074/jbc.M112.420620	http://dx.doi.org/10.1074/jbc.M112.420620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413028	Green Published, hybrid			2022-12-28	WOS:000317114000029
J	Liu, H; Lin, H; Zhang, L; Sun, Q; Yuan, GH; Zhang, L; Chen, S; Chen, Z				Liu, Huan; Lin, Heng; Zhang, Li; Sun, Qin; Yuan, Guohua; Zhang, Lu; Chen, Shuo; Chen, Zhi			miR-145 and miR-143 Regulate Odontoblast Differentiation through Targeting Klf4 and Osx Genes in a Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; TOOTH MORPHOGENESIS; CELL FATE; DENTIN; MICRORNAS; IDENTIFICATION; DSPP; DENTINOGENESIS; TRANSCRIPTION; EXPRESSION	Dentin tissue is derived from mesenchymal cells induced into the odontoblast lineage. The differentiation of odontoblasts is a complex process regulated by several transcriptional factor signaling transduction pathways. However, post-translational regulation of these factors during dentinogenesis remains unclear. To further explore the mechanisms, we investigated the role of microRNA (miRNA) during odontoblast differentiation. We profiled the miRNA expression pattern during mouse odontoblast differentiation using a microarray assay and identified that miR-145 and miR-143 were down-regulated during this process. In situ hybridization verified that the two miRNAs were gradually decreased during mouse odontoblast differentiation. Loss-of-function and gain-of-function experiments revealed that down-regulation of miR-145 and miR-143 could promote odontoblast differentiation and increased Dspp and Dmp1 expression in mouse primary dental pulp cells and vice versa. We found that miR-145 and miR-143 controlled odontoblast differentiation through several mechanisms. First, KLF4 and OSX bind to their motifs in Dspp and Dmp1 gene promoters and up-regulate their transcription thereby inducing odontoblast differentiation. The miR-145 binds to the 3'-UTRs of Klf4 and Osx genes, inhibiting their expression. Second, KLF4 repressed miR-143 transcription by binding to its motifs in miR-143 regulatory regions as detected by ChIP assay and dual luciferase reporter assay. Third, miR-143 regulates odontoblast differentiation in part through miR-145 pathway. Taken together, we for the first time showed that the miR-143 and miR-145 controlled odontoblast differentiation and dentin formation through KLF4 and OSX transcriptional factor signaling pathways.	[Liu, Huan; Lin, Heng; Zhang, Li; Sun, Qin; Yuan, Guohua; Zhang, Lu; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Peoples R China; [Liu, Huan; Lin, Heng; Zhang, Li; Sun, Qin; Yuan, Guohua; Zhang, Lu; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Peoples R China; [Chen, Shuo] Univ Texas Hlth Sci Ctr San Antonio, Dept Dev Dent, San Antonio, TX 78229 USA	Wuhan University; Wuhan University; University of Texas System; University of Texas Health San Antonio	Chen, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Dev Dent, San Antonio, TX 78229 USA.	chens0@uthscsa.edu; zhichen@whu.edu.cn	Chen, Zhi/V-2214-2017; Liu, Huan/AAJ-1566-2020; Liu, Huan/E-3115-2013	Chen, Zhi/0000-0003-2095-1324; Liu, Huan/0000-0002-9947-6687; 	National Natural Science Foundation of China [81070797, 81271099]; National 973 Project of China Grant [2010CB534915]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019802] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Project of China Grant(National Basic Research Program of China); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Natural Science Foundation of China Grants 81070797 and 81271099 and National 973 Project of China Grant 2010CB534915.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; Balic A, 2010, BONE, V47, P948, DOI 10.1016/j.bone.2010.08.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; Chen Z, 2009, ARCH ORAL BIOL, V54, P403, DOI 10.1016/j.archoralbio.2009.02.003; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jevnaker AM, 2008, ARCH ORAL BIOL, V53, P629, DOI 10.1016/j.archoralbio.2008.01.014; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Lin H, 2011, J ENDODONT, V37, P948, DOI 10.1016/j.joen.2011.03.030; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu H, 2012, BIOCHEM BIOPH RES CO, V422, P405, DOI 10.1016/j.bbrc.2012.05.002; Michon F, 2011, BIRTH DEFECTS RES A, V91, P763, DOI 10.1002/bdra.20787; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Ono K, 2011, CELL RES, V21, P864, DOI 10.1038/cr.2011.78; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sun Y, 2011, CELLS TISSUES ORGANS, V194, P199, DOI 10.1159/000324672; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 2001, Adv Dent Res, V15, P14; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Turan S, 2010, BONE, V46, P402, DOI 10.1016/j.bone.2009.09.016; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yi C, 2011, FEBS LETT, V585, P3303, DOI 10.1016/j.febslet.2011.09.015; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299	49	86	96	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9261	9271		10.1074/jbc.M112.433730	http://dx.doi.org/10.1074/jbc.M112.433730			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430263	Green Published, hybrid			2022-12-28	WOS:000316862200044
J	Stalin, J; Harhouri, K; Hubert, L; Subrini, C; Lafitte, D; Lissitzky, JC; Elganfoud, N; Robert, S; Foucault-Bertaud, A; Kaspi, E; Sabatier, F; Aurrand-Lions, M; Bardin, N; Holmgren, L; Dignat-George, F; Blot-Chabaud, M				Stalin, Jimmy; Harhouri, Karim; Hubert, Lucas; Subrini, Caroline; Lafitte, Daniel; Lissitzky, Jean-Claude; Elganfoud, Nadia; Robert, Stephane; Foucault-Bertaud, Alexandrine; Kaspi, Elise; Sabatier, Florence; Aurrand-Lions, Michel; Bardin, Nathalie; Holmgren, Lars; Dignat-George, Francoise; Blot-Chabaud, Marcel			Soluble Melanoma Cell Adhesion Molecule (sMCAM/sCD146) Promotes Angiogenic Effects on Endothelial Progenitor Cells through Angiomotin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS ANGIOGENESIS; ANGIOSTATIN; CD146; MIGRATION; PROTEIN; ACTIVATION; EXPRESSION; DOMAINS; DISPLAY; GROWTH	The melanoma cell adhesion molecule (CD146) contains a circulating proteolytic variant (sCD146), which is involved in inflammation and angiogenesis. Its circulating level is modulated in different pathologies, but its intracellular transduction pathways are still largely unknown. Using peptide pulldown and mass spectrometry, we identified angiomotin as a sCD146-associated protein in endothelial progenitor cells (EPC). Interaction between angiomotin and sCD146 was confirmed by enzyme-linked immunosorbent assay (ELISA), homogeneous time-resolved fluorescence, and binding of sCD146 on both immobilized recombinant angiomotin and angiomotin-transfected cells. Silencing angiomotin in EPC inhibited sCD146 angiogenic effects, i.e. EPC migration, proliferation, and capacity to form capillary-like structures in Matrigel. In addition, sCD146 effects were inhibited by the angiomotin inhibitor angiostatin and competition with recombinant angiomotin. Finally, binding of sCD146 on angiomotin triggered the activation of several transduction pathways that were identified by antibody array. These results delineate a novel signaling pathway where sCD146 binds to angiomotin to stimulate a proangiogenic response. This result is important to find novel target cells of sCD146 and for the development of therapeutic strategies based on EPC in the treatment of ischemic diseases.	[Stalin, Jimmy; Harhouri, Karim; Hubert, Lucas; Subrini, Caroline; Elganfoud, Nadia; Robert, Stephane; Foucault-Bertaud, Alexandrine; Kaspi, Elise; Sabatier, Florence; Bardin, Nathalie; Dignat-George, Francoise; Blot-Chabaud, Marcel] Aix Marseille Univ, INSERM, UMR S 1076, Format & Res Unit Pharm, F-13005 Marseille, France; [Lafitte, Daniel] Aix Marseille Univ, INSERM, UMR 911, Res Ctr Biol Oncol & Oncopharmacol, F-13005 Marseille, France; [Lissitzky, Jean-Claude; Aurrand-Lions, Michel] Aix Marseille Univ, Res Ctr Cancerol Marseille, INSERM, U1068, F-13009 Marseille, France; [Holmgren, Lars] Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Karolinska Institutet	Blot-Chabaud, M (corresponding author), Aix Marseille Univ, INSERM, UMR S 1076, Lab Hematol & Immunol,UFR Pharm, 27 Bd J Moulin, F-13005 Marseille, France.	marcel.blot-chabaud@laposte.net	Harhouri, Karim/M-3399-2016; Bardin, Nathalie/AAL-3663-2020; Blot-Chabaud, Marcel/D-4064-2017; Aurrand-Lions, Michel/O-9953-2016; DIGNAT-GEORGE, Françoise/R-1129-2016; Kaspi, Elise/I-4936-2016	Harhouri, Karim/0000-0003-2904-5221; Bardin, Nathalie/0000-0003-3680-082X; Aurrand-Lions, Michel/0000-0002-8361-3034; DIGNAT-GEORGE, Françoise/0000-0001-7006-4462; Kaspi, Elise/0000-0003-0458-5109; lafitte, daniel/0000-0001-9921-7522; Stalin, Jimmy/0000-0001-8092-7057	INSERM; Aix-Marseille University; Region Provence-Alpes-Cote d'Azur; Association for Research on Cancer; canceropole Provence-Alpes-Cote d'Azur; University Foundation Sport Sante et developpement durable	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille University; Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Association for Research on Cancer; canceropole Provence-Alpes-Cote d'Azur; University Foundation Sport Sante et developpement durable	This work was supported by INSERM and Aix-Marseille University.; Both authors contributed equally to this work. J. Stalin was supported by a grant from Region Provence-Alpes-Cote d'Azur.; The proteomic platform was supported by Association for Research on Cancer, canceropole Provence-Alpes-Cote d'Azur, and University Foundation Sport Sante et developpement durable. We thank Biocytex company for providing rsCD146.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Almeras L, 2007, PROTEOMICS, V7, P769, DOI 10.1002/pmic.200600392; Anfosso F, 1998, J BIOL CHEM, V273, P26852, DOI 10.1074/jbc.273.41.26852; Bardin N, 2006, INFLAMM BOWEL DIS, V12, P16, DOI 10.1097/01.MIB.0000194181.46930.88; Bardin N, 2003, THROMB HAEMOSTASIS, V90, P915, DOI 10.1160/TH02-11-0285; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Basile DP, 2004, AM J PHYSIOL-RENAL, V286, pF893, DOI 10.1152/ajprenal.00328.2003; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Bu PC, 2006, MOL CANCER THER, V5, P2872, DOI 10.1158/1535-7163.MCT-06-0260; Causey LD, 1996, NAT BIOTECHNOL, V14, P348, DOI 10.1038/nbt0396-348; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Cochrane D, 2000, J MOL BIOL, V297, P89, DOI 10.1006/jmbi.2000.3561; Daugherty PS, 1998, PROTEIN ENG, V11, P825, DOI 10.1093/protein/11.9.825; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Flanagan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040443; Harhouri K, 2010, BLOOD, V115, P3843, DOI 10.1182/blood-2009-06-229591; Holmgren L, 2006, P NATL ACAD SCI USA, V103, P9208, DOI 10.1073/pnas.0603110103; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Kang HT, 2004, J BIOCHEM MOL BIOL, V37, P159; Kebir A, 2010, CIRC RES, V107, P66, DOI 10.1161/CIRCRESAHA.109.213827; Li G, 2003, ONCOGENE, V22, P6891, DOI 10.1038/sj.onc.1206819; Lucas R, 1998, BLOOD, V92, P4730; Matsunaga T, 2005, AM J PHYSIOL-HEART C, V288, pH2042, DOI 10.1152/ajpheart.00669.2004; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Pasquier E, 2005, THROMB HAEMOSTASIS, V94, P1280, DOI 10.1160/TH05-04-0253; Pearson JD, 2009, J THROMB HAEMOST, V7, P255, DOI 10.1111/j.1538-7836.2008.03214.x; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wajih N, 2003, BLOOD, V101, P1857, DOI 10.1182/blood-2002-02-0582; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zheng CG, 2009, INT J BIOCHEM CELL B, V41, P2163, DOI 10.1016/j.biocel.2009.03.014	36	36	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8991	9000		10.1074/jbc.M112.446518	http://dx.doi.org/10.1074/jbc.M112.446518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389031	Green Published, hybrid			2022-12-28	WOS:000316862200018
J	Hong, L; Kenney, SR; Phillips, GK; Simpson, D; Schroeder, CE; Noth, J; Romero, E; Swanson, S; Waller, A; Strouse, JJ; Carter, M; Chigaev, A; Ursu, O; Oprea, T; Hjelle, B; Golden, JE; Aube, J; Hudson, LG; Buranda, T; Sklar, LA; Wandinger-Ness, A				Hong, Lin; Kenney, S. Ray; Phillips, Genevieve K.; Simpson, Denise; Schroeder, Chad E.; Noeth, Julica; Romero, Elsa; Swanson, Scarlett; Waller, Anna; Strouse, J. Jacob; Carter, Mark; Chigaev, Alexandre; Ursu, Oleg; Oprea, Tudor; Hjelle, Brian; Golden, Jennifer E.; Aube, Jeffrey; Hudson, Laurie G.; Buranda, Tione; Sklar, Larry A.; Wandinger-Ness, Angela			Characterization of a Cdc42 Protein Inhibitor and Its Use as a Molecular Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REAL-TIME MEASUREMENT; RHO-GTPASES; NUCLEOTIDE-BINDING; FLOW-CYTOMETRY; DIRECTED MIGRATION; ACTIN DYNAMICS; CELL MIGRATION; LUNG-CANCER; E-CADHERIN; RAS	Cdc42 plays important roles in cytoskeleton organization, cell cycle progression, signal transduction, and vesicle trafficking. Overactive Cdc42 has been implicated in the pathology of cancers, immune diseases, and neuronal disorders. Therefore, Cdc42 inhibitors would be useful in probing molecular pathways and could have therapeutic potential. Previous inhibitors have lacked selectivity and trended toward toxicity. We report here the characterization of a Cdc42-selective guanine nucleotide binding lead inhibitor that was identified by high throughput screening. A second active analog was identified via structure-activity relationship studies. The compounds demonstrated excellent selectivity with no inhibition toward Rho and Rac in the same GTPase family. Biochemical characterization showed that the compounds act as noncompetitive allosteric inhibitors. When tested in cellular assays, the lead compound inhibited Cdc42-related filopodia formation and cell migration. The lead compound was also used to clarify the involvement of Cdc42 in the Sin Nombre virus internalization and the signaling pathway of integrin VLA-4. Together, these data present the characterization of a novel Cdc42-selective allosteric inhibitor and a related analog, the use of which will facilitate drug development targeting Cdc42-related diseases and molecular pathway studies that involve GTPases.	[Hong, Lin; Romero, Elsa; Swanson, Scarlett; Waller, Anna; Strouse, J. Jacob; Carter, Mark; Chigaev, Alexandre; Hjelle, Brian; Buranda, Tione; Sklar, Larry A.; Wandinger-Ness, Angela] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Hong, Lin; Waller, Anna; Strouse, J. Jacob; Carter, Mark; Ursu, Oleg; Oprea, Tudor; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Kenney, S. Ray; Hudson, Laurie G.; Wandinger-Ness, Angela] Univ New Mexico, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Phillips, Genevieve K.; Ursu, Oleg; Oprea, Tudor; Hudson, Laurie G.; Sklar, Larry A.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Ursu, Oleg; Oprea, Tudor] Univ New Mexico, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Simpson, Denise; Schroeder, Chad E.; Noeth, Julica; Golden, Jennifer E.; Aube, Jeffrey] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66047 USA; [Aube, Jeffrey] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico; University of Kansas; University of Kansas	Sklar, LA (corresponding author), Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA.	lsklar@salud.unm.edu; wness@unm.edu	Jean-Louis, Denise/AAD-5029-2021; Wandinger-Ness, Angela/J-9104-2012; Oprea, Tudor I/A-5746-2011; Chigaev, Alexandre/A-3103-2010	Wandinger-Ness, Angela/0000-0003-0613-3157; Oprea, Tudor I/0000-0002-6195-6976; Chigaev, Alexandre/0000-0002-7726-638X; Golden, Jennifer/0000-0002-6813-3710; Aube, Jeffrey/0000-0003-1049-5767; Waller, Anna/0000-0003-3676-2501	National Science Foundation (NSF) [MCB0956027]; National Institutes of Health from the Molecular Libraries Program [R03 MH081231-01]; University of New Mexico Center for Molecular Discovery Molecular Libraries Probe Production Centers (UNMCMD MLPCN) National Institutes of Health [U54MH084690, R01HL081062]; UNM National Center for Research Resources (NCRR) [5P20RR016480]; National Institutes of Health through the NCI [R21 CA170375-01]; National Institutes of Health [NS066429, AI092130]; University of Kansas Specialized Chemistry Center (KUSCC) MLPCN National Institutes of Health [U54HG005031]; NATIONAL CANCER INSTITUTE [R21CA170375] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI092130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH081231, U54MH084690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066429] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health from the Molecular Libraries Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Center for Molecular Discovery Molecular Libraries Probe Production Centers (UNMCMD MLPCN) National Institutes of Health; UNM National Center for Research Resources (NCRR); National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Specialized Chemistry Center (KUSCC) MLPCN National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation (NSF) Grant MCB0956027 and National Institutes of Health Grant R03 MH081231-01 from the Molecular Libraries Program (to A. W. N.); University of New Mexico Center for Molecular Discovery Molecular Libraries Probe Production Centers (UNMCMD MLPCN) National Institutes of Health Grants U54MH084690 and R01HL081062 (to L. A. S.); UNM National Center for Research Resources (NCRR) Grant 5P20RR016480 (to L. G. H.); National Institutes of Health Grant R21 CA170375-01 through the NCI (to A. W. N., L. G. H., and J. E. G.); National Institutes of Health Grants NS066429 and AI092130 (to T. B.); and University of Kansas Specialized Chemistry Center (KUSCC) MLPCN National Institutes of Health Grant U54HG005031 (to J. A.).	Ahn SJ, 2003, CANCER LETT, V193, P99, DOI 10.1016/S0304-3835(03)00004-1; Antoine-Bertrand J, 2011, CURR DRUG TARGETS, V12, P1202, DOI 10.2174/138945011795906543; ASHMAN LK, 1985, LEUKEMIA RES, V9, P157, DOI 10.1016/0145-2126(85)90029-3; Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Chen QY, 2012, INT J ONCOL, V40, P1561, DOI 10.3892/ijo.2012.1336; Cheung LWT, 2010, ONCOGENE, V29, P2427, DOI 10.1038/onc.2009.523; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2011, METHODS MOL BIOL, V757, P3, DOI 10.1007/978-1-61779-166-6_1; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Copeland R. A., 2005, EVALUATION ENZYME IN; Cotteret S, 2002, GENOME BIOL, V3; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faure Sandrine, 2011, Small GTPases, V2, P310; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kikuchi K, 2011, FEBS LETT, V585, P286, DOI 10.1016/j.febslet.2010.12.010; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; Korlach J, 2004, P NATL ACAD SCI USA, V101, P2800, DOI 10.1073/pnas.0308579100; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Leszczynska K, 2011, BIOCHEM SOC T, V39, P1606, DOI 10.1042/BST20110702; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mitra S, 2011, SEMIN CELL DEV BIOL, V22, P57, DOI 10.1016/j.semcdb.2010.12.005; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nalla AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013006; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Petermann P, 2009, J VIROL, V83, P9759, DOI 10.1128/JVI.00835-09; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; Prescott JB, 2007, J IMMUNOL, V179, P1796, DOI 10.4049/jimmunol.179.3.1796; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Reeder MK, 2001, J BIOL CHEM, V276, P40606, DOI 10.1074/jbc.M103925200; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Schwartz SL, 2008, ANAL BIOCHEM, V381, P258, DOI 10.1016/j.ab.2008.06.039; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Surviladze Z., 2010, PROBE REPORTS NIH MO; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; Torimura M, 2001, ANAL SCI, V17, P155, DOI 10.2116/analsci.17.155; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Woodside DG, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-2; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; YUMURA S, 1983, J CELL BIOL, V96, P857, DOI 10.1083/jcb.96.3.857; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	70	106	113	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8531	8543		10.1074/jbc.M112.435941	http://dx.doi.org/10.1074/jbc.M112.435941			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382385	Green Published, hybrid			2022-12-28	WOS:000316564500049
J	Nihei, Y; Ito, D; Okada, Y; Akamatsu, W; Yagi, T; Yoshizaki, T; Okano, H; Suzuki, N				Nihei, Yoshihiro; Ito, Daisuke; Okada, Yohei; Akamatsu, Wado; Yagi, Takuya; Yoshizaki, Takahito; Okano, Hideyuki; Suzuki, Norihiro			Enhanced Aggregation of Androgen Receptor in Induced Pluripotent Stem Cell-derived Neurons from Spinal and Bulbar Muscular Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; MOTOR-NEURONS; GLUTAMINE REPEATS; DISEASE; EXPRESSION; GENE; INSTABILITY; PATHOGENESIS; PHENOTYPES; 17-AAG	Spinal and bulbar muscular atrophy (SBMA) is an X-linked motor neuron disease caused by a CAG repeat expansion in the androgen receptor (AR) gene. Ligand-dependent nuclear accumulation of mutant AR protein is a critical characteristic of the pathogenesis of SBMA. SBMA has been modeled in AR-overexpressing animals, but precisely how the polyglutamine (polyQ) expansion leads to neurodegeneration is unclear. Induced pluripotent stem cells (iPSCs) are a new technology that can be used to model human diseases, study pathogenic mechanisms, and develop novel drugs. We established SBMA patient-derived iPSCs, investigated their cellular biochemical characteristics, and found that SBMA-iPSCs can differentiate into motor neurons. The CAG repeat numbers in the AR gene of SBMA-iPSCs and also in the atrophin-1 gene of iPSCs derived from another polyQ disease, dentato-rubro-pallido-luysian atrophy (DRPLA), remain unchanged during reprogramming, long term passage, and differentiation, indicating that polyQ disease-associated CAG repeats are stable during maintenance of iPSCs. The level of AR expression is up-regulated by neuronal differentiation and treatment with the AR ligand dihydrotestosterone. Filter retardation assays indicated that aggregation of ARs following dihydrotestosterone treatment in neurons derived from SBMA-iPSCs increases significantly compared with neurological control iPSCs, easily recapitulating the pathological feature of mutant ARs in SBMA-iPSCs. This phenomenon was not observed in iPSCs and fibroblasts, thereby showing the neuron-dominant phenotype of this disease. Furthermore, the HSP90 inhibitor 17-allylaminogeldanamycin sharply decreased the level of aggregated AR in neurons derived from SBMA-iPSCs, indicating a potential for discovery and validation of candidate drugs. We found that SBMA-iPSCs possess disease-specific biochemical features and could thus open new avenues of research into not only SBMA, but also other polyglutamine diseases.	[Nihei, Yoshihiro; Ito, Daisuke; Yagi, Takuya; Yoshizaki, Takahito; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei; Akamatsu, Wado; Okano, Hideyuki] Keio Univ, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Keio University	Ito, D (corresponding author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	d-ito@jk9.so-net.ne.jp	Suzuki, Norihiro/J-5125-2013; Ito, Daisuke/GXF-1648-2022; Okada, Yohei/L-1662-2013; Akamatsu, Wado/L-1214-2013; Ito, Daisuke/M-3608-2013; Okano, Hideyuki/I-7584-2019	Suzuki, Norihiro/0000-0002-0399-6590; Ito, Daisuke/0000-0002-4740-1675; 	Eisai Co., Ltd.; ALS Foundation; Japan ALS Association; Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25640038] Funding Source: KAKEN	Eisai Co., Ltd.(Eisai Co Ltd); ALS Foundation; Japan ALS Association; Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Eisai Co., Ltd. (to D.I. and N.S.), the ALS Foundation, the Japan ALS Association (to Y.N.), the Nakabayashi Trust for ALS Research (to Y.N.), and a grant from the Project for the Realization of Regenerative Medicine of the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.O.).	Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BROOKS BP, 1995, TRENDS NEUROSCI, V18, P459, DOI 10.1016/0166-2236(95)94497-S; Burnstein KL, 1995, MOL CELL ENDOCRINOL, V115, P177, DOI 10.1016/0303-7207(95)03688-1; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chang CY, 2006, FERTIL STERIL, V85, P1195, DOI 10.1016/j.fertnstert.2005.11.031; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9; Fischbeck KH, 1997, J INHERIT METAB DIS, V20, P152, DOI 10.1023/A:1005344403603; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Ito D, 2012, ANN NEUROL, V72, P167, DOI 10.1002/ana.23596; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lu SF, 1999, J NEUROBIOL, V41, P505, DOI 10.1002/(SICI)1097-4695(199912)41:4<505::AID-NEU6>3.0.CO;2-N; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Martorell L, 2007, PRENATAL DIAG, V27, P68, DOI 10.1002/pd.1627; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Neckers L, 2002, CLIN CANCER RES, V8, P962; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Paulson HL, 2000, BRAIN PATHOL, V10, P293, DOI 10.1111/j.1750-3639.2000.tb00263.x; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Rusmini P, 2011, NEUROBIOL DIS, V41, P83, DOI 10.1016/j.nbd.2010.08.023; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Takiyama Y, 1999, HUM MOL GENET, V8, P453, DOI 10.1093/hmg/8.3.453; Tanaka F, 1996, HUM MOL GENET, V5, P1253, DOI 10.1093/hmg/5.9.1253; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yagi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041572; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	55	40	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8043	8052		10.1074/jbc.M112.408211	http://dx.doi.org/10.1074/jbc.M112.408211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364790	Green Published, hybrid			2022-12-28	WOS:000316564500005
J	Sanematsu, F; Nishikimi, A; Watanabe, M; Hongu, T; Tanaka, Y; Kanaho, Y; Cote, JF; Fukui, Y				Sanematsu, Fumiyuki; Nishikimi, Akihiko; Watanabe, Mayuki; Hongu, Tsunaki; Tanaka, Yoshihiko; Kanaho, Yasunori; Cote, Jean-Francois; Fukui, Yoshinori			Phosphatidic Acid-dependent Recruitment and Function of the Rac Activator DOCK1 during Dorsal Ruffle Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE D1; EXCHANGE FACTORS; PLASMA-MEMBRANE; PROTEIN; BINDING; FAMILY; DOMAIN; ROLES; DIFFERENTIATION; REORGANIZATION	Activation of receptor tyrosine kinases leads to the formation of two different types of plasma membrane structures: peripheral ruffles and dorsal ruffles. Although the formation of both ruffle types requires activation of the small GTPase Rac, the difference in kinetics suggests that a distinct regulatory mechanism operates for their ruffle formation. DOCK1 and DOCK5 are atypical Rac activators and are both expressed in mouse embryonic fibroblasts (MEFs). We found that although PDGF-induced Rac activation and peripheral ruffle formation were coordinately regulated by DOCK1 and DOCK5 in MEFs, DOCK1 deficiency alone impaired dorsal ruffle formation in MEFs. Unlike DOCK5, DOCK1 bound to phosphatidic acid (PA) through the C-terminal polybasic amino acid cluster and was localized to dorsal ruffles. When this interaction was blocked, PDGF-induced dorsal ruffle formation was severely impaired. In addition, we show that phospholipase D, an enzyme that catalyzes PA synthesis, is required for PDGF-induced dorsal, but not peripheral, ruffle formation. These results indicate that the phospholipase D-PA axis selectively controls dorsal ruffle formation by regulating DOCK1 localization.	[Sanematsu, Fumiyuki; Nishikimi, Akihiko; Watanabe, Mayuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Sanematsu, Fumiyuki; Nishikimi, Akihiko; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 8128582, Japan; [Sanematsu, Fumiyuki; Nishikimi, Akihiko; Watanabe, Mayuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Hongu, Tsunaki; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); University of Tsukuba; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Fukui, Y (corresponding author), Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat,Higashi Ku, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Nishikimi, Akihiko/I-4692-2018	Nishikimi, Akihiko/0000-0001-9497-7557; Fukui, Yoshinori/0000-0003-2335-8745	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology; Canadian Cancer Society [019104]; Japan Society for the Promotion of Science; Fonds de Recherche en Sante du Quebec; Grants-in-Aid for Scientific Research [24590586] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency (to Y.F.), the Project for Development of Innovative Research for Cancer Therapeutics from the Ministry of Education, Culture, Sports, Science and Technology (to Y.F.), Canadian Cancer Society Grant 019104 (to J.-F.C.), and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to Y.F. and F.S.).; Recipient of a Junior Investigator award from the Fonds de Recherche en Sante du Quebec.	Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Haga Y, 2009, EMBO J, V28, P1197, DOI 10.1038/emboj.2009.78; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; OKADA T, 1994, J BIOL CHEM, V269, P3563; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Patel Manishha, 2011, Small GTPases, V2, P268; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sato T, 2013, MOL CELL BIOL, V33, P136, DOI 10.1128/MCB.00869-12; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Tu YZ, 2001, FEBS LETT, V491, P193, DOI 10.1016/S0014-5793(01)02195-0; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	47	36	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8092	8100		10.1074/jbc.M112.410423	http://dx.doi.org/10.1074/jbc.M112.410423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362269	hybrid, Green Published			2022-12-28	WOS:000316564500010
J	Peth, A; Kukushkin, N; Bosse, M; Goldberg, AL				Peth, Andreas; Kukushkin, Nikolay; Bosse, Marc; Goldberg, Alfred L.			Ubiquitinated Proteins Activate the Proteasomal ATPases by Binding to Usp14 or Uch37 Homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; 26S PROTEASOME; DEUBIQUITINATING ENZYME; DISTINCT ROLES; DEGRADATION; POLYUBIQUITIN; RECOGNITION; SUBUNIT; ARCHITECTURE; ASSOCIATION	Degradation of ubiquitinated proteins by 26 S proteasomes requires ATP hydrolysis, but it is unclear how the proteasomal ATPases are regulated and how proteolysis, substrate deubiquitination, degradation, and ATP hydrolysis are coordinated. Polyubiquitinated proteins were shown to stimulate ATP hydrolysis by purified proteasomes, but only if the proteins contain a loosely folded domain. If they were not ubiquitinated, such proteins did not increase ATPase activity. However, they did so upon addition of ubiquitin aldehyde, which mimics the ubiquitin chain and binds to 26 S-associated deubiquitinating enzymes (DUBs): in yeast to Ubp6, which is essential for the ATPase activation, and in mammalian 26 S to the Ubp6 homolog, Usp14, and Uch37. Occupancy of either DUB by a ubiquitin conjugate leads to ATPase stimulation, thereby coupling deubiquitination and ATP hydrolysis. Thus, ubiquitinated loosely folded proteins, after becoming bound to the 26 S, interact with Ubp6/Usp14 or Uch37 to activate ATP hydrolysis and enhance their own destruction.	[Peth, Andreas; Kukushkin, Nikolay; Goldberg, Alfred L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bosse, Marc] Inbiomed, Gipuzkoa 20009, Spain	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	Alfred_goldberg@hms.harvard.edu	Bosse, Marc/AAM-8593-2021		National Institutes of Health/NIGMS [R01 GM051923-17]; Amyotropic Lateral Sclerosis Association [K2Y740]; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Amyotropic Lateral Sclerosis Association; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health/NIGMS (R01 GM051923-17), the Amyotropic Lateral Sclerosis Association (K2Y740), and the Fidelity Biosciences Research Initiative.	Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Mizuguchi M, 1998, J MOL BIOL, V283, P265, DOI 10.1006/jmbi.1998.2100; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; TANAKA K, 1983, J CELL BIOL, V96, P1580, DOI 10.1083/jcb.96.6.1580; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	39	79	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7781	7790		10.1074/jbc.M112.441907	http://dx.doi.org/10.1074/jbc.M112.441907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341450	Green Published, hybrid			2022-12-28	WOS:000316455300033
J	Sarell, CJ; Woods, LA; Su, YC; Debelouchina, GT; Ashcroft, AE; Griffin, RG; Stockley, PG; Radford, SE				Sarell, Claire J.; Woods, Lucy A.; Su, Yongchao; Debelouchina, Galia T.; Ashcroft, Alison E.; Griffin, Robert G.; Stockley, Peter G.; Radford, Sheena E.			Expanding the Repertoire of Amyloid Polymorphs by Co-polymerization of Related Protein Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; A-BETA; BETA(2)-MICROGLOBULIN; BETA-2-MICROGLOBULIN; STATE; ALPHA; SPECTROSCOPY; SPECIFICITY; AGGREGATION; MECHANISMS	Amyloid fibrils can be generated from proteins with diverse sequences and folds. Although amyloid fibrils assembled in vitro commonly involve a single protein precursor, fibrils formed in vivo can contain more than one protein sequence. How fibril structure and stability differ in fibrils composed of single proteins (homopolymeric fibrils) from those generated by co-polymerization of more than one protein sequence (heteropolymeric fibrils) is poorly understood. Here we compare the structure and stability of homo and heteropolymeric fibrils formed from human beta(2)-microglobulin and its truncated variant Delta N6. We use an array of approaches (limited proteolysis, magic angle spinning NMR, Fourier transform infrared spectroscopy, and fluorescence) combined with measurements of thermodynamic stability to characterize the different fibril types. The results reveal fibrils with different structural properties, different side-chain packing, and strikingly different stabilities. These findings demonstrate how co-polymerization of related precursor sequences can expand the repertoire of structural and thermodynamic polymorphism in amyloid fibrils to an extent that is greater than that obtained by polymerization of a single precursor alone.	[Sarell, Claire J.; Woods, Lucy A.; Ashcroft, Alison E.; Stockley, Peter G.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Sarell, Claire J.; Woods, Lucy A.; Ashcroft, Alison E.; Stockley, Peter G.; Radford, Sheena E.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Su, Yongchao; Griffin, Robert G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Su, Yongchao; Griffin, Robert G.] MIT, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA; [Debelouchina, Galia T.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	University of Leeds; University of Leeds; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Princeton University	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk	Su, Yongchao/B-6749-2009	Su, Yongchao/0000-0001-5063-3218; Stockley, Peter/0000-0002-1360-2751; Radford, Sheena/0000-0002-3079-8039	National Institutes of Health [EB003151, EB002026]; Medical Research Council [G0900958]; Wellcome Trust [075099/Z/04/Z]; NMR [094232]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom [BB/526502/1, BB/E012558/I]; MRC [G0900958] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026, R01EB003151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NMR; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EB003151 and EB002026. This work was also supported by Medical Research Council Grant G0900958, the Wellcome Trust (grant code 075099/Z/04/Z (LCT Premier, mass spectrometry facility) and NMR (094232)), and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (BB/526502/1) (BB/E012558/I, for the Synapt HDMS).	APPEL W, 1986, CLIN BIOCHEM, V19, P317, DOI 10.1016/S0009-9120(86)80002-9; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bennett AE, 1998, J CHEM PHYS, V108, P9463, DOI 10.1063/1.476420; BENNETT AE, 1992, J CHEM PHYS, V96, P8624, DOI 10.1063/1.462267; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hodkinson JP, 2012, RAPID COMMUN MASS SP, V26, P1783, DOI 10.1002/rcm.6282; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ichishima E., 1970, METHOD ENZYMOL, V19, P397; Iwadate M, 1999, J BIOMOL NMR, V13, P199, DOI 10.1023/A:1008376710086; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lapko VN, 2000, J MASS SPECTROM, V35, P572, DOI 10.1002/(SICI)1096-9888(200004)35:4<572::AID-JMS971>3.0.CO;2-2; Lewandowski JR, 2011, J AM CHEM SOC, V133, P14686, DOI 10.1021/ja203736z; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Ma B, 2003, PROTEIN ENG, V16, P561, DOI 10.1093/protein/gzg079; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rahimi F., 2012, NONFIBRILLAR AMYLOID, P377; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Surmacz-Chwedoruk W, 2012, BIOCHEMISTRY-US, V51, P9460, DOI 10.1021/bi301144d; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yanagi K, 2012, J MOL BIOL, V422, P390, DOI 10.1016/j.jmb.2012.05.034	61	32	32	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7327	7337		10.1074/jbc.M112.447524	http://dx.doi.org/10.1074/jbc.M112.447524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329840	Green Published, hybrid			2022-12-28	WOS:000316002400052
J	Sommerville, C; Richardson, JM; Williams, RAM; Mottram, JC; Roberts, CW; Alexander, J; Henriquez, FL				Sommerville, Caroline; Richardson, Julia M.; Williams, Roderick A. M.; Mottram, Jeremy C.; Roberts, Craig W.; Alexander, James; Henriquez, Fiona L.			Biochemical and Immunological Characterization of Toxoplasma gondii Macrophage Migration Inhibitory Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAUTOMERASE ACTIVE-SITE; FACTOR MIF; DENDRITIC CELLS; FUNCTIONAL-CHARACTERIZATION; PARASITIC NEMATODE; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; REGULATORY ROLE; ACTIVATION; INFECTION	Macrophage migration inhibitory factor (MIF) is a proinflammatory molecule in mammals that, unusually for a cytokine, exhibits tautomerase and oxidoreductase enzymatic activities. Homologues of this well conserved protein are found within diverse phyla including a number of parasitic organisms. Herein, we produced recombinant histidine-tagged Toxoplasma gondii MIF (TgMIF), a 12-kDa protein that lacks oxidoreductase activity but exhibits tautomerase activity with a specific activity of 19.3 mu mol/min/mg that cannot be inhibited by the human MIF inhibitor ISO-1. The crystal structure of the TgMIF homotrimer has been determined to 1.82 angstrom, and although it has close structural homology with mammalian MIFs, it has critical differences in the tautomerase active site that account for the different inhibitor sensitivity. We also demonstrate that TgMIF can elicit IL-8 production from human peripheral blood mononuclear cells while also activating ERK MAPK pathways in murine bone marrow-derived macrophages. TgMIF may therefore play an immunomodulatory role during T. gondii infection in mammals.	[Sommerville, Caroline; Williams, Roderick A. M.; Roberts, Craig W.; Alexander, James] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Williams, Roderick A. M.; Henriquez, Fiona L.] Univ West Scotland, Sch Sci, Inst Biomed & Environm Hlth Res, Paisley PA1 2BE, Renfrew, Scotland	University of Strathclyde; University of Edinburgh; University of Glasgow; University of West Scotland	Henriquez, FL (corresponding author), Univ West Scotland, Sch Sci, 1 High St, Paisley PA1 2BE, Renfrew, Scotland.	fiona.henriquez@uws.ac.uk	Williams, Roderick/V-4317-2019; Richardson, Julia/D-1808-2013; Roberts, Craig William/B-8016-2008; Alexander, James/A-4238-2009	Williams, Roderick/0000-0001-5065-9768; Richardson, Julia/0000-0002-1547-3009; Roberts, Craig William/0000-0002-0653-835X; Mottram, Jeremy/0000-0001-5574-3766; Henriquez, Fiona/0000-0002-5534-1019	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	This work was supported by the Leverhulme Trust.	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Denkers EY, 2008, CELL HOST MICROBE, V3, P61, DOI 10.1016/j.chom.2008.01.003; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Denney CF, 1999, INFECT IMMUN, V67, P1547; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Ibrahim HM, 2009, INFECT IMMUN, V77, P3686, DOI 10.1128/IAI.00361-09; Jang SI, 2011, VACCINE, V29, P8998, DOI 10.1016/j.vaccine.2011.09.038; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; KAMIYAMA T, 1982, INFECT IMMUN, V36, P628; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Kudrin A, 2008, IMMUNOL CELL BIOL, V86, P232, DOI 10.1038/sj.icb.7100133; Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200; Kurosaka K, 2003, BIOCHEM BIOPH RES CO, V306, P1070, DOI 10.1016/S0006-291X(03)01105-7; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lang C, 2007, PARASITOL RES, V100, P191, DOI 10.1007/s00436-006-0306-9; Larson DF, 2006, CRIT CARE, V10, DOI 10.1186/cc4899; LEONARD EJ, 1990, AM J RESP CELL MOL, V2, P479, DOI 10.1165/ajrcmb/2.6.479; LIU DY, 1985, CELL IMMUNOL, V90, P539, DOI 10.1016/0008-8749(85)90218-7; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Pennock JL, 1998, BIOCHEM J, V331, P905, DOI 10.1042/bj3310905; Ren Y, 2004, ONCOGENE, V23, P4146, DOI 10.1038/sj.onc.1207490; Richardson JM, 2009, BIOCHEM BIOPH RES CO, V380, P442, DOI 10.1016/j.bbrc.2009.01.030; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; RYTEL MW, 1966, P SOC EXP BIOL MED, V123, P859, DOI 10.3181/00379727-123-31624; Sakai Y, 2003, GASTROENTEROLOGY, V124, P725, DOI 10.1053/gast.2003.50099; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Tan THP, 2001, BIOCHEM J, V357, P373, DOI 10.1042/0264-6021:3570373; Zang XX, 2002, J BIOL CHEM, V277, P44261, DOI 10.1074/jbc.M204655200	51	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12733	12741		10.1074/jbc.M112.419911	http://dx.doi.org/10.1074/jbc.M112.419911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23443656	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000318555100030
J	Eren, E; Parkin, J; Adelanwa, A; Cheneke, B; Movileanu, L; Khalid, S; van den Berg, B				Eren, Elif; Parkin, Jamie; Adelanwa, Ayodele; Cheneke, Belete; Movileanu, Liviu; Khalid, Syma; van den Berg, Bert			Toward Understanding the Outer Membrane Uptake of Small Molecules by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; AUTOMATED DOCKING; EFFLUX PUMPS; ACINETOBACTER-BAUMANNII; MULTIDRUG-RESISTANCE; DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; FORCE-FIELD; CHANNEL	Because small molecules enter Gram-negative bacteria via outer membrane (OM) channels, understanding OM transport is essential for the rational design of improved and new antibiotics. In the human pathogen Pseudomonas aeruginosa, most small molecules are taken up by outer membrane carboxylate channel (Occ) proteins, which can be divided into two distinct subfamilies, OccD and OccK. Here we characterize substrate transport mediated by Occ proteins belonging to both subfamilies. Based on the determination of the OccK2-glucuronate co-crystal structure, we identify the channel residues that are essential for substrate transport. We further show that the pore regions of the channels are rigid in the OccK subfamily and highly dynamic in the OccD subfamily. We also demonstrate that the substrate carboxylate group interacts with central residues of the basic ladder, a row of arginine and lysine residues that leads to and away from the binding site at the channel constriction. Moreover, the importance of the basic ladder residues corresponds to their degree of conservation. Finally, we apply the generated insights by converting the archetype of the entire family, OccD1, from a basic amino acid-specific channel into a channel with a preference for negatively charged amino acids.	[Eren, Elif; Adelanwa, Ayodele; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Parkin, Jamie; Khalid, Syma] Univ Southampton, Sch Chem, Syst & Synthet Biol Modelling Grp, Southampton SO17 1BJ, Hants, England; [Cheneke, Belete; Movileanu, Liviu] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Southampton; Syracuse University	van den Berg, B (corresponding author), Newcastle Univ, Sch Med, Inst Cellular & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	bert.van-den-berg@ncl.ac.uk		van den Berg, Bert/0000-0003-1966-8804; Eren, Elif/0000-0002-7942-4943	National Institutes of Health [R01 GM088403, R01 GM085785]; National Science Foundation [DMR-1006332]; EPSRC [EP/L000253/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1094646, EP/L000253/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085785, R01GM088403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM088403 (to L. M.) and R01 GM085785 (to B. v. d. B.). This work was also supported by National Science Foundation Grant DMR-1006332 (to L. M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Biswas S, 2008, STRUCTURE, V16, P1027, DOI 10.1016/j.str.2008.04.009; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Bolla JM, 2011, FEBS LETT, V585, P1682, DOI 10.1016/j.febslet.2011.04.054; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cheneke BR, 2011, BIOCHEMISTRY-US, V50, P4987, DOI 10.1021/bi200454j; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Goo KS, 2011, CURR COMPUT-AID DRUG, V7, P53, DOI 10.2174/157340911793743538; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang HJ, 1996, J BACTERIOL, V178, P3085, DOI 10.1128/jb.178.11.3085-3090.1996; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khalid S, 2008, BBA-BIOMEMBRANES, V1778, P1871, DOI 10.1016/j.bbamem.2007.05.024; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Liu JM, 2012, BIOCHEMISTRY-US, V51, P2319, DOI 10.1021/bi300066w; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Mahendran KR, 2010, J BIOMOL SCREEN, V15, P302, DOI 10.1177/1087057109357791; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pongprayoon P, 2009, P NATL ACAD SCI USA, V106, P21614, DOI 10.1073/pnas.0907315106; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamber S, 2006, J BACTERIOL, V188, P45, DOI 10.1128/JB.188.1.45-54.2006; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Ziervogel BK, 2013, STRUCTURE, V21, P76, DOI 10.1016/j.str.2012.10.014	59	44	44	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12042	12053		10.1074/jbc.M113.463570	http://dx.doi.org/10.1074/jbc.M113.463570			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467408	hybrid, Green Published			2022-12-28	WOS:000318157600038
J	Korytowski, W; Pilat, A; Schmitt, JC; Girotti, AW				Korytowski, Witold; Pilat, Anna; Schmitt, Jared C.; Girotti, Albert W.			Deleterious Cholesterol Hydroperoxide Trafficking in Steroidogenic Acute Regulatory (StAR) Protein-expressing MA-10 Leydig Cells IMPLICATIONS FOR OXIDATIVE STRESS-IMPAIRED STEROIDOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZODIAZEPINE RECEPTOR; GLUTATHIONE-PEROXIDASE; INTERMEMBRANE TRANSFER; TUMOR-CELLS; TRANSPORT; MITOCHONDRIA; MECHANISMS; OXYSTEROLS; INDUCTION; MEMBRANES	Steroidogenic acute regulatory (StAR) proteins in steroidogenic cells are implicated in the delivery of cholesterol (Ch) from internal or external sources to mitochondria (Mito) for initiation of steroid hormone synthesis. In this study, we tested the hypothesis that under oxidative stress, StAR-mediated trafficking of redox-active cholesterol hydroperoxides (ChOOHs) can result in site-specific Mito damage and dysfunction. Steroidogenic stimulation of mouse MA-10 Leydig cells with dibutyryl-cAMP (Bt(2)cAMP) resulted in strong expression of StarD1 and StarD4 proteins over insignificant levels in nonstimulated controls. During incubation with the ChOOH 3 beta-hydroxycholest-5-ene-7 alpha-hydroperoxide (7 alpha-OOH) in liposomes, stimulated cells took up substantially more hydroperoxide in Mito than controls, with a resulting loss of membrane potential (Delta Psi(m)) and ability to drive progesterone synthesis. 7 alpha-OOH uptake and Delta Psi(m) loss were greatly reduced by StarD1 knockdown, thus establishing the role of this protein in 7 alpha-OOH delivery. Moreover, 7 alpha-OOH was substantially more toxic to stimulated than nonstimulated cells, the former dying mainly by apoptosis and the latter dying by necrosis. Importantly, tert-butyl hydroperoxide, which is not a StAR protein ligand, was equally toxic to stimulated and nonstimulated cells. These findings support the notion that like Ch itself, 7 alpha-OOH can be transported to/into Mito of steroidogenic cells by StAR proteins and therein induce free radical damage, which compromises steroid hormone synthesis.	[Korytowski, Witold; Pilat, Anna; Schmitt, Jared C.; Girotti, Albert W.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Korytowski, Witold; Pilat, Anna] Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	Medical College of Wisconsin; Jagiellonian University	Korytowski, W (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	witekkor@mcw.edu; agirotti@mcw.edu	Girotti, Albert/AAF-6910-2020		National Institutes of Health [HL85677]; Polish National Science Center [2011/01/B/NZ3/02167]; Medical College of Wisconsin Research Affairs Committee [3726]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish National Science Center; Medical College of Wisconsin Research Affairs Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL85677 (to A. W. G.) and by Polish National Science Center Grant 2011/01/B/NZ3/02167 and Medical College of Wisconsin Research Affairs Committee Grant 3726 (to W. K.).	Abidi P, 2008, J ENDOCRINOL, V198, P193, DOI 10.1677/JOE-07-0570; Ariyoshi K, 2002, FREE RADICAL RES, V36, P661, DOI 10.1080/10715760290029100; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Astort F, 2009, DIABETES-METAB RES, V25, P477, DOI 10.1002/dmrr.978; AZHAR S, 1995, J CLIN INVEST, V96, P1414, DOI 10.1172/JCI118177; Bhowmick R, 2010, FREE RADICAL BIO MED, V48, P1296, DOI 10.1016/j.freeradbiomed.2010.01.040; Chen H, 2008, ENDOCRINOLOGY, V149, P2612, DOI 10.1210/en.2007-1245; Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Connelly MA, 2003, TRENDS ENDOCRIN MET, V14, P467, DOI 10.1016/j.tem.2003.10.002; Culty M, 2002, J ANDROL, V23, P439; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Diemer T, 2003, ENDOCRINOLOGY, V144, P2882, DOI 10.1210/en.2002-0090; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fluiter K, 1999, J BIOL CHEM, V274, P8893, DOI 10.1074/jbc.274.13.8893; Girotti AW, 2008, FREE RADICAL BIO MED, V44, P956, DOI 10.1016/j.freeradbiomed.2007.12.004; Girotti AW, 1998, J LIPID RES, V39, P1529; Girotti AW, 2000, METHOD ENZYMOL, V319, P85; Girotti AW, 2002, STEROLS OXYSTEROLS C, P121; Hales DB, 1999, ENDOCRINE, V10, P201, DOI 10.1007/BF02738619; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KODAMAN PH, 1994, ENDOCRINOLOGY, V135, P2723, DOI 10.1210/en.135.6.2723; Korytowski W, 1996, BIOCHEMISTRY-US, V35, P8670, DOI 10.1021/bi960522k; Korytowski W, 1999, METHOD ENZYMOL, V300, P23; KORYTOWSKI W, 1991, ANAL BIOCHEM, V197, P149, DOI 10.1016/0003-2697(91)90371-Y; Korytowski W, 2010, BIOCHEM BIOPH RES CO, V392, P58, DOI 10.1016/j.bbrc.2009.12.165; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kriska T, 2006, J BIOL CHEM, V281, P23643, DOI 10.1074/jbc.M600744200; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rodriguez-Agudo D, 2005, J LIPID RES, V46, P1615, DOI 10.1194/jlr.M400501-JLR200; Rodriguez-Agudo D, 2008, J LIPID RES, V49, P1409, DOI 10.1194/jlr.M700537-JLR200; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; SPECTOR DL, 1997, CELLS LAB MANUAL, V1; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; STOCCO DM, 1988, BIOCHEM J, V249, P95, DOI 10.1042/bj2490095; THOMAS JP, 1990, J BIOL CHEM, V265, P454; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vila A, 2004, BIOCHEMISTRY-US, V43, P12592, DOI 10.1021/bi0491200; Vila A, 2002, BIOCHEMISTRY-US, V41, P13705, DOI 10.1021/bi026467z; Vila A, 2001, BIOCHEMISTRY-US, V40, P14715, DOI 10.1021/bi011408r; Wang XJ, 2002, MOL CELL ENDOCRINOL, V188, P55, DOI 10.1016/S0303-7207(01)00748-1; Yoshioka N, 2005, FREE RADICAL RES, V39, P299, DOI 10.1080/10715760400023002; Zirkin BR, 2000, BIOL REPROD, V63, P977, DOI 10.1095/biolreprod63.4.977	61	18	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11509	11519		10.1074/jbc.M113.452151	http://dx.doi.org/10.1074/jbc.M113.452151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23467407	Green Published, hybrid			2022-12-28	WOS:000317915500057
J	DeVay, RM; Shelton, DL; Liang, H				DeVay, Rachel M.; Shelton, David L.; Liang, Hong			Characterization of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Trafficking Reveals a Novel Lysosomal Targeting Mechanism via Amyloid Precursor-like Protein 2 (APLP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; C-TERMINAL DOMAIN; SECRETED PCSK9; MEDIATED ENDOCYTOSIS; LDL RECEPTORS; NONHUMAN-PRIMATES; STATISTICAL-MODEL; HEPG2 CELLS; IN-VIVO	Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates low density lipoprotein receptor protein levels by diverting it to lysosomes. Monoclonal antibody therapeutics aimed to neutralize PCSK9 have been shown to successfully lower serum LDL levels; however, we previously found that such therapeutic antibodies are subject to PCSK9-mediated clearance. In this study, we discovered that PCSK9 interacts via its C-terminal domain directly and in a pH-dependent manner with amyloid precursor protein as well as its closely related family member, amyloid precursor protein-like protein 2. Furthermore, we determined that amyloid precursor protein-like protein-2, but not amyloid precursor protein, is involved in mediating postendocytic delivery of PCSK9 to lysosomes and is therefore important for PCSK9 function. Based on our data, we propose a model for a lysosomal transport complex by which a soluble protein can target another protein for degradation from the luminal side of the membrane by bridging it to a lysosomally targeted transmembrane protein.	[DeVay, Rachel M.; Shelton, David L.; Liang, Hong] Rinat Pfizer Inc, San Francisco, CA 94080 USA	Pfizer	Liang, H (corresponding author), Rinat Pfizer Inc, 230 E Grand Ave, San Francisco, CA 94080 USA.	hong.liang@pfizer.com						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Beglova N, 2004, BIOCHEM SOC T, V32, P721, DOI 10.1042/BST0320721; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Holla OL, 2010, MOL GENET METAB, V99, P149, DOI 10.1016/j.ymgme.2009.09.012; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Tibolla G, 2011, NUTR METAB CARDIOVAS, V21, P835, DOI 10.1016/j.numecd.2011.06.002; Tuli A, 2008, J IMMUNOL, V181, P1978, DOI 10.4049/jimmunol.181.3.1978; Tuli A, 2009, J BIOL CHEM, V284, P34296, DOI 10.1074/jbc.M109.039727; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	44	40	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10805	10818		10.1074/jbc.M113.453373	http://dx.doi.org/10.1074/jbc.M113.453373			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430252	hybrid, Green Published			2022-12-28	WOS:000317565000058
J	Hubbi, ME; Hu, HX; Kshitiz; Ahmed, I; Levchenko, A; Semenza, GL				Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Ahmed, Ishrat; Levchenko, Andre; Semenza, Gregg L.			Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) for Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; PYRUVATE-KINASE; FACTOR 1-ALPHA; HIF-ALPHA; EXPRESSION; GENE; PROTEIN; GROWTH; TRANSACTIVATION; INHIBITOR	Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor that mediates adaptive responses to hypoxia. We demonstrate that lysosomal degradation of the HIF-1 alpha subunit by chaperone-mediated autophagy (CMA) is a major regulator of HIF-1 activity. Pharmacological inhibitors of lysosomal degradation, such as bafilomycin and chloroquine, increased HIF-1 alpha levels and HIF-1 activity, whereas activators of chaper-one-mediated autophagy, including 6-aminonicotinamide and nutrient starvation, decreased HIF-1 alpha levels and HIF-1 activity. In contrast, macroautophagy inhibitors did not increase HIF-1 activity. Transcription factor EB, a master regulator of lysosomal biogenesis, also negatively regulated HIF-1 activity. HIF-1 alpha interacts with HSC70 and LAMP2A, which are core components of the CMA machinery. Overexpression of HSC70 or LAMP2A decreased HIF-1 alpha protein levels, whereas knockdown had the opposite effect. Finally, hypoxia increased the transcription of genes involved in CMA and lysosomal biogenesis in cancer cells. Thus, pharmacological and genetic approaches identify CMA as a major regulator of HIF-1 activity and identify interplay between autophagy and the response to hypoxia.	[Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Levchenko, Andre; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Hu, Hongxia; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Hu, Hongxia] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Kshitiz; Levchenko, Andre] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Ahmed, Ishrat] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Kz, Kshitiz/I-3657-2013; Hu, Hongxia/Q-7765-2016; Kz, Kshitiz/B-9143-2013	Kz, Kshitiz/0000-0003-4241-9427; Kz, Kshitiz/0000-0003-4241-9427; Hubbi, Maimon/0000-0001-9763-287X	National Institutes of Health from the United States Public Health Service [N01-HV28180, HHS-N268201000032c]; Johns Hopkins Institute for Cell Engineering and Dean's Research Funding; American Heart Association Predoctoral Fellowship [10PRE4160120]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; Johns Hopkins Institute for Cell Engineering and Dean's Research Funding; American Heart Association Predoctoral Fellowship(American Heart Association); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Contracts N01-HV28180 and HHS-N268201000032c from the United States Public Health Service. This work was also supported by the Johns Hopkins Institute for Cell Engineering and Dean's Research Funding and American Heart Association Predoctoral Fellowship 10PRE4160120.	Argani P, 2005, CLIN LAB MED, V25, P363, DOI 10.1016/j.cll.2005.01.008; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dice J., 2000, MOL BIOL INTELLIGENC; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; EKSTROM P, 1984, J NEUROCHEM, V43, P1342, DOI 10.1111/j.1471-4159.1984.tb05392.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Kshitiz, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003002; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lin J, 2012, IUBMB LIFE, V64, P921, DOI 10.1002/iub.1089; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Platz EA, 2011, CANCER DISCOV, V1, P68, DOI 10.1158/2159-8274.CD-10-0020; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhong H, 1999, CANCER RES, V59, P5830	60	161	167	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10703	10714		10.1074/jbc.M112.414771	http://dx.doi.org/10.1074/jbc.M112.414771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457305	Green Published, hybrid			2022-12-28	WOS:000317565000048
J	Liu, L; Xu, YX; Caradonna, KL; Kruzel, EK; Burleigh, BA; Bangs, JD; Hirschberg, CB				Liu, Li; Xu, Yu-Xin; Caradonna, Kacey L.; Kruzel, Emilia K.; Burleigh, Barbara A.; Bangs, James D.; Hirschberg, Carlos B.			Inhibition of Nucleotide Sugar Transport in Trypanosoma brucei Alters Surface Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; UDP-GLUCOSE 4'-EPIMERASE; POLY-N-ACETYLLACTOSAMINE; ENDOPLASMIC-RETICULUM; STRUCTURAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; BIOCHEMICAL-PROPERTIES; AFRICAN TRYPANOSOMES; GALACTOSE METABOLISM; MEMBRANE-PROTEINS	Nucleotide sugar transporters (NSTs) are indispensible for the biosynthesis of glycoproteins by providing the nucleotide sugars needed for glycosylation in the lumen of the Golgi apparatus. Mutations in NST genes cause human and cattle diseases and impaired cell walls of yeast and fungi. Information regarding their function in the protozoan parasite, Trypanosoma brucei, a causative agent of African trypanosomiasis, is unknown. Here, we characterized the substrate specificities of four NSTs, TbNST1-4, which are expressed in both the insect procyclic form (PCF) and mammalian bloodstream form (BSF) stages. TbNST1/2 transports UDP-Gal/UDP-GlcNAc, TbNST3 transports GDP-Man, and TbNST4 transports UDP-GlcNAc, UDP-GalNAc, and GDP-Man. TbNST4 is the first NST shown to transport both pyrimidine and purine nucleotide sugars and is demonstrated here to be localized at the Golgi apparatus. RNAi-mediated silencing of TbNST4 in the procyclic form caused underglycosylated surface glycoprotein EP-procyclin. Similarly, defective glycosylation of the variant surface glycoprotein (VSG221) as well as the lysosomal membrane protein p67 was observed in Delta tbnst4 BSF T. brucei. Relative infectivity analysis showed that defects in glycosylation of the surface coat resulting from tbnst4 deletion were insufficient to impact the ability of this parasite to infect mice. Notably, the fact that inactivation of a single NST gene results in measurable defects in surface glycoproteins in different life cycle stages of the parasite highlights the essential role of NST(s) in glycosylation of T. brucei. Thus, results presented in this study provide a framework for conducting functional analyses of other NSTs identified in T. brucei.	[Liu, Li; Xu, Yu-Xin; Hirschberg, Carlos B.] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Caradonna, Kacey L.; Burleigh, Barbara A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kruzel, Emilia K.; Bangs, James D.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hirschberg, CB (corresponding author), Evans 438,72 East Concord St, Boston, MA 02118 USA.	chirschb@bu.edu		Hirschberg, Carlos/0000-0003-2299-7721; Xu, Yu-Xin/0000-0002-0200-4633	National Institutes of Health [R01 GM30365, R01 AI35739, AI090366]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035739, R21AI090366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM30365 (to C. B. H.), R01 AI35739 (to J. D. B.), and AI090366 (to B. B.).	Abeijon C, 1996, J BIOL CHEM, V271, P8851, DOI 10.1074/jbc.271.15.8851; ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Alexander DL, 2002, J CELL SCI, V115, P3253; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; Bangs JD, 2011, MOL MICROBIOL, V82, P1433, DOI 10.1111/j.1365-2958.2011.07900.x; BANGS JD, 1988, J BIOL CHEM, V263, P17697; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Borst P, 1998, ANNU REV MICROBIOL, V52, P745, DOI 10.1146/annurev.micro.52.1.745; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; BRUN R, 1979, ACTA TROP, V36, P387; Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dean N, 1996, GLYCOBIOLOGY, V6, P73, DOI 10.1093/glycob/6.1.73; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; DESCOTEAUX A, 1995, SCIENCE, V269, P1869, DOI 10.1126/science.7569927; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Ellerton S. S., 2008, J BIOL SCI, V8, P1211; Gao XD, 2001, J BIOL CHEM, V276, P4424, DOI 10.1074/jbc.M009114200; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; HIRUMI H, 1980, PARASITOLOGY, V80, P371, DOI 10.1017/S0031182000000822; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; Hwa KY, 1999, GLYCOBIOLOGY, V9, P181, DOI 10.1093/glycob/9.2.181; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; Kuettel S, 2012, MOL MICROBIOL, V84, P340, DOI 10.1111/j.1365-2958.2012.08026.x; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Liu L, 2013, GLYCOCONJUGATE J, V30, P5, DOI 10.1007/s10719-012-9375-4; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Marino K, 2011, EUKARYOT CELL, V10, P985, DOI 10.1128/EC.05025-11; Marino K, 2010, GLYCOBIOLOGY, V20, P1619, DOI 10.1093/glycob/cwq115; MBAWA ZR, 1991, EUR J CELL BIOL, V56, P243; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Mehlert A, 2010, MOL BIOCHEM PARASIT, V174, P74, DOI 10.1016/j.molbiopara.2010.06.007; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Nishikawa A, 2002, YEAST, V19, P691, DOI 10.1002/yea.854; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; PEREZ M, 1987, METHOD ENZYMOL, V138, P709; Roditi I, 1999, MOL BIOCHEM PARASIT, V103, P99, DOI 10.1016/S0166-6851(99)00124-3; Roper JR, 2003, MOL BIOCHEM PARASIT, V132, P47, DOI 10.1016/j.molbiopara.2003.07.002; Roper JR, 2005, J BIOL CHEM, V280, P19728, DOI 10.1074/jbc.M502370200; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; Rudenko G, 2011, ESSAYS BIOCHEM, V51, P47, DOI [10.1042/BSE0510047, 10.1042/bse0510047]; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Schwartz KJ, 2013, EUKARYOT CELL, V12, P132, DOI 10.1128/EC.00293-12; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Schwede A, 2010, PARASITOLOGY, V137, P2029, DOI 10.1017/S0031182009992034; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stokes MJ, 2008, J BIOL CHEM, V283, P16147, DOI 10.1074/jbc.M709581200; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Urbaniak MD, 2006, EUKARYOT CELL, V5, P1906, DOI 10.1128/EC.00156-06; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xu YX, 2010, J BIOL CHEM, V285, P24600, DOI 10.1074/jbc.M110.134544; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244	78	11	11	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10599	10615		10.1074/jbc.M113.453597	http://dx.doi.org/10.1074/jbc.M113.453597			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443657	Green Published, hybrid			2022-12-28	WOS:000317565000039
J	Belghiti, M; Estevez-Herrera, J; Gimenez-Garzo, C; Gonzalez-Usano, A; Montoliu, C; Ferrer-Montiel, A; Felipo, V; Planells-Cases, R				Belghiti, Majedeline; Estevez-Herrera, Judith; Gimenez-Garzo, Carla; Gonzalez-Usano, Alba; Montoliu, Carmina; Ferrer-Montiel, Antonio; Felipo, Vicente; Planells-Cases, Rosa			Potentiation of the Transient Receptor Potential Vanilloid 1 Channel Contributes to Pruritogenesis in a Rat Model of Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; LYSOPHOSPHATIDIC ACID; SCRATCHING BEHAVIOR; NEUROGENIC INFLAMMATION; THERMAL NOCICEPTION; MAST-CELLS; ITCH; TRPV1; PRURITUS; INVOLVEMENT	Persistent pruritus is a common disabling dermatologic symptom associated with different etiologic factors. These include primary skin conditions, as well as neuropathic, psychogenic, or systemic disorders like chronic liver disease. Defective clearance of potential pruritogenic substances that activate itch-specific neurons innervating the skin is thought to contribute to cholestatic pruritus. However, because the underlying disease-specific pruritogens and itch-specific neuronal pathways and mechanism(s) are unknown, symptomatic therapeutic intervention often leads to no or only limited success. In the current study, we aimed to first validate rats with bile duct ligation (BDL) as a model for hepatic pruritus and then to evaluate the contribution of inflammation, peripheral neuronal sensitization, and specific signaling pathways and subpopulations of itch-responsive neurons to scratching behavior and thermal hypersensitivity. Chronic BDL rats displayed enhanced scratching behavior and thermal hyperalgesia indicative of peripheral neuroinflammation. BDL-induced itch and hypersensitivity involved a minor contribution of histaminergic/serotonergic receptors, but significant activation of protein-activated receptor 2 (PAR(2)) receptors, prostaglandin PGE(2) formation, and potentiation of transient receptor potential vanilloid 1 (TRPV1) channel activity. The sensitization of dorsal root ganglion nociceptors in BDL rats was associated with increased surface expression of PAR(2) and TRPV1 proteins and an increase in the number of PAR(2)-and TRPV1-expressing peptidergic neurons together with a shift of TRPV1 receptor expression to medium sized dorsal root ganglion neurons. These results suggest that pruritus and hyperalgesia in chronic cholestatic BDL rats are associated with neuroinflammation and involve PAR(2)-induced TRPV1 sensitization. Thus, pharmacological modulation of PAR2 and/or TRPV1 may be a valuable therapeutic approach for patients with chronic liver pruritus refractory to conventional treatments.	[Belghiti, Majedeline; Estevez-Herrera, Judith; Gimenez-Garzo, Carla; Gonzalez-Usano, Alba; Felipo, Vicente; Planells-Cases, Rosa] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Montoliu, Carmina] Fdn Invest Hosp Clin Valencia, INCLIVA, Valencia 46010, Spain; [Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Spain; [Planells-Cases, Rosa] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Planells-Cases, Rosa] Max Delbruck Centrum Mol Med MDC, D-13125 Berlin, Germany	Prince Felipe Research Center; Universidad Miguel Hernandez de Elche; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Planells-Cases, R (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Roessle Str 10, D-13125 Berlin, Germany.	planells-cases@fmp-berlin.de	Ferrer-Montiel, Antonio/C-3072-2015; Montoliu, Carmina/ABB-1904-2021; Felipo, Vicente/A-9265-2014; Estevez Herrera, Judith/R-5333-2018	Ferrer-Montiel, Antonio/0000-0002-2973-6607; Felipo, Vicente/0000-0003-3145-9538; Gimenez-Garzo, Carla/0000-0002-9748-443X; Estevez Herrera, Judith/0000-0001-8130-2294	Ministry of Science and Innovation [BFU2009-08346, SAF2008-00062, SAF2007-63193]; Consolider-Ingenio Program [CSD2008-00005]; la Generalitat Valenciana [Prometeo-2010-046, AP-092/09, Prometeo-2009-027, ACOMP2010-220]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio Program(Spanish Government); la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by the Ministry of Science and Innovation Grants BFU2009-08346 (to A. F.-M.), SAF2008-00062 (to V. F.), and SAF2007-63193 (to R. P.-C.); Consolider-Ingenio 2010 Program Grant CSD2008-00005 (to A. F.-M., V. F., and R. P.-C.); and la Generalitat Valenciana Grants Prometeo-2010-046 (to A. F.-M.), AP-092/09, Prometeo-2009-027, and ACOMP2010-220 (to V. F.).	Akiyama T, 2009, J PHARMACOL EXP THER, V329, P945, DOI 10.1124/jpet.109.152256; Akiyama T, 2009, J NEUROSCI, V29, P6691, DOI 10.1523/JNEUROSCI.6103-08.2009; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Banik RK, 2001, NEUROSCI LETT, V299, P21, DOI 10.1016/S0304-3940(00)01770-5; Barak V, 2009, J AUTOIMMUN, V33, P178, DOI 10.1016/j.jaut.2009.09.010; Bergasa NV, 2000, BEST PRACT RES CL GA, V14, P643, DOI 10.1053/bega.2000.0109; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; CLEMENTS WDB, 1994, AGENTS ACTIONS, V41, pC30, DOI 10.1007/BF02007753; Costa R, 2008, BRIT J PHARMACOL, V154, P1094, DOI 10.1038/bjp.2008.172; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Glasova H, 2002, J GASTROEN HEPATOL, V17, P938, DOI 10.1046/j.1440-1746.2002.02717.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hasanein P, 2007, EUR J PHARMACOL, V554, P123, DOI 10.1016/j.ejphar.2006.10.026; Hashimoto T, 2005, PHARMACOLOGY, V75, P13, DOI 10.1159/000085784; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jover R, 2006, HEPATOLOGY, V43, P1257, DOI 10.1002/hep.21180; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Kremer AE, 2010, J HEPATOL, V52, pS1, DOI 10.1016/S0168-8278(10)00232-1; Kremer AE, 2012, HEPATOLOGY, V56, P1391, DOI 10.1002/hep.25748; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kremer AE, 2009, ACTA DERM-VENEREOL, V89, P702; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Mela M, 2003, ALIMENT PHARM THER, V17, P857, DOI 10.1046/j.1365-2036.2003.01458.x; Miura T, 2005, J PHARMACOL SCI, V97, P429, DOI 10.1254/jphs.FPJ04050X; Montoliu C, 2009, J CLIN GASTROENTEROL, V43, P272, DOI 10.1097/MCG.0b013e31815e7f58; Mori K, 2007, VIRCHOWS ARCH, V451, P47, DOI 10.1007/s00428-007-0425-4; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Nelson L, 2006, J HEPATOL, V44, P1141, DOI 10.1016/j.jhep.2005.11.043; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; PERKINS MN, 1992, BRIT J PHARMACOL, V107, P329, DOI 10.1111/j.1476-5381.1992.tb12746.x; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Seeliger S, 2003, FASEB J, V17, P1871, DOI 10.1096/fj.02-1112com; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Ui H, 2006, EUR J PHARMACOL, V530, P172, DOI 10.1016/j.ejphar.2005.11.021; van der Merwe JQ, 2009, J PHARMACOL EXP THER, V329, P747, DOI 10.1124/jpet.108.145466; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Weisshaar E, 2003, ACTA DERM-VENEREOL, P5; Weisshaar E, 1999, EXP DERMATOL, V8, P254; Yosipovitch G, 2008, CURR ALLERGY ASTHM R, V8, P306, DOI 10.1007/s11882-008-0049-z; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61	56	30	31	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9675	9685		10.1074/jbc.M113.455162	http://dx.doi.org/10.1074/jbc.M113.455162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408423	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000317114000010
J	Halova, I; Draberova, L; Bambouskova, M; Machyna, M; Stegurova, L; Smrz, D; Draber, P				Halova, Ivana; Draberova, Lubica; Bambouskova, Monika; Machyna, Martin; Stegurova, Lucie; Smrz, Daniel; Draber, Petr			Cross-talk between Tetraspanin CD9 and Transmembrane Adaptor Protein Non-T Cell Activation Linker (NTAL) in Mast Cell Activation and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; ANTI-CD9 MONOCLONAL-ANTIBODY; FC-EPSILON RECEPTOR; GAMMA-II RECEPTOR; NEGATIVE REGULATION; PLATELET ACTIVATION; IMMUNOGLOBULIN-E; TERMINAL DOMAIN; LIPID RAFTS; MAJOR CD9	Chemotaxis, a process leading to movement of cells toward increasing concentrations of chemoattractants, is essential, among others, for recruitment of mast cells within target tissues where they play an important role in innate and adaptive immunity. Chemotaxis is driven by chemoattractants, produced by various cell types, as well as by intrinsic cellular regulators, which are poorly understood. In this study we prepared a new mAb specific for the tetraspanin CD9. Binding of the antibody to bone marrow-derived mast cells triggered activation events that included cell degranulation, Ca2+ response, dephosphorylation of ezrin/radixin/moesin (ERM) family proteins, and potent tyrosine phosphorylation of the non-T cell activation linker (NTAL) but only weak phosphorylation of the linker for activation of T cells (LAT). Phosphorylation of the NTAL was observed with whole antibody but not with its F(ab)(2) or Fab fragments. This indicated involvement of the Fc gamma receptors. As documented by electron microscopy of isolated plasma membrane sheets, CD9 colocalized with the high-affinity IgE receptor (Fc epsilon RI) and NTAL but not with LAT. Further tests showed that both anti-CD9 antibody and its F(ab)(2) fragment inhibited mast cell chemotaxis toward antigen. Experiments with bone marrow-derived mast cells deficient in NTAL and/or LAT revealed different roles of these two adaptors in antigen-driven chemotaxis. The combined data indicate that chemotaxis toward antigen is controlled in mast cells by a cross-talk among Fc epsilon RI, tetraspanin CD9, transmembrane adaptor proteins NTAL and LAT, and cytoskeleton-regulatory proteins of the ERM family.	[Halova, Ivana; Draberova, Lubica; Bambouskova, Monika; Machyna, Martin; Stegurova, Lucie; Smrz, Daniel; Draber, Petr] Acad Sci Czech Republ, Inst Mol Genet, Dept Signal Transduct, CZ-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Draber, P (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Lab Signal Transduct, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	draberpe@img.cas.cz	Smrz, Daniel/D-4853-2014; Halova, Ivana/G-3512-2014; Draber, Petr/G-3412-2014; Draberova, Lubica/G-3505-2014; Draber, Petr/E-1119-2018	Smrz, Daniel/0000-0003-0143-8744; Halova, Ivana/0000-0003-3078-7986; Draber, Petr/0000-0002-3986-2025; Draberova, Lubica/0000-0002-2459-4435; Draber, Petr/0000-0002-3986-2025; Machyna, Martin/0000-0002-3624-3472	Grant Agency of the Czech Republic [301/09/1826, P302/10/1759, P302/12/G101, 204/09/H084]; European Cooperation in Science and Technology [Action BM1007]; Technology Agency of the Czech Republic [LD12073 COST-CZ-MAST, TA01010436]; Ministry of Industry and Trade of the Czech Republic [FR-TI3/067]; Faculty of Science, Charles University, Prague, Czech Republic;  [RVO 68378050]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Technology Agency of the Czech Republic; Ministry of Industry and Trade of the Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government); 	This work was supported in part by the Projects 301/09/1826, P302/10/1759 and P302/12/G101, 204/09/H084 from Grant Agency of the Czech Republic, Action BM1007 from the European Cooperation in Science and Technology. Project LD12073 COST-CZ-MAST, Project TA01010436 of the Technology Agency of the Czech Republic, Project FR-TI3/067 of the Ministry of Industry and Trade of the Czech Republic, and Institutional Support Grant RVO 68378050.; Supported in part by the Faculty of Science, Charles University, Prague, Czech Republic.	BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2001, J CELL SCI, V114, P4143; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; DRABER P, 1980, J IMMUNOGENET, V7, P455; Draber P, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00095; Draberova L, 1996, IMMUNOLOGY, V87, P141; Draberova L, 2007, J IMMUNOL, V179, P5169, DOI 10.4049/jimmunol.179.8.5169; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Fleming TJ, 1997, J EXP MED, V186, P1307, DOI 10.1084/jem.186.8.1307; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Halova I, 2002, INT IMMUNOL, V14, P213, DOI 10.1093/intimm/14.2.213; Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 1996, BBA-REV CANCER, V1287, P67, DOI 10.1016/0304-419X(96)00007-8; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Kimura T, 2001, IMMUNOL LETT, V75, P123, DOI 10.1016/S0165-2478(00)00295-9; Kotha J, 2008, EXP CELL RES, V314, P1811, DOI 10.1016/j.yexcr.2008.01.024; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kramer B, 2009, EUR J IMMUNOL, V39, P3447, DOI 10.1002/eji.200939234; KURODA K, 1995, J IMMUNOL, V155, P4427; Lebduska P, 2007, J IMMUNOL METHODS, V328, P139, DOI 10.1016/j.jim.2007.08.015; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Linnekin D, 1999, INT J BIOCHEM CELL B, V31, P1053, DOI 10.1016/S1357-2725(99)00078-3; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; ORTEGA E, 1988, EMBO J, V7, P4101, DOI 10.1002/j.1460-2075.1988.tb03304.x; Parameswaran N, 2011, J IMMUNOL, V186, P4088, DOI 10.4049/jimmunol.1001139; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; Qi JC, 2006, BLOOD, V107, P135, DOI 10.1182/blood-2005-03-1312; Qi RM, 1996, J IMMUNOL, V157, P5638; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Rivera J, 2005, TRENDS IMMUNOL, V26, P119, DOI 10.1016/j.it.2005.01.001; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Simeoni L, 2008, IMMUNOL REV, V224, P215, DOI 10.1111/j.1600-065X.2008.00656.x; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; Staser K, 2013, EXP HEMATOL, V41, P56, DOI 10.1016/j.exphem.2012.10.001; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Tolar P, 2001, FOLIA BIOL-PRAGUE, V47, P215; Treanor B, 2011, J EXP MED, V208, P1055, DOI 10.1084/jem.20101125; Tumova M, 2010, EUR J IMMUNOL, V40, P3235, DOI 10.1002/eji.201040403; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wedemeyer J, 2000, BRIT MED BULL, V56, P936, DOI 10.1258/0007142001903616; WORTHINGTON RE, 1990, BRIT J HAEMATOL, V74, P216, DOI 10.1111/j.1365-2141.1990.tb02568.x; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	64	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9801	9814		10.1074/jbc.M112.449231	http://dx.doi.org/10.1074/jbc.M112.449231			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23443658	hybrid, Green Published			2022-12-28	WOS:000317114000021
J	Han, WJ; Gu, JY; Liu, HH; Li, FC; Wu, ZH; Li, YZ				Han, Wen-Jun; Gu, Jing-Yan; Liu, Hui-Hui; Li, Fu-Chuan; Wu, Zhi-Hong; Li, Yue-Zhong			An Extra Peptide within the Catalytic Module of a beta-Agarase Affects the Agarose Degradation Pattern	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARINE BACTERIUM; ZOBELLIA-GALACTANIVORANS; PSEUDOMONAS-ATLANTICA; FLAMMEOVIRGA-APRICA; ALPHA-AGARASE; COMB-NOV; PURIFICATION; CLONING; AGAB; EXPRESSION	Agarase hydrolyzes agarose into a series of oligosaccharides with repeating disaccharide units. The glycoside hydrolase (GH) module of agarase is known to be responsible for its catalytic activity. However, variations in the composition of the GH module and its effects on enzymatic functions have been minimally elucidated. The agaG4 gene, cloned from the genome of the agarolytic Flammeovirga strain MY04, encodes a 503-amino acid protein, AgaG4. Compared with elucidated agarases, AgaG4 contains an extra peptide (Asn(246)-Gly(302)) within its GH module. Heterologously expressed AgaG4 (recombinant AgaG4; rAgaG4) was determined to be an endo-type beta-agarase. The protein degraded agarose into neoagarotetraose and neoagarohexaose at a final molar ratio of 1.5:1. Neoagarooctaose was the smallest substrate for rAgaG4, whereas neoagarotetraose was the minimal degradation product. Removing the extra fragment from the GH module led to the inability of the mutant (rAgaG4-T57) to degrade neoagarooctaose, and the final degradation products of agarose by the truncated protein were neoagarotetraose, neoagarohexaose, and neoagarooctaose at a final molar ratio of 2.7:2.8:1. The optimal temperature for agarose degradation also decreased to 40 degrees C for this mutant. Bioinformatic analysis suggested that tyrosine 276 within the extra fragment was a candidate active site residue for the enzymatic activity. Site-swapping experiments of Tyr(276) to 19 various other amino acids demonstrated that the characteristics of this residue were crucial for the AgaG4 degradation of agarose and the cleavage pattern of substrate.	[Han, Wen-Jun; Gu, Jing-Yan; Liu, Hui-Hui; Wu, Zhi-Hong; Li, Yue-Zhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Han, Wen-Jun; Li, Fu-Chuan] Shandong Univ, Sch Life Sci, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Li, YZ (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, 27 S Shanda Rd, Jinan 250100, Peoples R China.	lilab@sdu.edu.cn	wu, zhi/GXH-3041-2022; Han, Wenjun/N-7214-2014; Han, Wen Jun/A-4859-2013; Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638	National Natural Science Foundation of China [30825001, 31130004, 30870001]; Independent Innovation Foundation of Shandong University Grant [2012GN014]; State Key Laboratory of Microbial Technology Grant [M2010-12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University Grant; State Key Laboratory of Microbial Technology Grant	This work was financially supported by National Natural Science Foundation of China Grants 30825001, 31130004, and 30870001; Independent Innovation Foundation of Shandong University Grant 2012GN014; and State Key Laboratory of Microbial Technology Grant M2010-12.	Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Chi WJ, 2012, APPL MICROBIOL BIOT, V94, P917, DOI 10.1007/s00253-012-4023-2; Dong JH, 2006, APPL ENVIRON MICROB, V72, P6399, DOI 10.1128/AEM.00935-06; Flament D, 2007, APPL ENVIRON MICROB, V73, P4691, DOI 10.1128/AEM.00496-07; Fu XT, 2010, MAR DRUGS, V8, P200, DOI 10.3390/md8010200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Han WJ, 2012, J OCEAN U CHINA, V11, P375, DOI 10.1007/s11802-012-1929-3; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2010, ACTA CRYSTALLOGR F, V66, P413, DOI 10.1107/S174430911000429X; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hosoya S, 2007, INT J SYST EVOL MICR, V57, P1327, DOI 10.1099/ijs.0.64977-0; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Jang MK, 2010, BIOTECHNOL LETT, V32, P943, DOI 10.1007/s10529-010-0237-5; Lee S, 2011, J MICROBIOL BIOTECHN, V21, P1116, DOI 10.4014/jmb.1107.07001; Ma CP, 2007, J BIOL CHEM, V282, P3747, DOI 10.1074/jbc.M607888200; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Michel G, 2009, GLYCOBIOLOGY, V19, P615, DOI 10.1093/glycob/cwp028; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MORRICE LM, 1983, EUR J BIOCHEM, V137, P149, DOI 10.1111/j.1432-1033.1983.tb07808.x; MORRICE LM, 1983, EUR J BIOCHEM, V135, P553, DOI 10.1111/j.1432-1033.1983.tb07688.x; Nakagawa Y, 1997, INT J SYST BACTERIOL, V47, P220, DOI 10.1099/00207713-47-1-220; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Ohta Y, 2005, CURR MICROBIOL, V50, P212, DOI 10.1007/s00284-004-4435-z; POTIN P, 1993, EUR J BIOCHEM, V214, P599, DOI 10.1111/j.1432-1033.1993.tb17959.x; Rees D A, 1969, Adv Carbohydr Chem Biochem, V24, P267; Ren AM, 2010, ACTA CRYSTALLOGR F, V66, P1635, DOI 10.1107/S174430911004114X; ROCHAS C, 1994, CARBOHYD RES, V253, P69, DOI 10.1016/0008-6215(94)80056-1; ROCHAS C, 1986, CARBOHYD RES, V148, P199, DOI 10.1016/S0008-6215(00)90388-4; Sambrook J, 2001, MOL CLONING LAB MANU; Shi C, 2008, APPL BIOCHEM BIOTECH, V151, P51, DOI 10.1007/s12010-008-8169-4; Suzuki H, 2002, J BIOSCI BIOENG, V93, P456, DOI 10.1263/jbb.93.456; Takahashi M, 2006, INT J SYST EVOL MICR, V56, P2095, DOI 10.1099/ijs.0.64324-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang SY, 2012, APPL MICROBIOL BIOT, V93, P1503, DOI 10.1007/s00253-011-3480-3; Xu H, 2012, INT J SYST EVOL MICR, V62, P937, DOI 10.1099/ijs.0.030676-0; Yang JL, 2011, J BIOSCI BIOENG, V112, P225, DOI 10.1016/j.jbiosc.2011.05.016; Zhong ZP, 2001, APPL ENVIRON MICROB, V67, P5771, DOI 10.1128/AEM.67.12.5771-5779.2001	41	18	22	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9519	9531		10.1074/jbc.M112.412247	http://dx.doi.org/10.1074/jbc.M112.412247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23378534	Green Published, hybrid			2022-12-28	WOS:000316862200067
J	Mardones, GA; Burgos, PV; Lin, Y; Kloer, DP; Magadan, JG; Hurley, JH; Bonifacino, JS				Mardones, Gonzalo A.; Burgos, Patricia V.; Lin, Yimo; Kloer, Daniel P.; Magadan, Javier G.; Hurley, James H.; Bonifacino, Juan S.			Structural Basis for the Recognition of Tyrosine-based Sorting Signals by the mu 3A Subunit of the AP-3 Adaptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-ASSOCIATED PROTEINS; LYSOSOMAL MEMBRANE-PROTEINS; HERMANSKY-PUDLAK-SYNDROME; MEDIUM CHAINS; ENDOCYTIC MACHINERY; CYTOPLASMIC TAIL; BETA-3A SUBUNIT; AP2 COMPLEX; RECEPTOR; BINDING	Tyrosine-based signals fitting the YXX empty set motif mediate sorting of transmembrane proteins to endosomes, lysosomes, the basolateral plasma membrane of polarized epithelial cells, and the somatodendritic domain of neurons through interactions with the homologous mu 1, mu 2, mu 3, and mu 4 subunits of the corresponding AP-1, AP-2, AP-3, and AP-4 complexes. Previous x-ray crystallographic analyses identified distinct binding sites for YXX empty set signals on mu 2 and mu 4, which were located on opposite faces of the proteins. To elucidate the mode of recognition of YXX empty set signals by other members of the mu family, we solved the crystal structure at 1.85 angstrom resolution of the C-terminal domain of the mu 3 subunit of AP-3 (isoform A) in complex with a peptide encoding a YXX empty set signal (SDYQRL) from the trans-Golgi network protein TGN38. The mu 3A C-terminal domain consists of an immunoglobulin-like beta-sandwich organized into two sub-domains, A and B. The YXX empty set signal binds in an extended conformation to a site on mu 3A subdomain A, at a location similar to the YXX empty set -binding site on mu 2 but not mu 4. The binding sites on mu 3A and mu 2 exhibit similarities and differences that account for the ability of both proteins to bind distinct sets of YXX empty set signals. Biochemical analyses confirm the identification of the mu 3A site and show that this protein binds YXX empty set signals with 14-19 mu M affinity. The surface electrostatic potential of mu 3A is less basic than that of mu 2, in part explaining the association of AP-3 with intracellular membranes having less acidic phosphoinositides.	[Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Inst Fisiol, Fac Med, Valdivia 5110566, Chile; [Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Ctr Invest Sur Austral Enfermedades Sistema Nervi, Valdivia 5110566, Chile; [Mardones, Gonzalo A.; Burgos, Patricia V.; Lin, Yimo; Magadan, Javier G.; Bonifacino, Juan S.] NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Kloer, Daniel P.; Hurley, James H.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Universidad Austral de Chile; Universidad Austral de Chile; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Mardones, GA (corresponding author), Univ Austral Chile, Inst Fisiol, Fac Med, Valdivia 5110566, Chile.	gonzalo.mardones@uach.cl; hurley@helix.nih.gov; juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile [1100896]; Intramural Program of NICHD, National Institutes of Health; Intramural Program of NIDDK, National Institutes of Health; U. S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036130] Funding Source: NIH RePORTER	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile; Intramural Program of NICHD, National Institutes of Health; Intramural Program of NIDDK, National Institutes of Health; U. S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant 1100896 from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (to G. A. M.), and the Intramural Programs of NICHD (to J. S. B.) and NIDDK (to J. H. H.), National Institutes of Health. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Basic Energy Sciences, Office of Science under Contract W-31-109-Eng-38.	Aguilar RC, 1997, J BIOL CHEM, V272, P27160, DOI 10.1074/jbc.272.43.27160; Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cosson P, 1996, EMBO J, V15, P1792, DOI 10.1002/j.1460-2075.1996.tb00528.x; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; HONING S, 1995, J CELL BIOL, V128, P321, DOI 10.1083/jcb.128.3.321; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mullins C, 1999, MOL GEN GENET, V262, P401, DOI 10.1007/s004380051099; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Stephens DJ, 1998, BIOCHEM J, V335, P567, DOI 10.1042/bj3350567; Umasankar PK, 2012, NAT CELL BIOL, V14, P488, DOI 10.1038/ncb2473; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2	48	28	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9563	9571		10.1074/jbc.M113.450775	http://dx.doi.org/10.1074/jbc.M113.450775			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404500	Green Published, hybrid			2022-12-28	WOS:000316862200070
J	Aguirre, JD; Clark, HM; McIlvin, M; Vazquez, C; Palmere, SL; Grab, DJ; Seshu, J; Hart, PJ; Saito, M; Culotta, VC				Aguirre, J. Dafhne; Clark, Hillary M.; McIlvin, Matthew; Vazquez, Christine; Palmere, Shaina L.; Grab, Dennis J.; Seshu, J.; Hart, P. John; Saito, Mak; Culotta, Valeria C.			A Manganese-rich Environment Supports Superoxide Dismutase Activity in a Lyme Disease Pathogen, Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LEUCINE AMINOPEPTIDASE; NEISSERIA-GONORRHOEAE; STAPHYLOCOCCUS-AUREUS; OXIDATIVE STRESS; BINDING PROTEIN; IRON; RESISTANCE; TRANSPORTER; SPECIFICITY	The Lyme disease pathogen Borrelia burgdorferi represents a novel organism in which to study metalloprotein biology in that this spirochete has uniquely evolved with no requirement for iron. Not only is iron low, but we show here that B. burgdorferi has the capacity to accumulate remarkably high levels of manganese. This high manganese is necessary to activate the SodA superoxide dismutase (SOD) essential for virulence. Using a metalloproteomic approach, we demonstrate that a bulk of B. burgdorferi SodA directly associates with manganese, and a smaller pool of inactive enzyme accumulates as apoprotein. Other metalloproteins may have similarly adapted to using manganese as co-factor, including the BB0366 aminopeptidase. Whereas B. burgdorferi SodA has evolved in a manganese-rich, iron-poor environment, the opposite is true for Mn-SODs of organisms such as Escherichia coli and bakers' yeast. These Mn-SODs still capture manganese in an iron-rich cell, and we tested whether the same is true for Borrelia SodA. When expressed in the iron-rich mitochondria of Saccharomyces cerevisiae, B. burgdorferi SodA was inactive. Activity was only possible when cells accumulated extremely high levels of manganese that exceeded cellular iron. Moreover, there was no evidence for iron inactivation of the SOD. B. burgdorferi SodA shows strong overall homology with other members of the Mn-SOD family, but computer-assisted modeling revealed some unusual features of the hydrogen bonding network near the enzyme's active site. The unique properties of B. burgdorferi SodA may represent adaptation to expression in the manganese-rich and iron-poor environment of the spirochete.	[Aguirre, J. Dafhne; Clark, Hillary M.; Vazquez, Christine; Palmere, Shaina L.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [McIlvin, Matthew; Saito, Mak] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Grab, Dennis J.] Johns Hopkins Univ, Sch Med, Div Med Microbiol, Dept Pathol, Baltimore, MD 21205 USA; [Seshu, J.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Woods Hole Oceanographic Institution; Johns Hopkins University; University of Texas System; University of Texas at San Antonio (UTSA); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Saito, Mak/ADT-4986-2022; McIlvin, Matthew/ABB-4762-2020	Vazquez, Christine/0000-0001-7647-1966; Aguirre, J. Dafhne/0000-0001-7056-9719; Saito, Mak/0000-0001-6040-9295	National Institutes of Health [R01 ES08996, GM50016, SC1 AI078559, T32 GM080189]; Johns Hopkins University NIEHS, National Institutes of Health, center; Robert A. Welch Foundation [AQ-1399]; Veterans Affairs Department Grant, South Texas Veterans Health Care System [I01BX000506]; Gordon and Betty Moore Foundation Marine Microbiology Program; National Science Foundation Chemical Oceanography Grant [OCE-1031271]; Division Of Ocean Sciences [1260233] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI078559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, R01ES008996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080189, R01GM050016, R37GM050016] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University NIEHS, National Institutes of Health, center; Robert A. Welch Foundation(The Welch Foundation); Veterans Affairs Department Grant, South Texas Veterans Health Care System; Gordon and Betty Moore Foundation Marine Microbiology Program; National Science Foundation Chemical Oceanography Grant(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES08996 and GM50016 (to V. C. C.) and SC1 AI078559 (to J. S.). This work was also supported in part by the Johns Hopkins University NIEHS, National Institutes of Health, center, by Robert A. Welch Foundation Grant AQ-1399, and in part by Veterans Affairs Department Grant I01BX000506, South Texas Veterans Health Care System (to P. J. H.). Metalloproteomic studies were funded by the Gordon and Betty Moore Foundation Marine Microbiology Program and National Science Foundation Chemical Oceanography Grant OCE-1031271 (to M. A. S.).; Supported by National Institutes of Health Grant T32 GM080189.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; BEYER WF, 1991, J BIOL CHEM, V266, P303; Cassat JE, 2012, SEMIN IMMUNOPATHOL, V34, P215, DOI 10.1007/s00281-011-0294-4; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gleason JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024741; Govoni G, 1998, INFLAMM RES, V47, P277, DOI 10.1007/s000110050330; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Guan Y, 1998, BIOCHEMISTRY-US, V37, P4722, DOI 10.1021/bi972394l; HAFKENSCHEID JCM, 1985, J CLIN CHEM CLIN BIO, V23, P393; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Iranzo O, 2011, BIOORG CHEM, V39, P73, DOI 10.1016/j.bioorg.2011.02.001; Jackson TA, 2004, ACCOUNTS CHEM RES, V37, P461, DOI 10.1021/ar030272h; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kale A, 2010, J MOL BIOL, V398, P703, DOI 10.1016/j.jmb.2010.03.042; Kang Y, 2011, ACTA CRYSTALLOGR F, V67, P1173, DOI 10.1107/S1744309111029186; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Lancaster WA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-64; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ouyang ZM, 2009, P NATL ACAD SCI USA, V106, P3449, DOI 10.1073/pnas.0812999106; Perry JJP, 2009, BIOCHEMISTRY-US, V48, P3417, DOI 10.1021/bi8023288; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; PRIVALLE CT, 1992, J BIOL CHEM, V267, P9140; Reddi AR, 2011, GENETICS, V189, P1261, DOI 10.1534/genetics.111.134007; Robinson N., 2008, PROTOC EXCH, DOI [10.1038/nprot.2008.236, DOI 10.1038/NPROT.2008.236]; Rosenfeld L, 2012, BIOCHEM BIOPH RES CO, V418, P414, DOI 10.1016/j.bbrc.2012.01.047; Rosenfeld L, 2010, J BIOL INORG CHEM, V15, P1051, DOI 10.1007/s00775-010-0664-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Sheng YW, 2012, P NATL ACAD SCI USA, V109, P14314, DOI 10.1073/pnas.1212367109; SIKORSKI RS, 1989, GENETICS, V122, P19; Sule N, 2012, J INORG BIOCHEM, V106, P84, DOI 10.1016/j.jinorgbio.2011.09.020; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; Troxell B, 2012, J BIOL CHEM, V287, P19284, DOI 10.1074/jbc.M112.344903; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; Waldron KJ, 2007, J BIOL CHEM, V282, P3837, DOI 10.1074/jbc.M609916200; Wang P, 2012, MOL MICROBIOL, V86, P1441, DOI 10.1111/mmi.12068; Whitehouse CA, 1997, INFECT IMMUN, V65, P4865, DOI 10.1128/IAI.65.11.4865-4868.1997; Whittaker MM, 2012, ARCH BIOCHEM BIOPHYS, V523, P191, DOI 10.1016/j.abb.2012.04.016; Wintjens R, 2004, J BIOL CHEM, V279, P9248, DOI 10.1074/jbc.M312329200; Yamakura F, 2007, FREE RADICAL BIO MED, V43, P423, DOI 10.1016/j.freeradbiomed.2007.04.024; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Yannone SM, 2012, CURR OPIN BIOTECH, V23, P89, DOI 10.1016/j.copbio.2011.11.005	57	57	59	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8468	8478		10.1074/jbc.M112.433540	http://dx.doi.org/10.1074/jbc.M112.433540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23376276	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000316564500044
J	Manna, PR; Cohen-Tannoudji, J; Counis, R; Garner, CW; Huhtaniemi, I; Kraemer, FB; Stocco, DM				Manna, Pulak R.; Cohen-Tannoudji, Joelle; Counis, Raymond; Garner, Charles W.; Huhtaniemi, Ilpo; Kraemer, Fredric B.; Stocco, Douglas M.			Mechanisms of Action of Hormone-sensitive Lipase in Mouse Leydig Cells ITS ROLE IN THE REGULATION OF THE STEROIDOGENIC ACUTE REGULATORY PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; HIGH-DENSITY-LIPOPROTEIN; B TYPE-I; SCAVENGER RECEPTOR; TUMOR-CELLS; MOLECULAR-MECHANISMS; MEDIATED REGULATION; DIFFERENTIAL REGULATION; CHOLESTEROL ESTER; NUCLEAR RECEPTORS	Hormone-sensitive lipase (HSL) catalyzes the hydrolysis of cholesteryl esters in steroidogenic tissues and, thus, facilitates cholesterol availability for steroidogenesis. The steroidogenic acute regulatory protein (StAR) controls the rate-limiting step in steroid biosynthesis. However, the modes of action of HSL in the regulation of StAR expression remain obscure. We demonstrate in MA-10 mouse Leydig cells that activation of the protein kinase A (PKA) pathway, by a cAMP analog Bt(2)cAMP, enhanced expression of HSL and its phosphorylation (P) at Ser-660 and Ser-563, but not at Ser-565, concomitant with increased HSL activity. Phosphorylation and activation of HSL coincided with increases in StAR, P-StAR (Ser-194), and progesterone levels. Inhibition of HSL activity by CAY10499 effectively suppressed Bt(2)cAMP-induced StAR expression and progesterone synthesis. Targeted silencing of endogenous HSL, with siRNAs, resulted in increased cholesteryl ester levels and decreased cholesterol content in MA-10 cells. Depletion of HSL affected lipoprotein-derived cellular cholesterol influx, diminished the supply of cholesterol to the mitochondria, and resulted in the repression of StAR and P-StAR levels. Cells overexpressing HSL increased the efficacy of liver X receptor (LXR) ligands on StAR expression and steroid synthesis, suggesting HSL-mediated steroidogenesis entails enhanced oxysterol production. Conversely, cells deficient in LXRs exhibited decreased HSL responsiveness. Furthermore, an increase in HSL was correlated with the LXR target genes, steroid receptor element-binding protein 1c and ATP binding cassette transporter A1, demonstrating HSL-dependent regulation of steroidogenesis predominantly involves LXR signaling. LXRs interact/cooperate with RXRs and result in the activation of StAR gene transcription. These findings provide novel insight and demonstrate the molecular events by which HSL acts to drive cAMP/PKA-mediated regulation of StAR expression and steroidogenesis in mouse Leydig cells.	[Stocco, Douglas M.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Cohen-Tannoudji, Joelle; Counis, Raymond] Univ Paris Diderot, EAC CNRS 4413, Paris, France; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England; [Kraemer, Fredric B.] Vet Affairs Palo Alto Heath Care Syst, Dept Med, Palo Alto, CA 94304 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Stocco, DM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	doug.stocco@ttuhsc.edu	Kraemer, Fredric/AAC-3633-2019	Kraemer, Fredric/0000-0003-2468-7807	National Institutes of Health [HD-17481]; Robert A. Welch Foundation [B1-0028]; Universite Paris Diderot-Paris 7; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017481, R01HD017481] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Universite Paris Diderot-Paris 7; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant HD-17481 (to D. M. S.), Robert A. Welch Foundation Grant B1-0028 (to D. M. S.), and the Universite Paris Diderot-Paris 7.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; BARTKE A, 1973, PROSTAGLANDINS, V3, P97, DOI 10.1016/0090-6980(73)90141-X; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Christenson LK, 1998, J BIOL CHEM, V273, P30729, DOI 10.1074/jbc.273.46.30729; Chung SR, 2001, ENDOCRINOLOGY, V142, P4272, DOI 10.1210/en.142.10.4272; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Dyson MT, 2009, MOL CELL ENDOCRINOL, V300, P94, DOI 10.1016/j.mce.2008.11.029; Fredrikson G, 1981, Methods Enzymol, V71 Pt C, P636; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Holst LS, 1996, GENOMICS, V35, P441, DOI 10.1006/geno.1996.0383; Kabbaj O, 2003, BIOL REPROD, V68, P722, DOI 10.1095/biolreprod.102.008169; King SR, 2004, J MOL ENDOCRINOL, V32, P507, DOI 10.1677/jme.0.0320507; Kolmakova A, 2010, ENDOCRINOLOGY, V151, P5519, DOI 10.1210/en.2010-0347; Kraemer FB, 2004, MOL ENDOCRINOL, V18, P549, DOI 10.1210/me.2003-0179; Krintel C, 2009, FEBS J, V276, P4752, DOI 10.1111/j.1742-4658.2009.07172.x; Lee YS, 2003, NUCLEIC ACIDS RES, V31, P7165, DOI 10.1093/nar/gkg934; Li H, 2002, ENDOCRINOLOGY, V143, P3333, DOI 10.1210/en.2002-220341; Lukyanenko YO, 2001, BIOL REPROD, V64, P790, DOI 10.1095/biolreprod64.3.790; Mairal A, 2002, BIOCHEM BIOPH RES CO, V291, P286, DOI 10.1006/bbrc.2002.6427; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Manna PR, 1999, J BIOL CHEM, V274, P5909, DOI 10.1074/jbc.274.9.5909; Manna PR, 2004, MOL ENDOCRINOL, V18, P558, DOI 10.1210/me.2003-0223; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; Manna PR, 2011, ENDOCRINOLOGY, V152, P313, DOI 10.1210/en.2010-0874; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; Manna PR, 2009, ENDOCRINOLOGY, V150, P187, DOI 10.1210/en.2008-0368; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Osterlund T, 2001, EUR J BIOCHEM, V268, P1899, DOI 10.1046/j.1432-1327.2001.02097.x; Osuga J, 1997, BIOCHEM BIOPH RES CO, V233, P655, DOI 10.1006/bbrc.1997.6518; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rao RM, 2003, BIOL REPROD, V68, P114, DOI 10.1095/biolreprod.102.007518; Reaven E, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-43; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Rigamonti E, 2005, CIRC RES, V97, P682, DOI 10.1161/01.RES.0000184678.43488.9f; Robertson KM, 2005, ENDOCRINOLOGY, V146, P2519, DOI 10.1210/en.2004-1413; Savinainen JR, 2010, ANAL BIOCHEM, V399, P132, DOI 10.1016/j.ab.2009.12.009; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Shen WJ, 2003, J BIOL CHEM, V278, P43870, DOI 10.1074/jbc.M303934200; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; SZTALRYD C, 1995, J CLIN INVEST, V95, P2652, DOI 10.1172/JCI117967; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Tazoe F, 2008, BIOCHEM BIOPH RES CO, V376, P111, DOI 10.1016/j.bbrc.2008.08.101; Volle DH, 2007, MOL CELL ENDOCRINOL, V265, P183, DOI 10.1016/j.mce.2006.12.018; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Wang SP, 2004, ENDOCRINOLOGY, V145, P5688, DOI 10.1210/en.2004-0919; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wu Q, 2003, ENDOCRINOLOGY, V144, P2437, DOI 10.1210/en.2002-221110; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811	61	54	58	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8505	8518		10.1074/jbc.M112.417873	http://dx.doi.org/10.1074/jbc.M112.417873			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362264	Green Published, hybrid			2022-12-28	WOS:000316564500047
J	Peixoto, PD; Laurent, G; Azais, T; Mosser, G				Peixoto, Paulo De Sa; Laurent, Guillaume; Azais, Thierry; Mosser, Gervaise			Solid-state NMR Study Reveals Collagen I Structural Modifications of Amino Acid Side Chains upon Fibrillogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SHIFTS; 2-DIMENSIONAL NMR; C-13; FIBRILS; DYNAMICS; PROTEIN; CONFORMATION; PREFERENCES; RESOLUTION; PEPTIDES	In vivo, collagen I, the major structural protein in human body, is found assembled into fibrils. In the present work, we study a high concentrated collagen sample in its soluble, fibrillar, and denatured states using one and two dimensional {H-1}-C-13 solid-state NMR spectroscopy. We interpret C-13 chemical shift variations in terms of dihedral angle conformation changes. Our data show that fibrillogenesis increases the side chain and backbone structural complexity. Nevertheless, only three to five rotameric equilibria are found for each amino acid residue, indicating a relatively low structural heterogeneity of collagen upon fibrillogenesis. Using side chain statistical data, we calculate equilibrium constants for a great number of amino acid residues. Moreover, based on a C-13 quantitative spectrum, we estimate the percentage of residues implicated in each equilibrium. Our data indicate that fibril formation greatly affects hydroxyproline and proline prolyl pucker ring conformation. Finally, we discuss the implication of these structural data and propose a model in which the attractive force of fibrillogenesis comes from a structural reorganization of 10 to 15% of the amino acids. These results allow us to further understand the self-assembling process and fibrillar structure of collagen.	[Peixoto, Paulo De Sa; Laurent, Guillaume; Azais, Thierry; Mosser, Gervaise] Univ Paris 06, CNRS, Coll France, Lab Chim Mat Condensee Paris,UMR 7574, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France	Mosser, G (corresponding author), UPMC, CNRS, Coll France, Lab Chim Mat Condensee Paris,UMR7574, F-75005 Paris, France.	gmosser@snv.jussieu.fr	Laurent, Guillaume P./J-4328-2012; Mosser, Gervaise/M-4943-2018	Laurent, Guillaume P./0000-0002-8127-5326; Mosser, Gervaise/0000-0002-9812-5340	Ecole Doctorale Iviv 387; Universite Pierre et Marie Curie	Ecole Doctorale Iviv 387; Universite Pierre et Marie Curie	This work was supported by Ecole Doctorale Iviv 387 and the Universite Pierre et Marie Curie (to P. D. S. P.).	Aliev AE, 2005, BIOPOLYMERS, V77, P230, DOI 10.1002/bip.20217; BATCHELDER LS, 1982, P NATL ACAD SCI-BIOL, V79, P386, DOI 10.1073/pnas.79.2.386; Bella J, 2010, J STRUCT BIOL, V170, P377, DOI 10.1016/j.jsb.2010.02.003; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; Bolboaca S., 2007, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies, V63/64, P311; DEDIOS AC, 1994, J AM CHEM SOC, V116, P11485, DOI 10.1021/ja00104a031; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; EJCHART A, 1977, ORG MAGN RESONANCE, V9, P351, DOI 10.1002/mrc.1270090614; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; Gobeaux F, 2008, J MOL BIOL, V376, P1509, DOI 10.1016/j.jmb.2007.12.047; Hansen DF, 2010, J AM CHEM SOC, V132, P7589, DOI 10.1021/ja102090z; JELINSKI LW, 1980, J MOL BIOL, V138, P255, DOI 10.1016/0022-2836(80)90286-7; JELINSKI LW, 1980, NATURE, V284, P531, DOI 10.1038/284531a0; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KOHDA D, 1991, BIOCHEMISTRY-US, V30, P4896, DOI 10.1021/bi00234a009; LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205; LEIKIN S, 1994, P NATL ACAD SCI USA, V91, P276, DOI 10.1073/pnas.91.1.276; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; London RE, 2008, J AM CHEM SOC, V130, P11097, DOI 10.1021/ja802729t; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; MIKHAILOV D, 1995, BIOPHYS J, V68, P1540, DOI 10.1016/S0006-3495(95)80326-7; Mooney SD, 2002, BIOPOLYMERS, V64, P63, DOI 10.1002/bip.10123; Mosser G, 2006, MATRIX BIOL, V25, P3, DOI 10.1016/j.matbio.2005.09.002; Okuyama K, 2004, BIOPOLYMERS, V76, P367, DOI 10.1002/bip.20107; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Peixoto PD, 2011, SOFT MATTER, V7, P11203, DOI 10.1039/c1sm06076g; Reichert D, 2004, MAGN RESON CHEM, V42, P276, DOI 10.1002/mrc.1334; RICHARZ R, 1978, BIOPOLYMERS, V17, P2133, DOI 10.1002/bip.1978.360170908; SAITO H, 1984, BIOPOLYMERS, V23, P2279, DOI 10.1002/bip.360231111; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; TORCHIA DA, 1975, BIOCHEMISTRY-US, V14, P887, DOI 10.1021/bi00676a004; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028	35	10	10	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7528	7535		10.1074/jbc.M112.390146	http://dx.doi.org/10.1074/jbc.M112.390146			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341452	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000316455300009
J	Thomas, SE; Malzer, E; Ordonez, A; Dalton, LE; van 't Wout, EFA; Liniker, E; Crowther, DC; Lomas, DA; Marciniak, SJ				Thomas, Sally E.; Malzer, Elke; Ordonez, Adriana; Dalton, Lucy E.; van 't Wout, Emily F. A.; Liniker, Elizabeth; Crowther, Damian C.; Lomas, David A.; Marciniak, Stefan J.			p53 and Translation Attenuation Regulate Distinct Cell Cycle Checkpoints during Endoplasmic Reticulum (ER) Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-SYNTHASE KINASE-3-BETA; MESSENGER-RNA TRANSLATION; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; DOWN-REGULATION; IN-VIVO; APOPTOSIS; ISOFORMS; PHOSPHORYLATION	Cell cycle checkpoints ensure that proliferation occurs only under permissive conditions, but their role in linking nutrient availability to cell division is incompletely understood. Protein folding within the endoplasmic reticulum ( ER) is exquisitely sensitive to energy supply and amino acid sources because deficiencies impair luminal protein folding and consequently trigger ER stress signaling. Following ER stress, many cell types arrest within the G(1) phase, although recent studies have identified a novel ER stress G(2) checkpoint. Here, we report that ER stress affects cell cycle progression via two classes of signal: an early inhibition of protein synthesis leading to G(2) delay involving CHK1 and a later induction of G(1) arrest associated both with the induction of p53 target genes and loss of cyclin D-1. We show that substitution of p53/47 for p53 impairs the ER stress G(1) checkpoint, attenuates the recovery of protein translation, and impairs induction of NOXA, a mediator of cell death. We propose that cell cycle regulation in response to ER stress comprises redundant pathways invoked sequentially first to impair G(2) progression prior to ultimate G(1) arrest.	[Thomas, Sally E.; Malzer, Elke; Ordonez, Adriana; Dalton, Lucy E.; van 't Wout, Emily F. A.; Liniker, Elizabeth; Lomas, David A.; Marciniak, Stefan J.] Univ Cambridge, Wellcome Trust, Dept Med, Cambridge CB2 0XY, England; [Thomas, Sally E.; Malzer, Elke; Ordonez, Adriana; Dalton, Lucy E.; van 't Wout, Emily F. A.; Liniker, Elizabeth; Lomas, David A.; Marciniak, Stefan J.] Univ Cambridge, Wellcome Trust, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Malzer, Elke; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge	Marciniak, SJ (corresponding author), Univ Cambridge, Wellcome Trust, Dept Med, Med Res Council Bldg,Hills Rd, Cambridge CB2 0XY, England.	sjm20@cam.ac.uk	Marciniak, Stefan J/F-1855-2010	Marciniak, Stefan/0000-0001-8472-7183	Diabetes UK; Medical Research Council (MRC) (UK); British Lung Foundation; MRC [G1002610]; Medical Research Council [G1002610, G0601840, G0700990, G0901786] Funding Source: researchfish; National Institute for Health Research [ACF-2011-14-006] Funding Source: researchfish; MRC [G0700990, G0601840, G0901786] Funding Source: UKRI	Diabetes UK(Diabetes UK); Medical Research Council (MRC) (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Diabetes UK, the Medical Research Council (MRC) (UK), and the British Lung Foundation.; An MRC Senior Clinical Fellow (Grant G1002610). To whom correspondence should be addressed. Tel.: 44-1223-762660; Fax: 44-1223-336827; E-mail: sjm20@cam.ac.uk.	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Ganzinelli M, 2008, CLIN CANCER RES, V14, P5131, DOI 10.1158/1078-0432.CCR-08-0304; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He L, 2009, FEBS LETT, V583, P903, DOI 10.1016/j.febslet.2009.02.002; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Irving JA, 2011, METHOD ENZYMOL, V501, P421, DOI 10.1016/B978-0-12-385950-1.00018-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Krastev DB, 2011, NAT CELL BIOL, V13, P809, DOI 10.1038/ncb2264; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma W, 2012, ONCOGENE, V31, P1024, DOI 10.1038/onc.2011.300; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malzer E, 2010, J CELL SCI, V123, P2892, DOI 10.1242/jcs.070078; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; RABINOVITZ M, 1962, J BIOL CHEM, V237, P477; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Steller H, 2000, NAT CELL BIOL, V2, pE100, DOI 10.1038/35014093; Thomas SE, 2010, DIABETES-METAB RES, V26, P611, DOI 10.1002/dmrr.1132; van Schadewijk A, 2012, CELL STRESS CHAPERON, V17, P275, DOI 10.1007/s12192-011-0306-2; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	58	33	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7606	7617		10.1074/jbc.M112.424655	http://dx.doi.org/10.1074/jbc.M112.424655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341460	Green Published, hybrid			2022-12-28	WOS:000316455300018
J	Blum, AP; Van Arnam, EB; German, LA; Lester, HA; Dougherty, DA				Blum, Angela P.; Van Arnam, Ethan B.; German, Laurel A.; Lester, Henry A.; Dougherty, Dennis A.			Binding Interactions with the Complementary Subunit of Nicotinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTORS; DEPENDENT CONTRIBUTIONS; HYDROGEN-BOND; M2 DOMAIN; CHANNEL; AGONISTS; PROTEIN; ACHBP; SITE	The agonist-binding site of nicotinic acetylcholine receptors (nAChRs) spans an interface between two subunits of the pentameric receptor. The principal component of this binding site is contributed by an alpha subunit, and it binds the cationic moiety of the nicotinic pharmacophore. The other part of the pharmacophore, a hydrogen bond acceptor, has recently been shown to bind to the complementary non-alpha subunit via the backbone NH of a conserved Leu. This interaction was predicted by studies of ACh-binding proteins and confirmed by functional studies of the neuronal (CNS) nAChR, alpha 4 beta 2. The ACh-binding protein structures further suggested that the hydrogen bond to the backbone NH is mediated by a water molecule and that a second hydrogen bonding interaction occurs between the water molecule and the backbone CO of a conserved Asn, also on the non-alpha subunit. Here, we provide new insights into the nature of the interactions between the hydrogen bond acceptor of nicotinic agonists and the complementary subunit backbone. We studied both the nAChR of the neuromuscular junction (muscle-type) and a neuronal subtype, (alpha 4)(2)(beta 4)(3). In the muscle-type receptor, both ACh and nicotine showed a strong interaction with the Leu NH, but the potent nicotine analog epibatidine did not. This interaction was much attenuated in the alpha 4 beta 4 receptor. Surprisingly, we found no evidence for a functionally significant interaction with the backbone carbonyl of the relevant Asn in either receptor with an array of agonists.	[Blum, Angela P.; Van Arnam, Ethan B.; German, Laurel A.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS34407, NS11756]; Tobacco-Related Disease Research Program Award from the University of California [19XT-0102]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R37NS034407, R01NS011756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program Award from the University of California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS34407 and NS11756. This work was also supported by Tobacco-Related Disease Research Program Award 19XT-0102 from the University of California.	BEERS WH, 1970, NATURE, V228, P917, DOI 10.1038/228917a0; Blum A. P., 2012, THESIS CALTECH PASAD; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deechongkit S, 2004, J AM CHEM SOC, V126, P16762, DOI 10.1021/ja045934s; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2006, J MOL NEUROSCI, V30, P101, DOI 10.1385/JMN:30:1:101; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; LINNELL RH, 1960, J ORG CHEM, V25, P290, DOI 10.1021/jo01072a623; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Tavares XDS, 2012, J AM CHEM SOC, V134, P11474, DOI 10.1021/ja3011379; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	30	20	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6991	6997		10.1074/jbc.M112.439968	http://dx.doi.org/10.1074/jbc.M112.439968			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23349463	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000316002400021
J	Yu, HG; Dong, J; Gu, YH; Liu, HY; Xin, AJ; Shi, HJ; Sun, F; Zhang, YL; Lin, DH; Diao, H				Yu, Heguo; Dong, Jing; Gu, Yihua; Liu, Haiyan; Xin, Aijie; Shi, Huijuan; Sun, Fei; Zhang, Yonglian; Lin, Donghai; Diao, Hua			The Novel Human beta-Defensin 114 Regulates Lipopolysaccharide (LPS)-mediated Inflammation and Protects Sperm from Motility Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; DISULFIDE BONDS; GENE CLUSTERS; TNF-ALPHA; IN-VITRO; EXPRESSION; EPIDIDYMIS; ENDOTOXIN; LPS; IMPROVES	Lipopolysaccharide (LPS) is an important pathological factor involved in serious inflammatory diseases and male reproductive impairments. Emerging evidence demonstrates that antimicrobial peptides possess protective activity in response to LPS-induced inflammation. However, the LPS-binding and/or immunosuppressive activity of beta-defensins (DEFBs) has been underestimated. In the present work, we characterized a novel human defensin, DEFB114, which was expressed predominantly in the epididymis and gingival cells at the RNA level. Homogenous recombinant DEFB114 peptides were prepared and characterized using mass spectrometry. DEFB114 protein exhibited a broad spectrum of antimicrobial activity with salt sensitivity against typical pathogenic microbes (i.e. Escherichia coli, Staphylococcus aureus, and Candida albicans). Interestingly, DEFB114 demonstrated novel LPS-binding activity in vitro and inhibited TNF-alpha release in RAW264.7 cultures through the inhibition of MAPK p42/44 when challenged with LPS. Moreover, DEFB114 could also rescue the LPS-induced reduction of human sperm motility in vitro and protect D-galactosamine-sensitized C57BL/6 mice from LPS-induced lethality in vivo. The protective activity of DEFB114 on RAW264.7, human sperm, and the D-galactosamine-sensitized mice was disulfide bond-dependent because alkylated DEFB114 lost its activity. The low cytotoxicity of the DEFB114 peptide toward human erythrocytes is indicative of its potential therapeutic use in the treatment of LPS-induced inflammation, LPS contamination, and potentially septic shock.	[Yu, Heguo; Gu, Yihua; Xin, Aijie; Shi, Huijuan; Zhang, Yonglian; Diao, Hua] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Commiss, Key Lab Contracept & Devices, Shanghai 200032, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Peoples R China; [Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China; [Sun, Fei] Univ Sci & Technol China, Reprod Biol Lab, Sch Life Sci, Hefei 230027, Peoples R China; [Dong, Jing] NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Liu, Haiyan] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Peoples R China; [Xin, Aijie] E China Univ Sci & Technol, Shanghai 200237, Peoples R China	Xiamen University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Northwest University Xi'an; China Pharmaceutical University; East China University of Science & Technology	Zhang, YL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China.	ylzhang@sibs.ac.cn; dhlin@xmu.edu.cn; diaohua@gmail.com	Sun, Fei/N-2850-2013		National Basic Research Program of China [2007CB914304, 2009CB941702]; Natural Science Foundation of China [31101030, 31170717, 30900233, 91129713]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2007CB914304 and 2009CB941702 and Natural Science Foundation of China Grants 31101030, 31170717, 30900233, and 91129713.	Abd-Allah ARA, 2009, OXID MED CELL LONGEV, V2, P73, DOI 10.4161/oxim.2.2.8177; Bhattacharjya S, 2010, CURR MED CHEM, V17, P3080, DOI 10.2174/092986710791959756; Biswas B, 2011, AM J REPROD IMMUNOL, V65, P557, DOI 10.1111/j.1600-0897.2010.00937.x; Brackett NL, 2007, J ANDROL, V28, P717, DOI 10.2164/jandrol.106.002022; Cao DM, 2010, BIOL REPROD, V83, P1064, DOI 10.1095/biolreprod.109.082180; Diao H, 2007, BIOCHEM BIOPH RES CO, V357, P840, DOI 10.1016/j.bbrc.2007.03.149; Dong J, 2011, PROTEIN PEPTIDE LETT, V18, P1126, DOI 10.2174/092986611797201020; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Eggert-Kruse W, 2007, FERTIL STERIL, V87, P810, DOI 10.1016/j.fertnstert.2006.08.103; Fei Z, 2012, GENES IMMUN, V13, P445, DOI 10.1038/gene.2012.13; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Fujita Y, 2011, HUM REPROD, V26, P2799, DOI 10.1093/humrep/der234; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Huang GTJ, 2002, HUM GENE THER, V13, P2017, DOI 10.1089/10430340260395875; Jerala R, 2004, CURR TOP MED CHEM, V4, P1173, DOI 10.2174/1568026043388079; Kajihara T, 2006, MED MOL MORPHOL, V39, P203, DOI 10.1007/s00795-006-0334-7; Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Lampiao F, 2008, REPROD BIOMED ONLINE, V17, P628, DOI 10.1016/S1472-6483(10)60309-4; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lepper PM, 2002, INTENS CARE MED, V28, P824, DOI 10.1007/s00134-002-1330-6; Mignon A, 1999, AM J RESP CRIT CARE, V159, P1308, DOI 10.1164/ajrccm.159.4.9712012; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Okazaki T, 2010, THERIOGENOLOGY, V74, P1691, DOI 10.1016/j.theriogenology.2010.05.019; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Premratanachai P, 2004, ORAL MICROBIOL IMMUN, V19, P111, DOI 10.1111/j.0902-0055.2002.00127.x; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tollner TL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002289; TURNER TT, 1995, J ANDROL, V16, P292; Verma Chandra, 2007, Biotechnology Journal, V2, P1353, DOI 10.1002/biot.200700148; Walker AK, 2011, BRAIN BEHAV IMMUN, V25, P674, DOI 10.1016/j.bbi.2011.01.004; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Zhang JS, 2006, MOL CELL ENDOCRINOL, V250, P169, DOI 10.1016/j.mce.2005.12.041; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127	49	46	52	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12270	12282		10.1074/jbc.M112.411884	http://dx.doi.org/10.1074/jbc.M112.411884			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482568	hybrid, Green Published			2022-12-28	WOS:000318157600058
J	Perry, MD; Ng, CA; Vandenberg, JI				Perry, Matthew D.; Ng, Chai Ann; Vandenberg, Jamie I.			Pore Helices Play a Dynamic Role as Integrators of Domain Motion during Kv11.1 Channel Inactivation Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE INACTIVATION; POTASSIUM-CHANNEL; K+ CHANNEL; CRYSTAL-STRUCTURE; SWISS-MODEL; MOLECULAR DETERMINANTS; SELECTIVITY FILTER; SLOW INACTIVATION; TRANSITION-STATE; HERG	Proteins that form ion-selective pores in the membrane of cells are integral to many rapid signaling processes, including regulating the rhythm of the heartbeat. In potassium channels, the selectivity filter is critical for both endowing an exquisite selectivity for potassium ions, as well as for controlling the flow of ions through the pore. Subtle rearrangements in the complex hydrogen-bond network that link the selectivity filter to the surrounding pore helices differentiate conducting (open) from nonconducting (inactivated) conformations of the channel. Recent studies suggest that beyond the selectivity filter, inactivation involves widespread rearrangements of the channel protein. Here, we use rate equilibrium free energy relationship analysis to probe the structural changes that occur during selectivity filter gating in Kv11.1 channels, at near atomic resolution. We show that the pore helix plays a crucial dynamic role as a bidirectional interface during selectivity filter gating. We also define the molecular bases of the energetic coupling between the pore helix and outer helix of the pore domain that occurs early in the transition from open to inactivated states, as well as the coupling between the pore helix and inner helix late in the transition. Our data demonstrate that the pore helices are more than just static structural elements supporting the integrity of the selectivity filter; instead they play a crucial dynamic role during selectivity filter gating.	[Perry, Matthew D.; Ng, Chai Ann; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW 2010, Australia; [Perry, Matthew D.; Ng, Chai Ann; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Programme Cardiac Electro, Mol Cardiol & Biophys Div, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450	National Health and Medical Research Council of Australia (NHMRC) [635520]; NHMRC [459401, 1019693]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a project grant from the National Health and Medical Research Council of Australia (NHMRC, Grant 635520) and fellowships (NHMRC Grants 459401 and 1019693) (to J. I. V.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Auerbach A, 2007, J GEN PHYSIOL, V130, P543, DOI 10.1085/jgp.200709898; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ferrer T, 2011, J BIOL CHEM, V286, P39091, DOI 10.1074/jbc.M111.292060; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P14338, DOI 10.1073/pnas.0406091101; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Perry M, 2009, P NATL ACAD SCI USA, V106, P20075, DOI 10.1073/pnas.0906597106; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Raghuraman H, 2012, STRUCTURE, V20, P1332, DOI 10.1016/j.str.2012.03.027; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Seebohm G, 2001, J BIOL CHEM, V276, P13600, DOI 10.1074/jbc.M008373200; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Stary A, 2010, CHEMMEDCHEM, V5, P455, DOI 10.1002/cmdc.200900461; Sun YX, 2011, J MOL CELL CARDIOL, V50, P433, DOI 10.1016/j.yjmcc.2010.11.017; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x	56	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11482	11491		10.1074/jbc.M113.461442	http://dx.doi.org/10.1074/jbc.M113.461442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23471968	Green Published, hybrid			2022-12-28	WOS:000317915500049
J	Datta, D; McClendon, CL; Jacobson, MP; Wells, JA				Datta, Debajyoti; McClendon, Christopher L.; Jacobson, Matthew P.; Wells, James A.			Substrate and Inhibitor-induced Dimerization and Cooperativity in Caspase-1 but Not Caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; COMBINATORIAL APPROACH; PROTEIN INTERACTIONS; MECHANISM; ACTIVATION; SPECIFICITIES; STABILITY; SECRETION; APOPTOSIS; PROTEASES	Caspases are intracellular cysteine-class proteases with aspartate specificity that is critical for driving processes as diverse as the innate immune response and apoptosis, exemplified by caspase-1 and caspase-3, respectively. Interestingly, caspase-1 cleaves far fewer cellular substrates than caspase-3 and also shows strong positive cooperativity between the two active sites of the homodimer, unlike caspase-3. Biophysical and kinetic studies here present a molecular basis for this difference. Analytical ultracentrifugation experiments show that mature caspase-1 exists predominantly as a monomer under physiological concentrations that undergoes dimerization in the presence of substrate; specifically, substrate binding shifts the K-D for dimerization by 20-fold. We have created a hemi-active site-labeled dimer of caspase-1, where one site is blocked with the covalent active site inhibitor, benzyloxycarbonyl-Val-Ala-Aspfluoromethylketone. This hemi-labeled enzyme is about 9-fold more active than the apo-dimer of caspase-1. These studies suggest that substrate not only drives dimerization but also, once bound to one site in the dimer, promotes an active conformation in the other monomer. Steady-state kinetic analysis and modeling independently support this model, where binding of one substrate molecule not only increases substrate binding in preformed dimers but also drives the formation of heterodimers. Thus, the cooperativity in caspase-1 is driven both by substrate-induced dimerization as well as substrate-induced activation. Substrate-induced dimerization and activation seen in caspase-1 and not in caspase-3 may reflect their biological roles. Whereas caspase-1 cleaves a dramatically smaller number of cellular substrates that need to be concentrated near inflammasomes, caspase-3 is a constitutively active dimer that cleaves many more substrates located diffusely throughout the cell.	[Datta, Debajyoti; McClendon, Christopher L.; Jacobson, Matthew P.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), UCSF Mission Bay, MC 2552 Byers Hall S504,1700 4th St, San Francisco, CA 94158 USA.	Jim.Wells@ucsf.edu	Jacobson, Matthew/Y-5161-2018; Wells, Jim A/O-9854-2016	Jacobson, Matthew/0000-0001-6262-655X; 	National Institutes of Health [R01-AI070292, GMO7618]; PhRMA Foundation fellowship; National Science Foundation East Asia and Pacific Summer Institutes grant; National Institutes of Health Postdoctoral Fellowship [F32-GM099197]; National Science Foundation Teragrid program at the Texas Advanced Supercomputing Center [TG-MCB090109]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation fellowship; National Science Foundation East Asia and Pacific Summer Institutes grant; National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Teragrid program at the Texas Advanced Supercomputing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI070292 (to J. A. W.) and GMO7618 (to D. D.). This work was also supported by a PhRMA Foundation fellowship and a National Science Foundation East Asia and Pacific Summer Institutes grant (to C. L. M., who is currently funded by National Institutes of Health Postdoctoral Fellowship F32-GM099197). This work was also supported by supercomputer time provided by the National Science Foundation Teragrid program at the Texas Advanced Supercomputing Center (Project TG-MCB090109 to M. P. J., a consultant for Schrodinger, Inc.).	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Bose K, 2005, PROTEIN SCI, V14, P24; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; MADSEN NB, 1967, J BIOL CHEM, V242, P3301; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Talanian RV, 1996, J BIOL CHEM, V271, P21853, DOI 10.1074/jbc.271.36.21853; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0	39	27	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9971	9981		10.1074/jbc.M112.426460	http://dx.doi.org/10.1074/jbc.M112.426460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23386603	Green Published, hybrid			2022-12-28	WOS:000317114000036
J	Ozaki, T; Nishiyama, M; Kuzuyama, T				Ozaki, Taro; Nishiyama, Makoto; Kuzuyama, Tomohisa			Novel Tryptophan Metabolism by a Potential Gene Cluster That Is Widely Distributed among Actinomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; COMPLETE GENOME SEQUENCE; NATURAL-PRODUCT; STREPTOMYCES; IDENTIFICATION; BIOSYNTHESIS; CONVERSION; DISCOVERY; OXIME	The characterization of potential gene clusters is a promising strategy for the identification of novel natural products and the expansion of structural diversity. However, there are often difficulties in identifying potential metabolites because their biosynthetic genes are either silenced or expressed only at a low level. Here, we report the identification of a novel metabolite that is synthesized by a potential gene cluster containing an indole prenyltransferase gene (SCO7467) and a flavin-dependent monooxygenase (FMO) gene (SCO7468), which were mined from the genome of Streptomyces coelicolor A3(2). We introduced these two genes into the closely related Streptomyces lividans TK23 and analyzed the culture broths of the transformants. This process allowed us to identify a novel metabolite, 5-dimethylallylindole-3-acetonitrile (5-DMAIAN) that was overproduced in the transformant. Biochemical characterization of the recombinant SCO7467 and SCO7468 demonstrated the novel L-tryptophan metabolism leading to 5-DMAIAN. SCO7467 catalyzes the prenylation of L-tryptophan to form 5-dimethylallyl-L-tryptophan (5-DMAT). This enzyme is the first actinomycetes prenyltransferase known to catalyze the addition of a dimethylallyl group to the C-5 of tryptophan. SCO7468 then catalyzes the conversion of 5-DMAT into 5-dimethylallylindole-3-acetaldoxime (5-DMAIAOx). An aldoxime-forming reaction catalyzed by the FMO enzyme was also identified for the first time in this study. Finally, dehydration of 5-DMAIAOx presumably occurs to yield 5-DMAIAN. This study provides insight into the biosynthesis of prenylated indoles that have been purified from actinomycetes.	[Ozaki, Taro; Nishiyama, Makoto; Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Kuzuyama, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	utkuz@mail.ecc.u-tokyo.ac.jp	OZAKI, Taro/F-1614-2016	OZAKI, Taro/0000-0002-4673-4478; Nishiyama, Makoto/0000-0001-8143-8052; Kuzuyama, Tomohisa/0000-0002-7221-5858	Japan Society for the Promotion of Science through the "Funding Program for Next Generation World Leading Researchers (NEXT Program)" [LS028];  [22-3411]	Japan Society for the Promotion of Science through the "Funding Program for Next Generation World Leading Researchers (NEXT Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by the Japan Society for the Promotion of Science through the "Funding Program for Next Generation World Leading Researchers (NEXT Program)" Grant LS028 (to T. K.), which was initiated by the Council for Science and Technology Policy.; Supported by Grant-in-aid 22-3411 for Japan Society for the Promotion of Science Fellows.	AHMAD A, 1974, B CHEM SOC JPN, V47, P1819, DOI 10.1246/bcsj.47.1819; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; DAIRI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1835, DOI 10.1271/bbb.59.1835; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Isogai S, 2012, BIOORG MED CHEM LETT, V22, P5823, DOI 10.1016/j.bmcl.2012.07.084; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawase Y, 2009, HETEROCYCLES, V78, P463, DOI 10.3987/COM-08-11532; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Komatsu M, 2003, GENE, V306, P79, DOI 10.1016/S0378-1119(03)00405-0; Komatsu M, 2006, MOL MICROBIOL, V62, P1534, DOI 10.1111/j.1365-2958.2006.05461.x; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Lin J, 1997, J PHARMACOL EXP THER, V282, P1269; Lopez JMS, 2003, J NAT PROD, V66, P863, DOI 10.1021/np0204444; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Motohashi K, 2008, J ANTIBIOT, V61, P75, DOI 10.1038/ja.2008.113; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; POULSEN LL, 1986, MOL PHARMACOL, V30, P680; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki T, 2002, J ANTIBIOT, V55, P1009, DOI 10.7164/antibiotics.55.1009; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Takano H, 2011, GENE, V477, P12, DOI 10.1016/j.gene.2011.01.005; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Yu X, 2012, J BIOL CHEM, V287, P1371, DOI 10.1074/jbc.M111.317982	31	27	28	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9946	9956		10.1074/jbc.M112.436451	http://dx.doi.org/10.1074/jbc.M112.436451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430264	Green Published, hybrid			2022-12-28	WOS:000317114000034
J	McCoy, F; Darbandi, R; Chen, SI; Eckard, L; Dodd, K; Jones, K; Baucum, AJ; Gibbons, JA; Lin, SH; Colbran, RJ; Nutt, LK				McCoy, Francis; Darbandi, Rashid; Chen, Si-Ing; Eckard, Laura; Dodd, Keela; Jones, Kelly; Baucum, Anthony J., II; Gibbons, Jennifer A.; Lin, Sue-Hwa; Colbran, Roger J.; Nutt, Leta K.			Metabolic Regulation of CaMKII Protein and Caspases in Xenopus laevis Egg Extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-II; CELL-DEATH; PHOSPHATASES; APOPTOSIS; OOCYTE; ACTIVATION; EXPRESSION; PP1	The metabolism of the Xenopus laevis egg provides a cell survival signal. We found previously that increased carbon flux from glucose-6-phosphate (G6P) through the pentose phosphate pathway in egg extracts maintains NADPH levels and calcium/calmodulin regulated protein kinase II (CaMKII) activity to phosphorylate caspase 2 and suppress cell death pathways. Here we show that the addition of G6P to oocyte extracts inhibits the dephosphorylation/inactivation of CaMKII bound to caspase 2 by protein phosphatase 1. Thus, G6P sustains the phosphorylation of caspase 2 by CaMKII at Ser-135, preventing the induction of caspase 2-mediated apoptotic pathways. These findings expand our understanding of oocyte biology and clarify mechanisms underlying the metabolic regulation of CaMKII and apoptosis. Furthermore, these findings suggest novel approaches to disrupt the suppressive effects of the abnormal metabolism on cell death pathways.	[McCoy, Francis; Darbandi, Rashid; Chen, Si-Ing; Eckard, Laura; Dodd, Keela; Jones, Kelly; Nutt, Leta K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Baucum, Anthony J., II; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Baucum, Anthony J., II; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Gibbons, Jennifer A.] Qiagen Inc, Frederick, MD 21703 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	St Jude Children's Research Hospital; Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center	Nutt, LK (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, MS 340,262 Danny Thomas Pl, Memphis, TN 38105 USA.	leta.nutt@stjude.org	Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013	Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865; Darbandi, Rashid/0000-0002-1239-6191	National Cancer Institute, National Institutes of Health [P30CA021765]; V Foundation and by the American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation and by the American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Cancer Institute, National Institutes of Health Award Number P30CA021765. This work was also supported by the V Foundation and by the American Lebanese Syrian Associated Charities (ALSAC).	Baucum AJ, 2013, J NEUROCHEM, V124, P490, DOI 10.1111/jnc.12101; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Carmody LC, 2008, FASEB J, V22, P1660, DOI 10.1096/fj.07-092841; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DWORKIN MB, 1989, DEV BIOL, V132, P512, DOI 10.1016/0012-1606(89)90246-7; Evans EK, 1998, ADV ENZYME REGUL, V38, P265, DOI 10.1016/S0065-2571(97)00020-4; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; ICHINOSE M, 1990, BRAIN RES, V533, P137, DOI 10.1016/0006-8993(90)91806-R; Jalan-Sakrikar N, 2012, J BIOL CHEM, V287, P15275, DOI 10.1074/jbc.M112.351817; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Nutt LK, 2012, SEMIN CELL DEV BIOL, V23, P412, DOI 10.1016/j.semcdb.2012.03.015; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rokhlin OW, 2007, CANCER BIOL THER, V6, P732, DOI 10.4161/cbt.6.5.3975; Rokhlin OW, 2010, CANCER BIOL THER, V9, P223, DOI 10.4161/cbt.9.3.10747; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Strack S, 1997, J NEUROCHEM, V68, P2119; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weiser D. C., 2003, CURR PROTOC PROTEIN	33	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8838	8848		10.1074/jbc.M112.437186	http://dx.doi.org/10.1074/jbc.M112.437186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400775	hybrid, Green Published			2022-12-28	WOS:000316862200006
J	Nguyen, AD; Nguyen, TA; Cenik, B; Yu, G; Herz, J; Walther, TC; Davidson, WS; Farese, RV				Nguyen, Andrew D.; Nguyen, Thi A.; Cenik, Basar; Yu, Gang; Herz, Joachim; Walther, Tobias C.; Davidson, W. Sean; Farese, Robert V., Jr.			Secreted Progranulin Is a Homodimer and Is Not a Component of High Density Lipoproteins (HDL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HOST-DEFENSE; A-I; PLASMA; PROTEIN; INFLAMMATION; GROWTH; SERUM; MICE; CONVERSION	Progranulin is a secreted glycoprotein, and the GRN gene is mutated in some cases of frontotemporal dementia. Progranulin has also been implicated in cell growth, wound healing, inflammation, and cancer. We investigated the molecular nature of secreted progranulin and provide evidence that progranulin exists as a homodimer. Although recombinant progranulin has a molecular mass of similar to 85 kDa by SDS-PAGE, it elutes in fractions corresponding to similar to 170-180 kDa by gel-filtration chromatography. Additionally, recombinant progranulin can be intermolecularly cross-linked, yielding a complex corresponding to a dimer (similar to 180 kDa), and progranulins containing different epitope tags physically interact. In plasma, progranulin similarly forms complexes of similar to 180-190 kDa. Although progranulin partially co-fractionated with high density lipoproteins (HDL) by gel-filtration chromatography, we found no evidence that progranulin in mouse or human plasma is a component of HDL either by ultracentrifugation or by lipid binding assays. We conclude that circulating progranulin exists as a dimer and is not likely a component of HDL.	[Nguyen, Andrew D.; Nguyen, Thi A.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Cenik, Basar; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cenik, Basar; Yu, Gang; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Walther, Tobias C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Davidson, W. Sean] Univ Cincinnati, Ctr Lipid & Arteriosclerosis Sci, Cincinnati, OH 45237 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; University System of Ohio; University of Cincinnati; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Farese, RV (corresponding author), Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu		Davidson, William/0000-0003-2756-2989; Nguyen, Andrew/0000-0002-9492-9472; Walther, Tobias/0000-0003-1442-1327	National Institutes of Health [P50 AG023501, GMO100909, R01 AG029547, R01 HL63762, R01 GM097194, F32 HL116197]; Consortium for Frontotemporal Dementia Research; Alzheimer's Disease Research Center; American Diabetes Association; Alzheimer's Association; Welch Foundation; American Health Assistance Foundation; Murchison Foundation; Ted Nash Longlife Foundation; Gladstone Institutes; National Center for Research Resources [RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, F32HL116197, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, R01AG029547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Alzheimer's Disease Research Center; American Diabetes Association(American Diabetes Association); Alzheimer's Association(Alzheimer's Association); Welch Foundation(The Welch Foundation); American Health Assistance Foundation(BrightFocus Foundation); Murchison Foundation; Ted Nash Longlife Foundation; Gladstone Institutes(University of California System); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 AG023501 (to R. V. F.), GMO100909 (to R. V. F.), R01 AG029547 (to G. Y.), R01 HL63762 (to J. H.), R01 GM097194 (to T. C. W.), and F32 HL116197 (to A. D. N.). This work was also supported by Consortium for Frontotemporal Dementia Research (to R. V. F., G. Y., and J. H.), the Alzheimer's Disease Research Center (to R. V. F.), the American Diabetes Association (to R. V. F.), the Alzheimer's Association (to G. Y.), the Welch Foundation (to G. Y.), the American Health Assistance Foundation (to J. H.), the Murchison Foundation (to J. H.), the Ted Nash Longlife Foundation (to J. H.), and the Gladstone Institutes.; We thank Karl Weisgraber and Stephen Young for antibodies, the UCSF Memory and Aging Center for blood samples, Robert Mahley, Yadong Huang, Jay Heinecke, and Daniel Rader for advice, Laura Mitic and members of the Farese laboratory for helpful discussions, Anna Lisa Lucido, and Gary Howard for editorial assistance, John Carroll for assistance with graphics, and Walter Brecht, Grisell Diaz-Ramirez, and Michael Ward for technical assistance. The Gladstone Institutes received support from National Center for Research Resources Grant RR18928.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Carecchio M, 2009, J NEUROL SCI, V287, P291, DOI 10.1016/j.jns.2009.07.011; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; CHAM BE, 1976, J LIPID RES, V17, P176; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ong CHP, 2006, AM J PHYSIOL-REG I, V291, pR1602, DOI 10.1152/ajpregu.00616.2005; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tolkatchev D, 2000, BIOCHEMISTRY-US, V39, P2878, DOI 10.1021/bi992130u; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vranken WF, 1999, J PEPT RES, V53, P590, DOI 10.1034/j.1399-3011.1999.00048.x; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	34	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8627	8635		10.1074/jbc.M112.441949	http://dx.doi.org/10.1074/jbc.M112.441949			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364791	Green Published, hybrid			2022-12-28	WOS:000316564500063
J	Lopez-Huertas, MR; Mateos, E; del Cojo, MS; Gomez-Esquer, F; Diaz-Gil, G; Rodriguez-Mora, S; Lopez, JA; Calvo, E; Lopez-Campos, G; Alcami, J; Coiras, M				Rosa Lopez-Huertas, Maria; Mateos, Elena; Sanchez del Cojo, Maria; Gomez-Esquer, Francisco; Diaz-Gil, Gema; Rodriguez-Mora, Sara; Antonio Lopez, Juan; Calvo, Enrique; Lopez-Campos, Guillermo; Alcami, Jose; Coiras, Mayte			The Presence of HIV-1 Tat Protein Second Exon Delays Fas Protein-mediated Apoptosis in CD4(+) T Lymphocytes A POTENTIAL MECHANISM FOR PERSISTENT VIRAL PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; CYTOCHROME-C RELEASE; CELL-DEATH; CODING EXON; INTERACTING PROTEIN; GENE-EXPRESSION; DOWN-REGULATION; ACTIVATION; BCL-2	HIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codified by two exons, although the first exon (1-72 amino acids) is sufficient for this process. Tat can be released to the extracellular medium, acting as a soluble pro-apoptotic factor in neighboring cells. However, HIV-1-infected CD4(+) T lymphocytes show a higher resistance to apoptosis. We observed that the intracellular expression of Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is an essential pathway to control T cell homeostasis during immune activation. Jurkat-Tat cells showed impairment in the activation of caspase-8, deficient release of mitochondrial cytochrome c, and delayed activation of both caspase-9 and -3. This protection was due to a profound deregulation of proteins that stabilized the mitochondrial membrane integrity, such as heat shock proteins, prohibitin, or nucleophosmin, as well as to the up-regulation of NF-kappa B-dependent anti-apoptotic proteins, such as BCL2, c-FLIPS, XIAP, and C-IAP2. These effects were observed in Jurkat expressing full-length Tat (Jurkat-Tat101) but not in Jurkat expressing the first exon of Tat (Jurkat-Tat72), proving that the second exon, and particularly the NF-kappa B-related motif ESKKKVE, was necessary for Tat-mediated protection against FasL apoptosis. Accordingly, the protection exerted by Tat was independent of its function as a regulator of both viral transcription and elongation. Moreover, these data proved that HIV-1 could have developed strategies to delay FasL-mediated apoptosis in infected CD4(+) T lymphocytes through the expression of Tat, thus favoring the persistent replication of HIV-1 in infected T cells.	[Rosa Lopez-Huertas, Maria; Mateos, Elena; Sanchez del Cojo, Maria; Rodriguez-Mora, Sara; Alcami, Jose; Coiras, Mayte] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Inmunopatol SIDA, Majadahonda 28220, Spain; [Gomez-Esquer, Francisco; Diaz-Gil, Gema] Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid 28922, Spain; [Antonio Lopez, Juan; Calvo, Enrique] Ctr Nacl Invest Cardiovasc, Unidad Prote, Madrid 28029, Spain; [Lopez-Campos, Guillermo] Melbourne Med Sch, Hlth & Biomed Informat Res Unit, Melbourne, Vic 3010, Australia	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad Rey Juan Carlos; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Coiras, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, AIDS Immunopathol Unit, Ctra Majadahonda Pozuelo Km2, Madrid 28220, Spain.	mcoiras@isciii.es	Campos, Guillermo H Lopez/G-2883-2015; Coiras, Mayte/R-9530-2019; Alcami, Pepe/T-2242-2018; Diaz-Gil, Gema/ABG-6454-2020; Lopez, Juan Antonio/G-7750-2015; Esquer, Francisco Gomez/K-8236-2017; Lopez-Campos, Guillermo/O-4349-2017; Lopez Huertas, Maria Rosa/J-6282-2014	Alcami, Pepe/0000-0003-0023-7377; Lopez, Juan Antonio/0000-0002-9097-6060; Lopez-Campos, Guillermo/0000-0003-3011-0940; Lopez Huertas, Maria Rosa/0000-0002-4183-2773; Diaz Gil, Gema/0000-0003-3480-1490; Coiras, Mayte/0000-0001-6464-5770; Rodriguez Mora, Sara/0000-0003-2467-116X; Gomez-Esquer, Francisco/0000-0002-5426-4349	Fundacion para la Investigacion y la Prevencion del Sida en Espana Grant [360924/10]; Spanish Ministry of Economy and Competitiveness [SAF2010-18388]; Spanish Ministry of Health [EC11-285]; AIDS Network Instituto del Salud Carlos III-Redes Tematicas de Investigacion Cooperativa Grant [RD06/0006]; Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness Grant Fondo de Investigaciones Sanitarias [PI080752]; Network of Excellence EUROPRISE; European Union; Fondo de Investigaciones Sanitarias [FI09/00347]	Fundacion para la Investigacion y la Prevencion del Sida en Espana Grant; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AIDS Network Instituto del Salud Carlos III-Redes Tematicas de Investigacion Cooperativa Grant; Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness Grant Fondo de Investigaciones Sanitarias; Network of Excellence EUROPRISE; European Union(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported in part by Fundacion para la Investigacion y la Prevencion del Sida en Espana Grant 360924/10, Spanish Ministry of Economy and Competitiveness Grant SAF2010-18388), Spanish Ministry of Health Grant EC11-285, AIDS Network Instituto del Salud Carlos III-Redes Tematicas de Investigacion Cooperativa Grant RD06/0006, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness Grant Fondo de Investigaciones Sanitarias PI080752, and the Network of Excellence EUROPRISE.; Supported by a fellowship from the European Union Programme Health 2009 (Combined Highly Active Anti-Retroviral Microbicides).; Supported by Fellowship FI09/00347 from the Fondo de Investigaciones Sanitarias.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Aillet F, 1998, J VIROL, V72, P9698, DOI 10.1128/JVI.72.12.9698-9705.1998; Alekseev OM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-45; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; ARENZANASEISDEDOS F, 1993, J VIROL, V67, P6596, DOI 10.1128/JVI.67.11.6596-6604.1993; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Brenner C, 2003, J CLIN INVEST, V111, P1455, DOI 10.1172/JCI200318609; CARROLL R, 1991, J VIROL, V65, P3460, DOI 10.1128/JVI.65.7.3460-3467.1991; Casula M, 2005, J INFECT DIS, V191, P1468, DOI 10.1086/429412; Chiang CW, 2008, METHOD ENZYMOL, V446, P237, DOI 10.1016/S0076-6879(08)01614-5; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Chowdhury I, 2011, LIFE SCI, V89, P295, DOI 10.1016/j.lfs.2011.06.022; Coiras M, 2006, PROTEOMICS, V6, pS63, DOI 10.1002/pmic.200500437; Conti L, 1998, J EXP MED, V187, P403, DOI 10.1084/jem.187.3.403; Corallini A, 2002, VIROLOGY, V299, P1, DOI 10.1006/viro.2002.1459; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Dandekar DH, 2004, NUCLEIC ACIDS RES, V32, P1270, DOI 10.1093/nar/gkh289; de Lera TL, 1999, ONCOGENE, V18, P1581, DOI 10.1038/sj.onc.1202455; Deniaud A, 2004, MITOCHONDRION, V4, P223, DOI 10.1016/j.mito.2004.06.012; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Gadad SS, 2011, J MOL BIOL, V410, P997, DOI 10.1016/j.jmb.2011.04.009; Gatignol A, 2000, Adv Pharmacol, V48, P209; GIBELLINI D, 1995, BRIT J HAEMATOL, V89, P24, DOI 10.1111/j.1365-2141.1995.tb08915.x; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golstein P, 1998, SCIENCE, V281, P1283, DOI 10.1126/science.281.5381.1283; Gougeon ML, 2005, CELL DEATH DIFFER, V12, P845, DOI 10.1038/sj.cdd.4401616; Hyer ML, 2006, CLIN CANCER RES, V12, P5929, DOI 10.1158/1078-0432.CCR-06-2098; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Just MA, 2001, NEUROIMAGE, V14, P417, DOI 10.1006/nimg.2001.0826; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kelly GL, 2011, ADV CANCER RES, V111, P39, DOI 10.1016/B978-0-12-385524-4.00002-7; Kerr LE, 2007, ONCOGENE, V26, P2554, DOI 10.1038/sj.onc.1210044; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; KURKI P, 1987, J IMMUNOL, V138, P4114; Larrosa PNF, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-19; Lelievre JD, 2004, CELL DEATH DIFFER, V11, P1017, DOI 10.1038/sj.cdd.4401441; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mahlknecht U, 2008, J LEUKOCYTE BIOL, V83, P718, DOI 10.1189/jlb.0607405; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; McCloskey TW, 1997, J IMMUNOL, V158, P1014; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Moon HS, 2006, MOL CELLS, V21, P7; NARDELLI B, 1995, P NATL ACAD SCI USA, V92, P7312, DOI 10.1073/pnas.92.16.7312; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Osakabe A, 2010, J BIOL CHEM, V285, P11913, DOI 10.1074/jbc.M109.083238; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Paulo Joao A., 2012, Yale Journal of Biology and Medicine, V85, P59; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; PINCUS SH, 1994, J CLIN INVEST, V93, P2505, DOI 10.1172/JCI117260; Pugliese A, 2005, CELL BIOCHEM FUNCT, V23, P223, DOI 10.1002/cbf.1147; Richard A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.18; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmitz I, 2004, J IMMUNOL, V172, P2194, DOI 10.4049/jimmunol.172.4.2194; Schories B, 2004, CELL DEATH DIFFER, V11, P940, DOI 10.1038/sj.cdd.4401411; Schwab BL, 1998, EXP CELL RES, V238, P415, DOI 10.1006/excr.1997.3850; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Smith SM, 2003, J BIOL CHEM, V278, P44816, DOI 10.1074/jbc.M307546200; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Szebeni A, 1999, PROTEIN SCI, V8, P905; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Varbanov M, 2006, AIDS REV, V8, P221; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WEISS A, 1984, J IMMUNOL, V133, P123; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Xiao H, 1998, BIOCHEM BIOPH RES CO, V244, P384, DOI 10.1006/bbrc.1998.8274; Yang LP, 1997, VIROLOGY, V235, P48, DOI 10.1006/viro.1997.8672; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zachos G, 2001, J VIROL, V75, P2710, DOI 10.1128/JVI.75.6.2710-2728.2001; ZAULI G, 1995, BLOOD, V86, P3823, DOI 10.1182/blood.V86.10.3823.bloodjournal86103823; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045	113	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7626	7644		10.1074/jbc.M112.408294	http://dx.doi.org/10.1074/jbc.M112.408294			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23364796	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000316455300020
J	Hart, GW				Hart, Gerald W.			Thematic Minireview Series on Glycobiology and Extracellular Matrices: Glycan Functions Pervade Biology at All Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLYCOSYLATION		Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	ghart@asbmb.org		Hart, Gerald/0000-0001-7812-4351	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL107153] Funding Source: Medline; NIDDK NIH HHS [P30 DK079637] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Springer SA, 2013, J BIOL CHEM, V288, P6904, DOI 10.1074/jbc.R112.424523; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978	5	16	16	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6903	6903		10.1074/jbc.R113.453977	http://dx.doi.org/10.1074/jbc.R113.453977			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329844	hybrid, Green Published			2022-12-28	WOS:000316002400011
J	Kim, MK; Jeon, BN; Koh, DI; Kim, KS; Park, SY; Yun, CO; Hur, MW				Kim, Min-Kyeong; Jeon, Bu-Nam; Koh, Dong-In; Kim, Kyung-Sup; Park, So-Yoon; Yun, Chae-Ok; Hur, Man-Wook			Regulation of the Cyclin-dependent Kinase Inhibitor 1A Gene (CDKN1A) by the Repressor BOZF1 through Inhibition of p53 Acetylation and Transcription Factor Sp1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; FINGER ENCODING GENE; ZINC-FINGER; DNA-DAMAGE; CELL-CYCLE; PROMYELOCYTIC LEUKEMIA; IN-VITRO; P21; ACTIVATION; APOPTOSIS	The human POZ domain and Kruppel-like zinc finger (POK) family proteins play important roles in the regulation of apoptosis, cell proliferation, differentiation, development, oncogenesis, and tumor suppression. A novel POK family transcription factor, BTB/POZ and zinc finger domains factor on chromosome 1 (BOZF-1; also called ZBTB8A), contains a POZ domain and two C2H2-type Kruppel-like zinc fingers and is localized at nuclear speckles. Compared with paired normal tissues, BOZF1 expression is increased in cancer tissues of the prostate, breast, and cervix. BOZF1 repressed the transcription of p21WAF/CDKN1A by acting on the proximal promoter concentrated with Sp1-binding GC boxes. BOZF1 competed with Sp1 in binding to GC boxes 1-5/6 of the CDKN1A proximal promoter. In addition, BOZF1 interacted with p53 and decreased the acetylation of p53 by p300, which reduced the DNA binding activity of p53 at the far distal p53-binding element. BOZF1 blocked the two major molecular events that are important in both constitutive and inducible transcription activation of CDKN1A. BOZF1 is unique in that it bound to all the proximal GC boxes to repress transcription, and it inhibited p53 acetylation without affecting p53 stability. BOZF1 might be a novel proto-oncoprotein that stimulates cell proliferation.	[Kim, Min-Kyeong; Jeon, Bu-Nam; Koh, Dong-In; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Severance Biomed Res Inst,Sch Med, Seoul 120752, South Korea; [Park, So-Yoon] SoonChunHyang Univ Hosp, Dept Pathol, Gumi Si 730706, Gyeongbuk, South Korea; [Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 134791, South Korea	Yonsei University; Soonchunhyang University; Soonchunhyang University Hospital; Hanyang University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac	Yun, Chae-Ok/P-3698-2015	Hur, Man-Wook/0000-0002-3416-1334; Yun, Chae-Ok/0000-0002-9466-4531; Kim, Kyung-sup/0000-0001-8483-8537	Do-Yak Program [2011-0028817]; Midcareer Researcher Program [2009-0081294]; Medical Research Center from the National Research Foundation of Korea [2011-0030708]; Korean government (Ministry of Education, Science and Technology)	Do-Yak Program; Midcareer Researcher Program; Medical Research Center from the National Research Foundation of Korea(National Research Foundation of Korea); Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Do-Yak Program Grant 2011-0028817 (to M.-W. H.) and Midcareer Researcher Program Grant 2009-0081294) (to M.-W. H.) and in part by Medical Research Center Grant 2011-0030708) (to M.-W. H.) from the National Research Foundation of Korea, which is funded through the Korean government (Ministry of Education, Science and Technology).	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; HARPER JW, 1993, CELL, V75, P805; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jeon BN, 2012, CANCER RES, V72, P1137, DOI 10.1158/0008-5472.CAN-11-2433; Jeon BN, 2009, J BIOL CHEM, V284, P17935, DOI 10.1074/jbc.M809559200; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Koh DI, 2009, J BIOL CHEM, V284, P19856, DOI 10.1074/jbc.M109.025817; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lee KM, 2012, ONCOGENE, V31, P1442, DOI 10.1038/onc.2011.331; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Prives C, 1999, J PATHOL, V187, P112; Schneider A, 1997, CURR TOP MICROBIOL, V224, P137; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; WALDMAN T, 1995, CANCER RES, V55, P5187; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Weber A, 2008, EMBO J, V27, P1563, DOI 10.1038/emboj.2008.85; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	46	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7053	7064		10.1074/jbc.M112.416297	http://dx.doi.org/10.1074/jbc.M112.416297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329847	hybrid, Green Published			2022-12-28	WOS:000316002400027
J	Crowe, A; James, MJ; Lee, VMY; Smith, AB; Trojanowski, JQ; Ballatore, C; Brunden, KR				Crowe, Alex; James, Michael J.; Lee, Virginia M. -Y.; Smith, Amos B., III; Trojanowski, John Q.; Ballatore, Carlo; Brunden, Kurt R.			Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; IN-VITRO; AGGREGATION; INHIBITION; NEURODEGENERATION; DISCOVERY; PEPTIDES; DEMENTIA	Alzheimer disease and several other neurodegenerative disorders are characterized by the accumulation of intraneuronal fibrils comprised of the protein Tau. Tau is normally a soluble protein that stabilizes microtubules, with splice isoforms that contain either three (3-R) or four (4-R) microtubule binding repeats. The formation of Tau fibrils is thought to result in neuronal damage, and inhibitors of Tau fibrillization may hold promise as therapeutic agents. The process of Tau fibrillization can be replicated in vitro, and a number of small molecules have been identified that inhibit Tau fibril formation. However, little is known about how these molecules affect Tau fibrillization. Here, we examined the mechanism by which the previously described aminothieno pyridazine (ATPZ) series of compounds inhibit Tau fibrillization. Active ATPZs were found to promote the oxidation of the two cysteine residues within 4-R Tau by a redox cycling mechanism, resulting in the formation of a disulfide-containing compact monomer that was refractory to fibrillization. Moreover, the ATPZs facilitated intermolecular disulfide formation between 3-R Tau monomers, leading to dimers that were capable of fibrillization. The ATPZs also caused cysteine oxidation in molecules unrelated to Tau. Interestingly, methylene blue, an inhibitor of Tau fibrillization under evaluation in Alzheimer disease clinical trials, caused a similar oxidation of cysteines in Tau and other molecules. These findings reveal that the ATPZs and methylene blue act by a mechanism that may affect their viability as potential therapeutic agents.	[Crowe, Alex; James, Michael J.; Lee, Virginia M. -Y.; Trojanowski, John Q.; Ballatore, Carlo; Brunden, Kurt R.] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Amos B., III; Ballatore, Carlo] Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Brunden, KR (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, 3600 Spruce St,Maloney 3, Philadelphia, PA 19104 USA.	kbrunden@upenn.edu	Ballatore, Carlo/L-1034-2017	Ballatore, Carlo/0000-0002-2718-3850	National Institutes of Health (NIA) [AG17586]; Alzheimer Disease Research program of the American Health Assistance Foundation; Coins for Alzheimer's Research Trust; Comprehensive Neuroscience Center at the University of Pennsylvania; Marian S. Ware Alzheimer's Program; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer Disease Research program of the American Health Assistance Foundation; Coins for Alzheimer's Research Trust; Comprehensive Neuroscience Center at the University of Pennsylvania; Marian S. Ware Alzheimer's Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586 (NIA; V. M.-Y. L.). This work was also supported by grants from the Alzheimer Disease Research program of the American Health Assistance Foundation (to K. R. B.) and the Coins for Alzheimer's Research Trust (to K. R. B.), a pilot grant from the Comprehensive Neuroscience Center at the University of Pennsylvania (to C. B.), and by the Marian S. Ware Alzheimer's Program.	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Ballatore C, 2011, CURR TOP MED CHEM, V11, P317, DOI 10.2174/156802611794072605; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Ballatore C, 2012, BIOORGAN MED CHEM, V20, P4451, DOI 10.1016/j.bmc.2012.05.027; Ballatore C, 2010, J MED CHEM, V53, P3739, DOI 10.1021/jm100138f; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Brunden KR, 2010, EXP NEUROL, V223, P304, DOI 10.1016/j.expneurol.2009.08.031; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Chang E, 2009, J MED CHEM, V52, P3539, DOI 10.1021/jm900116d; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; Crowe A, 2009, BIOCHEMISTRY-US, V48, P7732, DOI 10.1021/bi9006435; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GORMAN JJ, 1987, ANAL BIOCHEM, V160, P376, DOI 10.1016/0003-2697(87)90064-9; Hasegawa M, 2006, NEUROPATHOLOGY, V26, P484, DOI 10.1111/j.1440-1789.2006.00666.x; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LEE VMY, 1994, NEUROBIOL AGING, V15, pS87; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Smith GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P195, DOI 10.1006/abbi.2002.2757; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; STAFF RT, 2008, ALZHEIMERS DEMENT, V4, pT775; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wilson DM, 1997, AM J PATHOL, V150, P2181; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Zhang HQ, 2012, SEMIN CELL DEV BIOL, V23, P722, DOI 10.1016/j.semcdb.2012.03.017; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	51	105	107	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11024	11037		10.1074/jbc.M112.436006	http://dx.doi.org/10.1074/jbc.M112.436006			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443659	hybrid, Green Published			2022-12-28	WOS:000317915500009
J	Kjaer-Sorensen, K; Engholm, DH; Kamei, H; Morch, MG; Kristensen, AO; Zhou, JF; Conover, CA; Duan, CM; Oxvig, C				Kjaer-Sorensen, Kasper; Engholm, Ditte H.; Kamei, Hiroyasu; Morch, Maria G.; Kristensen, Anisette O.; Zhou, Jianfeng; Conover, Cheryl A.; Duan, Cunming; Oxvig, Claus			Pregnancy-associated Plasma Protein A (PAPP-A) Modulates the Early Developmental Rate in Zebrafish Independently of Its Proteolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-BINDING PROTEIN-4; MAJOR BASIC-PROTEIN; MESSENGER-RIBONUCLEIC-ACID; TARGETED GENE KNOCKDOWN; SUBSTRATE-SPECIFICITY; EMBRYONIC-DEVELOPMENT; CELL-SURVIVAL; GROWTH; EXPRESSION; DUPLICATION	Pregnancy-associated plasma protein-A (PAPP-A) is a large metalloproteinase specifically cleaving insulin-like growth factor (IGF) binding proteins, causing increased IGF bioavailability and, hence, local regulation of IGF receptor activation. We have identified two highly conserved zebrafish homologs of the human PAPP-A gene. Expression of zebrafish Papp-a, one of the two paralogs, begins during gastrulation and persists throughout the first week of development, and analyses demonstrate highly conserved patterns of expression between adult zebrafish, humans, and mice. We show that the specific knockdown of zebrafish papp-a limits the developmental rate beginning during gastrulation without affecting the normal patterning of the embryo. This phenotype is different from those resulting from deficiency of Igf receptor or ligand in zebrafish, suggesting a function of Papp-a outside of the Igf system. Biochemical analysis of recombinant zebrafish Papp-a demonstrates conservation of proteolytic activity, specificity, and the intrinsic regulatory mechanism. However, in vitro transcribed mRNA, which encodes a proteolytically inactive Papp-a mutant, recues the papp-a knockdown phenotype as efficiently as wildtype Papp-a. Thus, the developmental phenotype of papp-a knockdown is not a consequence of lacking Papp-a proteolytic activity. We conclude that Papp-a possesses biological functions independent of its proteolytic activity. Our data represent the first evidence for a non-proteolytic function of PAPP-A.	[Kjaer-Sorensen, Kasper; Engholm, Ditte H.; Morch, Maria G.; Kristensen, Anisette O.; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Kamei, Hiroyasu; Zhou, Jianfeng; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48105 USA; [Conover, Cheryl A.] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA	Aarhus University; University of Michigan System; University of Michigan; Mayo Clinic	Oxvig, C (corresponding author), Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.	co@mb.au.dk	Kjaer-Sorensen, Kasper/AAF-1457-2020	KAMEI, HIROYASU/0000-0001-7123-040X; Oxvig, Claus/0000-0002-4715-9719	Danish Council for Independent Research (Medical Sciences, and Technology and Production Sciences); Novo Nordic Foundation; Karen Elise Jensen Foundation; Danish National Research Infrastructure Program; Division Of Integrative Organismal Systems [1051034] Funding Source: National Science Foundation	Danish Council for Independent Research (Medical Sciences, and Technology and Production Sciences); Novo Nordic Foundation(Novo Nordisk Foundation); Karen Elise Jensen Foundation; Danish National Research Infrastructure Program; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the Danish Council for Independent Research (Medical Sciences, and Technology and Production Sciences), by the Novo Nordic Foundation, by the Karen Elise Jensen Foundation, and by the Danish National Research Infrastructure Program.	Bale LK, 2005, J ENDOCRINOL, V186, P325, DOI 10.1677/joe.1.06259; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; BONNO M, 1994, LAB INVEST, V71, P560; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Burns JL, 2001, DEVELOPMENT, V128, P3819; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; CONOVER CA, 1995, J BIOL CHEM, V270, P4395, DOI 10.1074/jbc.270.9.4395; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Fox NS, 2009, PRENATAL DIAG, V29, P1244, DOI 10.1002/pd.2397; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirkegaard I, 2011, ULTRASOUND OBST GYN, V37, P341, DOI 10.1002/uog.8808; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Laursen LS, 2002, J BIOL CHEM, V277, P47225, DOI 10.1074/jbc.M209155200; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mikkelsen JH, 2008, J BIOL CHEM, V283, P16772, DOI 10.1074/jbc.M802429200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ning Y, 2008, MOL ENDOCRINOL, V22, P1213, DOI 10.1210/me.2007-0536; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; Overgaard MT, 2003, J BIOL CHEM, V278, P2106, DOI 10.1074/jbc.M208777200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peterson SE, 2008, AM J OBSTET GYNECOL, V198, pE43, DOI 10.1016/j.ajog.2007.12.026; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; Soe R, 2002, EUR J BIOCHEM, V269, P2247, DOI 10.1046/j.1432-1033.2002.02883.x; Weyer K, 2004, EUR J BIOCHEM, V271, P1525, DOI 10.1111/j.1432-1033.2004.04061.x; Weyer K, 2007, J BIOL CHEM, V282, P10988, DOI 10.1074/jbc.M607903200; White YAR, 2009, ENDOCRINOLOGY, V150, P4366, DOI 10.1210/en.2009-0356; Zhong YB, 2011, J CELL SCI, V124, P1925, DOI 10.1242/jcs.082644; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	40	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9982	9992		10.1074/jbc.M112.426304	http://dx.doi.org/10.1074/jbc.M112.426304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430244	Green Published, hybrid			2022-12-28	WOS:000317114000037
J	Thompson, CA; Purushothaman, A; Ramani, VC; Vlodavsky, I; Sanderson, RD				Thompson, Camilla A.; Purushothaman, Anurag; Ramani, Vishnu C.; Vlodavsky, Israel; Sanderson, Ralph D.			Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA; SULFATE PROTEOGLYCANS; METASTASIS; SYNDECAN-1; GROWTH; EXPRESSION; PROMOTES; ACTIVATION; PROLIFERATION; STIMULATION	Emerging evidence indicates that exosomes play a key role in tumor-host cross-talk and that exosome secretion, composition, and functional capacity are altered as tumors progress to an aggressive phenotype. However, little is known regarding the mechanisms that regulate these changes. Heparanase is an enzyme whose expression is up-regulated as tumors become more aggressive and is associated with enhanced tumor growth, angiogenesis, and metastasis. We have discovered that in human cancer cells (myeloma, lymphoblastoid, and breast cancer), when expression of heparanase is enhanced or when tumor cells are exposed to exogenous heparanase, exosome secretion is dramatically increased. Heparanase enzyme activity is required for robust enhancement of exosome secretion because enzymatically inactive forms of heparanase, even when present in high amounts, do not dramatically increase exosome secretion. Heparanase also impacts exosome protein cargo as reflected by higher levels of syndecan-1, VEGF, and hepatocyte growth factor in exosomes secreted by heparanase-high expressing cells as compared with heparanase-low expressing cells. In functional assays, exosomes from heparanase-high cells stimulated spreading of tumor cells on fibronectin and invasion of endothelial cells through extracellular matrix better than did exosomes secreted by heparanase-low cells. These studies reveal that heparanase helps drive exosome secretion, alters exosome composition, and facilitates production of exosomes that impact both tumor and host cell behavior, thereby promoting tumor progression.	[Thompson, Camilla A.; Purushothaman, Anurag; Ramani, Vishnu C.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Sanderson, Ralph D.] Univ Alabama Birmingham, Univ Alabama UAB, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, 602 WTI,1720 2nd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA135075, CA138340]; United States-Israel Binational Science Foundation; NATIONAL CANCER INSTITUTE [R01CA138340, R01CA135075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.). This work was also supported by a grant from the United States-Israel Binational Science Foundation (jointly to R. D. S. and I. V.).	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Borset M, 2000, BLOOD, V96, P2528; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Henderson MC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00038; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hov H, 2009, EUR J HAEMATOL, V82, P277, DOI 10.1111/j.1600-0609.2009.01212.x; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Kelly T, 2003, CANCER RES, V63, P8749; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910	40	233	240	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10093	10099		10.1074/jbc.C112.444562	http://dx.doi.org/10.1074/jbc.C112.444562			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430739	Green Published, hybrid			2022-12-28	WOS:000317114000050
J	Stepanchick, A; Zhi, HJ; Cavanaugh, AH; Rothblum, K; Schneider, DA; Rothblum, LI				Stepanchick, Ann; Zhi, Huijun; Cavanaugh, Alice H.; Rothblum, Katrina; Schneider, David A.; Rothblum, Lawrence I.			DNA Binding by the Ribosomal DNA Transcription Factor Rrn3 Is Essential for Ribosomal DNA Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE ENCODES; RDNA TRANSCRIPTION; FACTOR UBF; FACTOR SL1; NUCLEOLAR TRANSCRIPTION; CORE PROMOTER; TIF-IA; INITIATION; PHOSPHORYLATION	The human homologue of yeast Rrn3 is an RNA polymerase I-associated transcription factor that is essential for ribosomal DNA (rDNA) transcription. The generally accepted model is that Rrn3 functions as a bridge between RNA polymerase I and the transcription factors bound to the committed template. In this model Rrn3 would mediate an interaction between the mammalian Rrn3-polymerase I complex and SL1, the rDNA transcription factor that binds to the core promoter element of the rDNA. In the course of studying the role of Rrn3 in recruitment, we found that Rrn3 was in fact a DNA-binding protein. Analysis of the sequence of Rrn3 identified a domain with sequence similarity to the DNA binding domain of heat shock transcription factor 2. Randomization, or deletion, of the amino acids in this region in Rrn3, amino acids 382-400, abrogated its ability to bind DNA, indicating that this domain was an important contributor to DNA binding by Rrn3. Control experiments demonstrated that these mutant Rrn3 constructs were capable of interacting with both rpa43 and SL1, two other activities demonstrated to be essential for Rrn3 function. However, neither of these Rrn3 mutants was capable of functioning in transcription in vitro. Moreover, although wild-type human Rrn3 complemented a yeast rrn3-ts mutant, the DNA-binding site mutant did not. These results demonstrate that DNA binding by Rrn3 is essential for transcription by RNA polymerase I.	[Stepanchick, Ann; Zhi, Huijun; Cavanaugh, Alice H.] Geisinger Med Clin, Sigfried & Janet Weis Ctr Res, Danville, PA 17821 USA; [Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Rothblum, Katrina; Rothblum, Lawrence I.] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73104 USA	Geisinger Medical Center; University of Alabama System; University of Alabama Birmingham; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rothblum, LI (corresponding author), Univ Oklahoma, Coll Med, Dept Cell Biol, 940 Stanton L Young,BMSB 553C, Oklahoma City, OK 73104 USA.	lrothblu@OUHSC.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM069841, HL077814, GM084946]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946, R01GM069841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069841 and HL077814 (to L. I. R.) and GM084946 (to D. A. S.).	BAZETTJONES DP, 1994, SCIENCE, V264, P1134, DOI 10.1126/science.8178172; BECKMANN H, 1995, SCIENCE, V270, P1506, DOI 10.1126/science.270.5241.1506; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; Cavanaugh A., RIBOSOMAL DNA TRANSC; Cavanaugh AH, 2002, J BIOL CHEM, V277, P27423, DOI 10.1074/jbc.M201232200; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; CAVANAUGH AH, 1984, P NATL ACAD SCI-BIOL, V81, P718, DOI 10.1073/pnas.81.3.718; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; COPENHAVER GP, 1994, NUCLEIC ACIDS RES, V22, P2651, DOI 10.1093/nar/22.13.2651; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; GOKAL PK, 1986, J BIOL CHEM, V261, P2536; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; HAGLUND RE, 1987, MOL CELL BIOCHEM, V73, P11; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Hannan RD, 1999, NUCLEIC ACIDS RES, V27, P3720, DOI 10.1093/nar/27.18.3720; Hannan RD, 1998, J BIOL CHEM, V273, P1257, DOI 10.1074/jbc.273.2.1257; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KEYS DA, 1994, GENE DEV, V8, P2349, DOI 10.1101/gad.8.19.2349; Keys DA, 1996, GENE DEV, V10, P887, DOI 10.1101/gad.10.7.887; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lin CW, 1996, MOL CELL BIOL, V16, P6436; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; MILLER KG, 1985, MOL CELL BIOL, V5, P554, DOI 10.1128/MCB.5.3.554; Moorefield B, 2000, P NATL ACAD SCI USA, V97, P4724, DOI 10.1073/pnas.080063997; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; NAGAMINE M, 1987, MOL CELL BIOL, V7, P1486, DOI 10.1128/MCB.7.4.1486; OMAHONY DJ, 1992, NUCLEIC ACIDS RES, V20, P1301; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; PIKAARD CS, 1990, MOL CELL BIOL, V10, P3810, DOI 10.1128/MCB.10.7.3810; ROTHBLUM LI, 1982, NUCLEIC ACIDS RES, V10, P7345, DOI 10.1093/nar/10.22.7345; SMITH SD, 1990, MOL CELL BIOL, V10, P3105, DOI 10.1128/MCB.10.6.3105; Steffan JS, 1996, GENE DEV, V10, P2551, DOI 10.1101/gad.10.20.2551; THURIAUX P, 1995, J BIOL CHEM, V270, P24252, DOI 10.1074/jbc.270.41.24252; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Yamamoto K, 2000, NUCLEIC ACIDS RES, V28, P1199, DOI 10.1093/nar/28.5.1199; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V281, P1001, DOI 10.1006/bbrc.2001.4457; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x; YANGYEN HF, 1988, MOL CELL BIOL, V8, P3406, DOI 10.1128/MCB.8.8.3406; Zhai WG, 1997, GENE DEV, V11, P1605, DOI 10.1101/gad.11.12.1605; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	53	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9135	9144		10.1074/jbc.M112.444265	http://dx.doi.org/10.1074/jbc.M112.444265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393135	Green Published, hybrid			2022-12-28	WOS:000316862200033
J	Gorski, PA; Glaves, JP; Vangheluwe, P; Young, HS				Gorski, Przemek A.; Glaves, John Paul; Vangheluwe, Peter; Young, Howard S.			Sarco(endo)plasmic Reticulum Calcium ATPase (SERCA) Inhibition by Sarcolipin Is Encoded in Its Luminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; SOLID-STATE NMR; SKELETAL-MUSCLE; CA2+ PUMP; FUNCTIONAL INTERACTIONS; PEPTIDE INHIBITORS; TWITCH SKELETAL; PHOSPHOLAMBAN; PHOSPHORYLATION; CA2+-ATPASE	The sarco(endo)plasmic reticulum calcium ATPase (SERCA) is regulated in a tissue-dependent manner via interaction with the short integral membrane proteins phospholamban (PLN) and sarcolipin (SLN). Although defects in SERCA activity are known to cause heart failure, the regulatory mechanisms imposed by PLN and SLN could have clinical implications for both heart and skeletal muscle diseases. PLN and SLN have significant sequence homology in their transmembrane regions, suggesting a similar mode of binding to SERCA. However, unlike PLN, SLN has a conserved C-terminal luminal tail composed of five amino acids ((27)RSYQY), which may contribute to a distinct SERCA regulatory mechanism. We have functionally characterized alanine mutants of the C-terminal tail of SLN using co-reconstituted proteoliposomes of SERCA and SLN. We found that Arg(27) and Tyr(31) are essential for SLN function. We also tested the effect of a truncated variant of SLN (Arg(27)stop) and extended chimeras of PLN with the five luminal residues of SLN added to its C terminus. The Arg(27)stop form of SLN resulted in loss of function, whereas the PLN chimeras resulted in superinhibition with characteristics of both PLN and SLN. Based on our results, we propose that the C-terminal tail of SLN is a distinct, essential domain in the regulation of SERCA and that the functional properties of the SLN tail can be transferred to PLN.	[Gorski, Przemek A.; Glaves, John Paul; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Glaves, John Paul; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada; [Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, B-3000 Louvain, Belgium	University of Alberta; National Research Council Canada; University of Alberta; KU Leuven	Young, HS (corresponding author), Univ Alberta, Dept Biochem, Med Sci Bldg,Rm 327, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Young, Howard/0000-0002-5990-8422	Canadian Institutes of Health Research [MOP53306]; Alberta Innovates Technology Futures	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures	This work was supported in part by Canadian Institutes of Health Research Grant MOP53306.; Supported by doctoral awards from the Canadian Institutes of Health Research and Alberta Innovates Technology Futures.	Afara MR, 2008, BIOCHEMISTRY-US, V47, P9522, DOI 10.1021/bi800880q; Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Becucci L, 2009, BIOPHYS J, V97, P2693, DOI 10.1016/j.bpj.2009.08.035; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Buck B, 2003, PROTEIN EXPRES PURIF, V30, P253, DOI 10.1016/S1046-5928(03)00127-X; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; Ferrington DA, 2002, BIOCHEMISTRY-US, V41, P13289, DOI 10.1021/bi026407t; FOWLER C, 1989, BIOCHIM BIOPHYS ACTA, V980, P348, DOI 10.1016/0005-2736(89)90323-4; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; INESI G, 1988, METHOD ENZYMOL, V157, P154; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2001, J BIOL CHEM, V276, P38814, DOI 10.1074/jbc.M104006200; Karim CB, 2000, BIOCHEMISTRY-US, V39, P10892, DOI 10.1021/bi0003543; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Lockwood NA, 2003, BIOPOLYMERS, V69, P283, DOI 10.1002/bip.10365; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; Negash S, 1996, BIOCHEMISTRY-US, V35, P11247, DOI 10.1021/bi960864q; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; SASAKI T, 1992, J BIOL CHEM, V267, P1674; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Stokes DL, 2006, BIOPHYS J, V90, P4213, DOI 10.1529/biophysj.105.079640; Thomas DD, 1998, ANN NY ACAD SCI, V853, P186, DOI 10.1111/j.1749-6632.1998.tb08266.x; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Tupling AR, 2002, J BIOL CHEM, V277, P44740, DOI 10.1074/jbc.M206171200; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Waggoner JR, 2007, BIOCHEMISTRY-US, V46, P1999, DOI 10.1021/bi061365k; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	61	53	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8456	8467		10.1074/jbc.M112.446161	http://dx.doi.org/10.1074/jbc.M112.446161			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362265	hybrid, Green Published			2022-12-28	WOS:000316564500043
J	Sekiguchi, T; Ito, R; Hayakawa, H; Sekiguchi, M				Sekiguchi, Takeshi; Ito, Riyoko; Hayakawa, Hiroshi; Sekiguchi, Mutsuo			Elimination and Utilization of Oxidized Guanine Nucleotides in the Synthesis of RNA and Its Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; ESCHERICHIA-COLI MUTT; PROTEIN HYDROLYZES; ADENYLATE KINASE; DNA; DAMAGE; RIBONUCLEOTIDE; MUTATIONS; GUANOSINE; ENZYME	Reactive oxygen species are produced as side products of oxygen utilization and can lead to the oxidation of nucleic acids and their precursor nucleotides. Among the various oxidized bases, 8-oxo-7,8-dihydroguanine seems to be the most critical during the transfer of genetic information because it can pair with both cytosine and adenine. During the de novo synthesis of guanine nucleotides, GMP is formed first, and it is converted to GDP by guanylate kinase. This enzyme hardly acts on an oxidized form of GMP(8-oxo-GMP) formed by the oxidation of GMP or by the cleavage of 8-oxo-GDP and 8-oxo-GTP by MutT protein. Although the formation of 8-oxo-GDP from 8-oxo-GMP is thus prevented, 8-oxo-GDP itself may be produced by the oxidation of GDP by reactive oxygen species. The 8-oxo-GDP thus formed can be converted to 8-oxo-GTP because nucleoside-diphosphate kinase and adenylate kinase, both of which catalyze the conversion of GDP to GTP, do not discriminate 8-oxo-GDP from normal GDP. The 8-oxo-GTP produced in this way and by the oxidation of GTP can be used for RNA synthesis. This misincorporation is prevented by MutT protein, which has the potential to cleave 8-oxo-GTP as well as 8-oxo-GDP to 8-oxo-GMP. When C-14-labeled 8-oxo-GTP was applied to CaCl2-permeabilized cells of a mutT(-) mutant strain, it could be incorporated into RNA at 4% of the rate for GTP. Escherichia coli cells appear to possess mechanisms to prevent misincorporation of 8-oxo-7,8-dihydroguanine into RNA.	[Sekiguchi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; [Ito, Riyoko; Hayakawa, Hiroshi; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Dept Biochem, Fukuoka 8140193, Japan; [Ito, Riyoko; Hayakawa, Hiroshi; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan	Kyushu University; Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Sekiguchi, M (corresponding author), Fukuoka Dent Coll, Dept Biochem, Fukuoka 8140193, Japan.	mseki@college.fdcnet.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, including the MEXT-supported Program for the Strategic Research Foundation at Private Universities and grants-in-aid for scientific research.	ALMAULA N, 1995, J BACTERIOL, V177, P2524, DOI 10.1128/jb.177.9.2524-2529.1995; Baker T. A., 1992, DNA REPLICATION, P55; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Boyer P.D, 1973, ENZYMES, P279; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Fowler RG, 2003, DNA REPAIR, V2, P159, DOI 10.1016/S1568-7864(02)00193-3; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; GENTRY D, 1993, J BIOL CHEM, V268, P14316; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; LAGERKVIST U, 1958, J BIOL CHEM, V233, P143; Lu Q, 1996, P NATL ACAD SCI USA, V93, P5720, DOI 10.1073/pnas.93.12.5720; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Nakatsu Y, 2006, OXIDATIVE STRESS, DISEASE AND CANCER, P221, DOI 10.1142/9781860948046_0006; OESCHGER MP, 1966, J BIOL CHEM, V241, P5452; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Sambrook J., 1989, MOL CLONING LAB MANU, P116; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Sekiguchi M, 1996, GENES CELLS, V1, P139, DOI 10.1046/j.1365-2443.1996.d01-232.x; Setoyama D, 2011, MUTAT RES-FUND MOL M, V707, P9, DOI 10.1016/j.mrfmmm.2010.12.001; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Willemoes M, 2005, ARCH BIOCHEM BIOPHYS, V444, P195, DOI 10.1016/j.abb.2005.10.003	30	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8128	8135		10.1074/jbc.M112.418723	http://dx.doi.org/10.1074/jbc.M112.418723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23376345	hybrid, Green Published			2022-12-28	WOS:000316564500013
J	Chen, RHC; Wislet-Gendebien, S; Samuel, F; Visanji, NP; Zhang, G; Marsilio, D; Langman, T; Fraser, PE; Tandon, A				Chen, Robert H. C.; Wislet-Gendebien, Sabine; Samuel, Filsy; Visanji, Naomi P.; Zhang, Gang; Marsilio, Diana; Langman, Tammy; Fraser, Paul E.; Tandon, Anurag			alpha-Synuclein Membrane Association Is Regulated by the Rab3a Recycling Machinery and Presynaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CSP-ALPHA; DIFFERENTIAL REGULATION; WILD-TYPE; IN-VIVO; DISEASE; BINDING; PROTEIN; DISSOCIATION; PROMOTES; RELEASE	alpha-Synuclein is an abundant presynaptic protein and a primary component of Lewy bodies in Parkinson disease. Although its pathogenic role remains unclear, in healthy nerve terminals alpha-synuclein undergoes a cycle of membrane binding and dissociation. An alpha-synuclein binding assay was used to screen for vesicle proteins involved in alpha-synuclein membrane interactions and showed that antibodies directed to the Ras-related GTPase Rab3a and its chaperone RabGDI abrogated alpha-synuclein membrane binding. Biochemical analyses, including density gradient sedimentation and co-immunoprecipitation, suggested that alpha-synuclein interacts with membrane-associated GTP-bound Rab3a but not to cytosolic GDP-Rab3a. Accumulation of membrane-bound alpha-synuclein was induced by the expression of a GTPase-deficient Rab3a mutant, by a dominant-negative GDP-dissociation inhibitor mutant unable to recycle Rab3a off membranes, and by Hsp90 inhibitors, radicicol and geldanamycin, which are known to inhibit Rab3a dissociation from membranes. Thus, all treatments that inhibited Rab3a recycling also increased alpha-synuclein sequestration on intracellular membranes. Our results suggest that membrane-bound GTP-Rab3a stabilizes alpha-synuclein on synaptic vesicles and that the GDP dissociation inhibitor.Hsp90 complex that controls Rab3 a membrane dissociation also regulates alpha-synuclein dissociation during synaptic activity.	[Chen, Robert H. C.; Wislet-Gendebien, Sabine; Samuel, Filsy; Visanji, Naomi P.; Zhang, Gang; Marsilio, Diana; Langman, Tammy; Fraser, Paul E.; Tandon, Anurag] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; [Tandon, Anurag] Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada	University of Toronto; University of Toronto; University of Toronto	Tandon, A (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent West, Toronto, ON M5S 3H2, Canada.	a.tandon@utoronto.ca	Visanji, Naomi P/AAW-4618-2021; Chen, Robert HC/K-9348-2019	Chen, Robert HC/0000-0003-3141-7637; Visanji, Naomi/0000-0001-5968-7845; wislet, sabine/0000-0003-4279-9669	Canadian Institutes of Health Research Operating Grants [MOP 84501, MOP 115056]; Parkinson Society of Canada operating grant; Canadian Institutes of Health Research; Edmond J. Safra Foundation; Parkinson's Society of Canada	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Parkinson Society of Canada operating grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Edmond J. Safra Foundation; Parkinson's Society of Canada	This work was supported in part by Canadian Institutes of Health Research Operating Grants MOP 84501 (to A. T.) and MOP 115056 (to P. E. F.) and a Parkinson Society of Canada operating grant (to A. T.).; Supported by fellowships from the Canadian Institutes of Health Research.; Supported by a fellowship from the Edmond J. Safra Foundation.; Supported by a fellowship from the Parkinson's Society of Canada.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen CY, 2005, METHOD ENZYMOL, V403, P339, DOI 10.1016/S0076-6879(05)03029-6; Chen FS, 2003, J BIOL CHEM, V278, P19974, DOI 10.1074/jbc.M210049200; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dalfo E, 2004, NEUROBIOL DIS, V16, P92, DOI 10.1016/j.nbd.2004.01.001; Dalfo E, 2005, NEUROSCI LETT, V380, P170, DOI 10.1016/j.neulet.2005.01.034; Dalfo E, 2004, J NEUROPATH EXP NEUR, V63, P302, DOI 10.1093/jnen/63.4.302; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo E, 2004, EUR J BIOCHEM, V271, P3180, DOI 10.1111/j.1432-1033.2004.04250.x; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lang Thorsten, 2008, V184, P107; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Luan P, 2000, TRAFFIC, V1, P270, DOI 10.1034/j.1600-0854.2000.010309.x; Luan P, 1999, J BIOL CHEM, V274, P14806, DOI 10.1074/jbc.274.21.14806; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; MUSHA T, 1992, J BIOL CHEM, V267, P9821; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Scott D, 2012, J NEUROSCI, V32, P10129, DOI 10.1523/JNEUROSCI.0535-12.2012; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Visanji NP, 2011, J BIOL CHEM, V286, P35863, DOI 10.1074/jbc.M111.253450; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wislet-Gendebien S, 2006, J BIOL CHEM, V281, P32148, DOI 10.1074/jbc.M605965200; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	63	71	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7438	7449		10.1074/jbc.M112.439497	http://dx.doi.org/10.1074/jbc.M112.439497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23344955	hybrid, Green Published			2022-12-28	WOS:000316455300002
J	Roedel, EK; Schwarz, E; Kanse, SM				Roedel, Elfie Kathrin; Schwarz, Elisabeth; Kanse, Sandip Madhav			The Factor VII-activating Protease (FSAP) Enhances the Activity of Bone Morphogenetic Protein-2 (BMP-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARBURG-I POLYMORPHISM; TGF-BETA; PLASMINOGEN-ACTIVATOR; CELL-PROLIFERATION; GROWTH; CALCIFICATION; RECEPTOR; DIFFERENTIATION; EXPRESSION; HEPARIN	Factor VII-activating protease (FSAP) is a circulating protease involved in the pathogenesis of atherosclerosis, calcification, and fibrotic processes. To understand how FSAP controls the balance of local growth factors, we have investigated its effect on the regulation of bone morphogenetic proteins (BMPs). BMP-2 is produced as a large pro-form and secreted as a mature heparin-binding growth factor after intracellular processing by proprotein convertases (PCs). In this study, we discovered that FSAP enhances the biological activity of mature BMP-2 as well as its pro-form, as shown by osteogenic differentiation of C2C12 myoblasts. These findings were complemented by knockdown of FSAP in hepatocytes, which revealed BMP-2 processing by endogenous FSAP. N-terminal sequencing indicated that pro-BMP-2 was cleaved by FSAP at the canonical PC cleavage site, giving rise to mature BMP-2 (Arg(282) down arrow Gln(283)), as well as in the N-terminal heparin binding region of mature BMP-2, generating a truncated mature BMP-2 peptide (Arg(289) down arrow Lys(290)). Similarly, mature BMP-2 was also cleaved to a truncated peptide within its N-terminal region (Arg(289) down arrow Lys(290)). Plasmin exhibited a similar activity, but it was weaker compared with FSAP. Thrombin, Factor VIIa, Factor Xa, and activated protein C were not effective. These results were further supported by the observation that the mutation of the heparin binding region of BMP-2 inhibited the processing by FSAP but not by PC. Thus, the proteolysis and activation of pro-BMP-2 and mature BMP-2 by FSAP can regulate cell differentiation and calcification in vasculature and may explain why polymorphisms in the gene encoding for FSAP are related to vascular diseases.	[Roedel, Elfie Kathrin; Kanse, Sandip Madhav] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Schwarz, Elisabeth] Univ Halle Wittenberg, D-06108 Halle, Germany; [Kanse, Sandip Madhav] Univ Oslo, Inst Basic Med Sci, Dept Biochem, N-0372 Oslo, Norway	Justus Liebig University Giessen; Martin Luther University Halle Wittenberg; University of Oslo	Kanse, SM (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biochem, Sognsvannsveien 9, N-0372 Oslo, Norway.	sandip.kanse@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018	Kanse, Sandip/0000-0003-0782-9957	Deutsche Forschungsgemeinschaft Grant [Ka 1468]; Excellence Cluster in Cardiopulmonary Sciences (ECCPS); Behring Rontgen Stiftung (BRS)	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Excellence Cluster in Cardiopulmonary Sciences (ECCPS)(German Research Foundation (DFG)); Behring Rontgen Stiftung (BRS)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Ka 1468 and grants from the Excellence Cluster in Cardiopulmonary Sciences (ECCPS) and the Behring Rontgen Stiftung (BRS) (to S. M. K.).	Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Borkham-Kamphorst E, 2013, J HEPATOL, V58, P104, DOI 10.1016/j.jhep.2012.09.007; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Chu TM, 1998, BIOCHEM BIOPH RES CO, V253, P128, DOI 10.1006/bbrc.1998.9760; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Etscheid M, 2004, EUR J CELL BIOL, V82, P597, DOI 10.1078/0171-9335-00349; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gardener H, 2011, STROKE, V42, P889, DOI 10.1161/STROKEAHA.110.591065; Harrison CA, 2011, GROWTH FACTORS, V29, P174, DOI 10.3109/08977194.2011.608666; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200; Hurst NJ, 2012, BIOCHEM J, V441, P909, DOI 10.1042/BJ20111020; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Ishisaki A, 2006, CURR PHARM DESIGN, V12, P877, DOI 10.2174/138161206776056083; Israel DI, 1992, GROWTH FACTORS, V7, P139, DOI 10.3109/08977199209046403; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Kannemeier C, 2004, FASEB J, V18, P728, DOI 10.1096/fj.03-0898fje; Kannemeier C, 2001, EUR J BIOCHEM, V268, P3789, DOI 10.1046/j.1432-1327.2001.02285.x; Kanse SM, 2011, HAMOSTASEOLOGIE, V31, P174, DOI 10.5482/ha-1159; Kanse SM, 1997, ARTERIOSCL THROM VAS, V17, P2848, DOI 10.1161/01.ATV.17.11.2848; Kanse SM, 2004, J CELL SCI, V117, P477, DOI 10.1242/jcs.00861; Kanzaki S, 2011, PHARMACOL REP, V63, P1222, DOI 10.1016/S1734-1140(11)70642-9; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Kuhfahl S, 2011, BIOCHEM BIOPH RES CO, V408, P300, DOI 10.1016/j.bbrc.2011.04.021; Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z; Lories RJU, 2003, ARTHRITIS RHEUM, V48, P2807, DOI 10.1002/art.11389; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meleady P, 2008, PROTEOMICS, V8, P2611, DOI 10.1002/pmic.200700854; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Muhl L, 2009, FEBS J, V276, P4828, DOI 10.1111/j.1742-4658.2009.07183.x; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Posner BI, 2010, PROG BRAIN RES, V181, P1, DOI 10.1016/S0079-6123(08)81001-1; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P433, DOI 10.1097/00001721-200207000-00008; Romisch J, 2002, BIOL CHEM, V383, P1119, DOI 10.1515/BC.2002.121; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sedding D, 2006, J EXP MED, V203, P2801, DOI 10.1084/jem.20052546; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Sopory S, 2010, DEV BIOL, V346, P102, DOI 10.1016/j.ydbio.2010.07.019; Stephan F, 2011, CRIT CARE, V15, DOI 10.1186/cc10131; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; Trompet S, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/424759; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Willeit J, 2003, CIRCULATION, V107, P667, DOI 10.1161/01.CIR.0000055189.18831.B1; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Zakai NA, 2011, J THROMB HAEMOST, V9, P267, DOI 10.1111/j.1538-7836.2010.04149.x; Zhou AJ, 2012, GROWTH FACTORS, V30, P267, DOI 10.3109/08977194.2012.686497	65	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7193	7203		10.1074/jbc.M112.433029	http://dx.doi.org/10.1074/jbc.M112.433029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341458	Green Published, hybrid			2022-12-28	WOS:000316002400040
J	Dejima, K; Kleinschmit, A; Takemura, M; Choi, PY; Kinoshita-Toyoda, A; Toyoda, H; Nakato, H				Dejima, Katsufumi; Kleinschmit, Adam; Takemura, Masahiko; Choi, Pui Yee; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Nakato, Hiroshi			The Role of Drosophila Heparan Sulfate 6-O-Endosulfatase in Sulfation Compensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE PROTEOGLYCAN; MORPHOGEN GRADIENT FORMATION; CUBITUS-INTERRUPTUS PROTEIN; HEDGEHOG; DPP; BINDING; QSULF1; GENES; ENDOSULFATASE; SPECIFICITY	The biosynthesis of heparan sulfate proteoglycans is tightly regulated by multiple feedback mechanisms, which support robust developmental systems. One of the regulatory network systems controlling heparan sulfate (HS) biosynthesis is sulfation compensation. A previous study using Drosophila HS 2-O- and 6-O-sulfotransferase (Hs2st and Hs6st) mutants showed that loss of sulfation at one position is compensated by increased sulfation at other positions, supporting normal FGF signaling. Here, we show that HS sulfation compensation rescues both Decapentaplegic and Wingless signaling, suggesting a universal role of this regulatory system in multiple pathways in Drosophila. Furthermore, we identified Sulf1, extracellular HS6-O-endosulfatase, as a novel component of HS sulfation compensation. Simultaneous loss of Hs2st and Sulf1 ledto6-O-oversulfation, leading to patterning defects, overgrowth, and lethality. These phenotypes are caused at least partly by abnormal up-regulation of Hedgehog signaling. Thus, sulfation compensation depends on the coordinated activities of Hs2st, Hs6st, and Sulf1.	[Dejima, Katsufumi; Kleinschmit, Adam; Takemura, Masahiko; Choi, Pui Yee; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao] Ritsumeikan Univ, Fac Pharmaceut Sci, Shiga 5258577, Japan	University of Minnesota System; University of Minnesota Twin Cities; Ritsumeikan University	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Takemura, Masahiko/0000-0003-3984-4481	National Institutes of Health [R01 HD042769]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD042769 (to H. N.).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Burke R, 1996, DEVELOPMENT, V122, P2261; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Fujise M, 2001, DEV BIOL, V235, P433, DOI 10.1006/dbio.2001.0290; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Isidor B, 2010, AM J HUM GENET, V87, P95, DOI 10.1016/j.ajhg.2010.05.012; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kamimura K, 2011, GLYCOBIOLOGY, V21, P607, DOI 10.1093/glycob/cwq202; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kleinschmit A, 2010, DEV BIOL, V345, P204, DOI 10.1016/j.ydbio.2010.07.006; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lander D, 2007, B MATH BIOL, V69, P33, DOI 10.1007/s11538-006-9152-2; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Merry CLR, 2002, BBA-GEN SUBJECTS, V1573, P319, DOI 10.1016/S0304-4165(02)00399-9; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Townley RA, 2011, J BIOL CHEM, V286, P16824, DOI 10.1074/jbc.M111.227926; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wojcinski A, 2011, DEV BIOL, V358, P168, DOI 10.1016/j.ydbio.2011.07.027; You J, 2011, DEV DYNAM, V240, P640, DOI 10.1002/dvdy.22562; Yu K, 1996, DEVELOPMENT, V122, P4033	44	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6574	6582		10.1074/jbc.M112.404830	http://dx.doi.org/10.1074/jbc.M112.404830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23339195	Green Published, hybrid			2022-12-28	WOS:000315820700050
J	Basak, S; Lim, J; Manimekalai, MSS; Balakrishna, AM; Gruber, G				Basak, Sandip; Lim, Jackwee; Manimekalai, Malathy Sony Subramanian; Balakrishna, Asha Manikkoth; Grueber, Gerhard			Crystal and NMR Structures Give Insights into the Role and Dynamics of Subunit F of the Eukaryotic V-ATPase from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR-TYPE ATPASE; H+-ATPASE; CENTRAL STALK; COUPLING SUBUNIT; PERIPHERAL STALK; TERMINAL DOMAIN; V1VO ATPASE; V-1 ATPASE; SYNTHASE; COMPLEX	Subunit F of V-ATPases is proposed to undergo structural alterations during catalysis and reversible dissociation from the V1VO complex. Recently, we determined the low resolution structure of F from Saccharomyces cerevisiae V-ATPase, showing an N-terminal egg shape, connected to a C-terminal hook-like segment via a linker region. To understand the mechanistic role of subunit F of S. cerevisiae V-ATPase, composed of 118 amino acids, the crystal structure of the major part of F, F(1-94), was solved at 2.3 angstrom resolution. The structural features were confirmed by solution NMR spectroscopy using the entire F subunit. The eukaryotic F subunit consists of the N-terminal F(1-94) domain with four-parallel beta-strands, which are intermittently surrounded by four alpha-helices, and the C terminus, including the alpha 5-helix encompassing residues 103 to 113. Two loops (26)GQITPETQEK(35) and (ERDDI64)-E-60 are described to be essential in mechanistic processes of the V-ATPase enzyme. The (26)GQITPETQEK(35) loop becomes exposed when fitted into the recently determined EM structure of the yeast V1VO-ATPase. A mechanism is proposed in which the (26)GQITPETQEK(35) loop of subunit F and the flexible C-terminal domain of subunit H move in proximity, leading to an inhibitory effect of ATPase activity in V-1. Subunits D and F are demonstrated to interact with subunit d. Together with NMR dynamics, the role of subunit F has been discussed in the light of its interactions in the processes of reversible disassembly and ATP hydrolysis of V-ATPases by transmitting movements of subunit d and H of the V-O and V-1 sector, respectively.	[Basak, Sandip; Lim, Jackwee; Manimekalai, Malathy Sony Subramanian; Balakrishna, Asha Manikkoth; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg	Manikkoth Balakrishna, Asha/AFP-1973-2022; Basak, sandip/B-8007-2018	Manikkoth Balakrishna, Asha/0000-0001-5239-9015; Basak, sandip/0000-0003-4018-8020; Lim, Jackwee/0000-0003-4344-6822	A*STAR Biomedical Research Council [09/1/22/19/609]; Nanyang Technological University; National Research Program for Genomic Medicine	A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Nanyang Technological University(Nanyang Technological University); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This work was supported by A*STAR Biomedical Research Council Grant 09/1/22/19/609.; Supported by a Nanyang Technological University research scholarship.; We thank the staff at beamline 13B1 at National Synchrotron Radiation Research Centre, a national user facility supported by the National Science Council of Taiwan, for expert help with data collection. The Synchrotron Radiation Protein Crystallography Facility at the National Synchrotron Radiation Research Centre is supported by the National Research Program for Genomic Medicine. We thank Professor M. Featherstone (SBS, NTU) for reading the manuscript.	Armbruster A, 2004, FEBS LETT, V570, P119, DOI 10.1016/j.febslet.2004.06.029; Balakrishna AM, 2012, J MOL BIOL, V420, P155, DOI 10.1016/j.jmb.2012.04.012; Basak S, 2012, ACTA CRYSTALLOGR F, V68, P1055, DOI 10.1107/S1744309112032526; Basak S, 2011, BBA-BIOMEMBRANES, V1808, P360, DOI 10.1016/j.bbamem.2010.09.003; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Boniecki MT, 2012, J BIOL CHEM, V287, P11285, DOI 10.1074/jbc.C111.325795; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Coskun U, 2004, J BIOENERG BIOMEMBR, V36, P249, DOI 10.1023/B:JOBB.0000031976.44466.6e; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gayen S, 2007, BIOCHEMISTRY-US, V46, P11684, DOI 10.1021/bi701102n; Goddard T., 1997, SPARKY VERSION 3; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Hosokawa H, 2013, J BIOL CHEM, V288, P5896, DOI 10.1074/jbc.M112.409169; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar A, 2010, J MOL BIOL, V396, P301, DOI 10.1016/j.jmb.2009.11.046; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Raghunathan D, 2010, BIOCHEMISTRY-US, V49, P4181, DOI 10.1021/bi9021236; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P447, DOI 10.1007/s10863-011-9379-y; Rishikesan S, 2010, BBA-BIOMEMBRANES, V1798, P1961, DOI 10.1016/j.bbamem.2010.06.012; Rishikesan S, 2009, BBA-BIOENERGETICS, V1787, P242, DOI 10.1016/j.bbabio.2009.01.010; Rusu M, 2008, BIOINFORMATICS, V24, P2460, DOI 10.1093/bioinformatics/btn461; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thaker YR, 2007, J BIOENERG BIOMEMBR, V39, P275, DOI 10.1007/s10863-007-9089-7; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	57	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11930	11939		10.1074/jbc.M113.461533	http://dx.doi.org/10.1074/jbc.M113.461533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23476018	hybrid, Green Published			2022-12-28	WOS:000318157600028
J	Hu, HY; Li, SQ; Cui, XY; Lv, XB; Jiao, Y; Yu, FY; Yao, HR; Song, EW; Chen, YS; Wang, MH; Lin, L				Hu, Haiyan; Li, Shuqin; Cui, Xiuying; Lv, Xiaobin; Jiao, Yu; Yu, Fengyan; Yao, Herui; Song, Erwei; Chen, Yongsong; Wang, Minghui; Lin, Ling			The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNAS; EXPRESSION; CHEMORESISTANCE; PROMOTES; CARCINOMA; PROTEIN; DRUG	MicroRNAs are involved in regulating the biology of cancer cells, but their involvement in chemoresistance is not fully understood. We found that miR-663 was up-regulated in our induced multidrug-resistant MDA-MB-231/ADM cell line and that this up-regulation was closely related to chemosensitivity. In the present study, we aimed to clarify the role of miR-663 in regulating the chemoresistance of breast cancer. MicroRNA microarray and quantitative RT-PCR assays were used to identify differentially expressed microRNAs. Cell apoptosis was evaluated by annexin V/propidium iodide staining, TUNEL, and reactive oxygen species generation analysis. The expression of miR-663 and HSPG2 in breast cancer tissues was detected by in situ hybridization and immunohistochemistry. The potential targets of miR-663 were defined by a luciferase reporter assay. Bisulfite sequencing PCR was used to analyze the methylation status. We found that miR-663 was significantly elevated in MDA-MB-231/ADM cells, and the down-regulation of miR-663 sensitized MDA-MB-231/ADM cells to both cyclophosphamide and docetaxel. The overexpression of miR-663 in breast tumor tissues was associated with chemoresistance; in MDA-MB-231 cells, this chemoresistance was accompanied by the down-regulation of HSPG2, which was identified as a target of miR-663. MDA-MB-231/ADM contained fewer methylated CpG sites than its parental cell line, and miR-663 expression in MDA-MB-231 cells was reactivated by 5-aza-29-deoxycytidine treatment, indicating that DNA methylation may play a functional role in the expression of miR-663. Our findings suggest that the over-expression of hypomethylated miR-663 induced chemoresistance in breast cancer cells by down-regulating HSPG2, thus providing a potential target for the development of an microRNA-based approach for breast cancer therapy.	[Hu, Haiyan; Li, Shuqin; Jiao, Yu; Yu, Fengyan; Yao, Herui; Song, Erwei] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Cui, Xiuying; Lv, Xiaobin] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Sun Yat Sen Mem Hosp, Guangdong Higher Educ Inst, Guangzhou 510120, Peoples R China; [Wang, Minghui] Sun Yat Sen Univ, Dept Cardiothorac Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Chen, Yongsong; Lin, Ling] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou 515041, Guangdong, Peoples R China; [Hu, Haiyan; Song, Erwei] Shanghai Jiao Tong Univ, Dept Oncol, Peoples Hosp 6, Shanghai 200233, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shantou University; Shanghai Jiao Tong University	Chen, YS (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	yongsongchen@126.com; wangminghui01@yahoo.com.cn; llinc@163.net	Lv, Xiao-Bin/T-7607-2019	Lin, Ling/0000-0001-5603-0688; Chen, Yongsong/0000-0002-8208-4951	973 Projects from the Ministry of Science and Technology of China [2010CB912800, 2011CB504203]; National Science Foundation of China [81230060, 81261140373, 81072176, 81072177, 30800486]; Foundation of Ministry of Education of the People's Republic of China [20120171110075]; Science Foundation of Guangdong Province [S2012030006287]; China Postdoctoral Science Foundation [201003379, 201104379]; Guangdong Natural Science Foundation [10151503102000019]; Science and Technology Foundation of the Guangdong Province [2008B030301238, 2008B030301243]; National S&T Major Special Project on New Drug Innovation of China [2011ZX09102-010-02]	973 Projects from the Ministry of Science and Technology of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Ministry of Education of the People's Republic of China(Ministry of Education, China); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Foundation of the Guangdong Province; National S&T Major Special Project on New Drug Innovation of China	This work was supported by 973 Projects from the Ministry of Science and Technology of China Grants 2010CB912800 and 2011CB504203; National Science Foundation of China Grants 81230060, 81261140373, 81072176, 81072177, and 30800486; National S&T Major Special Project on New Drug Innovation of China Grant 2011ZX09102-010-02; Foundation of Ministry of Education of the People's Republic of China Grant 20120171110075; Science Foundation of Guangdong Province Grant S2012030006287; the special financial grant from the China Postdoctoral Science Foundation (Grants 201003379 and 201104379); Guangdong Natural Science Foundation Grant 10151503102000019; and Science and Technology Foundation of the Guangdong Province Grants 2008B030301238 and 2008B030301243.	Amant F, 2010, EUR J CANCER, V46, P3158, DOI 10.1016/j.ejca.2010.09.010; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Duarte IL, 2012, BREAST, V21, P343, DOI 10.1016/j.breast.2012.02.011; Elhassan MO, 2012, J BIOL CHEM, V287, P5267, DOI 10.1074/jbc.M111.318865; Gogna R, 2012, J BIOL CHEM, V287, P2907, DOI 10.1074/jbc.M111.317354; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Krell J, 2012, PHARMACOGENOMICS, V13, P709, DOI [10.2217/PGS.12.15, 10.2217/pgs.12.15]; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma KL, 2012, J BIOL CHEM, V287, P5639, DOI 10.1074/jbc.M111.291229; Majumder S, 2011, GENE EXPRESSION, V15, P141, DOI 10.3727/105221611X13176664479287; Naci D, 2012, J BIOL CHEM, V287, P17065, DOI 10.1074/jbc.M112.349365; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Stark M, 2011, J BIOL CHEM, V286, P3741, DOI 10.1074/jbc.M110.163444; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Zhu YH, 2011, CLIN CANCER RES, V17, P7105, DOI 10.1158/1078-0432.CCR-11-0071	23	93	95	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10973	10985		10.1074/jbc.M112.434340	http://dx.doi.org/10.1074/jbc.M112.434340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23436656	Green Published, hybrid			2022-12-28	WOS:000317915500004
J	Suzuki, M; Takaishi, S; Nagasaki, M; Onozawa, Y; Iino, I; Maeda, H; Komai, T; Oda, T				Suzuki, Masakatsu; Takaishi, Sachiko; Nagasaki, Miyuki; Onozawa, Yoshiko; Iino, Ikue; Maeda, Hiroaki; Komai, Tomoaki; Oda, Tomiichiro			Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; INFLAMMATORY CHANGES; INSULIN-RESISTANCE; ALPHA; ADIPOCYTES; LIPOLYSIS; GPR120; DEORPHANIZATION; CHROMATOGRAPHY; PROPIONATE	G protein-coupled receptor 84 (GPR84) is a putative receptor for medium-chain fatty acids (MCFAs), whose pathophysiological roles have not yet been clarified. Here, we show that GPR84 was activated by MCFAs with the hydroxyl group at the 2- or 3-position more effectively than nonhydroxylated MCFAs. We also identified a surrogate agonist, 6-n-octylaminouracil (6-OAU), for GPR84. These potential ligands and the surrogate agonist, 6-OAU, stimulated [S-35]GTP binding and accumulated phosphoinositides in a GPR84-dependent manner. The surrogate agonist, 6-OAU, internalized GPR84-EGFP from the cell surface. Both the potential ligands and 6-OAU elicited chemotaxis of human polymorphonuclear leukocytes (PMNs) and macrophages and amplified LPS-stimulated production of the proinflammatory cytokine IL-8 from PMNs and TNF alpha from macrophages. Furthermore, the intravenous injection of 6-OAU raised the blood CXCL1 level in rats, and the inoculation of 6-OAU into the rat air pouch accumulated PMNs and macrophages in the site. Our results indicate a proinflammatory role of GPR84, suggesting that the receptor may be a novel target to treat chronic low grade inflammation associated-disease.	[Suzuki, Masakatsu; Nagasaki, Miyuki; Onozawa, Yoshiko; Maeda, Hiroaki; Komai, Tomoaki] Daiichi Sankyo Co Ltd, Frontier Res Labs, Tokyo 140871, Japan; [Takaishi, Sachiko] Daiichi Sankyo Co Ltd, Oncol Res Labs, Tokyo 140871, Japan; [Oda, Tomiichiro] Daiichi Sankyo Co Ltd, R&D Adm & Support Dept, R&D Div, Tokyo 140871, Japan; [Iino, Ikue] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Tokyo 1408710, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Suzuki, M (corresponding author), Daiichi Sankyo Co Ltd, Frontier Res Labs, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan.	suzuki.masakatsu.mr@daiichisankyo.co.jp						Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Bouchard C, 2007, GLIA, V55, P790, DOI 10.1002/glia.20506; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Costa CG, 1998, CLIN CHEM, V44, P463; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Guo L, 2012, J LIPID RES, V53, P1327, DOI 10.1194/jlr.M025742; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jones PM, 2011, BBA-MOL CELL BIOL L, V1811, P657, DOI 10.1016/j.bbalip.2011.06.026; KIMACHI T, 1991, J HETEROCYCLIC CHEM, V28, P439, DOI 10.1002/jhet.5570280244; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Nagasaki H, 2012, FEBS LETT, V586, P368, DOI 10.1016/j.febslet.2012.01.001; Nakagawa H, 1996, BIOCHEM BIOPH RES CO, V220, P945, DOI 10.1006/bbrc.1996.0511; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; PARLESAK A, 1995, J CHROMATOGR A, V711, P277, DOI 10.1016/0021-9673(95)00518-R; Rodrigues HG, 2010, LIPIDS, V45, P809, DOI 10.1007/s11745-010-3461-9; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; SHIBATA F, 1995, EUR J BIOCHEM, V231, P306, DOI 10.1111/j.1432-1033.1995.tb20701.x; Soydan AS, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/64980; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Takeda S, 2003, LIFE SCI, V74, P367, DOI 10.1016/j.lfs.2003.09.030; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045	41	128	137	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10684	10691		10.1074/jbc.M112.420042	http://dx.doi.org/10.1074/jbc.M112.420042			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23449982	Green Published, hybrid			2022-12-28	WOS:000317565000046
J	Wang, J; Wang, YL; Wang, Y; Ma, Y; Lan, Y; Yang, X				Wang, Jun; Wang, Youliang; Wang, Yu; Ma, Ying; Lan, Yu; Yang, Xiao			Transforming Growth Factor beta-regulated MicroRNA-29a Promotes Angiogenesis through Targeting the Phosphatase and Tensin Homolog in Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; PTEN; OVEREXPRESSION; ACTIVATION; REVEALS; MALFORMATIONS; HEMATOPOIESIS; SUPPRESSION; MECHANISMS; INTEGRITY	The TGF-beta pathway plays an important role in physiological and pathological angiogenesis. MicroRNAs (miRNAs) are a class of 18- to 25-nucleotide, small, noncoding RNAs that function by regulating gene expression. A number of miRNAs have been found to be regulated by the TGF-beta pathway. However, the role of endothelial miRNAs in the TGF-beta-mediated control of angiogenesis is still largely unknown. Here we investigated the regulation of endothelial microRNA-29a (miR-29a) by TGF-beta signaling and the potential role of miR-29a in angiogenesis. MiR-29a was directly up-regulated by TGF-beta/Smad4 signaling in human and mice endothelial cells. In a chick chorioallantoic membrane assay, miR-29a overexpression promoted the formation of new blood vessels, and miR-29a suppression completely blocked TGF-beta 1-stimulated angiogenesis. Consistently, miR-29a overexpression increased tube formation and migration in endothelial cultures. Mechanistically, miR-29a directly targeted the phosphatase and tensin homolog (PTEN) in endothelial cells, leading to activation of the AKT pathway. PTEN knockdown recapitulated the role of miR-29a in endothelial migration, whereas AKT inhibition completely attenuated the stimulating role of miR-29a in angiogenesis. Taken together, these results reveal a crucial role of a TGF-beta-regulated miRNA in promoting angiogenesis by targeting PTEN to stimulate AKT activity.	[Wang, Jun; Wang, Youliang; Wang, Yu; Ma, Ying; Lan, Yu; Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [Yang, Xiao] Shanghai Jiao Tong Univ, Model Organism Div, E Inst Shanghai Univ, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Lan, Y (corresponding author), Inst Biotechnol, State Key Lab Prote, Genet Lab Dev & Dis, Beijing 100071, Peoples R China.	rainyblue_1999@yahoo.com; yangx@bmi.ac.cn	Lan, Yu/AAV-2236-2021	Lan, Yu/0000-0002-4731-5945; Yang, Xiao/0000-0002-0298-9831; Wang, Jun/0000-0001-6498-0675	Chinese National Key Program on Basic Research [2012CB945103, 2011CB964803, 2011CB504202]; National Natural Science Foundation of China [31030040, 31171410]; State Key Laboratory of Proteomics [SKLP-K201102]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Proteomics	This work was supported by Chinese National Key Program on Basic Research Grants 2012CB945103, 2011CB964803, and 2011CB504202; by National Natural Science Foundation of China Grants 31030040 and 31171410; and by State Key Laboratory of Proteomics Grant SKLP-K201102.	Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Chow JYC, 2008, CANCER BIOL THER, V7, P1694, DOI 10.4161/cbt.7.10.6665; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Chow JYC, 2010, AM J PHYSIOL-GASTR L, V298, pG275, DOI 10.1152/ajpgi.00344.2009; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Lenato GM, 2006, CURR PHARM DESIGN, V12, P1173, DOI 10.2174/138161206776361291; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Muramatsu F, 2013, ONCOGENE, V32, P414, DOI 10.1038/onc.2012.68; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Perry B, 2007, ARCH DERMATOL, V143, P504, DOI 10.1001/archderm.143.4.504; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; Wang F, 2012, MOL BIOL REP, V39, P2713, DOI 10.1007/s11033-011-1026-5; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu YH, 2011, BLOOD, V118, P2896, DOI 10.1182/blood-2011-01-330589; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yang X, 1999, DEVELOPMENT, V126, P1571; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	62	61	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10418	10426		10.1074/jbc.M112.444463	http://dx.doi.org/10.1074/jbc.M112.444463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426367	Green Published, hybrid			2022-12-28	WOS:000317565000022
J	Batra, J; Szabo, A; Caulfield, TR; Soares, AS; Sahin-Toth, M; Radisky, ES				Batra, Jyotica; Szabo, Andras; Caulfield, Thomas R.; Soares, Alexei S.; Sahin-Toth, Miklos; Radisky, Evette S.			Long-range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; PROTEIN INHIBITOR COMPLEXES; CIS-TRANS ISOMERIZATION; EGLIN-C; CHRONIC-PANCREATITIS; MOLECULAR-STRUCTURE; SUBTILISIN CARLSBERG; CRYSTAL-STRUCTURE; SERINE PROTEASES; HEREDITARY PANCREATITIS	Human chymotrypsin C (CTRC) is a pancreatic serine protease that regulates activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors. In cleaving these regulatory sites, which are characterized by multiple flanking acidic residues, CTRC shows substrate specificity that is distinct from that of other isoforms of chymotrypsin and elastase. Here, we report the first crystal structure of active CTRC, determined at 1.9-angstrom resolution, revealing the structural basis for binding specificity. The structure shows human CTRC bound to the small protein protease inhibitor eglin c, which binds in a substrate-like manner filling the S-6-S-5' subsites of the substrate binding cleft. Significant binding affinity derives from burial of preferred hydrophobic residues at the P-1, P-4, and P-2' positions of CTRC, although acidic P-2' residues can also be accommodated by formation of an interfacial salt bridge. Acidic residues may also be specifically accommodated in the P-6 position. The most unique structural feature of CTRC is a ring of intense positive electrostatic surface potential surrounding the primarily hydrophobic substrate binding site. Our results indicate that long-range electrostatic attraction toward substrates of concentrated negative charge governs substrate discrimination, which explains CTRC selectivity in regulating active digestive enzyme levels.	[Batra, Jyotica; Caulfield, Thomas R.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Caulfield, Thomas R.] Mayo Clin, Ctr Canc, Dept Neurosci, Jacksonville, FL 32224 USA; [Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; Mayo Clinic; Boston University; United States Department of Energy (DOE); Brookhaven National Laboratory	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu; radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Soares, Alexei S/F-4800-2014	Radisky, Evette S/0000-0003-3121-109X; Soares, Alexei S/0000-0002-6565-8503; Caulfield, Thomas/0000-0002-1055-3069; Sahin-Toth, Miklos/0000-0003-4513-9922	Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; National Institutes of Health [R01 DK082412-S2, R01 DK082412, R01 DK058088, R01 DK095753]; Florida Department of Health Postdoctoral Fellowship [1BD-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095753, R01DK058088, R01DK082412] Funding Source: NIH RePORTER	Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Diffraction data were measured at beamline X29 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy, and the National Center for Research Resources of the National Institutes of Health.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082412-S2 (ARRA), R01 DK082412, R01 DK058088, and R01 DK095753 (to M. S.-T.) and Florida Department of Health Postdoctoral Fellowship 1BD-01 (to J. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; Bence M, 2011, FEBS J, V278, P4338, DOI 10.1111/j.1742-4658.2011.08351.x; BIRKTOFT JJ, 1976, BIOCHEMISTRY-US, V15, P4481, DOI 10.1021/bi00665a023; BODE W, 1986, EMBO J, V5, P813, DOI 10.1002/j.1460-2075.1986.tb04286.x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; FRIGERIO F, 1992, J MOL BIOL, V225, P107, DOI 10.1016/0022-2836(92)91029-O; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; Grocock CJ, 2010, GUT, V59, P357, DOI 10.1136/gut.2009.186817; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HEINZ DW, 1992, BIOCHEMISTRY-US, V31, P8755, DOI 10.1021/bi00152a011; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Kardos J, 1999, BIOCHEMISTRY-US, V38, P12248, DOI 10.1021/bi990764v; Koch U, 2001, BIOCHEMISTRY-US, V40, P631, DOI 10.1021/bi002160t; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Loving K, 2009, J COMPUT AID MOL DES, V23, P541, DOI 10.1007/s10822-009-9268-1; Lu WY, 1999, CHEM BIOL, V6, P419, DOI 10.1016/S1074-5521(99)80060-X; Lu WY, 2000, BIOCHEMISTRY-US, V39, P3575, DOI 10.1021/bi992292q; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCPHALEN CA, 1985, P NATL ACAD SCI USA, V82, P7242, DOI 10.1073/pnas.82.21.7242; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; MCPHALEN CA, 1985, FEBS LETT, V188, P55, DOI 10.1016/0014-5793(85)80873-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTZEN DE, 1995, BIOCHEMISTRY-US, V34, P13051, DOI 10.1021/bi00040a016; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pasternak A, 1999, PROTEIN SCI, V8, P253; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POLAK E, 1969, REV FR INFORM RECH O, V3, P35; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Salam NK, 2009, J CHEM INF MODEL, V49, P2356, DOI 10.1021/ci900212v; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHIMMEL PR, 1968, J MOL BIOL, V34, P105, DOI 10.1016/0022-2836(68)90237-4; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; SEEMULLER U, 1977, H-S Z PHYSIOL CHEM, V358, P1105, DOI 10.1515/bchm2.1977.358.2.1105; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Wang HB, 2011, ACTA BIOCH BIOPH SIN, V43, P568, DOI 10.1093/abbs/gmr047; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Zhou JY, 2011, J GASTROEN HEPATOL, V26, P1238, DOI 10.1111/j.1440-1746.2011.06791.x	70	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9848	9859		10.1074/jbc.M113.457382	http://dx.doi.org/10.1074/jbc.M113.457382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430245	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000317114000025
J	Eaton, JM; Mullins, GR; Brindley, DN; Harris, TE				Eaton, James M.; Mullins, Garrett R.; Brindley, David N.; Harris, Thurl E.			Phosphorylation of Lipin 1 and Charge on the Phosphatidic Acid Head Group Control Its Phosphatidic Acid Phosphatase Activity and Membrane Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; RAT-LIVER; PHOSPHOLIPID-SYNTHESIS; FATTY-ACIDS; PHOSPHOHYDROLASE; YEAST; PROTEINS; LOCALIZATION; METABOLISM	The lipin gene family encodes a class of Mg2+-dependent phosphatidic acid phosphatases involved in the de novo synthesis of phospholipids and triglycerides. Unlike other enzymes in the Kennedy pathway, lipins are not integral membrane proteins, and they need to translocate from the cytosol to intracellular membranes to participate in glycerolipid synthesis. The movement of lipin 1 within the cell is closely associated with its phosphorylation status. Although cellular analyses have demonstrated that highly phosphorylated lipin 1 is enriched in the cytosol and dephosphorylated lipin 1 is found on membranes, the effects of phosphorylation on lipin 1 activity and binding to membranes has not been recapitulated in vitro. Herein we describe a new biochemical assay for lipin 1 using mixtures of phosphatidic acid (PA) and phosphatidylethanolamine that reflects its physiological activity and membrane interaction. This depends on our observation that lipin 1 binding to PA in membranes is highly responsive to the electrostatic charge of PA. The studies presented here demonstrate that phosphorylation regulates the ability of the polybasic domain of lipin 1 to recognize di-anionic PA and identify mTOR as a crucial upstream signaling component regulating lipin 1 phosphorylation. These results demonstrate how phosphorylation of lipin 1 together with pH and membrane phospholipid composition play important roles in the membrane association of lipin 1 and thus the regulation of its enzymatic activity.	[Eaton, James M.; Mullins, Garrett R.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada	University of Virginia; University of Alberta	Harris, TE (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave,Jordan Hall Rm 5, Charlottesville, VA 22908 USA.	teh3c@virginia.edu			American Diabetes Association [7-11-JF-21]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta; Northwest Territories; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Junior Faculty Grant 7-11-JF-21 (to T. E. H.) and the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Alberta and the Northwest Territories (to D. N. B.).	BOWLEY M, 1977, BIOCHEM J, V165, P447, DOI 10.1042/bj1650447; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Civelek VN, 1996, P NATL ACAD SCI USA, V93, P10139, DOI 10.1073/pnas.93.19.10139; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hofer CT, 2010, METHODS MOL BIOL, V606, P69, DOI 10.1007/978-1-60761-447-0_6; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Liu GH, 2010, BIOCHEM J, V432, P65, DOI 10.1042/BJ20100584; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MARTIN A, 1986, BIOCHIM BIOPHYS ACTA, V876, P581, DOI 10.1016/0005-2760(86)90047-0; MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8; MOLLER F, 1981, CAN J BIOCHEM CELL B, V59, P9, DOI 10.1139/o81-002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Scott PH, 1998, J BIOL CHEM, V273, P34496, DOI 10.1074/jbc.273.51.34496; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR SJ, 1986, BIOCHEM J, V239, P275, DOI 10.1042/bj2390275; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798	45	63	66	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9933	9945		10.1074/jbc.M112.441493	http://dx.doi.org/10.1074/jbc.M112.441493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426360	Green Published, hybrid			2022-12-28	WOS:000317114000033
J	Pozdnyakov, N; Murrey, HE; Crump, CJ; Pettersson, M; Ballard, TE; Ende, CWA; Ahn, K; Li, YM; Bales, KR; Johnson, DS				Pozdnyakov, Nikolay; Murrey, Heather E.; Crump, Christina J.; Pettersson, Martin; Ballard, T. Eric; Ende, Christopher W. Am; Ahn, Kwangwook; Li, Yue-Ming; Bales, Kelly R.; Johnson, Douglas S.			gamma-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; AMYLOID PRECURSOR PROTEIN; ACTIVE-SITE; TRANSMEMBRANE DOMAIN; CLICK CHEMISTRY; MOUSE MODEL; IN-VIVO; INHIBITOR; TARGET; MECHANISM	gamma-Secretase is an intramembrane aspartyl protease that cleaves the amyloid precursor protein to produce neurotoxic beta-amyloid peptides (i.e. A beta 42) that have been implicated in the pathogenesis of Alzheimer disease. Small molecule gamma-secretase modulators (GSMs) have emerged as potential disease-modifying treatments for Alzheimer disease because they reduce the formation of A beta 42 while not blocking the processing of gamma-secretase substrates. We developed clickable GSM photoaffinity probes with the goal of identifying the target of various classes of GSMs and to better understand their mechanism of action. Here, we demonstrate that the photoaffinity probe E2012-BPyne specifically labels the N-terminal fragment of presenilin-1 (PS1-NTF) in cell membranes as well as in live cells and primary neuronal cultures. The labeling is competed in the presence of the parent imidazole GSM E2012, but not with acid GSM-1, allosteric GSI BMS-708163, or substrate docking site peptide inhibitor pep11, providing evidence that these compounds have distinct binding sites. Surprisingly, we found that the cross-linking of E2012-BPyne to PS1-NTF is significantly enhanced in the presence of the active site-directed GSI L-685,458 (L458). In contrast, L458 does not affect the labeling of the acid GSM photoprobe GSM-5. We also observed that E2012-BPyne specifically labels PS1-NTF (active gamma-secretase) but not full-length PS1 (inactive gamma-secretase) in ANP.24 cells. Taken together, our results support the hypothesis that multiple binding sites within the gamma-secretase complex exist, each of which may contribute to different modes of modulatory action. Furthermore, the enhancement of PS1-NTF labeling by E2012-BPyne in the presence of L458 suggests a degree of cooperativity between the active site of gamma-secretase and the modulatory binding site of certain GSMs.	[Pozdnyakov, Nikolay; Murrey, Heather E.; Pettersson, Martin; Ballard, T. Eric; Ende, Christopher W. Am; Bales, Kelly R.; Johnson, Douglas S.] Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA; [Crump, Christina J.; Ahn, Kwangwook; Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Crump, Christina J.; Ahn, Kwangwook; Li, Yue-Ming] Cornell Univ, Dept Pharmacol, Weill Grad Sch Med Sci, New York, NY 10021 USA	Pfizer; Memorial Sloan Kettering Cancer Center; Cornell University	Bales, KR (corresponding author), Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA.	kelly.bales@pfizer.com; doug.johnson@pfizer.com	LI, Yue/GRS-8071-2022		National Institutes of Health [1R01NS076117-01]; Alzheimer Association [IIRG-08-90824]; Institutional Training Grant [T32 GM073546-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Institutional Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01NS076117-01 (to Y. M. L.). This work was also supported by Alzheimer Association Grant IIRG-08-90824 (to Y. M. L.).; Supported by Institutional Training Grant T32 GM073546-01A1.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Barrett PJ, 2011, BIOCHEMISTRY-US, V50, P10328, DOI 10.1021/bi201371j; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; Crump CJ, 2012, BIOORG MED CHEM LETT, V22, P2997, DOI 10.1016/j.bmcl.2012.02.027; Crump CJ, 2011, ACS CHEM NEUROSCI, V2, P705, DOI 10.1021/cn200098p; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eirich J, 2011, J AM CHEM SOC, V133, P12144, DOI 10.1021/ja2039979; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Gillman KW, 2010, ACS MED CHEM LETT, V1, P120, DOI 10.1021/ml1000239; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkins J, 2011, NEURODEGENER DIS, V8, P455, DOI 10.1159/000324511; Jumpertz T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030484; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kreft AF, 2009, J MED CHEM, V52, P6169, DOI 10.1021/jm900188z; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MacKinnon AL, 2007, J AM CHEM SOC, V129, P14560, DOI 10.1021/ja076250y; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Miller DL, 2007, AMYLOID, V14, P39, DOI 10.1080/13506120601116500; Oborski C. E., 2012, NEUROSCI MED, V3, P149; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Pettersson M, 2011, EXPERT OPIN THER PAT, V21, P205, DOI 10.1517/13543776.2011.547479; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Salisbury CM, 2008, J AM CHEM SOC, V130, P2184, DOI 10.1021/ja074138u; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi HB, 2011, CHEM COMMUN, V47, P11306, DOI 10.1039/c1cc14824a; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Van Broeck B, 2011, BRIT J PHARMACOL, V163, P375, DOI 10.1111/j.1476-5381.2011.01207.x; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591	50	83	84	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9710	9720		10.1074/jbc.M112.398602	http://dx.doi.org/10.1074/jbc.M112.398602			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23396974	Green Published, hybrid			2022-12-28	WOS:000317114000013
J	Bektas, M; Jolly, PS; Berkowitz, P; Amagai, M; Rubenstein, DS				Bektas, Meryem; Jolly, Puneet S.; Berkowitz, Paula; Amagai, Masayuki; Rubenstein, David S.			A Pathophysiologic Role for Epidermal Growth Factor Receptor in Pemphigus Acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CARCINOMA-CELL LINE; EGF RECEPTOR; MONOCLONAL-ANTIBODY; HUMAN AUTOANTIBODIES; SIGNAL-TRANSDUCTION; VULGARIS; P38; DESMOGLEIN; INHIBITION	The pemphigus family of autoimmune bullous disorders is characterized by autoantibody binding to desmoglein 1 and/or 3 (dsg1/dsg3). In this study we show that EGF receptor (EGFR) is activated following pemphigus vulgaris (PV) IgG treatment of primary human keratinocytes and that EGFR activation is downstream of p38 mitogen-activated protein kinase (p38). Inhibition of EGFR blocked PV IgG-triggered dsg3 endocytosis, keratin intermediate filament retraction, and loss of cell-cell adhesion in vitro. Significantly, inhibiting EGFR prevented PV IgG-induced blister formation in the passive transfer mouse model of pemphigus. These data demonstrate cross-talk between dsg3 and EGFR, that this cross-talk is regulated by p38, and that EGFR is a potential therapeutic target for pemphigus. Small-molecule inhibitors and monoclonal antibodies directed against EGFR are currently used to treat several types of solid tumors. This study provides the experimental rationale for investigating the use of EGFR inhibitors in pemphigus.	[Bektas, Meryem; Jolly, Puneet S.; Berkowitz, Paula; Rubenstein, David S.] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Keio University	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Suite 405 Mary Ellen Jones CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu	Amagai, Masayuki/K-5325-2013	Amagai, Masayuki/0000-0003-3314-7052; Bektas, Meryem/0000-0001-8080-7557	National Institutes of Health Grant [RO1 AI49427]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI49427 (to D. S. R.).	Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cirillo N, 2007, J CELL PHYSIOL, V210, P411, DOI 10.1002/jcp.20856; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; EYRE RW, 1988, J CLIN INVEST, V81, P807, DOI 10.1172/JCI113387; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Jans R, 2004, J INVEST DERMATOL, V123, P564, DOI 10.1111/j.0022-202X.2004.23221.x; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; KOULU L, 1984, J EXP MED, V160, P1509, DOI 10.1084/jem.160.5.1509; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Li X, 1998, EMBO J, V17, P2574, DOI 10.1093/emboj/17.9.2574; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Lorch JH, 2007, CANCER RES, V67, P727, DOI 10.1158/0008-5472.CAN-06-2162; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Schmidt E, 2009, AM J PHYSIOL-CELL PH, V296, pC162, DOI 10.1152/ajpcell.00161.2008; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Sloss CM, 2010, ONCOGENE, V29, P3146, DOI 10.1038/onc.2010.52; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; STANLEY JR, 1986, J IMMUNOL, V136, P1227; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	44	45	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9447	9456		10.1074/jbc.M112.438010	http://dx.doi.org/10.1074/jbc.M112.438010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404504	Green Published, hybrid			2022-12-28	WOS:000316862200061
J	Jiang, GC; Plo, I; Wang, T; Rahman, M; Cho, JH; Yang, E; Lopez, BS; Xia, F				Jiang, Guochun; Plo, Isabelle; Wang, Tong; Rahman, Mohammad; Cho, Ju Hwan; Yang, Eddy; Lopez, Bernard S.; Xia, Fen			BRCA1-Ku80 Protein Interaction Enhances End-joining Fidelity of Chromosomal Double-strand Breaks in the G(1) Phase of the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; DNA-DAMAGE CHECKPOINT; MAMMALIAN-CELLS; NUCLEAR PHOSPHOPROTEIN; COMPLEX-FORMATION; REPAIR PATHWAY; MUTATIONS; CANCER; PHOSPHORYLATION; KU80	Quality control of DNA double-strand break (DSB) repair is vital in preventing mutagenesis. Non-homologous end-joining (NHEJ), a repair process predominant in the G(1) phase of the cell cycle, rejoins DSBs either accurately or with errors, but the mechanisms controlling its fidelity are poorly understood. Here we show that BRCA1, a tumor suppressor, enhances the fidelity of NHEJ-mediated DSB repair and prevents mutagenic deletional end-joining through interaction with canonical NHEJ machinery during G(1). BRCA1 binds and stabilizes Ku80 at DSBs through its N-terminal region, promotes precise DSB rejoining, and increases cellular resistance to radiation-induced DNA damage in a G(1) phase-specific manner. These results suggest that BRCA1, as a central player in genome integrity maintenance, ensures high fidelity repair of DSBs by not only promoting homologous recombination repair in G(2)/M phase but also facilitating fidelity of Ku80-dependent NHEJ repair, thus preventing deletional end-joining of chromosomal DSBs during G(1).	[Jiang, Guochun; Rahman, Mohammad; Cho, Ju Hwan; Xia, Fen] Ohio State Univ, Med Ctr, Arthur G James Comprehens Canc Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Plo, Isabelle; Lopez, Bernard S.] CNRS, UMR217, F-92265 Fontenay Aux Roses, France; [Plo, Isabelle; Lopez, Bernard S.] Inst Radiobiol Cellulaire & Mol, F-92265 Fontenay Aux Roses, France; [Wang, Tong] Vanderbilt Univ, Sch Med, Div Cardiol, Nashville, TN 37232 USA; [Yang, Eddy] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35249 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Vanderbilt University; University of Alabama System; University of Alabama Birmingham	Xia, F (corresponding author), Ohio State Univ, Sch Med, Arthur G James Comprehens Canc Ctr, Richard L Solove Res Inst,Dept Radiat Oncol, 300 W 10th Ave, Columbus, OH 43210 USA.	fen.xia@osumc.edu	Plo, Isabelle/C-9056-2017; Xia, Fen/G-3708-2013; Jiang, Guochun/H-8809-2019; Plo, Isabelle/AAT-6742-2021; Lopez, Bernard S/O-7308-2017	Plo, Isabelle/0000-0002-5915-6910; Jiang, Guochun/0000-0003-1911-5089; Lopez, Bernard S/0000-0001-5088-0155	National Institutes of Health [R01 CA118158, UL1 RR024975]; NATIONAL CANCER INSTITUTE [R01CA118158] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA118158 (to F. X.) and UL1 RR024975 (Vanderbilt Clinical and Translational Science Award; to G. J.).	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Baldeyron C, 2002, ONCOGENE, V21, P1401, DOI 10.1038/sj.onc.1205200; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen YM, 1996, CANCER RES, V56, P3168; Choudhary SK, 2002, J CELL BIOCHEM, V84, P666, DOI 10.1002/jcb.10081; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Dohrn L, 2012, BIOCHEM J, V441, P919, DOI 10.1042/BJ20110314; Durant ST, 2005, CELL CYCLE, V4, P1216, DOI 10.4161/cc.4.9.2027; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Hsu LC, 2001, CANCER RES, V61, P7713; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kao GD, 2001, ONCOGENE, V20, P3486, DOI 10.1038/sj.onc.1204445; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Keimling M, 2011, FASEB J, V25, P3849, DOI 10.1096/fj.11-185546; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; Moisan A, 2006, J BIOL CHEM, V281, P21119, DOI 10.1074/jbc.M600712200; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Quennet V, 2011, NUCLEIC ACIDS RES, V39, P2144, DOI 10.1093/nar/gkq1175; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Summers K C, 2011, Int J Proteomics, V2011, P373816, DOI 10.1155/2011/373816; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; Thomas JE, 1997, CELL GROWTH DIFFER, V8, P801; Thompson EG, 2012, ENVIRON MOL MUTAGEN, V53, P32, DOI 10.1002/em.21674; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Veras L, 2009, J MOL BIOL, V387, P523, DOI 10.1016/j.jmb.2009.02.008; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; Willers H, 2006, RADIAT RES, V166, P567, DOI 10.1667/RR0524.1; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yang ES, 2009, J CLIN INVEST, V119, P1124, DOI 10.1172/JCI34051; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444	72	38	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8966	8976		10.1074/jbc.M112.412650	http://dx.doi.org/10.1074/jbc.M112.412650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23344954	Green Published, hybrid			2022-12-28	WOS:000316862200016
J	Kopecny, D; Koncitikova, R; Tylichova, M; Vigouroux, A; Moskalikova, H; Soural, M; Sebela, M; Morera, S				Kopecny, David; Koncitikova, Radka; Tylichova, Martina; Vigouroux, Armelle; Moskalikova, Hana; Soural, Miroslav; Sebela, Marek; Morera, Solange			Plant ALDH10 Family IDENTIFYING CRITICAL RESIDUES FOR SUBSTRATE SPECIFICITY AND TRAPPING A THIOHEMIACETAL INTERMEDIATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETAINE-ALDEHYDE DEHYDROGENASE; PEROXISOMAL POLYAMINE OXIDASE; ACTIVE-SITE; AMINOALDEHYDE DEHYDROGENASE; BIOCHEMICAL-CHARACTERIZATION; GENE SUPERFAMILY; ACID-RESIDUES; ARABIDOPSIS; GLYCINEBETAINE; EXPRESSION	Plant ALDH10 family members are aminoaldehyde dehydrogenases (AMADHs), which oxidize omega-aminoaldehydes to the corresponding acids. They have been linked to polyamine catabolism, osmoprotection, secondary metabolism (fragrance), and carnitine biosynthesis. Plants commonly contain two AMADH isoenzymes. We previously studied the substrate specificity of two AMADH isoforms from peas (PsAMADHs). Here, two isoenzymes from tomato (Solanum lycopersicum), SlAMADHs, and three AMADHs from maize (Zea mays), ZmAMADHs, were kinetically investigated to obtain further clues to the catalytic mechanism and the substrate specificity. We also solved the high resolution crystal structures of SlAMADH1 and ZmAMADH1a because these enzymes stand out from the others regarding their activity. From the structural and kinetic analysis, we can state that five residues at positions 163, 288, 289, 444, and 454 (PsAMADHs numbering) can, directly or not, significantly modulate AMADH substrate specificity. In the SlAMADH1 structure, a PEG aldehyde derived from the precipitant forms a thiohemiacetal intermediate, never observed so far. Its absence in the SlAMADH1-E260A structure suggests that Glu-260 can activate the catalytic cysteine as a nucleophile. We show that the five AMADHs studied here are capable of oxidizing 3-dimethylsulfoniopropionaldehyde to the cryo- and osmoprotectant 3-dimethylsulfoniopropionate. For the first time, we also show that 3-acetamidopropionaldehyde, the third aminoaldehyde besides 3-aminopropionaldehyde and 4-aminobutyraldehyde, is generally oxidized by AMADHs, meaning that these enzymes are unique in metabolizing and detoxifying aldehyde products of polyamine degradation to nontoxic amino acids. Finally, gene expression profiles in maize indicate that AMADHs might be important for controlling omega-aminoaldehyde levels during early stages of the seed development.	[Kopecny, David; Koncitikova, Radka; Tylichova, Martina; Sebela, Marek] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, CZ-78371 Olomouc, Czech Republic; [Koncitikova, Radka; Moskalikova, Hana; Sebela, Marek] Palacky Univ, Fac Sci, Dept Biochem, CZ-78371 Olomouc, Czech Republic; [Vigouroux, Armelle; Morera, Solange] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Soural, Miroslav] Palacky Univ, Dept Organ Chem, Fac Sci, Olomouc 77146, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Palacky University Olomouc	Kopecny, D (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, Slechtitelu 11, CZ-78371 Olomouc, Czech Republic.	kopecny_david@yahoo.co.uk; marek.sebela@upol.cz; morera@lebs.cnrs-gif.fr	Kopecny, David/ABH-4250-2020; Kopecna, Martina/H-2188-2014; Koncitikova, Radka/ABA-4128-2021; Sebela, Marek/AAL-2747-2020	Kopecny, David/0000-0002-4309-4284; Koncitikova, Radka/0000-0002-4398-8982; Sebela, Marek/0000-0001-9835-1375; Kopecna, Martina/0000-0003-2136-4615	Czech Science Foundation [P501/11/1591, 522/08/0555]; OP RDI [ED0007/01/01]; CNRS	Czech Science Foundation(Grant Agency of the Czech Republic); OP RDI; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Czech Science Foundation Grants P501/11/1591 and 522/08/0555 and OP RD&I Grant ED0007/01/01 (Centre of the Region Hana for Biotechnological and Agricultural Research) and supported in part by CNRS (to S. M. and A.V.).	Arikit S, 2011, PLANT BIOTECHNOL J, V9, P75, DOI 10.1111/j.1467-7652.2010.00533.x; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; Bradbury LMT, 2008, PLANT MOL BIOL, V68, P439, DOI 10.1007/s11103-008-9381-x; Brauner F, 2003, PLANT PHYSIOL BIOCH, V41, P1, DOI 10.1016/S0981-9428(02)00002-5; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; BROUQUISSE R, 1989, PLANT PHYSIOL, V90, P322, DOI 10.1104/pp.90.1.322; BRUNK DG, 1989, PLANT PHYSIOL, V91, P1122, DOI 10.1104/pp.91.3.1122; Charlton AJ, 2008, METABOLOMICS, V4, P312, DOI 10.1007/s11306-008-0128-0; Charrier A, 2012, PLANTA, V235, P123, DOI 10.1007/s00425-011-1499-4; Chen SH, 2008, PLANT CELL, V20, P1850, DOI 10.1105/tpc.108.058917; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Diaz-Sanchez AG, 2012, PLANT PHYSIOL, V158, P1570, DOI 10.1104/pp.112.194514; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara T, 2008, PHYSIOL PLANTARUM, V134, P22, DOI 10.1111/j.1399-3054.2008.01122.x; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hibino T, 2001, PLANT MOL BIOL, V45, P353, DOI 10.1023/A:1006497113323; HILL EJ, 1975, J BIOL CHEM, V250, P1734; Hjelmqvist L, 2003, CELL MOL LIFE SCI, V60, P2009, DOI 10.1007/s00018-003-3287-1; Holt A, 2007, J NEURAL TRANSM, V114, P733, DOI 10.1007/s00702-007-0680-1; ISHITANI M, 1993, PLANT CELL PHYSIOL, V34, P493; Izaguirre G, 2001, J BIOMOL STRUCT DYN, V19, P429, DOI 10.1080/07391102.2001.10506752; JAMES F, 1995, PLANT PHYSIOL, V108, P1439, DOI 10.1104/pp.108.4.1439; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada-Nobusada T, 2008, PLANT CELL PHYSIOL, V49, P1272, DOI 10.1093/pcp/pcn114; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kopecny D, 2011, FEBS J, V278, P3130, DOI 10.1111/j.1742-4658.2011.08239.x; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; LERMA C, 1991, PLANT PHYSIOL, V95, P1113, DOI 10.1104/pp.95.4.1113; Li W, 2003, BIOCHEM J, V371, P429, DOI 10.1042/BJ20021520; Makela P, 1998, IND CROP PROD, V7, P139, DOI 10.1016/S0926-6690(97)00042-3; Mann CJ, 1999, PROTEIN SCI, V8, P1922, DOI 10.1110/ps.8.10.1922; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Missihoun TD, 2011, PLANTA, V233, P369, DOI 10.1007/s00425-010-1297-4; Moschou PN, 2008, PLANT PHYSIOL, V147, P1845, DOI 10.1104/pp.108.123802; Nakamura T, 1997, PLANT J, V11, P1115, DOI 10.1046/j.1365-313X.1997.11051115.x; Nakamura T, 2001, PLANT CELL PHYSIOL, V42, P1088, DOI 10.1093/pcp/pce136; Niu XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-100; PAQUET L, 1994, AUST J PLANT PHYSIOL, V21, P37, DOI 10.1071/PP9940037; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Raman SB, 2003, PLANT PHYSIOL, V132, P1642, DOI 10.1104/pp.103.020453; RASTOGI R, 1990, PLANT PHYSIOL, V94, P1449, DOI 10.1104/pp.94.3.1449; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Rippa S, 2012, PLANT PHYSIOL BIOCH, V60, P109, DOI 10.1016/j.plaphy.2012.08.001; Sebela M, 2006, PROTEOMICS, V6, P2959, DOI 10.1002/pmic.200500576; Sebela M, 2000, BBA-PROTEIN STRUCT M, V1480, P329, DOI 10.1016/S0167-4838(00)00086-8; Sebela M, 2002, STUDIES NATURAL PR G, V26, P1259; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Takahata Y, 2010, PLANT CELL REP, V29, P535, DOI 10.1007/s00299-010-0842-8; Tavladoraki P, 2006, PLANT PHYSIOL, V141, P1519, DOI 10.1104/pp.106.080911; Trossat C, 1997, PLANT PHYSIOL, V113, P1457, DOI 10.1104/pp.113.4.1457; Tylichova M, 2008, ACTA CRYSTALLOGR F, V64, P88, DOI 10.1107/S1744309107068522; Tylichova M, 2010, J MOL BIOL, V396, P870, DOI 10.1016/j.jmb.2009.12.015; VALENZUELASOTO EM, 1994, J PLANT PHYSIOL, V143, P145, DOI 10.1016/S0176-1617(11)81678-0; Vaz FM, 2000, J BIOL CHEM, V275, P7390, DOI 10.1074/jbc.275.10.7390; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; WEIGEL P, 1986, PLANT PHYSIOL, V82, P753, DOI 10.1104/pp.82.3.753; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wymore T, 2004, PROTEINS, V57, P758, DOI 10.1002/prot.20256; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	67	31	37	0	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9491	9507		10.1074/jbc.M112.443952	http://dx.doi.org/10.1074/jbc.M112.443952			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408433	Green Published, hybrid			2022-12-28	WOS:000316862200065
J	Okamoto, Y; Bernstein, JD; Shikano, S				Okamoto, Yukari; Bernstein, Joshua David; Shikano, Sojin			Role of C-terminal Membrane-proximal Basic Residues in Cell Surface Trafficking of HIV Coreceptor GPR15 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; COUPLED RECEPTORS; SELECTIVE EXPORT; ER EXPORT; COPII; PALMITOYLATION; MOTIF; RETENTION; SIGNALS; TAIL	Cell surface density of G protein-coupled receptors (GPCRs) is controlled by dynamic molecular interactions that often involve recognition of the distinct sequence signals on the cargo receptors. We reported previously that the RXR-type dibasic motif in the distal C-terminal tail of an HIV coreceptor GPR15 negatively regulates the cell surface expression by mediating the coatomer protein I complex-dependent retrograde transport to the endoplasmic reticulum (ER). Here we demonstrate that another pair of basic residues (Arg(310)-Arg(311)) in the membrane-proximal region of the C-terminal tail plays a pivotal role in mediating the anterograde trafficking of GPR15. The Ala mutation of the C-terminal membrane-proximal basic residues (MPBRs) (R310/311A) abolished the O-glycosylation and cell surface expression of GPR15. The subcellular fractionation and immunocytochemistry assays indicated that the R310/311A mutant was more localized in the ER but much less in the trans-Golgi when compared with the wild-type GPR15, suggesting the positive role of Arg(310)-Arg(311) in the ER-to-Golgi transport of GPR15. Sequence analysis on human GPCRs showed that the basic residues are frequent in the membrane-proximal region of the C-terminal tail. Similar to GPR15, mutation of the C-terminal MPBRs resulted in a marked reduction of the cell surface expression in multiple different GPCRs. Our results suggest that the C-terminal MPBRs are critically involved in mediating the anterograde trafficking of a broad range of membrane proteins, including GPCRs.	[Okamoto, Yukari; Bernstein, Joshua David; Shikano, Sojin] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shikano, S (corresponding author), 900 S Ashland Ave,MBRB2006, Chicago, IL 60607 USA.	sshikano@uic.edu			National Institutes of Health Grant [1R01GM099974-01]; LUNGevity Foundation/American Cancer Society Lung Cancer Research Grant [2009-07001-00-00]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099974] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LUNGevity Foundation/American Cancer Society Lung Cancer Research Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant 1R01GM099974-01 (to S. S.). this work was also supported by LUNGevity Foundation/American Cancer Society Lung Cancer Research Grant 2009-07001-00-00 (to S. S.).	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Glick BS, 2001, CURR BIOL, V11, pR361; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; Khalil H, 2005, J CELL SCI, V118, P4679, DOI 10.1242/jcs.02592; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Palmer KJ, 2004, TRENDS CELL BIOL, V14, P57, DOI 10.1016/j.tcb.2003.12.001; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Sato Ken, 2010, Seikagaku, V82, P1011; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9189	9199		10.1074/jbc.M112.445817	http://dx.doi.org/10.1074/jbc.M112.445817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430259	hybrid, Green Published			2022-12-28	WOS:000316862200038
J	Shah, NB; Hutcheon, ML; Haarer, BK; Duncan, TM				Shah, Naman B.; Hutcheon, Marcus L.; Haarer, Brian K.; Duncan, Thomas M.			F-1-ATPase of Escherichia coli THE epsilon-INHIBITED STATE FORMS AFTER ATP HYDROLYSIS, IS DISTINCT FROM THE ADP-INHIBITED STATE, AND RESPONDS DYNAMICALLY TO CATALYTIC SITE LIGANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING SITES; C-TERMINAL DOMAIN; SUBUNIT-EPSILON; GAMMA-SUBUNIT; F1 ATPASE; ADENOSINE-TRIPHOSPHATASE; MITOCHONDRIAL F1-ATPASE; CRYSTAL-STRUCTURE; BETA-SUBUNIT; F-1 MOTOR	F-1-ATPase is the catalytic complex of rotary nanomotor ATP synthases. Bacterial ATP synthases can be autoinhibited by the C-terminal domain of subunit epsilon, which partially inserts into the enzyme's central rotor cavity to block functional subunit rotation. Using a kinetic, optical assay of F-1.epsilon binding and dissociation, we show that formation of the extended, inhibitory conformation of epsilon (epsilon(X)) initiates after ATP hydrolysis at the catalytic dwell step. Prehydrolysis conditions prevent formation of the epsilon(X) state, and post-hydrolysis conditions stabilize it. We also show that epsilon inhibition and ADP inhibition are distinct, competing processes that can follow the catalytic dwell. We show that the N-terminal domain of epsilon is responsible for initial binding to F-1 and provides most of the binding energy. Without the C-terminal domain, partial inhibition by the epsilon N-terminal domain is due to enhanced ADP inhibition. The rapid effects of catalytic site ligands on conformational changes of F-1-bound epsilon suggest dynamic conformational and rotational mobility in F-1 that is paused near the catalytic dwell position.	[Shah, Naman B.; Hutcheon, Marcus L.; Haarer, Brian K.; Duncan, Thomas M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Duncan, TM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	duncant@upstate.edu		Duncan, Thomas/0000-0002-6432-4958	National Institutes of Health Grant [R01GM083088]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083088] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM083088 (to T. M. D.).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bhardwaj A, 2008, PROTEIN SCI, V17, P1475, DOI 10.1110/ps.036111.108; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bulygin VV, 2009, BBA-BIOENERGETICS, V1787, P1016, DOI 10.1016/j.bbabio.2009.02.025; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; COX GB, 1992, MOL MECHANISMS BIOEN, P283; DALLMANN HG, 1992, J BIOL CHEM, V267, P18953; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; Duncan T. M., 2004, ENZYMES, VXXIII, P203; Duncan TM, 1995, BIOCHEM SOC T, V23, P736, DOI 10.1042/bst0230736; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; DUNN SD, 1982, J BIOL CHEM, V257, P7354; DUNN SD, 1986, ANAL BIOCHEM, V159, P35, DOI 10.1016/0003-2697(86)90304-0; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; GUERRERO KJ, 1990, J BIOL CHEM, V265, P16280; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; JAULT JM, 1993, J BIOL CHEM, V268, P20762; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; KATO Y, 1995, BBA-BIOENERGETICS, V1231, P275, DOI 10.1016/0005-2728(95)00087-Y; Kinosita K, 2012, ADV EXP MED BIOL, V726, P5, DOI 10.1007/978-1-4614-0980-9_2; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P1278, DOI 10.1021/bi00219a017; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P10987, DOI 10.1021/bi00109a025; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; MILGROM YM, 1993, J BIOL CHEM, V268, P23179; MURATALIEV MB, 1991, BIOCHEMISTRY-US, V30, P8305, DOI 10.1021/bi00098a004; MURATALIEV MB, 1992, EUR J BIOCHEM, V209, P681, DOI 10.1111/j.1432-1033.1992.tb17336.x; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 2011, CHEM SCI, V2, P2086, DOI 10.1039/c1sc00276g; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Rees DM, 2012, P NATL ACAD SCI USA, V109, P11139, DOI 10.1073/pnas.1207587109; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Spetzler D, 2012, ADV PHOTOSYNTH RESP, V34, P561, DOI 10.1007/978-94-007-1579-0_22; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; TOZER RG, 1986, EUR J BIOCHEM, V161, P513, DOI 10.1111/j.1432-1033.1986.tb10472.x; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1994, BIOL CHEM H-S, V375, P43; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	81	38	39	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9383	9395		10.1074/jbc.M113.451583	http://dx.doi.org/10.1074/jbc.M113.451583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400782	Green Published, hybrid			2022-12-28	WOS:000316862200055
J	Ding, Y; Zhang, Y; Xu, C; Tao, QH; Chen, YG				Ding, Yi; Zhang, Yan; Xu, Chao; Tao, Qing-Hua; Chen, Ye-Guang			HECT Domain-containing E3 Ubiquitin Ligase NEDD4L Negatively Regulates Wnt Signaling by Targeting Dishevelled for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; PATHWAY; CANCER; XENOPUS; FAMILY; GENE; ITCH	Wnt signaling plays a pivotal role in embryogenesis and tissue homeostasis. Dishevelled (Dvl) is a central mediator for both Wnt/beta-catenin and Wnt/planar cell polarity pathways. NEDD4L, an E3 ubiquitin ligase, has been shown to regulate ion channel activity, cell signaling, and cell polarity. Here, we report a novel role of NEDD4L in the regulation of Wnt signaling. NEDD4L induces Dvl2 polyubiquitination and targets Dvl2 for proteasomal degradation. Interestingly, the NEDD4L-mediated ubiquitination of Dvl2 is Lys-6, Lys-27, and Lys-29 linked but not typical Lys-48-linked ubiquitination. Consistent with the role of Dvl in both Wnt/beta-catenin and Wnt/planar cell polarity signaling, NEDD4L regulates the cellular beta-catenin level and Rac1, RhoA, and JNK activities. We have further identified a hierarchical regulation that Wnt5a induces JNK-mediated phosphorylation of NEDD4L, which in turn promotes its ability to degrade Dvl2. Finally, we show that NEDD4L inhibits Dvl2-induced axis duplication in Xenopus embryos. Our work thus demonstrates that NEDD4L is a negative feedback regulator of Wnt signaling.	[Ding, Yi; Xu, Chao; Chen, Ye-Guang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Zhang, Yan; Tao, Qing-Hua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Tao, QH (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	qhtaolab@tsinghua.edu.cn; ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019	Ding, Yi/0000-0001-7525-7124	National Key Basic Research Program of China (973 Program) [2011CB943800]; National Natural Science Foundation of China [30930050, 30921004, 30930012]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of China (973 Program) Grants 2011CB943800 (to Y. G. C. and Q. H. T.) and National Natural Science Foundation of China Grants 30930050 and 30921004 (to Y. G. C.) and 30930012 (to Q. H. T.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dibbens LM, 2007, GENES BRAIN BEHAV, V6, P750, DOI 10.1111/j.1601-183X.2007.00305.x; Dwyer Jessica L, 2012, Spermatogenesis, V2, P104; Feng J, 2004, NEOPLASIA, V6, P623, DOI 10.1593/neo.04142; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Ganner A, 2009, P NATL ACAD SCI USA, V106, P17799, DOI 10.1073/pnas.0909465106; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Hallows KR, 2010, J BIOL CHEM, V285, P21671, DOI 10.1074/jbc.M109.084731; He SM, 2012, JPN J CLIN ONCOL, V42, P196, DOI 10.1093/jjco/hyr195; Hu XY, 2009, EJSO-EUR J SURG ONC, V35, P527, DOI 10.1016/j.ejso.2008.09.015; Kamnasaran D, 2003, CLIN INVEST MED, V26, P285; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Rao L, 2010, J PEDIATR NEUROSCI, V5, P64, DOI 10.4103/1817-1745.66686; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zhang L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/831092	47	83	87	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8289	8298		10.1074/jbc.M112.433185	http://dx.doi.org/10.1074/jbc.M112.433185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23396981	Green Published, hybrid			2022-12-28	WOS:000316564500029
J	Harmon, B; Kozina, C; Maar, D; Carpenter, TS; Branda, CS; Negrete, OA; Carson, BD				Harmon, Brooke; Kozina, Carol; Maar, Dianna; Carpenter, Timothy S.; Branda, Catherine S.; Negrete, Oscar A.; Carson, Bryan D.			Identification of Critical Amino Acids within the Nucleoprotein of Tacaribe Virus Important for Anti-interferon Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; INFECTION; INHIBITION; INDUCTION; FEVER; HOST; RNA	The arenavirus nucleoprotein (NP) can suppress induction of type I interferon (IFN). This anti-IFN activity is thought to be shared by all arenaviruses with the exception of Tacaribe virus (TCRV). To identify the TCRV NP amino acid residues that prevent its IFN-countering ability, we created a series of NP chimeras between residues of TCRV NP and Pichinde virus (PICV) NP, an arenavirus NP with potent anti-IFN function. Chimera NP analysis revealed that a minimal four amino acid stretch derived from PICV NP could impart efficient anti-IFN activity to TCRV NP. Strikingly, the TCRV NP gene cloned and sequenced from viral stocks obtained through National Institutes of Health Biodefense and Emerging Infections (BEI) resources deviated from the reference sequence at this particular four-amino acid region, GPPT (GenBank KC329849) versus DLQL (GenBank NC004293), respectively at residues 389-392. When efficiently expressed in cells through codon-optimization, TCRV NP containing the GPPT residues rescued the antagonistic IFN function. Consistent with cell expression results, TCRV infection did not stimulate an IFN beta response early in infection in multiple cells types (e.g. A549, P388D1), and IRF-3 was not translocated to the nucleus in TCRV-infected A549 cells. Collectively, these data suggest that certain TCRV strain variants contain the important NP amino acids necessary for anti-IFN activity.	[Harmon, Brooke; Kozina, Carol; Maar, Dianna; Branda, Catherine S.; Negrete, Oscar A.] Sandia Natl Labs, Livermore, CA 94550 USA; [Carpenter, Timothy S.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA; [Carson, Bryan D.] Sandia Natl Labs, Albuquerque, NM 87123 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories	Negrete, OA (corresponding author), Sandia Natl Labs, POB 969,MS9292, Livermore, CA 94551 USA.	onegret@sandia.gov		Carpenter, Timothy/0000-0001-7848-9983	Laboratory Directed Research and Development Grants; United States Department of Energy National Nuclear Security Administration [DE-AC04-94AL85000]	Laboratory Directed Research and Development Grants; United States Department of Energy National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE))	This work was supported by Laboratory Directed Research and Development Grants (to B. D. C. and O. A. N.).; Sandia National Laboratories is a multiprogram laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the United States Department of Energy National Nuclear Security Administration under contract DE-AC04-94AL85000.	Baird NL, 2012, J VIROL, V86, P11301, DOI 10.1128/JVI.01635-12; Borrow P, 2010, VIRUSES-BASEL, V2, P2443, DOI 10.3390/v2112443; Buchmeier M., 2007, FIELDS VIROL, V2, P1792; Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12; DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Groseth A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001137; Groseth A, 2010, J VIROL, V84, P3603, DOI 10.1128/JVI.02429-09; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; Harrison LH, 1999, CLIN INFECT DIS, V28, P1091, DOI 10.1086/514749; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Huang C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001659; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Liang YY, 2009, ANN NY ACAD SCI, V1171, pE65, DOI 10.1111/j.1749-6632.2009.05051.x; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Nunberg JH, 2012, VIRUSES-BASEL, V4, P83, DOI 10.3390/v4010083; Ogbu O., 2007, Journal of Vector Borne Diseases, V44, P1; Pythoud C, 2012, J VIROL, V86, P7728, DOI 10.1128/JVI.00187-12; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WEISSENBACHER MC, 1987, CURR TOP MICROBIOL, V134, P77; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	30	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8702	8711		10.1074/jbc.M112.444760	http://dx.doi.org/10.1074/jbc.M112.444760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382389	Green Published, hybrid			2022-12-28	WOS:000316564500070
J	Roiko, MS; Carruthers, VB				Roiko, Marijo S.; Carruthers, Vern B.			Functional Dissection of Toxoplasma gondii Perforin-like Protein 1 Reveals a Dual Domain Mode of Membrane Binding for Cytolysis and Parasite Egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; HOST-CELL INVASION; LISTERIOLYSIN-O; MICRONEME DISCHARGE; PORE FORMATION; ATTACK; COMPLEMENT; MECHANISM; VIRULENCE; MOTILITY	The recently discovered role of a perforin-like protein (PLP1) for rapid host cell egress by the protozoan parasite Toxoplasma gondii expanded the functional diversity of pore-forming proteins. Whereas PLP1 was found to be necessary for rapid egress and pathogenesis, the sufficiency for and mechanism of membrane attack were yet unknown. Here we further dissected the PLP1 knock-out phenotype, the mechanism of PLP1 pore formation, and the role of each domain by genetic complementation. We found that PLP1 is sufficient for membrane disruption and has a conserved mechanism of pore formation through target membrane binding and oligomerization to form large, multimeric membrane-embedded complexes. The highly conserved, central MACPF domain and the beta-sheet-rich C-terminal domain were required for activity. Loss of the unique N-terminal extension reduced lytic activity and led to a delay in rapid egress, but did not significantly decrease virulence, suggesting that small amounts of lytic activity are sufficient for pathogenesis. We found that both N- and C-terminal domains have membrane binding activity, with the C-terminal domain being critical for function. This dual mode of membrane association may promote PLP1 activity and parasite egress in the diverse cell types in which this parasite replicates.	[Roiko, Marijo S.] Univ Michigan, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA; [Roiko, Marijo S.; Carruthers, Vern B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Carruthers, Vern/0000-0001-6859-8895	National Institutes of Health [R01AI046675]; Cellular and Molecular Biology Training Grant [T32 GM007315]; University of Michigan Rackham merit fellowship; Rackham student research grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biology Training Grant; University of Michigan Rackham merit fellowship(University of Michigan System); Rackham student research grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Operating Grant R01AI046675 (to V. B. C.) and Cellular and Molecular Biology Training Grant T32 GM007315. This work was also supported by a University of Michigan Rackham merit fellowship and Rackham student research grants (to M. S. R.).	Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; BJERRUM PJ, 1979, J MEMBRANE BIOL, V48, P43, DOI 10.1007/BF01869256; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Bouyain S, 2012, STRUCTURE, V20, P197, DOI 10.1016/j.str.2012.01.013; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Decatur AL, 2000, SCIENCE, V290, P992, DOI 10.1126/science.290.5493.992; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; ENDO T, 1987, J PROTOZOOL, V34, P291, DOI 10.1111/j.1550-7408.1987.tb03177.x; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Farrand S, 2008, BIOCHEMISTRY-US, V47, P7097, DOI 10.1021/bi8005835; Feil SC, 2012, STRUCTURE, V20, P248, DOI 10.1016/j.str.2011.11.017; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kafsack Bjorn F.C., 2010, Communicative & Integrative Biology, V3, P18; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Laliberte J, 2011, MOL BIOCHEM PARASIT, V177, P49, DOI 10.1016/j.molbiopara.2011.01.009; Lavine MD, 2007, CURR PHARM DESIGN, V13, P641, DOI 10.2174/138161207780162854; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lukoyanova N, 2008, TRENDS IMMUNOL, V29, P51, DOI 10.1016/j.it.2007.11.003; McDonald V, 2011, EXPERT REV ANTI-INFE, V9, P1077, DOI [10.1586/ERI.11.123, 10.1586/eri.11.123]; McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029; Muller-Eberhard H J, 1985, Biochem Soc Symp, V50, P235; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nagamune Kisaburo, 2008, V47, P70; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schnupf P, 2006, CELL MICROBIOL, V8, P353, DOI 10.1111/j.1462-5822.2005.00631.x; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Schreck SF, 2000, BBA-PROTEIN STRUCT M, V1482, P199, DOI 10.1016/S0167-4838(00)00155-2; Scibek JJ, 2002, BIOCHEMISTRY-US, V41, P14546, DOI 10.1021/bi026641j; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Sibley LD, 1999, IMMUNOBIOLOGY, V201, P210, DOI 10.1016/S0171-2985(99)80061-8; Singh S, 2012, MICROBES INFECT, V14, P820, DOI 10.1016/j.micinf.2012.05.007; Tegla CA, 2011, IMMUNOL RES, V51, P45, DOI 10.1007/s12026-011-8239-5; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Van Den Steen P E, 2011, Verh K Acad Geneeskd Belg, V73, P123; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983	53	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8712	8725		10.1074/jbc.M113.450932	http://dx.doi.org/10.1074/jbc.M113.450932			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23376275	Green Published, hybrid			2022-12-28	WOS:000316564500071
J	Manne, BK; Getz, TM; Hughes, CE; Alshehri, O; Dangelmaier, C; Naik, UP; Watson, SP; Kunapuli, SP				Manne, Bhanu Kanth; Getz, Todd M.; Hughes, Craig E.; Alshehri, Osama; Dangelmaier, Carol; Naik, Ulhas P.; Watson, Steve P.; Kunapuli, Satya P.			Fucoidan Is a Novel Platelet Agonist for the C-type Lectin-like Receptor 2 (CLEC-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT FUCOIDAN; COLLAGEN RECEPTOR; GLYCOPROTEIN-VI; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; GAMMA-CHAIN; P-SELECTIN; A-BETA; SYK	Fucoidan, a sulfated polysaccharide from Fucus vesiculosus, decreases bleeding time and clotting time in hemophilia, possibly through inhibition of tissue factor pathway inhibitor. However, its effect on platelets and the receptor by which fucoidan induces cellular processes has not been elucidated. In this study, we demonstrate that fucoidan induces platelet activation in a concentration-dependent manner. Fucoidan-induced platelet activation was completely abolished by the pan-Src family kinase (SFK) inhibitor, PP2, or when Syk is inhibited. PP2 abolished phosphorylations of Syk and Phospholipase C-gamma 2. Fucoidan-induced platelet activation had a lag phase, which is reminiscent of platelet activation by collagen and CLEC-2 receptor agonists. Platelet activation by fucoidan was only slightly inhibited in FcR gamma-chain null mice, indicating that fucoidan was not acting primarily through GPVI receptor. On the other hand, fucoidan-induced platelet activation was inhibited in platelet-specific CLEC-2 knock-out murine platelets revealing CLEC-2 as a physiological target of fucoidan. Thus, our data show fucoidan as a novel CLEC-2 receptor agonist that activates platelets through a SFK-dependent signaling pathway. Furthermore, the efficacy of fucoidan in hemophilia raises the possibility that decreased bleeding times could be achieved through activation of platelets.	[Manne, Bhanu Kanth; Getz, Todd M.; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Manne, Bhanu Kanth; Getz, Todd M.; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA; [Hughes, Craig E.; Alshehri, Osama; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Naik, Ulhas P.] Univ Delaware, Cardiovasc Res Inst, Newark, DE 19716 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Birmingham; University of Delaware	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Rm 403 MRB,3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Watson, Stephen P/Q-6292-2016	Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820	National Institutes of Health [HL60683, HL93231]; National Institutes of Health Training Grant in Thrombosis [HL07777]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093231, T32HL007777, R01HL060683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Thrombosis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Grants HL60683 and HL93231 from the National Institutes of Health (to S. P. K.).; Supported by National Institutes of Health Training Grant in Thrombosis HL07777.	Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; Brandenburg LO, 2010, J NEUROCHEM, V113, P749, DOI 10.1111/j.1471-4159.2010.06637.x; Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387; Broos K, 2012, THROMB RES, V129, P245, DOI 10.1016/j.thromres.2011.11.002; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Durand E, 2008, J VASC RES, V45, P529, DOI 10.1159/000129687; Durig J, 1997, THROMB RES, V85, P479, DOI 10.1016/S0049-3848(97)00037-6; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Gao YL, 2012, ENVIRON TOXICOL PHAR, V33, P304, DOI 10.1016/j.etap.2011.12.022; Getz TM, 2011, J THROMB HAEMOST, V9, P608, DOI 10.1111/j.1538-7836.2011.04192.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hooley E, 2008, BIOCHEMISTRY-US, V47, P7831, DOI 10.1021/bi800528t; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hughes CE, 2008, J THROMB HAEMOST, V6, P2152, DOI 10.1111/j.1538-7836.2008.03166.x; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Jarvis GE, 2002, BRIT J PHARMACOL, V137, P107, DOI 10.1038/sj.bjp.0704834; Jhamandas JH, 2005, EUR J NEUROSCI, V21, P2649, DOI 10.1111/j.1460-9568.2005.04111.x; Kawasaki Tomihisa, 2006, Folia Pharmacologica Japonica, V128, P23, DOI 10.1254/fpj.128.23; KOEDAM JA, 1992, J CELL BIOL, V116, P617, DOI 10.1083/jcb.116.3.617; Li ZY, 2010, J BIOL CHEM, V285, P12559, DOI 10.1074/jbc.M109.098756; Liu TY, 2006, THROMB HAEMOSTASIS, V95, P68, DOI 10.1160/TH05-05-0361; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Mazurov AV, 1996, EUR J HAEMATOL, V57, P38; Millet J, 1999, THROMB HAEMOSTASIS, V81, P391; PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Prasad S, 2008, BLOOD, V111, P672, DOI 10.1182/blood-2007-07-098913; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; SHUMAN MA, 1978, J CLIN INVEST, V61, P1102, DOI 10.1172/JCI109010; Sobanov Y, 2001, EUR J IMMUNOL, V31, P3493, DOI 10.1002/1521-4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2-9; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Speich HE, 2008, AM J PHYSIOL-CELL PH, V295, pC1045, DOI 10.1152/ajpcell.90644.2007; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2004, BIOCHEM J, V378, P1023, DOI 10.1042/BJ20031430; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Trento F, 2001, THROMB RES, V102, P457, DOI 10.1016/S0049-3848(01)00264-X; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Uemura T, 2006, BRIT J PHARMACOL, V148, P61, DOI 10.1038/sj.bjp.0706711; Watson AA, 2008, PROTEIN SCI, V17, P1611, DOI 10.1110/ps.035568.108; Watson AA, 2011, TOXINS, V3, P991, DOI 10.3390/toxins3080991; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; ZIMMERMAN TS, 1985, CLIN HAEMATOL, V14, P343; ZIMMERMAN TS, 1971, J CLIN INVEST, V50, P244, DOI 10.1172/JCI106480	50	43	46	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7717	7726		10.1074/jbc.M112.424473	http://dx.doi.org/10.1074/jbc.M112.424473			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341451	Green Published, hybrid			2022-12-28	WOS:000316455300028
J	Zhu, QS; Liu, WX; Kao, LY; Azimov, R; Newman, D; Abuladze, N; Kurtz, I				Zhu, Quansheng; Liu, Weixin; Kao, Liyo; Azimov, Rustam; Newman, Debra; Abuladze, Natalia; Kurtz, Ira			Topology of NBCe1 Protein Transmembrane Segment 1 and Structural Effect of Proximal Renal Tubular Acidosis (pRTA) S427L Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; CYTOPLASMIC DOMAIN; CYSTEINE; SODIUM; ACCESSIBILITY; TRAFFICKING; MECHANISM; TRANSPORT; MUTANTS	In the kidney proximal tubule, NBCe1-A plays a critical role in absorbing HCO3- from cell to blood. NBCe1-A transmembrane segment 1 (TM1) is involved in forming part of the ion permeation pathway, and a missense mutation S427L in TM1 impairs ion transport, causing proximal renal tubular acidosis. In the present study, we examined the topology of NBCe1-A-TM1 in detail and its structural perturbation induced by S427L. We analyzed the N-terminal cytoplasmic region (Cys-389-Gln-424) of NBCe1-A-TM1 using the substituted cysteine scanning accessibility method combined with extensive chemical stripping, in situ chemical probing, and functional transport assays. NBCe1-A-TM1 was previously modeled on the anion exchanger 1 TM1 (AE1-TM1); however, our data demonstrated that the topology of AE1-TM1 differs significantly from NBCe1-A-TM1. Our findings revealed that NBCe1-A-TM1 is unusually long, consisting of 31 membrane-embedded amino acids (Phe-412 to Thr-442). The linker region (Arg-394-Pro-411) between the N terminus of TM1 and the cytoplasmic domain is minimally exposed to aqueous and is potentially folded in a helical structure that intimately interacts with the NBCe1-A cytoplasmic domain. In contrast, AE1-TM1 contains 25 amino acids connected to an aqueous-exposed cytoplasmic region. Based on our new NBCe1-A-TM1 model, Ser-427 resides in the middle of TM1. Leucine substitution at Ser-427 blocks the normal aqueous access to Thr-442, Ala-435, and Lys-404, implying a significant alteration of NBCe1-TM1 orientation. Our study provides novel structural insights into the pathogenic mechanism of S427L in mediating proximal renal tubular acidosis.	[Zhu, Quansheng; Liu, Weixin; Kao, Liyo; Azimov, Rustam; Newman, Debra; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, QS (corresponding author), Univ Calif Los Angeles, Dept Med, 7-155 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90024 USA.	quzhu@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563]; Coplon grant; UCLA Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK058563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coplon grant; UCLA Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563 (to I. K.). This work was also supported in part by a Coplon grant and the UCLA Department of Medicine (to Q. Z.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Cheung JC, 2005, BIOCHEM J, V390, P137, DOI 10.1042/BJ20050315; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Li HC, 2005, AM J PHYSIOL-RENAL, V289, pF61, DOI 10.1152/ajprenal.00032.2005; Lo YF, 2011, KIDNEY INT, V79, P730, DOI 10.1038/ki.2010.523; MOHANDAS N, 1992, J CLIN INVEST, V89, P686, DOI 10.1172/JCI115636; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; STECK TL, 1976, BIOCHEMISTRY-US, V15, P1154, DOI 10.1021/bi00650a030; Suzuki M, 2008, PFLUG ARCH EUR J PHY, V455, P583, DOI 10.1007/s00424-007-0319-y; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Zhang DC, 2000, BLOOD, V96, P2925; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	28	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7894	7906		10.1074/jbc.M112.404533	http://dx.doi.org/10.1074/jbc.M112.404533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362273	hybrid, Green Published			2022-12-28	WOS:000316455300043
J	Springer, SA; Gagneux, P				Springer, Stevan A.; Gagneux, Pascal			Glycan Evolution in Response to Collaboration, Conflict, and Constraint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BLOOD-GROUP ANTIGENS; SIALIC-ACID; HLA-G; OLIGOSACCHARIDE DIVERSITY; PROTEIN GLYCOSYLATION; CONGENITAL DISORDERS; MOLECULAR DIVERSITY; POSITIVE SELECTION; GENETIC EVOLUTION; LECTIN	Glycans, oligo-and polysaccharides secreted or attached to proteins and lipids, cover the surfaces of all cells and have a regulatory capacity and structural diversity beyond any other class of biological molecule. Glycans may have evolved these properties because they mediate cellular interactions and often face pressure to evolve new functions rapidly. We approach this idea two ways. First, we discuss evolutionary innovation. Glycan synthesis, regulation, and mode of chemical interaction influence the spectrum of new forms presented to evolution. Second, we describe the evolutionary conflicts that arise when alleles and individuals interact. Glycan regulation and diversity are integral to these biological negotiations. Glycans are tasked with such an amazing diversity of functions that no study of cellular interaction can begin without considering them. We propose that glycans predominate the cell surface because their physical and chemical properties allow the rapid innovation required of molecules on the frontlines of evolutionary conflict.	[Gagneux, Pascal] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gagneux, P (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	pgagneux@ucsd.edu			National Institutes of Health [R01 GM095882]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM095882. This work was also supported by a grant from the G. Harold and Leila Y. Mathers Charitable Foundation. This is the first article in the Thematic Minireview Series on Glycobiology and Extracellular Matrices: Glycan Functions Pervade Biology at All Levels.	Angata T, 2006, MOL DIVERS, V10, P555, DOI 10.1007/s11030-006-9029-1; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Clark NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000570; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Cummerson JA, 2006, IMMUNOLOGY, V118, P333, DOI 10.1111/j.1365-2567.2006.02374.x; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Ding N, 2011, AGE AGEING, V40, P568, DOI 10.1093/ageing/afr084; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fossum S, 2011, IMMUNOGENETICS, V63, P809, DOI 10.1007/s00251-011-0553-5; Freeze HH, 2001, BIOCHIMIE, V83, P791, DOI 10.1016/S0300-9084(01)01292-5; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Ghaderi D, 2011, P NATL ACAD SCI USA, V108, P17743, DOI 10.1073/pnas.1102302108; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; He BB, 2009, BIOLOGIA, V64, P819, DOI 10.2478/s11756-009-0117-4; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; IOBST ST, 1994, J BIOL CHEM, V269, P15512; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Javaud C, 2003, GENETICA, V118, P157, DOI 10.1023/A:1024101625214; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Kirchhoff C, 2001, CELLS TISSUES ORGANS, V168, P93, DOI 10.1159/000016810; Koike C, 2007, P NATL ACAD SCI USA, V104, P559, DOI 10.1073/pnas.0610012104; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Lam KKW, 2011, J BIOL CHEM, V286, P37118, DOI 10.1074/jbc.M111.233841; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Litynska A, 1998, MECH AGEING DEV, V102, P33, DOI 10.1016/S0047-6374(98)00006-2; Ma F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380584; Dall'Olio GM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-98; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Marth JD, 2008, NAT CELL BIOL, V10, P1015, DOI 10.1038/ncb0908-1015; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; McMaster M, 1998, J IMMUNOL, V160, P5922; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Ogawa T, 2005, TOXICON, V45, P1, DOI 10.1016/j.toxicon.2004.07.028; OhUigin C, 1997, HUM GENET, V101, P141, DOI 10.1007/s004390050603; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Paul P, 1998, P NATL ACAD SCI USA, V95, P4510, DOI 10.1073/pnas.95.8.4510; Rini J., 2009, ESSENTIALS GLYCOBIOL, P63; Rogers KM, 2009, J INNATE IMMUN, V1, P405, DOI 10.1159/000226422; Schauer R, 2009, CARBOHYD RES, V344, P1494, DOI 10.1016/j.carres.2009.05.020; Schollen E, 2004, J MED GENET, V41, P877, DOI 10.1136/jmg.2004.022350; Schroter S, 1999, HUM REPROD UPDATE, V5, P302, DOI 10.1093/humupd/5.4.302; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Springer SA, 2008, INT J DEV BIOL, V52, P759, DOI 10.1387/ijdb.082581ss; Springer SA, 2007, EVOLUTION, V61, P772, DOI 10.1111/j.1558-5646.2007.00073.x; Springer SA, 2011, MOL ECOL, V20, P2240, DOI 10.1111/j.1365-294X.2011.05116.x; Stanley P., 2009, ESSENTIALS GLYCOBIOL, V1; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vacquier VD, 2012, BIOCHEM BIOPH RES CO, V425, P583, DOI 10.1016/j.bbrc.2012.07.132; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; VANDERPUYE OA, 1992, BIOCHIM BIOPHYS ACTA, V1121, P301, DOI 10.1016/0167-4838(92)90161-6; Varki A., 2009, ESSENTIALS GLYCOBIOL, P1; Varki A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005462; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wagner A, 2011, TRENDS GENET, V27, P397, DOI 10.1016/j.tig.2011.06.002; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; Wang XX, 2012, P NATL ACAD SCI USA, V109, P9935, DOI 10.1073/pnas.1119459109; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wuhrer M, 2006, GLYCOBIOLOGY, V16, P991, DOI 10.1093/glycob/cwl020; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547; Yamamoto E, 2009, ENDOCRINOLOGY, V150, P990, DOI 10.1210/en.2008-1005; Yeung WSB, 2009, J REPROD IMMUNOL, V83, P26, DOI 10.1016/j.jri.2009.04.012; Yim M, 2001, P NATL ACAD SCI USA, V98, P2222, DOI 10.1073/pnas.041621998	93	56	57	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6904	6911		10.1074/jbc.R112.424523	http://dx.doi.org/10.1074/jbc.R112.424523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329843	Green Published, hybrid			2022-12-28	WOS:000316002400012
J	Ngok, SP; Geyer, R; Kourtidis, A; Storz, P; Anastasiadis, PZ				Ngok, Siu P.; Geyer, Rory; Kourtidis, Antonis; Storz, Peter; Anastasiadis, Panos Z.			Phosphorylation-mediated 14-3-3 Protein Binding Regulates the Function of the Rho-specific Guanine Nucleotide Exchange Factor (RhoGEF) Syx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; P120 CATENIN; KINASE-D; GTPASES; POLARITY; COMPLEX; GEF; 14-3-3-PROTEINS; JUNCTIONS; MOTILITY	Syx is a Rho-specific guanine nucleotide exchange factor (GEF) that localizes at cell-cell junctions and promotes junction stability by activating RhoA and the downstream effector Diaphanous homolog 1 (Dia1). Previously, we identified several molecules, including 14-3-3 proteins, as Syx-interacting partners. In the present study, we show that 14-3-3 isoforms interact with Syx at both its N- and C-terminal regions in a phosphorylation-dependent manner. We identify the protein kinase D-mediated phosphorylation of serine 92 on Syx, and additional phosphorylation at serine 938, as critical sites for 14-3-3 association. Our data indicate that the binding of 14-3-3 proteins inhibits the GEF activity of Syx. Furthermore, we show that phosphorylation-deficient, 14-3-3-uncoupled Syx exhibits increased junctional targeting and increased GEF activity, resulting in the strengthening of the circumferential junctional actin ring in Madin-Darby canine kidney cells. These findings reveal a novel means of regulating junctional Syx localization and function by phosphorylation-induced 14-3-3 binding and further support the importance of Syx function in maintaining stable cell-cell contacts.	[Ngok, Siu P.; Geyer, Rory; Kourtidis, Antonis; Storz, Peter; Anastasiadis, Panos Z.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA	Mayo Clinic	Anastasiadis, PZ (corresponding author), Dept Canc Biol, Griffin Canc Res Bldg,Rm 307,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	anastasiadis.panos@mayo.edu		Kourtidis, Antonis/0000-0002-8128-6391	National Institutes of Health [R01 NS069753, R21 NS070117, R01 GM086435, 10BG11]; Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753, R21NS070117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS069753 and R21 NS070117 (to P. Z. A.) and R01 GM086435 and 10BG11 (to P. S.). This work was also supported by the Mayo Graduate School (to S. P. N.).	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Estevez MA, 2008, J NEUROCHEM, V106, P1287, DOI 10.1111/j.1471-4159.2008.05472.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ling C, 2010, GENE DEV, V24, P947, DOI 10.1101/gad.1896810; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Wood NT, 2009, FEBS LETT, V583, P615, DOI 10.1016/j.febslet.2009.01.003; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	29	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6640	6650		10.1074/jbc.M112.432682	http://dx.doi.org/10.1074/jbc.M112.432682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335514	Green Published, hybrid			2022-12-28	WOS:000315820700063
J	Cheng, XX; Veverka, V; Radhakrishnan, A; Waters, LC; Muskett, FW; Morgan, SH; Huo, JD; Yu, C; Evans, EJ; Leslie, AJ; Griffiths, M; Stubberfield, C; Griffin, R; Henry, AJ; Jansson, A; Ladbury, JE; Ikemizu, S; Carr, MD; Davis, SJ				Cheng, Xiaoxiao; Veverka, Vaclav; Radhakrishnan, Anand; Waters, Lorna C.; Muskett, Frederick W.; Morgan, Sara H.; Huo, Jiandong; Yu, Chao; Evans, Edward J.; Leslie, Alasdair J.; Griffiths, Meryn; Stubberfield, Colin; Griffin, Robert; Henry, Alistair J.; Jansson, Andreas; Ladbury, John E.; Ikemizu, Shinji; Carr, Mark D.; Davis, Simon J.			Structure and Interactions of the Human Programmed Cell Death 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE DETERMINATION; N-TERMINAL DOMAIN; T-CELLS; CRYSTAL-STRUCTURE; PD-1 EXPRESSION; QUANTITATIVE-ANALYSIS; TISSUE INHIBITOR; MOLECULAR-BASIS; NMR ASSIGNMENT; HCV INFECTION	PD-1, a receptor expressed by T cells, B cells, and monocytes, is a potent regulator of immune responses and a promising therapeutic target. The structure and interactions of human PD-1 are, however, incompletely characterized. We present the solution nuclear magnetic resonance (NMR)-based structure of the human PD-1 extracellular region and detailed analyses of its interactions with its ligands, PD-L1 and PD-L2. PD-1 has typical immunoglobulin superfamily topology but differs at the edge of the GFCC' sheet, which is flexible and completely lacks a C '' strand. Changes in PD-1 backbone NMR signals induced by ligand binding suggest that, whereas binding is centered on the GFCC' sheet, PD-1 is engaged by its two ligands differently and in ways incompletely explained by crystal structures of mouse PD-1.ligand complexes. The affinities of these interactions and that of PD-L1 with the costimulatory protein B7-1, measured using surface plasmon resonance, are significantly weaker than expected. The 3-4-fold greater affinity of PD-L2 versus PD-L1 for human PD-1 is principally due to the 3-fold smaller dissociation rate for PD-L2 binding. Isothermal titration calorimetry revealed that the PD-1/PD-L1 interaction is entropically driven, whereas PD-1/PD-L2 binding has a large enthalpic component. Mathematical simulations based on the biophysical data and quantitative expression data suggest an unexpectedly limited contribution of PD-L2 to PD-1 ligation during interactions of activated T cells with antigen-presenting cells. These findings provide a rigorous structural and biophysical framework for interpreting the important functions of PD-1 and reveal that potent inhibitory signaling can be initiated by weakly interacting receptors.	[Cheng, Xiaoxiao; Morgan, Sara H.; Huo, Jiandong; Yu, Chao; Evans, Edward J.; Leslie, Alasdair J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England; [Cheng, Xiaoxiao; Morgan, Sara H.; Huo, Jiandong; Yu, Chao; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford OX3 9DU, England; [Veverka, Vaclav; Waters, Lorna C.; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Veverka, Vaclav] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic; [Radhakrishnan, Anand] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Griffiths, Meryn; Stubberfield, Colin; Griffin, Robert; Henry, Alistair J.] UCB Pharma, Slough SL1 4EN, Berks, England; [Jansson, Andreas; Ladbury, John E.] Univ Skovde, Sch Life Sci, Syst Biol Res Ctr, Skovde, Sweden; [Ikemizu, Shinji] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kumamoto 8620973, Japan	University of Oxford; University of Oxford; University of Leicester; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Texas System; UTMD Anderson Cancer Center; UCB Pharma SA; University of Skovde; Kumamoto University	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk; simon.davis@imm.ox.ac.uk	Huo, Jiandong/AAL-5945-2021; Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019	Huo, Jiandong/0000-0002-7899-1815; Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Ladbury, John/0000-0002-6328-7200; Carr, Mark/0000-0002-3939-0996; leslie, alasdair/0000-0003-2538-6467	Wellcome Trust; United Kingdom Medical Research Council; UCB Celltech Ltd.; G. Harold and Leila Y. Mathers Charitable Foundation; Medical Research Council [MC_UU_12010/4] Funding Source: researchfish; MRC [MC_UU_12010/4] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCB Celltech Ltd.(UCB Pharma SA); G. Harold and Leila Y. Mathers Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, the United Kingdom Medical Research Council, UCB Celltech Ltd., and a grant from the G. Harold and Leila Y. Mathers Charitable Foundation (to J. E. L.).	AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; DAS MRP, 1995, EUR J IMMUNOL, V25, P207, DOI 10.1002/eji.1830250134; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Dong HD, 2003, J CLIN INVEST, V111, P363, DOI 10.1172/JCI200316015; Dong HD, 1999, NAT MED, V5, P1365; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM-US, V50, P2590, DOI 10.1002/art.20436; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; James ES, 2005, GENES IMMUN, V6, P430, DOI 10.1038/sj.gene.6364223; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; Jansson A, 2011, MOL IMMUNOL, V49, P527, DOI 10.1016/j.molimm.2011.09.021; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kong EKP, 2005, ARTHRITIS RHEUM-US, V52, P1058, DOI 10.1002/art.20966; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; SANSOM DM, 1993, EUR J IMMUNOL, V23, P295, DOI 10.1002/eji.1830230148; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072; SPRINGER TA, 1991, NATURE, V353, P704, DOI 10.1038/353704a0; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Wilkinson IC, 2009, J BIOL CHEM, V284, P31928, DOI 10.1074/jbc.M109.025304; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yu C, 2011, J BIOL CHEM, V286, P6685, DOI 10.1074/jbc.M110.182394; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2	65	197	234	2	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11771	11785		10.1074/jbc.M112.448126	http://dx.doi.org/10.1074/jbc.M112.448126			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23417675	Green Published, hybrid			2022-12-28	WOS:000318157600014
J	Spallotta, F; Cencioni, C; Straino, S; Nanni, S; Rosati, J; Artuso, S; Manni, I; Colussi, C; Piaggio, G; Martelli, F; Valente, S; Mai, A; Capogrossi, MC; Farsetti, A; Gaetano, C				Spallotta, Francesco; Cencioni, Chiara; Straino, Stefania; Nanni, Simona; Rosati, Jessica; Artuso, Simona; Manni, Isabella; Colussi, Claudia; Piaggio, Giulia; Martelli, Fabio; Valente, Sergio; Mai, Antonello; Capogrossi, Maurizio C.; Farsetti, Antonella; Gaetano, Carlo			A Nitric Oxide-dependent Cross-talk between Class I and III Histone Deacetylases Accelerates Skin Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED KERATINOCYTES; DIFFERENTIATION; INHIBITORS; CELLS; SIRT1; PROLIFERATION; RESVERATROL; FIBROBLASTS; RELAXATION; ACTIVATION	In a mouse model of skin repair we found that the class I-IIa histone deacetylase inhibitor trichostatin A accelerated tissue regeneration. Unexpectedly, this effect was suppressed by Sirtinol, a class III histone deacetylase (HDAC) (sirtuin)-selective inhibitor. The role of sirtuins (SIRTs) was then investigated by using resveratrol and a novel SIRT1-2-3 activator, the MC2562 compound we synthesized recently. Both resveratrol and MC2562 were effective in accelerating wound repair. The local administration of natural or synthetic SIRT activators, in fact, significantly accelerated skin regeneration by increasing keratinocyte proliferation. In vitro experiments revealed that the activation of SIRTs stimulated keratinocyte proliferation via endothelial NO synthase phosphorylation and NO production. In this condition, the class I member HDAC2 was found S-nitrosylated on cysteine, a post-transduction modification associated with loss of activity and DNA binding capacity. After deacetylase inhibitor or SIRT activator treatment, ChIP showed, in fact, a significant HDAC2 detachment from the promoter region of insulin growth factor I (IGF-I), fibroblast growth factor 10 (FGF-10), and Epithelial Growth Factor (EGF), which may be the final recipients and effectors of the SIRT-NO-HDAC signaling cascade. Consistently, the effect of SIRT activators was reduced in the presence of NG-nitro-L-arginine methyl ester (L-NAME), a general inhibitor of NO synthesis. In conclusion, the NO-dependent cross-talk among class III and I histone deacetylases suggests an unprecedented signaling pathway important for skin repair.	[Spallotta, Francesco; Cencioni, Chiara] Ist Ric & Cura Carattere Sci, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, I-20138 Milan, Italy; [Straino, Stefania; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, I-00167 Rome, Italy; [Nanni, Simona; Colussi, Claudia] Univ Cattolica Sacro Cuore, Ist Patol Med, I-00168 Rome, Italy; [Rosati, Jessica] Ist CSS Mendel, Unita Neurogenet, I-00198 Rome, Italy; [Artuso, Simona; Manni, Isabella; Piaggio, Giulia] Ist Nazl Tumori Regina Elena, Dipartimento Oncol Sperimentale, I-00144 Rome, Italy; [Martelli, Fabio] IRCCS, Policlin San Donato, Lab Cardiol Mol, I-20097 Milan, Italy; [Valente, Sergio; Mai, Antonello] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy; [Farsetti, Antonella] CNR, Ist Biol Cellulare & Neurobiol, I-00185 Rome, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, Dept Cardiol, Div Cardiovasc Epigenet, D-60590 Frankfurt, Germany	IRCCS Centro Cardiologico Monzino; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Policlinico San Donato; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Goethe University Frankfurt	Gaetano, C (corresponding author), Goethe Univ Frankfurt, Div Cardiovasc Epigenet, Dept Cardiol, Internal Med Clin 3, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	carlo.gaetano@gmail.com	Rosati, Jessica Diana/H-2867-2016; Martelli, Fabio/AAL-3788-2020; Cencioni, Chiara/I-8490-2018; Piaggio, Giulia/J-7214-2018; Valente, Sergio/K-2198-2016; Rosati, Jessica Diana/AAK-6084-2020; Mai, Antonello/AAC-2144-2019; Colussi, Claudia/H-8609-2019; Manni, Isabella/ABH-6460-2020; Gaetano, Carlo/P-9997-2019; Spallotta, Francesco/AAB-6261-2019; Farsetti, Antonella/I-8710-2018; Piaggio, Giulia/AAD-7336-2022	Rosati, Jessica Diana/0000-0002-4483-386X; Martelli, Fabio/0000-0002-8624-7738; Cencioni, Chiara/0000-0001-6284-539X; Piaggio, Giulia/0000-0003-2114-1892; Valente, Sergio/0000-0002-2241-607X; Rosati, Jessica Diana/0000-0002-4483-386X; Manni, Isabella/0000-0003-4823-0596; Gaetano, Carlo/0000-0002-5238-1832; Spallotta, Francesco/0000-0002-0466-6286; Farsetti, Antonella/0000-0002-8603-7925; Mai, Antonello/0000-0001-9176-2382; Colussi, Claudia/0000-0002-7727-8911	Italian Ministry of Education, University, and Research [PRIN2010TYCL9B_006, FIRB RBFR087JMZ_002]; LOEWE Center for Cell and Gene Therapy, Goethe University Frankfurt, Germany [III L 4-518/17.004]; Duchenne Parent Project, The Netherlands; AIRC [IG-13234]; CARIPLO Foundation [2009-2439]; Ministry of Health, Ricerca Corrente (RC) [4.3]	Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); LOEWE Center for Cell and Gene Therapy, Goethe University Frankfurt, Germany; Duchenne Parent Project, The Netherlands(Netherlands Government); AIRC(Fondazione AIRC per la ricerca sul cancro); CARIPLO Foundation(Fondazione Cariplo); Ministry of Health, Ricerca Corrente (RC)	This work was supported by Italian Ministry of Education, University, and Research Grants PRIN2010TYCL9B_006 and FIRB RBFR087JMZ_002 (to A. F.). This work was also supported by the LOEWE Center for Cell and Gene Therapy, Goethe University Frankfurt, Germany (Funding Number III L 4-518/17.004 (2010) (to C. G. and F. S.), by the Duchenne Parent Project, The Netherlands (to C. C.), by grants from AIRC (IG-13234) and the CARIPLO Foundation (grant no. 2009-2439) (to G.P.), and by the Ministry of Health, Ricerca Corrente (RC) 4.3 (to the Istituto Dermopatico dell'Immacolata-IRCCS).	Bashmakov YK, 2011, MED HYPOTHESES, V77, P364, DOI 10.1016/j.mehy.2011.05.016; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Colussi C, 2012, ARTERIOSCL THROM VAS, V32, P2435, DOI 10.1161/ATVBAHA.112.254011; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Dal Farra C, 2006, J COSMET SCI, V57, P187; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Goeman F, 2012, MOL BIOL CELL, V23, P1467, DOI 10.1091/mbc.E12-01-0039; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Isenberg JS, 2005, MICROSURG, V25, P442, DOI 10.1002/micr.20168; Khanna S, 2002, FREE RADICAL BIO MED, V33, P1089, DOI 10.1016/S0891-5849(02)00999-1; Luo JD, 2005, ACTA PHARMACOL SIN, V26, P259, DOI 10.1111/j.1745-7254.2005.00058.x; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2009, J MED CHEM, V52, P5496, DOI 10.1021/jm9008289; Marchese C, 2001, J INVEST DERMATOL, V116, P623, DOI 10.1046/j.0022-202x.2001.01280.x; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; O'Connor EJF, 2012, J INVEST DERMATOL, V132, P1293, DOI 10.1038/jid.2011.432; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Rafehi H, 2011, INT WOUND J, V8, P12, DOI 10.1111/j.1742-481X.2010.00745.x; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Soneja A, 2005, PHARMACOL REP, V57, P108; Spallotta F, 2010, STEM CELLS, V28, P431, DOI 10.1002/stem.300; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Watson P Marc D, 2009, Commun Integr Biol, V2, P11	28	59	61	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11004	11012		10.1074/jbc.M112.441816	http://dx.doi.org/10.1074/jbc.M112.441816			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463510	Green Published, hybrid			2022-12-28	WOS:000317915500007
J	Zhao, BY; Yuan, C; Li, R; Qu, D; Huang, MD; Ngo, JCK				Zhao, Baoyu; Yuan, Cai; Li, Rui; Qu, Dan; Huang, Mingdong; Ngo, Jacky Chi Ki			Crystal Structures of Matriptase in Complex with Its Inhibitor Hepatocyte Growth Factor Activator Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE MICROARRAY ANALYSIS; SERINE-PROTEASE; CATALYTIC DOMAIN; BREAST-CANCER; EXPRESSION; SURFACE; HAI-1; LOCALIZATION; PURIFICATION; PROGRESSION	Matriptase, a type II trans-membrane serine protease of the S1 trypsin-like family, is expressed on the surface of nearly all normal human epithelium and found in biological fluid-like human milk. Matriptase overexpression has been implicated in tumor progression in certain epithelium-derived cancer cells. Matriptase is tightly regulated by its cognate inhibitor hepatocyte growth factor activator inhibitor-1 (HAI-1). It has been demonstrated that the Kunitz domain I (KD1) but not Kunitz domain II (KD2) of HAI-1 is responsible for the inhibitory activity of HAI-1 against matriptase. To investigate the molecular basis of inhibition of matriptase by HAI-1, we solved several crystal structures of matriptase serine protease domain in complex with the fragments of HAI-1. Based on these structures, we found that the binding of KD1 was different from previously predicted binding mode. The P3 arginine residue occupies the S3 specificity pocket of matriptase, but not the S4 pocket as in the cases of hepatocyte growth factor activator.HAI-1 KD1 and matriptase.sunflower trypsin inhibitor-1 complexes. The long 60-loop of matriptase makes direct contact with HAI-1 but remains flexible even in the complexes, and its apex does not bind with KD1 tightly. The interactions between this unique 60-loop and KD1 may provide an opportunity to increase the specificity and inhibitory activity of KD1 for matriptase. Furthermore, comparison between KD1 and a homology model of HAI-1 KD2 rationalizes the structural basis of why KD1 but not KD2 is responsible for the inhibitory activity of HAI-1 against matriptase.	[Zhao, Baoyu; Yuan, Cai; Li, Rui; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Zhao, Baoyu; Li, Rui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhao, Baoyu; Yuan, Cai; Li, Rui; Qu, Dan; Huang, Mingdong; Ngo, Jacky Chi Ki] Danish Chinese Ctr Proteases & Canc, Shatin, Hong Kong, Peoples R China; [Qu, Dan; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.	mhuang@fjirsm.ac.cn; jackyngo@cuhk.edu.hk	Ngo, Jacky C/O-8093-2017; Huang, Mingdong/J-4278-2017	Ngo, Jacky C/0000-0002-6004-7041; Huang, Mingdong/0000-0003-0085-9141; Li, Rui/0000-0001-5343-3027	Natural Science Foundation of China [31161130356, 31170707]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Grants 31161130356 and 31170707.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Cheng MF, 2006, DIS ESOPHAGUS, V19, P482, DOI 10.1111/j.1442-2050.2006.00613.x; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Jin L, 2005, ACTA CRYSTALLOGR D, V61, P1418, DOI [10.1107/S0907444905024340, 10.1107/S090744905024340]; Kang JY, 2003, CANCER RES, V63, P1101; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Lee JW, 2005, HUM PATHOL, V36, P626, DOI 10.1016/j.humpath.2005.03.003; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Santin AD, 2003, CANCER, V98, P1898, DOI 10.1002/cncr.11753; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Tsai WC, 2006, HISTOPATHOLOGY, V49, P388, DOI 10.1111/j.1365-2559.2006.02516.x; Tsai WC, 2008, DIS MARKERS, V24, P89, DOI 10.1155/2008/945197; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; vandeLocht A, 1997, EMBO J, V16, P2977, DOI 10.1093/emboj/16.11.2977; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30	43	29	31	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11155	11164		10.1074/jbc.M113.454611	http://dx.doi.org/10.1074/jbc.M113.454611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443661	Green Published, hybrid			2022-12-28	WOS:000317915500020
J	Newman, JA; Rodrigues, C; Lewis, RJ				Newman, Joseph A.; Rodrigues, Cecilia; Lewis, Richard J.			Molecular Basis of the Activity of SinR Protein, the Master Regulator of Biofilm Formation in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORULATION; REPRESSOR; EXPRESSION; COMPLEX; SYSTEM	Bacterial biofilms are complex communities of cells that are attached to a surface by an extracellular matrix. Biofilms are an increasing environmental and healthcare issue, causing problems ranging from the biofouling of ocean-going vessels, to dental plaque, infections of the urinary tract, and contamination of medical instruments such as catheters. A complete understanding of biofilm formation therefore requires knowledge of the regulatory pathways underpinning its formation so that effective intervention strategies can be determined. The master regulator that determines whether the Gram-positive model organism Bacillus subtilis switches from a free-living, planktonic lifestyle to form a biofilm is called SinR. The activity of SinR, a transcriptional regulator, is controlled by its antagonists, SinI, SlrA, and SlrR. The interaction of these four proteins forms a switch, which determines whether or not SinR can inhibit biofilm formation by its repression of a number of extracellular matrix-associated operons. To determine the thermodynamic and kinetic parameters governing the protein-protein and protein-DNA interactions at the heart of this epigenetic switch, we have analyzed the protein-protein and protein-DNA interactions by isothermal titration calorimetry and surface plasmon resonance. We also present the crystal structure of SinR in complex with DNA, revealing the molecular basis of base-specific DNA recognition by SinR and suggesting that the most effective means of transcriptional control occurs by the looping of promoter DNA. The structural analysis also enables predictions about how SinR activity is controlled by its interaction with its antagonists.	[Newman, Joseph A.; Rodrigues, Cecilia; Lewis, Richard J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Lewis, RJ (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.lewis@ncl.ac.uk	Rodrigues, Cecilia MP/M-3572-2013	Rodrigues, Cecilia MP/0000-0002-4829-754X; lewis, richard/0000-0003-2641-8643; newman, Joseph/0000-0003-4488-0516; Rodrigues, Cecilia/0000-0002-9643-9733	Biotechnology and Biological Sciences Research Council as part of the BaCell SysMO2 consortium; BBSRC [BB/I004572/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004572/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council as part of the BaCell SysMO2 consortium(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council grant (to R. J. L.) as part of the BaCell SysMO2 consortium.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAI U, 1993, GENE DEV, V7, P139, DOI 10.1101/gad.7.1.139; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chai YR, 2009, MOL MICROBIOL, V74, P876, DOI 10.1111/j.1365-2958.2009.06900.x; Chai YR, 2009, J BACTERIOL, V191, P2423, DOI 10.1128/JB.01464-08; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Colledge VL, 2011, J MOL BIOL, V411, P597, DOI 10.1016/j.jmb.2011.06.004; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GAUR NK, 1988, J BACTERIOL, V170, P1046, DOI 10.1128/jb.170.3.1046-1053.1988; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kobayashi K, 2008, MOL MICROBIOL, V69, P1399, DOI 10.1111/j.1365-2958.2008.06369.x; Lewis RJ, 1996, FEBS LETT, V378, P98, DOI 10.1016/0014-5793(95)01432-2; Lewis RJ, 1998, J MOL BIOL, V283, P907, DOI 10.1006/jmbi.1998.2163; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Margot P, 1996, MICROB DRUG RESIST, V2, P119, DOI 10.1089/mdr.1996.2.119; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Scott DJ, 1999, J MOL BIOL, V293, P997, DOI 10.1006/jmbi.1999.3221; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	31	68	69	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10766	10778		10.1074/jbc.M113.455592	http://dx.doi.org/10.1074/jbc.M113.455592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430750	hybrid, Green Published			2022-12-28	WOS:000317565000055
J	Roffe, M; Hajj, GNM; Azevedo, HF; Alves, VS; Castilho, BA				Roffe, Martin; Hajj, Glaucia N. M.; Azevedo, Hatylas F.; Alves, Viviane S.; Castilho, Beatriz A.			IMPACT Is a Developmentally Regulated Protein in Neurons That Opposes the Eukaryotic Initiation Factor 2 alpha Kinase GCN2 in the modulation of Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA TRANSLATION; AMINO-ACID CONTROL; EIF2-ALPHA KINASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; PHOSPHORYLATION; ACTIVATION; BRAIN; ASSOCIATION	The product of the mouse Imprinted and Ancient gene, IMPACT, is preferentially expressed in neurons. We have previously shown that IMPACT overexpression inhibits the activation of the protein kinase GCN2, which signals amino acid starvation. GCN2 phosphorylates the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2 alpha), resulting in inhibition of general protein synthesis but increased translation of specific messages, such as ATF4. GCN2 is also involved in the regulation of neuronal functions, controlling synaptic plasticity, memory, and feeding behavior. We show here that IMPACT abundance increases during differentiation of neurons and neuron-like N2a cells, whereas GCN2 displays lowered activation levels. Upon differentiation, IMPACT associates with translating ribosomes, enhances translation initiation, and down-regulates the expression of ATF4. We further show that endogenous IMPACT promotes neurite outgrowth whereas GCN2 is a strong inhibitor of spontaneous neuritogenesis. Together, these results uncover the participation of the GCN2-IMPACT module of translational regulation in a highly controlled step in the development of the nervous system.	[Roffe, Martin; Azevedo, Hatylas F.; Alves, Viviane S.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, BR-04023062 Sao Paulo, Brazil; [Hajj, Glaucia N. M.] Hosp AC Camargo Fund Antonio Prudente, Int Res Ctr, Natl Inst Translat Neurosci, BR-01509010 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); A.C.Camargo Cancer Center	Castilho, BA (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Rua Botucatu 862, BR-04023062 Sao Paulo, Brazil.	bacastilho@unifesp.br	Castilho, Beatriz A/C-2503-2012; Azevedo, Hatylas FZ/M-5332-2013; Roffe, Martin/S-1124-2019; Roffé, Martín/I-1864-2013; Alves, Viviane S/C-2776-2013; de Souza Alves, Viviane/M-8954-2019; Hajj, Glaucia N M/I-8176-2015	Castilho, Beatriz A/0000-0003-4509-5237; Azevedo, Hatylas FZ/0000-0001-9233-0696; Roffe, Martin/0000-0001-7247-3067; Roffé, Martín/0000-0001-7247-3067; de Souza Alves, Viviane/0000-0002-0625-6619; Hajj, Glaucia N M/0000-0003-2342-7384	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to B. A. C. and G. N. M. H.).; Received research fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Angelastro JM, 2003, J NEUROSCI, V23, P4590; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Donnelly N, 2013, CELL MOL LI IN PRESS; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Waller T, 2012, FEBS J, V279, P1761, DOI 10.1111/j.1742-4658.2012.08553.x; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	44	39	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10860	10869		10.1074/jbc.M113.461970	http://dx.doi.org/10.1074/jbc.M113.461970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447528	hybrid, Green Published			2022-12-28	WOS:000317565000063
J	Ronchi, VP; Klein, JM; Haas, AL				Ronchi, Virginia P.; Klein, Jennifer M.; Haas, Arthur L.			E6AP/UBE3A Ubiquitin Ligase Harbors Two E2 similar to ubiquitin Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CONJUGATING ENZYME; E1-E2 INTERACTIONS; PROTEIN LIGASE; DEGRADATION; E6-AP; DETERMINANTS; MECHANISM; COMPLEX; UBE3A	By exploiting I-125-polyubiquitin chain formation as a functional readout of enzyme activity, we have quantitatively examined the mechanism of human E6AP/UBE3A for the first time. Initial rate studies identify UbcH7 as the cognate E2 carrier protein for E6AP, although related Ubc5 isoforms and the ISG15-specific UbcH8 paralog also support E6AP with reduced efficacy due to impaired binding and catalytic competence. Initial rates of polyubiquitin chain formation displayed hyperbolic kinetics with respect to UbcH7 concentration (K-m = 57.6 +/- 5.7 nM and k(cat) = 0.032 +/- 0.001 s(-1)) and substrate inhibition above 2 mu M. Competitive inhibition by an isosteric UbcH7C86S-ubiquitin oxyester substrate analog (K-i = 64 +/- 18 nM) demonstrates that Km reflects intrinsic substrate affinity. In contrast, noncompetitive inhibition by a UbcH7C86A product analog (K-i = 7 +/- 0.7 mu M) and substrate inhibition at high concentrations require two functionally distinct E2 similar to ubiquitin substrate binding sites. The kinetics of polyubiquitin chain formation reflect binding at a cryptic Site 1 not previously recognized that catalyzes E6AP similar to ubiquitin thioester formation. Subsequent binding of E2 similar to ubiquitin at the canonical Site 2 present in the extant crystal structure is responsible for polyubiquitin chain elongation. Other rate studies show that the conserved -4 Phe(849) residue is required for polyubiquitin chain formation rather than target protein conjugation as originally suggested. The present studies unambiguously preclude earlier models for the mechanism of Hect domain-catalyzed conjugation through the canonical binding site suggested by the crystal structure and define a novel two-step mechanism for formation of the polyubiquitin degradation signal.	[Ronchi, Virginia P.; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034009 (to A. L. H.).	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Bedard KM, 2008, J VIROL, V82, P3894, DOI 10.1128/JVI.01818-07; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cook EH, 1997, AM J HUM GENET, V60, P928; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Gao QS, 2001, J VIROL, V75, P4459, DOI 10.1128/JVI.75.9.4459-4466.2001; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Haas AL, 1997, FASEB J, V11, P1257; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HAAS AL, 2006, PROTEIN DEGRADATION, P103; Haas Arthur L., 2005, V301, P23; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hu Y, 2009, CANCER INVEST, V27, P298, DOI 10.1080/07357900802350798; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Ng CC, 2003, ONCOGENE, V22, P4449, DOI 10.1038/sj.onc.1206586; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Purbeck C, 2010, BIOCHEMISTRY-US, V49, P1361, DOI 10.1021/bi9014693; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	62	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10349	10360		10.1074/jbc.M113.458059	http://dx.doi.org/10.1074/jbc.M113.458059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439649	Green Published, hybrid			2022-12-28	WOS:000317565000016
J	Song, DS; Li, LS; Heaton-Johnson, KJ; Arsenault, PR; Master, SR; Lee, FS				Song, Daisheng; Li, Lin-Sheng; Heaton-Johnson, Katherine J.; Arsenault, Patrick R.; Master, Stephen R.; Lee, Frank S.			Prolyl Hydroxylase Domain Protein 2 (PHD2) Binds a Pro-Xaa-Leu-Glu Motif, Linking It to the Heat Shock Protein 90 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; TUMOR-SUPPRESSOR PROTEIN; PROLINE HYDROXYLATION; CRYSTAL-STRUCTURE; CO-CHAPERONE; MYND DOMAIN; HIF-ALPHA; HSP90; OXYGEN; ERYTHROCYTOSIS	Prolyl hydroxylase domain protein 2 (PHD2, also known as Egg Laying Defective Nine homolog 1) is a key oxygen-sensing protein in metazoans. In an oxygen-dependent manner, PHD2 site-specifically prolyl hydroxylates the master transcription factor of the hypoxic response, hypoxia-inducible factor-alpha (HIF-alpha), thereby targeting HIF-alpha for degradation. In this report we show that the heat shock protein 90 (HSP90) co-chaperones p23 and FKBP38 interact via a conserved Pro-Xaa-Leu-Glu motif (where Xaa = any amino acid) in these proteins with the N-terminal Myeloid Nervy and DEAF-1 (MYND)-type zinc finger of PHD2. Knockdown of p23 augments hypoxia-induced HIF-1 alpha protein levels and HIF target genes. We propose that p23 recruits PHD2 to the HSP90 machinery to facilitate HIF-1 alpha hydroxylation. These findings identify a link between two ancient pathways, the PHD: HIF and the HSP90 pathways, and suggest that this link was established concurrent with the emergence of the PHD: HIF pathway in evolution.	[Song, Daisheng; Li, Lin-Sheng; Heaton-Johnson, Katherine J.; Arsenault, Patrick R.; Master, Stephen R.; Lee, Frank S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, FS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	Arsenault, Patrick/F-3429-2011	Arsenault, Patrick/0000-0001-6670-0809; Lee, Frank/0000-0003-2511-1834; Master, Stephen/0000-0002-6808-631X	National Institutes of Health [R01-GM090301, R01-CA153347]; NATIONAL CANCER INSTITUTE [R01CA153347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM090301 (to F. S. L. and S. R. M.) and R01-CA153347 (to F. S. L.).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Beall CM, 2011, HIGH ALT MED BIOL, V12, P101, DOI 10.1089/ham.2011.1007; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Edlich F, 2011, CURR OPIN PHARMACOL, V11, P348, DOI 10.1016/j.coph.2011.03.011; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Huang JH, 2010, CANCER BIOL THER, V9, P303, DOI 10.4161/cbt.9.4.10744; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Somarelli JA, 2008, PROTEINS, V72, P197, DOI 10.1002/prot.21908; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; WINIEWSKI JR, 2009, NAT METHODS, V6, P359, DOI DOI 10.1038/NMETH.1322; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu F, 2001, CANCER RES, V61, P4136	55	44	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9662	9674		10.1074/jbc.M112.440552	http://dx.doi.org/10.1074/jbc.M112.440552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413029	Green Published, hybrid			2022-12-28	WOS:000317114000009
J	Galea, GL; Meakin, LB; Sugiyama, T; Zebda, N; Sunters, A; Taipaleenmaki, H; Stein, GS; van Wijnen, AJ; Lanyon, LE; Price, JS				Galea, Gabriel L.; Meakin, Lee B.; Sugiyama, Toshihiro; Zebda, Noureddine; Sunters, Andrew; Taipaleenmaki, Hanna; Stein, Gary S.; van Wijnen, Andre J.; Lanyon, Lance E.; Price, Joanna S.			Estrogen Receptor alpha Mediates Proliferation of Osteoblastic Cells Stimulated by Estrogen and Mechanical Strain, but Their Acute Down-regulation of the Wnt Antagonist Sost Is Mediated by Estrogen Receptor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INHIBITS ADIPOCYTE DIFFERENTIATION; MESENCHYMAL STEM-CELLS; ER-ALPHA; GENE-EXPRESSION; CORTICAL BONE; IN-VIVO; OSTEOGENIC RESPONSE; POSTMENOPAUSAL WOMEN; SIGNALING PATHWAYS	Mechanical strain and estrogens both stimulate osteoblast proliferation through estrogen receptor (ER)-mediated effects, and both down-regulate the Wnt antagonist Sost/sclerostin. Here, we investigate the differential effects of ER alpha and -beta in these processes in mouse long bone-derived osteoblastic cells and human Saos-2 cells. Recruitment to the cell cycle following strain or 17 beta-estradiol occurs within 30 min, as determined by Ki-67 staining, and is prevented by the ER alpha antagonist 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride. ER beta inhibition with 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-beta]pyrimidin-3-yl]phenol (PTHPP) increases basal proliferation similarly to strain or estradiol. Both strain and estradiol down-regulate Sost expression, as does in vitro inhibition or in vivo deletion of ER alpha. The ER beta agonists 2,3-bis(4-hydroxyphenyl)-propionitrile and ERB041 also down-regulated Sost expression in vitro, whereas the ER alpha agonist 4,4',4 ''-[4-propyl-(1H)-pyrazol-1,3,5-triyl]tris-phenol or the ER beta antagonist PTHPP has no effect. Tamoxifen, a nongenomic ER beta agonist, down-regulates Sost expression in vitro and in bones in vivo. Inhibition of both ERs with fulvestrant or selective antagonism of ER beta, but not ER alpha, prevents Sost down-regulation by strain or estradiol. Sost down-regulation by strain or ER beta activation is prevented by MEK/ERK blockade. Exogenous sclerostin has no effect on estradiol-induced proliferation but prevents that following strain. Thus, in osteoblastic cells the acute proliferative effects of both estradiol and strain are ER alpha-mediated. Basal Sost down-regulation follows decreased activity of ER alpha and increased activity of ER beta. Sost down-regulation by strain or increased estrogens is mediated by ER beta, not ER alpha. ER-targeting therapy may facilitate structurally appropriate bone formation by enhancing the distinct ligand-independent, strain-related contributions to proliferation of both ER alpha and ER beta.	[Galea, Gabriel L.; Meakin, Lee B.; Sugiyama, Toshihiro; Zebda, Noureddine; Lanyon, Lance E.; Price, Joanna S.] Univ Bristol, Sch Vet Sci, Bristol BS40 5DU, Avon, England; [Sunters, Andrew] Univ London, Royal Vet Coll, London NW1 0TU, England; [Taipaleenmaki, Hanna; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Taipaleenmaki, Hanna; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA	University of Bristol; University of London; University of London Royal Veterinary College; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Galea, GL (corresponding author), Univ Bristol, Sch Vet Sci, Southwell St, Bristol BS2 8EJ, Avon, England.	gabriel.galea@bristol.ac.uk	Meakin, Lee/H-7726-2019; Taipaleennmäki, Hanna/GRX-7143-2022; Galea, Gabriel/I-9374-2019; van Wijnen, Andre J./AAG-3578-2019	Meakin, Lee/0000-0002-2161-9414; Galea, Gabriel/0000-0003-2515-1342; van Wijnen, Andre J./0000-0002-4458-0946; Sugiyama, Toshihiro/0000-0001-5551-1340	Wellcome Trust; National Institutes of Health Grant [R01AR049069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Wellcome Trust. This work was also supported in part by National Institutes of Health Grant R01AR049069 (to A. v. W.).; Recipients of veterinary integrated training fellowships from the Wellcome Trust.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P1789, DOI 10.1007/s00198-011-1806-8; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Barou O, 1998, AM J PHYSIOL-ENDOC M, V274, pE108, DOI 10.1152/ajpendo.1998.274.1.E108; Bartella V, 2012, BREAST CANCER RES TR, V134, P569, DOI 10.1007/s10549-012-2090-9; Becker K. A., 2005, CELL BIOL HDB LAB MA, P103; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Bradford PG, 2010, PHYSIOL BEHAV, V99, P181, DOI 10.1016/j.physbeh.2009.04.025; Braidman IP, 2001, J BONE MINER RES, V16, P214, DOI 10.1359/jbmr.2001.16.2.214; Callewaert F, 2010, J BONE MINER RES, V25, P124, DOI 10.1359/jbmr.091001; Cao LH, 2003, J CELL BIOCHEM, V89, P152, DOI 10.1002/jcb.10486; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Cheng MZ, 2002, J BONE MINER RES, V17, P593, DOI 10.1359/jbmr.2002.17.4.593; Chung CJ, 2007, AM J ORTHOD DENTOFAC, V132, pU13, DOI 10.1016/j.ajodo.2007.02.049; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Cooke AL, 2008, J CLIN ONCOL, V26, P5227, DOI 10.1200/JCO.2007.15.7123; Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Dupont S, 2000, DEVELOPMENT, V127, P4277; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Ghule PN, 2007, J CELL PHYSIOL, V213, P9, DOI 10.1002/jcp.21119; Ghule PN, 2011, J CELL PHYSIOL, V226, P1149, DOI 10.1002/jcp.22440; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hagino H, 2005, BONE, V36, P444, DOI 10.1016/j.bone.2004.12.013; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Hawse JR, 2008, MOL ENDOCRINOL, V22, P1579, DOI 10.1210/me.2007-0253; Hong L, 2011, STEM CELLS DEV, V20, P925, DOI 10.1089/scd.2010.0125; Hong L, 2009, J STEROID BIOCHEM, V114, P180, DOI 10.1016/j.jsbmb.2009.02.001; Il Modder U, 2011, J BONE MINER RES, V26, P27, DOI 10.1002/jbmr.128; Ivanova MM, 2011, FASEB J, V25, P1402, DOI 10.1096/fj.10-169029; Jessop HL, 2004, J BONE MINER RES, V19, P938, DOI 10.1359/jbmr.2004.19.6.938; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Jessop HL, 2001, J BONE MINER RES, V16, P1045, DOI 10.1359/jbmr.2001.16.6.1045; Jin WJ, 2012, OSTEOPOROSIS INT, V23, P2469, DOI 10.1007/s00198-011-1859-8; Kallio A, 2008, MOL CELL ENDOCRINOL, V289, P38, DOI 10.1016/j.mce.2008.03.005; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Khalid O, 2008, ENDOCRINOLOGY, V149, P5984, DOI 10.1210/en.2008-0680; Kietz S, 2004, BIOCHEM BIOPH RES CO, V320, P76, DOI 10.1016/j.bbrc.2004.05.132; Kim JH, 2011, BMB REP, V44, P452, DOI 10.5483/BMBRep.2011.44.7.452; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Kudwa AE, 2003, J NEUROENDOCRINOL, V15, P978, DOI 10.1046/j.1365-2826.2003.01089.x; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Lanyon LE, 2007, CLIN REV BONE MINER, V5, P234, DOI 10.1007/s12018-008-9011-9; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Leskela HV, 2006, BONE, V39, P1026, DOI 10.1016/j.bone.2006.05.003; Li Y, 2012, J BONE MINER RES, V27, P1263, DOI 10.1002/jbmr.1574; Lindberg K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2865; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Maran A, 2006, BONE, V39, P523, DOI 10.1016/j.bone.2006.03.006; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; McCarthy TL, 2011, GENE, V479, P16, DOI 10.1016/j.gene.2011.02.002; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Niziolek PJ, 2012, BONE, V51, P459, DOI 10.1016/j.bone.2012.05.023; Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002; Ogita M, 2008, ENDOCRINOLOGY, V149, P5713, DOI 10.1210/en.2008-0369; Okazaki R, 2002, ENDOCRINOLOGY, V143, P2349, DOI 10.1210/en.143.6.2349; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Pettersson K, 2000, ONCOGENE, V19, P4970, DOI 10.1038/sj.onc.1203828; Quaedackers ME, 2001, ENDOCRINOLOGY, V142, P1156, DOI 10.1210/en.142.3.1156; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Rozen S, 2000, Methods Mol Biol, V132, P365; Saika M, 2001, ENDOCRINOLOGY, V142, P2205, DOI 10.1210/en.142.6.2205; Sakai D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024847; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE484, DOI 10.1152/ajpendo.00189.2007; Saxon LK, 2012, ENDOCRINOLOGY, V153, P2254, DOI 10.1210/en.2011-1977; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Silvestrini G, 2007, J MOL HISTOL, V38, P261, DOI 10.1007/s10735-007-9096-3; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Somjen D, 2011, J STEROID BIOCHEM, V125, P226, DOI 10.1016/j.jsbmb.2011.03.006; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Taku K, 2011, MATURITAS, V70, P333, DOI 10.1016/j.maturitas.2011.09.001; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; van der Eerden BCJ, 2004, J ENDOCRINOL, V180, P457, DOI 10.1677/joe.0.1800457; Waters KM, 2001, J CELL BIOCHEM, V83, P448, DOI 10.1002/jcb.1242; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Windahl SH, 2013, J BONE MINER RES, V28, P291, DOI 10.1002/jbmr.1754; Windahl SH, 2001, J BONE MINER RES, V16, P1388, DOI 10.1359/jbmr.2001.16.8.1388; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Xie H, 2011, J BONE MINER RES, V26, P156, DOI 10.1002/jbmr.169; Yu LC, 2011, BONE, V49, P1131, DOI 10.1016/j.bone.2011.08.016; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zaman G, 2000, BONE, V27, P233, DOI 10.1016/S8756-3282(00)00324-0; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035736; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhao YY, 2009, EXP MOL MED, V41, P478, DOI 10.3858/emm.2009.41.7.053	119	79	89	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9035	9048		10.1074/jbc.M112.405456	http://dx.doi.org/10.1074/jbc.M112.405456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23362266	Green Published, hybrid			2022-12-28	WOS:000316862200023
J	Nadanaka, S; Zhou, SB; Kagiyama, S; Shoji, N; Sugahara, K; Sugihara, K; Asano, M; Kitagawa, H				Nadanaka, Satomi; Zhou, Shaobo; Kagiyama, Shoji; Shoji, Naoko; Sugahara, Kazuyuki; Sugihara, Kazushi; Asano, Masahide; Kitagawa, Hiroshi			EXTL2, a Member of the EXT Family of Tumor Suppressors, Controls Glycosaminoglycan Biosynthesis in a Xylose Kinase-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; CHONDROITIN N-ACETYLGALACTOSAMINYLTRANSFERASE; HEPARAN-SULFATE; GENOMIC STRUCTURE; GENE; IDENTIFICATION; EXPRESSION; INITIATION; PROTEOGLYCANS; LOCALIZATION	Mutant alleles of EXT1 or EXT2, two members of the EXT gene family, are causative agents in hereditary multiple exostoses, and their gene products function together as a polymerase in the biosynthesis of heparan sulfate. EXTL2, one of three EXT-like genes in the human genome that are homologous to EXT1 and EXT2, encodes a transferase that adds not only GlcNAc but also N-acetylgalactosamine to the glycosaminoglycan (GAG)-protein linkage region via an alpha 1,4-linkage. However, both the role of EXTL2 in the biosynthesis of GAGs and the biological significance of EXTL2 remain unclear. Here we show that EXTL2 transfers a GlcNAc residue to the tetrasaccharide linkage region that is phosphorylated by a xylose kinase 1 (FAM20B) and thereby terminates chain elongation. We isolated an oligosaccharide from the mouse liver, which was not detected in EXTL2 knock-out mice. Based on structural analysis by a combination of glycosidase digestion and 500-MHz H-1 NMR spectroscopy, the oligosaccharide was found to be GlcNAc alpha 1-4GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate), which was considered to be a biosynthetic intermediate of an immature GAG chain. Indeed, EXTL2 specifically transferred a GlcNAc residue to a phosphorylated linkage tetrasaccharide, GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate). Remarkably, the phosphorylated linkage pentasaccharide generated by EXTL2 was not used as an acceptor for heparan sulfate or chondroitin sulfate polymerases. Moreover, production of GAGs was significantly higher in EXTL2 knock-out mice than in wild-type mice. These results indicate that EXTL2 functions to suppress GAG biosynthesis that is enhanced by a xylose kinase and that the EXTL2-dependent mechanism that regulates GAG biosynthesis might be a "quality control system" for proteoglycans.	[Nadanaka, Satomi; Zhou, Shaobo; Kagiyama, Shoji; Shoji, Naoko; Sugahara, Kazuyuki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan	Kobe Pharmaceutical University; Kanazawa University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Program for the Strategic Research Foundation at Private Universities; MEXT, Japan [23110002]; Grants-in-Aid for Scientific Research [23500493] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Strategic Research Foundation at Private Universities; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities, 2012-2017 (to H. K.) and was supported in part by a Grant-in-Aid for Scientific Research in Innovative Areas 23110002 (Deciphering Sugar Chain-based Signals Regulating Integrative Neuronal Functions (to H. K.)) from MEXT, Japan.	Arai T, 1999, INT J ONCOL, V15, P915; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; DEWAARD P, 1992, J BIOL CHEM, V267, P6036; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Fansson LA, 2000, MATRIX BIOL, V19, P367, DOI 10.1016/S0945-053X(00)00083-4; HECHT JT, 1995, AM J HUM GENET, V56, P1125; HEINEGAR.D, 1972, BIOCHIM BIOPHYS ACTA, V285, P193, DOI 10.1016/0005-2795(72)90191-2; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; KITAGAWA H, 1995, J BIOL CHEM, V270, P22190, DOI 10.1074/jbc.270.38.22190; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; KITAGAWA H, 1995, J BIOCHEM-TOKYO, V117, P1083, DOI 10.1093/oxfordjournals.jbchem.a124810; Kitagawa H, 2001, BIOCHEM J, V358, P539, DOI 10.1042/0264-6021:3580539; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Kitagawa H, 1999, GLYCOBIOLOGY, V9, P697, DOI 10.1093/glycob/9.7.697; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Prante C, 2006, STEM CELLS, V24, P2252, DOI 10.1634/stemcells.2005-0508; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; VanHul W, 1997, AM J HUM GENET, V61, P363, DOI 10.1086/514844; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796; Wuyts W, 1999, CYTOGENET CELL GENET, V86, P267, DOI 10.1159/000015317	36	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9321	9333		10.1074/jbc.M112.416909	http://dx.doi.org/10.1074/jbc.M112.416909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395820	Green Published, hybrid			2022-12-28	WOS:000316862200050
J	Reed, JH; Jain, M; Lee, K; Kandimalla, ER; Faridi, MH; Buyon, JP; Gupta, V; Clancy, RM				Reed, Joanne H.; Jain, Manish; Lee, Kristen; Kandimalla, Ekambar R.; Faridi, Mohd Hafeez; Buyon, Jill P.; Gupta, Vineet; Clancy, Robert M.			Complement Receptor 3 Influences Toll-like Receptor 7/8-Dependent Inflammation IMPLICATIONS FOR AUTOIMMUNE DISEASES CHARACTERIZED BY ANTIBODY REACTIVITY TO RIBONUCLEOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIAC MANIFESTATIONS; FUNCTIONAL VARIANT; ITGAM; TOLL-LIKE-RECEPTOR-7; ASSOCIATION; AUTOANTIGEN; PATHWAY; CELLS; RISK	Toll-like receptor (TLR) signaling is an important component in the inflammatory response generated in diseases characterized by autoantibody reactivity to proteins such as SSA/Ro in complex with endogenous nucleic acids. Complement receptor 3 (CR3), a genetic variant of which has been identified as a risk factor in systemic lupus erythematosus, has been shown to induce tolerogenic responses in dendritic cells and suppress TLR4 responses in a murine sepsis model. Accordingly, this study addressed the hypothesis that activation of CR3, influenced by genotype of CD11b, negatively regulates TLR7/8-dependent effector function. Allosteric activation of CD11b via pretreatment with the small molecule, leukadhedrin 1 (LA1), significantly attenuated TLR7/8-induced (hY3 RNA, R848) secretion of TNF alpha in THP-1 cells and human macrophages isolated from donors homozygous for the ancestral common ITGAM allele at rs1143679. This inhibition was accompanied by profound degradation of the adaptor protein MyD88, an effect not observed with direct inhibition of TLR ligation by an antagonist oligonucleotide. In contrast, the addition of LA1 after incubation with the TLR agonists did not result in MyD88 degradation and subsequent attenuation of TNF alpha secretion. In TLR7/8-stimulated macrophages isolated from donors heterozygous for the CD11b variant, pretreatment with LA1 did not down-regulate TNF alpha release. These novel findings support a negative cross-talk between CR3 and TLR pathways likely to be induced by antibodies reactive with ribonucleoproteins and point to the development of CR3-specific agonists as potential therapeutics for diseases such as neonatal lupus.	[Reed, Joanne H.; Jain, Manish; Lee, Kristen; Buyon, Jill P.; Clancy, Robert M.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10016 USA; [Kandimalla, Ekambar R.] Idera Pharmaceut Inc, Cambridge, MA 02139 USA; [Faridi, Mohd Hafeez; Gupta, Vineet] Univ Miami, Div Nephrol & Hypertens, Dept Med, Peggy & Harold Katz Family Drug Discovery Ctr, Miami, FL 33136 USA	New York University; University of Miami	Reed, JH (corresponding author), NYU, Sch Med, Dept Med, 560 1st Ave,TCH 407, New York, NY 10016 USA.	Joanne.Reed@nyumc.org		Reed, Joanne/0000-0002-7585-7848; Lee, Kristen/0000-0002-6837-9569; Buyon, Jill/0000-0002-3852-7129; Gupta, Vineet/0000-0001-6987-2550	Alliance for Lupus Research grant; American Heart Association; Arthritis Foundation grant; National Institutes of Health [AR-42455, DK-084195]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR042455, R01AR042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084195] Funding Source: NIH RePORTER	Alliance for Lupus Research grant; American Heart Association(American Heart Association); Arthritis Foundation grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an Alliance for Lupus Research grant (to R. C.), American Heart Association grants (to J. R. and V. G.), Arthritis Foundation grant (to J. R.), and National Institutes of Health Grants AR-42455 (to J. B.) and DK-084195 (to V. G.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Alvarez D., 2011, J BIOL CHEM; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Clancy RM, 2010, J IMMUNOL, V184, P2148, DOI 10.4049/jimmunol.0902248; Fan Y, 2011, J EUR ACAD DERMATOL, V25, P271, DOI 10.1111/j.1468-3083.2010.03776.x; Faridi MH, 2009, BIOORG MED CHEM LETT, V19, P6902, DOI 10.1016/j.bmcl.2009.10.077; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Hoffmann MH, 2010, J AUTOIMMUN, V34, pJ178, DOI 10.1016/j.jaut.2009.11.013; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Izmirly PM, 2012, CIRCULATION, V126, P76, DOI 10.1161/CIRCULATIONAHA.111.089268; Izmirly PM, 2010, ANN RHEUM DIS, V69, P1827, DOI 10.1136/ard.2009.119263; Lan T, 2007, P NATL ACAD SCI USA, V104, P13750, DOI 10.1073/pnas.0706059104; Lan T, 2009, J MED CHEM, V52, P6871, DOI 10.1021/jm901145s; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; MacPherson M, 2011, J BIOL CHEM, V286, P17303, DOI 10.1074/jbc.M110.182998; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; MERRILL JT, 1990, J IMMUNOL, V145, P2608; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Rhodes B, 2012, ANN RHEUM DIS, V71, P2028, DOI 10.1136/annrheumdis-2012-201390; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Yu D, 2009, J MED CHEM, V52, P5108, DOI 10.1021/jm900730r	28	36	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9077	9083		10.1074/jbc.M112.403303	http://dx.doi.org/10.1074/jbc.M112.403303			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386618	hybrid, Green Published			2022-12-28	WOS:000316862200027
J	Klein, G; Muller-Loennies, S; Lindner, B; Kobylak, N; Brade, H; Raina, S				Klein, Gracjana; Mueller-Loennies, Sven; Lindner, Buko; Kobylak, Natalia; Brade, Helmut; Raina, Satish			Molecular and Structural Basis of Inner Core Lipopolysaccharide Alterations in Escherichia coli INCORPORATION OF GLUCURONIC ACID AND PHOSPHOETHANOLAMINE IN THE HEPTOSE REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; GENE; OLIGOSACCHARIDE; TRANSFERASE; O157-H7; TYPHIMURIUM; REGIONS; CLONING; PROTEIN; OPERON	It is well established that lipopolysaccharide (LPS) often carries nonstoichiometric substitutions in lipid A and in the inner core. In this work, the molecular basis of inner core alterations and their physiological significance are addressed. A new inner core modification of LPS is described, which arises due to the addition of glucuronic acid on the third heptose with a concomitant loss of phosphate on the second heptose. This was shown by chemical and structural analyses. Furthermore, the gene whose product is responsible for the addition of this sugar was identified in all Escherichia coli core types and in Salmonella and was designated waaH. Its deduced amino acid sequence exhibits homology to glycosyltransferase family 2. The transcription of the waaH gene is positively regulated by the PhoB/R two-component system in a growth phase-dependent manner, which is coordinated with the transcription of the ugd gene explaining the genetic basis of this modification. Glucuronic acid modification was observed in E. coli B, K12, R2, and R4 core types and in Salmonella. We also show that the phosphoethanolamine (P-EtN) addition on heptose I in E. coli K12 requires the product of the ORF yijP, a new gene designated as eptC. Incorporation of P-EtN is also positively regulated by PhoB/R, although it can occur at a basal level without a requirement for any regulatory inducible systems. This P-EtN modification is essential for resistance to a variety of factors, which destabilize the outer membrane like the addition of SDS or challenge to sublethal concentrations of Zn2+.	[Klein, Gracjana; Mueller-Loennies, Sven; Lindner, Buko; Brade, Helmut; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Klein, Gracjana; Kobylak, Natalia; Raina, Satish] Gdansk Univ Technol, Dept Microbiol, PL-80233 Gdansk, Poland	Forschungszentrum Borstel; Fahrenheit Universities; Gdansk University of Technology	Raina, S (corresponding author), Gdansk Univ Technol, Dept Microbiol, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932; Klein, Gracjana/0000-0001-8695-8065; Kobylak, Natalia/0000-0002-7908-2613	National Science Centre [2011/03/B/NZ1/02825]	National Science Centre(National Science Centre, Poland)	This work was supported by National Science Centre Grant 2011/03/B/NZ1/02825 (to S.R.).	Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; ARONSON BD, 1989, J BIOL CHEM, V264, P5226; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; BOCK K, 1992, CARBOHYD RES, V229, P213, DOI 10.1016/S0008-6215(00)90571-8; Currie CG, 1999, FEMS IMMUNOL MED MIC, V24, P57, DOI 10.1016/S0928-8244(99)00007-3; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Fresno S, 2007, J BACTERIOL, V189, P1128, DOI 10.1128/JB.01489-06; Frirdich E, 2005, J ENDOTOXIN RES, V11, P133, DOI 10.1179/096805105X46592; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gronow Sabine, 2009, Innate Immun, V15, P13, DOI 10.1177/1753425908099765; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; LUDERITZ O, 1966, ANN NY ACAD SCI, V133, P349, DOI 10.1111/j.1749-6632.1966.tb52376.x; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Muller-Loennies S, 2002, EUR J BIOCHEM, V269, P5982, DOI 10.1046/j.1432-1033.2002.03322.x; Muller-Loennies S, 1999, EUR J BIOCHEM, V260, P235, DOI 10.1046/j.1432-1327.1999.00134.x; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1991, J BACTERIOL, V173, P5999, DOI 10.1128/jb.173.19.5999-6008.1991; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMIDT G, 1969, EUR J BIOCHEM, V10, P501, DOI 10.1111/j.1432-1033.1969.tb00717.x; SCHMIDT G, 1974, EUR J BIOCHEM, V42, P303, DOI 10.1111/j.1432-1033.1974.tb03340.x; SCHMIDT G, 1970, EUR J BIOCHEM, V14, P357, DOI 10.1111/j.1432-1033.1970.tb00297.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Tamayo R, 2002, INFECT IMMUN, V70, P6770, DOI 10.1128/IAI.70.12.6770-6778.2002; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Vinogradov EV, 1999, EUR J BIOCHEM, V261, P629, DOI 10.1046/j.1432-1327.1999.00280.x; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yoon JW, 2004, MOL MICROBIOL, V51, P419, DOI 10.1046/j.1365-2958.2003.03827.x; Yoshida Y, 2011, J MICROBIOL, V49, P285, DOI 10.1007/s12275-011-0360-6; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503	48	36	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8111	8127		10.1074/jbc.M112.445981	http://dx.doi.org/10.1074/jbc.M112.445981			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23372159	Green Published, hybrid			2022-12-28	WOS:000316564500012
J	Shimamoto, S; Kubota, Y; Yamaguchi, F; Tokumitsu, H; Kobayashi, R				Shimamoto, Seiko; Kubota, Yasuo; Yamaguchi, Fuminori; Tokumitsu, Hiroshi; Kobayashi, Ryoji			Ca2+/S100 Proteins Act as Upstream Regulators of the Chaperone-associated Ubiquitin Ligase CHIP (C Terminus of Hsc70-interacting Protein)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; U-BOX PROTEINS; TETRATRICOPEPTIDE REPEAT; PROTEASOMAL DEGRADATION; CARBOXYL-TERMINUS; S100 PROTEINS; MEDIATED DEGRADATION; MOLECULAR CHAPERONES; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI	The U-box E3 ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein) binds Hsp90 and/or Hsp70 via its tetratricopeptide repeat (TPR), facilitating ubiquitination of the chaperone-bound client proteins. Mechanisms that regulate the activity of CHIP are, at present, poorly understood. We previously reported that Ca2+/S100 proteins directly associate with the TPR proteins, such as Hsp70/Hsp90-organizing protein (Hop), kinesin light chain, Tom70, FKBP52, CyP40, and protein phosphatase 5 (PP5), leading to the dissociation of the interactions of the TPR proteins with their target proteins. Therefore, we have hypothesized that Ca2+/S100 proteins can interact with CHIP and regulate its function. GST pulldown assays indicated that Ca2+/S100A2 and S100P bind to the TPR domain and lead to interference with the interactions of CHIP with Hsp70, Hsp90, HSF1, and Smad1. In vitro ubiquitination assays indicated that Ca2+/S100A2 and S100P are efficient and specific inhibitors of CHIP-mediated ubiquitination of Hsp70, Hsp90, HSF1, and Smad1. Overexpression of S100A2 and S100P suppressed CHIP-chaperone complex-dependent mutant p53 ubiquitination and degradation in Hep3B cells. The association of the S100 proteins with CHIP provides a Ca2+-dependent regulatory mechanism for the ubiquitination and degradation of intracellular proteins by the CHIP-proteasome pathway.	[Shimamoto, Seiko; Tokumitsu, Hiroshi; Kobayashi, Ryoji] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Miki, Kagawa 7610793, Japan; [Kubota, Yasuo] Kagawa Univ, Fac Med, Dept Dermatol, Miki, Kagawa 7610793, Japan; [Yamaguchi, Fuminori] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Shimamoto, Seiko] Kagawa Univ, Nanomicro Struct Device Integrated Res Ctr, Takamatsu, Kagawa 7610396, Japan	Kagawa University; Kagawa University; Kagawa University; Kagawa University	Kobayashi, R (corresponding author), Kagawa Univ, Fac Med, Dept Signal Transduct Sci, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	ryoji@med.kagawa-u.ac.jp	Tokumitsu, Hiroshi/M-3978-2015	Tokumitsu, Hiroshi/0000-0002-2193-6794	Kagawa University Characteristic Prior Research Fund	Kagawa University Characteristic Prior Research Fund	This research was supported by the Kagawa University Characteristic Prior Research Fund 2011.	Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Arumugam T, 2011, AMINO ACIDS, V41, P893, DOI 10.1007/s00726-010-0496-4; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bennett MK, 1997, CURR OPIN NEUROBIOL, V7, P316, DOI 10.1016/S0959-4388(97)80058-X; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kim SA, 2005, FEBS LETT, V579, P6559, DOI 10.1016/j.febslet.2005.10.043; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Li RF, 2005, COLLOID SURFACE B, V40, P133, DOI 10.1016/j.colsurfb.2004.10.013; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Morano KA, 1999, GENE EXPRESSION, V7, P271; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Murata S, 2005, METHOD ENZYMOL, V398, P271, DOI 10.1016/S0076-6879(05)98022-1; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; Shimamoto S, 2008, J BIOL CHEM, V283, P28246, DOI 10.1074/jbc.M801473200; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Wolf S, 2011, AMINO ACIDS, V41, P849, DOI 10.1007/s00726-010-0623-2; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Yamashita K, 1999, PROTEIN EXPRES PURIF, V16, P47, DOI 10.1006/prep.1998.1026; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	62	30	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7158	7168		10.1074/jbc.M112.436758	http://dx.doi.org/10.1074/jbc.M112.436758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344957	Green Published, hybrid			2022-12-28	WOS:000316002400037
J	Ito, T; Katayama, T; Hattie, M; Sakurama, H; Wada, J; Suzuki, R; Ashida, H; Wakagi, T; Yamamoto, K; Stubbs, KA; Fushinobu, S				Ito, Tasuku; Katayama, Takane; Hattie, Mitchell; Sakurama, Haruko; Wada, Jun; Suzuki, Ryuichiro; Ashida, Hisashi; Wakagi, Takayoshi; Yamamoto, Kenji; Stubbs, Keith A.; Fushinobu, Shinya			Crystal Structures of a Glycoside Hydrolase Family 20 Lacto-N-biosidase from Bifidobacterium bifidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; HUMAN-MILK OLIGOSACCHARIDES; BETA-HEXOSAMINIDASE-B; ACETYL-D-GLUCOSAMINE; MOLECULAR-CLONING; BIOSE; ACETYLHEXOSAMINIDASE; ENZYME; MECHANISM; INSIGHTS	Human milk oligosaccharides contain a large variety of oligosaccharides, of which lacto-N-biose I (Gal-beta 1,3-GlcNAc; LNB) predominates as a major core structure. A unique metabolic pathway specific for LNB has recently been identified in the human commensal bifidobacteria. Several strains of infant gut-associated bifidobacteria possess lacto-N-biosidase, a membrane-anchored extracellular enzyme, that liberates LNB from the nonreducing end of human milk oligosaccharides and plays a key role in the metabolic pathway of these compounds. Lacto-N-biosidase belongs to the glycoside hydrolase family 20, and its reaction proceeds via a substrate-assisted catalytic mechanism. Several crystal structures of GH20 beta-N-acetylhexosaminidases, which release monosaccharide GlcNAc from its substrate, have been determined, but to date, a structure of lacto-N-biosidase is unknown. Here, we have determined the first three-dimensional structures of lacto-N-biosidase from Bifidobacterium bifidum JCM1254 in complex with LNB and LNB-thiazoline (Gal-beta 1,3-GlcNAc-thiazoline) at 1.8-angstrom resolution. Lacto-N-biosidase consists of three domains, and the C-terminal domain has a unique beta-trefoil-like fold. Compared with other beta-N-acetylhexosaminidases, lacto-N-biosidase has a wide substrate-binding pocket with a -2 subsite specific for beta-1,3-linked Gal, and the residues responsible for Gal recognition were identified. The bound ligands are recognized by extensive hydrogen bonds at all of their hydroxyls consistent with the enzyme's strict substrate specificity for the LNB moiety. The GlcNAc sugar ring of LNB is in a distorted conformation near E-4, whereas that of LNB-thiazoline is in a C-4(1) conformation. A possible conformational pathway for the lacto-N-biosidase reaction is discussed.	[Ito, Tasuku; Suzuki, Ryuichiro; Wakagi, Takayoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Katayama, Takane; Sakurama, Haruko; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Hattie, Mitchell; Stubbs, Keith A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Wada, Jun] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Ashida, Hisashi] Kinki Univ, Fac Biol Oriented Sci & Technol, Dept Sci & Technol Food Safety, Wakayama 6496493, Japan	University of Tokyo; Ishikawa Prefecture University; University of Western Australia; Kyoto University; Kindai University (Kinki University)	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Ashida, Hisashi/HCI-0293-2022; Stubbs, Keith/H-5909-2014; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; Katayama, Takane/0000-0003-4009-7874; Ashida, Hisashi/0000-0001-5844-4075; Stubbs, Keith/0000-0001-6899-402X	Program for the Promotion of Basic Research Activities for Innovative Bioscience, Japan; Japan Society for the Promotion of Science KAKENHI [24380053]; Australian Research Council; Priority Program for Disaster-affected Quantum Beam Facilities [PF 2011G080, SPring-8 2011A1908]; Grants-in-Aid for Scientific Research [24580119] Funding Source: KAKEN	Program for the Promotion of Basic Research Activities for Innovative Bioscience, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Australian Research Council(Australian Research Council); Priority Program for Disaster-affected Quantum Beam Facilities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for the Promotion of Basic Research Activities for Innovative Bioscience, Japan (to S. F., K. Y., and T. K.), by Japan Society for the Promotion of Science KAKENHI Grant 24380053 (to S. F. and H. A.), and by the Australian Research Council. Part of this work was performed under the Priority Program for Disaster-affected Quantum Beam Facilities Proposals PF 2011G080 and SPring-8 2011A1908.	Amorelli B, 2008, BIOORG MED CHEM LETT, V18, P2944, DOI 10.1016/j.bmcl.2008.03.067; Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barboza M, 2009, APPL ENVIRON MICROB, V75, P7319, DOI 10.1128/AEM.00842-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Greig IR, 2008, J AM CHEM SOC, V130, P17620, DOI 10.1021/ja805640c; Hattie M, 2012, CHEMBIOCHEM, V13, P1128, DOI 10.1002/cbic.201200135; Hidaka M, 2009, J BIOL CHEM, V284, P7273, DOI 10.1074/jbc.M808525200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hou YM, 2001, BIOCHEMISTRY-US, V40, P2201, DOI 10.1021/bi002018s; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MAGNANI JL, 1983, CANCER RES, V43, P5489; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P42131, DOI 10.1074/jbc.M107154200; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Rappleye J, 2002, J APPL CRYSTALLOGR, V35, P374, DOI 10.1107/S0021889802005782; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; SANO M, 1992, P NATL ACAD SCI USA, V89, P8512, DOI 10.1073/pnas.89.18.8512; SANO M, 1993, J BIOL CHEM, V268, P18560; Sattelle BM, 2011, GLYCOBIOLOGY, V21, P1651, DOI 10.1093/glycob/cwr101; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; SINNOTT ML, 1984, BIOCHEM J, V224, P817, DOI 10.1042/bj2240817; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Urashima T., 2011, MILK OLIGOSACCHARIDE; Urashima T, 2012, ADV NUTR, V3, p473S, DOI 10.3945/an.111.001412; Urashima T, 2009, GLYCOBIOLOGY, V19, P499, DOI 10.1093/glycob/cwp006; Usuki H, 2008, J AM CHEM SOC, V130, P4146, DOI 10.1021/ja077641f; Venema K, 2012, INT DAIRY J, V22, P123, DOI 10.1016/j.idairyj.2011.10.011; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wada M, 2009, ACTA CRYSTALLOGR E, V65, pO1781, DOI 10.1107/S1600536809024775; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	71	38	40	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11795	11806		10.1074/jbc.M112.420109	http://dx.doi.org/10.1074/jbc.M112.420109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479733	Green Published, hybrid			2022-12-28	WOS:000318157600016
J	Ofer, N; Forer, N; Korman, M; Vishkautzan, M; Khalaila, I; Gur, E				Ofer, Naomi; Forer, Nadav; Korman, Maayan; Vishkautzan, Marina; Khalaila, Isam; Gur, Eyal			Allosteric Transitions Direct Protein Tagging by PafA, the Prokaryotic Ubiquitin-like Protein (Pup) Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PROTEASOME; DEGRADATION; PATHWAY; PUPYLATION; SMEGMATIS; MACHINE; DOP	Protein degradation via prokaryotic ubiquitin-like protein (Pup) tagging is conserved in bacteria belonging to the phyla Actinobacteria and Nitrospira. The physiological role of this novel proteolytic pathway is not yet clear, although in Mycobacterium tuberculosis, the world's most threatening bacterial pathogen, Pup tagging is important for virulence. PafA, the Pup ligase, couples ATP hydrolysis with Pup conjugation to lysine side chains of protein substrates. PafA is the sole Pup ligase in M. tuberculosis and apparently, in other bacteria. Thus, whereas PafA is a key player in the Pup tagging (i.e. pupylation) system, control of its activity and interactions with target protein substrates remain poorly understood. In this study, we examined the mechanism of protein pupylation by PafA in Mycobacterium smegmatis, a model mycobacterial organism. We report that PafA is an allosteric enzyme that binds its target substrates cooperatively and find that PafA allostery is controlled by the binding of target protein substrates, yet is unaffected by Pup binding. Analysis of PafA pupylation using engineered substrates differing in the number of pupylation sites points to PafA acting as a dimer. These findings suggest that protein pupylation can be regulated at the level of PafA allostery.	[Ofer, Naomi; Forer, Nadav; Korman, Maayan; Gur, Eyal] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Vishkautzan, Marina; Gur, Eyal] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Khalaila, Isam] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Gur, E (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Rager Blvd, IL-84105 Beer Sheva, Israel.	gure@bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778; Gur, Eyal/0000-0002-2157-1270	German-Israeli Foundation Grant [I-2230-2055.13/2009]	German-Israeli Foundation Grant(German-Israeli Foundation for Scientific Research and Development)	This work was supported in part by the German-Israeli Foundation Grant I-2230-2055.13/2009.	Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2010, CELL MICROBIOL, V12, P424, DOI 10.1111/j.1462-5822.2010.01447.x; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; Chaudhuri BN, 2003, STRUCTURE, V11, P753, DOI 10.1016/S0969-2126(03)00106-0; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Knipfer N, 1999, GENE, V231, P95, DOI 10.1016/S0378-1119(99)00087-6; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; LUPAS A, 1994, TRENDS BIOCHEM SCI, V19, P533, DOI 10.1016/0968-0004(94)90054-X; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nagy I, 1998, J BACTERIOL, V180, P5448, DOI 10.1128/JB.180.20.5448-5453.1998; Ozcelik D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2009; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Segel IH, 1975, ENZYME KINETICS, P421; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918	27	16	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11287	11293		10.1074/jbc.M112.435842	http://dx.doi.org/10.1074/jbc.M112.435842			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23471967	Green Published, hybrid			2022-12-28	WOS:000317915500031
J	Goltermann, L; Good, L; Bentin, T				Goltermann, Lise; Good, Liam; Bentin, Thomas			Chaperonins Fight Aminoglycoside-induced Protein Misfolding and Promote Short-term Tolerance in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERICIDAL ACTION; ANTIBIOTICS; SHOCK; HEAT; GROE; DNAK	For almost half of a century, we have known that aminoglycoside antibiotics corrupt ribosomes, causing translational misreading, yet it remains unclear whether or not misreading triggers protein misfolding, and possible effects of chaperone action on drug susceptibilities are poorly understood. Here, we show that aminoglycosides cause cytosolic protein misfolding and that chaperonin GroEL/GroES overexpression counters this defect. During aminoglycoside exposure to exponential cultures, chaperonin overexpression protected the bacterial membrane potential, rescued cell growth, and facilitated survival, whereas inhibition of chaperonin expression sensitized bacteria. Overexpression of the DnaK/DnaJ/GrpE chaperone system similarly facilitated survival but did not promote growth of aminoglycoside-treated bacteria. Inhibition of chaperonin expression sensitized bacteria to aminoglycosides as measured by reduced minimum inhibitory concentrations, whereas GroEL/GroES overexpression did not increase minimum inhibitory concentrations. Our observations establish misfolding of cytosolic proteins as an effect of aminoglycoside action and reveal that chaperones, chaperonins in particular, help bacteria cope during early exposure to these drugs.	[Goltermann, Lise; Bentin, Thomas] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-200 Copenhagen, Denmark; [Good, Liam] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London NW1 0TU, England	University of Copenhagen; University of London; University of London Royal Veterinary College	Bentin, T (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	bentin@sund.ku.dk		Goltermann, Lise/0000-0002-6679-9762; Good, Liam/0000-0002-2798-8640	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Carlsberg Foundation.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Cardoso K, 2010, J MED MICROBIOL, V59, P1061, DOI 10.1099/jmm.0.020339-0; DAVIES J, 1965, SCIENCE, V149, P1096, DOI 10.1126/science.149.3688.1096; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Goltermann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010104; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kindrachuk KN, 2011, ANTIMICROB AGENTS CH, V55, P1874, DOI 10.1128/AAC.00935-10; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lin JT, 2005, ANTIMICROB AGENTS CH, V49, P1915, DOI 10.1128/AAC.49.5.1915-1926.2005; Ling JQ, 2012, MOL CELL, V48, P713, DOI 10.1016/j.molcel.2012.10.001; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4	22	51	52	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10483	10489		10.1074/jbc.M112.420380	http://dx.doi.org/10.1074/jbc.M112.420380			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447537	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000317565000028
J	Zakova, L; Kletvikova, E; Veverka, V; Lepsik, M; Watson, CJ; Turkenburg, JP; Jiracek, J; Brzozowski, AM				Zakova, Lenka; Kletvikova, Emilia; Veverka, Vaclav; Lepsik, Martin; Watson, Christopher J.; Turkenburg, Johan P.; Jiracek, Jiri; Brzozowski, Andrzej M.			Structural Integrity of the B24 Site in Human Insulin Is Important for Hormone Functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENTIAL RESONANCE ASSIGNMENT; RECEPTOR-BINDING REGION; MUTANT HUMAN INSULIN; NEGATIVE COOPERATIVITY; MOLECULAR-DYNAMICS; PROTEIN; ANALOGS; CHAIN; RESIDUES; SEMISYNTHESIS	Despite the recent first structural insight into the insulin-insulin receptor complex, the role of the C terminus of the B-chain of insulin in this assembly remains unresolved. Previous studies have suggested that this part of insulin must rearrange to reveal amino acids crucial for interaction with the receptor. The role of the invariant Phe(B24), one of the key residues of the hormone, in this process remains unclear. For example, the B24 site functionally tolerates substitutions to D-amino acids but not to L-amino acids. Here, we prepared and characterized a series of B24-modified insulin analogues, also determining the structures of [D-HisB24]-insulin and [HisB24]-insulin. The inactive [HisB24]-insulin molecule is remarkably rigid due to a tight accommodation of the L-His side chain in the B24 binding pocket that results in the stronger tethering of B25-B28 residues to the protein core. In contrast, the highly active [D-HisB24]-insulin is more flexible, and the reverse chirality of the B24C(alpha) atom swayed the D-His(B24) side chain into the solvent. Furthermore, the pocket vacated by Phe(B24) is filled by Phe(B25), which mimics the Phe(B24) side and main chains. The B25 -> B24 downshift results in a subsequent downshift of Tyr(B26) into the B25 site and the departure of B26-B30 residues away from the insulin core. Our data indicate the importance of the aromatic L-amino acid at the B24 site and the structural invariance/integrity of this position for an effective binding of insulin to its receptor. Moreover, they also suggest limited, B25-B30 only, unfolding of the C terminus of the B-chain upon insulin activation.	[Zakova, Lenka; Kletvikova, Emilia; Veverka, Vaclav; Lepsik, Martin; Jiracek, Jiri] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague 6, Czech Republic; [Watson, Christopher J.; Turkenburg, Johan P.; Brzozowski, Andrzej M.] Univ York, York Struct Biol Lab, Dept Chem, York YO10 5DD, N Yorkshire, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of York - UK	Jiracek, J (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	jiracek@uochb.cas.cz; marek.brzozowski@york.ac.uk	Lepšík, Martin/X-8603-2019; Zakova, Lenka/Y-6234-2019; Jiracek, Jiri/Y-6703-2019; Lepsik, Martin/C-6614-2012; Jiracek, Jiri/A-7124-2008; Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019; Zakova, Lenka/A-7119-2008	Lepšík, Martin/0000-0003-2607-8132; Zakova, Lenka/0000-0001-6439-2574; Jiracek, Jiri/0000-0003-3848-2773; Lepsik, Martin/0000-0003-2607-8132; Jiracek, Jiri/0000-0003-3848-2773; Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Turkenburg, Johan/0000-0001-6992-6838	Grant Agency of the Czech Republic [P207/11/P430]; Ministry of Education of the Czech Republic [LK11205]; Academy of Sciences of the Czech Republic [RVO:61388963]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Diamond Light Source (Did-cot, United Kingdom); MRC [MR/K000179/1] Funding Source: UKRI; Medical Research Council [MR/K000179/1] Funding Source: researchfish	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diamond Light Source (Did-cot, United Kingdom); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Grant Agency of the Czech Republic Grant P207/11/P430 (to L.Z.), the Ministry of Education of the Czech Republic (Program "NAVRAT" LK11205, to V. V.), Research Project of the Academy of Sciences of the Czech Republic RVO:61388963 (to the Institute of Organic Chemistry and Biochemistry), and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (a Ph.D. studentship to C.J.W.). This work was also supported by the Diamond Light Source (Did-cot, United Kingdom).	Antolikova E, 2011, J BIOL CHEM, V286, P36968, DOI 10.1074/jbc.M111.265249; ASSOIAN RK, 1982, P NATL ACAD SCI-BIOL, V79, P5147, DOI 10.1073/pnas.79.17.5147; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; CASARETTO M, 1987, BIOL CHEM H-S, V368, P709, DOI 10.1515/bchm3.1987.368.1.709; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Cosgrove MS, 2002, BIOCHEMISTRY-US, V41, P6939, DOI 10.1021/bi0255219; DEMEYTS P, 1978, NATURE, V273, P504; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; DODSON EJ, 1983, BIOPOLYMERS, V22, P281, DOI 10.1002/bip.360220137; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GATTNER HG, 1980, H-S Z PHYSIOL CHEM, V361, P1135; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Glendorf T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020288; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1992, BIOCHEMISTRY-US, V31, P11940, DOI 10.1021/bi00162a037; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; INOUYE K, 1981, EXPERIENTIA, V37, P811, DOI 10.1007/BF01985653; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurapkat G, 1999, PROTEIN SCI, V8, P499; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; LUDVIGSEN S, 1994, BIOCHEMISTRY-US, V33, P7998, DOI 10.1021/bi00192a003; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAGAWA SH, 1993, BIOCHEMISTRY-US, V32, P7237, DOI 10.1021/bi00079a021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SHOELSON S, 1983, P NATL ACAD SCI-BIOL, V80, P7390, DOI 10.1073/pnas.80.24.7390; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Steiner DF, 2011, J BIOL CHEM, V286, P17399, DOI 10.1074/jbc.X111.244764; SVOBODA I, 1994, BIOL CHEM H-S, V375, P373, DOI 10.1515/bchm3.1994.375.6.373; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; Tran TT, 2006, PROTEIN ENG DES SEL, V19, P401, DOI 10.1093/protein/gzl024; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; WOLLMER A, 1981, H-S Z PHYSIOL CHEM, V362, P581, DOI 10.1515/bchm2.1981.362.1.581; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yao ZP, 1999, ACTA CRYSTALLOGR D, V55, P1524, DOI 10.1107/S0907444999008562; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2007, J PEPT SCI, V13, P334, DOI 10.1002/psc.847; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	64	35	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10230	10240		10.1074/jbc.M112.448050	http://dx.doi.org/10.1074/jbc.M112.448050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447530	Green Published, hybrid			2022-12-28	WOS:000317565000005
J	Brannmark, C; Nyman, E; Fagerholm, S; Bergenholm, L; Ekstrand, EM; Cedersund, G; Stralfors, P				Brannmark, Cecilia; Nyman, Elin; Fagerholm, Siri; Bergenholm, Linnea; Ekstrand, Eva-Maria; Cedersund, Gunnar; Stralfors, Peter			Insulin Signaling in Type 2 Diabetes EXPERIMENTAL AND MODELING ANALYSES REVEAL MECHANISMS OF INSULIN RESISTANCE IN HUMAN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SUBSTRATE-1; FAT-CELLS; GLUCOSE-TRANSPORT; PHOSPHORYLATION; ADIPOCYTES; IRS1; EXPRESSION; TRANSLOCATION; CONTRIBUTES; SENSITIVITY	Type 2 diabetes originates in an expanding adipose tissue that for unknown reasons becomes insulin resistant. Insulin resistance reflects impairments in insulin signaling, but mechanisms involved are unclear because current research is fragmented. We report a systems level mechanistic understanding of insulin resistance, using systems wide and internally consistent data from human adipocytes. Based on quantitative steady-state and dynamic time course data on signaling intermediaries, normally and in diabetes, we developed a dynamic mathematical model of insulin signaling. The model structure and parameters are identical in the normal and diabetic states of the model, except for three parameters that change in diabetes: (i) reduced concentration of insulin receptor, (ii) reduced concentration of insulin-regulated glucose transporter GLUT4, and (iii) changed feedback from mammalian target of rapamycin in complex with raptor (mTORC1). Modeling reveals that at the core of insulin resistance in human adipocytes is attenuation of a positive feedback from mTORC1 to the insulin receptor substrate-1, which explains reduced sensitivity and signal strength throughout the signaling network. Model simulations with inhibition of mTORC1 are comparable with experimental data on inhibition of mTORC1 using rapamycin in human adipocytes. We demonstrate the potential of the model for identification of drug targets, e. g. increasing the feedback restores insulin signaling, both at the cellular level and, using a multilevel model, at the whole body level. Our findings suggest that insulin resistance in an expanded adipose tissue results from cell growth restriction to prevent cell necrosis.	[Brannmark, Cecilia; Nyman, Elin; Fagerholm, Siri; Bergenholm, Linnea; Ekstrand, Eva-Maria; Cedersund, Gunnar; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	peter.stralfors@liu.se	Nyman, Elin/I-3363-2019; Ekstrand, Eva-Maria/AAI-8504-2020	Nyman, Elin/0000-0002-4261-0291; Ekstrand, Eva-Maria/0000-0001-5260-1826	Swedish Diabetes Fund; Novo Nordic Foundation; University of Linkoping; Swedish Research Council	Swedish Diabetes Fund; Novo Nordic Foundation(Novo Nordisk Foundation); University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Diabetes Fund, Novo Nordic Foundation, University of Linkoping, and the Swedish Research Council.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Danielsson A, 2009, MOL MED, V15, P228, DOI 10.2119/molmed.2009.00037; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; FROST SC, 1987, J BIOL CHEM, V262, P9872; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hussey SE, 2011, DIABETES OBES METAB, V13, P959, DOI 10.1111/j.1463-1326.2011.01426.x; Im SS, 2006, BIOCHEM J, V399, P131, DOI 10.1042/BJ20060696; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Nyman E, 2012, TRENDS ENDOCRIN MET, V23, P107, DOI 10.1016/j.tem.2011.12.007; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; OLEFSKY JM, 1976, J CLIN INVEST, V57, P1165, DOI 10.1172/JCI108384; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.057067	48	73	74	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9867	9880		10.1074/jbc.M112.432062	http://dx.doi.org/10.1074/jbc.M112.432062			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23400783	hybrid, Green Published			2022-12-28	WOS:000317114000027
J	Dugast, E; Kiss-Toth, E; Docherty, L; Danger, R; Chesneau, M; Pichard, V; Judor, JP; Pettre, S; Conchon, S; Soulillou, JP; Brouard, S; Ashton-Chess, J				Dugast, Emilie; Kiss-Toth, Endre; Docherty, Louise; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie; Soulillou, Jean-Paul; Brouard, Sophie; Ashton-Chess, Joanna			Identification of Tribbles-1 as a Novel Binding Partner of Foxp3 in Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR FOXP3; NF-KAPPA-B; SIGNALING PATHWAYS; GENE-EXPRESSION; PROLIFERATION; TRIB1; MORPHOGENESIS; DROSOPHILA	In a previous study, we identified TRIB1, a serine-threonine kinase-like molecule, as a biomarker of chronic antibody-mediated rejection of human kidneys when measured in peripheral blood mononuclear cells. Here, we focused our analysis on a specific subset of peripheral blood mononuclear cells that play a dominant role in regulating immune responses in health and disease, so-called CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs). We isolated both human and murine Treg and non-Treg counterparts and analyzed TRIB1 and Foxp3 mRNA expression by quantitative PCR on the freshly isolated cells or following 24 h of activation. Physical interaction between the human TRIB1 and Foxp3 proteins was analyzed in live cell lines by protein complementation assay using both flow cytometry and microscopy and confirmed in primary freshly isolated human CD4(+)CD25(hi)CD127(-) Tregs by co-immunoprecipitation. Both TRIB1 and Foxp3 were expressed at significantly higher levels in Tregs than in their CD4(+)CD25(+) counterparts (p < 0.001). Moreover, TRIB1 and Foxp3 mRNA levels correlated tightly in Tregs (Spearman r = 1.0; p < 0.001, n = 7), but not in CD4(+)D25(+) T cells. The protein complementation assay revealed a direct physical interaction between TRIB1 and Foxp3 in live cells. This interaction was impaired upon deletion of the TRIB1 N-terminal but not the C-terminal domain, suggesting an interaction in the nucleus. This direct interaction within the nucleus was confirmed in primary human Tregs by co-immunoprecipitation. These data show a direct relationship between TRIB1 and Foxp3 in terms of their expression and physical interaction and highlight Tribbles-1 as a novel binding partner of Foxp3 in Tregs.	[Dugast, Emilie; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie; Soulillou, Jean-Paul; Brouard, Sophie] Inst Natl Sante & Rech Med, UMR1064, F-44000 Nantes, France; [Dugast, Emilie; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie] Univ Nantes, Fac Med, F-44000 Nantes, France; [Kiss-Toth, Endre; Docherty, Louise] Univ Sheffield, Dept Cardiovasc Sci, Sheffield S10 2TN, S Yorkshire, England; [Dugast, Emilie; Ashton-Chess, Joanna] TcLand Express, F-44200 Nantes, France; [Dugast, Emilie; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie; Soulillou, Jean-Paul; Brouard, Sophie] Inst Transplantat Urol Nephrol, Inst Rech Transplantat, F-44000 Nantes, France; [Soulillou, Jean-Paul; Brouard, Sophie] CHU Nantes, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; University of Sheffield; Nantes Universite; CHU de Nantes	Ashton-Chess, J (corresponding author), TcLand Express, 21 Rue Noue Bras de Fer, F-44200 Nantes, France.	jashtonchess@tcland-expression.com	Kiss-Toth, Endre/AAC-4252-2020; Kiss-Toth, Endre/A-8596-2014; brouard, sophie c/Q-1285-2016	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Dugast, Emilie/0000-0001-7439-1903; Danger, Richard/0000-0002-5058-795X; Conchon, Sophie/0000-0003-2602-3385	Fondation de Cooperation Scientifique CENTAURE; Convention Industrielle de Formation par la REcherche Grant [717/2008]; ANR [ANR-07-1215-0101]	Fondation de Cooperation Scientifique CENTAURE; Convention Industrielle de Formation par la REcherche Grant; ANR(French National Research Agency (ANR))	This work was supported in part by the Fondation de Cooperation Scientifique CENTAURE.; Recipient of Convention Industrielle de Formation par la REcherche Grant 717/2008.; Recipient of an ANR Grant ANR-07-1215-0101. To whom correspondence may be addressed: Institut de Recherche en Transplantation, ITUN, Nantes 44000, France. Tel.: 33-0-2-40-08-74-10; Fax: 33-0-2-40-08-74-11; E-mail: sophie.brouard@univ-nantes.fr.	Alvarez CM, 2009, TRANSPLANTATION, V87, P857, DOI 10.1097/TP.0b013e318199fa57; Ashton-Chess J, 2008, J AM SOC NEPHROL, V19, P1116, DOI 10.1681/ASN.2007101056; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barbarulo A, 2011, J IMMUNOL, V186, P6199, DOI 10.4049/jimmunol.1002136; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Dedhia PH, 2010, BLOOD, V116, P1321, DOI 10.1182/blood-2009-07-229450; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Eder K, 2008, IMMUNOL LETT, V116, P178, DOI 10.1016/j.imlet.2007.12.011; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gilby DC, 2010, IMMUNOL LETT, V130, P115, DOI 10.1016/j.imlet.2009.12.007; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ostertag A, 2010, DIABETES, V59, P1991, DOI 10.2337/db09-1537; Pichard V, 2013, HUM GENE THER, V24, P143, DOI 10.1089/hum.2011.227; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Puskas LG, 2005, CELL MOL BIOL, V51, P177, DOI 10.1170/T617; Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rothlisberger B, 2007, CANCER GENET CYTOGEN, V176, P58, DOI 10.1016/j.cancergencyto.2007.03.003; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Varbo A, 2011, ARTERIOSCL THROM VAS, V31, P451, DOI 10.1161/ATVBAHA.110.216333; Wang J, 2008, HUM MOL GENET, V17, P2894, DOI 10.1093/hmg/ddn188; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	48	17	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10051	10060		10.1074/jbc.M112.448654	http://dx.doi.org/10.1074/jbc.M112.448654			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417677	hybrid, Green Published			2022-12-28	WOS:000317114000043
J	de Silva, S; Hoy, H; Hake, TS; Wong, HK; Porcu, P; Wu, L				de Silva, Suresh; Hoy, Heather; Hake, Timothy S.; Wong, Henry K.; Porcu, Pierluigi; Wu, Li			Promoter Methylation Regulates SAMHD1 Gene Expression in Human CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AICARDI-GOUTIERES SYNDROME; RESTRICTS HIV-1 INFECTION; DNA METHYLATION; CPG ISLANDS; IDENTIFICATION; DEMETHYLATION; TRANSCRIPTION; REPLICATION; MACROPHAGES	The retrovirus restriction factor SAMHD1 is the first identified mammalian dNTP triphosphohydrolase that is highly expressed in human myeloid lineage cells and CD4(+) T lymphocytes. Although SAMHD1 expression is variable in human cell lines and tissue types, mechanisms underlying SAMHD1 gene regulation have not been defined. Recent studies showed that SAMHD1 is highly expressed in human primary CD4(+) T lymphocytes, but not in some CD4(+) T cell lines. Here, we report that SAMHD1 expression varies among four CD4(+) T cell lines and is transcriptionally regulated. Cloning and sequence analysis of the human SAMHD1 promoter revealed a CpG island that is methylated in CD4(+) T cell lines (such as Jurkat and Sup-T1), resulting in transcriptional repression of SAMHD1. We also found that the SAMHD1 promoter is unmethylated in primary CD4(+) T lymphocytes, which express high levels of SAMHD1, indicating a direct correlation between the methylation of the SAMHD1 promoter and transcriptional repression. SAMHD1 expression was induced in CD4(+) T cell lines by blocking DNA methyltransferase activity, suggesting that promoter methylation is one of the key epigenetic mechanisms by which SAMHD1 expression is regulated.	[de Silva, Suresh; Hoy, Heather; Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Wong, Henry K.; Porcu, Pierluigi] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Hake, Timothy S.; Wong, Henry K.; Porcu, Pierluigi; Wu, Li] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wong, Henry K.] Ohio State Univ, Div Dermatol, Columbus, OH 43210 USA; [Porcu, Pierluigi] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, L (corresponding author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011; Wong, Henry K/AAU-8810-2021	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Wong, Henry/0000-0001-9181-7195; Porcu, Pierluigi/0000-0002-8056-023X	National Institutes of Health [AI098524, AI102822]; Public Health Preparedness for Infectious Diseases Program (PHPID) of The Ohio State University; NATIONAL CANCER INSTITUTE [R21CA164911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098524, R21AI102822] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases Program (PHPID) of The Ohio State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI098524 and AI102822 (to L. W.).; Supported in part by the Public Health Preparedness for Infectious Diseases Program (PHPID) of The Ohio State University. To whom correspondence should be addressed: Center for Retrovirus Research, Department of Veterinary Biosciences, The Ohio State University, 1900 Coffey Rd., Columbus, OH43210. Tel.:614-292-5408; Fax:614-292-6473; E-mail: wu.840@osu.edu.	Ayinde D, 2012, NAT REV MICROBIOL, V10, P675, DOI 10.1038/nrmicro2862; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Baylin SB, 1998, ADV CANCER RES, V72, P141; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chan MF, 2000, CURR TOP MICROBIOL, V249, P75; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Coon S, 2012, AIDS RES HUM RETROV, V28, P1565, DOI [10.1089/AID.2012.0039, 10.1089/aid.2012.0039]; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035385; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; KALTOFT K, 1992, IN VITRO CELL DEV-AN, V28A, P161; LAFUSE WP, 1995, J LEUKOCYTE BIOL, V57, P477, DOI 10.1002/jlb.57.3.477; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Raghavendra NK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-66; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Welbourn S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-86; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-88	39	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9284	9292		10.1074/jbc.M112.447201	http://dx.doi.org/10.1074/jbc.M112.447201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23426363	hybrid, Green Published			2022-12-28	WOS:000316862200046
J	Rawat, SJ; Creasy, CL; Peterson, JR; Chernoff, J				Rawat, Sonali Jalan; Creasy, Caretha L.; Peterson, Jeffrey R.; Chernoff, Jonathan			The Tumor Suppressor Mst1 Promotes Changes in the Cellular Redox State by Phosphorylation and Inactivation of Peroxiredoxin-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; MAMMALIAN PEROXIREDOXIN; HYDROGEN-PEROXIDE; KINASE; APOPTOSIS; PATHWAY; ISOFORMS; GROWTH; CELLS; H2O2	The serine/threonine protein kinases Mst1 and Mst2 can be activated by cellular stressors including hydrogen peroxide. Using two independent protein interaction screens, we show that these kinases associate, in an oxidation-dependent manner, with Prdx1, an enzyme that regulates the cellular redox state by reducing hydrogen peroxide to water and oxygen. Mst1 inactivates Prdx1 by phosphorylating it at Thr-90 and Thr-183, leading to accumulation of hydrogen peroxide in cells. These results suggest that hydrogen peroxide-stimulated Mst1 activates a positive feedback loop to sustain an oxidizing cellular state.	[Rawat, Sonali Jalan; Creasy, Caretha L.; Peterson, Jeffrey R.; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Rawat, Sonali Jalan] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19102 USA	Fox Chase Cancer Center; Drexel University	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014; Rawat, Sonali/N-7827-2014	Chernoff, Jonathan/0000-0002-4803-7836; Peterson, Jeffrey/0000-0002-0604-718X	National Institutes of Health [R01 CA58836, R01 CA098830, P30 CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA098830, R01CA058836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA58836 and R01 CA098830 (to J. C.), as well as by an appropriation from the state of Pennsylvania.; We thank Carola Neumann for Prdx1 plasmids and Prdx1<SUP>-/-</SUP> MEFs, Matthias Gstaiger for the tap-tagging vector pcDNA5/FRT/TO/SH/GW, and Steven Gygi and the Taplin Mass Spectrometry Facility for assistance with analysis of protein complexes and phosphorylation site determinations. The Fox Chase Cancer Center was supported by a grant from the National Institutes of Health (Grant P30 CA006927).	Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goyal MM, 2010, PROTEIN CELL, V1, P888, DOI 10.1007/s13238-010-0113-z; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hsu JL, 1996, J BIOL CHEM, V271, P17687, DOI 10.1074/jbc.271.30.17687; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Kakeya H, 1998, CANCER RES, V58, P4888; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Luo XL, 2009, INT J MOL MED, V23, P357, DOI 10.3892/ijmm_00000139; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Morinaka A, 2011, ONCOGENE, V30, P4208, DOI 10.1038/onc.2011.139; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song H, 2010, BIOCHEM BIOPH RES CO, V391, P969, DOI 10.1016/j.bbrc.2009.11.175; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Wen WH, 2010, J BIOL CHEM, V285, P39108, DOI 10.1074/jbc.M110.151753; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; You B, 2009, BIOCHEM J, V418, P93, DOI 10.1042/BJ20081340; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	45	44	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8762	8771		10.1074/jbc.M112.414524	http://dx.doi.org/10.1074/jbc.M112.414524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386615	Green Published, hybrid			2022-12-28	WOS:000316564500075
J	Yandek, LE; Lin, HC; Harris, ME				Yandek, Lindsay E.; Lin, Hsuan-Chun; Harris, Michael E.			Alternative Substrate Kinetics of Escherichia coli Ribonuclease P DETERMINATION OF RELATIVE RATE CONSTANTS BY INTERNAL COMPETITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; RNASE-P; C5 PROTEIN; ENZYME SPECIFICITY; MESSENGER-RNA; ACTIVE-SITE; RECOGNITION; BINDING; CLEAVAGE; HOLOENZYME	A single enzyme, ribonuclease P (RNase P), processes the 5' ends of tRNA precursors (ptRNA) in cells and organelles that carry out tRNA biosynthesis. This substrate population includes over 80 different competing ptRNAs in Escherichia coli. Although the reaction kinetics and molecular recognition of a few individual model substrates of bacterial RNase P have been well described, the competitive substrate kinetics of the enzyme are comparatively unexplored. To understand the factors that determine how different ptRNA substrates compete for processing by E. coli RNase P, we compared the steady state reaction kinetics of two ptRNAs that differ at sequences that are contacted by the enzyme. For both ptRNAs, substrate cleavage is fast relative to dissociation. As a consequence, V/K, the rate constant for the reaction at limiting substrate concentrations, reflects the substrate association step for both ptRNAs. Reactions containing two or more ptRNAs follow simple competitive alternative substrate kinetics in which the relative rates of processing are determined by ptRNA concentration and their V/K. The relative V/K values for eight different ptRNAs, which were selected to represent the range of structure variation at sites contacted by RNase P, were determined by internal competition in reactions in which all eight substrates were present simultaneously. The results reveal a relatively narrow range of V/K values, suggesting that rates of ptRNA processing by RNase P are tuned for uniform specificity and consequently optimal coupling to precursor biosynthesis.	[Yandek, Lindsay E.; Lin, Hsuan-Chun; Harris, Michael E.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Harris, ME (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	meh2@case.edu			National Institutes of Health [GM056740]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM056740 (to M. E. H.).	Altman S, 2005, P NATL ACAD SCI USA, V102, P11284, DOI 10.1073/pnas.0505271102; Ando T, 2002, BIOSCI BIOTECH BIOCH, V66, P1967, DOI 10.1271/bbb.66.1967; BEEBE JA, 1994, BIOCHEMISTRY-US, V33, P10294, DOI 10.1021/bi00200a009; Bremer H, 2008, BIOCHIMIE, V90, P493, DOI 10.1016/j.biochi.2007.10.008; Buck AH, 2005, NAT STRUCT MOL BIOL, V12, P958, DOI 10.1038/nsmb1004; Buck AH, 2005, EMBO J, V24, P3360, DOI 10.1038/sj.emboj.7600805; CHA S, 1968, MOL PHARMACOL, V4, P621; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cleland W. W., 2007, ENZYME KINETICS MECH, P253; Cleland WW, 2006, ISOTOPE EFFECTS CHEM, P915; Cook P. F., 2007, ENZYME KINETICS MECH, P253; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dale T, 2005, TRENDS BIOCHEM SCI, V30, P659, DOI 10.1016/j.tibs.2005.10.006; Dale T, 2005, RNA, V11, P1610, DOI 10.1261/rna.2130505; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Ellis JC, 2009, RNA BIOL, V6, P362, DOI 10.4161/rna.6.4.9241; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; Fersht A., 1998, STRUCTURE MECH PROTE, P121; GARDINER KJ, 1985, J BIOL CHEM, V260, P5415; GAUR RK, 1993, NUCLEIC ACIDS RES, V21, P21, DOI 10.1093/nar/21.1.21; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guo X, 2006, J MOL BIOL, V360, P190, DOI 10.1016/j.jmb.2006.05.001; Hansen A, 2001, MOL MICROBIOL, V41, P131, DOI 10.1046/j.1365-2958.2001.02467.x; Harris M, 2010, PROTEIN REV, V10, P135, DOI 10.1007/978-1-4419-1142-1_8; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Hiller DA, 2011, PHILOS T R SOC B, V366, P2929, DOI 10.1098/rstb.2011.0143; Hori Y, 2000, EUR J BIOCHEM, V267, P4781, DOI 10.1046/j.1432-1327.2000.01534.x; Hougland JL, 2006, COLD SPRING HARB MON, V43, P133; Hsieh J, 2010, J MOL BIOL, V400, P38, DOI 10.1016/j.jmb.2010.04.050; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Karbstein K, 2004, RNA, V10, P1730, DOI 10.1261/rna.7118104; Kirsebom LA, 2007, BIOCHIMIE, V89, P1183, DOI 10.1016/j.biochi.2007.05.009; Kirsebom LA, 2009, IUBMB LIFE, V61, P189, DOI 10.1002/iub.160; Ko JH, 2007, P NATL ACAD SCI USA, V104, P7815, DOI 10.1073/pnas.0701715104; Koutmou KS, 2010, J MOL BIOL, V396, P195, DOI 10.1016/j.jmb.2009.11.039; KURLAND CG, 1993, BIOCHEM SOC T, V21, P841, DOI 10.1042/bst0210841; KURLAND CG, 1991, FEBS LETT, V285, P165, DOI 10.1016/0014-5793(91)80797-7; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leung EKY, 2011, ANNU REV BIOCHEM, V80, P527, DOI 10.1146/annurev-biochem-082108-165150; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Liu JCH, 1998, RNA, V4, P639, DOI 10.1017/S1355838298980013; Loria A, 2000, RNA, V6, P1413, DOI 10.1017/S1355838200000959; Loria A, 1998, BIOCHEMISTRY-US, V37, P15466, DOI 10.1021/bi9816507; Marvin MC, 2011, RNA, V17, P1429, DOI 10.1261/rna.2633611; Marvin MC, 2011, RNA, V17, P1441, DOI 10.1261/rna.2737511; Mohanty BK, 2007, NUCLEIC ACIDS RES, V35, P7614, DOI 10.1093/nar/gkm917; Mohanty BK, 2008, NUCLEIC ACIDS RES, V36, P364, DOI 10.1093/nar/gkm991; Mohanty BK, 2010, NUCLEIC ACIDS RES, V38, P597, DOI 10.1093/nar/gkp997; Moor N, 2003, BIOCHEMISTRY-US, V42, P10697, DOI 10.1021/bi034732q; Niranjanakumari S, 1998, P NATL ACAD SCI USA, V95, P15212, DOI 10.1073/pnas.95.26.15212; Northrop DB, 1999, ADV ENZYMOL RAMB, V73, P25, DOI 10.1002/9780470123195.ch2; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Okamura K, 2012, WIRES RNA, V3, P351, DOI 10.1002/wrna.113; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Pan T, 1995, P NATL ACAD SCI USA, V92, P12510, DOI 10.1073/pnas.92.26.12510; Pettersson BMF, 2005, J MOL BIOL, V351, P9, DOI 10.1016/j.jmb.2005.05.022; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Reiter NJ, 2012, NUCLEIC ACIDS RES, V40, P10384, DOI 10.1093/nar/gks744; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; ROSE IA, 1974, J BIOL CHEM, V249, P5163; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; Seif E, 2008, RNA, V14, P1237, DOI 10.1261/rna.833408; Siew D, 1999, BIOCHEMISTRY-US, V38, P1873, DOI 10.1021/bi982329r; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Smith JK, 2007, BIOPOLYMERS, V87, P329, DOI 10.1002/bip.20846; Steimer L, 2012, RNA BIOL, V9, P751, DOI 10.4161/rna.20090; Sun L, 2007, RNA, V13, P1505, DOI 10.1261/rna.571007; Sun L, 2006, EMBO J, V25, P3998, DOI 10.1038/sj.emboj.7601290; Sun L, 2010, J MOL BIOL, V395, P1019, DOI 10.1016/j.jmb.2009.11.027; Suwa S, 2009, J BIOCHEM, V145, P151, DOI 10.1093/jb/mvn150; Tamura K, 1997, Nucleic Acids Symp Ser, P133; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Van Slyke DD, 1914, J BIOL CHEM, V19, P141; Wu SY, 2011, J MOL BIOL, V411, P384, DOI 10.1016/j.jmb.2011.05.049; Zahler NH, 2005, J MOL BIOL, V345, P969, DOI 10.1016/j.jmb.2004.10.080; Zahler NH, 2003, RNA, V9, P734, DOI 10.1261/rna.5220703	88	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8342	8354		10.1074/jbc.M112.435420	http://dx.doi.org/10.1074/jbc.M112.435420			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362254	Green Published, hybrid			2022-12-28	WOS:000316564500034
J	Zhang, JP; Fei, T; Li, ZW; Zhu, GY; Wang, L; Chen, YG				Zhang, Jianping; Fei, Teng; Li, Zhongwei; Zhu, Gaoyang; Wang, Lu; Chen, Ye-Guang			BMP Induces Cochlin Expression to Facilitate Self- renewal and Suppress Neural Differentiation of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; FUNCTIONAL-CHARACTERIZATION; DEVELOPMENTAL REGULATORS; BETA; SPECIFICITY; ACTIVATION; BINDING; IDENTIFICATION; POLYCOMB; PROMOTER	BMP4 maintains self-renewal of mouse embryonic stem cells (ESCs) in collaboration with LIF. Here, we report the identification of a novel key BMP target gene, cochlin (Coch) in mouse ESCs. Coch can be significantly up-regulated by BMP4 specifically in ESCs but not in somatic differentiated cells, and this up-regulation is dependent on the BMP signaling mediators Smad1/5 and Smad4. Overexpression of Coch can partially substitute BMP4 to promote self-renewal of mouse ESCs together with LIF, whereas knockdown of Coch impairs self-renewal marker gene expression even in the presence of both BMP4 and LIF. Further studies showed that COCH could mimic BMP4 in repressing neural differentiation of mouse ESCs upon LIF withdrawal and the inhibitory effect of BMP4 on neural differentiation is compromised by Coch knockdown. Taken together, our data suggest that COCH is a part of the downstream target network of BMP signaling and serves as another important effector to fine-tune mouse ESC fates.	[Zhang, Jianping; Fei, Teng; Li, Zhongwei; Zhu, Gaoyang; Wang, Lu; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Fei, Teng/G-5324-2015	Fei, Teng/0000-0001-5707-0673; FEI, TENG/0000-0001-9620-0450	National Key Basic Research Program of China (973 Program) [2011CB943803]; National Natural Science Foundation of China [30930050, 30921004]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (973 Program) (2011CB943803) and the National Natural Science Foundation of China (30930050, 30921004) (to Y.G.C.).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Bhattacharya SK, 2009, INVEST OPHTH VIS SCI, V50, P551, DOI 10.1167/iovs.08-2632; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fei T, 2010, SCI CHINA LIFE SCI, V53, P497, DOI 10.1007/s11427-010-0096-2; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZW, 2012, PROTEIN CELL, V3, P401, DOI 10.1007/s13238-012-2925-5; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Rodriguez CI, 2004, ENDOCRINOLOGY, V145, P1410, DOI 10.1210/en.2003-1361; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	35	22	24	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8053	8060		10.1074/jbc.M112.433995	http://dx.doi.org/10.1074/jbc.M112.433995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23344953	hybrid, Green Published			2022-12-28	WOS:000316564500006
J	Brooks, TM; Unterweger, D; Bachmann, V; Kostiuk, B; Pukatzki, S				Brooks, Teresa M.; Unterweger, Daniel; Bachmann, Verena; Kostiuk, Benjamin; Pukatzki, Stefan			Lytic Activity of the Vibrio cholerae Type VI Secretion Toxin VgrG-3 Is Inhibited by the Antitoxin TsaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEM; REQUIRES; EFFECTOR; PROTEIN	The type VI secretion system (T6SS) of Gram-negative bacteria has been implicated in microbial competition; however, which components serve purely structural roles, and which serve as toxic effectors remains unresolved. Here, we present evidence that VgrG-3 of the Vibrio cholerae T6SS has both structural and toxin activity. Specifically, we demonstrate that the C-terminal extension of VgrG-3 acts to degrade peptidoglycan and hypothesize that this assists in the delivery of accessory T6SS toxins of V. cholerae. To avoid self-intoxication, V. cholerae expresses an anti-toxin encoded immediately downstream of vgrG-3 that inhibits VgrG-3-mediated lysis through direct interaction.	[Brooks, Teresa M.; Unterweger, Daniel; Bachmann, Verena; Kostiuk, Benjamin; Pukatzki, Stefan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Pukatzki, S (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	spukatzki@ualberta.ca	Unterweger, Daniel/AAP-6082-2021; Unterweger, Daniel/J-6867-2017	Unterweger, Daniel/0000-0001-7459-6386; Unterweger, Daniel/0000-0002-3021-0960	Canadian Institute for Health Research Operating Grant [MOP-84473]; Alberta Innovates-Health Solutions; Alberta Heritage Foundation for Medical Research Endowment Fund; Canadian Foundation for Innovation [LOFS1-21139]	Canadian Institute for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Alberta Heritage Foundation for Medical Research Endowment Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by Canadian Institute for Health Research Operating Grant MOP-84473 and Alberta Innovates-Health Solutions (funded by the Alberta Heritage Foundation for Medical Research Endowment Fund).; We thank Sarah Miyata and Cory Brooks for helpful discussions, Marcia Craig for critically reviewing the manuscript, and the laboratory of Joel Weiner for the gift of the pBAD24-LS plasmid. The Leica Microsystems microscope was purchased with funds from the Canadian Foundation for Innovation (LOFS1-21139).	Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HOYLE BD, 1984, CAN J MICROBIOL, V30, P204, DOI 10.1139/m84-031; Kanamaru S, 1999, J BACTERIOL, V181, P2739, DOI 10.1128/JB.181.9.2739-2744.1999; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Son B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-33; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Wilkesman Jeff, 2009, Recent Pat Biotechnol, V3, P175; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	26	117	123	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7618	7625		10.1074/jbc.M112.436725	http://dx.doi.org/10.1074/jbc.M112.436725			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341465	hybrid, Green Published			2022-12-28	WOS:000316455300019
J	Gourlaouen, M; Welti, JC; Vasudev, NS; Reynolds, AR				Gourlaouen, Morgane; Welti, Jonathan C.; Vasudev, Naveen S.; Reynolds, Andrew R.			Essential Role for Endocytosis in the Growth Factor-stimulated Activation of ERK1/2 in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; SIGNAL-TRANSDUCTION; ANTIANGIOGENESIS THERAPY; TUMOR ANGIOGENESIS; TARGETED THERAPY; FACTOR RECEPTOR; PROTEIN-KINASE; GENE DELIVERY; SOLID TUMORS; PHASE-I	Vascular endothelial growth factor (VEGF) stimulates angiogenesis by binding to VEGF receptor 2 (VEGFR2) on endothelial cells (ECs). Downstream activation of the extracellular related kinases 1/2 (ERK1/2) is important for angiogenesis to proceed. Receptor internalization has been implicated in VEGFR2 signaling, but its role in the activation of ERK1/2 is unclear. To explore this question we utilized pitstop and dynasore, two small molecule inhibitors of endocytosis. First, we confirmed that both inhibitors block the internalization of VEGFR2 in ECs. We then stimulated ECs with VEGF in the presence and absence of the inhibitors and examined VEGFR2 signaling to ERK1/2. Activation of VEGFR2 and C-Raf still occurred in the presence of the inhibitors, whereas the activation of MEK1/2 and ERK1/2 was abrogated. Therefore, although internalization is not required for activation of either VEGFR2 or C-Raf in ECs stimulated with VEGF, internalization is necessary to activate the more distal kinases in the cascade. Importantly, inhibition of internalization also prevented activation of ERK1/2 when ECs were stimulated with other pro-angiogenic growth factors, namely fibroblast growth factor 2 and hepatocyte growth factor. In contrast, the same inhibitors did not block ERK1/2 activation in fibroblasts or cancer cells stimulated with growth factors. Finally, we show that these small molecule inhibitors of endocytosis block angiogenesis in vitro and in vivo. Therefore, receptor internalization may be a generic requirement for pro-angiogenic growth factors to activate ERK1/2 signaling in human ECs, and targeting receptor trafficking may present a therapeutic opportunity to block tumor angiogenesis.	[Gourlaouen, Morgane; Welti, Jonathan C.; Vasudev, Naveen S.; Reynolds, Andrew R.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Tumour Biol Team, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Reynolds, AR (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Tumour Biol Team, 237 Fulham Rd, London SW3 6JB, England.	andrew.reynolds@icr.ac.uk		Vasudev, Naveen/0000-0001-8470-7481; Welti, Jonathan/0000-0002-9433-8138	Breakthrough Breast Cancer; Royal Marsden NIHR Biomedical Research Centre	Breakthrough Breast Cancer; Royal Marsden NIHR Biomedical Research Centre(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by Breakthrough Breast Cancer and the Royal Marsden NIHR Biomedical Research Centre.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Anderson SM, 2011, INTEGR BIOL-UK, V3, P887, DOI 10.1039/c1ib00037c; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; da Silva RG, 2010, AM J PATHOL, V177, P1534, DOI 10.2353/ajpath.2010.100043; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jonker DJ, 2011, ANN ONCOL, V22, P1413, DOI 10.1093/annonc/mdq599; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerbel RS, 2005, CANCER CELL, V8, P269, DOI 10.1016/j.ccr.2005.09.016; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Kurzrock R, 2011, J CLIN ONCOL, V29, P2660, DOI 10.1200/JCO.2010.32.4145; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Luwor RB, 2012, GROWTH FACTORS, V30, P220, DOI 10.3109/08977194.2012.683189; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAHADEVAN V, 1989, CANCER RES, V49, P415; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Porta C, 2013, ONCOLOGY-BASEL, V84, P115, DOI 10.1159/000342099; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2003, TRENDS MOL MED, V9, P2, DOI 10.1016/S1471-4914(02)00004-7; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; SILVAGNO F, 1995, ARTERIOSCL THROM VAS, V15, P1857, DOI 10.1161/01.ATV.15.11.1857; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Welti JC, 2011, ONCOGENE, V30, P1183, DOI 10.1038/onc.2010.503; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603	64	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7467	7480		10.1074/jbc.M112.446401	http://dx.doi.org/10.1074/jbc.M112.446401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341459	Green Published, hybrid			2022-12-28	WOS:000316455300004
J	Sebag, SC; Bastarache, JA; Ware, LB				Sebag, Sara C.; Bastarache, Julie A.; Ware, Lorraine B.			Mechanical Stretch Inhibits Lipopolysaccharide-induced Keratinocyte-derived Chemokine and Tissue Factor Expression While Increasing Procoagulant Activity in Murine Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; LIPID RAFTS; IN-VITRO; INJURY; VENTILATION; ENDOTOXIN; ETHANOL	Previous studies have shown that the innate immune stimulant LPS augments mechanical ventilation-induced pulmonary coagulation and inflammation. Whether these effects are mediated by alveolar epithelial cells is unclear. The alveolar epithelium is a key regulator of the innate immune reaction to pathogens and can modulate both intra-alveolar inflammation and coagulation through up-regulation of pro-inflammatory cytokines and tissue factor (TF), the principal initiator of the extrinsic coagulation pathway. We hypothesized that cyclic mechanical stretch (MS) potentiates LPS-mediated alveolar epithelial cell (MLE-12) expression of the chemokine keratinocyte-derived cytokine (KC) and TF. Contrary to our hypothesis, MS significantly decreased LPS-induced KC and TF mRNA and protein expression. Investigation into potential mechanisms showed that stretch significantly reduced LPS-induced surface expression of TLR4 that was not a result of increased degradation. Decreased cell surface TLR4 expression was concomitant with reduced LPS-mediated NF-kappa B activation. Immunofluorescence staining showed that cyclic MS markedly altered LPS-induced organization of actin filaments. In contrast to expression, MS significantly increased LPS-induced cell surface TF activity independent of calcium signaling. These findings suggest that cyclic MS of lung epithelial cells down-regulates LPS-mediated inflammatory and procoagulant expression by modulating actin organization and reducing cell surface TLR4 expression and signaling. However, because LPS-induced surface TF activity was enhanced by stretch, these data demonstrate differential pathways regulating TF expression and activity. Ultimately, loss of LPS responsiveness in the epithelium induced by MS could result in increased susceptibility of the lung to bacterial infections in the setting of mechanical ventilation.	[Sebag, Sara C.; Bastarache, Julie A.; Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Ware, LB (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, T1218 Med Ctr North, Nashville, TN 37232 USA.	lorraine.ware@vanderbilt.edu	Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702	National Institutes of Health from NHLBI [HL103836, T32HL087738]; National Institutes of Health [HL090785]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL090785, K24HL103836, T32HL087738] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL103836 (to L. B. W.), T32HL087738 from NHLBI (to S. C. S.), and HL090785 (to J. A. B.). This work was also supported by an American Heart Association established investigator award (to L. B. W.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; Bach RR, 1998, BLOOD COAGUL FIBRIN, V9, pS37; Banan A, 2000, J SURG RES, V88, P104, DOI 10.1006/jsre.1999.5786; Bastarache JA, 2007, THORAX, V62, P608, DOI 10.1136/thx.2006.063305; Beutler B, 2004, NAT REV IMMUNOL, V4, P498, DOI 10.1038/nri1401; Bhadade RR, 2011, J POSTGRAD MED, V57, P286, DOI 10.4103/0022-3859.90077; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; CARSON SD, 1994, BLOOD, V84, P526; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chiang CH, 2011, INTENS CARE MED, V37, P1360, DOI 10.1007/s00134-011-2251-z; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Chu EK, 2006, AM J RESP CELL MOL, V35, P628, DOI 10.1165/rcmb.2006-0040OC; Cohen TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038748; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Girard TD, 2007, CHEST, V131, P921, DOI 10.1378/chest.06-1515; GROSS TJ, 1992, AM J RESP CELL MOL, V6, P397, DOI 10.1165/ajrcmb/6.4.397; Henriksson CE, 2005, THROMB HAEMOSTASIS, V94, P1236, DOI 10.1160/TH05-07-0463; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Kato T, 1998, BIOCHEM BIOPH RES CO, V244, P615, DOI 10.1006/bbrc.1998.8335; Loureiro SO, 2011, TOXICOL IN VITRO, V25, P28, DOI 10.1016/j.tiv.2010.09.003; Mourgeon E, 2000, AM J PHYSIOL-LUNG C, V279, pL699, DOI 10.1152/ajplung.2000.279.4.L699; Muller M, 1999, EXP CELL RES, V248, P136, DOI 10.1006/excr.1999.4395; Parker JC, 2000, J APPL PHYSIOL, V89, P2241, DOI 10.1152/jappl.2000.89.6.2241; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Schultz MJ, 2004, THORAX, V59, P130, DOI 10.1136/thorax.2003.013888; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Silverman MD, 1996, BLOOD COAGUL FIBRIN, V7, P281, DOI 10.1097/00001721-199604000-00001; Siore AM, 2005, AM J PHYSIOL-LUNG C, V289, pL769, DOI 10.1152/ajplung.00137.2005; SITRIN RG, 1983, AM REV RESPIR DIS, V128, P282; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; SUMPIO BE, 1991, J VASC SURG, V13, P744, DOI 10.1016/0741-5214(91)90372-2; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; Tumminia SJ, 1998, INVEST OPHTH VIS SCI, V39, P1361; Ware Lorraine B., 2005, Keio Journal of Medicine, V54, P142, DOI 10.2302/kjm.54.142; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; Zhu Shengsi, 2005, BMC Cardiovasc Disord, V5, P22, DOI 10.1186/1471-2261-5-22	48	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7875	7884		10.1074/jbc.M112.403220	http://dx.doi.org/10.1074/jbc.M112.403220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362270	hybrid, Green Published			2022-12-28	WOS:000316455300041
J	Freeze, HH				Freeze, Hudson H.			Understanding Human Glycosylation Disorders: Biochemistry Leads the Charge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHOSPHOMANNOSE ISOMERASE DEFICIENCY; PHOSPHATE-MANNOSE SYNTHASE; CONGENITAL DISORDERS; ZEBRAFISH MODEL; O-MANNOSYLATION; MUTATIONS; GENE; GLYCOSYLPHOSPHATIDYLINOSITOL; DOLICHOL; HYPERPHOSPHATASIA	Nearly 70 inherited human glycosylation disorders span a breathtaking clinical spectrum, impacting nearly every organ system and launching a family-driven diagnostic odyssey. Advances in genetics, especially next generation sequencing, propelled discovery of many glycosylation disorders in single and multiple pathways. Interpretation of whole exome sequencing results, insights into pathological mechanisms, and possible therapies will hinge on biochemical analysis of patient-derived materials and animal models. Biochemical diagnostic markers and readouts offer a physiological context to confirm candidate genes. Recent discoveries suggest novel perspectives for textbook biochemistry and novel research opportunities. Basic science and patients are the immediate beneficiaries of this bidirectional collaboration.	Sanford Burnham Med Res Inst, Genet Dis Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Genet Dis Program, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Freeze, Hudson/0000-0001-6316-0501	National Institutes of Health [R01 DK55615]; Rocket Fund; Bertrand Might Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; Bertrand Might Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK55615. This work was also supported by The Rocket Fund and The Bertrand Might Research Fund. This is the fifth article in the Thematic Minireview Series on Glycobiology and Extracellular Matrices: Glycan Functions Pervade Biology at All Levels.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aebi M, 1999, Glycoconj J, V16, P669; Almeida AM, 2007, NEW ENGL J MED, V356, P1641, DOI 10.1056/NEJMoa063369; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Carrera IA, 2012, AM J MED GENET A, V158A, P2027, DOI 10.1002/ajmg.a.35472; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Belaya K, 2012, AM J HUM GENET, V91, P193, DOI 10.1016/j.ajhg.2012.05.022; Brockington M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014434; Cantagrel V, 2011, J INHERIT METAB DIS, V34, P859, DOI 10.1007/s10545-011-9301-0; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chu J, 2013, DIS MODEL MECH, V6, P95, DOI 10.1242/dmm.010116; Cline A, 2012, MOL BIOL CELL, V23, P4175, DOI 10.1091/mbc.E12-05-0411; Committee on Assessing the Importance and Impact of Glycomics and Glycosciences Board on Chemical Sciences and Technology Board on Life Sciences Division on Earth and Life Studies and National Research Council, 2012, TRANSF GLYC ROADM FU; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; Eklund Erik A, 2006, NeuroRx, V3, P254; Farrugia ME, 2011, J ROY COLL PHYS EDIN, V41, P43, DOI 10.4997/JRCPE.2011.111; Ferguson MAJ, 2009, ESSENTIALS GLYCOBIOL, V2nd, P143; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL, P162; Freeze HH, 2009, ESSENTIALS GLYCOBIOL, P47; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Freeze HH, 2010, SEMIN CELL DEV BIOL, V21, P655, DOI 10.1016/j.semcdb.2010.03.011; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gao NG, 2011, MOL BIOL CELL, V22, P2994, DOI 10.1091/mbc.E11-04-0286; Geisler C, 2012, J BIOL CHEM, V287, P29599, DOI 10.1074/jbc.M112.379313; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Harms HK, 2002, ACTA PAEDIATR, V91, P1065, DOI 10.1080/080352502760311566; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Heuston S, 2012, MICROBIOL-SGM, V158, P1389, DOI 10.1099/mic.0.051599-0; Hu H, 2011, AM J HUM GENET, V89, P407, DOI 10.1016/j.ajhg.2011.08.008; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Jones MA, 2012, AM J HUM GENET, V90, P363, DOI 10.1016/j.ajhg.2011.12.024; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Matthijs G, 2013, GLYCOCONJUGATE J, V30, P67, DOI 10.1007/s10719-012-9445-7; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Mefford HC, 2012, NEW ENGL J MED, V367, P1951, DOI 10.1056/NEJMe1211659; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; O'Brien JF, 2007, CURR PROTOC HUM GENE; Perez B, 2013, J INHERIT METAB DIS, V36, P535, DOI 10.1007/s10545-012-9525-7; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pronicka E, 2007, PEDIATR RES, V62, P101, DOI 10.1203/PDR.0b013e318068641a; Pu JJ, 2011, CTS-CLIN TRANSL SCI, V4, P219, DOI 10.1111/j.1752-8062.2011.00262.x; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Senderek J, 2011, AM J HUM GENET, V88, P162, DOI 10.1016/j.ajhg.2011.01.008; Shang J, 2002, GLYCOBIOLOGY, V12, P307, DOI 10.1093/glycob/12.5.307; Stalnaker SH, 2011, CURR OPIN STRUC BIOL, V21, P603, DOI 10.1016/j.sbi.2011.09.001; Stiles AR, 2010, CELL, V142, P196, DOI 10.1016/j.cell.2010.07.003; Sturiale L, 2011, J INHERIT METAB DIS, V34, P891, DOI 10.1007/s10545-011-9306-8; Tang M, 2012, MOL GENET METAB, V105, P44, DOI 10.1016/j.ymgme.2011.09.028; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yoshida-Moriguchi T., 2010, AIDS RES HUM RETRO S, V327, P88, DOI DOI 10.1126/SCIENCE.1180512; Zelinger L, 2011, AM J HUM GENET, V88, P207, DOI 10.1016/j.ajhg.2011.01.002; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	82	147	150	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6936	6945		10.1074/jbc.R112.429274	http://dx.doi.org/10.1074/jbc.R112.429274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329837	Green Published, hybrid			2022-12-28	WOS:000316002400016
J	Rodriguez, G; Ross, JA; Nagy, ZS; Kirken, RA				Rodriguez, Georgialina; Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.			Forskolin-inducible cAMP Pathway Negatively Regulates T-cell Proliferation by Uncoupling the Interleukin-2 Receptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADENOSINE-MONOPHOSPHATE; SIGNAL TRANSDUCER; SERINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; CONSTITUTIVE ACTIVATION; FEEDBACK INHIBITION; DNA-BINDING; STAT5; RECEPTOR; MODULATION	Cytokine-mediated regulation of T-cell activity involves a complex interplay between key signal transduction pathways. Determining how these signaling pathways cross-talk is essential to understanding T-cell function and dysfunction. In this work, we provide evidence that cross-talk exists between at least two signaling pathways: the Jak3/Stat5 and cAMP-mediated cascades. The adenylate cyclase activator forskolin (Fsk) significantly increased intracellular cAMP levels and reduced proliferation of the human T-cells via inhibition of cell cycle regulatory genes but did not induce apoptosis. To determine this inhibitory mechanism, effects of Fsk on IL-2 signaling was investigated. Fsk treatment of MT-2 and Kit 225 T-cells inhibited IL-2-induced Stat5a/b tyrosine and serine phosphorylation, nuclear translocation, and DNA binding activity. Fsk treatment also uncoupled IL-2 induced association of the iL-2R beta and gamma(c) chain, consequently blocking Jak3 activation. Interestingly, phosphoamino acid analysis revealed that Fsk-treated cells resulted in elevated serine phosphorylation of Jak3 but not Stat5, suggesting that Fsk can negatively regulate Jak3 activity possibly mediated through PKA. Indeed, in vitro kinase assays and small molecule inhibition studies indicated that PKA can directly serine phosphorylate and functionally inactivate Jak3. Taken together, these findings suggest that Fsk activation of adenylate cyclase and PKA can negatively regulate IL-2 signaling at multiple levels that include IL-2R complex formation and Jak3/Stat5 activation.	[Rodriguez, Georgialina; Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79902 USA	University of Texas System; University of Texas El Paso	Kirken, RA (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	rkirken@utep.edu			Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; National Institutes on Minority Health and Health Disparities, National Institutes of Health [G12MD007592]; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; National Institutes on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the Lizanell and Colbert Coldwell Foundation, the Edward N. and Margaret G. Marsh Foundation, and Grant G12MD007592 from the National Institutes on Minority Health and Health Disparities, National Institutes of Health.	ANTONYSAMY MA, 1995, J IMMUNOL, V155, P2813; BARTIK MM, 1993, CELL IMMUNOL, V148, P408, DOI 10.1006/cimm.1993.1122; Behbod F, 2003, J IMMUNOL, V171, P3919, DOI 10.4049/jimmunol.171.8.3919; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; BURY TB, 1992, ALLERGY, V47, P624, DOI 10.1111/j.1398-9995.1992.tb02385.x; Chai SK, 1997, J IMMUNOL, V159, P4720; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Cone RE, 1996, CELL IMMUNOL, V173, P246, DOI 10.1006/cimm.1996.0274; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Ekholm D, 1999, BIOCHEM PHARMACOL, V58, P935, DOI 10.1016/S0006-2952(99)00188-4; Ellery JM, 2002, CYTOKINE GROWTH F R, V13, P27, DOI 10.1016/S1359-6101(01)00023-5; ELLIOTT L, 1992, CELL MOL NEUROBIOL, V12, P411, DOI 10.1007/BF00711542; ESSAYAN DM, 1994, J IMMUNOL, V153, P3408; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; HORI T, 1987, BLOOD, V70, P1069; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; KAMMER GM, 1988, P NATL ACAD SCI USA, V85, P792, DOI 10.1073/pnas.85.3.792; Kirken RA, 1999, J LEUKOCYTE BIOL, V65, P891, DOI 10.1002/jlb.65.6.891; KIRKEN RA, 1995, CYTOKINE, V7, P689, DOI 10.1006/cyto.1995.0081; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; LINGK DS, 1990, J IMMUNOL, V145, P449; MACA RD, 1984, IMMUNOPHARMACOLOGY, V8, P53, DOI 10.1016/0162-3109(84)90043-2; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; Mitra A, 2012, J BIOL CHEM, V287, P16596, DOI 10.1074/jbc.M111.319756; MIYOSHI I, 1981, GANN, V72, P978; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Mullen P, 2004, METH MOLEC MED, V88, P171; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Nagy ZS, 2006, J IMMUNOL, V177, P5032, DOI 10.4049/jimmunol.177.8.5032; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; NOKTA M, 1991, VIROLOGY, V181, P211, DOI 10.1016/0042-6822(91)90486-U; NOKTA MA, 1992, AIDS RES HUM RETROV, V8, P1255, DOI 10.1089/aid.1992.8.1255; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Ross JA, 2010, J BIOL CHEM, V285, P3582, DOI 10.1074/jbc.M109.053843; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; Weaver AM, 2007, BIOCHEM BIOPH RES CO, V362, P1026, DOI 10.1016/j.bbrc.2007.08.087; Weaver AM, 2006, MOL ENDOCRINOL, V20, P2392, DOI 10.1210/me.2005-0418; WeberNordt RM, 1996, BLOOD, V88, P809; Xue HH, 2002, INT IMMUNOL, V14, P1263, DOI 10.1093/intimm/dxf101; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang H, 2004, J IMMUNOL, V173, P932, DOI 10.4049/jimmunol.173.2.932; Zhou YJ, 1997, P NATL ACAD SCI USA, V94, P13850, DOI 10.1073/pnas.94.25.13850; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	60	32	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7137	7146		10.1074/jbc.M112.408765	http://dx.doi.org/10.1074/jbc.M112.408765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341462	Green Published, hybrid			2022-12-28	WOS:000316002400035
J	Chen, M; Herring, BP				Chen, Meng; Herring, B. Paul			Regulation of MicroRNAs by Brahma-related Gene 1 (Brg1) in Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWI/SNF COMPLEXES; IN-VIVO; EXPRESSION; PROLIFERATION; MYOCARDIN; DIFFERENTIATION; PHENOTYPE; PROTEINS; MIR-145; TARGET	MicroRNAs are involved in phenotypic switching of smooth muscle cells (SMCs). Brg1-containing SWI/SNF chromatin-remodeling complexes also play an important role in controlling the phenotype of SMCs. We thus determined whether Brg1 influences the transcription of microRNAs in SMCs. Microarray and quantitative RT-PCR analysis of smooth muscle from mice harboring smooth muscle-specific deletion of Brg1 revealed altered expression of several microRNAs, including miRs-143/145 and miR-133. Ablation of Brg1 in SMCs in vitro either by expression of dominant negative Brg1 or Brg1 knock-out attenuated miRs-143/145 expression. Knockdown of serum response factor (SRF) in SMCs significantly reduced the expression levels of miRs-143/145 and miR-133, whereas knockdown of myocardin only attenuated miRs-143/145 expression. Myocardin induced expression of miRs-143/145 and miR-133a and increased SRF binding to these genes in 10T1/2 cells. This myocardin-mediated induction was attenuated by dominant negative Brg1. In Brg1-null SW13 cells, miRs-143/145 were dramatically induced by myocardin only in the presence of Brg1, whereas miR-133 was not induced by myocardin in a Brg1-dependent manner. Chromatin immunoprecipitation assays demonstrated that in the presence of Brg1, myocardin increased SRF binding to both the miRs-143/145 and miR-133a loci. Together, these data suggest a mechanism in which Brg1-containing SWI/SNF complexes are required for myocardin to induce expression of miRs-143/145 in smooth muscle cells. In contrast, miR-133 expression appears to be regulated by Brg1-containing chromatin remodeling complexes in a partially SRF-dependent, although largely myocardin-independent manner. SWI/SNF-mediated chromatin remodeling thus regulates the phenotype of smooth muscle by affecting expression of protein-coding genes and microRNAs.	[Chen, Meng; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Herring, BP (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pherring@iupui.edu			National Institutes of Health [DK63110, RR02576]; Indiana Clinical and Translational Sciences Institute; Indiana University School of Medicine; American Heart Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical and Translational Sciences Institute; Indiana University School of Medicine; American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK63110. This work was also supported by a grant from the Indiana Clinical and Translational Sciences Institute funded, in part, by Grant RR02576 from the National Institutes of Health and by a Biomedical Research Grant and Elwert award from the Indiana University School of Medicine.; Supported by an American Heart Association predoctoral fellowship.	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YH, 2001, J BIOL CHEM, V276, P47658, DOI 10.1074/jbc.M108678200; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Gebuhr TC, 2003, J EXP MED, V198, P1937, DOI 10.1084/jem.20030714; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Mallappa C, 2010, MOL CELL BIOL, V30, P3176, DOI 10.1128/MCB.00214-10; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	33	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6397	6408		10.1074/jbc.M112.409474	http://dx.doi.org/10.1074/jbc.M112.409474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23339192	Green Published, hybrid			2022-12-28	WOS:000315820700034
J	Labriola, JM; Pandhare, A; Jansen, M; Blanton, MP; Corringer, PJ; Baenziger, JE				Labriola, Jonathan M.; Pandhare, Akash; Jansen, Michaela; Blanton, Michael P.; Corringer, Pierre-Jean; Baenziger, John E.			Structural Sensitivity of a Prokaryotic Pentameric Ligand-gated Ion Channel to Its Membrane Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP RECEPTOR; X-RAY-STRUCTURE; TRANSMEMBRANE DOMAIN; ALLOSTERIC TRANSITIONS; LIPID-COMPOSITION; CHOLESTEROL; TORPEDO; DESENSITIZATION; MECHANISM	Although the activity of the nicotinic acetylcholine receptor (nAChR) is exquisitely sensitive to its membrane environment, the underlying mechanisms remain poorly defined. The homologous prokaryotic pentameric ligand-gated ion channel, Gloebacter ligand-gated ion channel (GLIC), represents an excellent model for probing the molecular basis of nAChR sensitivity because of its high structural homology, relative ease of expression, and amenability to crystallographic analysis. We show here that membrane-reconstituted GLIC exhibits structural and biophysical properties similar to those of the membrane-reconstituted nAChR, although GLIC is substantially more thermally stable. GLIC, however, does not possess the same exquisite lipid sensitivity. In particular, GLIC does not exhibit the same propensity to adopt an uncoupled conformation where agonist binding is uncoupled from channel gating. Structural comparisons provide insight into the chemical features that may predispose the nAChR to the formation of an uncoupled state.	[Labriola, Jonathan M.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Pandhare, Akash; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Pandhare, Akash; Jansen, Michaela; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Corringer, Pierre-Jean] Inst Pasteur, CNRS, URA 2182, Grp Channel Receptors G5, F-75015 Paris, France	University of Ottawa; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca	Pandhare, Akash/M-1827-2016	Baenziger, John/0000-0002-2888-5328; Jansen, Michaela/0000-0003-1325-9700	Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Bourses d'Etudes pour la France from l'Ambassade de France au Canada; South Plains Foundation; Center for Membrane Protein Research, Texas Tech University Health Science Center; National Institutes of Health [NS059841]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS059841, K99NS059841] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bourses d'Etudes pour la France from l'Ambassade de France au Canada; South Plains Foundation; Center for Membrane Protein Research, Texas Tech University Health Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Canadian Institute of Health Research and the Natural Sciences and Engineering Research Council of Canada (to J. E. B.), by a Bourses d'Etudes pour la France (to J. E. B.) from l'Ambassade de France au Canada, by grants from the South Plains Foundation and the Center for Membrane Protein Research, Texas Tech University Health Science Center (to M. P. B. and M. J.), and by a grant from the National Institutes of Health Grant NS059841 (to M. J.).	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Baenziger JE, 1997, BIOCHEMISTRY-US, V36, P3617, DOI 10.1021/bi962845m; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BAENZIGER JE, 1995, J BIOL CHEM, V270, P29129, DOI 10.1074/jbc.270.49.29129; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Baenziger John E, 2013, Biophys Rev, V5, P1, DOI 10.1007/s12551-012-0078-7; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Carswell CL, 2008, J BACTERIOL, V190, P5650, DOI 10.1128/JB.00298-08; Changeux JPG, 2012, CURR OPIN ANESTHESIO, V25, P397, DOI 10.1097/ACO.0b013e32835561de; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2011, BIOCHEM BIOPH RES CO, V407, P456, DOI 10.1016/j.bbrc.2011.03.026; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; De Almeida RFM, 2006, MOL MEMBR BIOL, V23, P305, DOI 10.1080/09687860600703613; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Goyal R, 2011, J BIOL CHEM, V286, P34635, DOI 10.1074/jbc.M111.269647; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; MARSH D, 1981, BIOCHIM BIOPHYS ACTA, V645, P97, DOI 10.1016/0005-2736(81)90516-2; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; Methot N, 2001, J BIOL CHEM, V276, P23726, DOI 10.1074/jbc.M102101200; MORALES A, 1995, P NATL ACAD SCI USA, V92, P8468, DOI 10.1073/pnas.92.18.8468; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pandhare A, 2012, BIOCHEMISTRY-US, V51, P2425, DOI 10.1021/bi300101r; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Reid SE, 1996, SPECTROCHIM ACTA A, V52, P1347, DOI 10.1016/0584-8539(96)01718-7; Ryan SE, 2002, J BIOL CHEM, V277, P10420, DOI 10.1074/jbc.M107412200; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Sayeed WMH, 2009, BBA-BIOMEMBRANES, V1788, P1108, DOI 10.1016/j.bbamem.2009.01.010; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Velisetty P, 2012, J BIOL CHEM, V287, P36864, DOI 10.1074/jbc.M112.401067; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang H. L., 2011, J BIOL CHEM; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i	51	30	30	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11294	11303		10.1074/jbc.M113.458133	http://dx.doi.org/10.1074/jbc.M113.458133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463505	Green Published, hybrid			2022-12-28	WOS:000317915500032
J	Song, ZC; Liu, C; Iwata, J; Gu, SP; Suzuki, A; Sun, C; He, W; Shu, R; Li, L; Chai, Y; Chen, YP				Song, Zhongchen; Liu, Chao; Iwata, Junichi; Gu, Shuping; Suzuki, Akiko; Sun, Cheng; He, Wei; Shu, Rong; Li, Lu; Chai, Yang; Chen, YiPing			Mice with Tak1 Deficiency in Neural Crest Lineage Exhibit Cleft Palate Associated with Abnormal Tongue Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIERRE-ROBIN-SEQUENCE; SECONDARY PALATE; MUTANT MICE; NORMAL PALATOGENESIS; CELL-PROLIFERATION; BETA; DIFFERENTIATION; MORPHOGENESIS; MUTATIONS; GROWTH	Cleft palate represents one of the most common congenital birth defects in humans. TGF beta signaling, which is mediated by Smad-dependent and Smad-independent pathways, plays a crucial role in regulating craniofacial development and patterning, particularly in palate development. However, it remains largely unknown whether the Smad-independent pathway contributes to TGF beta signaling function during palatogenesis. In this study, we investigated the function of TGF beta activated kinase 1 (Tak1), a key regulator of Smad-independent TGF beta signaling in palate development. We show that Tak1 protein is expressed in both the epithelium and mesenchyme of the developing palatal shelves. Whereas deletion of Tak1 in the palatal epithelium or mesenchyme did not give rise to a cleft palate defect, inactivation of Tak1 in the neural crest lineage using the Wnt1-Cre transgenic allele resulted in failed palate elevation and subsequently the cleft palate formation. The failure in palate elevation in Wnt1-Cre; Tak1(F/F) mice results from a malformed tongue and micrognathia, resembling human Pierre Robin sequence cleft of the secondary palate. We found that the abnormal tongue development is associated with Fgf10 overexpression in the neural crest-derived tongue tissue. The failed palate elevation and cleft palate were recapitulated in an Fgf10-overexpressing mouse model. The repressive effect of the Tak1-mediated noncanonical TGF beta signaling on Fgf10 expression was further confirmed by inhibition of p38, a downstream kinase of Tak1, in the primary cell culture of developing tongue. Tak1 thus functions to regulate tongue development by controlling Fgf10 expression and could represent a candidate gene for mutation in human PRS clefting.	[Song, Zhongchen; Shu, Rong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Key Lab Stomatol, Dept Periodontol,Sch Med, Shanghai 200011, Peoples R China; [Song, Zhongchen; Liu, Chao; Gu, Shuping; Sun, Cheng; He, Wei; Li, Lu; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Iwata, Junichi; Suzuki, Akiko; Chai, Yang] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA	Shanghai Jiao Tong University; Tulane University; University of Southern California	Chai, Y (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA.	ychai@usc.edu; ychen@tulane.edu			National Institutes of Health [DE14044, DE12711, DE14078, DE17007]; Shanghai JiaoTong University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014044, R37DE012711, R01DE014078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711, R01DE017007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai JiaoTong University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE14044 (to Y.P. C.) and DE12711, DE14078, and DE17007 (to Y. C.).; Supported by a fellowship from Shanghai JiaoTong University.	Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FERGUSON MWJ, 1977, VIRCHOWS ARCH A, V375, P97, DOI 10.1007/BF00428098; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; He FL, 2010, DEV DYNAM, V239, P3235, DOI 10.1002/dvdy.22466; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jakobsen LP, 2007, J MED GENET, V44, P381, DOI 10.1136/jmg.2006.046177; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lan Y, 2007, GENESIS, V45, P618, DOI 10.1002/dvg.20334; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsumura K, 2011, BIOCHEM BIOPH RES CO, V404, P1076, DOI 10.1016/j.bbrc.2010.12.116; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Robin P, 1994, Plast Reconstr Surg, V93, P1301; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Xiong W, 2009, DEV BIOL, V330, P131, DOI 10.1016/j.ydbio.2009.03.021; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	51	39	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10440	10450		10.1074/jbc.M112.432286	http://dx.doi.org/10.1074/jbc.M112.432286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23460641	hybrid, Green Published			2022-12-28	WOS:000317565000024
J	Yu, S; Huang, H; Iliuk, A; Wang, WH; Jayasundera, KB; Tao, WA; Post, CB; Geahlen, RL				Yu, Shuai; Huang, He; Iliuk, Anton; Wang, Wen-Horng; Jayasundera, Keerthi B.; Tao, W. Andy; Post, Carol B.; Geahlen, Robert L.			Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ELEMENT-BINDING PROTEIN; BREAST-CANCER CELLS; NON-HODGKIN-LYMPHOMA; TRANSCRIPTION FACTOR; THERAPEUTIC TARGET; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TERMINAL TAIL; B-CELLS	The Syk protein-tyrosine kinase can have multiple effects on cancer cells, acting in some as a tumor suppressor by inhibiting motility and in others as a tumor promoter by enhancing survival. Phosphoproteomic analyses identified PKA as a Syk-specific substrate. Syk catalyzes the phosphorylation of the catalytic subunit of PKA (PKAc) both in vitro and in cells on Tyr-330. Tyr-330 lies within the adenosine-binding motif in the C-terminal tail of PKAc within a cluster of acidic amino acids (DDY-EEEE), which is a characteristic of Syk substrates. The phosphorylation of PKAc on Tyr-330 by Syk strongly inhibits its catalytic activity. Molecular dynamics simulations suggest that this additional negative charge prevents the C-terminal tail from interacting with the substrate and the nucleotide-binding site to stabilize the closed conformation of PKAc, thus preventing catalysis from occurring. Phosphoproteomic analyses and Western blotting studies indicate that Tyr-330 can be phosphorylated in a Syk-dependent manner in MCF7 breast cancer cells and DT40 B cells. The phosphorylation of a downstream substrate of PKAc, cAMP-responsive element-binding protein (CREB), is inhibited in cells expressing Syk but can be rescued by a selective inhibitor of Syk. Modulation of CREB activity alters the expression of the CREB-regulated gene BCL2 and modulates cellular responses to genotoxic agents. Thus, PKA is a novel substrate of Syk, and its phosphorylation on Tyr-330 inhibits its participation in downstream signaling pathways.	[Yu, Shuai; Huang, He; Wang, Wen-Horng; Tao, W. Andy; Post, Carol B.; Geahlen, Robert L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Iliuk, Anton; Jayasundera, Keerthi B.; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tao, W. Andy; Post, Carol B.; Geahlen, Robert L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu	Post, Carol/AAD-7910-2021; Jayasundera, Keerthi/AGG-1997-2022; Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020	Tao, Weiguo/0000-0002-5535-5517; Iliuk, Anton/0000-0002-2914-1363; Geahlen, Robert/0000-0001-8400-2924	National Institutes of Health from the NIAID [R01AI098132]; NCI [R01CA115465]; NIGMS [R01GM039478, R01GM088317]; National Cancer Institute [R25CA128770]; NATIONAL CANCER INSTITUTE [R01CA115465, R25CA128770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317, R01GM039478] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI098132 (to R. L. G.) from the NIAID, R01CA115465 (to R. L. G. and W. A. T.) from the NCI, and R01GM039478 (to C. B. P.) and R01GM088317 (to W. A. T. and R. L. G.) from the NIGMS.; Supported by the National Cancer Institute Cancer Prevention Internship Program Grant R25CA128770.	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Caldwell GB, 2012, J CELL BIOCHEM, V113, P39, DOI 10.1002/jcb.23325; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Chestukhin A, 1996, J BIOL CHEM, V271, P10175, DOI 10.1074/jbc.271.17.10175; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Goodman RH, 2000, GENE DEV, V14, P1553; Gurumurthy S, 2005, MOL CELL BIOL, V25, P1146, DOI 10.1128/MCB.25.3.1146-1161.2005; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Luo YD, 2009, CELL SIGNAL, V21, P1370, DOI 10.1016/j.cellsig.2009.04.004; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Moujalled D, 2011, EMBO REP, V12, P77, DOI 10.1038/embor.2010.190; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Thompson EE, 2009, PROTEIN SCI, V18, P2016, DOI 10.1002/pro.209; Toyama T, 2003, CANCER LETT, V189, P97, DOI 10.1016/S0304-3835(02)00463-9; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Xue L, 2012, P NATL ACAD SCI USA, V109, P5615, DOI 10.1073/pnas.1119418109; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou F, 2006, MOL CELL BIOL, V26, P3478, DOI 10.1128/MCB.26.9.3478-3491.2006; Zhou Q, 2009, ONCOGENE, V28, P1348, DOI 10.1038/onc.2008.493	52	12	12	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10870	10881		10.1074/jbc.M112.426130	http://dx.doi.org/10.1074/jbc.M112.426130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447535	Green Published, hybrid			2022-12-28	WOS:000317565000064
J	Zhang, R; Huang, H; Cao, PJ; Wang, ZZ; Chen, Y; Pan, Y				Zhang, Rui; Huang, Heng; Cao, Peijuan; Wang, Zhenzhen; Chen, Yan; Pan, Yi			Sma- and Mad-related Protein 7 (Smad7) Is Required for Embryonic Eye Development in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTERIOR SEGMENT DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; NEURAL CREST; TGF-BETA; RETINAL DEVELOPMENT; KNOCKOUT MICE; OPTIC VESICLE; GENE; EXPRESSION; OVEREXPRESSION	Smad7 is an intracellular inhibitory protein that antagonizes the signaling of TGF-beta family members. Deletion of Smad7 in the mouse leads to an abnormality in heart development. However, whether Smad7 has a functional role in the development of other organs has been elusive. Here we present evidence that Smad7 imparts a role to eye development in the mouse. Smad7 is expressed in both the lens and retina in the developing embryonic eye. Depletion of Smad7 caused various degrees of coloboma and microphthalmia with alterations in cell apoptosis and proliferation in eyes. Smad7 was implicated in lens differentiation but was not required for the induction of the lens placode. The development of the periocular mesenchyme was retarded with the down-regulation of Bmp7 and Pitx2 in mutant mice. Retinal spatial patterning was affected by Smad7 deletion and was accompanied by altered bone morphogenetic protein (BMP) signaling. At late gestation stages, TGF-beta signaling was up-regulated in the differentiating retina. Smad7 mutant mice displayed an expanded optic disc with increasing of sonic hedgehog (SHH) signaling. Furthermore, loss of Smad7 led to a temporal change in retinal neurogenesis. In conclusion, our study suggests that Smad7 is essential for eye development. In addition, our data indicate that alterations in the signaling of BMP, TGF-beta, and SHH likely underlie the defects in eye development caused by Smad7 deletion.	[Zhang, Rui; Huang, Heng; Cao, Peijuan; Wang, Zhenzhen; Chen, Yan; Pan, Yi] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, Y (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	ychen3@sibs.ac.cn; ypan@sibs.ac.cn			Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; National Natural Science Foundation of China [81021002, 81130077, 30971660]; Chinese Academy of Sciences [KSCX2-EW-R-08]; SA-SIBS Scholarship Program	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); SA-SIBS Scholarship Program	This work was supported by Research Grants 2012CB524900 (to Y. C.) and 2010CB529506 (to Y. P. and Z. W.) from the Ministry of Science and Technology of China, 81021002 and 81130077 (to Y. C.) and 30971660 (to Y. P.) from the National Natural Science Foundation of China, and KSCX2-EW-R-08 (to Y. C.) from the Chinese Academy of Sciences and by a grant from the SA-SIBS Scholarship Program (to Y. P.).	Adler R, 2002, DEVELOPMENT, V129, P3161; Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Bassett EA, 2010, HUM MOL GENET, V19, P1791, DOI 10.1093/hmg/ddq060; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Flugel-Koch C, 2002, DEV DYNAM, V225, P111, DOI 10.1002/dvdy.10144; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Funaki T, 2003, CORNEA, V22, P153, DOI 10.1097/00003226-200303000-00015; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Grocott T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1269; Hammerschmidt M, 2003, DEV DYNAM, V227, P128, DOI 10.1002/dvdy.10281; He W, 2002, EMBO J, V21, P2580, DOI 10.1093/emboj/21.11.2580; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Iwao K, 2009, J CLIN INVEST, V119, P1997, DOI 10.1172/JCI38519; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liu J, 2003, DEV BIOL, V256, P34, DOI 10.1016/S0012-1606(02)00115-X; Lupo G, 2005, DEVELOPMENT, V132, P1737, DOI 10.1242/dev.01726; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Mui SH, 2005, GENE DEV, V19, P1249, DOI 10.1101/gad.1276605; Mui SH, 2002, DEVELOPMENT, V129, P797; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Saika S, 2004, LAB INVEST, V84, P1259, DOI 10.1038/labinvest.3700151; Saika S, 2007, ARCH OPHTHALMOL-CHIC, V125, P647, DOI 10.1001/archopht.125.5.647; Sakuta H, 2006, J NEUROSCI, V26, P10868, DOI 10.1523/JNEUROSCI.3027-06.2006; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Sasagawa S, 2002, GENESIS, V33, P86, DOI 10.1002/gene.10095; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195	57	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10275	10285		10.1074/jbc.M112.416719	http://dx.doi.org/10.1074/jbc.M112.416719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426374	hybrid, Green Published			2022-12-28	WOS:000317565000009
J	Camus, G; Herker, E; Modi, AA; Haas, JT; Ramage, HR; Farese, RV; Ott, M				Camus, Gregory; Herker, Eva; Modi, Ankit A.; Haas, Joel T.; Ramage, Holly R.; Farese, Robert V., Jr.; Ott, Melanie			Diacylglycerol Acyltransferase-1 Localizes Hepatitis C Virus NS5A Protein to Lipid Droplets and Enhances NS5A Interaction with the Viral Capsid Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; INFECTIOUS VIRUS; HEPG2 CELLS; ASSOCIATION; 5A; REPLICATION; INHIBITOR; PROMOTES; POTENT; DGAT2	The triglyceride-synthesizing enzyme acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) plays a critical role in hepatitis C virus (HCV) infection by recruiting the HCV capsid protein core onto the surface of cellular lipid droplets (LDs). Here we find a new interaction between the non-structural protein NS5A and DGAT1 and show that the trafficking of NS5A to LDs depends on DGAT1 activity. DGAT1 forms a complex with NS5A and core and facilitates the interaction between both viral proteins. A catalytically inactive mutant of DGAT1 (H426A) blocks the localization of NS5A, but not core, to LDs in a dominant-negative manner and impairs the release of infectious viral particles, underscoring the importance of DGAT1-mediated translocation of NS5A to LDs in viral particle production. We propose a model whereby DGAT1 serves as a cellular hub for HCV core and NS5A proteins, guiding both onto the surface of the same subset of LDs, those generated by DGAT1. These results highlight the critical role of DGAT1 as a host factor for HCV infection and as a potential drug target for antiviral therapy.	[Camus, Gregory; Herker, Eva; Modi, Ankit A.; Ramage, Holly R.; Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Herker, Eva] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Haas, Joel T.; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Heinrich Pette Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Haas, Joel/R-6379-2018; Herker, Eva/B-9699-2014	Haas, Joel/0000-0002-0028-5988; Herker, Eva/0000-0001-9644-2484; Ramage, Holly/0000-0002-0390-6786; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R056 AI069090, P30 K026743]; American Liver Foundation; Human Frontiers Science Program; A. P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069090, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK056084, P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; Human Frontiers Science Program(Human Frontier Science Program); A. P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R056 AI069090 (to M. O.) and P30 K026743 (to the University of California San Francisco Liver Center). This work was also supported by funds from the Gladstone Institutes and fellowships from the American Liver Foundation (to G. C.), the Human Frontiers Science Program (to E. H.), and the A. P. Giannini Foundation (to H. R. R.).	Amgen J. T. I., 2005, Anorectic Compounds, World Intellectual Property Organization, Patent No. [WO/2005/072740, 2005072740]; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Goh PY, 2001, VIROLOGY, V290, P224, DOI 10.1006/viro.2001.1195; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nevo-Yassaf I, 2012, J VIROL, V86, P6491, DOI 10.1128/JVI.00496-12; Pharmaceuticals N., 2011, SAF TOL PHARM PK PHA; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wurie HR, 2012, FEBS J, V279, P3033, DOI 10.1111/j.1742-4658.2012.08684.x; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	35	81	82	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9915	9923		10.1074/jbc.M112.434910	http://dx.doi.org/10.1074/jbc.M112.434910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420847	Green Published, hybrid			2022-12-28	WOS:000317114000031
J	Hojo, H; Ohba, S; Taniguchi, K; Shirai, M; Yano, F; Saito, T; Ikeda, T; Nakajima, K; Komiyama, Y; Nakagata, N; Suzuki, K; Mishina, Y; Yamada, M; Konno, T; Takato, T; Kawaguchi, H; Kambara, H; Chung, U				Hojo, Hironori; Ohba, Shinsuke; Taniguchi, Kiyomi; Shirai, Masataka; Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Nakagata, Naomi; Suzuki, Kentaro; Mishina, Yuji; Yamada, Masahisa; Konno, Tomohiro; Takato, Tsuyoshi; Kawaguchi, Hiroshi; Kambara, Hideki; Chung, Ung-il			Hedgehog-Gli Activators Direct Osteo-chondrogenic Function of Bone Morphogenetic Protein toward Osteogenesis in the Perichondrium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; ENDOCHONDRAL SKELETON; LIMB CHONDROGENESIS; C3H10T1/2 CELLS; GROWTH-PLATE; FACTOR SOX9; TGF-BETA; IN-VIVO; OSTEOBLASTS; CARTILAGE	Specification of progenitors into the osteoblast lineage is an essential event for skeletogenesis. During endochondral ossification, cells in the perichondrium give rise to osteoblast precursors. Hedgehog (Hh) and bone morphogenetic protein (BMP) are suggested to regulate the commitment of these cells. However, properties of perichondrial cells and regulatory mechanisms of the specification process are still poorly understood. Here, we investigated the machineries by combining a novel organ culture system and single-cell expression analysis with mouse genetics and biochemical analyses. In a metatarsal organ culture reproducing bone collar formation, activation of BMP signaling enhanced the bone collar formation cooperatively with Hh input, whereas the signaling induced ectopic chondrocyte formation in the perichondrium without Hh input. Similar phenotypes were also observed in compound mutant mice, where signaling activities of Hh and BMP were genetically manipulated. Single-cell quantitative RT-PCR analyses showed heterogeneity of perichondrial cells in terms of natural characteristics and responsiveness to Hh input. In vitro analyses revealed that Hh signaling suppressed BMP-induced chondrogenic differentiation; Gli1 inhibited the expression of Sox5, Sox6, and Sox9 (SRY box-containing gene 9) as well as transactivation by Sox9. Indeed, ectopic expression of chondrocyte maker genes were observed in the perichondrium of metatarsals in Gli1(-/-) fetuses, and the phenotype was more severe in Gli1(-/-); Gli2(-/-) newborns. These data suggest that Hh-Gli activators alter the function of BMP to specify perichondrial cells into osteoblasts; the timing of Hh input and its target populations are critical for BMP function.	[Hojo, Hironori; Ohba, Shinsuke; Yano, Fumiko; Nakajima, Keiji; Komiyama, Yuske; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan; [Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Takato, Tsuyoshi; Kawaguchi, Hiroshi] Univ Tokyo, Dept Sensory & Motor Syst Med, Tokyo 1130033, Japan; [Konno, Tomohiro; Chung, Ung-il] Univ Tokyo, Dept Bioengn, Tokyo 1130033, Japan; [Taniguchi, Kiyomi; Shirai, Masataka; Kambara, Hideki] Hitachi Cent Res Lab, Tokyo 1858601, Japan; [Nakagata, Naomi; Suzuki, Kentaro] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Yamada, Masahisa] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Yamada, Masahisa] Okinawa Inst Sci & Technol, Common Resources Grp, Okinawa 9040412, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Hitachi Limited; Kumamoto University; University of Michigan System; University of Michigan; RIKEN; Okinawa Institute of Science & Technology Graduate University	Hojo, H (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hojo@bmw.t.u-tokyo.ac.jp; soba@bmw.t.u-tokyo.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022; Konno, Tomohiro/E-5244-2011	Konno, Tomohiro/0000-0002-7814-3306; Hojo, Hironori/0000-0003-2245-6853; Ohba, Shinsuke/0000-0002-6874-8539; Nakagata, Naomi/0000-0002-5737-9993	Japan Society for the Promotion of Science; Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World Leading Innovative R&D on Science and Technology (FIRST program); Grants-in-Aid for Scientific Research [25670851] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World Leading Innovative R&D on Science and Technology (FIRST program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, as well as by the Center for NanoBio Integration, the Center for Medical System Innovation, and the Funding Program for World Leading Innovative R&D on Science and Technology (FIRST program).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Date T, 2004, J ORTHOP SCI, V9, P503, DOI 10.1007/s00776-004-0815-2; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Fernandez-Lloris R, 2003, MOL ENDOCRINOL, V17, P1332, DOI 10.1210/me.2002-0254; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Hojo H, 2010, J BONE MINER METAB, V28, P627, DOI 10.1007/s00774-010-0179-y; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Matsunobu T, 2009, DEV BIOL, V332, P325, DOI 10.1016/j.ydbio.2009.06.002; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Mo R, 1997, DEVELOPMENT, V124, P113; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Park HL, 2000, DEVELOPMENT, V127, P1593; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Taniguchi K, 2009, NAT METHODS, V6, P503, DOI 10.1038/nmeth.1338; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	44	46	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9924	9932		10.1074/jbc.M112.409342	http://dx.doi.org/10.1074/jbc.M112.409342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23423383	Green Published, hybrid			2022-12-28	WOS:000317114000032
J	Mansky, KC; Jensen, ED; Davidova, J; Yamamoto, M; Gopalakrishnan, R				Mansky, Kim C.; Jensen, Eric D.; Davidova, Julia; Yamamoto, Masato; Gopalakrishnan, Rajaram			Protein Kinase D Promotes in Vitro Osteoclast Differentiation and Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; CELL; REPRESSION	Although PKD is broadly expressed and involved in numerous cellular processes, its function in osteoclasts has not been previously reported. In this study, we found that PKD2 is the main PKD isoform expressed in osteoclastic cells. PKD phosphorylation, indicative of the activated state, increased after 2-3 days of treatment of bone marrow macrophages with M-CSF and RANKL, corresponding to the onset of preosteoclast fusion. RNAi against PKD2 and treatment with the PKD inhibitor CID755673 showed that PKD activity is dispensable for induction of bone marrow macrophages into tartrate-resistant acid phosphatase-positive preosteoclasts in culture but is required for the transition from mononucleated preosteoclasts to multinucleated osteoclasts. Loss of PKD activity reduced expression of DC-STAMP in RANKL-stimulated cultures. Overexpression of DC-STAMP was sufficient to rescue treatment with CID755673 and restore fusion into multinucleated osteoclasts. From these data, we conclude that PKD activity promotes differentiation of osteoclast progenitors through increased expression of DC-STAMP.	[Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Jensen, Eric D.; Gopalakrishnan, Rajaram] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Davidova, Julia; Yamamoto, Masato] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jensen, ED (corresponding author), Univ Minnesota, Dept Diagnost & Biol Sci, Sch Dent, 515 Delaware St SE, Minneapolis, MN 55455 USA.	jens0709@umn.edu; gopal007@umn.edu		Mansky, Kim/0000-0002-2826-5030	National Institutes of Health [AR056642]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061352, R01AR056642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR056642.	Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Davydova J, 2004, CANCER RES, V64, P4319, DOI 10.1158/0008-5472.CAN-04-0064; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Tan MQ, 2009, ARTERIOSCL THROM VAS, V29, P1376, DOI 10.1161/ATVBAHA.109.191585; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	21	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9826	9834		10.1074/jbc.M112.444133	http://dx.doi.org/10.1074/jbc.M112.444133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430742	Green Published, hybrid			2022-12-28	WOS:000317114000023
J	Ando, K; Tsushima, H; Matsuo, E; Horio, K; Tominaga-Sato, S; Imanishi, D; Imaizumi, Y; Iwanaga, M; Itonaga, H; Yoshida, S; Hata, T; Moriuchi, R; Kiyoi, H; Nimer, S; Mano, H; Naoe, T; Tomonaga, M; Miyazaki, Y				Ando, Koji; Tsushima, Hideki; Matsuo, Emi; Horio, Kensuke; Tominaga-Sato, Shinya; Imanishi, Daisuke; Imaizumi, Yoshitaka; Iwanaga, Masako; Itonaga, Hidehiro; Yoshida, Shinichiro; Hata, Tomoko; Moriuchi, Ryozo; Kiyoi, Hitoshi; Nimer, Stephen; Mano, Hiroyuki; Naoe, Tomoki; Tomonaga, Masao; Miyazaki, Yasushi			Mutations in the Nucleolar Phosphoprotein, Nucleophosmin, Promote the Expression of the Oncogenic Transcription Factor MEF/ELF4 in Leukemia Cells and Potentiates Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ETS PROTEIN MEF; HEMATOPOIETIC-CELLS; NUCLEAR EXPORT; CANCER-CELLS; P53; GENE; IDENTIFICATION; LOCALIZATION; QUIESCENCE	Myeloid ELF1-like factor (MEF/ELF4), a member of the ETS transcription factors, can function as an oncogene in murine cancer models and is overexpressed in various human cancers. Here, we report a mechanism by which MEF/ELF4 may be activated by a common leukemia-associated mutation in the nucleophosmin gene. By using a tandem affinity purification assay, we found that MEF/ELF4 interacts with multifactorial protein nucleophosmin (NPM1). Coimmunoprecipitation and GST pull-down experiments demonstrated that MEF/ELF4 directly forms a complex with NPM1 and also identified the region of NPM1 that is responsible for this interaction. Functional analyses showed that wild-type NPM1 inhibited the DNA binding and transcriptional activity of MEF/ELF4 on the HDM2 promoter, whereas NPM1 mutant protein (Mt-NPM1) enhanced these activities of MEF/ELF4. Induction of Mt-NPM1 into MEF/ELF4-overexpressing NIH3T3 cells facilitated malignant transformation. In addition, clinical leukemia samples with NPM1 mutations had higher human MDM2 (HDM2) mRNA expression. Our data suggest that enhanced HDM2 expression induced by mutant NPM1 may have a role in MEF/ELF4-dependent leukemogenesis.	[Ando, Koji; Imanishi, Daisuke; Iwanaga, Masako; Itonaga, Hidehiro; Miyazaki, Yasushi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki 8528523, Japan; [Tsushima, Hideki; Imaizumi, Yoshitaka; Hata, Tomoko] Nagasaki Univ Hosp, Dept Hematol, Nagasaki 8528523, Japan; [Matsuo, Emi; Yoshida, Shinichiro] Nagasaki Med Ctr, Dept Hematol, Omura, Nagasaki 8560835, Japan; [Horio, Kensuke; Tomonaga, Masao] Japanese Red Cross Nagasaki Atom Bomb Hosp, Dept Hematol, Nagasaki 8528104, Japan; [Tominaga-Sato, Shinya] Sasebo City Gen Hosp, Div Hematol, Sasebo, Nagasaki 8578511, Japan; [Moriuchi, Ryozo] Keijyu Hosp, Dept Internal Med, Isahaya, Nagasaki 8540121, Japan; [Kiyoi, Hitoshi; Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4668550, Japan; [Nimer, Stephen] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10021 USA; [Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Shimotsuke, Tochigi 3290498, Japan	Nagasaki University; Nagasaki University; Nagoya University; Memorial Sloan Kettering Cancer Center; Jichi Medical University	Miyazaki, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	y-miyaza@nagasaki-u.ac.jp	Naoe, Tomoki/I-1888-2012		Ministry of Health, Welfare, and Labor; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24591387] Funding Source: KAKEN	Ministry of Health, Welfare, and Labor(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Ministry of Health, Welfare, and Labor and a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Bhat UG, 2011, J BIOL CHEM, V286, P41425, DOI 10.1074/jbc.M111.270843; Bolli N, 2010, BLOOD, V115, P3329, DOI 10.1182/blood-2009-02-207225; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cheng K, 2010, BLOOD, V115, P3341, DOI 10.1182/blood-2009-03-208587; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; den Besten W, 2005, CELL CYCLE, V4, P1593; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Fukushima T, 2003, LEUKEMIA RES, V27, P387, DOI 10.1016/S0145-2126(02)00214-X; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hedvat CV, 2004, J BIOL CHEM, V279, P6395, DOI 10.1074/jbc.M307524200; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Li J, 2005, LEUKEMIA RES, V29, P1415, DOI 10.1016/j.leukres.2005.05.005; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lu Z, 2004, FEBS LETT, V561, P117, DOI 10.1016/S0014-5793(04)00138-3; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Mariano AR, 2006, ONCOGENE, V25, P4376, DOI 10.1038/sj.onc.1209453; Miyazaki Y, 2001, J BIOL CHEM, V276, P40528, DOI 10.1074/jbc.M103051200; Miyazaki Y, 1996, ONCOGENE, V13, P1721; Narayan V, 2011, J BIOL CHEM, V286, P14291, DOI 10.1074/jbc.M110.204602; Phelps M, 2003, CANCER RES, V63, P2616; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Seki Y, 2002, CANCER RES, V62, P6579; Smith AM, 2012, MOL CELL BIOL, V32, P763, DOI 10.1128/MCB.05745-11; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Taura M, 2011, NUCLEIC ACIDS RES, V39, P76, DOI 10.1093/nar/gkq762; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Yao JJ, 2007, ONCOGENE, V26, P4032, DOI 10.1038/sj.onc.1210170; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006	37	12	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9457	9467		10.1074/jbc.M112.415703	http://dx.doi.org/10.1074/jbc.M112.415703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393136	Green Published, hybrid			2022-12-28	WOS:000316862200062
J	Bittner, MA; Aikman, RL; Holz, RW				Bittner, Mary A.; Aikman, Rachel L.; Holz, Ronald W.			A Nibbling Mechanism for Clathrin-mediated Retrieval of Secretory Granule Membrane after Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; DOPAMINE-BETA-HYDROXYLASE; RAPID ENDOCYTOSIS; PLASMA-MEMBRANE; MEDULLA; DYNAMIN; RECRUITMENT; CATECHOLAMINES; VISUALIZATION; RECAPTURE	Clathrin-mediated endocytosis is the major pathway for recycling of granule membrane components after strong stimulation and high exocytotic rates. It resembles "classical" receptor-mediated endocytosis but has a trigger that is unique to secretion, the sudden appearance of the secretory granule membrane in the plasma membrane. The spatial localization, the relationship to individual fusion events, the nature of the cargo, and the timing and nature of the nucleation events are unknown. Furthermore, a size mismatch between chromaffin granules (similar to 300-nm diameter) and typical clathrin-coated vesicles (similar to 90 nm) makes it unlikely that clathrin-mediated endocytosis internalizes as a unit the entire fused granule membrane. We have used a combination of total internal reflection fluorescence microscopy of transiently expressed proteins and time-resolved quantitative confocal imaging of endogenous proteins along with a fluid-phase marker to address these issues. We demonstrate that the fused granule membrane remains a distinct entity and serves as a nucleation site for clathrin- and dynamin-mediated endocytosis that internalizes granule membrane components in small increments.	[Bittner, Mary A.; Aikman, Rachel L.; Holz, Ronald W.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bittner, MA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 2220C MSRB 3, Ann Arbor, MI 48109 USA.	mbittner@umich.edu			National Institutes of Health [R01-NS38129, R56-NS38129, R21-NS073686, DK20572]; University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038129, R21NS073686, R01NS038129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS38129, R56-NS38129, and R21-NS073686.; We thank Dr. Arun Anantharam (Wayne State University) for preparing the chromaffin cells for electron microscopy and Dorothy Sorenson (Microscope and Image Analysis Laboratory, Univ. of Michigan) for performing the electron microscopy. We thank Dr. Annita Ngatchou-Weiss for helpful suggestions about the manuscript. We are grateful to Dr. Bruno Gasnier (Institut de Biologie Physico-Chimique CNRS, Paris, France) for providing the VMAT2 antibody and to Dr. Phillip Robinson (University of Sidney, Sidney, Australia) for providing dyngo4a and dyngo8a. This research used the Sequencing Core of the Michigan Diabetes Research and Training Center, supported by National Institutes of Health Grant DK20572, and the Morphology Core, supported by the University of Michigan Comprehensive Cancer Center.	ABRAHAMS SJ, 1973, J CELL BIOL, V56, P540, DOI 10.1083/jcb.56.2.540; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Anantharam A, 2010, J CELL BIOL, V188, P415, DOI 10.1083/jcb.200908010; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; BUCKLEY JT, 1971, BIOCHIM BIOPHYS ACTA, V239, P517, DOI 10.1016/0005-2760(71)90047-6; Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; COUPLAND RE, 1968, NATURE, V217, P384, DOI 10.1038/217384a0; CREUTZ CE, 1984, NATURE, V308, P208, DOI 10.1038/308208a0; DECAMILLI P, 1976, J CELL BIOL, V70, P59, DOI 10.1083/jcb.70.1.59; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRYNSZPA.O, 1971, PHILOS T ROY SOC B, V261, P291, DOI 10.1098/rstb.1971.0058; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HERZOG V, 1977, P NATL ACAD SCI USA, V74, P5073, DOI 10.1073/pnas.74.11.5073; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; HUNTER A, 1989, EXP CELL RES, V182, P445, DOI 10.1016/0014-4827(89)90249-8; Kong MY, 2005, GEOL SOC AM BULL, V117, P244, DOI 10.1130/B25000.1; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; NAGASAWA J, 1972, BRAIN RES, V37, P141, DOI 10.1016/0006-8993(72)90356-3; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; PATZAK A, 1986, J CELL BIOL, V102, P510, DOI 10.1083/jcb.102.2.510; PATZAK A, 1984, J CELL BIOL, V98, P1817, DOI 10.1083/jcb.98.5.1817; PHILLIPS JH, 1983, J CELL BIOL, V97, P1906, DOI 10.1083/jcb.97.6.1906; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; THEODOSIS DT, 1976, J CELL BIOL, V70, P294, DOI 10.1083/jcb.70.2.294; TRIFARO JM, 1984, CELL TISSUE RES, V235, P365; VIVEROS OH, 1968, LIFE SCI PT 1 PHYSI, V7, P609, DOI 10.1016/0024-3205(68)90186-0; WICK PF, 1993, J BIOL CHEM, V268, P10983; Wick PF, 1997, NEUROSCIENCE, V80, P847, DOI 10.1016/S0306-4522(97)00062-6; WINKLER H, 1972, N-S ARCH PHARMAKOL, V273, P43, DOI 10.1007/BF00508079; WINKLER H, 1970, BIOCHEM J, V118, P303, DOI 10.1042/bj1180303; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	42	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9177	9188		10.1074/jbc.M113.450361	http://dx.doi.org/10.1074/jbc.M113.450361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386611	hybrid, Green Published			2022-12-28	WOS:000316862200037
J	Hor, L; Dobson, RCJ; Downton, MT; Wagner, J; Hutton, CA; Perugini, MA				Hor, Lilian; Dobson, Renwick C. J.; Downton, Matthew T.; Wagner, John; Hutton, Craig A.; Perugini, Matthew A.			Dimerization of Bacterial Diaminopimelate Epimerase Is Essential for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN INTERACTIONS; LYSINE BIOSYNTHESIS; ESCHERICHIA-COLI; SELF-ASSOCIATION; ACID EPIMERASE; ENZYME; MECHANISM	Diaminopimelate (DAP) epimerase is involved in the biosynthesis of meso-DAP and lysine, which are important precursors for the synthesis of peptidoglycan, housekeeping proteins, and virulence factors in bacteria. Accordingly, DAP epimerase is a promising antimicrobial target. Previous studies report that DAP epimerase exists as a monomeric enzyme. However, we show using analytical ultracentrifugation, X-ray crystallography, and enzyme kinetic analyses that DAP epimerase from Escherichia coli exists as a functional dimer in solution and the crystal state. Furthermore, the 2.0-angstrom X-ray crystal structure of the E. coli DAP epimerase dimer shows for the first time that the enzyme exists in an open, active conformation. The importance of dimerization was subsequently probed by using site-directed mutagenesis to generate a monomeric mutant (Y268A). Our studies show that Y268A is catalytically inactive, thus demonstrating that dimerization of DAP epimerase is essential for catalysis. Molecular dynamics simulations indicate that the DAP epimerase monomer is inherently more flexible than the dimer, suggesting that dimerization optimizes protein dynamics to support function. Our findings offer insight into the development of novel antimicrobial agents targeting the dimeric antibiotic target DAP epimerase.	[Hor, Lilian; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia; [Hor, Lilian; Dobson, Renwick C. J.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Hor, Lilian; Hutton, Craig A.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Hor, Lilian; Dobson, Renwick C. J.; Hutton, Craig A.; Perugini, Matthew A.] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; [Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Downton, Matthew T.; Wagner, John] Univ Melbourne, Victorian Life Sci Computat Initiat, IBM Res Collaboratory Life Sci Melbourne, Melbourne, Vic 3010, Australia	La Trobe University; University of Melbourne; University of Melbourne; University of Canterbury; University of Canterbury; University of Melbourne	Perugini, MA (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia.	M.Perugini@latrobe.edu.au	Dobson, Renwick/AAZ-7020-2021; Hutton, Craig/M-2442-2013	Dobson, Renwick/0000-0002-5506-4939; Hutton, Craig/0000-0002-2353-9258; Downton, Matthew/0000-0002-4693-1965	Victorian Life Sciences Computation Initiative Grant [VR0089]; University of Melbourne C.R. Roper Fellowship; Australian Research Council for Future Fellowship [FT0991245]	Victorian Life Sciences Computation Initiative Grant; University of Melbourne C.R. Roper Fellowship(University of Melbourne); Australian Research Council for Future Fellowship(Australian Research Council)	This work was supported in part by Victorian Life Sciences Computation Initiative Grant VR0089 to its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia.; Supported by the University of Melbourne C.R. Roper Fellowship.; Supported by Australian Research Council for Future Fellowship FT0991245. To whom correspondence should be addressed: Dept. of Biochemistry, La Trobe Inst. for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia. Tel.: 61-3-9479-6570; Fax: 61-3-9479-1266; E-mail: M.Perugini@latrobe.edu.au.	ANTIA M, 1957, BIOCHEM J, V65, P448, DOI 10.1042/bj0650448; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; Boughton BA, 2008, BIOORGAN MED CHEM, V16, P9975, DOI 10.1016/j.bmc.2008.10.026; Boughton BA, 2012, BIOORGAN MED CHEM, V20, P2419, DOI 10.1016/j.bmc.2012.01.045; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; Cardinale D, 2010, CURR MED CHEM, V17, P826, DOI 10.2174/092986710790712156; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cirilli M, 1998, BIOCHEMISTRY-US, V37, P16452, DOI 10.1021/bi982138o; Cox RJ, 2002, J CHEM SOC PERK T 1, P1029, DOI 10.1039/b201727j; Cox RJ, 2000, BIOORGAN MED CHEM, V8, P843, DOI 10.1016/S0968-0896(00)00044-4; Davis AJ, 2004, J BIOL CHEM, V279, P12462, DOI 10.1074/jbc.M312365200; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2005, BIOINFORMATICS BASIC, P226; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Dogovski C., 2009, BIOTECHNOLOGY, P116; Dogovski C, 2012, BIOCHEMISTRY-US, P225, DOI DOI 10.85772/34121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; Garvey GS, 2007, PROTEIN SCI, V16, P1274, DOI 10.1110/ps.072801907; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Grassick A, 2004, PROTEINS, V55, P764, DOI 10.1002/prot.20025; Hor L, 2010, ACTA CRYSTALLOGR F, V66, P37, DOI 10.1107/S1744309109047708; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Koo CW, 1999, BIOCHEMISTRY-US, V38, P4416, DOI 10.1021/bi982911f; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Liger D, 2005, PROTEINS, V60, P778, DOI 10.1002/prot.20548; Lloyd AJ, 2004, ACTA CRYSTALLOGR D, V60, P397, DOI 10.1107/S0907444903027999; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parsons JF, 2004, BIOCHEMISTRY-US, V43, P12427, DOI 10.1021/bi049059z; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pillai B, 2009, J MOL BIOL, V385, P580, DOI 10.1016/j.jmb.2008.10.072; Pillai B, 2007, BIOCHEM BIOPH RES CO, V363, P547, DOI 10.1016/j.bbrc.2007.09.012; Pillai B, 2006, P NATL ACAD SCI USA, V103, P8668, DOI 10.1073/pnas.0602537103; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Usha V, 2009, ACTA CRYSTALLOGR D, V65, P383, DOI 10.1107/S0907444909002522; Velarde M, 2009, J MOL BIOL, V391, P609, DOI 10.1016/j.jmb.2009.06.052; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WISEMAN JS, 1984, J BIOL CHEM, V259, P8907	55	33	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9238	9248		10.1074/jbc.M113.450148	http://dx.doi.org/10.1074/jbc.M113.450148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23426375	hybrid, Green Published			2022-12-28	WOS:000316862200042
J	Wang, YT; Kuo, PH; Chiang, CH; Liang, JR; Chen, YR; Wang, SY; Shen, JCK; Yuan, HNS				Wang, Yi-Ting; Kuo, Pan-Hsien; Chiang, Chien-Hao; Liang, Jhe-Ruei; Chen, Yun-Ru; Wang, Shuying; Shen, James C. K.; Yuan, Hanna S.			The Truncated C-terminal RNA Recognition Motif of TDP-43 Protein Plays a Key Role in Forming Proteinaceous Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; DNA-BINDING PROTEIN-43; NEURONAL INCLUSIONS; SOLUTION SCATTERING; CELLULAR TOXICITY; AMYLOID FIBRILS; CFTR EXON-9; MUTATIONS	TDP-43 is the major pathological protein identified in the cellular inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. The pathogenic forms of TDP-43 are processed C-terminal fragments containing a truncated RNA-recognition motif (RRM2) and a glycine-rich region. Although extensive studies have focused on this protein, it remains unclear how the dimeric full-length TDP-43 is folded and assembled and how the processed C-terminal fragments are misfolded and aggregated. Here, using size-exclusion chromatography, pulldown assays, and small angle x-ray scattering, we show that the C-terminal- deleted TDP-43 without the glycine-rich tail is sufficient to form a head-to-head homodimer primarily via its N-terminal domain. The truncated RRM2, as well as two beta-strands within the RRM2, form fibrils in vitro with a similar amyloid-negative staining property to those of TDP-43 pathogenic fibrils in diseases. In addition to the glycine-rich region, the truncated RRM2, but not the intact RRM2, plays a key role in forming cytoplasmic inclusions in neuronal cells. Our data thus suggest that the process that disrupts the dimeric structure, such as the proteolytic cleavage of TDP-43 within the RRM2 that removes the N-terminal dimerization domain, may produce unassembled truncated RRM2 fragments with abnormally exposed beta-strands, which can oligomerize into high-order inclusions.	[Wang, Yi-Ting; Kuo, Pan-Hsien; Chiang, Chien-Hao; Liang, Jhe-Ruei; Shen, James C. K.; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Chiang, Chien-Hao] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Liang, Jhe-Ruei] Natl Yang Ming Univ, Dept Life Sci, Inst Genome Sci, Taipei 11221, Taiwan; [Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Wang, Shuying] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70457, Taiwan; [Wang, Shuying] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70457, Taiwan; [Yuan, Hanna S.] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Taipei 10048, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University; National Taiwan University	Yuan, HNS (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	hanna@sinica.edu.tw	Kuo, Po-Hsiu/H-9882-2013; Yuan, Hanna S./AAA-4005-2021; shen, Che-Kun James/L-1343-2015; Chen, Yun-Ru/C-9304-2014; wang, shuying/HHZ-4516-2022	Yuan, Hanna S./0000-0001-9671-6967; Chen, Yun-Ru/0000-0002-6596-6338; 	Academia Sinica; National Science Council (Taiwan)	Academia Sinica(Academia Sinica - Taiwan); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Academia Sinica (to H. Y. and J. C. K. S.) and the National Science Council (Taiwan) (to H. Y. and J. C. K. S.).	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Stromer T, 2005, MICROSC RES TECHNIQ, V67, P210, DOI 10.1002/jemt.20190; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thorpe J, 2008, J NEURAL TRANSM, V115, P1661, DOI 10.1007/s00702-008-0137-1; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu RM, 1997, STRUCTURE, V5, P559, DOI 10.1016/S0969-2126(97)00211-6; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	60	74	74	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9049	9057		10.1074/jbc.M112.438564	http://dx.doi.org/10.1074/jbc.M112.438564			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23372158	Green Published, hybrid			2022-12-28	WOS:000316862200024
J	Lu, DY; Liu, JP; Jiao, JQ; Long, B; Li, Q; Tan, WQ; Li, PF				Lu, Daoyuan; Liu, Jinping; Jiao, Jianqin; Long, Bo; Li, Qian; Tan, Weiqi; Li, Peifeng			Transcription Factor Foxo3a Prevents Apoptosis by Regulating Calcium through the Apoptosis Repressor with Caspase Recruitment Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL-RAT CARDIOMYOCYTES; HYPOXIA-INDUCED APOPTOSIS; PROTEIN-KINASE CK2; CELL-DEATH; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; VENTRICULAR MYOCYTES; ENDOPLASMIC-RETICULUM; NA+-CA2+ EXCHANGER; PRESSURE-OVERLOAD	Apoptosis can occur in the myocardium under a variety of pathological conditions, including myocardial infarction and heart failure. The forkhead family of transcription factor Foxo3a plays a pivotal role in apoptosis; however, its role in regulating cardiac apoptosis remains to be fully elucidated. We showed that enforced expression of Foxo3a inhibits cardiomyocyte apoptosis, whereas knockdown of endogenous Foxo3a sensitizes cardiomyocytes to undergo apoptosis. The apoptosis repressor with caspase recruitment domain (ARC) is a potent anti-apoptotic protein. Here, we demonstrate that it attenuates the release of calcium from the sarcoplasmic reticulum and inhibits calcium elevations in the cytoplasm and mitochondria provoked by oxidative stress in cardiomyocytes. Furthermore, Foxo3a is shown to maintain cytoplasmic and mitochondrial calcium homeostasis through ARC. We observed that Foxo3a knock-out mice exhibited enlarged myocardial infarction sizes upon ischemia/reperfusion, and ARC transgenic mice demonstrated reduced myocardial infarction and balanced calcium levels in mitochondria and sarcoplasmic reticulum. Moreover, we showed that Foxo3a activates ARC expression by directly binding to its promoter. This study reveals that Foxo3a maintains calcium homeostasis and inhibits cardiac apoptosis through trans-activation of the ARC promoter. These findings provided novel evidence that Foxo3a and ARC constitute an anti-apoptotic pathway that regulates calcium homeostasis in the heart.	[Lu, Daoyuan; Liu, Jinping; Jiao, Jianqin; Long, Bo; Li, Qian; Tan, Weiqi] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China; [Li, Peifeng] Univ Illinois, Coll Med, Chicago, IL 60612 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Li, PF (corresponding author), Univ Illinois, Coll Med, Chicago, IL 60612 USA.	peifli@uic.edu	Long, Bo/AGX-8013-2022; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021; Long, Bo/GQH-5131-2022	Li, Peifeng/0000-0002-0969-9407; 	National Institutes of Health [1R01HL102202, 5R21HL092315]; National Natural Science Foundation of China [31010103911, 81070119]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092315, R01HL102202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HL102202 and 5R21HL092315. This work was also supported by National Natural Science Foundation of China Grants 31010103911 and 81070119.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen HP, 2009, EUR J PHARMACOL, V603, P86, DOI 10.1016/j.ejphar.2008.12.003; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Ekhterae D, 1999, CIRC RES, V85, pE70; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Jo DG, 2004, MOL CELL BIOL, V24, P9763, DOI 10.1128/MCB.24.22.9763-9770.2004; Jo H, 2006, J MOL CELL CARDIOL, V40, P394, DOI 10.1016/j.yjmcc.2005.12.012; Kabbara AA, 2001, J PHYSIOL-LONDON, V534, P87, DOI 10.1111/j.1469-7793.2001.00087.x; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Kohlhaas M, 2010, CIRCULATION, V122, P2273, DOI 10.1161/CIRCULATIONAHA.110.968057; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; Long XL, 2004, J MOL CELL CARDIOL, V37, P63, DOI 10.1016/j.yjmcc.2004.04.001; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Morris TE, 1997, FREE RADICAL BIO MED, V22, P37, DOI 10.1016/S0891-5849(96)00238-9; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nam YJ, 2007, J BIOL CHEM, V282, P5522, DOI 10.1074/jbc.M609186200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Neuss M, 2001, J BIOL CHEM, V276, P33915, DOI 10.1074/jbc.M104080200; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pacher P, 2001, BIOL SIGNAL RECEPT, V10, P200; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Pyo JO, 2008, J BIOL CHEM, V283, P30707, DOI 10.1074/jbc.M804209200; Reeve JLV, 2005, J CELL MOL MED, V9, P609, DOI 10.1111/j.1582-4934.2005.tb00492.x; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shannon TR, 2003, CIRC RES, V93, P40, DOI 10.1161/01.RES.0000079967.11815.19; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Stamm C, 2002, CIRCULATION, V106, pI290, DOI 10.1161/01.cir.0000032896.55215.a0; Tajima M, 1999, CIRCULATION, V99, P127, DOI 10.1161/01.CIR.99.1.127; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tan WQ, 2008, CIRCULATION, V118, P2268, DOI 10.1161/CIRCULATIONAHA.107.750869; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Webster KA, 1999, J CLIN INVEST, V104, P239; Yao AS, 1998, CIRC RES, V82, P657, DOI 10.1161/01.RES.82.6.657	57	34	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8491	8504		10.1074/jbc.M112.442061	http://dx.doi.org/10.1074/jbc.M112.442061			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382383	Green Published, hybrid			2022-12-28	WOS:000316564500046
J	Nakashima, M; Shirogane, Y; Hashiguchi, T; Yanagi, Y				Nakashima, Mai; Shirogane, Yuta; Hashiguchi, Takao; Yanagi, Yusuke			Mutations in the Putative Dimer-Dimer Interfaces of the Measles Virus Hemagglutinin Head Domain Affect Membrane Fusion Triggering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL INTERACTION; PARAMYXOVIRUS FUSION; CRYSTAL-STRUCTURE; VACCINIA VIRUS; 4-HELIX BUNDLE; HN PROTEIN; F-PROTEIN; NEURAMINIDASE; STALK; ACTIVATION	Measles virus (MV), an enveloped RNA virus belonging to the Paramyxoviridae family, enters the cell through membrane fusion mediated by two viral envelope proteins, an attachment protein hemagglutinin (H) and a fusion (F) protein. The crystal structure of the receptor-binding head domain of MV-H bound to its cellular receptor revealed that the MV-H head domain forms a tetrameric assembly (dimer of dimers), which occurs in two forms (forms I and II). In this study, we show that mutations in the putative dimer-dimer interface of the head domain in either form inhibit the ability of MV-H to support membrane fusion, without greatly affecting its cell surface expression, receptor binding, and interaction with the F protein. Notably, some anti-MV-H neutralizing monoclonal antibodies are directed to the region around the dimer-dimer interface in form I rather than receptor-binding sites. These observations suggest that the dimer-dimer interactions of the MV-H head domain, especially that in form I, contribute to triggering membrane fusion, and that conformational shift of head domain tetramers plays a role in the process. Furthermore, our results indicate that although the stalk and transmembrane regions may be mainly responsible for the tetramer formation of MV-H, the head domain alone can form tetramers, albeit at a low efficiency.	[Nakashima, Mai; Shirogane, Yuta; Yanagi, Yusuke] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan; [Nakashima, Mai] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Hashiguchi, Takao] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Kyushu University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Scripps Research Institute	Shirogane, Y (corresponding author), Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan.	yuuta@virology.med.kyushu-u.ac.jp; yyanagi@virology.med.kyushu-u.ac.jp	Shirogane, Yuta/AAO-1073-2021	Shirogane, Yuta/0000-0002-4284-0310; Hashiguchi, Takao/0000-0001-7578-7571; Yanagi, Yusuke/0000-0001-7815-1667	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [21249032, 24115005]; Japan Society for the Promotion of Science	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan and by Grants-in-Aid for Scientific Research 21249032 and 24115005 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad.	Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; Bair CH, 1996, J VIROL, V70, P4655, DOI 10.1128/JVI.70.7.4655-4666.1996; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Brindley MA, 2012, P NATL ACAD SCI USA, V109, pE3018, DOI 10.1073/pnas.1210925109; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Ennis MK, 2010, J VIROL, V84, P10913, DOI 10.1128/JVI.00789-10; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1551; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Lorio RM, 2008, TRENDS MICROBIOL, V16, P135, DOI 10.1016/j.tim.2008.01.006; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; MCFARLIN DE, 1980, J GEN VIROL, V48, P425, DOI 10.1099/0022-1317-48-2-425; MCGINNES L, 1993, VIROLOGY, V196, P101, DOI 10.1006/viro.1993.1458; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Navaratnarajah CK, 2012, J BIOL CHEM, V287, P38543, DOI 10.1074/jbc.M112.410563; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Wang ZY, 2004, VIRUS RES, V99, P177, DOI 10.1016/j.virusres.2003.11.010; YANAGI Y, 1992, VIROLOGY, V187, P280, DOI 10.1016/0042-6822(92)90316-H; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2008, VIROLOGY, V378, P282, DOI 10.1016/j.virol.2008.05.023; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	35	8	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8085	8091		10.1074/jbc.M112.427609	http://dx.doi.org/10.1074/jbc.M112.427609			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362271	hybrid, Green Published			2022-12-28	WOS:000316564500009
J	Streich, FC; Ronchi, VP; Connick, JP; Haas, AL				Streich, Frederick C., Jr.; Ronchi, Virginia P.; Connick, J. Patrick; Haas, Arthur L.			Tripartite Motif Ligases Catalyze Polyubiquitin Chain Formation through a Cooperative Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; GLUTATHIONE-S-TRANSFERASE; RING DOMAIN; MULTIUBIQUITIN CHAIN; PROTEIN INTERACTIONS; E2 ENZYMES; TRIM32; FINGER; DIMERIZATION; TRIM5-ALPHA	Ligation of polyubiquitin chains to proteins is a fundamental post-translational modification, often resulting in targeted degradation of conjugated proteins. Attachment of polyubiquitin chains requires the activities of an E1 activating enzyme, an E2 carrier protein, and an E3 ligase. The mechanism by which polyubiquitin chains are formed remains largely speculative, especially for RING-based ligases. The tripartite motif (TRIM) superfamily of ligases functions in many cellular processes including innate immunity, cellular localization, development and differentiation, signaling, and cancer progression. The present results show that TRIM ligases catalyze polyubiquitin chain formation in the absence of substrate, the rates of which can be used as a functional readout of enzyme function. Initial rate studies under biochemically defined conditions show that TRIM32 and TRIM25 are specific for the Ubc5 family of E2-conjugating proteins and, along with TRIM5 alpha, exhibit cooperative kinetics with respect to Ubc5 concentration, with submicromolar [S](0.5) and Hill coefficients of 3-5, suggesting they possess multiple binding sites for their cognate E2-ubiquitin thioester. Mutation studies reveal a second, non-canonical binding site encompassing the C-terminal Ubc5 alpha-helix. Polyubiquitin chain formation requires TRIM subunit oligomerization through the conserved coiled-coil domain, but can be partially replaced by fusing the catalytic domain to GST to promote dimerization. Other results suggest that TRIM32 assembles polyubiquitin chains as a Ubc5-linked thioester intermediate. These results represent the first detailed mechanistic study of TRIM ligase activity and provide a functional context for oligomerization observed in the superfamily.	[Streich, Frederick C., Jr.; Ronchi, Virginia P.; Connick, J. Patrick; Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu		Streich Jr, Frederick/0000-0002-7549-424X	National Institutes of Health [R01 GM0034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM0034009 (to A.L.H.).	Albor A, 2007, MOL CARCINOGEN, V46, P585, DOI 10.1002/mc.20344; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Guglieri M, 2005, CLIN CHIM ACTA, V361, P54, DOI 10.1016/j.cccn.2005.05.020; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Haas AL, 1997, FASEB J, V11, P1257; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Horn EJ, 2004, CARCINOGENESIS, V25, P157, DOI 10.1093/carcin/bgh003; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Kim I, 2006, SCI STKE, V2006, P18; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; Kumar B, 2010, J BIOL CHEM, V285, P41300, DOI 10.1074/jbc.M110.169136; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Liu YG, 2010, J INVEST DERMATOL, V130, P1384, DOI 10.1038/jid.2009.416; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Muller J, 2010, HUM GENET, V127, P583, DOI 10.1007/s00439-010-0804-9; Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2; Nakajima A, 2007, BIOCHEM BIOPH RES CO, V357, P245, DOI 10.1016/j.bbrc.2007.03.134; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Russell Nathaniel S., 2005, V301, P207; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; SEGAL IH, 1975, ENZYME KINETICS; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Urano T, 2009, BIOCHEM BIOPH RES CO, V383, P263, DOI 10.1016/j.bbrc.2009.04.010; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zou WG, 2007, BIOCHEM BIOPH RES CO, V354, P321, DOI 10.1016/j.bbrc.2006.12.210	74	36	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8209	8221		10.1074/jbc.M113.451567	http://dx.doi.org/10.1074/jbc.M113.451567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23408431	Green Published, hybrid			2022-12-28	WOS:000316564500021
J	Hur, JK; Zinchenko, MK; Djuranovic, S; Green, R				Hur, Junho K.; Zinchenko, Michelle K.; Djuranovic, Sergej; Green, Rachel			Regulation of Argonaute Slicer Activity by Guide RNA 3 ' End Interactions with the N-terminal Lobe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRANSLATIONAL REPRESSION; TARGET RECOGNITION; PROTEINS; MICRORNA; GW182; CLEAVAGE; REQUIRES; COMPLEX; DEGRADATION	Structural studies indicate that binding of both the guide RNA(siRNA and miRNA) and the target mRNA trigger substantial conformational changes in the Argonaute proteins. Here we explore the role of the N-terminal lobe (and its PAZ domain) in these conformational changes using biochemical and cell culture-based approaches. In vitro, whereas deletion (or mutation) of the N-terminal lobe of DmAgo1 and DmAgo2 had no effect on binding affinity to guide RNAs, we observed a loss of protection of the 3' end of the guide RNA and decreased target RNA binding; consistent with this, in cells, loss of function DmAgo1 PAZ variant proteins (PAZ6 and Delta N-PAZ) still bind RNA, although the RNAs are shorter than normal. We also find that deletion of the N-terminal lobe results in constitutive activation of endogenous PIWI domain-based cleavage activity in vitro, providing insights into how cleavage activity may be regulated in vivo in response to different types of pairing interactions with the target mRNAs.	[Hur, Junho K.; Zinchenko, Michelle K.; Djuranovic, Sergej; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.	ragreen@jhmi.edu	Hur, Junho/ADK-0757-2022	Hur, Junho/0000-0003-3794-1149; Djuranovic, Sergej/0000-0002-9417-0822	Howard Hughes Medical Institute; Samsung Foundation of Culture	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Samsung Foundation of Culture(Samsung)	This work was supported by funding from the Howard Hughes Medical Institute (to R. G.).; Supported in part by the Samsung Foundation of Culture.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Djuranovic S, 2010, NAT STRUCT MOL BIOL, V17, P144, DOI 10.1038/nsmb.1736; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Enright AJ, 2004, GENOME BIOL, V5; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gu S, 2012, CURR BIOL, V22, P1536, DOI 10.1016/j.cub.2012.06.040; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Huntzinger E, 2013, NUCLEIC ACIDS RES, V41, P978, DOI 10.1093/nar/gks1078; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Milligan J. F., 1989, METHOD ENZYMOL, V180, P51; Miyoshi K, 2009, RNA, V15, P1282, DOI 10.1261/rna.1541209; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Nahvi A, 2009, RNA, V15, P814, DOI 10.1261/rna.1565109; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	41	27	29	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7829	7840		10.1074/jbc.M112.441030	http://dx.doi.org/10.1074/jbc.M112.441030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23329841	Green Published, hybrid			2022-12-28	WOS:000316455300037
J	Lossi, NS; Manoli, E; Forster, A; Dajani, R; Pape, T; Freemont, P; Filloux, A				Lossi, Nadine S.; Manoli, Eleni; Foerster, Andreas; Dajani, Rana; Pape, Tillmann; Freemont, Paul; Filloux, Alain			The HsiB1C1 (TssB-TssC) Complex of the Pseudomonas aeruginosa Type VI Secretion System Forms a Bacteriophage Tail Sheathlike Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN HOMOLOGY DETECTION; ESCHERICHIA-COLI; PHAGE; GENES; MECHANISM; MACHINE; TARGETS; ICMF; DNA	Protein secretion systems in Gram-negative bacteria evolved into a variety of molecular nanomachines. They are related to cell envelope complexes, which are involved in assembly of surface appendages or transport of solutes. They are classified as types, the most recent addition being the type VI secretion system (T6SS). The T6SS displays similarities to bacteriophage tail, which drives DNA injection into bacteria. The Hcp protein is related to the T4 bacteriophage tail tube protein gp19, whereas VgrG proteins structurally resemble the gp27/gp5 puncturing device of the phage. The tube and spike of the phage are pushed through the bacterial envelope upon contraction of a tail sheath composed of gp18. In Vibrio cholerae it was proposed that VipA and VipB assemble into a tail sheathlike structure. Here we confirm these previous data by showing that HsiB1 and HsiC1 of the Pseudomonas aeruginosa H1-T6SS assemble into tubules resulting from stacking of cogwheel-like structures showing predominantly 12-fold symmetry. The internal diameter of the cogwheels is similar to 100 angstrom, which is large enough to accommodate an Hcp tube whose external diameter has been reported to be 85 angstrom. The N-terminal 212 residues of HsiC1 are sufficient to form a stable complex with HsiB1, but the C terminus of HsiC1 is essential for the formation of the tubelike structure. Bioinformatics analysis suggests that HsiC1 displays similarities to gp18-like proteins in its C-terminal region. In conclusion, we provide further structural and mechanistic insights into the T6SS and show that a phage sheathlike structure is likely to be a conserved element across all T6SSs.	[Lossi, Nadine S.; Manoli, Eleni; Dajani, Rana; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Mol Bacteriol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England; [Foerster, Andreas; Pape, Tillmann; Freemont, Paul] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Imperial College London; Imperial College London	Filloux, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Mol Bacteriol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England.	a.filloux@imperial.ac.uk		Freemont, Paul/0000-0002-5658-8486; Pape, Tillmann/0000-0002-0612-3568; Forster, Andreas/0000-0003-1472-3990	Medical Research Council (MRC) [G0800171/ID86344]; Wellcome Trust [WT091939]; MRC [G0800171/ID86344]; MRC [MR/J006874/1, G0800171, MR/K001930/1] Funding Source: UKRI; Medical Research Council [G0800171, MR/K001930/1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Medical Research Council (MRC) Grant G0800171/ID86344.; Supported by Wellcome Trust Grant WT091939.; Supported by MRC Grant G0800171/ID86344 and Wellcome Trust Grant WT091939. To whom correspondence should be addressed: MRC Centre for Molecular Bacteriology and Infection (MRC-CMBI), Division of Cell and Molecular Biology, Imperial College London, London SW7 2AZ, UK. Tel.: 44-20-7594-9651; Fax: 44-20-7594-3069; E-mail: a.filloux@imperial.ac.uk.	Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; ARISAKA F, 1990, BIOCHEMISTRY-US, V29, P5057, DOI 10.1021/bi00473a009; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Efimov AV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1366, DOI 10.1023/A:1021857926152; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Filloux A, 2009, EMBO J, V28, P309, DOI 10.1038/emboj.2008.301; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Jones AM, 2010, CHEST, V137, P1405, DOI 10.1378/chest.09-2406; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Kuznetsova TA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P702; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MOODY MF, 1973, J MOL BIOL, V80, P613, DOI 10.1016/0022-2836(73)90200-3; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Pederson DM, 2001, J MOL BIOL, V309, P401, DOI 10.1006/jmbi.2001.4685; Poglazov BF, 1999, J STRUCT BIOL, V127, P224, DOI 10.1006/jsbi.1999.4164; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Williams SR, 2008, APPL ENVIRON MICROB, V74, P3868, DOI 10.1128/AEM.00141-08; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X	59	64	66	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7536	7548		10.1074/jbc.M112.439273	http://dx.doi.org/10.1074/jbc.M112.439273			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341461	Green Published, hybrid			2022-12-28	WOS:000316455300010
J	Theisen, JWM; Gucwa, JS; Yusufzai, T; Khuong, MT; Kadonaga, JT				Theisen, Joshua W. M.; Gucwa, James S.; Yusufzai, Timur; Khuong, Mai T.; Kadonaga, James T.			Biochemical Analysis of Histone Deacetylase-independent Transcriptional Repression by MeCP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME MUTATIONS; CPG-BINDING PROTEIN-2; METHYL-CPG; CHROMOSOMAL PROTEIN; RNA-POLYMERASE; IN-VITRO; DNA; CHROMATIN; SELECTIVITY; PROMOTER	MeCP2 is an abundant methyl-cytosine-guanine (CG)-binding protein and transcriptional repressor. We developed a biochemical system that exhibits CG methylation-specific transcriptional repression by purified human MeCP2. MeCP2 represses transcription by histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Our system appears to recreate the HDAC-independent component of MeCP2-mediated repression and occurs via inhibition of the assembly of transcription preinitiation complexes. At a ratio of approximately one molecule of MeCP2 per two methyl-CG dinucleotides, as found in mammalian neurons, the magnitude of methylation-specific repression was greater than 10-fold. Notably, the HDAC inhibitor trichostatin A had no effect on MeCP2-mediated repression with either naked DNA or chromatin templates. We designed a CG-deficient core promoter that is resistant to MeCP2-mediated repression when placed in a plasmid lacking CG dinucleotides. By using this CG-deficient reporter as a reference, we found that eight CG dinucleotides in the core promoter region are sufficient for strong methylation-specific repression by MeCP2. In contrast, MeCP2 does not repress a construct with 13 CG dinucleotides located similar to 1.7 kbp upstream of the promoter. Furthermore, by analysis of C-terminally truncated MeCP2 proteins, we found that binding of MeCP2 to methyl-CG dinucleotides is not sufficient for transcriptional repression. Hence, MeCP2-mediated repression is not due to the simple steric blockage of the transcriptional machinery. These experiments suggest that MeCP2 can function as a global methyl-CG-specific, HDAC-independent repressor. This HDAC-independent mechanism of MeCP2-mediated repression may be important in cells, such as mammalian neurons, that have high levels of CG methylation and MeCP2.	[Theisen, Joshua W. M.; Gucwa, James S.; Yusufzai, Timur; Khuong, Mai T.; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, 0347,Pacific Hall,Room 2212B,9500 Gilman Dr, La Jolla, CA 92093 USA.	jkadonaga@ucsd.edu		Theisen, Joshua/0000-0002-6267-5391	National Institutes of Health [GM041249]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041249, T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant GM041249 (to J. T. K.). This project was initiated by an International Rett Syndrome Foundation (Rett Syndrome Research Foundation) grant.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; Huang XJ, 2001, J BIOL CHEM, V276, P12497, DOI 10.1074/jbc.C100034200; Ishibashi T, 2008, FEBS LETT, V582, P1157, DOI 10.1016/j.febslet.2008.03.005; Jiang W, 2000, J BIOL CHEM, V275, P39819, DOI 10.1074/jbc.C000713200; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Yu F, 2000, NUCLEIC ACIDS RES, V28, P2201, DOI 10.1093/nar/28.10.2201; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	25	9	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7096	7104		10.1074/jbc.M112.438697	http://dx.doi.org/10.1074/jbc.M112.438697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23349465	Green Published, hybrid			2022-12-28	WOS:000316002400031
J	Daddacha, W; Noble, E; Nguyen, LA; Kennedy, EM; Kim, B				Daddacha, Waaqo; Noble, Erin; Nguyen, Laura A.; Kennedy, Edward M.; Kim, Baek			Effect of Ribonucleotides Embedded in a DNA Template on HIV-1 Reverse Transcription Kinetics and Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SAMHD1 RESTRICTS; FREQUENT INCORPORATION; LEUKEMIA-VIRUS; RNA; PROCESSIVITY; POLYMERASE; SUBSTRATE; INFECTION; EXPRESSION	HIV-1 reverse transcriptase (RT) frequently incorporates ribonucleoside triphosphates (rNTPs) during proviral DNA synthesis, particularly under the limited dNTP conditions found in macrophages. We investigated the mechanistic impacts of an rNMP embedded in DNA templates on HIV-1 RT-mediated DNA synthesis. We observed that the template-embedded rNMP induced pausing of RT and delayed DNA synthesis kinetics at low macrophage dNTP concentrations but not at high T cell dNTP concentrations. Although the binding affinity of RT to the rNMP-containing template-primer was not altered, the dNTP incorporation kinetics of RT were significantly reduced at one nucleotide upstream and downstream of the rNMP site, leading to pause sites. Finally, HIV-1 RT becomes more error-prone at rNMP sites with an elevated mismatch extension capability but not enhanced misinsertion capability. Together these data suggest that rNMPs embedded in DNA templates may influence reverse transcription kinetics and impact viral mutagenesis in macrophages.	[Daddacha, Waaqo; Noble, Erin; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Nguyen, Laura A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Kennedy, Edward M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	University of Rochester; University of Rochester; Duke University	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [F31 GM095190, AI049781]; Oral Cellular and Molecular Biology Training Grant [T32 E007202]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral Cellular and Molecular Biology Training Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31 GM095190 (to W. D.), AI049781 (to B. K.), and Oral Cellular and Molecular Biology Training Grant T32 E007202 (to E. N.).	Amie SM, 2013, VIROLOGY, V436, P247, DOI 10.1016/j.virol.2012.11.010; Avidan O, 1998, NUCLEIC ACIDS RES, V26, P1713, DOI 10.1093/nar/26.7.1713; Avidan O, 2002, EUR J BIOCHEM, V269, P859, DOI 10.1046/j.0014-2956.2001.02719.x; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; Bishop G Reid, 2003, Curr Protoc Nucleic Acid Chem, VChapter 7, DOI 10.1002/0471142700.nc0711s11; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; DeRose EF, 2012, BIOCHEMISTRY-US, V51, P2407, DOI 10.1021/bi201710q; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; FRY M, 1992, P NATL ACAD SCI USA, V89, P763, DOI 10.1073/pnas.89.2.763; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1986, J VIROL, V58, P67, DOI 10.1128/JVI.58.1.67-74.1986; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gorshkova II, 2001, ANAL BIOCHEM, V291, P198, DOI 10.1006/abio.2001.5053; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; JAISHREE TN, 1993, BIOCHEMISTRY-US, V32, P4903, DOI 10.1021/bi00069a027; Jenkins JL, 2011, J BIOL CHEM, V286, P24626, DOI 10.1074/jbc.M111.230375; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kennedy EM, 2011, J BIOL CHEM, V286, P25047, DOI 10.1074/jbc.M111.234047; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 1996, J BIOL CHEM, V271, P4872, DOI 10.1074/jbc.271.9.4872; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LETVIN NL, 1983, P NATL ACAD SCI-BIOL, V80, P2718, DOI 10.1073/pnas.80.9.2718; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Myszka DG, 1999, J MOL RECOGNIT, V12, P390, DOI 10.1002/(SICI)1099-1352(199911/12)12:6<390::AID-JMR482>3.0.CO;2-8; Nguyen LA, 2012, J MOL BIOL, V415, P248, DOI 10.1016/j.jmb.2011.11.014; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rezende LF, 2001, J BIOMED SCI, V8, P197, DOI 10.1007/BF02256413; Romainczyk O, 2011, MOL BIOSYST, V7, P1050, DOI 10.1039/c0mb00258e; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tsoi PY, 2004, BIOSENS BIOELECTRON, V19, P1209, DOI 10.1016/j.bios.2003.11.004; Van Cor-Hosmer SK, 2012, VIROLOGY, V422, P393, DOI 10.1016/j.virol.2011.11.004; Wawryn J, 1999, ACTA BIOCHIM POL, V46, P249, DOI 10.18388/abp.1999_4158; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; YU H, 1992, J BIOL CHEM, V267, P10888	50	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12522	12532		10.1074/jbc.M113.458398	http://dx.doi.org/10.1074/jbc.M113.458398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23479739	hybrid, Green Published			2022-12-28	WOS:000318555100011
J	Aparicio, D; Perez-Luque, R; Carpena, X; Diaz, M; Ferrer, JC; Loewen, PC; Fita, I				Aparicio, David; Perez-Luque, Rosa; Carpena, Xavier; Diaz, Mireia; Ferrer, Joan C.; Loewen, Peter C.; Fita, Ignacio			Structural Asymmetry and Disulfide Bridges among Subunits Modulate the Activity of Human Malonyl-CoA Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAXIMUM-LIKELIHOOD; ACID; MITOCHONDRIAL; REFINEMENT; DEFICIENCY; SERVER	Decarboxylation of malonyl-CoA to acetyl-CoA by malonyl-CoA decarboxylase (MCD; EC 4.1.1.9) is an essential facet in the regulation of fatty acid metabolism. The structure of human peroxisomal MCD reveals a molecular tetramer that is best described as a dimer of structural heterodimers, in which the two subunits present markedly different conformations. This molecular organization is consistent with half-of-the-sites reactivity. Each subunit has an all-helix N-terminal domain and a catalytic C-terminal domain with an acetyltransferase fold (GNAT superfamily). Intersubunit disulfide bridges, Cys-206-Cys-206 and Cys-243-Cys-243, can link the four subunits of the tetramer, imparting positive cooperativity to the catalytic process. The combination of a half-of the-sites mechanism within each structural heterodimer and positive cooperativity in the tetramer produces a complex regulatory picture that is further complicated by the multiple intracellular locations of the enzyme. Transport into the peroxisome has been investigated by docking human MCD onto the peroxisomal import protein peroxin 5, which revealed interactions that extend beyond the C-terminal targeting motif.	[Aparicio, David; Perez-Luque, Rosa; Carpena, Xavier; Fita, Ignacio] CSIC, IBMB, E-08028 Barcelona, Spain; [Diaz, Mireia; Ferrer, Joan C.] Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; University of Manitoba	Fita, I (corresponding author), CSIC, IBMB, Parc Cient,Baldiri Reixac 10, E-08028 Barcelona, Spain.	ifrcri@ibmb.csic.es	Ferrer, Joan C./AAP-2145-2021; Carpena, Xavi/J-5877-2017; Aparicio, David/R-4640-2019; Aparicio, David/AAX-7388-2020; Fita, Ignasi/R-4515-2019	Carpena, Xavi/0000-0002-8646-0440; Aparicio, David/0000-0002-1971-5335; Fita, Ignasi/0000-0002-7521-2679; Perez Luque, Rosa/0000-0003-0759-0608; Ferrer, Joan C./0000-0003-1212-5161	Natural Sciences and Engineering Research Council of Canada [9600]; Canada Research Chair Program; Ministerio de Ciencia e Innovacion (MICINN) [BFU2012-36827]; Generalitat de Catalunya [SGR2009-00327]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Discovery Grant 9600 from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair Program (to P. C. L.) and by Grant BFU2012-36827 from the Ministerio de Ciencia e Innovacion (MICINN) and Grant SGR2009-00327 from the Generalitat de Catalunya (to I. F.).	Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Cowtan K., 1994, PROTEIN CRYSTALLOGR, V31, P34; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; HAAN EA, 1986, EUR J PEDIATR, V144, P567, DOI 10.1007/BF00496037; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HATCH MD, 1962, PLANT PHYSIOL, V37, P121, DOI 10.1104/pp.37.2.121; HAYAISHI O, 1955, J BIOL CHEM, V215, P125; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joly E, 2005, FEBS LETT, V579, P6581, DOI 10.1016/j.febslet.2005.10.050; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM YS, 1978, ARCH BIOCHEM BIOPHYS, V190, P234, DOI 10.1016/0003-9861(78)90273-4; Kolattukudy P E, 1981, Methods Enzymol, V71 Pt C, P150; LYNEN F, 1962, METHOD ENZYMOL, V5, P443, DOI 10.1016/S0076-6879(62)05256-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKADA HI, 1957, J BIOL CHEM, V226, P145; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Sacksteder KA, 1999, J BIOL CHEM, V274, P24461, DOI 10.1074/jbc.274.35.24461; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WOLFE JB, 1954, J BIOL CHEM, V209, P885; Zhou W, 2009, ONCOGENE, V28, P2979, DOI 10.1038/onc.2009.160	26	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11907	11919		10.1074/jbc.M112.443846	http://dx.doi.org/10.1074/jbc.M112.443846			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482565	Green Published, hybrid			2022-12-28	WOS:000318157600026
J	Engelman, R; Weisman-Shomer, P; Ziv, T; Xu, JQ; Arner, ESJ; Benhar, M				Engelman, Rotem; Weisman-Shomer, Pnina; Ziv, Tamar; Xu, Jianqiang; Arner, Elias S. J.; Benhar, Moran			Multilevel Regulation of 2-Cys Peroxiredoxin Reaction Cycle by S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; PROTEIN DENITROSYLATION; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; THIOREDOXIN; PEROXYNITRITE; NITROSOTHIOLS; H2O2; MACROPHAGES; MECHANISMS	S-Nitrosothiols (SNOs), formed by nitric oxide (NO)-mediated S-nitrosylation, and hydrogen peroxide (H2O2), a prominent reactive oxygen species, are implicated in diverse physiological and pathological processes. Recent research has shown that the cellular action and metabolism of SNOs and H2O2 involve overlapping, thiol-based mechanisms, but how these reactive species may affect each other's fate and function is not well understood. In this study we investigated how NO/SNO may affect the redox cycle of mammalian peroxiredoxin-1 (Prx1), a representative of the 2-Cys Prxs, a group of thioredoxin (Trx)-dependent peroxidases. We found that, both in a cell-free system and in cells, NO/SNO donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the S-nitrosylation of Prx1, causing structural and functional alterations. In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity. A highly potent inhibition of the peroxidase catalytic reaction by NO/SNO was seen in assays employing the coupled Prx-Trx system. In this setting, S-nitrosocysteine (10 mu M) effectively blocked the Trx-mediated regeneration of oxidized Prx1. This effect appeared to be due to both competition between S-nitrosocysteine and Prx1 for the Trx system and direct modulation by S-nitrosocysteine of Trx reductase activity. Our findings that NO/SNO target both Prx and Trx reductase may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.	[Engelman, Rotem; Weisman-Shomer, Pnina; Benhar, Moran] Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-31096 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Fac Biol, IL-31096 Haifa, Israel; [Xu, Jianqiang; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Karolinska Institutet	Benhar, M (corresponding author), Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	benhar@tx.technion.ac.il	Arnér, Elias/K-6737-2019; Benhar, Moran/AAV-5764-2020; Xu, Jianqiang/T-7507-2019; Arnér, Elias S.J./J-5832-2012	Arnér, Elias/0000-0002-4807-6114; Benhar, Moran/0000-0002-7094-3456; Xu, Jianqiang/0000-0002-1289-5943; Arnér, Elias S.J./0000-0002-4807-6114; Ziv, Tamar/0000-0003-4299-7454	Israel Science Foundation [1336/10]; FP7 European Commission (Marie Curie) grant program [256438]; Mallat family foundation; Karolinska Institutet; Swedish Research Council (Medicine); Swedish Cancer Society	Israel Science Foundation(Israel Science Foundation); FP7 European Commission (Marie Curie) grant program; Mallat family foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council (Medicine)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants from the Israel Science Foundation (1336/10), the FP7 European Commission (Marie Curie) grant program (256438), and the Mallat family foundation (to M. B.). This work was also supported by grants from the Karolinska Institutet, the Swedish Research Council (Medicine), and the Swedish Cancer Society (to E. S. J. A.).	ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Barglow KT, 2011, P NATL ACAD SCI USA, V108, pE600, DOI 10.1073/pnas.1110736108; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Bast A, 2010, FREE RADICAL BIO MED, V49, P1881, DOI 10.1016/j.freeradbiomed.2010.09.015; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2010, BIOCHEMISTRY-US, V49, P6963, DOI 10.1021/bi100619k; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Dammeyer P, 2011, BBA-GEN SUBJECTS, V1810, P111, DOI 10.1016/j.bbagen.2010.07.004; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Filep JG, 1997, BIOCHEM J, V321, P897, DOI 10.1042/bj3210897; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Karplus PA, 2012, MOL CELL, V45, P275, DOI 10.1016/j.molcel.2012.01.012; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Marcinkiewicz J, 1997, IMMUNOPHARMACOLOGY, V37, P35, DOI 10.1016/S0162-3109(96)00168-3; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Nelson Kimberly J, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0710s49; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Sengupta R, 2012, BBA-GEN SUBJECTS, V1820, P689, DOI 10.1016/j.bbagen.2011.08.012; Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034	47	49	49	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11312	11324		10.1074/jbc.M112.433755	http://dx.doi.org/10.1074/jbc.M112.433755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479738	Green Published, hybrid			2022-12-28	WOS:000317915500034
J	Brophy, TM; Coller, BS; Ahamed, J				Brophy, Teresa M.; Coller, Barry S.; Ahamed, Jasimuddin			Identification of the Thiol Isomerase-binding Peptide, Mastoparan, as a Novel Inhibitor of Shear-induced Transforming Growth Factor beta 1 (TGF-beta 1) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; MEDIATES PLATELET-AGGREGATION; IN-VIVO EVIDENCE; LATENT TGF-BETA; WASP VENOM; SITE; THROMBOSPONDIN-1; MECHANISMS; CLUSTERIN; DOMAINS	TGF-beta 1 is a disulfide-bonded homodimeric protein produced by platelets and other cells that plays a role in many physiologic and pathologic processes. TGF-beta 1 is secreted as an inactive large latent complex (LLC) comprised of TGF-beta 1, latency-associated peptide, and latent TGF-beta binding protein 1. We previously demonstrated that shear force can activate LLC and that thiol-disulfide exchange contributes to the process. We have now investigated the role of thiol isomerases in the activation of LLC in platelet releasates (PR) and recombinant LLC. The wasp venom peptide mastoparan, which inhibits the chaperone activity of PDI, inhibited stirring-and shear-induced activation of latent TGF-beta 1 by 90 and 75% respectively. To identify the proteins that bind to mastoparan either directly or indirectly, PR were chromatographed on a mastoparan affinity column. Latent TGF-beta binding protein 1, latency-associated peptide, TGF-beta 1, clusterin, von Willebrand factor, multimerin-1, protein disulfide isomerase (PDI), ERp5, ERp57, and ERp72 eluted specifically from the column. Anti-PDI RL90 attenuated the inhibitory effect of mastoparan on LLC activation. Furthermore, reduced PDI inhibited activation of PR LLC, whereas oxidized PDI had no effect. We conclude that thiol isomerases and thiol-disulfide exchange contribute to TGF-beta 1 activation and identify a number of molecules that may participate in the process.	[Brophy, Teresa M.; Coller, Barry S.; Ahamed, Jasimuddin] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10065 USA	Rockefeller University	Coller, BS (corresponding author), Rockefeller Univ, Lab Blood & Vasc Biol, 1230 York Ave, New York, NY 10065 USA.	collerb@rockefeller.edu; jahamed@rockefeller.edu		Brophy, Teresa/0000-0003-4064-409X	National Heart, Lung, and Blood Institute [HL19278]; National Center for Research Resources [TR000043]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [TR000043]; New York City Community Trust; Irma T. Hirschl/Monique Weill-Caulier Trust; Stony Brook University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL019278, R01HL019278] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); New York City Community Trust; Irma T. Hirschl/Monique Weill-Caulier Trust; Stony Brook University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant HL19278 from the National Heart, Lung, and Blood Institute; a Clinical and Translational Science Award (TR000043) from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health; a New York City Community Trust Grant Award; an Irma T. Hirschl/Monique Weill-Caulier Trust Research Award (to J. A.); and funds from Stony Brook University.	Ahamed J, 2008, BLOOD, V112, P3650, DOI 10.1182/blood-2008-04-151753; Ahamed J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006608; Alanen HI, 2006, ANTIOXID REDOX SIGN, V8, P283, DOI 10.1089/ars.2006.8.283; ARGIOLAS A, 1983, J BIOL CHEM, V258, P3697; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; BARNETTE MS, 1983, BIOCHEM PHARMACOL, V32, P2929, DOI 10.1016/0006-2952(83)90398-2; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; CHEN K, 1992, BLOOD, V79, P2226; Choi H, 2007, J BIOL CHEM, V282, P35604, DOI 10.1074/jbc.M704047200; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Essex DW, 1999, BRIT J HAEMATOL, V104, P448, DOI 10.1046/j.1365-2141.1999.01197.x; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; HAYWARD CPM, 1993, J CLIN INVEST, V91, P2630, DOI 10.1172/JCI116502; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIRAI Y, 1979, CHEM PHARM BULL, V27, P1942; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; Huang EM, 1997, BLOOD, V89, P3205, DOI 10.1182/blood.V89.9.3205; Jeimy SB, 2008, PLATELETS, V19, P83, DOI 10.1080/09537100701832157; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jobling ME, 2006, RADIAT RES, V166, P839, DOI 10.1667/RR0695.1; Jones S, 2006, CURR PROTEIN PEPT SC, V7, P501, DOI 10.2174/138920306779025585; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Jung GS, 2012, J AM SOC NEPHROL, V23, P73, DOI 10.1681/ASN.2011010048; Kikuchi M, 2002, J BIOCHEM, V132, P451, DOI 10.1093/oxfordjournals.jbchem.a003242; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lenferink AEG, 2010, ONCOGENE, V29, P831, DOI 10.1038/onc.2009.399; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; OZAKI Y, 1990, BIOCHEM BIOPH RES CO, V170, P779, DOI 10.1016/0006-291X(90)92159-W; PFEIFFER DR, 1995, J BIOL CHEM, V270, P4923, DOI 10.1074/jbc.270.9.4923; Raturi A, 2010, J THROMB HAEMOST, V8, P1863, DOI 10.1111/j.1538-7836.2010.03918.x; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Schiavinato A, 2012, J BIOL CHEM, V287, P11498, DOI 10.1074/jbc.M111.303578; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; TSCHOPP J, 1993, BLOOD, V82, P118, DOI 10.1182/blood.V82.1.118.bloodjournal821118; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; WHEELERJONES CPD, 1992, BIOCHEM J, V281, P465, DOI 10.1042/bj2810465; Wu Y, 2012, BLOOD, V119, P1737, DOI 10.1182/blood-2011-06-360685; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	51	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10628	10639		10.1074/jbc.M112.439034	http://dx.doi.org/10.1074/jbc.M112.439034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23463512	Green Published, hybrid			2022-12-28	WOS:000317565000041
J	Ding, XM; Park, SI; McCauley, LK; Wang, CY				Ding, Xiangming; Park, Serk In; McCauley, Laurie K.; Wang, Cun-Yu			Signaling between Transforming Growth Factor beta (TGF-beta) and Transcription Factor SNAI2 Represses Expression of MicroRNA miR-203 to Promote Epithelial-Mesenchymal Transition and Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; E-CADHERIN; ZEB1; FAMILY; SLUG; CARCINOMA; INVASION; PHENOTYPE; MIGRATION; PROFILES	TGF-beta promotes tumor invasion and metastasis by inducing an epithelial-mesenchymal transition (EMT). Understanding the molecular and epigenetic mechanisms by which TGF-beta induces EMT may facilitate the development of new therapeutic strategies for metastasis. Here, we report that TGF-beta induced SNAI2 to promote EMT by repressing miR-203. Although miR-203 targeted SNAI2, SNAI2 induced by TGF-beta could directly bind to the miR-203 promoter to inhibit its transcription. SNAI2 and miR-203 formed a double negative feedback loop to inhibit each other's expression, thereby controlling EMT. Moreover, we found that miR-203 was significantly down-regulated in highly metastatic breast cancer cells. The restoration of miR-203 in highly metastatic breast cancer cells inhibited tumor cell invasion in vitro and lung metastatic colonization in vivo by repressing SNAI2. Taken together, our results suggest that the SNAI2 and miR-203 regulatory loop plays important roles in EMT and tumor metastasis.	[Ding, Xiangming; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Ding, Xiangming; Wang, Cun-Yu] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Ding, Xiangming; Wang, Cun-Yu] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Park, Serk In; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Park, Serk In; McCauley, Laurie K.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cunywang@ucla.edu	Park, Serk In/D-2840-2011	Park, Serk In/0000-0001-8643-5096; ding, xiangming/0000-0003-1169-5998	National Institutes of Health from the NIDCR [R01 CA132134, R37 DE013848, R01 DE15964]; NATIONAL CANCER INSTITUTE [R01CA132134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013848, R01DE015964] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA132134 and R37 DE013848 and R01 DE15964 from the NIDCR (to C.-Y.W.).	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hajra KM, 2002, CANCER RES, V62, P1613; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Caro M, 2008, BRIT J CANCER, V98, P480, DOI 10.1038/sj.bjc.6604084; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Shalgi R, 2009, AGING-US, V1, P762, DOI 10.18632/aging.100085; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Takeshita N, 2012, INT J ONCOL, V41, P1653, DOI 10.3892/ijo.2012.1614; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-58; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743	48	138	144	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10241	10253		10.1074/jbc.M112.443655	http://dx.doi.org/10.1074/jbc.M112.443655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447531	Green Published, hybrid			2022-12-28	WOS:000317565000006
J	Sainz-Polo, MA; Ramirez-Escudero, M; Lafraya, A; Gonzalez, B; Marin-Navarro, J; Polaina, J; Sanz-Aparicio, J				Angela Sainz-Polo, M.; Ramirez-Escudero, Mercedes; Lafraya, Alvaro; Gonzalez, Beatriz; Marin-Navarro, Julia; Polaina, Julio; Sanz-Aparicio, Julia			Three-dimensional Structure of Saccharomyces Invertase ROLE OF A NON-CATALYTIC DOMAIN IN OLIGOMERIZATION AND SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCCIDENTALIS BETA-FRUCTOFURANOSIDASE; RAY-DIFFRACTION STRUCTURE; CRYSTAL-STRUCTURE; INTERNAL INVERTASE; YEAST INVERTASE; CEREVISIAE; BINDING; PROTEIN; ENZYME; INULINASE	Invertase is an enzyme that is widely distributed among plants and microorganisms and that catalyzes the hydrolysis of the disaccharide sucrose into glucose and fructose. Despite the important physiological role of Saccharomyces invertase (SInv) and the historical relevance of this enzyme as a model in early biochemical studies, its structure had not yet been solved. We report here the crystal structure of recombinant SInv at 3.3 angstrom resolution showing that the enzyme folds into the catalytic beta-propeller and beta-sandwich domains characteristic of GH32 enzymes. However, SInv displays an unusual quaternary structure. Monomers associate in two different kinds of dimers, which are in turn assembled into an octamer, best described as a tetramer of dimers. Dimerization plays a determinant role in substrate specificity because this assembly sets steric constraints that limit the access to the active site of oligosaccharides of more than four units. Comparative analysis of GH32 enzymes showed that formation of the SInv octamer occurs through a beta-sheet extension that seems unique to this enzyme. Interaction between dimers is determined by a short amino acid sequence at the beginning of the beta-sandwich domain. Our results highlight the role of the non-catalytic domain in fine-tuning substrate specificity and thus supplement our knowledge of the activity of this important family of enzymes. In turn, this gives a deeper insight into the structural features that rule modularity and protein-carbohydrate recognition.	[Angela Sainz-Polo, M.; Ramirez-Escudero, Mercedes; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estructural, E-28006 Madrid, Spain; [Lafraya, Alvaro; Marin-Navarro, Julia; Polaina, Julio] CSIC, Inst Agroquim & Tecnol Alimentos, Valencia 46980, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estructural, Serrano 119, E-28006 Madrid, Spain.	xjulia@iqfr.csic.es	Polaina, Julio/H-4498-2012; Escudero, Mercedes Ramirez/O-1690-2019; , Marín-Navarro/F-7630-2016; Sanz-Aparicio, Julia/F-6201-2013; ESCUDERO, MERCEDES RAMIREZ/Q-3965-2018; Sainz-Polo, Maria-Angela/F-3947-2016; Gonzalez, Beatriz/M-1219-2014	Escudero, Mercedes Ramirez/0000-0001-7253-9572; , Marín-Navarro/0000-0001-7893-3423; Sanz-Aparicio, Julia/0000-0002-6849-8621; ESCUDERO, MERCEDES RAMIREZ/0000-0001-7253-9572; Sainz-Polo, Maria-Angela/0000-0002-6269-4330; Gonzalez, Beatriz/0000-0002-0710-0202; LAFRAYA, ALVARO/0000-0001-7488-8354; Polaina, Julio/0000-0001-9912-0640	Spanish Ministry of Education and Science [BIO2010-20508-C04-02, BIO2010-20508-C04-03]; Junta para la Ampliacion de Estudios (JAE) predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Education and Science(Spanish Government); Junta para la Ampliacion de Estudios (JAE) predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas	This work was supported in part by Grants BIO2010-20508-C04-02 and BIO2010-20508-C04-03 from the Spanish Ministry of Education and Science.; Supported by a Junta para la Ampliacion de Estudios (JAE) predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alvaro-Benito M, 2012, J BIOL CHEM, V287, P19674, DOI 10.1074/jbc.M112.355503; Alvaro-Benito M, 2010, APPL ENVIRON MICROB, V76, P7491, DOI 10.1128/AEM.01614-10; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; Sainz-Polo MA, 2012, ACTA CRYSTALLOGR F, V68, P1538, DOI 10.1107/S1744309112044417; Barnett JA, 2003, MICROBIOL-SGM, V149, P557, DOI 10.1099/mic.0.26089-0; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARLSON M, 1980, COLD SPRING HARB SYM, V45, P799, DOI 10.1101/SQB.1981.045.01.098; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conde R, 2004, J BIOL CHEM, V279, P43789, DOI 10.1074/jbc.M406678200; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DELAFUENTE G, 1962, BIOCHIM BIOPHYS ACTA, V56, P49, DOI 10.1016/0006-3002(62)90526-7; DeLano W.L, PYMOL MOL GRAPHICS S; Dou YM, 2004, BIOINFORMATICS, V20, P2767, DOI 10.1093/bioinformatics/bth326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESMON PC, 1987, J BIOL CHEM, V262, P4387; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; GASCON S, 1968, J BIOL CHEM, V243, P1567; GASCON S, 1968, J BIOL CHEM, V243, P1573; GILL BLAND R. B., 1949, COMPT REND TRAV LAB CARLSBERG [COPENHAGEN] SER PHYSIOL, V24, P347; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GROSSMANN MK, 1979, MOL GEN GENET, V175, P223, DOI 10.1007/BF00425540; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Lammens W, 2012, PLANT J, V70, P205, DOI 10.1111/j.1365-313X.2011.04858.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Michaelis L, 1913, BIOCHEM Z, V49, P333; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Park J, 2012, J BIOL CHEM, V287, P31233, DOI 10.1074/jbc.M112.389270; PERLMAN D, 1981, CELL, V25, P525, DOI 10.1016/0092-8674(81)90071-4; Pouyez J, 2012, BIOCHIMIE, V94, P2423, DOI 10.1016/j.biochi.2012.06.020; REDDY AV, 1990, BIOCHEMISTRY-US, V29, P2482, DOI 10.1021/bi00462a007; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; TAMMI M, 1987, J BIOL CHEM, V262, P4395; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WILLIAMS RS, 1985, J BIOL CHEM, V260, P3334; WINGE O, 1952, CR TRAV LAB CARLS P, V25, P141; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	44	63	67	2	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9755	9766		10.1074/jbc.M112.446435	http://dx.doi.org/10.1074/jbc.M112.446435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430743	Green Published, hybrid			2022-12-28	WOS:000317114000017
J	Hashimoto, K; Otero, M; Imagawa, K; de Andres, MC; Coico, JM; Roach, HI; Oreffo, ROC; Marcu, KB; Goldring, MB				Hashimoto, Ko; Otero, Miguel; Imagawa, Kei; de Andres, Mara C.; Coico, Jonathan M.; Roach, Helmtrud I.; Oreffo, Richard O. C.; Marcu, Kenneth B.; Goldring, Mary B.			Regulated Transcription of Human Matrix Metalloproteinase 13 (MMP13) and Interleukin-1 beta (IL1B) Genes in Chondrocytes Depends on Methylation of Specific Proximal Promoter CpG Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OSTEOARTHRITIC CHONDROCYTES; HUMAN ARTICULAR CHONDROCYTES; DNA METHYLATION; RHEUMATOID-ARTHRITIS; THERAPEUTIC INTERVENTION; EPIGENETIC MEMORY; MOLECULAR TARGET; SYNOVIAL TISSUE; DOWN-REGULATION; IN-VIVO	The role of DNA methylation in the regulation of catabolic genes such as MMP13 and IL1B, which have sparse CpG islands, is poorly understood in the context of musculoskeletal diseases. We report that demethylation of specific CpG sites at -110 bp and -299 bp of the proximal MMP13 and IL1B promoters, respectively, detected by in situ methylation analysis of chondrocytes obtained directly from human cartilage, strongly correlated with higher levels of gene expression. The methylation status of these sites had a significant impact on promoter activities in chondrocytes, as revealed in transfection experiments with site-directed CpG mutants in a CpG-free luciferase reporter. Methylation of the -110 and -299 CpG sites, which reside within a hypoxia-inducible factor (HIF) consensus motif in the respective MMP13 and IL1B promoters, produced the most marked suppression of their transcriptional activities. Methylation of the -110 bp CpG site in the MMP13 promoter inhibited its HIF-2 alpha-driven transactivation and decreased HIF-2 alpha binding to the MMP13 proximal promoter in chromatin immunoprecipitation assays. In contrast to HIF-2 alpha, MMP13 transcriptional regulation by other positive (RUNX2, AP-1, ELF3) and negative (Sp1, GATA1, and USF1) factors was not affected by methylation status. However, unlike the MMP13 promoter, IL1B was not susceptible to HIF-2 alpha transactivation, indicating that the -299 CpG site in the IL1B promoter must interact with other transcription factors to modulate IL1B transcriptional activity. Taken together, our data reveal that the methylation of different CpG sites in the proximal promoters of the human MMP13 and IL1B genes modulates their transcription by distinct mechanisms.	[Hashimoto, Ko; Otero, Miguel; Coico, Jonathan M.; Goldring, Mary B.] Hosp Special Surg, Div Res, New York, NY 10021 USA; [Hashimoto, Ko; Otero, Miguel; Coico, Jonathan M.; Goldring, Mary B.] Weill Cornell Med Coll, New York, NY 10021 USA; [Hashimoto, Ko] Tohoku Univ, Dept Orthoped, Sendai, Miyagi 9808574, Japan; [Imagawa, Kei; de Andres, Mara C.; Roach, Helmtrud I.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Southampton SO16 6YD, Hants, England; [Marcu, Kenneth B.] Ist Ortoped Rizzoli, Ctr Ric Codivilla Putti, Lab Immunoreumatol & Rigeneraz Tissutale, I-40136 Bologna, Italy; [Marcu, Kenneth B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cornell University; Tohoku University; University of Southampton; IRCCS Istituto Ortopedico Rizzoli; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goldring, MB (corresponding author), Hosp Special Surg, Caspary Res Bldg,5th Fl,535 E 70th St, New York, NY 10021 USA.	goldringm@hss.edu	de+Andrés, María/AAP-1473-2020; de Andrés González, M del Carmen/ABD-7612-2021; Oreffo, Richard OC/A-4615-2011	de Andrés González, M del Carmen/0000-0003-2260-6356; Oreffo, Richard OC/0000-0001-5995-6726; Hashimoto, Ko/0000-0002-9644-054X	National Institutes of Health [R21-AR054887, R01-AG022021, RC4-AR060546]; Arthritis Foundation Postdoctoral Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC) [sLOLA BB/GO10579/1]; BBSRC [BB/G010579/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR054887, RC4AR060546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Postdoctoral Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or part, by National Institutes of Health Grants R21-AR054887, R01-AG022021, and RC4-AR060546 (to M. B. G.), an Arthritis Foundation Postdoctoral Fellowship (to M. O.), and Biotechnology and Biological Sciences Research Council (BBSRC) Grant sLOLA BB/GO10579/1 (to R. O. C. O.).	Aigner T, 2006, ADV DRUG DELIVER REV, V58, P128, DOI 10.1016/j.addr.2006.01.020; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Barter MJ, 2012, OSTEOARTHR CARTILAGE, V20, P339, DOI 10.1016/j.joca.2011.12.012; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bui C, 2012, FASEB J, V26, P3000, DOI 10.1096/fj.12-206367; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Cheung KSC, 2009, RHEUMATOL INT, V29, P525, DOI 10.1007/s00296-008-0744-z; COGSWELL JP, 1994, J IMMUNOL, V153, P712; da Silva MA, 2009, J ORTHOP RES, V27, P593, DOI 10.1002/jor.20799; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ema M, 1996, MOL CELL BIOL, V16, P5865; Fan ZY, 2006, ARTHRITIS RHEUM-US, V54, P2471, DOI 10.1002/art.21961; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring MB, 2012, TRENDS MOL MED, V18, P109, DOI 10.1016/j.molmed.2011.11.005; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hashimoto K, 2007, EPIGENETICS-US, V2, P86, DOI 10.4161/epi.2.2.4203; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Horiuchi M, 2009, J RHEUMATOL, V36, P1580, DOI 10.3899/jrheum.081115; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Huber LC, 2007, ARTHRITIS RHEUM, V56, P1087, DOI 10.1002/art.22512; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Irvine RA, 2002, MOL CELL BIOL, V22, P6689, DOI 10.1128/MCB.22.19.6689-6696.2002; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Kawabata Tomoko, 2010, Arthritis Res Ther, V12, pR133, DOI 10.1186/ar3071; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P513, DOI 10.1016/j.joca.2008.08.003; Maciejewska-Rodrigues H, 2010, J AUTOIMMUN, V35, P15, DOI 10.1016/j.jaut.2009.12.010; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Moffett P, 1997, MOL CELL BIOL, V17, P4933, DOI 10.1128/MCB.17.9.4933; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Neidhart M, 2000, ARTHRITIS RHEUM-US, V43, P2634, DOI 10.1002/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Poschl E, 2005, ANN RHEUM DIS, V64, P477, DOI 10.1136/ard.2004.022509; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reynard LN, 2011, HUM MOL GENET, V20, P3450, DOI 10.1093/hmg/ddr253; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Roach HI, 2007, OSTEOARTHR CARTILAGE, V15, P128, DOI 10.1016/j.joca.2006.07.002; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Saito T, 2010, OSTEOARTHR CARTILAGE, V18, P1552, DOI 10.1016/j.joca.2010.10.006; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Semenza GL, 2000, GENE DEV, V14, P1983; Sesselmann S, 2009, OSTEOARTHR CARTILAGE, V17, P507, DOI 10.1016/j.joca.2008.09.006; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Strietholt S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2500; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Woods S, 2008, NUCLEIC ACIDS RES, V36, P3716, DOI 10.1093/nar/gkn247; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zimmermann P, 2008, ARTHRITIS RHEUM, V58, P2743, DOI 10.1002/art.23736	66	105	111	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10061	10072		10.1074/jbc.M112.421156	http://dx.doi.org/10.1074/jbc.M112.421156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417678	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000317114000044
J	Rosenberg, MM; Ronen, D; Lahav, N; Nazirov, E; Ravid, S; Friedler, A				Rosenberg, Masha M.; Ronen, Daniel; Lahav, Noa; Nazirov, Elvira; Ravid, Shoshana; Friedler, Assaf			High Resolution Characterization of Myosin IIC Protein Tailpiece and Its Effect on Filament Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN PHOSPHORYLATION; AMINO-ACID-SEQUENCE; NONMUSCLE MYOSIN; CELLULAR-LOCALIZATION; COILED-COIL; ROD; REGIONS; CHARGE; TAIL; DETERMINES	The motor protein nonmuscle myosin II (NMII) must undergo dynamic oligomerization into filaments to perform its cellular functions. A small nonhelical region at the tail of the long coiled-coil region (tailpiece) is a common feature of all dynamically assembling myosin II proteins. This tailpiece is a key regulatory domain affecting NMII filament assembly properties and is subject to phosphorylation in vivo. We previously demonstrated that the positively charged region of the tailpiece binds to assembly-incompetent NMII-C fragments, inducing filament assembly. In the current study, we investigated the molecular mechanisms by which the tailpiece regulates NMII-C self-assembly. Using alanine scan, we found that specific positive and aromatic residues within the positively charged region of the tailpiece are important for inducing NMII-C filament assembly and for filament elongation. Combining peptide arrays with deletion studies allowed us to identify the tailpiece binding sites in the coiled-coil rod. Elucidation of the mechanism by which the tailpiece induces filament assembly permitted us further investigation into the role of tailpiece phosphorylation. Sedimentation and CD spectroscopy identified that phosphorylation of Thr(1957) or Thr(1960) inhibited the ability of the tailpiece to bind the coiled-coil rod and to induce NMII-C filament formation. This study provides molecular insight into the role of specific residues within the NMII-C tailpiece that are responsible for shifting the oligomeric equilibrium of NMII-C toward filament assembly and determining its morphology.	[Rosenberg, Masha M.; Lahav, Noa; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Ronen, Daniel; Nazirov, Elvira; Ravid, Shoshana] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ravid, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel.	shoshr@ekmd.huji.ac.il; assaf.friedler@mail.huji.ac.il			European Research Council under the European Community [203413]	European Research Council under the European Community(European Research Council (ERC))	Supported by a starting grant from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/ERC Grant 203413. To whom correspondence may be addressed. E-mail: assaf.friedler@mail.huji.ac.il.	ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Ben-Ya'acov A, 2003, J BIOL CHEM, V278, P40032, DOI 10.1074/jbc.M306948200; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; Katz C, 2011, CHEM SOC REV, V40, P2131, DOI 10.1039/c0cs00029a; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCLACHLAN AD, 1984, ANNU REV BIOPHYS BIO, V13, P167; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Reingewertz TH, 2009, PROTEIN ENG DES SEL, V22, P281, DOI 10.1093/protein/gzp004; Ricketson D, 2010, P NATL ACAD SCI USA, V107, P20964, DOI 10.1073/pnas.1007025107; Ronen D, 2010, J BIOL CHEM, V285, P7079, DOI 10.1074/jbc.M109.049221; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sellers J. R., 1999, MYOSINS; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SINARD JH, 1990, J CELL BIOL, V111, P2417, DOI 10.1083/jcb.111.6.2417; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R., 2005, THESIS HEBREW U JERU; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115	33	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9779	9789		10.1074/jbc.M112.430173	http://dx.doi.org/10.1074/jbc.M112.430173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426373	Green Published, hybrid			2022-12-28	WOS:000317114000019
J	Rubinow, KB; Wall, VZ; Nelson, J; Mar, D; Bomsztyk, K; Askari, B; Lai, MA; Smith, KD; Han, MS; Vivekanandan-Giri, A; Pennathur, S; Albert, CJ; Ford, DA; Davis, RJ; Bornfeldt, KE				Rubinow, Katya B.; Wall, Valerie Z.; Nelson, Joel; Mar, Daniel; Bomsztyk, Karol; Askari, Bardia; Lai, Marvin A.; Smith, Kelly D.; Han, Myoung Sook; Vivekanandan-Giri, Anuradha; Pennathur, Subramaniam; Albert, Carolyn J.; Ford, David A.; Davis, Roger J.; Bornfeldt, Karin E.			Acyl-CoA Synthetase 1 Is Induced by Gram-negative Bacteria and Lipopolysaccharide and Is Required for Phospholipid Turnover in Stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPRESSION; FATTY-ACIDS; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; BIOLOGICAL SAMPLES; TERMINAL KINASE; MAP-KINASES; PPAR-ALPHA; IFN-GAMMA	The enzyme acyl-CoA synthetase 1 (ACSL1) is induced by peroxisome proliferator-activated receptor alpha (PPAR alpha) and PPAR gamma in insulin target tissues, such as skeletal muscle and adipose tissue, and plays an important role in beta-oxidation in these tissues. In macrophages, however, ACSL1 mediates inflammatory effects without significant effects on beta-oxidation. Thus, the function of ACSL1 varies in different tissues. We therefore investigated the signals and signal transduction pathways resulting in ACSL1 induction in macrophages as well as the consequences of ACSL1 deficiency for phospholipid turnover in LPS-activated macrophages. LPS, Gram-negative bacteria, IFN-gamma, and TNF alpha all induce ACSL1 expression in macrophages, whereas PPAR agonists do not. LPS-induced ACSL1 expression is dependent on Toll-like receptor 4 (TLR4) and its adaptor protein TRIF (Toll-like receptor adaptor molecule 1) but does not require the MyD88 (myeloid differentiation primary response gene 88) arm of TLR4 signaling; nor does it require STAT1 (signal transducer and activator of transcription 1) for maximal induction. Furthermore, ACSL1 deletion attenuates phospholipid turnover in LPS-stimulated macrophages. Thus, the regulation and biological function of ACSL1 in macrophages differ markedly from that in insulin target tissues. These results suggest that ACSL1 may have an important role in the innate immune response. Further, these findings illustrate an interesting paradigm in which the same enzyme, ACSL1, confers distinct biological effects in different cell types, and these disparate functions are paralleled by differences in the pathways that regulate its expression.	[Rubinow, Katya B.; Wall, Valerie Z.; Nelson, Joel; Mar, Daniel; Bomsztyk, Karol; Bornfeldt, Karin E.] Univ Washington, Diabet & Obes Ctr Excellence, Dept Med, Seattle, WA 98109 USA; [Askari, Bardia; Lai, Marvin A.; Smith, Kelly D.; Bornfeldt, Karin E.] Univ Washington, Diabet & Obes Ctr Excellence, Dept Pathol, Seattle, WA 98109 USA; [Han, Myoung Sook; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Vivekanandan-Giri, Anuradha; Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Albert, Carolyn J.; Ford, David A.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Albert, Carolyn J.; Ford, David A.] St Louis Univ, Sch Med, Ctr Cardiovasc Res, St Louis, MO 63104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; Saint Louis University; Saint Louis University	Bornfeldt, KE (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Diabet & Obes Ctr Excellence, 850 Republican St, Seattle, WA 98109 USA.	bornf@uw.edu	Bornfeldt, Karin/AAI-2241-2019; Ford, David/D-1819-2018	Bornfeldt, Karin/0000-0001-9208-6523; Ford, David/0000-0002-0029-1560; Davis, Roger/0000-0002-0130-1652; Han, Myoung Sook/0000-0002-7226-2590	National Institutes of Health [HL062887, HL092969, HL097365, 6K12HD053984, AI062859, HL074214, HL111906, DK082841, DK083310, R37 DK45978, T32DK007247, T32HL007312]; Juvenile Diabetes Research Foundation [42-2009-779]; Diabetes Research Center at the University of Washington (National Institutes of Health) [DK017047]; NIAID, National Institutes of Health [HHSN272200700038C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD053984, U54HD042454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092969, R21HL111906, T32HL007028, T32HL007312, R01HL074214, R01HL062887, R01HL097365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R24DK082841, T32DK007247, P30DK017047, R01DK083310, R37DK045978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Research Center at the University of Washington (National Institutes of Health); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL062887, HL092969, HL097365 (to K. E. B.); 6K12HD053984 (to K. B. R.); AI062859 (to K. D. S.); HL074214 and HL111906 (to D. A. F.); DK082841 (to S. P.); and DK083310 and R37 DK45978 (to K. B.). This work was also supported by Juvenile Diabetes Research Foundation Grant 42-2009-779 (to K. B.). Part of the study was supported by the Diabetes Research Center at the University of Washington (National Institutes of Health Grant DK017047). This work was also supported by NIAID, National Institutes of Health, contract HHSN272200700038C, "Systems Approach to Immunity and Inflammation."; Supported by National Institutes of Health Training Grant T32DK007247.; Supported by National Institutes of Health Training Grant T32HL007312.	Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Comalada M, 2012, EUR J IMMUNOL, V42, P1938, DOI 10.1002/eji.201242441; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jong H, 2007, BBA-MOL CELL BIOL L, V1771, P75, DOI 10.1016/j.bbalip.2006.11.007; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Ford DA, 2008, J NEUROCHEM, V105, P1032, DOI 10.1111/j.1471-4159.2007.05203.x; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Hale KK, 1999, J IMMUNOL, V162, P4246; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Han XL, 2002, ANAL BIOCHEM, V302, P199, DOI 10.1006/abio.2001.5536; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Ma W, 2004, J IMMUNOL, V172, P318, DOI 10.4049/jimmunol.172.1.318; Maloney NS, 2012, J VIROL, V86, P12655, DOI 10.1128/JVI.01564-12; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Ruiz-Garcia A, 2011, J BIOL CHEM, V286, P19247, DOI 10.1074/jbc.M110.190298; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; SCHOONJANS K, 1993, EUR J BIOCHEM, V216, P615, DOI 10.1111/j.1432-1033.1993.tb18181.x; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Utsugi M, 2010, CYTOKINE, V51, P127, DOI 10.1016/j.cyto.2010.04.002; Wagner JD, 2010, J PHARMACOL EXP THER, V333, P844, DOI 10.1124/jpet.110.166736; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	49	45	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9957	9970		10.1074/jbc.M113.458372	http://dx.doi.org/10.1074/jbc.M113.458372			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426369	Green Published, hybrid			2022-12-28	WOS:000317114000035
J	Xu, YY; Wei, XY; Wang, M; Zhang, R; Fu, YB; Xing, MZ; Hua, QH; Xie, X				Xu, Yongyu; Wei, Xiaoyuan; Wang, Min; Zhang, Ru; Fu, Yanbin; Xing, Mingzhe; Hua, Qiuhong; Xie, Xin			Proliferation Rate of Somatic Cells Affects Reprogramming Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; SUBEROYLANILIDE HYDROXAMIC ACID; DEXAMETHASONE INHIBITS PROLIFERATION; SIGNALING PROMOTES PROLIFERATION; HISTONE DEACETYLASE INHIBITORS; HUMAN NEUROBLASTOMA-CELLS; C-MYC; SELF-RENEWAL; CANCER-CELLS; IN-VIVO	The discovery of induced pluripotent stem (iPS) cells provides not only new approaches for cell replacement therapy, but also new ways for drug screening. However, the undefined mechanism and relatively low efficiency of reprogramming have limited the application of iPS cells. In an attempt to further optimize the reprogramming condition, we unexpectedly observed that removing c-Myc from the Oct-4, Sox-2, Klf-4, and c-Myc (OSKM) combination greatly enhanced the generation of iPS cells. The iPS cells generated without c-Myc attained salient pluripotent characteristics and were capable of producing fullterm mice through tetraploid complementation. We observed that forced expression of c-Myc induced the expression of many genes involved in cell cycle control and a hyperproliferation state of the mouse embryonic fibroblasts during the early stage of reprogramming. This enhanced proliferation of mouse embryonic fibroblasts correlated negatively to the overall reprogramming efficiency. By applying small molecule inhibitors of cell proliferation at the early stage of reprogramming, we were able to improve the efficiency of iPS cell generation mediated by OSKM. Our data demonstrated that the proliferation rate of the somatic cell plays critical roles in reprogramming. Slowing down the proliferation of the original cells might be beneficial to the induction of iPS cells.	[Xu, Yongyu; Wei, Xiaoyuan; Zhang, Ru; Fu, Yanbin; Xing, Mingzhe; Hua, Qiuhong; Xie, Xin] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Lab Receptor Based Biomed, Shanghai 200092, Peoples R China; [Xu, Yongyu; Wei, Xiaoyuan; Wang, Min; Fu, Yanbin; Xing, Mingzhe; Xie, Xin] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Stake Key Lab Drug Res, Shanghai 201203, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhang, R (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	ru.zhang@tongji.edu.cn; xxie@mail.shcnc.ac.cn			Chinese Academy of Sciences [XDA01040301]; Ministry of Science and Technology of China [2009CB940900, 2010CB944900, 2011CB965104, 2011DFB30010]; Shanghai Commission of Science and Technology [11DZ2292200, 12XD1402100]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by Chinese Academy of Sciences Grant XDA01040301, Ministry of Science and Technology of China Grants 2009CB940900, 2010CB944900, 2011CB965104, and 2011DFB30010, and Shanghai Commission of Science and Technology Grant 11DZ2292200 and 12XD1402100.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bavaresco L, 2007, J NEURO-ONCOL, V84, P1, DOI 10.1007/s11060-007-9342-2; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Butler LM, 2000, CANCER RES, V60, P5165; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Chen MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028203; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hindley C, 2012, BIOCHEM J, V444, P375, DOI 10.1042/BJ20112040; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hurlin PJ, 2003, EMBO J, V22, P4584, DOI 10.1093/emboj/cdg442; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kaufmann L, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-15; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; KUNERTRADEK J, 1990, AGENTS ACTIONS, V29, P254, DOI 10.1007/BF01966455; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Liu HO, 2009, BRAIN RES, V1265, P1, DOI 10.1016/j.brainres.2009.01.050; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luo JC, 2007, J PHARMACOL EXP THER, V320, P687, DOI 10.1124/jpet.106.113035; Lusher B, 2007, EMBO REP, V8, P1110, DOI 10.1038/sj.embor.7401121; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Malynn BA, 2000, GENE DEV, V14, P1390; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Medina V, 1997, CANCER RES, V57, P3697; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miller JP, 2007, CELL CYCLE, V6, P2932, DOI 10.4161/cc.6.23.5042; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Ota S, 2009, HUM MOL GENET, V18, P2609, DOI 10.1093/hmg/ddp195; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Pluck Anne, 2009, Methods Mol Biol, V561, P199, DOI 10.1007/978-1-60327-019-9_13; Richon VM, 2001, BLOOD CELL MOL DIS, V27, P260, DOI 10.1006/bcmd.2000.0376; ROCCHI P, 1992, ANTICANCER RES, V12, P917; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Schmidt K, 1999, ARCH PHARM, V332, P353, DOI 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shang YC, 2007, ACTA PHARMACOL SIN, V28, P1761, DOI 10.1111/j.1745-7254.2007.00671.x; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; WELLER EM, 1993, CELL PROLIFERAT, V26, P45, DOI 10.1111/j.1365-2184.1993.tb00005.x; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; Yamamura S, 2012, INT J CANCER, V130, P20, DOI 10.1002/ijc.25961; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	83	42	45	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9767	9778		10.1074/jbc.M112.403881	http://dx.doi.org/10.1074/jbc.M112.403881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23439651	Green Published, hybrid			2022-12-28	WOS:000317114000018
J	Doganli, C; Beck, HC; Ribera, AB; Oxvig, C; Lykke-Hartmann, K				Doganli, Canan; Beck, Hans C.; Ribera, Angeles B.; Oxvig, Claus; Lykke-Hartmann, Karin			alpha Na-3(+)/K+-ATPase Deficiency Causes Brain Ventricle Dilation and Abrupt Embryonic Motility in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID-ONSET DYSTONIA; NA,K-ATPASE ALPHA-SUBUNIT; CALCIUM-BINDING PROTEINS; MOLECULAR-CLONING; PARKINSONISM RDP; BETA-SUBUNIT; SODIUM-PUMP; RAT; EXPRESSION; NA+,K+-ATPASE	Na+/K+-ATPases are transmembrane ion pumps that maintain ion gradients across the basolateral plasma membrane in all animal cells to facilitate essential biological functions. Mutations in the Na+/K+-ATPase alpha(3) subunit gene (ATP1A3) cause rapid-onset dystonia-parkinsonism, a rare movement disorder characterized by sudden onset of dystonic spasms and slow movements. In the brain, ATP1A3 is principally expressed in neurons. In zebrafish, the transcripts of the two ATP1A3 orthologs, Atp1a3a and Atp1a3b, show distinct expression in the brain. Surprisingly, targeted knockdown of either Atp1a3a or Atp1a3b leads to brain ventricle dilation, a likely consequence of ion imbalances across the plasma membrane that cause accumulation of cerebrospinal fluid in the ventricle. The brain ventricle dilation is accompanied by a depolarization of spinal Rohon-Beard neurons in Atp1a3a knockdown embryos, suggesting impaired neuronal excitability. This is further supported by Atp1a3a or Atp1a3b knockdown results where altered responses to tactile stimuli as well as abnormal motility were observed. Finally, proteomic analysis identified several protein candidates highlighting proteome changes associated with the knockdown of Atp1a3a or Atp1a3b. Our data thus strongly support the role of alpha Na-3(+)/K+-ATPase in zebrafish motility and brain development, associating for the first time the alpha Na-3(+)/K(+)ATPase deficiency with brain ventricle dilation.	[Doganli, Canan; Lykke-Hartmann, Karin] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1057 Copenhagen, Denmark; [Doganli, Canan; Lykke-Hartmann, Karin] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Doganli, Canan; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Beck, Hans C.] Odense Univ Hosp, Ctr Clin Prote, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Ribera, Angeles B.] Univ Colorado Denver, Dept Physiol & Biophys, Aurora, CO 80045 USA	Danmarks Grundforskningsfond; Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Lykke-Hartmann, K (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3, DK-8000 Aarhus C, Denmark.	kly@biokemi.au.dk	Beck, Hans Christian/AAK-9147-2021	Oxvig, Claus/0000-0002-4715-9719; Ribera, Angie/0000-0002-0966-5856; Beck, Hans Christian/0000-0002-7763-3637; Lykke-Hartmann, Karin/0000-0002-6702-183X	Aarhus University Forskningsfond (AUFF); Danish National Research Foundation (DNRF) (Centre for Membrane Pumps in Cells and Disease (PUMPKIN) [DNRF85]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025217] Funding Source: NIH RePORTER	Aarhus University Forskningsfond (AUFF); Danish National Research Foundation (DNRF) (Centre for Membrane Pumps in Cells and Disease (PUMPKIN); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from Aarhus University Forskningsfond (AUFF), and Danish National Research Foundation (DNRF) (Centre for Membrane Pumps in Cells and Disease (PUMPKIN)) (DNRF85).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Ballerini L, 1997, J NEUROPHYSIOL, V77, P17, DOI 10.1152/jn.1997.77.1.17; Barut BA, 2000, PHYSIOL GENOMICS, V2, P49, DOI 10.1152/physiolgenomics.2000.2.2.49; Beck HC, 2011, NEUROCHEM RES, V36, P2002, DOI 10.1007/s11064-011-0524-0; Benarroch EE, 2011, NEUROLOGY, V77, P281, DOI [10.1212/WNL.0b013e31822550e2, 10.1212/WNL.0b013e3182074c2f]; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Bottger P, 2012, NEUROSCI BIOBEHAV R, V36, P855, DOI 10.1016/j.neubiorev.2011.10.005; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Brashear A, 1997, NEUROLOGY, V48, P1066, DOI 10.1212/WNL.48.4.1066; Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Chang JT, 2012, DEV BIOL, V368, P312, DOI 10.1016/j.ydbio.2012.05.034; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; CLARKE JDW, 1984, J PHYSIOL-LONDON, V348, P511, DOI 10.1113/jphysiol.1984.sp015122; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Dobretsov M, 2003, NEUROSCIENCE, V116, P1069, DOI 10.1016/S0306-4522(02)00922-3; Doganli C., 2012, J CELL SCI IN PRESS; Doganli C, 2010, DNA CELL BIOL, V29, P713, DOI 10.1089/dna.2010.1085; FETCHO JR, 1992, BRAIN BEHAV EVOLUT, V40, P82, DOI 10.1159/000113905; Fiorio M, 2007, BRAIN, V130, P134, DOI 10.1093/brain/awl283; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; Gutzman J. H., 2009, J VIS EXP, V26, P1218; HALLETT M, 1995, ANN NEUROL, V38, P139, DOI 10.1002/ana.410380203; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kim J, 2012, J NEUROSCI RES, V90, P1437, DOI 10.1002/jnr.23017; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lingrel J, 2003, ANN NY ACAD SCI, V986, P354, DOI 10.1111/j.1749-6632.2003.tb07214.x; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lowery LA, 2009, BIOESSAYS, V31, P446, DOI 10.1002/bies.200800207; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moreno RL, 2009, J NEUROPHYSIOL, V102, P2477, DOI 10.1152/jn.00446.2009; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nemeth A. H., 1993, GENEREVIEWS; Parker D, 1996, J NEUROPHYSIOL, V76, P540, DOI 10.1152/jn.1996.76.1.540; Pineda RH, 2005, J NEUROPHYSIOL, V93, P3582, DOI 10.1152/jn.01070.2004; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Ribera AB, 1998, J NEUROSCI, V18, P9181; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rozzo A, 2002, J NEUROPHYSIOL, V88, P676, DOI 10.1152/jn.2002.88.2.676; SCHNEIDER JW, 1985, P NATL ACAD SCI USA, V82, P6357, DOI 10.1073/pnas.82.18.6357; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SETOOHSHIMA A, 1994, ACTA HISTOCHEM CYTOC, V27, P93, DOI 10.1267/ahc.27.93; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHYJAN AW, 1989, BIOCHEMISTRY-US, V28, P4531, DOI 10.1021/bi00437a002; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Stockler S, 1996, AM J HUM GENET, V58, P914; Sun YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035645; SWEADNER KJ, 1987, P NATL ACAD SCI USA, V84, P8404, DOI 10.1073/pnas.84.23.8404; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield D., 1995, ZEBRAFISH BOOK GUIDE, P787; Zhang HY, 2012, CURR BIOL, V22, P526, DOI 10.1016/j.cub.2012.01.058; Zugno AI, 2003, INT J DEV NEUROSCI, V21, P183, DOI 10.1016/S0736-5748(03)00038-8	66	17	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8862	8874		10.1074/jbc.M112.421529	http://dx.doi.org/10.1074/jbc.M112.421529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400780	Green Published, hybrid			2022-12-28	WOS:000316862200008
J	Gonzalez-Sancho, JM; Greer, YE; Abrahams, CL; Takigawa, Y; Baljinnyam, B; Lee, KH; Lee, KS; Rubin, JS; Brown, AMC				Gonzalez-Sancho, Jose M.; Greer, Yoshimi Endo; Abrahams, Cristina L.; Takigawa, Yutaka; Baljinnyam, Bolormaa; Lee, Kyung Ho; Lee, Kyung S.; Rubin, Jeffrey S.; Brown, Anthony M. C.			Functional Consequences of Wnt-induced Dishevelled 2 Phosphorylation in Canonical and Noncanonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABILIZE BETA-CATENIN; PROTEIN ASSEMBLIES; NEURITE OUTGROWTH; DIX DOMAIN; PATHWAY; MECHANISM; DROSOPHILA; WINGLESS; CELL; ACTIVATION	Dishevelled (Dvl) proteins are intracellular effectors of Wnt signaling that have essential roles in both canonical and noncanonical Wnt pathways. It has long been known that Wnts stimulate Dvl phosphorylation, but relatively little is known about its functional significance. We have previously reported that both Wnt3a and Wnt5a induce Dvl2 phosphorylation that is associated with an electrophoretic mobility shift and loss of recognition by monoclonal antibody 10B5. In the present study, we mapped the 10B5 epitope to a 16-amino acid segment of human Dvl2 (residues 594-609) that contains four Ser/Thr residues. Alanine substitution of these residues (P4m) eliminated the mobility shift induced by either Wnt3a or Wnt5a. The Dvl2 P4m mutant showed a modest increase in canonical Wnt/beta-catenin signaling activity relative to wild type. Consistent with this finding, Dvl2 4Pm preferentially localized to cytoplasmic puncta. In contrast to wild-type Dvl2, however, the P4m mutant was unable to rescue Wnt3a-dependent neurite outgrowth in TC-32 cells following suppression of endogenous Dvl2/3. Earlier work has implicated casein kinase 1 delta/epsilon as responsible for the Dvl mobility shift, and a CK1 delta in vitro kinase assay confirmed that Ser(594), Thr(595), and Ser(597) of Dvl2 are CK1 targets. Alanine substitution of these three residues was sufficient to abrogate the Wnt-dependent mobility shift. Thus, we have identified a cluster of Ser/Thr residues in the C-terminal domain of Dvl2 that are Wnt-induced phosphorylation (WIP) sites. Our results indicate that phosphorylation at the WIP sites reduces Dvl accumulation in puncta and attenuates beta-catenin signaling, whereas it enables noncanonical signaling that is required for neurite outgrowth.	[Gonzalez-Sancho, Jose M.; Abrahams, Cristina L.; Takigawa, Yutaka; Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Greer, Yoshimi Endo; Baljinnyam, Bolormaa; Rubin, Jeffrey S.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lee, Kyung Ho; Lee, Kyung S.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brown, AMC (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA.	amcbrown@med.cornell.edu	Greer, Yoshimi/K-2155-2019; Gonzalez-Sancho, Jose/AAA-6010-2019; Takigawa, Yutaka/ABD-8063-2020	Gonzalez-Sancho, Jose/0000-0001-5875-1964; 	National Institutes of Health Grant [R01 CA123238]; Ministerio de Educacion, Cultura, y Deportes, of Spain; New York State Department of Health postdoctoral Fellowship [NYS C021339];  [F32 CA117662]; NATIONAL CANCER INSTITUTE [ZIABC011224, ZIABC011324] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion, Cultura, y Deportes, of Spain; New York State Department of Health postdoctoral Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA123238 (to A. M. C. B.) and Postdoctoral Fellowship F32 CA117662 (to C. L. A.). This work was also supported by a fellowship from the Ministerio de Educacion, Cultura, y Deportes, of Spain (to J. M. G.-S.), by New York State Department of Health postdoctoral Fellowship NYS C021339 (to Y. T.), and by charitable donations to Strang Cancer Prevention Center. This research also was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Brown A. M., 1995, DNA CLONING, P113; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Greer YE, 2013, J BIOL CHEM, V288, P9438, DOI 10.1074/jbc.M112.448282; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; James Richard G., 2008, V468, P131, DOI 10.1007/978-1-59745-249-6_10; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yanfeng WA, 2011, DEV BIOL, V360, P132, DOI 10.1016/j.ydbio.2011.09.017; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	54	47	48	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9428	9437		10.1074/jbc.M112.448480	http://dx.doi.org/10.1074/jbc.M112.448480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396967	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000316862200059
J	Li, SJ; Qi, Y; Zhao, JJ; Li, Y; Liu, XY; Chen, XH; Xu, P				Li, Shu-Jing; Qi, Yao; Zhao, Jing-Jing; Li, Ya; Liu, Xiao-Yan; Chen, Xian-Hua; Xu, Ping			Characterization of Nuclear Localization Signals (NLSs) and Function of NLSs and Phosphorylation of Serine Residues in Subcellular and Subnuclear Localization of Transformer-2 beta (Tra2 beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ALTERNATIVE SPLICING PATTERNS; SR PROTEINS; IN-VIVO; MOLECULAR-CLONING; CELL-CYCLE; RS DOMAIN; SEQUENCE; GENE; ENHANCER	The serine/arginine-rich (SR) proteins are one type of major actors in regulation of pre-mRNA splicing. Their functions are closely related to the intracellular spatial organization. The RS domain and phosphorylation status of SR proteins are two critical factors in determining the subcellular distribution. Mammalian Transformer-2 beta (Tra2 beta) protein, a member of SR proteins, is known to play multiple important roles in development and diseases. In the present study, we characterized the subcellular and subnuclear localization of Tra2 beta protein and its related mechanisms. The results demonstrated that in the brain the nuclear and cytoplasmic localization of Tra2 beta were correlated with its phosphorylation status. Using deletional mutation analysis, we showed that the nuclear localization of Tra2 beta was determined by multiple nuclear localization signals (NLSs) in the RS domains. The point-mutation analysis disclosed that phosphorylation of serine residues in the NLSs inhibited the function of NLS in directing Tra2 beta to the nucleus. In addition, we identified at least two nuclear speckle localization signals within the RS1 domain, but not in the RS2 domain. The nuclear speckle localization signals determined the localization of RS1 domain-contained proteins to the nuclear speckle. The function of the signals did not depend on the presence of serine residues. The results provide new insight into the mechanisms by which the subcellular and subnuclear localization of Tra2 beta proteins are regulated.	[Li, Shu-Jing; Qi, Yao; Zhao, Jing-Jing; Li, Ya; Liu, Xiao-Yan; Chen, Xian-Hua; Xu, Ping] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Lab Genom Physiol,Inst Brain Sci,Sch Basic Med Sc, Shanghai 200032, Peoples R China	Fudan University	Chen, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Lab Genom Physiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	xhchen@fudan.edu.cn; matibuck@yahoo.com		Li, Shujing/0000-0003-2793-3065	National Foundation of Natural Sciences of China [30770661, 30971464, 81030020]; Shanghai Leading Academic Discipline Project [B111]	National Foundation of Natural Sciences of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Foundation of Natural Sciences of China (No. 30770661, 30971464, 81030020), and the Shanghai Leading Academic Discipline Project (No. B111).	Beil B, 1997, DNA CELL BIOL, V16, P679, DOI 10.1089/dna.1997.16.679; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chen XH, 2003, CELL BIOL INT, V27, P491, DOI 10.1016/S1065-6995(03)00072-6; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Daoud R, 2002, J NEUROSCI, V22, P5889; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FU XD, 1995, RNA, V1, P663; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Han Y, 2007, J NEUROTRAUM, V24, P722, DOI 10.1089/neu.2006.0174; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Huang S, 1996, J CELL BIOL, V133, P719, DOI 10.1083/jcb.133.4.719; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; JIMENEZGARCIA LF, 1993, CELL, V73, P47, DOI 10.1016/0092-8674(93)90159-N; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MATTOX W, 1990, GENE DEV, V4, P789, DOI 10.1101/gad.4.5.789; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Misteli T, 1997, TRENDS CELL BIOL, V7, P135, DOI 10.1016/S0962-8924(96)20043-1; Nayler O, 1998, GENOMICS, V53, P191, DOI 10.1006/geno.1998.5471; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Segade F, 1996, FEBS LETT, V387, P152, DOI 10.1016/0014-5793(96)00496-6; Shukla S, 2008, CIRC RES, V103, P485, DOI 10.1161/CIRCRESAHA.108.178384; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wang B, 2008, ANAL CHEM, V80, P9526, DOI 10.1021/ac801708p; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	50	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8898	8909		10.1074/jbc.M113.456715	http://dx.doi.org/10.1074/jbc.M113.456715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396973	Green Published, hybrid			2022-12-28	WOS:000316862200011
J	Walkinshaw, DR; Weist, R; Kim, GW; You, LY; Xiao, L; Nie, JY; Li, CS; Zhao, SP; Xu, MH; Yang, XJ				Walkinshaw, Donald R.; Weist, Ryan; Kim, Go-Woon; You, Linya; Xiao, Lin; Nie, Jianyun; Li, Cathy S.; Zhao, Songping; Xu, Minghong; Yang, Xiang-Jiao			The Tumor Suppressor Kinase LKB1 Activates the Downstream Kinases SIK2 and SIK3 to Stimulate Nuclear Export of Class IIa Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-INDUCIBLE KINASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; PROTEIN-KINASES; CELL-CYCLE; PHOSPHORYLATION; SKELETAL; DIFFERENTIATION; LOCALIZATION	Histone deacetylases 4 (HDAC4), -5, -7, and -9 form class IIa within the HDAC superfamily and regulate diverse physiological and pathological cellular programs. With conserved motifs for phosphorylation-dependent 14-3-3 binding, these deacetylases serve as novel signal transducers that are able to modulate histone acetylation and gene expression in response to extracellular cues. Here, we report that in a PKA-sensitive manner the tumor suppressor kinase LKB1 acts through salt-inducible kinase 2 (SIK2) and SIK3 to promote nucleocytoplasmic trafficking of class IIa HDACs. Both SIK2 and SIK3 phosphorylate the deacetylases at the conserved motifs and stimulate 14-3-3 binding. SIK2 activates MEF2-dependent transcription and relieves repression of myogenesis by the deacetylases. Distinct from SIK2, SIK3 induces nuclear export of the deacetylases independent of kinase activity and 14-3-3 binding. These findings highlight the difference among members of the SIK family and indicate that LKB1-dependent SIK activation constitutes an important signaling module upstream from class IIa deacetylases for regulating cellular programs controlled by MEF2 and other transcription factors.	[Walkinshaw, Donald R.; Weist, Ryan; Kim, Go-Woon; You, Linya; Xiao, Lin; Nie, Jianyun; Li, Cathy S.; Xu, Minghong; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Walkinshaw, Donald R.; Weist, Ryan; Kim, Go-Woon; You, Linya; Xiao, Lin; Nie, Jianyun; Li, Cathy S.; Zhao, Songping; Xu, Minghong; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada; [Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nie, Jianyun] Kunming Med Univ, Affiliated Hosp 3, Yunnan 650031, Peoples R China	McGill University; McGill University; McGill University; McGill University; Kunming Medical University	Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Canadian Cancer Society; Ministere du Developpement Economique, l'Innovation et Exportation (MDEIE, Quebec), Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Ministere du Developpement Economique, l'Innovation et Exportation (MDEIE, Quebec), Canada	This work was supported in part by the Canadian Institutes of Health Research, Canadian Cancer Society, and Ministere du Developpement Economique, l'Innovation et Exportation (MDEIE, Quebec), Canada (to X. J. Y.).	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Feldman JD, 2000, J NEUROCHEM, V74, P2227, DOI 10.1046/j.1471-4159.2000.0742227.x; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2000, GENE DEV, V14, P55; Kasler HG, 2012, EMBO J, V31, P4453, DOI 10.1038/emboj.2012.295; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Larochelle N, 1997, GENE THER, V4, P465, DOI 10.1038/sj.gt.3300414; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Siow NL, 2002, J BIOL CHEM, V277, P36129, DOI 10.1074/jbc.M206498200; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Williams S, 2010, BRIT DENT J, V208, P4, DOI 10.1038/sj.bdj.2010.7; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Yu X, 2000, BIOCHEM BIOPH RES CO, V276, P564, DOI 10.1006/bbrc.2000.3508; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	81	67	77	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9345	9362		10.1074/jbc.M113.456996	http://dx.doi.org/10.1074/jbc.M113.456996			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393134	hybrid, Green Published			2022-12-28	WOS:000316862200052
J	Glatz, G; Gogl, G; Alexa, A; Remenyi, A				Glatz, Gabor; Gogl, Gergo; Alexa, Anita; Remenyi, Attila			Structural Mechanism for the Specific Assembly and Activation of the Extracellular Signal Regulated Kinase 5 (ERK5) Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOCKING INTERACTIONS; PB1 DOMAIN; MEK5 PB1; DIFFERENTIAL REGULATION; PROTEIN-KINASES; GENE-EXPRESSION; MAP; SITES; BMK1/ERK5; MOTIFS	Mitogen-activated protein kinase (MAPK) activation depends on a linear binding motif found in all MAPK kinases (MKK). In addition, the PB1 (Phox and Bem1) domain of MKK5 is required for extracellular signal regulated kinase 5 (ERK5) activation. We present the crystal structure of ERK5 in complex with an MKK5 construct comprised of the PB1 domain and the linear binding motif. We show that ERK5 has distinct protein-protein interaction surfaces compared with ERK2, which is the closest ERK5 paralog. The two MAPKs have characteristically different physiological functions and their distinct protein-protein interaction surface topography enables them to bind different sets of activators and substrates. Structural and biochemical characterization revealed that the MKK5 PB1 domain cooperates with the MAPK binding linear motif to achieve substrate specific binding, and it also enables co-recruitment of the upstream activating enzyme and the downstream substrate into one signaling competent complex. Studies on present day MAPKs and MKKs hint on the way protein kinase networks may evolve. In particular, they suggest how paralogous enzymes with similar catalytic properties could acquire novel signaling roles by merely changing the way they make physical links to other proteins.	[Glatz, Gabor; Gogl, Gergo; Alexa, Anita; Remenyi, Attila] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Eotvos Lorand University	Remenyi, A (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	remenyi@elte.hu	Remenyi, Attila/N-1345-2016; Gogl, Gergo/ABH-4309-2020	Gogl, Gergo/0000-0002-8597-3711; Remenyi, Attila/0000-0002-8345-1311; Alexa, Anita/0000-0002-5740-7835	Hungarian Scientific Research Fund [OTKA NK81950, NKTH-OTKA H07A 74216]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (OTKA NK81950 and NKTH-OTKA H07A 74216).	Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Barsyte-Lovejoy D, 2004, BIOCHEM J, V381, P693, DOI 10.1042/BJ20031940; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Caffrey DR, 1999, J MOL EVOL, V49, P567, DOI 10.1007/PL00006578; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Gogl G., 2012, ACTA CRYS D IN PRESS; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hu Q, 2007, BIOCHEMISTRY-US, V46, P13478, DOI 10.1021/bi701341n; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026999; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Ma WF, 2010, STRUCTURE, V18, P1502, DOI 10.1016/j.str.2010.08.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milanesi L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S20; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Nakamura K, 2007, MOL CELL BIOL, V27, P4566, DOI 10.1128/MCB.00125-07; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Piserchio A, 2011, BIOCHEMISTRY-US, V50, P3660, DOI 10.1021/bi2000559; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won AP, 2011, P NATL ACAD SCI USA, V108, P9809, DOI 10.1073/pnas.1016337108; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	58	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8596	8609		10.1074/jbc.M113.452235	http://dx.doi.org/10.1074/jbc.M113.452235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382384	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000316564500060
J	Korner, C; Keklikoglou, I; Bender, C; Worner, A; Munstermann, E; Wiemann, S				Koerner, Cindy; Keklikoglou, Ioanna; Bender, Christian; Woerner, Angelika; Muenstermann, Ewald; Wiemann, Stefan			MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C epsilon (PKC epsilon)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; ACTIVATION; MIR-31; PROLIFERATION; METASTASIS; GENES; SUPPRESSION; EXPRESSION; INVASION	MicroRNAs post-transcriptionally regulate gene expression and thereby contribute to the modulation of numerous complex and disease-relevant cellular phenotypes, including cell proliferation, cell motility, apoptosis, and stress response. In breast cancer cell systems, miR-31 has been shown to inhibit cell migration, invasion, and metastasis. Here, we link enhanced expression of miR-31 to the inhibition of the oncogenic NF-kappa B pathway, thus supporting the tumor-suppressive function of this microRNA. We identified protein kinase C epsilon (PKC epsilon encoded by the PRKCE gene) as a novel direct target of miR-31 and show that down-regulation of PKC epsilon results in impaired NF-kappa B signaling, enhanced apoptosis, and increased sensitivity of MCF10A breast epithelial and MDA-MB-231 triple-negative breast cancer cells toward ionizing radiation as well as treatment with chemotherapeutics. Mechanistically, we attribute this sensitization to anti-cancer treatments to the PRKCE-mediated down-regulation of the anti-apoptotic factor BCL2. In clinical breast cancer samples, high BCL2 expression was associated with poor prognosis. Furthermore, we found an inverse correlation between miR-31 and BCL2 expression, highlighting the functional relevance of the indirect down-regulation of BCL2 via direct targeting of PRKCE by miR-31.	[Koerner, Cindy; Keklikoglou, Ioanna; Bender, Christian; Woerner, Angelika; Muenstermann, Ewald; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Wiemann, S (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	s.wiemann@dkfz-heidelberg.de	Wiemann, Stefan/E-4424-2013	Wiemann, Stefan/0000-0003-4683-3174; Keklikoglou, Ioanna/0000-0003-1219-6912; Koerner, Cindy/0000-0003-1150-9462	German Research Foundation within the German-Israeli Funding Program; National Genome Research Network of the German Federal Ministry of Education and Research; DKFZ International Ph.D. program	German Research Foundation within the German-Israeli Funding Program; National Genome Research Network of the German Federal Ministry of Education and Research; DKFZ International Ph.D. program	This work was supported by the German Research Foundation within the German-Israeli Funding Program and by the National Genome Research Network of the German Federal Ministry of Education and Research.; Supported by the DKFZ International Ph.D. program.	Augoff K, 2011, MOL CANCER RES, V9, P1500, DOI 10.1158/1541-7786.MCR-11-0311; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2003, CANCER RES, V63, P290; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garg Amit K., 2003, Current Opinion in Oncology, V15, P405, DOI 10.1097/00001622-200311000-00001; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Malhotra GK, 2010, CANCER BIOL THER, V10, P955, DOI 10.4161/cbt.10.10.13879; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perego P, 2001, CURR MED CHEM, V8, P31, DOI 10.2174/0929867013373994; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Shankar E, 2010, INT J ONCOL, V36, P883, DOI 10.3892/ijo_00000566; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Valastyan S, 2011, GENE DEV, V25, P646, DOI 10.1101/gad.2004211; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Xu HS, 2006, ARTHRITIS RHEUM-US, V54, P3441, DOI 10.1002/art.22169; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	39	115	119	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8750	8761		10.1074/jbc.M112.414128	http://dx.doi.org/10.1074/jbc.M112.414128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364795	Green Published, hybrid			2022-12-28	WOS:000316564500074
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			Cdc45 Protein-Single-stranded DNA Interaction Is Important for Stalling the Helicase during Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA; S-PHASE; CHROMOSOME-REPLICATION; STRUCTURAL BASIS; DAMAGE RESPONSE; MCM2-7 HELICASE; GINS; COMPLEX; INITIATION; KINASE	Replicative polymerase stalling is coordinated with replicative helicase stalling in eukaryotes, but the mechanism underlying this coordination is not known. Cdc45 activates the Mcm2-7 helicase. We report here that Cdc45 from budding yeast binds tightly to long (>= 40 nucleotides) genomic single-stranded DNA (ssDNA) and that 60mer ssDNA specifically disrupts the interaction between Cdc45 and Mcm2-7. We identified a mutant of Cdc45 that does not bind to ssDNA. When this mutant of cdc45 is expressed in budding yeast cells exposed to hydroxyurea, cell growth is severely inhibited, and excess RPA accumulates at or near an origin. Chromatin immunoprecipitation suggests that helicase movement is uncoupled from polymerase movement for mutant cells exposed to hydroxyurea. These data suggest that Cdc45-ssDNA interaction is important for stalling the helicase during replication stress.	[Bruck, Irina; Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Kaplan, DL (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	daniel.kaplan@med.fsu.edu		Kaplan, Daniel/0000-0003-2760-7745	National Science Foundation [1121534]; Direct For Biological Sciences [1265431] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1121534 (to D. L. K.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Handa T, 2012, MOL BIOL CELL, V23, P3240, DOI 10.1091/mbc.E12-05-0339; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kang YH, 2012, P NATL ACAD SCI USA, V109, P6042, DOI 10.1073/pnas.1203734109; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krastanova I, 2012, J BIOL CHEM, V287, P4121, DOI 10.1074/jbc.M111.285395; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lundblad V, 2001, CURR PROTOC MOL BIOL; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023	55	30	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7550	7563		10.1074/jbc.M112.440941	http://dx.doi.org/10.1074/jbc.M112.440941			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382391	Green Published, hybrid			2022-12-28	WOS:000316455300012
J	Ravindran, A; Sawant, KV; Sarmiento, J; Navarro, J; Rajarathnam, K				Ravindran, Aishwarya; Sawant, Kirti V.; Sarmiento, Jose; Navarro, Javier; Rajarathnam, Krishna			Chemokine CXCL1 Dimer Is a Potent Agonist for the CXCR2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-STIMULATING ACTIVITY; NEUTROPHIL-ACTIVATING PEPTIDE-2; STRUCTURAL BASIS; BINDING; INTERLEUKIN-8; RECOGNITION; AFFINITY; MONOMER; MUTANT; OLIGOMERIZATION	The CXCL1/CXCR2 axis plays a crucial role in recruiting neutrophils in response to microbial infection and tissue injury, and dysfunction in this process has been implicated in various inflammatory diseases. Chemokines exist as monomers and dimers, and compelling evidence now exists that both forms regulate in vivo function. Therefore, knowledge of the receptor activities of both CXCL1 monomer and dimer is essential to describe the molecular mechanisms by which they orchestrate neutrophil function. The monomer-dimer equilibrium constant (similar to 20 mu M) and the CXCR2 binding constant (1 nM) indicate that WT CXCL1 is active as a monomer. To characterize dimer activity, we generated a trapped dimer by introducing a disulfide across the dimer interface. This disulfide-linked CXCL1 dimer binds CXCR2 with nanomolar affinity and shows potent agonist activity in various cellular assays. We also compared the receptor binding mechanism of this dimer with that of a CXCL1 monomer, generated by deleting the C-terminal residues that stabilize the dimer interface. We observe that the binding interactions of the dimer and monomer to the CXCR2 N-terminal domain, which plays an important role in determining affinity and activity, are essentially conserved. The potent activity of the CXCL1 dimer is novel: dimers of the CC chemokines CCL2 and CCL4 are inactive, and the dimer of the CXC chemokine CXCL8 (which is closely related to CXCL1) is marginally active for CXCR1 but shows variable activity for CXCR2. We conclude that large differences in dimer activity among different chemokine-receptor pairs have evolved for fine-tuned leukocyte function.	[Ravindran, Aishwarya; Sawant, Kirti V.; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sarmiento, Jose; Navarro, Javier] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Ravindran, Aishwarya; Navarro, Javier; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, 5-142 Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	krrajara@utmb.edu	Sawant, Kirti V/H-3778-2013; Sawant, Kirti/L-1602-2013	Navarro, Javier/0000-0001-7098-4373	National Institutes of Health [P01 HL107152, R01AI069152, R01 HD049471]; American Heart Association Predoctoral Fellowship [0815354F]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL107152 and R01AI069152 (to K. R.) and R01 HD049471 (to J. N.). This work was also supported by American Heart Association Predoctoral Fellowship 0815354F (to A. R.).	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Baly DL, 1998, J IMMUNOL, V161, P4944; Barter EF, 2012, BIOCHEMISTRY-US, V51, P1322, DOI 10.1021/bi201615y; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; FAIRBROTHER WJ, 1993, FEBS LETT, V330, P302, DOI 10.1016/0014-5793(93)80893-Y; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fernando H, 2007, FEBS J, V274, P241, DOI 10.1111/j.1742-4658.2006.05579.x; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; HESSELGESSER J, 1995, J BIOL CHEM, V270, P11472, DOI 10.1074/jbc.270.19.11472; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; KIM KS, 1994, J BIOL CHEM, V269, P32909; Koelink PJ, 2012, PHARMACOL THERAPEUT, V133, P1, DOI 10.1016/j.pharmthera.2011.06.008; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Lowman HB, 1997, PROTEIN SCI, V6, P598; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; Rajarathnam K, 2002, CURR PHARM DESIGN, V8, P2159, DOI 10.2174/1381612023393233; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Ye JP, 2000, J BIOL CHEM, V275, P27250	48	44	46	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12244	12252		10.1074/jbc.M112.443762	http://dx.doi.org/10.1074/jbc.M112.443762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479735	hybrid, Green Published			2022-12-28	WOS:000318157600056
J	Crack, JC; Stapleton, MR; Green, J; Thomson, AJ; Le Brun, NE				Crack, Jason C.; Stapleton, Melanie R.; Green, Jeffrey; Thomson, Andrew J.; Le Brun, Nick E.			Mechanism of [4Fe-4S](Cys)(4) Cluster Nitrosylation Is Conserved among NO-responsive Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FNR; ESCHERICHIA-COLI; NITRIC-OXIDE; DNA-BINDING; SULFUR; PROTEIN; NITRATE; 4FE-4S; FLAVOHAEMOGLOBIN; REDUCTASE	The Fumarate nitrate reduction (FNR) regulator from Escherichia coli controls expression of >300 genes in response to O-2 through reaction with its [4Fe-4S] cluster cofactor. FNR is the master switch for the transition between anaerobic and aerobic respiration. In response to physiological concentrations of nitric oxide (NO), FNR also regulates genes, including the nitrate reductase (nar) operon, a major source of endogenous cellular NO, and hmp, which encodes an NO-detoxifying enzyme. Here we show that the [4Fe-4S] cluster of FNR reacts rapidly in a multiphasic reaction with eight NO molecules. Oxidation of cluster sulfide ions (S2-) to sulfane (S-0) occurs, some of which remains associated with the protein as Cys persulfide. The nitrosylation products are similar to a pair of dinuclear dinitrosyl iron complexes, [Fe(I)(2)(NO)(4)(Cys)(2)](0), known as Roussin's red ester. A similar reactivity with NO was reported for the Wbl family of [4Fe-4S]-containing proteins found only in actinomycetes, such as Streptomyces and Mycobacteria. These results show that NO reacts via a common mechanism with [4Fe-4S] clusters in phylogenetically unrelated regulatory proteins that, although coordinated by four Cys residues, have different cluster environments. The reactivity of E. coli FNR toward NO, in addition to its sensitivity toward O-2, is part of a hierarchal network that monitors, and responds to, NO, both endogenously generated and exogenously derived.	[Crack, Jason C.; Thomson, Andrew J.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Stapleton, Melanie R.; Green, Jeffrey] Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst, Sheffield S10 2TN, S Yorkshire, England	University of East Anglia; University of Sheffield	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk		Crack, Jason C./0000-0002-4979-1910; Le Brun, Nick/0000-0001-9780-4061	Biotechnology and Biological Sciences Research Council [BB/G018960/1, BB/J003247/1]; BBSRC [BB/J003247/1, BB/G019347/1, BB/G018960/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G019347/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants BB/G018960/1 and BB/J003247/1 from the Biotechnology and Biological Sciences Research Council.	Bates DM, 2000, J BIOL CHEM, V275, P6234, DOI 10.1074/jbc.275.9.6234; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; BRYAR TR, 1992, CAN J CHEM, V70, P1917, DOI 10.1139/v92-240; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; Crack JC, 2008, METHOD ENZYMOL, V437, P191, DOI 10.1016/S0076-6879(07)37011-0; Crack JC, 2008, J AM CHEM SOC, V130, P1749, DOI 10.1021/ja077455+; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; FROLOV EN, 1973, BIOFIZIKA+, V18, P605; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Green J, 2001, ADV MICROB PHYSIOL, V44, P1, DOI 10.1016/S0065-2911(01)44010-0; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; LAZAZZERA BA, 1993, GENE DEV, V7, P1993, DOI 10.1101/gad.7.10.1993; Metheringham R, 1997, MICROBIOL-UK, V143, P2647, DOI 10.1099/00221287-143-8-2647; Pieper GM, 2003, P NATL ACAD SCI USA, V100, P3125, DOI 10.1073/pnas.0636938100; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; RALT D, 1988, J BACTERIOL, V170, P359, DOI 10.1128/jb.170.1.359-364.1988; Rowley G, 2012, BIOCHEM J, V441, P755, DOI 10.1042/BJ20110971; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Vasilieva S. V., 2012, Biophysics, V57, P166, DOI 10.1134/S0006350912020248; Vasilieva SV, 2010, DOKL BIOCHEM BIOPHYS, V435, P283, DOI 10.1134/S1607672910060013; Vine CE, 2011, FEMS MICROBIOL LETT, V325, P108, DOI 10.1111/j.1574-6968.2011.02385.x; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Zal F, 1998, P NATL ACAD SCI USA, V95, P8997, DOI 10.1073/pnas.95.15.8997; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109	47	47	47	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11492	11502		10.1074/jbc.M112.439901	http://dx.doi.org/10.1074/jbc.M112.439901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23471974	hybrid, Green Published			2022-12-28	WOS:000317915500050
J	Hoffmann, I; Jerneren, F; Oliw, EH				Hoffmann, Inga; Jerneren, Fredrik; Oliw, Ernst H.			Expression of Fusion Proteins of Aspergillus terreus Reveals a Novel Allene Oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS GAEUMANNOMYCES-GRAMINIS; HYDROPEROXIDE ISOMERASE; LINOLEIC-ACID; REACTION-MECHANISM; DIOL SYNTHASE; DIOXYGENASE; BIOSYNTHESIS; PATHWAYS; ENZYMES; STEREOCHEMISTRY	Aspergilli oxidize C-18 unsaturated fatty acids by dioxygenase-cytochrome P450 fusion proteins to signal molecules involved in reproduction and host-pathogen interactions. Aspergillus terreus expresses linoleate 9R-dioxygenase (9R-DOX) and allene oxide synthase (AOS) activities in membrane fractions. The genome contains five genes (ATEG), which may code for a 9R-DOX-AOS fusion protein. The genes were cloned and expressed, but none of them oxidized 18:2n-6 to 9R-hydroperoxy-10(E), 12(Z)-octadecadienoic acid (9R-HPODE). ATEG_02036 transformed 9R-HPODE to an unstable allene oxide, 9(R), 10-epoxy-10,12(Z)-octadecadienoic acid. A substitution in the P450 domain (C1073S) abolished AOS activity. The N964V and N964D mutants both showed markedly reduced AOS activity, suggesting that Asn(964) may facilitate homolytic cleavage of the dioxygen bond of 9R-HPODE with formation of compound II in analogy with plant AOS (CYP74) and prostacyclin synthase (CYP8A1). ATEG_03992 was identified as 5,8-linoleate diol synthase (5,8-LDS). Replacement of Asn(878) in 5,8-LDS with leucine (N878L) mainly shifted ferryl oxygen insertion from C-5 toward C-6, but replacements of Gln(881) markedly affected catalysis. The Q881L mutant virtually abolished the diol synthase activity. Replacement of Gln(881) with Asn, Glu, Asp, or Lys residues augmented the homolytic cleavage of 8R-HPODE with formation of 10-hydroxy-8(9)-epoxy-12(Z)-octadecenoic acid (erythro/threo, 1-4:1) and/or shifted ferryl oxygen insertion from C-5 toward C-11. We conclude that homolysis and heterolysis of the dioxygen bond with formation of compound II in AOS and compound I in 5,8-LDS are influenced by Asn and Gln residues, respectively, of the I-helices. AOS of A. terreus appears to have evolved independently of CYP74 but with an analogous reaction mechanism.	[Hoffmann, Inga; Jerneren, Fredrik; Oliw, Ernst H.] Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, Uppsala Biomed Ctr, SE-75124 Uppsala, Sweden	Uppsala University	Oliw, EH (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se		Oliw, Ernst/0000-0002-7986-8130; Jerneren, Fredrik/0000-0003-0897-7177	Vetenskapsradet Grant [03X-06523]; Knut and Alice Wallenberg Foundation [KAW 2004.123]; Uppsala University	Vetenskapsradet Grant; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Uppsala University	This work was supported by Vetenskapsradet Grant 03X-06523, Knut and Alice Wallenberg Foundation Grant KAW 2004.123, and Uppsala University.	ALDRIDGE DC, 1971, J CHEM SOC C, P1623, DOI 10.1039/j39710001623; Andersen MR, 2009, FUNGAL GENET BIOL, V46, pS180, DOI 10.1016/j.fgb.2008.07.006; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brodhun F, 2010, BIOCHEM J, V425, P553, DOI 10.1042/BJ20091096; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Chang MS, 1996, BIOCHEMISTRY-US, V35, P464, DOI 10.1021/bi952081v; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; CROSS BE, 1970, J CHEM SOC C, P1839, DOI 10.1039/j39700001839; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; ENDO A, 1992, J LIPID RES, V33, P1569; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; Hoffmann I, 2012, BBA-MOL CELL BIOL L, V1821, P1508, DOI 10.1016/j.bbalip.2012.09.001; Hoffmann I, 2011, ARCH BIOCHEM BIOPHYS, V506, P216, DOI 10.1016/j.abb.2010.11.022; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Jerneren F, 2012, LIPIDS, V47, P65, DOI 10.1007/s11745-011-3622-5; Jerneren F, 2010, ARCH BIOCHEM BIOPHYS, V495, P67, DOI 10.1016/j.abb.2009.12.022; Jerneren F, 2010, BBA-MOL CELL BIOL L, V1801, P503, DOI 10.1016/j.bbalip.2009.12.012; Jerneren F, 2010, J BIOL CHEM, V285, P5308, DOI 10.1074/jbc.M109.062810; Klinman JP, 2006, PHILOS T R SOC B, V361, P1323, DOI 10.1098/rstb.2006.1870; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; MIERSCH O, 1987, PHYTOCHEMISTRY, V26, P1037, DOI 10.1016/S0031-9422(00)82345-6; Nazir KHMNH, 2010, ARCH MICROBIOL, V192, P395, DOI 10.1007/s00203-010-0562-z; Nelson David R., 2009, Human Genomics, V4, P59; Oliw EH, 2011, J LIPID RES, V52, P1995, DOI 10.1194/jlr.M018259; PENG YL, 1994, J BIOL CHEM, V269, P3755; Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsukada K, 2010, PHYTOCHEMISTRY, V71, P2019, DOI 10.1016/j.phytochem.2010.09.013; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787; Wennman A, 2012, J BIOL CHEM, V287, P31757, DOI 10.1074/jbc.M112.364331; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003; Wu G, 2011, J INORG BIOCHEM, V105, P382, DOI 10.1016/j.jinorgbio.2010.11.015; Yin GC, 2010, COORDIN CHEM REV, V254, P1826, DOI 10.1016/j.ccr.2010.01.016; Zain ME, 2009, AFR J MICROBIOL RES, V3, P280	53	26	26	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11459	11469		10.1074/jbc.M113.458257	http://dx.doi.org/10.1074/jbc.M113.458257			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479731	hybrid, Green Published			2022-12-28	WOS:000317915500047
J	Leung, KKK; Shilton, BH				Leung, Kevin K. K.; Shilton, Brian H.			Chloroquine Binding Reveals Flavin Redox Switch Function of Quinone Reductase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOMAL DEGRADATION; CRYSTAL-STRUCTURE; OLD DRUG; P53; OXIDOREDUCTASE-2; PRIMAQUINE; APOPTOSIS; INSIGHTS; ANALOGS; AGENTS	Quinone reductase 2 (NQO2) is an FAD-linked enzyme and the only known human target of two antimalarial drugs, primaquine (PQ) and chloroquine (CQ). The structural differences between oxidized and reduced NQO2 and the structural basis for inhibition by PQ and CQ were investigated by x-ray crystallography. Structures of oxidized NQO2 in complex with PQ and CQ were solved at 1.4 angstrom resolion. CQ binds preferentially to reduced NQO2, and upon reduction of NQO2-CQ crystals, the space group changed from P2 (1)2(1)2(1) to P2(1), with 1-angstrom decreases in all three unit cell dimensions. The change in crystal packing originated in the negative charge and 4-5 degrees bend in the reduced isoalloxazine ring of FAD, which resulted in a new mode of CQ binding and closure of a flexible loop (Phe(126)-Leu(136)) over the active site. This first structure of a reduced quinone reductase shows that reduction of the FAD cofactor and binding of a specific inhibitor lead to global changes in NQO2 structure and is consistent with a functional role for NQO2 as a flavin redox switch.	[Leung, Kevin K. K.; Shilton, Brian H.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shilton, BH (corresponding author), Univ Western Ontario, Dept Biochem, 1151 Richmond St, London, ON N6A 5C1, Canada.	bshilton@uwo.ca	Shilton, Brian H/A-6667-2011	Leung, Kevin/0000-0002-2087-4974	Natural Sciences and Engineering Research Council; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; University of Saskatchewan; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by a Natural Sciences and Engineering Research Council Discovery Grant (to B. H. S.). Beamline CMCF-1 and the Canadian Light Source are supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, and the University of Saskatchewan.; Recipient of an Ontario Graduate Scholarship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn KS, 2007, CANCER RES, V67, P10004, DOI 10.1158/0008-5472.CAN-07-2213; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Becker DF, 2011, ANTIOXID REDOX SIGN, V14, P1079, DOI 10.1089/ars.2010.3417; Benfield T, 2008, JAIDS-J ACQ IMM DEF, V48, P63, DOI 10.1097/QAI.0b013e31816de84d; BERMAN JD, 1984, J PARASITOL, V70, P220, DOI 10.2307/3281866; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brehmer D, 2004, MOL CELL PROTEOMICS, V3, P490, DOI 10.1074/mcp.M300139-MCP200; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Calamini B, 2008, BIOCHEM J, V413, P81, DOI 10.1042/BJ20071373; Duncan JS, 2008, MOL CELL PROTEOMICS, V7, P1077, DOI 10.1074/mcp.M700559-MCP200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fitch CD, 2004, LIFE SCI, V74, P1957, DOI 10.1016/j.lfs.2003.10.003; Foley M, 1998, PHARMACOL THERAPEUT, V79, P55, DOI 10.1016/S0163-7258(98)00012-6; Foster CE, 1999, BIOCHEMISTRY-US, V38, P9881, DOI 10.1021/bi990799v; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Graves PR, 2002, MOL PHARMACOL, V62, P1364, DOI 10.1124/mol.62.6.1364; He YZ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001450; HEMMERIC.P, 1970, FEBS LETT, V8, P69, DOI 10.1016/0014-5793(70)80229-0; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARLE JM, 1988, ACTA CRYSTALLOGR C, V44, P1605, DOI 10.1107/S0108270188004652; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kim EL, 2010, NEURO-ONCOLOGY, V12, P389, DOI 10.1093/neuonc/nop046; Kinnamon KE, 1996, ANN TROP MED PARASIT, V90, P467, DOI 10.1080/00034983.1996.11813071; Kwiek JJ, 2004, BIOCHEMISTRY-US, V43, P4538, DOI 10.1021/bi035923w; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Lange N.A., 1999, LANGES HDB CHEM; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Leung KKK, 2012, ANAL BIOCHEM, V420, P84, DOI 10.1016/j.ab.2011.09.011; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200; LOWE HJ, 1956, J BIOL CHEM, V221, P983; Mailliet F, 2005, BIOCHEM PHARMACOL, V71, P74, DOI 10.1016/j.bcp.2005.09.030; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Reybier K, 2011, FREE RADICAL RES, V45, P1184, DOI 10.3109/10715762.2011.605788; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; RUBIN JR, 1992, ACTA CRYSTALLOGR C, V48, P379, DOI 10.1107/S0108270191008831; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Sollner S, 2009, BIOCHEMISTRY-US, V48, P8636, DOI 10.1021/bi900734a; Sollner S, 2009, FEBS J, V276, P4313, DOI 10.1111/j.1742-4658.2009.07143.x; Sollner S, 2009, EMBO REP, V10, P65, DOI 10.1038/embor.2008.218; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Vella F, 2005, BIOCHEM PHARMACOL, V71, P1, DOI 10.1016/j.bcp.2005.09.019; Wallace DJ, 2012, NAT REV RHEUMATOL, V8, P522, DOI 10.1038/nrrheum.2012.106; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7; Yu KD, 2009, HUM MOL GENET, V18, P2502, DOI 10.1093/hmg/ddp171; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	53	29	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11242	11251		10.1074/jbc.M113.457002	http://dx.doi.org/10.1074/jbc.M113.457002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23471972	Green Published, hybrid			2022-12-28	WOS:000317915500027
J	Morishita, H; Eguchi, S; Kimura, H; Sasaki, J; Sakamaki, Y; Robinson, ML; Sasaki, T; Mizushima, N				Morishita, Hideaki; Eguchi, Satoshi; Kimura, Hirotaka; Sasaki, Junko; Sakamaki, Yuriko; Robinson, Michael L.; Sasaki, Takehiko; Mizushima, Noboru			Deletion of Autophagy-related 5 (Atg5) and Pik3c3 Genes in the Lens Causes Cataract Independent of Programmed Organelle Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBER CELL-DIFFERENTIATION; MOUSE EYE LENS; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSGENIC MICE; EPITHELIUM; NEURODEGENERATION; MACROAUTOPHAGY; MUTATIONS; ENDOSOMES; ZEBRAFISH	The lens of the eye is composed of fiber cells, which differentiate from epithelial cells and undergo programmed organelle degradation during terminal differentiation. Although autophagy, a major intracellular degradation system, is constitutively active in these cells, its physiological role has remained unclear. We have previously shown that Atg5-dependent macroautophagy is not necessary for lens organelle degradation, at least during the embryonic period. Here, we generated lens-specific Atg5 knock-out mice and showed that Atg5 is not required for lens organelle degradation at any period of life. However, deletion of Atg5 in the lens results in age-related cataract, which is accompanied by accumulation of polyubiquitinated and oxidized proteins, p62, and insoluble crystallins, suggesting a defect in intracellular quality control. We also produced lens-specific Pik3c3 knock-out mice to elucidate the possible involvement of Atg5-independent alternative autophagy, which is proposed to be dependent on Pik3c3 (also known as Vps34), in lens organelle degradation. Deletion of Pik3c3 in the lens does not affect lens organelle degradation, but it leads to congenital cataract and a defect in lens development after birth likely due to an impairment of the endocytic pathway. Taken together, these results suggest that clearance of lens organelles is independent of macroautophagy. These findings also clarify the physiological role of Atg5 and Pik3c3 in quality control and development of the lens, respectively.	[Morishita, Hideaki; Sakamaki, Yuriko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Sakamaki, Yuriko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Tokyo 1138519, Japan; [Eguchi, Satoshi; Kimura, Hirotaka; Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Eguchi, Satoshi; Kimura, Hirotaka; Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Global Ctr Excellence Program, Akita 0108543, Japan; [Robinson, Michael L.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Sasaki, Takehiko] Akita Univ, Biosignal Res Ctr, Akita 0108543, Japan; [Mizushima, Noboru] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Akita University; Akita University; University System of Ohio; Miami University; Akita University; University of Tokyo; University of Tokyo	Mizushima, N (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Sasaki, Takehiko/0000-0003-1837-3748; Morishita, Hideaki/0000-0003-0860-8371	National Institutes of Health from NEI [R01EY012995]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers; Takeda Science Foundation; Toray Science Foundation; Japan Society for the Promotion of Science for Young Scientists; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency; NATIONAL EYE INSTITUTE [R01EY012995] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Toray Science Foundation(Toray Industries, Inc.); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY012995 from NEI (to M. L. R.). This work was also supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Funding Program for Next Generation World-Leading Researchers (to T. S. and N. M.), the Takeda Science Foundation (to T. S. and N. M.), the Toray Science Foundation (to T. S.), grants for a research fellowship of the Japan Society for the Promotion of Science for Young Scientists (to H. M.), and Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (to J. S.).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brennan LA, 2012, MOL VIS, V18, P1773; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Frederikse PH, 2012, DEV BIOL, V368, P255, DOI 10.1016/j.ydbio.2012.05.022; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; HANNA C, 1961, ARCH OPHTHALMOL-CHIC, V66, P103; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Imai F, 2010, DEVELOPMENT, V137, P3257, DOI 10.1242/dev.053124; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; Li W, 2012, J CELL BIOL, V197, P27, DOI 10.1083/jcb.201111053; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Martinez G, 2009, INVEST OPHTH VIS SCI, V50, P4794, DOI 10.1167/iovs.09-3567; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; Murphy TR, 2011, EXP EYE RES, V93, P460, DOI 10.1016/j.exer.2011.06.010; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; RAFFERTY NS, 1981, J CELL PHYSIOL, V107, P309, DOI 10.1002/jcp.1041070302; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Simirskii VN, 2007, DEV BIOL, V306, P658, DOI 10.1016/j.ydbio.2007.04.004; Sugiyama Y, 2009, DEV BIOL, V336, P246, DOI 10.1016/j.ydbio.2009.10.010; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; WALTON J, 1984, EXP EYE RES, V39, P217, DOI 10.1016/0014-4835(84)90010-1; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028; Zhao HT, 2004, INVEST OPHTH VIS SCI, V45, P1930, DOI 10.1167/iovs.03-0856; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhou XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016358; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	59	96	104	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11436	11447		10.1074/jbc.M112.437103	http://dx.doi.org/10.1074/jbc.M112.437103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479732	Green Published, hybrid			2022-12-28	WOS:000317915500045
J	Liu, JX; Fan, SL; Lee, CJ; Greenleaf, AL; Zhou, P				Liu, Jiangxin; Fan, Shilong; Lee, Chul-Jin; Greenleaf, Arno L.; Zhou, Pei			Specific Interaction of the Transcription Elongation Regulator TCERG1 with RNA Polymerase II Requires Simultaneous Phosphorylation at Ser(2), Ser(5), and Ser(7) within the Carboxyl-terminal Domain Repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FF DOMAINS; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; CA150 BIND; CTD CODE; KINASE-I; PROTEINS; IDENTIFICATION; PHOSPHOCTD; INSIGHTS	The human transcription elongation regulator TCERG1 physically couples transcription elongation and splicing events by interacting with splicing factors through its N-terminal WW domains and the hyperphosphorylated C-terminal domain (CTD) of RNA polymerase II through its C-terminal FF domains. Here, we report biochemical and structural characterization of the C-terminal three FF domains (FF4-6) of TCERG1, revealing a rigid integral domain structure of the tandem FF repeat that interacts with the hyperphosphorylated CTD (PCTD). Although FF4 and FF5 adopt a classical FF domain fold containing three orthogonally packed alpha helices and a 310 helix, FF6 contains an additional insertion helix between alpha 1 and alpha 2. The formation of the integral tandem FF4-6 repeat is achieved by merging the last helix of the preceding FF domain and the first helix of the following FF domain and by direct interactions between neighboring FF domains. Using peptide column binding assays and NMR titrations, we show that binding of the FF4-6 tandem repeat to the PCTD requires simultaneous phosphorylation at Ser(2), Ser(5), and Ser(7) positions within two consecutive (YSPTSPS7)-S-1-P-2-T-3-S-4-P-5-S-6 heptad repeats. Such a sequence-specific PCTD recognition is achieved through CTD-docking sites on FF4 and FF5 of TCERG1 but not FF6. Our study presents the first example of a nuclear factor requiring all three phospho-Ser marks within the heptad repeat of the CTD for high affinity binding and provides a molecular interpretation for the biochemical connection between the Ser(7) phosphorylation enrichment in the CTD of the transcribing RNA polymerase II over introns and co-transcriptional splicing events.	[Liu, Jiangxin; Lee, Chul-Jin; Greenleaf, Arno L.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Fan, Shilong] Med Res Council MRC Ctr, Mol Biol Lab, Cambridge CB2 0QH, England	Duke University; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	National Institutes of Health [GM079376, GM040505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505, R01GM079376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079376 (to P. Z.) and GM040505 (to A. L. G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; Bartkowiak B, 2011, GENET RES INT, V2011, DOI 10.4061/2011/623718; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bonet R, 2008, PROTEINS, V73, P1001, DOI 10.1002/prot.22127; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ester C, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-29; Gasch A, 2006, J BIOL CHEM, V281, P356, DOI 10.1074/jbc.M508047200; Ghosh A, 2011, MOL CELL, V43, P299, DOI 10.1016/j.molcel.2011.06.001; Goddard T., 2008, SPARKY, V3; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Lu M, 2009, J MOL BIOL, V393, P397, DOI 10.1016/j.jmb.2009.07.086; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Murphy JM, 2009, J MOL BIOL, V393, P409, DOI 10.1016/j.jmb.2009.08.049; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani Hemali P, 2004, Methods Mol Biol, V257, P17, DOI 10.1385/1-59259-750-5:017; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Zeng JY, 2009, J BIOMOL NMR, V45, P265, DOI 10.1007/s10858-009-9366-3; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214; ZHANG J, 1991, J BIOL CHEM, V266, P2290; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	67	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10890	10901		10.1074/jbc.M113.460238	http://dx.doi.org/10.1074/jbc.M113.460238			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23436654	Green Published, hybrid			2022-12-28	WOS:000317565000066
J	Barone, A; Benktander, J; Angstrom, J; Aspegren, A; Bjorquist, P; Teneberg, S; Breimer, ME				Barone, Angela; Benktander, John; Angstrom, Jonas; Aspegren, Anders; Bjorquist, Petter; Teneberg, Susann; Breimer, Michael. E.			Structural Complexity of Non-acid Glycosphingolipids in Human Embryonic Stem Cells Grown under Feeder-free Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP; MASS-SPECTROMETRY; GLOBOSERIES GLYCOSPHINGOLIPIDS; CORRELATED SPECTROSCOPY; SMALL-INTESTINE; GANGLIO-SERIES; UDP-GALACTOSE; GLOBO-SERIES; O-GLYCANS; GROUP-A	Due to their pluripotency and growth capability, there are great expectations for human embryonic stem cells, both as a resource for functional studies of early human development and as a renewable source of cells for use in regenerative medicine and transplantation. However, to bring human embryonic stem cells into clinical applications, their cell surface antigen expression and its chemical structural complexity have to be defined. In the present study, total non-acid glycosphingolipid fractions were isolated from two human embryonic stem cell lines (SA121 and SA181) originating from leftover in vitro fertilized human embryos, using large amounts of starting material (1 x 10(9) cells/cell line). The total non-acid glycosphingolipid fractions were characterized by antibody and lectin binding, mass spectrometry, and proton NMR. In addition to the globo-series and type 1 core chain glycosphingolipids previously described in human embryonic stem cells, a number of type 2 core chain glycosphingolipids (neo-lactotetraosylceramide, the H type 2 pentaosylceramide, the Lex pentaosylceramide, and the Ley hexaosylceramide) were identified as well as the blood group A type 1 hexaosylceramide. Finally, the mono-, di-, and triglycosylceramides were characterized as galactosylceramide, glucosylceramide, lactosylceramide, galabiaosylceramide, globotriaosylceramide, and lactotriaosylceramide. Thus, the glycan diversity of human embryonic stem cells, including cell surface immune determinants, is more complex than previously appreciated.	[Barone, Angela; Breimer, Michael. E.] Sahlgrens Univ Hosp, Dept Surg, S-41345 Gothenburg, Sweden; [Benktander, John; Angstrom, Jonas; Teneberg, Susann] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden; [Aspegren, Anders; Bjorquist, Petter] Cellartis AB, Cellectis Stem Cells, S-41346 Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Takara Bio Inc.; Cellartis	Teneberg, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, POB 440, S-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Research Council [12628, 342-2004-4434]; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by Swedish Research Council Grant 12628, the Swedish Cancer Foundation, and governmental grants to the Sahlgrenska University Hospital.; The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by Swedish Research Council Grant 342-2004-4434 to Gunnar Hansson) and the Varian 600-MHz instrument at the Swedish NMR Centre, Hasselblad Laboratory, Goteborg University, is gratefully acknowledged.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Andrews PD, 2010, BIOCHEM J, V432, P21, DOI 10.1042/BJ20101022; Angstrom J, 2004, GLYCOBIOLOGY, V14, P1, DOI 10.1093/glycob/cwh003; Benktander J, 2012, J BIOL CHEM, V287, P31712, DOI 10.1074/jbc.M112.387654; BREIMER ME, 1982, J BIOL CHEM, V257, P906; Breimer ME, 2011, XENOTRANSPLANTATION, V18, P215, DOI 10.1111/j.1399-3089.2011.00644.x; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; CHEN C, 1989, BIOCHEMISTRY-US, V28, P2229, DOI 10.1021/bi00431a039; Chester MA, 1998, EUR J BIOCHEM, V257, P293; DABROWSKI J, 1988, CHEM PHYS LIPIDS, V49, P31, DOI 10.1016/0009-3084(88)90061-8; Diswall M, 2007, TRANSPLANTATION, V84, P1348, DOI 10.1097/01.tp.0000287599.46165.15; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FENDERSON BA, 1986, DEV BIOL, V114, P12, DOI 10.1016/0012-1606(86)90379-9; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; HAKOMORI S, 1984, J BIOL CHEM, V259, P4672; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hallen U, 2008, GLYCOCONJUGATE J, V25, P561, DOI 10.1007/s10719-008-9113-0; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; HANSSON GC, 1983, J BIOL CHEM, V258, P4091; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; HOLGERSSON J, 1991, J BIOCHEM-TOKYO, V110, P120, DOI 10.1093/oxfordjournals.jbchem.a123530; HOLGERSSON J, 1990, J BIOCHEM-TOKYO, V108, P766, DOI 10.1093/oxfordjournals.jbchem.a123279; ITO M, 1989, J BIOL CHEM, V264, P9510; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KOBATA A, 1992, EUR J BIOCHEM, V209, P483, DOI 10.1111/j.1432-1033.1992.tb17313.x; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; Li YT, 2009, GLYCOCONJUGATE J, V26, P929, DOI 10.1007/s10719-008-9125-9; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; SCHNAAR RL, 2008, ESSENTIALS GLYCOBIOL, P129; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; Smith A, 1998, CURR BIOL, V8, pR802, DOI 10.1016/S0960-9822(07)00504-0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Suila H, 2011, J MOL CELL BIOL, V3, P99, DOI 10.1093/jmcb/mjq041; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; TENEBERG S, 1994, J BIOL CHEM, V269, P8554; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Williams SA, 2009, GLYCOCONJUGATE J, V26, P335, DOI 10.1007/s10719-008-9181-1; Wright AJ, 2009, STEM CELL RES, V3, P3, DOI 10.1016/j.scr.2009.04.001; Yanagisawa M, 2011, NEUROCHEM RES, V36, P1623, DOI 10.1007/s11064-010-0358-1; ZHU ZM, 1995, BIOL REPROD, V52, P903, DOI 10.1095/biolreprod52.4.903	53	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10035	10050		10.1074/jbc.M112.436162	http://dx.doi.org/10.1074/jbc.M112.436162			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23404501	Green Published, hybrid			2022-12-28	WOS:000317114000042
J	Ma, L; Yu, HG; Ni, ZM; Hu, SG; Ma, WB; Chu, C; Liu, Q; Zhang, YL				Ma, Li; Yu, Heguo; Ni, Zimei; Hu, Shuanggang; Ma, Wubin; Chu, Chen; Liu, Qiang; Zhang, Yonglian			Spink13, an Epididymis-specific Gene of the Kazal-type Serine Protease Inhibitor (SPINK) Family, Is Essential for the Acrosomal Integrity and Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; IN-VITRO FERTILIZATION; AMINO-ACID-SEQUENCE; TRYPSIN-INHIBITOR; SPERM MATURATION; MOUSE SPERMATOZOA; ANCHORED PROTEIN; CHRONIC-PANCREATITIS; NETHERTON-SYNDROME; MOLECULAR-CLONING	Sperm maturation involves numerous surface modifications by a variety of secreted proteins from epididymal epithelia. The sperm surface architecture depends on correct localization of its components and highlights the importance of the sequence of the proteolytic processing of the sperm surface in the epididymal duct. The presence of several protease inhibitors from different families is consistent with the hypothesis that correctly timed epididymal protein processing is essential for proper sperm maturation. Here we show that the rat (Rattus norvegicus) epididymis-specific gene Spink13, an androgen-responsive serine protease inhibitor, could bind to the sperm acrosome region. Furthermore, knockdown of Spink13 in vivo dramatically enhanced the acrosomal exocytosis during the process of capacitation and thus led to a significant reduction in male fertility, indicating that Spink13 was essential for sperm maturation. We conclude that blockade of SPINK13 may provide a new putative target for post-testicular male contraceptives.	[Ma, Li; Ni, Zimei; Hu, Shuanggang; Ma, Wubin; Chu, Chen; Liu, Qiang; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China; [Yu, Heguo; Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Commiss Key Lab Co, Shanghai 200032, Peoples R China; [Ma, Li; Hu, Shuanggang; Ma, Wubin; Chu, Chen] Chinese Acad Sci, Grad Univ, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, Q (corresponding author), Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	qliu@sibcb.ac.cn; ylzhang@sibcb.ac.cn	Chu, Chen/J-6527-2019; Ma, Wubin/P-3045-2017	Chu, Chen/0000-0001-8084-0867; 	Chinese Academy of Sciences [KSCX2-EW-R-07]; National Natural Science Foundation [30930053, 31271600, 30770815]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences Knowledge Innovation Program Grant KSCX2-EW-R-07, and National Natural Science Foundation Grants 30930053, 31271600, and 30770815.	AGERBERTH B, 1989, P NATL ACAD SCI USA, V86, P8590, DOI 10.1073/pnas.86.21.8590; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Bendahmane M, 2002, ARCH BIOCHEM BIOPHYS, V404, P38, DOI 10.1016/S0003-9861(02)00278-3; Berger T, 2000, REPROD TOXICOL, V14, P45, DOI 10.1016/S0890-6238(99)00062-3; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Cesari A, 2010, THERIOGENOLOGY, V74, P699, DOI 10.1016/j.theriogenology.2010.03.029; Chen H, 2006, BIOL REPROD, V74, P923, DOI 10.1095/biolreprod.105.048587; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; COURTY Y, 1991, J REPROD FERTIL, V91, P293; Cui YP, 2010, INT J ONCOL, V37, P1521, DOI 10.3892/ijo_00000805; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; Dematteis A, 2008, BIOL REPROD, V79, P493, DOI 10.1095/biolreprod.107.067538; FINK E, 1990, FEBS LETT, V270, P222, DOI 10.1016/0014-5793(90)81273-Q; Frenette G, 2001, MOL REPROD DEV, V59, P115, DOI 10.1002/mrd.1013; Gasiorowska A, 2011, DIGEST DIS SCI, V56, P894, DOI 10.1007/s10620-010-1349-4; Gyamera-Acheampong C, 2009, HUM REPROD UPDATE, V15, P237, DOI 10.1093/humupd/dmn060; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Jalkanen J, 2006, BIOCHEM BIOPH RES CO, V349, P245, DOI 10.1016/j.bbrc.2006.08.023; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jones R, 1996, J CELL SCI, V109, P2561; Jones R, 1998, J REPROD FERTIL, P73; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Lee B, 2011, J BIOL CHEM, V286, P29108, DOI 10.1074/jbc.M111.244905; Legare C, 1999, MOL REPROD DEV, V52, P225, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;225::AID-MRD14&gt;3.0.CO;2-M; LIU DY, 1993, BIOL REPROD, V48, P340, DOI 10.1095/biolreprod48.2.340; Liu Q, 2001, ENDOCRINOLOGY, V142, P4529, DOI 10.1210/en.142.10.4529; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Martin-DeLeon PA, 2006, MOL CELL ENDOCRINOL, V250, P114, DOI 10.1016/j.mce.2005.12.033; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; MOORE HDM, 1992, FERTIL STERIL, V58, P776; MORITZ A, 1991, FEBS LETT, V278, P127, DOI 10.1016/0014-5793(91)80099-O; Nakamura Yasuo, 2003, Journal of Medical Investigation, V50, P78; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Ou CM, 2012, INT J ANDROL, V35, P52, DOI 10.1111/j.1365-2605.2011.01159.x; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Rockett JC, 2004, MUTAT RES-FUND MOL M, V549, P225, DOI 10.1016/j.mrfmmm.2003.11.017; Sipila P, 2009, REPRODUCTION, V137, P379, DOI 10.1530/REP-08-0132; Stenman UH, 2011, ASIAN J ANDROL, V13, P628, DOI 10.1038/aja.2011.45; Syntin P, 1999, BIOL REPROD, V60, P1542, DOI 10.1095/biolreprod60.6.1542; Takano N, 2005, MOL REPROD DEV, V70, P1, DOI 10.1002/mrd.20184; Tulsiani DRP, 2003, MICROSC RES TECHNIQ, V61, P18, DOI 10.1002/jemt.10313; Tuysuz B, 2010, ACTA DERM-VENEREOL, V90, P95, DOI 10.2340/00015555-0769; van Hoef V., 2012, PEPTIDES IN PRESS; Wang J, 2008, HISTOCHEM CELL BIOL, V130, P387, DOI 10.1007/s00418-008-0425-8; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Xiao LQ, 2004, ACTA BIOCH BIOPH SIN, V36, P571, DOI 10.1093/abbs/36.8.571; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yeung CH, 2001, MOL HUM REPROD, V7, P617, DOI 10.1093/molehr/7.7.617; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhen W, 2009, BIOL REPROD, V80, P696, DOI 10.1095/biolreprod.108.071589; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	66	33	37	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10154	10165		10.1074/jbc.M112.445866	http://dx.doi.org/10.1074/jbc.M112.445866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430248	Green Published, hybrid			2022-12-28	WOS:000317114000056
J	Gattis, SG; Chung, HS; Trent, MS; Raetz, CRH				Gattis, Samuel G.; Chung, Hak Suk; Trent, M. Stephen; Raetz, Christian R. H.			The Origin of 8-Amino-3,8-dideoxy-D-manno-octulosonic Acid (Kdo8N) in the Lipopolysaccharide of Shewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; LINKED ACYL CHAINS; ESCHERICHIA-COLI; LIPID-A; SP-NOV; IDENTIFICATION; MOLECULES; BACTERIUM; ENZYMES; CLONING	Lipopolysaccharide (LPS; endotoxin) is an essential component of the outer monolayer of nearly all Gram-negative bacteria. LPS is composed of a hydrophobic anchor, known as lipid A, an inner core oligosaccharide, and a repeating O-antigen polysaccharide. In nearly all species, the first sugar bridging the hydrophobic lipid A and the polysaccharide domain is 3-deoxy-D-manno-octulosonic acid (Kdo), and thus it is critically important for LPS biosynthesis. Modifications to lipid A have been shown to be important for resistance to antimicrobial peptides as well as modulating recognition by the mammalian innate immune system. Therefore, lipid A derivatives have been used for development of vaccine strains and vaccine adjuvants. One derivative that has yet to be studied is 8-amino-3,8-dideoxy-D-manno-octulosonic acid (Kdo8N), which is found exclusively in marine bacteria of the genus Shewanella. Using bioinformatics, a candidate gene cluster for Kdo8N biosynthesis was identified in Shewanella oneidensis. Expression of these genes recombinantly in Escherichia coli resulted in lipid A containing Kdo8N, and in vitro assays confirmed their proposed enzymatic function. Both the in vivo and in vitro data were consistent with direct conversion of Kdo to Kdo8N prior to its incorporation into the Kdo8N-lipid A domain of LPS by a metal-dependent oxidase followed by a glutamate-dependent aminotransferase. To our knowledge, this oxidase is the first enzyme shown to oxidize an alcohol using a metal and molecular oxygen, not NAD(P)(+). Creation of an S. oneidensis in-frame deletion strain showed increased sensitivity to the cationic antimicrobial peptide polymyxin as well as bile salts, suggesting a role in outer membrane integrity.	[Gattis, Samuel G.; Chung, Hak Suk; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Chung, Hak Suk] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul 130650, South Korea; [Trent, M. Stephen] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Trent, M. Stephen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Duke University; Korea Institute of Science & Technology (KIST); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Trent, MS (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, 2506 Speedway Stop A5000, Austin, TX 78712 USA.	strent@mail.utexas.edu		Chung, Hak Suk/0000-0003-1166-9909	National Institutes of Health [GM051310, GM069338, AI064184, AI76322]; Korea Institute of Science and Technology Grants; Army Research Office Grant [61789-MA-MUR]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064184, R01AI076322, R56AI076322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM051310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Institute of Science and Technology Grants; Army Research Office Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051310 (to C. R. H. R.), GM069338 from the Lipid Maps Large Scale Collaborative (to C. R. H. R.), and AI064184 and AI76322 (to M. S. T.).; Supported by Korea Institute of Science and Technology Grants.; Supported by Army Research Office Grant 61789-MA-MUR. To whom correspondence should be addressed: Section of Molecular Genetics and Microbiology, The University of Texas at Austin, 2506 Speedway Stop A5000, Austin, TX 78712-1191. Tel.: 512-232-8371; E-mail: strent@mail.utexas.edu.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Del Rio TG, 2010, STAND GENOMIC SCI, V2, P87, DOI 10.4056/sigs.661199; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; JANNASCH HW, 1985, INT J SYST BACTERIOL, V35, P422, DOI 10.1099/00207713-35-4-422; Jorens PG, 2004, RESPIRATION, V71, P199, DOI 10.1159/000076686; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Otsuka T, 2007, J GASTROENTEROL, V42, P87, DOI 10.1007/s00535-006-1957-0; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Romo AJ, 2011, BBA-PROTEINS PROTEOM, V1814, P1534, DOI 10.1016/j.bbapap.2011.02.003; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Seidman C E, 2001, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0108s37; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P913, DOI [10.1099/ijs.0.02034-0, 10.1099/00207713-52-3-913]; Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200; Sweet CR, 2004, J BIOL CHEM, V279, P25411, DOI 10.1074/jbc.M400597200; Tan CK, 2008, J CLIN MICROBIOL, V46, P2817, DOI 10.1128/JCM.01018-08; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Vinogradov E, 2004, CARBOHYD RES, V339, P737, DOI 10.1016/j.carres.2003.12.010; Vinogradov E, 2003, CARBOHYD RES, V338, P1991, DOI 10.1016/S0008-6215(03)00325-2; Vinogradov E, 2008, CARBOHYD RES, V343, P2701, DOI 10.1016/j.carres.2008.06.006; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth	33	13	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9216	9225		10.1074/jbc.M113.453324	http://dx.doi.org/10.1074/jbc.M113.453324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23413030	Green Published, hybrid			2022-12-28	WOS:000316862200040
J	Kosenko, T; Golder, M; Leblond, G; Weng, W; Lagace, TA				Kosenko, Tanja; Golder, Mia; Leblond, Geoffrey; Weng, Willy; Lagace, Thomas A.			Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL RECEPTOR; APOLIPOPROTEIN-B; SECRETED PCSK9; CHOLESTEROL; MUTATIONS; TARGET; IDENTIFICATION; DECREASES; CORRELATE; ANTIBODY	Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a secreted protein that binds to the epidermal growth factor-like-A domain of the low density lipoprotein receptor (LDLR) and mediates LDLR degradation in liver. Gain-of-function mutations in PCSK9 are associated with autosomal dominant hypercholesterolemia in humans. Size-exclusion chromatography of human plasma has shown PCSK9 to be partly associated with undefined high molecular weight complexes within the LDL size range. We used density gradient centrifugation to isolate LDL in plasma pooled from 5 normolipidemic subjects and report that >40% of totalPCSK9was associated with LDL. Binding of fluorophore-labeled recombinant PCSK9 to isolated LDL in vitro was saturable with a K-D similar to 325 nM. This interaction was competed >95% by excess unlabeled PCSK9, and competition binding curves were consistent with a one-site binding model. An N-terminal region of the PCSK9 prodomain (amino acids 31-52) was required for binding to LDL in vitro. LDL dose-dependently inhibited binding and degradation of cell surface LDLRs by exogenous PCSK9 in HuH7 cells. LDL also inhibited PCSK9 binding to mutant LDLRs defective at binding LDL. These data suggest that association of PCSK9 with LDL particles in plasma lowers the ability of PCSK9 to bind to cell surface LDLRs, thereby blunting PCSK9-mediated LDLR degradation.	[Kosenko, Tanja; Golder, Mia; Leblond, Geoffrey; Weng, Willy; Lagace, Thomas A.] Univ Ottawa, Inst Heart, Dept Pathol & Lab Med, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute	Lagace, TA (corresponding author), Univ Ottawa, Inst Heart, Dept Pathol & Lab Med, 40 Ruskin St,Rm H-4213, Ottawa, ON K1Y 4W7, Canada.	tlagace@ottawaheart.ca		Weng, Willy/0000-0002-2848-5295	Heart and Stroke Foundation of Ontario [000120]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Heart and Stroke Foundation of Ontario Grant-in-aid 000120 (to T.A.L.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Browning JD, 2010, J LIPID RES, V51, P3359, DOI 10.1194/jlr.P009860; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Davignon Jean, 2009, Trans Am Clin Climatol Assoc, V120, P163; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Lambert G, 2008, CLIN CHEM, V54, P1038, DOI 10.1373/clinchem.2007.099747; Luo Y, 2009, J LIPID RES, V50, P1581, DOI 10.1194/jlr.M800542-JLR200; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, P832, DOI 10.1161/01.ATV.8.6.832; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mayne J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-22; Mayne J, 2007, BIOCHEM BIOPH RES CO, V361, P451, DOI 10.1016/j.bbrc.2007.07.029; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Yee MS, 2008, J LIPID RES, V49, P1364, DOI 10.1194/jlr.D700044-JLR200; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	50	123	135	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8279	8288		10.1074/jbc.M112.421370	http://dx.doi.org/10.1074/jbc.M112.421370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23400816	hybrid, Green Published			2022-12-28	WOS:000316564500028
J	Watts, AO; Verkaar, F; van der Lee, MMC; Timmerman, CAW; Kuijer, M; van Offenbeek, J; van Lith, LHCJ; Smit, MJ; Leurs, R; Zaman, GJR; Vischer, HF				Watts, Anne O.; Verkaar, Folkert; van der Lee, Miranda M. C.; Timmerman, Claudia A. W.; Kuijer, Martien; van Offenbeek, Jody; van Lith, Lambertus H. C. J.; Smit, Martine J.; Leurs, Rob; Zaman, Guido J. R.; Vischer, Henry F.			beta-Arrestin Recruitment and G Protein Signaling by the Atypical Human Chemokine Decoy Receptor CCX-CKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTORS; CRYSTAL-STRUCTURE; CELLS; CXCR7; CAMP; IDENTIFICATION; TRANSDUCTION; INVOLVEMENT; TRAFFICKING; ACTIVATION	Chemokine receptors form a large subfamily of G protein-coupled receptors that predominantly activate heterotrimeric G(i) proteins and are involved in immune cell migration. CCX-CKR is an atypical chemokine receptor with high affinity for CCL19, CCL21, and CCL25 chemokines, but is not known to activate intracellular signaling pathways. However, CCX-CKR acts as decoy receptor and efficiently internalizes these chemokines, thereby preventing their interaction with other chemokine receptors, like CCR7 and CCR9. Internalization of fluorescently labeled CCL19 correlated with beta-arrestin2-GFP translocation. Moreover, recruitment of beta-arrestins to CCX-CKR in response to CCL19, CCL21, and CCL25 was demonstrated using enzyme-fragment complementation and bioluminescence resonance energy transfer methods. To unravel why CCX-CKR is unable to activate G(i) signaling, CCX-CKR chimeras were constructed by substituting its intracellular loops with the corresponding CCR7 or CCR9 domains. The signaling properties of chimeric CCX-CKR receptors were characterized using a cAMP-responsive element (CRE)-driven reporter gene assay. Unexpectedly, wild type CCX-CKR and a subset of the chimeras induced an increase in CRE activity in response to CCL19, CCL21, and CCL25 in the presence of the G(i) inhibitor pertussis toxin. CCX-CKR signaling to CRE required an intact DRY motif. These data suggest that inactive G(i) proteins impair CCX-CKR signaling most likely by hindering the interaction of this receptor with pertussis toxin-insensitive G proteins that transduce signaling to CRE. On the other hand, recruitment of the putative signaling scaffold beta-arrestin to CCX-CKR in response to chemokines might allow activation of yet to be identified signal transduction pathways.	[Watts, Anne O.; Verkaar, Folkert; Kuijer, Martien; van Offenbeek, Jody; Smit, Martine J.; Leurs, Rob; Vischer, Henry F.] Vrije Univ Amsterdam, Fac Sci, Div Med Chem, NL-1081 HV Amsterdam, Netherlands; [Verkaar, Folkert; van der Lee, Miranda M. C.; Timmerman, Claudia A. W.; van Offenbeek, Jody; van Lith, Lambertus H. C. J.] Merck Res Labs, Mol Pharmacol & DMPK, NL-5340 BH Oss, Netherlands; [Zaman, Guido J. R.] Netherlands Translat Res Ctr BV, NL-5340 AG Oss, Netherlands	Vrije Universiteit Amsterdam; Merck & Company	Vischer, HF (corresponding author), Vrije Univ Amsterdam, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	h.f.vischer@vu.nl	Leurs, Rob/ABB-4299-2021; Leurs, Rob/AAC-8508-2022	Leurs, Rob/0000-0003-1354-2848; Smit, Martine/0000-0003-2713-0238	Dutch Top Institute Pharma initiative program [D1-105]	Dutch Top Institute Pharma initiative program	This work was supported by the Dutch Top Institute Pharma initiative program D1-105.	Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bahia DS, 1998, BIOCHEMISTRY-US, V37, P11555, DOI 10.1021/bi980284o; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; Comerford I, 2010, BLOOD, V116, P4130, DOI 10.1182/blood-2010-01-264390; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Feng LY, 2009, CLIN CANCER RES, V15, P2962, DOI 10.1158/1078-0432.CCR-08-2495; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gosling J, 2000, J IMMUNOL, V164, P2851, DOI 10.4049/jimmunol.164.6.2851; Haraldsen G, 2006, EUR J IMMUNOL, V36, P1659, DOI 10.1002/eji.200636327; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Khoja H, 2000, GENE, V246, P229, DOI 10.1016/S0378-1119(00)00076-7; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kriegova E, 2006, INFLAMM RES, V55, P441, DOI 10.1007/s00011-006-6019-9; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Manson ME, 2011, BIOCHEMISTRY-US, V50, P6022, DOI 10.1021/bi200015h; Maruko T, 2005, N-S ARCH PHARMACOL, V372, P153, DOI 10.1007/s00210-005-0001-x; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Nijmeijer S, 2010, J BIOL CHEM, V285, P29632, DOI 10.1074/jbc.M110.115618; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rode I, 2012, P NATL ACAD SCI USA, V109, P3463, DOI 10.1073/pnas.1118823109; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Townson JR, 2002, EUR J IMMUNOL, V32, P1230, DOI 10.1002/1521-4141(200205)32:5<1230::AID-IMMU1230>3.0.CO;2-L; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Van der Lee MMC, 2008, J BIOMOL SCREEN, V13, P986, DOI 10.1177/1087057108326144; van Lith LHC, 2009, J BIOMOL SCREEN, V14, P1067, DOI 10.1177/1087057109341407; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Vischer HF, 2008, BIOCHEM BIOPH RES CO, V377, P93, DOI 10.1016/j.bbrc.2008.09.082; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	46	35	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7169	7181		10.1074/jbc.M112.406108	http://dx.doi.org/10.1074/jbc.M112.406108			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341447	hybrid, Green Published			2022-12-28	WOS:000316002400038
J	Liu, CR; Weng, HB; Chen, LX; Yang, SM; Wang, H; Debnath, G; Guo, XH; Wu, LC; Mohandas, N; An, XL				Liu, Congrong; Weng, Haibao; Chen, Lixiang; Yang, Shaomin; Wang, Hua; Debnath, Gargi; Guo, Xinhua; Wu, Liancheng; Mohandas, Narla; An, Xiuli			Impaired Intestinal Calcium Absorption in Protein 4.1R-deficient Mice Due to Altered Expression of Plasma Membrane Calcium ATPase 1b (PMCA1b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ PUMP; FUNCTIONAL-CHARACTERIZATION; GENE FAMILY; 4.1R; CELLS; BINDING; ISOFORMS; COMPLEX; PHOSPHORYLATION; CYTOSKELETON	Protein 4.1R was first identified in the erythrocyte membrane skeleton. It is now known that the protein is expressed in a variety of epithelial cell lines and in the epithelia of many tissues, including the small intestine. However, the physiological function of 4.1R in the epithelial cells of the small intestine has not so far been explored. Here, we show that 4.1R knock-out mice exhibited a significantly impaired small intestinal calcium absorption that resulted in secondary hyperparathyroidism as evidenced by increased serum 1,25-(OH)(2)-vitamin D-3 and parathyroid hormone levels, decreased serum calcium levels, hyperplasia of the parathyroid, and demineralization of the bones. 4.1R is located on the basolateral membrane of enterocytes, where it co-localizes with PMCA1b (plasma membrane calcium ATPase 1b). Expression of PMCA1b in enterocytes was decreased in 4.1(-/-) mice. 4.1R directly associated with PMCA1b, and the association involved the membrane-binding domain of 4.1R and the second intracellular loop and C terminus of PMCA1b. Our findings have enabled us to define a functional role for 4.1R in small intestinal calcium absorption through regulation of membrane expression of PMCA1b.	[Liu, Congrong; Weng, Haibao; Chen, Lixiang; Yang, Shaomin; Wang, Hua; Debnath, Gargi; Guo, Xinhua; Wu, Liancheng; Mohandas, Narla; An, Xiuli] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10065 USA; [Liu, Congrong; Yang, Shaomin; Wang, Hua] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China; [Weng, Haibao; Chen, Lixiang; An, Xiuli] Zhengzhou Univ, Dept Bioengn, Zhengzhou 450051, Peoples R China	New York Blood Center; Peking University; Zhengzhou University	An, XL (corresponding author), Red Cell Physiol Lab, 310 East 67th St, New York, NY 10065 USA.	xan@nybloodcenter.org			National Institutes of Health [DK26263, DK32094]; Beijing Municipal Natural Science Foundation of China [7082055]; Natural Science Foundation of China [81171905]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, P01DK032094, R01DK026263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Municipal Natural Science Foundation of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26263 and DK32094. This work was also supported by Grant 7082055 from Beijing Municipal Natural Science Foundation of China and Grant 81171905 from the Natural Science Foundation of China.	An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; An XL, 1996, J BIOL CHEM, V271, P33187, DOI 10.1074/jbc.271.52.33187; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; BRONNER F, 1986, AM J PHYSIOL, V250, pG561, DOI 10.1152/ajpgi.1986.250.5.G561; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DeCarcer G, 1995, BIOCHEM J, V312, P871, DOI 10.1042/bj3120871; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; FREEMAN TC, 1995, AM J PHYSIOL-GASTR L, V269, pG126, DOI 10.1152/ajpgi.1995.269.1.G126; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; GIANGRANDE A, 1992, NEPHROL DIAL TRANSPL, V7, P412; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Krauss SW, 1997, P NATL ACAD SCI USA, V94, P7297, DOI 10.1073/pnas.94.14.7297; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; Parra MK, 2003, BLOOD, V101, P4164, DOI 10.1182/blood-2002-06-1796; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Ramez M, 2003, KIDNEY INT, V63, P1321, DOI 10.1046/j.1523-1755.2003.00870.x; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; TCHERNIA G, 1981, J CLIN INVEST, V68, P454, DOI 10.1172/JCI110275; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Yang SM, 2011, MOL CELL BIOL, V31, P2276, DOI 10.1128/MCB.01105-10; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	35	23	25	5	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11407	11415		10.1074/jbc.M112.436659	http://dx.doi.org/10.1074/jbc.M112.436659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23460639	Green Published, hybrid			2022-12-28	WOS:000317915500043
J	Padilla-Benavides, T; Long, JE; Raimunda, D; Sassetti, CM; Arguello, JM				Padilla-Benavides, Teresita; Long, Jarukit E.; Raimunda, Daniel; Sassetti, Christopher M.; Argueello, Jose M.			A Novel P-1B-type Mn2+-transporting ATPase Is Required for Secreted Protein Metallation in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; ZINC TRANSPORTER; TUBERCULOSIS; IDENTIFICATION; PATHOGEN; COPPER; RESISTANCE; ZNTA; EXPRESSION	Transition metals are central for bacterial virulence and host defense. P-1B-ATPases are responsible for cytoplasmic metal efflux and play roles either in limiting cytosolic metal concentrations or in the maturation of secreted metalloproteins. The P-1B-ATPase, CtpC, is required for Mycobacterium tuberculosis survival in a mouse model (Sassetti, C. M., and Rubin, E. J. (2003) Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U. S. A. 100, 12989-12994). CtpC prevents Zn2+ toxicity, suggesting a role in Zn2+ export from the cytosol (Botella, H., Peyron, P., Levillain, F., Poincloux, R., Poquet, Y., Brandli, I., Wang, C., Tailleux, L., Tilleul, S., Charriere, G. M., Waddell, S. J., Foti, M., Lugo-Villarino, G., Gao, Q., Maridonneau-Parini, I., Butcher, P. D., Castagnoli, P. R., Gicquel, B., de Chastellier, C., and Neyrolles, O. (2011) Mycobacterial P-1-type ATPases mediate resistance to zinc poisoning in human macrophages. Cell Host Microbe 10, 248-259). However, key metal-coordinating residues and the overall structure of CtpC are distinct from Zn2+-ATPases. We found that isolated CtpC has metal-dependent ATPase activity with a strong preference for Mn2+ over Zn2+. In vivo, CtpC is unable to complement Escherichia coli lacking a functional Zn2+-ATPase. Deletion of M. tuberculosis or Mycobacterium smegmatis ctpC leads to cytosolic Mn2+ accumulation but no alterations in other metals levels. Whereas ctpC-deficient M. tuberculosis is sensitive to extracellular Zn2+, the M. smegmatis mutant is not. Both ctpC mutants are sensitive to oxidative stress, which might explain the Zn2+-sensitive phenotype of the M. tuberculosis ctpC mutant. CtpC is a high affinity/slow turnover ATPase, suggesting a role in protein metallation. Consistent with this hypothesis, mutation of CtpC leads to a decrease of Mn2+ bound to secreted proteins and of the activity of secreted Fe/Mn-superoxide dismutase, particularly in M. smegmatis. Alterations in the assembly of metalloenzymes involved in redox stress response might explain the sensitivity of M. tuberculosis ctpC mutants to oxidative stress and growth and persistence defects in mice infection models.	[Padilla-Benavides, Teresita; Raimunda, Daniel; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Long, Jarukit E.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Padilla-Benavides, Teresita/K-1968-2012; Arguello, Jose/D-1997-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Raimunda, Daniel/0000-0001-7392-1407; Arguello, Jose/0000-0003-3940-6297	National Institutes of Health [1R21AI082484-01, F32A1093049]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082484, F32AI093049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21AI082484-01 (to J. M. A.) and Award F32A1093049 (to J. E. L.).	Achard-Joris M, 2007, BIOCHIMIE, V89, P1474, DOI 10.1016/j.biochi.2007.06.005; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Begum NA, 2002, GENOMICS, V80, P630, DOI 10.1006/geno.2002.7000; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Bunting K, 1998, EUR J BIOCHEM, V251, P795, DOI 10.1046/j.1432-1327.1998.2510795.x; Calder KM, 1998, MICROB PATHOGENESIS, V24, P133, DOI 10.1006/mpat.1997.9999; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Dussurget O, 2001, INFECT IMMUN, V69, P529, DOI 10.1128/IAI.69.1.529-533.2001; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; GREGORY EM, 1983, ARCH BIOCHEM BIOPHYS, V220, P293, DOI 10.1016/0003-9861(83)90413-7; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Grover A, 2006, J BACTERIOL, V188, P7026, DOI 10.1128/JB.00643-06; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Harth G, 1999, J BIOL CHEM, V274, P4281, DOI 10.1074/jbc.274.7.4281; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim R, 1998, BIOTECHNOL LETT, V20, P207, DOI 10.1023/A:1005305330517; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; MEIER B, 1994, EUR J BIOCHEM, V219, P463, DOI 10.1111/j.1432-1033.1994.tb19960.x; MEIER B, 1982, J BIOL CHEM, V257, P3977; Okkeri J, 2006, BBA-BIOENERGETICS, V1757, P1485, DOI 10.1016/j.bbabio.2006.06.008; Osman D, 2011, ADV MICROB PHYSIOL, V58, P175, DOI 10.1016/B978-0-12-381043-4.00005-2; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raimunda D, 2012, BBA-BIOMEMBRANES, V1818, P1374, DOI 10.1016/j.bbamem.2012.02.020; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rensing C, 1998, J BIOL CHEM, V273, P32614, DOI 10.1074/jbc.273.49.32614; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scherer J, 2009, MOL MICROBIOL, V73, P601, DOI 10.1111/j.1365-2958.2009.06792.x; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Thakur KG, 2010, J MOL BIOL, V397, P1199, DOI 10.1016/j.jmb.2010.02.026; TSAI KJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P267, DOI 10.1006/abbi.1993.1421; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Yamakura F, 1995, BIOCHEM MOL BIOL INT, V36, P233; Zielazinski EL, 2012, BIOCHEMISTRY-US, V51, P7891, DOI 10.1021/bi3006708	68	61	63	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11334	11347		10.1074/jbc.M112.448175	http://dx.doi.org/10.1074/jbc.M112.448175			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23482562	hybrid, Green Published			2022-12-28	WOS:000317915500036
J	Patki, M; Chari, V; Sivakumaran, S; Gonit, M; Trumbly, R; Ratnam, M				Patki, Mugdha; Chari, Venkatesh; Sivakumaran, Suneethi; Gonit, Mesfin; Trumbly, Robert; Ratnam, Manohar			The ETS Domain Transcription Factor ELK1 Directs a Critical Component of Growth Signaling by the Androgen Receptor in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; DEPRIVATION THERAPY; BINDING; PROTEIN; FUSIONS; PHOSPHORYLATION; OVEREXPRESSION; DETERMINANTS; ACTIVATION; PATHWAYS	The androgen receptor (AR) is essential for diverse aspects of prostate development and function. Molecular mechanisms by which prostate cancer (PC) cells redirect AR signaling to genes that primarily support growth are unclear. A systematic search for critical AR-tethering proteins led to ELK1, an ETS transcription factor of the ternary complex factor subfamily. Although genetically redundant, ELK1 was obligatory for AR-dependent growth and clonogenic survival in both hormone-dependent PC and castration-recurrent PC cells but not for AR-negative cell growth. AR required ELK1 to up-regulate a major subset of its target genes that was strongly and primarily enriched for cell growth functions. AR functioned as a coactivator of ELK1 by association through its A/B domain, bypassing the classical mechanism of ELK1 activation by phosphorylation and without inducing ternary complex target genes. The ELK1-AR synergy per se was ligand-independent, although it required ligand for nuclear localization of AR as targeting the ARA/B domain to the nucleus recapitulated the action of hormone; accordingly, Casodex was a poor antagonist of the synergy. ELK3, the closest substitute for ELK1 in structure/function and genome recognition, did not interact with AR. ELK1 thus directs selective and sustained gene induction that is a substantial and critical component of growth signaling by AR in PC cells. The ELK1-AR interaction offers a functionally tumor-selective drug target.	[Patki, Mugdha; Chari, Venkatesh; Ratnam, Manohar] Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Patki, Mugdha; Chari, Venkatesh; Sivakumaran, Suneethi; Gonit, Mesfin; Trumbly, Robert] Univ Toledo, Med Ctr, Dept Biochem & Canc Biol, Toledo, OH 43614 USA; [Gonit, Mesfin] NCI, Lab Canc Prevent, NIH, Frederick, MD 21702 USA	Barbara Ann Karmanos Cancer Institute; University System of Ohio; University of Toledo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ratnam, M (corresponding author), Barbara Ann Karmanos Canc Inst, 4100 John R, Detroit, MI 48201 USA.	ratnamm@karmanos.org	Trumbly, Robert/AAF-6667-2020	Trumbly, Robert/0000-0001-5618-146X	Harold and Helen McMaster endowment	Harold and Helen McMaster endowment	This work was supported by the Harold and Helen McMaster endowment (to M. R.).	BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Glass CK, 2000, GENE DEV, V14, P121; Gonit M, 2011, MOL ENDOCRINOL, V25, P621, DOI 10.1210/me.2010-0409; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hayward SW, 2000, RADIOL CLIN N AM, V38, P1, DOI 10.1016/S0033-8389(05)70146-9; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Holzbeierlein JM, 2004, CURR OPIN UROL, V14, P177, DOI 10.1097/00042307-200405000-00007; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Larsson R, 2011, CURR MED CHEM, V18, P4440, DOI 10.2174/092986711797287539; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Linja MJ, 2001, CANCER RES, V61, P3550; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mukhopadhyay NK, 2006, EXP CELL RES, V312, P3782, DOI 10.1016/j.yexcr.2006.07.017; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Shore P, 1996, MOL CELL BIOL, V16, P3338; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang J, 2010, ONCOGENE, V29, P723, DOI 10.1038/onc.2009.373; Zhang J, 2008, PROSTATE, V68, P1206, DOI 10.1002/pros.20779	54	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11047	11065		10.1074/jbc.M112.438473	http://dx.doi.org/10.1074/jbc.M112.438473			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23426362	hybrid, Green Published			2022-12-28	WOS:000317915500011
J	Nonaka, S; Nagaosa, K; Mori, T; Shiratsuchi, A; Nakanishi, Y				Nonaka, Saori; Nagaosa, Kaz; Mori, Toshinobu; Shiratsuchi, Akiko; Nakanishi, Yoshinobu			Integrin alpha PS3/beta nu-mediated Phagocytosis of Apoptotic Cells and Bacteria in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-NU; ENGULFMENT; CLEARANCE; MORPHOGENESIS; RECOGNITION; RECEPTOR; ELEGANS; PROTEIN; DRAPER; CED-1	Integrins exert a variety of cellular functions as heterodimers of two transmembrane subunits named alpha and beta. Integrin beta nu, a beta-subunit of Drosophila integrin, is involved in the phagocytosis of apoptotic cells and bacteria. Here, we searched for an alpha-subunit that forms a complex and cooperates with beta nu. Examinations of RNAi-treated animals suggested that alpha PS3, but not any of four other alpha-subunits, is required for the effective phagocytosis of apoptotic cells in Drosophila embryos. The mutation of alpha PS3-encoding scb, deficiency, insertion of P-element, or alteration of nucleotide sequences, brought about a reduction in the level of phagocytosis. The defect in phagocytosis by deficiency was reverted by the forced expression of scb. Furthermore, flies in which the expression of both alpha PS3 and beta nu was inhibited by RNAi showed a level of phagocytosis almost equal to that observed in flies with RNAi for either subunit alone. A loss of alpha PS3 also decreased the activity of larval hemocytes in the phagocytosis of Staphylococcus aureus. Finally, a co-immunoprecipitation analysis using a Drosophila cell line treated with a chemical cross-linker suggested a physical association between alpha PS3 and beta nu. These results collectively indicated that integrin alpha PS3/beta nu serves as a receptor in the phagocytosis of apoptotic cells and bacteria by Drosophila phagocytes.	[Nonaka, Saori; Nagaosa, Kaz; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Mori, Toshinobu; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University	Nagaosa, K (corresponding author), Shizenken, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	knagaosa@p.kanazawa-u.ac.jp; nakanaka@p.kanazawa-u.ac.jp	Nagaosa, Kaz/G-3857-2014; Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015; Nonaka, Saori/L-4092-2015	Nagaosa, Kaz/0000-0002-1695-2562; Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409; Nonaka, Saori/0000-0003-2672-3082	Japan Society for the Promotion of Science [22370049, 23570160]; Astellas Foundation for Research on Metabolic Disorders; Danone Foundation; Grants-in-Aid for Scientific Research [22370049] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Danone Foundation(Danone Nutricia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 22370049 (to Y. N.) and 23570160 (to A. S.) from the Japan Society for the Promotion of Science, a grant from Astellas Foundation for Research on Metabolic Disorders (to A. S.), and a grant from the Danone Foundation (to A. S.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; Hsieh HH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002663; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kang YY, 2012, GENE DEV, V26, P1339, DOI 10.1101/gad.187815.112; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Liao J, 2005, MED HYPOTHESES, V65, P23, DOI 10.1016/j.mehy.2005.01.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Okada R, 2012, J BIOL CHEM, V287, P3138, DOI 10.1074/jbc.M111.277921; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shiratsuchi A, 2012, J BIOL CHEM, V287, P21663, DOI 10.1074/jbc.M111.333807; Stark KA, 1997, DEVELOPMENT, V124, P4583; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tsai PI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-26; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; YEE GH, 1993, DEVELOPMENT, V118, P845; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	46	48	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10374	10380		10.1074/jbc.M113.451427	http://dx.doi.org/10.1074/jbc.M113.451427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426364	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000317565000018
J	Wang, DY; Fu, Q; Zhou, Y; Xu, B; Shi, Q; Igwe, B; Matt, L; Hell, JW; Wisely, EV; Oddo, S; Xiang, YK				Wang, Dayong; Fu, Qin; Zhou, Yuan; Xu, Bing; Shi, Qian; Igwe, Benedict; Matt, Lucas; Hell, Johannes W.; Wisely, Elena V.; Oddo, Salvatore; Xiang, Yang K.			beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA; SYNAPSE-LOSS; PHOSPHORYLATION; MICROTUBULE; ACTIVATION; PEPTIDE; BINDING; NEURODEGENERATION; DEGENERATION; DYSFUNCTION	Alzheimer disease (AD) is characterized by neurodegeneration marked by loss of synapses and spines associated with hyperphosphorylation of tau protein. Accumulating amyloid beta peptide (A beta) in brain is linked to neurofibrillary tangles composed of hyperphosphorylated tau in AD. Here, we identify beta(2)-adrenergic receptor (beta(2)AR) that mediates A beta-induced tau pathology. In the prefrontal cortex (PFC) of 1-year-old transgenic mice with human familial mutant genes of presenilin 1 and amyloid precursor protein (PS1/APP), the phosphorylation of tau at Ser-214 Ser-262 and Thr-181, and the protein kinases including JNK, GSK3 alpha/beta, and Ca2+/calmodulin-dependent protein kinase II is increased significantly. Deletion of the beta(2)AR gene in PS1/APP mice greatly decreases the phosphorylation of these proteins. Further analysis reveals that in primary PFC neurons, A beta signals through a beta(2)AR-PKA-JNK pathway, which is responsible for most of the phosphorylation of tau at Ser-214 and Ser-262 and a significant portion of phosphorylation at Thr-181. A beta also induces a beta(2)AR-dependent arrestin-ERK1/2 activity that does not participate in phosphorylation of tau. However, inhibition of the activity of MEK, an upstream enzyme of ERK1/2, partially blocks A beta-induced tau phosphorylation at Thr-181. The density of dendritic spines and synapses is decreased in the deep layer of the PFC of 1-year-old PS1/APP mice, and the mice exhibit impairment of learning and memory in a novel object recognition paradigm. Deletion of the beta(2)AR gene ameliorates pathological effects in these senile PS1/APP mice. The study indicates that beta(2)AR may represent a potential therapeutic target for preventing the development of AD.	[Wang, Dayong; Fu, Qin; Zhou, Yuan; Shi, Qian; Igwe, Benedict; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Sch Mol & Cellular Biol, Urbana, IL 61801 USA; [Fu, Qin; Xu, Bing; Shi, Qian; Matt, Lucas; Hell, Johannes W.; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Fu, Qin] Huazhong Univ Sci & Technol, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Wisely, Elena V.; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis; Huazhong University of Science & Technology; University of Texas System; University of Texas Health San Antonio	Xiang, YK (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	ykxiang@ucdavis.edu	Hell, Johannes W./P-5085-2019; Fu, Qin/O-6960-2014	Igwe, Benedict/0000-0001-6008-6617; Matt, Lucas/0000-0003-3235-5140; Daoud, Elena/0000-0001-8840-5106; Shi, Qian/0000-0003-2634-9553; Wang, Dayong/0000-0002-2086-1663; Oddo, Salvatore/0000-0001-7304-7430; Fu, Qin/0000-0002-7954-7708	Alzheimer's Association; National Alliance for Research on Schizophrenia and Depression (NARSAD); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [F30AG043248] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a new investigator research grant from the Alzheimer's Association (to Y. K. X.) and by The National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award and Alzheimer's Disease Research Fund from the Illinois Department of Public Health (to D. W.).	Bittner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015477; Echeverria V, 2005, NEUROSCIENCE, V135, P1193, DOI 10.1016/j.neuroscience.2005.06.057; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Hall GF, 2000, J CELL SCI, V113, P1373; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Jaworski Tomasz, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/573138; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; JOHNSON GVW, 1992, J NEUROCHEM, V59, P2056; Johnson JD, 2008, BRAIN BEHAV IMMUN, V22, P1078, DOI 10.1016/j.bbi.2008.03.007; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mitsuyama F, 2012, INT J ALZHEIMERS DIS, V2012; Mitsuyama Fuyuki, 2009, Italian Journal of Anatomy and Embryology, V114, P109; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Prapong T, 2001, EXP NEUROL, V167, P59, DOI 10.1006/exnr.2000.7519; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Vogel J, 2009, NEUROPHARMACOLOGY, V57, P539, DOI 10.1016/j.neuropharm.2009.07.021; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Wang DY, 2011, J BIOL CHEM, V286, P31852, DOI 10.1074/jbc.M111.244335; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Yoshimura Y, 2003, NEUROSCI LETT, V353, P185, DOI 10.1016/j.neulet.2003.09.037; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Yu JT, 2011, BRAIN RES BULL, V84, P111, DOI 10.1016/j.brainresbull.2010.11.004; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	35	65	69	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10298	10307		10.1074/jbc.M112.415141	http://dx.doi.org/10.1074/jbc.M112.415141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430246	Green Published, hybrid			2022-12-28	WOS:000317565000011
J	Barua, B; Fagnant, PM; Winkelmann, DA; Trybus, KM; Hitchcock-DeGregori, SE				Barua, Bipasha; Fagnant, Patricia M.; Winkelmann, Donald A.; Trybus, Kathleen M.; Hitchcock-DeGregori, Sarah E.			A Periodic Pattern of Evolutionarily Conserved Basic and Acidic Residues Constitutes the Binding Interface of Actin-Tropomyosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-BRIDGE KINETICS; ALPHA-TROPOMYOSIN; COILED-COIL; F-ACTIN; ISOMETRIC TENSION; ATOMIC MODEL; FLEXIBILITY; MUTATIONS; SITES; GENE	Actin filament cytoskeletal and muscle functions are regulated by actin binding proteins using a variety of mechanisms. A universal actin filament regulator is the protein tropomyosin, which binds end-to-end along the length of the filament. The actin-tropomyosin filament structure is unknown, but there are atomic models in different regulatory states based on electron microscopy reconstructions, computational modeling of actin-tropomyosin, and docking of atomic resolution structures of tropomyosin to actin filament models. Here, we have tested models of the actin-tropomyosin interface in the "closed state" where tropomyosin binds to actin in the absence of myosin or troponin. Using mutagenesis coupled with functional analyses, we determined residues of actin and tropomyosin required for complex formation. The sites of mutations in tropomyosin were based on an evolutionary analysis and revealed a pattern of basic and acidic residues in the first halves of the periodic repeats (periods) in tropomyosin. In periods P1, P4, and P6, basic residues are most important for actin affinity, in contrast to periods P2, P3, P5, and P7, where both basic and acidic residues or predominantly acidic residues contribute to actin affinity. Hydrophobic interactions were found to be relatively less important for actin binding. We mutated actin residues in subdomains 1 and 3 (Asp(25)-Glu(334)-Lys(326)-Lys(328)) that are poised to make electrostatic interactions with the residues in the repeating motif on tropomyosin in the models. Tropomyosin failed to bind mutant actin filaments. Our mutagenesis studies provide the first experimental support for the atomic models of the actin-tropomyosin interface.	[Barua, Bipasha; Hitchcock-DeGregori, Sarah E.] Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Barua, Bipasha; Winkelmann, Donald A.; Hitchcock-DeGregori, Sarah E.] Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Fagnant, Patricia M.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Vermont	Barua, B (corresponding author), Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	baruabi@umdnj.edu			National Institutes of Health [GM093065, HL110869]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM093065 (to S. E. H.-D.) and HL110869 (to K. M. T.).	Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109; Barua B, 2011, P NATL ACAD SCI USA, V108, P10150, DOI 10.1073/pnas.1101221108; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BOURDIEU L, 1995, PHYS REV E, V52, P6573, DOI 10.1103/PhysRevE.52.6573; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Frieden C, 2000, BIOCHEM BIOPH RES CO, V271, P464, DOI 10.1006/bbrc.2000.2650; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; HITCHCOCKDEGREGORI SE, 1982, J BIOL CHEM, V257, P2573; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Kawai M, 2009, J BIOPHYS, V2009; Kee AJ, 2008, ADV EXP MED BIOL, V644, P143; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Lu XY, 2006, BIOPHYS J, V91, P4230, DOI 10.1529/biophysj.106.084608; Lu XY, 2003, J PHYSIOL-LONDON, V553, P457, DOI 10.1113/jphysiol.2003.053694; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; Miki M, 2011, J MOL BIOL, V414, P765, DOI 10.1016/j.jmb.2011.10.033; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Noguchi TQP, 2010, J BIOL CHEM, V285, P4337, DOI 10.1074/jbc.M109.059881; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS GN, 1986, J MOL BIOL, V192, P128, DOI 10.1016/0022-2836(86)90469-9; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Singh A, 2007, BIOCHEMISTRY-US, V46, P14917, DOI 10.1021/bi701570b; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006336; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; WATERSTON RH, 1984, J MOL BIOL, V180, P473, DOI 10.1016/0022-2836(84)90023-8; WERTMAN KF, 1992, GENETICS, V132, P337; Whitby FG, 2000, PROTEINS, V38, P49; Wieczorek DF, 2008, ADV EXP MED BIOL, V644, P132; WINKELMANN DA, 1995, BIOPHYS J, V68, P2444, DOI 10.1016/S0006-3495(95)80426-1	49	42	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9602	9609		10.1074/jbc.M113.451161	http://dx.doi.org/10.1074/jbc.M113.451161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420843	hybrid, Green Published			2022-12-28	WOS:000317114000004
J	Ranoa, DRE; Kelley, SL; Tapping, RI				Ranoa, Diana Rose E.; Kelley, Stacy L.; Tapping, Richard I.			Human Lipopolysaccharide-binding Protein (LBP) and CD14 Independently Deliver Triacylated Lipoproteins to Toll-like Receptor 1 (TLR1) and TLR2 and Enhance Formation of the Ternary Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI LIPOPROTEINS; ACTIVATES IMMUNE CELLS; GRAM-NEGATIVE BACTERIA; TREPONEMA-PALLIDUM; CRYSTAL-STRUCTURE; SOLUBLE CD14; STAPHYLOCOCCUS-AUREUS; CD14-DEFICIENT MICE; PATTERN-RECOGNITION; TLR4-MD-2 COMPLEX	Bacterial lipoproteins are the most potent microbial agonists for the Toll-like receptor 2 (TLR2) subfamily, and this pattern recognition event induces cellular activation, leading to host immune responses. Triacylated bacterial lipoproteins coordinately bind TLR1 and TLR2, resulting in a stable ternary complex that drives intracellular signaling. The sensitivity of TLR-expressing cells to lipoproteins is greatly enhanced by two lipid-binding serum proteins known as lipopolysaccharide-binding protein (LBP) and soluble CD14 (sCD14); however, the physical mechanism that underlies this increased sensitivity is not known. To address this, we measured the ability of LBP and sCD14 to drive ternary complex formation between soluble extracellular domains of TLR1 and TLR2 and a synthetic triacylated lipopeptide agonist. Importantly, addition of substoichiometric amounts of either LBP or sCD14 significantly enhanced formation of a TLR1.TLR2 lipopeptide ternary complex as measured by size exclusion chromatography. However, neither LBP nor sCD14 was physically associated with the final ternary complex. Similar results were obtained using outer surface proteinA(OspA), a naturally occurring triacylated lipoprotein agonist from Borrelia burgdorferi. Activation studies revealed that either LBP or sCD14 sensitized TLR-expressing cells to nanogram levels of either the synthetic lipopeptide or OspA lipoprotein agonist. Together, our results show that either LBP or sCD14 can drive ternary complex formation and TLR activation by acting as mobile carriers of triacylated lipopeptides or lipoproteins.	[Ranoa, Diana Rose E.; Tapping, Richard I.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Kelley, Stacy L.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tapping, Richard I.] Univ Illinois, Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tapping, RI (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab CLSL B103, MC 110,601 S Goodwin Ave, Urbana, IL 61801 USA.	tapping@illinois.edu			National Institutes of Health from the NIAID [R01 AI052344]; University of Illinois Department of Microbiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Illinois Department of Microbiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI052344 (to R. I. T.) from the NIAID. This work was also supported by the University of Illinois Department of Microbiology.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BRANDT ME, 1990, INFECT IMMUN, V58, P983, DOI 10.1128/IAI.58.4.983-991.1990; Branger J, 2005, CLIN IMMUNOL, V116, P174, DOI 10.1016/j.clim.2005.03.014; Branger J, 2004, INT IMMUNOL, V16, P1605, DOI 10.1093/intimm/dxh161; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Ehlers S, 2001, IMMUNOLOGY, V103, P113, DOI 10.1046/j.1365-2567.2001.01214.x; Elass E, 2007, FEBS LETT, V581, P1383, DOI 10.1016/j.febslet.2007.02.056; Erdile LF, 1997, VACCINE, V15, P988, DOI 10.1016/S0264-410X(96)00295-2; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Fan XL, 1999, INFECT IMMUN, V67, P2964, DOI 10.1128/IAI.67.6.2964-2968.1999; Fierer J, 2002, J IMMUNOL, V168, P6396, DOI 10.4049/jimmunol.168.12.6396; FROON AHM, 1995, J INFECT DIS, V171, P1250, DOI 10.1093/infdis/171.5.1250; Funda DP, 2001, INFECT IMMUN, V69, P3772, DOI 10.1128/IAI.69.6.3772-3781.2001; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; HAZIOT A, 1988, J IMMUNOL, V141, P547; Haziot A, 1999, J IMMUNOL, V162, P4801; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; HOFFMANN P, 1988, IMMUNOBIOLOGY, V177, P158, DOI 10.1016/S0171-2985(88)80036-6; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kelley SL, 2013, J IMMUNOL, V190, P1304, DOI 10.4049/jimmunol.1202446; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Knapp S, 2003, INFECT IMMUN, V71, P6747, DOI 10.1128/IAI.71.12.6747-6753.2003; KRUGER C, 1991, CLIN EXP IMMUNOL, V85, P297; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Morrison TB, 1997, J IMMUNOL, V158, P4838; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Piazza M, 2010, BIOCHEM PHARMACOL, V80, P2050, DOI 10.1016/j.bcp.2010.06.019; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schimke J, 1998, P NATL ACAD SCI USA, V95, P13875, DOI 10.1073/pnas.95.23.13875; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Sellati TJ, 1999, J IMMUNOL, V163, P2049; Sellati TJ, 1998, J IMMUNOL, V160, P5455; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Vasselon T, 2004, J IMMUNOL, V173, P7401, DOI 10.4049/jimmunol.173.12.7401; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; WEIS JJ, 1994, INFECT IMMUN, V62, P4632, DOI 10.1128/IAI.62.10.4632-4636.1994; Wooten RM, 1998, J IMMUNOL, V160, P5485; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	71	76	80	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9729	9741		10.1074/jbc.M113.453266	http://dx.doi.org/10.1074/jbc.M113.453266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430250	Green Published, hybrid			2022-12-28	WOS:000317114000015
J	Liu, SJ; Qian, Y; Li, L; Wei, GG; Guan, YT; Pan, HJ; Guan, X; Zhang, L; Lu, XL; Zhao, YX; Liu, MY; Li, DL				Liu, Shijie; Qian, Yu; Li, Liang; Wei, Gaigai; Guan, Yuting; Pan, Hongjie; Guan, Xin; Zhang, Long; Lu, Xiaoling; Zhao, Yongxiang; Liu, Mingyao; Li, Dali			Lgr4 Gene Deficiency Increases Susceptibility and Severity of Dextran Sodium Sulfate-induced Inflammatory Bowel Disease in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL STEM-CELL; COUPLED RECEPTOR 48; MALE REPRODUCTIVE-TRACT; PANETH CELLS; WNT/BETA-CATENIN; EPITHELIAL STEM; DOWN-REGULATION; HOMEOSTASIS; EXPRESSION; CANCER	Lgr4/Gpr48 is one of the newly identified R-spondins receptors and potentiates Wnt signaling, which regulates intestinal homeostasis. We used a hypomorphic mouse strain to determine the role of Lgr4 in intestinal inflammation and recovery. Intestinal inflammation was induced with dextran sulfate sodium (DSS) followed by a recovery period. Intestinal inflammation symptoms and molecular mechanisms were examined. We found that Lgr4(-/-) mice exhibited dramatically higher susceptibility to and mortality from DSS-induced inflammatory bowel disease than WT mice. Lgr4 deficiency resulted in greatly reduced numbers of either Paneth cells or stem cells in the intestine. During the intestinal regeneration process, cell proliferation but not apoptosis of intestinal epithelial cells was significantly impaired in Lgr4(-/-) mice. When Wnt/beta-catenin signaling was reactivated by crossing with APC(min/+) mice or by treating with a GSK-3 beta inhibitor, the number of Paneth cells was partially restored and the mortality caused by DSS-induced inflammatory bowel disease was strikingly reduced in Lgr4-deficient animals. Thus, Lgr4 is critically involved in the maintenance of intestinal homeostasis and protection against inflammatory bowel disease through modulation of the Wnt/beta-catenin signaling pathway.	[Liu, Shijie; Qian, Yu; Li, Liang; Wei, Gaigai; Guan, Yuting; Pan, Hongjie; Guan, Xin; Zhang, Long; Liu, Mingyao; Li, Dali] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Liu, Shijie; Qian, Yu; Li, Liang; Wei, Gaigai; Guan, Yuting; Pan, Hongjie; Guan, Xin; Zhang, Long; Liu, Mingyao; Li, Dali] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Lu, Xiaoling; Zhao, Yongxiang] Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, Nanning 530021, Guangxi, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	East China Normal University; East China Normal University; Guangxi Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Liu, MY (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China.	myliu@bio.ecnu.edu.cn; dlli@bio.ecnu.edu.cn	lu, xl/HDO-8340-2022	Liu, Mingyao/0000-0001-7339-5048; Li, Dali/0000-0002-0046-8493; Guan, Yuting/0000-0003-1866-270X	State Key Development Programs of China [2012CB910400, 2010CB945403]; National Natural Science Foundation of China [31171318, 30930055]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	State Key Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was partially supported by grants from the State Key Development Programs of China (Grants 2012CB910400 and 2010CB945403), the National Natural Science Foundation of China (Grants 31171318 and 30930055), and the Science and Technology Commission of Shanghai Municipality (Grant 11DZ2260300).	Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang DH, 2011, P NATL ACAD SCI USA, V108, P10272, DOI 10.1073/pnas.1017668108; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	43	37	39	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8794	8803		10.1074/jbc.M112.436204	http://dx.doi.org/10.1074/jbc.M112.436204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393138	Green Published, hybrid			2022-12-28	WOS:000316862200002
J	Sanbe, A; Marunouchi, T; Abe, T; Tezuka, Y; Okada, M; Aoki, S; Tsumura, H; Yamauchi, J; Tanonaka, K; Nishigori, H; Tanoue, A				Sanbe, Atsushi; Marunouchi, Tetsuro; Abe, Tsutomu; Tezuka, Yu; Okada, Mizuki; Aoki, Sayuri; Tsumura, Hideki; Yamauchi, Junji; Tanonaka, Kouichi; Nishigori, Hideo; Tanoue, Akito			Phenotype of Cardiomyopathy in Cardiac-specific Heat Shock Protein B8 K141N Transgenic Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESMIN-RELATED CARDIOMYOPATHY; MARIE-TOOTH DISEASE; CRYSTALLIN; ASSOCIATION; MODEL; PRESERVATION; PATHOGENESIS; DYSFUNCTION; INHIBITORS; INTEGRITY	A K141N missense mutation in heat shock protein (HSP) B8, which belongs to the small HSP family, causes distal hereditary motor neuropathy, which is characterized by the formation of inclusion bodies in cells. Although the HSPB8 gene causes hereditary motor neuropathy, obvious expression of HSPB8 is also observed in other tissues, such as the heart. The effects of a single mutation in HSPB8 upon the heart were analyzed using rat neonatal cardiomyocytes. Expression of HSPB8 K141N by adenoviral infection resulted in increased HSPB8-positive aggregates around nuclei, whereas no aggregates were observed in myocytes expressing wild-type HSPB8. HSPB8-positive aggresomes contained amyloid oligomer intermediates that were detected by a specific anti-oligomer antibody (A11). Expression of HSPB8 K141N induced slight cellular toxicity. Recombinant HSPB8 K141N protein showed reactivity against the anti-oligomer antibody, and reactivity of the mutant HSPB8 protein was much higher than that of wild-type HSPB8 protein. To extend our in vitro study, cardiac-specific HSPB8 K141N transgenic (TG) mice were generated. Echocardiography revealed that the HSPB8 K141N TG mice exhibited mild hypertrophy and apical fibrosis as well as slightly reduced cardiac function, although no phenotype was detected in wild-type HSPB8 TG mice. A single point mutation of HSPB8, such as K141N, can cause cardiac disease.	[Sanbe, Atsushi; Tezuka, Yu; Okada, Mizuki; Aoki, Sayuri; Nishigori, Hideo] Iwate Med Univ, Dept Pharmacotherapeut, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Sanbe, Atsushi; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo 1578535, Japan; [Marunouchi, Tetsuro; Abe, Tsutomu; Tanonaka, Kouichi] Tokyo Univ Pharm & Life Sci, Dept Pharmacol, Tokyo 1920392, Japan; [Tsumura, Hideki] Natl Res Inst Child Hlth & Dev, Div Lab Anim Resources, Tokyo 1578535, Japan	Iwate Medical University; National Center for Child Health & Development - Japan; Tokyo University of Pharmacy & Life Sciences; National Center for Child Health & Development - Japan	Sanbe, A (corresponding author), Iwate Med Univ, Dept Pharmacotherapeut, Sch Pharm, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan.	asanbe@iwate-med.ac.jp			Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare; Japan Health Sciences Foundation; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Pharma Research Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Pharma Research Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	This work was supported in part by research grants from the Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour and Welfare, the Japan Health Sciences Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Mitsubishi Pharma Research Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Suzuken Memorial Foundation.	BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lee JS, 1998, BIOCHEM BIOPH RES CO, V244, P379, DOI 10.1006/bbrc.1998.8272; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Motegi K, 2007, BRIT J PHARMACOL, V151, P963, DOI 10.1038/sj.bjp.0707321; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Sanbe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018922; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016	31	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8910	8921		10.1074/jbc.M112.368324	http://dx.doi.org/10.1074/jbc.M112.368324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389032	Green Published, hybrid			2022-12-28	WOS:000316862200012
J	Arshad, M; Ye, ZD; Gu, XF; Wong, CK; Liu, Y; Li, D; Zhou, LK; Zhang, Y; Bay, WP; Yu, VC; Li, P				Arshad, Muhammad; Ye, Zhongde; Gu, Xiaofeng; Wong, Chung Kai; Liu, Yang; Li, De; Zhou, Linkang; Zhang, Yi; Bay, Wan Ping; Yu, Victor C.; Li, Peng			RNF13, a RING Finger Protein, Mediates Endoplasmic Reticulum Stress-induced Apoptosis through the Inositol-requiring Enzyme (IRE1 alpha)/c-Jun NH2-terminal Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER; ACTIVATION; JNK; TRANSLOCATION; DEATH; STEP; BIM	Disturbance of homeostasis at endoplasmic reticulum (ER) causes stress to cells that in turn triggers an adaptive signaling pathway termed unfolded protein response for the purpose of restoring normal cellular physiology or initiating signaling events leading to apoptosis. Identification of those genes that are involved in the unfolded protein response-mediated apoptotic signaling pathway would be valuable toward elucidating the molecular mechanism underlying the relationship between ER stress and apoptosis. We initiated a genetic screen by using the retroviral insertion mutation system to search for genes whose inactivation confers resistance to apoptosis induction by staurosporine. Using this approach, RING finger protein 13 (RNF13) was identified. Interestingly, RNF13 is highly enriched in ER. RNF13 knockdown cells are resistant to apoptosis and JNK activation triggered by ER stress. Conversely, overexpression of RNF13 induces JNK activation and caspase-dependent apoptosis. The RING and transmembrane domains of RNF13 are both required for its effects on JNK activation and apoptosis. Moreover, systematic analysis of the involvement of individual signaling components in the ER stress pathway using knockdown approach reveals that RNF13 acts upstream of the IRE1 alpha-TRAF2 signaling axis for JNK activation and apoptosis. Finally, RNF13 co-immunoprecipitates with IRE1 alpha, and the intact RING domain is also required for mediating its interaction. Together, our data support a model that RNF13 is a critical mediator for facilitating ER stress-induced apoptosis through the activation of the IRE1 alpha-TRAF2-JNK signaling pathway.	[Arshad, Muhammad; Ye, Zhongde; Gu, Xiaofeng; Liu, Yang; Zhou, Linkang; Li, Peng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Wong, Chung Kai] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong 100044, Hong Kong, Peoples R China; [Li, De] Tsinghua Univ, Ctr Biomed Anal, Beijing 100084, Peoples R China; [Zhang, Yi] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Bay, Wan Ping; Yu, Victor C.] Natl Univ Singapore, Dept Pharm, Singapore 119077, Singapore; [Arshad, Muhammad] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad 44000, Pakistan	Tsinghua University; Hong Kong University of Science & Technology; Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; International Islamic University, Pakistan	Li, P (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	li-peng@mail.tsinghua.edu.cn	Yu, Victor/A-7899-2015; Zhou, Linkang/AAH-9911-2020; Zhou, Linkang/C-8812-2015	Yu, Victor/0000-0003-3270-4734; Zhou, Linkang/0000-0002-7009-5776; Zhang, Yi/0000-0003-2785-1780; LIU, Yang/0000-0002-4428-3562	National Natural Science Foundation of China [30670418]; National High Technology Research and Development Program from the Ministry of Science and Technology of China [2010AA023002]; Singapore Ministry of Health National Medical Research Council [NMRC/1317/2011]; National University of Singapore [R148-000-121-133]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA023002] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Natural Science Foundation of China Grant 30670418 (to P. L.) and National High Technology Research and Development Program Grant 2010AA023002 from the Ministry of Science and Technology of China.; Supported by grants from Singapore Ministry of Health National Medical Research Council under its Individual Research Grant (NMRC/1317/2011) and National University of Singapore (R148-000-121-133). A Minjiang Scholar Chair Professor at School of Life Sciences, Xiamen University, China.	Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Hoeflich KP, 1999, ONCOGENE, V18, P5814, DOI 10.1038/sj.onc.1202975; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li JQ, 2004, J CELL SCI, V117, P4673, DOI 10.1242/jcs.01339; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Plonne D, 1999, ANAL BIOCHEM, V276, P88, DOI 10.1006/abio.1999.4311; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito S, 2005, PHYSIOL GENOMICS, V22, P8, DOI 10.1152/physiolgenomics.00142.2004; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tranque P, 1996, P NATL ACAD SCI USA, V93, P3105, DOI 10.1073/pnas.93.7.3105; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang Q, 2010, FEBS J, V277, P466, DOI 10.1111/j.1742-4658.2009.07498.x; Zhang Q, 2009, CELL RES, V19, P348, DOI 10.1038/cr.2008.285	28	34	36	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8726	8736		10.1074/jbc.M112.368829	http://dx.doi.org/10.1074/jbc.M112.368829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378536	Green Published, hybrid			2022-12-28	WOS:000316564500072
J	Corbett, GT; Roy, A; Pahan, K				Corbett, Grant T.; Roy, Avik; Pahan, Kalipada			Sodium Phenylbutyrate Enhances Astrocytic Neurotrophin Synthesis via Protein Kinase C (PKC)-mediated Activation of cAMP-response Element-binding Protein (CREB) IMPLICATIONS FOR ALZHEIMER DISEASE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-LOWERING DRUG; PHASE-I; BRAIN; BDNF; EXPRESSION; FAMILY; PHENYLACETATE; TRANSCRIPTION; GEMFIBROZIL; MULTIPLE	Neurotrophins, such as brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), are believed to be genuine molecular mediators of neuronal growth and homeostatic synapse activity. However, levels of these neurotrophic factors decrease in different brain regions of patients with Alzheimer disease (AD). Induction of astrocytic neurotrophin synthesis is a poorly understood phenomenon but represents a plausible therapeutic target because neuronal neurotrophin production is aberrant in AD and other neurodegenerative diseases. Here, we delineate that sodium phenylbutyrate (NaPB), a Food and Drug Administration-approved oral medication for hyperammonemia, induces astrocytic BDNF and NT-3 expression via the protein kinase C (PKC)-cAMP-response element-binding protein (CREB) pathway. NaPB treatment increased the direct association between PKC and CREB followed by phosphorylation of CREB (Ser(133)) and induction of DNA binding and transcriptional activation of CREB. Up-regulation of markers for synaptic function and plasticity in cultured hippocampal neurons by NaPB-treated astroglial supernatants and its abrogation by anti-TrkB blocking antibody suggest that NaPB-induced astroglial neurotrophins are functionally active. Moreover, oral administration of NaPB increased the levels of BDNF and NT-3 in the CNS and improved spatial learning and memory in a mouse model of AD. Our results highlight a novel neurotrophic property of NaPB that may be used to augment neurotrophins in the CNS and improve synaptic function in disease states such as AD.	[Corbett, Grant T.] Rush Univ, Med Ctr, Dept Neurol Sci, Grad Program Neurosci, Chicago, IL 60612 USA; [Corbett, Grant T.; Roy, Avik; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University; Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		Corbett, Grant/0000-0003-3606-9686	National Institutes of Health [AT6681, NS64564, NS71479]; NIA, National Institutes of Health [T32 AG00269]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064564, R21NS071479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000269, P01AG014449, R01AG043375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681, NS64564, and NS71479.; Supported by NIA, National Institutes of Health, Grant T32 AG00269.	Balkowiec A, 2002, J NEUROSCI, V22, P10399; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Carducci MA, 2001, CLIN CANCER RES, V7, P3047; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; El-Hussein AE, 2000, SCIENCE, V290, P1364; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; GALL CM, 1992, TRENDS PHARMACOL SCI, V13, P401, DOI 10.1016/0165-6147(92)90123-N; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu B, 1997, REV NEUROSCIENCE, V8, P1; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; MATSUMOTO K, 1995, CANCER RES, V55, P1798; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pardridge WM, 2006, CURR OPIN PHARMACOL, V6, P494, DOI 10.1016/j.coph.2006.06.001; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THIBAULT A, 1994, CANCER RES, V54, P1690; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; ZAFRA F, 1992, J NEUROSCI, V12, P4793	59	44	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8299	8312		10.1074/jbc.M112.426536	http://dx.doi.org/10.1074/jbc.M112.426536			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23404502	Green Published, hybrid			2022-12-28	WOS:000316564500030
J	Rowat, AC; Jaalouk, DE; Zwerger, M; Ung, WL; Eydelnant, IA; Olins, DE; Olins, AL; Herrmann, H; Weitz, DA; Lammerding, J				Rowat, Amy C.; Jaalouk, Diana E.; Zwerger, Monika; Ung, W. Lloyd; Eydelnant, Irwin A.; Olins, Don E.; Olins, Ada L.; Herrmann, Harald; Weitz, David A.; Lammerding, Jan			Nuclear Envelope Composition Determines the Ability of Neutrophil-type Cells to Passage through Micron-scale Constrictions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASSIVE MECHANICAL-BEHAVIOR; LAMIN-A; DIFFERENTIATION; HL-60; MIGRATION; LEUKOCYTES; CHROMATIN; RETENTION; LINE; SEQUESTRATION	Neutrophils are characterized by their distinct nuclear shape, which is thought to facilitate the transit of these cells through pore spaces less than one-fifth of their diameter. We used human promyelocytic leukemia (HL-60) cells as a model system to investigate the effect of nuclear shape in whole cell deformability. We probed neutrophil-differentiated HL-60 cells lacking expression of lamin B receptor, which fail to develop lobulated nuclei during granulopoiesis and present an in vitro model for Pelger-Huet anomaly; despite the circular morphology of their nuclei, the cells passed through micron-scale constrictions on similar timescales as scrambled controls. We then investigated the unique nuclear envelope composition of neutrophil-differentiated HL-60 cells, which may also impact their deformability; although lamin A is typically down-regulated during granulopoiesis, we genetically modified HL-60 cells to generate a subpopulation of cells with well defined levels of ectopic lamin A. The lamin A-overexpressing neutrophil-type cells showed similar functional characteristics as the mock controls, but they had an impaired ability to pass through micron-scale constrictions. Our results suggest that levels of lamin A have a marked effect on the ability of neutrophils to passage through micron-scale constrictions, whereas the unusual multilobed shape of the neutrophil nucleus is less essential.	[Rowat, Amy C.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Rowat, Amy C.; Jaalouk, Diana E.; Zwerger, Monika; Lammerding, Jan] Harvard Univ, Dept Med, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02139 USA; [Rowat, Amy C.; Ung, W. Lloyd; Eydelnant, Irwin A.; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rowat, Amy C.; Ung, W. Lloyd; Eydelnant, Irwin A.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Olins, Don E.; Olins, Ada L.] Univ New England, Dept Pharmaceut Sci, Coll Pharm, Portland, ME 04103 USA; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Lammerding, Jan] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Biomed Engn, Ithaca, NY 14853 USA	University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; University of New England - Maine; Helmholtz Association; German Cancer Research Center (DKFZ); Cornell University	Rowat, AC (corresponding author), Dept Integrat Biol & Physiol, Terasaki Life Sci Bldg 1125,610 Charles E Young D, Los Angeles, CA 90095 USA.	rowat@ucla.edu	Lammerding, Jan/A-9498-2016	Lammerding, Jan/0000-0003-4335-8611; Ung, Warren/0000-0003-3352-9974	Cross-Disciplinary Fellowship of the International Human Frontiers Science Program (HFSP); National Institutes of Health [R01 NS059348, R01 HL082792, CA-16042, AI-28697]; Department of Defense [BC102152]; Natural Sciences and Engineering Research Council of Canada (NSERC); American Heart Association (AHA) [09POST2320042]; HFSP [RGP0004/2005-C102]; National Science Foundation (NSF) [DMR-1006546, DBI-649865]; Harvard Materials Research Science and Engineering Center (MRSEC) [DMR-0820484]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; UCLA Chancellor's Office; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER	Cross-Disciplinary Fellowship of the International Human Frontiers Science Program (HFSP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Heart Association (AHA)(American Heart Association); HFSP(Human Frontier Science Program); National Science Foundation (NSF)(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); UCLA Chancellor's Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Cross-Disciplinary Fellowship of the International Human Frontiers Science Program (HFSP) (to A. C. R.) and National Institutes of Health Grants R01 NS059348 and R01 HL082792 and Department of Defense Breast Cancer Idea Award BC102152 (to J. L.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (to W. L. U. and I. A. E.), an American Heart Association fellowship (AHA Award 09POST2320042) (to D. E. J.), and HFSP Grant RGP0004/2005-C102, National Science Foundation (NSF) Contracts DMR-1006546 and DBI-649865, and Harvard Materials Research Science and Engineering Center (MRSEC) Contract DMR-0820484.; We acknowledge the Center for Nanoscale Systems, Harvard University, for access to the profilometer and Bino Varghese for advice on data analysis protocols. Cell sorting was performed by Brian Tilton, Bauer Center at Harvard University, and Jeff Calimlim in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility. The UCLA JCCC and Center for AIDS Research Flow Cytometry Core Facility are supported by National Institutes of Health Awards CA-16042 and AI-28697 and by the JCCC, the UCLA AIDS Institute, the David Geffen School of Medicine at UCLA, and the UCLA Chancellor's Office.	Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bathe M, 2002, BIOPHYS J, V83, P1917, DOI 10.1016/S0006-3495(02)73955-6; Batrakou D. G., 2012, SEMIN CANC IN PRESS; Berliner N., 2005, CURRENT PROTOCOLS IM; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Campbell MS, 1995, J LEUKOCYTE BIOL, V58, P659, DOI 10.1002/jlb.58.6.659; CANO ML, 1991, J CELL BIOL, V115, P677, DOI 10.1083/jcb.115.3.677; COLLINS SJ, 1987, BLOOD, V70, P1233; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; DOWNEY GP, 1990, J APPL PHYSIOL, V69, P1767, DOI 10.1152/jappl.1990.69.5.1767; DOWNEY GP, 1993, AM REV RESPIR DIS, V147, P168, DOI 10.1164/ajrccm/147.1.168; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Ekpenyong AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045237; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; ERZURUM SC, 1991, AM J RESP CELL MOL, V5, P230, DOI 10.1165/ajrcmb/5.3.230; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Fleck RA, 2003, IN VITRO CELL DEV-AN, V39, P235; Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j; Gaines P, 2008, EXP HEMATOL, V36, P965, DOI 10.1016/j.exphem.2008.04.006; GALLAGHER R, 1979, BLOOD, V54, P713; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gonzalez AL, 2007, J LEUKOCYTE BIOL, V81, P686, DOI 10.1189/jlb.0906553; HIRSCH JG, 1959, BACTERIOL REV, V23, P48, DOI 10.1128/MMBR.23.2.48-60.1959; Jaalouk DE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-97; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lautenschlager F, 2009, P NATL ACAD SCI USA, V106, P15696, DOI 10.1073/pnas.0811261106; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; MATSUMOTO T, 1984, ACTA HAEMATOL-BASEL, V72, P264, DOI 10.1159/000206399; MEYER PA, 1990, ENVIRON HEALTH PERSP, V88, P179, DOI 10.2307/3431071; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Olins AL, 2000, EXP CELL RES, V254, P130, DOI 10.1006/excr.1999.4727; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; Olins AL, 1998, EXP CELL RES, V245, P91, DOI 10.1006/excr.1998.4210; Olins AL, 2010, NUCLEUS, V1, P1, DOI DOI 10.4161/NUCL.1.6.13271; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; PARK BH, 1977, P SOC EXP BIOL MED, V155, P51; REPO H, 1979, CLIN EXP IMMUNOL, V36, P326; Rosenbluth MJ, 2008, LAB CHIP, V8, P1062, DOI 10.1039/b802931h; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; Spitzer D, 2006, J IMMUNOL, V177, P4953, DOI 10.4049/jimmunol.177.8.4953; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; TINGBEALL HP, 1995, ANN BIOMED ENG, V23, P666, DOI 10.1007/BF02584463; TSAI MA, 1994, BIOPHYS J, V66, P2166, DOI 10.1016/S0006-3495(94)81012-4; Tsai MA, 1998, BIOPHYS J, V74, P3282, DOI 10.1016/S0006-3495(98)78035-X; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	48	202	203	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8610	8618		10.1074/jbc.M112.441535	http://dx.doi.org/10.1074/jbc.M112.441535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23355469	Green Published, hybrid			2022-12-28	WOS:000316564500061
J	Nayak, MK; Kulkarni, PP; Dash, D				Nayak, Manasa K.; Kulkarni, Paresh P.; Dash, Debabrata			Regulatory Role of Proteasome in Determination of Platelet Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; KAPPA-B; APOPTOSIS; DEGRADATION; SURVIVAL; RECEPTOR; BETA; BAX; MECHANISMS; SENESCENCE	Limit of platelet life span (8-10 days) is determined by the activity of a putative "internal clock" composed of Bcl-2 family proteins, whereas the role of other molecular players in this process remains obscure. Here, we sought to establish a central role of proteasome in platelet life span regulation. Administration of mice with inhibitors of proteasome peptidase activity induced significant thrombocytopenia. This was associated with enhanced clearance of biotin-labeled platelets from circulation and reduction in average platelet half-life from 66 to 37 h. Cells pretreated in vitro with proteasome inhibitors exhibited augmented annexin V binding and a drop in mitochondrial transmembrane potential indicative of apoptotic cell death and decreased platelet life span. These cells were preferentially phagocytosed by monocyte-derived macrophages, thus linking proteasome activity with platelet survival. The decisive role of proteasome in this process was underscored from enhanced expression of conformationally active Bax in platelets with attenuated proteasome activity, which was consistent with proapoptotic phenotype of these cells. The present study establishes a critical role of proteasome in delimiting platelet life span ostensibly through constitutive elimination of the conformationally active Bax. These findings bear potential implications in clinical settings where proteasome peptidase activities are therapeutically targeted.	[Nayak, Manasa K.; Kulkarni, Paresh P.; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Dash, D (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	ddass@satyam.net.in	Kulkarni, Paresh P/AAB-3190-2019; Nayak, Manasa/AAZ-9439-2021; DASH, DEBABRATA/AAF-1837-2020; Dash, Debabrata/F-3774-2014	Kulkarni, Paresh P/0000-0002-9108-0485; Nayak, Manasa/0000-0001-6461-0543	Council of Scientific and Industrial Research; Department of Biotechnology; Department of Science and Technology, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by grants from the Council of Scientific and Industrial Research, the Department of Biotechnology, and the Department of Science and Technology, Government of India (all to D. D.).	Avcu F, 2008, THROMB RES, V121, P567, DOI 10.1016/j.thromres.2007.06.013; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dowling MR, 2010, BLOOD, V116, P1776, DOI 10.1182/blood-2009-12-259663; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Falcieri E, 2000, ANAT RECORD, V258, P90, DOI 10.1002/(SICI)1097-0185(20000101)258:1<90::AID-AR10>3.0.CO;2-G; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Gaczynska M, 2001, MECH AGEING DEV, V122, P235, DOI 10.1016/S0047-6374(00)00246-3; HARKER LA, 1977, CLIN HAEMATOL, V6, P671; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Ji LL, 2008, TOXICOL APPL PHARM, V231, P393, DOI 10.1016/j.taap.2008.05.015; Kodama T, 2011, J BIOL CHEM, V286, P13905, DOI 10.1074/jbc.M110.195370; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Lopez JJ, 2007, J THROMB HAEMOST, V5, P1283, DOI 10.1111/j.1538-7836.2007.02505.x; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; MURPHY EA, 1971, THROMB DIATH HAEMOST, V26, P431, DOI 10.1055/s-0038-1653696; MURPHY EA, 1971, THROMB DIATH HAEMOST, V25, P53, DOI 10.1055/s-0038-1654280; MUSTARD JF, 1966, BRIT J HAEMATOL, V12, P1, DOI 10.1111/j.1365-2141.1966.tb00121.x; Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178; Nayak MK, 2011, CELL CALCIUM, V49, P226, DOI 10.1016/j.ceca.2011.02.005; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ostrowska JK, 2004, THROMB HAEMOSTASIS, V92, P171, DOI 10.1160/TH03-11-0707; Pereira J, 1999, THROMB HAEMOSTASIS, V82, P1318; Perfettini JL, 2002, INFECT IMMUN, V70, P55, DOI 10.1128/IAI.70.1.55-61.2002; Richardson JL, 2005, BLOOD, V106, P4066, DOI 10.1182/blood-2005-06-2206; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Varshavsky A, 1989, Biotechnology, V13, P109; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Wadhawan V, 2004, ARCH BIOCHEM BIOPHYS, V422, P183, DOI 10.1016/j.abb.2003.12.024; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; YUKAWA M, 1993, J BIOCHEM-TOKYO, V114, P317, DOI 10.1093/oxfordjournals.jbchem.a124174; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhang WL, 2012, THROMB RES, V130, P81, DOI 10.1016/j.thromres.2012.02.013	44	37	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6826	6834		10.1074/jbc.M112.403154	http://dx.doi.org/10.1074/jbc.M112.403154			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329846	hybrid, Green Published			2022-12-28	WOS:000316002400005
J	Patil, AGG; Sang, PB; Govindan, A; Varshney, U				Patil, Aravind Goud G.; Sang, Pau Biak; Govindan, Ashwin; Varshney, Umesh			Mycobacterium tuberculosis MutT1 (Rv2985) and ADPRase (Rv1700) Proteins Constitute a Two-stage Mechanism of 8-Oxo-dGTP and 8-Oxo-GTP Detoxification and Adenosine to Cytidine Mutation Avoidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUDIX HYDROLASE; MUTAGENIC SUBSTRATE; ESCHERICHIA-COLI; OXIDATIVE STRESS; HYDROLYZES; STRAINS; FORMS; MICE; MTH1	Approximately one third of the world population is infected with Mycobacterium tuberculosis, the causative agent of tuberculosis. A better understanding of the pathogen biology is crucial to develop new tools/strategies to tackle its spread and treatment. In the host macrophages, the pathogen is exposed to reactive oxygen species, known to damage dGTP and GTP to 8-oxo-dGTP and 8-oxo-GTP, respectively. Incorporation of the damaged nucleotides in nucleic acids is detrimental to organisms. MutT proteins, belonging to a class of Nudix hydrolases, hydrolyze 8-oxo-G nucleoside triphosphates/diphosphates to the corresponding nucleoside monophosphates and sanitize the nucleotide pool. Mycobacteria possess several MutT proteins. However, a functional homolog of Escherichia coli MutT has not been identified. Here, we characterized MtuMutT1 and Rv1700 proteins of M. tuberculosis. Unlike other MutT proteins, MtuMutT1 converts 8-oxo-dGTP to 8-oxo-dGDP, and 8-oxo-GTP to 8-oxo-GDP. Rv1700 then converts them to the corresponding nucleoside monophosphates. This observation suggests the presence of a two-stage mechanism of 8-oxo-dGTP/8-oxo-GTP detoxification in mycobacteria. MtuMutT1 converts 8-oxo-dGTP to 8-oxo-dGDP with a K-m of similar to 50 mu M and V-max of similar to 0.9 pmol/min per ng of protein, and Rv1700 converts 8-oxo-dGDP to 8-oxo-dGMP with a K-m of similar to 9.5 mu M and V-max of similar to 0.04 pmol/min per ng of protein. Together, MtuMutT1 and Rv1700 offer maximal rescue to E. coli for its MutT deficiency by decreasing A to C mutations (a hallmark of MutT deficiency). We suggest that the concerted action of MtuMutT1 and Rv1700 plays a crucial role in survival of bacteria against oxidative stress.	[Patil, Aravind Goud G.; Sang, Pau Biak; Govindan, Ashwin; Varshney, Umesh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varshney, Umesh] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varshney, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	varshney@mcbl.iisc.ernet.in	Sang, Pau Biak/AAK-7980-2021; Govindan, Ashwin/M-5897-2014; Sang, Pau Biak/ABB-3621-2021; Varshney, Umesh/Q-6914-2019	Sang, Pau Biak/0000-0001-7261-5117; Govindan, Ashwin/0000-0003-1759-707X; Sang, Pau Biak/0000-0001-7261-5117; 	Department of Biotechnology, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, New Delhi, and the Council of Scientific and Industrial Research, New Delhi.	AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; Arif SM, 2012, ACTA CRYSTALLOGR F, V68, P1214, DOI 10.1107/S1744309112035804; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dos Vultos T, 2006, J BACTERIOL, V188, P3159, DOI 10.1128/JB.188.8.3159-3161.2006; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Egashira A, 2001, Tanpakushitsu Kakusan Koso, V46, P1162; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Gonzalez-Juarrero M, 2011, TUBERCULOSIS, V91, P86, DOI 10.1016/j.tube.2010.08.007; Jain R, 2007, DNA REPAIR, V6, P1774, DOI 10.1016/j.dnarep.2007.06.009; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kurthkoti K, 2010, MICROBIOL-SGM, V156, P88, DOI 10.1099/mic.0.033621-0; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mishima M, 2004, J BIOL CHEM, V279, P33806, DOI 10.1074/jbc.M402393200; Moreland NJ, 2009, BIOCHEMISTRY-US, V48, P699, DOI 10.1021/bi8009554; Nakamura T, 2010, J BIOL CHEM, V285, P444, DOI 10.1074/jbc.M109.066373; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sang PB, 2013, J BACTERIOL, V195, P1552, DOI 10.1128/JB.02102-12; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Tsuzuki T, 2001, MUTAT RES-FUND MOL M, V477, P71, DOI 10.1016/S0027-5107(01)00108-7; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200	31	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11252	11262		10.1074/jbc.M112.442566	http://dx.doi.org/10.1074/jbc.M112.442566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463507	hybrid, Green Published			2022-12-28	WOS:000317915500028
J	Chandra, V; Mahajan, S; Saini, A; Dkhar, HK; Nanduri, R; Raj, EB; Kumar, A; Gupta, P				Chandra, Vemika; Mahajan, Sahil; Saini, Ankita; Dkhar, Hedwin K.; Nanduri, Ravikanth; Raj, Ella B.; Kumar, Ashwani; Gupta, Pawan			Human IL10 Gene Repression by Rev-erb alpha Ameliorates Mycobacterium tuberculosis Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; NF-KAPPA-B; NUCLEAR RECEPTORS; PPAR-GAMMA; PHAGOLYSOSOME BIOGENESIS; RESPONSE ELEMENT; ORPHAN RECEPTOR; DENDRITIC CELLS; IL-10 GENE; ROR-ALPHA	Nuclear receptors modulate macrophage effector functions, which are imperative for clearance or survival of mycobacterial infection. The adopted orphan nuclear receptor Rev-erb alpha is a constitutive transcriptional repressor as it lacks AF2 domain and was earlier shown to be present in macrophages. In the present study, we highlight the differences in the relative subcellular localization of Rev-erb alpha in monocytes and macrophages. The nuclear localization of Rev-erb alpha in macrophages is subsequent to monocyte differentiation. Expression analysis of Rev-erb alpha elucidated it to be considerably more expressed in M1 phenotype in comparison with M2. Rev-erb alpha overexpression augments antimycobacterial properties of macrophage by keeping IL10 in a basal repressed state. Further, promoter analysis revealed that IL10 promoter harbors a Rev-erb alpha binding site exclusive to humans and higher order primates and not mouse, demonstrating a species barrier in its functionality. This direct gene repression is mediated by recruitment of co-repressors NCoR and HDAC3. In addition, our data elucidate that its overexpression reduced the survival of intracellular pathogen Mycobacterium tuberculosis by enhancing phagosome lysosome maturation, an event resulting from IL10 repression. Thus, these findings suggest that Rev-erb alpha bestows protection against mycobacterial infection by direct gene repression of IL10 and thus provide a novel target in modulating macrophage microbicidal properties.	[Chandra, Vemika; Mahajan, Sahil; Saini, Ankita; Dkhar, Hedwin K.; Nanduri, Ravikanth; Raj, Ella B.; Kumar, Ashwani; Gupta, Pawan] CSIR, Dept Prot Sci & Mol Biol, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR, Dept Prot Sci & Mol Biol, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	pawan@imtech.res.in	Kumar, Ashwani/AAU-5045-2020; Chandra, Vemika/AAK-6997-2020; NANDURI, RAVIKANTH/Q-9729-2018; Ella, Bhagyaraj/X-2823-2019	Kumar, Ashwani/0000-0002-6240-6810; Chandra, Vemika/0000-0001-5360-7875; NANDURI, RAVIKANTH/0000-0002-0031-2333; Gupta, Pawan/0000-0001-6692-7237; Ella, Bhagyaraj/0000-0002-5887-9228	Department of Biotechnology-India [BT/01/IYBA/2009]	Department of Biotechnology-India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology-India Project BT/01/IYBA/2009 and the also thank the Institute of Microbial Technology (IMTech), a constituent laboratory of the Council of Scientific and Industrial Research.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Cowley SC, 2001, GENE, V264, P225, DOI 10.1016/S0378-1119(01)00336-5; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; DOWNES M, 1995, MOL ENDOCRINOL, V9, P1666, DOI 10.1210/me.9.12.1666; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Grenningloh K, 2005, J EXP MED, V201, P615, DOI 10.1084/jem.20041330; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Journiac N, 2009, P NATL ACAD SCI USA, V106, P21365, DOI 10.1073/pnas.0911782106; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Laitinen S, 2005, BIOCHIMIE, V87, P21, DOI 10.1016/j.biochi.2004.12.006; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; LAZAR MA, 1990, DNA CELL BIOL, V9, P77, DOI 10.1089/dna.1990.9.77; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McLean KJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P228, DOI 10.1016/j.abb.2007.03.026; Migita H, 2004, FEBS LETT, V561, P69, DOI 10.1016/S0014-5793(04)00118-8; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Pazos M, 2008, J AGR FOOD CHEM, V56, P11478, DOI 10.1021/jf802359t; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan Sathiya N, 2006, Nucl Recept Signal, V4, pe009; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Riemann M, 2005, J IMMUNOL, V175, P3560, DOI 10.4049/jimmunol.175.6.3560; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Rojas M, 1999, J IMMUNOL, V162, P6122; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; Yee CSK, 2005, J IMMUNOL, V174, P1222, DOI 10.4049/jimmunol.174.3.1222	50	41	44	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10692	10702		10.1074/jbc.M113.455915	http://dx.doi.org/10.1074/jbc.M113.455915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23449984	hybrid, Green Published			2022-12-28	WOS:000317565000047
J	Infantes, S; Lorente, E; Barnea, E; Beer, I; Barriga, A; Lasala, F; Jimenez, M; Admon, A; Lopez, D				Infantes, Susana; Lorente, Elena; Barnea, Eilon; Beer, Ilan; Barriga, Alejandro; Lasala, Fatima; Jimenez, Mercedes; Admon, Arie; Lopez, Daniel			Natural HLA-B*2705 Protein Ligands with Glutamine as Anchor Motif IMPLICATIONS FOR HLA-B27 ASSOCIATION WITH SPONDYLOARTHROPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; CONNECTIVE-TISSUE DISEASE; MASS-SPECTROMETRY DATA; T-CELL LYMPHOMA; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; MUTANTS MIMICKING; PEPTIDE LIGANDS; HLA-B27; BINDING	The presentation of short viral peptide antigens by human leukocyte antigen (HLA) class I molecules on cell surfaces is a key step in the activation of cytotoxic T lymphocytes, which mediate the killing of pathogen-infected cells or initiate autoimmune tissue damage. HLA-B27 is a well known class I molecule that is used to study both facets of the cellular immune response. Using mass spectrometry analysis of complex HLA-bound peptide pools isolated from large amounts of HLA-B*2705(+) cells, we identified 200 naturally processed HLA-B*2705 ligands. Our analyses revealed that a change in the position (P) 2 anchor motif was detected in the 3% of HLA-B*2705 ligands identified. B*2705 class I molecules were able to bind these six GlnP2 peptides, which showed significant homology to pathogenic bacterial sequences, with a broad range of affinities. One of these ligands was able to bind with distinct conformations to HLA-B27 subtypes differentially associated with ankylosing spondylitis. These conformational differences could be sufficient to initiate autoimmune damage in patients with ankylosing spondylitis-associated subtypes. Therefore, these kinds of peptides (short, with GlnP2, and similar low affinity to all HLA-B27 subtypes tested but with unlike conformations in differentially ankylosing spondylitis-associated subtypes) must not be excluded from future researches involving potential arthritogenic peptides.	[Infantes, Susana; Lorente, Elena; Barriga, Alejandro; Lasala, Fatima; Jimenez, Mercedes; Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, IL-32000 Haifa, Israel; [Beer, Ilan] IBM Haifa Res Lab, IL-3498825 Haifa, Israel	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Technion Israel Institute of Technology	Lopez, D (corresponding author), Inst Salud Carlos III, Unidad Proc Antigen, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	López, Daniel/I-2632-2014; Lorente, Elena/B-1219-2019	López, Daniel/0000-0003-0268-5878; Lorente, Elena/0000-0002-2246-6851; LASALA, FATIMA/0000-0001-8183-1866; Barriga, Alejandro/0000-0001-6357-1917; Admon, Arie/0000-0003-0504-3950	Programa Ramon y Cajal; Ministerio de Ciencia e Innovacion; Israel Science Foundation [ISF 916/05]	Programa Ramon y Cajal(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Programa Ramon y Cajal and the Ministerio de Ciencia e Innovacion (to D. L.) and from the Israel Science Foundation (ISF 916/05) (to A. A.).	Alvarez I, 2001, J BIOL CHEM, V276, P32729, DOI 10.1074/jbc.M104663200; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BREWERTON DA, 1973, LANCET, V1, P904; CALVO V, 1990, J IMMUNOL, V144, P4038; Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1165, DOI 10.1177/002215540104900910; Colmegna I, 2004, CLIN MICROBIOL REV, V17, P348, DOI 10.1128/CMR.17.2.348-369.2004; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Galocha B, 1996, TISSUE ANTIGENS, V48, P509, DOI 10.1111/j.1399-0039.1996.tb02664.x; Haroon N, 2012, ANN RHEUM DIS, V71, P589, DOI 10.1136/annrheumdis-2011-200347; HASSFELD W, 1995, ARTHRITIS RHEUM-US, V38, P777, DOI 10.1002/art.1780380610; Hoffman RW, 2008, CLIN IMMUNOL, V128, P8, DOI 10.1016/j.clim.2008.03.461; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Levy Y, 1997, CLIN RHEUMATOL, V16, P606, DOI 10.1007/BF02247801; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LOPEZ D, 1992, J IMMUNOL, V148, P996; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; Marcilla M, 2008, TISSUE ANTIGENS, V71, P495, DOI 10.1111/j.1399-0039.2008.01051.x; McKie N, 1997, BIOCHEM BIOPH RES CO, V230, P335, DOI 10.1006/bbrc.1996.5957; PARKER KC, 1994, J IMMUNOL, V152, P163; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Samino Y, 2004, J BIOL CHEM, V279, P1151, DOI 10.1074/jbc.M305343200; Sandberg Y, 2004, J AM ACAD DERMATOL, V51, P111, DOI 10.1016/j.jaad.2004.01.043; SELEZNICK MJ, 1989, J RHEUMATOL, V16, P1379; Sesma L, 2005, J IMMUNOL, V174, P7833, DOI 10.4049/jimmunol.174.12.7833; Sesma L, 2002, J BIOL CHEM, V277, P16744, DOI 10.1074/jbc.M200371200; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; VILLADANGOS JA, 1994, J IMMUNOL, V152, P2317; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Yague J, 2001, J BIOL CHEM, V276, P43699, DOI 10.1074/jbc.M105981200; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	46	17	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10882	10889		10.1074/jbc.M113.455352	http://dx.doi.org/10.1074/jbc.M113.455352			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430249	hybrid, Green Published			2022-12-28	WOS:000317565000065
J	Smulski, CR; Beyrath, J; Decossas, M; Chekkat, N; Wolff, P; Estieu-Gionnet, K; Guichard, G; Speiser, D; Schneider, P; Fournel, S				Smulski, Cristian R.; Beyrath, Julien; Decossas, Marion; Chekkat, Neila; Wolff, Philippe; Estieu-Gionnet, Karine; Guichard, Gilles; Speiser, Daniel; Schneider, Pascal; Fournel, Sylvie			Cysteine-rich Domain 1 of CD40 Mediates Receptor Self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND; REQUIREMENT; DIMERIZATION; HOMODIMERS; PROTEIN	The activation of CD40 on B cells, macrophages, and dendritic cells by its ligand CD154 (CD40L) is essential for the development of humoral and cellular immune responses. CD40L and other TNF superfamily ligands are noncovalent homotrimers, but the form under which CD40 exists in the absence of ligand remains to be elucidated. Here, we show that both cell surface-expressed and soluble CD40 self-assemble, most probably as noncovalent dimers. The cysteine-rich domain 1 (CRD1) of CD40 participated to dimerization and was also required for efficient receptor expression. Modelization of a CD40 dimer allowed the identification of lysine 29 in CRD1, whose mutation decreased CD40 self-interaction without affecting expression or response to ligand. When expressed alone, recombinant CD40-CRD1 bound CD40 with a K-D of 0.6 mu M. This molecule triggered expression of maturation markers on human dendritic cells and potentiated CD40L activity. These results suggest that CD40 self-assembly modulates signaling, possibly by maintaining the receptor in a quiescent state.	[Smulski, Cristian R.; Beyrath, Julien; Decossas, Marion; Chekkat, Neila; Fournel, Sylvie] CNRS, UPR 9021, Inst Biol Mol & Cellulaire Immunol & Chim Therape, F-67084 Strasbourg, France; [Wolff, Philippe] Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Estieu-Gionnet, Karine; Guichard, Gilles] Univ Bordeaux 1, Inst Europeen Chim & Biol CBMN, CNRS, UMR 5248, F-33607 Pessac, France; [Speiser, Daniel] Univ Lausanne, Dept Oncol, CH-1011 Lausanne, Switzerland; [Speiser, Daniel] Univ Lausanne, Ludwig Ctr Canc Res, CH-1011 Lausanne, Switzerland; [Smulski, Cristian R.; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; University of Lausanne; University of Lausanne; University of Lausanne	Smulski, CR (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	cristianroberto.smulski@unil.ch; s.fournel@unistra.fr	GUICHARD, Gilles/I-3858-2016; Speiser, Daniel E./F-2173-2013; Fournel, Sylvie/C-1195-2014	GUICHARD, Gilles/0000-0002-2584-7502; Fournel, Sylvie/0000-0003-3583-6548; Schneider, Pascal/0000-0003-0677-9409; decossas, marion/0000-0003-0810-4309; Smulski, Cristian/0000-0003-4186-8116	Centre National de la Recherche Scientifique; Swiss National Science Foundation; Agence Nationale Recherche [ANR-08-PCVI-0034-01]; Agence Nationale de la Recherche; University of Strasbourg; French Ministere de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence Nationale Recherche(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); University of Strasbourg; French Ministere de la Recherche(Ministry of Research, France)	This work was supported by the Centre National de la Recherche Scientifique (to S. F. and G. G.), the Swiss National Science Foundation (to P. S.), and the Agence Nationale Recherche Grant ANR-08-PCVI-0034-01) (to G. G.).; Recipient of grants from the Agence Nationale de la Recherche and the University of Strasbourg. To whom correspondence may be sent at the present address: Dept. of Biochemistry, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland. Tel.: 41-216925743; Fax: 41-216925705; E-mail: cristianroberto.smulski@unil.ch.; Recipient of a grant from the French Ministere de la Recherche.	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Cardoso LS, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-1; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Deng GM, 2005, NAT MED, V11, P1066, DOI 10.1038/nm1304; Girouard J, 2005, MOL IMMUNOL, V42, P773, DOI 10.1016/j.molimm.2004.07.048; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Reyes-Moreno C, 2004, J BIOL CHEM, V279, P7799, DOI 10.1074/jbc.M313168200; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; RichaletSecordel PM, 1997, ANAL BIOCHEM, V249, P165, DOI 10.1006/abio.1997.2183; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Smulski C, 2006, FASEB J, V20, P1396, DOI 10.1096/fj.05-5699com; Tetsch L, 2009, AMINO ACIDS, V37, P467, DOI 10.1007/s00726-009-0235-x; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wu YL, 2003, INT J CANCER, V105, P724, DOI 10.1002/ijc.11138; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	25	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10914	10922		10.1074/jbc.M112.427583	http://dx.doi.org/10.1074/jbc.M112.427583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23463508	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000317565000068
J	Li, Y; Zhang, H; Jiang, CT; Xu, MJ; Pang, YL; Feng, J; Xiang, XX; Kong, W; Xu, GH; Li, Y; Wang, X				Li, Yang; Zhang, Heng; Jiang, Changtao; Xu, Mingjiang; Pang, Yanli; Feng, Juan; Xiang, Xinxin; Kong, Wei; Xu, Guoheng; Li, Yin; Wang, Xian			Hyperhomocysteinemia Promotes Insulin Resistance by Inducing Endoplasmic Reticulum Stress in Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; ACCELERATED ATHEROSCLEROSIS; MACROPHAGE POLARIZATION; TRANSCRIPTION FACTOR; QUALITY CONTROL; MESSENGER-RNA; JNK PATHWAY; OBESITY; HOMOCYSTEINE	Type 2 diabetes is a chronic inflammatory metabolic disease, the key point being insulin resistance. Endoplasmic reticulum (ER) stress plays a critical role in the pathogenesis of type 2 diabetes. Previously, we found that hyperhomocysteinemia (HHcy) induced insulin resistance in adipose tissue. Here, we hypothesized that HHcy induces ER stress, which in turn promotes insulin resistance. In the present study, the direct effect of Hcy on adipose ER stress was investigated by the use of primary rat adipocytes in vitro and mice with HHcy in vivo. The mechanism and the effect of G protein-coupled receptor 120 (GPR120) were also investigated. We found that phosphorylation or expression of variant ER stress markers was elevated in adipose tissue of HHcy mice. HHcy activated c-Jun N-terminal kinase (JNK), the downstream signal of ER stress in adipose tissue, and activated JNK participated in insulin resistance by inhibiting Akt activation. Furthermore, JNK activated c-Jun and p65, which in turn triggered the transcription of proinflammatory cytokines. Both in vivo and in vitro assays revealed that Hcy-promoted macrophage infiltration aggravated ER stress in adipose tissue. Chemical chaperones PBA and TUDCA could reverse Hcy-induced inflammation and restore insulin-stimulated glucose uptake and Akt activation. Activation of GPR120 reversed Hcy-induced JNK activation and prevented inflammation but not ER stress. Therefore, HHcy inhibited insulin sensitivity in adipose tissue by inducing ER stress, activating JNK to promote proinflammatory cytokine production and facilitating macrophage infiltration. These findings reveal a new mechanism of HHcy in the pathogenesis of insulin resistance.	[Li, Yin; Wang, Xian] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 10091, Peoples R China; Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Peking University	Li, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 10091, Peoples R China.	yinli@bjmu.edu.cn; xwang@bjmu.edu.cn	Li, Yin/P-9296-2016	Li, Yin/0000-0002-4019-3391; Jiang, Changtao/0000-0002-5206-2372; Li, Yang/0000-0002-6286-2939	National Natural Science Foundation of China [81070683, 81121061, 31230035, 81170795, 30971085]; Major National Basic Research Program of China [2011CB503904, 2010CB912504]; Program for New Century Excellent Talents in University [NCET-10-0183]; Beijing Natural Science Foundation [7112080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 81070683, 81121061, and 31230035 (to X. W.) and 81170795 and 30971085 (to Y. L.); Major National Basic Research Program of China Grants 2011CB503904 and 2010CB912504 (to X. W.); Program for New Century Excellent Talents in University Grant NCET-10-0183 (to Y. L.); and Beijing Natural Science Foundation Grant 7112080 (to Y. L.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bourlier V, 2009, DIABETES METAB, V35, P251, DOI 10.1016/j.diabet.2009.05.001; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Buysschaert M, 2000, DIABETES CARE, V23, P1816, DOI 10.2337/diacare.23.12.1816; Dai J, 2006, FREE RADICAL BIO MED, V41, P1566, DOI 10.1016/j.freeradbiomed.2006.08.020; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Jakubowski H, 2003, CLIN CHEM LAB MED, V41, P1462, DOI 10.1515/CCLM.2003.224; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Masharani UB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019878; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Robinson K, 1996, CIRCULATION, V94, P2743, DOI 10.1161/01.CIR.94.11.2743; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wei HL, 2010, ANTIOXID REDOX SIGN, V12, P1079, DOI 10.1089/ars.2009.2898; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng XK, 2003, CIRC RES, V93, P311, DOI 10.1161/01.RES.0000087642.01082.E4; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	40	82	93	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9583	9592		10.1074/jbc.M112.431627	http://dx.doi.org/10.1074/jbc.M112.431627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417716	Green Published, hybrid			2022-12-28	WOS:000317114000002
J	Luang, S; Cho, JI; Mahong, B; Opassiri, R; Akiyama, T; Phasai, K; Komvongsa, J; Sasaki, N; Hua, YL; Matsuba, Y; Ozeki, Y; Jeon, JS; Cairns, JRK				Luang, Sukanya; Cho, Jung-Il; Mahong, Bancha; Opassiri, Rodjana; Akiyama, Takashi; Phasai, Kannika; Komvongsa, Juthamath; Sasaki, Nobuhiro; Hua, Yan-Ling; Matsuba, Yuki; Ozeki, Yoshihiro; Jeon, Jong-Seong; Cairns, James R. Ketudat			Rice Os9BGlu31 Is a Transglucosidase with the Capacity to Equilibrate Phenylpropanoid, Flavonoid, and Phytohormone Glycoconjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; PLANT GLYCOSYLTRANSFERASES; EXPRESSION ANALYSIS; HYDROLASE; GLUCOSE; GLUCOSYLTRANSFERASE; CLASSIFICATION; TOLERANCE; MECHANISM; CLONING	Glycosylation is an important mechanism of controlling the reactivities and bioactivities of plant secondary metabolites and phytohormones. Rice (Oryza sativa) Os9BGlu31 is a glycoside hydrolase family GH1 transglycosidase that acts to transfer glucose between phenolic acids, phytohormones, and flavonoids. The highest activity was observed with the donors feruloyl-glucose, 4-coumaroyl-glucose, and sinapoyl-glucose, which are known to serve as donors in acyl and glucosyl transfer reactions in the vacuole, where Os9BGlu31 is localized. The free acids of these compounds also served as the best acceptors, suggesting that Os9BGlu31 may equilibrate the levels of phenolic acids and carboxylated phytohormones and their glucoconjugates. The Os9BGlu31 gene is most highly expressed in senescing flag leaf and developing seed and is induced in rice seedlings in response to drought stress and treatment with phytohormones, including abscisic acid, ethephon, methyljasmonate, 2,4-dichlorophenoxyacetic acid, and kinetin. Although site-directed mutagenesis of Os9BGlu31 indicated a function for the putative catalytic acid/base (Glu(169)), catalytic nucleophile residues (Glu(387)), and His(386), the wild type enzyme displays an unusual lack of inhibition by mechanism-based inhibitors of GH1 beta-glucosidases that utilize a double displacement retaining mechanism.	[Luang, Sukanya; Opassiri, Rodjana; Phasai, Kannika; Komvongsa, Juthamath; Hua, Yan-Ling; Cairns, James R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand; [Luang, Sukanya; Opassiri, Rodjana; Phasai, Kannika; Komvongsa, Juthamath; Hua, Yan-Ling; Cairns, James R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Chem, Nakhon Ratchasima 30000, Thailand; [Cho, Jung-Il; Mahong, Bancha; Jeon, Jong-Seong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea; [Cho, Jung-Il; Mahong, Bancha; Jeon, Jong-Seong] Kyung Hee Univ, Crop Biotech Inst, Yongin 446701, South Korea; [Akiyama, Takashi] Natl Agr Res Ctr Hokkaido Reg, Toyohira Ku, Sapporo, Hokkaido 0628555, Japan; [Sasaki, Nobuhiro; Matsuba, Yuki; Ozeki, Yoshihiro] Tokyo Univ Agr & Technol, Fac Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Hua, Yan-Ling] Suranaree Univ Technol, Ctr Sci & Technol Equipment, Nakhon Ratchasima 30000, Thailand; [Cairns, James R. Ketudat] Chulabhorn Res Inst, Biochem Lab, Bangkok 10210, Thailand	Suranaree University of Technology; Suranaree University of Technology; Kyung Hee University; Kyung Hee University; National Agriculture & Food Research Organization - Japan; Tokyo University of Agriculture & Technology; Suranaree University of Technology; Chulabhorn Research Institute	Jeon, JS (corresponding author), Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea.	jjeon@khu.ac.kr; cairns@sut.ac.th	Ozeki, Yoshihiro/C-2052-2013; OZEKI, Yoshihiro/AAM-2229-2020; Cairns, James R Ketudat/B-6407-2019; Jeon, Jong-Seong/AAJ-2161-2020; Rattanapitoon, Nathkapach/M-8175-2018	Ozeki, Yoshihiro/0000-0002-3002-368X; Jeon, Jong-Seong/0000-0001-6221-4993; Rattanapitoon, Nathkapach/0000-0002-2806-2129; Ketudat Cairns, James/0000-0003-3042-1626	Suranaree University of Technology; National Research Council; Higher Education Research Promotion and National Research University Project, Office of the Higher Education Commission of Thailand; Next-Generation BioGreen 21 Program from the Rural Development Administration [PJ008114022011]; World Class University Program [R33-2008-000-10168-0]	Suranaree University of Technology; National Research Council; Higher Education Research Promotion and National Research University Project, Office of the Higher Education Commission of Thailand; Next-Generation BioGreen 21 Program from the Rural Development Administration; World Class University Program	This work was supported by Suranaree University of Technology and the National Research Council, along with the Higher Education Research Promotion and National Research University Project, Office of the Higher Education Commission of Thailand; by Next-Generation BioGreen 21 Program Grant PJ008114022011 from the Rural Development Administration; and by World Class University Program Grant R33-2008-000-10168-0.	Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; Cho JI, 2006, PLANTA, V224, P598, DOI 10.1007/s00425-006-0251-y; Cho JI, 2009, PLANT PHYSIOL, V149, P745, DOI 10.1104/pp.108.131227; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Gantt RW, 2011, NAT CHEM BIOL, V7, P685, DOI [10.1038/NCHEMBIO.638, 10.1038/nchembio.638]; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HIRAGA K, 1974, AGR BIOL CHEM TOKYO, V38, P2521, DOI 10.1080/00021369.1974.10861512; HOSEL W, 1987, ARCH BIOCHEM BIOPHYS, V252, P152, DOI 10.1016/0003-9861(87)90019-1; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Koshland D. E., 1953, BIOL REV CAMB PHILOS, V28, P415; Kwon Y, 2012, PLANT BIOTECHNOL REP, V6, P213, DOI 10.1007/s11816-011-0214-z; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lim EK, 2005, CHEM-EUR J, V11, P5486, DOI 10.1002/chem.200500115; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Miyahara T., 2013, J PLANT PHYSL, DOI org/10.1016/j.jplph.2012.12.001; MOCK HP, 1993, PHYTOCHEMISTRY, V32, P575, DOI 10.1016/S0031-9422(00)95139-2; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Mugford ST, 2009, PLANT CELL, V21, P2473, DOI 10.1105/tpc.109.065870; Obel N, 2003, PLANTA, V216, P620, DOI 10.1007/s00425-002-0863-9; Opassiri R, 2003, PLANT SCI, V165, P627, DOI 10.1016/S0168-9452(03)00235-8; Opassiri R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-33; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piens K, 2008, J BIOL CHEM, V283, P21864, DOI 10.1074/jbc.M803057200; Raychaudhuri A, 2002, PLANT PHYSIOL, V130, P2061, DOI 10.1104/pp.011049; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Stehle F, 2009, PHYTOCHEMISTRY, V70, P1652, DOI 10.1016/j.phytochem.2009.07.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanthanuch W, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-84; Wang PT, 2011, CHINESE SCI BULL, V56, P3538, DOI 10.1007/s11434-011-4802-7; WANG QP, 1995, J AM CHEM SOC, V117, P10137, DOI 10.1021/ja00145a035; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Xu ZY, 2012, PLANT CELL, V24, P2184, DOI 10.1105/tpc.112.095935; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	47	39	42	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10111	10123		10.1074/jbc.M112.423533	http://dx.doi.org/10.1074/jbc.M112.423533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430256	Green Published, hybrid			2022-12-28	WOS:000317114000052
J	Alghamdi, TA; Ho, CY; Mrakovic, A; Taylor, D; Mao, D; Botelho, RJ				Alghamdi, Tamadher A.; Ho, Cheuk Y.; Mrakovic, Amra; Taylor, Danielle; Mao, Daniel; Botelho, Roberto J.			Vac14 Protein Multimerization Is a Prerequisite Step for Fab1 Protein Complex Assembly and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MEMBRANE HOMEOSTASIS; MULTIVESICULAR BODY; 5-KINASE ACTIVITY; PIKFYVE; PHOSPHATASE; MORPHOLOGY; SIZE; NEURODEGENERATION	Phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) helps control various endolysosome functions including organelle morphology, membrane recycling, and ion transport. Further highlighting its importance, PtdIns(3,5)P-2 misregulation leads to the development of neurodegenerative diseases like Charcot-Marie-Tooth disease. The Fab1/PIKfyve lipid kinase phosphorylates PtdIns(3)P into PtdIns(3,5)P-2 whereas the Fig4/Sac3 lipid phosphatase antagonizes this reaction. Interestingly, Fab1 and Fig4 form a common protein complex that coordinates synthesis and degradation of PtdIns(3,5)P-2 by a poorly understood process. Assembly of the Fab1 complex requires Vac14/ArPIKfyve, a multimeric scaffolding adaptor protein that coordinates synthesis and turnover of PtdIns(3,5)P-2. However, the properties and function of Vac14 multimerization remain mostly uncharacterized. Here we identify several conserved C-terminal motifs on Vac14 required for self-interaction and provide evidence that Vac14 likely forms a dimer. We also show that monomeric Vac14 mutants do not support interaction with Fab1 or Fig4, suggesting that Vac14 multimerization is likely the first molecular event in the assembly of the Fab1 complex. Finally, we show that cells expressing monomeric Vac14 mutants have enlarged vacuoles that do not fragment after hyperosmotic shock, which indicates that PtdIns(3,5)P-2 levels are greatly abated. Therefore, our observations support an essential role for the Vac14 homocomplex in controlling PtdIns(3,5)P-2 levels.	[Alghamdi, Tamadher A.; Ho, Cheuk Y.; Mrakovic, Amra; Botelho, Roberto J.] Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada; [Alghamdi, Tamadher A.; Ho, Cheuk Y.; Mrakovic, Amra; Botelho, Roberto J.] Ryerson Univ, Mol Sci Program, Toronto, ON M5B 2K3, Canada; [Taylor, Danielle] Univ Toronto, Inst Med Sci, Neurogenet Sect, Ctr Addict & Mental Hlth, Toronto, ON M5B 2K3, Canada; [Mao, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Toronto Metropolitan University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Botelho, RJ (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada.	rbotelho@ryerson.ca	Botelho, Roberto J/B-9145-2013	Botelho, Roberto J/0000-0002-7820-0999; Ho, Shannon/0000-0001-9301-3430	King Abdullah scholarship from Saudi Arabia; Natural Sciences and Engineering Research Council of Canada discovery grant; Dean's Research Fund from Ryerson University; Health Research Fund from Ryerson University	King Abdullah scholarship from Saudi Arabia; Natural Sciences and Engineering Research Council of Canada discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dean's Research Fund from Ryerson University; Health Research Fund from Ryerson University	Supported by a King Abdullah scholarship from Saudi Arabia.; Supported by an Natural Sciences and Engineering Research Council of Canada discovery grant and the Dean's Research and the Health Research Funds from Ryerson University. To whom correspondence should be addressed. Tel.: 416-979-5000 (ext. 2059); Fax: 416-979-5044; E-mail: rbotelho@ryerson.ca.	Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Romero-Suarez S, 2010, AGING-US, V2, P504, DOI 10.18632/aging.100190; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zieger M, 2012, MOL BIOL CELL, V23, P3438, DOI 10.1091/mbc.E12-05-0347	35	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9363	9372		10.1074/jbc.M113.453712	http://dx.doi.org/10.1074/jbc.M113.453712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389034	hybrid, Green Published			2022-12-28	WOS:000316862200053
J	Fujihashi, M; Mito, K; Pai, EF; Miki, K				Fujihashi, Masahiro; Mito, Kazuya; Pai, Emil F.; Miki, Kunio			Atomic Resolution Structure of the Orotidine 5 '-Monophosphate Decarboxylase Product Complex Combined with Surface Plasmon Resonance Analysis IMPLICATIONS FOR THE CATALYTIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROFICIENT ENZYME; TRANSITION-STATE; VINYL CARBANION; ACTIVE-SITE; X-RAY; SUBSTRATE; DERIVATIVES; CRYSTALLIZATION; FALCIPARUM; INHIBITORS	Orotidine 5'-monophosphate decarboxylase (ODCase) accelerates the decarboxylation of its substrate by 17 orders of magnitude. One argument brought forward against steric/electrostatic repulsion causing substrate distortion at the carboxylate substituent as part of the catalysis has been the weak binding affinity of the decarboxylated product (UMP). The crystal structure of the UMP complex of ODCase at atomic resolution (1.03 angstrom) shows steric competition between the product UMP and the side chain of a catalytic lysine residue. Surface plasmon resonance analysis indicates that UMP binds 5 orders of magnitude more tightly to a mutant in which the interfering side chain has been removed than to wild-type ODCase. These results explain the low affinity of UMP and counter a seemingly very strong argument against a contribution of substrate distortion to the catalytic reaction mechanism of ODCase.	[Fujihashi, Masahiro; Mito, Kazuya; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Pai, Emil F.] Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada	Kyoto University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Pai, EF (corresponding author), Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada.	pai@hera.med.utoronto.ca; miki@kuchem.kyoto-u.ac.jp	Pai, Emil/R-8908-2019	Pai, Emil/0000-0002-1162-7242	Japan Society for the Promotion of Science (JSPS) [20770081, 2277012, 24570130]; Uehara Memorial Foundation; Canadian Institutes for Health Research; Canada Research Chairs Program; Ontario Ministry of Health and Long Term Care; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Institute of General Medical Sciences [P41GM103543, P41RR007707]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103543] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants-in-aid for Young Scientists (B) (20770081 and 2277012) and Scientific Research (C) (24570130) from the Japan Society for the Promotion of Science (JSPS) and the Uehara Memorial Foundation (to M. F.) as well as the Canadian Institutes for Health Research, the Canada Research Chairs Program, and the Ontario Ministry of Health and Long Term Care (to E. F. P.).; We are grateful to the staff members at the beamlines of the Photon Factory, SPring-8, and the BioCARS sector of the Advanced Photon Source for the help with data collection, to Wanda Gillon for sample preparation, and to Marie-Louise Hjaersen for help with crystallization experiments. Use of beamlines at the Photon Factory and SPring-8 was approved by the Photon Factory Advisory Committee (Proposal 2006G164) and by the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal 2006B1212), respectively. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357. Use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Institute of General Medical Sciences grant P41GM103543 (formerly National Center for Research Resources P41RR007707).	Amyes TL, 2008, J AM CHEM SOC, V130, P1574, DOI 10.1021/ja710384t; Amyes TL, 2012, BIOCHEMISTRY-US, V51, P4630, DOI 10.1021/bi300585e; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Bello AM, 2008, J MED CHEM, V51, P439, DOI 10.1021/jm7010673; Bello AM, 2009, J MED CHEM, V52, P1648, DOI 10.1021/jm801224t; Callahan BP, 2006, BIOORG CHEM, V34, P59, DOI 10.1016/j.bioorg.2005.12.001; Chan KK, 2009, BIOCHEMISTRY-US, V48, P5518, DOI 10.1021/bi900623r; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Desai BJ, 2012, BIOCHEMISTRY-US, V51, P8665, DOI 10.1021/bi301188k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujihashi M, 2005, J AM CHEM SOC, V127, P15048, DOI 10.1021/ja054865u; Fujihashi M, 2009, J MOL BIOL, V387, P1199, DOI 10.1016/j.jmb.2009.02.037; Gao JL, 2003, CURR OPIN STRUC BIOL, V13, P184, DOI 10.1016/S0959-440X(03)00041-1; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; Heinrich D, 2009, CHEM-EUR J, V15, P6619, DOI 10.1002/chem.200900397; Kamerlin SCL, 2010, J ORG CHEM, V75, P6391, DOI 10.1021/jo100651s; Krungkrai SR, 2005, BIOCHEMISTRY-US, V44, P1643, DOI 10.1021/bi048439h; Lewis CA, 2007, BIOCHEMISTRY-US, V46, P13331, DOI 10.1021/bi700796t; Lewis M, 2011, J MED CHEM, V54, P2891, DOI 10.1021/jm101642g; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; Meza-Avina ME, 2010, BIOORGAN MED CHEM, V18, P4032, DOI 10.1016/j.bmc.2010.04.017; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Miller BG, 2001, BIOCHEMISTRY-US, V40, P6227, DOI 10.1021/bi0028993; Miller BG, 2000, ACTA CRYSTALLOGR D, V56, P472, DOI 10.1107/S0907444900000949; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poduch E, 2008, J MED CHEM, V51, P432, DOI 10.1021/jm700968x; Poduch E, 2006, J MED CHEM, V49, P4937, DOI 10.1021/jm060202r; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Thirumalairajan S, 2010, CHEM COMMUN, V46, P3158, DOI 10.1039/b926894d; Tokuoka K, 2008, J BIOCHEM, V143, P69, DOI 10.1093/jb/mvm193; Toth K, 2010, J AM CHEM SOC, V132, P7018, DOI 10.1021/ja102408k; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797; Wu N, 2002, J BIOL CHEM, V277, P28080, DOI 10.1074/jbc.M202362200; Wu N, 2002, BIOCHEMISTRY-US, V41, P4002, DOI 10.1021/bi015758p; Wu N, 2000, ACTA CRYSTALLOGR D, V56, P912, DOI 10.1107/S090744490000576X	39	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9011	9016		10.1074/jbc.M112.427252	http://dx.doi.org/10.1074/jbc.M112.427252			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395822	Green Published, hybrid			2022-12-28	WOS:000316862200020
J	Oh, Y; Chung, KC				Oh, Yohan; Chung, Kwang Chul			UHRF2, a Ubiquitin E3 Ligase, Acts as a Small Ubiquitin-like Modifier E3 Ligase for Zinc Finger Protein 131	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE NETWORK; SUMO E3; CONJUGATING ENZYME; TUMOR-SUPPRESSOR; IN-VITRO; SUMOYLATION; P53; NIRF; ACTIVATION; IDENTIFICATION	Small ubiquitin-like modifier (SUMO), a member of the ubiquitin-related protein family, is covalently conjugated to lysine residues of its substrates in a process referred to as SUMOylation. SUMOylation occurs through a series of enzymatic reactions analogous to that of the ubiquitination pathway, resulting in modification of the biochemical and functional properties of substrates. To date, four mammalian SUMO isoforms, a single heterodimeric SUMO-activating E1 enzyme SAE1/SAE2, a single SUMO-conjugating E2 enzyme ubiquitin-conjugating enzyme E2I (UBC9), and a few subgroups of SUMO E3 ligases have been identified. Several SUMO E3 ligases such as topoisomerase I binding, arginine/serine-rich (TOPORS), TNF receptor-associated factor 7 (TRAF7), and tripartite motif containing 27 (TRIM27) have dual functions as ubiquitin E3 ligases. Here, we demonstrate that the ubiquitin E3 ligase UHRF2 also acts as a SUMO E3 ligase. UHRF2 effectively enhances zinc finger protein 131 (ZNF131) SUMOylation but does not enhance ZNF131 ubiquitination. In addition, the SUMO E3 activity of UHRF2 on ZNF131 depends on the presence of SET and RING finger-associated and nuclear localization signal-containing region domains, whereas the critical ubiquitin E3 activity RING domain is dispensable. Our findings suggest that UHRF2 has independent functional domains and regulatory mechanisms for these two distinct enzymatic activities.	[Oh, Yohan; Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Yonsei Ro 50, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Oh, Yohan/C-9107-2013; rchnds, rchnds/D-7595-2016	Oh, Yohan/0000-0002-9249-8664; 	National Research Foundation Grant [2012R1A1A2021749]; Ministry of Education, Science, and Technology (MEST); Basic Science Research Program through NRF (Korea) [2012-0000810]; Brain Research Center of the 21st Century Frontier Research Program Technology [2009K-001251]; MEST; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea [A092004, A111653]	National Research Foundation Grant(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through NRF (Korea)(National Research Foundation of Korea); Brain Research Center of the 21st Century Frontier Research Program Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea	This work was supported by National Research Foundation Grant 2012R1A1A2021749 (to K. C. C.) funded by the Ministry of Education, Science, and Technology (MEST) and by the Basic Science Research Program through NRF (Korea) 2012-0000810 (to K. C. C.). This work was also supported by the Brain Research Center of the 21st Century Frontier Research Program Technology (2009K-001251 (to K. C. C.) funded by MEST. This work was also supported in part by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea Grants A092004 and A111653 (to K. C. C.).	Bai L, 2012, BIOCHEM BIOPH RES CO, V425, P908, DOI 10.1016/j.bbrc.2012.08.009; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Donaldson NS, 2007, BBA-MOL CELL RES, V1773, P546, DOI 10.1016/j.bbamcr.2006.12.005; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Li YY, 2004, BIOCHEM BIOPH RES CO, V319, P464, DOI 10.1016/j.bbrc.2004.04.190; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mori T, 2002, BIOCHEM BIOPH RES CO, V296, P530, DOI 10.1016/S0006-291X(02)00890-2; Mori T, 2012, FEBS LETT, V586, P1570, DOI 10.1016/j.febslet.2012.04.038; Mori T, 2011, CELL CYCLE, V10, P3284, DOI 10.4161/cc.10.19.17176; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; Oh Y, 2013, BIOCHEM BIOPH RES CO, V430, P400, DOI 10.1016/j.bbrc.2012.11.031; Oh Y, 2012, J BIOL CHEM, V287, P17517, DOI 10.1074/jbc.M111.336354; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; TOMMERUP N, 1995, GENOMICS, V27, P259, DOI 10.1006/geno.1995.1040; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	44	18	22	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9102	9111		10.1074/jbc.M112.438234	http://dx.doi.org/10.1074/jbc.M112.438234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404503	hybrid, Green Published			2022-12-28	WOS:000316862200030
J	Ritt, M; Guan, JL; Sivaramakrishnan, S				Ritt, Michael; Guan, Jun Lin; Sivaramakrishnan, Sivaraj			Visualizing and Manipulating Focal Adhesion Kinase Regulation in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-TYROSINE KINASE; STRUCTURAL BASIS; FERM DOMAIN; IN-VITRO; FAK; PHOSPHORYLATION; MIGRATION; PH; OVEREXPRESSION	Focal Adhesion Kinase (FAK) is essential for cell migration and plays an important role in tumor metastasis. However, the complex intermolecular and intramolecular interactions that regulate FAK activity at the focal adhesion remain unresolved. We have engineered a toolbox of FRET sensors that retain all of the individual FAK domains but modulate a key intramolecular regulatory interaction between the band 4.1/ezrin/radixin/moesin (FERM) and kinase domains of FAK. We demonstrate systematic control and quantitative measurement of the FERM-kinase interaction at focal adhesions, which in turn allows us to control cell migration. Using these sensors, we find that Tyr-397 phosphorylation, rather than kinase activity of FAK, is the key determinant of cell migration. Our sensors directly demonstrate, for the first time, a pH-dependent change in a protein-protein interaction at a macromolecular structure in live cells. The FERM-kinase interaction at focal adhesions is enhanced at acidic pH, with a concomitant decrease in Tyr-397 phosphorylation, providing a potential mechanism for enhanced migration of cancer cells.	[Ritt, Michael; Guan, Jun Lin; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Guan, Jun Lin] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Dept Cell & Dev Biol, 3045 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sivaraj@umich.edu			American Heart Association National Scientist Development Grant [13SDG14270009]; McKay Award; University of Michigan; National Institutes of Health [CA 163493]; NATIONAL CANCER INSTITUTE [R01CA163493] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Grant(American Heart Association); McKay Award; University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Heart Association National Scientist Development Grant 13SDG14270009, the McKay Award, and University of Michigan startup funds (to S. S.). This work was also supported in part by National Institutes of Health Grant CA 163493 (to J. L. G.).	Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Baumann Kim, 2012, Nat Rev Mol Cell Biol, V13, P138, DOI 10.1038/nrm3297; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Cabrita MA, 2011, MOL ONCOL, V5, P517, DOI 10.1016/j.molonc.2011.10.004; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Cary LA, 1996, J CELL SCI, V109, P1787; Chow S, 2001, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0903s14; Chu PY, 2009, J BIOL CHEM, V284, P20215, DOI 10.1074/jbc.M109.018259; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; Ding LS, 2010, TRANSL RES, V156, P45, DOI 10.1016/j.trsl.2010.05.001; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Golubovskaya VM, 2012, CARCINOGENESIS, V33, P1004, DOI 10.1093/carcin/bgs120; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kiyokawa E, 2006, CANCER SCI, V97, P8, DOI 10.1111/j.1349-7006.2006.00141.x; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; LYU PCC, 1992, J MOL BIOL, V223, P343, DOI 10.1016/0022-2836(92)90735-3; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Moglich A, 2006, P NATL ACAD SCI USA, V103, P12394, DOI 10.1073/pnas.0604748103; OWENS LV, 1995, CANCER RES, V55, P2752; Papusheva E, 2009, J CELL SCI, V122, P656, DOI 10.1242/jcs.028738; Recher C, 2004, CANCER RES, V64, P3191, DOI 10.1158/0008-5472.CAN-03-3005; Salonikidis PS, 2011, J BIOL CHEM, V286, P23419, DOI 10.1074/jbc.M111.236869; Sawai H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-37; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STUBBS M, 1994, CANCER RES, V54, P4011; Sun XG, 2009, MICROVASC RES, V77, P304, DOI 10.1016/j.mvr.2008.12.004; Taylor J. R., 1997, INTRO ERROR ANAL STU, P73; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Withers BE, 1996, PROTEIN EXPRES PURIF, V7, P12, DOI 10.1006/prep.1996.0002; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang J, 2007, MOL BIOSYST, V3, P759, DOI 10.1039/b706628g; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	55	29	29	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8875	8886		10.1074/jbc.M112.421164	http://dx.doi.org/10.1074/jbc.M112.421164			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393139	hybrid, Green Published			2022-12-28	WOS:000316862200009
J	Soderberg, CAG; Rajan, S; Shkumatov, AV; Gakh, O; Schaefer, S; Ahlgren, EC; Svergun, DI; Isaya, G; Al-Karadaghi, S				Soderberg, Christopher A. G.; Rajan, Sreekanth; Shkumatov, Alexander V.; Gakh, Oleksandr; Schaefer, Susanne; Ahlgren, Eva-Christina; Svergun, Dmitri I.; Isaya, Grazia; Al-Karadaghi, Salam			The Molecular Basis of Iron-induced Oligomerization of Frataxin and the Role of the Ferroxidation Reaction in Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; ESCHERICHIA-COLI CYAY; YEAST FRATAXIN; FRIEDREICHS-ATAXIA; SOLUTION SCATTERING; BINDING-PROPERTIES; MISSENSE MUTATION; CRYSTAL-STRUCTURE; POINT MUTATIONS; 2FE-2S CLUSTERS	The role of the mitochondrial protein frataxin in iron storage and detoxification, iron delivery to iron-sulfur cluster biosynthesis, heme biosynthesis, and aconitase repair has been extensively studied during the last decade. However, still no general consensus exists on the details of the mechanism of frataxin function and oligomerization. Here, using small-angle x-ray scattering and x-ray crystallography, we describe the solution structure of the oligomers formed during the iron-dependent assembly of yeast (Yfh1) and Escherichia coli (CyaY) frataxin. At an iron-to-protein ratio of 2, the initially monomeric Yfh1 is converted to a trimeric form in solution. The trimer in turn serves as the assembly unit for higher order oligomers induced at higher iron-to-protein ratios. The x-ray crystallographic structure obtained from iron-soaked crystals demonstrates that iron binds at the trimer-trimer interaction sites, presumably contributing to oligomer stabilization. For the ferroxidation-deficient D79A/D82A variant of Yfh1, iron-dependent oligomerization may still take place, although > 50% of the protein is found in the monomeric state at the highest iron-to-protein ratio used. This demonstrates that the ferroxidation reaction controls frataxin assembly and presumably the iron chaperone function of frataxin and its interactions with target proteins. For E. coli CyaY, the assembly unit of higher order oligomers is a tetramer, which could be an effect of the much shorter N-terminal region of this protein. The results show that understanding of the mechanistic features of frataxin function requires detailed knowledge of the interplay between the ferroxidation reaction, iron-induced oligomerization, and the structure of oligomers formed during assembly.	[Soderberg, Christopher A. G.; Rajan, Sreekanth; Schaefer, Susanne; Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Inst Chem & Chem Engn, Ctr Mol Prot Sci, SE-22100 Lund, Sweden; [Shkumatov, Alexander V.; Svergun, Dmitri I.] DESY, Hamburg Unit, EMBL, D-22603 Hamburg, Germany; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Lund University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	isaya@mayo.edu; salam.al-karadaghi@biochemistry.lu.se	Al-karadaghi, Salam/F-1492-2011; Söderberg, Christopher/E-1819-2013	Al-karadaghi, Salam/0000-0001-8608-0635; RAJAN, SREEKANTH/0000-0003-4453-3936; Svergun, Dmitri/0000-0003-0830-5696	National Institutes of Health (NIA) [AG15709]; Swedish Research Council (Vetenskapsradet); Natural Science Faculty of Lund University; Crafoord Foundation; Carl Trygger Foundation; Bundesministerium fur Bildung und Forschung [05K10YEA]; EU [261572]; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Natural Science Faculty of Lund University; Crafoord Foundation; Carl Trygger Foundation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EU(European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709 (NIA; to G.I.). This work was also supported by the Swedish Research Council (Vetenskapsradet), a MAX IV/ESS grant from the Natural Science Faculty of Lund University, the Crafoord Foundation, and the Carl Trygger Foundation (to S.A.K.).; Supported by Bundesministerium fur Bildung und Forschung Research Grant SYNC-LIFE (contract 05K10YEA) and the EU FP7 e-Infrastructure Grant WeNMR (contract 261572).	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bartolo C, 1998, AM J MED GENET, V79, P396, DOI 10.1002/(SICI)1096-8628(19981012)79:5<396::AID-AJMG13>3.3.CO;2-B; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; Blanchet CE, 2012, J APPL CRYSTALLOGR, V45, P489, DOI 10.1107/S0021889812013490; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Castro M, 2000, HUM GENET, V106, P86, DOI 10.1007/s004399900201; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Forrest SM, 1998, NEUROGENETICS, V1, P253, DOI 10.1007/s100480050037; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Knaapila M, 2009, J SYNCHROTRON RADIAT, V16, P498, DOI 10.1107/S0909049509018986; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Ptitsyn OB, 1998, J MOL BIOL, V278, P655, DOI 10.1006/jmbi.1997.1620; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vaubel R. A., 2012, MOL CELL NEUROSCI; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	75	21	20	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8156	8167		10.1074/jbc.M112.442285	http://dx.doi.org/10.1074/jbc.M112.442285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23344952	Green Published, hybrid			2022-12-28	WOS:000316564500016
J	Ishida, Y; Park, JH; Mao, LL; Yamaguchi, Y; Inouye, M				Ishida, Yojiro; Park, Jung-Ho; Mao, Lili; Yamaguchi, Yoshihiro; Inouye, Masayori			Replacement of All Arginine Residues with Canavanine in MazF-bs mRNA Interferase Changes Its Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-ANTITOXIN SYSTEMS; UNNATURAL AMINO-ACIDS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GENETIC-CODE; PROTEINS	Replacement of a specific amino acid residue in a protein with nonnatural analogues is highly challenging because of their cellular toxicity. We demonstrate for the first time the replacement of all arginine (Arg) residues in a protein with canavanine (Can), a toxic Arg analogue. All Arg residues in the 5-base specific (UACAU) mRNA interferase from Bacillus subtilis (MazF-bs(arg)) were replaced with Can by using the single-protein production system in Escherichia coli. The resulting MazF-bs(can) gained a 6-base recognition sequence, UACAUA, for RNA cleavage instead of the 5-base sequence, UACAU, for MazF-bs(arg). Mass spectrometry analysis confirmed that all Arg residues were replaced with Can. The present system offers a novel approach to create new functional proteins by replacing a specific amino acid in a protein with its analogues.	[Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Inouye, M (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@cabm.rutgers.edu		Park, Jung-Ho/0000-0003-0441-4457; Yamaguchi, Yoshihiro/0000-0003-4663-6963	National Institutes of Health [RO1GM081567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM081567.	Angaji SA, 2010, J GENET, V89, P527; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bae JH, 2003, J MOL BIOL, V328, P1071, DOI 10.1016/S0022-2836(03)00364-4; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Gogos A, 2003, PROTEINS, V53, P320, DOI 10.1002/prot.10457; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; ROSENTHAL GA, 1989, J BIOL CHEM, V264, P13693; ROSENTHAL GA, 1989, J BIOL CHEM, V264, P9768; ROSENTHAL GA, 1991, J BIOL CHEM, V266, P15684; Stigers DJ, 2011, CHEM COMMUN, V47, P1839, DOI 10.1039/c0cc02879g; Suzuki M, 2006, J BIOL CHEM, V281, P37559, DOI 10.1074/jbc.M608806200; Vaiphei ST, 2010, APPL ENVIRON MICROB, V76, P6063, DOI 10.1128/AEM.00815-10; Yamaguchi Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1621; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200	22	12	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7564	7571		10.1074/jbc.M112.434969	http://dx.doi.org/10.1074/jbc.M112.434969			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23378533	hybrid, Green Published			2022-12-28	WOS:000316455300013
J	Lai, LH; Song, YJ; Liu, Y; Chen, QY; Han, Q; Chen, WL; Pan, T; Zhang, YY; Cao, XT; Wang, QQ				Lai, Lihua; Song, Yinjing; Liu, Yang; Chen, Qingyun; Han, Quan; Chen, Weilin; Pan, Ting; Zhang, Yuanyuan; Cao, Xuetao; Wang, Qingqing			MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; DENDRITIC CELLS; PROTEIN; ACTIVATION; INDUCTION; CYTOKINE; CANCER; EXPRESSION; CLUSTER	Toll-like receptors (TLRs) play a critical role in the initiation of immune responses against invading pathogens. MicroRNAs have been shown to be important regulators of TLR signaling. In this study, we have found that the stimulation of multiple TLRs rapidly reduced the levels of microRNA-92a (miRNA-92a) and some other members of the miRNA-92a family in macrophages. miR-92a mimics significantly decreased, whereas miR-92a knockdown increased, the activation of the JNK/c-Jun pathway and the production of inflammatory cytokines in macrophages when stimulated with ligands for TLR4. Furthermore, mitogen-activated protein kinase kinase 4 (MKK4), a kinase that activates JNK/stress-activated protein kinase, was found to be directly targeted by miR-92a. Similar to the effects of the miR-92a mimics, knockdown of MKK4 inhibited the activation of JNK/c-Jun signaling and the production of TNF-alpha and IL-6. In conclusion, we have demonstrated that TLR-mediated miR-92a reduction feedback enhances TLR-triggered production of inflammatory cytokines in macrophages, thus outlining new mechanisms for fine-tuning the TLR-triggered inflammatory response.	[Lai, Lihua; Song, Yinjing; Liu, Yang; Chen, Qingyun; Han, Quan; Chen, Weilin; Pan, Ting; Zhang, Yuanyuan; Cao, Xuetao; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol & Inst Immunol, Shanghai 200433, Peoples R China	Zhejiang University; Naval Medical University	Wang, QQ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, 388 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	wqq@zju.edu.cn	yang, liu/GVU-8760-2022; zhang, yuanyuan/GYA-4428-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81230074]; National Basic Research Program of China [2013CB530502]; Zhejiang Provincial Natural Science Foundation [R2100528]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents in Zhejiang Province; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province [2010R50046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents in Zhejiang Province; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province	This work was supported by National Natural Science Foundation of China Grant 81230074, National Basic Research Program of China Grant 2013CB530502, Zhejiang Provincial Natural Science Foundation Grant R2100528, and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and for Innovative Research Team in Zhejiang Province Grant 2010R50046.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ebi H, 2009, ONCOGENE, V28, P3371, DOI 10.1038/onc.2009.201; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Iijima N, 2005, INT IMMUNOL, V17, P1201, DOI 10.1093/intimm/dxh297; Inoue T, 2006, ARTHRITIS RHEUM-US, V54, P2127, DOI 10.1002/art.21919; Jalava SE, 2012, ONCOGENE, V31, P4460, DOI 10.1038/onc.2011.624; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lanza G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-54; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravindranath TM, 2009, J IMMUNOL, V183, P8128, DOI 10.4049/jimmunol.0900720; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shin D, 2012, NEUROSCIENCE, V213, P29, DOI 10.1016/j.neuroscience.2012.03.054; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; YASHAR BM, 1993, MOL CELL BIOL, V13, P5738, DOI 10.1128/MCB.13.9.5738; Zhang HY, 2012, ONCOL REP, V27, P594, DOI 10.3892/or.2011.1530; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	65	104	111	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7956	7967		10.1074/jbc.M112.445429	http://dx.doi.org/10.1074/jbc.M112.445429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355465	hybrid, Green Published			2022-12-28	WOS:000316455300048
J	Ohira, T; Suzuki, T; Miyauchi, K; Suzuki, T; Yokobori, S; Yamagishi, A; Watanabe, K				Ohira, Takayuki; Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu; Yokobori, Shin-ichi; Yamagishi, Akihiko; Watanabe, Kimitsuna			Decoding Mechanism of Non-universal Genetic Codes in Loligo bleekeri Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTICODON WOBBLE POSITION; METHIONINE TRANSFER-RNA; TRANSLATION; TAURINE; CODON; 7-METHYLGUANOSINE; BIOSYNTHESIS; SEQUENCES; INSIGHTS; RULE	Non-universal genetic codes are frequently found in animal mitochondrial decoding systems. In squid mitochondria, four codons deviate from the universal genetic code, namely AUA, UGA, and AGA/AGG (AGR) for Met, Trp, and Ser, respectively. To understand the molecular basis for establishing the non-universal genetic code, we isolated and analyzed five mitochondrial tRNAs from a squid, Loligo bleekeri. Primary structures of the isolated tRNAs, including their post-transcriptional modifications, were analyzed by mass spectrometry. tRNA(Met)(AUR) possessed an unmodified cytidine at the first position of the anticodon, suggesting that the AUA codon is deciphered by CAU anticodon via non-canonical A-C pairing. We identified 5-taurinomethyluridine (tau m(5)U) at the first position of the anticodon in tRNA(Trp)(UGR). tau m(5)U enables tRNA(Trp) to decipher UGR codons as Trp. In addition, 5-taurinomethyl-2-thiouridine (tau m(5)s(2)U) was found in mitochondrial tRNAs for Leu(UUR) and Lys in L. bleekeri. This is the first discovery of tau m(5)U and tau m(5)s(2)U in molluscan mitochondrial tRNAs.	[Ohira, Takayuki; Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Yokobori, Shin-ichi; Yamagishi, Akihiko; Watanabe, Kimitsuna] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Biol, Hachioji, Tokyo 1920392, Japan; [Watanabe, Kimitsuna] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Watanabe, Kimitsuna] RIKEN SPring 8 Ctr, Harima Inst, Mikazuki, Hyogo 6795148, Japan	University of Tokyo; Tokyo University of Pharmacy & Life Sciences; University of Tokyo; RIKEN	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp; kim-wata@toyaku.ac.jp	Suzuki, Tsutomu/J-1776-2015; Yokobori, Shin-ichi/K-9537-2017	Suzuki, Tsutomu/0000-0002-9731-1731; Yokobori, Shin-ichi/0000-0002-7356-3299; Yamagishi, Akihiko/0000-0001-5162-3927	Japan Society for the promotion of Science; Ministry of Education, Science, Sports, and Culture of Japan	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (B) from the Japan Society for the promotion of Science (to K. W.) and by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to Takeo Suzuki and Tsutomu Suzuki).	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; CANADAY J, 1980, NUCLEIC ACIDS RES, V8, P1445, DOI 10.1093/nar/8.7.1445; DUBIN DT, 1984, NUCLEIC ACIDS RES, V12, P4185, DOI 10.1093/nar/12.10.4185; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; HIRSH D, 1970, NATURE, V228, P57, DOI 10.1038/228057a0; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kiryu H, 2011, BIOINFORMATICS, V27, P1788, DOI 10.1093/bioinformatics/btr276; Lusic H, 2008, NUCLEIC ACIDS RES, V36, P6548, DOI 10.1093/nar/gkn703; MARTIN RP, 1990, BIOCHEMISTRY-US, V29, P956, DOI 10.1021/bi00456a016; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Nobles KN, 2002, NUCLEIC ACIDS RES, V30, P4751, DOI 10.1093/nar/gkf595; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Sakurai M, 2005, FEBS LETT, V579, P2767, DOI 10.1016/j.febslet.2005.04.009; Sasuga J, 1999, J MOL EVOL, V48, P692, DOI 10.1007/PL00006513; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Shimayama T, 1990, NUCL ACIDS S SERIES, V22, P73; SIBLER AP, 1985, NUCLEIC ACIDS RES, V13, P1341, DOI 10.1093/nar/13.4.1341; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Suzuki T, 2011, J BIOL CHEM, V286, P35494, DOI 10.1074/jbc.M111.279810; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Takemoto C, 2009, NUCLEIC ACIDS RES, V37, P1616, DOI 10.1093/nar/gkp001; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P4291, DOI 10.1093/nar/27.21.4291; Tomita K, 1998, BBA-GENE STRUCT EXPR, V1399, P78, DOI 10.1016/S0167-4781(98)00099-2; Tomita K, 2002, J MOL EVOL, V54, P486, DOI 10.1007/s00239-001-0039-4; Tomita Kozo, 1997, Nucleic Acids Symposium Series, V37, P197; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Watanabe K, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/623095; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	39	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7645	7652		10.1074/jbc.M112.439554	http://dx.doi.org/10.1074/jbc.M112.439554			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362261	Green Published, hybrid			2022-12-28	WOS:000316455300021
J	Bansal, S; Anandatheerthavarada, HK; Prabu, GK; Milne, GL; Martin, MV; Guengerich, FP; Avadhani, NG				Bansal, Seema; Anandatheerthavarada, Hindupur K.; Prabu, Govindaswamy K.; Milne, Ginger L.; Martin, Martha V.; Guengerich, F. Peter; Avadhani, Narayan G.			Human Cytochrome P450 2E1 Mutations That Alter Mitochondrial Targeting Efficiency and Susceptibility to Ethanol-induced Toxicity in Cellular Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MONOXIDE-BINDING PIGMENT; OXIDATIVE STRESS; GENETIC POLYMORPHISMS; LIVER-MICROSOMES; ENDOPLASMIC-RETICULUM; METABOLIZING-ENZYMES; LIPID-PEROXIDATION; LUNG-CANCER; CYP2E1	Human polymorphisms in the 5'-upstream regulatory regions and also protein coding regions of cytochrome P450 2E1 (CYP2E1) are known to be associated with several diseases, including cancer and alcohol liver toxicity. In this study, we report novel mutations in the N-terminal protein targeting regions of CYP2E1 that markedly affect subcellular localization of the protein. Variant W23R/W30R protein (termed W23/30R) is preferentially targeted to mitochondria but very poorly to the endoplasmic reticulum, whereas the L32N protein is preferentially targeted to the endoplasmic reticulum and poorly to mitochondria. These results explain the physiological significance of bimodal CYP targeting to the endoplasmic reticulum and mitochondria previously described. COS-7 cells and HepG2 cells stably expressing W23/30R mutations showed markedly increased alcohol toxicity in terms of increased production of reactive oxygen species, respiratory dysfunction, and loss of cytochrome c oxidase subunits and activity. Stable cells expressing the L32N variant, on the other hand, were relatively less responsive to alcohol-induced toxicity and mitochondrial dysfunction. These results further support our previous data, based on mutational studies involving altered targeting, indicating that mitochondria-targeted CYP2E1 plays an important role in alcohol liver toxicity. The results also provide an interesting new link to genetic variations affecting subcellular distribution of CYP2E1 with alcohol-induced toxicity.	[Bansal, Seema; Anandatheerthavarada, Hindupur K.; Prabu, Govindaswamy K.; Avadhani, Narayan G.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bansal, Seema; Anandatheerthavarada, Hindupur K.; Prabu, Govindaswamy K.; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Milne, Ginger L.; Martin, Martha V.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Milne, Ginger L.; Martin, Martha V.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X	National Institutes of Health [R01 GM34883, R01 AA017749, R37 CA090426]; Harriet Ellison Woodward Trust; NATIONAL CANCER INSTITUTE [P30CA016520, R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM34883 and R01 AA017749 (to N. G. A.) and R37 CA090426 (to F. P. G.). This work was also supported by the Harriet Ellison Woodward Trust (to N. G. A.).	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Avadhani NG, 2011, FEBS J, V278, P4217, DOI 10.1111/j.1742-4658.2011.08355.x; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; Bhagwat SV, 2000, BIOCHEM PHARMACOL, V59, P573, DOI 10.1016/S0006-2952(99)00362-7; BHAT NK, 1984, BIOCHEM BIOPH RES CO, V118, P514, DOI 10.1016/0006-291X(84)91333-0; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; BONDY SC, 1992, TOXICOL LETT, V63, P231, DOI 10.1016/0378-4274(92)90086-Y; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; BOVERIS A, 1983, ARCH BIOCHEM BIOPHYS, V227, P534, DOI 10.1016/0003-9861(83)90482-4; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377; Dasari VR, 2006, J BIOL CHEM, V281, P30834, DOI 10.1074/jbc.M510725200; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; DICKER E, 1988, FASEB J, V2, P2901, DOI 10.1096/fasebj.2.13.3169467; Dong HB, 2009, MOL PHARMACOL, V75, P555, DOI 10.1124/mol.108.051888; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Dostalek M, 2007, MOL PHARMACOL, V72, P1419, DOI 10.1124/mol.107.040238; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; El-Zein R, 1997, MUTAT RES-FUND MOL M, V381, P189, DOI 10.1016/S0027-5107(97)00166-8; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; Eliasson E, 1998, CHEM-BIOL INTERACT, V116, P123, DOI 10.1016/S0009-2797(98)00081-7; Farker K, 1998, EXP TOXICOL PATHOL, V50, P425, DOI 10.1016/S0940-2993(98)80029-8; Fernandez-Checa JC, 1997, ALCOHOL HEALTH RES W, V21, P321; French SW, 1997, J NUTR, V127, pS907, DOI 10.1093/jn/127.5.907S; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Gonzalez FJ, 2007, DRUG METAB DISPOS, V35, P1, DOI 10.1124/dmd.106.012492; GUENGERICH FP, 1982, XENOBIOTICA, V12, P701, DOI 10.3109/00498258209038945; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1; Hu Y, 1997, MOL PHARMACOL, V51, P370; Ingelman-Sundberg M, 2005, PHILOS T R SOC B, V360, P1563, DOI 10.1098/rstb.2005.1685; Knockaert L, 2011, TOXICOL IN VITRO, V25, P475, DOI 10.1016/j.tiv.2010.11.019; KOCH JA, 1991, METHOD ENZYMOL, V206, P305; Kongruttanachok N, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-4; Konishi T, 2003, EXP MOL PATHOL, V74, P183, DOI 10.1016/S0014-4800(03)00006-6; Koop DR, 2006, ALCOHOL RES HEALTH, V29, P274; KOOP DR, 1990, BIOESSAYS, V12, P429, DOI 10.1002/bies.950120906; KOOP DR, 1986, ALCOHOL CLIN EXP RES, V10, pS44, DOI 10.1111/j.1530-0277.1986.tb05179.x; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Marchand L, 1999, CANCER EPIDEM BIOMAR, V8, P495; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lieber C S, 1994, Alcohol Alcohol Suppl, V2, P315; Lieber CS, 2004, HEPATOL RES, V28, P1, DOI 10.1016/j.hepres.2003.08.001; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Lin DX, 1998, CANCER EPIDEM BIOMAR, V7, P1013; Liu S, 2001, ORAL ONCOL, V37, P437, DOI 10.1016/S1368-8375(00)00099-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720; Morrow Jason D, 2002, Methods Mol Biol, V186, P57; Neve EPA, 1999, FEBS LETT, V460, P309, DOI 10.1016/S0014-5793(99)01361-7; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; RASHBASTEP J, 1993, ARCH BIOCHEM BIOPHYS, V300, P391, DOI 10.1006/abbi.1993.1053; Robin MA, 2005, FEBS LETT, V579, P6895, DOI 10.1016/j.febslet.2005.11.029; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Sangar MC, 2010, MOL GENET METAB, V99, P90, DOI 10.1016/j.ymgme.2009.08.009; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Shields PG, 1996, MOL CARCINOGEN, V17, P144, DOI 10.1002/(SICI)1098-2744(199611)17:3<144::AID-MC6>3.0.CO;2-F; SONG BJ, 1986, J BIOL CHEM, V261, P6689; Sun F, 2002, BEHAV GENET, V32, P229, DOI 10.1023/A:1019711812074; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; UEMATSU F, 1994, PHARMACOGENETICS, V4, P58, DOI 10.1097/00008571-199404000-00002; UEMATSU F, 1992, TOHOKU J EXP MED, V168, P113; UEMATSU F, 1991, JPN J CANCER RES, V82, P254, DOI 10.1111/j.1349-7006.1991.tb01838.x; Vodicka P, 2001, MUTAT RES-FUND MOL M, V482, P89, DOI 10.1016/S0027-5107(01)00214-7; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu XF, 1997, CARCINOGENESIS, V18, P967, DOI 10.1093/carcin/18.5.967; Wu XF, 1998, CANCER EPIDEM BIOMAR, V7, P13; YAMAZAKI H, 1992, CARCINOGENESIS, V13, P1789, DOI 10.1093/carcin/13.10.1789; ZANGAR RC, 1995, DRUG METAB DISPOS, V23, P681	84	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12627	12644		10.1074/jbc.M113.452367	http://dx.doi.org/10.1074/jbc.M113.452367			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23471973	Green Published, hybrid			2022-12-28	WOS:000318555100021
J	Bocian, C; Urbanowitz, AK; Owens, RT; Iozzo, RV; Gotte, M; Seidler, DG				Bocian, Carla; Urbanowitz, Ann-Kathrin; Owens, Rick T.; Iozzo, Renato V.; Goette, Martin; Seidler, Daniela G.			Decorin Potentiates Interferon-gamma Activity in a Model of Allergic Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTACT HYPERSENSITIVITY RESPONSE; DELAYED-TYPE HYPERSENSITIVITY; ENDOTHELIAL-GROWTH-FACTOR; TOLL-LIKE RECEPTOR; IFN-GAMMA; INDUCIBLE PROTEIN-10; T-CELLS; SKIN INFLAMMATION; MURINE MODEL; MAST-CELLS	The proteoglycan decorin modulates leukocyte recruitment during delayed-type hypersensitivity responses. Decorin-deficient (Dcn(-/-)) mice show reduced edema formation during the first 24 h with a concurrent attenuated recruitment of CD8(+) leukocytes in the inflamed Dcn(-/-) ears. The aim of this study was to elucidate the molecular pathways affected by the loss of decorin. In vivo, reduced numbers of CD8(+) cells in Dcn(-/-) ears correlated with a reduced interferon-gamma (Ifn-gamma) and CXCL-10 expression. In vitro, Dcn(-/-) lymphocytes displayed an increased adhesion to brain microvascular (bEnd.3) endothelial cells. Decorin treatment of bEnd.3 increased Icam1 and down-regulated Vcam1 expression after TNF-alpha stimulation. However, Dcn(-/-) and wild-type lymphocytes produced IFN-gamma after activation with CD3 epsilon. Upon incubation with decorin, endothelial cells and fibroblasts responded differently to IFN-gamma and TNF-alpha; CCL2 in bEnd.3 cells was more prominently up-regulated by TNF-alpha compared with IFN-gamma. Notably, both factors were more potent in the presence of decorin. Compared with TNF-alpha, IFN-gamma treatment induced significantly more CXCL-10, and both factors increased synthesis of CXCL-10 in the presence of decorin. The response to IFN-gamma was similar in Dcn(-/-) and wild-type fibroblasts, an additional source of CXCL-10. However, addition of decorin yielded significantly more CXCL-10. Notably, decorin increased the stability of IFN-gamma in vitro and potentiated IFN-gamma-induced activation of STAT-1. Furthermore, only dermatan sulfate influenced IFN-gamma signaling by significantly increasing CXCL-10 expression in contrast to decorin protein core alone. Our data demonstrate that decorin modulates delayed-type hypersensitivity responses by augmenting the induction of downstream effector cytokines of IFN-gamma and TNF-alpha, thereby influencing the recruitment of CD8(+) lymphocytes into the inflamed tissue.	[Bocian, Carla; Urbanowitz, Ann-Kathrin; Seidler, Daniela G.] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Bocian, Carla; Urbanowitz, Ann-Kathrin; Goette, Martin] Munster Univ Hosp, Dept Gynecol & Obstet, D-48149 Munster, Germany; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	University of Munster; University of Munster; Jefferson University; Jefferson University	Seidler, DG (corresponding author), Univ Munster, UKM, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	dgseidle@uni-muenster.de	Iozzo, Renato/AAS-1980-2020; Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018	Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496; Iozzo, Renato/0000-0002-5908-5112	Innovative Medizinische Forschung of the Medical Faculty Munster Grant [I-SE 12 08 11]; Deutsche Forschungsgemeinschaft Grant [SE1431/3-1]; International Research Training Group "Molecular and Cellular GlycoSciences" Grant [GRK 1549]; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER	Innovative Medizinische Forschung of the Medical Faculty Munster Grant; Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); International Research Training Group "Molecular and Cellular GlycoSciences" Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Innovative Medizinische Forschung of the Medical Faculty Munster Grant I-SE 12 08 11, Deutsche Forschungsgemeinschaft Grant SE1431/3-1 (to D. G. S. and M. G.), and International Research Training Group "Molecular and Cellular GlycoSciences" Grant GRK 1549 (to A. K. U.).	Ahlfors EE, 2010, SCAND J IMMUNOL, V72, P8, DOI 10.1111/j.1365-3083.2010.02402.x; Anthoni M, 2008, BRIT J DERMATOL, V159, P546, DOI 10.1111/j.1365-2133.2008.08696.x; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Brooks B, 2000, J IMMUNOL, V164, P573, DOI 10.4049/jimmunol.164.2.573; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Comalada M, 2003, J IMMUNOL, V170, P4450, DOI 10.4049/jimmunol.170.9.4450; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Engeman T, 2004, J LEUKOCYTE BIOL, V76, P941, DOI 10.1189/jlb.0304193; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; Fernandez-Botran R, 1999, CYTOKINE, V11, P313, DOI 10.1006/cyto.1998.0438; Flacher V, 2008, IMMUNOLOGY, V123, P339, DOI 10.1111/j.1365-2567.2007.02785.x; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; GOKA AKJ, 1987, J IMMUNOASSAY, V8, P29, DOI 10.1080/01971528708063053; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; GOTTE M, 1995, EUR J CELL BIOL, V66, P226; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hope JC, 2000, EUR J IMMUNOL, V30, P197, DOI 10.1002/1521-4141(200001)30:1<197::AID-IMMU197>3.3.CO;2-0; Huckel M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1869; Itakura A, 2006, INT ARCH ALLERGY IMM, V140, P8, DOI 10.1159/000092705; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Jungmann O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050809; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kish DD, 2011, J IMMUNOL, V186, P2117, DOI 10.4049/jimmunol.1002337; Ku HO, 2009, TOXICOL LETT, V190, P231, DOI 10.1016/j.toxlet.2009.07.022; Kusumoto M, 2007, J INTERF CYTOK RES, V27, P901, DOI 10.1089/jir.2006.0064; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Lehtimaki S, 2010, J INVEST DERMATOL, V130, P2743, DOI 10.1038/jid.2010.208; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchica CL, 2011, AM J PHYSIOL-LUNG C, V300, pL863, DOI 10.1152/ajplung.00300.2009; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; Penc SF, 1999, J CLIN INVEST, V103, P1329, DOI 10.1172/JCI4742; PORTOLES P, 1989, J IMMUNOL, V142, P4169; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; Reeves EP, 2010, J IMMUNOL, V184, P1642, DOI 10.4049/jimmunol.0902605; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Salek-Ardakani S, 2000, BLOOD, V96, P1879, DOI 10.1182/blood.V96.5.1879.h8001879_1879_1888; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Seidler DG, 2005, BIOCHEM BIOPH RES CO, V332, P1162, DOI 10.1016/j.bbrc.2005.04.175; Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961; Shibata M, 2005, J DERMATOL, V32, P523, DOI 10.1111/j.1346-8138.2005.tb00794.x; Tamassia N, 2007, EUR J IMMUNOL, V37, P2627, DOI 10.1002/eji.200737340; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; THOMSON JA, 1993, IMMUNOLOGY, V78, P185; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Wang BH, 2002, J IMMUNOL, V168, P3303, DOI 10.4049/jimmunol.168.7.3303; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Xu H, 1997, J IMMUNOL, V158, P4721; Yin Y, 2011, EUR J PHARMACOL, V651, P205, DOI 10.1016/j.ejphar.2010.10.068; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zamfir AD, 2009, PROTEOMICS, V9, P3435, DOI 10.1002/pmic.200800440	67	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12699	12711		10.1074/jbc.M112.419366	http://dx.doi.org/10.1074/jbc.M112.419366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23460644	Green Published, hybrid			2022-12-28	WOS:000318555100027
J	Donnelly, BF; Needham, PG; Snyder, AC; Roy, A; Khadem, S; Brodsky, JL; Subramanya, AR				Donnelly, Bridget F.; Needham, Patrick G.; Snyder, Avin C.; Roy, Ankita; Khadem, Shaheen; Brodsky, Jeffrey L.; Subramanya, Arohan R.			Hsp70 and Hsp90 Multichaperone Complexes Sequentially Regulate Thiazide-sensitive Cotransporter Endoplasmic Reticulum-associated Degradation and Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NA-CL COTRANSPORTER; HEAT-SHOCK PROTEINS; CHAPERONE MACHINERY; QUALITY-CONTROL; MOLECULAR CHAPERONES; GITELMANS-SYNDROME; MUTATIONS; CHIP; CFTR	The thiazide-sensitive NaCl cotransporter (NCC) is the primary mediator of salt reabsorption in the distal convoluted tubule and is a key determinant of the blood pressure set point. Given its complex topology, NCC is inefficiently processed and prone to endoplasmic reticulum (ER)-associated degradation (ERAD), although the mechanisms governing this process remain obscure. Here, we identify factors that impact the ER quality control of NCC. Analyses of NCC immunoprecipitates revealed that the cotransporter formed complexes with the core chaperones Hsp90, Hsp70, and Hsp40. Disruption of Hsp90 function accelerated NCC degradation, suggesting that Hsp90 promotes NCC folding. In addition, two cochaperones, the C terminus of Hsp70-interacting protein (CHIP) and the Hsp70/Hsp90 organizer protein, were associated with NCC. Although CHIP, an E3 ubiquitin ligase, promoted NCC ubiquitination and ERAD, the Hsp70/Hsp90 organizer protein stabilized NCC turnover, indicating that these two proteins differentially remodel the core chaperone systems to favor cotransporter degradation and biogenesis, respectively. Adjusting the folding environment in mammalian cells via reduced temperature enhanced NCC biosynthetic trafficking, increased Hsp90-NCC interaction, and diminished binding to Hsp70. In contrast, cotransporters harboring disease-causing mutations that impair NCC biogenesis failed to escape ERAD as efficiently as the wild type protein when cells were incubated at a lower temperature. Instead, these mutants interacted more strongly with Hsp70, Hsp40, and CHIP, consistent with a role for the Hsp70/Hsp40 system in selecting misfolded NCC for ERAD. Collectively, these observations indicate that Hsp70 and Hsp90 comprise two functionally distinct ER quality control checkpoints that sequentially monitor NCC biogenesis.	[Needham, Patrick G.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Donnelly, Bridget F.; Snyder, Avin C.; Roy, Ankita; Khadem, Shaheen; Subramanya, Arohan R.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Khadem, Shaheen; Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Subramanya, AR (corresponding author), 3550 Terrace St,S832 Scaife Hall, Pittsburgh, PA 15261 USA.	ars129@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643; ROY, ANKITA/0000-0002-3032-6365	National Institutes of Health [DK79307, GM75061]; U.S. Dept. of Veterans Affairs; James A. Shaver Fund of the American Heart Association [10BGIA3890010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); James A. Shaver Fund of the American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79307 (to the Pittsburgh Center for Kidney Research, Model Organisms Core) and GM75061 (to J. L. B.). This work was also supported by a Mid-Level Career Development Award from the U.S. Dept. of Veterans Affairs (to A. R. S.) and Grant 10BGIA3890010 from the James A. Shaver Fund of the American Heart Association (to A. R. S.).	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Warmuth S, 2009, STRUCTURE, V17, P538, DOI 10.1016/j.str.2009.02.009; Whitesell L, 2012, CURR MOL MED, V12, P1108, DOI 10.2174/156652412803306657; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	52	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13124	13135		10.1074/jbc.M113.455394	http://dx.doi.org/10.1074/jbc.M113.455394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23482560	hybrid, Green Published			2022-12-28	WOS:000318555100062
J	Ejarque, M; Cervantes, S; Pujadas, G; Tutusaus, A; Sanchez, L; Gasa, R				Ejarque, Miriam; Cervantes, Sara; Pujadas, Gemma; Tutusaus, Anna; Sanchez, Lidia; Gasa, Rosa			Neurogenin3 Cooperates with Foxa2 to Autoactivate Its Own Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MALABSORPTIVE DIARRHEA; PANCREATIC-ISLET DIFFERENTIATION; CELL-DIFFERENTIATION; TRANSCRIPTION FACTORS; PROGENITOR CELLS; BETA-CELL; GENE; ENDOCRINE; AUTOREGULATION; NETWORK	The transcription factor Neurogenin3 functions as a master regulator of endocrine pancreas formation, and its deficiency leads to the development of diabetes in humans and mice. In the embryonic pancreas, Neurogenin3 is transiently expressed at high levels for a narrow time window to initiate endocrine differentiation in scattered progenitor cells. The mechanisms controlling these rapid and robust changes in Neurogenin3 expression are poorly understood. In this study, we characterize a Neurogenin3 positive autoregulatory loop whereby this factor may rapidly induce its own levels. We show that Neurogenin3 binds to a conserved upstream fragment of its own gene, inducing deposition of active chromatin marks and the activation of Neurog3 transcription. Additionally, we show that the broadly expressed endodermal forkhead factors Foxa1 and Foxa2 can cooperate synergistically to amplify Neurogenin3 autoregulation in vitro. However, only Foxa2 colocalizes with Neurogenin3 in pancreatic progenitors, thus indicating a primary role for this factor in regulating Neurogenin3 expression in vivo. Furthermore, in addition to decreasing Neurog3 autoregulation, inhibition of Foxa2 by RNA interference attenuates Neurogenin3-dependent activation of the endocrine developmental program in cultured duct mPAC cells. Hence, these data uncover the potential functional cooperation between the endocrine lineage-determining factor Neurogenin3 and the widespread endoderm progenitor factor Foxa2 in the implementation of the endocrine developmental program in the pancreas.	[Ejarque, Miriam; Cervantes, Sara; Pujadas, Gemma; Tutusaus, Anna; Sanchez, Lidia; Gasa, Rosa] IDIBAPS, Hosp Clin, Diabet & Obes Lab, Barcelona 08036, Spain; [Ejarque, Miriam; Cervantes, Sara; Pujadas, Gemma; Sanchez, Lidia; Gasa, Rosa] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona 08036, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Gasa, R (corresponding author), IDIBAPS, Lab Diabet & Obes, C Rossello 153, Barcelona 08036, Spain.	rgasa@clinic.ub.es	Ejarque, Miriam/H-1503-2015; Tutusaus, Anna/AAA-2353-2020	Ejarque, Miriam/0000-0003-0545-9817; Tutusaus, Anna/0000-0002-1133-321X; Pujadas, Gemma/0000-0002-3871-5883	Spanish Ministerio de Ciencia e Innovacion [BFU2008-02299/BMC]; IDIBAPS; European Community [229673]; NICHD	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); IDIBAPS; European Community(European Commission); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (BFU2008-02299/BMC) (to R. G.). Predoctoral fellowships were provided by IDIBAPS (to M. E.) and by the Spanish Ministerio de Ciencia e Innovacion (to G. P.). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2009-2013) under Grant Agreement No 229673 (to S. C.).; We thank Dr. M. Parrizas for critical reading of this manuscript. The mouse monoclonal antibodies against Neurog3 and Nkx6.1 were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Beucher A, 2012, DEV BIOL, V361, P277, DOI 10.1016/j.ydbio.2011.10.025; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hermsen R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000813; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Lantz KA, 2005, CLIN SCI, V108, P195, DOI 10.1042/CS20040309; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Masui T, 2008, MOL CELL BIOL, V28, P5458, DOI 10.1128/MCB.00549-08; Miyatsuka T, 2009, DIABETES, V58, P1863, DOI 10.2337/db09-0390; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pinney SE, 2011, J CLIN ENDOCR METAB, V96, P1960, DOI 10.1210/jc.2011-0029; Pujadas G, 2011, DIFFERENTIATION, V82, P66, DOI 10.1016/j.diff.2011.05.006; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Rubio-Cabezas O, 2011, DIABETES, V60, P1349, DOI 10.2337/db10-1008; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shih HP, 2012, DEVELOPMENT, V139, P2488, DOI 10.1242/dev.078634; Siciliano V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002074; Smith SB, 2004, MOL ENDOCRINOL, V18, P142, DOI 10.1210/me.2003-0037; Smith SB, 2003, J BIOL CHEM, V278, P38254, DOI 10.1074/jbc.M302229200; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Thompson N, 2012, MOL CELL BIOL, V32, P1189, DOI 10.1128/MCB.06318-11; Villasenor A, 2008, DEV DYNAM, V237, P3270, DOI 10.1002/dvdy.21740; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Yang Y, 2011, DIABETOLOGIA, V54, P2595, DOI 10.1007/s00125-011-2255-9; Yechoor V, 2009, ENDOCRINOLOGY, V150, P4863, DOI 10.1210/en.2009-0527; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; ZINGG JM, 1994, NUCLEIC ACIDS RES, V22, P2234, DOI 10.1093/nar/22.12.2234; zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015	49	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11705	11717		10.1074/jbc.M112.388173	http://dx.doi.org/10.1074/jbc.M112.388173			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23471965	Green Published, hybrid			2022-12-28	WOS:000318157600008
J	Kemble, DJ; Whitby, FG; Robinson, H; McCullough, LL; Formosa, T; Hill, CP				Kemble, David J.; Whitby, Frank G.; Robinson, Howard; McCullough, Laura L.; Formosa, Tim; Hill, Christopher P.			Structure of the Spt16 Middle Domain Reveals Functional Features of the Histone Chaperone FACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; BINDING; TRANSCRIPTION; REPLICATION; H3-H4; DNA; CHROMATIN	The histone chaperone FACT is an essential and abundant heterodimer found in all eukaryotes. Here we report a crystal structure of the middle domain of the large subunit of FACT (Spt16-M) to reveal a double pleckstrin homology architecture. This structure was found previously in the Pob3-M domain of the small subunit of FACT and in the related histone chaperone Rtt106, although Spt16-M is distinguished from these structures by the presence of an extended alpha-helix and a C-terminal addition. Consistent with our finding that the double pleckstrin homology structure is common to these three histone chaperones and reports that Pob3 and Rtt106 double pleckstrin homology domains bind histones H3-H4, we also find that Spt16-M binds H3-H4 with low micromolar affinity. Our structure provides a framework for interpreting a large body of genetic data regarding the physiological functions of FACT, including the identification of potential interaction surfaces for binding histones or other proteins.	[Kemble, David J.; Whitby, Frank G.; McCullough, Laura L.; Formosa, Tim; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Formosa, T (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	tim@biochem.utah.edu; chris@biochem.utah.edu		Formosa, Tim/0000-0002-8477-2483	National Institutes of Health [R01 GM59135, GM064649]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064649, R01GM059135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM59135 (to C. P. H. and T. F.) and GM064649 (to T. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Hainer SJ, 2012, G3-GENES GENOM GENET, V2, P555, DOI 10.1534/g3.112.002451; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; McCullough L, 2011, GENETICS, V188, P835, DOI 10.1534/genetics.111.128769; Myers CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020847; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0; Zunder RM, 2012, P NATL ACAD SCI USA, V109, pE144, DOI 10.1073/pnas.1119095109	30	44	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10188	10194		10.1074/jbc.C113.451369	http://dx.doi.org/10.1074/jbc.C113.451369			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23417676	Green Published, hybrid			2022-12-28	WOS:000317565000001
J	Kilari, S; Remadevi, I; Zhao, BF; Pan, J; Miao, R; Ramchandran, R; North, PE; You, M; Rahimi, N; Wilkinson, GA				Kilari, Sreenivasulu; Remadevi, Indulekha; Zhao, Baofeng; Pan, Jing; Miao, Robert; Ramchandran, Ramani; North, Paula E.; You, Ming; Rahimi, Nader; Wilkinson, George A.			Endothelial Cell-specific Chemotaxis Receptor (ECSCR) Enhances Vascular Endothelial Growth Factor (VEGF) Receptor-2/Kinase Insert Domain Receptor (KDR) Activation and Promotes Proteolysis of Internalized KDR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR ANGIOGENESIS; HUMAN PLACENTA; NEUROPILIN-1; EXPRESSION; MIGRATION; ZEBRAFISH; PATHWAY; BINDING; UBIQUITINATION; IDENTIFICATION	The endothelial cell-specific chemotaxis receptor (ECSCR) is a cell-surface protein selectively expressed by endothelial cells (ECs), with roles in EC migration, apoptosis and proliferation. Our previous study (Verma, A., Bhattacharya, R., Remadevi, I., Li, K., Pramanik, K., Samant, G. V., Horswill, M., Chun, C. Z., Zhao, B., Wang, E., Miao, R. Q., Mukhopadhyay, D., Ramchandran, R., and Wilkinson, G. A. (2010) Blood 115, 4614-4622) showed that loss of ECSCR in primary ECs reduced tyrosine phosphorylation of vascular endothelial growth factor (VEGF) receptor 2/kinase insert domain receptor (KDR) but not VEGF receptor 1/FLT1. Here, we show that ECSCR biochemically associates with KDR but not FLT1 and that the predicted ECSCR cytoplasmic and transmembrane regions can each confer association with KDR. Stimulation with VEGF(165) rapidly and transiently increases ECSCR-KDR complex formation, a process blocked by the KDR tyrosine kinase inhibitor compound SU5416 or inhibitors of endosomal acidification. Triple labeling experiments show VEGF-stimulated KDR+/ECSCR+ intracellular co-localization. Silencing of ECSCR disrupts VEGF-induced KDR activation and AKT and ERK phosphorylation and impairs VEGF-stimulated KDR degradation. In zebrafish, ecscr interacts with kdrl during intersomitic vessel sprouting. Human placenta and infantile hemangioma samples highly express ECSCR protein, suggesting a role for ECSCR-KDR interaction in these tissues.	[Kilari, Sreenivasulu; Remadevi, Indulekha; Ramchandran, Ramani; Wilkinson, George A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Kilari, Sreenivasulu; Remadevi, Indulekha; Ramchandran, Ramani; Wilkinson, George A.] Med Coll Wisconsin, Dev Vasc Biol Program, Milwaukee, WI 53226 USA; [Zhao, Baofeng; Miao, Robert] Med Coll Wisconsin, Div Pediat Surg, Milwaukee, WI 53226 USA; [Zhao, Baofeng; Miao, Robert] Med Coll Wisconsin, Div Pediat Pathol, Milwaukee, WI 53226 USA; [Zhao, Baofeng; Miao, Robert] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Zhao, Baofeng; Miao, Robert] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Pan, Jing; You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [North, Paula E.] Med Coll Wisconsin, Dept Pathol & Lab Med, Milwaukee, WI 53226 USA; Childrens Res Inst, Milwaukee, WI 53226 USA; [Rahimi, Nader] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Rahimi, Nader] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Boston University; Boston University	Wilkinson, GA (corresponding author), Dev Vasc Biol Program, TBRC-CRI C-3415,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gwilkins@mcw.edu	Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238; Kilari, Sreenivasulu/0000-0002-9149-7360; Rahimi, Nader/0000-0002-6745-1725	Children's Research Institute; American Heart Association [11SDG5310020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108938, R01HL112639] Funding Source: NIH RePORTER	Children's Research Institute; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Children's Research Institute startup funds and American Heart Association Scientist Development Grant 11SDG5310020 (to G. A. W.).	Armstrong LJ, 2008, ARTERIOSCL THROM VAS, V28, P1640, DOI 10.1161/ATVBAHA.108.162511; Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chun CZ, 2009, BLOOD, V113, P1192, DOI 10.1182/blood-2008-06-162156; Clark DE, 1996, HUM REPROD, V11, P1090; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Horowitz A, 2012, CELL SIGNAL, V24, P1810, DOI 10.1016/j.cellsig.2012.05.007; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P8227, DOI 10.1073/pnas.0806780106; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Koide M, 2011, P NATL ACAD SCI USA, V108, P9472, DOI 10.1073/pnas.1101296108; LEIJH PCJ, 1984, INFECT IMMUN, V46, P448, DOI 10.1128/IAI.46.2.448-452.1984; Ma FX, 2009, GENES CELLS, V14, P281, DOI 10.1111/j.1365-2443.2008.01267.x; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; North PE, 2006, CARDIOVASC PATHOL, V15, P303, DOI 10.1016/j.carpath.2006.03.001; North PE, 2001, ARCH DERMATOL, V137, P559; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rainero E, 2011, SCI SIGNAL, V4, P1, DOI 10.1126/scisignal.2002053; Raldua D, 2008, TOXICOL APPL PHARM, V228, P301, DOI 10.1016/j.taap.2007.11.016; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Shi CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021482; Sinha S, 2009, J CELL SCI, V122, P3385, DOI 10.1242/jcs.053124; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Verma A, 2010, BLOOD, V115, P4614, DOI 10.1182/blood-2009-10-248856; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; You MS, 2013, CANCER METAST REV, V32, P77, DOI 10.1007/s10555-012-9406-4	39	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10265	10274		10.1074/jbc.M112.413542	http://dx.doi.org/10.1074/jbc.M112.413542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23393131	Green Published, hybrid			2022-12-28	WOS:000317565000008
J	Krasikova, YS; Rechkunova, NI; Maltseva, EA; Pestryakov, PE; Petruseva, IO; Sugasawa, K; Chen, XJ; Min, JH; Lavrik, OI				Krasikova, Yuliya S.; Rechkunova, Nadejda I.; Maltseva, Ekaterina A.; Pestryakov, Pavel E.; Petruseva, Irina O.; Sugasawa, Kaoru; Chen, Xuejing; Min, Jung-Hyun; Lavrik, Olga I.			Comparative Analysis of Interaction of Human and Yeast DNA Damage Recognition Complexes with Damaged DNA in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-C PROTEIN; XPA-RPA; MECHANISMS; XPC-HR23B; NUCLEASE; AFFINITY; LINKING; BINDING; CHECK; TFIIH	The human XPC-RAD23B complex and its yeast ortholog, Rad4-Rad23, are the primary initiators of global genome nucleotide excision repair. The interaction of these proteins with damaged DNA was analyzed using model DNA duplexes containing a single fluorescein-substituted dUMP analog as a lesion. An electrophoretic mobility shift assay revealed similarity between human and yeast proteins in DNA binding. Quantitative analyses of XPC/Rad4 binding to the model DNA structures were performed by fluorescent depolarization measurements. XPC-RAD23B and Rad4-Rad23 proteins demonstrate approximately equal binding affinity to the damaged DNA duplex (K-D similar to (0.5 +/- 0.1) and (0.6 +/- 0.3) nM, respectively). Using photoreactive DNA containing 5-iodo-dUMP in defined positions, XPC/Rad4 location on damaged DNA was shown. Under conditions of equimolar binding to DNA both proteins exhibited the highest level of cross-links to 5I-dUMP located exactly opposite the damaged nucleotide. The positioning of the XPC and Rad4 proteins on damaged DNA by photocross-linking footprinting is consistent with x-ray analysis of the Rad4-DNA crystal complex. The identity of the XPC and Rad4 location illustrates the common principles of structure organization of DNA damage-scanning proteins from different Eukarya organisms.	[Krasikova, Yuliya S.; Rechkunova, Nadejda I.; Maltseva, Ekaterina A.; Pestryakov, Pavel E.; Petruseva, Irina O.; Lavrik, Olga I.] Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia; [Rechkunova, Nadejda I.; Lavrik, Olga I.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Sugasawa, Kaoru] Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Chen, Xuejing; Min, Jung-Hyun] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University; Kobe University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lavrik, OI (corresponding author), Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia.	lavrik@niboch.nsc.ru	Pestryakov, Pavel/AAH-2022-2020; Krasikova, Yuliya S/G-4748-2013; Rechkunova, Nadezda I/G-5093-2013; Petruseva, Irina/AAE-8923-2021; Maltseva, Ekaterina/ABE-2612-2021; Lavrik, Olga I/G-4641-2013; Maltseva, Ekaterina/G-6953-2013	Pestryakov, Pavel/0000-0003-3277-5321; Maltseva, Ekaterina/0000-0002-6800-5989; Min, Jung-Hyun/0000-0002-4221-9321	Russian Foundation for Basic Research [10-04-00837, 12-04-31323, 12-04-33162, 13-04-00538]; Russian Ministry of Education and Science [14.B37.21.0188]; program of the Presidium of Russian Academy of Sciences "Molecular and Cellular Biology"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); program of the Presidium of Russian Academy of Sciences "Molecular and Cellular Biology"	This work was supported by Russian Foundation for Basic Research Grants 10-04-00837, 12-04-31323, 12-04-33162, and 13-04-00538; the Russian Ministry of Education and Science Contract 14.B37.21.0188; and the program of the Presidium of Russian Academy of Sciences "Molecular and Cellular Biology."	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; Bunick CG, 2006, BIOCHEMISTRY-US, V45, P14965, DOI 10.1021/bi061370o; Camenisch U, 2009, EMBO J, V28, P2387, DOI 10.1038/emboj.2009.187; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Fagbemi AF, 2011, DNA REPAIR, V10, P722, DOI 10.1016/j.dnarep.2011.04.022; Guzder SN, 1998, J BIOL CHEM, V273, P31541, DOI 10.1074/jbc.273.47.31541; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hey T, 2002, BIOCHEMISTRY-US, V41, P6583, DOI 10.1021/bi012202t; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jansen LET, 1998, J BIOL CHEM, V273, P33111, DOI 10.1074/jbc.273.50.33111; Krasikova YS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P886, DOI 10.1134/S0006297908080063; Krasikova YS, 2010, NUCLEIC ACIDS RES, V38, P8083, DOI 10.1093/nar/gkq649; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Maillard O, 2007, PLOS BIOL, V5, P717, DOI 10.1371/journal.pbio.0050079; Maltseva EA, 2007, BBA-GEN SUBJECTS, V1770, P781, DOI 10.1016/j.bbagen.2007.01.007; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nishi R, 2005, MOL CELL BIOL, V25, P5664, DOI 10.1128/MCB.25.13.5664-5674.2005; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Overmeer RM, 2011, J CELL BIOL, V192, P401, DOI 10.1083/jcb.201006011; Petruseva IO, 2008, J MOL RECOGNIT, V21, P154, DOI 10.1002/jmr.877; Reardon JT, 1996, J BIOL CHEM, V271, P19451, DOI 10.1074/jbc.271.32.19451; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Sambrook J., 1989, MOL CLONING LAB MANU; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scharer OD, 2003, ANGEW CHEM INT EDIT, V42, P2946, DOI 10.1002/anie.200200523; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Thoma BS, 2003, MOL CARCINOGEN, V38, P1, DOI 10.1002/mc.10143; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	37	20	25	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10936	10947		10.1074/jbc.M112.444026	http://dx.doi.org/10.1074/jbc.M112.444026			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443653	Green Published, hybrid			2022-12-28	WOS:000317565000070
J	Snyder, JC; Rochelle, LK; Lyerly, HK; Caron, MG; Barak, LS				Snyder, Joshua C.; Rochelle, Lauren K.; Lyerly, H. Kim; Caron, Marc G.; Barak, Lawrence S.			Constitutive Internalization of the Leucine-rich G Protein-coupled Receptor-5 (LGR5) to the Trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; BETA-ARRESTIN; WNT/BETA-CATENIN; RETROGRADE TRANSPORT; PLASMA-MEMBRANE; HAIR FOLLICLE; WNT RECEPTORS; SELF-RENEWAL; IN-VITRO; PHOSPHORYLATION	LGR5 is a Wnt pathway associated G protein-coupled receptor (GPCR) that serves as a molecular determinant of stem cells in numerous tissues including the intestine, stomach, hair follicle, eye, and mammary gland. Despite its importance as a marker for this critical niche, little is known about LGR5 signaling nor the biochemical mechanisms and receptor determinants that regulate LGR5 membrane expression and intracellular trafficking. Most importantly, in cells LGR5 is predominantly intracellular, yet the mechanisms underlying this behavior have not been determined. In this work we elucidate a precise trafficking program for LGR5 and identify the motif at its C terminus that is responsible for the observed constitutive internalization. We show that this process is dependent upon dynamin GTPase activity and find that wild-type full-length LGR5 rapidly internalizes into EEA1- and Rab5-positive endosomes. However, LGR5 fails to rapidly recycle to the plasmid membrane through Rab4-positive vesicles, as is common for other GPCRs. Rather, internalized LGR5 transits through Rab7- and Rab9-positive vesicles, co-localizes in vesicles with Vps26, a retromer complex component that regulates retrograde trafficking to the trans-Golgi network (TGN) and reaches a steady-state distribution in the TGN within 2 h. Using mutagenesis, particularly of putative phosphorylation sites, we show that the amino acid pair, serine 861 and 864, is the principal C-tail determinant that mediates LGR5 constitutive internalization. The constitutive internalization of LGR5 to the TGN suggests the existence of novel biochemical roles for its Wnt pathway related, but ill defined signaling program.	[Snyder, Joshua C.; Rochelle, Lauren K.; Caron, Marc G.; Barak, Lawrence S.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287, Durham, NC 27710 USA.	marc.caron@dm.duke.edu; lawrence.barak@dm.duke.edu	Lyerly, Herbert Kim/AAX-4925-2020; Lyerly, Herbert K/B-6528-2014	Lyerly, Herbert Kim/0000-0002-0063-4770; Lyerly, Herbert K/0000-0002-0063-4770; Snyder, Joshua/0000-0002-9787-3371	Susan G. Komen Foundation [KG080627]; Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; National Institute of Drug Abuse [P30 5P30DA29925]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA029925] Funding Source: NIH RePORTER	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Susan G. Komen Foundation Grant KG080627 (to J.C.S. and H. K. L.); Duke Cancer Center Stewart Trust and Duke Cancer Center Cancer and the Environment (to J.C.S., L. K. R., L. S. B., and M. C. G.); and National Institute of Drug Abuse Grant P30 5P30DA29925 (to L. S. B. and M.G.C.).	BARAK LS, 1994, J BIOL CHEM, V269, P2790; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Brzeszczynska J, 2012, INT J MOL MED, V29, P871, DOI 10.3892/ijmm.2012.904; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Chia PZC, 2011, J CELL SCI, V124, P2401, DOI 10.1242/jcs.083782; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; RIOS RM, 1994, J CELL BIOL, V125, P997, DOI 10.1083/jcb.125.5.997; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Snyder JC, 2009, AM J RESP CELL MOL, V40, P633, DOI 10.1165/rcmb.2008-0334OC; SOLDATI T, 1995, J BIOL CHEM, V270, P25541, DOI 10.1074/jbc.270.43.25541; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; von Zastrow M, 2012, NEURON, V76, P22, DOI 10.1016/j.neuron.2012.09.022; Wilbanks AM, 2002, BIOCHEMISTRY-US, V41, P11981, DOI 10.1021/bi020275m; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Windheim M, 2004, CURR TOP MICROBIOL, V273, P29; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	61	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10286	10297		10.1074/jbc.M112.447540	http://dx.doi.org/10.1074/jbc.M112.447540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439653	hybrid, Green Published			2022-12-28	WOS:000317565000010
J	Basu, D; Liang, Y; Liu, X; Himmeldirk, K; Faik, A; Kieliszewski, M; Held, M; Showalter, AM				Basu, Debarati; Liang, Yan; Liu, Xiao; Himmeldirk, Klaus; Faik, Ahmed; Kieliszewski, Marcia; Held, Michael; Showalter, Allan M.			Functional Identification of a Hydroxyproline-O-galactosyltransferase Specific for Arabinogalactan Protein Biosynthesis in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; LECTIN DOMAINS; I-TASSER; GLYCOSYLATION; GALNAC; POLYSACCHARIDE; SOLUBILIZATION; CLASSIFICATION; COMPONENTS	Although plants contain substantial amounts of arabinogalactan proteins (AGPs), the enzymes responsible for AGP glycosylation are largely unknown. Bioinformatics indicated that AGP galactosyltransferases (GALTs) are members of the carbohydrate-active enzyme glycosyltransferase (GT) 31 family (CAZy GT31) involved in N- and O-glycosylation. Six Arabidopsis GT31 members were expressed in Pichia pastoris and tested for enzyme activity. The At4g21060 gene (named AtGALT2) was found to encode activity for adding galactose (Gal) to hydroxyproline (Hyp) in AGP protein backbones. AtGALT2 specifically catalyzed incorporation of [C-14] Gal from UDP-[C-14] Gal to Hyp of model substrate acceptors having AGP peptide sequences, consisting of non-contiguous Hyp residues, such as (Ala-Hyp) repetitive units exemplified by chemically synthesized (AO)(7) and anhydrous hydrogen fluoride-deglycosylated d(AO)(51). Microsomal preparations from Pichia cells expressing AtGALT2 incorporated [C-14] Gal to (AO)(7), and the resulting product co-eluted with (AO)(7) by reverse-phase HPLC. Acid hydrolysis of the [C-14]Gal-(AO)(7) product released C-14-radiolabel as Gal only. Base hydrolysis of the [C-14] Gal-(AO)(7) product released a C-14-radiolabeled fragment that co-eluted with a Hyp-Gal standard after high performance anion-exchange chromatography fractionation. AtGALT2 is specific for AGPs because substrates lacking AGP peptide sequences did not act as acceptors. Moreover, AtGALT2 uses only UDP-Gal as the substrate donor and requires Mg2+ or Mn2+ for high activity. Additional support that AtGALT2 encodes an AGP GALT was provided by two allelic AtGALT2 knock-out mutants, which demonstrated lower GALT activities and reductions in beta-Yariv-precipitated AGPs compared with wild type plants. Confocal microscopic analysis of fluorescently tagged AtGALT2 in tobacco epidermal cells indicated that AtGALT2 is probably localized in the endomembrane system consistent with its function.	[Basu, Debarati; Liang, Yan; Liu, Xiao; Faik, Ahmed; Showalter, Allan M.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Himmeldirk, Klaus; Kieliszewski, Marcia; Held, Michael] Ohio Univ, Dept Chem & Biochem, Mol & Cellular Biol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Showalter, AM (corresponding author), Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA.	showalte@ohio.edu	Liang, Yan/K-8199-2016; Faik, Ahmed/ABB-9120-2020	Liang, Yan/0000-0002-2144-1388; Held, Michael/0000-0003-2604-8048; Showalter, Allan/0000-0003-0775-4991	Ohio Plant Biotechnology Consortium [020340004090 GR0017687.01]; National Science Foundation [0918661]	Ohio Plant Biotechnology Consortium; National Science Foundation(National Science Foundation (NSF))	This work was supported by Ohio Plant Biotechnology Consortium Grant 020340004090 GR0017687.01 and National Science Foundation Grant 0918661.	BACIC A, 1987, CARBOHYD RES, V162, P85, DOI 10.1016/0008-6215(87)80203-3; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Castilho A, 2012, J BIOL CHEM, V287, P36518, DOI 10.1074/jbc.M112.402685; CLARKE A, 1979, P NATL ACAD SCI USA, V76, P3358, DOI 10.1073/pnas.76.7.3358; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Egelund J, 2011, ANNU PLANT REV, V41, P213, DOI 10.1002/9781444391015.ch7; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Gao MG, 1999, PLANT J, V18, P43, DOI 10.1046/j.1365-313X.1999.00428.x; Geshi N, 2002, PHYSIOL PLANTARUM, V114, P540, DOI 10.1034/j.1399-3054.2002.1140406.x; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Kato H, 2003, PLANTA, V217, P271, DOI 10.1007/s00425-003-0978-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieliszewski MJ, 2001, CELL MOL LIFE SCI, V58, P1386, DOI 10.1007/PL00000783; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Liu CG, 2007, PLANT PHYSIOL, V145, P863, DOI 10.1104/pp.107.102657; Molhoj M, 2004, PLANT PHYSIOL, V135, P1221, DOI 10.1104/pp.104.043745; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Peugnet I, 2001, PLANTA, V213, P435, DOI 10.1007/s004250100539; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STRAHM A, 1981, PHYTOCHEMISTRY, V20, P1061, DOI 10.1016/0031-9422(81)83027-0; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tryfona T, 2012, PLANT PHYSIOL, V160, P653, DOI 10.1104/pp.112.202309; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Yang Z, 2012, J BIOL CHEM, V287, P11911, DOI 10.1074/jbc.M111.312918; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	50	61	64	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10132	10143		10.1074/jbc.M112.432609	http://dx.doi.org/10.1074/jbc.M112.432609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430255	Green Published, hybrid			2022-12-28	WOS:000317114000054
J	Biskup, T; Paulus, B; Okafuji, A; Hitomi, K; Getzoff, ED; Weber, S; Schleicher, E				Biskup, Till; Paulus, Bernd; Okafuji, Asako; Hitomi, Kenichi; Getzoff, Elizabeth D.; Weber, Stefan; Schleicher, Erik			Variable Electron Transfer Pathways in an Amphibian Cryptochrome TRYPTOPHAN VERSUS TYROSINE-BASED RADICAL PAIRS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT PHOTORECEPTOR; COLI DNA PHOTOLYASE; TIME-RESOLVED EPR; PARAMAGNETIC-RESONANCE; FLAVIN COFACTOR; DROSOPHILA CRYPTOCHROME; DIMER REPAIR; ACTIVE-SITE; DUPLEX DNA; IN-VIVO	Electron transfer reactions play vital roles in many biological processes. Very often the transfer of charge(s) proceeds stepwise over large distances involving several amino acid residues. By using time-resolved electron paramagnetic resonance and optical spectroscopy, we have studied the mechanism of light-induced reduction of the FAD cofactor of cryptochrome/photolyase family proteins. In this study, we demonstrate that electron abstraction from a nearby amino acid by the excited FAD triggers further electron transfer steps even if the conserved chain of three tryptophans, known to be an effective electron transfer pathway in these proteins, is blocked. Furthermore, we were able to characterize this secondary electron transfer pathway and identify the amino acid partner of the resulting flavin-amino acid radical pair as a tyrosine located at the protein surface. This alternative electron transfer pathway could explain why interrupting the conserved tryptophan triad does not necessarily alter photoreactions of cryptochromes in vivo. Taken together, our results demonstrate that light-induced electron transfer is a robust property of cryptochromes and more intricate than commonly anticipated.	[Biskup, Till] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Paulus, Bernd; Okafuji, Asako; Weber, Stefan; Schleicher, Erik] Univ Freiburg, Inst Phys Chem, D-79104 Freiburg, Germany; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan; [Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Oxford; University of Freiburg; National Institute of Health Sciences - Japan; Scripps Research Institute; Scripps Research Institute	Schleicher, E (corresponding author), Univ Freiburg, Inst Phys Chem, Albertstr 21, D-79104 Freiburg, Germany.	erik.schleicher@physchem.uni-freiburg.de	Biskup, Till/D-5249-2012; Weber, Stefan/G-6164-2010; Biskup, Till/AAX-1107-2020; Schleicher, Erik/C-9951-2010	Biskup, Till/0000-0003-2913-0004; Biskup, Till/0000-0003-2913-0004; Schleicher, Erik/0000-0003-2953-050X	National Institutes of Health Grant [GM37684]; Deutsche Forschungsgemeinschaft [BI 1249/1-1, BI 1249/1-2]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM37684 (to E. D. G.), Deutsche Forschungsgemeinschaft Grants BI 1249/1-1 and BI 1249/1-2 (to T. B.), and a grant from the Skaggs Institute for Chemical Biology (to K. H.).	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Biskup T, 2011, ANGEW CHEM INT EDIT, V50, P12647, DOI 10.1002/anie.201104321; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; Bittl R, 2005, BBA-BIOENERGETICS, V1707, P117, DOI 10.1016/j.bbabio.2004.03.012; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brazard J, 2010, J AM CHEM SOC, V132, P4935, DOI 10.1021/ja1002372; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Brunelle SA, 2007, J PHYCOL, V43, P509, DOI 10.1111/j.1529-8817.2007.00339.x; BUCKLEY CD, 1987, CHEM PHYS LETT, V135, P307, DOI 10.1016/0009-2614(87)85162-X; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Byrdin M, 2010, J PHYS CHEM A, V114, P3207, DOI 10.1021/jp9093589; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; CLOSS GL, 1987, J PHYS CHEM-US, V91, P3592, DOI 10.1021/j100297a026; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Gindt YM, 1999, BIOCHEMISTRY-US, V38, P3857, DOI 10.1021/bi981191+; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Henbest KB, 2008, P NATL ACAD SCI USA, V105, P14395, DOI 10.1073/pnas.0803620105; Hitomi K, 2000, NUCLEIC ACIDS RES, V28, P2353, DOI 10.1093/nar/28.12.2353; Hitomi K, 2012, J BIOL CHEM, V287, P12060, DOI 10.1074/jbc.M111.244020; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; HORE PJ, 1987, CHEM PHYS LETT, V137, P495, DOI 10.1016/0009-2614(87)80617-6; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; Kiontke S, 2011, EMBO J, V30, P4437, DOI 10.1038/emboj.2011.313; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Kowalczyk RM, 2004, J AM CHEM SOC, V126, P11393, DOI 10.1021/ja049554i; Krapf S, 2010, PHYS CHEM CHEM PHYS, V12, P9516, DOI 10.1039/c000876a; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; Liu ZY, 2011, P NATL ACAD SCI USA, V108, P14831, DOI 10.1073/pnas.1110927108; Losi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P491, DOI 10.1111/j.1751-1097.2011.00913.x; Lukacs A, 2008, J AM CHEM SOC, V130, P14394, DOI 10.1021/ja805261m; MacFarlane AW, 2003, BIOCHEMISTRY-US, V42, P8558, DOI 10.1021/bi034015w; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P1, DOI 10.1021/bi00594a001; Moldt J, 2009, J BIOL CHEM, V284, P21670, DOI 10.1074/jbc.M109.018697; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Okafuji A, 2010, DNA REPAIR, V9, P495, DOI 10.1016/j.dnarep.2010.01.014; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Popovic DM, 2002, J AM CHEM SOC, V124, P3775, DOI 10.1021/ja016249d; Porcal G, 2003, PHYS CHEM CHEM PHYS, V5, P4123, DOI 10.1039/b306945a; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Sancar A, 2004, ADV PROTEIN CHEM, V69, P73; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Thiagarajan V, 2011, P NATL ACAD SCI USA, V108, P9402, DOI 10.1073/pnas.1101026108; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; WANG BY, 1989, BIOCHEMISTRY-US, V28, P1148, DOI 10.1021/bi00429a032; Wang HY, 2005, J PHYS CHEM B, V109, P1329, DOI 10.1021/jp044652b; Weber S, 2002, P NATL ACAD SCI USA, V99, P1319, DOI 10.1073/pnas.032469399; Weber S, 2011, PHOTOCHEM PHOTOBIOL, V87, P574, DOI 10.1111/j.1751-1097.2010.00885.x; Weber S, 2010, J PHYS CHEM B, V114, P14745, DOI 10.1021/jp103401u; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200; Zikihara K, 2008, PHOTOCHEM PHOTOBIOL, V84, P1016, DOI 10.1111/j.1751-1097.2007.00364.x; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s	79	48	50	0	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9249	9260		10.1074/jbc.M112.417725	http://dx.doi.org/10.1074/jbc.M112.417725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430261	Green Published, hybrid			2022-12-28	WOS:000316862200043
J	Murakami, KS				Murakami, Katsuhiko S.			X-ray Crystal Structure of Escherichia coli RNA Polymerase sigma(70) Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR-DEPENDENT TRANSCRIPTION; C-TERMINAL DOMAIN; ALPHA-SUBUNIT; OMEGA-SUBUNIT; ANGSTROM RESOLUTION; DNA-BINDING; SEQUENCE INSERTIONS; INITIATION; PROMOTER; PPGPP	Escherichia coli RNA polymerase (RNAP) is the most studied bacterial RNAP and has been used as the model RNAP for screening and evaluating potential RNAP-targeting antibiotics. However, the x-ray crystal structure of E. coli RNAP has been limited to individual domains. Here, I report the x-ray structure of the E. coli RNAP sigma(70) holoenzyme, which shows sigma region 1.1 (sigma(1.1)) and the alpha subunit C-terminal domain for the first time in the context of an intact RNAP. sigma(1.1) is positioned at the RNAP DNA-binding channel and completely blocks DNA entry to the RNAP active site. The structure reveals that sigma(1.1) contains a basic patch on its surface, which may play an important role in DNA interaction to facilitate open promoter complex formation. The alpha subunit C-terminal domain is positioned next to sigma domain 4 with a fully stretched linker between the N- and C-terminal domains. E. coli RNAP crystals can be prepared from a convenient overexpression system, allowing further structural studies of bacterial RNAP mutants, including functionally deficient and antibiotic-resistant RNAPs.	Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health Grant [GM087350-A1]; Center of Excellence of the Japan Society for the Promotion of Science; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence of the Japan Society for the Promotion of Science; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087350-A1. This work was also supported by a research fellowship from the Center of Excellence of the Japan Society for the Promotion of Science and a long-term postdoctoral research fellowship from the Human Frontier Science Program.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Blanco AG, 2011, EMBO J, V30, P3776, DOI 10.1038/emboj.2011.271; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Brueckner F, 2009, CURR OPIN STRUC BIOL, V19, P294, DOI 10.1016/j.sbi.2009.04.005; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Chen H, 2003, MOL CELL, V11, P1621, DOI 10.1016/S1097-2765(03)00201-6; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Ho MX, 2009, CURR OPIN STRUC BIOL, V19, P715, DOI 10.1016/j.sbi.2009.10.010; Hudson BP, 2009, P NATL ACAD SCI USA, V106, P19830, DOI 10.1073/pnas.0908782106; Hurwitz J, 2005, J BIOL CHEM, V280, P42477, DOI 10.1074/jbc.X500006200; IGARASHI K, 1989, NUCLEIC ACIDS RES, V17, P8755, DOI 10.1093/nar/17.21.8755; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Mathew R, 2006, TRENDS MICROBIOL, V14, P450, DOI 10.1016/j.tim.2006.08.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mukherjee K, 1999, EUR J BIOCHEM, V266, P228, DOI 10.1046/j.1432-1327.1999.00848.x; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ross W, 2003, GENE DEV, V17, P1293, DOI 10.1101/gad.1079403; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; Svetlov V, 2009, CURR OPIN STRUC BIOL, V19, P701, DOI 10.1016/j.sbi.2009.10.002; Tang H, 1996, METHOD ENZYMOL, V273, P130; Tebbutt J, 2002, FEMS MICROBIOL LETT, V210, P55, DOI 10.1016/S0378-1097(02)00586-4; Terui Y, 2012, INT J BIOCHEM CELL B, V44, P412, DOI 10.1016/j.biocel.2011.11.017; Tupin A, 2010, EMBO J, V29, P2527, DOI 10.1038/emboj.2010.135; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vrentas CE, 2008, J MOL BIOL, V377, P551, DOI 10.1016/j.jmb.2008.01.042; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	59	131	136	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9126	9134		10.1074/jbc.M112.430900	http://dx.doi.org/10.1074/jbc.M112.430900			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389035	Green Published, hybrid			2022-12-28	WOS:000316862200032
J	Goult, BT; Zacharchenko, T; Bate, N; Tsang, R; Hey, F; Gingras, AR; Elliott, PR; Roberts, GCK; Ballestrem, C; Critchley, DR; Barsukov, IL				Goult, Benjamin T.; Zacharchenko, Thomas; Bate, Neil; Tsang, Ricky; Hey, Fiona; Gingras, Alexandre R.; Elliott, Paul R.; Roberts, Gordon C. K.; Ballestrem, Christoph; Critchley, David R.; Barsukov, Igor L.			RIAM and Vinculin Binding to Talin Are Mutually Exclusive and Regulate Adhesion Assembly and Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN; ACTIVATION; REVEALS; COMPLEX; SITES; HEAD; ROD; IDENTIFICATION; RECRUITMENT; MECHANISMS	Talin activates integrins, couples them to F-actin, and recruits vinculin to focal adhesions (FAs). Here, we report the structural characterization of the talin rod: 13 helical bundles (R1-R13) organized into a compact cluster of four-helix bundles (R2-R4) within a linear chain of five-helix bundles. Nine of the bundles contain vinculin-binding sites (VBS); R2R3 are atypical, with each containing two VBS. Talin R2R3 also binds synergistically to RIAM, a Rap1 effector involved in integrin activation. Biochemical and structural data show that vinculin and RIAM binding to R2R3 is mutually exclusive. Moreover, vinculin binding requires domain unfolding, whereas RIAM binds the folded R2R3 double domain. In cells, RIAM is enriched in nascent adhesions at the leading edge whereas vinculin is enriched in FAs. We propose a model in which RIAM binding to R2R3 initially recruits talin to membranes where it activates integrins. As talin engages F-actin, force exerted on R2R3 disrupts RIAM binding and exposes the VBS, which recruit vinculin to stabilize the complex.	[Goult, Benjamin T.; Bate, Neil; Hey, Fiona; Gingras, Alexandre R.; Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Zacharchenko, Thomas; Elliott, Paul R.; Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Tsang, Ricky; Ballestrem, Christoph] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Leicester; University of Liverpool; University of Manchester	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk; barsukov@liverpool.ac.uk	Goult, Benjamin T/B-3127-2009; Gingras, Alexandre R/E-1867-2011	Goult, Benjamin T/0000-0002-3438-2807; Gingras, Alexandre R/0000-0002-5373-0176; Ballestrem, Christoph/0000-0002-5375-7985; Elliott, Paul/0000-0002-7641-2103; Roberts, Gordon/0000-0001-6200-1373	National Institutes of Health Cell Migration Consortium, NIGMS [U54 GM64346]; Wellcome Trust; BBSRC; Cancer Research UK; BBSRC [BB/G003637/1, BB/G004552/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G004552/1, BB/G003637/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health Cell Migration Consortium, NIGMS; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Cell Migration Consortium Grant U54 GM64346 from NIGMS, the Wellcome Trust, BBSRC, and Cancer Research UK.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Banno A, 2012, J BIOL CHEM, V287, P13799, DOI 10.1074/jbc.M112.341214; Bate N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034461; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2008, BIOMOL NMR ASSIGN, V2, P17, DOI 10.1007/s12104-007-9073-5; Goult BT, 2010, FEBS LETT, V584, P2237, DOI 10.1016/j.febslet.2010.04.028; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hemmings L, 1996, J CELL SCI, V109, P2715; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; MCLACHLAN AD, 1994, J MOL BIOL, V235, P1278, DOI 10.1006/jmbi.1994.1081; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wynne JP, 2012, J CELL BIOL, V199, P317, DOI 10.1083/jcb.201201157; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zamir E, 1999, J CELL SCI, V112, P1655; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	49	117	122	4	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8238	8249		10.1074/jbc.M112.438119	http://dx.doi.org/10.1074/jbc.M112.438119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23389036	hybrid, Green Published			2022-12-28	WOS:000316564500024
J	Hendricks, GL; Weirich, KL; Viswanathan, K; Li, J; Shriver, ZH; Ashour, J; Ploegh, HL; Kurt-Jones, EA; Fygenson, DK; Finberg, RW; Comolli, JC; Wang, JP				Hendricks, Gabriel L.; Weirich, Kim L.; Viswanathan, Karthik; Li, Jing; Shriver, Zachary H.; Ashour, Joseph; Ploegh, Hidde L.; Kurt-Jones, Evelyn A.; Fygenson, Deborah K.; Finberg, Robert W.; Comolli, James C.; Wang, Jennifer P.			Sialylneolacto-N-tetraose c (LSTc)-bearing Liposomal Decoys Capture Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRONGLY INHIBIT AGGLUTINATION; SIALIC-ACID; RECEPTOR-BINDING; GLYCAN TOPOLOGY; HEMAGGLUTININS; ERYTHROCYTES; SPECIFICITY; FUSION; RECOGNITION; ATTACHMENT	Influenza is a severe disease in humans and animals with few effective therapies available. All strains of influenza virus are prone to developing drug resistance due to the high mutation rate in the viral genome. A therapeutic agent that targets a highly conserved region of the virus could bypass resistance and also be effective against multiple strains of influenza. Influenza uses many individually weak ligand binding interactions for a high avidity multivalent attachment to sialic acid-bearing cells. Polymerized sialic acid analogs can form multivalent interactions with influenza but are not ideal therapeutics due to solubility and toxicity issues. We used liposomes as a novel means for delivery of the glycan sialylneolacto-N-tetraose c (LSTc). LSTc-bearing decoy liposomes form multivalent, polymer-like interactions with influenza virus. Decoy liposomes competitively bind influenza virus in hemagglutination inhibition assays and inhibit infection of target cells in a dose-dependent manner. Inhibition is specific for influenza virus, as inhibition of Sendai virus and respiratory syncytial virus is not observed. In contrast, monovalent LSTc does not bind influenza virus or inhibit infectivity. LSTc decoy liposomes prevent the spread of influenza virus during multiple rounds of replication in vitro and extend survival of mice challenged with a lethal dose of virus. LSTc decoy liposomes co-localize with fluorescently tagged influenza virus, whereas control liposomes do not. Considering the conservation of the hemagglutinin binding pocket and the ability of decoy liposomes to form high avidity interactions with influenza hemagglutinin, our decoy liposomes have potential as a new therapeutic agent against emerging influenza strains.	[Hendricks, Gabriel L.; Kurt-Jones, Evelyn A.; Finberg, Robert W.; Wang, Jennifer P.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Weirich, Kim L.; Fygenson, Deborah K.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Fygenson, Deborah K.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Viswanathan, Karthik; Li, Jing; Shriver, Zachary H.] MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Ashour, Joseph; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Comolli, James C.] Charles Stark Draper Lab, Dept Bioengn, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; The Charles Stark Draper Laboratory, Inc.	Wang, JP (corresponding author), Univ Massachusetts, Sch Med, Dept Med, 364 Plantation St, Worcester, MA 01605 USA.	Jennifer.Wang@umassmed.edu	Fygenson, Deborah K/U-3105-2017	Fygenson, Deborah K/0000-0002-5681-3938; Li, Jing/0000-0002-2414-8523; Weirich, Kimberly/0000-0003-0440-8612; wang, jennifer/0000-0002-2556-9100; Hendricks, Gabriel/0000-0003-4419-1235; Ashour, Joseph/0000-0003-3809-2783	Defense Advanced Research Projects Agency, Defense Sciences Office [W911NF-10-1-0268]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092105] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency, Defense Sciences Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Defense Advanced Research Projects Agency, Defense Sciences Office W911NF-10-1-0268.	Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Choi SK, 1996, CHEM BIOL, V3, P97, DOI 10.1016/S1074-5521(96)90285-9; Deol P, 1997, BBA-GEN SUBJECTS, V1334, P161, DOI 10.1016/S0304-4165(96)00088-8; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Gambaryan AS, 2002, ANTIVIR RES, V55, P201, DOI 10.1016/S0166-3542(02)00020-7; GAMIAN A, 1991, CAN J MICROBIOL, V37, P233, DOI 10.1139/m91-035; GLICK GD, 1991, J BIOL CHEM, V266, P23660; Guo CT, 2002, GLYCOBIOLOGY, V12, P183, DOI 10.1093/glycob/12.3.183; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; ITOH M, 1995, VIROLOGY, V212, P340, DOI 10.1006/viro.1995.1491; Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X; KINGERYWOOD JE, 1992, J AM CHEM SOC, V114, P7303, DOI 10.1021/ja00044a057; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; Krause JC, 2012, J VIROL, V86, P6334, DOI 10.1128/JVI.07158-11; LEES WJ, 1994, J MED CHEM, V37, P3419, DOI 10.1021/jm00046a027; MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007; MARKWELL MAK, 1980, P NATL ACAD SCI-BIOL, V77, P5693, DOI 10.1073/pnas.77.10.5693; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; MOCHALOVA LV, 1994, ANTIVIR RES, V23, P179, DOI 10.1016/0166-3542(94)90016-7; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Ohkura T, 2012, BIOCHEM BIOPH RES CO, V418, P38, DOI 10.1016/j.bbrc.2011.12.108; Popp MWL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002604; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; PRITCHETT TJ, 1987, VIROLOGY, V160, P502, DOI 10.1016/0042-6822(87)90026-2; Reuter JD, 1999, BIOCONJUGATE CHEM, V10, P271, DOI 10.1021/bc980099n; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SPALTENSTEIN A, 1991, J AM CHEM SOC, V113, P686, DOI 10.1021/ja00002a053; SPARKS MA, 1993, TETRAHEDRON, V49, P1, DOI 10.1016/S0040-4020(01)80502-0; SPEVAK W, 1993, J AM CHEM SOC, V115, P1146, DOI 10.1021/ja00056a047; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Sullivan KM, 1996, PHARMACOECONOMICS, V9, P26, DOI 10.2165/00019053-199600093-00008; TOOGOOD PL, 1991, J MED CHEM, V34, P3138, DOI 10.1021/jm00114a025; Tuzikov AB, 2000, J CARBOHYD CHEM, V19, P1191, DOI 10.1080/07328300008544143; VAN MEER G, 1985, BIOCHEMISTRY-US, V24, P3593, DOI 10.1021/bi00335a030; vanSteensel B, 1996, J CELL SCI, V109, P787; WEINHOLD EG, 1992, J AM CHEM SOC, V114, P9270, DOI 10.1021/ja00050a004; Weirich KL, 2010, BIOPHYS J, V98, P85, DOI 10.1016/j.bpj.2009.09.050; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040	47	50	52	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8061	8073		10.1074/jbc.M112.437202	http://dx.doi.org/10.1074/jbc.M112.437202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362274	Green Published, hybrid			2022-12-28	WOS:000316564500007
J	Zhu, L; Wasey, A; White, SH; Dalbey, RE				Zhu, Lu; Wasey, Abdul; White, Stephen H.; Dalbey, Ross E.			Charge Composition Features of Model Single-span Membrane Proteins That Determine Selection of YidC and SecYEG Translocase Pathways in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F1F0 ATP SYNTHASE; PROTON MOTIVE FORCE; INNER MEMBRANE; SUBUNIT-C; TRANSMEMBRANE HELICES; LEADER PEPTIDASE; TERMINAL DOMAINS; PROCOAT PROTEIN; PLASMA-MEMBRANE; INSERTION	We have investigated the features of single-span model membrane proteins based upon leader peptidase that determines whether the proteins insert by a YidC/Sec-independent, YidC-only, or YidC/Sec mechanism. We find that a protein with a highly hydrophobic transmembrane segment that inserts into the membrane by a YidC/Sec-independent mechanism becomes YidC-dependent if negatively charged residues are inserted into the translocated periplasmic domain or if the hydrophobicity of the transmembrane segment is reduced by substituting polar residues for nonpolar ones. This suggests that charged residues in the translocated domain and the hydrophobicity within the transmembrane segment are important determinants of the insertion pathway. Strikingly, the addition of a positively charged residue to either the translocated region or the transmembrane region can switch the insertion requirements such that insertion requires both YidC and SecYEG. To test conclusions from the model protein studies, we confirmed that a positively charged residue is a SecYEG determinant for the endogenous proteins ATP synthase subunits a and b and the TatC subunit of the Tat translocase. These findings provide deeper insights into how pathways are selected for the insertion of proteins into the Escherichia coli inner membrane.	[Zhu, Lu; Wasey, Abdul; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [White, Stephen H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University System of Ohio; Ohio State University; University of California System; University of California Irvine	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu	White, Stephen/N-1507-2019; White, Stephen H/B-1053-2009	White, Stephen H/0000-0001-8540-7907	National Institutes of Health [GM074637]; National Science Foundation [MCB-1052033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074637 (to S. H. W.). This work was also supported by National Science Foundation Grant MCB-1052033 (to R. E. D.).	Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; BOYD D, 1989, P NATL ACAD SCI USA, V86, P9446, DOI 10.1073/pnas.86.23.9446; CAO GQ, 1994, EMBO J, V13, P4662, DOI 10.1002/j.1460-2075.1994.tb06789.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Ernst S, 2011, J MOL BIOL, V412, P165, DOI 10.1016/j.jmb.2011.07.023; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Facey SJ, 2003, EUR J BIOCHEM, V270, P1724, DOI 10.1046/j.1432-1033.2003.03531.x; Fillingame RH, 2000, J EXP BIOL, V203, P9; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; GALLUSSER A, 1990, EMBO J, V9, P2723, DOI 10.1002/j.1460-2075.1990.tb07459.x; Gray AN, 2011, MBIO, V2, DOI 10.1128/mBio.00238-11; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAWS JK, 1989, EMBO J, V8, P2095, DOI 10.1002/j.1460-2075.1989.tb03618.x; LEE JI, 1992, J BIOL CHEM, V267, P938; Maniatis T., 1982, MOL CLONING; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Neugebauer SA, 2012, J MOL BIOL, V417, P375, DOI 10.1016/j.jmb.2012.01.046; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Price CE, 2010, J BIOL CHEM, V285, P3575, DOI 10.1074/jbc.M109.051128; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Schuenemann TA, 1999, J BIOL CHEM, V274, P6855, DOI 10.1074/jbc.274.11.6855; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; STEFFENS K, 1987, J BIOL CHEM, V262, P5866; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	55	26	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7704	7716		10.1074/jbc.M112.429431	http://dx.doi.org/10.1074/jbc.M112.429431			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355473	hybrid, Green Published			2022-12-28	WOS:000316455300027
J	Gibson, MP; Zhu, QL; Wang, SZ; Liu, QL; Liu, Y; Wang, XF; Yuan, BZ; Ruest, LB; Feng, JQ; D'Souza, RN; Qin, CL; Lu, YB				Gibson, Monica Prasad; Zhu, Qinglin; Wang, Suzhen; Liu, Qilin; Liu, Ying; Wang, Xiaofang; Yuan, Baozhi; Ruest, L. Bruno; Feng, Jian Q.; D'Souza, Rena N.; Qin, Chunlin; Lu, Yongbo			The Rescue of Dentin Matrix Protein 1 (DMP1)-deficient Tooth Defects by the Transgenic Expression of Dentin Sialophosphoprotein (DSPP) Indicates That DSPP Is a Downstream Effector Molecule of DMP1 in Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIBLING PROTEINS; ENDOPLASMIC-RETICULUM; DMP1-DEFICIENT MICE; GENE-TRANSCRIPTION; IN-VIVO; SIALOPROTEIN; MUTATION; IDENTIFICATION; PHOSPHOPROTEIN; ODONTOGENESIS	Dentin matrix protein 1 (DMP1) and dentin sialophosphoprotein (DSPP) are essential for the formation of dentin. Previous in vitro studies have indicated that DMP1 might regulate the expression of DSPP during dentinogenesis. To examine whether DMP1 controls dentinogenesis through the regulation of DSPP in vivo, we cross-bred transgenic mice expressing normal DSPP driven by a 3.6-kb rat Col1a1 promoter with Dmp1 KO mice to generate mice expressing the DSPP transgene in the Dmp1 KO genetic background (referred to as "Dmp1 KO/DSPP Tg mice"). We used morphological, histological, and biochemical techniques to characterize the dentin and alveolar bone of Dmp1 KO/DSPP Tg mice compared with Dmp1 KO and wild-type mice. Our analyses showed that the expression of endogenous DSPP was remarkably reduced in the Dmp1 KO mice. Furthermore, the transgenic expression of DSPP rescued the tooth and alveolar bone defects of the Dmp1 KO mice. In addition, our in vitro analyses showed that DMP1 and its 57-kDa C-terminal fragment significantly up-regulated the Dspp promoter activities in a mesenchymal cell line. In contrast, the expression of DMP1 was not altered in the Dspp KO mice. These results provide strong evidence that DSPP is a downstream effector molecule that mediates the roles of DMP1 in dentinogenesis.	[Gibson, Monica Prasad; Zhu, Qinglin; Wang, Suzhen; Liu, Qilin; Liu, Ying; Wang, Xiaofang; Ruest, L. Bruno; Feng, Jian Q.; D'Souza, Rena N.; Qin, Chunlin; Lu, Yongbo] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA; [Yuan, Baozhi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Yuan, Baozhi] Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center	Qin, CL (corresponding author), Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu; ylu@bcd.tamhsc.edu		Ruest, L. Bruno/0000-0002-5446-9985; Lu, Yongbo/0000-0003-3692-1736; Wang, Xiaofang/0000-0002-7370-7192; D'Souza, Rena/0000-0002-1505-5173	National Institutes of Health [DE005092, DE021773, DE015209]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021773, R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE005092 (to C. Q.), DE021773 (to Y. L.), and DE015209 (to J. F.).	Avery J. K., 2001, ORAL DEV HISTOLOGY, P235; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Duverger O, 2012, J BIOL CHEM, V287, P12230, DOI 10.1074/jbc.M111.326900; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1994, J HISTOCHEM CYTOCHEM, V42, P1527, DOI 10.1177/42.12.7983353; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gibson MP, 2013, J PERIODONTAL RES, V48, P221, DOI 10.1111/j.1600-0765.2012.01523.x; Holappa H, 2006, EUR J ORAL SCI, V114, P381, DOI 10.1111/j.1600-0722.2006.00391.x; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Jiang BC, 2010, J BONE MINER RES, V25, P2155, DOI 10.1002/jbmr.117; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; Li Y, 2011, Adv Dent Res, V23, P280, DOI 10.1177/0022034511405387; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nikdin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031525; Orsini G, 2007, CALCIFIED TISSUE INT, V81, P39, DOI 10.1007/s00223-007-9027-z; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; QIN C, 2005, P 8 ICCBMT, P174; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Siyam A, 2012, BIOCHEM BIOPH RES CO, V424, P641, DOI 10.1016/j.bbrc.2012.07.037; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sreenath TL, 1999, INT J DEV BIOL, V43, P509; Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839; Sun Y, 2010, INT J ORAL MAX SURG, V39, P272, DOI 10.1016/j.ijom.2009.12.017; Verdelis K, 2008, BONE, V43, P983, DOI 10.1016/j.bone.2008.08.110; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wu H, 2011, J BIOL CHEM, V286, P29462, DOI 10.1074/jbc.M110.194746; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang B, 2010, ORAL DIS, V16, P453, DOI 10.1111/j.1601-0825.2010.01656.x; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhu QL, 2012, J BIOL CHEM, V287, P30426, DOI 10.1074/jbc.M112.388587; Zhu QL, 2012, CONNECT TISSUE RES, V53, P307, DOI 10.3109/03008207.2011.650301	50	58	59	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7204	7214		10.1074/jbc.M112.445775	http://dx.doi.org/10.1074/jbc.M112.445775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23349460	Green Published, hybrid			2022-12-28	WOS:000316002400041
J	Lu, F; Taghbalout, A				Lu, Feng; Taghbalout, Aziz			Membrane Association via an Amino-terminal Amphipathic Helix Is Required for the Cellular Organization and Function of RNase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; TARGETING SEQUENCE; CHROMOSOMAL GENES; RIBONUCLEASE-II; MIND; BINDING; LOCALIZATION; DEGRADATION; REDISTRIBUTION	The subcellular localization of the exoribonuclease RNase II is not known despite the advanced biochemical characterization of the enzyme. Here we report that RNase II is organized into cellular structures that appear to coil around the Escherichia coli cell periphery and that RNase II is associated with the cytoplasmic membrane by its amino-terminal amphipathic helix. The helix also acts as an autonomous transplantable membrane binding domain capable of directing normally cytoplasmic proteins to the membrane. Assembly of the organized cellular structures of RNase II required the RNase II amphipathic membrane binding domain. Co-immunoprecipitation of the protein from cell extracts indicated that RNase II interacts with itself. The RNase II self-interaction and the ability of the protein to assemble into organized cellular structures required the membrane binding domain. The ability of RNase II to maintain cell viability in the absence of the exoribonuclease polynucleotide phosphorylase was markedly diminished when the RNase II cellular structures were lost due to changes in the amphipathicity of the amino-terminal helix, suggesting that membrane association and assembly of RNase II into organized cellular structures play an important role in the normal function of the protein within the bacterial cell.	[Lu, Feng; Taghbalout, Aziz] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06032 USA	University of Connecticut	Taghbalout, A (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 263 Farmington Ave, Farmington, CT 06032 USA.	taghbalout@neuron.uchc.edu			National Institutes of Health Grant [R37 GM060632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060632] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM060632.	Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Carabetta VJ, 2009, J BACTERIOL, V191, P6812, DOI 10.1128/JB.00870-09; Carpousis AJ, 2008, METHOD ENZYMOL, V447, P65, DOI 10.1016/S0076-6879(08)02204-0; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; COVARRUBIAS L, 1981, GENE, V13, P25, DOI 10.1016/0378-1119(81)90040-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DeLano W.L., 2005, PYMOL MOL GRAPHICS S; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; Diestra E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008301; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; ISHIDATE K, 1986, J BIOL CHEM, V261, P428; JACKSON ME, 1988, MOL MICROBIOL, V2, P563, DOI 10.1111/j.1365-2958.1988.tb00064.x; Jasiecki J, 2005, BIOCHEM BIOPH RES CO, V329, P598, DOI 10.1016/j.bbrc.2005.02.025; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Maniatis T., 1982, MOL CLONING; MICZAK A, 1991, MOL MICROBIOL, V5, P1801, DOI 10.1111/j.1365-2958.1991.tb01929.x; MILLER JH, 1992, SHORT COURSE BACTERI, P268; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Murashko ON, 2012, P NATL ACAD SCI USA, V109, P7019, DOI 10.1073/pnas.1120181109; NOSSAL NG, 1968, J BIOL CHEM, V243, P913; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Swulius MT, 2012, J BACTERIOL, V194, P6382, DOI 10.1128/JB.00505-12; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Taghbalout A, 2006, J BACTERIOL, V188, P2993, DOI 10.1128/JB.188.8.2993-3001.2006; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	44	21	25	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7241	7251		10.1074/jbc.M112.408674	http://dx.doi.org/10.1074/jbc.M112.408674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344958	hybrid, Green Published			2022-12-28	WOS:000316002400044
J	Whiteman, P; de Madrid, BH; Taylor, P; Li, DM; Heslop, R; Viticheep, N; Tan, JZ; Shimizu, H; Callaghan, J; Masiero, M; Li, JL; Banham, AH; Harris, AL; Lea, SM; Redfield, C; Baron, M; Handford, PA				Whiteman, Pat; de Madrid, Beatriz Hernandez; Taylor, Paul; Li, Demin; Heslop, Rebecca; Viticheep, Nattnee; Tan, Joyce Zi; Shimizu, Hideyuki; Callaghan, Juliana; Masiero, Massimo; Li, Ji Liang; Banham, Alison H.; Harris, Adrian L.; Lea, Susan M.; Redfield, Christina; Baron, Martin; Handford, Penny A.			Molecular Basis for Jagged-1/Serrate Ligand Recognition by the Notch Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVATION; BINDING; FRINGE; DOMAIN; ANTIBODIES; CLEAVAGE; JAGGED1; MODULATION; MUTATIONS; SERRATE	We have mapped a Jagged/Serrate-binding site to specific residues within the 12th EGF domain of human and Drosophila Notch. Two critical residues, involved in a hydrophobic interaction, provide a ligand-binding platform and are adjacent to a Fringe-sensitive residue that modulates Notch activity. Our data suggest that small variations within the binding site fine-tune ligand specificity, which may explain the observed sequence heterogeneity in mammalian Notch paralogues, and should allow the development of paralogue-specific ligand-blocking antibodies. As a proof of principle, we have generated a Notch-1-specific monoclonal antibody that blocks binding, thus paving the way for antibody tools for research and therapeutic applications.	[Whiteman, Pat; Taylor, Paul; Heslop, Rebecca; Viticheep, Nattnee; Callaghan, Juliana; Redfield, Christina; Handford, Penny A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [de Madrid, Beatriz Hernandez; Shimizu, Hideyuki; Baron, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Tan, Joyce Zi; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Li, Demin; Masiero, Massimo; Banham, Alison H.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford Natl Inst Hlth Res NIHR, Biomed Res Ctr,John Radcliffe Hosp, Oxford OX3 9DU, England; [Masiero, Massimo; Li, Ji Liang; Harris, Adrian L.] Univ Oxford, Weatherall Inst Mol Med, Mol Oncol Labs, Dept Oncol,John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford; University of Manchester; University of Oxford; University of Oxford; University of Oxford	Handford, PA (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	penny.handford@bioch.ox.ac.uk	Banham, Alison H/B-2966-2009; Harris, Adrian L/ABA-3343-2020; Li, Demin/O-4065-2019; Lea, Susan M/B-7678-2009	Harris, Adrian L/0000-0003-1376-8409; Li, Demin/0000-0002-7118-3401; Lea, Susan M/0000-0001-9287-8053; Redfield, Christina/0000-0001-7297-7708; Banham, Alison/0000-0002-3197-273X	Wellcome Trust [087928, 079440]; Cancer Research UK [A10702]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/E002285/1, BB/H000976/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H000976/1, BB/C503162/1, BB/E002285/1] Funding Source: researchfish; Cancer Research UK [10702, 11359] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Wellcome Trust Grants 087928 (to P. A. H., S. M. L., and M. B.) and 079440 (to C. R.), Cancer Research UK Programme Grant A10702 (to A. H. B., A. L. H., P. H., and S. M. L.), and Biotechnology and Biological Sciences Research Council studentship (to P. T.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Mason DY, 1983, TECHNIQUES IMMUNOCYT, VII, P175; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Parks AL, 2000, DEVELOPMENT, V127, P1373; Peters N, 2004, EXP CELL RES, V299, P454, DOI 10.1016/j.yexcr.2004.06.004; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sharma A, 2012, MOL CANCER THER, V11, P77, DOI 10.1158/1535-7163.MCT-11-0508; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	35	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7305	7312		10.1074/jbc.M112.428854	http://dx.doi.org/10.1074/jbc.M112.428854			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23339193	Green Published, hybrid			2022-12-28	WOS:000316002400050
J	Bovijn, C; Desmet, AS; Uyttendaele, I; Van Acker, T; Tavernier, J; Peelman, F				Bovijn, Celia; Desmet, Anne-Sophie; Uyttendaele, Isabel; Van Acker, Tim; Tavernier, Jan; Peelman, Frank			Identification of Binding Sites for Myeloid Differentiation Primary Response Gene 88 (MyD88) and Toll-like Receptor 4 in MyD88 Adapter-like (Mal)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MULTIPLE SEQUENCE ALIGNMENT; BRUTONS TYROSINE KINASE; SIGNAL-TRANSDUCTION; TIR-DOMAIN; CRYSTAL-STRUCTURE; INTERFERON-BETA; INTERACTION TRAP; STRUCTURAL BASIS; MAPPIT ANALYSIS	Upon activation, Toll-like receptor 4 (TLR4) binds adapter proteins, including MyD88 (myeloid differentiation primary response gene 88) and Mal (MyD88 adapter-like) for its signal transduction. TLR4 and the adapter proteins each contain a Toll/Il-1 receptor domain (TIR domain). In this study we used random mutagenesis and the mammalian two-hybrid method MAPPIT (mammalian protein-protein interaction trap) to identify mutations in Mal that disrupt its interaction with TLR4 and/or MyD88. Our study shows that four potential binding sites and the AB-loop in the Mal TIR domain all contribute to formation of the TLR4-Mal-MyD88 complex. Mutations in the symmetrical back-to-back Mal homodimer interface affect Mal homodimerization and interaction with MyD88 and TLR4. Our data suggest that Mal dimerization may lead to formation of potential binding platforms on the top and the side of the Mal dimer that bind MyD88 or TLR4. Mutations that affect the interaction of Mal with MyD88 also affect NF-kappa B activation induced by Mal overexpression. In MAPPIT, co-expression of the MyD88 TIR domain enhances Mal dimerization and Mal binding to TLR4. Similarly, co-expression of Mal and the MyD88 TIR domain strongly promotes dimerization of the TLR4 intracellular domain in MAPPIT. The different types of TIR-TIR interactions in the TLR4-Mal-MyD88 complex thus show cooperative binding in MAPPIT. We present plausible models for the TIR-TIR interactions in the TLR4-Mal-MyD88 complex.	[Peelman, Frank] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Peelman, Frank] Univ Ghent, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Peelman, F (corresponding author), Univ Ghent VIB, Dept Med Prot Res, Baertsoenkaai 3, B-9000 Ghent, Belgium.	frank.peelman@vib-ugent.be	Tavernier, Jan/AAG-3636-2019		Ugent BOF Grant [01Z03306]; Group-ID Multidisciplinary Research Partnership of Ghent University; FWO "krediet aan navorsers" Grant [1.5.256.08N]; FWO-V of the Fund for Scientific Research-Flanders (FWO); grant "doctoraatsbeurs voor strategisch basisonderzoek" of the agency for innovation by Science and Technology (IWT)	Ugent BOF Grant; Group-ID Multidisciplinary Research Partnership of Ghent University; FWO "krediet aan navorsers" Grant; FWO-V of the Fund for Scientific Research-Flanders (FWO)(FWO); grant "doctoraatsbeurs voor strategisch basisonderzoek" of the agency for innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by Ugent BOF Grant 01Z03306, the Group-ID Multidisciplinary Research Partnership of Ghent University, and by FWO "krediet aan navorsers" Grant 1.5.256.08N.; Recipient of grant FWO-V of the Fund for Scientific Research-Flanders (FWO).; Recipient of a grant "doctoraatsbeurs voor strategisch basisonderzoek" of the agency for innovation by Science and Technology (IWT).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bovijn C, 2012, J BIOL CHEM, V287, P4088, DOI 10.1074/jbc.M111.282350; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman Sven, 2002, Sci STKE, V2002, ppl18; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Lemmens I, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng075; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Ulrichts P, 2008, IMMUNOL LETT, V116, P141, DOI 10.1016/j.imlet.2007.11.026; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Ulrichts Peter, 2009, V517, P133, DOI 10.1007/978-1-59745-541-1_9; Uyttendaele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044143; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Ve T, 2012, CURR DRUG TARGETS, V13, P1360, DOI 10.2174/138945012803530260; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	55	34	34	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12054	12066		10.1074/jbc.M112.415810	http://dx.doi.org/10.1074/jbc.M112.415810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23460645	hybrid, Green Published			2022-12-28	WOS:000318157600039
J	Shah, NR; AlBitar-Nehme, S; Kim, E; Marr, N; Novikov, A; Caroff, M; Fernandez, RC				Shah, Nita R.; AlBitar-Nehme, Sami; Kim, Emma; Marr, Nico; Novikov, Alexey; Caroff, Martine; Fernandez, Rachel C.			Minor Modifications to the Phosphate Groups and the C3 ' Acyl Chain Length of Lipid A in Two Bordetella pertussis Strains, BP338 and 18-323, Independently Affect Toll-like Receptor 4 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE ACYLTRANSFERASES; GRAM-NEGATIVE BACTERIA; RANGE CLONING VECTOR; ESCHERICHIA-COLI; STRUCTURAL BASIS; LIPOPOLYSACCHARIDES; 4-AMINO-4-DEOXY-L-ARABINOSE; MICROEXTRACTION; PATHOGENESIS; DEACETYLASE	Lipopolysaccharides (LPS) of Bordetella pertussis are important modulators of the immune system. Interaction of the lipid A region of LPS with the Toll-like receptor 4 (TLR4) complex causes dimerization of TLR4 and activation of downstream nuclear factor kappa B (NF kappa B), which can lead to inflammation. We have previously shown that two strains of B. pertussis, BP338 (a Tohama I-derivative) and 18-323, display two differences in lipid A structure. 1) BP338 can modify the 1- and 4'-phosphates by the addition of glucosamine (GlcN), whereas 18-323 cannot, and 2) the C3' acyl chain in BP338 is 14 carbons long, but only 10 or 12 carbons long in 18-323. In addition, BP338 lipid A can activate TLR4 to a greater extent than 18-323 lipid A. Here we set out to determine the genetic reasons for the differences in these lipid A structures and the contribution of each structural difference to the ability of lipid A to activate TLR4. We show that three genes of the lipid A GlcN modification (Lgm) locus, lgmA, lgmB, and lgmC (previously locus tags BP0399-BP0397), are required for GlcN modification and a single amino acid difference in LpxA is responsible for the difference in C3' acyl chain length. Furthermore, by introducing lipid A-modifying genes into 18-323 to generate isogenic strains with varying penta-acyl lipid A structures, we determined that both modifications increase TLR4 activation, although the GlcN modification plays a dominant role. These results shed light on how TLR4 may interact with penta-acyl lipid A species.	[Shah, Nita R.; Kim, Emma; Marr, Nico; Fernandez, Rachel C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [AlBitar-Nehme, Sami; Novikov, Alexey; Caroff, Martine] Univ Paris 11, IGM, Ctr Natl Rech Sci, Equipe Struct & Activites Endotoxines,UMR 8621, F-91405 Orsay, France	University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Fernandez, RC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	rachelf@mail.ubc.ca	Marr, Nico/T-7741-2019; Caroff, Martine/N-4293-2019; Nehme, Sami Al Bitar/AAH-9585-2019	Marr, Nico/0000-0002-1927-7072; AL BITAR NEHME, SAMI/0000-0002-6472-5380; CAROFF, Martine/0000-0002-7329-5247	Canadian Institutes of Health Research [MOP-102706]; CNRS; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by an operating grant from the Canadian Institutes of Health Research (Grant MOP-102706) and a Programme International de Collaboration Scientifique (Franco-Canadien) grant from the CNRS to fund exchanges between the two countries.; The recipient of a Natural Sciences and Engineering Research Council of Canada scholarship.	Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; Caroff M., 2012, Patent, Patent No. [WO 2004/062690 A1, 2004062690]; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; El Hamidi A, 2005, J LIPID RES, V46, P1773, DOI 10.1194/jlr.D500014-JLR200; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Imagawa T, 2008, BIOCHEM BIOPH RES CO, V367, P535, DOI 10.1016/j.bbrc.2007.12.144; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Llewellyn AC, 2012, MOL MICROBIOL, V86, P611, DOI 10.1111/mmi.12004; Marr N, 2008, J BACTERIOL, V190, P4281, DOI 10.1128/JB.01875-07; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Marr N, 2010, J INFECT DIS, V202, P1897, DOI 10.1086/657409; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Sambrook J., 1989, MOL CLONING LAB MANU, p[153, 510]; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Therisod H, 2001, ANAL CHEM, V73, P3804, DOI 10.1021/ac010313s; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirsoaga A, 2007, J LIPID RES, V48, P2419, DOI 10.1194/jlr.M700193-JLR200; Tirsoaga A, 2007, APPL ENVIRON MICROB, V73, P1803, DOI 10.1128/AEM.02452-06; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; Williams AH, 2007, P NATL ACAD SCI USA, V104, P13543, DOI 10.1073/pnas.0705833104; Wyckoff TJO, 1998, J BIOL CHEM, V273, P32369, DOI 10.1074/jbc.273.49.32369	40	33	33	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11751	11760		10.1074/jbc.M112.434365	http://dx.doi.org/10.1074/jbc.M112.434365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467413	Green Published, hybrid			2022-12-28	WOS:000318157600012
J	Liu, Y; Qin, K; Meng, G; Zhang, JF; Zhou, JF; Zhao, GY; Luo, M; Zheng, XF				Liu, Yong; Qin, Kun; Meng, Geng; Zhang, Jinfang; Zhou, Jianfang; Zhao, Guangyu; Luo, Ming; Zheng, Xiaofeng			Structural and Functional Characterization of K339T Substitution Identified in the PB2 Subunit Cap-binding Pocket of Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; RNA-POLYMERASE; HOST-RANGE; MOLECULAR-BASIS; HIGH VIRULENCE; PA SUBUNIT; AMINO-ACID; REPLICATION; ENDONUCLEASE; SWINE	Influenza virus RNA-dependent RNA polymerase is a heterotrimer composed of PA, PB1, and PB2 subunits. RNA-dependent RNA polymerase is required for both transcription and replication of influenza viral RNA taking place in the nucleus of infected cells. A "cap-snatching" mechanism is used to generate a 5'-capped primer for transcription in which the cap-binding domain of PB2 (PB2(cap)) captures the 5' cap of the host pre-mRNA. Our statistical analysis of PB2 sequences showed that residue Lys(339) located in the cap-binding pocket of H5N1 PB2(cap) was gradually replaced by Thr(339) over the past decade. To understand the role of this amino acid polymorphism, we solved the crystal structures of PB2(cap) with or without a pre-mRNA cap analog, m(7)GTP, in the presence of Lys(339) or Thr(339). The structures showed that Lys(339) contributes to binding the gamma-phosphate group of m(7)GTP, and the replacement of Lys(339) by Thr eliminates this interaction. Isothermal titration calorimetry analysis showed that Thr(339) attenuated the PB2(cap) cap binding activity in vitro compared with Lys(339). Further functional studies confirmed that Thr(339)-PB2-containing ribonucleoprotein complex has a reduced influenza polymerase activity and RNA synthesis activity, and a reconstituted H5N1 virus containing the Thr(339) substitution exhibited a lower virulence to mice but more active replication in Madin-Darby canine kidney cells. The K339T substitution in the cap-binding pocket of PB2 modulates the polymerase activity and virulence by regulating the cap binding activity. It is informative to track variations in the cap-binding pocket of PB2 in surveillance of the evolution and spread of influenza virus.	[Liu, Yong; Meng, Geng; Zhang, Jinfang; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Liu, Yong; Meng, Geng; Zhang, Jinfang; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Qin, Kun; Zhou, Jianfang] Chinese Ctr Dis Control & Prevent, Chinese Natl Influenza Ctr, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Luo, Ming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Zhao, Guangyu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Peking University; Peking University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Alabama System; University of Alabama Birmingham; Beijing Institute of Microbiology & Epidemiology	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Meng, Geng/ACY-1510-2022		National High Technology and Development Program of China 973 Programs [2010CB911800]; National Natural Science Foundation of China [30930020]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN09-01]; major research project for infectious disease [2013ZX10004611-003]	National High Technology and Development Program of China 973 Programs; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Centre for Genetic Engineering and Biotechnology; major research project for infectious disease	This work was supported by the National High Technology and Development Program of China 973 Programs (Grant 2010CB911800), National Natural Science Foundation of China (Grant 30930020), International Centre for Genetic Engineering and Biotechnology (Project CRP/CHN09-01), and a major research project for infectious disease (Project 2013ZX10004611-003).	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Bogs J, 2011, J VIROL, V85, P10691, DOI 10.1128/JVI.00786-11; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chan AY, 2006, VIROLOGY, V351, P210, DOI 10.1016/j.virol.2006.03.005; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foeglein A, 2011, J GEN VIROL, V92, P1650, DOI 10.1099/vir.0.031492-0; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hudjetz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002488; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Lee MS, 2007, VET MICROBIOL, V124, P193, DOI 10.1016/j.vetmic.2007.04.021; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu QF, 2012, J VIROL, V86, P1233, DOI 10.1128/JVI.05699-11; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakazono Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032634; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036415; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reperant LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043115; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Rolling T, 2009, J VIROL, V83, P6673, DOI 10.1128/JVI.00212-09; Schat KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030960; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhang SJ, 2012, BBA-GENE REGUL MECH, V1819, P78, DOI 10.1016/j.bbagrm.2011.11.006; Zhu WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033383; Zhu WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-29	50	34	36	2	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11013	11023		10.1074/jbc.M112.392878	http://dx.doi.org/10.1074/jbc.M112.392878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23436652	hybrid, Green Published			2022-12-28	WOS:000317915500008
J	Zheng, HY; Zhou, MH; Hu, CL; Kuo, E; Peng, X; Hu, JJ; Kuo, L; Zhang, SYL				Zheng, Hongying; Zhou, Meng-Hua; Hu, Changlong; Kuo, Enoch; Peng, Xu; Hu, Junjie; Kuo, Lih; Zhang, Shenyuan L.			Differential Roles of the C and N Termini of Orai1 Protein in Interacting with Stromal Interaction Molecule 1 (STIM1) for Ca2(+) Release-activated Ca2+ (CRAC) Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; PLASMA-MEMBRANE; T-LYMPHOCYTES; MECHANISTIC INSIGHTS; ION SELECTIVITY; SMOOTH-MUSCLE; I-CRAC; STORE; CELLS; DEPLETION	The entry of extracellular Ca2+, which is mediated by Ca2+ release-activated Ca2+ (CRAC) channels, is essential for T cell activation and the normal functioning of other immune cells. Although the molecular components of CRAC channels, the Orai1 pore-forming subunit and the STIM1-activating subunit have been recently identified, the gating mechanism by which Orai1 channels conduct Ca2+ entry upon Orai1-STIM1 interaction following Ca2+ store release remains elusive. Herein, we show that C-terminal truncations or point mutations prevented Orai1 from binding to STIM1 and subsequent channel opening. In contrast, an Orai1 mutant with an N-terminal truncation interacted with but failed to be activated by STIM1. Moreover, Orai1 channels with C-terminal disruption, but not N-terminal truncation, could be gated by fused functional domains of STIM1. Interestingly, the channel activities of Orai1 mutants carrying either an N-terminal or a C-terminal truncation were restored by a methionine mutation at the putative gating hinge, the conserved Gly-98 site in the first transmembrane segment (TM1) of Orai1. Collectively, these results support a stepwise gating mechanism of STIM1-operated Orai1 channels; the initial binding between STIM1 and the C terminus of Orai1 docks STIM1 onto the N terminus of Orai1 to initiate conformational changes of the pore-lining TM1 helix of Orai1, leading to the opening of the channel.	[Zheng, Hongying; Zhou, Meng-Hua; Kuo, Enoch; Peng, Xu; Kuo, Lih; Zhang, Shenyuan L.] Texas A&M Hlth Sci Ctr, Dept Med Physiol, Coll Med, Temple, TX 76504 USA; [Hu, Changlong] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Hu, Junjie] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Hu, Junjie] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Kuo, Lih] Texas A&M Hlth Sci Ctr, Coll Med, Scott & White Mem Hosp, Dept Surg, Temple, TX 76504 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Fudan University; Nankai University; Nankai University; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Zhang, SYL (corresponding author), Texas A&M Hlth Sci Ctr, Dept Med Physiol, Coll Med, 702 Southwest HK Dodgen Loop, Temple, TX 76504 USA.	shenyuan.zhang@medicine.tamhsc.edu	Hu, Junjie/F-9713-2013; Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947; Kuo, Lih/0000-0002-4912-6910	Texas A&M-Weizmann Program; Research Grants Program Grant [110598]; Scott & White Memorial Hospital; Kruse Family Centennial Chair Fund; National Basic Research Program of China (973 Program) [2010CB833702]; National Natural Science Foundation of China (NSFC) [31000515]	Texas A&M-Weizmann Program; Research Grants Program Grant; Scott & White Memorial Hospital; Kruse Family Centennial Chair Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the 2012 Texas A&M-Weizmann Program (to S. L. Z. and X. P.), the Research Grants Program Grant 110598, Scott & White Memorial Hospital (to S. L. Z.), the Kruse Family Centennial Chair Fund, Scott & White Memorial Hospital (to L. K.), the National Basic Research Program of China (973 Program; Grant 2010CB833702 to J. H.), and National Natural Science Foundation of China (NSFC) Grant 31000515 (to C. H.).	Beech DJ, 2012, PFLUG ARCH EUR J PHY, V463, P635, DOI 10.1007/s00424-012-1090-2; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Gemes G, 2011, J NEUROSCI, V31, P3536, DOI 10.1523/JNEUROSCI.5053-10.2011; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; Li J, 2011, BRIT J PHARMACOL, V164, P382, DOI 10.1111/j.1476-5381.2011.01368.x; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	57	75	75	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11263	11272		10.1074/jbc.M113.450254	http://dx.doi.org/10.1074/jbc.M113.450254			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23447534	Green Published, hybrid			2022-12-28	WOS:000317915500029
J	Catterall, WA; Leal, K; Nanou, E				Catterall, William A.; Leal, Karina; Nanou, Evanthia			Calcium Channels and Short-term Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PAIRED-PULSE FACILITATION; TRANSMITTER RELEASE; N-TYPE; CA(V)2.1 CHANNELS; CA2+ CHANNELS; MOLECULAR DETERMINANTS; NEUROTRANSMITTER RELEASE; STRUCTURAL-CHANGES; SYNAPTOTAGMIN-I; DELAYED RELEASE	Voltage-gated Ca2+ channels in presynaptic nerve terminals initiate neurotransmitter release in response to depolarization by action potentials from the nerve axon. The strength of synaptic transmission is dependent on the third to fourth power of Ca2+ entry, placing the Ca2+ channels in a unique position for regulation of synaptic strength. Short-term synaptic plasticity regulates the strength of neurotransmission through facilitation and depression on the millisecond time scale and plays a key role in encoding information in the nervous system. Ca(V)2.1 channels are the major source of Ca2+ entry for neurotransmission in the central nervous system. They are tightly regulated by Ca2+, calmodulin, and related Ca2+ sensor proteins, which cause facilitation and inactivation of channel activity. Emerging evidence reviewed here points to this mode of regulation of Ca(V)2.1 channels as a major contributor to short-term synaptic plasticity of neurotransmission and its diversity among synapses.	[Catterall, William A.; Leal, Karina; Nanou, Evanthia] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu			National Institutes of Health [R01 NS22625]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS22625. This article is part of the Thematic Minireview Series on Calcium Function and Disease.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Ali AB, 2006, CEREB CORTEX, V16, P386, DOI 10.1093/cercorbhi117; Atluri PP, 1998, J NEUROSCI, V18, P8214; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DICKINSONNELSON A, 1983, J NEUROSCI, V3, P42; Dittman JS, 2000, J NEUROSCI, V20, P1374; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Few AP, 2012, P NATL ACAD SCI USA, V109, pE452, DOI 10.1073/pnas.1121103109; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Halling D Brent, 2005, Sci STKE, V2005, pre15, DOI 10.1126/stke.3152005re15; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; HUBBARD JI, 1963, J PHYSIOL-LONDON, V169, P641, DOI 10.1113/jphysiol.1963.sp007286; Inchauspe CG, 2007, J PHYSIOL-LONDON, V584, P835, DOI 10.1113/jphysiol.2007.139683; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Leal K, 2012, P NATL ACAD SCI USA, V109, P17069, DOI 10.1073/pnas.1215172109; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Lipscombe D, 2007, CHANNELS, V1, P225, DOI 10.4161/chan.4809; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Muller M, 2007, J NEUROSCI, V27, P2261, DOI 10.1523/JNEUROSCI.5582-06.2007; Muller M, 2008, J PHYSIOL-LONDON, V586, P5503, DOI 10.1113/jphysiol.2008.155838; Nanou E, 2012, J BIOL CHEM, V287, P504, DOI 10.1074/jbc.M111.292581; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Park HY, 2008, P NATL ACAD SCI USA, V105, P542, DOI 10.1073/pnas.0710810105; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; RAHAMIMOFF R, 1973, J PHYSIOL-LONDON, V228, P241, DOI 10.1113/jphysiol.1973.sp010084; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Rettig J, 1997, J NEUROSCI, V17, P6647; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Sheng JS, 2012, NAT NEUROSCI, V15, P998, DOI 10.1038/nn.3129; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sullivan JM, 2007, J NEUROPHYSIOL, V97, P948, DOI 10.1152/jn.00554.2006; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xie M, 2007, J CELL BIOL, V178, P489, DOI 10.1083/jcb.200702072; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	99	87	88	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10742	10749		10.1074/jbc.R112.411645	http://dx.doi.org/10.1074/jbc.R112.411645			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23400776	Green Published, hybrid			2022-12-28	WOS:000317565000052
J	Malasarn, D; Kropat, J; Hsieh, SI; Finazzi, G; Casero, D; Loo, JA; Pellegrini, M; Wollman, FA; Merchant, SS				Malasarn, Davin; Kropat, Janette; Hsieh, Scott I.; Finazzi, Giovanni; Casero, David; Loo, Joseph A.; Pellegrini, Matteo; Wollman, Francis-Andre; Merchant, Sabeeha S.			Zinc Deficiency Impacts CO2 Assimilation and Disrupts Copper Homeostasis in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-CONCENTRATING MECHANISM; GENE-EXPRESSION; PLASMA-MEMBRANE; IRON; ANHYDRASE; TRANSPORTERS; PROTEIN; REGULATOR; ENCODES; DIOXIDE	Zinc is an essential nutrient because of its role in catalysis and in protein stabilization, but excess zinc is deleterious. We distinguished four nutritional zinc states in the alga Chlamydomonas reinhardtii: toxic, replete, deficient, and limited. Growth is inhibited in zinc-limited and zinc-toxic cells relative to zinc-replete cells, whereas zinc deficiency is visually asymptomatic but distinguished by the accumulation of transcripts encoding ZIP family transporters. To identify targets of zinc deficiency and mechanisms of zinc acclimation, we used RNA-seq to probe zinc nutrition-responsive changes in gene expression. We identified genes encoding zinc-handling components, including ZIP family transporters and candidate chaperones. Additionally, we noted an impact on two other regulatory pathways, the carbon-concentrating mechanism (CCM) and the nutritional copper regulon. Targets of transcription factor Ccm1 and various CAH genes are up-regulated in zinc deficiency, probably due to reduced carbonic anhydrase activity, validated by quantitative proteomics and immunoblot analysis of Cah1, Cah3, and Cah4. Chlamydomonas is therefore not able to grow photoautotrophically in zinc-limiting conditions, but supplementation with 1% CO2 restores growth to wild-type rates, suggesting that the inability to maintain CCM is a major consequence of zinc limitation. The Crr1 regulon responds to copper limitation and is turned on in zinc deficiency, and Crr1 is required for growth in zinc-limiting conditions. Zinc-deficient cells are functionally copper-deficient, although they hyperaccumulate copper up to 50-fold over normal levels. We suggest that zinc-deficient cells sequester copper in a biounavailable form, perhaps to prevent mismetallation of critical zinc sites.	[Malasarn, Davin; Kropat, Janette; Hsieh, Scott I.; Loo, Joseph A.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Casero, David; Loo, Joseph A.; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Finazzi, Giovanni; Wollman, Francis-Andre] Univ Paris 06, CNRS, Inst Biol Physicochim, F-75005 Paris, France; [Finazzi, Giovanni] Univ Grenoble 1, CNRS,Commissariat Energie Atom Grenoble,UMR 5168, Commissariat Energie Atom & Energies Alternat,Ins, Inst Natl Rech Agron,Lab Physiol Cellulaire & Veg, F-38054 Grenoble, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Merchant, SS (corresponding author), 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu	Casero, David/E-7365-2010	Casero, David/0000-0002-7347-3330; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health [GM42143]; Office of Science (Biological and Environmental Research), United States Department of Energy [DE-FC02-02ER63421]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [F32GM083562, T32 GM07185]; Chateaubriand Fellowship for collaborative experiments; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042143, R37GM042143, F32GM083562, T32GM007185, R29GM042143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science (Biological and Environmental Research), United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chateaubriand Fellowship for collaborative experiments; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42143 (to S. M.) for work on the zinc-deficiency transcriptome. The proteomic analyses and expression of proteins for use as antigens were supported by the Institute of Genomics and Proteomics at UCLA (funded by the Office of Science (Biological and Environmental Research), United States Department of Energy, through Cooperative Agreement DE-FC02-02ER63421).r Supported in part by National Institutes of Health Ruth L. Kirschstein National Research Service Award F32GM083562 and a Chateaubriand Fellowship for collaborative experiments with G. F. and F. A. W.r Supported in part by National Institutes of Health Ruth L. Kirschstein National Research Service Award T32 GM07185 for the UCLA predoctoral Cellular and Molecular Biology Training Program.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; Ballestin R, 2011, ALCOHOL ALCOHOLISM, V46, P17, DOI 10.1093/alcalc/agq079; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; DIEZ M, 1989, CANCER, V63, P726, DOI 10.1002/1097-0142(19890215)63:4<726::AID-CNCR2820630421>3.0.CO;2-P; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; Finazzi G, 1997, BIOCHEMISTRY-US, V36, P2867, DOI 10.1021/bi962717y; Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Harris EH., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; HUTNER S. H., 1950, PROC AMER PHIL SOC, V94, P152; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; Lane TW, 2000, PLANT PHYSIOL, V123, P345, DOI 10.1104/pp.123.1.345; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9; Moroney JV, 2011, PHOTOSYNTH RES, V109, P133, DOI 10.1007/s11120-011-9635-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Page MD, 2009, PLANT CELL, V21, P928, DOI 10.1105/tpc.108.064907; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Quinn JM, 2000, J BIOL CHEM, V275, P6080, DOI 10.1074/jbc.275.9.6080; Roberts K, 2007, PHOTOSYNTH RES, V93, P79, DOI 10.1007/s11120-007-9172-2; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Ryu MS, 2008, J NUTR, V138, P2076, DOI 10.3945/jn.108.093575; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Sinetova MA, 2012, BBA-BIOENERGETICS, V1817, P1248, DOI 10.1016/j.bbabio.2012.02.014; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; TACHIKI A, 1992, BIOSCI BIOTECH BIOCH, V56, P794, DOI 10.1271/bbb.56.794; Toepel J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-579; Villarejo A, 2001, PLANTA, V213, P286, DOI 10.1007/s004250000508; Wang YJ, 2011, PHOTOSYNTH RES, V109, P115, DOI 10.1007/s11120-011-9643-3; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yee D, 1996, LIMNOL OCEANOGR, V41, P573, DOI 10.4319/lo.1996.41.3.0573; Ynalvez RA, 2008, PHYSIOL PLANTARUM, V133, P15, DOI 10.1111/j.1399-3054.2007.01043.x; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	72	54	57	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10672	10683		10.1074/jbc.M113.455105	http://dx.doi.org/10.1074/jbc.M113.455105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439652	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000317565000045
J	Rodriguez-Guilbe, M; Oyola-Robles, D; Schreiter, ER; Baerga-Ortiz, A				Rodriguez-Guilbe, Maria; Oyola-Robles, Delise; Schreiter, Eric R.; Baerga-Ortiz, Abel			Structure, Activity, and Substrate Selectivity of the Orf6 Thioesterase from Photobacterium profundum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOG-FOLD THIOESTERASE; SP STRAIN SU; 4-HYDROXYBENZOYL-COA THIOESTERASE; ESCHERICHIA-COLI; FATTY-ACIDS; BIODIESEL PRODUCTION; CATALYTIC MECHANISM; HOTDOG-FOLD; BIOSYNTHESIS; PATHWAY	Thioesterase activity is typically required for the release of products from polyketide synthase enzymes, but no such enzyme has been characterized in deep-sea bacteria associated with the production of polyunsaturated fatty acids. In this work, we have expressed and purified the Orf6 thioesterase from Photobacterium profundum. Enzyme assays revealed that Orf6 has a higher specific activity toward long-chain fatty acyl-CoA substrates (palmitoyl-CoA and eicosapentaenoyl-CoA) than toward short-chain or aromatic acyl-CoA substrates. We determined a high resolution (1.05 angstrom) structure of Orf6 that reveals a hotdog hydrolase fold arranged as a dimer of dimers. The putative active site of this structure is occupied by additional electron density not accounted for by the protein sequence, consistent with the presence of an elongated compound. A second crystal structure (1.40 angstrom) was obtained from a crystal that was grown in the presence of Mg2+, which reveals the presence of a binding site for divalent cations at a crystal contact. The Mg2+-bound structure shows localized conformational changes (root mean square deviation of 1.63 angstrom), and its active site is unoccupied, suggesting a mechanism to open the active site for substrate entry or product release. These findings reveal a new thioesterase enzyme with a preference for long-chain CoA substrates in a deep-sea bacterium whose potential range of applications includes bioremediation and the production of biofuels.	[Rodriguez-Guilbe, Maria; Oyola-Robles, Delise; Baerga-Ortiz, Abel] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Schreiter, Eric R.] Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA; [Schreiter, Eric R.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Howard Hughes Medical Institute	Schreiter, ER (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	schreitere@janelia.hhmi.org; abel.baerga@upr.edu		Schreiter, Eric/0000-0002-2864-7469	National Institutes of Health [R25GM061838]; National Science Foundation [CHE0953254]; United States Department of Energy Office [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, United States Department of Energy [DE-AC02-05CH11231]; National Center for Research Resources [2G12-RR003051]; National Institute on Minority Health and Health Disparities from the National Institutes of Health [8G12-MD007600]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy Office(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R25GM061838 (MBRS-RISE Program; to M. R.-G. and D. O.-R.). This work was also supported by National Science Foundation Grant CHE0953254 (to A. B.-O.).; We thank Dr. Eric Allen for providing the pfa genes from P. profundum and Mar~a Malave for initial cloning of the orf6 gene. Dr. Orestes Quesada and Ms. Carol Rodriguez helped with mass spectrometric analysis of the purified protein. We thank the staff of Advanced Photon Source beamline 23-ID and Advanced Light Source beamline 4.2.2 for support during x-ray data collection. M. R.-G. is especially grateful to Dr. Ruslan Sanishvili (Advanced Photon Source, Argonne National Laboratory) for invaluable help with crystallographic collection. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by the Argonne National Laboratory, was supported by the United States Department of Energy Office under Contract DE-AC02-06CH11357. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, United States Department of Energy under Contract DE-AC02-05CH11231. Shared instrumentation was supported by National Center for Research Resources Grant 2G12-RR003051 and National Institute on Minority Health and Health Disparities Grant 8G12-MD007600 from the National Institutes of Health.	Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Chen DQ, 2009, BIOCHEMISTRY-US, V48, P511, DOI 10.1021/bi802207t; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo ZF, 2009, BIOCHEMISTRY-US, V48, P1712, DOI 10.1021/bi802165x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Liew CW, 2010, J MOL BIOL, V404, P291, DOI 10.1016/j.jmb.2010.09.041; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Metz JG, 2009, PLANT PHYSIOL BIOCH, V47, P472, DOI 10.1016/j.plaphy.2009.02.002; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nawabi P, 2011, APPL ENVIRON MICROB, V77, P8052, DOI 10.1128/AEM.05046-11; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Shulse CN, 2011, ENVIRON MICROBIOL, V13, P684, DOI 10.1111/j.1462-2920.2010.02373.x; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Song F, 2012, BIOCHEMISTRY-US, V51, P7000, DOI 10.1021/bi301059m; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Thoden JB, 2003, J BIOL CHEM, V278, P43709, DOI 10.1074/jbc.M308198200; Thoden JB, 2002, J BIOL CHEM, V277, P27468, DOI 10.1074/jbc.M203904200; Zheng YN, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-76; Zhuang ZH, 2002, BIOCHEMISTRY-US, V41, P11152, DOI 10.1021/bi0262303	33	14	15	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10841	10848		10.1074/jbc.M112.446765	http://dx.doi.org/10.1074/jbc.M112.446765			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430744	Green Published, hybrid			2022-12-28	WOS:000317565000061
J	Ahmedli, NB; Gribanova, Y; Njoku, CC; Naidu, A; Young, A; Mendoza, E; Yamashita, CK; Ozgul, RK; Johnson, JE; Fox, DA; Farber, DB				Ahmedli, Novruz B.; Gribanova, Yekaterina; Njoku, Collins C.; Naidu, Akash; Young, Alejandra; Mendoza, Emmanuel; Yamashita, Clyde K.; Ozgul, Riza Koksal; Johnson, Jerry E.; Fox, Donald A.; Farber, Debora B.			Dynamics of the Rhomboid-like Protein RHBDD2 Expression in Mouse Retina and Involvement of Its Human Ortholog in Retinitis Pigmentosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; FINGER PROTEIN; SALT BRIDGES; DROSOPHILA; PHOTORECEPTOR; PROTEASES; GENES; CONES; ROD; SPECIFICITY	The novel rhomboid-like protein RHBDD2 is distantly related to rhomboid proteins, a group of highly specialized membrane-bound proteases that catalyze regulated intramembrane proteolysis. In retina, RHBDD2 is expressed from embryonic stages to adulthood, and its levels show age-dependent changes. RHBDD2 is distinctly abundant in the perinuclear region of cells, and it localizes to their Golgi. A glycine zipper motif present in one of the transmembrane domains of RHBDD2 is important for its packing into the Golgi membranes. Its deletion causes dislodgment of RHBDD2 from the Golgi. A specific antibody against RHBDD2 recognizes two forms of the protein, one with low (39 kDa; RHBDD2(L)) and the other with high (117 kDa; RHBDD2(H)) molecular masses in mouse retinal extracts. RHBDD2(L) seems to be ubiquitously expressed in all retinal cells. In contrast, RHBDD2(H) seems to be present only in the outer segments of cone photoreceptors and may correspond to a homotrimer of RHBDD2(L). This protein consistently co-localizes with S- and M-types of cone opsins. We identified a homozygous mutation in the human RHBDD2 gene, R85H, that co-segregates with disease in affected members of a family with autosomal recessive retinitis pigmentosa. Our findings suggest that the RHBDD2 protein plays important roles in the development and normal function of the retina.	[Ahmedli, Novruz B.; Gribanova, Yekaterina; Njoku, Collins C.; Naidu, Akash; Young, Alejandra; Mendoza, Emmanuel; Yamashita, Clyde K.; Farber, Debora B.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ozgul, Riza Koksal] Hacettepe Univ, Dept Mol Biol, TR-06230 Beytepe, Turkey; [Johnson, Jerry E.] Univ Houston Downtown, Dept Nat Sci, Houston, TX 77002 USA; [Fox, Donald A.] Univ Houston, Coll Optometry, Houston, TX 77004 USA; [Fox, Donald A.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Fox, Donald A.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77004 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Hacettepe University; University of Houston System; University of Houston; University of Houston Downtown; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston	Ahmedli, NB (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.	akhmedov@jsei.ucla.edu	OZGUL, RIZA KOKSAL/J-1569-2013	Ozgul, Riza Koksal/0000-0002-0283-635X; Farber, Debora/0000-0002-3207-697X; Young, Alejandra/0000-0002-1855-0559	National Institutes of Health [RO1 EY08285, RO1 ES012482, P30 EY000331, T32 EY07024, P30 EY07551]; Hope for Vision; Oppenheimer Foundation; NATIONAL EYE INSTITUTE [T32EY007024, P30EY007551, P30EY000331, R01EY008285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; Oppenheimer Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY08285 (to D. B. F.), RO1 ES012482 (to D. A. F.), P30 EY000331 (to the Jules Stein Eye Institute), and T32 EY07024 and P30 EY07551 (to the University of Houston College of Optometry). This work was also supported by Hope for Vision and Oppenheimer Foundation grants (to N. B. A.).	Abba MC, 2009, BBA-MOL BASIS DIS, V1792, P988, DOI 10.1016/j.bbadis.2009.07.006; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chiu CF, 2008, EMBO J, V27, P934, DOI 10.1038/emboj.2008.40; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Frigyes D, 2001, J MOL STRUC-THEOCHEM, V574, P39, DOI 10.1016/S0166-1280(01)00368-2; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Giddabasappa A, 2011, ENVIRON HEALTH PERSP, V119, P71, DOI 10.1289/ehp.1002524; Gough LL, 2003, MOL BIOL CELL, V14, P2410, DOI 10.1091/mbc.E02-07-0446; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; Johnson JE, 2007, MOL VIS, V13, P887; Kerov VS, 2005, MOL CELL NEUROSCI, V28, P485, DOI 10.1016/j.mcn.2004.10.010; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Lacunza E, 2012, TUMOR BIOL, V33, P2393, DOI 10.1007/s13277-012-0503-3; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; LLEWELLYN DH, 1993, HUM MOL GENET, V2, P1315, DOI 10.1093/hmg/2.8.1315; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Morahan BJ, 2009, EXP PARASITOL, V122, P280, DOI 10.1016/j.exppara.2009.04.013; Perkins GA, 2003, MOL VIS, V9, P60; Saghizadeh M, 2011, MOL VIS, V17, P2011; Saghizadeh M, 2009, INVEST OPHTH VIS SCI, V50, P3580, DOI 10.1167/iovs.08-2751; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; SUNDARALINGAM M, 1985, P NATL ACAD SCI USA, V82, P7944, DOI 10.1073/pnas.82.23.7944; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Walder K, 2005, DIABETOLOGIA, V48, P459, DOI 10.1007/s00125-005-1675-9; Wasserman JD, 2000, GENE DEV, V14, P1651; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187	41	10	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9742	9754		10.1074/jbc.M112.419960	http://dx.doi.org/10.1074/jbc.M112.419960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23386608	Green Published, hybrid			2022-12-28	WOS:000317114000016
J	Morla, L; Brideau, G; Fila, M; Crambert, G; Cheval, L; Houillier, P; Ramakrishnan, S; Imbert-Teboul, M; Doucet, A				Morla, Luciana; Brideau, Gaelle; Fila, Marc; Crambert, Gilles; Cheval, Lydie; Houillier, Pascal; Ramakrishnan, Sureshkrishna; Imbert-Teboul, Martine; Doucet, Alain			Renal Proteinase-activated Receptor 2, a New Actor in the Control of Blood Pressure and Plasma Potassium Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL COLLECTING DUCT; ANGIOTENSIN-II; SODIUM-TRANSPORT; RAT; CHANNELS; CHLORIDE; VASOPRESSIN; KIDNEY; ENAC; HYPERTENSION	Proteinase-activated receptor 2 (PAR2) is a G protein-coupled membrane receptor that is activated upon cleavage of its extracellular N-terminal domain by trypsin and related proteases. PAR2 is expressed in kidney collecting ducts, a main site of control of Na+ and K+ homeostasis, but its function remains unknown. We evaluated whether and how PAR2 might control electrolyte transport in collecting ducts, and thereby participate in the regulation of blood pressure and plasma K+ concentration. PAR2 is expressed at the basolateral border of principal and intercalated cells of the collecting duct where it inhibits K+ secretion and stimulates Na+ reabsorption, respectively. Invalidation of PAR2 gene impairs the ability of the kidney to control Na+ and K+ balance and promotes hypotension and hypokalemia in response to Na+ and K+ depletion, respectively. This study not only reveals a new role of proteases in the control of blood pressure and plasma potassium level, but it also identifies a second membrane receptor, after angiotensin 2 receptor, that differentially controls sodium reabsorption and potassium secretion in the late distal tubule. Conversely to angiotensin 2 receptor, PAR2 is involved in the regulation of sodium and potassium balance in the context of either stimulation or non-stimulation of the renin/angiotensin/aldosterone system. Therefore PAR2 appears not only as a new actor of the aldosterone paradox, but also as an aldosterone-independent modulator of blood pressure and plasma potassium.	[Morla, Luciana; Brideau, Gaelle; Fila, Marc; Crambert, Gilles; Cheval, Lydie; Houillier, Pascal; Ramakrishnan, Sureshkrishna; Imbert-Teboul, Martine; Doucet, Alain] Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, INSERM,UMRS872, F-75270 Paris 06, France; [Morla, Luciana; Brideau, Gaelle; Fila, Marc; Crambert, Gilles; Cheval, Lydie; Houillier, Pascal; Ramakrishnan, Sureshkrishna; Imbert-Teboul, Martine; Doucet, Alain] CNRS, ERL7226, F-75270 Paris 06, France; [Houillier, Pascal] Univ Paris 05, Fac Med, F-75006 Paris, France; [Houillier, Pascal] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Physiol, F-75004 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Doucet, A (corresponding author), Ctr Rech Cordeliers, ERL7226, 15 Rue Ecole Med, F-75270 Paris 06, France.	alain.doucet@crc.jussieu.fr	Crambert, Gilles/ABF-2753-2020; Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917; Morla, Luciana/0000-0002-1527-4392; Crambert, Gilles/0000-0001-7065-9124; CHEVAL, LYDIE/0000-0003-2957-6487	Amgen [2005/29-N]; Societe de Nephrologie; Agence Nationale de la Recherche [ANR-06-PHYSIO-035-01]; Fondation Leducq	Amgen(Amgen); Societe de Nephrologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Leducq(Leducq Foundation)	This work was supported in part by grants from Amgen (2005/29-N), the Societe de Nephrologie, the Agence Nationale de la Recherche (ANR-06-PHYSIO-035-01), and the Fondation Leducq.	Babilonia E, 2006, J AM SOC NEPHROL, V17, P2687, DOI 10.1681/ASN.2006050426; Bohm SK, 1996, J BIOL CHEM, V271, P22003; BOURDEAU JE, 1982, AM J PHYSIOL, V242, pF285, DOI 10.1152/ajprenal.1982.242.3.F285; Bucci M, 2005, VASC PHARMACOL, V43, P247, DOI 10.1016/j.vph.2005.07.009; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; COSTANZO LS, 1978, AM J PHYSIOL, V235, pF492, DOI 10.1152/ajprenal.1978.235.5.F492; Cuffe JE, 2002, J PHYSIOL-LONDON, V539, P209, DOI 10.1113/jphysiol.2001.013159; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Frindt G, 2010, AM J PHYSIOL-RENAL, V299, pF890, DOI 10.1152/ajprenal.00323.2010; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Michlig S, 2004, J BIOL CHEM, V279, P51002, DOI 10.1074/jbc.M405674200; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; MORGAN T, 1982, Australian Family Physician, V11, P264; Morla L, 2008, J BIOL CHEM, V283, P28020, DOI 10.1074/jbc.M804399200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Schmidlin O, 2005, HYPERTENSION, V45, P867, DOI 10.1161/01.HYP.0000164628.46415.66; Sekiguchi F., 2007, Inflammopharmacology, V15, P246, DOI 10.1007/s10787-007-1591-3; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; TOMITA K, 1986, J CLIN INVEST, V77, P136, DOI 10.1172/JCI112268; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; Verlander JW, 2011, AM J PHYSIOL-RENAL, V301, pF1314, DOI 10.1152/ajprenal.00114.2011; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; WHITESCARVER SA, 1984, SCIENCE, V223, P1430, DOI 10.1126/science.6322303; Youn JH, 2009, ANNU REV PHYSIOL, V71, P381, DOI 10.1146/annurev.physiol.010908.163241; Yue P, 2011, KIDNEY INT, V79, P423, DOI 10.1038/ki.2010.380	36	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10124	10131		10.1074/jbc.M112.446393	http://dx.doi.org/10.1074/jbc.M112.446393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430254	hybrid, Green Published			2022-12-28	WOS:000317114000053
J	Fricker, M; Vilalta, A; Tolkovsky, AM; Brown, GC				Fricker, Michael; Vilalta, Anna; Tolkovsky, Aviva M.; Brown, Guy C.			Caspase Inhibitors Protect Neurons by Enabling Selective Necroptosis of Inflamed Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIC BRAIN-INJURY; PRIMARY PHAGOCYTOSIS; CELL-DEATH; CEREBRAL-ISCHEMIA; VIABLE NEURONS; RIP1 KINASE; TNF-ALPHA; NEURODEGENERATION; ACTIVATION; APOPTOSIS	Microglia are resident brain macrophages, which can cause neuronal loss when activated in infectious, ischemic, traumatic, and neurodegenerative diseases. Caspase-8 has both prodeath and prosurvival roles, mediating apoptosis and/or preventing RIPK1-mediated necroptosis depending on cell type and stimulus. We found that inflammatory stimuli (LPS, lipoteichoic acid, or TNF-alpha) caused an increase in caspase-8 IETDase activity in primary rat microglia without inducing apoptosis. Inhibition of caspase-8 with either Z-VAD-fmk or IETD-fmk resulted in necrosis of activated microglia. Inhibition of caspases with Z-VAD-fmk did not kill non-activated microglia, or astrocytes and neurons in any condition. Necrostatin-1, a specific inhibitor of RIPK1, prevented microglial caspase inhibition-induced death, indicating death was by necroptosis. In mixed cerebellar cultures of primary neurons, astrocytes, and microglia, LPS induced neuronal loss that was prevented by inhibition of caspase-8 (resulting in microglial necroptosis), and neuronal death was restored by rescue of microglia with necrostatin-1. We conclude that the activation of caspase-8 in inflamed microglia prevents their death by necroptosis, and thus, caspase-8 inhibitors may protect neurons in the inflamed brain by selectively killing activated microglia.	[Fricker, Michael; Vilalta, Anna; Brown, Guy C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Tolkovsky, Aviva M.] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 OPY, England	University of Cambridge; University of Cambridge	Fricker, M (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2305, Australia.	michael.fricker@gmail.com	Brown, Guy C./HHC-1102-2022; FRICKER, MICHAEL/ABE-2316-2021	Vilalta, Anna/0000-0002-2183-072X; Brown, Guy/0000-0002-3610-1730; Fricker, Michael/0000-0002-8587-1774	Wellcome Trust Grant [RG50995]	Wellcome Trust Grant(Wellcome Trust)	This work was supported by Wellcome Trust Grant RG50995.	Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Ciechomska Iwona A., 2008, V445, P175, DOI 10.1007/978-1-59745-157-4_12; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Feng YZ, 2003, EUR J PHARMACOL, V481, P169, DOI 10.1016/j.ejphar.2003.09.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Inoue S, 2006, ANESTH ANALG, V102, P1548, DOI 10.1213/01.ane.0000202381.40516.8d; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kinsner A, 2005, J NEUROCHEM, V95, P1132, DOI 10.1111/j.1471-4159.2005.03422.x; Neher JJ, 2007, BIOCHEM SOC T, V35, P1166, DOI 10.1042/BST0351166; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Solorzano CC, 1997, SHOCK, V7, P427, DOI 10.1097/00024382-199706000-00007; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; Wiessner C, 2000, CELL MOL BIOL, V46, P53	28	68	71	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9145	9152		10.1074/jbc.M112.427880	http://dx.doi.org/10.1074/jbc.M112.427880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386613	Green Published, hybrid			2022-12-28	WOS:000316862200034
J	Sun, XX; Ai, MD; Wang, Y; Shen, SS; Gu, Y; Jin, Y; Zhou, ZY; Long, YQ; Yu, Q				Sun, Xiaoxiao; Ai, Midan; Wang, Ying; Shen, Shensi; Gu, Yuan; Jin, Yi; Zhou, Zuyu; Long, Yaqiu; Yu, Qiang			Selective Induction of Tumor Cell Apoptosis by a Novel P450-mediated Reactive Oxygen Species (ROS) Inducer Methyl 3-(4-Nitrophenyl) Propiolate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PHENETHYL ISOTHIOCYANATE; OXIDATIVE STRESS; REDOX REGULATION; CANCER; GENERATION; P53; METABOLISM; CYTOTOXICITY; ACTIVATION	Induction of tumor cell apoptosis has been recognized as a valid anticancer strategy. However, therapeutic selectivity between tumor and normal cells has always been a challenge. Here, we report a novel anti-cancer compound methyl 3-(4-nitrophenyl) propiolate (NPP) preferentially induces apoptosis in tumor cells through P450-catalyzed reactive oxygen species (ROS) production. A compound sensitivity study on multiple cell lines shows that tumor cells with high basal ROS levels, low antioxidant capacities, and p53 mutations are especially sensitive to NPP. Knockdown of p53 sensitized non-transformed cells to NPP-induced cell death. Additionally, by comparing NPP with other ROS inducers, we show that the susceptibility of tumor cells to the ROS-induced cell death is influenced by the mode, amount, duration, and perhaps location of ROS production. Our studies not only discovered a unique anticancer drug candidate but also shed new light on the understanding of ROS generation and function and the potential application of a ROS-promoting strategy in cancer treatment.	[Sun, Xiaoxiao; Ai, Midan; Wang, Ying; Shen, Shensi; Gu, Yuan; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 201203, Peoples R China; [Jin, Yi; Zhou, Zuyu; Long, Yaqiu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Yu, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, 555 Zhchongzhi Rd, Shanghai 201203, Peoples R China.	qyu@sibs.ac.cn	Sun, Xiaoxiao/AAR-9563-2021; SHEN, Shensi/AAW-2735-2020	Sun, Xiaoxiao/0000-0002-9689-9385; SHEN, Shensi/0000-0002-5087-8220; Gu, Yuan/0000-0003-1401-6233	China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program [2013ZX09102015]; China Ministry of Science and Technology Research [2013ZX10002010-009]; China National Natural Science Foundation [31129004, 91129701, 91213304]; National Science and Technology 973 Grants [2012CB910704, 2013CB910900]	China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program; China Ministry of Science and Technology Research(Ministry of Science and Technology, China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology 973 Grants	This work was supported by China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program Grant 2013ZX09102015; by China Ministry of Science and Technology Research Grant 2013ZX10002010-009; by China National Natural Science Foundation Grants 31129004, 91129701, and 91213304; and by National Science and Technology 973 Grants 2012CB910704 and 2013CB910900.	Agostinelli E, 2006, AMINO ACIDS, V31, P341, DOI 10.1007/s00726-005-0271-8; Bhana S, 2008, MUTAGENESIS, V23, P43, DOI 10.1093/mutage/gem041; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Cai L, 2003, CELL RES, V13, P93, DOI 10.1038/sj.cr.7290154; Celik H, 2008, J PHARM PHARM SCI, V11, P68; Cerna D, 2012, J BIOL CHEM, V287, P22408, DOI 10.1074/jbc.M112.357301; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Constan AA, 1999, TOXICOL APPL PHARM, V160, P120, DOI 10.1006/taap.1999.8756; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Fischer U, 2005, CELL DEATH DIFFER, V12, P942, DOI 10.1038/sj.cdd.4401556; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; Hodson PV, 2007, AQUAT TOXICOL, V81, P275, DOI 10.1016/j.aquatox.2006.12.012; Hsieh JL, 2003, CLIN CANCER RES, V9, P338; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Joseph P, 1998, BRIT J CANCER, V77, P709, DOI 10.1038/bjc.1998.117; Kamdem LK, 2010, BRIT J CLIN PHARMACO, V70, P854, DOI 10.1111/j.1365-2125.2010.03791.x; Khan D, 2008, CHEM-BIOL INTERACT, V175, P231, DOI 10.1016/j.cbi.2008.05.024; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mao L, 2009, MOL CELL BIOL, V29, P5426, DOI 10.1128/MCB.00105-09; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; Omiecinski CJ, 1999, TOXICOL SCI, V48, P151, DOI 10.1093/toxsci/48.2.151; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Park JY, 2003, ANTIMICROB AGENTS CH, V47, P3464, DOI 10.1128/AAC.47.11.3464-3469.2003; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; ROBERTSON IGC, 1993, BIOCHEM PHARMACOL, V45, P2159, DOI 10.1016/0006-2952(93)90031-Q; Seliskar M, 2007, BBA-GEN SUBJECTS, V1770, P458, DOI 10.1016/j.bbagen.2006.09.016; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6; Xu K, 2001, BIOCHEM PHARMACOL, V61, P165, DOI 10.1016/S0006-2952(00)00526-8	51	38	40	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8826	8837		10.1074/jbc.M112.429316	http://dx.doi.org/10.1074/jbc.M112.429316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23382387	Green Published, hybrid			2022-12-28	WOS:000316862200005
J	Zelazny, E; Santambrogio, M; Pourcher, M; Chambrier, P; Berne-Dedieu, A; Fobis-Loisy, I; Miege, C; Jaillais, Y; Gaude, T				Zelazny, Enric; Santambrogio, Martina; Pourcher, Mikael; Chambrier, Pierre; Berne-Dedieu, Annick; Fobis-Loisy, Isabelle; Miege, Christine; Jaillais, Yvon; Gaude, Thierry			Mechanisms Governing the Endosomal Membrane Recruitment of the Core Retromer in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED STORAGE PROTEINS; MAMMALIAN RETROMER; COMPLEX; RECEPTOR; RETRIEVAL; THALIANA; VPS35P; YEAST; COMPONENT; IDENTIFICATION	The retromer complex localizes to endosomal membranes and is involved in protein trafficking. In mammals, it is composed of a dimer of sorting nexins and of the core retromer consisting of vacuolar protein sorting (VPS)26, VPS29, and VPS35. Although homologs of these proteins have been identified in plants, how the plant retromer functions remains elusive. To better understand the role of VPS components in the assembly and function of the core retromer, we characterize here Arabidopsis vps26-null mutants. We show that impaired VPS26 function has a dramatic effect on VPS35 levels and causes severe phenotypic defects similar to those observed in vps29-null mutants. This implies that functions of plant VPS26, VPS29, and VPS35 are tightly linked. Then, by combining live-cell imaging with immunochemical and genetic approaches, we report that VPS35 alone is able to bind to endosomal membranes and plays an essential role in VPS26 and VPS29 membrane recruitment. We also show that the Arabidopsis Rab7 homolog RABG3f participates in the recruitment of the core retromer to the endosomal membrane by interacting with VPS35. Altogether our data provide original information on the molecular interactions that mediate assembly of the core retromer in plants.	CNRS, F-69342 Lyon, France; Inst Natl Rech Agron, F-69364 Lyon, France; Ecole Normale Super Lyon, F-69342 Lyon, France; Univ Lyon 1, F-69622 Villeurbanne, France; Unite Mixte Serv Biosci Gerland, F-69366 Lyon, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gaude, T (corresponding author), ENS Lyon, Plant Reprod & Dev Lab, 46 Allee Italie, F-69364 Lyon 07, France.	thierry.gaude@ens-lyon.fr	JAILLAIS, Yvon/U-3223-2018	JAILLAIS, Yvon/0000-0003-4923-883X; BERNE DEDIEU, Annick/0000-0002-9982-8793	Agence Nationale de la Recherche BLANC RETROMER Project [ANR-08-BLAN-0142]	Agence Nationale de la Recherche BLANC RETROMER Project(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche BLANC RETROMER Project Grant ANR-08-BLAN-0142.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Attar N, 2010, ADV ENZYME REGUL, V50, P216, DOI 10.1016/j.advenzreg.2009.10.002; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Fobis-Loisy I, 2007, PLANT CELL REP, V26, P745, DOI 10.1007/s00299-006-0282-7; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Gokool S, 2007, BIOCHEM J, V408, P287, DOI 10.1042/BJ20070555; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Hashiguchi Y, 2010, PLANT CELL, V22, P159, DOI 10.1105/tpc.109.069294; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Jaillais Y, 2007, CELL, V130, P1057, DOI 10.1016/j.cell.2007.08.040; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Liu TT, 2012, MOL BIOL CELL, V23, P2505, DOI 10.1091/mbc.E11-11-0915; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Pourcher M, 2010, PLANT CELL, V22, P3980, DOI 10.1105/tpc.110.078451; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; Restrepo R, 2007, TRAFFIC, V8, P1841, DOI 10.1111/j.1600-0854.2007.00659.x; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shimada T, 2003, P NATL ACAD SCI USA, V100, P16095, DOI 10.1073/pnas.2530568100; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Yamazaki M, 2008, PLANT CELL PHYSIOL, V49, P142, DOI 10.1093/pcp/pcn006; Zhao X, 2007, TRAFFIC, V8, P1829, DOI 10.1111/j.1600-0854.2007.00658.x	44	46	49	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8815	8825		10.1074/jbc.M112.440503	http://dx.doi.org/10.1074/jbc.M112.440503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23362252	Green Published, hybrid			2022-12-28	WOS:000316862200004
J	Khan, M; Rozhon, W; Bigeard, J; Pflieger, D; Husar, S; Pitzschke, A; Teige, M; Jonak, C; Hirt, H; Poppenberger, B				Khan, Mamoona; Rozhon, Wilfried; Bigeard, Jean; Pflieger, Delphine; Husar, Sigrid; Pitzschke, Andrea; Teige, Markus; Jonak, Claudia; Hirt, Heribert; Poppenberger, Brigitte			Brassinosteroid-regulated GSK3/Shaggy-like Kinases Phosphorylate Mitogen-activated Protein (MAP) Kinase Kinases, Which Control Stomata Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL FATE; SIGNAL-TRANSDUCTION; PLANT-GROWTH; GSK3; PATHWAY; PATTERN; TRANSFORMATION; BIOSYNTHESIS; ELONGATION; SPEECHLESS	Brassinosteroids (BRs) are steroid hormones that coordinate fundamental developmental programs in plants. In this study we show that in addition to the well established roles of BRs in regulating cell elongation and cell division events, BRs also govern cell fate decisions during stomata development in Arabidopsis thaliana. In wild-type A. thaliana, stomatal distribution follows the one-cell spacing rule; that is, adjacent stomata are spaced by at least one intervening pavement cell. This rule is interrupted in BR-deficient and BR signaling-deficient A. thaliana mutants, resulting in clustered stomata. We demonstrate that BIN2 and its homologues, GSK3/Shaggy-like kinases involved in BR signaling, can phosphorylate the MAPK kinases MKK4 and MKK5, which are members of the MAPK module YODA-MKK4/5-MPK3/6 that controls stomata development and patterning. BIN2 phosphorylates a GSK3/Shaggy-like kinase recognition motif in MKK4, which reduces MKK4 activity against its substrate MPK6 in vitro. In vivo we show that MKK4 and MKK5 act downstream of BR signaling because their overexpression rescued stomata patterning defects in BR-deficient plants. A model is proposed in which GSK3-mediated phosphorylation of MKK4 and MKK5 enables for a dynamic integration of endogenous or environmental cues signaled by BRs into cell fate decisions governed by the YODA-MKK4/5-MPK3/6 module.	[Khan, Mamoona; Rozhon, Wilfried; Poppenberger, Brigitte] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Inst Biotechnol Hort Crops, D-85354 Freising Weihenstephan, Germany; [Khan, Mamoona; Rozhon, Wilfried; Husar, Sigrid; Poppenberger, Brigitte] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Bigeard, Jean; Poppenberger, Brigitte] Unite Rech Genom Vegetale Plant Genom 2, F-91057 Evry, France; [Pflieger, Delphine] Univ Evry, CNRS, Lab Anal & Modelisat Biol & Environm, F-91025 Evry, France; [Pitzschke, Andrea] Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Teige, Markus] Univ Vienna, Dept Mol Syst Biol, A-1090 Vienna, Austria; [Jonak, Claudia] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; [Hirt, Heribert] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Technical University of Munich; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Centre National de la Recherche Scientifique (CNRS); University of Natural Resources & Life Sciences, Vienna; University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); King Saud University	Poppenberger, B (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Liesel Beckmann Str 1, D-85354 Freising Weihenstephan, Germany.	brigitte.poppenberger@wzw.tum.de	Jonak, Claudia/G-1362-2016; Rozhon, Wilfried/AFK-4445-2022; Teige, Markus/R-6443-2016; Rozhon, Wilfried/AAG-3162-2022; Pflieger, Delphine/ABD-1496-2021	Rozhon, Wilfried/0000-0003-0659-0593; Teige, Markus/0000-0001-7204-1379; Rozhon, Wilfried/0000-0003-0659-0593; Pitzschke, Andrea/0000-0002-3451-1429; Jonak, Claudia/0000-0001-9605-6751; Khan, Mamoona/0000-0003-3301-9536	Austrian Science Fund FWF [P19948, P22734]; Higher Education Commission of Pakistan; Hertha-Firnberg fellowship of the FWF; Austrian Science Fund (FWF) [P 25359, P 23435, P 22734] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Hertha-Firnberg fellowship of the FWF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund FWF (Projects P19948 and P22734) and by a Ph.D. fellowship of the Higher Education Commission of Pakistan (to M. K.) and a Hertha-Firnberg fellowship of the FWF (to B. P.).	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Altmann T, 1998, CURR OPIN PLANT BIOL, V1, P378, DOI 10.1016/S1369-5266(98)80259-8; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2004, CURR OPIN PLANT BIOL, V7, P26, DOI 10.1016/j.pbi.2003.10.001; Bergmann D, 2006, CURR OPIN PLANT BIOL, V9, P478, DOI 10.1016/j.pbi.2006.07.001; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Cardinale F, 2002, PLANT CELL, V14, P703, DOI 10.1105/tpc.010256; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; Dal Santo S, 2012, PLANT CELL, V24, P3380, DOI 10.1105/tpc.112.101279; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukuda H, 1997, CELL DEATH DIFFER, V4, P684, DOI 10.1038/sj.cdd.4400310; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hu YX, 2000, PLANT J, V24, P693, DOI 10.1046/j.1365-313x.2000.00915.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; IWASAKI T, 1991, PLANT CELL PHYSIOL, V32, P1007, DOI 10.1093/oxfordjournals.pcp.a078163; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Kim TW, 2012, NATURE, V482, P419, DOI 10.1038/nature10794; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kuppusamy KT, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0811633106; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau JA, 2003, TRENDS PLANT SCI, V8, P294, DOI 10.1016/S1360-1385(03)00102-X; Nakaya M, 2002, PLANT CELL PHYSIOL, V43, P239, DOI 10.1093/pcp/pcf024; Poppenberger B, 2011, EMBO J, V30, P1149, DOI 10.1038/emboj.2011.35; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang ZY, 2012, P NATL ACAD SCI USA, V109, P7, DOI 10.1073/pnas.1118600109; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111	55	115	126	0	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7519	7527		10.1074/jbc.M112.384453	http://dx.doi.org/10.1074/jbc.M112.384453			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341468	hybrid, Green Published			2022-12-28	WOS:000316455300008
J	Sahoo, SK; Shaikh, SA; Sopariwala, DH; Bal, NC; Periasamy, M				Sahoo, Sanjaya K.; Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.; Periasamy, Muthu			Sarcolipin Protein Interaction with Sarco(endo) plasmic Reticulum Ca2+ ATPase (SERCA) Is Distinct from Phospholamban Protein, and Only Sarcolipin Can Promote Uncoupling of the SERCA Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CALCIUM-PUMP; FUNCTIONAL CONSEQUENCES; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE HELIX; HEAT-PRODUCTION; CROSS-LINKING; CA2+-ATPASE; TRANSPORT	Sarco(endo) plasmic reticulum Ca2+ ATPase (SERCA) pump activity is modulated by phospholamban (PLB) and sarcolipin (SLN) in cardiac and skeletal muscle. Recent data suggest that SLN could play a role in muscle thermogenesis by promoting uncoupling of the SERCA pump( Lee, A. G.(2002) Curr. Opin. Struct. Biol. 12, 547-554 and Bal, N. C., Maurya, S. K., Sopariwala, D. H., Sahoo, S. K., Gupta, S. C., Shaikh, S. A., Pant, M., Rowland, L. A., Bombardier, E., Goonasekera, S. A., Tupling, A. R., Molkentin, J. D., and Periasamy, M.(2012) Nat. Med. 18, 1575-1579), but the mechanistic details are unknown. To better define how binding of SLN to SERCA promotes uncoupling of SERCA, we compared SLN and SERCA1 interaction with that of PLB in detail. The homo-bifunctional cross-linker (1,6-bismaleimidohexane) was employed to detect dynamic protein interaction during the SERCA cycle. Our studies reveal that SLN differs significantly from PLB: 1) SLN primarily affects the V-max of SERCA-mediated Ca2+ uptake but not the pump affinity for Ca2+; 2) SLN can bind to SERCA in the presence of high Ca2+, but PLB can only interact to the ATP-bound Ca2+ -free E2 state; and 3) unlike PLB, SLN interacts with SERCA throughout the kinetic cycle and promotes uncoupling of the SERCA pump. Using SERCA transmembrane mutants, we additionally show that PLB and SLN can bind to the same groove but interact with a different set of residues on SERCA. These data collectively suggest that SLN is functionally distinct from PLB;its ability to interact with SERCA in the presence of Ca2+ causes uncoupling of the SERCA pump and increased heat production.	[Sahoo, Sanjaya K.; Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Periasamy, Muthu] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Periasamy, M (corresponding author), 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Bal, Naresh/E-9377-2011	Periasamy, Muthu/0000-0001-8834-5975	National Institutes of Health [R01 HL080551]; American Heart Association [10POST3360007]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL080551 (to M. P.). Supported by a postdoctoral fellowship from the American Heart Association (10POST3360007).	Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; ANDERSEN JP, 1995, J BIOL CHEM, V270, P908, DOI 10.1074/jbc.270.2.908; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2003, TRENDS CARDIOVAS MED, V13, P152, DOI 10.1016/S1050-1738(03)00037-9; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; Hughes G, 1996, BIOCHEM J, V318, P973, DOI 10.1042/bj3180973; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Ji Y, 1999, ANAL BIOCHEM, V269, P236, DOI 10.1006/abio.1999.4059; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Lee AG, 2002, CURR OPIN STRUC BIOL, V12, P547, DOI 10.1016/S0959-440X(02)00360-3; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; Reis M, 2001, J BIOL CHEM, V276, P42793, DOI 10.1074/jbc.M107625200; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; SCARPA A, 1972, J GEN PHYSIOL, V60, P735, DOI 10.1085/jgp.60.6.735; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Tupling AR, 2002, J BIOL CHEM, V277, P44740, DOI 10.1074/jbc.M206171200; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200	55	74	75	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6881	6889		10.1074/jbc.M112.436915	http://dx.doi.org/10.1074/jbc.M112.436915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341466	Green Published, hybrid			2022-12-28	WOS:000316002400009
J	Tate, CM; Blosser, W; Wyss, L; Evans, G; Xue, Q; Pan, Y; Stancato, L				Tate, Courtney M.; Blosser, Wayne; Wyss, Lisa; Evans, Glenn; Xue, Qi; Pan, Yong; Stancato, Louis			LY2228820 Dimesylate, a Selective Inhibitor of p38 Mitogen-activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formation in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC CARDIOVASCULAR DEVELOPMENT; GROWTH-FACTOR; MAP KINASE; CELL-MIGRATION; PROLIFERATION; PATHWAY; P38-ALPHA; EXPRESSION; SURVIVAL; VEGF	LY2228820 dimesylate is a highly selective small molecule inhibitor of p38 alpha and p38 beta mitogen-activated protein kinases (MAPKs) that is currently under clinical investigation for human malignancies. p38 MAPK is implicated in a wide range of biological processes, in particular those that support tumorigenesis. One such process, angiogenesis, is required for tumor growth and metastasis, and many new cancer therapies are therefore directed against the tumor vasculature. Using an in vitro co-culture endothelial cord formation assay, a surrogate of angiogenesis, we investigated the role of p38 MAPK in growth factor-and tumor-driven angiogenesis using LY2228820 dimesylate treatment and by shRNA gene knockdown. p38 MAPK was activated in endothelial cells upon growth factor stimulation, with inhibition by LY2228820 dimesylate treatment causing a significant decrease in VEGF-, bFGF-, EGF-, and IL-6-induced endothelial cord formation and an even more dramatic decrease in tumor-driven cord formation. In addition to involvement in downstream cytokine signaling, p38 MAPK was important for VEGF, bFGF, EGF, IL-6, and other proangiogenic cytokine secretion in stromal and tumor cells. LY2228820 dimesylate results were substantiated using p38 alpha MAPK-specific shRNA and shRNA against the downstream p38 MAPK effectors MAPKAPK-2 and HSP27. Using in vivo models of functional neoangiogenesis, LY2228820 dimesylate treatment reduced hemoglobin content in a plug assay and decreased VEGF-A-stimulated vascularization in a mouse ear model. Thus, p38 alpha MAPK is implicated in tumor angiogenesis through direct tumoral effects and through reduction of proangiogenic cytokine secretion via the microenvironment.	[Tate, Courtney M.; Blosser, Wayne; Evans, Glenn; Stancato, Louis] Eli Lilly & Co, Lilly Corp Ctr, Oncol, Indianapolis, IN 46285 USA; [Wyss, Lisa] Discovery Res, Adv Testing Lab, Cincinnati, OH 45242 USA; [Xue, Qi; Pan, Yong] ImClone Syst, New York, NY 10016 USA	Eli Lilly; Eli Lilly	Stancato, L (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Oncol Res, Indianapolis, IN 46285 USA.	stancato_louis@lilly.com		Stancato, Louis/0000-0002-6242-5771				Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Ennis BW, 2005, J PHARMACOL EXP THER, V313, P325, DOI 10.1124/jpet.104.078873; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Fan F, 2012, J ONCOL, V2012, DOI 10.1155/2012/281261; Folkman J, 1997, EXS, V79, P1; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hirschi K K, 1997, EXS, V79, P419; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Ishitsuka K, 2008, BRIT J HAEMATOL, V141, P598, DOI 10.1111/j.1365-2141.2008.07044.x; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Meier T, 2011, MOL CANCER THER, V10, P2168, DOI 10.1158/1535-7163.MCT-11-0323; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; NICOSIA RF, 1995, LAB INVEST, V73, P658; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Prasain N, 2012, JOVE-J VIS EXP, DOI 10.3791/3872; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Reinmuth N, 2001, FASEB J, V15, P1239, DOI 10.1096/fj.00-0693fje; Rocic P, 2007, AM J PHYSIOL-HEART C, V292, pH2729, DOI 10.1152/ajpheart.01330.2006; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sodhi A, 2000, CANCER RES, V60, P4873; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanaka K, 1999, JPN J CANCER RES, V90, P647, DOI 10.1111/j.1349-7006.1999.tb00796.x; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Thuraisingam T, 2010, J INVEST DERMATOL, V130, P278, DOI 10.1038/jid.2009.209; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Ventura J., 2007, NAT GENET, V128, P295; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yang SY, 2001, ARTERIOSCL THROM VAS, V21, P1934, DOI 10.1161/hq1201.099432; Ye J, 2007, BIOSCI BIOTECH BIOCH, V71, P1162, DOI 10.1271/bbb.60617; Yoshino Y, 2006, INT J ONCOL, V29, P981; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhu WH, 2003, J VASC RES, V40, P140, DOI 10.1159/000070711	50	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6743	6753		10.1074/jbc.M112.425553	http://dx.doi.org/10.1074/jbc.M112.425553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335506	Green Published, hybrid			2022-12-28	WOS:000315820700071
J	Mills, LD; Zhang, YQ; Marler, RJ; Herreros-Villanueva, M; Zhang, LZ; Almada, LL; Couch, F; Wetmore, C; di Magliano, MP; Fernandez-Zapico, ME				Mills, Lisa D.; Zhang, Yaqing; Marler, Ronald J.; Herreros-Villanueva, Marta; Zhang, Lizhi; Almada, Luciana L.; Couch, Fergus; Wetmore, Cynthia; di Magliano, Marina Pasca; Fernandez-Zapico, Martin E.			Loss of the Transcription Factor GLI1 Identifies a Signaling Network in the Tumor Microenvironment Mediating KRAS Oncogene-induced Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KI-RAS GENE; PANCREATIC INTRADUCTAL NEOPLASIAS; DUCTAL ADENOCARCINOMA; CODON-12 MUTATIONS; CANCER; STAT3; PROGRESSION; ACTIVATION; FREQUENCY; COMBINATION	Although the biological role of KRAS is clearly established in carcinogenesis, the molecular mechanisms underlying this phenomenon are not completely understood. In this study, we provide evidence of a novel signaling network regulated by the transcription factor GLI1 mediating KRAS-induced carcinogenesis. Using pancreatic cancer (a disease with high prevalence of KRAS mutations) as a model, we show that loss of GLI1 blocks the progression of KRAS-induced pancreatic preneoplastic lesions in mice with pancreas-specific Cre-activated oncogenic mutant kras. Mice lacking GLI1 develop only low-grade lesions at low frequency, and in most cases, the pancreata are histologically normal. Further characterization of the phenotype showed a decrease in the activation of STAT3 in pancreatic preneoplastic lesions; STAT3 is a transcription factor required for the development of premalignant lesions and their progression into pancreatic cancer. Analysis of the mechanisms revealed a key role for GLI1 in maintaining the levels of activated STAT3 through the modulation of IL-6 signaling. GLI1 binds to the IL-6 mouse promoter and regulates the activity and expression of this cytokine. This newly identified GLI1/IL-6 axis is active in fibroblasts, a known source of IL-6 in the tumor microenvironment. Sonic hedgehog induces GLI1 binding to the IL-6 promoter and increases IL-6 expression in fibroblasts in a paracrine manner. Finally, we demonstrate that mutant KRAS initiates this cascade by inducing the expression of Sonic hedgehog in cancer cells. Collectively, these results define a novel role for GLI1 in carcinogenesis acting as a downstream effector of oncogenic KRAS in the tumor microenvironment.	[Mills, Lisa D.; Herreros-Villanueva, Marta; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Zhang, Lizhi; Couch, Fergus] Mayo Clin, Rochester, MN 55905 USA; [Zhang, Yaqing; di Magliano, Marina Pasca] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI 48109 USA; [Marler, Ronald J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Wetmore, Cynthia] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic Phoenix; St Jude Children's Research Hospital	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	zhang, yaqing/C-2283-2015; , Herreros-Villanueva/M-5702-2016	, Herreros-Villanueva/0000-0002-6905-0693; Pasca di Magliano, Marina/0000-0001-9632-9035	National Institutes of Health from NCI [CA136526]; Mayo Clinic Pancreatic SPORE Grant [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Pancreatic SPORE Grant; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136526 from NCI. This work was also supported by Mayo Clinic Pancreatic SPORE Grant P50 CA102701 and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK84567 (to M. E. F.-Z.).	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Brat DJ, 1998, AM J SURG PATHOL, V22, P163, DOI 10.1097/00000478-199802000-00003; Brockie E, 1998, Ann Diagn Pathol, V2, P286, DOI 10.1016/S1092-9134(98)80020-8; CALDAS C, 1995, INT J PANCREATOL, V18, P1; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Ellis CA, 2000, CELL SIGNAL, V12, P425, DOI 10.1016/S0898-6568(00)00084-X; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Fan JG, 1997, ONCOGENE, V14, P2595, DOI 10.1038/sj.onc.1201105; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; GRUNEWALD K, 1989, INT J CANCER, V43, P1037, DOI 10.1002/ijc.2910430614; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Hruban RH, 1999, CURR OPIN GASTROEN, V15, P404, DOI 10.1097/00001574-199909000-00006; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lohr M, 2005, NEOPLASIA, V7, P17, DOI 10.1593/neo.04445; Luttges J, 2005, PATHOLOGE, V26, P12, DOI 10.1007/s00292-004-0735-0; MARIYAMA M, 1989, JPN J CANCER RES, V80, P622, DOI 10.1111/j.1349-7006.1989.tb01687.x; NAGATA Y, 1990, JPN J CANCER RES, V81, P135, DOI 10.1111/j.1349-7006.1990.tb02539.x; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; Park HL, 2000, DEVELOPMENT, V127, P1593; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; VANLAETHEM JL, 1995, GUT, V36, P781, DOI 10.1136/gut.36.5.781	37	81	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11786	11794		10.1074/jbc.M112.438846	http://dx.doi.org/10.1074/jbc.M112.438846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482563	Green Published, hybrid			2022-12-28	WOS:000318157600015
J	Zhang, ZH; Xu, XH; Xiang, ZH; Yu, ZW; Feng, JF; He, C				Zhang, Zhaohuan; Xu, Xiaohui; Xiang, Zhenghua; Yu, Zhongwang; Feng, Jifeng; He, Cheng			LINGO-1 Receptor Promotes Neuronal Apoptosis by Inhibiting WNK3 Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CELL-SURVIVAL; MOUSE-BRAIN; EXPRESSION; PHOSPHORYLATION; INACTIVATION; HYPERTENSION; REGULATOR; REPAIR; DOMAIN	LINGO-1 is a functional component of the Nogo receptor 1.p75(NTR).LINGO-1 and Nogo receptor 1.TAJ (TNFRSF19/TROY).LINGO-1 signaling complexes. It has recently been shown that LINGO-1 antagonists significantly improve neuronal survival after neural injury. However, the mechanism by which LINGO-1 signaling influences susceptibility to apoptosis remains unknown. In an effort to better understand how LINGO-1 regulates these signaling pathways, we used an established model of serum deprivation (SD) to induce neuronal apoptosis. We demonstrate that treatment either with a construct containing the intracellular domain of LINGO-1 or with Nogo66, a LINGO-1 receptor complex agonist, resulted in an enhanced rate of apoptosis in primary cultured cortical neurons under SD. Reducing the expression levels of the serine/threonine kinase WNK3 using shRNA or inhibiting its kinase activity had similar effects on the survival of serum-deprived neurons. Consistent with these observations, we found that LINGO-1 and WNK3 co-localized and co-precipitated in cultured cortical neurons and brain tissue. Significantly, this co-association was enhanced by Nogo66 treatment. Binding of WNK3 to the intracellular domain of LINGO-1 led to a reduction in WNK3 kinase activity, as did Nogo66 stimulation. Moreover, in vitro and in vivo evidence indicates that endogenous WNK3 suppresses SD-induced neuronal apoptosis in a kinase-dependent manner, as the expression of either a WNK3 RNAi construct or a kinase-dead N-terminal fragment of WNK3 led to increased apoptosis. Taken together, our results show that LINGO-1 potentiates neuronal apoptosis, likely by inhibiting WNK3 kinase activity.	[He, Cheng] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, MOE Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn		Zhang, Zhaohuan/0000-0001-6882-9761	National Key Basic Research Program Grant [2011CB504401]; National Natural Science Foundation [81000524, 31070922, 31130024]	National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grant 2011CB504401 and National Natural Science Foundation Grants 81000524, 31070922, and 31130024.	Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Arboleda G, 2009, BRAIN RES REV, V59, P333, DOI 10.1016/j.brainresrev.2008.10.001; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cheng CJ, 2011, J AM SOC NEPHROL, V22, P460, DOI 10.1681/ASN.2010060681; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Fu QL, 2010, EUR J NEUROSCI, V31, P1091, DOI 10.1111/j.1460-9568.2010.07127.x; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; Gerin CG, 2011, SYNAPSE, V65, P1255, DOI 10.1002/syn.20903; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Holden S, 2004, GENE, V335, P109, DOI 10.1016/j.gene.2004.03.009; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Leng Q, 2006, J PHYSIOL-LONDON, V571, P275, DOI 10.1113/jphysiol.2005.102202; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029771; Lorenzo-Betancor O, 2011, MOVEMENT DISORD, V26, P722, DOI 10.1002/mds.23452; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pepinsky RB, 2011, BIOCONJUGATE CHEM, V22, P200, DOI 10.1021/bc1002746; Qi B, 2003, J CELL PHYSIOL, V196, P312, DOI 10.1002/jcp.10297; Qiao Y, 2008, CLIN GENET, V74, P134, DOI 10.1111/j.1399-0004.2008.01028.x; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Satoh J, 2007, NEUROPATH APPL NEURO, V33, P99, DOI 10.1111/j.1365-2990.2006.00787.x; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Verissimo F, 2006, ONCOGENE, V25, P4172, DOI 10.1038/sj.onc.1209449; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zhang W, 2008, AM J PHYSIOL-RENAL, V295, pF1472, DOI 10.1152/ajprenal.90229.2008; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200; Zhao XH, 2008, CELL MOL NEUROBIOL, V28, P727, DOI 10.1007/s10571-007-9258-6	42	17	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12152	12160		10.1074/jbc.M112.447771	http://dx.doi.org/10.1074/jbc.M112.447771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482566	Green Published, hybrid			2022-12-28	WOS:000318157600047
J	Maxwell, BA; Suo, ZC				Maxwell, Brian A.; Suo, Zucai			Single-molecule Investigation of Substrate Binding Kinetics and Protein Conformational Dynamics of a B-family Replicative DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; FINGERS SUBDOMAIN; NUCLEOTIDE INCORPORATION; FIDELITY; MECHANISM; FLUORESCENCE; EXONUCLEASE	Replicative DNA polymerases use a complex, multistep mechanism for efficient and accurate DNA replication as uncovered by intense kinetic and structural studies. Recently, single-molecule fluorescence spectroscopy has provided new insights into real time conformational dynamics utilized by DNA polymerases during substrate binding and nucleotide incorporation. We have used single-molecule Forster resonance energy transfer techniques to investigate the kinetics and conformational dynamics of Sulfolobus solfataricus DNA polymerase B1 (PolB1) during DNA and nucleotide binding. Our experiments demonstrate that this replicative polymerase can bind to DNA in at least three conformations, corresponding to an open and closed conformation of the finger domain as well as a conformation with the DNA substrate bound to the exonuclease active site of PolB1. Additionally, our results show that PolB1 can transition between these conformations without dissociating from a primer-template DNA substrate. Furthermore, we show that the closed conformation is promoted by a matched incoming dNTP but not by a mismatched dNTP and that mismatches at the primer-template terminus lead to an increase in the binding of the DNA to the exonuclease site. Our analysis has also revealed new details of the biphasic dissociation kinetics of the polymerase-DNA binary complex. Notably, comparison of the results obtained in this study with PolB1 with those from similar single-molecule studies with an A-family DNA polymerase suggests mechanistic differences between these polymerases. In summary, our findings provide novel mechanistic insights into protein conformational dynamics and substrate binding kinetics of a high fidelity B-family DNA polymerase.	Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Suo, Zucai] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Suo, ZC (corresponding author), Ohio State Univ, Dept Chem & Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu		Maxwell, Brian/0000-0002-0177-3991	National Science Foundation [MCB-0960961]; Div Of Molecular and Cellular Bioscience [0960961] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-0960961 (to Z.S.).	Allen WJ, 2008, PROTEIN SCI, V17, P401, DOI 10.1110/ps.073309208; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Berezhna SY, 2012, J AM CHEM SOC, V134, P11261, DOI 10.1021/ja3038273; Brown JA, 2009, BIOCHEMISTRY-US, V48, P7502, DOI 10.1021/bi9005336; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CARVER TE, 1994, P NATL ACAD SCI USA, V91, P10670, DOI 10.1073/pnas.91.22.10670; Choi JY, 2011, J BIOL CHEM, V286, P31180, DOI 10.1074/jbc.M111.258038; Christian TD, 2009, P NATL ACAD SCI USA, V106, P21109, DOI 10.1073/pnas.0908640106; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Hashimoto H, 2001, J MOL BIOL, V306, P469, DOI 10.1006/jmbi.2000.4403; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kornberg A., 1980, DNA REPLICATION, P101; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Markiewicz RP, 2012, NUCLEIC ACIDS RES, V40, P7975, DOI 10.1093/nar/gks523; Maxwell BA, 2012, J BIOL CHEM, V287, P13040, DOI 10.1074/jbc.M112.345835; Ortiz TP, 2005, J PHYS CHEM B, V109, P16127, DOI 10.1021/jp051778f; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Savino C, 2004, STRUCTURE, V12, P2001, DOI 10.1016/j.str.2004.09.007; Selvin P. R., 2008, SINGLE MOL TECHNIQUE, P3; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Zhang H, 2006, BIOCHEMISTRY-US, V45, P2211, DOI 10.1021/bi052099y; Zhang LK, 2009, BIOCHEMISTRY-US, V48, P7492, DOI 10.1021/bi900532w; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2	45	21	21	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11590	11600		10.1074/jbc.M113.459982	http://dx.doi.org/10.1074/jbc.M113.459982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23463511	hybrid, Green Published			2022-12-28	WOS:000317915500064
J	Buzza, MS; Martin, EW; Driesbaugh, KH; Desilets, A; Leduc, R; Antalis, TM				Buzza, Marguerite S.; Martin, Erik W.; Driesbaugh, Kathryn H.; Desilets, Antoine; Leduc, Richard; Antalis, Toni M.			Prostasin Is Required for Matriptase Activation in Intestinal Epithelial Cells to Regulate Closure of the Paracellular Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE MATRIPTASE; AUTOSOMAL RECESSIVE ICHTHYOSIS; INFLAMMATORY-BOWEL-DISEASE; EPIDERMAL BARRIER FUNCTION; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; CELLULAR-LOCALIZATION; EXPRESSION; PERMEABILITY; INHIBITION	The type II transmembrane serine protease matriptase is a key regulator of epithelial barriers in skin and intestine. In skin, matriptase acts upstream of the glycosylphosphatidylinositol-anchored serine protease, prostasin, to activate the prostasin zymogen and initiate a proteolytic cascade that is required for stratum corneum barrier functionality. Here, we have investigated the relationship between prostasin and matriptase in intestinal epithelial barrier function. We find that similar to skin, matriptase and prostasin are components of a common intestinal epithelial barrier-forming pathway. Depletion of prostasin by siRNA silencing in Caco-2 intestinal epithelium inhibits barrier development similar to loss of matriptase, and the addition of recombinant prostasin to the basal side of polarized Caco-2 epithelium stimulates barrier forming changes similar to the addition of recombinant matriptase. However, in contrast to the proteolytic cascade in skin, prostasin functions upstream of matriptase to activate the endogenous matriptase zymogen. Prostasin is unable to proteolytically activate the matriptase zymogen directly but induces matriptase activation indirectly. Prostasin requires expression of endogenous matriptase to stimulate barrier formation since matriptase depletion by siRNA silencing abrogates prostasin barrier-forming activity. Active recombinant matriptase, however, does not require the expression of endogenous prostasin for barrier-forming activity. Together, these data show that matriptase and not prostasin is the primary effector protease of tight junction assembly in simple columnar epithelia and further highlight a spatial and tissue-specific aspect of cell surface proteolytic cascades.	[Buzza, Marguerite S.; Martin, Erik W.; Driesbaugh, Kathryn H.; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Buzza, Marguerite S.; Martin, Erik W.; Driesbaugh, Kathryn H.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Desilets, Antoine; Leduc, Richard] Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Sherbrooke	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu		Desilets, Antoine/0000-0001-5081-5564; Martin, Erik/0000-0003-3979-2378	National Institutes of Health [CA098369, HL084387]; Department of Defense [PR110378]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R56CA098369, R01CA098369, P30CA134274] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084387, R01HL118390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants CA098369 and HL084387 (to T. M. A.), Department of Defense Grants PR110378 (to T. M. A.), and by the Canadian Institutes of Health Research (to R. L.).	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; CEREIJIDO M, 1981, AM J PHYSIOL, V240, pC96, DOI 10.1152/ajpcell.1981.240.3.C96; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Desilets A, 2008, J BIOL CHEM, V283, P10535, DOI 10.1074/jbc.M707012200; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Inouye K, 2013, J BIOCHEM, V153, P51, DOI 10.1093/jb/mvs118; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sanders SE, 1995, EPITHELIAL CELL BIOL, V4, P25; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shen L, 2009, DIGEST DIS, V27, P443, DOI 10.1159/000233282; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Steensgaard M, 2010, ACTA PHYSIOL, V200, P347, DOI 10.1111/j.1748-1716.2010.02170.x; Swystun VA, 2009, AM J PHYSIOL-GASTR L, V297, pG60, DOI 10.1152/ajpgi.00096.2009; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Vetrano S, 2011, P NATL ACAD SCI USA, V108, P19830, DOI 10.1073/pnas.1107140108; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	58	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10328	10337		10.1074/jbc.M112.443432	http://dx.doi.org/10.1074/jbc.M112.443432			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443662	Green Published, hybrid			2022-12-28	WOS:000317565000014
J	Nambu, S; Matsui, T; Goulding, CW; Takahashi, S; Ikeda-Saito, M				Nambu, Shusuke; Matsui, Toshitaka; Goulding, Celia W.; Takahashi, Satoshi; Ikeda-Saito, Masao			A New Way to Degrade Heme THE MYCOBACTERIUM TUBERCULOSIS ENZYME MhuD CATALYZES HEME DEGRADATION WITHOUT GENERATING CO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-OPENING MECHANISM; STAPHYLOCOCCUS-AUREUS; CARBON-MONOXIDE; OXYGENASE COMPLEX; RESONANCE RAMAN; ISDG; IRON; SITE; VERDOHEME; SYSTEM	MhuD is an oxygen-dependent heme-degrading enzyme from Mycobacterium tuberculosis with high sequence similarity (similar to 45%) to Staphylococcus aureus IsdG and IsdI. Spectroscopic and mutagenesis studies indicate that the catalytically active 1: 1 heme-MhuD complex has an active site structure similar to those of IsdG and IsdI, including the nonplanarity (ruffling) of the heme group bound to the enzyme. Distinct from the canonical heme degradation, we have found that the MhuD catalysis does not generate CO. Product analyses by electrospray ionization-MS and NMR show that MhuD cleaves heme at the alpha-meso position but retains the meso-carbon atom at the cleavage site, which is removed by canonical heme oxygenases. The novel tetrapyrrole product of MhuD, termed "mycobilin," has an aldehyde group at the cleavage site and a carbonyl group at either the beta-meso or the delta-meso position. Consequently, MhuD catalysis does not involve verdoheme, the key intermediate of ring cleavage by canonical heme oxygenase enzymes. Ruffled heme is apparently responsible for the heme degradation mechanism unique to MhuD. In addition, MhuD heme degradation without CO liberation is biologically significant as one of the signals of M. tuberculosis transition to dormancy is mediated by the production of host CO.	[Nambu, Shusuke; Matsui, Toshitaka; Takahashi, Satoshi; Ikeda-Saito, Masao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	Tohoku University; University of California System; University of California Irvine; University of California System; University of California Irvine	Ikeda-Saito, M (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	mis2@tagen.tohoku.ac.jp	Takahashi, Satoshi/AAC-5532-2019; Ikeda-Saito, Masao/K-2703-2015; Matsui, Toshitaka/B-1570-2008; Ikeda-Saito, Masao/A-5992-2008	Takahashi, Satoshi/0000-0003-1506-9222; Matsui, Toshitaka/0000-0003-3865-8468; 	Japan Society for the Promotion of Science [21350087, 2412006, 24350081, 23657097, 23107702, 23550186]; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institutes of Health [AI081161]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081161] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants-in-aid for Scientific Research 21350087, 2412006, and 24350081 (to M. I. S.), 23657097 and 23107702 (to S. T.), and 23550186 (to T. M.) from the Japan Society for the Promotion of Science; by the Strategic Alliance Project for the Creation of Nano-Materials, Nano-devices and Nano-systems from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and by National Institutes of Health Grant AI081161 (to C.W.G.).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P40; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; De Montellano PRO, 1998, ACCOUNTS CHEM RES, V31, P543; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Haley KP, 2011, J BACTERIOL, V193, P4749, DOI 10.1128/JB.00436-11; Hawkins BK, 1996, BBA-PROTEIN STRUCT M, V1295, P165, DOI 10.1016/0167-4838(96)00031-3; KERR EA, 1983, BIOCHEMISTRY-US, V22, P4373, DOI 10.1021/bi00288a005; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lai WZ, 2010, J AM CHEM SOC, V132, P12960, DOI 10.1021/ja104674q; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Matera KM, 1997, BIOCHEMISTRY-US, V36, P4909, DOI 10.1021/bi962321m; Matsui T, 2005, J BIOL CHEM, V280, P36833, DOI 10.1074/jbc.M503529200; Matsui T, 2008, J AM CHEM SOC, V130, P4220, DOI 10.1021/ja710495z; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Migita CT, 2005, BIOCHEM BIOPH RES CO, V338, P584, DOI 10.1016/j.bbrc.2005.08.045; MORISHIMA I, 1995, INORG CHEM, V34, P1528, DOI 10.1021/ic00110a035; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Suematsu M, 2000, HEPATOLOGY, V31, P3, DOI 10.1002/hep.510310102; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; TAKAHASHI S, 1994, BIOCHEMISTRY-US, V33, P5531, DOI 10.1021/bi00184a023; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Ukpabi G, 2012, J BIOL CHEM, V287, P34179, DOI 10.1074/jbc.M112.393249; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YONETANI T, 1972, J BIOL CHEM, V247, P2447; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230	41	81	83	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10101	10109		10.1074/jbc.M112.448399	http://dx.doi.org/10.1074/jbc.M112.448399			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420845	Green Published, hybrid			2022-12-28	WOS:000317114000051
J	Sung, RJ; Zhang, M; Qi, Y; Verdine, GL				Sung, Rou-Jia; Zhang, Michael; Qi, Yan; Verdine, Gregory L.			Structural and Biochemical Analysis of DNA Helix Invasion by the Bacterial 8-Oxoguanine DNA Glycosylase MutM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-STRUCTURE; FPG PROTEIN; REPAIR; LESION; SYSTEM; RECOGNITION; VALIDATION; CLONING; ACID	MutM is a bacterial DNA glycosylase that serves as the first line of defense against the highly mutagenic 8-oxoguanine (oxoG) lesion, catalyzing glycosidic bond cleavage of oxoG to initiate base excision DNA repair. Previous work has shown that MutM actively interrogates DNA for the presence of an intrahelical oxoG lesion. This interrogation process involves significant buckling and bending of the DNA to promote extrusion of oxoG from the duplex. Structural snapshots have revealed several different highly conserved residues that are prominently inserted into the duplex in the vicinity of the target oxoG before and after base extrusion has occurred. However, the roles of these helix-invading residues during the lesion recognition and base extrusion process remain unclear. In this study, we set out to probe the function of residues Phe(114) and Met(77) in oxoG recognition and repair. Here we report a detailed biochemical and structural characterization of MutM variants containing either a F114A or M77A mutation, both of which showed significant decreases in the efficiency of oxoG repair. These data reveal that Met77 plays an important role in stabilizing the lesion-extruded conformation of the DNA. Phe(114), on the other hand, appears to destabilize the intrahelical state of the oxoG lesion, primarily by buckling the target base pair. We report the observation of a completely unexpected interaction state, in which the target base pair is ruptured but remains fully intrahelical; this structure vividly illustrates the disruptive influence of MutM on the target base pair.	[Sung, Rou-Jia; Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Zhang, Michael; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Sung, Rou-Jia; Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Qi, Yan] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu		Zhang, Michael/0000-0002-7067-0689	National Institutes of Health [GM044853, CA100742]; Harvard College Research Program; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard College Research Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044853 and CA100742.; Supported by a grant by the Harvard College Research Program.; Supported by a predoctoral fellowship from the National Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Dunn AR, 2011, NUCLEIC ACIDS RES, V39, P7487, DOI 10.1093/nar/gkr459; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova OS, 2002, BIOCHEMISTRY-US, V41, P1520, DOI 10.1021/bi011524u; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; Ishchenko AA, 2002, BIOCHEMISTRY-US, V41, P7540, DOI 10.1021/bi0121297; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nam K, 2009, J AM CHEM SOC, V131, P18208, DOI 10.1021/ja907544b; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Qi Y, 2012, P NATL ACAD SCI USA, V109, P1086, DOI 10.1073/pnas.1111237108; Qi Y, 2010, J BIOL CHEM, V285, P1468, DOI 10.1074/jbc.M109.069799; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Sung RJ, 2012, J BIOL CHEM, V287, P18044, DOI 10.1074/jbc.M111.313635; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197	33	21	21	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10012	10023		10.1074/jbc.M112.415612	http://dx.doi.org/10.1074/jbc.M112.415612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23404556	Green Published, hybrid			2022-12-28	WOS:000317114000040
J	Kong, E; Peng, SY; Chandra, G; Sarkar, C; Zhang, ZJ; Bagh, MB; Mukherjee, AB				Kong, Eryan; Peng, Shiyong; Chandra, Goutam; Sarkar, Chinmoy; Zhang, Zhongjian; Bagh, Maria B.; Mukherjee, Anil B.			Dynamic Palmitoylation Links Cytosol-Membrane Shuttling of Acyl-protein Thioesterase-1 and Acyl-protein Thioesterase-2 with That of Proto-oncogene H-Ras Product and Growth-associated Protein-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DEVELOPMENT; LYSOPHOSPHOLIPASE I; MOLECULAR-CLONING; EXPRESSION; IDENTIFICATION; LOCALIZATION; PURIFICATION; PALMITATE; ACYLATION	Acyl-protein thioesterase-1 (APT1) and APT2 are cytosolic enzymes that catalyze depalmitoylation of membrane-anchored, palmitoylated H-Ras and growth-associated protein-43 (GAP-43), respectively. However, the mechanism(s) of cytosol-membrane shuttling of APT1 and APT2, required for depalmitoylating their substrates H-Ras and GAP-43, respectively, remained largely unknown. Here, we report that both APT1 and APT2 undergo palmitoylation on Cys-2. Moreover, blocking palmitoylation adversely affects membrane localization of both APT1 and APT2 and that of their substrates. We also demonstrate that APT1 not only catalyzes its own depalmitoylation but also that of APT2 promoting dynamic palmitoylation (palmitoylation-depalmitoylation) of both thioesterases. Furthermore, shRNA suppression of APT1 expression or inhibition of its thioesterase activity by palmostatin B markedly increased membrane localization of APT2, and shRNA suppression of APT2 had virtually no effect on membrane localization of APT1. In addition, mutagenesis of the active site Ser residue to Ala (S119A), which renders catalytic inactivation of APT1, also increased its membrane localization. Taken together, our findings provide insight into a novel mechanism by which dynamic palmitoylation links cytosol-membrane trafficking of APT1 and APT2 with that of their substrates, facilitating steady- state membrane localization and function of both.	[Kong, Eryan; Peng, Shiyong; Chandra, Goutam; Sarkar, Chinmoy; Zhang, Zhongjian; Bagh, Maria B.; Mukherjee, Anil B.] Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mukherjee, AB (corresponding author), NIH, Bldg 10,Room 9D42,10 Ctr Dr, Bethesda, MD 20892 USA.	mukherja@exchange.nih.gov	Kong, Eryan/GRS-2219-2022; Sarkar, Chinmoy/AAI-2461-2019; Peng, Shiyong/D-6391-2014	Kong, Eryan/0000-0002-4086-1441; Peng, Shiyong/0000-0003-0697-3674	National Institutes of Health Intramural Program of the Eunice Kennedy-Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program of the Eunice Kennedy-Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in whole by National Institutes of Health Intramural Program of the Eunice Kennedy-Shriver NICHD.	Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hellsten E, 1996, EMBO J, V15, P5240, DOI 10.1002/j.1460-2075.1996.tb00909.x; Hirano T, 2009, BBA-MOL CELL BIOL L, V1791, P797, DOI 10.1016/j.bbalip.2009.05.001; Ladygina N, 2011, ADV IMMUNOL, V109, P1, DOI 10.1016/B978-0-12-387664-5.00001-7; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; SCHMIDT MFG, 1989, BIOCHIM BIOPHYS ACTA, V988, P411, DOI 10.1016/0304-4157(89)90013-0; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang AJ, 1997, J BIOL CHEM, V272, P22030, DOI 10.1074/jbc.272.35.22030; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	33	86	86	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9112	9125		10.1074/jbc.M112.421073	http://dx.doi.org/10.1074/jbc.M112.421073			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396970	Green Published, hybrid			2022-12-28	WOS:000316862200031
J	Quan, Y; Jiang, JX; Dingledine, R				Quan, Yi; Jiang, Jianxiong; Dingledine, Ray			EP2 Receptor Signaling Pathways Regulate Classical Activation of Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN E-2 BIOSYNTHESIS; PROTEIN-KINASE INHIBITORS; TUMOR-NECROSIS-FACTOR; KAPPA-B PATHWAYS; CYCLIC-AMP; PROSTANOID RECEPTORS; RAT MICROGLIA; INTERFERON-GAMMA; MOUSE MICROGLIA; INNATE IMMUNITY	Activation of EP2 receptors by prostaglandin E2 (PGE(2)) promotes brain inflammation in neurodegenerative diseases, but the pathways responsible are unclear. EP2 receptors couple to G alpha(s) and increase cAMP, which associates with protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factors (Epacs). Here, we studied EP2 function and its signaling pathways in rat microglia in their resting state or undergoing classical activation in vitro following treatment with low concentrations of lipopolysaccharide and interferon-gamma. Real time PCR showed that PGE(2) had no effect on expression of CXCL10, TGF-beta 1, and IL-11 and exacerbated the rapid up-regulation of mRNAs encoding cyclooxygenase-2, inducible NOS, IL-6, and IL-1 beta but blunted the production of mRNAs encoding TNF-alpha, IL-10, CCL3, and CCL4. These effects were mimicked fully by the EP2 agonist butaprost but only weakly by the EP1/EP3 agonist 17-phenyl trinor PGE(2) or the EP4 agonist CAY10598 and not at all by the EP3/EP1 agonist sulprostone and confirmed by protein measurements of cyclooxygenase-2, IL-6, IL-10, and TNF-alpha. In resting microglia, butaprost induced cAMP formation and altered the mRNA expression of inflammatory mediators, but protein expression was unchanged. The PKA inhibitor H89 had little or no effect on inflammatory mediators modulated by EP2, whereas the Epac activator 8-(4-chlorophenylthio)-2'-O-methyladenosine 3',5'-cyclic monophosphate acetoxymethyl ester mimicked all butaprost effects. These results indicate that EP2 activation plays a complex immune regulatory role during classical activation of microglia and that Epac pathways are prominent in this role.	[Quan, Yi; Jiang, Jianxiong; Dingledine, Ray] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Dingledine, R (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rdingledine@pharm.emory.edu	Jiang, Jianxiong/A-1987-2010	Jiang, Jianxiong/0000-0003-3955-8928; Dingledine, Ray/0000-0001-7128-4520	National Institutes of Health from the NINDS [U01NS058158, R21NS074169]; Countermeasures against Chemical Threats (CounterACT) Program, National Institutes of Health Office of the Director; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074169, U01NS058158] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; Countermeasures against Chemical Threats (CounterACT) Program, National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01NS058158 and R21NS074169 (both to R.D.) from the NINDS and the Countermeasures against Chemical Threats (CounterACT) Program, National Institutes of Health Office of the Director. This work was also supported by the Epilepsy Foundation (to J.J.).	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Aloisi F, 1999, J NEUROSCI RES, V56, P571; Aloisi F, 1997, J IMMUNOL, V159, P1604; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Caggiano AO, 1999, J NEUROCHEM, V72, P565, DOI 10.1046/j.1471-4159.1999.0720565.x; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chavant F, 2010, J PHARMACOL EXP THER, V332, P505, DOI 10.1124/jpet.109.162164; Chen HJ, 2012, BIOORG MED CHEM LETT, V22, P4038, DOI 10.1016/j.bmcl.2012.04.082; Chen K, 2010, BRAIN STRUCT FUNCT, V214, P219, DOI 10.1007/s00429-009-0226-4; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Cimino PJ, 2008, CURR MED CHEM, V15, P1863, DOI 10.2174/092986708785132915; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Dargahi L, 2011, J MOL NEUROSCI, V45, P10, DOI 10.1007/s12031-010-9401-6; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ezcurra ALD, 2010, NEUROBIOL DIS, V37, P630, DOI 10.1016/j.nbd.2009.11.018; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Foey AD, 1998, J IMMUNOL, V160, P920; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Iglesias BM, 1997, J NEUROIMMUNOL, V72, P83, DOI 10.1016/S0165-5728(96)00155-5; Jiang JX, 2013, P NATL ACAD SCI USA, V110, P3591, DOI 10.1073/pnas.1218498110; Jiang JX, 2013, J PHARMACOL EXP THER, V344, P360, DOI 10.1124/jpet.112.200444; Jiang JX, 2012, P NATL ACAD SCI USA, V109, P3149, DOI 10.1073/pnas.1120195109; Jiang JX, 2010, P NATL ACAD SCI USA, V107, P2307, DOI 10.1073/pnas.0909310107; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2010, NEUROSCI RES, V66, P271, DOI 10.1016/j.neures.2009.11.009; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; Liu J, 2011, J MOL NEUROSCI, V45, P186, DOI 10.1007/s12031-010-9426-x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melchior B, 2006, NEUROCHEM INT, V49, P145, DOI 10.1016/j.neuint.2006.04.002; Minghetti L, 1997, GLIA, V19, P152, DOI 10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Quan Y, 2007, J NEUROSCI RES, V85, P3150, DOI 10.1002/jnr.21421; Quan Y, 2011, ACTA PHARMACOL SIN, V32, P188, DOI 10.1038/aps.2010.174; Quan Y, 2009, NEUROSCI LETT, V464, P29, DOI 10.1016/j.neulet.2009.08.013; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Sanchez-Pernaute R, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-6; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serrano GE, 2011, J NEUROSCI, V31, P14850, DOI 10.1523/JNEUROSCI.3922-11.2011; Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487; Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220; Shie FS, 2005, AM J PATHOL, V166, P1163, DOI 10.1016/S0002-9440(10)62336-X; Tanaka T, 2001, CYTOKINE, V13, P193, DOI 10.1006/cyto.2000.0828; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Weinstein JR, 2009, NEUROCHEM RES, V34, P445, DOI 10.1007/s11064-008-9803-9; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yamashita M, 2007, AM J PHYSIOL-CELL PH, V293, pC184, DOI 10.1152/ajpcell.00346.2006; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102	59	79	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9293	9302		10.1074/jbc.M113.455816	http://dx.doi.org/10.1074/jbc.M113.455816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404506	hybrid, Green Published			2022-12-28	WOS:000316862200047
J	Schael, S; Nuchel, J; Muller, S; Petermann, P; Kormann, J; Perez-Otano, I; Martinez, SM; Paulsson, M; Plomann, M				Schael, Sylvia; Nuechel, Julian; Mueller, Stefan; Petermann, Philipp; Kormann, Jan; Perez-Otano, Isabel; Marco Martinez, Sonia; Paulsson, Mats; Plomann, Markus			Casein Kinase 2 Phosphorylation of Protein Kinase C and Casein Kinase 2 Substrate in Neurons (PACSIN) 1 Protein Regulates Neuronal Spine Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; F-BAR DOMAIN; NEUROTROPHIC FACTOR; DENDRITIC SPINES; NMDA RECEPTORS; RHO GTPASES; SYNDAPIN-I; BRAIN; ENDOCYTOSIS; MEMBRANE	The PACSIN (protein kinase C and casein kinase 2 substrate in neurons) adapter proteins couple components of the clathrin-mediated endocytosis machinery with regulators of actin polymerization and thereby regulate the surface expression of specific receptors. The brain-specific PACSIN 1 is enriched at synapses and has been proposed to affect neuromorphogenesis and the formation and maturation of dendritic spines. In studies of how phosphorylation of PACSIN 1 contributes to neuronal function, we identified serine 358 as a specific site used by casein kinase 2 (CK2) in vitro and in vivo. Phosphorylated PACSIN 1 was found in neuronal cytosol and membrane fractions. This localization could be modulated by trophic factors such as brain-derived neurotrophic factor (BDNF). We further show that expression of a phospho-negative PACSIN 1 mutant, S358A, or inhibition of CK2 drastically reduces spine formation in neurons. We identified a novel protein complex containing the spine regulator Rac1, its GTPase-activating protein neuron-associated developmentally regulated protein (NADRIN), and PACSIN 1. CK2 phosphorylation of PACSIN 1 leads to a dissociation of the complex upon BDNF treatment and induces Rac1-dependent spine formation in dendrites of hippocampal neurons. These findings suggest that upon BDNF signaling PACSIN 1 is phosphorylated by CK2 which is essential for spine formation.	[Schael, Sylvia; Nuechel, Julian; Petermann, Philipp; Kormann, Jan; Paulsson, Mats; Plomann, Markus] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Schael, Sylvia; Mueller, Stefan; Paulsson, Mats; Plomann, Markus] Univ Cologne, Fac Med, CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Fac Med, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Perez-Otano, Isabel; Marco Martinez, Sonia] Univ Clin & Med Sch, Ctr Res Appl Med CIMA, Dept Neurosci, E-31008 Pamplona, Spain	University of Cologne; University of Cologne; University of Cologne	Plomann, M (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	markus.plomann@uni-koeln.de	Marco, Sonia/AAB-4691-2019; Marco, Sonia/AAA-6591-2019; Perez-Otano, Isabel/S-9613-2017	Marco, Sonia/0000-0001-5930-9553; Marco, Sonia/0000-0001-5930-9553; Perez-Otano, Isabel/0000-0002-7222-8202; Nuchel, Julian/0000-0002-8126-415X	Center for Molecular Medicine Cologne (CMMC); Koln Fortune program of the Medical Faculty of the University of Cologne; Fonds der Chemischen Industrie; Centro de Investigacion Medica Aplicada; Government of Navarra; Spanish Ministry of Innovation and Science [CSD2008-00005]	Center for Molecular Medicine Cologne (CMMC); Koln Fortune program of the Medical Faculty of the University of Cologne; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Centro de Investigacion Medica Aplicada; Government of Navarra; Spanish Ministry of Innovation and Science(Spanish Government)	This work was supported by the Center for Molecular Medicine Cologne (CMMC) and the Koln Fortune program of the Medical Faculty of the University of Cologne (to M. Plomann).; Supported by a fellowship from the Fonds der Chemischen Industrie.; Supported by Centro de Investigacion Medica Aplicada and grants from the Government of Navarra and Spanish Ministry of Innovation and Science (Grant CSD2008-00005 to I. P.-O.).	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Blanquet PR, 1998, NEUROSCIENCE, V86, P739, DOI 10.1016/S0306-4522(98)00087-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Furuta B, 2002, J NEUROCHEM, V82, P1018, DOI 10.1046/j.1471-4159.2002.01021.x; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gorski JA, 2003, J NEUROSCI, V23, P6856; Guerra B, 1999, FEBS LETT, V462, P353, DOI 10.1016/S0014-5793(99)01553-7; Haditsch U, 2009, MOL CELL NEUROSCI, V41, P409, DOI 10.1016/j.mcn.2009.04.005; Halbach A, 2007, FEBS J, V274, P773, DOI 10.1111/j.1742-4658.2006.05622.x; Hilton JM, 2001, J BIOL CHEM, V276, P16341, DOI 10.1074/jbc.M011122200; Hinton R. H., 1997, SUBCELLULAR FRACTION, P31; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Modregger J, 2000, J CELL SCI, V113, P4511; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Plomann M., 2009, POMBE CDC15 HOMOLOGY, P39; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Solyakov L, 2004, J BIOL CHEM, V279, P43403, DOI 10.1074/jbc.M403239200; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Tashiro A, 2003, HISTOL HISTOPATHOL, V18, P617, DOI 10.14670/HH-18.617; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011	45	25	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9303	9312		10.1074/jbc.M113.461293	http://dx.doi.org/10.1074/jbc.M113.461293			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23420842	Green Published, hybrid			2022-12-28	WOS:000316862200048
J	Buffen, K; Oosting, M; Mennens, S; Anand, PK; Plantinga, TS; Sturm, P; van de Veerdonk, FL; van der Meer, JWM; Xavier, RJ; Kanneganti, TD; Netea, MG; Joosten, LAB				Buffen, Kathrin; Oosting, Marije; Mennens, Svenja; Anand, Paras K.; Plantinga, Theo S.; Sturm, Patrick; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Xavier, Ramnik J.; Kanneganti, Thirumala-Devi; Netea, Mihai G.; Joosten, Leo A. B.			Autophagy Modulates Borrelia burgdorferi-induced Production of Interleukin-1 beta (IL-1 beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE ACTIVATION; TREPONEMA-PALLIDUM; INFLAMMASOME; DISEASE; CELLS; LIPOPROTEINS; RECOGNITION; LIPOPOLYSACCHARIDE; PHAGOCYTOSIS; INDUCTION	Borrelia burgdorferi sensu lato is the causative agent of Lyme disease. Recent studies have shown that recognition of the spirochete is mediated by TLR2 and NOD2. The latter receptor has been associated with the induction of the intracellular degradation process called autophagy. The present study demonstrated for the first time the induction of autophagy by exposure to B. burgdorferi and that autophagy modulates the B. burgdorferi-dependent cytokine production. Human peripheral blood mononuclear cells treated with autophagy inhibitors showed an increased IL-1 beta and IL-6 production in response to the exposure of the spirochete, whereas TNF alpha production was unchanged. Autophagy induction against B. burgdorferi was dependent on reactive oxygen species (ROS) because cells from patients with chronic granulomatous disease, which are defective in ROS production, also produced elevated IL-1 beta. Further, the enhanced production of the proinflammatory cytokines was because of the elevated mRNA expression in the absence of autophagy. Our results thus demonstrate the induction of autophagy, which, in turn, modulates cytokine production by B. burgdorferi for the first time.	[Buffen, Kathrin; Oosting, Marije; Mennens, Svenja; Plantinga, Theo S.; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 GA Nijmegen, Netherlands; [Buffen, Kathrin; Oosting, Marije; Plantinga, Theo S.; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 GA Nijmegen, Netherlands; [Mennens, Svenja; Anand, Paras K.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Sturm, Patrick] Radboud Univ Nijmegen, Dept Microbiol, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA	Radboud University Nijmegen; Radboud University Nijmegen; St Jude Children's Research Hospital; Radboud University Nijmegen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Joosten, LAB (corresponding author), Radboud Univ Nijmegen, Dept Med 463, Med Ctr, Geert Grootepl Zuid 8, NL-6525 GA Nijmegen, Netherlands.	l.joosten@aig.umcn.nl	Mennens, Svenja/F-3106-2016; Plantinga, Theo S./A-6895-2015; Kanneganti, Thirumala-Devi/M-9435-2018; van der Meer, Jos W.M./C-8521-2013; Netea, Mihai/N-5155-2014; Kanneganti, Thirumala-Devi/Y-2503-2019; Oosting, Marije/H-7437-2015; Joosten, Leo AB/H-3138-2015; van de Veerdonk, Frank L/C-7256-2008	Mennens, Svenja/0000-0003-1099-2894; Plantinga, Theo S./0000-0003-4990-6084; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; van der Meer, Jos W.M./0000-0001-5120-3690; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Joosten, Leo AB/0000-0001-6166-9830; van de Veerdonk, Frank L/0000-0002-1121-4894; Anand, Paras/0000-0003-2503-3653	Dutch Arthritis Association [NR 10-1-303]; Veni Grant from the Netherlands Organization for Scientific Research; National Institute of Health [R01AR056296]; Vici grant from The Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Dutch Arthritis Association; Veni Grant from the Netherlands Organization for Scientific Research; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vici grant from The Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Dutch Arthritis Association Grant NR 10-1-303.; Supported by a Veni Grant from the Netherlands Organization for Scientific Research.; Supported by National Institute of Health Grant R01AR056296.; Supported by a Vici grant from The Netherlands Organization for Scientific Research.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Derdakova M, 2005, ANN AGR ENV MED, V12, P165; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hefty PS, 2001, INFECT IMMUN, V69, P3618, DOI 10.1128/IAI.69.6.3618-3627.2001; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Huang J, 2009, AUTOPHAGY, V5, P887, DOI 10.4161/auto.9125; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Liu N, 2009, INFECT IMMUN, V77, P3320, DOI 10.1128/IAI.00100-09; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Marquez A, 2009, INFLAMM BOWEL DIS, V15, P1697, DOI 10.1002/ibd.21001; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Netea MG, 2010, NAT MED, V16, P28, DOI 10.1038/nm0110-28; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Oh JE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00044; Oosting M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025998; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pietruczuk Adam, 2004, Pol Merkur Lekarski, V17, P446; Plantinga TS, 2012, CURR OPIN PHARMACOL, V12, P497, DOI 10.1016/j.coph.2012.01.017; Plantinga TS, 2011, AUTOPHAGY, V7, P1074, DOI 10.4161/auto.7.9.15867; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Segovia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029695; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; TOSATO G, 1990, BLOOD, V75, P1305, DOI 10.1182/blood.V75.6.1305.1305; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vincent MS, 1998, J IMMUNOL, V161, P5762; Zhang HF, 2009, HUM GENET, V125, P627, DOI 10.1007/s00439-009-0660-7	46	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8658	8666		10.1074/jbc.M112.412841	http://dx.doi.org/10.1074/jbc.M112.412841			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386602	hybrid, Green Published			2022-12-28	WOS:000316564500066
J	Gleyzer, N; Scarpulla, RC				Gleyzer, Natalie; Scarpulla, Richard C.			Activation of a PGC-1-related Coactivator (PRC)-dependent Inflammatory Stress Program Linked to Apoptosis and Premature Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELLULAR SENESCENCE; ENERGY-METABOLISM; CANCER; TRANSCRIPTION; EXPRESSION; INTEGRATION; PGC-1-ALPHA; MECHANISMS; REGULATOR	PGC-1-related coactivator (PRC), a growth-regulated member of the PGC-1 coactivator family, contributes to the expression of the mitochondrial respiratory apparatus. PRC also orchestrates a robust response to metabolic stress by promoting the expression of multiple genes specifying inflammation, proliferation, and metabolic reprogramming. Here, we demonstrate that this PRC-dependent stress program is activated during apoptosis and senescence, two major protective mechanisms against cellular dysfunction. Both PRC and its targets (IL1 alpha, SPRR2D, and SPRR2F) were rapidly induced by menadione, an agent that promotes apoptosis through the generation of intracellular oxidants. Menadione-induced apoptosis and the PRC stress program were blocked by the antioxidant N-acetylcysteine. The PRC stress response was also activated by the topoisomerase I inhibitor 7-ethyl-10-hydroxycamptothecin (SN-38), an inducer of premature senescence in tumor cells. Cells treated with SN-38 displayed morphological characteristics of senescence and express senescence-associated beta-galactosidase activity. In contrast to menadione, the SN-38 induction of the PRC program occurred over an extended time course and was antioxidant-insensitive. The potential adaptive function of the PRC stress response was investigated by treating cells with meclizine, a drug that promotes glycolytic energy metabolism and has been linked to cardio- and neuroprotection against ischemia-reperfusion injury. Meclizine increased lactate production and was a potent inducer of the PRC stress program, suggesting that PRC may contribute to the protective effects of meclizine. Finally, c-MYC and PRC were coordinately induced under all conditions tested, implicating c-MYC in the biological response to metabolic stress. The results suggest a general role for PRC in the adaptive response to cellular dysfunction.	[Gleyzer, Natalie; Scarpulla, Richard C.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of Health, NIGMS [GM 32525-29]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032525, R56GM032525] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 32525-29 from the NIGMS.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Bihani T, 2004, CELL CYCLE, V3, P1201; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Calabrese V, 2011, MOL ASPECTS MED, V32, P279, DOI 10.1016/j.mam.2011.10.007; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Dominy JE, 2011, COLD SH Q B, V76, P203, DOI 10.1101/sqb.2012.76.010843; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gilbert DC, 2012, BRIT J CANCER, V106, P18, DOI 10.1038/bjc.2011.498; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gleyzer N, 2011, J BIOL CHEM, V286, P39715, DOI 10.1074/jbc.M111.291575; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He X, 2012, DEV DYNAM, V241, P975, DOI 10.1002/dvdy.23769; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Kahlem P, 2004, J CLIN INVEST, V113, P169, DOI 10.1172/JCI200420784; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lohman FP, 1997, EXP CELL RES, V231, P141, DOI 10.1006/excr.1996.3458; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Roninson IB, 2003, CANCER RES, V63, P2705; Savagner F, 2003, BIOCHEM BIOPH RES CO, V310, P779, DOI 10.1016/j.bbrc.2003.09.076; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Stockl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005; te Poele RH, 2002, CANCER RES, V62, P1876; Tesfaigzi Johannes, 1999, Cell Biochemistry and Biophysics, V30, P243, DOI 10.1007/BF02738069; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433; Vermeij WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011957; Verrax J, 2004, APOPTOSIS, V9, P223, DOI 10.1023/B:APPT.0000018804.26026.1a; Verrax J, 2009, CURR MED CHEM, V16, P1821, DOI 10.2174/092986709788186057; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Whitfield JR, 2012, CELL MOL LIFE SCI, V69, P931, DOI 10.1007/s00018-011-0860-x; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4	63	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8004	8015		10.1074/jbc.M112.426841	http://dx.doi.org/10.1074/jbc.M112.426841			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364789	Green Published, hybrid			2022-12-28	WOS:000316564500002
J	Cao-Ehlker, X; Zong, XG; Hammelmann, V; Gruner, C; Fenske, S; Michalakis, S; Wahl-Schott, C; Biel, M				Cao-Ehlker, Xiaochun; Zong, Xiangang; Hammelmann, Verena; Gruner, Christian; Fenske, Stefanie; Michalakis, Stylianos; Wahl-Schott, Christian; Biel, Martin			Up-regulation of Hyperpolarization-activated Cyclic Nucleotide-gated Channel 3 (HCN3) by Specific Interaction with K+ Channel Tetramerization Domain-containing Protein 3 (KCTD3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACEMAKER CHANNEL; CATION CHANNEL; WD-REPEAT; TRIP8B; TRAFFICKING; SUBUNIT; LOCALIZATION; MODULATION; EXPRESSION; FAMILY	Most ion channels consist of the principal ion-permeating core subunit(s) and accessory proteins that are assembled with the channel core. The biological functions of the latter proteins are diverse and include the regulation of the biophysical properties of the ion channel, its connection to signaling pathways and the control of its cell surface expression. There is recent evidence that native hyperpolarization-activated cyclic nucleotide-gated channel complexes (HCN1-4) also contain accessory subunits, among which TRIP8b (tetratricopeptide repeat-containing Rab8b-interacting protein) has been most extensively studied. Here, we identify KCTD3, a so far uncharacterized member of the potassium channel tetramerization-domain containing (KCTD) protein family as an HCN3-interacting protein. KCTD3 is widely expressed in brain and some non-neuronal tissues and colocalizes with HCN3 in specific regions of the brain including hypothalamus. Within the HCN channel family, KCTD3 specifically binds to HCN3 and leads to a profound up-regulation of cell surface expression and current density of this channel. HCN3 can also functionally interact with TRIP8b; however, we found no evidence for channel complexes containing both TRIP8b and KCTD3. The C terminus of HCN3 is crucially required for functional interaction with KCTD3. Replacement of the cytosolic C terminus of HCN2 by the corresponding domain of HCN3 renders HCN2 sensitive to regulation by KCTD3. The C-terminal-half of KCTD3 is sufficient for binding to HCN3. However, the complete protein including the N-terminal tetramerization domain is needed for HCN3 current up-regulation. Together, our experiments indicate that KCTD3 is an accessory subunit of native HCN3 complexes.	Univ Munich, Ctr Integrated Prot Sci CIPS M, D-81377 Munich, Germany; Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany	University of Munich; University of Munich	Biel, M (corresponding author), Univ Munich, Dept Pharm, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de	Michalakis, Stylianos/W-2094-2018; Michalakis, Stylianos/M-4677-2019; Biel, Martin/G-1175-2014; Wahl-Schott, Christian A/J-2623-2015	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Fenske, Stefanie/0000-0002-6994-8401	Deutsche Forschungsgemeinschaft (DFG); Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 870 (SFB 870)]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was support by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Sonderforschungsbereich 870 (SFB 870).	Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Barbuti A, 2007, J MOL CELL CARDIOL, V42, P71, DOI 10.1016/j.yjmcc.2006.09.018; Baruscotti M, 2010, J MOL CELL CARDIOL, V48, P55, DOI 10.1016/j.yjmcc.2009.06.019; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hammelmann V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017078; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Hurtado R, 2010, KIDNEY INT, V77, P500, DOI 10.1038/ki.2009.483; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kimura K, 2004, GENES CELLS, V9, P631, DOI 10.1111/j.1356-9597.2004.00752.x; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Li CH, 2008, AM J PHYSIOL-CELL PH, V294, pC355, DOI 10.1152/ajpcell.00236.2007; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Michalakis S, 2011, J NEUROSCI, V31, P133, DOI 10.1523/JNEUROSCI.4735-10.2011; Michels G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001511; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Yan RT, 2001, P NATL ACAD SCI USA, V98, P15014, DOI 10.1073/pnas.261455698; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	56	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7580	7589		10.1074/jbc.M112.434803	http://dx.doi.org/10.1074/jbc.M112.434803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382386	Green Published, hybrid			2022-12-28	WOS:000316455300015
J	Takahashi, M; Izawa, K; Kashiwakura, J; Yamanishi, Y; Enomoto, Y; Kaitani, A; Maehara, A; Isobe, M; Ito, S; Matsukawa, T; Nakahara, F; Oki, T; Kajikawa, M; Ra, C; Okayama, Y; Kitamura, T; Kitaura, J				Takahashi, Mariko; Izawa, Kumi; Kashiwakura, Jun-ichi; Yamanishi, Yoshinori; Enomoto, Yutaka; Kaitani, Ayako; Maehara, Akie; Isobe, Masamichi; Ito, Shinichi; Matsukawa, Toshihiro; Nakahara, Fumio; Oki, Toshihiko; Kajikawa, Masunori; Ra, Chisei; Okayama, Yoshimichi; Kitamura, Toshio; Kitaura, Jiro			Human CD300C Delivers an Fc Receptor-gamma-dependent Activating Signal in Mast Cells and Monocytes and Differs from CD300A in Ligand Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; INHIBITORY RECEPTOR; APOPTOTIC CELLS; INFLAMMATORY RESPONSES; DENDRITIC CELLS; IRP60 CD300A; EPSILON-RI; DEAD CELLS; NK CELLS; PHOSPHATIDYLSERINE	CD300C is highly homologous with an inhibitory receptor CD300A in an immunoglobulin-like domain among the human CD300 family of paired immune receptors. To clarify the precise expression and function of CD300C, we generated antibodies discriminating between CD300A and CD300C, which recognized a unique epitope involving amino acid residues CD300A(F56-L57) and CD300C(L63-R64). Notably, CD300C was highly expressed in human monocytes and mast cells. Cross-linking of CD300C by its specific antibody caused cytokine/chemokine production of human monocytes and mast cells. Fc receptor gamma was indispensable for both efficient surface expression and activating functions of CD300C. To identify a ligand for CD300A or CD300C, we used reporter cell lines expressing a chimera receptor harboring extracellular CD300A or CD300C and intracellular CD3 zeta, in which its unknown ligand induced GFP expression. Our results indicated that phosphatidylethanolamine (PE) among the lipids tested and apoptotic cells were possible ligands for both CD300C and CD300A. PE and apoptotic cells more strongly induced GFP expression in the reporter cells through binding to extracellular CD300A as compared with CD300C. Differential recognition of PE by extracellular CD300A and CD300C depended on different amino acid residues CD300A(F56-L57) and CD300C(L63-R64). Interestingly, GFP expression induced by extracellular CD300C-PE binding in the reporter cells was dampened by co-expression of full-length CD300A, indicating the predominance of CD300A over CD300C in PE recognition/signaling. PE consistently failed to stimulate cytokine production in monocytes expressing CD300C with CD300A. In conclusion, specific engagement of CD300C led to Fc receptor gamma-dependent activation of mast cells and monocytes.	[Takahashi, Mariko; Izawa, Kumi; Yamanishi, Yoshinori; Enomoto, Yutaka; Kaitani, Ayako; Maehara, Akie; Isobe, Masamichi; Ito, Shinichi; Matsukawa, Toshihiro; Nakahara, Fumio; Oki, Toshihiko; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Adv Clin Res Ctr, Div Cellular Therapy, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Signaling, Minato Ku, Tokyo 1088639, Japan; [Kashiwakura, Jun-ichi; Ra, Chisei; Okayama, Yoshimichi] Nihon Univ, Sch Med, Dept Mol Cell Immunol & Allergol, Itabashi Ku, Tokyo 1738610, Japan; [Kashiwakura, Jun-ichi] RIKEN Res Ctr Allergy & Immunol, Res Unit Allergy, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kajikawa, Masunori] ACTGen Inc, Komagane, Nagano 3994117, Japan	University of Tokyo; University of Tokyo; Nihon University; RIKEN	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp; kitaura-tky@umin.ac.jp	Kitamura, Toshio/AAA-2071-2021; Okayama, Yoshimichi/AAG-4352-2021; Matsukawa, Toshihiro/A-4194-2016	Enomoto, Yutaka/0000-0002-6346-9362; Matsukawa, Toshihiro/0000-0003-2371-3778; Nakahara, Fumio/0000-0003-1515-8284	Ministry of Education, Science, Technology, Sports and Culture, Japan; Grants-in-Aid for Scientific Research [10J07783] Funding Source: KAKEN	Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Technology, Sports and Culture, Japan.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Bachelet I, 2006, J ALLERGY CLIN IMMUN, V117, P1314, DOI 10.1016/j.jaci.2006.04.031; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Comas-Casellas E, 2012, J BIOL CHEM, V287, P9682, DOI 10.1074/jbc.M111.279224; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Kato N, 2011, BLOOD, V117, P221, DOI 10.1182/blood-2010-02-270181; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lankry D, 2010, J IMMUNOL, V185, P2877, DOI 10.4049/jimmunol.0903347; Lu Y, 2007, LEUKEMIA, V21, P2246, DOI 10.1038/sj.leu.2404883; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Munitz A, 2006, J ALLERGY CLIN IMMUN, V118, P1082, DOI 10.1016/j.jaci.2006.07.041; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Narayanan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010636; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Okumura S, 2003, BLOOD, V102, P2547, DOI 10.1182/blood-2002-12-3929; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Silva R, 2011, BLOOD, V117, P5870, DOI 10.1182/blood-2010-09-310318; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	51	27	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7662	7675		10.1074/jbc.M112.434746	http://dx.doi.org/10.1074/jbc.M112.434746			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23372157	Green Published, hybrid			2022-12-28	WOS:000316455300023
J	Zeymer, C; Werbeck, ND; Schlichting, I; Reinstein, J				Zeymer, Cathleen; Werbeck, Nicolas D.; Schlichting, Ilme; Reinstein, Jochen			The Molecular Mechanism of Hsp100 Chaperone Inhibition by the Prion Curing Agent Guanidinium Chloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; PROTEINS; CLPB; THERMOTOLERANCE; DISAGGREGATION; HYDROCHLORIDE; ELIMINATION; PROPAGATION; STABILITY; MOTOR	The Hsp100 chaperones ClpB and Hsp104 utilize the energy from ATP hydrolysis to reactivate aggregated proteins in concert with the DnaK/Hsp70 chaperone system, thereby playing an important role in protein quality control. They belong to the family of AAA+ proteins (ATPases associated with various cellular activities), possess two nucleotide binding domains per monomer (NBD1 and NBD2), and oligomerize into hexameric ring complexes. Furthermore, Hsp104 is involved in yeast prion propagation and inheritance. It is well established that low concentrations of guanidinium chloride (GdmCl) inhibit the ATPase activity of Hsp104, leading to so called "prion curing," the loss of prion-related phenotypes. Here, we present mechanistic details about the Hsp100 chaperone inhibition by GdmCl using the Hsp104 homolog ClpB from Thermus thermophilus. Initially, we demonstrate that NBD1 of ClpB, which was previously considered inactive as a separately expressed construct, is a fully active ATPase on its own. Next, we show that only NBD1, but not NBD2, is affected by GdmCl. We present a crystal structure of ClpB NBD1 in complex with GdmCl and ADP, showing that the Gdm(+) ion binds specifically to the active site of NBD1. A conserved essential glutamate residue is involved in this interaction. Additionally, Gdm(+) interacts directly with the nucleotide, thereby increasing the nucleotide binding affinity of NBD1. We propose that both the interference with the essential glutamate and the modulation of nucleotide binding properties in NBD1 is responsible for the GdmCl-specific inhibition of Hsp100 chaperones.	[Zeymer, Cathleen; Werbeck, Nicolas D.; Schlichting, Ilme; Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Reinstein, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	jochen.reinstein@mpimf-heidelberg.mpg.de	Schlichting, Ilme/I-1339-2013	Zeymer, Cathleen/0000-0001-7138-381X	Max Planck Society; German National Academic Foundation	Max Planck Society(Max Planck Society); German National Academic Foundation	This work was supported by the Max Planck Society and a Ph.D. scholarship (to C. Z.) from the German National Academic Foundation.	Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hodson S, 2012, J STRUCT BIOL, V179, P161, DOI 10.1016/j.jsb.2012.05.015; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klostermeier D, 1999, J MOL BIOL, V287, P511, DOI 10.1006/jmbi.1999.2636; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGLAK TJ, 1992, BIOTECHNOL BIOENG, V39, P732, DOI 10.1002/bit.260390706; Nowicki L, 2012, CELL STRESS CHAPERON, V17, P361, DOI 10.1007/s12192-011-0312-4; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; TUITE MF, 1981, GENETICS, V98, P691; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2010, BIOCHEM CELL BIOL, V88, P89, DOI [10.1139/O09-164, 10.1139/o09-164]; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Werbeck ND, 2011, BIOCHEMISTRY-US, V50, P899, DOI 10.1021/bi1018286; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074	47	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7065	7076		10.1074/jbc.M112.432583	http://dx.doi.org/10.1074/jbc.M112.432583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341453	Green Published, hybrid			2022-12-28	WOS:000316002400028
J	Yang, F; Zhang, WM; Li, D; Zhan, QM				Yang, Fang; Zhang, Weimin; Li, Dan; Zhan, Qimin			Gadd45a Suppresses Tumor Angiogenesis via Inhibition of the mTOR/STAT3 Protein Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PHOSPHORYLATION; MAXIMAL ACTIVATION; BETA-CATENIN; STAT3; EXPRESSION; CANCER; RAPAMYCIN; KINASE; TARGET; TRANSCRIPTION	Gadd45a, a p53-regulated and DNA damage-inducible gene, is implicated in protection against tumor malignancy, although the underlying mechanism remains to be defined further. Here we demonstrate that Gadd45a plays an important role in suppression of tumor angiogenesis. Gadd45a deletion significantly increases microvessel density in tumors and stimulates an angiogenic response in a chicken embryo chorioallantoic membrane assay. Disruption of endogenous Gadd45a promotes tube formation and migration of endothelial cells. We further show that Gadd45a deletion increases phosphorylation of STAT3 at Ser-727 and, in turn, elevates the STAT3 transcriptional activity. This process substantially induces both expression and secretion of VEGFa, a STAT3 responsive gene, and promotes tumor angiogenesis. Interestingly, Gadd45a is able to physically associate with mammalian target of rapamycin (mTOR), a kinase that mediates Ser-727 phosphorylation of STAT3. The interaction of Gadd45a with mTOR suppresses STAT3 phosphorylation at Ser-727 and leads to down-regulated expression of VEGFa. Further analysis reveals that Gadd45a overexpression attenuates the association between mTOR and STAT3, whereas Gadd45a disruption strengthens this interaction, indicating that Gadd45a suppression of STAT3 phosphorylation is mainly through the dissociation of mTOR with STAT3. Taken together, these findings provide the first evidence that Gadd45a inhibits tumor angiogenesis via blocking of the mTOR/STAT3 pathway.	Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 National Key Fundamental Research Program of China Grant 2009CB521801 and National Natural Science Foundation of China Grant 81021061.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Balasubramanian SP, 2002, BRIT J CANCER, V87, P1057, DOI 10.1038/sj.bjc.6600625; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Carrier F, 1999, MOL CELL BIOL, V19, P1673; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hildesheim J, 2004, ONCOGENE, V23, P1829, DOI 10.1038/sj.onc.1207301; Hildesheim J, 2002, CANCER RES, V62, P7305; Hollander MC, 2001, CANCER RES, V61, P2487; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Liu AMF, 2006, J BIOL CHEM, V281, P35812, DOI 10.1074/jbc.M605288200; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Ramachandran K, 2009, CANCER RES, V69, P1527, DOI 10.1158/0008-5472.CAN-08-3609; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tong T, 2005, MOL CELL BIOL, V25, P4488, DOI 10.1128/MCB.25.11.4488-4500.2005; Wang W, 2005, ONCOGENE, V24, P2705, DOI 10.1038/sj.onc.1208464; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamasawa K, 2002, CLIN CANCER RES, V8, P2563; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	30	56	62	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6552	6560		10.1074/jbc.M112.418335	http://dx.doi.org/10.1074/jbc.M112.418335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23329839	Green Published, hybrid			2022-12-28	WOS:000315820700048
J	Wang, BF; Wen, X; Qin, XH; Wang, ZF; Tan, Y; Shen, YQ; Xi, Z				Wang, Baifan; Wen, Xin; Qin, Xiaohong; Wang, Zhifang; Tan, Ying; Shen, Yuequan; Xi, Zhen			Quantitative Structural Insight into Human Variegate Porphyria Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTOPORPHYRINOGEN OXIDASE; ENZYMATIC DEFECT; SOUTH-AFRICAN; GROUND-STATE; FORCE-FIELD; PORPHOBILINOGEN; IDENTIFICATION; CONFORMATIONS; MUTATION	Defects in the human protoporphyrinogen oxidase (hPPO) gene, resulting in similar to 50% decreased activity of hPPO, is responsible for the dominantly inherited disorder variegate porphyria (VP). To understand the molecular mechanism of VP, we employed the site-directed mutagenesis, biochemical assays, structural biology, and molecular dynamics simulation studies to investigate VP-causing hPPO mutants. We report here the crystal structures of R59Q and R59G mutants in complex with acifluorfen at a resolution of 2.6 and 2.8 angstrom. The r.m.s.d. of the C alpha atoms of the active site structure of R59G and R59Q with respect to the wild-type was 0.20 and 0.15 angstrom, respectively. However, these highly similar static crystal structures of mutants with the wild-type could not quantitatively explain the observed large differences in their enzymatic activity. To understand how the hPPO mutations affect their catalytic activities, we combined molecular dynamics simulation and statistical analysis to quantitatively understand the molecular mechanism of VP-causing mutants. We have found that the probability of the privileged conformations of hPPO can be correlated very well with the k(cat)/K-m of PPO (correlation coefficient, R-2 > 0.9), and the catalytic activity of 44 clinically reported VP-causing mutants can be accurately predicted. These results indicated that the VP-causing mutation affect the catalytic activity of hPPO by affecting the ability of hPPO to sample the privileged conformations. The current work, together with our previous crystal structure study on the wild-type hPPO, provided the quantitative structural insight into human variegate porphyria disease.	[Wang, Baifan; Wen, Xin; Wang, Zhifang; Tan, Ying; Xi, Zhen] Nankai Univ, Coll Chem, Dept Biol Chem, State Key Lab Elemento Organ Chem, Tianjin 300071, Peoples R China; [Qin, Xiaohong; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Xi, Z (corresponding author), Nankai Univ, Coll Chem, Dept Biol Chem, State Key Lab Elemento Organ Chem, 94 Weijin Rd, Tianjin 300071, Peoples R China.	zhenxi@nankai.edu.cn	TAN, YING/AAT-4671-2020; Wang, Baifan/J-3491-2014	TAN, YING/0000-0003-2957-0165; Wang, Baifan/0000-0003-0887-5795	Ministry of Science and Technology of the People's Republic of China [2010CB126102, 2011BAE06B05]; National Natural Science Foundation of China [20932005, 21172122]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of the People's Republic of China Grants 2010CB126102 and 2011BAE06B05 and National Natural Science Foundation of China Grants 20932005 and 21172122.	Akhtar M., 1991, BIOSYNTHESIS TETRAPY, P67; Arnould S, 1998, P NATL ACAD SCI USA, V95, P10553, DOI 10.1073/pnas.95.18.10553; Bonnin A, 2009, J INHERIT METAB DIS, V32, pS59, DOI 10.1007/s10545-009-1059-2; BRENNER DA, 1980, NEW ENGL J MED, V302, P765, DOI 10.1056/NEJM198004033021401; Bruice TC, 1999, ACCOUNTS CHEM RES, V32, P127, DOI 10.1021/ar960131y; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Corrigall AV, 2001, MOL GENET METAB, V73, P91, DOI 10.1006/mgme.2001.3163; Corrigall AV, 2000, MOL GENET METAB, V69, P323, DOI 10.1006/mgme.2000.2975; Dailey H. A., 1990, BIOSYNTHESIS HEME CH, P287; Dailey TA, 1996, PROTEIN SCI, V5, P98; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEYBACH JC, 1981, HUM GENET, V58, P425, DOI 10.1007/BF00282829; Di Pierro E, 2009, CELL MOL BIOL, V55, P79, DOI 10.1170/T856; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frisch M.J., 2016, GAUSSIAN16 REV B01; HAWORTH P, 1988, PLANT PHYSIOL, V86, P672, DOI 10.1104/pp.86.3.672; Hur S, 2003, P NATL ACAD SCI USA, V100, P12015, DOI 10.1073/pnas.1534873100; JONES C, 1979, J CHEM SOC CHEM COMM, P96, DOI 10.1039/c39790000096; JONES C, 1984, J CHEM SOC PERK T 1, P2625, DOI 10.1039/p19840002625; Kauppinen R, 2005, LANCET, V365, P241; Kirsch RE, 1998, SEMIN LIVER DIS, V18, P33, DOI 10.1055/s-2007-1007138; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau EY, 1998, J AM CHEM SOC, V120, P12387, DOI 10.1021/ja9827447; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Lightstone FC, 1996, J AM CHEM SOC, V118, P2595, DOI 10.1021/ja952589l; Luo J, 2001, J AM CHEM SOC, V123, P11952, DOI 10.1021/ja0109747; Maneli MH, 2003, BBA-PROTEINS PROTEOM, V1650, P10, DOI 10.1016/S1570-9639(03)00186-9; MATRINGE M, 1992, J BIOL CHEM, V267, P4646; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meissner PN, 2012, SAMJ S AFR MED J, V102, P422, DOI 10.7196/SAMJ.5710; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; MEISSNER PN, 1986, EUR J CLIN INVEST, V16, P257, DOI 10.1111/j.1365-2362.1986.tb01339.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POST CB, 1994, PURE APPL CHEM, V66, P83, DOI 10.1351/pac199466010083; POULSON R, 1975, J BIOL CHEM, V250, P1269; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Qin XH, 2010, J STRUCT BIOL, V170, P76, DOI 10.1016/j.jsb.2009.11.012; Rossetti MV, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-54; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider-Yin X, 2009, SWISS MED WKLY, V139, P198, DOI smw-12496; SEEMAN JI, 1983, CHEM REV, V83, P83, DOI 10.1021/cr00054a001; Shepherd M, 2005, ANAL BIOCHEM, V344, P115, DOI 10.1016/j.ab.2005.06.012; Sun L, 2009, AMINO ACIDS, V37, P523, DOI 10.1007/s00726-009-0256-5; Warnich L, 1996, HUM MOL GENET, V5, P981, DOI 10.1093/hmg/5.7.981	53	27	29	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11731	11740		10.1074/jbc.M113.459768	http://dx.doi.org/10.1074/jbc.M113.459768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467411	Green Published, hybrid			2022-12-28	WOS:000318157600010
J	Nakayama, H; Fukuda, S; Matsushita, N; Nishida-Fukuda, H; Inoue, H; Shirakata, Y; Hashimoto, K; Higashiyama, S				Nakayama, Hironao; Fukuda, Shinji; Matsushita, Natsuki; Nishida-Fukuda, Hisayo; Inoue, Hirofumi; Shirakata, Yuji; Hashimoto, Koji; Higashiyama, Shigeki			Human Antigen R-mediated mRNA Stabilization Is Required for Ultraviolet B-induced Autoinduction of Amphiregulin in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; GENE-EXPRESSION; FACTOR FAMILY; HB-EGF; BINDING; PROTEIN; HUR; ACTIVATION; ELEMENT	All members of the EGF family are produced as transmembrane precursors that are proteolytically processed into soluble forms by disintegrin and metalloproteinases (ADAMs) for autocrine/paracrine pathways. In turn, the ligand-activated EGF receptor (EGFR) induces the expression of EGF family members, so-called "autoinduction." However, it is not well understood how this autoinduction occurs. In this study, we investigated the molecular mechanism of the autoinduction of amphiregulin (AREG), a member of the EGF family. We found that ultraviolet B (UVB) exposure increased the AREG mRNA level by stabilization of its mRNA in a human immortalized keratinocyte cell line, HaCaT. The 3' UTR of AREG mRNA was responsible for binding to an mRNA-binding protein, human antigen R (HuR), and the interaction between AREG mRNA and HuR was enhanced by UVB. Inducible knockdown of HuR expression significantly decreased AREG mRNA stability. Interestingly, treatment of HaCaT cells with an EGFR inhibitor, an EGFR neutralizing antibody, or an ADAM inhibitor destabilized AREG mRNA. In the case of ADAM inhibition, administration of soluble AREG restored the mRNA level, indicating that the stabilization occurs in a shedding-dependent manner of EGFR ligands. The HuR dependence of AREG mRNA and protein expression was also confirmed in human primary keratinocytes. Taken together, we propose a novel mechanism by which HuR regulates the stability of AREG mRNA in keratinocytes after UVB exposure and suggest that targeting of HuR functions might be crucial for understanding skin cancers caused by aberrant EGF family member-EGFR signaling.	[Nakayama, Hironao; Fukuda, Shinji; Nishida-Fukuda, Hisayo; Inoue, Hirofumi; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan; [Nakayama, Hironao; Shirakata, Yuji; Hashimoto, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan; [Matsushita, Natsuki] Ehime Univ, Funct Genom Core Lab, Toon, Ehime 7910295, Japan; [Inoue, Hirofumi] Ehime Univ, Ehime Nikon BioImaging Core Lab, Toon, Ehime 7910295, Japan; [Inoue, Hirofumi; Higashiyama, Shigeki] Ehime Univ, Dept Cell Growth & Tumor Regulat, Proteomed Res Ctr ProMRes, Toon, Ehime 7910295, Japan; [Nakayama, Hironao; Higashiyama, Shigeki] Japan Soc Promot Sci, Strateg Young Researcher Overseas Visiting Progra, Chiyoda Ku, Tokyo 1020083, Japan	Ehime University; Ehime University; Ehime University; Ehime University; Ehime University; Japan Society for the Promotion of Science	Higashiyama, S (corresponding author), Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan.	shigeki@m.ehime-u.ac.jp		Nishida-Fukuda, Hisayo/0000-0002-4661-779X	Ehime University; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390074, 22650228, 20390082]; Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation, Japan Society for the Promotion of Science (JSPS), Japan [S2207]	Ehime University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation, Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for scientific research from Ehime University (to H. N.). This work was also supported by Grants-in-Aid for Scientific Research 24390074, 22650228, and 20390082 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. H.) and by Grant-in-Aid for Scientific Research S2207 from the Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation, Japan Society for the Promotion of Science (JSPS), Japan (to S. H.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; BARNARD JA, 1994, J BIOL CHEM, V269, P22817; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; COOK PW, 1992, CANCER RES, V52, P3224; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Higashiyama S, 2011, J BIOCHEM, V150, P15, DOI 10.1093/jb/mvr068; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Matsushita N., 2013, BIOSCI BIOT IN PRESS; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; O'Reilly SM, 2006, AM J PHYSIOL-CELL PH, V290, pC592, DOI 10.1152/ajpcell.00278.2005; Ornskov D, 2007, BIOCHEM BIOPH RES CO, V354, P885, DOI 10.1016/j.bbrc.2007.01.047; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Qin L, 2005, J CELL BIOCHEM, V96, P632, DOI 10.1002/jcb.20550; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; Seo MR, 2007, J BIOL CHEM, V282, P24720, DOI 10.1074/jbc.M702343200; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Singh B, 2009, INT J CANCER, V124, P531, DOI 10.1002/ijc.23974; Sorensen BS, 2004, MOL CELL BIOCHEM, V260, P129, DOI 10.1023/B:MCBI.0000026063.96267.98; Soyensen BS, 2006, EXP CELL RES, V312, P3651, DOI 10.1016/j.yexcr.2006.08.007; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Tong X, 2007, MOL CELL BIOL, V27, P283, DOI 10.1128/MCB.01282-06; Uetani T, 2009, J BIOL CHEM, V284, P12399, DOI 10.1074/jbc.M900463200; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Weinheimer EM, 2007, AM J PHYSIOL-REG I, V292, pR2241, DOI 10.1152/ajpregu.00718.2006; Westmark CJ, 2005, ONCOGENE, V24, P502, DOI 10.1038/sj.onc.1208224; Xie GF, 2009, AM J PHYSIOL-GASTR L, V296, pG755, DOI 10.1152/ajpgi.90519.2008; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Yoshida M, 2012, CANCER SCI, V103, P708, DOI 10.1111/j.1349-7006.2012.02204.x	53	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10338	10348		10.1074/jbc.M112.417527	http://dx.doi.org/10.1074/jbc.M112.417527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430747	hybrid, Green Published			2022-12-28	WOS:000317565000015
J	Miles, EW				Miles, Edith Wilson			The Tryptophan Synthase alpha(2)beta(2) Complex: A Model for Substrate Channeling, Allosteric Communication, and Pyridoxal Phosphate Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-METHYLSERINE HYDROXYMETHYLTRANSFERASE; ASPARTATE BETA-DECARBOXYLASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; BIENZYME COMPLEX; B-PROTEIN; ALPHA-2-BETA-2 COMPLEX; ENZYMATIC-ACTIVITIES; MONOVALENT CATIONS; SUBUNIT	I reflect on my research on pyridoxal phosphate (PLP) enzymes over fifty-five years and on how I combined research with marriage and family. My Ph.D. research with Esmond E. Snell established one aspect of PLP enzyme mechanism. My postdoctoral work first with Hans L. Kornberg and then with Alton Meister characterized the structure and function of another PLP enzyme, L-aspartate beta-decarboxylase. My independent research at the National Institutes of Health (NIH) since 1966 has focused on the bacterial tryptophan synthase alpha(2)beta(2) complex. The beta subunit catalyzes a number of PLP-dependent reactions. We have characterized these reactions and the allosteric effects of the alpha subunit. We also used chemical modification to probe enzyme structure and function. Our crystallization of the tryptophan synthase alpha(2)beta(2) complex from Salmonella typhimurium led to the determination of the three-dimensional structure with Craig Hyde and David Davies at NIH in 1988. This landmark structure was the first structure of a multienzyme complex and the first structure revealing an intramolecular tunnel. The structure has provided a basis for exploring mechanisms of catalysis, channeling, and allosteric communication in the tryptophan synthase alpha(2)beta(2) complex. The structure serves as a model for many other multiprotein complexes that are important for biological processes in prokaryotes and eukaryotes.	NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miles, EW (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	edithm@intra.niddk.nih.gov						ADACHI O, 1974, J BIOL CHEM, V249, P5430; ADACHI O, 1974, J BIOL CHEM, V249, P7756; AHMED SA, 1985, J BIOL CHEM, V260, P3716; AHMED SA, 1987, BIOCHEMISTRY-US, V26, P5492, DOI 10.1021/bi00391a042; ANDERSON KS, 1995, J BIOL CHEM, V270, P29936; ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; BRZOVIC PS, 1992, J BIOL CHEM, V267, P13028; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P1180, DOI 10.1021/bi00119a030; CRAWFORD IP, 1958, P NATL ACAD SCI USA, V44, P1161, DOI 10.1073/pnas.44.12.1161; Dunn MF, 2012, ARCH BIOCHEM BIOPHYS, V519, P154, DOI 10.1016/j.abb.2012.01.016; Fan YX, 2000, BIOCHEMISTRY-US, V39, P4692, DOI 10.1021/bi9921586; HIGGINS W, 1979, BIOCHEMISTRY-US, V18, P4827, DOI 10.1021/bi00589a010; HYDE CC, 1988, J BIOL CHEM, V263, P17857; KUMAGAI H, 1971, BIOCHEM BIOPH RES CO, V44, P1271, DOI 10.1016/S0006-291X(71)80223-1; Miles E W, 1977, Methods Enzymol, V47, P431; MILES EW, 1988, J BIOL CHEM, V263, P8611; MILES EW, 1986, BIOCHEMISTRY-US, V25, P4240, DOI 10.1021/bi00363a011; MILES EW, 1982, BIOCHEMISTRY-US, V21, P2586, DOI 10.1021/bi00540a002; MILES EW, 1967, BIOCHEMISTRY-US, V6, P1734, DOI 10.1021/bi00858a023; MILES EW, 1970, J BIOL CHEM, V245, P6016; MILES EW, 1989, J BIOL CHEM, V264, P6280; MILES EW, 1974, J BIOL CHEM, V249, P2843; MILES EW, 1968, BIOCHEMISTRY-US, V7, P2742, DOI 10.1021/bi00848a008; MOZZARELLI A, 1989, J BIOL CHEM, V264, P15774; NAGATA S, 1989, J BIOL CHEM, V264, P6288; PERACCHI A, 1995, BIOCHEMISTRY-US, V34, P9459, DOI 10.1021/bi00029a022; Peracchi A, 1996, BIOCHEMISTRY-US, V35, P1872, DOI 10.1021/bi951889c; PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P6228, DOI 10.1021/bi00320a052; Rhee S, 1998, BIOCHEMISTRY-US, V37, P10653, DOI 10.1021/bi980779d; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; RUVINOV SB, 1995, J BIOL CHEM, V270, P6357, DOI 10.1074/jbc.270.11.6357; WILSON EM, 1963, BIOCHEM J, V88, P578, DOI 10.1042/bj0880578; WILSON EM, 1962, J BIOL CHEM, V237, P3171; WILSON EM, 1966, BIOCHEMISTRY-US, V5, P1166, DOI 10.1021/bi00868a008; WILSON EM, 1962, J BIOL CHEM, V237, P3180; YANG XJ, 1992, J BIOL CHEM, V267, P7520	36	16	16	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10084	10091		10.1074/jbc.X113.463331	http://dx.doi.org/10.1074/jbc.X113.463331			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426371	hybrid, Green Published			2022-12-28	WOS:000317114000048
J	Mori, Y; Matsui, T; Fukuda, M				Mori, Yasunori; Matsui, Takahide; Fukuda, Mitsunori			Rabex-5 Protein Regulates Dendritic Localization of Small GTPase Rab17 and Neurite Morphogenesis in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; DOMAIN-CONTAINING PROTEINS; CAENORHABDITIS-ELEGANS; RECYCLING ENDOSOMES; EPITHELIAL-CELLS; BINDING-ACTIVITY; DENN DOMAIN; COATED-PIT; FAMILY	Small GTPase Rab17 has recently been shown to regulate dendritic morphogenesis of mouse hippocampal neurons; however, the exact molecular mechanism of Rab17-mediated dendritogenesis remained to be determined, because no guanine nucleotide exchange factor (GEF) for Rab17 had been identified. In this study we screened for the Rab17-GEF by performing yeast two-hybrid assays with a GDP-locked Rab17 mutant as bait and found that Rabex-5 and ALS2, both of which were originally described as Rab5-GEFs, interact with Rab17. We also found that expression of Rabex-5, but not of ALS2, promotes translocation of Rab17 from the cell body to the dendrites of developing mouse hippocampal neurons. The shRNA-mediated knockdown of Rabex-5 or its known downstream target Rab5 in hippocampal neurons inhibited morphogenesis of both axons and dendrites, whereas knockdown of Rab17 affected dendrite morphogenesis alone. Based on these findings, we propose that Rabex-5 regulates neurite morphogenesis of hippocampal neurons by activating at least two downstream targets, Rab5, which is localized in both axons and dendrites, and Rab17, which is localized in dendrites alone.	[Mori, Yasunori; Matsui, Takahide; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015; Matsui, Takahide/S-4986-2018	Fukuda, MItsunori/0000-0002-8620-5853; Matsui, Takahide/0000-0002-3342-0170	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [24700308] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to Y. M. and M. F.) and by a grant from the Daiichi-Sankyo Foundation of Life Science (to M. F.).; Supported by the Japan Society for the Promotion of Science (JSPS).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; James P, 1996, GENETICS, V144, P1425; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lai C, 2006, J NEUROSCI, V26, P11798, DOI 10.1523/JNEUROSCI.2084-06.2006; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Ohbayashi N, 2012, MOL BIOL CELL, V23, P669, DOI 10.1091/mbc.E11-04-0324; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810	45	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9835	9847		10.1074/jbc.M112.427591	http://dx.doi.org/10.1074/jbc.M112.427591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430262	Green Published, hybrid			2022-12-28	WOS:000317114000024
J	Takhar, HK; Kemp, K; Kim, M; Howell, PL; Burrows, LL				Takhar, Herlinder K.; Kemp, Kevin; Kim, Melissa; Howell, P. Lynne; Burrows, Lori L.			The Platform Protein Is Essential for Type IV Pilus Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; NEISSERIA-GONORRHOEAE; THERMUS-THERMOPHILUS; SUBCELLULAR-LOCALIZATION; RETRACTION MOTOR; COMPLEX; COMPONENT; PHAGE	A systematic genetic analysis was performed to identify the inner membrane proteins essential for type IV pilus (T4P) expression in Pseudomonas aeruginosa. By inactivating the retraction aspect of pilus function, genes essential for T4P assembly were discriminated. In contrast to previous studies in the T4P system of Neisseria spp., we found that components of the inner membrane subcomplex consisting of PilMNOP were not essential for surface pilus expression, whereas the highly conserved inner membrane protein PilC was essential. Here, we present data that PilC may coordinate the activity of cytoplasmic polymerization (PilB) and depolymerization (PilT) ATPases via their interactions with its two cytoplasmic domains. Using in vitro co-affinity purification, we show that PilB interacts with the N-terminal cytoplasmic domain of PilC. We hypothesized that PilT similarly interacts with the PilC C-terminal cytoplasmic domain. Overexpression of that domain in the wild-type protein reduced twitching motility by similar to 50% compared with the vector control. Site-directed mutagenesis of conserved T4P-specific residues in the PilC C-terminal domain yielded mutant proteins that supported wild-type pilus assembly but had a reduced capacity to support twitching motility, suggesting impairment of putative PilC-PilT interactions. Taken together, our results show that PilC is an essential inner membrane component of the T4P system, controlling both pilus assembly and disassembly.	[Takhar, Herlinder K.; Kemp, Kevin; Kim, Melissa; Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Takhar, Herlinder K.; Kemp, Kevin; Kim, Melissa; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca; burrowl@mcmaster.ca			Canadian Institutes of Health Research [MOP 93585]; Canadian Institutes of Health Research Banting studentship; Ontario graduate scholarship; Cystic Fibrosis Canada studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Banting studentship(Canadian Institutes of Health Research (CIHR)); Ontario graduate scholarship(Ontario Graduate Scholarship); Cystic Fibrosis Canada studentship	This work was supported in part by Operating Grant MOP 93585 from the Canadian Institutes of Health Research (to L. L. B. and P. L. H.).; Recipient of a Canadian Institutes of Health Research Banting studentship and an Ontario graduate scholarship.; Recipient of a Cystic Fibrosis Canada studentship.	Abendroth J, 2009, J STRUCT BIOL, V166, P303, DOI 10.1016/j.jsb.2009.03.009; Albers SV, 2009, EXTREMOPHILES, V13, P403, DOI 10.1007/s00792-009-0241-7; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; BRADLEY DE, 1972, BIOCHEM BIOPH RES CO, V47, P142, DOI 10.1016/S0006-291X(72)80021-4; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Collins RF, 2007, J BACTERIOL, V189, P6389, DOI 10.1128/JB.00648-07; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Harvey H, 2009, J BACTERIOL, V191, P6513, DOI 10.1128/JB.00943-09; Herdendorf TJ, 2002, J BACTERIOL, V184, P6465, DOI 10.1128/JB.184.23.6465-6471.2002; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Koo J, 2012, FEMS MICROBIOL LETT, V328, P1, DOI 10.1111/j.1574-6968.2011.02464.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Milgotina EI, 2011, MOL MICROBIOL, V81, P1125, DOI 10.1111/j.1365-2958.2011.07771.x; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; NUNN D, 1990, J BACTERIOL, V172, P2911, DOI 10.1128/jb.172.6.2911-2919.1990; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Ramer SW, 2002, J BACTERIOL, V184, P3457, DOI 10.1128/JB.184.13.3457-3465.2002; Roux N, 2012, RES MICROBIOL, V163, P659, DOI 10.1016/j.resmic.2012.10.015; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Savvides SN, 2007, STRUCTURE, V15, P255, DOI 10.1016/j.str.2007.02.003; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; WHITCHURCH CB, 1994, MOL MICROBIOL, V13, P1079, DOI 10.1111/j.1365-2958.1994.tb00499.x; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wolfgang M, 1998, P NATL ACAD SCI USA, V95, P14973, DOI 10.1073/pnas.95.25.14973; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544	52	79	79	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9721	9728		10.1074/jbc.M113.453506	http://dx.doi.org/10.1074/jbc.M113.453506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413032	hybrid, Green Published			2022-12-28	WOS:000317114000014
J	Boitz, JM; Strasser, R; Yates, PA; Jardim, A; Ullman, B				Boitz, Jan M.; Strasser, Rona; Yates, Phillip A.; Jardim, Armando; Ullman, Buddy			Adenylosuccinate Synthetase and Adenylosuccinate Lyase Deficiencies Trigger Growth and Infectivity Deficits in Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; PURINE METABOLISM; ESCHERICHIA-COLI; ADENOSINE-DEAMINASE; IN-VITRO; ENZYMATIC AMPLIFICATION; ADENINE AMINOHYDROLASE; GENETIC-ANALYSIS; KINASE; RESISTANCE	Leishmania are auxotrophic for purines, and consequently purine acquisition from the host is a requisite nutritional function for the parasite. Both adenylosuccinate synthetase (ADSS) and adenylosuccinate lyase (ASL) have been identified as vital components of purine salvage in Leishmania donovani, and therefore Delta adss and Delta asl null mutants were constructed to test this hypothesis. Unlike wild type L. donovani, Delta adss and Delta asl parasites in culture exhibited a profoundly restricted growth phenotype in which the only permissive growth conditions were a 6-aminopurine source in the presence of 2'-deoxycoformycin, an inhibitor of adenine aminohydrolase activity. Although both knock-outs showed a diminished capacity to infect murine peritoneal macrophages, only the Delta asl null mutant was profoundly incapacitated in its ability to infect mice. The enormous discrepancy in parasite loads observed in livers and spleens from mice infected with either Delta adss or Delta asl parasites can be explained by selective accumulation of adenylosuccinate in the Delta asl knock-out and consequent starvation for guanylate nucleotides. Genetic complementation of a Delta asl lesion in Escherichia coli implied that the L. donovani ASL could also recognize 5-aminoimidazole-(N-succinylocarboxamide) ribotide as a substrate, and purified recombinant ASL displayed an apparent K-m of similar to 24 mu M for adenylosuccinate. Unlike many components of the purine salvage pathway of L. donovani, both ASL and ADSS are cytosolic enzymes. Overall, these data underscore the paramount importance of ASL to purine salvage by both life cycle stages of L. donovani and authenticate ASL as a potential drug target in Leishmania.	[Boitz, Jan M.; Yates, Phillip A.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Strasser, Rona; Jardim, Armando] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Oregon Health & Science University; McGill University	Ullman, B (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	ullmanb@ohsu.edu			National Institutes of Health from the NIAID [AI023682]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682 from the NIAID (to B. U.). This work was also supported by a grant from the Canadian Institutes of Health Research (to A. J.).	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2012, J BIOL CHEM, V287, P7626, DOI 10.1074/jbc.M111.307884; Boitz JM, 2010, J BIOL CHEM, V285, P18555, DOI 10.1074/jbc.M110.125393; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; CASEY PJ, 1986, J BIOL CHEM, V261, P3637; CRAIG SP, 1991, P NATL ACAD SCI USA, V88, P2500, DOI 10.1073/pnas.88.6.2500; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; DATTA AK, 1987, J BIOL CHEM, V262, P5515; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Dobie F, 2007, MOL BIOCHEM PARASIT, V152, P11, DOI 10.1016/j.molbiopara.2006.11.007; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; Eaazhisai K, 2004, J MOL BIOL, V335, P1251, DOI 10.1016/j.jmb.2003.11.036; Galazka J, 2006, MOL BIOCHEM PARASIT, V149, P223, DOI 10.1016/j.molbiopara.2006.06.001; Garg R, 2006, INDIAN J MED RES, V123, P439; Goyard S, 2000, MOL BIOCHEM PARASIT, V108, P249, DOI 10.1016/S0166-6851(00)00210-3; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; Iovannisci D M, 1984, Adv Exp Med Biol, V165 Pt A, P239; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Jardim A, 2002, MOL BIOCHEM PARASIT, V124, P51, DOI 10.1016/S0166-6851(02)00164-0; Jayalakshmi R, 2002, PROTEIN EXPRES PURIF, V25, P65, DOI 10.1006/prep.2001.1610; JOCHIMSEN B, 1975, MOL GEN GENET, V143, P85, DOI 10.1007/BF00269424; KIDDER GW, 1979, P NATL ACAD SCI USA, V76, P3670, DOI 10.1073/pnas.76.8.3670; KIDDER GW, 1977, ARCH BIOCHEM BIOPHYS, V183, P7, DOI 10.1016/0003-9861(77)90412-X; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Krenitsky T A, 1979, Adv Exp Med Biol, V122B, P51; LAFON SW, 1982, BIOCHEM PHARMACOL, V31, P231, DOI 10.1016/0006-2952(82)90216-7; LOOKER DL, 1983, MOL BIOCHEM PARASIT, V9, P15, DOI 10.1016/0166-6851(83)90053-1; MARR JJ, 1982, BIOCHEM PHARMACOL, V31, P143, DOI 10.1016/0006-2952(82)90203-9; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Michaelis L, 1913, BIOCHEM Z, V49, P333; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; MILLER SI, 1986, NUCLEIC ACIDS RES, V14, P7341, DOI 10.1093/nar/14.18.7341; Mullen AB, 1998, ANTIMICROB AGENTS CH, V42, P2722, DOI 10.1128/AAC.42.10.2722; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Parsons M, 2001, MOL BIOCHEM PARASIT, V115, P19, DOI 10.1016/S0166-6851(01)00261-4; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Pilar AVC, 2008, MOL BIOCHEM PARASIT, V158, P72, DOI 10.1016/j.molbiopara.2007.11.013; Poland BW, 1996, J MOL BIOL, V264, P1013, DOI 10.1006/jmbi.1996.0693; Russel D. W., 2001, MOL CLONING LAB MANU, P1633; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHAEFFER HJ, 1974, J MED CHEM, V17, P6, DOI 10.1021/jm00247a002; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Sillero MAG, 2001, EUR J BIOCHEM, V268, P3605, DOI 10.1046/j.1432-1327.2001.02271.x; SPECTOR T, 1982, BIOCHEM PHARMACOL, V31, P3891, DOI 10.1016/0006-2952(82)90307-0; SPECTOR T, 1979, J BIOL CHEM, V254, P8422; SPECTOR T, 1984, BIOCHEM PHARMACOL, V33, P1611, DOI 10.1016/0006-2952(84)90282-X; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; WIGINTON DA, 1982, J BIOL CHEM, V257, P3211; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; WOLFE SA, 1988, J BIOL CHEM, V263, P19147; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016	67	26	27	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8977	8990		10.1074/jbc.M112.431486	http://dx.doi.org/10.1074/jbc.M112.431486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404497	hybrid, Green Published			2022-12-28	WOS:000316862200017
J	Guzik-Lendrum, S; Heissler, SM; Billington, N; Takagi, Y; Yang, Y; Knight, PJ; Homsher, E; Sellers, JR				Guzik-Lendrum, Stephanie; Heissler, Sarah M.; Billington, Neil; Takagi, Yasuharu; Yang, Yi; Knight, Peter J.; Homsher, Earl; Sellers, James R.			Mammalian Myosin-18A, a Highly Divergent Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; PHOSPHORYLATION-DEPENDENT REGULATION; REGULATORY LIGHT-CHAIN; PDZ-CONTAINING MYOSIN; SMOOTH-MUSCLE MYOSIN; HEAVY-MEROMYOSIN; ADENOSINE-TRIPHOSPHATASE; KINETIC MECHANISM; BINDING-SITE; ACTIN	The Mus musculus myosin-18A gene is expressed as two alternatively spliced isoforms, alpha and beta, with reported roles in Golgi localization, in maintenance of cytoskeleton, and as receptors for immunological surfactant proteins. Both myosin-18A isoforms feature a myosin motor domain, a single predicted IQ motif, and a long coiled-coil reminiscent of myosin-2. The myosin-18A alpha isoform, additionally, has an N-terminal PDZ domain. Recombinant heavy meromyosin- and subfragment-1 (S1)-like constructs for both myosin-18A alpha and -18 beta species were purified from the baculovirus/Sf9 cell expression system. These constructs bound both essential and regulatory light chains, indicating an additional noncanonical light chain binding site in the neck. Myosin-18A alpha-S1 and -18A beta-S1 molecules bound actin weakly with K-d values of 4.9 and 54 mu M, respectively. The actin binding data could be modeled by assuming an equilibrium between two myosin conformations, a competent and an incompetent form to bind actin. Actin binding was unchanged by presence of nucleotide. Both myosin-18A isoforms bound N-methylanthraniloyl- nucleotides, but the rate of ATP hydrolysis was very slow (<0.002 s(-1)) and not significantly enhanced by actin. Phosphorylation of the regulatory light chain had no effect on ATP hydrolysis, and neither did the addition of tropomyosin or of GOLPH3, a myosin-18A binding partner. Electron microscopy of myosin-18A-S1 showed that the lever is strongly angled with respect to the long axis of the motor domain, suggesting a pre-power stroke conformation regardless of the presence of ATP. These data lead us to conclude that myosin-18A does not operate as a traditional molecular motor in cells.	[Homsher, Earl; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Yang, Yi] Hunan Agr Univ, Coll Vet Med, Lab Funct Prote, Changsha 410128, Hunan, Peoples R China; [Knight, Peter J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Homsher, Earl] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Hunan Agricultural University; University of Leeds; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3523, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov		Billington, Neil/0000-0003-2306-0228	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232, ZIAHL001786] Funding Source: NIH RePORTER	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Fang Zhang for technical assistance with myosin-18A experiments and protein purification, Melanie Barzik and John A. Hammer III (NHLBI, National Institutes of Health) for providing a full-length clone of mouse myosin-18A alpha and -beta as starting points for cloning in this project, and Kathryn Callahan (NIDDK, National Institutes of Health) for assistance with filter binding assays. We thank the NHLBI Proteomics Core Facility, which provided excellent service. We thank the Electron Microscopy Core Facility of the NHLBI for support and the use of facilities.	ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Ajima R, 2007, BIOCHEM BIOPH RES CO, V356, P851, DOI 10.1016/j.bbrc.2007.03.060; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Beach JR, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-52; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Brown JH, 2011, P NATL ACAD SCI USA, V108, P114, DOI 10.1073/pnas.1016288107; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; JANSON LW, 1992, CELL MOTIL CYTOSKEL, V22, P274, DOI 10.1002/cm.970220407; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nakano T, 2005, GENE CHROMOSOME CANC, V43, P162, DOI 10.1002/gcc.20180; Nishioka M, 2002, P NATL ACAD SCI USA, V99, P12269, DOI 10.1073/pnas.192445899; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Onishi H, 1997, BIOCHEMISTRY-US, V36, P3767, DOI 10.1021/bi9630772; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Preller M, 2011, J BIOL CHEM, V286, P35051, DOI 10.1074/jbc.M111.265298; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Risal D, 2004, P NATL ACAD SCI USA, V101, P8930, DOI 10.1073/pnas.0403002101; Sellers J. R., 1999, MYOSINS; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; SELLERS JR, 1993, METHOD CELL BIOL, V39, P23, DOI 10.1016/S0091-679X(08)60159-4; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Sweeney HL, 2000, J BIOL CHEM, V275, P41273, DOI 10.1074/jbc.M008310200; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; TRYBUS KM, 1989, J CELL BIOL, V109, P2887, DOI 10.1083/jcb.109.6.2887; Uchimura T, 2002, CELL STRUCT FUNCT, V27, P479, DOI 10.1247/csf.27.479; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wendt T, 1999, J CELL BIOL, V147, P1385, DOI 10.1083/jcb.147.7.1385; Yamashita RA, 2000, J MUSCLE RES CELL M, V21, P491, DOI 10.1023/A:1026589626422; Yanaihara N, 2004, INT J CANCER, V112, P150, DOI 10.1002/ijc.20339; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	71	44	45	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9532	9548		10.1074/jbc.M112.441238	http://dx.doi.org/10.1074/jbc.M112.441238			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23382379	Green Published, hybrid			2022-12-28	WOS:000316862200068
J	Gortazar, AR; Martin-Millan, M; Bravo, B; Plotkin, LI; Bellido, T				Gortazar, Arancha R.; Martin-Millan, Marta; Bravo, Beatriz; Plotkin, Lilian I.; Bellido, Teresita			Crosstalk between Caveolin-1/Extracellular Signal-regulated Kinase (ERK) and beta-Catenin Survival Pathways in Osteocyte Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; FRIZZLED-RELATED PROTEIN-1; ESTROGEN-RECEPTOR; MECHANICAL STIMULATION; OSTEOBLAST APOPTOSIS; BONE; ACTIVATION; CELLS; BISPHOSPHONATES; SCLEROSTIN	Osteocyte viability is a critical determinant of bone strength and is promoted by both mechanical stimulation and activation of the Wnt signaling pathway. Earlier studies demonstrated that both stimuli promote survival of osteocytes by activating the ERKs. Here, we show that there is interaction between the caveolin-1/ERK and Wnt/beta-catenin signaling pathways in the transduction of mechanical cues into osteocyte survival. Thus, ERK nuclear translocation and anti-apoptosis induced by mechanical stimulation are abolished by the Wnt antagonist Dkk1 and the beta-catenin degradation stimulator Axin2. Conversely, GSK3 beta phosphorylation and beta-catenin accumulation induced by mechanical stimulation are abolished by either pharmacologic inhibition of ERKs or silencing caveolin-1. In contrast, the canonical Wnt signaling inhibitor dominant-negative T cell factor does not alter ERK nuclear translocation or survival induced by mechanical stimulation. These findings demonstrate that beta-catenin accumulation is an essential component of the mechanotransduction machinery in osteocytes, albeit beta-catenin/T cell factor-mediated transcription is not required. The simultaneous requirement of beta-catenin for ERK activation and of ERK activation for beta-catenin accumulation suggests a bidirectional crosstalk between the caveolin-1/ERK and Wnt/beta-catenin pathways in mechanotransduction leading to osteocyte survival.	[Gortazar, Arancha R.; Bravo, Beatriz] San Pablo CEU Univ, Sch Med, IMMA, Madrid 28003, Spain; [Martin-Millan, Marta] Inst Formac & Invest Marques Valdecilla IFIVAV, Santander 39011, Spain; [Plotkin, Lilian I.; Bellido, Teresita] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA	San Pablo CEU University; Hospital Universitario Marques de Valdecilla (HUMV); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 5035, Indianapolis, IN 46202 USA.	tbellido@iupui.edu	Gortazar, Arancha/G-5385-2017; Plotkin, Lilian/H-7188-2019	Gortazar, Arancha/0000-0001-5072-3141; Plotkin, Lilian/0000-0002-9537-4544	National Institutes of Health [R01 AR059357]; Fundacion Universitaria San Pablo CEU Grant [USPPPCO07/09]; Conchita Rabago Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Universitaria San Pablo CEU Grant; Conchita Rabago Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR059357 (to T.B.). This work was also supported by Fundacion Universitaria San Pablo CEU Grant USPPPCO07/09 and a fellowship from the Conchita Rabago Foundation (to A.R.G.).	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Javaheri B, 2011, J BONE MINER RES, V26, pS24; Jilka RL, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P237, DOI 10.1016/B978-0-12-373884-4.00032-X; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mo SJ, 2010, DEV BIOL, V344, P210, DOI 10.1016/j.ydbio.2010.04.033; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Plotkin LI, 2007, J BIOL CHEM, V282, P24120, DOI 10.1074/jbc.M611435200; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547	43	57	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8168	8175		10.1074/jbc.M112.437921	http://dx.doi.org/10.1074/jbc.M112.437921			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362257	Green Published, hybrid			2022-12-28	WOS:000316564500017
J	Ashraf, M; Sreejith, P; Yadav, U; Komath, SS				Ashraf, Mohammad; Sreejith, Perinthottathil; Yadav, Usha; Komath, Sneha Sudha			Catalysis by N-Acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase (PIG-L) from Entamoeba histolytica NEW ROLES FOR CONSERVED RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHOR BIOSYNTHESIS; GLYCOSYLPHOSPHATIDYLINOSITOL; PROTEIN; CELLS	We showed previously that Entamoeba histolytica PIG-L exhibits a novel metal-independent albeit metal-stimulated activity. Using mutational and biochemical analysis, here we identify Asp-46 and His-140 of the enzyme as being important for catalysis. We show that these mutations neither affect the global conformational of the enzyme nor alter its metal binding affinity. The defect in catalysis, due to the mutations, is specifically due to an effect on V-max and not due to altered substrate affinity (or K-m). We propose a general acid-base pair mechanism to explain our results.	[Ashraf, Mohammad; Sreejith, Perinthottathil; Yadav, Usha; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Komath, SS (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@mail.jnu.ac.in	Peri, Sreejith/AAY-9076-2021	Peri, Sreejith/0000-0001-5445-3265; KOMATH, SNEHA SUDHA/0000-0002-0491-7102	Council for Scientific and Industrial Research (CSIR) [37(1441)/10/EMR-II]; Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE); CSIR	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council for Scientific and Industrial Research (CSIR) Research Grant 37(1441)/10/EMR-II (to S. S. K.), publication support through Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE), and CSIR fellowships (to M. A. and U. Y.).	Ashraf M, 2011, J BIOL CHEM, V286, P2543, DOI 10.1074/jbc.C110.178343; de Macedo CS, 2003, BIOCHIMIE, V85, P465, DOI 10.1016/S0300-9084(03)00065-8; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Jain R, 2010, CELL MICROBIOL, V12, P432, DOI 10.1111/j.1462-5822.2009.01406.x; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; McCarthy AA, 2004, J MOL BIOL, V335, P1131, DOI 10.1016/j.jmb.2003.11.034; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Urbaniak MD, 2005, J BIOL CHEM, V280, P22831, DOI 10.1074/jbc.M502402200; Vats D, 2005, INFECT IMMUN, V73, P8381, DOI 10.1128/IAI.73.12.8381-8392.2005	12	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7590	7595		10.1074/jbc.M112.427245	http://dx.doi.org/10.1074/jbc.M112.427245			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341455	Green Published, hybrid			2022-12-28	WOS:000316455300016
J	Fluharty, BR; Biasini, E; Stravalaci, M; Sclip, A; Diomede, L; Balducci, C; La Vitola, P; Messa, M; Colombo, L; Forloni, G; Borsello, T; Gobbi, M; Harris, DA				Fluharty, Brian R.; Biasini, Emiliano; Stravalaci, Matteo; Sclip, Alessandra; Diomede, Luisa; Balducci, Claudia; La Vitola, Pietro; Messa, Massimo; Colombo, Laura; Forloni, Gianluigi; Borsello, Tiziana; Gobbi, Marco; Harris, David A.			An N-terminal Fragment of the Prion Protein Binds to Amyloid-beta Oligomers and Inhibits Their Neurotoxicity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; IMPAIRMENT; CLEAVAGE; BRAIN	A hallmark of Alzheimer disease (AD) is the accumulation of the amyloid-beta (A beta) peptide in the brain. Considerable evidence suggests that soluble A beta oligomers are responsible for the synaptic dysfunction and cognitive deficit observed in AD. However, the mechanism by which these oligomers exert their neurotoxic effect remains unknown. Recently, it was reported that A beta oligomers bind to the cellular prion protein with high affinity. Here, we show that N1, the main physiological cleavage fragment of the cellular prion protein, is necessary and sufficient for binding early oligomeric intermediates during A beta polymerization into amyloid fibrils. The ability of N1 to bind A beta oligomers is influenced by positively charged residues in two sites (positions 23-31 and 95-105) and is dependent on the length of the sequence between them. Importantly, we also show that N1 strongly suppresses A beta oligomer toxicity in cultured murine hippocampal neurons, in a Caenorhabditis elegans-based assay, and in vivo in a mouse model of A beta-induced memory dysfunction. These data suggest that N1, or small peptides derived from it, could be potent inhibitors of A beta oligomer toxicity and represent an entirely new class of therapeutic agents for AD.	[Fluharty, Brian R.; Biasini, Emiliano; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Stravalaci, Matteo; Diomede, Luisa; Messa, Massimo; Colombo, Laura; Gobbi, Marco] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [Sclip, Alessandra; Balducci, Claudia; La Vitola, Pietro; Forloni, Gianluigi; Borsello, Tiziana] Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy	Boston University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Biasini, E (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 East Concord St, Boston, MA 02118 USA.	biasini@bu.edu	Borsello, Tiziana/ABG-7759-2020; Balducci, Claudia/AAA-8465-2020; Gobbi, Marco/J-2638-2016; Forloni, Gianluigi/AAB-2115-2020; Biasini, Emiliano/A-3147-2011; Stravalaci, Matteo/AAB-8963-2019; colombo, laura/AAA-6716-2020; Diomede, Luisa/P-3417-2014; La Vitola, Pietro/AHE-9241-2022; Borsello, Tiziana/J-8232-2016	Balducci, Claudia/0000-0002-3870-835X; Gobbi, Marco/0000-0003-1014-6225; Forloni, Gianluigi/0000-0001-5374-3914; Biasini, Emiliano/0000-0002-3927-6341; Stravalaci, Matteo/0000-0002-5636-4204; colombo, laura/0000-0002-3243-0270; Diomede, Luisa/0000-0002-2258-0531; Harris, David/0000-0002-6985-5790; Borsello, Tiziana/0000-0002-9729-7642	National Institutes of Health [R01 NS065244, R01 NS040975]; Eben Ellison Foundation; Cassa di Risparmio delle Provincie Lombarde (CARIPLO, Italy) [2009-2425, 2009-2543]; Alzheimer's Drug Discovery Foundation (ADDF); Telethon Foundation [GGP10120]; Alzheimer's Association [NIRG-10-171655]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040975, R01NS065244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eben Ellison Foundation(Lawrence Ellison Foundation); Cassa di Risparmio delle Provincie Lombarde (CARIPLO, Italy); Alzheimer's Drug Discovery Foundation (ADDF); Telethon Foundation(Fondazione Telethon); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS065244 and R01 NS040975 (to D. A. H.). This work was also supported by the Eben Ellison Foundation (to D. A. H.), Cassa di Risparmio delle Provincie Lombarde (CARIPLO, Italy) Grants 2009-2425 (to T. B.) and 2009-2543 (to L. D.), the Alzheimer's Drug Discovery Foundation (ADDF; to T. B.), Telethon Foundation Grant GGP10120 (to L. D.), and Alzheimer's Association Grant NIRG-10-171655 (to L.D.).	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cisse MA, 2008, MOL CELL NEUROSCI, V39, P400, DOI 10.1016/j.mcn.2008.07.013; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Panza F, 2012, IMMUNOTHERAPY-UK, V4, P213, DOI [10.2217/IMT.11.170, 10.2217/imt.11.170]; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Stravalaci M, 2011, BIOSENS BIOELECTRON, V26, P2772, DOI 10.1016/j.bios.2010.10.038; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vincent B, 2001, J BIOL CHEM, V276, P37743; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	34	148	153	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7857	7866		10.1074/jbc.M112.423954	http://dx.doi.org/10.1074/jbc.M112.423954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362282	Green Published, hybrid			2022-12-28	WOS:000316455300039
J	Sulaiman, P; Xu, Y; Fina, ME; Tummala, SR; Ramakrishnan, H; Dhingra, A; Vardi, N				Sulaiman, Pyroja; Xu, Ying; Fina, Marie E.; Tummala, Shanti R.; Ramakrishnan, Hariharasubramanian; Dhingra, Anuradha; Vardi, Noga			Kir2.4 Surface Expression and Basal Current Are Affected by Heterotrimeric G-Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; RECTIFYING POTASSIUM CHANNELS; K+ CHANNEL; BIPOLAR CELLS; PLASMA-MEMBRANE; LIGHT RESPONSE; SUBUNITS; ACTIVATION; ORGANIZATION; TRANSPORT	Kir2.4, a strongly rectifying potassium channel that is localized to neurons and is especially abundant in retina, was fished with yeast two-hybrid screen using a constitutively active G alpha(o1). Here, we wished to determine whether and how G alpha(o) affects this channel. Using transfected HEK 293 cells and retinal tissue, we showed that Kir2.4 interacts with G alpha(o), and this interaction is stronger with the GDP-bound form of G alpha(o). Using two-electrode voltage clamp, we recorded from oocytes that were injected with Kir2.4 mRNA and a combination of G-protein subunit mRNAs. We found that the wild type and the inactive mutant of G alpha(o) reduce the Kir2.4 basal current, whereas the active mutant has little effect. Other pertussis-sensitive G alpha subunits also reduce this current, whereas G alpha(s) increases it. G beta gamma increases the current, whereas m-phosducin, which binds G beta gamma without affecting the state of G alpha, reduces it. We then tested the effect of G-protein subunits on the surface expression of the channel fused to cerulean by imaging the plasma membranes of the oocytes. We found that the surface expression is affected, with effects paralleling those seen with the basal current. This suggests that the observed effects on the current are mainly indirect and are due to surface expression. Similar results were obtained in transfected HEK cells. Moreover, we show that in retinal ON bipolar cells lacking G beta 3, localization of Kir2.4 in the dendritic tips is reduced. We conclude that G beta gamma targets Kir2.4 to the plasma membrane, and G alpha(o) slows this down by binding G beta gamma.	[Sulaiman, Pyroja; Fina, Marie E.; Tummala, Shanti R.; Ramakrishnan, Hariharasubramanian; Dhingra, Anuradha; Vardi, Noga] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Xu, Ying] Jinan Univ, Joint Lab Brain Funct & Hlth, Guangzhou 510632, Guangdong, Peoples R China; [Xu, Ying] Jinan Univ, Univ Hong Kong, Guangzhou 510632, Guangdong, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Jinan University; Jinan University; University of Hong Kong	Vardi, N (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	noga@mail.med.upenn.edu		Tummala, Shanti/0000-0003-2428-6771; Xu, Ying/0000-0002-9987-2057; ramakrishnan, hari/0000-0003-3613-1822	National Institutes of Health [EY11105]; NEI [P30 EY01583]; NATIONAL EYE INSTITUTE [R01EY011105, P30EY001583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY11105 (to N. V.) and NEI P30 EY01583 (Vision Research Core of the University of Pennsylvania).	Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Block BM, 1996, J GEN PHYSIOL, V107, P473, DOI 10.1085/jgp.107.4.473; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Dascal N., 1992, PROTOCOLS MOL NEUROB, P205; de Boer TP, 2010, ACTA PHYSIOL, V199, P243, DOI 10.1111/j.1748-1716.2010.02108.x; Dhingra A, 2004, J NEUROSCI, V24, P5684, DOI 10.1523/JNEUROSCI.0492-04.2004; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dhingra A, 2008, J COMP NEUROL, V510, P484, DOI 10.1002/cne.21807; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Holzapfel HP, 2002, EUR J ENDOCRINOL, V147, P109, DOI 10.1530/eje.0.1470109; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Hughes BA, 2000, AM J PHYSIOL-CELL PH, V279, pC771, DOI 10.1152/ajpcell.2000.279.3.C771; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Ma YP, 2003, J NEUROPHYSIOL, V90, P3479, DOI 10.1152/jn.00426.2003; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PERLMAN I, 1988, J NEUROPHYSIOL, V60, P1322, DOI 10.1152/jn.1988.60.4.1322; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Schram G, 2002, J PHYSIOL-LONDON, V544, P337, DOI 10.1113/jphysiol.2002.026047; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Topert C, 1998, J NEUROSCI, V18, P4096; Vardi N., 2012, ARVO ABSTR 4314 A540; Wang JS, 2011, CRIT REV EUKAR GENE, V21, P303, DOI 10.1615/CritRevEukarGeneExpr.v21.i4.10; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798	40	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7420	7429		10.1074/jbc.M112.412791	http://dx.doi.org/10.1074/jbc.M112.412791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23339194	Green Published, hybrid			2022-12-28	WOS:000316002400060
J	Alasmari, W; Costello, S; Correia, J; Oxenham, SK; Morris, J; Fernandes, L; Ramalho-Santos, J; Kirkman-Brown, J; Michelangeli, F; Publicover, S; Barratt, CLR				Alasmari, Wardah; Costello, Sarah; Correia, Joao; Oxenham, Senga K.; Morris, Jennifer; Fernandes, Leonor; Ramalho-Santos, Joao; Kirkman-Brown, Jackson; Michelangeli, Francesco; Publicover, Stephen; Barratt, Christopher L. R.			Ca2+ Signals Generated by CatSper and Ca2+ Stores Regulate Different Behaviors in Human Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; HUMAN SPERMATOZOA; MOUSE SPERM; ZONA-PELLUCIDA; RYANODINE RECEPTORS; INTRACELLULAR CA2+; S-NITROSYLATION; CALCIUM-ENTRY; NITRIC-OXIDE; K+ CURRENT	[Ca2+](i) signaling regulates sperm motility, enabling switching between functionally different behaviors that the sperm must employ as it ascends the female tract and fertilizes the oocyte. We report that different behaviors in human sperm are recruited according to the Ca2+ signaling pathway used. Activation of CatSper (by raising pH(i) or stimulating with progesterone) caused sustained [Ca2+](i) elevation but did not induce hyperactivation, the whiplash-like behavior required for progression along the oviduct and penetration of the zona pellucida. In contrast, penetration into methylcellulose (mimicking penetration into cervical mucus or cumulus matrix) was enhanced by activation of CatSper. NNC55-0396, which abolishes CatSper currents in human sperm, inhibited this effect. Treatment with 5 mu M thimerosal to mobilize stored Ca2+ caused sustained [Ca2+](i) elevation and induced strong, sustained hyperactivation that was completely insensitive to NNC55-0396. Thimerosal had no effect on penetration into methylcellulose. 4-Aminopyridine, a powerful modulator of sperm motility, both raised pHi and mobilized Ca2+ stored in sperm (and from microsomal membrane preparations). 4-Aminopyridineinduced hyperactivation even in cells suspended in Ca2+-depleted medium and also potentiated penetration into methylcellulose. The latter effect was sensitive to NNC55-039, but induction of hyperactivation was not. We conclude that these two components of the [Ca2+](i) signaling apparatus have strikingly different effects on sperm motility. Furthermore, since stored Ca2+ at the sperm neck can be mobilized by Ca2+-induced Ca2+ release, we propose that CatSper activation can elicit functionally different behaviors according to the sensitivity of the Ca2+ store, which may be regulated by capacitation and NO from the cumulus.	[Alasmari, Wardah; Oxenham, Senga K.; Barratt, Christopher L. R.] Univ Dundee, Ninewells Hosp, Sch Med, Dundee DD1 9SY, Scotland; [Costello, Sarah; Correia, Joao; Morris, Jennifer; Michelangeli, Francesco; Publicover, Stephen] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Kirkman-Brown, Jackson] Univ Birmingham, Sch Med, Reprod Biol & Genet Res Grp, Birmingham B15 2TT, W Midlands, England; [Costello, Sarah; Correia, Joao; Kirkman-Brown, Jackson; Publicover, Stephen] Birmingham Womens Hosp, Ctr Human Reprod Sci, Birmingham B15 2TG, W Midlands, England; [Fernandes, Leonor; Ramalho-Santos, Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3001401 Coimbra, Portugal; [Fernandes, Leonor; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, P-3001401 Coimbra, Portugal; [Alasmari, Wardah] Umm Al Qura Univ, Sch Med, Dept Anat, Mecca, Saudi Arabia	University of Dundee; University of Birmingham; University of Birmingham; Birmingham Women's Hospital; Universidade de Coimbra; Universidade de Coimbra; Umm Al Qura University	Publicover, S (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	s.j.publicover@bham.ac.uk	Kirkman-Brown, Jackson CJC/C-6600-2013; Santos, João/HHZ-5595-2022; Publicover, Steve J/E-7970-2018; Ramalho-Santos, João/F-8641-2012	Kirkman-Brown, Jackson CJC/0000-0003-2833-8970; Ramalho-Santos, João/0000-0002-1172-4018; Barratt, christopher/0000-0003-0062-9979; Correia, Joao/0000-0002-4376-978X	Wellcome Trust [086470]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by Wellcome Trust Grant 086470.	Aitken R J, 2007, Soc Reprod Fertil Suppl, V63, P273; Alasmari W, 2013, HUM REPROD, V28, P866, DOI 10.1093/humrep/des467; Arienti G, 2002, ARCH BIOCHEM BIOPHYS, V402, P255, DOI 10.1016/S0003-9861(02)00090-5; Bedford JM, 1998, BIOL REPROD, V59, P1275, DOI 10.1095/biolreprod59.6.1275; Bedu-Addo K, 2007, DEV BIOL, V302, P324, DOI 10.1016/j.ydbio.2006.09.040; Bedu-Addo K, 2005, MOL HUM REPROD, V11, P683, DOI 10.1093/molehr/gah226; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; Bhaskar A, 2008, Indian J Physiol Pharmacol, V52, P366; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Buffone MG, 2012, MOL REPROD DEV, V79, P4, DOI 10.1002/mrd.21393; Caballero-Campo P, 2006, BIOL REPROD, V74, P760, DOI 10.1095/biolreprod.105.047522; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chiarella P, 2004, J CELL SCI, V117, P4127, DOI 10.1242/jcs.01283; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; DROBNIS EZ, 1988, DEV BIOL, V130, P311, DOI 10.1016/0012-1606(88)90437-X; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; GOBET I, 1995, INT J DEV BIOL, V39, P485; Grimaldi M, 2001, J NEUROSCI, V21, P3135, DOI 10.1523/JNEUROSCI.21-09-03135.2001; Gu Y, 2004, DEV BIOL, V274, P308, DOI 10.1016/j.ydbio.2004.06.025; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; HOWE JR, 1991, J PHYSIOL-LONDON, V433, P183, DOI 10.1113/jphysiol.1991.sp018421; Ivic A, 2002, HUM REPROD, V17, P143, DOI 10.1093/humrep/17.1.143; Jensen MB, 2011, HUM REPROD, V26, P1307, DOI 10.1093/humrep/der059; Kay VJ, 1998, HUM REPROD UPDATE, V4, P776, DOI 10.1093/humupd/4.6.776; Kirkman-Brown JC, 2011, MOL HUM REPROD, V17, P539, DOI 10.1093/molehr/gar043; Kirkman-Brown JC, 2004, BIOCHEM J, V378, P827, DOI 10.1042/BJ20031368; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Lefievre L, 2012, BIOCHEM J, V448, P189, DOI 10.1042/BJ20120339; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Machado-Oliveira G, 2008, DEVELOPMENT, V135, P3677, DOI 10.1242/dev.024521; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; MICHELANGELI F, 1991, BIOCHEM SOC T, V19, pS183, DOI 10.1042/bst019183s; MORTIMER D, 1986, HUM REPROD, V1, P247, DOI 10.1093/oxfordjournals.humrep.a136394; Mortimer ST, 1997, HUM REPROD UPDATE, V3, P403, DOI 10.1093/humupd/3.5.403; Mortimer ST, 2000, J ANDROL, V21, P515; Naaby-Hansen S, 2001, MOL HUM REPROD, V7, P923, DOI 10.1093/molehr/7.10.923; Nash Katherine, 2010, J Vis Exp, DOI 10.3791/1996; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Olsona SD, 2010, B MATH BIOL, V72, P1925, DOI 10.1007/s11538-010-9516-5; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Pessah IN, 2002, FRONT BIOSCI-LANDMRK, V7, pA72, DOI 10.2741/pessah; Pujianto DA, 2010, ENDOCRINOLOGY, V151, P1269, DOI 10.1210/en.2009-0964; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Servin-Vences MR, 2012, REPRODUCTION, V144, P101, DOI 10.1530/REP-11-0268; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SAYERS LG, 1993, BIOCHEM J, V289, P883, DOI 10.1042/bj2890883; STAUSS CR, 1995, BIOL REPROD, V53, P1280, DOI 10.1095/biolreprod53.6.1280; STEPHENS GJ, 1994, J PHYSIOL-LONDON, V477, P187, DOI 10.1113/jphysiol.1994.sp020183; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; SUAREZ SS, 1992, BIOL REPROD, V46, P686, DOI 10.1095/biolreprod46.4.686; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; TANAKA Y, 1994, J BIOL CHEM, V269, P11247; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tomes CN, 1996, MOL REPROD DEV, V43, P196, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;196::AID-MRD9&gt;3.0.CO;2-M; Tovey SC, 1998, EUR J PHARMACOL, V354, P245, DOI 10.1016/S0014-2999(98)00446-4; Trevino CL, 1998, ZYGOTE, V6, P159, DOI 10.1017/S0967199498000094; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	79	112	116	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6248	6258		10.1074/jbc.M112.439356	http://dx.doi.org/10.1074/jbc.M112.439356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23344959	Green Published, hybrid			2022-12-28	WOS:000315820700020
J	Cornelius, F; Kanai, R; Toyoshima, C				Cornelius, Flemming; Kanai, Ryuta; Toyoshima, Chikashi			A Structural View on the Functional Importance of the Sugar Moiety and Steroid Hydroxyls of Cardiotonic Steroids in Binding to Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ADENOSINE-TRIPHOSPHATASE; DISSOCIATION RATE CONSTANTS; HIGH-AFFINITY BINDING; CARDIAC GLYCOSIDE; GASTRIC H,K-ATPASE; RECTAL GLANDS; ION PATHWAY; K+-ATPASE; POTASSIUM; OUABAIN	The Na,K-ATPase is specifically inhibited by cardiotonic steroids (CTSs) like digoxin and is of significant therapeutic value in the treatment of congestive heart failure and arrhythmia. Recently, new interest has arisen in developing Na,K-ATPase inhibitors as anticancer agents. In the present study, we compare the potency and rate of inhibition as well as the reactivation of enzyme activity following inhibition by various cardiac glycosides and their aglycones at different pH values using shark Na, K-ATPase stabilized in the E2MgP(i) or in the E2BeF(x) conformations. The effects of the number and nature of various sugar residues as well as changes in the positions of hydroxyl groups on the beta-side of the steroid core of cardiotonic steroids were investigated by comparing various cardiac glycoside compounds like ouabain, digoxin, digitoxin, and gitoxin with their aglycones. The results confirm our previous hypothesis that CTS binds primarily to the E2-P ground state through an extracellular access channel and that binding of extracellular Na+ ions to K+ binding sites relieved the CTS inhibition. This reactivation depended on the presence or absence of the sugar moiety on the CTS, and a single sugar is enough to impede reactivation. Finally, increasing the number of hydroxyl groups of the steroid was sterically unfavorable and was found to decrease the inhibitory potency and to confer high pH sensitivity, depending on their position on the steroid beta-face. The results are discussed with reference to the recent crystal structures of Na,K-ATPase in the unbound and ouabain-bound states.	[Cornelius, Flemming] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kanai, Ryuta; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Aarhus University; University of Tokyo	Cornelius, F (corresponding author), Univ Aarhus, Dept Biomed, Ole Worms Alle 6, DK-8000 Aarhus C, Denmark.	fc@biophys.au.dk	Cornelius, Flemming/C-1912-2019; Toyoshima, Chikashi/R-4153-2019	Cornelius, Flemming/0000-0003-1566-0020; Toyoshima, Chikashi/0000-0001-9640-0778	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by The Danish Medical Research Foundation and by an FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation (to F. C.); by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by a Strategic Japanese-Danish Cooperative Program Grant from Japan Science and Technology Agency (to C. T.).	AHMED K, 1983, J BIOL CHEM, V258, P8092; AKERA T, 1971, J PHARMACOL EXP THER, V176, P545; BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; BROWN L, 1983, BIOCHEM PHARMACOL, V32, P2767, DOI 10.1016/0006-2952(83)90090-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; DEPOVER A, 1982, N-S ARCH PHARMACOL, V321, P135, DOI 10.1007/BF00518481; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Farr CD, 2002, BIOCHEMISTRY-US, V41, P1137, DOI 10.1021/bi011511g; FENG JN, 1994, BIOCHEMISTRY-US, V33, P4218, DOI 10.1021/bi00180a015; Fiske CH, 1925, J BIOL CHEM, V66, P375; FULLERTON DS, 1979, SCIENCE, V205, P917, DOI 10.1126/science.224455; FULLERTON DS, 1983, CURR TOP MEMBR TRANS, V19, P257; GO K, 1980, ACTA CRYSTALLOGR B, V36, P3034, DOI 10.1107/S0567740880010746; Grell E, 2004, J THERM ANAL CALORIM, V77, P471, DOI 10.1023/B:JTAN.0000038987.75618.33; Grell E, 2001, THERMOCHIM ACTA, V380, P245, DOI 10.1016/S0040-6031(01)00678-5; GRIFFIN JF, 1986, MOL PHARMACOL, V29, P270; HASHIMOTO T, 1986, J MED CHEM, V29, P997, DOI 10.1021/jm00156a017; Kamano Y, 1998, BIOORGAN MED CHEM, V6, P1103, DOI 10.1016/S0968-0896(98)00067-4; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Lingrel JB, 1997, ANN NY ACAD SCI, V834, P194, DOI 10.1111/j.1749-6632.1997.tb52251.x; LINGREL JB, 1991, SOC GEN PHY, V46, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Qiu LY, 2006, J BIOL CHEM, V281, P13533, DOI 10.1074/jbc.M600551200; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Qiu LY, 2003, J BIOL CHEM, V278, P47240, DOI 10.1074/jbc.M308833200; Radkov R, 2007, BIOCHEM BIOPH RES CO, V356, P142, DOI 10.1016/j.bbrc.2007.02.119; REPKE K, 1985, TRENDS PHARMACOL SCI, V6, P275, DOI 10.1016/0165-6147(85)90126-9; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; SKOU JC, 1988, METHOD ENZYMOL, V156, P43; THOMAS R, 1974, J PHARMACOL EXP THER, V191, P219; TOBIN T, 1972, BIOCHEM PHARMACOL, V21, P1553, DOI 10.1016/0006-2952(72)90305-X; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Wang HYL, 2012, EXPERT OPIN THER PAT, V22, P587, DOI 10.1517/13543776.2012.690033; WOODCOCK BG, 1985, TRENDS PHARMACOL SCI, V6, P273, DOI 10.1016/0165-6147(85)90125-7; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YODA A, 1982, MOL PHARMACOL, V22, P700; YODA A, 1978, MOL PHARMACOL, V14, P624; YODA A, 1977, MOL PHARMACOL, V13, P352; YODA A, 1973, MOL PHARMACOL, V9, P766; YODA A, 1973, MOL PHARMACOL, V9, P51; YODA S, 1975, MOL PHARMACOL, V11, P647	56	53	53	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6602	6616		10.1074/jbc.M112.442137	http://dx.doi.org/10.1074/jbc.M112.442137			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23341448	hybrid, Green Published			2022-12-28	WOS:000315820700060
J	Wauquier, F; Philippe, C; Leotoing, L; Mercier, S; Davicco, MJ; Lebecque, P; Guicheux, J; Pilet, P; Miot-Noirault, E; Poitout, V; Alquier, T; Coxam, V; Wittrant, Y				Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Guicheux, Jerome; Pilet, Paul; Miot-Noirault, Elisabeth; Poitout, Vincent; Alquier, Thierry; Coxam, Veronique; Wittrant, Yohann			The Free Fatty Acid Receptor G Protein-coupled Receptor 40 (GPR40) Protects from Bone Loss through Inhibition of Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; PPAR-GAMMA; IN-VIVO; EXPRESSION; CELLS; ACTIVATION; MICE; OSTEOBLASTS; MODULATION; LIGANDS	The mechanisms linking fat intake to bone loss remain unclear. By demonstrating the expression of the free fatty acid receptor G-coupled protein receptor 40 (GPR40) in bone cells, we hypothesized that this receptor may play a role in mediating the effects of fatty acids on bone remodeling. Using micro-CT analysis, we showed that GPR40(-/-) mice exhibit osteoporotic features suggesting a positive role of GPR40 on bone density. In primary cultures of bone marrow, we showed that GW9508, a GRP40 agonist, abolished bone-resorbing cell differentiation. This alteration of the receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast differentiation occurred via the inhibition of the nuclear factor kappa B (NF-kappa B) signaling pathway as demonstrated by decrease in gene reporter activity, inhibitor of kappa B kinase (IKK-/-) activation, inhibitor of kappa B (IkB alpha) phosphorylation, and nuclear factor of activated T cells 1 (NFATc1) expression. The GPR40-dependent effect of GW9508 was confirmed using shRNA interference in osteoclast precursors and GPR40(-/-) primary cell cultures. In addition, in vivo administration of GW9508 counteracted ovariectomy-induced bone loss in wild-type but not GPR40(-/-) mice, enlightening the obligatory role of the GPR40 receptor. Then, in a context of growing prevalence of metabolic and age-related bone disorders, our results demonstrate for the first time in translational approaches that GPR40 is a relevant target for the design of new nutritional and therapeutic strategies to counter bone complications.	[Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Coxam, Veronique; Wittrant, Yohann] Ctr Rech Nutr Humaine Auvergne, Unite Nutr Humaine, Unite Mixte Rech 1019, Inst Natl Rech Agron, F-63009 Clermont Ferrand, France; [Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Miot-Noirault, Elisabeth; Coxam, Veronique; Wittrant, Yohann] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, F-63000 Clermont Ferrand, France; [Wauquier, Fabien; Philippe, Claire; Leotoing, Laurent; Mercier, Sylvie; Davicco, Marie-Jeanne; Lebecque, Patrice; Coxam, Veronique; Wittrant, Yohann] Equipe Alimentat Squelette & Metab, F-44042 Nantes, France; [Guicheux, Jerome] INSERM, UMR S791, Lab Ingn Osteoarticulaire & Dent, F-44042 Nantes, France; [Guicheux, Jerome] Univ Nantes, Pole Rech & Enseignement Super Univ Nantes Angers, Unite Format & Rech Odontol, F-44042 Nantes, France; [Miot-Noirault, Elisabeth] INSERM, UMR 990, F-63000 Clermont Ferrand, France; [Poitout, Vincent; Alquier, Thierry] CRCHUM, Ctr Rech Diabet Montreal, Montreal, PQ H3T 1J4, Canada; [Poitout, Vincent; Alquier, Thierry] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	INRAE; Universite Clermont Auvergne (UCA); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Universite de Montreal	Wittrant, Y (corresponding author), Univ Auvergne, Clermont Univ, CRNH Auvergne, INRA,UNH,UMR 1019, BP 10448, F-63000 Clermont Ferrand, France.	yohann.wittrant@clermont.inra.fr	Alquier, Thierry/Z-1917-2019; Miot-Noirault, Elisabeth/Y-2272-2019; Paul, Pilet/A-3755-2015; guicheux, Jerome/F-7767-2013	Alquier, Thierry/0000-0001-8171-802X; guicheux, Jerome/0000-0003-2754-3024; Poitout, Vincent/0000-0002-6555-5053	Canadian Institutes of Health Research [MOP 177381]; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported in part by the Canadian Institutes of Health Research Grant MOP 177381 (to V. P.).; Supported by a postdoctoral fellowship from the Canadian Diabetes Association.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chan BY, 2007, BONE, V40, P149, DOI 10.1016/j.bone.2006.07.029; Coenen KR, 2009, DIABETOLOGIA, V52, P318, DOI 10.1007/s00125-008-1221-7; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Corwin RL, 2003, PROSTAG LEUKOTR ESS, V68, P379, DOI 10.1016/S0952-3278(03)00062-0; Covington DK, 2006, BIOCHEM SOC T, V34, P770, DOI 10.1042/BST0340770; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Himes RW, 2010, FASEB J, V24, P731, DOI 10.1096/fj.09-141929; Hounoki H, 2008, BONE, V42, P765, DOI 10.1016/j.bone.2007.11.016; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Johnson GB, 2004, FASEB J, V18, P1282, DOI 10.1096/fj.04-1572fje; Kotarsky K, 2003, PHARMACOL TOXICOL, V93, P249, DOI 10.1111/j.1600-0773.2003.pto930601.x; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Mano H, 2000, J BIOL CHEM, V275, P8126, DOI 10.1074/jbc.275.11.8126; Maurin AC, 2005, CALCIFIED TISSUE INT, V76, P385, DOI 10.1007/s00223-004-0108-y; Mieczkowska A, 2012, J BIOL CHEM, V287, P23517, DOI 10.1074/jbc.M111.324814; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oh SR, 2010, J LIPID RES, V51, P892, DOI [10.1194/jlr.M800626-JLR200, 10.1194/jlr.M800626]; Ono K, 2005, J BONE MINER RES, V20, P23, DOI 10.1359/JBMR.041027; RAISZ LG, 1989, PROSTAG OTH LIPID M, V37, P615, DOI 10.1016/0090-6980(89)90076-2; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Still K, 2008, CALCIFIED TISSUE INT, V83, P285, DOI 10.1007/s00223-008-9175-9; Tsutsumi R, 2009, J BONE MINER RES, V24, P1753, DOI [10.1359/JBMR.090412, 10.1359/jbmr.090412]; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wittrant Y, 2008, BONE, V42, P1122, DOI 10.1016/j.bone.2008.02.006	37	64	69	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6542	6551		10.1074/jbc.M112.429084	http://dx.doi.org/10.1074/jbc.M112.429084			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335512	Green Published, hybrid			2022-12-28	WOS:000315820700047
J	Evertts, AG; Zee, BM; DiMaggio, PA; Gonzales-Cope, M; Coller, HA; Garcia, BA				Evertts, Adam G.; Zee, Barry M.; DiMaggio, Peter A.; Gonzales-Cope, Michelle; Coller, Hilary A.; Garcia, Benjamin A.			Quantitative Dynamics of the Link between Cellular Metabolism and Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; METHYLATION; DEACETYLASE; TRANSCRIPTION; EXTRACTION; COMPLEXES; CHROMATIN; TURNOVER; TARGETS; REVEAL	Acetylation on the tails of histones plays an important role in controlling transcription initiation. Although the steady-state abundances of histone acetyl groups have been reported, the rate at which histones are acetylated and deacetylated on a residue-specific basis has not been quantitatively established. We added [C-13]glucose to human cells and monitored the dynamic incorporation of C-13-labeled acetyl groups onto specific histone lysines with quantitative mass spectrometry. We determined the turnover of acetylation to be generally slower than phosphorylation, but fast relative to methylation, and that the rate varied depending on the histone, the residue modified, and also the neighboring modifications. Cells were also treated with a deacetylase inhibitor to determine the rate due to histone acetyltransferase activity alone and in the absence of deacetylase activity. Introduction of C-13-labeled glucose also resulted in the incorporation of C-13 into alanine, which allowed us to partition histones into existing and newly synthesized protein categories. Newly synthesized histones were slower to accumulate histone modifications, especially modifications associated with silent chromatin. Finally, we applied our new approaches to find that quiescent fibroblasts exhibited lower levels of labeled acetyl accumulation compared with proliferating fibroblasts. This suggests that acetylation rates can be modulated in cells in different biological states and that these changes can be detected with the approach presented here. The methods we describe can be broadly applied to defining the turnover of histone acetylation in other cell states such as during cellular reprogramming and to quantify non-histone protein acetylation dynamics.	[Evertts, Adam G.; Zee, Barry M.; Gonzales-Cope, Michelle; Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Zee, Barry M.; Gonzales-Cope, Michelle; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Program, Philadelphia, PA 19104 USA; [DiMaggio, Peter A.] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England	Princeton University; University of Pennsylvania; Pennsylvania Medicine; Imperial College London	Garcia, BA (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Program, Philadelphia, PA 19104 USA.	bgarci@mail.med.upenn.edu		Zee, Barry/0000-0002-3123-8375; DiMaggio, Peter/0000-0003-1996-0813	National Institutes of Health [5T32CA009528, 5T32HG003284, DP2OD007447]; National Science Foundation; NATIONAL CANCER INSTITUTE [T32CA009528] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health Training Grants 5T32CA009528 and 5T32HG003284.; Supported by a National Science Foundation graduate research fellowship.; Supported by a National Science Foundation Early Faculty CAREER award and National Institutes of Health Innovator Grant DP2OD007447. To whom correspondence should be addressed. Tel.: 215-573-9423; Fax: 215-898-4217; E-mail: bgarci@ mail.med.upenn.edu.	ALLFREY VG, 1968, SCIENCE, V159, P314, DOI 10.1126/science.159.3812.314; Aponte AM, 2009, J PROTEOME RES, V8, P2679, DOI 10.1021/pr800913j; Baliban RC, 2010, MOL CELL PROTEOMICS, V9, P764, DOI 10.1074/mcp.M900487-MCP200; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DiMaggio PA, 2009, MOL CELL PROTEOMICS, V8, P2527, DOI 10.1074/mcp.M900144-MCP200; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Dose A, 2011, ACS CHEM BIOL, V6, P419, DOI 10.1021/cb1003866; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Ito T, 2011, CHEM BIOL, V18, P495, DOI 10.1016/j.chembiol.2011.02.009; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Morrish F, 2010, J BIOL CHEM, V285, P36267, DOI 10.1074/jbc.M110.141606; Mosley AL, 2003, J BIOL CHEM, V278, P19660, DOI 10.1074/jbc.M212375200; ODESSEY R, 1974, J BIOL CHEM, V249, P7623; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PERRIELLO G, 1995, AM J PHYSIOL-ENDOC M, V269, pE443, DOI 10.1152/ajpendo.1995.269.3.E443; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simone C, 2004, ONCOGENE, V23, P2177, DOI 10.1038/sj.onc.1207327; Sinha I, 2010, EPIGENOMICS-UK, V2, P377, DOI 10.2217/EPI.10.18; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Waterborg JH, 1998, J BIOL CHEM, V273, P27602, DOI 10.1074/jbc.273.42.27602; Waterborg JH, 2001, BIOCHEMISTRY-US, V40, P2599, DOI 10.1021/bi002480c; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu Y, 2013, J PROTEOME RES, V12, P316, DOI 10.1021/pr300408v; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zee BM, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-22; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; ZHANG DE, 1988, BIOCHEM J, V250, P233, DOI 10.1042/bj2500233	49	76	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12142	12151		10.1074/jbc.M112.428318	http://dx.doi.org/10.1074/jbc.M112.428318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482559	hybrid, Green Published			2022-12-28	WOS:000318157600046
J	Chiba, Y; Horita, S; Ohtsuka, J; Arai, H; Nagata, K; Igarashi, Y; Tanokura, M; Ishii, M				Chiba, Yoko; Horita, Shoichiro; Ohtsuka, Jun; Arai, Hiroyuki; Nagata, Koji; Igarashi, Yasuo; Tanokura, Masaru; Ishii, Masaharu			Structural Units Important for Activity of a Novel-type Phosphoserine Phosphatase from Hydrogenobacter thermophilus TK-6 Revealed by Crystal Structure Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHOGLYCERATE MUTASE; BROAD-SPECIFICITY PHOSPHATASE; BACILLUS-STEAROTHERMOPHILUS; SWISS-MODEL; FUNCTIONAL-ANALYSIS; PROTEIN; SUPERFAMILY; MECHANISM; HOMOLOG; ENVIRONMENT	Novel-type serine-synthesizing enzymes, termed metal-independent phosphoserine phosphatases (iPSPs), were recently identified and characterized from Hydrogenobacter thermophilus, a chemolithoautotrophic bacterium belonging to the order Aquificales. iPSPs are cofactor-dependent phosphoglycerate mutase (dPGM)-like phosphatases that have significant amino acid sequence similarity to dPGMs but lack phosphoglycerate mutase activity. Genes coding dPGM-like phosphatases have been identified in a broad range of organisms; however, predicting the function of the corresponding proteins based on sequence information alone is difficult due to their diverse substrate preferences. Here, we determined the crystal structure of iPSP1 from H. thermophilus in the apo-form and in complex with its substrate L-phosphoserine to find structural units important for its phosphatase activity toward L-phosphoserine. Structural and biochemical characterization of iPSP1 revealed that the side chains of His(85) and C-terminal region characteristic of iPSP1 are responsible for the PSP activity. The importance of these structural units for PSP activity was confirmed by high PSP activity observed in two novel dPGM-like proteins from Cyanobacteria and Chloroflexus in which the two structural units were conserved. We anticipate that our present findings will facilitate understanding of the serine biosynthesis pathways of organisms that lack gene(s) encoding conventional PSPs, as the structural information revealed here will help to identify iPSP from sequence databases.	[Chiba, Yoko; Arai, Hiroyuki; Igarashi, Yasuo; Ishii, Masaharu] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Horita, Shoichiro; Ohtsuka, Jun; Nagata, Koji; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ishii, M (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amishii@mail.ecc.u-tokyo.ac.jp		Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480; Chiba, Yoko/0000-0002-2734-0836	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Platform for Drug Discovery, Informatics and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [21248010]; Japan Society for the Promotion of Science Fellows [23-3030]; Grants-in-Aid for Scientific Research [11J03030] Funding Source: KAKEN	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Platform for Drug Discovery, Informatics and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Masahiko Ikeuchi (University of Tokyo), Shin Haruta, Katsumi Matsuura, and Hiromi Fukushima (Tokyo Metropolitan University) for providing T. elongatus and R. castenholzii cells. Homology modeling was supported by Tohru Terada and Kentaro Shimizu (University of Tokyo). We also thank Masafumi Kameya (Toyama Prefectural University) for frequent and fruitful discussions. The synchrotron radiation experiments were performed at beamline BL- 32XU at SPring- 8 (Hyogo, Japan) with the approval of the Targeted Proteins Research Program Office at RIKEN/SPring-8 and at beamline NE3A at Photon Factory-Advanced Ring (Ibaraki, Japan) under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2008S2-001).; This work was supported in part by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Platform for Drug Discovery, Informatics and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-aid for Scientific Research (A) 21248010 from the Japan Society for the Promotion of Science, and Grant-in-aid for Japan Society for the Promotion of Science Fellows 23-3030.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bond CS, 2001, J BIOL CHEM, V276, P3247, DOI 10.1074/jbc.M007318200; Bourgis F, 2005, J EXP BOT, V56, P1129, DOI 10.1093/jxb/eri105; Chiba Y, 2012, ACTA CRYSTALLOGR F, V68, P911, DOI 10.1107/S1744309112025213; Chiba Y, 2012, J BIOL CHEM, V287, P11934, DOI 10.1074/jbc.M111.330621; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Colman B, 1997, PHYSIOL PLANTARUM, V100, P133, DOI 10.1034/j.1399-3054.1997.1000114.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamada K, 2005, GENES CELLS, V10, P1, DOI 10.1111/j.1365-2443.2005.00817.x; Hills T, 2011, MOL BIOCHEM PARASIT, V179, P69, DOI 10.1016/j.molbiopara.2011.06.001; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAWASUMI T, 1984, INT J SYST BACTERIOL, V34, P5, DOI 10.1099/00207713-34-1-5; KAWASUMI T, 1980, AGR BIOL CHEM TOKYO, V44, P1985, DOI 10.1080/00021369.1980.10864255; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Parkinson G, 1996, NAT STRUCT BIOL, V3, P837, DOI 10.1038/nsb1096-837; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 2002, J MOL BIOL, V315, P1129, DOI 10.1006/jmbi.2001.5290; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; Rigden DJ, 1999, J MOL BIOL, V286, P1507, DOI 10.1006/jmbi.1999.2566; SASAKI R, 1966, ARCH BIOCHEM BIOPHYS, V115, P53, DOI 10.1016/S0003-9861(66)81037-8; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smiechowski M, 2010, CHEM PHYS LETT, V501, P123, DOI 10.1016/j.cplett.2010.10.063; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Walter RA, 1999, BIOCHEM J, V337, P89, DOI 10.1042/0264-6021:3370089; Watkins HA, 2006, J BACTERIOL, V188, P3589, DOI 10.1128/JB.188.10.3589-3599.2006; WHITE MF, 1992, EUR J BIOCHEM, V207, P709, DOI 10.1111/j.1432-1033.1992.tb17099.x; Zachariou M, 1996, J PHYS CHEM-US, V100, P12680, DOI 10.1021/jp9601476	35	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11448	11458		10.1074/jbc.M112.449561	http://dx.doi.org/10.1074/jbc.M112.449561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479726	Green Published, hybrid			2022-12-28	WOS:000317915500046
J	Dehennaut, V; Loison, I; Dubuissez, M; Nassour, J; Abbadie, C; Leprince, D				Dehennaut, Vanessa; Loison, Ingrid; Dubuissez, Marion; Nassour, Joe; Abbadie, Corinne; Leprince, Dominique			DNA Double-strand Breaks Lead to Activation of Hypermethylated in Cancer 1 (HIC1) by SUMOylation to Regulate DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; IIA HISTONE DEACETYLASES; KAPPA-B ACTIVATION; GENOTOXIC STRESS; DAMAGE RESPONSE; TRANSCRIPTIONAL REPRESSION; TARGET GENES; SUMO; PATHWAY; CELLS	HIC1 (hypermethylated in cancer 1) is a tumor suppressor gene frequently epigenetically silenced in human cancers. HIC1 encodes a transcriptional repressor involved in the regulation of growth control and DNA damage response. We previously demonstrated that HIC1 can be either acetylated or SUMOylated on lysine 314. This deacetylation/SUMOylation switch is governed by an unusual complex made up of SIRT1 and HDAC4 which deacetylates and thereby favors SUMOylation of HIC1 by a mechanism not yet fully deciphered. This switch regulates the interaction of HIC1 with MTA1, a component of the NuRD complex and potentiates the repressor activity of HIC1. Here, we show that HIC1 silencing in human fibroblasts impacts the repair of DNA double-strand breaks whereas ectopic expression of wild-type HIC1, but not of nonsumoylatable mutants, leads to a reduced number of gamma H2AX foci induced by etoposide treatment. In this way, we demonstrate that DNA damage leads to (i) an enhanced HDAC4/Ubc9 interaction, (ii) the activation of SIRT1 by SUMOylation (Lys-734), and (iii) the SUMO-dependent recruitment of HDAC4 by SIRT1 which permits the deacetylation/SUMOylation switch of HIC1. Finally, we show that this increase of HIC1 SUMOylation favors the HIC1/MTA1 interaction, thus demonstrating that HIC1 regulates DNA repair in a SUMO-dependent way. Therefore, epigenetic HIC1 inactivation, which is an early step in tumorigenesis, could contribute to the accumulation of DNA mutations through impaired DNA repair and thus favor tumorigenesis.	[Dehennaut, Vanessa; Loison, Ingrid; Dubuissez, Marion; Nassour, Joe; Abbadie, Corinne; Leprince, Dominique] Univ Lille Nord France, CNRS UMR 8161, Inst Biol Lille, Inst Pasteur Lille,IFR 142, F-59017 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Leprince, D (corresponding author), Univ Lille Nord France, CNRS UMR 8161, Inst Biol Lille, Inst Pasteur Lille,IFR 142, 1 Rue Calmette,BP447, F-59017 Lille, France.	dominique.leprince@ibl.fr	dehennaut, vanessa/I-7435-2018; ABBADIE, Corinne/F-4949-2018	dehennaut, vanessa/0000-0001-6421-0793; ABBADIE, Corinne/0000-0002-8174-2393; Leprince, Dominique/0000-0002-1999-0775	CNRS; "Association pour la Recherche sur le Cancer" (ARC); "Ligue Nationale Contre le Cancer," Comite du Pas de Calais; Association pour la Recherche sur le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); "Association pour la Recherche sur le Cancer" (ARC)(Fondation ARC pour la Recherche sur le Cancer); "Ligue Nationale Contre le Cancer," Comite du Pas de Calais; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the CNRS, the "Association pour la Recherche sur le Cancer" (ARC), and the "Ligue Nationale Contre le Cancer," Comite du Pas de Calais.; Recipient of a postdoctoral fellowship from the Association pour la Recherche sur le Cancer.	Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Boulay G, 2012, J BIOL CHEM, V287, P10509, DOI 10.1074/jbc.M111.320234; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Britschgi C, 2006, ONCOGENE, V25, P2030, DOI 10.1038/sj.onc.1209240; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dehennaut V, 2009, B CANCER, V96, pE66, DOI 10.1684/bdc.2009.0959; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Lee FY, 2011, DEV CELL, V21, P315, DOI 10.1016/j.devcel.2011.06.028; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stankovic-Valentin N, 2006, FEBS J, V273, P2879, DOI 10.1111/j.1742-4658.2006.05301.x; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Xu XA, 2010, J BIOL CHEM, V285, P18139, DOI 10.1074/jbc.C110.131599; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	46	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10254	10264		10.1074/jbc.M112.421610	http://dx.doi.org/10.1074/jbc.M112.421610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23417673	hybrid, Green Published			2022-12-28	WOS:000317565000007
J	Jiang, YL; Lin, AHY; Xia, Y; Lee, S; Paudel, O; Sun, H; Yang, XR; Ran, PX; Sham, JSK				Jiang, Yong-Liang; Lin, Amanda H. Y.; Xia, Yang; Lee, Suengwon; Paudel, Omkar; Sun, Hui; Yang, Xiao-Ru; Ran, Pixin; Sham, James S. K.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Activates Global and Heterogeneous Local Ca2+ Signals from NAADP- and Ryanodine Receptor-gated Ca2+ Stores in Pulmonary Arterial Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE; INOSITOL TRISPHOSPHATE; MOBILIZES CALCIUM; 2-PORE CHANNELS; RELEASE CHANNEL; CHRONIC HYPOXIA; SENSITIVE CA2+; TRIGGER ZONE; LYSOSOMES; SPARKS	Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent Ca2+-mobilizing messenger that releases Ca2+ from endolysosomal organelles. Recent studies showed that NAADP-induced Ca2+ release is mediated by the two-pore channels (TPCs) TPC1 and TPC2. However, the expression of TPCs and the NAADP-induced local Ca2+ signals have not been examined in vascular smooth muscle. Here, we found that both TPC1 and TPC2 are expressed in rat pulmonary arterial smooth muscle cells (PASMCs), with TPC1 being the major subtype. Application of membrane-permeant NAADP acetoxymethyl ester to PASMCs elicited a biphasic increase in global [Ca2+](i), which was independent of extracellular Ca2+ and blocked by the NAADP antagonist Ned-19 or the vacuolar H+-ATPase inhibitor bafilomycin A1, indicating Ca2+ release from acidic endolysosomal Ca2+ stores. The Ca2+ response was unaffected by xestospongin C but was partially blocked by ryanodine or thapsigargin. NAADP triggered heterogeneous local Ca2+ signals, including a diffuse increase in cytosolic [Ca2+], Ca2+ sparks, Ca2+ bursts, and regenerative Ca2+ release. The diffuse Ca2+ increase and Ca(2+)bursts were ryanodine-insensitive, presumably arising from different endolysosomal sources. Ca2+ sparks and regenerative Ca2+ release were inhibited by ryanodine, consistent with cross-activation of loosely coupled ryanodine receptors. Moreover, Ca2+ release stimulated by endothelin-1 was inhibited by Ned-19, ryanodine, or xestospongin C, suggesting that NAADP-mediated Ca2+ signals interact with both ryanodine and inositol 1,4,5-trisphosphate receptors during agonist stimulation. Our results show that NAADP mediates complex global and local Ca2+ signals. Depending on the physiological stimuli, these diverse Ca2+ signals may serve to regulate different cellular functions in PASMCs.	[Jiang, Yong-Liang; Lin, Amanda H. Y.; Xia, Yang; Lee, Suengwon; Paudel, Omkar; Sun, Hui; Yang, Xiao-Ru; Sham, James S. K.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21224 USA; [Jiang, Yong-Liang; Ran, Pixin] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China	Johns Hopkins University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Ran, PX (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.	pxran@gzhmc.edu.cn; jsks@jhmi.edu	Lin, Amanda/C-6964-2014	Xia, Yang/0000-0003-2487-2244; Sham, James/0000-0002-3571-8712	National Institutes of Health [R01 HL071835, R01 HL075134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071835, R01HL075134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL071835 and R01 HL075134 (to J. S. K. S.).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Collins TP, 2011, CELL CALCIUM, V50, P449, DOI 10.1016/j.ceca.2011.07.007; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Esposito B, 2011, BLOOD, V117, P4968, DOI 10.1182/blood-2010-02-266338; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Lipp P, 2002, J PHYSIOL-LONDON, V542, P383, DOI 10.1113/jphysiol.2001.013382; Lipp P, 1996, J PHYSIOL-LONDON, V492, P31, DOI 10.1113/jphysiol.1996.sp021286; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Lopez Sanjurjo C. I., 2013, J CELL SCI IN PRESS; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Narayanan D, 2012, AM J PHYSIOL-HEART C, V302, pH2190, DOI 10.1152/ajpheart.01146.2011; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Remillard CV, 2002, AM J PHYSIOL-LUNG C, V283, pL433, DOI 10.1152/ajplung.00468.2001; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Rybalchenko V, 2012, J BIOL CHEM, V287, P20407, DOI 10.1074/jbc.M112.359612; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; SHAM JSK, 1995, P NATL ACAD SCI USA, V92, P121, DOI 10.1073/pnas.92.1.121; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF510, DOI 10.1152/ajprenal.00116.2009; TINKER A, 1992, J GEN PHYSIOL, V100, P479, DOI 10.1085/jgp.100.3.479; Umesh A, 2006, J BIOL CHEM, V281, P34312, DOI 10.1074/jbc.M606765200; Umesh A, 2011, J VASC RES, V48, P525, DOI 10.1159/000329593; Wang SQ, 2004, P NATL ACAD SCI USA, V101, P3979, DOI 10.1073/pnas.0306157101; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; YANAI K, 1992, N-S ARCH PHARMACOL, V346, P51, DOI 10.1007/BF00167570; Yang XR, 2005, AM J PHYSIOL-LUNG C, V289, pL338, DOI 10.1152/ajplung.00328.2004; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yusufi ANK, 2002, EXP BIOL MED, V227, P36, DOI 10.1177/153537020222700107; Yusufi ANK, 2001, BIOCHEM J, V353, P531, DOI 10.1042/0264-6021:3530531; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zhang WM, 2004, J CARDIOVASC PHARM, V44, pS121, DOI 10.1097/01.fjc.0000166226.03712.4f; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	62	25	26	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10381	10394		10.1074/jbc.M112.423053	http://dx.doi.org/10.1074/jbc.M112.423053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443655	Green Published, hybrid			2022-12-28	WOS:000317565000019
J	Stutzer, I; Selevsek, N; Esterhazy, D; Schmidt, A; Aebersold, R; Stoffel, M				Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Schmidt, Alexander; Aebersold, Ruedi; Stoffel, Markus			Systematic Proteomic Analysis Identifies beta-Site Amyloid Precursor Protein Cleaving Enzyme 2 and 1 (BACE2 and BACE1) Substrates in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSOLUTE QUANTIFICATION; STATISTICAL-MODEL; IGF-II; INSULIN; GLUCOSE; EXPRESSION; SECRETASE; MEMBRANE; EXOCYTOSIS; RECEPTORS	Expansion of functional islet beta-cell mass is a physiological process to compensate for increased insulin demand. Deficiency or pharmacological inhibition of the plasma membrane protease BACE2 enhances pancreatic beta-cell function and proliferation, and therefore BACE2 is a putative target for the therapeutic intervention under conditions of beta-cell loss and dysfunction. To gain a molecular understanding of BACE2 function, we performed a systematic and quantitative proteomic analysis to map the natural substrate repertoire of BACE2 and its homologue BACE1 in beta-cells. Loss-and gain-of-function studies of in vitro and in vivo models identified specific and functionally heterogeneous targets. Our analysis revealed non-redundant roles of BACE1/2 in ectodomain shedding with BACE1 regulating a broader and BACE2 a more distinct set of beta-cell-enriched substrates including two proteins of the seizure 6 protein family (SEZ6L and SEZ6L2). Lastly, our study provides insights into the global beta-cell sheddome and secretome, an important prerequisite to uncover novel mechanisms contributing to beta-cell homeostasis and a resource for therapeutic target and biomarker discoveries.	[Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Stuetzer, Ina; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, CH-4056 Basel, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Stoffel, Markus] Univ Zurich, Fac Med, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Zurich; University of Geneva; University of Zurich	Stoffel, M (corresponding author), ETH, Inst Mol Hlth Sci, HPL H36,Schafmattstr 22, CH-8093 Zurich, Switzerland.	stoffel@biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817	Juvenile Diabetes Research Foundation; EU [CEED3]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); EU(European Commission)	This work was funded in part by a grant from the Juvenile Diabetes Research Foundation and EU Grant CEED3.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Arribas J, 2003, CURR TOP DEV BIOL, V54, P125, DOI 10.1016/S0070-2153(03)54007-8; Beraud-Dufour S, 2010, INT J BIOCHEM CELL B, V42, P1681, DOI 10.1016/j.biocel.2010.06.018; Blanton D, 2011, DIABETES, V60, P2566, DOI 10.2337/db11-0576; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Butler GS, 2007, CURR PHARM DESIGN, V13, P263, DOI 10.2174/138161207779313524; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chang CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014662; Danzer C, 2012, J PROTEOME RES, V11, P1598, DOI 10.1021/pr2007895; DOLAISKITABGI J, 1979, ENDOCRINOLOGY, V105, P256, DOI 10.1210/endo-105-1-256; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Dowling P, 2008, ELECTROPHORESIS, V29, P4141, DOI 10.1002/elps.200800152; Eberhard D, 2009, CURR OPIN GENET DEV, V19, P469, DOI 10.1016/j.gde.2009.07.003; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Figueroa DJ, 2001, J ALZHEIMERS DIS, V3, P393, DOI 10.3233/JAD-2001-3405; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; Hald J, 2012, DIABETOLOGIA, V55, P154, DOI 10.1007/s00125-011-2295-1; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hill DJ, 1998, DIABETES CARE, V21, pB60; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussain I, 2001, J BIOL CHEM, V276, P23322, DOI 10.1074/jbc.M101069200; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Schiess R, 2009, MOL CELL PROTEOMICS, V8, P624, DOI 10.1074/mcp.M800172-MCP200; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selevsek N, 2011, PROTEOMICS, V11, P1135, DOI 10.1002/pmic.201000599; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Stutzer I, 2012, DIABETOLOGIA, V55, P1877, DOI 10.1007/s00125-012-2531-3; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Whim MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019478; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zaina S, 1998, J BIOL CHEM, V273, P28610, DOI 10.1074/jbc.273.44.28610; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	59	63	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10536	10547		10.1074/jbc.M112.444703	http://dx.doi.org/10.1074/jbc.M112.444703			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430253	Green Published, hybrid			2022-12-28	WOS:000317565000033
J	Wei-LaPierre, L; Gong, GH; Gerstner, BJ; Ducreux, S; Yule, DI; Pouvreau, S; Wang, XH; Sheu, SS; Cheng, HP; Dirksen, RT; Wang, W				Wei-LaPierre, Lan; Gong, Guohua; Gerstner, Brent J.; Ducreux, Sylvie; Yule, David I.; Pouvreau, Sandrine; Wang, Xianhua; Sheu, Shey-Shing; Cheng, Heping; Dirksen, Robert T.; Wang, Wang			Respective Contribution of Mitochondrial Superoxide and pH to Mitochondria-targeted Circularly Permuted Yellow Fluorescent Protein (mt-cpYFP) Flash Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; RELEASE; PROBE	Superoxide flashes are transient bursts of superoxide production within the mitochondrial matrix that are detected using the superoxide-sensitive biosensor, mitochondria-targeted circularly permuted YFP (mt-cpYFP). However, due to the pH sensitivity of mt-cpYFP, flashes were suggested to reflect transient events of mitochondrial alkalinization. Here, we simultaneously monitored flashes with mt-cpYFP and mitochondrial pH with carboxy-SNARF-1. In intact cardiac myocytes and purified skeletal muscle mitochondria, robust mt-cpYFP flashes were accompanied by only a modest increase in SNARF-1 ratio (corresponding to a pH increase of <0.1), indicating that matrix alkalinization is minimal during an mt-cpYFP flash. Individual flashes were also accompanied by stepwise increases of MitoSOX signal and decreases of NADH autofluorescence, supporting the superoxide origin of mt-cpYFP flashes. Transient matrix alkalinization induced by NH4Cl only minimally influenced flash frequency and failed to alter flash amplitude. How-ever, matrix acidification modulated superoxide flash frequency in a bimodal manner. Low concentrations of nigericin (< 100 nM) that resulted in a mild dissipation of the mitochondrial pH gradient increased flash frequency, whereas a maximal concentration of nigericin (5 mu M) collapsed the pH gradient and abolished flash activity. These results indicate that mt-cpYFP flash events reflect a burst in electron transport chain-dependent superoxide production that is coincident with a modest increase in matrix pH. Furthermore, flash activity depends strongly on a combination of mitochondrial oxidation and pH gradient.	[Wei-LaPierre, Lan; Gerstner, Brent J.; Yule, David I.; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Gong, Guohua; Wang, Wang] Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98109 USA; [Ducreux, Sylvie; Pouvreau, Sandrine] Univ Lyon 1, CNRS, UMR 5123, F-69622 Villeurbanne, France; [Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Sheu, Shey-Shing] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Jefferson Med Coll, Philadelphia, PA 19107 USA	University of Rochester; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Peking University; Jefferson University	Dirksen, RT (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Robert_Dirksen@URMC.rochester.edu; wangwang@u.washington.edu	DUCREUX, SYLVIE/D-6257-2013; wang, wang/GWQ-7272-2022; Pouvreau, Sandrine/AFV-8178-2022; Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011; Sheu, Shey-Shing/Y-4009-2019	DUCREUX, SYLVIE/0000-0003-3207-9537; Heping, Cheng/0000-0002-9604-6702; Sheu, Shey-Shing/0000-0003-3838-3601; Wang, Wang/0000-0001-9093-412X	National Institutes of Health [AR44657, HL114760, HL093671]; American Heart Association; Universite Lyon 1; CNRS; Academia Dei Lincea Fund; National Basic Research Program of China [2013CB531201, 2011CB809102]; National Science Foundation of China [31221002, 31130067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110349, R01HL093671, R01HL114760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044657, R01AR044657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Universite Lyon 1; CNRS(Centre National de la Recherche Scientifique (CNRS)); Academia Dei Lincea Fund; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR44657 (to R. T. D.), HL114760 (to W. W.), and HL093671 (to S. S. S.). This work was also supported by a Scientist Development Grant from the American Heart Association (to W. W.) and grants from the Universite Lyon 1 and the CNRS (to S. P.), the Academia Dei Lincea Fund (to L. W. L.), and National Basic Research Program of China 2013CB531201 and 2011CB809102 and the National Science Foundation of China 31221002, 31130067 (to H. C).	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Azarias G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028505; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Hou TT, 2013, J BIOL CHEM, V288, P4602, DOI [10.1074/jbc.M113.527770, 10.1074/jbc.M112.398297]; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; Huang ZL, 2011, FREE RADICAL BIO MED, V51, P1937, DOI 10.1016/j.freeradbiomed.2011.08.024; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Lambert AJ, 2010, AGING CELL, V9, P78, DOI 10.1111/j.1474-9726.2009.00538.x; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Life Technologies Corp, 2013, MOL PROB HDB; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Quatresous E, 2012, J GEN PHYSIOL, V140, P567, DOI 10.1085/jgp.201210863; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Santo-Domingo J, 2011, J GEN PHYSIOL, V138, p16A; Schwarzlander M, 2012, TRENDS CELL BIOL, V22, P503, DOI 10.1016/j.tcb.2012.07.007; Schwarzlander M, 2012, PLANT CELL, V24, P1188, DOI 10.1105/tpc.112.096438; Schwarzlander M, 2011, BIOCHEM J, V437, P381, DOI 10.1042/BJ20110883; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Skolnick RL, 1998, AM J PHYSIOL-HEART C, V275, pH1788, DOI 10.1152/ajpheart.1998.275.5.H1788; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wei L, 2012, J GEN PHYSIOL, V139, P425, DOI 10.1085/jgp.201210790; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	31	59	62	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10567	10577		10.1074/jbc.M113.455709	http://dx.doi.org/10.1074/jbc.M113.455709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457298	hybrid, Green Published			2022-12-28	WOS:000317565000036
J	Zmrzljak, UP; Korencic, A; Kosir, R; Golicnik, M; Sassone-Corsi, P; Rozman, D				Zmrzljak, Ursula Prosenc; Korencic, Anja; Kosir, Rok; Golicnik, Marko; Sassone-Corsi, Paolo; Rozman, Damjana			Inducible cAMP Early Repressor Regulates the Period 1 Gene of the Hepatic and Adrenal Clocks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN TRANSCRIPTION; ICER; CREM; EXPRESSION; MOUSE; BRAIN; TIME; GLUCOCORTICOIDS; CRYPTOCHROME; MECHANISMS	Light, restricted feeding, and hormonal inputs may operate as time givers (zeitgebers) for the circadian clock within peripheral organs through the activation of tissue-specific signaling cascades. cAMP signaling through CREM (cAMP-responsive element modulator) and its variant ICER (inducible cAMP early repressor) is linked to the circadian regulation of pineal melatonin synthesis, although little is known about its influence in other organs. We performed experiments in the absence of light and feeding-time cues to test which core clock genes are controlled by CREM/ICER in the liver and adrenal gland. In vivo, Crem loss-of-function mutation resulted in fine-tuning of all measured adrenal clock genes (Per1/2/3, Cry1/2, Bmal1, and Rev-erb alpha), whereas only Per1 and Cry1 were affected in the liver. Icer expression was circadian in the adrenal gland, with peak gene expression at zeitgeber 12 and the highest protein levels at zeitgeber similar to 20. The expression of both Icer and Per1 genes responded to cAMP stimuli in an immediate-early fashion. In immortal cells, forskolin induced expression of Per1 after 2 h, and de novo protein synthesis led to Per1 attenuation. We show that the de novo synthesized protein responsible for Per1 attenuation is ICER. Indeed, Per1 expression is up-regulated in cells ectopically expressing antisense Icer, and mobility shift experiments identified ICER binding to cAMP-responsive elements of the Per1 promoter. We propose that ICER acts as a noise filter for different signals that could affect transcription in the adrenal gland. Because ICER is an immediate-early repressor, the circadian nature of adrenal Icer expression could serve a role in a time-dependent gating mechanism.	[Zmrzljak, Ursula Prosenc; Korencic, Anja; Kosir, Rok; Golicnik, Marko; Rozman, Damjana] Univ Ljubljana, Ctr Funct Genom & Biochips, Inst Biochem, Fac Med, SI-1000 Ljubljana, Slovenia; [Zmrzljak, Ursula Prosenc] Inst Oncol, Dept Lab Diagnost, SI-1000 Ljubljana, Slovenia; [Kosir, Rok] DiaGenomi Ltd, Ljubljana 1000, Slovenia; [Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92606 USA	University of Ljubljana; Institute of Oncology - Slovenia; University of California System; University of California Irvine	Rozman, D (corresponding author), Univ Ljubljana, Ctr Funct Genom & Biochips, Inst Biochem, Fac Med, Zaloska 4, SI-1000 Ljubljana, Slovenia.	damjana.rozman@mf.uni-lj.si	Kosir, Rok/AAT-2901-2020	Kosir, Rok/0000-0002-1197-9627; Prosenc Zmrzljak, Ursula/0000-0002-9034-790X; Rozman, Damjana/0000-0002-6501-2163	Slovenian Research Agency [P1-0104]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Program Grant P1-0104.	Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Bureau C, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-430, 10.3201/eid1508.080772]; Christ E, 2010, NEUROSCIENCE, V171, P398, DOI 10.1016/j.neuroscience.2010.09.009; Fink M, 2008, ACTA CHIM SLOV, V55, P85; Folco EJ, 1997, BIOCHEM J, V328, P37; Foulkes NS, 1997, BIOL CELL, V89, P487, DOI 10.1016/S0248-4900(98)80004-X; Ho AK, 2007, ENDOCRINOLOGY, V148, P743, DOI 10.1210/en.2006-1154; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kell CA, 2004, J COMP NEUROL, V478, P379, DOI 10.1002/cne.20290; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kovach SJ, 2006, J CELL PHYSIOL, V206, P411, DOI 10.1002/jcp.20474; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Maronde E, 1999, J NEUROSCI, V19, P3326; MELLSTROM B, 1993, NEURON, V10, P655, DOI 10.1016/0896-6273(93)90167-P; Memin E, 2011, EXP CELL RES, V317, P2490, DOI 10.1016/j.yexcr.2011.07.001; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; OKAMURA H, 2007, COLD SPRING HARB SYM, V72, P551; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pfeffer M, 2000, J PINEAL RES, V29, P24, DOI 10.1034/j.1600-079X.2000.290104.x; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schwartz WJ, 2005, NEUROSCI LETT, V385, P87, DOI 10.1016/j.neulet.2005.05.018; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Spencer CM, 2005, J NEUROSCI RES, V82, P273, DOI 10.1002/jnr.20617; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zmrzljak UP, 2012, CHEM RES TOXICOL, V25, P811, DOI 10.1021/tx200538r; Zwermann O, 2007, HORM METAB RES, V39, P560, DOI 10.1055/s-2007-985141	42	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10318	10327		10.1074/jbc.M112.445692	http://dx.doi.org/10.1074/jbc.M112.445692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443664	Green Published, hybrid			2022-12-28	WOS:000317565000013
J	Copits, BA; Swanson, GT				Copits, Bryan A.; Swanson, Geoffrey T.			Kainate Receptor Post-translational Modifications Differentially Regulate Association with 4.1N to Control Activity-dependent Receptor Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE PROTEIN 4.1; AMPA RECEPTOR; GLUTAMATE RECEPTORS; FUNCTIONAL-CHARACTERIZATION; SURFACE EXPRESSION; TRAFFICKING; PHOSPHORYLATION; SUMOYLATION; DOMAIN; PALMITOYLATION	Kainate receptors exhibit a highly compartmentalized distribution within the brain; however, the molecular and cellular mechanisms that coordinate their expression at neuronal sites of action are poorly characterized. Here we report that the GluK1 and GluK2 kainate receptor subunits interact with the spectrin-actin binding scaffolding protein 4.1N through a membrane-proximal domain in the C-terminal tail. We found that this interaction is important for the forward trafficking of GluK2a receptors, their distribution in the neuronal plasma membrane, and regulation of receptor endocytosis. The association between GluK2a receptors and 4.1N was regulated by both palmitoylation and protein kinase C (PKC) phosphorylation of the receptor subunit. Palmitoylation of the GluK2a subunit promoted 4.1N association, and palmitoylation-deficient receptors exhibited reduced neuronal surface expression and compromised endocytosis. Conversely, PKC activation decreased 4.1N interaction with GluK2/3-containing kainate receptors in acute brain slices, an effect that was reversed after inhibition of PKC. Our data and previous studies therefore demonstrate that these two post-translational modifications have opposing effects on 4.1N association with GluK2 kainate and GluA1 AMPA receptors. The convergence of the signaling pathways regulating 4.1N protein association could thus result in the selective removal of AMPA receptors from the plasma membrane while simultaneously promoting the insertion and stabilization of kainate receptors, which may be important for tuning neuronal excitability and synaptic plasticity.	[Copits, Bryan A.; Swanson, Geoffrey T.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Swanson, GT (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA.	gtswanson@northwestern.edu			National Institutes of Health, NINDS [R01 NS071952]; National Institutes of Health, NCI [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071952] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS071952 (to G. T. S.).; We thank Dr. William Marszalec (Northwestern University Feinberg School of Medicine, Chicago, IL) for preparation of the cultured hippocampal neurons used in these studies. Imaging was performed at the Northwestern University Cell Imaging Facility and was partially subsidized by National Institutes of Health, NCI, Grant CCSG P30 CA060553 (to the Robert H. Lurie Comprehensive Cancer Center).	An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; Baines AJ, 2009, BLOOD CELL MOL DIS, V42, P211, DOI 10.1016/j.bcmd.2009.01.016; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Coleman SK, 2003, J NEUROSCI, V23, P798; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2012, NAT REV NEUROSCI, V13, P675, DOI 10.1038/nrn3335; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Horresh I, 2010, J NEUROSCI, V30, P2480, DOI 10.1523/JNEUROSCI.5225-09.2010; Huyghe D, 2011, J NEUROSCI, V31, P11645, DOI 10.1523/JNEUROSCI.2206-11.2011; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Mondin M, 2010, J BIOL CHEM, V285, P40060, DOI 10.1074/jbc.M110.140442; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Pinheiro PS, 2013, CEREB CORTEX, V23, P323, DOI 10.1093/cercor/bhs022; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vivithanaporn P, 2007, J NEUROSCI, V27, P10423, DOI 10.1523/JNEUROSCI.2674-07.2007; Wozny C, 2009, J CELL SCI, V122, P735, DOI 10.1242/jcs.037382; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004	55	26	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8952	8965		10.1074/jbc.M112.440719	http://dx.doi.org/10.1074/jbc.M112.440719			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400781	Green Published, hybrid			2022-12-28	WOS:000316862200015
J	Megyeri, M; Harmat, V; Major, B; Vegh, A; Balczer, J; Heja, D; Szilagyi, K; Datz, D; Pal, G; Zavodszky, P; Gal, P; Dobo, J				Megyeri, Marton; Harmat, Veronika; Major, Balazs; Vegh, Adam; Balczer, Julia; Heja, David; Szilagyi, Katalin; Datz, Daniel; Pal, Gabor; Zavodszky, Peter; Gal, Peter; Dobo, Jozsef			Quantitative Characterization of the Activation Steps of Mannan-binding Lectin (MBL)-associated Serine Proteases (MASPs) Points to the Central Role of MASP-1 in the Initiation of the Complement Lectin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION MOLECULES; C1 COMPLEX; CATALYTIC REGION; STRUCTURAL INSIGHT; FACTOR-XII; AUTOACTIVATION; ZYMOGEN; PROTEIN; MECHANISM; REVEALS	Mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, have been thought to autoactivate when MBL/ficolin.MASP complexes bind to pathogens triggering the complement lectin pathway. Autoactivation of MASPs occurs in two steps: 1) zymogen autoactivation, when one proenzyme cleaves another proenzyme molecule of the same protease, and 2) autocatalytic activation, when the activated protease cleaves its own zymogen. Using recombinant catalytic fragments, we demonstrated that a stable proenzyme MASP-1 variant (R448Q) cleaved the inactive, catalytic site Ser-to-Ala variant (S646A). The autoactivation steps of MASP-1 were separately quantified using these mutants and the wild type enzyme. Analogous mutants were made for MASP-2, and rate constants of the autoactivation steps as well as the possible cross-activation steps between MASP-1 and MASP-2 were determined. Based on the rate constants, a kinetic model of lectin pathway activation was outlined. The zymogen autoactivation rate of MASP-1 is similar to 3000-fold higher, and the autocatalytic activation of MASP-1 is about 140-fold faster than those of MASP-2. Moreover, both activated and proenzyme MASP-1 can effectively cleave proenzyme MASP-2. MASP-3, which does not autoactivate, is also cleaved by MASP-1 quite efficiently. The structure of the catalytic region of proenzyme MASP-1 R448Q was solved at 2.5A. Proenzyme MASP-1 R448Q readily cleaves synthetic substrates, and it is inhibited by a specific canonical inhibitor developed against active MASP-1, indicating that zymogen MASP-1 fluctuates between an inactive and an active-like conformation. The determined structure provides a feasible explanation for this phenomenon. In summary, autoactivation of MASP-1 is crucial for the activation of MBL/ficolin.MASP complexes, and in the proenzymic phase zymogen MASP-1 controls the process.	[Megyeri, Marton; Major, Balazs; Balczer, Julia; Szilagyi, Katalin; Datz, Daniel; Zavodszky, Peter; Gal, Peter; Dobo, Jozsef] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Harmat, Veronika; Vegh, Adam] Eotvos Lorand Univ, Hungarian Acad Sci, Inst Chem, H-1117 Budapest, Hungary; [Harmat, Veronika; Vegh, Adam] Eotvos Lorand Univ, Hungarian Acad Sci, Prot Modeling Res Grp, H-1117 Budapest, Hungary; [Heja, David; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Datz, Daniel] Pazmany Peter Catholic Univ, Fac Informat Technol, H-1083 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University	Dobo, J (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, 29 Karolina St, H-1113 Budapest, Hungary.	dobo@enzim.hu	Pal, Gabor/A-6244-2009; Gal, Peter/B-5886-2011; Harmat, Veronika/B-8033-2016; Dobo, Jozsef/C-7331-2014	Pal, Gabor/0000-0001-7868-7971; Harmat, Veronika/0000-0002-1866-9904; Dobo, Jozsef/0000-0001-9187-8502	Hungarian Scientific Research Fund [NK77978, NK100834, NK101072, NK100769, NK81950]; National Development Agency Grant [KMOP 4.2.1.B/10-2011]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency Grant; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by Hungarian Scientific Research Fund Grants NK77978, NK100834, NK101072, NK100769, and NK81950; National Development Agency Grant KMOP 4.2.1.B/10-2011; and the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences. A preliminary version of this work was presented at the 13th European Meeting on Complement in Human Disease, August 22, 2011, Leiden, Netherlands.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2010, J IMMUNOL METHODS, V361, P37, DOI 10.1016/j.jim.2010.07.006; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobo J, 1999, J IMMUNOL, V162, P1108; Dobo J, 2008, ACTA CRYSTALLOGR F, V64, P781, DOI 10.1107/S174430910802294X; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Hess K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035690; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; KAY J, 1971, J BIOL CHEM, V246, P6661; Kereszturi E, 2009, J BIOL CHEM, V284, P33392, DOI 10.1074/jbc.M109.056812; Khan AR, 1998, PROTEIN SCI, V7, P815; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Kuzmic P, 2000, ANAL BIOCHEM, V281, P62, DOI 10.1006/abio.2000.4501; LACROIX MB, 1989, BIOCHEM J, V257, P885, DOI 10.1042/bj2570885; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorincz Z, 2000, J IMMUNOL, V165, P2048, DOI 10.4049/jimmunol.165.4.2048; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; NEUENSCHWANDER PF, 1993, J BIOL CHEM, V268, P21489; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6275, DOI 10.1021/bi0100992; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; SILVERBERG M, 1982, BLOOD, V60, P64; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; THIELENS NM, 1994, BIOCHEM J, V301, P509, DOI 10.1042/bj3010509; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	64	49	54	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8922	8934		10.1074/jbc.M112.446500	http://dx.doi.org/10.1074/jbc.M112.446500			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386610	hybrid, Green Published			2022-12-28	WOS:000316862200013
J	Spitzmaul, G; Tolosa, L; Winkelman, BHJ; Heidenreich, M; Frens, MA; Chabbert, C; de Zeeuw, CI; Jentsch, TJ				Spitzmaul, Guillermo; Tolosa, Leonardo; Winkelman, Beerend H. J.; Heidenreich, Matthias; Frens, Maarten A.; Chabbert, Christian; de Zeeuw, Chris I.; Jentsch, Thomas J.			Vestibular Role of KCNQ4 and KCNQ5 K+ Channels Revealed by Mouse Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HAIR-CELLS; INNER-EAR; POTASSIUM CHANNELS; DOMINANT DEAFNESS; ION CHANNELS; HEARING-LOSS; RAT UTRICLE; CALYX; EXPRESSION; CONDUCTANCES	The function of sensory hair cells of the cochlea and vestibular organs depends on an influx of K+ through apical mechanosensitive ion channels and its subsequent removal over their basolateral membrane. The KCNQ4 (K(v)7.4) K+ channel, which is mutated in DFNA2 human hearing loss, is expressed in the basal membrane of cochlear outer hair cells where it may mediate K+ efflux. Like the related K+ channel KCNQ5 (K(v)7.5), KCNQ4 is also found at calyx terminals ensheathing type I vestibular hair cells where it may be localized pre- or postsynaptically. Making use of Kcnq4(-/-) mice lacking KCNQ4, as well as Kcnq4(dn/dn) and Kcnq5(dn/dn) mice expressing dominant negative channel mutants, we now show unambiguously that in adult mice both channels reside in postsynaptic calyx-forming neurons, but cannot be detected in the innervated hair cells. Accordingly, whole cell currents of vestibular hair cells did not differ between genotypes. Neither Kcnq4(-/-), Kcnq5(dn/dn) nor Kcnq4(-/-)/Kcnq5(dn/dn) double mutant mice displayed circling behavior found with severe vestibular impairment. However, a milder form of vestibular dysfunction was apparent from altered vestibulo-ocular reflexes in Kcnq4(-/-)/Kcnq5(dn/dn) and Kcnq4(-/-) mice. The larger impact of KCNQ4 may result from its preferential expression in central zones of maculae and cristae, which are innervated by phasic neurons that are more sensitive than the tonic neurons present predominantly in the surrounding peripheral zones where KCNQ5 is found. The impact of postsynaptic KCNQ4 on vestibular function may be related to K+ removal and modulation of synaptic transmission.	[Spitzmaul, Guillermo; Heidenreich, Matthias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Spitzmaul, Guillermo; Heidenreich, Matthias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Tolosa, Leonardo; Winkelman, Beerend H. J.; de Zeeuw, Chris I.] Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Frens, Maarten A.; de Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Chabbert, Christian] Inst Neurosci Montpellier, INSERM, U1051, F-30491 Montpellier 5, France; [Jentsch, Thomas J.] Charite, Cluster Excellence NeuroCure, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	de Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl; jentsch@fmp-berlin.de	Spitzmaul, Guillermo/AAM-4785-2021	Spitzmaul, Guillermo/0000-0001-5123-8914; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [Exc 257]; Prix Louis-Jeantet de Medecine; Alexander von Humboldt Foundation; Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (Neuro-Basic); CEREBNET; C7 programs of the European Community; ERC (European Research Council)-advanced grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Prix Louis-Jeantet de Medecine; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); Senter (Neuro-Basic); CEREBNET; C7 programs of the European Community; ERC (European Research Council)-advanced grant	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Exc 257) and the Prix Louis-Jeantet de Medecine (to T. J. J.), by a stipend from the Alexander von Humboldt Foundation (to G. S.), by the Dutch Organization for Medical Sciences (ZonMw; to C. I. d. Z.), Life Sciences (ALW; to C. I. d. Z.), Senter (Neuro-Basic; to C. I. d. Z.), CEREBNET (to C. I. d. Z.), C7 programs of the European Community (to C. I. d. Z.), and ERC (European Research Council)-advanced grant (to C. I. d. Z.).	Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Chen JWY, 2000, J NEUROPHYSIOL, V84, P139, DOI 10.1152/jn.2000.84.1.139; Contini D, 2012, NEUROSCIENCE, V227, P232, DOI 10.1016/j.neuroscience.2012.09.051; CORREIA MJ, 1990, NEUROSCI LETT, V116, P106, DOI 10.1016/0304-3940(90)90394-O; De Leenheer EMR, 2002, ANN OTO RHINOL LARYN, V111, P267, DOI 10.1177/000348940211100312; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Eatock RA, 2008, J EXP BIOL, V211, P1764, DOI 10.1242/jeb.017350; Gaboyard S, 2005, NEUROSCIENCE, V133, P253, DOI 10.1016/j.neuroscience.2005.02.011; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; GOLDBERG JM, 1992, ANN NY ACAD SCI, V656, P92, DOI 10.1111/j.1749-6632.1992.tb25202.x; Goldberg JM, 1996, ANN NY ACAD SCI, V781, P474, DOI 10.1111/j.1749-6632.1996.tb15721.x; Goldberg JM, 1996, J NEUROPHYSIOL, V76, P1942, DOI 10.1152/jn.1996.76.3.1942; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kalluri R, 2010, J NEUROPHYSIOL, V104, P2034, DOI 10.1152/jn.00396.2010; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Lim R, 2011, EXP BRAIN RES, V210, P607, DOI 10.1007/s00221-011-2592-4; Lysakowski A, 1999, HEARING RES, V133, P149, DOI 10.1016/S0378-5955(99)00065-9; Lysakowski A, 2011, J NEUROSCI, V31, P10101, DOI 10.1523/JNEUROSCI.0521-11.2011; Marres H, 1997, ARCH OTOLARYNGOL, V123, P573; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Rennie KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC473, DOI 10.1152/ajpcell.2001.280.3.C473; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rocha-Sanchez SMS, 2007, BRAIN RES, V1139, P117, DOI 10.1016/j.brainres.2006.12.087; Rusch A, 1996, J NEUROPHYSIOL, V76, P995, DOI 10.1152/jn.1996.76.2.995; Rusch A, 1998, J NEUROSCI, V18, P7487; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Sogaard R, 2001, AM J PHYSIOL-CELL PH, V280, pC859; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Sousa AD, 2009, J NEUROSCI, V29, P3103, DOI 10.1523/JNEUROSCI.4868-08.2009; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Udagawa T, 2012, NEUROSCIENCE, V215, P209, DOI 10.1016/j.neuroscience.2012.04.037; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Zhang XM, 2011, AM J PHYSIOL-CELL PH, V301, pC1017, DOI 10.1152/ajpcell.00185.2011	49	24	24	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9334	9344		10.1074/jbc.M112.433383	http://dx.doi.org/10.1074/jbc.M112.433383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408425	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000316862200051
J	Amigo, I; Traba, J; Gonzalez-Barroso, MM; Rueda, CB; Fernandez, M; Rial, E; Sanchez, A; Satrustegui, J; del Arco, A				Amigo, Ignacio; Traba, Javier; Mar Gonzalez-Barroso, M.; Rueda, Carlos B.; Fernandez, Margarita; Rial, Eduardo; Sanchez, Aranzazu; Satrustegui, Jorgina; del Arco, Araceli			Glucagon Regulation of Oxidative Phosphorylation Requires an Increase in Matrix Adenine Nucleotide Content through Ca2+ Activation of the Mitochondrial ATP-Mg/P-i Carrier SCaMC-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PERMEABILITY TRANSITION; POSTNATAL-DEVELOPMENT; RESPIRATORY-CHAIN; CALCIUM; HEPATOCYTES; STIMULATION; MICE; IDENTIFICATION; ACCUMULATION	It has been known for a long time that mitochondria isolated from hepatocytes treated with glucagon or Ca2+-mobilizing agents such as phenylephrine show an increase in their adenine nucleotide (AdN) content, respiratory activity, and calcium retention capacity (CRC). Here, we have studied the role of SCaMC-3/slc25a23, the mitochondrial ATP-Mg/P-i carrier present in adult mouse liver, in the control of mitochondrial AdN levels and respiration in response to Ca2+ signals as a candidate target of glucagon actions. With the use of SCaMC-3 knock-out (KO) mice, we have found that the carrier is responsible for the accumulation of AdNs in liver mitochondria in a strictly Ca2+-dependent way with an S-0.5 for Ca2+ activation of 3.3 +/- 0.9 mu M. Accumulation of matrix AdNs allows a SCaMC-3-dependent increase in CRC. In addition, SCaMC-3-dependent accumulation of AdNs is required to acquire a fully active state 3 respiration in AdN-depleted liver mitochondria, although further accumulation of AdNs is not followed by increases in respiration. Moreover, glucagon addition to isolated hepatocytes increases oligomycin-sensitive oxygen consumption and maximal respiratory rates in cells derived from wild type, but not SCaMC-3-KO mice and glucagon administration in vivo results in an increase in AdN content, state 3 respiration and CRC in liver mitochondria in wild type but not in SCaMC-3-KO mice. These results show that SCaMC-3 is required for the increase in oxidative phosphorylation observed in liver mitochondria in response to glucagon and Ca2+-mobilizing agents, possibly by allowing a Ca2+-dependent accumulation of mitochondrial AdNs and matrix Ca2+, events permissive for other glucagon actions.	[Amigo, Ignacio; Traba, Javier; Rueda, Carlos B.; Satrustegui, Jorgina] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Amigo, Ignacio; Traba, Javier; Rueda, Carlos B.; Satrustegui, Jorgina] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28049, Spain; [Mar Gonzalez-Barroso, M.; Rial, Eduardo] CSIC, Dept Med Celular & Mol, CIB, E-28040 Madrid, Spain; [Fernandez, Margarita; Sanchez, Aranzazu] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, Area Bioquim, Ctr Reg Invest Biomed, Fac Ciencias Ambientales & Bioquim, Toledo 45071, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Universidad de Castilla-La Mancha	Satrustegui, J (corresponding author), Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, Madrid 28049, Spain.	jsatrustegui@cbm.uam.es; araceli.arco@uclm.es	Satrustegui, Jorgina/R-6732-2019; Rial, Eduardo/A-4242-2008; Sánchez, Aránzazu/H-7810-2015; Traba, Javier/AAA-9287-2020; del Arco, Araceli/R-5653-2019; Fernández, Margarita/H-9077-2015	Rial, Eduardo/0000-0001-8634-8902; Sánchez, Aránzazu/0000-0001-9145-6633; Traba, Javier/0000-0002-7855-3540; Fernández, Margarita/0000-0001-7207-2028; Amigo, Ignacio/0000-0003-0527-5954; GONZALEZ BARROSO, MARIA DEL MAR/0000-0002-0278-8298; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667; del Arco, Araceli/0000-0002-6839-542X; Rueda, Carlos/0000-0002-3876-612X	Ministerio de Educacion y Ciencia [BFU2008-04084/BMC, BFU2011-30456]; European Union [LSHM-CT-2006-518153]; CIBERER Centro de Investigaciones Biomedicas en Red de Enfermedades Raras (an initiative of the ISCIII Instituto de Salud Carlos III); Comunidad de Madrid [S-GEN-0269-2006, S2010/BMD-2402 MITOLAB-CM]; ISCIII [PI080610]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia	Ministerio de Educacion y Ciencia(Spanish Government); European Union(European Commission); CIBERER Centro de Investigaciones Biomedicas en Red de Enfermedades Raras (an initiative of the ISCIII Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); ISCIII(Instituto de Salud Carlos III); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by Ministerio de Educacion y Ciencia Grants BFU2008-04084/BMC and BFU2011-30456, European Union Grant LSHM-CT-2006-518153, and CIBERER Centro de Investigaciones Biomedicas en Red de Enfermedades Raras (an initiative of the ISCIII Instituto de Salud Carlos III) (to J. S.), Comunidad de Madrid Grants S-GEN-0269-2006 and S2010/BMD-2402 MITOLAB-CM (to J. S., E. R., and A. S.), by ISCIII Grant PI080610 (to A. delA), and an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa.; Recipient of a Formacion de Personal Investigador fellowship from the Ministerio de Educacion y Ciencia.	Amigo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040470; Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; APRILLE JR, 1982, BIOCHEM BIOPH RES CO, V108, P834, DOI 10.1016/0006-291X(82)90905-6; APRILLE JR, 1980, ARCH BIOCHEM BIOPHYS, V201, P564, DOI 10.1016/0003-9861(80)90546-9; APRILLE JR, 1988, FASEB J, V2, P2547, DOI 10.1096/fasebj.2.10.3290024; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; ASIMAKIS GK, 1980, ARCH BIOCHEM BIOPHYS, V203, P307, DOI 10.1016/0003-9861(80)90181-2; ASSIMACOPOULOSJEANNET F, 1986, J BIOL CHEM, V261, P8799; Balaban RS, 2012, J GEN PHYSIOL, V139, P407, DOI 10.1085/jgp.201210783; Barritt GJ, 2008, BBA-MOL CELL RES, V1783, P651, DOI 10.1016/j.bbamcr.2008.01.016; CARAFOLI E, 1965, J BIOL CHEM, V240, P2254; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; CROMPTON M, 1986, FEBS LETT, V204, P198, DOI 10.1016/0014-5793(86)80811-0; DAVIDSON AM, 1988, BIOCHEM J, V254, P379, DOI 10.1042/bj2540379; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; DRANSFIELD DT, 1993, AM J PHYSIOL, V264, pC663, DOI 10.1152/ajpcell.1993.264.3.C663; DSOUZA MP, 1982, BIOCHIM BIOPHYS ACTA, V680, P28, DOI 10.1016/0005-2728(82)90313-9; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Garlid KD, 2012, J MOL CELL CARDIOL, V52, P578, DOI 10.1016/j.yjmcc.2011.12.011; Gizatullina ZZ, 2005, BBA-BIOENERGETICS, V1706, P98, DOI 10.1016/j.bbabio.2004.09.013; Gomez-Galan M, 2012, J CEREBR BLOOD F MET, V32, P306, DOI 10.1038/jcbfm.2011.129; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; HALESTRAP AP, 1987, BIOCHIM BIOPHYS ACTA, V927, P280, DOI 10.1016/0167-4889(87)90145-5; HALESTRAP AP, 1982, BIOCHEM J, V204, P37, DOI 10.1042/bj2040037; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; HAMMAN HC, 1983, ARCH BIOCHEM BIOPHYS, V223, P85, DOI 10.1016/0003-9861(83)90574-X; HAYNES RC, 1986, J BIOL CHEM, V261, P6121; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Kao CY, 1996, BIOCHEM BIOPH RES CO, V222, P64, DOI 10.1006/bbrc.1996.0698; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Gonzalez-Barroso MM, 2012, BBA-BIOENERGETICS, V1817, P1768, DOI 10.1016/j.bbabio.2012.02.019; Marmol P, 2009, J BIOL CHEM, V284, P515, DOI 10.1074/jbc.M806729200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MORGAN NG, 1984, P NATL ACAD SCI-BIOL, V81, P4208, DOI 10.1073/pnas.81.13.4208; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; NOSEK MT, 1992, ARCH BIOCHEM BIOPHYS, V296, P691, DOI 10.1016/0003-9861(92)90628-A; PRPIC V, 1978, BIOCHEM J, V176, P705, DOI 10.1042/bj1760705; QUINLAN PT, 1983, BIOCHEM J, V214, P395, DOI 10.1042/bj2140395; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SOBOLL S, 1986, FEBS LETT, V205, P109, DOI 10.1016/0014-5793(86)80875-4; SUTTON R, 1978, DIFFERENTIATION, V12, P15; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; Traba J, 2011, CELL MOL LIFE SCI, V68, P1183, DOI 10.1007/s00018-010-0612-3; Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262; VALCARCE C, 1991, FEBS LETT, V294, P225, DOI 10.1016/0014-5793(91)81435-B; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; YAMAZAKI RK, 1975, J BIOL CHEM, V250, P7924	53	40	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7791	7802		10.1074/jbc.M112.409144	http://dx.doi.org/10.1074/jbc.M112.409144			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23344948	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000316455300034
J	Rico-Leo, EM; Alvarez-Barrientos, A; Fernandez-Salguero, PM				Rico-Leo, Eva M.; Alvarez-Barrientos, Alberto; Fernandez-Salguero, Pedro M.			Dioxin Receptor Expression Inhibits Basal and Transforming Growth Factor beta-induced Epithelial-to-mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR SNAIL; CONSTITUTIVE EXPRESSION; VAV3 PROTOONCOGENE; CELL PLASTICITY; GENE-EXPRESSION; TARGET GENE; FACTOR SLUG; CADHERIN; MECHANISM	Recent studies have emphasized the role of the dioxin receptor (AhR) in maintaining cell morphology, adhesion, and migration. These novel AhR functions depend on the cell phenotype, and although AhR expression maintains mesenchymal fibroblasts migration, it inhibits keratinocytes motility. These observations prompted us to investigate whether AhR modulates the epithelial-to-mesenchymal transition (EMT). For this, we have used primary AhR(+/+) and AhR(-/-) keratinocytes and NMuMG cells engineered to knock down AhR levels (sh-AhR) or to express a constitutively active receptor (CA-AhR). Both AhR(-/-) keratinocytes and sh-AhR NMuMG cells had increased migration, reduced levels of epithelial markers E-cadherin and beta-catenin, and increased expression of mesenchymal markers Snail, Slug/Snai2, vimentin, fibronectin, and alpha-smooth muscle actin. Consistently, AhR(+/+) and CA-AhR NMuMG cells had reduced migration and enhanced expression of epithelial markers. AhR activation by the agonist FICZ (6-formylindolo[3,2-b] carbazole) inhibited NMuMG migration, whereas the antagonist alpha-naphthoflavone induced migration as did AhR knockdown. Exogenous TGF beta exacerbated the promigratory mesenchymal phenotype in both AhR-expressing and AhR-depleted cells, although the effects on the latter were more pronounced. Rescuing AhR expression in sh-AhR cells reduced Snail and Slug/Snai2 levels and cell migration and restored E-cadherin levels. Interference of AhR in human HaCaT cells further supported its role in EMT. Interestingly, co-immunoprecipitation and immunofluorescence assays showed that AhR associates in common protein complexes with E-cadherin and beta-catenin, suggesting the implication of AhR in cell-cell adhesion. Thus, basal or TGF beta-induced AhR down-modulation could be relevant in the acquisition of a motile EMT phenotype in both normal and transformed epithelial cells.	[Rico-Leo, Eva M.; Fernandez-Salguero, Pedro M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain; [Alvarez-Barrientos, Alberto] Univ Extremadura, Serv Tecn Aplicadas Biociencias, E-06071 Badajoz, Spain	Universidad de Extremadura; Universidad de Extremadura	Fernandez-Salguero, PM (corresponding author), Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain.	pmfersal@unex.es	Alvarez-Barrientos, Alberto/L-9299-2014; Fernandez-Salguero, Pedro M./J-8437-2014	Alvarez-Barrientos, Alberto/0000-0003-4761-0212; Fernandez-Salguero, Pedro M./0000-0003-2839-5027	Spanish Ministry of Science and Innovation [SAF2008-00462, BFU2011-22678]; Red Tematica de Investigacion Cooperativa en Cancer; Fondo de Investigaciones Sanitarias; Carlos III Institute; Spanish Ministry of Health [RD06/0020/1016, RD12/0036/0032]; Junta de Extremadura [GRU10008]; European Union FEDER (Fondo Europeo de Desarrollo Regional) program; Servicio de Tecnicas Aplicadas a las Biociencias of the Universidad de Extremadura	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Carlos III Institute(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Junta de Extremadura; European Union FEDER (Fondo Europeo de Desarrollo Regional) program; Servicio de Tecnicas Aplicadas a las Biociencias of the Universidad de Extremadura	This work was funded by grants from the Spanish Ministry of Science and Innovation (SAF2008-00462 and BFU2011-22678), the Red Tematica de Investigacion Cooperativa en Cancer, Fondo de Investigaciones Sanitarias, Carlos III Institute, Spanish Ministry of Health (RD06/0020/1016 and RD12/0036/0032), and the Junta de Extremadura (GRU10008). All Spanish funding was co-sponsored by the European Union FEDER (Fondo Europeo de Desarrollo Regional) program.; We are very grateful to Drs. Alberto Munoz, Xose R. Bustelo, and Jesus M. Paramio for technical assistance with TER measurements, retroviral transduction, and primary keratinocytes cultures, respectively. We also thank Drs. Antonio Garcia de Herreros for the NMuMG cells and the anti-Snail antibody, Yoshiaki Fujii-Kuriyama for the CA-AhR construct, and Miguel Quintanilla for the HaCaT cell line. The technical help of Eva Barrasa is greatly appreciated. Support of the Servicio de Tecnicas Aplicadas a las Biociencias of the Universidad de Extremadura is greatly acknowledged.	ABBOTT BD, 1995, DEV DYNAM, V204, P133, DOI 10.1002/aja.1002040204; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Bergander L, 2003, DRUG METAB DISPOS, V31, P233, DOI 10.1124/dmd.31.2.233; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Roman AC, 2011, GENOME RES, V21, P422, DOI 10.1101/gr.111203.110; Roman AC, 2009, J BIOL CHEM, V284, P25135, DOI 10.1074/jbc.M109.013292; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Casado FL, 2011, MOL PHARMACOL, V80, P673, DOI 10.1124/mol.111.071381; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Cho YC, 2004, TOXICOL APPL PHARM, V199, P220, DOI 10.1016/j.taap.2003.12.025; Diry M, 2006, ONCOGENE, V25, P5570, DOI 10.1038/sj.onc.1209553; Dohr O, 1997, MOL PHARMACOL, V51, P703, DOI 10.1124/mol.51.5.703; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Fernandez-Salguero PM, 2010, CELL ADHES MIGR, V4, P172, DOI 10.4161/cam.4.2.10387; Fischer ANM, 2005, CARCINOGENESIS, V26, P931, DOI 10.1093/carcin/bgi043; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; Gomez-Duran A, 2009, BIOCHEM PHARMACOL, V77, P700, DOI 10.1016/j.bcp.2008.08.032; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; MERCHANT M, 1993, TOXICOL APPL PHARM, V120, P179, DOI 10.1006/taap.1993.1101; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Mulero-Navarro S, 2006, CARCINOGENESIS, V27, P1099, DOI 10.1093/carcin/bgi344; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pohjanvirta R, 2012, AH RECEPTOR BIOL TOX; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Puga A, 2002, TOXICOLOGY, V181, P171, DOI 10.1016/S0300-483X(02)00276-7; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Roman A.C., 2012, AH RECEPTOR BIOL TOX, P485; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Santiago-Josefat B, 2004, J CELL SCI, V117, P849, DOI 10.1242/jcs.00932; Santiago-Josefat B, 2003, J MOL BIOL, V333, P249, DOI 10.1016/j.jmb.2003.08.020; Seifert A, 2009, TOXICOL LETT, V184, P26, DOI 10.1016/j.toxlet.2008.10.026; Temchura VV, 2005, EUR J IMMUNOL, V35, P2738, DOI 10.1002/eji.200425641; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wolff S, 2001, MOL PHARMACOL, V59, P716, DOI 10.1124/mol.59.4.716; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313	61	43	44	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7841	7856		10.1074/jbc.M112.425009	http://dx.doi.org/10.1074/jbc.M112.425009			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382382	Green Published, hybrid			2022-12-28	WOS:000316455300038
J	Zhang, Z; Takeuchi, H; Gao, J; Wang, DG; James, DJ; Martin, TFJ; Hirata, M				Zhang, Zhao; Takeuchi, Hiroshi; Gao, Jing; Wang, DaGuang; James, Declan J.; Martin, Thomas F. J.; Hirata, Masato			PRIP (Phospholipase C-related but Catalytically Inactive Protein) Inhibits Exocytosis by Direct Interactions with Syntaxin 1 and SNAP-25 through Its C2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; SNARE COMPLEX-FORMATION; MEMBRANE-FUSION; FUNCTIONAL DIVERSITY; PLASMA-MEMBRANE; VESICLE FUSION; BINDING; SYNAPTOTAGMIN; CA2+; SECRETION	Membrane fusion for exocytosis is mediated by SNAREs, forming trans-ternary complexes to bridge vesicle and target membranes. There is an array of accessory proteins that directly interact with and regulate SNARE proteins. PRIP (phospholipase C-related but catalytically inactive protein) is likely one of these proteins; PRIP, consisting of multiple functional modules including pleckstrin homology and C2 domains, inhibited exocytosis, probably via the binding to membrane phosphoinositides through the pleckstrin homology domain. However, the roles of the C2 domain have not yet been investigated. In this study, we found that the C2 domain of PRIP directly interacts with syntaxin 1 and SNAP-25 but not with VAMP2. The C2 domain promoted PRIP to co-localize with syntaxin 1 and SNAP-25 in PC12 cells. The binding profile of the C2 domain to SNAP-25 was comparable with that of synaptotagmin I, and PRIP inhibited synaptotagmin I in binding to SNAP-25 and syntaxin 1. It was also shown that the C2 domain was required for PRIP to suppress SDS-resistant ternary SNARE complex formation and inhibit high K+-induced noradrenalin release from PC12 cells. These results suggest that PRIP inhibits regulated exocytosis through the interaction of its C2 domain with syntaxin 1 and SNAP-25, potentially competing with other SNARE-binding, C2 domain-containing accessory proteins such as synaptotagmin I and by directly inhibiting trans-SNARE complex formation.	[Zhang, Zhao; Takeuchi, Hiroshi; Gao, Jing; Wang, DaGuang; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Takeuchi, Hiroshi] Kyushu Dent Coll, Div Appl Pharmacol, Kitakyushu, Fukuoka 8038580, Japan; [Zhang, Zhao] Hebei Med Univ, Stomatol Hosp, Shijiazhuang 050017, Peoples R China; [James, Declan J.; Martin, Thomas F. J.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA	Kyushu University; Kyushu Dental University; Hebei Medical University; University of Wisconsin System; University of Wisconsin Madison	Takeuchi, H (corresponding author), Kyushu Dent Coll, Div Appl Pharmacol, Kitakyushu, Fukuoka 8038580, Japan.	r12takeuchi@fa.kyu-dent.ac.jp; hirata1@dent.kyushu-u.ac.jp	Takeuchi, Hiroshi/I-8849-2019	Takeuchi, Hiroshi/0000-0003-0033-2913	National Institutes of Health [DK025861]; Japan Society for the Promotion of Science KAKENHI [24592805, 23792127, 21249089, 23659782, 24229009]; Japanese Government; Hirose International Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025861, R01DK040428, R37DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Government; Hirose International Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK025861 (to T. F. J. M). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grants 24592805 (to H. T.), 23792127 (to J. G.), and 21249089, 23659782, and 24229009 (to M. H.).; Foreign graduate student supported by the Japanese Government.; Foreign graduate student supported by the Hirose International Scholarship.	Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Gao J, 2010, ADV ENZYME REGUL, V50, P237, DOI 10.1016/j.advenzreg.2009.10.011; Gao J, 2009, CELL SIGNAL, V21, P1180, DOI 10.1016/j.cellsig.2009.03.008; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Masumoto T, 2012, MOL CELL NEUROSCI, V49, P1, DOI 10.1016/j.mcn.2011.09.007; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sugita S, 2008, ACTA PHYSIOL, V192, P185, DOI 10.1111/j.1748-1716.2007.01803.x; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Takeuchi H, 2010, MOL CELL BIOL, V30, P1689, DOI 10.1128/MCB.01105-09; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Walter AM, 2011, TRENDS NEUROSCI, V34, P487, DOI 10.1016/j.tins.2011.07.003; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200	53	15	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7769	7780		10.1074/jbc.M112.419317	http://dx.doi.org/10.1074/jbc.M112.419317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341457	hybrid, Green Published			2022-12-28	WOS:000316455300032
J	Arystarkhova, E; Liu, YB; Salazar, C; Stanojevic, V; Clifford, RJ; Kaplan, JH; Kidder, GM; Sweadner, KJ				Arystarkhova, Elena; Liu, Yi B.; Salazar, Cynthia; Stanojevic, Violeta; Clifford, Rebecca J.; Kaplan, Jack H.; Kidder, Gerald M.; Sweadner, Kathleen J.			Hyperplasia of Pancreatic Beta Cells and Improved Glucose Tolerance in Mice Deficient in the FXYD2 Subunit of Na, K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; IMMUNOCYTOCHEMICAL LOCALIZATION; RENAL NA,K-ATPASE; CRYSTAL-STRUCTURE; FUNCTIONAL-ROLE; EXPRESSION; PROTEIN; MASS; PHOSPHOLEMMAN; REGULATORS	Restoration of the functional potency of pancreatic islets either through enhanced proliferation (hyperplasia) or increase in size (hypertrophy) of beta cells is a major objective for intervention in diabetes. We have obtained experimental evidence that global knock-out of a small, single-span regulatory subunit of Na,K-ATPase, FXYD2, alters glucose control. Adult Fxyd2(-/-) mice showed significantly lower blood glucose levels, no signs of peripheral insulin resistance, and improved glucose tolerance compared with their littermate controls. Strikingly, there was a substantial hyperplasia in pancreatic beta cells from the Fxyd2(-/-) mice compared with the wild type littermates, compatible with an observed increase in the level of circulating insulin. No changes were seen in the exocrine compartment of the pancreas, and the mice had only a mild, well-adapted renal phenotype. Morphometric analysis revealed an increase in beta cell mass in KO compared with WT mice. This appears to explain a phenotype of hyperinsulinemia. By RT-PCR, Western blot, and immunocytochemistry we showed the FXYD2b splice variant in pancreatic beta cells from wild type mice. Phosphorylation of Akt kinase was significantly higher under basal conditions in freshly isolated islets from Fxyd2(-/-) mice compared with their WT littermates. Inducible expression of FXYD2 in INS 832/13 cells produced a reduction in the phosphorylation level of Akt, and phosphorylation was restored in parallel with degradation of FXYD2. Thus we suggest that in pancreatic beta cells FXYD2 plays a role in Akt signaling pathways associated with cell growth and proliferation.	[Arystarkhova, Elena; Liu, Yi B.; Salazar, Cynthia; Sweadner, Kathleen J.] Massachusetts Gen Hosp, Lab Membrane Biol, Boston, MA 02114 USA; [Stanojevic, Violeta] Massachusetts Gen Hosp, Mol Endocrinol Lab, Boston, MA 02114 USA; [Clifford, Rebecca J.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Kidder, Gerald M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6C 2V5, Canada; [Kidder, Gerald M.] Childrens Hlth Res Inst, Div Genet & Dev, London, ON N6C 2V5, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University (University of Western Ontario)	Arystarkhova, E (corresponding author), Massachusetts Gen Hosp, Lab Membrane Biol, Edwards 410,55 Fruit St, Boston, MA 02114 USA.	aristarkhova@helix.mgh.harvard.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [HL036271, NS045083, NS050696]; Pilot Feasibility Grant [5P30DK057521-12]; American Recovery and Reinvestment Act supplement [NS050696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050696, R21NS045083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot Feasibility Grant; American Recovery and Reinvestment Act supplement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL036271, NS045083, and NS050696. This work was also supported by Pilot Feasibility Grant 5P30DK057521-12 (Boston Area Diabetes Endocrinology Research Center) and American Recovery and Reinvestment Act supplement to Grant NS050696.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Arystarkhova E, 2002, J BIOL CHEM, V277, P10162, DOI 10.1074/jbc.M111552200; Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Arystarkhova E, 2007, AM J PHYSIOL-CELL PH, V292, pC1179, DOI 10.1152/ajpcell.00328.2006; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Blandino-Rosano M, 2012, CELL CYCLE, V11, P1892, DOI 10.4161/cc.20036; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Elghazi L, 2007, DIABETES OBES METAB, V9, P147, DOI 10.1111/j.1463-1326.2007.00783.x; Flamez D, 2010, DIABETOLOGIA, V53, P1372, DOI 10.1007/s00125-010-1714-z; Floyd RV, 2010, ANN ANAT, V192, P7, DOI 10.1016/j.aanat.2009.09.003; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Kidder GM, 2002, CAN J PHYSIOL PHARM, V80, P110, DOI 10.1139/Y02-017; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Reinhard L, 2013, CELL MOL LIFE SCI, V70, P205, DOI 10.1007/s00018-012-1039-9; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sweadner KJ, 2011, J BIOL CHEM, V286, P18290, DOI 10.1074/jbc.M111.241901; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Venteo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029852; Wetzel RK, 2004, J BIOL CHEM, V279, P41750, DOI 10.1074/jbc.M405622200; Wetzel RK, 2001, AM J PHYSIOL-RENAL, V281, pF531, DOI 10.1152/ajprenal.2001.281.3.F531; Yesil P, 2008, HISTOL HISTOPATHOL, V23, P883, DOI 10.14670/HH-23.883	37	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7077	7085		10.1074/jbc.M112.401190	http://dx.doi.org/10.1074/jbc.M112.401190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344951	Green Published, hybrid			2022-12-28	WOS:000316002400029
J	Ly, S; Altman, R; Petrlova, J; Lin, Y; Hilt, S; Huser, T; Laurence, TA; Voss, JC				Ly, Sonny; Altman, Robin; Petrlova, Jitka; Lin, Yu; Hilt, Silvia; Huser, Thomas; Laurence, Ted A.; Voss, John C.			Binding of Apolipoprotein E Inhibits the Oligomer Growth of Amyloid-beta Peptide in Solution as Determined by Fluorescence Cross-correlation Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; TYPE-4 ALLELE; MOUSE MODEL; APOE; PATHOGENESIS; PATHWAYS; GENOTYPE; ASSOCIATION; EXCITATION; DEPOSITION	One of the primary neuropathological hallmarks of Alzheimer disease is the presence of extracellular amyloid plaques resulting from the aggregation of amyloid-beta (A beta) peptides. The intrinsic disorder of the A beta peptide drives self-association and progressive reordering of the conformation in solution, and this dynamic distribution of A beta complicates biophysical studies. This property poses a challenge for understanding the interaction of A beta with apolipoprotein E (apoE). ApoE plays a pivotal role in the aggregation and clearance of A beta peptides in the brain, and the epsilon 4 allele of APOE is the most significant known genetic modulator of Alzheimer risk. Understanding the interaction between apoE and A beta will provide insight into the mechanism by which different apoE isoforms determine Alzheimer disease risk. Here we applied alternating laser excitation fluorescence cross-correlation spectroscopy to observe the single molecule interaction of A beta with apoE in the hydrated state. The diffusion time of freely diffusing A beta in the absence of apoE shows significant self-aggregation, whereas in the presence of apoE, binding of the protein results in a more stable complex. These results show that apoE slows down the oligomerization of A beta in solution and provide direct insight into the process by which apoE influences the deposition and clearance of A beta peptides in the brain. Furthermore, by developing an approach to remove signals arising from very large A beta aggregates, we show that real-time single particle observations provide access to information regarding the fraction of apoE bound and the stoichiometry of apoE and A beta in the complex.	[Ly, Sonny; Laurence, Ted A.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Altman, Robin; Petrlova, Jitka; Hilt, Silvia; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Ly, Sonny; Lin, Yu; Huser, Thomas] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; National Science Foundation (NSF); University of California System; University of California Davis	Laurence, TA (corresponding author), Lawrence Livermore Natl Lab, L-470,7000 East Ave, Livermore, CA 94550 USA.	Laurence2@llnl.gov; jcvoss@ucdavis.edu	Huser, Thomas/K-7291-2019; Laurence, Ted A/E-4791-2011	Huser, Thomas/0000-0003-2348-7416; Laurence, Ted A/0000-0003-1474-779X; Voss, John/0000-0001-9279-209X; Lin, Yu/0000-0001-5109-0972	National Institutes of Health [R01 AG029246]; United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG029246 (to J.C.V.).; This work was also supported by the United States Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Basak JM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-14; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bien-Ly N, 2011, P NATL ACAD SCI USA, V108, P4236, DOI 10.1073/pnas.1018381108; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; den Hartigh LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050513; EHRENBERG M, 1976, Q REV BIOPHYS, V9, P69, DOI 10.1017/S003358350000216X; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; Hong HS, 2010, NEUROBIOL AGING, V31, P1690, DOI 10.1016/j.neurobiolaging.2008.09.019; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; Kohl T, 2002, P NATL ACAD SCI USA, V99, P12161, DOI 10.1073/pnas.192433499; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Laurence TA, 2008, J BIOL CHEM, V283, P22895, DOI 10.1074/jbc.M800174200; Ly S, 2011, BIOPHYS J, V101, P970, DOI 10.1016/j.bpj.2011.06.060; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 1999, J LIPID RES, V40, P1; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Miller AE, 2009, ANAL CHEM, V81, P5614, DOI 10.1021/ac9001645; Mitternacht S, 2011, J MOL BIOL, V410, P357, DOI 10.1016/j.jmb.2011.05.014; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Petrlova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035443; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Sharman MJ, 2010, J ALZHEIMERS DIS, V21, P403, DOI 10.3233/JAD-2010-100141; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tetali SD, 2006, J LIPID RES, V47, P1358, DOI 10.1194/jlr.M500559-JLR200; Tetali SD, 2010, J LIPID RES, V51, P1273, DOI 10.1194/jlr.M000406; Thews E, 2005, BIOPHYS J, V89, P2069, DOI 10.1529/biophysj.104.057919; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wildsmith KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038013; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Zlokovic BV, 2005, BRAIN PATHOL, V15, P78	52	32	32	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11628	11635		10.1074/jbc.M112.411900	http://dx.doi.org/10.1074/jbc.M112.411900			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23430745	hybrid, Green Published			2022-12-28	WOS:000318157600002
J	Vishnivetskiy, SA; Baameur, F; Findley, KR; Gurevich, VV				Vishnivetskiy, Sergey A.; Baameur, Faiza; Findley, Kristen R.; Gurevich, Vsevolod V.			Critical Role of the Central 139-Loop in Stability and Binding Selectivity of Arrestin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; BETA-ARRESTIN; PHOSPHORYLATION-RECOGNITION; FUNCTIONAL FORMS; LIGAND-BINDING; RHODOPSIN; MECHANISM; SPECIFICITY	Arrestin-1 selectively binds active phosphorylated rhodopsin (P-Rh*), demonstrating much lower affinity for inactive phosphorylated (P-Rh) and unphosphorylated active (Rh*) forms. Receptor interaction induces significant conformational changes in arrestin-1, which include large movement of the previously neglected 139-loop in the center of the receptor binding surface, away from the incoming receptor. To elucidate the functional role of this loop, in mouse arrestin-1 we introduced deletions of variable lengths and made several substitutions of Lys-142 in it and Asp-72 in the adjacent loop. Several mutants with perturbations in the 139-loop demonstrate increased binding to P-Rh*, dark P-Rh, Rh*, and phospho-opsin. Enhanced binding of arrestin-1 mutants to non-preferred forms of rhodopsin correlates with decreased thermal stability. The 139-loop perturbations increase P-Rh* binding of arrestin-1 at low temperatures and further change its binding profile on the background of 3A mutant, where the C-tail is detached from the body of the molecule by triple alanine substitution. Thus, the 139-loop stabilizes basal conformation of arrestin-1 and acts as a brake, preventing its binding to non-preferred forms of rhodopsin. Conservation of this loop in other subtypes suggests that it has the same function in all members of the arrestin family.	[Vishnivetskiy, Sergey A.; Baameur, Faiza; Findley, Kristen R.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [EY011500, GM077561, GM081756]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011500, GM077561, and GM081756 (to V. V. G.).	Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Cleghorn WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022797; Dinculescu A, 2002, J BIOL CHEM, V277, P11703, DOI 10.1074/jbc.M111833200; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Gurevich VV, 2012, CELL SIGNAL, V24, P1899, DOI 10.1016/j.cellsig.2012.05.012; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2011, J BIOL CHEM, V286, P7359, DOI 10.1074/jbc.M110.204941; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	74	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11741	11750		10.1074/jbc.M113.450031	http://dx.doi.org/10.1074/jbc.M113.450031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23476014	hybrid, Green Published			2022-12-28	WOS:000318157600011
J	Basu, S; Srinivasan, DK; Yang, K; Raina, H; Banerjee, S; Zhang, RL; Fisher, SA; Proweller, A				Basu, Sanchita; Srinivasan, Dinesh Kumar; Yang, Ke; Raina, Hema; Banerjee, Suhanti; Zhang, Rongli; Fisher, Steven A.; Proweller, Aaron			Notch Transcriptional Control of Vascular Smooth Muscle Regulatory Gene Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; AUTOSOMAL-DOMINANT ARTERIOPATHY; MESENTERIC RESISTANCE ARTERIES; TRANSGENIC MOUSE MODEL; MYOSIN PHOSPHATASE; CELL DIFFERENTIATION; SUBCORTICAL INFARCTS; MICE LACKING; HYPERTENSION; TARGET	Notch receptors and ligands mediate heterotypic cell signaling that is required for normal vascular development. Dysregulation of select Notch receptors in mouse vascular smooth muscle (VSM) and in genetic human syndromes causes functional impairment in some regional circulations, the mechanistic basis of which is undefined. In this study, we used a dominant-negative Mastermind-like (DNMAML1) to block signaling through all Notch receptors specifically in VSM to more broadly test a functional role for this pathway in vivo. Mutant DNMAML1-expressing mice exhibited blunted blood pressure responses to vasoconstrictors, and their aortic, femoral, and mesenteric arteries had reduced contractile responses to agonists and depolarization in vitro. The mutant arteries had significant and specific reduction in the expression and activity of myosin light chain kinase (MLCK), a primary regulator of VSM force production. Conversely, activated Notch signaling in VSM cells induced endogenous MLCK transcript levels. We identified MLCK as a direct target of activated Notch receptor as demonstrated by an evolutionarily conserved Notch-responsive element within the MLCK promoter that binds the Notch receptor complex and is required for transcriptional activity. We conclude that Notch signaling through the transcriptional control of key regulatory proteins is required for contractile responses of mature VSM. Genetic or pharmacological manipulation of Notch signaling is a potential strategy for modulating arterial function in human disease.	Case Western Reserve Univ, Dept Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Proweller, A (corresponding author), Case Western Reserve Univ, Dept Med, 4530 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44122 USA.	aaron.proweller@case.edu	Srinivasan, Dinesh Kumar/A-9872-2008; Srinivasan, Dinesh Kumar/E-6383-2017; Srinivasan, Dinesh Kumar/P-6528-2019	Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Srinivasan, Dinesh Kumar/0000-0001-6535-5441	National Institutes of Health [HL096603, HL066171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066171, R01HL096603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL096603 (to A. P.) and HL066171 (to S. F.).	Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Boulos N, 2011, HYPERTENSION, V57, P1176, DOI 10.1161/HYPERTENSIONAHA.111.170746; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Christ GJ, 1999, AM J PHYSIOL-HEART C, V276, pH1911, DOI 10.1152/ajpheart.1999.276.6.H1911; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; Del Bianco C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015034; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dubroca C, 2005, STROKE, V36, P113, DOI 10.1161/01.STR.0000149949.92854.45; Earley S, 2004, AM J PHYSIOL-HEART C, V287, pH2677, DOI 10.1152/ajpheart.00016.2004; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Lacombe P, 2005, STROKE, V36, P1053, DOI 10.1161/01.STR.0000163080.82766.eb; Lagaud G, 2002, AM J PHYSIOL-HEART C, V283, pH2187, DOI 10.1152/ajpheart.00554.2002; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Ruchoux MM, 2003, AM J PATHOL, V162, P329, DOI 10.1016/S0002-9440(10)63824-2; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Yang K, 2011, J BIOL CHEM, V286, P13741, DOI 10.1074/jbc.M110.181842; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	42	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11191	11202		10.1074/jbc.M112.442996	http://dx.doi.org/10.1074/jbc.M112.442996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23482558	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000317915500023
J	Hu, ZG; Hu, J; Zhang, ZH; Shen, WJ; Yun, CC; Berlot, CH; Kraemer, FB; Azhar, S				Hu, Zhigang; Hu, Jie; Zhang, Zhonghua; Shen, Wen-Jun; Yun, C. Chris; Berlot, Catherine H.; Kraemer, Fredric B.; Azhar, Salman			Regulation of Expression and Function of Scavenger Receptor Class B, Type I (SR-BI) by Na+/H+ Exchanger Regulatory Factors (NHERFs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTERYL ESTER UPTAKE; PROTEIN-COUPLED-RECEPTORS; DOMAIN-CONTAINING PROTEIN; CAMP-MEDIATED INHIBITION; OVARIAN GRANULOSA-CELLS; SELECTIVE UPTAKE; H+ EXCHANGER; PDZ PROTEINS; BETA(2)-ADRENERGIC RECEPTOR	Scavenger receptor class B, type I (SR-BI) binds HDL and mediates selective delivery of cholesteryl esters (CEs) to the liver, adrenals, and gonads for product formation (bile acids and steroids). Because relatively little is known about SR-BI posttranslational regulation in steroidogenic cells, we examined the roles of Na+/H+ exchanger regulatory factors (NHERFs) in regulating SR-BI expression, SR-BI-mediated selective CE uptake, and steroidogenesis. NHERF1 and NHERF2 mRNA and protein are expressed at varying levels in model steroidogenic cell lines and the adrenal, with only low expression of PDZK1 (NHERF3) and NHERF4. Dibutyryl cyclic AMP decreased NHERF1 and NHERF2 and increased SR-BI mRNA expression in primary rat granulosa cells and MLTC-1 cells, whereas ACTH had no effect on NHERF1 and NHERF2 mRNA levels but decreased their protein levels in rat adrenals. Co-immunoprecipitation, colocalization, bimolecular fluorescence complementation, and mutational analysis indicated that SR-BI associates with NHERF1 and NHERF2. NHERF1 and NHERF2 down-regulated SR-BI protein expression through inhibition of its de novo synthesis. NHERF1 and NHERF2 also inhibited SR-BI-mediated selective CE transport and steroidogenesis, which were markedly attenuated by partial deletions of the PDZ1 or PDZ2 domain of NHERF1, the PDZ2 domain of NHERF2, or the MERM domains of NHERF1/2 or by gene silencing of NHERF1/2. Moreover, an intact COOH-terminal PDZ recognition motif (EAKL) in SR-BI is needed. Transient transfection of hepatic cell lines with NHERF1 or NHERF2 caused a significant reduction in endogenous protein levels of SR-BI. Collectively, these data establish NHERF1 and NHERF2 as SR-BI protein binding partners that play a negative role in the regulation of SR-BI expression, selective CE transport, and steroidogenesis.	[Hu, Zhigang; Hu, Jie; Zhang, Zhonghua; Shen, Wen-Jun; Kraemer, Fredric B.; Azhar, Salman] Vet Affairs Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA; [Hu, Zhigang; Hu, Jie; Zhang, Zhonghua; Shen, Wen-Jun; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA; [Azhar, Salman] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Berlot, Catherine H.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Emory University	Azhar, S (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, GRECC 182B,3801 Miranda Ave, Palo Alto, CA 94304 USA.	salman.azhar@va.gov	Kraemer, Fredric/AAC-3633-2019; zhang, zh/GWV-4677-2022	Kraemer, Fredric/0000-0003-2468-7807; Shen, Wen-Jun/0000-0001-5150-1698	National Institutes of Health, NHLBI [2R01HL33881]; Office of Research and Development, Medical Service, Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061418, R01DK071597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050369] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398, I01BX001923] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Research and Development, Medical Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant 2R01HL33881. This work was also supported by the Office of Research and Development, Medical Service, Department of Veterans Affairs.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Azhar S, 1998, J CLIN ENDOCR METAB, V83, P983, DOI 10.1210/jc.83.3.983; Azhar S, 2003, FRONT BIOSCI-LANDMRK, V8, pS998, DOI 10.2741/1165; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; Azhar S, 2002, J LIPID RES, V43, P861; Azhar S, 1998, J LIPID RES, V39, P1616; AZHAR S, 1989, J LIPID RES, V30, P1799; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cherradi N, 2001, ENDOCRINOLOGY, V142, P4540, DOI 10.1210/en.142.10.4540; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Ediger TR, 1999, ENDOCRINOLOGY, V140, P2976, DOI 10.1210/en.140.7.2976; Fanellli T, 2008, BIOL CELL, V100, P399, DOI 10.1042/BC20070095; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; GWYNNE JT, 1980, J BIOL CHEM, V255, P875; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hu J, 2011, BIOCHEMISTRY-US, V50, P10860, DOI 10.1021/bi201264y; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mardones P, 2001, J LIPID RES, V42, P170; Minkoff C, 1999, CURR OPIN NEPHROL HY, V8, P603, DOI 10.1097/00041552-199909000-00012; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Rao RM, 2003, BIOL REPROD, V68, P114, DOI 10.1095/biolreprod.102.007518; REAVEN E, 1995, J LIPID RES, V36, P1602; Reaven E, 1999, BBA-MOL CELL BIOL L, V1436, P565, DOI 10.1016/S0005-2760(98)00169-6; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Reaven E, 2000, J LIPID RES, V41, P343; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; RINNINGER F, 1994, HEPATOLOGY, V19, P1100, DOI 10.1002/hep.1840190507; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Scott RO, 2002, J BIOL CHEM, V277, P22934, DOI 10.1074/jbc.M202434200; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Slattery C, 2011, CELL PHYSIOL BIOCHEM, V27, P171, DOI 10.1159/000325219; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Temel RE, 1997, P NATL ACAD SCI USA, V94, P13600, DOI 10.1073/pnas.94.25.13600; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Towns R, 2005, ENDOCRINE, V27, P269, DOI 10.1385/ENDO:27:3:269; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856	87	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11416	11435		10.1074/jbc.M112.437368	http://dx.doi.org/10.1074/jbc.M112.437368			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23482569	Green Published, hybrid			2022-12-28	WOS:000317915500044
J	Mahajan, N; Shi, HY; Lukas, TJ; Zhang, M				Mahajan, Nitin; Shi, Heidi Y.; Lukas, Thomas J.; Zhang, Ming			Tumor-suppressive Maspin Functions as a Reactive Oxygen Species Scavenger IMPORTANCE OF CYSTEINE RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAUROSPORINE-INDUCED APOPTOSIS; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; CRYSTAL-STRUCTURE; PROSTATE-CANCER; CHEMICAL PROBES; GENE-EXPRESSION; CARCINOMA CELLS; HUMAN BREAST; IN-VIVO	Maspin is a member of the serine protease inhibitor (serpin) superfamily and displays tumor-suppressing activity by controlling cell migration, proliferation, apoptosis, and adhesion. Here, we provide evidence that maspin acts as a reactive oxygen species (ROS) scavenger through oxidation of three structurally exposed cysteine thiols to sulfenic acid. Ablation of these cysteine residues in maspin resulted in a significant increase in total ROS production in mouse mammary TM40D cells. Also, cells containing a triple-cysteine mutant of maspin showed elevated ERK1/2 activity, a downstream target of ROS, and enhanced proliferation and colony formation. These findings establish a novel mechanism by which maspin utilizes its cysteine thiols to inhibit oxidative stress and cell growth.	[Zhang, Ming] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Zhang, M (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Lurie 6-107,303 E Super St, Chicago, IL 60611 USA.	m-zhang@northwestern.edu	Mahajan, Nitin/A-9144-2015	Mahajan, Nitin/0000-0002-0907-6410	National Institutes of Health [CA79736]; NATIONAL CANCER INSTITUTE [R01CA079736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported, in whole or in part, by National Institutes of Health Grant CA79736 (to M.Z.).	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Bodenstine TM, 2012, CANCER METAST REV, V31, P529, DOI 10.1007/s10555-012-9361-0; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cai Z, 2009, CANCER-AM CANCER SOC, V115, P36, DOI 10.1002/cncr.23991; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Corbett SA, 1996, BLOOD, V88, P158; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Duan H, 2003, ANTIOXID REDOX SIGN, V5, P677, DOI 10.1089/152308603770310356; Endsley MP, 2011, J BIOL CHEM, V286, P24599, DOI 10.1074/jbc.M111.235788; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Krohn AJ, 1998, J NEUROSCI, V18, P8186; Kulinsky V. I., 2009, Biomeditsinskaya Khimiya, V55, P255; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Li JJ, 1998, CARCINOGENESIS, V19, P833, DOI 10.1093/carcin/19.5.833; Li ZG, 2005, ONCOGENE, V24, P2008, DOI 10.1038/sj.onc.1208449; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Nawata S, 2011, INT J MOL MED, V27, P249, DOI 10.3892/ijmm.2010.572; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Qin L, 2010, J BIOL CHEM, V285, P32360, DOI 10.1074/jbc.M110.131045; Reddy KB, 2001, ONCOGENE, V20, P6538, DOI 10.1038/sj.onc.1204796; Sabherwal Y, 2012, INT J ONCOL, V40, P1889, DOI 10.3892/ijo.2012.1392; Schaefer JS, 2010, J BIOL CHEM, V285, P11258, DOI 10.1074/jbc.M109.073932; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Serru V, 2001, CLIN CHEM, V47, P1321; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shi HY, 2001, CANCER RES, V61, P6945; Wang Y, 2012, ANTIOXID REDOX SIGN, V16, P649, DOI 10.1089/ars.2011.4313; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang WG, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-50; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	46	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11611	11620		10.1074/jbc.M112.410852	http://dx.doi.org/10.1074/jbc.M112.410852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23471964	Green Published, hybrid			2022-12-28	WOS:000317915500066
J	Novellasdemunt, L; Tato, I; Navarro-Sabate, A; Ruiz-Meana, M; Mendez-Lucas, A; Perales, JC; Garcia-Dorado, D; Ventura, F; Bartrons, R; Rosa, JL				Novellasdemunt, Laura; Tato, Irantzu; Navarro-Sabate, Aurea; Ruiz-Meana, Marisol; Mendez-Lucas, Andres; Carlos Perales, Jose; Garcia-Dorado, David; Ventura, Francesc; Bartrons, Ramon; Luis Rosa, Jose			Akt-dependent Activation of the Heart 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase (PFKFB2) Isoenzyme by Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; GLUCOSE-METABOLISM; FRUCTOSE 2,6-BISPHOSPHATE; CANCER CELLS; GLYCOLYSIS; INSULIN; 6-PHOSPHOFRUCTO-2-KINASE; PHOSPHORYLATION; PATHWAYS; HYPOXIA	Reciprocal regulation of metabolism and signaling allows cells to modulate their activity in accordance with their metabolic resources. Thus, amino acids could activate signal transduction pathways that control cell metabolism. To test this hypothesis, we analyzed the effect of amino acids on fructose-2,6-bisphosphate (Fru-2,6-P-2) metabolism. We demonstrate that amino acids increase Fru-2,6-P-2 concentration in HeLa and in MCF7 human cells. In conjunction with this, 6-phosphofructo-2-kinase activity, glucose uptake, and lactate concentration were increased. These data correlate with the specific phosphorylation of heart 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB2) isoenzyme at Ser-483. This activation was mediated by the PI3K and p38 signaling pathways. Furthermore, Akt inactivation blocked PFKFB2 phosphorylation and Fru-2,6-P-2 production, thereby suggesting that the above signaling pathways converge at Akt kinase. In accordance with these results, kinase assays showed that amino acid-activated Akt phosphorylated PFKFB2 at Ser-483 and that knockdown experiments confirmed that the increase in Fru-2,6-P-2 concentration induced by amino acids was due to PFKFB2. In addition, similar effects on Fru-2,6-P-2 metabolism were observed in freshly isolated rat cardiomyocytes treated with amino acids, which indicates that these effects are not restricted to human cancer cells. In these cardiomyocytes, the glucose consumption and the production of lactate and ATP suggest an increase of glycolytic flux. Taken together, these results demonstrate that amino acids stimulate Fru-2,6-P-2 synthesis by Akt-dependent PFKFB2 phos-phorylation and activation and show how signaling and metabolism are inextricably linked.	[Novellasdemunt, Laura; Tato, Irantzu; Navarro-Sabate, Aurea; Mendez-Lucas, Andres; Carlos Perales, Jose; Ventura, Francesc; Bartrons, Ramon; Luis Rosa, Jose] Univ Barcelona, Dept Ciencies Fisiol 2, Inst Invest Biomed Bellvitge IDIBELL, Barcelona 08907, Spain; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Lab Expt Cardiol, Vall dHebron Univ Hosp & Res Inst, Barcelona 08035, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Bartrons, R (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, Campus Bellvitge, Barcelona 08907, Spain.	rbartrons@ub.edu; joseluisrosa@ub.edu	Ventura, Francesc/K-9700-2014; Navarro-Sabaté, Aurea/K-6329-2018; PERALES, JOSE C/J-7457-2017; Ventura, Francesc/ABG-2285-2020; Lucas, Andres Mendez/AAG-7488-2020; Rosa, Jose Luis/K-6685-2014; PERALES, JOSE C./AAC-3156-2019; PERALES, JOSE C. C/D-5586-2012	Ventura, Francesc/0000-0001-9673-9405; Navarro-Sabaté, Aurea/0000-0002-8286-9732; PERALES, JOSE C/0000-0001-7363-2226; Ventura, Francesc/0000-0001-9673-9405; Lucas, Andres Mendez/0000-0002-0725-4375; Rosa, Jose Luis/0000-0002-6161-5688; PERALES, JOSE C./0000-0001-7363-2226; PERALES, JOSE C. C/0000-0001-7363-2226; Novellasdemunt Vilaseca, Laura/0000-0003-1590-9842; Bartrons, Ramon/0000-0001-9349-5847	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2011-22498, BFU2009-07380]; Instituto de Salud Carlos III (ISCIII), Spain [RD06/0020]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (ISCIII), Spain(Instituto de Salud Carlos III)	This research was supported by Spanish Ministerio de Ciencia e Innovacion (MICINN) Grants BFU2011-22498 and BFU2009-07380 and by Instituto de Salud Carlos III (ISCIII) Grant RETIC, RD06/0020, Spain.	ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Atlante A, 2003, J NEUROCHEM, V86, P591, DOI 10.1046/j.1471-4159.2003.01863.x; Atsumi T, 2002, CANCER RES, V62, P5881; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Cubillos-Rojas M, 2010, ELECTROPHORESIS, V31, P1318, DOI 10.1002/elps.200900657; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gutmann I., 1974, METHOD ENZYMAT AN, P1461; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hue L, 2002, J MOL CELL CARDIOL, V34, P1091, DOI 10.1006/jmcc.2002.2063; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; Mouton V, 2010, BIOCHEM J, V431, P267, DOI 10.1042/BJ20101089; Novellasdemunt L, 2012, BIOCHEM J, V442, P345, DOI 10.1042/BJ20111418; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Ruckle T, 2004, J MED CHEM, V47, P6921, DOI 10.1021/jm031112e; Ryu JM, 2011, J BIOL CHEM, V286, P23667, DOI 10.1074/jbc.M110.216283; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vertii A, 2006, J BIOL CHEM, V281, P26966, DOI 10.1074/jbc.M602134200; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yamamoto N., 2011, CURR PROTOC PHARM, V12, P12141	41	51	52	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10640	10651		10.1074/jbc.M113.455998	http://dx.doi.org/10.1074/jbc.M113.455998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457334	Green Published, hybrid			2022-12-28	WOS:000317565000042
J	Raman, K; Trivedi, NN; Raymond, WW; Ganesan, R; Kirchhofer, D; Verghese, GM; Craik, CS; Schneider, EL; Nimishakavi, S; Caughey, GH				Raman, Kavita; Trivedi, Neil N.; Raymond, Wilfred W.; Ganesan, Rajkumar; Kirchhofer, Daniel; Verghese, George M.; Craik, Charles S.; Schneider, Eric L.; Nimishakavi, Shilpa; Caughey, George H.			Mutational Tail Loss Is an Evolutionary Mechanism for Liberating Marapsins and Other Type I Serine Proteases from Transmembrane Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; MAST-CELL; SUBSTRATE-SPECIFICITY; PRIMATE EVOLUTION; CATHEPSINS L; PROSTASIN; TRYPTASES; PEPTIDASES; CHYMASE; EXPRESSION	Human and mouse marapsins (Prss27) are serine proteases preferentially expressed by stratified squamous epithelia. However, mouse marapsin contains a transmembrane anchor absent from the human enzyme. To gain insights into physical forms, activities, inhibition, and roles in epithelial differentiation, we traced tail loss in human marapsin to a nonsense mutation in an ancestral ape, compared substrate preferences of mouse and human marapsins with those of the epithelial peptidase prostasin, designed a selective substrate and inhibitor, and generated Prss27-null mice. Phylogenetic analysis predicts that most marapsins are transmembrane proteins. However, nonsense mutations caused membrane anchor loss in three clades: human/bonobo/chimpanzee, guinea pig/degu/tuco-tuco/mole rat, and cattle/yak. Most marapsin-related proteases, including prostasins, are type I transmembrane proteins, but the closest relatives (prosemins) are not. Soluble mouse and human marapsins are tryptic with subsite preferences distinct from those of prostasin, lack general proteinase activity, and unlike prostasins resist antiproteases, including leupeptin, aprotinin, serpins, and alpha(2)-macroglobulin, suggesting the presence of non-canonical active sites. Prss27-null mice develop normally in barrier conditions and are fertile without overt epithelial defects, indicating that marapsin does not play critical, non-redundant roles in development, reproduction, or epithelial differentiation. In conclusion, marapsins are conserved, inhibitor-resistant, tryptic peptidases. Although marapsins are type I transmembrane proteins in their typical form, they mutated independently into anchorless forms in several mammalian clades, including one involving humans. Similar pathways appear to have been traversed by prosemins and tryptases, suggesting that mutational tail loss is an important means of evolving new functions of tryptic serine proteases from transmembrane ancestors.	[Raman, Kavita; Raymond, Wilfred W.; Nimishakavi, Shilpa; Caughey, George H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Trivedi, Neil N.; Caughey, George H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Craik, Charles S.; Schneider, Eric L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Verghese, George M.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Caughey, George H.] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; University of Virginia; Northern California Institute for Research & Education; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caughey, GH (corresponding author), Vet Affairs Med Ctr, 111D,4150 Clement St, San Francisco, CA 94121 USA.	george.caughey@ucsf.edu	Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664; Schneider, Eric/0000-0001-7274-7961	National Institutes of Health [P01 HL024136]; Northern California Institute for Research and Education; United States Department of Defense [PC111318]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northern California Institute for Research and Education; United States Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL024136 (to K. R, W. W. R., S. N., and G. H. C.). This work was also supported by the Northern California Institute for Research and Education (to N. N. T. and G. H. C.) and United States Department of Defense Grant PC111318 (to C. S. C.).	Adachi W, 2006, INVEST OPHTH VIS SCI, V47, P3801, DOI 10.1167/iovs.06-0216; Bhagwandin VJ, 2003, J BIOL CHEM, V278, P3363, DOI 10.1074/jbc.M209353200; Caughey GH, 2008, J BIOL CHEM, V283, P13943, DOI 10.1074/jbc.M710502200; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Le QT, 2011, J IMMUNOL, V187, P1912, DOI 10.4049/jimmunol.1001806; Le QT, 2011, J IMMUNOL, V186, P7136, DOI 10.4049/jimmunol.1001804; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li W, 2009, J BIOL CHEM, V284, P218, DOI 10.1074/jbc.M806267200; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Nimishakavi S, 2012, AM J PHYSIOL-LUNG C, V303, pL97, DOI 10.1152/ajplung.00303.2011; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; Raymond WW, 2009, J IMMUNOL, V182, P5770, DOI 10.4049/jimmunol.0900127; Raymond WW, 2006, J BIOL CHEM, V281, P1489, DOI 10.1074/jbc.M511154200; Raymond WW, 2005, ARCH BIOCHEM BIOPHYS, V435, P311, DOI 10.1016/j.abb.2004.12.025; Raymond WW, 2003, J BIOL CHEM, V278, P34517, DOI 10.1074/jbc.M304087200; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Reimer JM, 2010, IMMUNOGENETICS, V62, P369, DOI 10.1007/s00251-010-0443-2; Spraggon G, 2009, PROTEIN SCI, V18, P1081, DOI 10.1002/pro.118; Trivedi NN, 2008, J ALLERGY CLIN IMMUN, V121, P1262, DOI 10.1016/j.jaci.2008.01.019; Trivedi NN, 2007, J IMMUNOL, V179, P6072, DOI 10.4049/jimmunol.179.9.6072; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Verghese GM, 2004, AM J RESP CELL MOL, V30, P519, DOI 10.1165/rcmb.2003-0251OC; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Wong GW, 2005, BIOCHEM BIOPH RES CO, V336, P579, DOI 10.1016/j.bbrc.2005.08.137; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	41	4	4	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10588	10598		10.1074/jbc.M112.449033	http://dx.doi.org/10.1074/jbc.M112.449033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447538	Green Published, hybrid			2022-12-28	WOS:000317565000038
J	Ren, WY; Sun, YM; Cheema, S; Du, KY				Ren, Wenying; Sun, Yingmin; Cheema, Sarwat; Du, Keyong			Interaction of Constitutive Photomorphogenesis 1 Protein with Protein-Tyrosine Phosphatase 1B Suppresses Protein-Tyrosine Phosphatase 1B Activity and Enhances Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COP1; REGULATES C-JUN; TUMOR-SUPPRESSOR; DOWN-REGULATION; MICE LACKING; KINASE-B; PTP1B; TRB3; TRANSDUCTION; ACTIVATION	Recent studies reveal that COP1 suppresses the expression of gluconeogenetic genes and prohibits hepatic glucose production. To get more insight into COP1 in hepatic cells, we examined the impact of COP1 on insulin-responsive genes and insulin signaling. We found that COP1 increased the responsiveness of insulin-modulated genes to insulin in that it promoted the expression of insulin-induced genes and inhibited that of insulin-suppressed genes and that COP1 enhanced insulin signaling as it promoted phosphorylation of Akt and ERK as well as tyrosine phosphorylation of IR beta induced by insulin. To delineate the mechanism under which COP1 modulates insulin signaling, we examined the possibility that COP1 modulates the activity of PTP1B, the major insulin receptor tyrosine phosphatase. The results indicated that COP1 physically interacted with PTP1B and suppressed PTP1B phosphatase activity as well as the association of PTP1B with IR beta. We suggest that COP1 is a positive regulator of hepatic insulin signaling.	[Ren, Wenying; Sun, Yingmin; Cheema, Sarwat; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319, R56 DK084319]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319, R56DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK084319 and R56 DK084319 (to K. D.). This work was also supported by The American Diabetes Association Career Development Award (to K. D.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Baert JL, 2010, ONCOGENE, V29, P1810, DOI 10.1038/onc.2009.471; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; Baumann CA, 2001, BIOESSAYS, V23, P215, DOI 10.1002/1521-1878(200103)23:3<215::AID-BIES1031>3.0.CO;2-S; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Darnay BG, 1997, J LEUKOCYTE BIOL, V61, P559, DOI 10.1002/jlb.61.5.559; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ding JX, 2008, EXP CELL RES, V314, P1566, DOI 10.1016/j.yexcr.2008.01.026; Du KY, 2009, MOL ENDOCRINOL, V23, P475, DOI 10.1210/me.2008-0284; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FAURE R, 1992, J BIOL CHEM, V267, P11215; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kato S, 2008, J BIOL CHEM, V283, P35464, DOI 10.1074/jbc.M801011200; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Subramanian C, 2004, P NATL ACAD SCI USA, V101, P6798, DOI 10.1073/pnas.0307964101; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wing SS, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S6; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang ZY, 2003, EXPERT OPIN INV DRUG, V12, P223, DOI 10.1517/eoid.12.2.223.21411	59	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10902	10913		10.1074/jbc.M112.369371	http://dx.doi.org/10.1074/jbc.M112.369371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439647	hybrid, Green Published			2022-12-28	WOS:000317565000067
J	Tyagarajan, SK; Ghosh, H; Yevenes, GE; Imanishi, SY; Zeilhofer, HU; Gerrits, B; Fritschy, JM				Tyagarajan, Shiva K.; Ghosh, Himanish; Yevenes, Gonzalo E.; Imanishi, Susumu Y.; Zeilhofer, Hanns Ulrich; Gerrits, Bertran; Fritschy, Jean-Marc			Extracellular Signal-regulated Kinase and Glycogen Synthase Kinase 3 beta Regulate Gephyrin Postsynaptic Aggregation and GABAergic Synaptic Function in a Calpain-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTOR; INHIBITORY SYNAPSES; PHOSPHORYLATION SITES; SPLICE VARIANTS; PLASTICITY; PROTEIN; TRAFFICKING; COLLYBISTIN; NEURONS; MEMORY	Molecular mechanisms of plasticity at GABAergic synapses are currently poorly understood. To identify signaling cascades that converge onto GABAergic postsynaptic density proteins, we performed MS analysis using gephyrin isolated from rat brain and identified multiple novel phosphorylation and acetylation residues on gephyrin. Here, we report the characterization of one of these phosphoresidues, Ser-268, which when dephosphorylated leads to the formation of larger postsynaptic scaffolds. Using a combination of mutagenesis, pharmacological treatment, and biochemical assays, we identify ERK as the kinase phosphorylating Ser-268 and describe a functional interaction between residues Ser-268 and Ser-270. We further demonstrate that alterations in gephyrin clustering via ERK modulation are reflected by amplitude and frequency changes in miniature GABAergic postsynaptic currents. We unravel novel mechanisms for activity-and ERK-dependent calpain action on gephyrin, which are likely relevant in the context of cellular signaling affecting GABAergic transmission and homeostatic synaptic plasticity in pathology.	[Tyagarajan, Shiva K.; Ghosh, Himanish; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Zeilhofer, Hanns Ulrich] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Gerrits, Bertran] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Tyagarajan, Shiva K.; Ghosh, Himanish; Zeilhofer, Hanns Ulrich; Fritschy, Jean-Marc] Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Imanishi, Susumu Y.] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Imanishi, Susumu Y.] Abo Akad Univ, FIN-20520 Turku, Finland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Turku; Abo Akademi University	Tyagarajan, SK (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	tyagarajan@pharma.uzh.ch	Tyagarajan, Shiva/P-3135-2015; Imanishi, Susumu/B-8697-2014; Zeilhofer, Hanns Ulrich/A-4600-2008	Tyagarajan, Shiva/0000-0003-0074-1805; Imanishi, Susumu/0000-0002-3641-4390; Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Fritschy, Jean-Marc/0000-0002-8552-3702; Yevenes, Gonzalo/0000-0003-0294-4075	Forschungskredit of the University of Zurich; EMDO Foundation; Hartmann Muller Foundation; Swiss National Science Foundation	Forschungskredit of the University of Zurich; EMDO Foundation; Hartmann Muller Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Forschungskredit of the University of Zurich, the EMDO Foundation, and the Hartmann Muller Foundation (to S. K. T.) and from the Swiss National Science Foundation (to J. M. F.).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Herweg J, 2012, J BIOL CHEM, V287, P12645, DOI 10.1074/jbc.M112.341826; Houston CM, 2008, J NEUROSCI, V28, P7574, DOI 10.1523/JNEUROSCI.5531-07.2008; Imanishi SY, 2007, MOL CELL PROTEOMICS, V6, P1380, DOI 10.1074/mcp.M600480-MCP200; Jacob TC, 2009, P NATL ACAD SCI USA, V106, P12500, DOI 10.1073/pnas.0903943106; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; Lardi-Studler B, 2007, J CELL SCI, V120, P1371, DOI 10.1242/jcs.003905; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Vlachos A., 2012, CEREBRAL CO IN PRESS; Wuchter J, 2012, J NEUROSCI, V32, P14821, DOI 10.1523/JNEUROSCI.1261-12.2012; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	31	79	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9634	9647		10.1074/jbc.M112.442616	http://dx.doi.org/10.1074/jbc.M112.442616			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408424	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-28	WOS:000317114000007
J	Chen, CC; Wang, KY; Shen, CKJ				Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James			DNA 5-Methylcytosine Demethylation Activities of the Mammalian DNA Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DE-NOVO; PATERNAL GENOME; GENE-EXPRESSION; CALCIUM; METHYLATION; CANCER; 5-HYDROXYMETHYLCYTOSINE; OSCILLATIONS; DNMT3B	Methylation at the 5-position of DNA cytosine on the vertebrate genomes is accomplished by the combined catalytic actions of three DNA methyltransferases (DNMTs), the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1. Although several metabolic routes have been suggested for demethylation of the vertebrate DNA, whether active DNA demethylase(s) exist has remained elusive. Surprisingly, we have found that the mammalian DNMTs, and likely the vertebrates DNMTs in general, can also act as Ca2+ ion- and redox state-dependent active DNA demethylases. This finding suggests new directions for reinvestigation of the structures and functions of these DNMTs, in particular their roles in Ca2+ ion-dependent biological processes, including the genome-wide/local DNA demethylation during early embryogenesis, cell differentiation, neuronal activity-regulated gene expression, and carcinogenesis.	[Chen, Chun-Chang] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chen, Chun-Chang] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015		Frontier of Science Award from the National Science Council; Academia Sinica (Taipei, Taiwan)	Frontier of Science Award from the National Science Council; Academia Sinica (Taipei, Taiwan)(Academia Sinica - Taiwan)	This work was supported in part by the Frontier of Science Award from the National Science Council and Academia Sinica (Taipei, Taiwan).	Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; BONDY SC, 1993, FREE RADICAL BIO MED, V14, P633, DOI 10.1016/0891-5849(93)90144-J; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Girault I, 2003, CLIN CANCER RES, V9, P4415; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Har-Vardi I, 2007, HUM REPROD, V22, P2183, DOI 10.1093/humrep/dem170; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; HOMA ST, 1993, HUM REPROD, V8, P1274, DOI 10.1093/oxfordjournals.humrep.a138240; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ko YG, 2005, J BIOL CHEM, V280, P9627, DOI 10.1074/jbc.M413822200; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Sardet C, 1998, BIOPHYS CHEM, V72, P131, DOI 10.1016/S0301-4622(98)00129-X; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; TAYLOR CT, 1993, HUM REPROD, V8, P2174, DOI 10.1093/oxfordjournals.humrep.a137999; Ulrey CL, 2005, HUM MOL GENET, V14, pR139, DOI 10.1093/hmg/ddi100; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	58	65	68	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9084	9091		10.1074/jbc.M112.445585	http://dx.doi.org/10.1074/jbc.M112.445585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393137	Green Published, hybrid			2022-12-28	WOS:000316862200028
J	Corpe, CP; Eck, P; Wang, J; Al-Hasani, H; Levine, M				Corpe, Christopher P.; Eck, Peter; Wang, Jin; Al-Hasani, Hadi; Levine, Mark			Intestinal Dehydroascorbic Acid (DHA) Transport Mediated by the Facilitative Sugar Transporters, GLUT2 and GLUT8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASCORBIC-ACID; ISOLATED RAT ADIPOCYTES; VITAMIN-C; GLUCOSE TRANSPORTERS; HEXOSE TRANSPORTERS; XENOPUS OOCYTES; IRON-METABOLISM; MOUSE; CELLS; INHIBITION	Intestinal vitamin C (Asc) absorption was believed to be mediated by the Na+-dependent ascorbic acid transporter SVCT1. However, Asc transport across the intestines of SVCT1 knockout mice is normal indicating that alternative ascorbic acid transport mechanisms exist. To investigate these mechanisms, rodents were gavaged with Asc or its oxidized form dehydroascorbic acid (DHA), and plasma Asc concentrations were measured. Asc concentrations doubled following DHA but not Asc gavage. We hypothesized that the transporters responsible were facilitated glucose transporters (GLUTs). Using Xenopus oocyte expression, we investigated whether facilitative glucose transporters GLUT2 and GLUT5-12 transported DHA. Only GLUT2 and GLUT8, known to be expressed in intestines, transported DHA with apparent transport affinities (K-m) of 2.33 and 3.23 mM and maximal transport rates (V-max) of 25.9 and 10.1 pmol/min/oocyte, respectively. Maximal rates for DHA transport mediated by GLUT2 and GLUT8 in oocytes were lower than maximal rates for 2-deoxy-D-glucose (V-max of 224 and 32 pmol/min/oocyte for GLUT2 and GLUT8, respectively) and fructose (V-max of 406 and 116 pmol/min/oocyte for GLUT2 and GLUT8, respectively). These findings may be explained by differences in the exofacial binding of substrates, as shown by inhibition studies with ethylidine glucose. DHA transport activity in GLUT2- and GLUT8-expressing oocytes was inhibited by glucose, fructose, and by the flavonoids phloretin and quercetin. These studies indicate intestinal DHA transport may be mediated by the facilitative sugar transporters GLUT2 and GLUT8. Furthermore, dietary sugars and flavonoids in fruits and vegetables may modulate Asc bioavailability via inhibition of small intestinal GLUT2 and GLUT8.	[Corpe, Christopher P.; Eck, Peter; Wang, Jin; Al-Hasani, Hadi; Levine, Mark] NIDDK, Mol & Clin Nutr Sect, Digest Dis Branch, Intramural Res Program,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Corpe, CP (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, Sch Med, Room 3-114,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.		WANG, Jin/A-8327-2012	WANG, Jin/0000-0002-0062-2489; Eck, Peter/0000-0003-2371-9774; corpe, christopher/0000-0003-1994-8312	National Institutes of Health Intramural Research Program Grant from NIDDK [DK054506-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK053211, ZIADK053218, ZIADK054506] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program Grant from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant DK054506-15 from NIDDK.	Anderson Gregory J, 2005, Curr Gastroenterol Rep, V7, P365, DOI 10.1007/s11894-005-0005-1; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Corpe CP, 2005, J BIOL CHEM, V280, P5211, DOI 10.1074/jbc.M412925200; DEOLIVEIRA JED, 1959, AM J CLIN NUTR, V7, P630, DOI 10.1093/ajcn/7.6.630; GOLDMAN HM, 1981, AM J CLIN NUTR, V34, P24, DOI 10.1093/ajcn/34.1.24; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; Koshiishi I, 1998, BBA-GEN SUBJECTS, V1425, P209, DOI 10.1016/S0304-4165(98)00073-7; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Latunde-Dada GO, 2002, BLOOD CELL MOL DIS, V29, P356, DOI 10.1006/bcmd.2002.0574; Li HY, 2012, ANAL BIOCHEM, V426, P109, DOI 10.1016/j.ab.2012.04.014; Li Q, 2004, AM J PHYSIOL-GASTR L, V287, pG236, DOI 10.1152/ajpgi.00396.2003; Lisinski I, 2001, BIOCHEM J, V358, P517, DOI 10.1042/0264-6021:3580517; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; May JM, 2002, METHOD ENZYMOL, V347, P327; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; Ogiri Y, 2002, J AGR FOOD CHEM, V50, P227, DOI 10.1021/jf010910f; OTSUKA M, 1986, J NUTR SCI VITAMINOL, V32, P183, DOI 10.3177/jnsv.32.183; Park JB, 1999, BIOCHEM BIOPH RES CO, V260, P568, DOI 10.1006/bbrc.1999.0890; Romero A, 2009, J CELL BIOCHEM, V106, P1068, DOI 10.1002/jcb.22090; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Rumsey SC, 2000, J BIOL CHEM, V275, P28246; SMITH RM, 1993, ARCH BIOCHEM BIOPHYS, V300, P238, DOI 10.1006/abbi.1993.1033; Song J, 2002, J BIOL CHEM, V277, P15252, DOI 10.1074/jbc.M110496200; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Su D, 2006, J BIOL CHEM, V281, P39852, DOI 10.1074/jbc.M606543200; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; WASHKO PW, 1989, ANAL BIOCHEM, V181, P276, DOI 10.1016/0003-2697(89)90243-1	33	85	86	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9092	9101		10.1074/jbc.M112.436790	http://dx.doi.org/10.1074/jbc.M112.436790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396969	hybrid, Green Published			2022-12-28	WOS:000316862200029
J	Sharma, J; Mukherjee, D; Rao, SNR; Iyengar, S; Shankar, SK; Satishchandra, P; Jana, NR				Sharma, Jaiprakash; Mukherjee, Diptendu; Rao, Sudheendra N. R.; Iyengar, Soumya; Shankar, Susarla Krishna; Satishchandra, Parthasarathy; Jana, Nihar Ranjan			Neuronatin-mediated Aberrant Calcium Signaling and Endoplasmic Reticulum Stress Underlie Neuropathology in Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; E3 UBIQUITIN LIGASE; PROTEASOMAL FUNCTION; GLYCOGEN-SYNTHESIS; MESSENGER-RNA; MOUSE MODEL; MALIN; PROTEIN; GENE; DEGRADATION	Lafora disease (LD) is a teenage-onset inherited progressive myoclonus epilepsy characterized by the accumulations of intracellular inclusions called Lafora bodies and caused by mutations in protein phosphatase laforin or ubiquitin ligase malin. But how the loss of function of either laforin or malin causes disease pathogenesis is poorly understood. Recently, neuronatin was identified as a novel substrate of malin that regulates glycogen synthesis. Here we demonstrate that the level of neuronatin is significantly up-regulated in the skin biopsy sample of LD patients having mutations in both malin and laforin. Neuronatin is highly expressed in human fetal brain with gradual decrease in expression in developing and adult brain. However, in adult brain, neuronatin is predominantly expressed in parvalbumin-positive GABAergic interneurons and localized in their processes. The level of neuronatin is increased and accumulated as insoluble aggregates in the cortical area of LD brain biopsy samples, and there is also a dramatic loss of parvalbumin-positive GABAergic interneurons. Ectopic expression of neuronatin in cultured neuronal cells results in increased intracellular Ca2+, endoplasmic reticulum stress, proteasomal dysfunction, and cell death that can be partially rescued by malin. These findings suggest that the neuronatin-induced aberrant Ca2+ signaling and endoplasmic reticulum stress might underlie LD pathogenesis.	[Sharma, Jaiprakash; Mukherjee, Diptendu; Rao, Sudheendra N. R.; Jana, Nihar Ranjan] Natl Brain Res Ctr, Manesar 122050, Gurgaon, India; [Iyengar, Soumya] Natl Brain Res Ctr, Neuroanat Lab, Manesar 122050, Gurgaon, India; [Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Satishchandra, Parthasarathy] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Jana, NR (corresponding author), Natl Brain Res Ctr, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in	Rao, Sudheendra/K-3017-2014	Rao, Sudheendra/0000-0001-7576-1718; Jana, Nihar/0000-0002-6549-4211	Department of Biotechnology to National Brain Research Centre, Government of India; Extramural Grant from the Department of Biotechnology, Government of India [BT/PR13590/MED/30/286/2009]; Department of Biotechnology, Government of India	Department of Biotechnology to National Brain Research Centre, Government of India; Extramural Grant from the Department of Biotechnology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a core grant from the Department of Biotechnology to National Brain Research Centre, Government of India, and Extramural Grant BT/PR13590/MED/30/286/2009 from the Department of Biotechnology, Government of India.; Supported by a research fellowship from Department of Biotechnology, Government of India.	ACHARYA JN, 1993, EPILEPSIA, V34, P476, DOI 10.1111/j.1528-1157.1993.tb02588.x; Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Arava Y, 1999, DIABETES, V48, P552, DOI 10.2337/diabetes.48.3.552; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CARPENTER S, 1981, NEUROLOGY, V31, P1564, DOI 10.1212/WNL.31.12.1564; Chan EM, 2004, NEUROLOGY, V63, P565, DOI 10.1212/01.WNL.0000133215.65836.03; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dou DX, 1996, BRAIN RES, V723, P8, DOI 10.1016/0006-8993(96)00167-9; Dou DX, 1996, GENOMICS, V33, P292, DOI 10.1006/geno.1996.0195; Dugu L, 2010, J DERMATOL, V37, P846, DOI 10.1111/j.1346-8138.2010.00873.x; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; JOSEPH R, 1995, BRAIN RES, V690, P92, DOI 10.1016/0006-8993(95)00621-V; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Lin HH, 2010, STEM CELLS, V28, P1950, DOI 10.1002/stem.530; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mzhavia N, 2008, DIABETES, V57, P2774, DOI 10.2337/db07-1746; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Sharma J, 2011, NEUROBIOL DIS, V44, P133, DOI 10.1016/j.nbd.2011.06.013; Singh S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039479; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Sinha S, 2007, J NEUROL SCI, V252, P16, DOI 10.1016/j.jns.2006.09.021; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200	47	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9482	9490		10.1074/jbc.M112.416180	http://dx.doi.org/10.1074/jbc.M112.416180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408434	Green Published, hybrid			2022-12-28	WOS:000316862200064
J	Corvetta, D; Chayka, O; Gherardi, S; D'Acunto, CW; Cantilena, S; Valli, E; Piotrowska, I; Perini, G; Sala, A				Corvetta, Daisy; Chayka, Olesya; Gherardi, Samuele; D'Acunto, Cosimo W.; Cantilena, Sandra; Valli, Emanuele; Piotrowska, Izabela; Perini, Giovanni; Sala, Arturo			Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma FUNCTIONAL AND THERAPEUTIC IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TUMOR-SUPPRESSOR GENES; CELL-LINES; DNA HYPERMETHYLATION; HDAC INHIBITORS; EXPRESSION; TUMORIGENESIS; TRANSCRIPTION; CLUSTERIN; PATTERN	CLU (clusterin) is a tumor suppressor gene that we have previously shown to be negatively modulated by the MYCN protooncogene, but the mechanism of repression was unclear. Here, we show that MYCN inhibits the expression of CLU by direct interaction with the non-canonical E box sequence CACGCG in the 5'-flanking region. Binding of MYCN to the CLU gene induces bivalent epigenetic marks and recruitment of repressive proteins such as histone deacetylases and Polycomb members. MYCN physically binds in vitro and in vivo to EZH2, a component of the Polycomb repressive complex 2, required to repress CLU. Notably, EZH2 interacts with the Myc box domain 3, a segment of MYC known to be essential for its transforming effects. The expression of CLU can be restored in MYCN-amplified cells by epigenetic drugs with therapeutic results. Importantly, the anticancer effects of the drugs are ablated if CLU expression is blunted by RNA interference. Our study implies that MYC tumorigenesis can be effectively antagonized by epigenetic drugs that interfere with the recruitment of chromatin modifiers at repressive E boxes of tumor suppressor genes such as CLU.	[Piotrowska, Izabela; Sala, Arturo] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London WC1N 1EH, England; [Sala, Arturo] Brunel Univ, Inst Canc Genet & Pharmacogen, London UB8 3PH, England; [Gherardi, Samuele; Valli, Emanuele; Perini, Giovanni] Univ Bologna, Dept Biol, I-40126 Bologna, Italy	University of London; University College London; Brunel University; University of Bologna	Perini, G (corresponding author), Univ Bologna, Dept Biol, Via Belmeloro 8, I-40126 Bologna, Italy.	giovanni.perini@unibo.it; Arturo.Sala@brunel.ac.uk	Valli, Emanuele/ABD-7213-2020	Valli, Emanuele/0000-0002-0928-8624; Sala, Arturo/0000-0002-2841-7866	SPARKS; Neuroblastoma Society; Wellcome Trust; Italian Association for Cancer Research	SPARKS; Neuroblastoma Society; Wellcome Trust(Wellcome TrustEuropean Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from SPARKS, The Neuroblastoma Society, a Wellcome Trust grant (to A. S.), and the Italian Association for Cancer Research (to G. P.).	Balch C, 2007, BIOESSAYS, V29, P842, DOI 10.1002/bies.20619; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burkhart CA, 2003, J NATL CANCER I, V95, P1394, DOI 10.1093/jnci/djg045; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fox E, 2009, J NATL CANCER I, V101, P1105, DOI 10.1093/jnci/djp238; Garinis GA, 2002, HUM GENET, V111, P115, DOI 10.1007/s00439-002-0783-6; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Lutz W, 1996, ONCOGENE, V13, P803; Marchion D, 2007, EXPERT REV ANTICANC, V7, P583, DOI 10.1586/14737140.7.4.583; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1977, CANCER RES, V37, P1364; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	34	59	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8332	8341		10.1074/jbc.M113.454280	http://dx.doi.org/10.1074/jbc.M113.454280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362253	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000316564500033
J	Harris, NC; Davydova, N; Roufail, S; Paquet-Fifield, S; Paavonen, K; Karnezis, T; Zhang, YF; Sato, T; Rothacker, J; Nice, EC; Stacker, SA; Achen, MG				Harris, Nicole C.; Davydova, Natalia; Roufail, Sally; Paquet-Fifield, Sophie; Paavonen, Karri; Karnezis, Tara; Zhang, You-Fang; Sato, Teruhiko; Rothacker, Julie; Nice, Edouard C.; Stacker, Steven A.; Achen, Marc G.			The Propeptides of VEGF-D Determine Heparin Binding, Receptor Heterodimerization, and Effects on Tumor Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; FACTOR-D EXPRESSION; LYMPHATIC METASTASIS; MOLECULAR CONTROL; D PROMOTES; LYMPHANGIOGENESIS; CANCER; ANGIOGENESIS; NEUROPILIN-1; CELLS	VEGF-D is an angiogenic and lymphangiogenic glycoprotein that can be proteolytically processed generating various forms differing in subunit composition due to the presence or absence of N- and C-terminal propeptides. These propeptides flank the central VEGF homology domain, that contains the binding sites for VEGF receptors (VEGFRs), but their biological functions were unclear. Characterization of propeptide function will be important to clarify which forms of VEGF-D are biologically active and therefore clinically relevant. Here we use VEGF-D mutants deficient in either propeptide, and in the capacity to process the remaining propeptide, to monitor the functions of these domains. We report for the first time that VEGF-D binds heparin, and that the C-terminal propeptide significantly enhances this interaction (removal of this propeptide from fulllength VEGF-D completely prevents heparin binding). We also show that removal of either the N- or C-terminal propeptide is required for VEGF-D to drive formation of VEGFR-2/VEGFR-3 heterodimers which have recently been shown to positively regulate angiogenic sprouting. The mature form of VEGF-D, lacking both propeptides, can also promote formation of these receptor heterodimers. In a mouse tumor model, removal of only the C-terminal propeptide from full-length VEGF-D was sufficient to enhance angiogenesis and tumor growth. In contrast, removal of both propeptides is required for high rates of lymph node metastasis. The findings reported here show that the propeptides profoundly influence molecular interactions of VEGF-D with VEGF receptors, co-receptors, and heparin, and its effects on tumor biology.	[Harris, Nicole C.; Davydova, Natalia; Roufail, Sally; Paquet-Fifield, Sophie; Karnezis, Tara; Zhang, You-Fang; Sato, Teruhiko; Stacker, Steven A.; Achen, Marc G.] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic 3002, Australia; [Harris, Nicole C.; Paavonen, Karri; Rothacker, Julie; Nice, Edouard C.; Stacker, Steven A.; Achen, Marc G.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Stacker, Steven A.; Achen, Marc G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Peter Maccallum Cancer Center; University of Melbourne	Achen, MG (corresponding author), Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic 3002, Australia.	Marc.achen@petermac.org	Paquet-Fifield, Sophie/AAL-6410-2021	Achen, Marc/0000-0002-3791-803X; Rothacker, Julie/0000-0001-7560-4982; Stacker, Steven/0000-0003-4096-9273	National Health and Medical Research Council of Australia; Melbourne Research Scholarship; Victorian Government, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Research Scholarship; Victorian Government, Australia	This work was supported by a Program Grant and Research Fellowships (to S.A.S. and M.G.A.) from the National Health and Medical Research Council of Australia, a Melbourne Research Scholarship (to N.C.H.) and funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. S.A.S. and M.G.A. are consultants to Vegenics Ltd., a company developing anti-cancer therapeutics.	Achen MG, 2006, BRIT J CANCER, V94, P1355, DOI 10.1038/sj.bjc.6603120; Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Achen MG, 2012, GROWTH FACTORS, V30, P283, DOI 10.3109/08977194.2012.704917; Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Baldwin ME, 2005, MOL CELL BIOL, V25, P2441, DOI 10.1128/MCB.25.6.2441-2449.2005; Baldwin ME, 2002, BIOESSAYS, V24, P1030, DOI 10.1002/bies.10173; Baldwin ME, 2001, J BIOL CHEM, V276, P44307, DOI 10.1074/jbc.M106188200; Bhardwaj S, 2003, HUM GENE THER, V14, P1451, DOI 10.1089/104303403769211664; Debinski W, 2001, MOL MED, V7, P598, DOI 10.1007/BF03401866; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Grau S, 2011, J NEURO-ONCOL, V104, P103, DOI 10.1007/s11060-010-0480-6; Haiko P, 2008, MOL CELL BIOL, V28, P4843, DOI 10.1128/MCB.02214-07; Harris NC, 2011, FASEB J, V25, P2615, DOI 10.1096/fj.10-179788; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Juttner S, 2006, J CLIN ONCOL, V24, P228, DOI 10.1200/JCO.2004.00.3467; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Keck RG, 1997, ARCH BIOCHEM BIOPHYS, V344, P103, DOI 10.1006/abbi.1997.0145; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kopfstein L, 2007, AM J PATHOL, V170, P1348, DOI 10.2353/ajpath.2007.060835; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Moffat BA, 2006, CLIN CANCER RES, V12, P1525, DOI 10.1158/1078-0432.CCR-05-1408; Nakamura Y, 2003, CLIN CANCER RES, V9, P716; Nice EC, 1999, BIOESSAYS, V21, P339, DOI 10.1002/(SICI)1521-1878(199904)21:4<339::AID-BIES11>3.0.CO;2-C; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rutanen J, 2003, CARDIOVASC RES, V59, P971, DOI 10.1016/S0008-6363(03)00518-2; Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2; Seyama K, 2010, LYMPHAT RES BIOL, V8, P21, DOI 10.1089/lrb.2009.0018; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; van Iterson V, 2007, AM J CLIN PATHOL, V128, P759, DOI 10.1309/7FXVRMXF58PVRJUH; Von Marschall Z, 2005, INT J ONCOL, V27, P669; White JD, 2002, CANCER RES, V62, P1669; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yin X, 2011, J BIOL CHEM, V286, P14952, DOI 10.1074/jbc.M110.206664; Yuan L, 2002, DEVELOPMENT, V129, P4797	55	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8176	8186		10.1074/jbc.M112.439299	http://dx.doi.org/10.1074/jbc.M112.439299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23404505	hybrid, Green Published			2022-12-28	WOS:000316564500018
J	Malik, AR; Urbanska, M; Gozdz, A; Swiech, LJ; Nagalski, A; Perycz, M; Blazejczyk, M; Jaworski, J				Malik, Anna R.; Urbanska, Malgorzata; Gozdz, Agata; Swiech, Lukasz J.; Nagalski, Andrzej; Perycz, Malgorzata; Blazejczyk, Magdalena; Jaworski, Jacek			Cyr61, a Matricellular Protein, Is Needed for Dendritic Arborization of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-ANGIOGENIC ACTIVITIES; GENE-EXPRESSION; MAMMALIAN TARGET; CCN1 CYR61; GROWTH; MTOR; ACTIVATION; CELLS; PHOSPHORYLATION; ALPHA(V)BETA(3)	The shape of the dendritic arbor is one of the criteria of neuron classification and reflects functional specialization of particular classes of neurons. The development of a proper dendritic branching pattern strongly relies on interactions between the extracellular environment and intracellular processes responsible for dendrite growth and stability. We previously showed that mammalian target of rapamycin (mTOR) kinase is crucial for this process. In this work, we performed a screen for modifiers of dendritic growth in hippocampal neurons, the expression of which is potentially regulated by mTOR. As a result, we identified Cyr61, an angiogenic factor with unknown neuronal function, as a novel regulator of dendritic growth, which controls dendritic growth in a beta 1-integrin-dependent manner.	[Malik, Anna R.; Urbanska, Malgorzata; Gozdz, Agata; Swiech, Lukasz J.; Perycz, Malgorzata; Blazejczyk, Magdalena; Jaworski, Jacek] Int Inst Mol & Cell Biol, Lab Mol & Cellular Neurobiol, PL-02109 Warsaw, Poland; [Nagalski, Andrzej] Int Inst Mol & Cell Biol, Lab Neurodegenerat, PL-02109 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Jaworski, J (corresponding author), Int Inst Mol & Cell Biol, Lab Mol & Cellular Neurobiol, 4 Ks Trojdena St, PL-02109 Warsaw, Poland.	jaworski@iimcb.gov.pl	Nagalski, Andrzej/AAH-3366-2019; Nagalski, Andrzej/O-3173-2015; Gozdz, Agata/AAD-2974-2022; Perycz, Malgorzata/HHN-0050-2022; Malik, Anna R/O-7126-2017	Nagalski, Andrzej/0000-0002-4864-5604; Nagalski, Andrzej/0000-0002-4864-5604; Gozdz, Agata/0000-0001-8421-0598; Perycz, Malgorzata/0000-0003-3154-6594; Malik, Anna R/0000-0001-7732-0756; Jaworski, Jacek/0000-0001-8760-7865; Urbanska, Malgorzata/0000-0001-9521-0366	FP-7Health-Prot Grant [229697]; National Center for Research and Development; National Science Center [OPUS 2011/03/B/NZ3/01970]; European Union;  [ERA-NET-Neuron/03/2010]	FP-7Health-Prot Grant; National Center for Research and Development(National Centre for Research & Development, Poland); National Science Center(National Science Centre, Poland); European Union(European Commission); 	This work was supported by FP-7Health-Prot Grant 229697, ERA-NET-Neuron/03/2010 (co-financed by the National Center for Research and Development) and National Science Center Grant OPUS 2011/03/B/NZ3/01970 (JJ). Also co-financed by European Union funds from European Social Fund (M.U.).	Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chen XY, 2009, NEUROSCI RES, V64, P348, DOI 10.1016/j.neures.2009.04.007; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang YF, 2010, J NEUROSCI, V30, P6080, DOI 10.1523/JNEUROSCI.5493-09.2010; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Konopka W, 2005, NEUROBIOL DIS, V19, P283, DOI 10.1016/j.nbd.2005.01.018; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Latinkic BV, 2001, ENDOCRINOLOGY, V142, P2549, DOI 10.1210/en.142.6.2549; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Leu SJ, 2004, J BIOL CHEM, V279, P44177, DOI 10.1074/jbc.M407850200; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Li ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035754; Licht T, 2010, DEVELOPMENT, V137, P261, DOI 10.1242/dev.039636; Loewith R, 2010, ENZYMES, V27, P147, DOI 10.1016/S1874-6047(10)27009-9; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Ohkawa Y, 2011, BIOCHEM BIOPH RES CO, V411, P483, DOI 10.1016/j.bbrc.2011.06.118; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Perycz M, 2011, J NEUROSCI, V31, P5271, DOI 10.1523/JNEUROSCI.2387-10.2011; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Sampath D, 2002, ENDOCRINE, V18, P147, DOI 10.1385/ENDO:18:2:147; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlomann U, 2009, J CELL SCI, V122, P2034, DOI 10.1242/jcs.038232; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHOLL DA, 1953, J ANAT, V87, P387; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Stuart G, 2007, DENDRITES; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Tyburczy ME, 2010, AM J PATHOL, V176, P1878, DOI 10.2353/ajpath.2010.090950; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; Urbanska M, 2012, J BIOL CHEM, V287, P30240, DOI 10.1074/jbc.M112.374405; Ward NL, 2005, J COMP NEUROL, V482, P244, DOI 10.1002/cne.20422; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006; Zhang XD, 2012, AM J REPROD IMMUNOL, V67, P216, DOI 10.1111/j.1600-0897.2011.01080.x	70	31	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8544	8559		10.1074/jbc.M112.411629	http://dx.doi.org/10.1074/jbc.M112.411629			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362279	Green Published, hybrid			2022-12-28	WOS:000316564500050
J	Currie, MA; Cameron, K; Dias, FMV; Spencer, HL; Bayer, EA; Fontes, CMGA; Smith, SP; Jia, ZC				Currie, Mark A.; Cameron, Kate; Dias, Fernando M. V.; Spencer, Holly L.; Bayer, Edward A.; Fontes, Carlos M. G. A.; Smith, Steven P.; Jia, Zongchao			Small Angle X-ray Scattering Analysis of Clostridium thermocellum Cellulosome N-terminal Complexes Reveals a Highly Dynamic Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; COHESIN DOMAIN; BINDING; ENDOGLUCANASE; MECHANISM; PROTEINS; INSIGHTS; NANOMACHINES; PROVIDES; CIPA	Clostridium thermocellum produces the prototypical cellulosome, a large multienzyme complex that efficiently hydrolyzes plant cell wall polysaccharides into fermentable sugars. This ability has garnered great interest in its potential application in biofuel production. The core non-catalytic scaffoldin subunit, CipA, bears nine type I cohesin modules that interact with the type I dockerin modules of secreted hydrolytic enzymes and promotes catalytic synergy. Because the large size and flexibility of the cellulosome preclude structural determination by traditional means, the structural basis of this synergy remains unclear. Small angle x-ray scattering has been successfully applied to the study of flexible proteins. Here, we used small angle x-ray scattering to determine the solution structure and to analyze the conformational flexibility of two overlapping N-terminal cellulosomal scaffoldin fragments comprising two type I cohesin modules and the cellulose-specific carbohydrate-binding module from CipA in complex with Cel8A cellulases. The pair distribution functions, ab initio envelopes, and rigid body models generated for these two complexes reveal extended structures. These two N-terminal cellulosomal fragments are highly dynamic and display no preference for extended or compact conformations. Overall, our work reveals structural and dynamic features of the N terminus of the CipA scaffoldin that may aid in cellulosome substrate recognition and binding.	[Currie, Mark A.; Spencer, Holly L.; Smith, Steven P.; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Smith, Steven P.; Jia, Zongchao] Queens Univ, Prot Funct Discovery Grp, Kingston, ON K7L 3N6, Canada; [Cameron, Kate; Dias, Fernando M. V.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Fac Med Vet, Ctr Interdisciplinar Invest Sanidade Anim, P-1300477 Lisbon, Portugal; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Queens University - Canada; Queens University - Canada; Universidade de Lisboa; Weizmann Institute of Science	Smith, SP (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	steven.smith@queensu.ca; jia@queensu.ca	Dias, Fernando/I-4861-2012	Dias, Fernando/0000-0001-8109-2063; Smith, Steven/0000-0003-2710-4400; Fontes, Carlos/0000-0002-1219-9753	Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants from the Natural Science and Engineering Research Council of Canada (to S. P. S.) and the Canadian Institutes of Health Research (to Z. J.).	Adams JJ, 2010, J MOL BIOL, V396, P833, DOI 10.1016/j.jmb.2010.01.015; Alzari PM, 1996, STRUCTURE, V4, P265, DOI 10.1016/S0969-2126(96)00031-7; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Beguin P, 1998, BIOCHEM SOC T, V26, P178, DOI 10.1042/bst0260178; Brett CT, 1996, PHYSL BIOCH PLANT CE; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Currie MA, 2012, J BIOL CHEM, V287, P26953, DOI 10.1074/jbc.M112.343897; DeLano W.L, PYMOL MOL GRAPHICS S; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Garcia-Alvarez B, 2011, J MOL BIOL, V407, P571, DOI 10.1016/j.jmb.2011.01.060; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; GUINIER A, 1955, SMALL ANGLE XRAYS; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; LAMED R, 1983, BIOTECHNOL BIOENG, P163; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lytle BL, 2001, J MOL BIOL, V307, P745, DOI 10.1006/jmbi.2001.4522; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Molinier AL, 2011, J MOL BIOL, V405, P143, DOI 10.1016/j.jmb.2010.10.013; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; POOLE DM, 1992, FEMS MICROBIOL LETT, V99, P181, DOI 10.1111/j.1574-6968.1992.tb05563.x; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tormo J, 1996, J EUR MOL BIOL ORG E, V5, P5739; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183	41	19	19	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7978	7985		10.1074/jbc.M112.408757	http://dx.doi.org/10.1074/jbc.M112.408757			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341454	Green Published, hybrid			2022-12-28	WOS:000316455300050
J	Nallar, SC; Kalakonda, S; Lindner, DJ; Lorenz, RR; Lamarre, E; Xiao, WH; Kalvakolanu, DV				Nallar, Shreeram C.; Kalakonda, Sudhakar; Lindner, Daniel J.; Lorenz, Robert R.; Lamarre, Eric; Xiao Weihua; Kalvakolanu, Dhananjaya V.			Tumor-derived Mutations in the Gene Associated with Retinoid Interferon-induced Mortality (GRIM-19) Disrupt Its Anti-signal Transducer and Activator of Transcription 3 (STAT3) Activity and Promote Oncogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; DOWN-REGULATION; UNPHOSPHORYLATED STAT3; MITOCHONDRIAL STAT3; PROTEIN INHIBITOR; BONE METASTASIS; CORTACTIN; CANCER; INVASION; RECEPTOR	The signal transducer and activator of transcription 3 (STAT3) protein is critical for multiple cytokine and growth factor-induced biological responses in vivo. Its transcriptional activity is controlled by a transient phosphorylation of a critical tyrosine. Constitutive activation of STAT3 imparts resistance to apoptosis, promotes cell proliferation, and induces de novo micro-angiogenesis, three of the six cardinal hallmarks of a typical cancer cell. Earlier we reported the isolation of GRIM-19 as a growth suppressor using a genome-wide expression knockdown strategy. GRIM-19 binds to STAT3 and suppresses its transcriptional activity. To understand the pathological relevance of GRIM-19, we screened a set of primary head and neck tumors and identified three somatic mutations in GRIM-19. Wild-type GRIM-19 suppressed cellular transformation by a constitutively active form of STAT3, whereas tumor-derived mutants L71P, L91P and A95T significantly lost their ability to associate with STAT3, block gene expression, and suppress cellular transformation and tumor growth in vivo. Additionally, these mutants lost their capacity to prevent metastasis. These mutations define a mechanism by which STAT3 activity is deregulated in certain human head and neck tumors.	[Nallar, Shreeram C.; Kalakonda, Sudhakar; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Lindner, Daniel J.] Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Lorenz, Robert R.; Lamarre, Eric] Cleveland Clin Fdn, Head & Neck Inst, Cleveland, OH 44195 USA; [Xiao Weihua] Univ Sci Technol, Hefei 230027, Peoples R China	University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu	Lindner, Daniel/ABB-5440-2020; Xiao, Weihua/N-2775-2013	Xiao, Weihua/0000-0001-9102-6326	National Institutes of Health [R01 CA105005]; Cigarette Restitution Funds of the University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE [R01CA105005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cigarette Restitution Funds of the University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA105005 (to D. V. K.). This work was also supported by an intramural award from the Cigarette Restitution Funds of the University of Maryland Greenebaum Cancer Center (to D. V. K.).	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Anolik Robert, 2009, Dermatol Online J, V15, P16; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Couto JP, 2012, P NATL ACAD SCI USA, V109, pE2361, DOI 10.1073/pnas.1201232109; Du XL, 2009, ONCOGENE, V28, P3714, DOI 10.1038/onc.2009.237; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fan XY, 2012, MED ONCOL, V29, P3183, DOI 10.1007/s12032-012-0249-1; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gong Long-Bo, 2007, Ai Zheng, V26, P683; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao HB, 2012, J CELL PHYSIOL, V227, P1212, DOI 10.1002/jcp.24025; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jimenez-Lara AM, 2002, FEBS LETT, V526, P142, DOI 10.1016/S0014-5793(02)03154-X; Junicho A, 2000, BIOCHEM BIOPH RES CO, V278, P9, DOI 10.1006/bbrc.2000.3753; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kalvakolanu DV, 2004, CYTOKINE GROWTH F R, V15, P169, DOI 10.1016/j.cytogfr.2004.01.002; Kim DW, 2007, MOL ENDOCRINOL, V21, P3039, DOI 10.1210/me.2007-0269; KIMURA G, 1975, INT J CANCER, V15, P694, DOI 10.1002/ijc.2910150419; Kumanovics A, 2010, J CLIN IMMUNOL, V30, P886, DOI 10.1007/s10875-010-9452-z; Levy C, 2003, MOL CELL BIOL, V23, P9073, DOI 10.1128/MCB.23.24.9073-9080.2003; Li FF, 2012, MED ONCOL, V29, P3046, DOI 10.1007/s12032-012-0234-8; Li XH, 2008, INT J ONCOL, V33, P69; Li YS, 2001, CANCER RES, V61, P6906; Lindner DJ, 1997, CLIN CANCER RES, V3, P931; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Masuda M, 2010, CURR CANCER DRUG TAR, V10, P117, DOI 10.2174/156800910790980197; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; Nallar SC, 2010, AM J PATHOL, V177, P896, DOI 10.2353/ajpath.2010.091280; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; Papanastasiou AD, 2010, MOL IMMUNOL, V47, P1629, DOI 10.1016/j.molimm.2010.01.010; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Renner ED, 2007, NEW ENGL J MED, V357, P1667, DOI 10.1056/NEJMc076367; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Sato N, 2001, AM J PATHOL, V159, P2017, DOI 10.1016/S0002-9440(10)63053-2; Seo T, 2002, J VIROL, V76, P8797, DOI 10.1128/JVI.76.17.8797-8807.2002; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; USHIJIMA T, 1994, JPN J CANCER RES, V85, P455, DOI 10.1111/j.1349-7006.1994.tb02379.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Wang ZJ, 1999, BRIT J CANCER, V80, P70, DOI 10.1038/sj.bjc.6690323; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xie LX, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/289873; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176; Zhang YM, 2011, CANCER SCI, V102, P1991, DOI 10.1111/j.1349-7006.2011.02059.x; Zhou Ai-Min, 2009, Ai Zheng, V28, P431; Zhou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022065; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	70	25	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7930	7941		10.1074/jbc.M112.440610	http://dx.doi.org/10.1074/jbc.M112.440610			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23386605	Green Published, hybrid			2022-12-28	WOS:000316455300046
J	Morel, L; Regan, M; Higashimori, H; Ng, SK; Esau, C; Vidensky, S; Rothstein, J; Yang, YJ				Morel, Lydie; Regan, Melissa; Higashimori, Haruki; Seng Kah Ng; Esau, Christine; Vidensky, Svetlana; Rothstein, Jeffrey; Yang, Yongjie			Neuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA EXPRESSION; ASTROCYTES; SECRETION; VARIANTS; BRAIN; EAAT2; LOCALIZATION; BIOGENESIS; MECHANISMS; PEPTIDES	Perisynaptic astrocytes express important glutamate transporters, especially excitatory amino acid transporter 2 (EAAT2, rodent analog GLT1) to regulate extracellular glutamate levels and modulate synaptic activation. In this study, we investigated an exciting new pathway, the exosome-mediated transfer of microRNA (in particular, miR-124a), in neuron-to-astrocyte signaling. Exosomes isolated from neuron-conditioned medium contain abundant microRNAs and small RNAs. These exosomes can be directly internalized into astrocytes and increase astrocyte miR-124a and GLT1 protein levels. Direct miR-124a transfection also significantly and selectively increases protein (but not mRNA) expression levels of GLT1 in cultured astrocytes. Consistent with our in vitro findings, intrastriatal injection of specific antisense against miR-124a into adult mice dramatically reduces GLT1 protein expression and glutamate uptake levels in striatum without reducing GLT1 mRNA levels. MiR-124a-mediated regulation of GLT1 expression appears to be indirect and is not mediated by its suppression of the putative GLT1 inhibitory ligand ephrinA3. Moreover, miR-124a is selectively reduced in the spinal cord tissue of end-stage SOD1 G93A mice, the mouse model of ALS. Subsequent exogenous delivery of miR-124a in vivo through stereotaxic injection significantly prevents further pathological loss of GLT1 proteins, as determined by GLT1 immunoreactivity in SOD1 G93A mice. Together, our study characterized a new neuron-to-astrocyte communication pathway and identified miRNAs that modulate GLT1 protein expression in astrocytes in vitro and in vivo.	[Morel, Lydie; Higashimori, Haruki; Seng Kah Ng; Yang, Yongjie] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Yang, Yongjie] Tufts Sackler Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA; [Regan, Melissa; Vidensky, Svetlana; Rothstein, Jeffrey] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 20215 USA; [Esau, Christine] Regulus Therapeut Inc, San Diego, CA 92121 USA	Tufts University; Johns Hopkins University; Isis Pharmaceuticals Inc	Yang, YJ (corresponding author), Tufts Univ, Sackler Sch Biomed Sci, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	yongjie.yang@tufts.edu			National Institutes of Health [MH099554, NS233958, NS36465]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036465, P30NS047243, P30NS069254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH099554 (to Y. Y.) and NS233958 and NS36465 (to J. D. R.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Berger UV, 2005, J COMP NEUROL, V492, P78, DOI 10.1002/cne.20737; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Flowers JM, 2001, ANN NEUROL, V49, P643, DOI 10.1002/ana.1029; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kim SY, 2003, J NEUROCHEM, V86, P1458, DOI 10.1046/j.1471-4159.2003.01958.x; Kolotuev I, 2009, TRAFFIC, V10, P803, DOI [10.1111/j.1600-0854.2009.00871.x, 10.1111/j.1600-0854.2008.00871.x]; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; O'Loughlin AJ, 2012, CURR GENE THER, V12, P262, DOI 10.2174/156652312802083594; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Peacey E, 2009, MOL PHARMACOL, V75, P1062, DOI 10.1124/mol.108.052829; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; ROBINSON MB, 1991, BRAIN RES, V544, P196, DOI 10.1016/0006-8993(91)90054-Y; Rogelj B, 2004, REV NEUROSCIENCE, V15, P185; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schaeffer D, 2010, ADV EXP MED BIOL, V702, P79, DOI 10.1007/978-1-4419-7841-7_7; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Swanson RA, 1997, J NEUROSCI, V17, P932; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x	51	251	270	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7105	7116		10.1074/jbc.M112.410944	http://dx.doi.org/10.1074/jbc.M112.410944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23364798	Green Published, hybrid			2022-12-28	WOS:000316002400032
J	Lin, SB; Shen, HX; Li, JL; Tang, SJ; Gu, YM; Chen, ZR; Hu, CB; Rice, JC; Lu, JR; Wu, LZ				Lin, Shuibin; Shen, Huangxuan; Li, Jian-Liang; Tang, Shaojun; Gu, Yumei; Chen, Zirong; Hu, Chengbin; Rice, Judd C.; Lu, Jianrong; Wu, Lizi			Proteomic and Functional Analyses Reveal the Role of Chromatin Reader SFMBT1 in Regulating Epigenetic Silencing and the Myogenic Gene Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB GROUP; SKELETAL-MUSCLE; DNA-BINDING; DROSOPHILA-MELANOGASTER; DYNAMIC REGULATION; PCG RECRUITMENT; SATELLITE CELLS; PROTEIN; COMPLEX; COACTIVATOR	SFMBT1 belongs to the malignant brain tumor domain-containing chromatin reader family that recognizes repressive histone marks and represses transcription. The biological functions and molecular basis underlying SFMBT1-mediated transcriptional repression are poorly elucidated. Here, our proteomic analysis revealed that SFMBT1 is associated with multiple transcriptional corepressor complexes, including CtBP/LSD1/HDAC complexes, polycomb repressive complexes, and malignant brain tumor family proteins, that collectively contribute to SFMBT1 repressor activity. During myogenesis, Sfmbt1 represses myogenic differentiation of cultured and primary myoblasts. Mechanistically, Sfmbt1 interacts with MyoD and mediates epigenetic silencing of MyoD target genes via recruitment of its associated corepressors and subsequent induction of epigenetic modifications and chromatin compaction. Therefore, our study identified novel mechanisms accounting for SFMBT1-mediated transcription repression and revealed an essential role of Sfmbt1 in regulating MyoD-mediated transcriptional silencing that is required for the maintenance of undifferentiated states of myogenic progenitor cells.	[Lin, Shuibin; Shen, Huangxuan; Gu, Yumei; Chen, Zirong; Hu, Chengbin; Wu, Lizi] Univ Florida, Dept Mol Genet & Microbiol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Tang, Shaojun] Univ Florida, Genet Inst, Shands Canc Ctr, Gainesville, FL 32610 USA; [Lu, Jianrong] Univ Florida, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Shen, Huangxuan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Li, Jian-Liang] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA; [Rice, Judd C.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sun Yat Sen University; Sanford Burnham Prebys Medical Discovery Institute; University of Southern California	Lu, JR (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA.	jrlu@ufl.edu; lzwu@ufl.edu	TANG, SHAOJUN/J-4876-2015; chen, zirong/S-4042-2016; Li, Jian-Liang/AAE-9315-2019; Li, J L/E-6100-2018; Lu, Jianrong/F-5240-2013	chen, zirong/0000-0002-0589-4619; Li, Jian-Liang/0000-0002-6487-081X; Li, J L/0000-0002-6487-081X; tang, shaojun/0000-0002-5141-0515; Lu, Jianrong/0000-0002-4969-6040; Lin, Shuibin/0000-0002-7065-614X	Muscular Dystrophy Association [MDA 4315]; University of Florida Shands Cancer Center; Florida Bankhead-Coley Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075094] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); University of Florida Shands Cancer Center; Florida Bankhead-Coley Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Muscular Dystrophy Association Grant MDA 4315 (to L. W.), by the University of Florida Shands Cancer Center Startup fund, and by the Florida Bankhead-Coley Cancer Research Program.	Arai S, 2005, EMBO J, V24, P1863, DOI 10.1038/sj.emboj.7600654; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Basu A, 2010, J CELL BIOCHEM, V110, P62, DOI 10.1002/jcb.22487; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bharathy N., 2012, TRANSCRIPTION, V3, P1; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Philipot O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009425; Robson LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027116; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Springer ML, 2002, CURR PROTOC HUM GENE; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Usui H, 2000, GENE, V248, P127, DOI 10.1016/S0378-1119(00)00131-1; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332	38	20	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6238	6247		10.1074/jbc.M112.429605	http://dx.doi.org/10.1074/jbc.M112.429605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23349461	hybrid, Green Published			2022-12-28	WOS:000315820700019
J	Romanow, A; Haselhorst, T; Stummeyer, K; Claus, H; Bethe, A; Muenhoff, M; Vogel, U; von Itzstein, M; Gerardy-Schahn, R				Romanow, Angela; Haselhorst, Thomas; Stummeyer, Katharina; Claus, Heike; Bethe, Andrea; Muehlenhoff, Martina; Vogel, Ulrich; von Itzstein, Mark; Gerardy-Schahn, Rita			Biochemical and Biophysical Characterization of the Sialyl-/Hexosyltransferase Synthesizing the Meningococcal Serogroup W135 Heteropolysaccharide Capsule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; NEISSERIA-MENINGITIDIS; PASTEURELLA-MULTOCIDA; POLYSIALIC ACID; BACTERIAL SIALYLTRANSFERASES; STRUCTURAL DETERMINATION; POLYSACCHARIDE ANTIGENS; MOLECULAR RECOGNITION; CATALYTIC MECHANISM; SUBSTRATE-BINDING	Neisseria meningitidis (Nm) is a leading cause of bacterial meningitis and sepsis. Crucial virulence determinants of pathogenic Nm strains are the polysaccharide capsules that support invasion by hindering complement attack. In NmW-135 and NmY the capsules are built from the repeating units (-> 6)-alpha-D-Gal-(1 -> 4)-alpha-Neu5Ac-(2 ->)(n) and (-> 6)-alpha-D-Glc-(1 -> 4)-alpha-Neu5Ac-(2 ->)(n), respectively. These unusual heteropolymers represent unique examples of a conjugation between sialic acid and hexosyl-sugars in a polymer chain. Moreover, despite the various catalytic strategies needed for sialic acid and hexose transfer, single enzymes (SiaD(W-135/Y)) have been identified to form these heteropolymers. Here we used SiaD(W-135) as a model system to delineate structure-function relationships. In size exclusion chromatography active SiaD(W-135) migrated as a monomer. Fold recognition programs suggested two separate glycosyltransferase domains, both containing a GT-B-fold. Based on conserved motifs predicted folds could be classified as a hexosyl- and sialyltransferase. To analyze enzyme properties and interplay of the two identified glycosyltransferase domains, saturation transfer difference NMR and mutational studies were carried out. Simultaneous and independent binding of UDP-Gal and CMP-Sia was seen in the absence of an acceptor as well as when the catalytic cycle was allowed to proceed. Enzyme variants with only one functionality were generated by site-directed mutagenesis and shown to complement each other in trans when combined in an in vitro test system. Together the data strongly suggests that SiaD(W-135) has evolved by fusion of two independent ancestral genes encoding sialyl- and galactosyltransferase activity.	[Romanow, Angela; Stummeyer, Katharina; Bethe, Andrea; Muehlenhoff, Martina; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Haselhorst, Thomas; von Itzstein, Mark] Griffith Univ, Inst Glyc, Nathan, Qld 4222, Australia; [Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	Hannover Medical School; Griffith University; University of Wurzburg	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de	Haselhorst, Thomas/A-5066-2015; von Itzstein, Mark/E-4823-2010	Haselhorst, Thomas/0000-0002-3373-8680; 	LOM; Australian Research Council	LOM; Australian Research Council(Australian Research Council)	The work was supported by LOM (impact oriented funding) funds to the Institute for Cellular Chemistry and the Australian Research Council through a Federation Fellowship (to M. v. I.).	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Biet T, 2001, ANGEW CHEM INT EDIT, V40, P4189, DOI 10.1002/1521-3773(20011119)40:22<4189::AID-ANIE4189>3.0.CO;2-A; Bohm R, 2010, CHEMBIOCHEM, V11, P170, DOI 10.1002/cbic.200900659; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/s004380050620; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Damerow S, 2010, J BIOL CHEM, V285, P878, DOI 10.1074/jbc.M109.067223; Decosas J, 2002, LANCET INFECT DIS, V2, P763, DOI 10.1016/S1473-3099(02)00455-3; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; HAGOPIAN A, 1968, ARCH BIOCHEM BIOPHYS, V128, P387, DOI 10.1016/0003-9861(68)90045-3; Hao JJ, 2005, BIOCHEM BIOPH RES CO, V338, P1507, DOI 10.1016/j.bbrc.2005.10.113; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kean EL, 2004, BBA-GEN SUBJECTS, V1673, P56, DOI 10.1016/j.bbagen.2004.04.006; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DU, 2008, BMB REP, V41, P48; May JF, 2012, BIOCHEMISTRY-US, V51, P1148, DOI 10.1021/bi201820p; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McGowen MM, 2001, GLYCOBIOLOGY, V11, P613, DOI 10.1093/glycob/11.8.613; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Ni LS, 2006, BIOCHEMISTRY-US, V45, P2139, DOI 10.1021/bi0524013; Pollard A J, 2001, J Paediatr Child Health, V37, pS20, DOI 10.1046/j.1440-1754.2001.00679.x; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Raymond NJ, 1997, J INFECT DIS, V176, P1277, DOI 10.1086/514123; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Saksouk N, 2005, BIOCHEM J, V389, P63, DOI 10.1042/BJ20050217; Schwarzer D, 2007, J BIOL CHEM, V282, P2821, DOI 10.1074/jbc.M609543200; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; WEISGERBER C, 1990, J BIOL CHEM, V265, P1578; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Yamamoto T, 2008, BIOCHEM BIOPH RES CO, V365, P340, DOI 10.1016/j.bbrc.2007.10.201	47	21	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11718	11730		10.1074/jbc.M113.452276	http://dx.doi.org/10.1074/jbc.M113.452276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23439648	Green Published, hybrid			2022-12-28	WOS:000318157600009
J	Aley, PK; Singh, N; Brailoiu, GC; Brailoiu, E; Churchill, GC				Aley, Parvinder K.; Singh, Nisha; Brailoiu, G. Cristina; Brailoiu, Eugen; Churchill, Grant C.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Is a Second Messenger in Muscarinic Receptor-induced Contraction of Guinea Pig Trachea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY SMOOTH-MUSCLE; ADP-RIBOSYL CYCLASE; INDUCED CA2+ RELEASE; MOBILIZES CALCIUM; SENSITIVE CA2+; TRIGGER ZONE; CD38; STORES; ENZYME; CADPR	Nicotinic acid adenine dinucleotide phosphate (NAADP) is increasingly being demonstrated to be involved in calcium signaling in many cell types and species. Although it has been shown to play a role in smooth muscle cell contraction in several tissues, nothing is known about its possible role in tracheal smooth muscle, a muscle type that is clinically relevant to asthma. To determine whether NAADP functions as a second messenger in tracheal smooth muscle contraction, we used the criteria set out by Sutherland for a molecule to be designated a second messenger. We report that NAADP satisfies all five criteria as follows. First, the NAADP antagonist Ned-19 inhibited contractions in tracheal rings and calcium increases in isolated smooth muscle cells induced by the muscarinic agonist carbachol. Second, NAADP increased cytosolic calcium in isolated cells when microinjected and was blocked by Ned-19. Third, tracheal homogenates could synthesize NAADP by base exchange from exogenous NADP and nicotinic acid and metabolize exogenous NAADP to nicotinic acid adenine dinucleotide by a 2'-phosphatase. Fourth, carbachol induced a rapid and transient increase in endogenous NAADP levels. Fifth, tracheal homogenates contained NAADP-binding sites of high affinity. Taken together, these data demonstrate that NAADP functions as a second messenger in tracheal smooth muscle, and therefore, steps in the NAADP signaling pathway might provide possible new drug targets.	[Aley, Parvinder K.; Singh, Nisha; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Brailoiu, G. Cristina] Thomas Jefferson Univ, Jefferson Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of Oxford; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Singh, Nisha/M-3780-2015	Singh, Nisha/0000-0002-1312-688X; Aley, Parvinder/0000-0002-0749-8329	Asthma UK Grant [09/037]; BBSRC [BB/G008523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; Asthma UK [09/037] Funding Source: researchfish	Asthma UK Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Asthma UK	This work was supported by Asthma UK Grant 09/037.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Aley PK, 2010, J PHARMACOL EXP THER, V333, P726, DOI 10.1124/jpet.110.165837; AXELSON JT, 1981, ANAL BIOCHEM, V116, P357, DOI 10.1016/0003-2697(81)90371-7; Barcelo-Torns M, 2011, FEBS LETT, V585, P2300, DOI 10.1016/j.febslet.2011.05.062; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Billington RA, 2004, BIOCHEM J, V378, P275, DOI 10.1042/BJ20031284; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Campos-Bedolla P, 2005, J ETHNOPHARMACOL, V97, P267, DOI 10.1016/j.jep.2004.11.005; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Chen H, 2003, J APPL PHYSIOL, V95, P864, DOI 10.1152/japplphysiol.00140.2003; Chini EN, 2002, BIOCHEM J, V362, P125, DOI 10.1042/0264-6021:3620125; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Coxon CH, 2012, BIOCHEM J, V441, P435, DOI 10.1042/BJ20111175; Deshpande DA, 2005, AM J PHYSIOL-LUNG C, V288, pL773, DOI 10.1152/ajplung.00217.2004; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dickey Deborah M., 1998, Cell Biochemistry and Biophysics, V28, P63, DOI 10.1007/BF02738310; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Eglen RM, 1996, PHARMACOL REV, V48, P531; Esposito B, 2011, BLOOD, V117, P4968, DOI 10.1182/blood-2010-02-266338; Evans AM, 2010, ADV EXP MED BIOL, V661, P57, DOI 10.1007/978-1-60761-500-2_4; Evans AM, 2005, PHARMACOL THERAPEUT, V107, P286, DOI 10.1016/j.pharmthera.2005.03.003; Franco L, 2001, AM J PHYSIOL-LUNG C, V280, pL98; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Galione A, 2011, SCI CHINA LIFE SCI, V54, P725, DOI 10.1007/s11427-011-4207-5; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; GERTHOFFER WT, 1991, AM J PHYSIOL, V261, pL15, DOI 10.1152/ajplung.1991.261.2.L15; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hakonarson H, 1998, AM J RESP CRIT CARE, V158, pS115, DOI 10.1164/ajrccm.158.supplement_2.13tac700; Iizuka K, 1998, J PHYSIOL-LONDON, V511, P915, DOI 10.1111/j.1469-7793.1998.915bg.x; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Ito S, 2002, AM J RESP CELL MOL, V26, P491, DOI 10.1165/ajrcmb.26.4.4701; Jude Joseph A, 2008, Proc Am Thorac Soc, V5, P15, DOI 10.1513/pats.200704-047VS; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lee H C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.40.pe1; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, J BIOL CHEM, V272, P20378, DOI 10.1074/jbc.272.33.20378; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Palade P, 2007, AM J PHYSIOL-CELL PH, V292, pC4, DOI 10.1152/ajpcell.00390.2006; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2004, BIOL CELL, V96, P19, DOI 10.1016/j.biolcel.2003.12.001; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Prakash YS, 1998, AM J PHYSIOL-CELL PH, V274, pC1653, DOI 10.1152/ajpcell.1998.274.6.C1653; Prakash YS, 2000, CELL CALCIUM, V27, P153, DOI 10.1054/ceca.1999.0106; ROBERTSON DN, 1988, AM REV RESPIR DIS, V137, P1317, DOI 10.1164/ajrccm/137.6.1317; Robison G.A., 1971, CYCLIC AMP, DOI [10.1146/annurev.bi.37.070168.001053, DOI 10.1146/ANNUREV.BI.37.070168.001053]; ROFFEL AF, 1990, BRIT J PHARMACOL, V99, P293, DOI 10.1111/j.1476-5381.1990.tb14697.x; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Schmid F, 2012, J BIOL CHEM, V287, P32525, DOI 10.1074/jbc.M112.362715; Schultz C, 2003, BIOORGAN MED CHEM, V11, P885, DOI 10.1016/S0968-0896(02)00552-7; SHIEH CC, 1991, J PHARMACOL EXP THER, V256, P141; Siddiqui S, 2013, PULM PHARMACOL THER, V26, P132, DOI 10.1016/j.pupt.2012.08.008; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; SUTHERLAND EW, 1968, CIRCULATION, V37, P279, DOI 10.1161/01.CIR.37.2.279; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Tao FC, 1999, AM J RESP CRIT CARE, V160, P446, DOI 10.1164/ajrccm.160.2.9811098; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF510, DOI 10.1152/ajprenal.00116.2009; VANROSSUM JM, 1963, ARCH INT PHARMACOD T, V143, P240; Vasudevan SR, 2010, J BIOL CHEM, V285, P18262, DOI 10.1074/jbc.M109.087858; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; White RA, 2003, FASEB J, V17, P482, DOI 10.1096/fj.02-0622fje; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	91	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10986	10993		10.1074/jbc.M113.458620	http://dx.doi.org/10.1074/jbc.M113.458620			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23467410	hybrid, Green Published			2022-12-28	WOS:000317915500005
J	Konishi, H; Matsumoto, S; Namikawa, K; Kiyama, H				Konishi, Hiroyuki; Matsumoto, Sakiko; Namikawa, Kazuhiko; Kiyama, Hiroshi			N-terminal Cleaved Pancreatitis-associated Protein-III (PAP-III) Serves as a Scaffold for Neurites and Promotes Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECTIN REGIII-GAMMA; BACTERICIDAL LECTIN; WALLERIAN DEGENERATION; NEUROTROPHIC FACTOR; NERVE REGENERATION; MOTOR-NEURONS; SCHWANN-CELLS; RAT; EXPRESSION; FAMILY	Pancreatitis-associated protein (PAP)-III, also known as regenerating gene/regenerating islet-derived (Reg)-III gamma, is a small secretory protein whose expression is substantially induced in injured nerves. Here, we found that PAP-III protein underwent proteolytic N-terminal processing by trypsin-like protease(s) in injured sciatic nerves after axotomy. In vitro studies demonstrated that the N terminus-truncated PAP-III (Delta N-PAP-III) polymerized into a filament with a relatively uniform diameter of 10-20 nm, and the filaments formed higher order structures in a Na+ concentration-dependent manner. When the Delta N-PAP-III fibers were added to the culture media, the Delta N-PAP-III fibers were tightly attached to neurites and somata of primary cortical neurons in vitro. In contrast, little association with glial cells was observed. When dense matrices of Delta N-PAP-III fibers were sheeted on a culture dish, neurites preferentially adhered to the fibers, and neurite extension was enhanced. This neurite outgrowth activity was significantly suppressed by preincubation with antibodies against PAP-III. These results imply that the released PAP-III might be cleaved and forms Delta N-PAP-III fibers at the nerve injury sites. Consequently, these resulting fibers would provide regenerating axons with a platform for extension.	[Konishi, Hiroyuki; Matsumoto, Sakiko; Kiyama, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Funct Anat & Neurosci, Nagoya, Aichi 4668550, Japan; [Konishi, Hiroyuki; Matsumoto, Sakiko; Namikawa, Kazuhiko; Kiyama, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Anat & Neurobiol, Osaka 5458585, Japan; [Konishi, Hiroyuki; Kiyama, Hiroshi] Nagoya Univ, Grad Sch Med, CREST, Japan Sci & Technol Agcy, Nagoya, Aichi 4668550, Japan; [Namikawa, Kazuhiko] Tech Univ Carolo Wilhelmina Braunschweig, Div Cell Biol & Cell Physiol, Inst Zool, D-83106 Braunschweig, Germany	Nagoya University; Osaka Metropolitan University; Japan Science & Technology Agency (JST); Nagoya University; Braunschweig University of Technology	Kiyama, H (corresponding author), Dept Funct Anat & Neurosci, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kiyama@med.nagoya-u.ac.jp	KONISHI, Hiroyuki/M-8871-2014; Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by Grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency.	Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Ampo KI, 2009, J NEUROTRAUM, V26, P1683, DOI 10.1089/neu.2008-0847; Averill S, 2002, J NEUROSCI, V22, P7493; BEUCHE W, 1984, J NEUROCYTOL, V13, P767, DOI 10.1007/BF01148493; Bodeker H, 1999, Mol Cell Biol Res Commun, V2, P150, DOI 10.1006/mcbr.1999.0166; BRADSHAW AD, 1995, DEVELOPMENT, V121, P3593; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Fang MR, 2010, ANAT REC, V293, P464, DOI 10.1002/ar.21087; FRIGERIO JM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P329, DOI 10.1016/0167-4781(93)90167-C; FRIGERIO JM, 1993, BIOCHEMISTRY-US, V32, P9236, DOI 10.1021/bi00086a032; Gironella M, 2005, GUT, V54, P1244, DOI 10.1136/gut.2004.056309; Gironella M, 2007, GUT, V56, P1091, DOI 10.1136/gut.2006.116087; Graf R, 2001, J BIOL CHEM, V276, P21028, DOI 10.1074/jbc.M010717200; Hassanain E, 2011, PANCREAS, V40, P1151, DOI 10.1097/MPA.0b013e3182218006; Ho MR, 2006, J BIOL CHEM, V281, P33566, DOI 10.1074/jbc.M604513200; Hunt SP, 2007, HEPATOLOGY, V45, P1585, DOI 10.1002/hep.21705; Kawahara S, 2011, NEUROSCIENCE, V175, P273, DOI 10.1016/j.neuroscience.2010.11.020; KEIM V, 1991, GASTROENTEROLOGY, V100, P775, DOI 10.1016/0016-5085(91)80025-5; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Konishi H, 2006, GLIA, V53, P723, DOI 10.1002/glia.20327; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Maeda M, 2005, EXP NEUROL, V193, P350, DOI 10.1016/j.expneurol.2005.01.018; Marz-Weiss P, 2011, CELL MOL NEUROBIOL, V31, P1141, DOI 10.1007/s10571-011-9715-0; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Medveczky P, 2009, BIOCHEM J, V420, P335, DOI 10.1042/BJ20090005; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; MULLER U, 1995, MOL BIOL CELL, V6, P433; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; NAKANISHI K, 1994, BRAIN RES, V659, P169, DOI 10.1016/0006-8993(94)90876-1; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Namikawa K, 2006, J NEUROSCI, V26, P7460, DOI 10.1523/JNEUROSCI.0023-06.2006; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Schiesser M, 2001, PANCREAS, V22, P186, DOI 10.1097/00006676-200103000-00012; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Tebar LA, 2008, P NATL ACAD SCI USA, V105, P11400, DOI 10.1073/pnas.0711978105; TSUYUKI E, 1956, J BIOL CHEM, V222, P479; Ushijima R, 2005, BIOCHEM BIOPH RES CO, V330, P880, DOI 10.1016/j.bbrc.2005.03.063; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Van Ba IAT, 2012, J BIOL CHEM, V287, P4726, DOI 10.1074/jbc.M111.260349	42	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10205	10213		10.1074/jbc.M112.395301	http://dx.doi.org/10.1074/jbc.M112.395301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426365	hybrid, Green Published			2022-12-28	WOS:000317565000003
J	Lei, L; Cao, X; Yang, F; Shi, DJ; Tang, YQ; Zheng, J; Wang, KW				Lei, Lei; Cao, Xu; Yang, Fan; Shi, Di-Jing; Tang, Yi-Quan; Zheng, Jie; Wang, Kewei			A TRPV4 Channel C-terminal Folding Recognition Domain Critical for Trafficking and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL VANILLOID-4; NONSELECTIVE CATION CHANNEL; ION CHANNELS; PORE TURRET; VR-OAC; ACTIVATION; SENSITIVITY; STIMULI; DISRUPTION; KINASE	The Ca2+-permeable transient receptor potential vanilloid subtype 4 (TRPV4) channel mediates crucial physiological functions, such as calcium signaling, temperature sensing, and maintaining cell volume and energy homeostasis. Noticeably, most disease-causing genetic mutations are concentrated in the cytoplasmic domains. In the present study, we focused on the role of the TRPV4 C terminus in modulating protein folding, trafficking, and activity. By examining a series of C-terminal deletions, we identified a 20-amino acid distal region covering residues 838-857 that is critical for channel folding, maturation, and trafficking. Surface biotinylation, confocal imaging, and fluorescence-based calcium influx assay demonstrated that mutant proteins missing this region were trapped in the endoplasmic reticulum and unglycosylated, leading to accelerated degradation and loss of channel activity. Rosetta de novo structural modeling indicated that residues 838-857 assume a defined conformation, with Gly(849) and Pro(851) located at critical positions. Patch clamp recordings confirmed that lowering the temperature from 37 to 30 degrees C rescued channel activity of folding-defective mutants. Moreover, biochemical tests demonstrated that, in addition to participating in C-C interaction, the C terminus also interacts with the N terminus. Taken together, our findings indicate that the C-terminal region of TRPV4 is critical for channel protein folding and maturation, and the short distal segment plays an essential role in this process. Therefore, selectively disrupting the folding-sensitive region may present therapeutic potential for treating overactive TRPV4-mediated diseases, such as pain and skeletal dysplasias.	[Lei, Lei; Cao, Xu; Shi, Di-Jing; Tang, Yi-Quan; Wang, Kewei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China; [Yang, Fan; Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Wang, Kewei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China; [Wang, Kewei] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; University of California System; University of California Davis; Peking University; Peking University	Zheng, J (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	jzheng@ucdavis.edu; wangkw@bjmu.edu.cn	Yang, Fan/GYU-4249-2022; Cao, Xu/G-6209-2015; Yang, Fan/AAA-6904-2022; Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/J-4562-2015; Yang, Fan/C-6586-2012	Cao, Xu/0000-0003-1796-2735; Yang, Fan/0000-0002-0520-5254; Zhu, Ren-Yuan/0000-0003-3091-7461; Yang, Fan/0000-0002-9406-7710; Yang, Fan/0000-0002-9406-7710; Tang, Yiquan/0000-0002-6639-8897	National Institutes of Health [R01NS072377]; National Science Foundation of China [30970919, 81221002]; Ministry of Education of China [B07001]; Ministry of Science and Technology of China [2013CB531300]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS072377 (to J. Z.). This work was also supported by National Science Foundation of China Research Grants 30970919 and 81221002 (to K. W. W.); Ministry of Education of China, 111 Project China, Grant B07001; and Ministry of Science and Technology of China Grant 2013CB531300 (to K. W. W.).	Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Andreucci E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-37; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Blackshaw LA, 2010, GUT, V59, P126, DOI 10.1136/gut.2009.179523; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Guler AD, 2002, J NEUROSCI, V22, P6408; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Ramadass R, 2007, ARCH BIOCHEM BIOPHYS, V463, P27, DOI 10.1016/j.abb.2007.01.036; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yin J, 2008, CIRC RES, V102, P966, DOI 10.1161/CIRCRESAHA.107.168724; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001	56	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10427	10439		10.1074/jbc.M113.457291	http://dx.doi.org/10.1074/jbc.M113.457291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23457335	Green Published, hybrid			2022-12-28	WOS:000317565000023
J	Mizunuma, M; Tsubakiyama, R; Ogawa, T; Shitamukai, A; Kobayashi, Y; Inai, T; Kume, K; Hirata, D				Mizunuma, Masaki; Tsubakiyama, Ryohei; Ogawa, Takafumi; Shitamukai, Atsunori; Kobayashi, Yoshifumi; Inai, Tomomi; Kume, Kazunori; Hirata, Dai			Ras/cAMP-dependent Protein Kinase (PKA) Regulates Multiple Aspects of Cellular Events by Phosphorylating the Whi3 Cell Cycle Regulator in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE; G1; PATHWAY; CDC28; BINDS; CAMP	The Start/G(1) phase in the cell cycle is an important period during which cells determine their developmental fate, onset of mitotic progression, or the switch to developmental stages in response to both external and internal signals. In the budding yeast Saccharomyces cerevisiae, Whi3, a negative regulator of the G(1) cyclins, has been identified as a positive regulator of cell size control and is involved in the regulation of Start. However, the regulatory pathway of Whi3 governing the response to multiple signals remains largely unknown. Here, we show that Whi3 is phosphorylated by the Ras/cAMP-dependent protein kinase (PKA) and that phosphorylation of Ser-568 in Whi3 by PKA plays an inhibitory role in Whi3 function. Phosphorylation of Whi3 by PKA led to its decreased interaction with CLN3 G(1) cyclin mRNA and was required for the promotion of G(1)/S progression. Furthermore, we demonstrate that the phosphomimetic S568D mutation of Whi3 prevented the developmental fate switch to sporulation or invasive growth. Thus, PKA modulated the function of Whi3 by phosphorylation, thus implicating PKA-mediated modulation of Whi3 in multiple cellular events.	[Mizunuma, Masaki; Tsubakiyama, Ryohei; Ogawa, Takafumi; Shitamukai, Atsunori; Kobayashi, Yoshifumi; Inai, Tomomi; Kume, Kazunori; Hirata, Dai] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan	Hiroshima University	Mizunuma, M (corresponding author), Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	mmizu49120@hiroshima-u.ac.jp	Shitamukai, Atsunori/AAT-8802-2021; Mizunuma, Masaki/V-2941-2017; Shitamukai, Atsunori/C-6817-2014; Kume, Kazunori/T-4061-2018	Shitamukai, Atsunori/0000-0003-4216-927X; Mizunuma, Masaki/0000-0002-1531-1763; Kume, Kazunori/0000-0002-0613-8081; Ogawa, Takafumi/0000-0001-8673-8804	Japan Society for the Promotion of Science; Japan Society for the Promotion of Science [DC2]; Grants-in-Aid for Scientific Research [24580142, 24700361] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (to M. M. and D. H.).; Recipient of Research Fellowships for Young Scientists (DC2) from the Japan Society for the Promotion of Science.	BARONI MD, 1989, MOL CELL BIOL, V9, P2715, DOI 10.1128/MCB.9.6.2715; BARONI MD, 1994, NATURE, V371, P339, DOI 10.1038/371339a0; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Erez O, 2002, BIOCHEM BIOPH RES CO, V295, P1142, DOI 10.1016/S0006-291X(02)00823-9; Gari E, 2001, GENE DEV, V15, P2803; Hall DD, 1998, EMBO J, V17, P4370, DOI 10.1093/emboj/17.15.4370; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsumoto K, 1985, Yeast, V1, P15, DOI 10.1002/yea.320010103; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; Nash RS, 2001, GENETICS, V157, P1469; Nozaki T, 1996, BIOCHEM BIOPH RES CO, V228, P452, DOI 10.1006/bbrc.1996.1681; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sudbery P, 2002, SCIENCE, V297, P351, DOI 10.1126/science.1073042; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TOKIWA G, 1994, NATURE, V371, P342, DOI 10.1038/371342a0; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	20	15	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10558	10566		10.1074/jbc.M112.402214	http://dx.doi.org/10.1074/jbc.M112.402214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23471970	hybrid, Green Published			2022-12-28	WOS:000317565000035
J	Unciti-Broceta, JD; Maceira, J; Morales, S; Garcia-Perez, A; Munoz-Torres, ME; Garcia-Salcedo, JA				Unciti-Broceta, Juan D.; Maceira, Jose; Morales, Sonia; Garcia-Perez, Angelica; Munoz-Torres, Manuel E.; Garcia-Salcedo, Jose A.			Nicotinamide Inhibits the Lysosomal Cathepsin b-like Protease and Kills African Trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; REPLICATIVE LIFE-SPAN; IN-VITRO; CYSTEINE PROTEASE; HUMAN-CELLS; BRUCEI; RATS; DEGRADATION; EXTENDS; CYCLE	Nicotinamide, a soluble compound of the vitamin B-3 group, has antimicrobial activity against several microorganisms ranging from viruses to parasite protozoans. However, the mode of action of this antimicrobial activity is unknown. Here, we investigate the trypanocidal activity of nicotinamide on Trypanosoma brucei, the causative agent of African trypanosomiasis. Incubation of trypanosomes with nicotinamide causes deleterious defects in endocytic traffic, disruption of the lysosome, failure of cytokinesis, and, ultimately, cell death. At the same concentrations there was no effect on a cultured mammalian cell line. The effects on endocytosis and vesicle traffic were visible within 3 h and can be attributed to inhibition of lysosomal cathepsin b-like protease activity. The inhibitory effect of nicotinamide was confirmed by a direct activity assay of recombinant cathepsin b-like protein. Taken together, these data demonstrate that inhibition of the lysosomal protease cathepsin b-like blocks endocytosis, causing cell death. In addition, these results demonstrate for the first time the inhibitory effect of nicotinamide on a protease.	[Unciti-Broceta, Juan D.; Maceira, Jose; Morales, Sonia; Garcia-Perez, Angelica; Garcia-Salcedo, Jose A.] Inst Invest Biosanitaria Granada IBIG, Unidad Enfermedades Infecciosas, Granada 18012, Spain; [Munoz-Torres, Manuel E.] Inst Invest Biosanitaria Granada IBIG, Unidad Metab Oseo, Granada 18012, Spain; [Unciti-Broceta, Juan D.; Maceira, Jose; Morales, Sonia; Garcia-Perez, Angelica; Garcia-Salcedo, Jose A.] Inst Parasitol & Biomed Lopez Neyra IPBLN CSIC, Armilla 18016, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Garcia-Salcedo, JA (corresponding author), Inst Parasitol & Biomed Lopez Neyra IPBLN CSIC, Granada 18100, Spain.	jagarciasalcedo@ipb.csic.es	Torres, Manuel Muñoz/O-2330-2016; Garcia-Salcedo, Jose A/AAA-9434-2019; Morales-Santana, Sonia/ABG-8889-2020	Torres, Manuel Muñoz/0000-0002-9645-3260; Garcia-Salcedo, Jose A/0000-0003-3399-1835; Morales-Santana, Sonia/0000-0001-8403-2496; Unciti-Broceta, Juan Diego/0000-0002-4068-5943	Plan Nacional de Investigacion (Ministerio de Economia y Competitividad, Spain) [SAF2011-30528]; European Union [FP7-HEALTH-2007-B-2.3.4-1.223048]	Plan Nacional de Investigacion (Ministerio de Economia y Competitividad, Spain); European Union(European Commission)	This work was supported by Plan Nacional de Investigacion (Ministerio de Economia y Competitividad, Spain) Grant SAF2011-30528 (to J. A. G. S.) and European Union Grant FP7-HEALTH-2007-B-2.3.4-1.223048, NANOTRYP (to J. A. G. S.).	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; [Anonymous], 1986, WHO TECH REP SER, VXIV, p[211, I]; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; COPPENS I, 1993, MOL BIOCHEM PARASIT, V58, P223, DOI 10.1016/0166-6851(93)90044-X; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gazanion E, 2011, PARASITOL INT, V60, P19, DOI 10.1016/j.parint.2010.09.005; Gould MK, 2008, ANAL BIOCHEM, V382, P87, DOI 10.1016/j.ab.2008.07.036; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; JACKSON TM, 1995, J NUTR, V125, P1455; KALLMANN B, 1992, LIFE SCI, V51, P671, DOI 10.1016/0024-3205(92)90240-P; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Landeira D, 2007, J CELL BIOL, V176, P133, DOI 10.1083/jcb.200607174; Lim CS, 2006, MECH AGEING DEV, V127, P511, DOI 10.1016/j.mad.2006.02.001; LIU G, 1982, J BACTERIOL, V152, P1111; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mendoza-Palomares C, 2008, EUKARYOT CELL, V7, P684, DOI 10.1128/EC.00405-07; Mokudai T, 2000, STROKE, V31, P1679, DOI 10.1161/01.STR.31.7.1679; MURRAY MF, 1995, BIOCHEM BIOPH RES CO, V210, P954, DOI 10.1006/bbrc.1995.1749; Murray MF, 2003, CLIN INFECT DIS, V36, P453, DOI 10.1086/367544; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Prusty D, 2008, FEMS MICROBIOL LETT, V282, P266, DOI 10.1111/j.1574-6968.2008.01135.x; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Sakai Y, 2002, CELL TRANSPLANT, V11, P435; Scory S, 1999, EXP PARASITOL, V91, P327, DOI 10.1006/expr.1998.4381; Scory Stefan, 2007, Kinetoplastid Biol Dis, V6, P2, DOI 10.1186/1475-9292-6-2; Sereno D, 2005, ANTIMICROB AGENTS CH, V49, P808, DOI 10.1128/AAC.49.2.808-812.2005; Soares MBP, 2012, ACTA TROP, V122, P224, DOI 10.1016/j.actatropica.2012.01.001; Spitznagel D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012282; Sun AY, 1998, ACTA PHARMACOL SIN, V19, P104; Vaca P, 2003, TRANSPL P, V35, P2021, DOI 10.1016/S0041-1345(03)00735-8; Vermelrio A.B., 2007, CURR ENZYME INHIB, V3, P19; Wurtele H, 2010, NAT MED, V16, P774, DOI 10.1038/nm.2175	39	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10548	10557		10.1074/jbc.M112.449207	http://dx.doi.org/10.1074/jbc.M112.449207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443665	Green Published, hybrid			2022-12-28	WOS:000317565000034
J	Zhang, N; Lin, JK; Chen, J; Liu, XF; Liu, JL; Luo, HS; Li, YQ; Cui, S				Zhang, Nan; Lin, Jun-kai; Chen, Juan; Liu, Xiong-fei; Liu, Jia-li; Luo, Hao-shu; Li, Yue-qin; Cui, Sheng			MicroRNA 375 Mediates the Signaling Pathway of Corticotropin-releasing Factor (CRF) Regulating Pro-opiomelanocortin (POMC) Expression by Targeting Mitogen-activated Protein Kinase 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PITUITARY-ADRENAL AXIS; T-CELL LYMPHOMAS; GENE-EXPRESSION; NUCLEAR RECEPTORS; BETA-ENDORPHIN; TUMOR-CELLS; ALPHA-MSH; TRANSCRIPTION; TPL-2; INVOLVEMENT	Pro-opiomelanocortin (POMC) is a common precursor of melanocortin-related peptides in the pituitary and primarily regulated by corticotropin-releasing factor (CRF). Our results show that miR-375 is highly expressed in the mouse pituitary gland and located specifically in the intermediate lobe of pituitary. The functional studies show that the forced inhibition of endogenous miR-375 in AtT-20 mouse pituitary tumor cells and in the intermediate lobe of the pituitary gland significantly increases POMC expression, whereas miR-375 overexpression down-regulates POMC expression and ACTH secretion stimulated by CRF. This function of miR-375 is accomplished by its binding to the 3'-UTR of mitogen-activated protein kinase kinase kinase-8. Our results here have demonstrated that miR-375 acts as a negative regulating molecule mediating the signaling pathway of CRF and affecting POMC expression by targeting mitogen-activated protein kinase kinase kinase-8, which subsequently down-regulates ERK1/2 phosphorylation and nerve growth factor-induced clone B (NGFI-B) transcription activity. Taken together, our results show that miR-375 is a novel negative regulator of POMC expression and related hormone secretion.	[Zhang, Nan; Lin, Jun-kai; Chen, Juan; Liu, Xiong-fei; Liu, Jia-li; Luo, Hao-shu; Li, Yue-qin; Cui, Sheng] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China	China Agricultural University	Cui, S (corresponding author), China Agr Univ, 2 Yuanmingyuan Xilu, Beijing 100193, Peoples R China.	cuisheng@cau.edu.cn			National Basic Research Program of China [2009CB941702, 2012CB944703]; Natural Science Foundation of China [31172287, 31172289]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2009CB941702 and 2012CB944703) and the Natural Science Foundation of China (31172287 and 31172289).	AFFOLTER HU, 1985, J BIOL CHEM, V260, P5477; Arzt E, 2006, TRENDS PHARMACOL SCI, V27, P531, DOI 10.1016/j.tips.2006.08.007; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Becquet D, 2001, MOL CELL ENDOCRINOL, V175, P93, DOI 10.1016/S0303-7207(01)00393-8; BERTAGNA X, 1994, ENDOCRIN METAB CLIN, V23, P467, DOI 10.1016/S0889-8529(18)30079-3; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dermitzaki E, 2012, J CELL PHYSIOL, V227, P1861, DOI 10.1002/jcp.22914; Drouin J, 1998, J STEROID BIOCHEM, V65, P59, DOI 10.1016/S0960-0760(97)00180-5; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; Getting SJ, 1999, J IMMUNOL, V162, P7446; Hatziapostolou M, 2008, CANCER RES, V68, P1851, DOI 10.1158/0008-5472.CAN-07-5793; HEIJNEN C J, 1987, Brain Behavior and Immunity, V1, P284, DOI 10.1016/0889-1591(87)90031-6; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; KNIGHT RM, 1987, PEPTIDES, V8, P927, DOI 10.1016/0196-9781(87)90082-9; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; LITVIN Y, 1984, J BIOL CHEM, V259, P296; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; LUINI A, 1985, P NATL ACAD SCI USA, V82, P8034, DOI 10.1073/pnas.82.23.8034; LUNDBLAD JR, 1988, ENDOCR REV, V9, P135, DOI 10.1210/edrv-9-1-135; Maira M, 1999, MOL CELL BIOL, V19, P7549; MAKRIS A, 1993, J VIROL, V67, P4283, DOI 10.1128/JVI.67.7.4283-4289.1993; Mao ZG, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-79; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Nemoto T, 2012, AM J PHYSIOL-ENDOC M, V302, pE781, DOI 10.1152/ajpendo.00616.2011; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; RAYMOND V, 1981, MOL CELL ENDOCRINOL, V22, P295, DOI 10.1016/0303-7207(81)90038-1; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reyes R, 2008, ANAT HISTOL EMBRYOL, V37, P263, DOI 10.1111/j.1439-0264.2007.00839.x; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; Schneeberger M., 2012, MOL METAB IN PRESS; Sei C, 2002, PEPTIDES, V23, P1409, DOI 10.1016/S0196-9781(02)00079-7; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Stevens A, 2010, RESULTS PROBL CELL D, V50, P63, DOI 10.1007/400_2009_30; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	46	54	54	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10361	10373		10.1074/jbc.M112.425504	http://dx.doi.org/10.1074/jbc.M112.425504			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430746	Green Published, hybrid			2022-12-28	WOS:000317565000017
J	Yanagawa, M; Yamashita, T; Shichida, Y				Yanagawa, Masataka; Yamashita, Takahiro; Shichida, Yoshinori			Glutamate Acts as a Partial Inverse Agonist to Metabotropic Glutamate Receptor with a Single Amino Acid Mutation in the Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BINDING-SITE; FLUORESCENT PROTEIN; ACTIVATION SWITCH; RHODOPSIN; FAMILY; REARRANGEMENT; MODULATOR; VARIANT; TOOL	Metabotropic glutamate receptor (mGluR), a prototypical family 3 G protein-coupled receptor (GPCR), has served as a model for studying GPCR dimerization, and growing evidence has revealed that a glutamate-induced dimeric rearrangement promotes activation of the receptor. However, structural information of the seven-transmembrane domain is severely limited, in contrast to the well studied family 1 GPCRs including rhodopsins and adrenergic receptors. Homology modeling of mGluR8 transmembrane domain with rhodopsin as a template suggested the presence of a conserved water-mediated hydrogen-bonding network between helices VI and VII, which presumably constrains the receptor in an inactive conformation. We therefore conducted a mutational analysis to assess structural similarities between mGluR and family 1 GPCRs. Mutational experiments confirmed that the disruption of the hydrogen-bonding network by T789Y(6.43) mutation induced high constitutive activity. Unexpectedly, this high constitutive activity was suppressed by glutamate, the natural agonist ligand, indicating that glutamate acts as a partial inverse agonist to this mutant. Fluorescence energy transfer analysis of T789Y(6.43) suggested that the glutamate-induced reduction of the activity originated not from the dimeric rearrangement but from conformational changes within each protomer. Double mutational analysis showed that the specific interaction between Tyr-789(6.43) and Gly-831(7.45) in T789Y(6.43) mutant was important for this phenotype. Therefore, the present study is consistent with the notion that the metabotropic glutamate receptor shares a common activation mechanism with family 1 GPCRs, where rearrangement between helices VI and VII causes the active state formation.	[Yanagawa, Masataka; Yamashita, Takahiro; Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp	Yanagawa, Masataka/C-3789-2017	Yanagawa, Masataka/0000-0001-7832-0918	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" [A06]; Japan Society for the Promotion of Science (JSPS) [08J01259];  [20227002];  [21026019]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem"; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, Grants-in-aid for Scientific Research 20227002 and 21026019, and the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" (Program A06), and Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists 08J01259.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bruno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042023; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672; Hlavackova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002720; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Khelashvili G, 2010, BIOINFORMATICS, V26, P1804, DOI 10.1093/bioinformatics/btq264; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yamashita T, 2008, J NEUROCHEM, V106, P850, DOI 10.1111/j.1471-4159.2008.05443.x; Yanagawa M, 2011, J BIOL CHEM, V286, P22971, DOI 10.1074/jbc.M110.206870; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549	35	11	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9593	9601		10.1074/jbc.M112.437780	http://dx.doi.org/10.1074/jbc.M112.437780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420844	Green Published, hybrid			2022-12-28	WOS:000317114000003
J	Gerber, S; Lizak, C; Michaud, G; Bucher, M; Darbre, T; Aebi, M; Reymond, JL; Locher, KP				Gerber, Sabina; Lizak, Christian; Michaud, Gaelle; Bucher, Monika; Darbre, Tamis; Aebi, Markus; Reymond, Jean-Louis; Locher, Kaspar P.			Mechanism of Bacterial Oligosaccharyltransferase IN VITRO QUANTIFICATION OF SEQUON BINDING AND CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; HYDROXY AMINO-ACID; PROTEIN GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; CONSENSUS SEQUENCE; SITE; GLYCOPROTEINS; MANGANESE; CELLS; SPECIFICITY	N-Linked glycosylation is an essential post-translational protein modification in the eukaryotic cell. The initial transfer of an oligosaccharide from a lipid carrier onto asparagine residues within a consensus sequon is catalyzed by oligosaccharyltransferase (OST). The first X-ray structure of a complete bacterial OST enzyme, Campylobacter lari PglB, was recently determined. To understand the mechanism of PglB, we have quantified sequon binding and glycosylation turnover in vitro using purified enzyme and fluorescently labeled, synthetic peptide substrates. Using fluorescence anisotropy, we determined a dissociation constant of 1.0 mu M and a strict requirement for divalent metal ions for consensus (DQNAT) sequon binding. Using in-gel fluorescence detection, we quantified exceedingly low glycosylation rates that remained undetected using in vivo assays. We found that an alanine in the -2 sequon position, converting the bacterial sequon to a eukaryotic one, resulted in strongly lowered sequon binding, with in vitro turnover reduced 50,000-fold. A threonine is preferred over serine in the +2 sequon position, reflected by a 4-fold higher affinity and a 1.2-fold higher glycosylation rate. The interaction of the +2 sequon position with PglB is modulated by isoleucine 572. Our study demonstrates an intricate interplay of peptide and metal binding as the first step of protein N-glycosylation.	[Gerber, Sabina; Lizak, Christian; Bucher, Monika; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland; [Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Michaud, Gaelle; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, Dept Biol, Schafmattstr 20, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Reymond, Jean-Louis/0000-0003-2724-2942	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 200020_125020, SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the NCCR Structural Biology Zurich (to K. P. L.) and Swiss National Science Foundation Grants SNF 200020_125020 (to J. L. R.) and SNF 31003A-131075/1 (to K. P. L.).	BAUSE E, 1982, BIOCHEM J, V203, P761, DOI 10.1042/bj2030761; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1984, BIOCHEM SOC T, V12, P514, DOI 10.1042/bst0120514; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; DAS RC, 1980, P NATL ACAD SCI-BIOL, V77, P3811, DOI 10.1073/pnas.77.7.3811; DAVISON W, 1993, EARTH-SCI REV, V34, P119, DOI 10.1016/0012-8252(93)90029-7; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gawlitzek M, 2009, BIOTECHNOL BIOENG, V103, P1164, DOI 10.1002/bit.22348; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2011, GLYCOBIOLOGY, V21, P575, DOI 10.1093/glycob/cwq196; Ihssen J, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-67; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; Jervis AJ, 2012, J BACTERIOL, V194, P2355, DOI 10.1128/JB.00042-12; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; MAJZURAWSKA M, 1989, ANAL CHIM ACTA, V218, P47, DOI 10.1016/S0003-2670(00)80281-0; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nita-Lazar M, 2005, GLYCOBIOLOGY, V15, P361, DOI 10.1093/glycob/cwi019; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rukgauer M, 1997, J TRACE ELEM MED BIO, V11, P92; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; SUGIYAMA T, 1995, AM J PHYSIOL-CELL PH, V269, pC698, DOI 10.1152/ajpcell.1995.269.3.C698; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weisinger JR, 1998, LANCET, V352, P391, DOI 10.1016/S0140-6736(97)10535-9; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; Williams RJP, 2000, COORDIN CHEM REV, V200, P247, DOI 10.1016/S0010-8545(00)00324-6; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	55	65	65	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8849	8861		10.1074/jbc.M112.445940	http://dx.doi.org/10.1074/jbc.M112.445940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23382388	Green Published, hybrid			2022-12-28	WOS:000316862200007
J	Czyz, O; Bitew, T; Cuesta-Marban, A; McMaster, CR; Mollinedo, F; Zaremberg, V				Czyz, Ola; Bitew, Teshager; Cuesta-Marban, Alvaro; McMaster, Christopher R.; Mollinedo, Faustino; Zaremberg, Vanina			Alteration of Plasma Membrane Organization by an Anticancer Lysophosphatidylcholine Analogue Induces Intracellular Acidification and Internalization of Plasma Membrane Transporters in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; ENDOPLASMIC-RETICULUM; ET-18-OCH3 EDELFOSINE; PHOSPHATIDIC-ACID; SNF1 KINASE; H+-ATPASE; PH; APOPTOSIS; UBIQUITIN	The lysophosphatidylcholine analogue edelfosine is a potent antitumor lipid that targets cellular membranes. The underlying mechanisms leading to cell death remain controversial, although two cellular membranes have emerged as primary targets of edelfosine, the plasma membrane (PM) and the endoplasmic reticulum. In an effort to identify conditions that enhance or prevent the cytotoxic effect of edelfosine, we have conducted genome-wide surveys of edelfosine sensitivity and resistance in Saccharomyces cerevisiae presented in this work and the accompanying paper (Cuesta-Marban, A., Botet, J., Czyz, O., Cacharro, L. M., Gajate, C., Hornillos, V., Delgado, J., Zhang, H., Amat- Guerri, F., Acuna, A. U., McMaster, C. R., Revuelta, J. L., Zaremberg, V., and Mollinedo, F. (January 23, 2013) J. Biol. Chem. 288,), respectively. Our results point to maintenance of pH homeostasis as a major player in modulating susceptibility to edelfosine with the PM proton pump Pma1p playing a main role. We demonstrate that edelfosine alters PM organization and induces intracellular acidification. Significantly, we show that edelfosine selectively reduces lateral segregation of PM proteins like Pma1p and nutrient H+ - symporters inducing their ubiquitination and internalization. The biology associated to the mode of action of edelfosine we have unveiled includes selective modification of lipid raft integrity altering pH homeostasis, which in turn regulates cell growth.	[Czyz, Ola; Bitew, Teshager; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Cuesta-Marban, Alvaro; Mollinedo, Faustino] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain; [McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	University of Calgary; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Dalhousie University	Mollinedo, F (corresponding author), Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Campus Miguel Unamuno, E-37007 Salamanca, Spain.	fmollin@usal.es; vzarembe@ucalgary.ca		Cuesta Marban, Alvaro/0000-0002-7144-0500; McMaster, Christopher/0000-0003-0822-5776	Natural Sciences and Engineering Research Council of Canada; University of Calgary, a Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [14124]; Spanish Ministerio de Economia y Competitividad [SAF2008-02251, SAF2011-30518]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union [RD06/0020/1037, RD12/0036/0065]; European Community's Seventh Framework Programme [HEALTH-F2-2011-256986]; Junta de Castilla y Leon [CSI052A11-2, CSI221A12-2]; Spanish Ministerio de Ciencia e Innovacion	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary, a Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish Ministerio de Economia y Competitividad(Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union; European Community's Seventh Framework Programme(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada discovery grant, a seed grant from the University of Calgary, a Natural Sciences and Engineering Research Council of Canada University Faculty award (to V. Z.), Canadian Institutes of Health Research Grant 14124 (to C. R. M.), Spanish Ministerio de Economia y Competitividad Grants SAF2008-02251 and SAF2011-30518, Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union Grants RD06/0020/1037 and RD12/0036/0065, European Community's Seventh Framework Programme FP7-2007-2013 Grant HEALTH-F2-2011-256986, (PANACREAS), and Junta de Castilla y Leon Grants CSI052A11-2 and CSI221A12-2 (to F.M.).; Recipient of Formacion de Profesorado Universitario predoctoral fellowships from the Spanish Ministerio de Ciencia e Innovacion.	Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Bitew T, 2010, J BIOL CHEM, V285, P25731, DOI 10.1074/jbc.M110.122200; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BOGGS KP, 1995, J BIOL CHEM, V270, P11612, DOI 10.1074/jbc.270.19.11612; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Carmelo V, 1996, ARCH MICROBIOL, V166, P315, DOI 10.1007/s002030050389; Casamayor A, 2012, BIOCHEM J, V444, P39, DOI 10.1042/BJ20112099; Chen R, 2011, J IMMUNOL, V186, P3215, DOI 10.4049/jimmunol.1002710; Cuesta-Marban A, 2013, J BIOL CHEM, V288, P8405, DOI 10.1074/jbc.M112.425769; Fairn GD, 2005, METHODS, V36, P102, DOI 10.1016/j.ymeth.2004.11.005; Fyrst H, 1999, BIOCHEMISTRY-US, V38, P5864, DOI 10.1021/bi9824590; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2012, ONCOGENE, V31, P2627, DOI 10.1038/onc.2011.446; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hac-Wydro K, 2011, COLLOID SURFACE B, V88, P635, DOI 10.1016/j.colsurfb.2011.07.055; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Kaminska J, 2000, GENE, V242, P133, DOI 10.1016/S0378-1119(99)00535-1; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; Olivera-Couto A, 2012, MOL GENET GENOMICS, V287, P607, DOI 10.1007/s00438-012-0706-8; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Orij R, 2011, BBA-GEN SUBJECTS, V1810, P933, DOI 10.1016/j.bbagen.2011.03.011; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang J, 2010, CURR OPIN MICROBIOL, V13, P382, DOI 10.1016/j.mib.2010.04.004; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002	68	25	25	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8419	8432		10.1074/jbc.M112.425744	http://dx.doi.org/10.1074/jbc.M112.425744			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23344949	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000316564500040
J	Honsa, ES; Owens, CP; Goulding, CW; Maresso, AW				Honsa, Erin S.; Owens, Cedric P.; Goulding, Celia W.; Maresso, Anthony W.			The Near-iron Transporter (NEAT) Domains of the Anthrax Hemophore IsdX2 Require a Critical Glutamine to Extract Heme from Methemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS VACCINE; HEMOGLOBIN RECEPTOR; STRUCTURAL BASIS; SURFACE PROTEIN; ACQUISITION; DETERMINANT; BINDING; SYSTEM; IMMUNOGENICITY; STREPTOCOCCUS	Several Gram-positive pathogenic bacteria employ near-iron transporter (NEAT) domains to acquire heme from hemoglobin during infection. However, the structural requirements and mechanism of action for NEAT-mediated heme extraction remains unknown. Bacillus anthracis exhibits a rapid growth rate during systemic infection, suggesting that the bacterium expresses efficient iron acquisition systems. To understand how B. anthracis acquires iron from heme sources, which account for 80% of mammalian iron stores, we investigated the properties of the five-NEAT domain hemophore IsdX2. Using a combination of bioinformatics and site-directed mutagenesis, we determined that the heme extraction properties of IsdX2 are dependent on an amino acid with an amide side chain within the 3(10)-helix of the NEAT domain. Additionally, we used a spectroscopic analysis to show that IsdX2 NEAT domains only scavenge heme from methemoglobin (metHb) and that autoxidation of oxyhemoglobin to metHb must occur prior to extraction. We also report the crystal structures of NEAT5 wild type and a Q29T mutant and present surface plasmon resonance data that indicate that the loss of this amide side chain reduces the affinity of the NEAT domain for metHb. We propose a model whereby the amide side chain is first required to drive an interaction with metHb that destabilizes heme, which is subsequently extracted and coordinated in the aliphatic heme-binding environment of the NEAT domain. Because an amino acid with an amide side chain in this position is observed in NEAT domains of several genera of Gram-positive pathogenic bacteria, these results suggest that specific targeting of this or nearby residues may be an entry point for inhibitor development aimed at blocking bacterial iron acquisition during infection.	[Honsa, Erin S.; Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Owens, Cedric P.; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol, Irvine, CA 92617 USA; [Owens, Cedric P.; Goulding, Celia W.] Univ Calif Irvine, Dept Biochem, Irvine, CA 92617 USA	Baylor College of Medicine; University of California System; University of California Irvine; University of California System; University of California Irvine	Maresso, AW (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	maresso@bcm.edu		Owens, Cedric/0000-0002-8102-8181	National Institutes of Health [AI097167, AI069697, AI081161]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081161, R01AI097167, F32AI069697, R21AI096314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI097167 and AI069697 (to A. W. M.) and AI081161 (to C. W. G.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Crosa JH., 2004, IRON TRANSPORT BACTE; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Harro C, 2010, CLIN VACCINE IMMUNOL, V17, P1868, DOI 10.1128/CVI.00356-10; Harro CD, 2012, VACCINE, V30, P1729, DOI 10.1016/j.vaccine.2011.12.045; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; HILLIER J, 1953, J CELL COMPAR PHYSL, V42, P203, DOI 10.1002/jcp.1030420205; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; Howell S, 1998, J MOL RECOGNIT, V11, P200, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<200::AID-JMR423>3.0.CO;2-7; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lei Benfang, 2010, World J Biol Chem, V1, P286, DOI 10.4331/wjbc.v1.i9.286; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Murphy M., 2006, CURR PROTOC PROTEIN; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Spirig T, 2012, BIOMOL NMR ASSIGN, V6, P169, DOI 10.1007/s12104-011-9348-8; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Tsuruga M, 1997, BBA-PROTEIN STRUCT M, V1337, P96, DOI 10.1016/S0167-4838(96)00156-2; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	56	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8479	8490		10.1074/jbc.M112.430009	http://dx.doi.org/10.1074/jbc.M112.430009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364793	Green Published, hybrid			2022-12-28	WOS:000316564500045
J	Reidy, T; Rittenberg, A; Dwyer, M; D'Ortona, S; Pier, G; Gadjeva, M				Reidy, Thomas; Rittenberg, Alexander; Dwyer, Markryan; D'Ortona, Samantha; Pier, Gerald; Gadjeva, Mihaela			Homotrimeric Macrophage Migration Inhibitory Factor (MIF) Drives Inflammatory Responses in the Corneal Epithelium by Promoting Caveolin-rich Platform Assembly in Response to Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURE; INTERNALIZATION; PATHOGENESIS; EXPRESSION; ARTHRITIS; COMPONENT; CYTOKINE	A cute inflammation that arises during Pseudomonas aeruginosa- induced ocular infection can trigger tissue damage resulting in long term impairment of visual function, suggesting that the appropriate treatment strategy should include the use of anti-inflammatory agents in addition to antibiotics. We recently identified a potential target for modulation during ocular infection, macrophage migration inhibitory factor (MIF). MIF deficiency protected mice from inflammatory-mediated corneal damage resulting from acute bacterial keratitis. To gain a better understanding of the molecular mechanisms of MIF activity, we analyzed the oligomeric states and functional properties of MIF during infection. We found that in human primary corneal cells infected with P. aeruginosa, MIF is primarily in a homotrimeric state. Homotrimeric MIF levels correlated with the severity of infection in the corneas of infected mice, suggesting that the MIF homotrimers were the functionally active form of MIF. During infection, human primary corneal cells released more IL-8 when treated with recombinant, locked MIF trimers than when treated with lower MIF oligomers. MIF promoted P. aeruginosa-induced IL-8 responses via the formation of caveolin-1-rich "signaling hubs" in the corneal cells that led to elevated MAPKp42/p44 activation and sustained inflammatory signaling. These findings suggest that inhibiting homotrimerization of MIF or the functional activities of MIF homotrimers could have therapeutic benefits during ocular inflammation.	[Reidy, Thomas; Rittenberg, Alexander; Dwyer, Markryan; D'Ortona, Samantha; Pier, Gerald; Gadjeva, Mihaela] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gadjeva, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis,Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	mgadjeva@rics.bwh.harvard.edu	Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331	National Eye Institute [1R21EY019944, R01 EY022054, R01EY016144]; NATIONAL EYE INSTITUTE [R01EY016144, R21EY019944, R01EY022054] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute Grants 1R21EY019944 (to M.G.), R01 EY022054 (to M.G.), and R01EY016144 (to G.P.).	Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 1995, BIOTHERAPY, V8, P123, DOI 10.1007/BF01878495; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Brown FG, 2002, J AM SOC NEPHROL, V13, pS7; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 1996, J INFLAMM, V47, P39; Cherepkova O, 2005, NEUROCHEM RES, V30, P151, DOI 10.1007/s11064-004-9696-1; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Evans DJ, 2002, FEMS MICROBIOL LETT, V213, P73, DOI 10.1016/S0378-1097(02)00784-X; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Jorgensen WL, 2011, BIOORG MED CHEM LETT, V21, P4545, DOI 10.1016/j.bmcl.2011.05.127; Jorgensen WL, 2010, BIOORG MED CHEM LETT, V20, P7033, DOI 10.1016/j.bmcl.2010.09.118; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lolis E, 1996, P ASSOC AM PHYSICIAN, V108, P415; McClellan SA, 2006, OCUL IMMUNOL INFLAMM, V14, P21, DOI 10.1080/09273940500545650; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Potolicchio I, 2003, J BIOL CHEM, V278, P30889, DOI 10.1074/jbc.M302854200; PRESTON MJ, 1995, INFECT IMMUN, V63, P3497, DOI 10.1128/IAI.63.9.3497-3501.1995; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Srinivasan M, 2012, ARCH OPHTHALMOL-CHIC, V130, P143, DOI 10.1001/archophthalmol.2011.315; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Sun HW, 1996, PROTEIN ENG, V9, P631, DOI 10.1093/protein/9.8.631; Swant JD, 2005, J BIOL CHEM, V280, P23066, DOI 10.1074/jbc.M500636200; Thakur A, 2001, CLIN EXP OPHTHALMOL, V29, P179, DOI 10.1046/j.1442-9071.2001.00405.x; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Zaidi T, 2008, INVEST OPHTH VIS SCI, V49, P1000, DOI 10.1167/iovs.07-0993; Zaidi T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00058; Zaidi TS, 1999, INFECT IMMUN, V67, P1481, DOI 10.1128/IAI.67.3.1481-1492.1999	46	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8269	8278		10.1074/jbc.M112.351064	http://dx.doi.org/10.1074/jbc.M112.351064			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23372160	hybrid, Green Published			2022-12-28	WOS:000316564500027
J	Su, MY; Steiner, LA; Bogardus, H; Mishra, T; Schulz, VP; Hardison, RC; Gallagher, PG				Su, Mack Y.; Steiner, Laurie A.; Bogardus, Hannah; Mishra, Tejaswini; Schulz, Vincent P.; Hardison, Ross C.; Gallagher, Patrick G.			Identification of Biologically Relevant Enhancers in Human Erythroid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC ENHANCERS; CIS-REGULATORY MODULES; LONG NONCODING RNAS; CHIP-SEQ REVEALS; ANEMIA TYPE-II; HISTONE MODIFICATIONS; PHYLOGENETIC ODYSSEY; STEM-CELLS; TRANSCRIPTIONAL PROGRAM; CHROMATIN SIGNATURES	Identification of cell type-specific enhancers is important for understanding the regulation of programs controlling cellular development and differentiation. Enhancers are typically marked by the co-transcriptional activator protein p300 or by groups of cell-expressed transcription factors. We hypothesized that a unique set of enhancers regulates gene expression in human erythroid cells, a highly specialized cell type evolved to provide adequate amounts of oxygen throughout the body. Using chromatin immunoprecipitation followed by massively parallel sequencing, genome-wide maps of candidate enhancers were constructed for p300 and four transcription factors, GATA1, NF-E2, KLF1, and SCL, using primary human erythroid cells. These data were combined with gene expression analyses, and candidate enhancers were identified. Consistent with their predicted function as candidate enhancers, there was statistically significant enrichment of p300 and combinations of co-localizing erythroid transcription factors within 1-50 kb of the transcriptional start site (TSS) of genes highly expressed in erythroid cells. Candidate enhancers were also enriched near genes with known erythroid cell function or phenotype. Candidate enhancers exhibited moderate conservation with mouse and minimal conservation with nonplacental vertebrates. Candidate enhancers were mapped to a set of erythroid-associated, biologically relevant, SNPs from the genome-wide association studies (GWAS) catalogue of NHGRI, National Institutes of Health. Fourteen candidate enhancers, representing 10 genetic loci, mapped to sites associated with biologically relevant erythroid traits. Fragments from these loci directed statistically significant expression in reporter gene assays. Identification of enhancers in human erythroid cells will allow a better understanding of erythroid cell development, differentiation, structure, and function and provide insights into inherited and acquired hematologic disease.	[Su, Mack Y.; Bogardus, Hannah; Schulz, Vincent P.; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Steiner, Laurie A.] Univ Rochester, Dept Pediat, Rochester, NY 14642 USA; [Mishra, Tejaswini; Hardison, Ross C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Yale University; Yale University; Yale University; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gallagher, PG (corresponding author), Yale Univ, Sch Med, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	patrick.gallagher@yale.edu	Hardison, Ross C/G-1142-2010; Mishra, Tejaswini/D-3528-2018; cheng, yong/I-4270-2012	Hardison, Ross C/0000-0003-4084-7516; Mishra, Tejaswini/0000-0001-9931-1260; Steiner, Laurie/0000-0002-2923-4105; Schulz, Vincent/0000-0001-6333-4284	National Institutes of Health [K12HD000850, HL65448, DK62039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448, R01HL106184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062039, R01DK065806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K12HD000850, HL65448, and DK62039.	AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Borok MJ, 2010, DEVELOPMENT, V137, P5, DOI 10.1242/dev.036160; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-152; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Chlon TM, 2012, MOL CELL, V47, P608, DOI 10.1016/j.molcel.2012.05.051; Core LJ, 2009, GENE DEV, V23, P1606, DOI 10.1101/gad.1827709; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009059; Dore LC, 2012, BLOOD, V119, P3724, DOI 10.1182/blood-2011-09-380634; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Elnitski L, 1997, J BIOL CHEM, V272, P369; England SJ, 2011, BLOOD, V117, P2708, DOI 10.1182/blood-2010-07-299743; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fromm G, 2009, BIOCHEM CELL BIOL, V87, P781, DOI 10.1139/O09-048; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gallagher PG, 2005, J BIOL CHEM, V280, P39016, DOI 10.1074/jbc.M506062200; GALLAGHER PG, 1991, T ASSOC AM PHYSICIAN, V104, P32; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; GLOMSKI CA, 1992, HISTOL HISTOPATHOL, V7, P501; GLOMSKI CA, 1990, HISTOL HISTOPATHOL, V5, P513; Glomski CA, 1997, HISTOL HISTOPATHOL, V12, P147; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Guerrero L, 2010, DEV BIOL, V337, P16, DOI 10.1016/j.ydbio.2009.10.006; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Harju S, 2002, EXP BIOL MED, V227, P683, DOI 10.1177/153537020222700902; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Higgs DR, 2009, CELL MOL LIFE SCI, V66, P1154, DOI 10.1007/s00018-008-8529-9; Higgs DR, 2008, ADV GENET, V61, P143, DOI 10.1016/S0065-2660(07)00005-3; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Iolascon A, 2010, HAEMATOL-HEMATOL J, V95, P708, DOI 10.3324/haematol.2009.014985; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Maksimenko O, 2008, MOL CELL BIOL, V28, P5469, DOI 10.1128/MCB.00461-08; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mattick JS, 2010, DEV CELL, V19, P485, DOI 10.1016/j.devcel.2010.10.003; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P7976, DOI 10.1073/pnas.94.15.7976; McGrath KE, 2011, BLOOD, V117, P4600, DOI 10.1182/blood-2010-12-325357; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Migliaccio AR, 2002, BONE MARROW TRANSPL, V30, P75, DOI 10.1038/sj.bmt.1703599; Nikinmaa M, 1997, J EXP BIOL, V200, P369; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Ong CT, 2012, EMBO REP, V13, P423, DOI 10.1038/embor.2012.52; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Orom UA, 2011, TRENDS GENET, V27, P433, DOI 10.1016/j.tig.2011.06.009; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; Palis J, 2010, INT J DEV BIOL, V54, P1011, DOI 10.1387/ijdb.093056jp; Panzenbock B, 1998, BLOOD, V92, P3658, DOI 10.1182/blood.V92.10.3658.422k18_3658_3668; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Russo R, 2010, AM J HEMATOL, V85, P915, DOI 10.1002/ajh.21866; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Steiner LA, 2011, J BIOL CHEM, V286, P39457, DOI 10.1074/jbc.M111.243006; Steiner LA, 2009, MOL CELL BIOL, V29, P5399, DOI 10.1128/MCB.00777-09; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Valverde-Garduno V, 2004, BLOOD, V104, P3106, DOI 10.1182/blood-2004-04-1333; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yoo EJ, 2012, MOL CELL BIOL, V32, P2020, DOI 10.1128/MCB.06650-11; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	127	37	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8433	8444		10.1074/jbc.M112.413260	http://dx.doi.org/10.1074/jbc.M112.413260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23341446	Green Published, hybrid			2022-12-28	WOS:000316564500041
J	Resmi, MS; Verma, P; Gokhale, RS; Soniya, EV				Resmi, Mohankumar Saraladevi; Verma, Priyanka; Gokhale, Rajesh S.; Soniya, Eppurathu Vasudevan			Identification and Characterization of a Type III Polyketide Synthase Involved in Quinolone Alkaloid Biosynthesis from Aegle marmelos Correa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHALCONE SYNTHASE; BENZALACETONE SYNTHASE; ENZYMATIC FORMATION; MOLECULAR-CLONING; ACRIDONE SYNTHASE; SKIMMIANINE; FAMILY; FUROQUINOLINES; SCAFFOLDS; STILBENE	Quinolone alkaloids, found abundantly in the roots of bael (Aegle marmelos), possess various biological activities and have recently gained attention as potential lead molecules for novel drug designing. Here, we report the characterization of a novel Type III polyketide synthase, quinolone synthase (QNS), from A. marmelos that is involved in the biosynthesis of quinolone alkaloid. Using homology-based structural modeling, we identify two crucial amino acid residues (Ser-132 and Ala-133) at the putative QNS active site. Substitution of Ser-132 to Thr and Ala-133 to Ser apparently constricted the active site cavity resulting in production of naringenin chalcone from p-coumaroyl-CoA. Measurement of steady-state kinetic parameters demonstrates that the catalytic efficiency of QNS was several-fold higher for larger acyl-coenzymeA substrates as compared with smaller precursors. Our mutagenic studies suggest that this protein might have evolved from an evolutionarily related member of chalcone synthase superfamily by mere substitution of two active site residues. The identification and characterization of QNS offers a promising target for gene manipulation studies toward the production of novel alkaloid scaffolds.	[Resmi, Mohankumar Saraladevi; Soniya, Eppurathu Vasudevan] Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thiruvananthapuram 695014, Kerala, India; [Verma, Priyanka] Natl Inst Immunol, New Delhi 110067, India; [Gokhale, Rajesh S.] CSIR, Inst Genom & Integrat Biol, Syst Biol Grp, Delhi 110007, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Soniya, EV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.	evsoniya@rgcb.res.in			Department of Science and Technology, New Delhi, India; Council of Scientific and Industrial Research (New Delhi, India)	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Science and Technology, New Delhi, India, and a senior research fellowship from Council of Scientific and Industrial Research (New Delhi, India).	Abe I, 2006, ORG LETT, V8, P499, DOI 10.1021/ol052912h; Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2003, J BIOL CHEM, V278, P25218, DOI 10.1074/jbc.M303276200; Abe I, 2006, ORG LETT, V8, P6063, DOI 10.1021/ol0625233; Akiyama T, 1999, EUR J BIOCHEM, V263, P834, DOI 10.1046/j.1432-1327.1999.00562.x; ALHAIDER AA, 1985, J MED CHEM, V28, P1394, DOI 10.1021/jm00148a004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Chen KS, 2000, PLANTA MED, V66, P80, DOI 10.1055/s-0029-1243116; CHENG JT, 1990, ARCH INT PHARMACOD T, V306, P65; CHENG JT, 1986, ARCH INT PHARMACOD T, V281, P35; CHENG JT, 1994, J AUTON PHARMACOL, V14, P365, DOI 10.1111/j.1474-8673.1994.tb00617.x; Dewick P. M., 1997, MED NATURAL PRODUCTS, P123; Durbin ML, 2000, PLANT MOL BIOL, V42, P79, DOI 10.1023/A:1006375904820; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Ghosh R, 2008, J BIOL CHEM, V283, P11348, DOI 10.1074/jbc.M709588200; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Jansen O, 2006, J ETHNOPHARMACOL, V105, P241, DOI 10.1016/j.jep.2005.11.001; Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; JUNGHANNS KT, 1995, PLANT MOL BIOL, V27, P681, DOI 10.1007/BF00020222; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klundt T, 2009, J BIOL CHEM, V284, P30957, DOI 10.1074/jbc.M109.038927; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lukacin R, 2001, FEBS LETT, V508, P413, DOI 10.1016/S0014-5793(01)03061-7; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; Nugroho A. E., 2010, Journal of Basic & Applied Sciences, V6, P141; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Resmi MS, 2012, GENE, V491, P278, DOI 10.1016/j.gene.2011.09.025; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Riyanto S., 2001, MALAYSIAN J ANAL SCI, V7, P463; Robert A, 1998, CHEM SOC REV, V27, P273, DOI 10.1039/a827273z; Samappito S, 2003, PHYTOCHEMISTRY, V62, P313, DOI 10.1016/S0031-9422(02)00545-9; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Shi SP, 2009, ORG LETT, V11, P551, DOI 10.1021/ol802606w; Tillequin Francois, 2007, Phytochemistry Reviews, V6, P65, DOI 10.1007/s11101-006-9010-8; Zheng DS, 2001, PLANT MOL BIOL, V46, P1, DOI 10.1023/A:1010642517738	40	24	26	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7271	7281		10.1074/jbc.M112.429886	http://dx.doi.org/10.1074/jbc.M112.429886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23329842	hybrid, Green Published			2022-12-28	WOS:000316002400047
J	Thompson, MG; Foley, DA; Colley, KJ				Thompson, Matthew G.; Foley, Deirdre A.; Colley, Karen J.			The Polysialyltransferases Interact with Sequences in Two Domains of the Neural Cell Adhesion Molecule to Allow Its Polysialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHASE; ST8SIA II STX; IN-VIVO; GLYCAN POLYSIALYLATION; NERVOUS-SYSTEM; LUNG-CARCINOMA; WILMS TUMOR; NCAM; BRAIN; IDENTIFICATION	The neural cell adhesion molecule (NCAM) is the major substrate for the polysialyltransferases (polySTs), ST8SiaII/STX and ST8SiaIV/PST. The polysialylation of NCAM N-glycans decreases cell adhesion and alters signaling. Previous work demonstrated that the first fibronectin type III repeat (FN1) of NCAM is required for polyST recognition and the polysialylation of the N-glycans on the adjacent Ig5 domain. In this work, we highlight the importance of an FN1 acidic patch in polyST recognition and also reveal that the polySTs are required to interact with sequences in the Ig5 domain for polysialylation to occur. We find that features of the Ig5 domain of the olfactory cell adhesion molecule (OCAM) are responsible for its lack of polysialylation. Specifically, two basic OCAM Ig5 residues (Lys and Arg) found near asparagines equivalent to those carrying the polysialylated N-glycans in NCAM substantially decrease or eliminate polysialylation when used to replace the smaller and more neutral residues (Ser and Asn) in analogous positions in NCAM Ig5. This decrease in polysialylation does not reflect altered glycosylation but instead is correlated with a decrease in polyST-NCAM binding. In addition, inserting non-conserved OCAM sequences into NCAM Ig5, including an "extra" N-glycosylation site, decreases or completely blocks NCAM polysialylation. Taken together, these results indicate that the polySTs not only recognize an acidic patch in the FN1 domain of NCAM but also must contact sequences in the Ig5 domain for polysialylation of Ig5 N-glycans to occur.	[Thompson, Matthew G.; Foley, Deirdre A.; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM63843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843, R01GM101949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM63843 (to K. J. C.).	Alenius M, 1997, J BIOL CHEM, V272, P26083, DOI 10.1074/jbc.272.42.26083; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; Kulahin N, 2011, STRUCTURE, V19, P203, DOI 10.1016/j.str.2010.12.014; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; PaoloniGiacobino A, 1997, GENOMICS, V43, P43, DOI 10.1006/geno.1997.4782; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, VIRCHOWS ARCH B, V56, P95, DOI 10.1007/BF02890007; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Takahashi S, 2011, CANCER SCI, V102, P808, DOI 10.1111/j.1349-7006.2011.01855.x; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zapater JL, 2012, J BIOL CHEM, V287, P6441, DOI 10.1074/jbc.M111.322024; ZUBER C, 1992, J BIOL CHEM, V267, P9965	48	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7282	7293		10.1074/jbc.M112.438374	http://dx.doi.org/10.1074/jbc.M112.438374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341449	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000316002400048
J	Burgo, A; Casano, AM; Kuster, A; Arold, ST; Wang, G; Nola, S; Verraes, A; Dingli, F; Loew, D; Galli, T				Burgo, Andrea; Casano, Alessandra M.; Kuster, Aurelia; Arold, Stefan T.; Wang, Guan; Nola, Sebastien; Verraes, Agathe; Dingli, Florent; Loew, Damarys; Galli, Thierry			Increased activity of the Vesicular Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor TI-VAMP/VAMP7 by Tyrosine Phosphorylation in the Longin Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; PLASMA-MEMBRANE; GOLGI-APPARATUS; SNARE VAMP7; KINASE; VESICLES; ASSOCIATION; MECHANISM; PREDICTION; TRANSPORT	Vesicular (v)- and target (t)-SNAREs play essential roles in intracellular membrane fusion through the formation of cytoplasmic alpha-helical bundles. Several v-SNAREs have a Longin N-terminal extension that, by promoting a closed conformation, plays an autoinhibitory function and decreases SNARE complex formation and membrane fusion efficiency. The molecular mechanism leading to Longin v-SNARE activation is largely unknown. Here we find that exocytosis mediated by the Longin v-SNARE TI-VAMP/VAMP7 is activated by tonic treatment with insulin and insulin-like growth factor-1 but not by depolarization and intracellular calcium rise. In search of a potential downstream mechanism, we found that TI-VAMP is phosphorylated in vitro by c-Src kinase on tyrosine 45 of the Longin domain. Accordingly, a mutation of tyrosine 45 into glutamate, but not phenylalanine, activates both t-SNARE binding and exocytosis. Activation of TI-VAMP-mediated exocytosis thus relies on tyrosine phosphorylation.	[Burgo, Andrea; Casano, Alessandra M.; Kuster, Aurelia; Wang, Guan; Nola, Sebastien; Verraes, Agathe; Galli, Thierry] Univ Paris Diderot, CNRS, UMR 7592, Inst Jacques Monod, F-75013 Paris, France; [Burgo, Andrea; Casano, Alessandra M.; Kuster, Aurelia; Wang, Guan; Nola, Sebastien; Verraes, Agathe; Galli, Thierry] INSERM, ERL, U950, F-75013 Paris, France; [Arold, Stefan T.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Dingli, Florent; Loew, Damarys] Inst Curie, Ctr Rech, Lab Spectrometrie Masse Prote, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Texas System; UTMD Anderson Cancer Center; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Galli, T (corresponding author), Inst Jacques Monod, Bat Buffon,15 Rue Helene Brion, F-75205 Paris 13, France.	thierry.galli@inserm.fr	Arold, Stefan/T-2612-2019; Galli, Thierry/G-8842-2011; Galli, Thierry/Q-2249-2019; Nola, Sebastien/D-6518-2017; Burgo, Andrea/F-2076-2010; Burgo, Andrea/P-7640-2019	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455; Nola, Sebastien/0000-0002-6485-9856; Burgo, Andrea/0000-0002-0270-5448; Burgo, Andrea/0000-0002-0270-5448; Arold, Stefan T/0000-0001-5278-0668; Damarys, Loew/0000-0002-9111-8842; Casano, Alessandra Maria/0000-0002-6009-6804; Wang, Guan/0000-0002-0390-6057; Burgo, Andrea/0000-0001-8875-3434	INSERM; Association Francaise contre les Myopathies; Association pour la Recherche sur le Cancer; Mairie de Paris Medical Research and Health Program; Fondation pour la Recherche Medicale; Ecole des Neurosciences de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Mairie de Paris Medical Research and Health Program; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ecole des Neurosciences de Paris	This work was supported by grants from INSERM, the Association Francaise contre les Myopathies, the Association pour la Recherche sur le Cancer, the Mairie de Paris Medical Research and Health Program, the Fondation pour la Recherche Medicale, the Ecole des Neurosciences de Paris (to T. G.).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Blakesley Vicky A., 1996, Cytokine and Growth Factor Reviews, V7, P153, DOI 10.1016/1359-6101(96)00015-9; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Danglot L, 2003, MOL CELL NEUROSCI, V23, P264, DOI 10.1016/S1044-7431(03)00069-1; Danglot L, 2012, J NEUROSCI, V32, P1962, DOI 10.1523/JNEUROSCI.4436-11.2012; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Gurd JW, 1997, NEUROCHEM INT, V31, P635, DOI 10.1016/S0197-0186(97)00022-3; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; LINSTEDT AD, 1992, J CELL BIOL, V117, P1077, DOI 10.1083/jcb.117.5.1077; LUTTRELL LM, 1989, ONCOGENE, V4, P317; Fader CM, 2012, AUTOPHAGY, V8, P1741, DOI 10.4161/auto.21858; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Muzerelle A, 2003, NEUROSCIENCE, V122, P59, DOI 10.1016/S0306-4522(03)00567-0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schafer IB, 2012, NAT STRUCT MOL BIOL, V19, P1300, DOI 10.1038/nsmb.2414; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Verderio C, 2012, BIOL CELL, V104, P213, DOI 10.1111/boc.201100070; Vivona S, 2010, J BIOL CHEM, V285, P17965, DOI 10.1074/jbc.M110.120972; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Zhao WQ, 2000, P NATL ACAD SCI USA, V97, P8098, DOI 10.1073/pnas.97.14.8098; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	49	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11960	11972		10.1074/jbc.M112.415075	http://dx.doi.org/10.1074/jbc.M112.415075			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23471971	Green Published, hybrid			2022-12-28	WOS:000318157600031
J	Gallego, P; Velazquez-Campoy, A; Regue, L; Roig, J; Reverter, D				Gallego, Pablo; Velazquez-Campoy, Adrian; Regue, Laura; Roig, Joan; Reverter, David			Structural Analysis of the Regulation of the DYNLL/LC8 Binding to Nek9 by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; NIMA-FAMILY KINASE; INTERMEDIATE CHAIN; CYTOPLASMIC DYNEIN; LC8; DIMERIZATION; SWALLOW; DIMER; CENTROSOME; SEPARATION	The NIMA family protein kinases Nek9/Nercc1, Nek6, and Nek7 constitute a signaling module activated in early mitosis involved in the control of spindle organization. DYNLL/LC8 (dynein light chain 8) was originally described as a component of the dynein complex, but the recent discovery of multiple interaction partners for LC8 has suggested that it has a general role as a dimerization hub that organizes different protein partners. Recent experiments suggested that LC8 binding to Nek9 was regulated by Nek9 autophosphorylation on Ser(944), a residue immediately located N-terminal to the LC8 conserved (K/R)x-TQT binding motif, and that this was crucial for the control of signal transduction through the Nek/Nek6/7 module. In the present work, we present two crystal structures of LC8 with a peptide corresponding to the Nek9 binding region with and without a phosphorylation on Ser944. Structural analysis of LC8 with both Nek9 peptides, together with different biophysical experiments, explains the observed diminished binding affinity of Nek9 to LC8 upon phosphorylation on Ser944 within the Nek9 sequence, thus shedding light into a novel phosphorylation regulatory mechanism that interferes with LC8 protein.protein complex formation.	[Gallego, Pablo; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Struct Biol Unit, Bellaterra 08193, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Consejo Super Invest Cient BIFI, Dept Biochem & Mol & Cell Biol, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Consejo Super Invest Cient BIFI, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR, E-50009 Zaragoza, Spain; [Velazquez-Campoy, Adrian] 500018 Govt Aragon, Fdn ARAID, Aragon, Spain; [Regue, Laura; Roig, Joan] Inst Res Biomed, Barcelona 08028, Spain	Autonomous University of Barcelona; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	david.reverter@uab.cat	Velazquez-Campoy, Adrian/E-7946-2012; Barrufet, Laura Regue/AAB-9465-2020; Reverter, David/H-5360-2015; Roig, Joan/E-2836-2017	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Barrufet, Laura Regue/0000-0003-1341-3413; Reverter, David/0000-0002-5347-0992; Roig, Joan/0000-0002-3872-4712	"Ministerio de Ciencia e Innovacion" of Spain [BFU2012-37116, BFU2010-19451, BFU2011-25855]; European Community Grant [MIRG-CT-2007-200346]; Formacion Personal Investigador fellowship from the "Ministerio de Ciencia e Innovacion" of Spain; I3 program from the "Ministerio de Ciencia e Innovacion" of Spain; Ramon y Cajal program from the "Ministerio de Ciencia e Innovacion" of Spain	"Ministerio de Ciencia e Innovacion" of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community Grant(European Commission); Formacion Personal Investigador fellowship from the "Ministerio de Ciencia e Innovacion" of Spain; I3 program from the "Ministerio de Ciencia e Innovacion" of Spain; Ramon y Cajal program from the "Ministerio de Ciencia e Innovacion" of Spain	This work was supported by "Ministerio de Ciencia e Innovacion" of Spain Grants BFU2012-37116 (to D. R.), BFU2010-19451 (to A. V. C.), and BFU2011-25855 (to J. R.) and European Community Grant MIRG-CT-2007-200346 (to D. R.).; Supported by the Formacion Personal Investigador fellowship from the "Ministerio de Ciencia e Innovacion" of Spain.; Supported by the I3 program from the "Ministerio de Ciencia e Innovacion" of Spain.; Supported by the Ramon y Cajal program from the "Ministerio de Ciencia e Innovacion" of Spain. To whom the correspondence should be addressed: Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. Tel.: 93-5868955; Fax: 93-5812011; E-mail: david.reverter@uab.cat.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaiser FJ, 2003, HUM MOL GENET, V12, P1349, DOI 10.1093/hmg/ddg145; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mohan PMK, 2006, PROTEIN SCI, V15, P335, DOI 10.1110/ps.051854906; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Radnai L, 2010, J BIOL CHEM, V285, P38649, DOI 10.1074/jbc.M110.165894; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Regue L, 2011, J BIOL CHEM, V286, P18118, DOI 10.1074/jbc.M110.209080; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Sdelci S, 2011, CELL CYCLE, V10, P3816, DOI 10.4161/cc.10.22.18226; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Velazquez-Campoy A, 2000, PROTEIN SCI, V9, P1801, DOI 10.1110/ps.9.9.1801; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069	48	20	22	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12283	12294		10.1074/jbc.M113.459149	http://dx.doi.org/10.1074/jbc.M113.459149			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23482567	Green Published, hybrid			2022-12-28	WOS:000318157600059
J	Allen, S; Richardson, JM; Mehlert, A; Ferguson, MAJ				Allen, Simon; Richardson, Julia M.; Mehlert, Angela; Ferguson, Michael A. J.			Structure of a Complex Phosphoglycan Epitope from gp72 of Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEISHMANIA-MAJOR; SURFACE GLYCOPROTEIN; DICTYOSTELIUM-DISCOIDEUM; INSECT; LIPOPHOSPHOGLYCAN; ATTACHMENT; PARASITE; DELETION; MUCINS; GENE	The parasitic protozoan organism Trypanosoma cruzi is the causative agent of Chagas disease. The insect vector-dwelling epimastigote form of the organism expresses a low abundance glycoprotein associated with the flagellum adhesion zone, called gp72. The gp72 glycoprotein was first identified with an anti-carbohydrate IgG3 monoclonal antibody called WIC29.26 and has been shown to have an unusual sugar composition. Here, we describe a new way to isolate the WIC29.26 carbohydrate epitope of gp72. Using H-1 NMR and mass spectrometry before and after derivatization, we provide an almost complete primary chemical structure for the epitope, which is that of a complex phosphosaccharide: Galf beta 1-4Rhap alpha 1-2Fucp alpha 1-4(Galp beta 1-3)(Galp alpha 1-2)Xylp beta 1-4Xylp beta 1-3(Xylp beta 1-2Galp alpha 1-4(Galp beta 1-3)(Rhap alpha 1-2)Fucp alpha 1-4)GlcNAcp, with phosphate attached to one or other of the two Galp terminal residues and in which all residues are of the D-absolute configuration, except for fucose and rhamnose which are L. Combined with previous data (Haynes, P. A., Ferguson, M. A., and Cross, G. A. (1996) Glycobiology 6, 869-878), we postulate that this complex structure and its variants lacking one or more residues are linked to Thr and Ser residues in gp72 via a phosphodiester linkage (GlcNAcp alpha 1-P-Thr/Ser) and that these units may form phosphosaccharide repeats through GlcNAcp alpha 1-P-Galp linkages. The gp72 glycoprotein is associated with the flagellum adhesion zone on the parasite surface, and its ligation has been implicated in inhibiting parasite differentiation from the epimastigote to the metacyclic trypomastigote stage. The detailed structure of the unique phosphosaccharide component of gp72 reported here provides a template for future biosynthetic and functional studies.	[Allen, Simon; Mehlert, Angela; Ferguson, Michael A. J.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland; [Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	University of Dundee; University of Edinburgh	Ferguson, MAJ (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland.	m.a.j.ferguson@dundee.ac.uk	Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [085622, 083481, 100476]; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Programme Grant 085622 (to M. A. J. F.) and by a doctoral studentship from the Biotechnology and Biological Sciences Research Council (to S. A.). The mass spectrometry facility at the College of Life Sciences of the University of Dundee is supported by Wellcome Trust Strategic Awards 083481 and 100476.	Acosta-Serrano A, 2001, MOL BIOCHEM PARASIT, V114, P143, DOI 10.1016/S0166-6851(01)00245-6; Basombrio MA, 2002, J PARASITOL, V88, P489, DOI 10.1645/0022-3395(2002)088[0489:TDOTGG]2.0.CO;2; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; COOPER R, 1991, MOL BIOCHEM PARASIT, V49, P45, DOI 10.1016/0166-6851(91)90129-T; DEJESUS AR, 1993, J CELL SCI, V106, P1023; Dobson DE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001185; FERGUSON MAJ, 1985, BIOCHIM BIOPHYS ACTA, V842, P39, DOI 10.1016/0304-4165(85)90290-9; FERGUSON MAJ, 1983, BIOCHEM J, V213, P313, DOI 10.1042/bj2130313; FERGUSON MAJ, 1994, GLYCOBIOLOGY PRACTIC, P349; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Giorgi ME, 2011, CARBOHYD RES, V346, P1389, DOI 10.1016/j.carres.2011.04.006; GORIN PAJ, 1979, J PROTOZOOL, V26, P473, DOI 10.1111/j.1550-7408.1979.tb04656.x; GUSTAFSON GL, 1980, J BIOL CHEM, V255, P7208; Haynes PA, 1996, J CELL SCI, V109, P2979; Haynes PA, 1998, GLYCOBIOLOGY, V8, P1, DOI 10.1093/glycob/8.1.1; Haynes PA, 1996, GLYCOBIOLOGY, V6, P869, DOI 10.1093/glycob/6.8.869; Ilg T, 2000, PARASITOL TODAY, V16, P489, DOI 10.1016/S0169-4758(00)01791-9; Kamhawi S, 2000, PARASITOLOGY, V121, P25, DOI 10.1017/S0031182099006125; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; MacRae JI, 2005, J BIOL CHEM, V280, P12201, DOI 10.1074/jbc.M412939200; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; Mendonca-Previato L, 2005, CURR OPIN STRUC BIOL, V15, P499, DOI 10.1016/j.sbi.2005.08.011; Mreyen M, 2000, J BIOL CHEM, V275, P12164, DOI 10.1074/jbc.275.16.12164; Rocha GM, 2006, J STRUCT BIOL, V154, P89, DOI 10.1016/j.jsb.2005.11.008; SCHNEIDER P, 1994, J BIOL CHEM, V269, P18332; SHER A, 1982, NATURE, V300, P639, DOI 10.1038/300639a0; SNARY D, 1981, MOL BIOCHEM PARASIT, V3, P343, DOI 10.1016/0166-6851(81)90035-9; Soares RP, 2012, AM J TROP MED HYG, V87, P87, DOI 10.4269/ajtmh.2012.12-0015; Thomson LM, 2002, J BIOL CHEM, V277, P48899, DOI 10.1074/jbc.M208942200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07	33	19	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11093	11105		10.1074/jbc.M113.452763	http://dx.doi.org/10.1074/jbc.M113.452763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23436655	hybrid, Green Published			2022-12-28	WOS:000317915500015
J	Mizumoto, S; Ikegawa, S; Sugahara, K				Mizumoto, Shuji; Ikegawa, Shiro; Sugahara, Kazuyuki			Human Genetic Disorders Caused by Mutations in Genes Encoding Biosynthetic Enzymes for Sulfated Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EHLERS-DANLOS-SYNDROME; PROTEIN LINKAGE REGION; CHONDROITIN N-ACETYLGALACTOSAMINYLTRANSFERASE; TUMOR SUPPRESSORS EXT1; OF-FUNCTION MUTATIONS; MOLECULAR-CLONING; HEPARAN-SULFATE; DERMATAN SULFATE; SPONDYLOEPIPHYSEAL DYSPLASIA; CONGENITAL DISLOCATIONS	A number of genetic disorders are caused by mutations in the genes encoding glycosyltransferases and sulfotransferases, enzymes responsible for the synthesis of sulfated glycosaminoglycan (GAG) side chains of proteoglycans, including chondroitin sulfate, dermatan sulfate, and heparan sulfate. The phenotypes of these genetic disorders reflect disturbances in crucial biological functions of GAGs in human. Recent studies have revealed that mutations in genes encoding chondroitin sulfate and dermatan sulfate biosynthetic enzymes cause various disorders of connective tissues. This minireview focuses on growing glycobiological studies of recently described genetic diseases caused by disturbances in biosynthetic enzymes for sulfated GAGs.	[Mizumoto, Shuji; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido 0010021, Japan; [Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Tokyo 1088639, Japan	Hokkaido University; RIKEN	Sugahara, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp	Mizumoto, Shuji/F-8313-2018; Ikegawa, Shiro/N-6895-2015	Mizumoto, Shuji/0000-0002-4641-1505; Ikegawa, Shiro/0000-0003-0316-2147	Matching Program for Innovations in Future Drug Discovery and Medical Care; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [24110501]; Japan Society for the Promotion of Science [23790066]; Japan Heart Foundation; Akiyama Life Science Foundation	Matching Program for Innovations in Future Drug Discovery and Medical Care; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Heart Foundation; Akiyama Life Science Foundation	This work was supported in part by the Matching Program for Innovations in Future Drug Discovery and Medical Care and Grants-in-aid for Scientific Research on Innovative Areas (24110501) (to K.S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; to K. S.) and by a Grant-in-aid for Young Scientists (B) 23790066 from the Japan Society for the Promotion of Science, a Hiroshi and Aya Irisawa Memorial research grant from the Japan Heart Foundation, and a Grant-in-aid for Encouragement from the Akiyama Life Science Foundation (to S. M.).	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Baasanjav S, 2011, AM J HUM GENET, V89, P15, DOI 10.1016/j.ajhg.2011.05.021; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Budde B. S., 2012, 62 ANN M AM SOC HUM; Bui C, 2010, FEBS LETT, V584, P3962, DOI 10.1016/j.febslet.2010.08.001; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Dundar M, 2009, AM J HUM GENET, V85, P873, DOI 10.1016/j.ajhg.2009.11.010; Dundar M, 1997, CLIN GENET, V51, P61; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Faiyaz-Ul-Haque M, 2004, AM J MED GENET A, V128A, P39, DOI 10.1002/ajmg.a.30005; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; Goossens D, 2003, MOL PSYCHIATR, V8, P83, DOI 10.1038/sj.mp.4001190; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Gotte M, 2005, BIOCHEM GENET, V43, P65, DOI 10.1007/s10528-005-1068-2; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2008, J BIOL CHEM, V283, P27438, DOI 10.1074/jbc.M803279200; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Kosho T, 2005, AM J MED GENET A, V138A, P282, DOI 10.1002/ajmg.a.30965; Kosho T, 2010, AM J MED GENET A, V152A, P1333, DOI 10.1002/ajmg.a.33498; LARSEN LJ, 1950, J PEDIATR-US, V37, P574, DOI 10.1016/S0022-3476(50)80268-8; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Malfait F, 2010, HUM MUTAT, V31, P1233, DOI 10.1002/humu.21355; MALMSTROM A, 1975, J BIOL CHEM, V250, P3419; MALMSTROM A, 1984, J BIOL CHEM, V259, P161; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Miyake N, 2012, J MED GENET, V49, P533, DOI 10.1136/jmedgenet-2012-101039; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Mizumoto S, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P289; Mizumoto S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P98; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Ouvrier R, 2007, MUSCLE NERVE, V36, P131, DOI 10.1002/mus.20776; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Rahuel-Clermont S, 2010, BIOCHEM J, V432, P303, DOI 10.1042/BJ20100921; Rajab A, 2004, AM J MED GENET A, V126A, P413, DOI 10.1002/ajmg.a.20606; Rossi A, 1996, HUM GENET, V98, P657, DOI 10.1007/s004390050279; Saigoh K, 2011, J HUM GENET, V56, P143, DOI 10.1038/jhg.2010.148; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; SCHWARTZ NB, 1974, BIOCHEM BIOPH RES CO, V56, P717, DOI 10.1016/0006-291X(74)90664-0; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Sonoda T, 2000, AM J MED GENET, V91, P280, DOI 10.1002/(SICI)1096-8628(20000410)91:4<280::AID-AJMG8>3.3.CO;2-2; STEEL HH, 1972, J BONE JOINT SURG AM, VA 54, P75, DOI 10.2106/00004623-197254010-00007; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Tuysuz B, 2009, CLIN GENET, V75, P375, DOI 10.1111/j.1399-0004.2009.01167.x; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Unger S, 2010, AM J MED GENET A, V152A, P2543, DOI 10.1002/ajmg.a.33641; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; van Roij MHH, 2008, AM J MED GENET A, V146A, P2376, DOI 10.1002/ajmg.a.32482; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6; Zayed H, 2010, AM J MED GENET A, V152A, P916, DOI 10.1002/ajmg.a.33341	98	79	80	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10953	10961		10.1074/jbc.R112.437038	http://dx.doi.org/10.1074/jbc.R112.437038			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457301	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000317915500001
J	Vacaru, AM; van den Dikkenberg, J; Ternes, P; Holthuis, JCM				Vacaru, Ana M.; van den Dikkenberg, Joep; Ternes, Philipp; Holthuis, Joost C. M.			Ceramide Phosphoethanolamine Biosynthesis in Drosophila Is Mediated by a Unique Ethanolamine Phosphotransferase in the Golgi Lumen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RAT-LIVER; SPHINGOMYELIN SYNTHASES; STRUCTURAL ELUCIDATION; AQUATIC ANIMALS; SEA ANEMONE; MEMBRANE; CELLS; PHOSPHOLIPIDS; PROTEIN	Sphingomyelin (SM) is a vital component of mammalian membranes, providing mechanical stability and a structural framework for plasma membrane organization. Its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, a reaction catalyzed by SM synthase in the Golgi lumen. Drosophila lacks SM and instead synthesizes the SM analogue ceramide phosphoethanolamine (CPE) as the principal membrane sphingolipid. The corresponding CPE synthase shares mechanistic features with enzymes mediating phospholipid biosynthesis via the Kennedy pathway. Using a functional cloning strategy, we here identified a CDP-ethanolamine: ceramide ethanolamine phosphotransferase as the enzyme responsible for CPE production in Drosophila. CPE synthase constitutes a new branch within the CDP-alcohol phosphotransferase superfamily with homologues in Arthropoda (insects, spiders, mites, scorpions), Cnidaria (Hydra, sea anemones), and Mollusca (oysters) but not in most other animal phyla. The enzyme resides in the Golgi complex with its active site facing the lumen, contrary to the membrane topology of other CDP-alcohol phosphotransferases. Our findings open up an important new avenue to address the biological role of CPE, an enigmatic membrane constituent of a wide variety of invertebrate and marine organisms.	[Vacaru, Ana M.; van den Dikkenberg, Joep; Ternes, Philipp; Holthuis, Joost C. M.] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; [Vacaru, Ana M.; van den Dikkenberg, Joep; Ternes, Philipp; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Vacaru, Ana M.] Ichan Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Vacaru, Ana M.] Ichan Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Ternes, Philipp] Metanomics GmbH, D-10589 Berlin, Germany; [Holthuis, Joost C. M.] Univ Osnabruck, Mol Cell Biol Div, D-49076 Osnabruck, Germany	Utrecht University; Utrecht University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University Osnabruck	Ternes, P (corresponding author), Metanomics GmbH, Tegeler Weg 33, D-10589 Berlin, Germany.	philipp.ternes@arcor.de; holthuis@uos.de	Holthuis, Joost/AAL-9157-2020; Vacaru, Ana/AAR-7370-2021	Holthuis, Joost/0000-0001-8912-1586; Ternes, Philipp/0000-0003-0886-5474; Vacaru, Ana Maria/0000-0001-7976-8992	European Union Framework V Program (the Flippase Project); Marie Curie Intra-European Fellowship; European Molecular Biology Organization (EMBO) Long-Term Fellowship; Dutch Organization of Sciences (NWO-CW); Utrecht University High Potential Program	European Union Framework V Program (the Flippase Project); Marie Curie Intra-European Fellowship(European Commission); European Molecular Biology Organization (EMBO) Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Dutch Organization of Sciences (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Utrecht University High Potential Program	Supported by the European Union Framework V Program (the Flippase Project).; Supported by a Marie Curie Intra-European Fellowship and an European Molecular Biology Organization (EMBO) Long-Term Fellowship. To whom correspondence may be addressed: Metanomics GmbH, Tegeler Weg 33, 10589 Berlin, Germany. Tel.: 49-30-34807-177; Fax: 49-30-34807-300; E-mail: philipp.ternes@arcor.de.; Supported by grants from the Dutch Organization of Sciences (NWO-CW) and the Utrecht University High Potential Program. To whom correspondence may be addressed: Molecular Cell Biology Division, University of Osnabruck, Barbarastrasse 13, 49076 Osnabruck, Germany. Tel.: 49-541969-7140; Fax: 49-541969-2884; E-mail: holthuis@uos.de.	Abeytunga DTU, 2004, J LIPID RES, V45, P1221, DOI 10.1194/jlr.M300392-JLR200; Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Barenholz Y., 1982, PHOSPHOLIPIDS, V4, P129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; CRONE HD, 1963, BIOCHEM J, V89, P11, DOI 10.1042/bj0890011; Guan XL, 2013, DEV CELL, V24, P98, DOI 10.1016/j.devcel.2012.11.012; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; HORI T, 1968, BIOCHIM BIOPHYS ACTA, V152, P211; HORI T, 1967, J BIOCHEM-TOKYO, V62, P67, DOI 10.1093/oxfordjournals.jbchem.a128637; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kariotoglou DM, 2003, COMP BIOCHEM PHYS B, V136, P27, DOI 10.1016/S1096-4959(03)00168-4; KARLANDER SG, 1972, BIOCHIM BIOPHYS ACTA, V270, P117, DOI 10.1016/0005-2760(72)90185-3; KITTREDGE JS, 1962, BIOCHEMISTRY-US, V1, P624, DOI 10.1021/bi00910a013; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Grand F, 2011, COMP BIOCHEM PHYS A, V159, P383, DOI 10.1016/j.cbpa.2011.04.006; LUUKKONEN A, 1973, BIOCHIM BIOPHYS ACTA, V326, P256, DOI 10.1016/0005-2760(73)90251-8; MALGAT M, 1987, J LIPID RES, V28, P138; MALGAT M, 1986, J LIPID RES, V27, P251; MAURICE A, 1989, BIOCHIMIE, V71, P373, DOI 10.1016/0300-9084(89)90009-6; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Connor J. D, 1970, Biochim. biophys. Acta, V202, P195, DOI 10.1016/0005-2760(70)90234-1; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; SIMON G, 1967, LIPIDS, V2, P55, DOI 10.1007/BF02532001; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Terova B, 2005, BIOPHYS J, V88, P2661, DOI 10.1529/biophysj.104.058149; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; YANG TK, 1974, LIPIDS, V9, P1009, DOI 10.1007/BF02533827	48	42	43	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11520	11530		10.1074/jbc.M113.460972	http://dx.doi.org/10.1074/jbc.M113.460972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449981	Green Published, hybrid			2022-12-28	WOS:000317915500058
J	Souza-Fonseca-Guimaraes, F; Parlato, M; de Oliveira, RB; Golenbock, D; Fitzgerald, K; Shalova, IN; Biswas, SK; Cavaillon, JM; Adib-Conquy, M				Souza-Fonseca-Guimaraes, Fernando; Parlato, Marianna; de Oliveira, Rosane B.; Golenbock, Douglas; Fitzgerald, Katherine; Shalova, Irina N.; Biswas, Subhra K.; Cavaillon, Jean-Marc; Adib-Conquy, Minou			Interferon-gamma and Granulocyte/Monocyte Colony-stimulating Factor Production by Natural Killer Cells Involves Different Signaling Pathways and the Adaptor Stimulator of Interferon Genes (STING)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING ADAPTER; TOLL-LIKE RECEPTORS; NK CELLS; RANTES PRODUCTION; INNATE IMMUNITY; CUTTING EDGE; IFN-BETA; T-CELLS; KAPPA-B; PROTEIN	Natural killer (NK) cells are important for innate immunity in particular through the production of IFN-gamma and GM-CSF. Both cytokines are important in restoration of immune function of tolerized leukocytes under inflammatory events. The expression of TLRs in NK cells has been widely studied by analyzing the mRNA of these receptors, rarely seeking their protein expression. We previously showed that murine spleen NK cells express TLR9 intracellularly and respond to CpG oligodeoxynucleotide (CpG-ODN) by producing IFN-gamma and GM-CSF. However, to get such production the presence of accessory cytokines (such as IL-15 and IL-18) was required, whereas CpG-ODN or accessory cytokines alone did not induce IFN-gamma or GM-CSF. We show here that TLR9 overlaps with the Golgi apparatus in NK cells. Furthermore, CpG-ODN stimulation in the presence of accessory cytokines induces the phosphorylation of c-Jun, STAT3, and I kappa B alpha. IFN-gamma and GM-CSF production requires NF-kappa B and STAT3 activation as well as Erk-dependent mechanisms for IFN-gamma and p38 signaling for GM-CSF. Using knock-out-mice, we show that UNC93b1 and IL-12 (produced by NK cells themselves) are also necessary for IFN-gamma and GM-CSF production. IFN-gamma production was found to be MyD88- and TLR9-dependent, whereas GM-CSF was TLR9-independent but dependent on STING (stimulator of interferon genes), a cytosolic adaptor recently described for DNA sensing. Our study thereby allows us to gain insight into the mechanisms of synergy between accessory cytokines and CpG-ODN in NK cells. It also identifies a new and alternative signaling pathway for CpG-ODN in murine NK cells.	[Souza-Fonseca-Guimaraes, Fernando; Parlato, Marianna; Cavaillon, Jean-Marc; Adib-Conquy, Minou] Inst Pasteur, Unite Cytokines & Inflammat, Dept Infect & Epidemiol, F-75015 Paris, France; [de Oliveira, Rosane B.; Golenbock, Douglas; Fitzgerald, Katherine] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Shalova, Irina N.; Biswas, Subhra K.] ASTAR, Singapore Immunol Network, Singapore 13848, Singapore	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Massachusetts System; University of Massachusetts Worcester; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Adib-Conquy, M (corresponding author), Inst Pasteur, Unite Cytokines & Inflammat, Dept Infect & Epidemiol, 28 Rue Docteur Roux, F-75015 Paris, France.	minou.adib-conquy@pasteur.fr	Guimarães, Fernando/AAQ-2535-2021; Fitzgerald, Katherine/ABE-6317-2020; Parlato, Marianna/H-9467-2017	Guimarães, Fernando/0000-0002-2718-8993; Fitzgerald, Kate/0000-0003-3175-609X; Souza-Fonseca-Guimaraes, Fernando/0000-0002-2037-8946	Pasteur fellowship (Pasteur University International PhD Program); Pasteur-Weizmann fellowship; European Molecular Biology Organization short term fellowship; EGIDE (Merlion program)	Pasteur fellowship (Pasteur University International PhD Program); Pasteur-Weizmann fellowship; European Molecular Biology Organization short term fellowship; EGIDE (Merlion program)	Supported by a Pasteur fellowship (Pasteur University International PhD Program), a Pasteur-Weizmann fellowship, an European Molecular Biology Organization short term fellowship, and a travel grant by EGIDE (Merlion program). Present address: Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research, 300 Herston Rd., 4006 Brisbane, Queensland, Australia.	Beuneu H, 2011, J IMMUNOL, V187, P2084, DOI 10.4049/jimmunol.1004210; Boudreau JE, 2011, CANCER RES, V71, P2497, DOI 10.1158/0008-5472.CAN-10-3025; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Couture LA, 2012, J BIOL CHEM, V287, P24641, DOI 10.1074/jbc.M112.360925; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Engel A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3150pe45; Fitting C, 2004, J INFECT DIS, V189, P1295, DOI 10.1086/382657; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Hagele H, 2009, AM J PATHOL, V175, P1896, DOI 10.2353/ajpath.2009.090182; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Kapetanovic R, 2011, AM J PHYSIOL-CELL PH, V300, pC850, DOI 10.1152/ajpcell.00187.2010; Kashuba VI, 2002, GENE, V283, P209, DOI 10.1016/S0378-1119(01)00856-3; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Landrigan A, 2011, J IMMUNOL, V187, P3033, DOI 10.4049/jimmunol.1003414; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811; Ogbomo H, 2007, FEBS LETT, V581, P1317, DOI 10.1016/j.febslet.2007.02.045; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Sawaki J, 2007, INT IMMUNOL, V19, P311, DOI 10.1093/intimm/dxl148; Souza-Fonseca-Guimaraes F, 2012, J IMMUNOL, V188, P5850, DOI 10.4049/jimmunol.1103616; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	36	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10715	10721		10.1074/jbc.M112.435602	http://dx.doi.org/10.1074/jbc.M112.435602			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443666	Green Published, hybrid			2022-12-28	WOS:000317565000049
J	Ye, Q; Kantonen, S; Henkels, KM; Gomez-Cambronero, J				Ye, Qing; Kantonen, Samuel; Henkels, Karen M.; Gomez-Cambronero, Julian			A New Signaling Pathway (JAK-Fes-phospholipase D) That Is Enhanced in Highly Proliferative Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GROWTH-FACTOR RECEPTOR; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; EGF RECEPTOR; MIGRATION; ACTIVATION; PLD2; STIMULATION; CHEMOTAXIS	The products of the oncogene Fes and JAK3 are tyrosine kinases, whose expressions are elevated in tumor growth, angiogenesis, and metastasis. Phosphatidic acid, as synthesized by phospholipase D (PLD), enhances cancer cell survival. We report a new signaling pathway that integrates the two kinases with the lipase. Anew JAK3-Fes-PLD2 axis is responsible for the highly proliferative phenotype of MDA-MB-231 breast cancer cells. Conversely, this pathway is maintained at a low rate of expression and activity levels in untransformed cells such as MCF10A. We also deciphered the inter-regulation that exists between the two kinases (JAK3 and the oncogene Fes) and between these two kinases and the lipase (PLD2). Whereas JAK3 and Fes marginally activate PLD2 in non-transformed cells, these kinases greatly enhance (>200%) PLD activity following protein-protein interaction through the SH2 domain and the Tyr-415 residue of PLD2. We also found that phosphatidic acid enhances Fes activity in MDA-MB-231 cells providing a positive activation loop between Fes and PLD2. In summary, the JAK3, Fes and PLD2 interactions in transformed cells maintain PLD2 at an enhanced level that leads to abnormal cell growth. Modulating this new JAK3-Fes-PLD2 pathway could be important to control the highly invasive phenotype of breast cancer cells.	[Ye, Qing; Kantonen, Samuel; Henkels, Karen M.; Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; Boonshoft School of Medicine [229102]; State of Ohio Research Incentive Grant [668372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boonshoft School of Medicine; State of Ohio Research Incentive Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL056653, Boonshoft School of Medicine Grant 229102, and the State of Ohio Research Incentive Grant 668372 (to J. G. C.).	Andrews B, 2000, BIOCHEM BIOPH RES CO, V273, P302, DOI 10.1006/bbrc.2000.2938; Block ER, 2008, MOL BIOL CELL, V19, P4909, DOI 10.1091/mbc.E08-01-0097; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Di Fulvio M, 2006, ONCOGENE, V25, P3032, DOI 10.1038/sj.onc.1209340; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Frondorf K, 2010, J BIOL CHEM, V285, P15837, DOI 10.1074/jbc.M109.070524; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Henkels KM, 2011, J MOL BIOL, V408, P850, DOI 10.1016/j.jmb.2011.03.017; Henkels KM, 2010, MOL CELL BIOL, V30, P2251, DOI 10.1128/MCB.01239-09; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Kim YR, 2003, EXP MOL MED, V35, P118, DOI 10.1038/emm.2003.17; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Nagasaki A, 2008, CELL STRUCT FUNCT, V33, P27, DOI 10.1247/csf.07042; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Natarajan V, 1996, CHEM PHYS LIPIDS, V80, P103, DOI 10.1016/0009-3084(96)02548-0; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Singer WD, 1996, J BIOL CHEM, V271, P4504; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; WALKERNASIR E, 1982, JNCI-J NATL CANCER I, V69, P371; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	39	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9881	9891		10.1074/jbc.M113.450593	http://dx.doi.org/10.1074/jbc.M113.450593			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23404507	hybrid, Green Published			2022-12-28	WOS:000317114000028
J	Chen, WS; Chen, CC; Chen, LL; Lee, CC; Huang, TS				Chen, Wei-Shone; Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing			Secreted Heat Shock Protein 90 alpha (HSP90 alpha) Induces Nuclear Factor-kappa B-mediated TCF12 Protein Expression to Down-regulate E-cadherin and to Enhance Colorectal Cancer Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-ALPHA; HSP90; HSP70; BETA; PHOSPHORYLATION; CHAPERONE; COMPLEX	Secreted levels of HSP90 alpha and overexpression of TCF12 have been associated with the enhancement of colorectal cancer (CRC) cell migration and invasion. In this study, we observed that CRC patients with tumor TCF12 overexpression exhibited both a higher rate of metastatic occurrence and a higher average serum HSP90 alpha level compared with patients without TCF12 overexpression. Therefore, we studied the relationship between the actions of secreted HSP90 alpha and TCF12. Like overexpressed TCF12, secreted HSP90 alpha or recombinant HSP90 alpha (rHSP90 alpha) induced fibronectin expression and repressed E-cadherin, connexin-26, connexin-43, and gap junction levels in CRC cells. Consistently, rHSP90 alpha stimulated invasive outgrowths of CRC cells from spherical structures during three-dimensional culture. rHSP90 alpha also induced TCF12 expression in CRC cells. Its effects on CRC cell epithelial-mesenchymal transition, migration, and invasion were drastically prevented when TCF12 was knocked down. This suggests that TCF12 expression is required for secreted HSP90 alpha to enhance CRC cell spreading. Through the cellular receptor CD91, rHSP90 alpha facilitated the complex formation of CD91 with I kappa B kinases (IKKs) alpha and beta and increased the levels of phosphorylated (active) IKK alpha/beta and NF-kappa B. Use of an IKK alpha/beta inhibitor or ectopic overexpression of dominant-negative I kappa B alpha efficiently repressed rHSP90 alpha-induced TCF12 expression. Moreover, kappa B motifs were recognized in the gene sequence of the TCF12 promoter, and a physical association between NF-kappa B and the TCF12 promoter was detected in rHSP90 alpha-treated CRC cells. Together, these results suggest that the CD91/IKK/NF-kappa B signaling cascade is involved in secreted HSP90 alpha-induced TCF12 expression, leading to E-cadherin down-regulation and enhanced CRC cell migration/invasion.	[Chen, Wei-Shone] Taipei Vet Gen Hosp, Div Expt Surg, Taipei 112, Taiwan; [Chen, Wei-Shone] Taipei Vet Gen Hosp, Div Colorectal Surg, Taipei 112, Taiwan; [Chen, Wei-Shone] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 350, Miaoli, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Huang, TS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.	tshuang@nhri.org.tw	Huang, Tze-Sing/C-9361-2013; Huang, Tze-Sing/E-3667-2010	Huang, Tze-Sing/0000-0001-8736-4330; 	National Science Council Grant, Taiwan, Republic of China [NSC101-2314-B-400-006]; National Health Research Institutes Grant, Taiwan, Republic of China [CA-101-PP-10]; Department of Health Grant, Taiwan, Republic of China [DOH102-TD-C-111-004]	National Science Council Grant, Taiwan, Republic of China; National Health Research Institutes Grant, Taiwan, Republic of China; Department of Health Grant, Taiwan, Republic of China	This work was supported by National Science Council Grant NSC101-2314-B-400-006, National Health Research Institutes Grant CA-101-PP-10, and Department of Health Grant DOH102-TD-C-111-004, Taiwan, Republic of China.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Cappello F, 2006, J CANC MOL, V2, P73; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Chen WS, 2011, INT J COLORECTAL DIS, V26, P1009, DOI 10.1007/s00384-011-1200-1; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Huang TS, 1997, CANCER RES, V57, P2974; Lebret T, 2003, CANCER, V98, P970, DOI 10.1002/cncr.11594; Lee CC, 2012, J BIOL CHEM, V287, P2798, DOI 10.1074/jbc.M111.258947; Neckers Len, 2002, Breast Dis, V15, P53; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xu A, 2007, J CANC MOL, V3, P107; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhong L, 2003, CANCER DETECT PREV, V27, P285, DOI 10.1016/S0361-090X(03)00097-7	27	71	75	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9001	9010		10.1074/jbc.M112.437897	http://dx.doi.org/10.1074/jbc.M112.437897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386606	hybrid, Green Published			2022-12-28	WOS:000316862200019
J	Malecka, KA; Szentpetery, Z; Peterson, JR				Malecka, Kimberly A.; Szentpetery, Zsofia; Peterson, Jeffrey R.			Synergistic Activation of p21-activated Kinase 1 by Phosphatidylinositol 4,5-Bisphosphate and Rho GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SIGNALING COMPLEXES; PROTEIN-KINASE; N-WASP; PTDINS(4,5)P-2 SYNTHESIS; PLASMA-MEMBRANE; ARP2/3 COMPLEX; CELL POLARITY; LIVING CELLS; CDC42; ACTIN	Autoinhibited p21-activated kinase 1 (Pak1) can be activated in vitro by the plasma membrane-bound Rho GTPases Rac1 and Cdc42 as well as by the lipid phosphatidylinositol (4,5)-bisphosphate (PIP2). Activator binding is mediated by a GTPase-binding motif and an adjacent phosphoinositide-binding motif. Whether these two classes of activators play alternative, additive, or synergistic roles in Pak1 activation is unknown, as is their contributions to Pak1 activation in vivo. To address these questions, we developed a system to mimic the membrane anchoring of Rho GTPases by creating liposomes containing both PIP2 and a Ni2+-NTA modified lipid capable of binding hexahistidine-tagged Cdc42. We find that among all biologically relevant phosphoinositides, only PIP2 is able to synergistically activate Pak1 in concert with Cdc42. Membrane binding of the kinase was highly sensitive to the spatial density of PIP2 and Pak1 demonstrated dramatically enhanced affinity for Cdc42 anchored in a PIP2 environment. To validate these findings in vivo, we utilized an inducible recruitment system to drive the ectopic synthesis of PIP2 on Golgi membranes, which normally have active Cdc42 but lack significant concentrations of PIP2. Pak1 was recruited to PIP2-containing membranes in a manner dependent on the ability of Pak1 to bind to both PIP2 and Cdc42. These findings provide a mechanistic explanation for the essential role of both phosphoinositides and GTPases in Pak1 recruitment and activation. In contrast, Ack, another Cdc42 effector kinase that lacks an analogous phosphoinositide-binding motif, fails to show the same enhancement of membrane binding and activation by PIP2, thus indicating that regulation by PIP2 and Cdc42 could provide a combinatorial code for activation of different GTPase effectors in different subcellular locations.	[Malecka, Kimberly A.; Peterson, Jeffrey R.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Szentpetery, Zsofia] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Peterson, JR (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jeffrey.peterson@fccc.edu		Peterson, Jeffrey/0000-0002-0604-718X	National Institutes of Health [GM083025, T32 CA009035, P30 CA006927]; FCCC Keystone Program in Head Neck Cancer; NATIONAL CANCER INSTITUTE [T32CA009035, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCCC Keystone Program in Head Neck Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083025 (to J. R. P.), T32 CA009035 (to K. Malecka), and P30 CA006927 to the Fox Chase Cancer Center. Additional support was provided by the FCCC Keystone Program in Head & Neck Cancer.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Arias-Romero Luis E, 2010, Small GTPases, V1, P124, DOI 10.4161/sgtp.1.2.14109; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jung ID, 2004, EUR J BIOCHEM, V271, P1557, DOI 10.1111/j.1432-1033.2004.04066.x; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Montefusco DJ, 2007, METHOD ENZYMOL, V423, P267, DOI 10.1016/S0076-6879(07)23012-5; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pavey S, 2006, MELANOMA RES, V16, P285, DOI 10.1097/01.cmr.0000222589.30117.f2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Prehoda KE, 2002, CURR OPIN CELL BIOL, V14, P149, DOI 10.1016/S0955-0674(02)00307-1; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1998, J BIOL CHEM, V273, P18490, DOI 10.1074/jbc.273.29.18490; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Shrout AL, 2003, BIOCHEMISTRY-US, V42, P13379, DOI 10.1021/bi0352769; Strochlic TI, 2010, MOL CELL, V40, P493, DOI 10.1016/j.molcel.2010.10.015; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wild AC, 2004, J BIOL CHEM, V279, P17101, DOI 10.1074/jbc.M314035200; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhang H., 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcpM110.005678, DOI 10.1074/MCPM110.005678]; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	61	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8887	8897		10.1074/jbc.M112.428904	http://dx.doi.org/10.1074/jbc.M112.428904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393142	Green Published, hybrid			2022-12-28	WOS:000316862200010
J	Cuesta-Marban, A; Botet, J; Czyz, O; Cacharro, LM; Gajate, C; Hornillos, V; Delgado, J; Zhang, H; Amat-Guerri, F; Acuna, AU; McMaster, CR; Revuelta, JL; Zaremberg, V; Mollinedo, F				Cuesta-Marban, Alvaro; Botet, Javier; Czyz, Ola; Cacharro, Luis M.; Gajate, Consuelo; Hornillos, Valentin; Delgado, Javier; Zhang, Hui; Amat-Guerri, Francisco; Ulises Acuna, A.; McMaster, Christopher R.; Luis Revuelta, Jose; Zaremberg, Vanina; Mollinedo, Faustino			Drug Uptake, Lipid Rafts, and Vesicle Trafficking Modulate Resistance to an Anticancer Lysophosphatidylcholine Analogue in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PLASMA-MEMBRANE; ET-18-OCH3 EDELFOSINE; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; APOPTOSIS; COMPLEX; PROTEIN; RECRUITMENT; TRANSPORT	The ether-phospholipid edelfosine, a prototype antitumor lipid (ATL), kills yeast cells and selectively kills several cancer cell types. To gain insight into its mechanism of action, we performed chemogenomic screens in the Saccharomyces cerevisiae gene-deletion strain collection, identifying edelfosine-resistant mutants. LEM3, AGP2, and DOC1 genes were required for drug uptake. Edelfosine displaced the essential proton pump Pma1p from rafts, inducing its internalization into the vacuole. Additional ATLs, including miltefosine and perifosine, also displaced Pma1p from rafts to the vacuole, suggesting that this process is a major hallmark of ATL cytotoxicity in yeast. Radioactive and synthetic fluorescent edelfosine analogues accumulated in yeast plasma membrane rafts and subsequently the endoplasmic reticulum. Although both edelfosine and Pma1p were initially located at membrane rafts, internalization of the drug toward endoplasmic reticulum and Pma1p to the vacuole followed different routes. Drug internalization was not dependent on endocytosis and was not critical for yeast cytotoxicity. However, mutants affecting endocytosis, vesicle sorting, or trafficking to the vacuole, including the retromer and ESCRT complexes, prevented Pma1p internalization and were edelfosine-resistant. Our data suggest that edelfosine-induced cytotoxicity involves raft reorganization and retromer- and ESCRT-mediated vesicular transport and degradation of essential raft proteins leading to cell death. Cytotoxicity of ATLs is mainly dependent on the changes they induce in plasma membrane raft-located proteins that lead to their internalization and subsequent degradation. Edelfosine toxicity can be circumvented by inactivating genes that then result in the recycling of internalized cell-surface proteins back to the plasma membrane.	[Cuesta-Marban, Alvaro; Cacharro, Luis M.; Gajate, Consuelo; Zhang, Hui; Mollinedo, Faustino] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain; [Botet, Javier; Luis Revuelta, Jose] Univ Salamanca, Dept Microbiol & Genet, E-37007 Salamanca, Spain; [Czyz, Ola; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Hornillos, Valentin; Delgado, Javier; Amat-Guerri, Francisco] CSIC, Inst Quim Organ Gen, E-28006 Madrid, Spain; [Ulises Acuna, A.] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [McMaster, Christopher R.] Dalhousie Univ, Atlantic Res Ctr, Dept Pharmacol, Halifax, NS B3H 4R2, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Calgary; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Dalhousie University	Zaremberg, V (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vzarembe@ucalgary.ca; fmollin@usal.es	Revuelta, Jose L/C-2324-2012; Revuelta, Jose Luis/ABG-1502-2020; Delgado, Javier F/S-1688-2018; Hornillos, Valentin/L-9357-2014	Revuelta, Jose L/0000-0001-7838-5308; Revuelta, Jose Luis/0000-0001-7838-5308; Hornillos, Valentin/0000-0002-6181-9146; Gajate, Consuelo/0000-0003-0604-6459; McMaster, Christopher/0000-0003-0822-5776; Cuesta Marban, Alvaro/0000-0002-7144-0500; Delgado, Javier/0000-0003-1302-5445	Spanish Ministerio de Economia y Competitividad [SAF2005-04293, SAF2008-02251, SAF2011-30518, CTQ2010-16457]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional of the European Union [RD06/0020/1037, RD12/0036/0065]; European Community's Seventh Framework Programme [HEALTH-F2-2011-256986]; Fundacion "la Caixa" [BM05-30-0]; Junta de Castilla y Leon [CSI052A11-2, CSI221A12-2]; Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER) [06/0813, PS09/01915]; Junta de Castilla y Leon Biomedicine Project; Canadian Institutes of Health Research [14124]; Natural Sciences and Engineering Research Council of Canada; University of Calgary; Natural Sciences and Engineering Research Council of Canada University; Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Economia y Competitividad(Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional of the European Union; European Community's Seventh Framework Programme(European Commission); Fundacion "la Caixa"(La Caixa Foundation); Junta de Castilla y Leon(Junta de Castilla y Leon); Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER); Junta de Castilla y Leon Biomedicine Project(Junta de Castilla y Leon); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary; Natural Sciences and Engineering Research Council of Canada University(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Spanish Ministerio de Economia y Competitividad Grants SAF2005-04293, SAF2008-02251, and SAF2011-30518, Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union Grants RD06/0020/1037 and RD12/0036/0065, European Community's Seventh Framework Programme FP7-2007-2013 Grant HEALTH-F2-2011-256986 (PANACREAS), Fundacion "la Caixa" Grant BM05-30-0, Junta de Castilla y Leon Grants CSI052A11-2 and CSI221A12-2 (to F.M.), Spanish Ministerio de Economia y Competitividad Grants BIO2008-00194 and BIO2011-23901, Junta de Castilla y Leon Grant GR147 (to J.L.R.), Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER) Grants 06/0813 and PS09/01915, Junta de Castilla y Leon Biomedicine Project 2010-2011 (to C.G.), Spanish Ministerio de Economia y Competitividad Grant CTQ2010-16457 (to A.U.A.), Canadian Institutes of Health Research Grant 14124 (to C.R.M.), a Natural Sciences and Engineering Research Council of Canada discovery grant, a seed grant from the University of Calgary, and an Natural Sciences and Engineering Research Council of Canada University faculty award (to V.Z.).; Supported by the Ramon y Cajal Program from the Spanish Ministerio de Ciencia e Innovacion.	Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ausili A, 2008, J PHYS CHEM B, V112, P11643, DOI 10.1021/jp802165n; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Busto Jon V, 2008, J Chem Biol, V1, P89, DOI 10.1007/s12154-008-0009-z; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Czyz O, 2013, J BIOL CHEM, V288, P8419, DOI 10.1074/jbc.M112.425744; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2012, ONCOGENE, V31, P2627, DOI 10.1038/onc.2011.446; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jendrossek V., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P343, DOI 10.2174/1568011033482341; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; Mollinedo F, 2010, ONCOGENE, V29, P3748, DOI 10.1038/onc.2010.131; Mollinedo F, 2007, EXPERT OPIN THER PAT, V17, P385, DOI 10.1517/13543776.17.4.385; Mollinedo F, 2010, CLIN CANCER RES, V16, P2046, DOI 10.1158/1078-0432.CCR-09-2456; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	45	36	36	1	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8405	8418		10.1074/jbc.M112.425769	http://dx.doi.org/10.1074/jbc.M112.425769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23335509	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000316564500039
J	Liu, Y; Zhang, ZC; Qian, SW; Zhang, YY; Huang, HY; Tang, Y; Guo, L; Li, X; Tang, QQ				Liu, Yuan; Zhang, Zhi-chun; Qian, Shu-wen; Zhang, You-you; Huang, Hai-yan; Tang, Yan; Guo, Liang; Li, Xi; Tang, Qi-Qun			MicroRNA-140 Promotes Adipocyte Lineage Commitment of C3H10T1/2 Pluripotent Stem Cells via Targeting Osteopetrosis-associated Transmembrane Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; OBESITY; OSTM1; BETA	BMP4 has been shown to induce C3H10T1/2 pluripotent stem cells to commit to adipocyte lineage. In addition to several proteins identified, microRNAs also play a critical role in the process. In this study, we identified microRNA-140 (miR-140) as a direct downstream component of the BMP4 signaling pathway during the commitment of C3H10T1/2 cells to adipocyte lineage. Overexpression of miR-140 in C3H10T1/2 cells promoted commitment, whereas knockdown of its expression led to impairment. Additional studies indicated that Ostm1 is a bona fide target of miR-140, which is significantly decreased during commitment, and Ostm1 was also demonstrated to function as an anti-adipogenic factor.	[Liu, Yuan; Zhang, Zhi-chun; Qian, Shu-wen; Huang, Hai-yan; Tang, Yan; Guo, Liang; Li, Xi; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Key Lab Mol Med, Minist Educ, Shanghai 200032, Peoples R China; [Liu, Yuan; Zhang, Zhi-chun; Qian, Shu-wen; Huang, Hai-yan; Tang, Yan; Guo, Liang; Li, Xi; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Liu, Yuan; Qian, Shu-wen; Zhang, You-you; Huang, Hai-yan; Li, Xi; Tang, Qi-Qun] Fudan Univ, Inst Biomed Sci, Inst Stem Cell Res & Regenerat Med, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Li, X (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Mol Med, Minist Educ, Shanghai 200032, Peoples R China.	lixi@shmu.edu.cn; qqtang@shmu.edu.cn	Zhang, Youyou/H-9677-2017; Li, Xi/W-4034-2019		National Key Basic Research Project [2011CB910201, 2011CBA01103]; National Natural Science Foundation [31030048, 81270954, 30870510]; Shanghai Key Science and Technology Research Project [10JC1401000]; Shanghai Rising Star Program [08QA14012]; Shanghai Leading Academic Discipline Project [B110, 985III-YFX0302]	National Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Key Science and Technology Research Project; Shanghai Rising Star Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work supported in part by National Key Basic Research Project Grants 2011CB910201 and 2011CBA01103, State Key Program of National Natural Science Foundation Grant 31030048, and Shanghai Key Science and Technology Research Project Grant 10JC1401000 (to Q.-q.T.); National Natural Science Foundation Grants 81270954 and 30870510 and Shanghai Rising Star Program Grant 08QA14012 (to X.L.); and Shanghai Leading Academic Discipline Project Grants B110 and 985III-YFX0302 (to the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College).	Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Araldi E, 2010, GENE DEV, V24, P1075, DOI 10.1101/gad.1939310; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Cho SW, 2009, BONE, V44, P1069, DOI 10.1016/j.bone.2009.02.012; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Feigin ME, 2008, CELL SIGNAL, V20, P949, DOI 10.1016/j.cellsig.2008.01.009; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Ling HY, 2011, CLIN EXP PHARMACOL P, V38, P239, DOI 10.1111/j.1440-1681.2011.05493.x; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Nakamura Y., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P321; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yi C, 2011, FEBS LETT, V585, P3303, DOI 10.1016/j.febslet.2011.09.015; Yu ZK, 1997, OBES RES, V5, P9, DOI 10.1002/j.1550-8528.1997.tb00277.x; Zhao L, 2009, CALCIFIED TISSUE INT, V84, P56, DOI 10.1007/s00223-008-9189-3	36	24	26	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8222	8230		10.1074/jbc.M112.426163	http://dx.doi.org/10.1074/jbc.M112.426163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23389033	Green Published, hybrid			2022-12-28	WOS:000316564500022
J	Schlumm, F; Mauceri, D; Freitag, HE; Bading, H				Schlumm, Friederike; Mauceri, Daniela; Freitag, H. Eckehard; Bading, Hilmar			Nuclear Calcium Signaling Regulates Nuclear Export of a Subset of Class IIa Histone Deacetylases following Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NMDA RECEPTORS; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY; MEDIATED ACTIVATION; NEURONAL SURVIVAL; DENDRITIC GROWTH; KINASE-II; HDAC4; PHOSPHORYLATION	In neurons, dynamic changes in the subcellular localization of histone deacetylases (HDACs) are thought to contribute to signal-regulated gene expression. Here we show that in mouse hippocampal neurons, synaptic activity-dependent nucleo-cytoplasmic shuttling is a common feature of all members of class IIa HDACs, which distinguishes them from other classes of HDACs. Nuclear calcium, a key regulator in neuronal gene expression, is required for the nuclear export of a subset of class IIa HDACs. We found that inhibition of nuclear calcium signaling using CaMBP4 or increasing the nuclear calcium buffering capacity by means of expression of a nuclear targeted version of parvalbumin (PV.NLS-mC) led to a build-up of HDAC4 and HDAC5 in the cell nucleus, which in the case of PV. NLS-mC can be reversed by nuclear calcium transients triggered by bursts of action potential firing. A similar nuclear accumulation of HDAC4 and HDAC5 was observed in vivo in the mouse hippocampus following stereotaxic delivery of recombinant adeno-associated viruses expressing either CaMBP4 or PV. NLS-mC. The modulation of HDAC4 activity either by RNA interference-mediated reduction of HDAC4 protein levels or by expression of a constitutively nuclear localized mutant of HDAC4 leads to changes in the mRNA levels of several nuclear calcium-regulated genes with known functions in acquired neuroprotection (atf3, serpinb2), memory consolidation (homer1, arc), and the development of chronic pain (ptgs2, c1qc). These results identify nuclear calcium as a regulator of nuclear export of HDAC4 and HDAC5. The reduction of nuclear localized HDACs represents a novel transcription-promoting pathway stimulated by nuclear calcium.	[Schlumm, Friederike; Mauceri, Daniela; Freitag, H. Eckehard; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, INF 364, D-69120 Heidelberg, Germany.	hilmar.bading@uni-hd.de	Mauceri, Daniela/C-4969-2014	Mauceri, Daniela/0000-0003-1225-4633	Deutsche Forschungsgemeinschaft; ERC; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 636]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, an ERC Advanced Grant (to H.B.), and the Sonderforschungsbereich 636 of the Deutsche Forschungsgemeinschaft.	Ajamian F, 2003, NEUROSCI LETT, V346, P57, DOI 10.1016/S0304-3940(03)00545-7; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Baltan S, 2011, TRANSL STROKE RES, V2, P411, DOI 10.1007/s12975-011-0087-z; Bengtson CP, 2010, BIOPHYS J, V99, P4066, DOI 10.1016/j.bpj.2010.10.044; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen RH, 1996, ONCOGENE, V12, P1493; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Glozak MA, 2009, J BIOL CHEM, V284, P11446, DOI 10.1074/jbc.M809394200; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guan YJ, 2012, AM J PHYSIOL-CELL PH, V303, pC33, DOI 10.1152/ajpcell.00348.2011; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee JY, 2012, BBA-PROTEINS PROTEOM, V1824, P974, DOI 10.1016/j.bbapap.2012.05.006; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu YW, 2005, J CELL BIOL, V168, P887, DOI 10.1083/jcb.200408128; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Ma C, 2011, J BIOL CHEM, V286, P4819, DOI 10.1074/jbc.M110.146860; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Tian F, 2009, J NEUROCHEM, V109, P1375, DOI 10.1111/j.1471-4159.2009.06058.x; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zaidi SK, 2011, J BIOL CHEM, V286, P18355, DOI 10.1074/jbc.R110.197061; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056	83	44	46	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8074	8084		10.1074/jbc.M112.432773	http://dx.doi.org/10.1074/jbc.M112.432773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364788	Green Published, hybrid			2022-12-28	WOS:000316564500008
J	Xie, J; Yoon, J; Yang, SS; Lin, SH; Huang, CL				Xie, Jian; Yoon, Joonho; Yang, Sung-Sen; Lin, Shih-Hua; Huang, Chou-Long			WNK1 Protein Kinase Regulates Embryonic Cardiovascular Development through the OSR1 Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; SPAK; MICE; COTRANSPORTER; CELLS; PHOSPHORYLATION; SUBFAMILY; LACKING; MODEL; NA+	WNK1 is a widely expressed serine/threonine protein kinase that regulates multiple cellular and organ functions via diverse mechanisms. We previously reported that endothelial-specific deletion of Wnk1 in mice results in embryonic lethality, with angiogenesis and cardiac defects beginning at embryonic day similar to 10.5. Here, we further investigated the signaling mechanism by which WNK1 regulates embryonic cardiovascular development. We found that mice with a global deletion of Osr1, which encodes oxidative stress-responsive kinase-1, a protein kinase activated by WNK1, died in utero beginning at embryonic day similar to 11. The defects in Osr1-null yolk sacs and embryos were virtually identical to those observed in Wnk1-knock-out mice: no mature large vessels in yolk sacs, defective angiogenesis in the brain and intersomitic vessels, and smaller chambers and reduced myocardial trabeculation in mutant hearts. Endothelial-specific deletion of Osr1 generated by crossing Osr1(flox/flox) mice with Tie2-Cre mice phenocopied defects caused by global Osr1 deletion. To investigate whether OSR1 acts downstream of WNK1 in embryonic angiogenesis, we generated a mouse line that carries a catalytically and constitutively active human OSR1 transgene in the ROSA26 locus under the control of a cassette of floxed transcription stop codons. We found that endothelial-specific expression of the constitutively active mutant OSR1, generated by Tie2-Cre-mediated excision of floxed stop codons in the mutated ROSA26 locus, rescued angiogenesis and cardiac defects in global Wnk1-null embryos. These results indicate that WNK1 activation of the OSR1 signaling cascade is an essential pathway that regulates angiogenesis and cardiac formation during mouse embryo development.	[Xie, Jian; Yoon, Joonho; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Yang, Sung-Sen; Lin, Shih-Hua] Natl Def Med Ctr, Dept Med, Tri Serv Gen Hosp, Taipei 114, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Defense Medical Center; Tri-Service General Hospital	Huang, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	chou-long.huang@utsouthwestern.edu		Xie, Jian/0000-0001-9454-1358	National Institutes of Health [DK59530, DK85726, DK79328]; Taiwan National Science Council [NSC-100-2314-B016-018-MY3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK085726, R01DK059530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59530, DK85726, and DK79328. This work was also supported Taiwan National Science Council Grant NSC-100-2314-B016-018-MY3.	An SW, 2011, CURR BIOL, V21, P1979, DOI 10.1016/j.cub.2011.11.002; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Moya EMG, 2009, CELL SIGNAL, V21, P1727, DOI 10.1016/j.cellsig.2009.08.006; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Marlin JW, 2011, MAMM GENOME, V22, P306, DOI 10.1007/s00335-011-9326-6; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Tian YM, 2009, MECH DEVELOP, V126, P710, DOI 10.1016/j.mod.2009.05.002; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	34	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8566	8574		10.1074/jbc.M113.451575	http://dx.doi.org/10.1074/jbc.M113.451575			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386621	Green Published, hybrid			2022-12-28	WOS:000316564500057
J	Zomot, E; Bahar, I				Zomot, Elia; Bahar, Ivet			Intracellular Gating in an Inward-facing State of Aspartate Transporter Glt(Ph) Is Regulated by the Movements of the Helical Hairpin HP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE TRANSPORTER; EXTRACELLULAR GATE; SUBSTRATE-BINDING; REENTRANT LOOP; STOICHIOMETRY; HOMOLOG; ACCESSIBILITY; MECHANISM; DYNAMICS; RESIDUE	Sodium-coupled neurotransmitter transporters play a key role in neuronal signaling by clearing excess transmitter from the synapse. Structural data on a trimeric archaeal aspartate transporter, Glt(Ph), have provided valuable insights into structural features of human excitatory amino acid transporters. However, the time-resolved mechanisms of substrate binding and release, as well as that of coupling to sodium co-transport, remain largely unknown for this important family. We present here the results of the most extensive simulations performed to date for Glt(Ph) in both outward-facing and inward-facing states by taking advantage of significant advances made in recent years in molecular simulation technology. The generated multiple microsecond trajectories consistently show that the helical hairpin HP2, not HP1, serves as an intracellular gate (in addition to its extracellular gating role). In contrast to previous proposals, HP1 can neither initiate nor accommodate neurotransmitter release without prior opening of HP2 by at least 4.0 angstrom. Aspartate release invariably follows that of a sodium ion located near the HP2 gate entrance. Asp-394 on TM8 and Arg-276 on HP1 emerge as key residues that promote the reorientation and diffusion of substrate toward the cell interior. These findings underscore the significance of examining structural dynamics, as opposed to static structure(s), to make inferences on the mechanisms of transport and key interactions.	[Zomot, Elia; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST3,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020		Pittsburgh Supercomputing Center [RC2GM09337]; National Institutes of Health, NIGMS [R01GM086238]; National Institutes of Health [P41 GM103712];  [R01 LM007994-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238, P41GM103712] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007994] Funding Source: NIH RePORTER	Pittsburgh Supercomputing Center; National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Anton machine has been provided generously by David E. Shaw Research (19). Anton computer time was provided by the Pittsburgh Supercomputing Center through Grant RC2GM09337. We thank M. Dittrich, N. Simakov, and other staff at the Pittsburgh Supercomputing Center for their support.; This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086238 from the NIGMS (to I.B.) and R01 LM007994-08 (to I.B.) and the National Institutes of Health-funded Biomedical Technology Research Center (Grant P41 GM103712) (to I.B.).	Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Pastor RW, 2011, J PHYS CHEM LETT, V2, P1526, DOI 10.1021/jz200167q; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; STORMMATHISEN J, 1992, PROG BRAIN RES, V94, P225; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	32	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8231	8237		10.1074/jbc.M112.438432	http://dx.doi.org/10.1074/jbc.M112.438432			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386619	Green Published, hybrid			2022-12-28	WOS:000316564500023
J	Hosseini, S; Naderi-Manesh, H; Mountassif, D; Cerruti, M; Vali, H; Faghihi, S				Hosseini, Samaneh; Naderi-Manesh, Hossein; Mountassif, Driss; Cerruti, Marta; Vali, Hojatollah; Faghihi, Shahab			C-terminal Amidation of an Osteocalcin-derived Peptide Promotes Hydroxyapatite Crystallization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; MATRIX PROTEINS; HELICAL STRUCTURE; IN-VITRO; BINDING; NUCLEATION; PHOSPHORYLATION; MINERALIZATION; ADSORPTION; EXPRESSION	Genesis of natural biocomposite-based materials, such as bone, cartilage, and teeth, involves interactions between organic and inorganic systems. Natural biopolymers, such as peptide motif sequences, can be used as a template to direct the nucleation and crystallization of hydroxyapatite (HA). In this study, a natural motif sequence consisting of 13 amino acids present in the first helix of osteocalcin was selected based on its calcium binding ability and used as substrate for nucleation of HA crystals. The acidic (acidic osteocalcin-derived peptide (OSC)) and amidic (amidic osteocalcin-derived peptide (OSN)) forms of this sequence were synthesized to investigate the effects of different C termini on the process of biomineralization. Electron microscopy analyses show the formation of plate-like HA crystals with random size and shape in the presence of OSN. In contrast, spherical amorphous calcium phosphate is formed in the presence of OSC. Circular dichroism experiments indicate conformational changes of amidic peptide to an open and regular structure as a consequence of interaction with calcium and phosphate. There is no conformational change detectable in OSC. It is concluded that HA crystal formation, which only occurred in OSN, is attributable to C-terminal amidation of a natural peptide derived from osteocalcin. It is also proposed that natural peptides with the ability to promote biomineralization have the potential to be utilized in hard tissue regeneration.	[Hosseini, Samaneh; Naderi-Manesh, Hossein] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran 14115175, Iran; [Hosseini, Samaneh; Faghihi, Shahab] Natl Inst Genet Engn & Biotechnol, Tissue Engn & Biomat Div, Tehran 14965161, Iran; [Mountassif, Driss; Vali, Hojatollah] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Cerruti, Marta] McGill Univ, Dept Min & Mat Engn, Montreal, PQ H3A 0C7, Canada; [Vali, Hojatollah] McGill Univ, Facil Electron Microscopy Res, Montreal, PQ H3A 0C7, Canada	Tarbiat Modares University; McGill University; McGill University; McGill University	Naderi-Manesh, H (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran 14115175, Iran.	naderman@modares.ac.ir; sfaghihi@nigeb.ac.ir	Hosseini, Samaneh/I-1232-2019; Vali, Hojatollah/F-3511-2012	Vali, Hojatollah/0000-0003-3464-9943; Hosseini, Samaneh/0000-0002-5701-6666; Naderi-Manesh, Hossein/0000-0002-4227-171X	Tarbiat Modares University; Canada Research Chair Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada	Tarbiat Modares University; Canada Research Chair Foundation(Canada Research Chairs); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Tarbiat Modares University and Canada Research Chair Foundation (to M. C.) and the Natural Sciences and Engineering Research Council (NSERC) of Canada (to H. V.).	Aarden EM, 1996, HISTOCHEM CELL BIOL, V106, P495, DOI 10.1007/s004180050069; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Addison WN, 2010, BIOMATERIALS, V31, P9422, DOI 10.1016/j.biomaterials.2010.08.064; Amblard Muriel, 2005, V298, P3; ATKINSON RA, 1995, EUR J BIOCHEM, V232, P515, DOI 10.1111/j.1432-1033.1995.515zz.x; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Beniash E, 2011, WIRES NANOMED NANOBI, V3, P47, DOI 10.1002/wnan.105; Chan WC, 2000, PRACT APPROACH SER, V222, P41; Chung WJ, 2011, LANGMUIR, V27, P7620, DOI 10.1021/la104757g; Delak K, 2009, BIOCHEMISTRY-US, V48, P3669, DOI 10.1021/bi900113v; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2, DOI 10.1007/s001980070002; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; FUJISAWA R, 1991, BIOCHIM BIOPHYS ACTA, V1075, P56; GARNERO P, 1994, J BONE MINER RES, V9, P255; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Gungormus M, 2008, BIOMACROMOLECULES, V9, P966, DOI 10.1021/bm701037x; Gungormus M, 2010, BIOMATERIALS, V31, P7266, DOI 10.1016/j.biomaterials.2010.06.010; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; In Y, 2005, FEBS J, V272, P5079, DOI 10.1111/j.1742-4658.2005.04919.x; In Y, 2001, J PEPT RES, V58, P399, DOI 10.1034/j.1399-3011.2001.00891.x; In Y, 2001, ACTA CRYSTALLOGR B, V57, P72, DOI 10.1107/S0108768100013975; Juban M M, 1997, Methods Mol Biol, V78, P73; Kulp JL, 2005, LANGMUIR, V21, P11907, DOI 10.1021/la050961x; Kulp JL, 2007, LANGMUIR, V23, P3857, DOI 10.1021/la062442f; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leonor IB, 2007, J MATER CHEM, V17, P4057, DOI 10.1039/b707304f; LINDE A, 1995, INT J DEV BIOL, V39, P213; Novak JF, 1997, J BONE MINER RES, V12, P1035, DOI 10.1359/jbmr.1997.12.7.1035; PAGE AE, 1993, INT J BIOCHEM, V25, P545, DOI 10.1016/0020-711X(93)90662-X; POSER JW, 1979, J BIOL CHEM, V254, P431; Potetinova Z, 2006, BIOCHEMISTRY-US, V45, P11113, DOI 10.1021/bi060500q; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Roy MD, 2008, ADV MATER, V20, P1830, DOI 10.1002/adma.200702322; Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008; Shiba K, 2010, CHEM SOC REV, V39, P117, DOI 10.1039/b719081f; Srivastava AK, 2002, BONE, V31, P62, DOI 10.1016/S8756-3282(02)00793-7; Strandberg E, 2007, PURE APPL CHEM, V79, P717, DOI 10.1351/pac200779040717; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275	53	21	22	0	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7885	7893		10.1074/jbc.M112.422048	http://dx.doi.org/10.1074/jbc.M112.422048			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362258	Green Published, hybrid			2022-12-28	WOS:000316455300042
J	Kimura, T; Tsutsumi, K; Taoka, M; Saito, T; Masuda-Suzukake, M; Ishiguro, K; Plattner, F; Uchida, T; Isobe, T; Hasegawa, M; Hisanaga, SI				Kimura, Taeko; Tsutsumi, Koji; Taoka, Masato; Saito, Taro; Masuda-Suzukake, Masami; Ishiguro, Koichi; Plattner, Florian; Uchida, Takafumi; Isobe, Toshiaki; Hasegawa, Masato; Hisanaga, Shin-Ichi			Isomerase Pin1 Stimulates Dephosphorylation of Tau Protein at Cyclin-dependent Kinase (Cdk5)-dependent Alzheimer Phosphorylation Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROLYL ISOMERASE; MICROTUBULE-BINDING; WILD-TYPE; CDK5; P35; FTDP-17; MUTATIONS; ACTIVATOR; CLEAVAGE	Neurodegenerative diseases associated with the pathological aggregation of microtubule-associated protein Tau are classified as tauopathies. Alzheimer disease, the most common tauopathy, is characterized by neurofibrillary tangles that are mainly composed of abnormally phosphorylated Tau. Similar hyperphosphorylated Tau lesions are found in patients with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) that is induced by mutations within the tau gene. To further understand the etiology of tauopathies, it will be important to elucidate the mechanism underlying Tau hyper-phosphorylation. Tau phosphorylation occurs mainly at proline-directed Ser/Thr sites, which are targeted by protein kinases such as GSK3 beta and Cdk5. We reported previously that dephosphorylation of Tau at Cdk5-mediated sites was enhanced byPin1, a peptidyl-prolylisomerase that stimulates dephosphorylation at proline-directed sites by protein phosphatase 2A. Pin1 deficiency is suggested to cause Tau hyperphosphorylation in Alzheimer disease. Up to the present, Pin1 binding was only shown for two Tau phosphorylation sites (Thr-212 and Thr-231) despite the presence of many more hyperphosphorylated sites. Here, we analyzed the interaction of Pin1 with Tau phosphorylated by Cdk5-p25 using a GST pulldown assay and Biacore approach. We found that Pin1 binds and stimulates dephosphorylation of Tau at all Cdk5-mediated sites (Ser-202, Thr-205, Ser-235, and Ser-404). Furthermore, FTDP-17 mutant Tau (P301L or R406W) showed slightly weaker Pin1 binding than non-mutated Tau, suggesting that FTDP-17 mutations induce hyperphosphorylation by reducing the interaction between Pin1 and Tau. Together, these results indicate that Pin1 is generally involved in the regulation of Tau hyperphosphorylation and hence the etiology of tauopathies.	[Kimura, Taeko; Tsutsumi, Koji; Saito, Taro; Hisanaga, Shin-Ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan; [Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Biol Sci, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Masuda-Suzukake, Masami; Hasegawa, Masato] Tokyo Metropolitan Univ, Setagaya Ku, Tokyo 1568506, Japan; [Ishiguro, Koichi] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; [Plattner, Florian] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University; Tokyo Metropolitan University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Texas System; University of Texas Southwestern Medical Center Dallas; Tohoku University	Hisanaga, SI (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp	Isobe, Toshiaki/Q-9279-2017	Uchida, Takafumi/0000-0003-3665-4906; Taoka, Masato/0000-0001-5554-4951; Plattner, Florian/0000-0002-3150-1866	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. H.).	Allen B, 2002, J NEUROSCI, V22, P9340; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Asada A, 2012, J CELL SCI, V125, P3421, DOI 10.1242/jcs.100503; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Daum S, 2006, BIOCHEMISTRY-US, V45, P12125, DOI 10.1021/bi0608820; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Imahori K, 1997, J BIOCHEM, V121, P179; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambourne SL, 2005, MOL CELL BIOL, V25, P278, DOI 10.1128/MCB.25.1.278-293.2005; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liang ZH, 2008, J ALZHEIMERS DIS, V13, P295; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; Lu PJ, 1999, NATURE, V399, P784; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Michel G, 1998, BBA-GEN SUBJECTS, V1380, P177, DOI 10.1016/S0304-4165(97)00139-6; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Nykanen NP, 2012, J BIOL CHEM, V287, P6743, DOI 10.1074/jbc.M111.309385; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Smet C, 2005, J MED CHEM, V48, P4815, DOI 10.1021/jm0500119; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; Yotsumoto K, 2009, J BIOL CHEM, V284, P16840, DOI 10.1074/jbc.M109.003277; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	66	42	43	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7968	7977		10.1074/jbc.M112.433326	http://dx.doi.org/10.1074/jbc.M112.433326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362255	Green Published, hybrid			2022-12-28	WOS:000316455300049
J	Numata, Y; Morimura, T; Nakamura, S; Hirano, E; Kure, S; Goto, Y; Inoue, K				Numata, Yurika; Morimura, Toshifumi; Nakamura, Shoko; Hirano, Eriko; Kure, Shigeo; Goto, Yu-ich; Inoue, Ken			Depletion of Molecular Chaperones from the Endoplasmic Reticulum and Fragmentation of the Golgi Apparatus Associated with Pathogenesis in Pelizaeus-Merzbacher Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; PROTEOLIPID PROTEIN; CELL-DEATH; QUALITY-CONTROL; ER STRESS; MYELIN PROTEIN; POINT MUTATION; MOUSE; TRAFFICKING; CALNEXIN	Missense mutations in the proteolipid protein 1 (PLP1) gene cause a wide spectrum of hypomyelinating disorders, from mild spastic paraplegia type 2 to severe Pelizaeus-Merzbacher disease (PMD). Mutant PLP1 accumulates in the endoplasmic reticulum (ER) and induces ER stress. However, the link between the clinical severity of PMD and the cellular response induced by mutant PLP1 remains largely unknown. Accumulation of misfolded proteins in the ER generally leads to up-regulation of ER chaperones to alleviate ER stress. Here, we found that expression of the PLP1-A243V mutant, which causes severe disease, depletes some ER chaperones with a KDEL (Lys-Asp-Glu-Leu) motif, in HeLa cells, MO3.13 oligodendrocytic cells, and primary oligodendrocytes. The same PLP1 mutant also induces fragmentation of the Golgi apparatus (GA). These organelle changes are less prominent in cells with milder disease-associated PLP1 mutants. Similar changes are also observed in cells expressing another disease-causing gene that triggers ER stress, as well as in cells treated with brefeldin A, which induces ER stress and GA fragmentation by inhibiting GA to ER trafficking. We also found that mutant PLP1 disturbs localization of the KDEL receptor, which transports the chaperones with the KDEL motif from the GA to the ER. These data show that PLP1 mutants inhibit GA to ER trafficking, which reduces the supply of ER chaperones and induces GA fragmentation. We propose that depletion of ER chaperones and GA fragmentation induced by mutant misfolded proteins contribute to the pathogenesis of inherited ER stress-related diseases and affect the disease severity.	[Numata, Yurika; Morimura, Toshifumi; Nakamura, Shoko; Hirano, Eriko; Goto, Yu-ich; Inoue, Ken] NCNP, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Numata, Yurika; Kure, Shigeo] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9808574, Japan; [Morimura, Toshifumi] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Unit Neurobiol & Therapeut, Otsu, Shiga 5202192, Japan	National Center for Neurology & Psychiatry - Japan; Tohoku University; Shiga University of Medical Science	Inoue, K (corresponding author), NCNP, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi Machi, Kodaira, Tokyo 1878502, Japan.	kinoue@ncnp.go.jp			Health and Labor Sciences Research Grants, Research on Intractable Diseases [H24-Nanchitou-Ippan-072]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [KAKENHI: 21390103, 23659531, 23580417]; Grants-in-Aid for Scientific Research [23659531, 23580417] Funding Source: KAKEN	Health and Labor Sciences Research Grants, Research on Intractable Diseases; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Health and Labor Sciences Research Grants, Research on Intractable Diseases H24-Nanchitou-Ippan-072 (to K. I.), a grant from Takeda Science Foundation (to K. I.), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, KAKENHI: 21390103 and 23659531 (to K. I.) and 23580417 (to T. M.).	Abematsu M, 2006, J NEUROSCI RES, V83, P731, DOI 10.1002/jnr.20762; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Bernard-Marissal N, 2012, J NEUROSCI, V32, P4901, DOI 10.1523/JNEUROSCI.5431-11.2012; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; D'Antonio M, 2009, J NEUROSCI RES, V87, P3241, DOI 10.1002/jnr.22066; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; GENCIC S, 1990, J NEUROSCI, V10, P117; Gow A, 1998, J CELL BIOL, V140, P925, DOI 10.1083/jcb.140.4.925; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Ionasescu VV, 1997, MUSCLE NERVE, V20, P97, DOI 10.1002/(SICI)1097-4598(199701)20:1<97::AID-MUS13>3.0.CO;2-Z; Jaronen M, 2013, HUM MOL GENET, V22, P646, DOI 10.1093/hmg/dds472; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Khajavi M, 2005, AM J HUM GENET, V77, P841, DOI 10.1086/497541; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; Koizume S, 2006, NEUROSCIENCE, V141, P1861, DOI 10.1016/j.neuroscience.2006.05.067; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marie M, 2008, CELL MOL LIFE SCI, V65, P2859, DOI 10.1007/s00018-008-8355-0; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Roboti P, 2009, J CELL SCI, V122, P3942, DOI 10.1242/jcs.055160; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Warner LE, 1999, ANNU REV MED, V50, P263, DOI 10.1146/annurev.med.50.1.263; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamoto T, 1998, AM J MED GENET, V75, P439, DOI 10.1002/(SICI)1096-8628(19980203)75:4<439::AID-AJMG19>3.0.CO;2-P; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu LH, 2012, MOL GENET METAB, V106, P108, DOI 10.1016/j.ymgme.2012.02.016; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7451	7466		10.1074/jbc.M112.435388	http://dx.doi.org/10.1074/jbc.M112.435388			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23344956	hybrid, Green Published			2022-12-28	WOS:000316455300003
J	Lin, RK; Ho, CW; Liu, LF; Lyu, YL				Lin, Ren-Kuo; Ho, Chia-Wen; Liu, Leroy F.; Lyu, Yi Lisa			Topoisomerase II beta Deficiency Enhances Camptothecin-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; STRAND BREAK REPAIR; DNA TOPOISOMERASE; CELL-CYCLE; CLEAVABLE COMPLEXES; GENE-EXPRESSION; TRANSCRIPTION; DEGRADATION; INVOLVEMENT; PATHWAY	Camptothecin (CPT), a topoisomerase (Top) I-targeting drug that stabilizes Top1-DNA covalent adducts, can induce S-phase-specific cytotoxicity due to the arrest of progressing replication forks. However, CPT-induced non-S-phase cytotoxicity is less well characterized. In this study, we have identified topoisomerase II beta (Top2 beta) as a specific determinant for CPT sensitivity, but not for many other cytotoxic agents, in non-S-phase cells. First, quiescent mouse embryonic fibroblasts (MEFs) lacking Top2 beta were shown to be hypersensitive to CPT with prominent induction of apoptosis. Second, ICRF-187, a Top2 catalytic inhibitor known to deplete Top2 beta, specifically sensitized MEFs to CPT. To explore the molecular basis for CPT hypersensitivity in Top2 beta-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2 beta-deficient cells. Concomitant with the reduction of the RNAP LS level, the p53 protein level was greatly induced. Interestingly, RNAPLS depletion has been well documented to lead to p53-dependent apoptosis. Altogether, our findings support a model in which Top2 beta deficiency promotes CPT-induced apoptosis in quiescent non-S-phase cells, possibly due to RNAP LS depletion and p53 accumulation.	[Lin, Ren-Kuo; Ho, Chia-Wen; Liu, Leroy F.; Lyu, Yi Lisa] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Lyu, YL (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	lyuyi@umdnj.edu		Liu, Leroy/0000-0001-9396-763X	National Institutes of Health Grant [R01 CA039662]; Department of Defense Idea Award [W81XWH-07-1-0407]; NATIONAL CANCER INSTITUTE [R01CA039662, P30CA072720] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Idea Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by an National Institutes of Health Grant R01 CA039662 (to L. F. L.) and a Department of Defense Idea Award W81XWH-07-1-0407 (to Y. L. L.).	Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; BRILL SJ, 1988, CELL, V54, P403, DOI 10.1016/0092-8674(88)90203-6; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Champoux JJ, 2000, ANN NY ACAD SCI, V922, P56; DARPA P, 1990, CANCER RES, V50, P6919; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Enokido Y, 1996, EUR J NEUROSCI, V8, P1812, DOI 10.1111/j.1460-9568.1996.tb01325.x; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; French SL, 2011, MOL CELL BIOL, V31, P482, DOI 10.1128/MCB.00589-10; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; HSIANG YH, 1988, CANCER RES, V48, P3230; HSIANG YH, 1989, CANCER RES, V49, P5077; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KAPOOR R, 1995, ONCOL RES, V7, P83; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Keramaris E, 2000, MOL CELL NEUROSCI, V15, P368, DOI 10.1006/mcne.2000.0838; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rasheed ZA, 2003, ONCOGENE, V22, P7296, DOI 10.1038/sj.onc.1206935; Shaiu WL, 1998, MOL CELL BIOL, V18, P4358, DOI 10.1128/MCB.18.7.4358; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; SORENSEN M, 1995, BRIT J CANCER, V72, P399, DOI 10.1038/bjc.1995.345; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WATANABE M, 1994, NEUROSCI RES, V19, P51, DOI 10.1016/0168-0102(94)90007-8; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006	66	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7182	7192		10.1074/jbc.M112.415471	http://dx.doi.org/10.1074/jbc.M112.415471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344961	hybrid, Green Published			2022-12-28	WOS:000316002400039
J	McMahan, RH; Wang, XXX; Cheng, LL; Krisko, T; Smith, M; El Kasmi, K; Pruzanski, M; Adorini, L; Golden-Mason, L; Levi, M; Rosen, HR				McMahan, Rachel H.; Wang, Xiaoxin X.; Cheng, Lin Ling; Krisko, Tibor; Smith, Maxwell; El Kasmi, Karim; Pruzanski, Mark; Adorini, Luciano; Golden-Mason, Lucy; Levi, Moshe; Rosen, Hugo R.			Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID X RECEPTOR; INDUCED INSULIN-RESISTANCE; KUPFFER CELLS; ALTERNATIVE ACTIVATION; DENDRITIC CELLS; SCORING SYSTEM; STEATOHEPATITIS; TGR5; MACROPHAGES; MICE	Nonalcoholic fatty liver disease (NAFLD) affects a large proportion of the American population. The spectrum of disease ranges from bland steatosis without inflammation to nonalcoholic steatohepatitis and cirrhosis. Bile acids are critical regulators of hepatic lipid and glucose metabolism and signal through two major receptor pathways: farnesoid X receptor (FXR), a member of the nuclear hormone receptor superfamily, and TGR5, a G protein-coupled bile acid receptor (GPBAR1). Both FXR and TGR5 demonstrate pleiotropic functions, including immune modulation. To evaluate the effects of these pathways in NAFLD, we treated obese db/db mice with a dual FXR/TGR5 agonist (INT-767) for 6 weeks. Treatment with the agonist significantly improved the histological features of nonalcoholic steatohepatitis. Furthermore, treatment increased the proportion of intrahepatic monocytes with the anti-inflammatory Ly6C(low) phenotype and increased intrahepatic expression of genes expressed by alternatively activated macrophages, including CD206, Retnla, and Clec7a. In vitro treatment of monocytes with INT-767 led to decreased Ly6C expression and increased IL-10 production through a cAMP-dependent pathway. Our data indicate that FXR/TGR5 activation coordinates the immune phenotype of monocytes and macrophages, both in vitro and in vivo, identifying potential targeting strategies for treatment of NAFLD.	[McMahan, Rachel H.; Cheng, Lin Ling; Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado Denver, Div Gastroenterol, Dept Med, Aurora, CO 80045 USA; [Wang, Xiaoxin X.; Levi, Moshe] Univ Colorado Denver, Dept Med, Div Nephrol & Hypertens, Aurora, CO 80045 USA; [El Kasmi, Karim] Univ Colorado Denver, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Aurora, CO 80045 USA; [Krisko, Tibor] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Smith, Maxwell] Mayo Clin Arizona, Dept Lab Med & Pathol, Scottsdale, AZ 85259 USA; [Pruzanski, Mark] Intercept Pharmaceut, New York, NY 10013 USA; [Adorini, Luciano] Intercept Pharmaceut, I-06073 Perugia, Italy; [Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hosp, Integrated Program Immunol, Denver, CO 80206 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Mayo Clinic; Mayo Clinic Phoenix; Intercept Pharmaceuticals; Intercept Pharmaceuticals; National Jewish Health	Rosen, HR (corresponding author), Univ Colorado, Dept Med, Div Gastroenterol, Anschutz Med Campus,B-158,12631 E 17th Ave, Aurora, CO 80045 USA.	hugo.rosen@ucdenver.edu	Adorini, Luciano/AAE-5149-2020; Krisko, Tibor/AAG-7595-2020	Krisko, Tibor/0000-0002-9414-5846; Golden-Mason, Lucy/0000-0003-3347-4192; Golden-Mason, Lucy/0000-0002-2087-4405; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health [U19 AI 1066328]; Veterans Affairs Merit Review grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI083742, F31AI010663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, K01DK096025, R01DK098336] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grants(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant U19 AI 1066328 (to H. R. R.). This work was also supported by Veterans Affairs Merit Review grants (to H. R. R.).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Foey AD, 2004, IMMUNOLOGY, V112, P44, DOI 10.1111/j.1365-2567.2004.01852.x; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Huang H, 2008, J GASTROEN HEPATOL, V23, pS50, DOI 10.1111/j.1440-1746.2007.05284.x; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Musso G, 2010, ANNU REV MED, V61, P375, DOI 10.1146/annurev.med.60.101107.134820; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Peng YF, 2009, J IMMUNOL, V182, P2777, DOI 10.4049/jimmunol.0803172; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525	49	154	162	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11761	11770		10.1074/jbc.M112.446575	http://dx.doi.org/10.1074/jbc.M112.446575			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23460643	hybrid, Green Published			2022-12-28	WOS:000318157600013
J	Aurass, P; Schlegel, M; Metwally, O; Harding, CR; Schroeder, GN; Frankel, G; Flieger, A				Aurass, Philipp; Schlegel, Maren; Metwally, Omar; Harding, Clare R.; Schroeder, Gunnar N.; Frankel, Gad; Flieger, Antje			The Legionella pneumophila Dot/Icm-secreted Effector PlcC/CegC1 Together with PlcA and PlcB Promotes Virulence and Belongs to a Novel Zinc Metallophospholipase C Family Present in Bacteria and Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROLYZING PHOSPHOLIPASE-C; PERFRINGENS ALPHA-TOXIN; II PROTEIN SECRETION; TO-CELL SPREAD; PSEUDOMONAS-AERUGINOSA; LISTERIA-MONOCYTOGENES; INTRACELLULAR INFECTION; CLOSTRIDIUM-PERFRINGENS; CRYSTAL-STRUCTURE; BACILLUS-CEREUS	Legionella pneumophila is a water-borne bacterium that causes pneumonia in humans. PlcA and PlcB are two previously defined L. pneumophila proteins with homology to the phosphatidylcholine-specific phospholipase C (PC-PLC) of Pseudomonas fluorescens. Additionally, we found that Lpg0012 shows similarity to PLCs and has been shown to be a Dot/Icm-injected effector, CegC1, which is designated here as PlcC. It remained unclear, however, whether these L. pneumophila proteins exhibit PLC activity. PlcC expressed in Escherichia coli hydrolyzed a broad phospholipid spectrum, including PC, phosphatidylglycerol (PG), and phosphatidyl inositol. The addition of Zn2+ ions activated, whereas EDTA inhibited, PlcC-derived PLC activity. Protein homology search revealed that the three Legionella enzymes and P. fluorescens PC-PLC share conserved domains also present in uncharacterized fungal proteins. Fifteen conserved amino acids were essential for enzyme activity as identified via PlcC mutagenesis. Analysis of defined L. pneumophila knock-out mutants indicated Lsp-dependent export of PG-hydrolyzing PLC activity. PlcA and PlcB exhibited PG-specific activity and contain a predicted Sec signal sequence. In line with the reported requirement of host cell contact for Dot/Icm-dependent effector translocation, PlcC showed cell-associated PC-specific PLC activity after bacterial growth in broth. A PLC triple mutant, but not single or double mutants, exhibited reduced host killing in a Galleria mellonella infection model, highlighting the importance of the three PLCs in pathogenesis. In summary, we describe here a novel Zn2+-dependent PLC family present in Legionella, Pseudomonas, and fungi with broad substrate preference and function in virulence.	[Aurass, Philipp; Schlegel, Maren; Metwally, Omar; Flieger, Antje] Robert Koch Inst, Div Bacterial Infect, D-38855 Wernigerode, Germany; [Harding, Clare R.; Schroeder, Gunnar N.; Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England	Robert Koch Institute; Imperial College London	Flieger, A (corresponding author), Robert Koch Inst, Div Bacterial Infect, Burgstr 37, D-38855 Wernigerode, Germany.	fliegera@rki.de	Schroeder, Gunnar Neels/AAJ-2591-2020	Schroeder, Gunnar Neels/0000-0002-0412-7741; Flieger, Antje/0000-0003-3819-2979	Robert Koch Institute, Germany; German Research Foundation (DFG) [DFG FL 359/6-1]; MRC [G1001729, MR/J006874/1] Funding Source: UKRI; Medical Research Council [G1001729] Funding Source: researchfish	Robert Koch Institute, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the special research fund of the Robert Koch Institute, Germany, and by Grant DFG FL 359/6-1 from the German Research Foundation (DFG).	Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; Aragon V, 2002, MICROBIOL-SGM, V148, P2223, DOI 10.1099/00221287-148-7-2223; Aurass P, 2009, APPL ENVIRON MICROB, V75, P4506, DOI 10.1128/AEM.00187-09; BAINE WB, 1985, J GEN MICROBIOL, V131, P1383; BAINE WB, 1988, J GEN MICROBIOL, V134, P489; Banerji S, 2005, INFECT IMMUN, V73, P2899, DOI 10.1128/IAI.73.5.2899-2909.2005; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; Barker AP, 2004, MOL MICROBIOL, V53, P1089, DOI 10.1111/j.1365-2958.2004.04189.x; Benfield AP, 2007, ARCH BIOCHEM BIOPHYS, V460, P41, DOI 10.1016/j.abb.2007.01.023; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broich M, 2006, J BACTERIOL, V188, P1218, DOI 10.1128/JB.188.4.1218-1226.2006; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Cianciotto NP, 2009, FUTURE MICROBIOL, V4, P797, DOI 10.2217/FMB.09.53; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; Costas MJ, 2010, MOL MICROBIOL, V78, P1556, DOI 10.1111/j.1365-2958.2010.07425.x; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; DebRoy S, 2006, INFECT IMMUN, V74, P5152, DOI 10.1128/IAI.00484-06; DIAZLAVIADA I, 1990, EMBO J, V9, P3907, DOI 10.1002/j.1460-2075.1990.tb07611.x; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Faucher SP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00060; Felts RL, 2006, J BIOL CHEM, V281, P30289, DOI 10.1074/jbc.M606391200; Finck-Barbancon V, 1998, J BACTERIOL, V180, P6224; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Flieger A, 2000, J BACTERIOL, V182, P1321, DOI 10.1128/JB.182.5.1321-1327.2000; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Flieger A, 2000, ENZYME MICROB TECH, V26, P451, DOI 10.1016/S0141-0229(99)00190-8; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; FUJII Y, 1989, BRIT J PHARMACOL, V97, P119, DOI 10.1111/j.1476-5381.1989.tb11931.x; GEOFFROY C, 1991, INFECT IMMUN, V59, P2382, DOI 10.1128/IAI.59.7.2382-2388.1991; Hales LM, 1999, J BACTERIOL, V181, P4879, DOI 10.1128/JB.181.16.4879-4889.1999; HANSEN S, 1993, J MOL BIOL, V231, P870, DOI 10.1006/jmbi.1993.1333; Harding CR, 2012, INFECT IMMUN, V80, P2780, DOI 10.1128/IAI.00510-12; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; KRUG EL, 1984, ARCH BIOCHEM BIOPHYS, V231, P400, DOI 10.1016/0003-9861(84)90403-X; Kubiak RJ, 2001, BIOCHEMISTRY-US, V40, P5422, DOI 10.1021/bi002371y; Lang C, 2012, J BIOL CHEM, V287, P23464, DOI 10.1074/jbc.M112.346387; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; LEVINE L, 1987, PROSTAGLANDINS, V34, P633, DOI 10.1016/0090-6980(87)90288-7; Liles MR, 1999, MOL MICROBIOL, V31, P959, DOI 10.1046/j.1365-2958.1999.01239.x; MARQUIS H, 1995, INFECT IMMUN, V63, P4531, DOI 10.1128/IAI.63.11.4531-4534.1995; McCoy-Simandle K, 2011, INFECT IMMUN, V79, P1984, DOI 10.1128/IAI.01077-10; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; MEYERS DJ, 1990, INFECT IMMUN, V58, P659, DOI 10.1128/IAI.58.3.659-666.1990; MEZNA M, 1994, BIOCHEM J, V301, P503, DOI 10.1042/bj3010503; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Moser J, 1997, J MOL BIOL, V273, P269, DOI 10.1006/jmbi.1997.1290; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; PARKINSON EK, 1987, CARCINOGENESIS, V8, P857, DOI 10.1093/carcin/8.6.857; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Plekhanov AY, 1999, ANAL BIOCHEM, V271, P186, DOI 10.1006/abio.1999.4127; Preuss I, 2001, EUR J BIOCHEM, V268, P5081, DOI 10.1046/j.0014-2956.2001.02440.x; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; RECHNITZER C, 1992, J GEN MICROBIOL, V138, P1671, DOI 10.1099/00221287-138-8-1671; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; Rossier O, 2005, INFECT IMMUN, V73, P2020, DOI 10.1128/IAI.73.4.2020-2032.2005; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Rossier O, 2001, INFECT IMMUN, V69, P2092, DOI 10.1128/IAI.69.4.2092-2098.2001; Rossignol G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-189; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Saliba AM, 2005, CELL MICROBIOL, V7, P1811, DOI 10.1111/j.1462-5822.2005.00635.x; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Srinivas M, 2008, J BIOSCIENCES, V33, P221, DOI 10.1007/s12038-008-0039-2; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; VanRheenen SM, 2006, INFECT IMMUN, V74, P3597, DOI 10.1128/IAI.02060-05; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; WELLS MA, 1973, BIOCHEMISTRY-US, V12, P1080, DOI 10.1021/bi00730a010; WIATER LA, 1994, MOL MICROBIOL, V11, P641; Zavaleta-Pastor M, 2010, P NATL ACAD SCI USA, V107, P302, DOI 10.1073/pnas.0912930107; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	96	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11080	11092		10.1074/jbc.M112.426049	http://dx.doi.org/10.1074/jbc.M112.426049			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457299	hybrid, Green Published			2022-12-28	WOS:000317915500014
J	Nagalingam, RS; Sundaresan, NR; Gupta, MP; Geenen, DL; Solaro, RJ; Gupta, M				Nagalingam, Raghu S.; Sundaresan, Nagalingam R.; Gupta, Mahesh P.; Geenen, David L.; Solaro, R. John; Gupta, Madhu			RETRACTED: A Cardiac-enriched MicroRNA, miR-378, Blocks Cardiac Hypertrophy by Targeting Ras Signaling(Retracted article. See vol. 292, pg. 5123, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							FOCAL ADHESION KINASE; DIACYLGLYCEROL-BINDING MOTIFS; NUCLEOTIDE-RELEASING PROTEIN; MUTATIONS CAUSE NOONAN; SIGNALING PATHWAYS; GENE-EXPRESSION; THERAPEUTIC TARGET; PRESSURE-OVERLOAD; HEART-FAILURE; CARDIOMYOCYTE	Understanding the regulation of cardiomyocyte growth is crucial for the management of adverse ventricular remodeling and heart failure. MicroRNA-378 (miR-378) is a newly described member of the cardiac-enriched miRNAs, which is expressed only in cardiac myocytes and not in cardiac fibroblasts. We have previously shown that miR-378 regulates cardiac growth during the postnatal period by direct targeting of IGF1R (Knezevic, I., Patel, A., Sundaresan, N. R., Gupta, M. P., Solaro, R. J., Nagalingam, R. S., and Gupta, M. (2012) J. Biol. Chem. 287, 12913-12926). Here, we report that miR-378 is an endogenous negative regulator of cardiac hypertrophy, and its levels are down-regulated during hypertrophic growth of the heart and during heart failure. In primary cultures of cardiomyocytes, overexpression of miR-378 blocked phenylephrine (PE)-stimulated Ras activity and also prevented activation of two major growth-promoting signaling pathways, PI3K-AKT and Raf1-MEK1-ERK1/2, acting downstream of Ras signaling. Overexpression of miR-378 suppressed PE-induced phosphorylation of S6 ribosomal kinase, pERK1/2, pAKT, pGSK-3 beta, and nuclear accumulation of NFAT. There was also suppression of the fetal gene program that was induced by PE. Experiments carried out to delineate the mechanism behind the suppression of Ras, led us to identify Grb2, an upstream component of Ras signaling, as a bona fide direct target of miR-378-mediated regulation. Deficiency of miR-378 alone was sufficient to induce fetal gene expression, which was prevented by knocking down Grb2 expression and blocking Ras activation, thus suggesting that miR-378 interferes with Ras activation by targeting Grb2. Our study demonstrates that miR-378 is an endogenous negative regulator of Ras signaling and cardiac hypertrophy and its deficiency contributes to the development of cardiac hypertrophy.	[Nagalingam, Raghu S.; Geenen, David L.; Solaro, R. John; Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Nagalingam, Raghu S.; Geenen, David L.; Solaro, R. John; Gupta, Madhu] Univ Illinois, Ctr Cardiovasc Res, Chicago, IL 60612 USA; [Sundaresan, Nagalingam R.; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Comm Cellular & Mol Physiol, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Gupta, M (corresponding author), Univ Illinois, Dept Physiol & Biophys MC 901, 835 S Wolcott Ave, Chicago, IL 60612 USA.	guptam@uic.edu			National Institutes of Health [RO1 HL 22231, RO1 HL 83423, PO1 HL 062426]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062426, R01HL022231, R01HL111455, R01HL117041, R01HL083423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants Multi P. I. RO1 HL 22231 (to M. G. and R. J. S.), RO1 HL 83423 (to M. P. G.), and PO1 HL 062426 (to R. J. S.).	Barron AJ, 2003, BIOCHEM J, V371, P71, DOI 10.1042/BJ20021395; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Ciuffini L, 2008, ONCOGENE, V27, P528, DOI 10.1038/sj.onc.1210665; Denayer E, 2007, EUR J PEDIATR, V166, P1091, DOI 10.1007/s00431-007-0535-7; DiMichele LA, 2006, CIRC RES, V99, P636, DOI 10.1161/01.RES.0000240498.44752.d6; Dimmeler S, 2010, EUR HEART J, V31, P2705, DOI 10.1093/eurheartj/ehq221; Dong DL, 2010, HYPERTENSION, V55, P946, DOI 10.1161/HYPERTENSIONAHA.109.139519; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Freire G, 2007, J MOL CELL CARDIOL, V43, P465, DOI 10.1016/j.yjmcc.2007.07.046; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gupta M, 1998, MOL CELL BIOL, V18, P7243, DOI 10.1128/MCB.18.12.7243; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hennersdorf MG, 2001, J HYPERTENS, V19, P167, DOI 10.1097/00004872-200102000-00002; Ho PD, 1998, J BIOL CHEM, V273, P21730, DOI 10.1074/jbc.273.34.21730; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hua YN, 2012, J CELL MOL MED, V16, P83, DOI 10.1111/j.1582-4934.2011.01307.x; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Q, 2010, AM J PHYSIOL-HEART C, V298, pH1340, DOI 10.1152/ajpheart.00592.2009; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Mitchell S, 2006, PHYSIOL GENOMICS, V25, P50, DOI 10.1152/physiolgenomics.00224.2005; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Obata K, 2005, BIOCHEM BIOPH RES CO, V338, P1299, DOI 10.1016/j.bbrc.2005.10.083; Ocampo C, 2003, MOL CELL BIOCHEM, V251, P139, DOI 10.1023/A:1025450403668; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Rane S, 2010, CELL SIGNAL, V22, P1054, DOI 10.1016/j.cellsig.2010.02.008; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Sugden PH, 2003, CIRC RES, V93, P1179, DOI 10.1161/01.RES.0000106132.04301.F5; Sugden PH, 2000, TRENDS CARDIOVAS MED, V10, P1, DOI 10.1016/S1050-1738(00)00038-4; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	87	69	76	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11216	11232		10.1074/jbc.M112.442384	http://dx.doi.org/10.1074/jbc.M112.442384			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23447532	Green Published, hybrid			2022-12-28	WOS:000317915500025
J	Dolga, AM; Netter, MF; Perocchi, F; Doti, N; Meissner, L; Tobaben, S; Grohm, J; Zischka, H; Plesnila, N; Decher, N; Culmsee, C				Dolga, Amalia M.; Netter, Michael F.; Perocchi, Fabiana; Doti, Nunzianna; Meissner, Lilja; Tobaben, Svenja; Grohm, Julia; Zischka, Hans; Plesnila, Nikolaus; Decher, Niels; Culmsee, Carsten			Mitochondrial Small Conductance SK2 Channels Prevent Glutamate-induced Oxytosis and Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; ATP CHANNEL; PROVIDES NEUROPROTECTION; THERAPEUTIC TARGETS; MOUSE MODEL; CELL-DEATH; MODULATION; FORM; AIF	Small conductance calcium-activated potassium (SK2/K(Ca)2.2) channels are known to be located in the neuronal plasma membrane where they provide feedback control of NMDA receptor activity. Here, we provide evidence that SK2 channels are also located in the inner mitochondrial membrane of neuronal mitochondria. Patch clamp recordings in isolated mitoplasts suggest insertion into the inner mitochondrial membrane with the C and N termini facing the intermembrane space. Activation of SK channels increased mitochondrial K+ currents, whereas channel inhibition attenuated these currents. In a model of glutamate toxicity, activation of SK2 channels attenuated the loss of the mitochondrial transmembrane potential, blocked mitochondrial fission, prevented the release of proapoptotic mitochondrial proteins, and reduced cell death. Neuroprotection was blocked by specific SK2 inhibitory peptides and siRNA targeting SK2 channels. Activation of mitochondrial SK2 channels may therefore represent promising targets for neuroprotective strategies in conditions of mitochondrial dysfunction.	[Dolga, Amalia M.; Doti, Nunzianna; Tobaben, Svenja; Grohm, Julia; Culmsee, Carsten] Univ Marburg, Inst Pharmakol & Klin Pharm, Fachbereich Pharm, D-35032 Marburg, Germany; [Netter, Michael F.; Decher, Niels] Univ Marburg, Inst Physiol & Pathophysiol, Fachbereich Med, D-35037 Marburg, Germany; [Perocchi, Fabiana] Harvard Univ, Sch Med, Dept Syst Biol & Med, Boston, MA 02114 USA; [Perocchi, Fabiana] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Perocchi, Fabiana] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Doti, Nunzianna; Plesnila, Nikolaus] Royal Coll Surgeons Ireland, Dept Neurodegenerat, Dublin 2, Ireland; [Doti, Nunzianna] CNR, Inst Biostruct & Bioimaging, I-1680131 Naples, Italy; [Meissner, Lilja; Plesnila, Nikolaus] Univ Munich, Sch Med, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Zischka, Hans] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Toxicol, D-85764 Neuherberg, Germany	Philipps University Marburg; Philipps University Marburg; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Munich; Royal College of Surgeons - Ireland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Dolga, AM (corresponding author), Univ Marburg, Inst Pharmakol & Klin Pharm, Fachbereich Pharm, Karl von Frisch Str 1, D-35032 Marburg, Germany.	dolga@staff.uni-marburg.de; culmsee@staff.uni-marburg.de	Zischka, Hans/M-1490-2017; Decher, Niels/AAF-5002-2020; Culmsee, Carsten/ABC-3120-2021; Plesnila, Nikolaus/T-7522-2019; Doti, Nunzianna/ABC-9948-2020; Dolga, Amalia/C-9664-2018	Zischka, Hans/0000-0002-4047-1566; Culmsee, Carsten/0000-0002-5121-5015; perocchi, fabiana/0000-0002-1102-6500; Dolga, Amalia/0000-0001-5400-5614	Alzheimer Forschung Initiative e.V	Alzheimer Forschung Initiative e.V	This work was supported in part by a grant from Alzheimer Forschung Initiative e.V.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Alvina K, 2010, J NEUROSCI, V30, P7249, DOI 10.1523/JNEUROSCI.6341-09.2010; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bednarczyk P, 2009, ACTA BIOCHIM POL, V56, P385; Bishop MW, 2010, J NEUROPHYSIOL, V104, P3009, DOI 10.1152/jn.00466.2010; Blank T, 2003, NAT NEUROSCI, V6, P911, DOI 10.1038/nn1101; Cheng Y, 2010, FEBS LETT, V584, P2005, DOI 10.1016/j.febslet.2009.12.038; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Dolga AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.30; Dolga AM, 2008, J NEUROCHEM, V107, P1158, DOI 10.1111/j.1471-4159.2008.05701.x; Dolga AM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00196; Dolga AM, 2012, GLIA, V60, P2050, DOI 10.1002/glia.22419; Eliseev RA, 2003, BBA-BIOENERGETICS, V1604, P1, DOI 10.1016/S0005-2728(03)00005-7; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; HOCHMAN J, 1985, BIOCHEMISTRY-US, V24, P2509, DOI 10.1021/bi00331a017; Hougaard C, 2007, BRIT J PHARMACOL, V151, P655, DOI 10.1038/sj.bjp.0707281; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kasumu AW, 2012, CHEM BIOL, V19, P1340, DOI 10.1016/j.chembiol.2012.07.013; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Maher P, 1996, J NEUROSCI, V16, P6394; Malinska D, 2010, FEBS LETT, V584, P2043, DOI 10.1016/j.febslet.2010.01.013; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oxler EM, 2012, APOPTOSIS, V17, P1027, DOI 10.1007/s10495-012-0748-8; Peixoto PM, 2010, FEBS LETT, V584, P2142, DOI 10.1016/j.febslet.2010.02.046; Poulopoulou C, 2010, NEUROBIOL DIS, V37, P339, DOI 10.1016/j.nbd.2009.10.012; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Soh H, 2001, BIOPHYS J, V80, P2207, DOI 10.1016/S0006-3495(01)76193-0; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strobaek D, 2006, MOL PHARMACOL, V70, P1771, DOI 10.1124/mol.106.027110; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Szewczyk A, 2010, FEBS LETT, V584, P2063, DOI 10.1016/j.febslet.2010.02.048; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Tuteja D, 2010, CIRC RES, V107, P851, DOI 10.1161/CIRCRESAHA.109.215269; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wang Y, 2008, MED HYPOTHESES, V71, P546, DOI 10.1016/j.mehy.2008.05.021; YarovYarovoy V, 1997, BBA-BIOENERGETICS, V1321, P128, DOI 10.1016/S0005-2728(97)00051-0	51	68	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10792	10804		10.1074/jbc.M113.453522	http://dx.doi.org/10.1074/jbc.M113.453522			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430260	hybrid, Green Published			2022-12-28	WOS:000317565000057
J	Oshima, A; Matsuzawa, T; Nishikawa, K; Fujiyoshi, Y				Oshima, Atsunori; Matsuzawa, Tomohiro; Nishikawa, Kouki; Fujiyoshi, Yoshinori			Oligomeric Structure and Functional Characterization of Caenorhabditis elegans Innexin-6 Gap Junction Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANOSENSITIVE ION-CHANNEL; LOW RESISTANCE JUNCTIONS; MEMBRANE CHANNEL; 3-DIMENSIONAL STRUCTURE; INTERCELLULAR CHANNELS; PROJECTION STRUCTURE; ANGSTROM RESOLUTION; CRAYFISH; MOLECULES; FAMILY	Innexin is the molecular component of invertebrate gap junctions. Here we successfully expressed and purified Caenorhabditis elegans innexin-6 (INX-6) gap junction channels and characterized the molecular dimensions and channel permeability using electron microscopy (EM) and microinjection of fluorescent dye tracers, respectively. Negative staining and thin-section EM of isolated INX-6 gap junction membranes revealed a loosely packed hexagonal lattice and a greater cross-sectional width than that of connexin26 and connexin43 (Cx43)-GFP. In gel filtration analysis, the elution profile of purified INX-6 channels in dodecyl maltoside solution exhibited a peak at similar to 400 kDa that was shifted to similar to 800 kDa in octyl glucose neopentyl glycol. We also obtained the class averages of purified INX-6 channels from these peak fractions by single particle analysis. The class average from the similar to 800-kDa fraction showed features of the junction form with a longitudinal height of 220 angstrom, a channel diameter of 110 angstrom in the absence of detergent micelles, and an extracellular gap space of 60 angstrom, whereas the class averages from the similar to 400-kDa fraction showed diameters of up to 140 angstrom in the presence of detergent micelles. These findings indicate that the purified INX-6 channels are predominantly hemichannels in dodecyl maltoside and docked junction channels in octyl glucose neopentyl glycol. Dye transfer experiments revealed that the INX-6-GFP-His channels are permeable to 3- and 10-kDa tracers, whereas no significant amounts of these tracers passed through the Cx43-GFP channels. Based on these findings, INX-6 channels have a larger overall structure and greater permeability than connexin channels.	[Oshima, Atsunori; Nishikawa, Kouki; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst CeSPI, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Oshima, Atsunori; Fujiyoshi, Yoshinori] Nagoya Univ, Dept Basic Med Sci, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Matsuzawa, Tomohiro] Kyoto Univ, Dept Biophys, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Nagoya University; Nagoya University; Kyoto University	Oshima, A (corresponding author), Nagoya Univ, Cellular & Struct Physiol Inst CeSPI, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	atsu@cespi.nagoya-u.ac.jp	Oshima, Atsunori/F-8346-2010; Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493; Oshima, Atsunori/0000-0003-1174-1368	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan New Energy and Industrial Technology Development Organization (NEDO)	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants-in-aid for scientific research (S) (to Y. F.), the Platform for Drug Design, Discovery and Development (to A. O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Japan New Energy and Industrial Technology Development Organization (NEDO) (to Y. F.).	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; BAKER TS, 1983, J CELL BIOL, V96, P204, DOI 10.1083/jcb.96.1.204; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BERDAN RC, 1988, CELL TISSUE RES, V251, P257, DOI 10.1007/BF00215833; BOSCH E, 1989, J COMP NEUROL, V285, P399, DOI 10.1002/cne.902850307; Bukauskas FF, 1997, J PHYSIOL-LONDON, V499, P701, DOI 10.1113/jphysiol.1997.sp021962; BUKAUSKAS FF, 1995, PFLUG ARCH EUR J PHY, V429, P870, DOI 10.1007/BF00374812; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cheng A, 2003, CELL COMMUN ADHES, V10, P187, DOI 10.1080/714040425; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; DePriest A, 2011, BIOPHYS J, V101, P2408, DOI 10.1016/j.bpj.2011.10.004; FLAGGNEWTON J, 1979, J MEMBRANE BIOL, V50, P65, DOI 10.1007/BF01868788; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; GIAUME C, 1987, J PHYSIOL-LONDON, V386, P91, DOI 10.1113/jphysiol.1987.sp016524; Gilula N. B., 1978, INTERCELLULAR JUNCTI, P1; Hand GM, 2002, J MOL BIOL, V315, P587, DOI 10.1006/jmbi.2001.5262; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HERTZBERG EL, 1984, J BIOL CHEM, V259, P9936; HIROKAWA N, 1982, CELL, V30, P395, DOI 10.1016/0092-8674(82)90237-9; Kanaporis G, 2011, AM J PHYSIOL-CELL PH, V300, pC600, DOI 10.1152/ajpcell.00316.2010; Kandarian B, 2012, DEV GENES EVOL, V222, P29, DOI 10.1007/s00427-011-0387-z; KISTLER J, 1993, J STRUCT BIOL, V110, P28, DOI 10.1006/jsbi.1993.1002; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAMPE PD, 1991, J STRUCT BIOL, V107, P281, DOI 10.1016/1047-8477(91)90053-Y; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Ohta Y, 2011, J STRUCT BIOL, V175, P49, DOI 10.1016/j.jsb.2011.04.002; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; PERACCHIA C, 1973, J CELL BIOL, V57, P66, DOI 10.1083/jcb.57.1.66; PERACCHIA C, 1973, J CELL BIOL, V57, P54, DOI 10.1083/jcb.57.1.54; Phelan P, 1998, NATURE, V391, P181, DOI 10.1038/34426; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Phelan P, 1996, J NEUROSCI, V16, P1101; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Saint N, 1998, J BIOL CHEM, V273, P14667, DOI 10.1074/jbc.273.24.14667; SCHWARZMANN G, 1981, SCIENCE, V213, P551, DOI 10.1126/science.7244653; SIMPSON I, 1977, SCIENCE, V195, P294, DOI 10.1126/science.831276; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; STARICH TA, 1993, GENETICS, V133, P527; STAUFFER KA, 1995, J BIOL CHEM, V270, P6768; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; Suchyna TM, 1999, BIOPHYS J, V77, P2968, DOI 10.1016/S0006-3495(99)77129-8; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Unger VM, 1997, NAT STRUCT BIOL, V4, P39, DOI 10.1038/nsb0197-39; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; VEENSTRA RD, 1995, CIRC RES, V77, P1156, DOI 10.1161/01.RES.77.6.1156; Whitten SJ, 2007, DEV BIOL, V301, P432, DOI 10.1016/j.ydbio.2006.08.038; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; YEAGER M, 1992, J MOL BIOL, V223, P929, DOI 10.1016/0022-2836(92)90253-G; Yeager M, 1998, J STRUCT BIOL, V121, P231, DOI 10.1006/jsbi.1998.3972; Yeh E, 2009, J NEUROSCI, V29, P5207, DOI 10.1523/JNEUROSCI.0637-09.2009; ZAMPIGHI G, 1988, J CELL BIOL, V106, P1667, DOI 10.1083/jcb.106.5.1667; ZAMPIGHI G, 1978, TISSUE CELL, V10, P413, DOI 10.1016/S0040-8166(16)30337-8; ZAMPIGHI G, 1979, J MOL BIOL, V135, P451, DOI 10.1016/0022-2836(79)90446-7	64	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10513	10521		10.1074/jbc.M112.428383	http://dx.doi.org/10.1074/jbc.M112.428383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23460640	Green Published, hybrid			2022-12-28	WOS:000317565000031
J	Ekberg, K; Wielandt, AG; Buch-Pedersen, MJ; Palmgren, MG				Ekberg, Kira; Wielandt, Alex G.; Buch-Pedersen, Morten J.; Palmgren, Michael G.			A Conserved Asparagine in a P-type Proton Pump Is Required for Efficient Gating of Protons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; PLANT PLASMA-MEMBRANE; CYTOCHROME-C-OXIDASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; D-PATHWAY; PARACOCCUS-DENITRIFICANS; MOLECULAR-MECHANISMS; H+/ATP STOICHIOMETRY; ENERGY TRANSDUCTION	The minimal proton pumping machinery of the Arabidopsis thaliana P-type plasma membrane H+-ATPase isoform 2 (AHA2) consists of an aspartate residue serving as key proton donor/acceptor (Asp-684) and an arginine residue controlling the pK(a) of the aspartate. However, other important aspects of the proton transport mechanism such as gating, and the ability to occlude protons, are still unclear. An asparagine residue (Asn-106) in transmembrane segment 2 of AHA2 is conserved in all P-type plasma membrane H+-ATPases. In the crystal structure of the plant plasma membrane H+-ATPase, this residue is located in the putative ligand entrance pathway, in close proximity to the central proton donor/acceptor Asp-684. Substitution of Asn-106 resulted in mutant enzymes with significantly reduced ability to transport protons against a membrane potential. Sensitivity toward orthovanadate was increased when Asn-106 was substituted with an aspartate residue, but decreased in mutants with alanine, lysine, glutamine, or threonine replacement of Asn-106. The apparent proton affinity was decreased for all mutants, most likely due to a perturbation of the local environment of Asp-684. Altogether, our results demonstrate that Asn-106 is important for closure of the proton entrance pathway prior to proton translocation across the membrane.	[Ekberg, Kira; Wielandt, Alex G.; Buch-Pedersen, Morten J.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant & Environm Sci, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-1871 Frederiksberg, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Palmgren, MG (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Palmgren, Michael/A-9808-2013	Palmgren, Michael/0000-0002-9982-6114	Danish National Research Foundation through the PUMPKIN Center of Excellence	Danish National Research Foundation through the PUMPKIN Center of Excellence	This work was supported by the Danish National Research Foundation through the PUMPKIN Center of Excellence.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Berman MC, 2001, BBA-BIOMEMBRANES, V1513, P95, DOI 10.1016/S0005-2736(01)00356-X; BLATT MR, 1987, J MEMBRANE BIOL, V98, P169, DOI 10.1007/BF01872129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandsburg-Zabary S, 2000, BBA-BIOENERGETICS, V1458, P120, DOI 10.1016/S0005-2728(00)00063-3; BRISKIN DP, 1991, PLANT PHYSIOL, V95, P242, DOI 10.1104/pp.95.1.242; BROWN GC, 1992, FASEB J, V6, P2961, DOI 10.1096/fasebj.6.11.1644259; Buch-Pedersen MJ, 2009, PFLUG ARCH EUR J PHY, V457, P573, DOI 10.1007/s00424-008-0503-8; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; CAIN BD, 1989, J BIOL CHEM, V264, P3292; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; Durr KL, 2008, J MOL BIOL, V384, P865, DOI 10.1016/j.jmb.2008.09.074; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Henry RM, 2009, J MOL BIOL, V387, P1165, DOI 10.1016/j.jmb.2009.02.042; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Kaila VRI, 2008, BBA-BIOENERGETICS, V1777, P890, DOI 10.1016/j.bbabio.2008.03.016; Lanfermeijer FC, 1998, PROTEIN EXPRES PURIF, V12, P29, DOI 10.1006/prep.1997.0788; Lepp H, 2008, BBA-BIOENERGETICS, V1777, P897, DOI 10.1016/j.bbabio.2008.04.013; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; ONSAGER L, 1969, SCIENCE, V166, P1359, DOI 10.1126/science.166.3911.1359; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pawate AS, 2002, BIOCHEMISTRY-US, V41, P13417, DOI 10.1021/bi026582+; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PERLIN DS, 1986, ARCH BIOCHEM BIOPHYS, V248, P53, DOI 10.1016/0003-9861(86)90400-5; Pfitzner U, 2000, BIOCHEMISTRY-US, V39, P6756, DOI 10.1021/bi992235x; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; SKULACHEV VP, 1994, ANTON LEEUW INT J G, V65, P271, DOI 10.1007/BF00872213; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; WILSON TH, 1980, J SUPRAMOL STR CELL, V13, P421, DOI 10.1002/jss.400130403	47	12	12	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9610	9618		10.1074/jbc.M112.417345	http://dx.doi.org/10.1074/jbc.M112.417345			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420846	Green Published, hybrid			2022-12-28	WOS:000317114000005
J	Harmon, JM; Bacikova, D; Gable, K; Gupta, SD; Han, GS; Sengupta, N; Somashekarappa, N; Dunn, TM				Harmon, Jeffrey M.; Bacikova, Dagmar; Gable, Kenneth; Gupta, Sita D.; Han, Gongshe; Sengupta, Nivedita; Somashekarappa, Niranjanakumari; Dunn, Teresa M.			Topological and Functional Characterization of the ssSPTs, Small Activating Subunits of Serine Palmitoyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPATHY TYPE-I; SPHINGOLIPID BIOSYNTHESIS; CRYSTAL-STRUCTURE; PROTEINS MEDIATE; ENZYME; MUTATIONS; YEAST; CLONING; GENES; HOMEOSTASIS	The topological and functional organization of the two isoforms of the small subunits of human serine palmitoyltransferase (hssSPTs) that activate the catalytic hLCB1/hLCB2 heterodimer was investigated. A variety of experimental approaches placed the N termini of the ssSPTs in the cytosol, their C termini in the lumen, and showed that they contain a single transmembrane domain. Deletion analysis revealed that the ability to activate the heterodimer is contained in a conserved 33-amino acid core domain that has the same membrane topology as the full-length protein. In combination with analysis of isoform chimera and site-directed mutagenesis, a single amino acid residue in this core (Met(25) in ssSPTa and Val(25) in ssSPTb) was identified which confers specificity for palmitoylor stearoyl-CoA, respectively, in both yeast and mammalian cells. This same residue also determines which isoform is a better activator of a mutant heterodimer, hLCB1(S331)F/hLCB2a, which has increased basal SPT activity and decreased amino acid substrate selectivity. This suggests that the role of the ssSPTs is to increase SPT activity without compromising substrate specificity. In addition, the observation that the C-terminal domains of ssSPTa and ssSPTb, which are highly conserved within each subfamily but are the most divergent regions between isoform subfamilies, are not required for activation of the heterodimer or for acyl-CoA selectivity suggests that the ssSPTs have additional roles that remain to be discovered.	[Harmon, Jeffrey M.; Bacikova, Dagmar; Somashekarappa, Niranjanakumari] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Gable, Kenneth; Gupta, Sita D.; Han, Gongshe; Sengupta, Nivedita; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Dunn, TM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	tdunn@usuhs.edu		Harmon, Jeffrey/0000-0001-7833-931X	National Institutes of Health [R01NS072446]; Uniformed Services University [R071KD, CO75PI]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniformed Services University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS072446. This work was also supported by Uniformed Services University Grants R071KD and CO75PI.	Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2000, METHOD ENZYMOL, V312, P304; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Ikushiro H, 2003, BBA-PROTEINS PROTEOM, V1647, P116, DOI 10.1016/S1570-9639(03)00074-8; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Momin AA, 2009, LIPIDS, V44, P725, DOI 10.1007/s11745-009-3316-4; Monaghan E, 2002, YEAST, V19, P659, DOI 10.1002/yea.864; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Raman MCC, 2010, BIOPOLYMERS, V93, P811, DOI 10.1002/bip.21482; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Rotthier A, 2011, HUM MUTAT, V32, pE2211, DOI 10.1002/humu.21481; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; ZHAO C, 1994, J BIOL CHEM, V269, P21480	30	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10144	10153		10.1074/jbc.M113.451526	http://dx.doi.org/10.1074/jbc.M113.451526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426370	Green Published, hybrid			2022-12-28	WOS:000317114000055
J	Wang, YC; Liu, F; Mao, F; Hang, QL; Huang, XD; He, S; Wang, YY; Cheng, C; Wang, HJ; Xu, GF; Zhang, TY; Shen, AG				Wang, Yuchan; Liu, Fang; Mao, Feng; Hang, Qinlei; Huang, Xiaodong; He, Song; Wang, Yingying; Cheng, Chun; Wang, Huijie; Xu, Guangfei; Zhang, Tianyi; Shen, Aiguo			Interaction with Cyclin H/Cyclin-dependent Kinase 7 (CCNH/CDK7) Stabilizes C-terminal Binding Protein 2 (CtBP2) and Promotes Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COREPRESSOR CTBP; MESENCHYMAL TRANSITIONS; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; FAMILY PROTEINS; PROSTATE-CANCER; ACETYLATION; ASSOCIATION; METASTASIS; MECHANISMS	CtBP2 has been demonstrated to possess tumor-promoting capacities by virtue of up-regulating epithelial-mesenchymal transition (EMT) and down-regulating apoptosis in cancer cells. As a result, cellular CtBP2 levels are considered a key factor determining the outcome of oncogenic transformation. How pro-tumorigenic and anti-tumorigenic factors compete for fine-tuning CtBP2 levels is incompletely understood. Here we report that the cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) complex interacted with CtBP2 in vivo and in vitro. Depletion of either CCNH or CDK7 decreased CtBP2 protein levels by accelerating proteasome-dependent CtBP2 clearance. Further analysis revealed that CCNH/CDK7 competed with the tumor repressor HIPK2 for CtBP2 binding and consequently inhibited phosphorylation and dimerization of CtBP2. Phosphorylation-defective CtBP2 interacted more strongly with CCNH/CDK7 and was more resistant to degradation. Finally, overexpression of CtBP2 increased whereas depletion of CtBP2 dampened the invasive and migratory potential of breast cancer cells. CtBP2 promoted the invasion and migration of breast cancer cells in a CCNH-dependent manner. Taken together, our data have delineated a novel pathway that regulates CtBP2 stability, suggesting that targeting the CCNH/CDK7-CtBP2 axis may yield a viable anti-tumor strategy.	[Wang, Yuchan; Liu, Fang; Mao, Feng; Hang, Qinlei; Wang, Yingying; Cheng, Chun; Xu, Guangfei; Zhang, Tianyi; Shen, Aiguo] Nantong Univ, Coll Med, Dept Pathogen & Immunol, Nantong 226001, Peoples R China; [Shen, Aiguo] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Huang, Xiaodong; He, Song] Nantong Univ, Affiliated Hosp, Nantong 226001, Peoples R China; [Wang, Huijie] Fudan Univ, Shanghai Med Coll, Dept Oncol, Yangpu Shanghai 200082, Peoples R China	Nantong University; Nantong University; Nantong University; Fudan University	Shen, AG (corresponding author), Nantong Univ, Coll Med, Dept Pathogen & Immunol, Nantong 226001, Peoples R China.	shen_aiguo@yahoo.com	Mao, Feng/B-8280-2019; wang, yingying/GRS-3058-2022		National Basic Research Program 973 of China [2012CB822104, 2011CB910604]; National Natural Science Foundation of China [31070723, 81172879, 31270802, 81201858]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu province [BK2012231]	National Basic Research Program 973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Basic Research Program 973 of China Grants No. 2012CB822104 and No. 2011CB910604; the National Natural Science Foundation of China Grants 31070723, 81172879, 31270802, and 81201858; a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; and by the Natural Science Foundation of Jiangsu province Grant BK2012231.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Barroilhet L, 2013, ONCOGENE, V32, P3896, DOI 10.1038/onc.2012.380; Bergman LM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-35; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Birts CN, 2011, BIOL CELL, V103, P1, DOI 10.1042/BC20100067; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Kayaselcuk F, 2006, INT J GYNECOL CANCER, V16, P402, DOI 10.1111/j.1525-1438.2006.00407.x; Liang HZ, 2011, MOL CELL BIOL, V31, P955, DOI 10.1128/MCB.01062-10; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Straza MW, 2010, CELL CYCLE, V9, P3740, DOI 10.4161/cc.9.18.12936; Tang LD, 2010, EUR J CANCER, V46, P170, DOI 10.1016/j.ejca.2009.10.003; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Tsilidis KK, 2012, AM J EPIDEMIOL, V175, P926, DOI 10.1093/aje/kwr423; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	29	58	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9028	9034		10.1074/jbc.M112.432005	http://dx.doi.org/10.1074/jbc.M112.432005			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393140	Green Published, hybrid			2022-12-28	WOS:000316862200022
J	Cook, I; Wang, T; Almo, SC; Kim, J; Falany, CN; Leyh, TS				Cook, Ian; Wang, Ting; Almo, Steven C.; Kim, Jungwook; Falany, Charles N.; Leyh, Thomas S.			Testing the Sulfotransferase Molecular Pore Hypothesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATION; LIGAND; MODEL; ENZYMOLOGY; BIOLOGY	Human cytosolic sulfotransferases (SULTs) regulate the activities of hundreds of signaling metabolites via transfer of the sulfuryl moiety (-SO3) from activated sulfate (3'-phosphoadenosine 5'-phosphosulfate) to the hydroxyls and primary amines of xeno- and endobiotics. How SULTs select substrates from the scores of competing ligands present in a cytosolic milieu is an important issue in the field. Selectivity appears to be sterically controlled by a molecular pore that opens and closes in response to nucleotide binding. This point of view is fostered by structures showing nucleotide-dependent pore closure and the fact that nucleotide binding induces an isomerization that restricts access to the acceptor-binding pocket. Molecular dynamics models underscore the importance of pore isomerization in selectivity and predict that specific molecular linkages stabilize the closed pore in response to nucleotide binding. To test the pore model, these linkages were disrupted in SULT2A1 via mutagenesis, and the effects on selectivity were determined. The mutations uncoupled nucleotide binding from selectivity and produced enzymes that no longer discriminated between large and small substrates. The mutations did not affect the affinity or turnover of small substrates but resulted in a 183-fold gain in catalytic efficiently toward large substrates. Models predict that an 11-residue "flap" covering the acceptor-binding pocket can open and admit large substrates when nucleotide is bound; a mutant structure demonstrated that this is so. In summary, the model was shown to be a robust, accurate predictor of SULT structure and selectivity whose general features will likely apply to other members of the SULT family.	[Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Almo, Steven C.; Kim, Jungwook] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Falany, Charles N.] Univ Alabama Birmingham, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu	Wang, Ting/J-7577-2015; Kim, Jungwook/AAP-1322-2020	Kim, Jungwook/0000-0001-5213-9299	National Institutes of Health [GM54469, GM48623, GM38953]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469, R01GM038953, R29GM038953, R01GM048623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54469, GM48623, and GM38953.	Aidoo-Gyamfi K, 2009, ANTI-CANCER AGENT ME, V9, P599, DOI 10.2174/187152009788679985; Anderson JAM, 2001, J BIOL CHEM, V276, P9755, DOI 10.1074/jbc.M010048200; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W. W, 1970, ENZYMES, V2, P1; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Dong D, 2012, EXPERT OPIN DRUG MET, V8, P635, DOI 10.1517/17425255.2012.677027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Falany JL, 1996, ENDOCRINOLOGY, V137, P1395, DOI 10.1210/en.137.4.1395; Falany JL, 2002, BREAST CANCER RES TR, V74, P167, DOI 10.1023/A:1016147004188; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Li L, 2007, J CYST FIBROS, V6, P23, DOI 10.1016/j.jcf.2006.05.001; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Parker CR, 1999, STEROIDS, V64, P640, DOI 10.1016/S0039-128X(99)00046-X; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; Selvan RS, 1996, ANN NY ACAD SCI, V797, P127, DOI 10.1111/j.1749-6632.1996.tb52955.x; STEVENTON GB, 1989, NEUROLOGY, V39, P883, DOI 10.1212/WNL.39.7.883; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; VISSER TJ, 1994, CHEM-BIOL INTERACT, V92, P293, DOI 10.1016/0009-2797(94)90071-X; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	31	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8619	8626		10.1074/jbc.M112.445015	http://dx.doi.org/10.1074/jbc.M112.445015			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362278	hybrid, Green Published			2022-12-28	WOS:000316564500062
J	Kulkarni, MM; Karafova, A; Kamysz, W; Schenkman, S; Pelle, R; McGwire, BS				Kulkarni, Manjusha M.; Karafova, Anna; Kamysz, Wojciech; Schenkman, Sergio; Pelle, Roger; McGwire, Bradford S.			Secreted Trypanosome Cyclophilin Inactivates Lytic Insect Defense Peptides and Induces Parasite Calcineurin Activation and Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-METALLOPROTEASE; CYCLOSPORINE-BINDING; RHODNIUS-PROLIXUS; ENCODING GENES; A HOMOLOG; CRUZI; LEISHMANIA; EXPRESSION; PROTEIN; PATHWAY	The mechanisms by which Trypanosoma cruzi survives antimicrobial peptides and differentiates during its transit through the gastrointestinal tract of the reduviid vector are unknown. We show that cyclophilin, a peptidyl-prolyl isomerase secreted from T. cruzi epimastigotes, binds to and neutralizes the reduviid antimicrobial peptide trialysin promoting parasite survival. This is dependent on a singular proline residue in trialysin and is inhibited by the cyclophilin inhibitor cyclosporine A. In addition, cyclophilin-trialysin complexes enhance the production of ATP and reductase responses of parasites, which are inhibited by both calcineurin-specific inhibitors cyclosporine A and FK506. Calcineurin phosphatase activity of cyclophilin-trialysin-treated parasites was higher than in controls and was inhibited by preincubation by either inhibitor. Parasites exposed to cyclophilin-trialysin have enhanced binding and invasion of host cells leading to higher infectivity. Leishmanial cyclophilin also mediates trialysin protection and metabolic stimulation by T. cruzi, indicating that extracellular cyclophilin may be critical to adaptation in other insect-borne protozoa. This work demonstrates that cyclophilin serves as molecular sensor leading to the evasion and adaptive metabolic response to insect defense peptides.	[McGwire, Bradford S.] Ohio State Univ, Med Ctr, Div Infect Dis, Columbus, OH 43210 USA; [Kulkarni, Manjusha M.; McGwire, Bradford S.] Ohio State Univ, Med Ctr, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Karafova, Anna; Kamysz, Wojciech] Med Univ Gdansk, Fac Pharm, PL-80120 Gdansk, Poland; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Pelle, Roger] Int Livestock Res Inst, Nairobi 00100, Kenya	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Fahrenheit Universities; Medical University Gdansk; Universidade Federal de Sao Paulo (UNIFESP); CGIAR; International Livestock Research Institute (ILRI)	McGwire, BS (corresponding author), Doan N-1145,410 W 10th Ave, Columbus, OH 43210 USA.	brad.mcgwire@osumc.edu	Schenkman, Sergio/A-9227-2013; McGwire, Bradford/E-3637-2011	Schenkman, Sergio/0000-0001-9353-8480; McGwire, Bradford/0000-0002-9646-5931; Karafova, Anna/0000-0003-1346-7438; Kamysz, Wojciech/0000-0001-5335-3043	American Heart Association; Ohio State University	American Heart Association(American Heart Association); Ohio State University(Ohio State University)	This work was supported by the American Heart Association (to B. S. M) and The Ohio State University.	Akuffo H, 1998, INT J MOL MED, V1, P77; Amino R, 2002, J BIOL CHEM, V277, P6207, DOI 10.1074/jbc.M109874200; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Araya JE, 2008, MICROBES INFECT, V10, P892, DOI 10.1016/j.micinf.2008.05.003; Arias DG, 2011, FREE RADICAL BIO MED, V50, P37, DOI 10.1016/j.freeradbiomed.2010.10.695; ASIN S, 1995, J PARASITOL, V81, P1, DOI 10.2307/3283997; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bua J, 2008, PARASITOLOGY, V135, P217, DOI 10.1017/S003118200700371X; Bua J, 2004, BIOORG MED CHEM LETT, V14, P4633, DOI 10.1016/j.bmcl.2004.07.003; Bua J, 2001, FEMS MICROBIOL LETT, V200, P43, DOI 10.1016/S0378-1097(01)00193-8; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Burleigh Barbara A, 2005, Sci STKE, V2005, ppe36, DOI 10.1126/stke.2932005pe36; Dao-Thi MH, 1998, ACTA CRYSTALLOGR D, V54, P1046, DOI 10.1107/S0907444998001607; Diaz-Achirica P, 1998, BIOCHEM J, V330, P453, DOI 10.1042/bj3300453; Fearon P, 2011, J INVEST DERMATOL, V131, P1085, DOI 10.1038/jid.2010.415; Feng B, 1999, BIOCHEMISTRY-US, V38, P12481, DOI 10.1021/bi990492w; Florencio-Martinez L, 2010, EXP PARASITOL, V126, P332, DOI 10.1016/j.exppara.2010.04.015; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Fraidenraich Diego, 1993, Biological Research, V26, P279; Garcia ES, 1995, EXP PARASITOL, V81, P255, DOI 10.1006/expr.1995.1116; Gluenz E, 2007, INT J PARASITOL, V37, P617, DOI 10.1016/j.ijpara.2006.11.016; KRASSNER SM, 1990, J PROTOZOOL, V37, P128, DOI 10.1111/j.1550-7408.1990.tb05882.x; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Kulkarni MM, 2011, CELL MICROBIOL, V13, P913, DOI 10.1111/j.1462-5822.2011.01589.x; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lis M, 2010, FEMS YEAST RES, V10, P579, DOI 10.1111/j.1567-1364.2010.00638.x; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Lorenzen S, 2005, PROTEINS, V58, P589, DOI 10.1002/prot.20342; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Malaga S, 2001, INFECT IMMUN, V69, P353, DOI 10.1128/IAI.69.1.353-359.2001; Manque PM, 2000, INFECT IMMUN, V68, P478, DOI 10.1128/IAI.68.2.478-484.2000; Marin-Menendez A, 2011, PROTEIN EXPRES PURIF, V78, P225, DOI 10.1016/j.pep.2011.04.012; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Martins RM, 2006, BIOCHEMISTRY-US, V45, P1765, DOI 10.1021/bi0514515; McGwire BS, 2010, EXP PARASITOL, V126, P397, DOI 10.1016/j.exppara.2010.02.006; McGwire BS, 2003, J INFECT DIS, V188, P146, DOI 10.1086/375747; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; Miele R, 2003, PEPTIDES, V24, P1713, DOI 10.1016/j.peptides.2003.07.024; Moreno VR, 2007, ACTA TROP, V101, P80, DOI 10.1016/j.actatropica.2006.11.008; Naderer T, 2011, MOL MICROBIOL, V80, P471, DOI 10.1111/j.1365-2958.2011.07584.x; NOGUEIRA N, 1977, AM J TROP MED HYG, V26, P194, DOI 10.4269/ajtmh.1977.26.194; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; PALLEN CJ, 1984, J BIOL CHEM, V259, P6134; PALLEN CJ, 1983, J BIOL CHEM, V258, P8550; Pelle R, 2002, GENE, V290, P181, DOI 10.1016/S0378-1119(02)00559-0; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PERRINO BA, 1995, J BIOL CHEM, V270, P7012; Potenza M, 2006, PARASITOLOGY, V132, P867, DOI 10.1017/S0031182005009558; Rascher C, 1998, BIOCHEM J, V334, P659, DOI 10.1042/bj3340659; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; SCHUMACHER A, 1994, EUR J CELL BIOL, V63, P182; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; UEKI K, 1993, J BIOL CHEM, V268, P6554; Waniek PJ, 2009, J INSECT PHYSIOL, V55, P840, DOI 10.1016/j.jinsphys.2009.05.015; Watanabe Y, 1996, BIOCHEMISTRY-US, V35, P562, DOI 10.1021/bi951703+; Woolsey AM, 2004, CELL MICROBIOL, V6, P829, DOI 10.1111/j.1462-5822.2004.00405.x; Yamada-Ogatta SF, 2004, ACTA TROP, V90, P171, DOI 10.1016/j.actatropica.2003.10.018; Yau WL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000729	63	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8772	8784		10.1074/jbc.M112.421057	http://dx.doi.org/10.1074/jbc.M112.421057			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386612	Green Published, hybrid			2022-12-28	WOS:000316564500076
J	Zhang, J; Xu, ES; Chen, XB				Zhang, Jin; Xu, Enshun; Chen, Xinbin			TAp73 Protein Stability Is Controlled by Histone Deacetylase 1 via Regulation of Hsp90 Chaperone Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC TARGET GENES; BREAST-CANCER CELLS; KINASE C-ABL; DNA-DAMAGE; UBIQUITIN LIGASE; P73 EXPRESSION; FEEDBACK LOOP; MUTANT P53; DELTA-NP73; ACETYLATION	Histone deacetylases (HDACs) play important roles in fundamental cellular processes, and HDAC inhibitors are emerging as promising cancer therapeutics. p73, a member of the p53 family, plays a critical role in tumor suppression and neural development. Interestingly, p73 produces two classes of proteins with opposing functions: the full-length TAp73 and the N-terminally truncated Delta Np73. In the current study, we sought to characterize the potential regulation of p73 by HDACs and found that histone deacetylase 1 (HDAC1) is a key regulator of TAp73 protein stability. Specifically, we showed that HDAC1 inhibition by HDAC inhibitors or by siRNA shortened the half-life of TAp73 protein and subsequently decreased TAp73 expression under normal and DNA damage-induced conditions. Mechanistically, we found that HDAC1 knockdown resulted in hyperacetylation and inactivation of heat shock protein 90, which disrupted the interaction between heat shock protein 90 and TAp73 and thus promoted the proteasomal degradation of TAp73. Functionally, we found that down-regulation of TAp73 was required for the enhanced cell migration mediated by HDAC1 knockdown. Together, we uncover a novel regulation of TAp73 protein stability by HDAC1-heat shock protein 90 chaperone complex, and our data suggest that TAp73 is a critical downstream mediator of HDAC1-regulated cell migration.	[Zhang, Jin; Xu, Enshun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA081237, CA076069]; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA081237, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA081237 and CA076069.	Agami R, 1999, NATURE, V399, P809; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Dulloo I, 2005, J BIOL CHEM, V280, P28203, DOI 10.1074/jbc.M501702200; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Fuino L, 2003, MOL CANCER THER, V2, P971; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Goldschneider D, 2005, J CELL SCI, V118, P1245, DOI 10.1242/jcs.01704; Gong JG, 1999, NATURE, V399, P806; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jones EV, 2007, BIOCHEM J, V405, P617, DOI 10.1042/BJ20061778; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Kikuchi H, 2006, ONCOGENE, V25, P7608, DOI 10.1038/sj.onc.1209748; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marabese M, 2003, NUCLEIC ACIDS RES, V31, P6624, DOI 10.1093/nar/gkg869; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nishioka C, 2008, LEUKEMIA RES, V32, P1382, DOI 10.1016/j.leukres.2008.02.018; Ozaki T, 2009, BIOCHEM BIOPH RES CO, V386, P207, DOI 10.1016/j.bbrc.2009.06.035; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Qian YJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207241; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; Slade N, 2004, CELL DEATH DIFFER, V11, P357, DOI 10.1038/sj.cdd.4401335; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Wallace DM, 2009, J NEUROSCI RES, V87, P887, DOI 10.1002/jnr.21910; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wu S, 2008, BIOCHEM BIOPH RES CO, V365, P75, DOI 10.1016/j.bbrc.2007.10.145; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhang J, 2007, MOL CELL BIOL, V27, P3868, DOI 10.1128/MCB.02112-06; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	67	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7727	7737		10.1074/jbc.M112.429522	http://dx.doi.org/10.1074/jbc.M112.429522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362263	Green Published, hybrid			2022-12-28	WOS:000316455300029
J	Boiani, M; Daniel, C; Liu, XY; Hogarty, MD; Marnett, LJ				Boiani, Mariana; Daniel, Cristina; Liu, Xueyuan; Hogarty, Michael D.; Marnett, Lawrence J.			The Stress Protein BAG3 Stabilizes Mcl-1 Protein and Promotes Survival of Cancer Cells and Resistance to Antagonist ABT-737	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; BCL-2 FAMILY PROTEINS; BH3 MIMETIC ABT-737; DOWN-REGULATION; HEAT-SHOCK; BCL-2-BINDING PROTEIN; MYELOID-LEUKEMIA; IN-VIVO; NEUROBLASTOMA; DEATH	Members of the Bcl-2 family of proteins are important inhibitors of apoptosis in human cancer and are targets for novel anticancer agents such as the Bcl-2 antagonists, ABT-263 (Navitoclax), and its analog ABT-737. Unlike Bcl-2, Mcl-1 is not antagonized by ABT-263 or ABT-737 and is considered to be a major factor in resistance. Also, Mcl-1 exhibits differential regulation when compared with other Bcl-2 family members and is a target for anticancer drug discovery. Here, we demonstrate that BAG3, an Hsp70 co-chaperone, protects Mcl-1 from proteasomal degradation, thereby promoting its antiapoptotic activity. Using neuroblastoma cell lines, with a defined Bcl-2 family dependence, we found that BAG3 expression correlated with Mcl-1 dependence and ABT-737 resistance. RNA silencing of BAG3 led to a marked reduction in Mcl-1 protein levels and overcame ABT-737 resistance in Mcl-1-dependent cells. In ABT-737-resistant cells, Mcl-1 co-immunoprecipitated with BAG3, and loss of Mcl-1 after BAG3 silencing was prevented by proteasome inhibition. BAG3 and Mcl-1 were co-expressed in a panel of diverse cancer cell lines resistant to ABT-737. Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells. These studies identify BAG3-mediated Mcl-1 stabilization as a potential target for cancer drug discovery.	[Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Chem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Pharmacol,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Boiani, Mariana; Daniel, Cristina; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Liu, Xueyuan; Hogarty, Michael D.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Liu, Xueyuan; Hogarty, Michael D.] Univ Penn, Sch Med, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			National Institutes of Health from the NIEHS [ES013125, CA97323]; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE [P01CA097323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, P01ES013125] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES013125 (to L. J. M.) and CA97323 (to M. D. H.) from the NIEHS and an Innovator Award from Alex's Lemonade Stand Foundation (to M. D. H.).	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen Hao-Yue, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P838; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gentilella A, 2011, J BIOL CHEM, V286, P9205, DOI 10.1074/jbc.M110.175836; Goldsmith KC, 2010, CELL DEATH DIFFER, V17, P872, DOI 10.1038/cdd.2009.171; Goldsmith KC, 2005, CANCER LETT, V228, P133, DOI 10.1016/j.canlet.2005.01.048; Goldsmith KC, 2012, CANCER RES, V72, P2565, DOI 10.1158/0008-5472.CAN-11-3603; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hackett CS, 2003, CANCER RES, V63, P5266; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Iwasaki M, 2007, CANCER RES, V67, P10252, DOI 10.1158/0008-5472.CAN-07-0618; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; REED JC, 1990, CANCER RES, V50, P6565; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	69	63	65	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6980	6990		10.1074/jbc.M112.414177	http://dx.doi.org/10.1074/jbc.M112.414177			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341456	Green Published, hybrid			2022-12-28	WOS:000316002400020
J	Ishii, T; Funato, Y; Miki, H				Ishii, Tasuku; Funato, Yosuke; Miki, Hiroaki			Thioredoxin-related Protein 32 (TRP32) Specifically Reduces Oxidized Phosphatase of Regenerating Liver (PRL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CATALYTIC DOMAIN; METASTASIS; EXPRESSION; OXIDATION; TRP14; PLAYS; CELLS; PTEN	PRL family constitutes a unique class of phosphatases associated with metastasis. The phosphatase activity of PRL has been reported to be important for promoting metastasis, and it is inactivated by reversible oxidation of its catalytic cysteine. Here, we show that TRP32 specifically reduces PRL. Reduction of oxidized PRL in cells is inhibited by 2,4-dinitro-1-chlorobenzene, an inhibitor of TRX reductase. In vitro assays for the reduction of PRL show that only TRP32 can potently reduce oxidized PRL, whereas other TRX-related proteins linked to TRX reductase show little or no reducing activity. Indeed, TRP32 knockdown significantly prolongs the H2O2-induced oxidation of PRL. Binding analyses reveal that the unique C-terminal domain of TRP32 is required and sufficient for its direct interaction with PRL. These results suggest that TRP32 maintains the reduced state of PRL and thus regulates the biological function of PRL.	[Ishii, Tasuku; Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan	Osaka University	Miki, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@biken.osaka-u.ac.jp			Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (JSPS); Exciting Leading-Edge Research Projects from Osaka University; JSPS; Ministry of Education, Culture, Sports, Science and Technology-Japan	Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Exciting Leading-Edge Research Projects from Osaka University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (JSPS) (to H. M.), Exciting Leading-Edge Research Projects from Osaka University (to H. M.), and grants-in-aid for scientific research from the JSPS and Ministry of Education, Culture, Sports, Science and Technology-Japan (to H. M. and Y. F.).	Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Anagnostopoulos Athanasios K., 2005, Cancer Genomics & Proteomics, V2, P271; Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Cheng JZ, 2001, J BIOL CHEM, V276, P41213, DOI 10.1074/jbc.M106838200; Felberbaum-Corti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001144; Goroncy AK, 2010, PROTEINS, V78, P2176, DOI 10.1002/prot.22719; Guo K, 2004, CANCER BIOL THER, V3, P945, DOI 10.4161/cbt.3.10.1111; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Jeong W, 2004, J BIOL CHEM, V279, P3151, DOI 10.1074/jbc.M307959200; Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jin J, 2002, EUR J BIOCHEM, V269, P2060, DOI 10.1046/j.1432-1033.2002.02844.x; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Yu L, 2007, BBA-MOL CELL RES, V1773, P1473, DOI 10.1016/j.bbamcr.2007.06.005; Zeng Q, 2003, CANCER RES, V63, P2716	28	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7263	7270		10.1074/jbc.M112.418004	http://dx.doi.org/10.1074/jbc.M112.418004			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23362275	hybrid, Green Published			2022-12-28	WOS:000316002400046
J	Liu, XQ; Subramani, S				Liu, Xueqian; Subramani, Suresh			Unique Requirements for Mono- and Polyubiquitination of the Peroxisomal Targeting Signal Co-receptor, Pex20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING FINGER DOMAIN; PROTEIN IMPORT; CONSERVED CYSTEINE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; RECEPTOR PEX5P; UBIQUITINATION; PEX7P; PEX12P; IDENTIFICATION	In Pichia pastoris, the peroxisomal targeting signal 2 (PTS2)-dependent peroxisomal matrix protein import pathway requires the receptor, Pex7, and its co-receptor Pex20. A conserved lysine (Lys(19)) near the N terminus of Pex20 is required for its polyubiquitination and proteasomal degradation, whereas a conserved cysteine (Cys(8)) is essential for its recycling. In this study, we found that Cys(8) is required for the DTT-sensitive mono- and diubiquitination of Pex20. We also show that the PTS2 cargo receptor, Pex7, is required for Pex20 polyubiquitination. Pex4, the E2 ubiquitin-conjugation enzyme, is required for monoubiquitination of Pex20. However, it is also necessary for polyubiquitination of Pex20, making its behavior distinct from the ubiquitination described for other PTS receptors. Unlike the roles of specific RING peroxins in Pex5 ubiquitination, we found that all the RING peroxins (Pex2, Pex10, and Pex12) are required as E3 ubiquitin ligases for Pex20 mono- and polyubiquitination. A model for Pex20 ubiquitination is proposed based on these observations. This is the first description of the complete ubiquitination pathway of Pex20, which provides a better understanding of the recycling and degradation of this PTS2 cargo co-receptor.	[Liu, Xueqian; Subramani, Suresh] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, Rm 3326,Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu	liu, xueqian/N-9544-2013		National Institutes of Health MERIT (Method to Extend Research in Time) Award [DK41737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041737, R56DK041737, R37DK041737] Funding Source: NIH RePORTER	National Institutes of Health MERIT (Method to Extend Research in Time) Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health MERIT (Method to Extend Research in Time) Award DK41737 (to S. S.).	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 2001, EUR J CELL BIOL, V80, P257, DOI 10.1078/0171-9335-00164; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; El Magraoui F, 2012, FEBS J, V279, P2060, DOI 10.1111/j.1742-4658.2012.08591.x; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Harper CC, 2002, J BIOL CHEM, V277, P16498, DOI 10.1074/jbc.M111728200; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; Honsho M, 2011, J BIOCHEM, V149, P203, DOI 10.1093/jb/mvq130; KALISH JE, 1995, MOL CELL BIOL, V15, P6406; Kalish JE, 1996, EMBO J, V15, P3275, DOI 10.1002/j.1460-2075.1996.tb00692.x; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Krazy H, 2006, BBA-MOL CELL RES, V1763, P6, DOI 10.1016/j.bbamcr.2005.11.002; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Liu XQ, 2012, CURR OPIN CELL BIOL, V24, P484, DOI 10.1016/j.ceb.2012.05.003; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Otzen M, 2005, J CELL SCI, V118, P3409, DOI 10.1242/jcs.02463; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Ro M, 2012, J CHILD NEUROL, V27, P1270, DOI 10.1177/0883073811435507; Schumann U, 2003, P NATL ACAD SCI USA, V100, P9626, DOI 10.1073/pnas.1633697100; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Williams C, 2012, EMBO J, V31, P391, DOI 10.1038/emboj.2011.411; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042; Zhang L, 2006, MOL BIOL CELL, V17, P690, DOI 10.1091/mbc.E05-08-0758	43	43	45	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7230	7240		10.1074/jbc.M112.424911	http://dx.doi.org/10.1074/jbc.M112.424911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23344950	Green Published, hybrid			2022-12-28	WOS:000316002400043
J	Fortier, AM; Asselin, E; Cadrin, M				Fortier, Anne-Marie; Asselin, Eric; Cadrin, Monique			Keratin 8 and 18 Loss in Epithelial Cancer Cells Increases Collective Cell Migration and Cisplatin Sensitivity through Claudin1 Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TIGHT JUNCTION PROTEIN; X-LINKED INHIBITOR; CARCINOMA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; MESENCHYMAL TRANSITION; AKT ISOFORMS; INDUCED APOPTOSIS; DOWN-REGULATION; ACTIVATION	Keratins 8 and 18 (K8/18) are simple epithelial cell-specific intermediate filament proteins. Keratins are essential for tissue integrity and are involved in intracellular signaling pathways that regulate cell response to injuries, cell growth, and death. K8/18 expression is maintained during tumorigenesis; hence, they are used as a diagnostic marker in tumor pathology. In recent years, studies have provided evidence that keratins should be considered not only as markers but also as regulators of cancer cell signaling. The loss of K8/18 expression during epithelial-mesenchymal transition (EMT) is associated with metastasis and chemoresistance. In the present study, we investigated whether K8/18 expression plays an active role in EMT. We show that K8/18 stable knockdown using shRNA increased collective migration and invasiveness of epithelial cancer cells without modulating EMT markers. K8/18-depleted cells showed PI3K/Akt/NF-kappa B hyperactivation and increased MMP2 and MMP9 expression. K8/18 deletion also increased cisplatin-induced apoptosis. Increased Fas receptor membrane targeting suggests that apoptosis is enhanced via the extrinsic pathway. Interestingly, we identified the tight junction protein claudin1 as a regulator of these processes. This is the first indication that modulation of K8/18 expression can influence the phenotype of epithelial cancer cells at a transcriptional level and supports the hypothesis that keratins play an active role in cancer progression.	[Fortier, Anne-Marie; Asselin, Eric; Cadrin, Monique] Univ Quebec Trois Rivieres, Mol Oncol & Endocrinol Res Grp, Dept Med Biol, Trois Rivieres, PQ G9A 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Asselin, E (corresponding author), Univ Quebec Trois Rivieres, Mol Oncol & Endocrinol Res Grp, Dept Med Biol, CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	eric.asselin@uqtr.ca; monique.cadrin@uqtr.ca		Fortier, Anne-Marie/0000-0002-0428-3066	Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a research grant from the Natural Sciences and Engineering Research Council of Canada (to M.C.).; Holds research grants from the Canadian Institute of Health Research and Natural Sciences and Engineering Research Council of Canada and is Chairholder of the Canada Research Chair in molecular gyneco-oncology. To whom correspondence may be addressed: Molecular Oncology and Endocrinology Research Group, Dept. of Medical Biology, University of Quebec at Trois-Rivieres, C.P. 500, Trois-Rivieres, Quebec G9A 5H7, Canada. Tel.: 819-376-5011; Fax: 819-376-5057; E-mail: eric.asselin@uqtr.ca.; Holds a research grant from the Natural Sciences and Engineering Research Council of Canada. To whom correspondence may be addressed: Molecular Oncology and Endocrinology Research Group, Dept. of Medical Biology, University of Quebec at Trois-Rivieres, C.P. 500, Trois-Rivieres, Quebec G9A 5H7, Canada. Tel.: 819-376-5011; Fax: 819-376-5057; E-mail: monique.cadrin@uqtr.ca.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Amantana A, 2004, MOL CANCER THER, V3, P699; Asselin E, 2001, CANCER RES, V61, P1862; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Beeman N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.14; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chaudhry P, 2012, MOL CELL BIOL, V32, P826, DOI 10.1128/MCB.06321-11; CHOU CF, 1993, J BIOL CHEM, V268, P4465; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fortier Anne-Marie, 2011, Biomol Concepts, V2, P1, DOI 10.1515/bmc.2011.003; Fortier AM, 2010, FEBS LETT, V584, P984, DOI 10.1016/j.febslet.2010.01.045; French AD, 2009, INT J MED SCI, V6, P93; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Gaggioli C, 2008, CELL ADHES MIGR, V2, P45, DOI 10.4161/cam.2.1.5705; Gagnon V, 2008, APOPTOSIS, V13, P259, DOI 10.1007/s10495-007-0165-6; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Gilbert S, 2004, MOL CELL BIOL, V24, P7072, DOI 10.1128/MCB.24.16.7072-7081.2004; Girouard J, 2013, GYNECOL ONCOL, V128, P335, DOI 10.1016/j.ygyno.2012.11.016; Gregory M, 2001, ENDOCRINOLOGY, V142, P854, DOI 10.1210/en.142.2.854; Han YP, 2001, J CELL SCI, V114, P131; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanaji N, 2011, ONCOL REP, V26, P763, DOI 10.3892/or.2011.1357; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Lin ML, 2010, MOL CARCINOGEN, V49, P783, DOI 10.1002/mc.20652; Long HA, 2006, J CELL SCI, V119, P5147, DOI 10.1242/jcs.03304; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Paccione RJ, 2008, MOL CANCER THER, V7, P2894, DOI 10.1158/1535-7163.MCT-08-0450; Park BK, 2001, CANCER RES, V61, P7647; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Schaller G, 1996, CLIN CANCER RES, V2, P1879; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Singh AB, 2010, J ONCOL, V2010, DOI 10.1155/2010/541957; Sjo A, 2010, J MEMBRANE BIOL, V236, P181, DOI 10.1007/s00232-010-9289-7; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sullivan BT, 2010, INT J GYNECOL CANCER, V20, P1474, DOI 10.1111/IGC.0b013e3181fc3a03; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Van Themsche C, 2007, J BIOL CHEM, V282, P4794, DOI 10.1074/jbc.M608497200; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang Y, 2008, CANCER LETT, V265, P188, DOI 10.1016/j.canlet.2008.02.015; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	81	137	148	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11555	11571		10.1074/jbc.M112.428920	http://dx.doi.org/10.1074/jbc.M112.428920			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449973	Green Published, hybrid			2022-12-28	WOS:000317915500061
J	Lowery, J; Szul, T; Styers, M; Holloway, Z; Oorschot, V; Klumperman, J; Sztul, E				Lowery, Jason; Szul, Tomasz; Styers, Melanie; Holloway, Zoe; Oorschot, Viola; Klumperman, Judith; Sztul, Elizabeth			The Sec7 Guanine Nucleotide Exchange Factor GBF1 Regulates Membrane Recruitment of BIG1 and BIG2 Guanine Nucleotide Exchange Factors to the Trans-Golgi Network (TGN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTORS; CLASS-II ARFS; BREFELDIN-A; ENDOPLASMIC-RETICULUM; RECYCLING ENDOSOMES; VESICULAR TRANSPORT; DISTINCT FUNCTIONS; PROTEIN-1 BIG1; LIVING CELLS; GGA PROTEINS	Three Sec7 guanine nucleotide exchange factors (GEFs) activate ADP-ribosylation factors (ARFs) to facilitate coating of transport vesicles within the secretory and endosomal pathways. GBF1 recruits COPI to pre-Golgi and Golgi compartments, whereas BIG1 and BIG2 recruit AP1 and GGA clathrin adaptors to the trans-Golgi network (TGN) and endosomes. Here, we report a functional cascade between these GEFs by showing that GBF1-activated ARFs (ARF4 and ARF5, but not ARF3) facilitate BIG1 and BIG2 recruitment to the TGN. We localize GBF1 ultrastructurally to the pre-Golgi, the Golgi, and also the TGN. Our findings suggest a model in which GBF1 localized within pre-Golgi and Golgi compartments mediates ARF activation to facilitate recruitment of COPI to membranes, whereas GBF1 localized at the TGN mediates ARF activation that leads to the recruitment of BIG1 and BIG2 to the TGN. Membrane-associated BIG1/2 then activates ARFs that recruit clathrin adaptors. In this cascade, an early acting GEF (GBF1) activates ARFs that mediate recruitment of late acting GEFs (BIG1/2) to coordinate coating events within the pre-Golgi/Golgi/TGN continuum. Such coordination may optimize the efficiency and/or selectivity of cargo trafficking through the compartments of the secretory pathway.	[Lowery, Jason; Szul, Tomasz; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Styers, Melanie] Birmingham Southern Coll, Dept Biol, Birmingham, AL 35254 USA; [Holloway, Zoe; Oorschot, Viola] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Klumperman, Judith] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	University of Alabama System; University of Alabama Birmingham; University of Oxford; Wellcome Centre for Human Genetics; Utrecht University; Utrecht University Medical Center	Sztul, E (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 668, Birmingham, AL 35233 USA.	esztul@uab.edu			National Science Foundation [NSF0744471]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Science Foundation Grant NSF0744471 (to E. S.).	Alvarez C, 2003, SYNTHESE, V134, P1; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Citterio C, 2006, P NATL ACAD SCI USA, V103, P2683, DOI 10.1073/pnas.0510571103; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Cobbold C, 2004, MOL MEMBR BIOL, V21, P59, DOI 10.1080/096870310001607350; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Francis MJ, 1999, J CELL SCI, V112, P1721; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Ghosh P, 2004, EUR J CELL BIOL, V83, P257, DOI 10.1078/0171-9335-00374; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Grzmil P, 2010, INT J DEV BIOL, V54, P1259, DOI 10.1387/ijdb.092959pg; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Holloway ZG, 2007, AM J PHYSIOL-CELL PH, V293, pC1753, DOI 10.1152/ajpcell.00253.2007; Houghton FJ, 2009, CELL, V138, P787, DOI 10.1016/j.cell.2009.05.048; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kondo Y, 2012, CELL STRUCT FUNCT, V37, P141, DOI 10.1247/csf.12015; Kuroda F, 2007, P NATL ACAD SCI USA, V104, P3201, DOI 10.1073/pnas.0611696104; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Li CP, 2011, EUR PHYS J-SPEC TOP, V193, P1, DOI 10.1140/epjst/e2011-01377-3; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lowery J, 2011, J BIOL CHEM, V286, P36898, DOI 10.1074/jbc.M111.230631; Lu L, 2005, METHOD ENZYMOL, V404, P432, DOI 10.1016/S0076-6879(05)04038-3; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Padilla PI, 2004, P NATL ACAD SCI USA, V101, P2752, DOI 10.1073/pnas.0307345101; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Reaves BJ, 1998, MOL MEMBR BIOL, V15, P133, DOI 10.3109/09687689809074524; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Richardson BC, 2012, DEV CELL, V22, P799, DOI 10.1016/j.devcel.2012.02.006; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; SARASTE J, 1991, J CELL SCI, V100, P415; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen XY, 2006, P NATL ACAD SCI USA, V103, P2635, DOI 10.1073/pnas.0510599103; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	71	53	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11532	11545		10.1074/jbc.M112.438481	http://dx.doi.org/10.1074/jbc.M112.438481			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23386609	Green Published, hybrid			2022-12-28	WOS:000317915500059
J	Sen, R; Lahudkar, S; Durairaj, G; Bhaumik, SR				Sen, Rwik; Lahudkar, Shweta; Durairaj, Geetha; Bhaumik, Sukesh R.			Functional Analysis of Bre1p, an E3 Ligase for Histone H2B Ubiquitylation, in Regulation of RNA Polymerase II Association with Active Genes and Transcription in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ELONGATION-FACTORS; H3 METHYLATION; PAF1 COMPLEX; DNA-DAMAGE; YEAST; UBIQUITINATION; PROTEIN; EXPRESSION; SAGA	H2B ubiquitylation is carried out by Bre1p, an E3 ligase, along with an E2 conjugase, Rad6p. H2B ubiquitylation has been previously implicated in promoting the association of RNA polymerase II with the coding sequence of the active GAL1 gene, and hence transcriptional elongation. Intriguingly, we find here that the association of RNA polymerase II with the active GAL1 coding sequence is not decreased in Delta bre1, although it is required for H2B ubiquitylation. In contrast, the loss of Rad6p significantly impairs the association of RNA polymerase II with GAL1. Likewise, the point mutation of lysine 123 (ubiquitylation site) to arginine of H2B (H2B-K123R) also lowers the association of RNA polymerase II with GAL1, consistent with the role of H2B ubiquitylation in promoting RNA polymerase II association. Surprisingly, unlike the Delta rad6 and H2B-K123R strains, complete deletion of BRE1 does not impair the association of RNA polymerase II with GAL1. However, deletion of the RING domain of Bre1p (that is essential for H2B ubiquitylation) impairs RNA polymerase II association with GAL1. These results imply that a non-RING domain of Bre1p counteracts the stimulatory role of the RING domain in regulating the association of RNA polymerase II with GAL1, and hence RNA polymerase II occupancy is not impaired in Delta bre1. Consistently, GAL1 transcription is impaired in the absence of the RING domain of Bre1p, but not in Delta bre1. Similar results are also obtained at other genes. Collectively, our results implicate both the stimulatory and repressive roles of Bre1p in regulation of RNA polymerase II association with active genes (and hence transcription) in vivo.	[Sen, Rwik; Lahudkar, Shweta; Durairaj, Geetha; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu		Sen, Rwik/0000-0003-2853-2378	National Institutes of Health [1R15GM088798-01]; American Heart Association (Greater Midwest Affiliate) [10GRNT4300059]; Mallinckrodt Foundation; Excellence in Academic Medicine awards of the Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Greater Midwest Affiliate)(American Heart Association); Mallinckrodt Foundation; Excellence in Academic Medicine awards of the Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01 (to S. R. B.), Grant-in-aid 10GRNT4300059 from the American Heart Association (Greater Midwest Affiliate), a Mallinckrodt Foundation grant, and Excellence in Academic Medicine awards of the Southern Illinois University School of Medicine.	Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costa PJ, 2000, GENETICS, V156, P535; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Game JC, 2009, DNA REPAIR, V8, P470, DOI 10.1016/j.dnarep.2009.01.007; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Malik S, 2009, J BIOL CHEM, V284, P35714, DOI 10.1074/jbc.M109.035709; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Muren E, 2001, YEAST, V18, P163, DOI 10.1002/1097-0061(20010130)18:2<163::AID-YEA659>3.0.CO;2-#; Mutiu AI, 2007, MOL GENET GENOMICS, V277, P491, DOI 10.1007/s00438-007-0212-6; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Shukla A, 2007, BIOCHEM BIOPH RES CO, V359, P214, DOI 10.1016/j.bbrc.2007.05.105; SIKORSKI RS, 1989, GENETICS, V122, P19; Song YH, 2010, J BIOL CHEM, V285, P2361, DOI 10.1074/jbc.M109.039255; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Trujillo KM, 2012, MOL CELL, V48, P734, DOI 10.1016/j.molcel.2012.09.019; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; Walter D, 2010, J CELL SCI, V123, P1931, DOI 10.1242/jcs.065938; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	56	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9619	9633		10.1074/jbc.M113.450403	http://dx.doi.org/10.1074/jbc.M113.450403			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417674	Green Published, hybrid			2022-12-28	WOS:000317114000006
J	Sigfridsson, KGV; Chernev, P; Leidel, N; Popovic-Bijelic, A; Graslund, A; Haumann, M				Sigfridsson, Kajsa G. V.; Chernev, Petko; Leidel, Nils; Popovic-Bijelic, Ana; Graslund, Astrid; Haumann, Michael			Rapid X-ray Photoreduction of Dimetal-Oxygen Cofactors in Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-FUNCTIONAL THEORY; PROTEIN-STRUCTURE DETERMINATION; BIOLOGICAL METAL CENTERS; TYROSYL RADICAL COFACTOR; FREE-ELECTRON LASERS; SITE H-CLUSTER; PHOTOSYSTEM-II; CHLAMYDIA-TRACHOMATIS; ACTIVE-SITE; CRYSTAL-STRUCTURE	Prototypic dinuclear metal cofactors with varying metallation constitute a class of O-2-activating catalysts in numerous enzymes such as ribonucleotide reductase. Reliable structures are required to unravel the reaction mechanisms. However, protein crystallography data may be compromised by x-ray photoreduction (XRP). We studied XPR of Fe(III) Fe(III) and Mn(III)-Fe(III) sites in the R2 subunit of Chlamydia trachomatis ribonucleotide reductase using x-ray absorption spectroscopy. Rapid and biphasic x-ray photoreduction kinetics at 20 and 80 K for both cofactor types suggested sequential formation of (III, II) and (II, II) species and similar redox potentials of iron and manganese sites. Comparing with typical x-ray doses in crystallography implies that (II, II) states are reached in < 1 s in such studies. First-sphere metal coordination and metal-metal distances differed after chemical reduction at room temperature and after XPR at cryogenic temperatures, as corroborated by model structures from density functional theory calculations. The inter-metal distances in the XPR-induced (II, II) states, however, are similar to R2 crystal structures. Therefore, crystal data of initially oxidized R2-type proteins mostly contain photoreduced (II, II) cofactors, which deviate from the native structures functional in O-2 activation, explaining observed variable metal ligation motifs. This situation may be remedied by novel femtosecond free electron-laser protein crystallography techniques.	[Popovic-Bijelic, Ana; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Sigfridsson, Kajsa G. V.; Chernev, Petko; Leidel, Nils; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany	Stockholm University; Free University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, FB Phys, Arnimallee 14, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013; Chernev, Petko/F-9964-2018; Popovic Bijelic, Ana/C-6314-2017; MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019	Chernev, Petko/0000-0002-2836-838X; Popovic Bijelic, Ana/0000-0003-3121-2391; Sigfridsson Clauss, Kajsa/0000-0002-7604-251X	Stiftelsen Bengt Lundqvist minne; Wenner-Gren foundation; Swedish Research Council; Heisenberg fellowship; Deutsche Forschungsgemeinschaft [Ha3265/3-1, Ha3265/6-1]	Stiftelsen Bengt Lundqvist minne; Wenner-Gren foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Heisenberg fellowship(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by fellowships from the "Stiftelsen Bengt Lundqvist minne" and the Wenner-Gren foundation. Present address: MAX IV Laboratory, Lund University, 22100 Lund, Sweden.; Supported by the Swedish Research Council.; Supported by a Heisenberg fellowship and Grants Ha3265/3-1 and Ha3265/6-1 from the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Freie Universitat Berlin, FB Physik, Arnimallee 14, 14195 Berlin, Germany. Fax: 49-30-8385-6299; E-mail: michael. haumann@fu-berlin.de.	Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Adrait A, 2002, BIOCHEMISTRY-US, V41, P6510, DOI 10.1021/bi012043d; Andersson CS, 2012, J AM CHEM SOC, V134, P123, DOI 10.1021/ja209678x; Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Baldwin J, 2003, BIOCHEMISTRY-US, V42, P13269, DOI 10.1021/bi035198p; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Bollinger JM, 2008, CURR OPIN STRUC BIOL, V18, P650, DOI 10.1016/j.sbi.2008.11.007; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Brignole EJ, 2012, BIOCHEM SOC T, V40, P523, DOI 10.1042/BST20120081; Burdi D, 1998, J AM CHEM SOC, V120, P12910, DOI 10.1021/ja9824270; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; CHEN S.-H., 2006, Nuclear Engineering and Technology, V38, P201; Chernev P, 2011, J BIOL CHEM, V286, P5368, DOI 10.1074/jbc.M110.202879; Cotelesage JJH, 2012, J INORG BIOCHEM, V115, P127, DOI 10.1016/j.jinorgbio.2012.06.019; Cotruvo JA, 2012, METALLOMICS, V4, P1020, DOI 10.1039/c2mt20142a; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Danford JJ, 2009, INORG CHEM, V48, P11352, DOI 10.1021/ic901890d; Dassama LMK, 2012, J AM CHEM SOC, V134, P2520, DOI 10.1021/ja211314p; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; de Serrano VS, 2010, ACTA CRYSTALLOGR D, V66, P770, DOI 10.1107/S0907444910014605; Dubois L, 2006, CHEM COMMUN, P4521, DOI 10.1039/b609072a; Fromme P, 2011, CURR OPIN STRUC BIOL, V21, P509, DOI 10.1016/j.sbi.2011.06.001; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; GONZALEZ A, 1994, ACTA CRYSTALLOGR D, V50, P874, DOI 10.1107/S0907444994006311; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Griese JJ, 2012, METALLOMICS, V4, P894, DOI 10.1039/c2mt20080e; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Han WG, 2006, J INORG BIOCHEM, V100, P771, DOI 10.1016/j.jinorgbio.2006.01.032; Han WG, 2010, INORG CHEM, V49, P7266, DOI 10.1021/ic902051t; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Hermes S, 2006, BIOCHEMISTRY-US, V45, P353, DOI 10.1021/bi0515725; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Hogbom M, 2011, METALLOMICS, V3, P110, DOI 10.1039/c0mt00095g; Hogbom M, 2010, J BIOL INORG CHEM, V15, P339, DOI 10.1007/s00775-009-0606-5; Holton JM, 2009, J SYNCHROTRON RADIAT, V16, P133, DOI 10.1107/S0909049509004361; Hough MA, 2008, J MOL BIOL, V378, P353, DOI 10.1016/j.jmb.2008.01.097; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Kim JH, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3187544; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Krebs C, 2007, BIOCHEMISTRY-US, V46, P10413, DOI 10.1021/bi701060g; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; Leidel N, 2012, J AM CHEM SOC, V134, P14142, DOI 10.1021/ja304970p; Leidel N, 2012, BBA-BIOENERGETICS, V1817, P430, DOI 10.1016/j.bbabio.2011.12.008; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; Lomoth R, 2002, EUR J INORG CHEM, P2965; Macedo S, 2009, J SYNCHROTRON RADIAT, V16, P191, DOI 10.1107/S0909049509003331; Magnuson A, 2006, J INORG BIOCHEM, V100, P1234, DOI 10.1016/j.jinorgbio.2006.02.001; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Mitic N, 2007, J AM CHEM SOC, V129, P9049, DOI 10.1021/ja070909i; Neese F., 2008, ORCA AB INITIO DFT S; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Petrie S, 2012, PHYS CHEM CHEM PHYS, V14, P11333, DOI 10.1039/c2cp41020f; Popovic-Bijelic A, 2009, BIOCHEMISTRY-US, V48, P6532, DOI 10.1021/bi900693s; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Purwar N, 2011, BIOCHEMISTRY-US, V50, P4491, DOI 10.1021/bi200130r; Que L, 2004, J BIOL INORG CHEM, V9, P684, DOI 10.1007/s00775-004-0574-8; Que L, 2002, ANGEW CHEM INT EDIT, V41, P1114; QUE L, 1991, SCIENCE, V253, P273, DOI 10.1126/science.1857963; Rasaiah JC, 2008, ANNU REV PHYS CHEM, V59, P713, DOI 10.1146/annurev.physchem.59.032607.093815; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Rehr JJ, 2006, RADIAT PHYS CHEM, V75, P1547, DOI 10.1016/j.radphyschem.2005.11.014; Riggs-Gelasco PJ, 1998, J AM CHEM SOC, V120, P849, DOI 10.1021/ja9718230; Roos K, 2011, J BIOL INORG CHEM, V16, P553, DOI 10.1007/s00775-011-0755-1; Roos K, 2009, BIOCHEMISTRY-US, V48, P1878, DOI 10.1021/bi801695d; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Schenk G, 2001, J BIOL CHEM, V276, P19084, DOI 10.1074/jbc.M009778200; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schlichting I, 2012, CURR OPIN STRUC BIOL, V22, P613, DOI 10.1016/j.sbi.2012.07.015; Seal P, 2008, J PHYS CHEM A, V112, P3409, DOI 10.1021/jp076654c; Shi WX, 2011, CURR OPIN CHEM BIOL, V15, P144, DOI 10.1016/j.cbpa.2010.11.004; Sinnecker S, 2004, J AM CHEM SOC, V126, P2613, DOI 10.1021/ja0390202; Sinnecker S, 2006, J PHYS CHEM A, V110, P2235, DOI 10.1021/jp056016z; SJOBERG BM, 1983, ADV INORG BIOCHEM, V5, P87; Sommerhalter M, 2005, INORG CHEM, V44, P770, DOI 10.1021/ic0485256; Stripp S, 2009, BIOCHEMISTRY-US, V48, P5042, DOI 10.1021/bi900010b; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1991, BIOCHEMISTRY-US, V30, P830, DOI 10.1021/bi00217a037; Visser H, 2001, J AM CHEM SOC, V123, P7031, DOI 10.1021/ja004306h; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; Voevodskaya N, 2005, BIOCHEM BIOPH RES CO, V330, P1213, DOI 10.1016/j.bbrc.2005.03.104; Voevodskaya N, 2007, BBA-PROTEINS PROTEOM, V1774, P1254, DOI 10.1016/j.bbapap.2007.07.001; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; Voevodskaya N, 2009, J BIOL CHEM, V284, P4555, DOI 10.1074/jbc.M807190200; Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h; Westerheide L, 2000, CURR OPIN CHEM BIOL, V4, P235, DOI 10.1016/S1367-5931(99)00081-2; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Wuerges J, 2004, P NATL ACAD SCI USA, V101, P8569, DOI 10.1073/pnas.0308514101; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yi J, 2010, BIOCHEMISTRY-US, V49, P5969, DOI 10.1021/bi100801g; Younker JM, 2008, J AM CHEM SOC, V130, P15022, DOI 10.1021/ja804365e; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zwart PH, 2003, ACTA CRYSTALLOGR D, V59, P2104, DOI 10.1107/S0907444903018596	115	28	28	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9648	9661		10.1074/jbc.M112.438796	http://dx.doi.org/10.1074/jbc.M112.438796			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23400774	hybrid, Green Published			2022-12-28	WOS:000317114000008
J	Takusagawa, F				Takusagawa, Fusao			Microsomal Prostaglandin E Synthase Type 2 (mPGES2) Is a Glutathione-dependent Heme Protein, and Dithiothreitol Dissociates the Bound Heme to Produce Active Prostaglandin E-2 Synthase in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOXANE SYNTHASE; IDENTIFICATION; CYCLOOXYGENASES; DEGRADATION; ENZYME	An x-ray study indicated that microsomal prostaglandin E synthase type 2 (mPGES2) is a heme-bound protein and catalyzes prostaglandin (PG) H-2 degradation, but not PGE(2) formation (Yamada, T., and Takusagawa, F. (2007) Biochemistry 46, 8414-8424). In response to the x-ray study, Watanabe et al. claimed that mPGES2 is a heme-free protein and that both the heme-free and heme-bound proteins have PGE(2) synthesis activity in the presence of dithiothreitol (Watanabe, K., Ito, S., and Yamamoto, S. (2008) Biochem. Biophys. Res. Commun. 367, 782-786). To resolve the contradictory results, the heme-binding scheme of mPGES2 was further characterized in vivo and in vitro by absorption and fluorescence spectroscopies. A substantial amount of heme-bound mPGES2 was detected in cell extracts. The heme content in mPGES2 was increased along with an increase in Fe3+ in the culture medium. Heme-free mPGES2 was converted to the heme-bound form by mixing it with pig liver extract, indicating that mPGES2 is capable of forming a complex with heme in mammalian cells. Heme binds to mPGES2 only in the presence of glutathione. The newly determined heme dissociation constant (2.9 nM) supports strongly that mPGES2 is a heme-bound protein in vivo. The bound heme was not dissociated by oxidation by H2O2 or reduction by glutathione or 2-mercaptoethanol. However, reduction by dithiothreitol (an artificial reducing compound) induced the bound heme to dissociate from mPGES2 and released heme-free mPGES2, which exhibited PGE(2) synthesis activity in vitro. Imidazole bound to mPGES2 by stacking on the bound heme and inhibited heme oxidation by H2O2 and reduction by dithiothreitol.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Takusagawa, F (corresponding author), Univ Kansas, Dept Mol Biosci, 3004 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	xraymain@ku.edu						CAPDEVILA JH, 1995, BIOCHEMISTRY-US, V34, P3325, DOI 10.1021/bi00010a023; Chaudhry U, 2010, EXP NEUROL, V223, P359, DOI 10.1016/j.expneurol.2009.07.027; CHLOPICKI S, 2004, EICOSANOIDS, P267; DICZFALUSY U, 1977, FEBS LETT, V84, P271, DOI 10.1016/0014-5793(77)80704-7; Gonzalez-Michaca L, 2004, AM J PHYSIOL-RENAL, V286, pF370, DOI 10.1152/ajprenal.00300.2003; Gryglewski RJ, 2008, PHARMACOL REP, V60, P3; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; KEETING PE, 1987, EXP EYE RES, V44, P261, DOI 10.1016/S0014-4835(87)80010-6; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Nicholls D. G., 2002, BIOENERGETICS, P96; OHASHI K, 1992, J BIOL CHEM, V267, P789; Rife CL, 2003, PROTEINS, V53, P777, DOI 10.1002/prot.10452; Seo T, 2009, VIRCHOWS ARCH, V454, P667, DOI 10.1007/s00428-009-0777-z; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Watanabe K, 1999, BBA-MOL CELL BIOL L, V1439, P406, DOI 10.1016/S1388-1981(99)00084-0; Watanabe K, 1997, BIOCHEM BIOPH RES CO, V235, P148, DOI 10.1006/bbrc.1997.6708; Watanabe K, 2003, BIOCHEM BIOPH RES CO, V306, P577, DOI 10.1016/S0006-291X(03)01025-8; Watanabe K, 2008, BIOCHEM BIOPH RES CO, V367, P782, DOI 10.1016/j.bbrc.2008.01.029; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22; Yamada T, 2005, J MOL BIOL, V348, P1163, DOI 10.1016/j.jmb.2005.03.035; Yamada T, 2007, BIOCHEMISTRY-US, V46, P8414, DOI 10.1021/bi700605m; Yu R, 2011, J PHARMACOL EXP THER, V339, P716, DOI 10.1124/jpet.111.185405	29	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10166	10175		10.1074/jbc.M112.418475	http://dx.doi.org/10.1074/jbc.M112.418475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426368	Green Published, hybrid			2022-12-28	WOS:000317114000057
J	Desai, S; Liu, ZX; Yao, J; Patel, N; Chen, JQ; Wu, Y; Ahn, EEY; Fodstad, O; Tan, M				Desai, Shruti; Liu, Zixing; Yao, Jun; Patel, Nishant; Chen, Jieqing; Wu, Yun; Ahn, Erin Eun-Young; Fodstad, Oystein; Tan, Ming			Heat Shock Factor 1 (HSF1) Controls Chemoresistance and Autophagy through Transcriptional Regulation of Autophagy-related Protein 7 (ATG7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; PROMOTES; ACTIVATION; INDUCTION; INHIBITION; RESISTANCE; SURVIVAL; STRESS; PHOSPHORYLATION; OLIGOMERIZATION	Heat shock factor 1 (HSF1), a master regulator of heat shock responses, plays an important role in tumorigenesis. In this study we demonstrated that HSF1 is required for chemotherapeutic agent-induced cytoprotective autophagy through transcriptional up-regulation of autophagy-related gene ATG7. Interestingly, this is independent of the HSF1 heat shock response function. Treatment of cancer cells with the FDA-approved chemotherapeutic agent carboplatin induced autophagy and growth inhibition, which were significantly increased upon knockdown of HSF1. Mechanistic studies revealed that HSF1 regulates autophagy by directly binding to ATG7 promoter and transcriptionally up-regulating its expression. Significantly, breast cancer patient sample study revealed that a higher ATG7 expression level is associated with poor patient survival. This novel finding was further confirmed by analysis of two independent patient databases, demonstrating a prognostic value of ATG7. Furthermore, a strong positive correlation was observed between levels of HSF1 and ATG7 in triple-negative breast cancer patient samples, thus validating our in vitro findings. This is the first study identifying a critical role for HSF1 in controlling cytoprotective autophagy through regulation of ATG7, which is distinct from the HSF1 function in the heat shock response. This is also the first study demonstrating a prognostic value of ATG7 in breast cancer patients. These findings strongly argue that combining chemotherapeutic agents with autophagy inhibition by repressing HSF1/ATG7 axis represents a promising strategy for future cancer treatment.	[Desai, Shruti; Liu, Zixing; Ahn, Erin Eun-Young; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Yao, Jun] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Patel, Nishant] Northwest Florida State Coll, Dept Math, Niceville, FL 32578 USA; [Chen, Jieqing; Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fodstad, Oystein] Univ Oslo, Norwegian Radium Hosp, Dept Tumor Biol, N-0310 Oslo, Norway; [Tan, Ming] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36604 USA	University of South Alabama; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Oslo; University of South Alabama	Tan, M (corresponding author), Univ S Alabama, Mitchell Canc Inst, 1660 Spring Hill Ave, Mobile, AL 36604 USA.	mtan@usouthal.edu	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898; Desai, Shruti/0000-0002-5234-5890; Ahn, Eun-Young Erin/0000-0001-8795-7734	National Institutes of Health Grant [R01CA149646]; Radium-hospitalets Legater Award [334003]; Vincent F. Kilborn, Jr. Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA149646] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radium-hospitalets Legater Award; Vincent F. Kilborn, Jr. Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA149646 (to M. T.). This work was also supported by Radium-hospitalets Legater Award Project 334003 (to M. T. and O. F.) and by The Vincent F. Kilborn, Jr. Cancer Research Foundation (to M. T.).	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Cen H, 2004, WORLD J GASTROENTERO, V10, P3122; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Desai S, 2010, MOL CANCER RES, V8, P907, DOI 10.1158/1541-7786.MCR-10-0131; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Lopez G, 2011, CANCER RES, V71, P185, DOI 10.1158/0008-5472.CAN-10-2799; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Paglin S, 2001, CANCER RES, V61, P439; Perez EA, 2004, ONCOLOGIST, V9, P518, DOI 10.1634/theoncologist.9-5-518; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shousha S, 2008, HISTOPATHOLOGY, V53, P346, DOI 10.1111/j.1365-2559.2008.03075.x; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Uebersax J. S., 2006, TETMAT USER GUIDE V; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	46	93	101	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9165	9176		10.1074/jbc.M112.422071	http://dx.doi.org/10.1074/jbc.M112.422071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386620	hybrid, Green Published			2022-12-28	WOS:000316862200036
J	Greer, YE; Fields, AP; Brown, AMC; Rubin, JS				Greer, Yoshimi Endo; Fields, Alan P.; Brown, Anthony M. C.; Rubin, Jeffrey S.			Atypical Protein Kinase C iota Is Required for Wnt3a-dependent Neurite Outgrowth and Binds to Phosphorylated Dishevelled 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON GUIDANCE; NEURONAL POLARITY; EWINGS-SARCOMA; PKC-ZETA; WNT; CELLS; RYK; CENTROSOME; PATHWAY; GROWTH	Previously we reported that Wnt3a-dependent neurite outgrowth in Ewing sarcoma family tumor cell lines was mediated by Frizzled3, Dishevelled (Dvl), and c-Jun N-terminal kinase (Endo, Y., Beauchamp, E., Woods, D., Taylor, W. G., Toretsky, J. A., Uren, A., and Rubin, J. S. (2008) Mol. Cell. Biol. 28, 2368-2379). Subsequently, we observed that Dvl2/3 phosphorylation correlated with neurite outgrowth and that casein kinase 1 delta, one of the enzymes that mediate Wnt3a-dependent Dvl phosphorylation, was required for neurite extension (Greer, Y. E., and Rubin, J. S. (2011) J. Cell Biol. 192, 993-1004). However, the functional relevance of Dvl phosphorylation in neurite outgrowth was not established. Dvl1 has been shown by others to be important for axon specification in hippocampal neurons via an interaction with atypical PKC zeta, but the role of Dvl phosphorylation was not evaluated. Here we report that Ewing sarcoma family tumor cells express PKC iota but not PKC zeta. Wnt3a stimulated PKC iota activation and caused a punctate distribution of pPKC iota in the neurites and cytoplasm, with a particularly intense signal at the centrosome. Knockdown of PKC iota expression with siRNA reagents blocked neurite formation in response to Wnt3a. Aurothiomalate, a specific inhibitor of PKC iota/Par6 binding, also suppressed neurite extension. Wnt3a enhanced the co-immunoprecipitation of endogenous PKC iota and Dvl2. Although FLAG-tagged wild-type Dvl2 immunoprecipitated with PKC iota, a phosphorylation-deficient Dvl2 derivative did not. This derivative also was unable to rescue neurite outgrowth when endogenous Dvl2/3 was suppressed by siRNA (Gonzalez-Sancho, J. M., Greer, Y. E., Abrahams, C. L., Takigawa, Y., Baljinnyam, B., Lee, K. H., Lee, K. S., Rubin, J. S., and Brown, A. M. (2013) J. Biol. Chem. 288, 9428-9437). Taken together, these results suggest that site-specific Dvl2 phosphorylation is required for Dvl2 association with PKC iota. This interaction is likely to be one of the mechanisms essential for Wnt3a-dependent neurite outgrowth.	[Greer, Yoshimi Endo; Rubin, Jeffrey S.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Cornell University	Rubin, JS (corresponding author), NCI, Bldg 37,Rm 2042,37 Convent Dr,MSC 4256, Bethesda, MD 20892 USA.	rubinj@mail.nih.gov	Greer, Yoshimi/K-2155-2019		National Institutes of Health [R01 CA123238, R01 CA081436-15]; Intramural Research Program of the National Institutes of Health; National Cancer Institute; Florida Biomedical Research Program [KG05-339710-03]; NATIONAL CANCER INSTITUTE [ZIABC011224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA123238 (to A. M. C. B.) and R01 CA081436-15 (to A. P. F.). This work was also supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Florida Biomedical Research Program Grant KG05-339710-03 (to A. P. F.).	Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; CAVAZZANA AO, 1987, AM J PATHOL, V127, P507; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x; Frederick MJ, 2011, AM J PATHOL, V178, P548, DOI 10.1016/j.ajpath.2010.10.044; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Higginbotham H, 2006, MOL CELL NEUROSCI, V32, P118, DOI 10.1016/j.mcn.2006.03.003; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; LIPINSKI M, 1987, CANCER RES, V47, P183; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; NOGUERA R, 1992, LAB INVEST, V66, P143; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wang YS, 2002, J NEUROSCI, V22, P8563; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Yanfeng WA, 2011, DEV BIOL, V360, P132, DOI 10.1016/j.ydbio.2011.09.017; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	43	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9438	9446		10.1074/jbc.M112.448282	http://dx.doi.org/10.1074/jbc.M112.448282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396968	Green Published, hybrid			2022-12-28	WOS:000316862200060
J	Lobo, GP; Amengual, J; Baus, D; Shivdasani, RA; Taylor, D; von Lintig, J				Lobo, Glenn P.; Amengual, Jaume; Baus, Diane; Shivdasani, Ramesh A.; Taylor, Derek; von Lintig, Johannes			Genetics and Diet Regulate Vitamin A Production via the Homeobox Transcription Factor ISX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CAROTENE 15,15'-MONOOXYGENASE; RETINOIC ACID; CELLULAR UPTAKE; DOUBLE-TRACER; SR-BI; METABOLISM; CONVERSION; EXPRESSION; TRANSPORT; LOCALIZATION	Low dietary intake of beta-carotene is associated with chronic disease and vitamin A deficiency. beta-Carotene is converted to vitamin A in the intestine by the enzyme beta-carotene-15,15'-monoxygenase (BCMO1) to support vision, reproduction, immune function, and cell differentiation. Considerable variability for this key step in vitamin A metabolism, as reported in the human population, could be related to genetics and individual vitamin A status, but it is unclear how these factors influence beta-carotene metabolism and vitamin A homeostasis. Here we show that the intestine-specific transcription factor ISX binds to the Bcmo1 promoter. Moreover, upon induction by the beta-carotene derivative retinoic acid, this ISX binding decreased expression of a luciferase reporter gene in human colonic CaCo-2 cells indicating that ISX acts as a transcriptional repressor of BCMO1 expression. Mice deficient for this transcription factor displayed increased intestinal BCMO1 expression and produced significantly higher amounts of vitamin A from supplemental beta-carotene. The ISX binding site in the human BCMO1 promoter contains a common single nucleotide polymorphism that is associated with decreased conversion rates and increased fasting blood levels of beta-carotene. Thus, our study establishes ISX as a critical regulator of vitamin A production and provides a mechanistic explanation for how both genetics and diet can affect this process.	[Lobo, Glenn P.; Amengual, Jaume; Baus, Diane; Taylor, Derek; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Case Western Reserve University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W341, 10900 Euclid Ave, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu	Lobo, Glenn P./AAI-9736-2020	von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health [EY019641, EY020551]; NATIONAL EYE INSTITUTE [R01EY019641, R01EY020551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019641 and EY020551.	Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Bachmann H, 2002, J NUTR, V132, P3616, DOI 10.1093/jn/132.12.3616; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Borel P, 1998, J LIPID RES, V39, P2250; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Grune T, 2010, J NUTR, V140, p2268S, DOI 10.3945/jn.109.119024; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hickenbottom SJ, 2002, AM J CLIN NUTR, V75, P900, DOI 10.1093/ajcn/75.5.900; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756; Lietz G, 2010, ARCH BIOCHEM BIOPHYS, V502, P8, DOI 10.1016/j.abb.2010.06.032; Lin YM, 2000, AM J CLIN NUTR, V71, P1545; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Lobo GP, 2008, HUM MOL GENET, V17, P2877, DOI 10.1093/hmg/ddn185; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Nassif NT, 2004, ONCOGENE, V23, P617, DOI 10.1038/sj.onc.1207059; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Reboul E, 2011, PROG LIPID RES, V50, P388, DOI 10.1016/j.plipres.2011.07.001; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Seino Y, 2008, J BIOL CHEM, V283, P4905, DOI 10.1074/jbc.M707928200; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; von Lintig J, 2012, J BIOL CHEM, V287, P1627, DOI 10.1074/jbc.R111.303990; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; VONLINTIG J, 1994, J BACTERIOL, V176, P495, DOI 10.1128/JB.176.2.495-503.1994; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521	34	81	83	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9017	9027		10.1074/jbc.M112.444240	http://dx.doi.org/10.1074/jbc.M112.444240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393141	Green Published, hybrid			2022-12-28	WOS:000316862200021
J	Poteet, E; Choudhury, GR; Winters, A; Li, WJ; Ryou, MG; Liu, R; Tang, L; Ghorpade, A; Wen, Y; Yuan, F; Keir, ST; Yan, H; Bigner, DD; Simpkins, JW; Yang, SH				Poteet, Ethan; Choudhury, Gourav Roy; Winters, Ali; Li, Wenjun; Ryou, Myoung-Gwi; Liu, Ran; Tang, Lin; Ghorpade, Anuja; Wen, Yi; Yuan, Fang; Keir, Stephen T.; Yan, Hai; Bigner, Darell D.; Simpkins, James W.; Yang, Shao-Hua			Reversing the Warburg Effect as a Treatment for Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; CANCER CELLS; GROWTH; AMPK; PHOSPHORYLATION; METABOLISM; ACTIVATION; MULTIFORME; TEMOZOLOMIDE; SURVIVAL	Glioblastoma multiforme (GBM), like most cancers, possesses a unique bioenergetic state of aerobic glycolysis known as the Warburg effect. Here, we documented that methylene blue (MB) reverses the Warburg effect evidenced by the increasing of oxygen consumption and reduction of lactate production in GBM cell lines. MB decreases GBM cell proliferation and halts the cell cycle in S phase. Through activation of AMP-activated protein kinase, MB inactivates downstream acetyl-CoA carboxylase and decreases cyclin expression. Structure-activity relationship analysis demonstrated that toluidine blue O, an MB derivative with similar bioenergetic actions, exerts similar action in GBM cell proliferation. In contrast, two other MB derivatives, 2-chlorophenothiazine and promethazine, exert no effect on cellular bioenergetics and do not inhibit GBM cell proliferation. MB inhibits cell proliferation in both temozolomide-sensitive and -insensitive GBM cell lines. In a human GBM xenograft model, a single daily dosage of MB does not activate AMP-activated protein kinase signaling, and no tumor regression was observed. In summary, the current study provides the first in vitro proof of concept that reversal of Warburg effect might be a novel therapy for GBM.	[Poteet, Ethan; Choudhury, Gourav Roy; Winters, Ali; Li, Wenjun; Ryou, Myoung-Gwi; Liu, Ran; Wen, Yi; Simpkins, James W.; Yang, Shao-Hua] Univ N Texas, Dept Pharmacol & Neurosci, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Tang, Lin; Ghorpade, Anuja] Univ N Texas, Dept Cell Biol & Anat, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Yuan, Fang; Yang, Shao-Hua] Capital Med Univ, Beijing Neurosurg Inst, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Keir, Stephen T.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Beijing Neurosurgical Institute; Capital Medical University; Duke University	Yang, SH (corresponding author), Univ N Texas, Dept Pharmacol & Neurosci, Hlth Sci Ctr, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu	Choudhury, Gourav Roy/L-7707-2016	Choudhury, Gourav Roy/0000-0001-8664-7638; Liu, Ran/0000-0002-3882-0616	National Institutes of Health [R01NS054687, R01NS054651, T32 AG020494]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054651, R01NS054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054687 and R01NS054651 (to S. Y.). The University of North Texas Health Science Center has filed a Patent Cooperation Treaty patent application titled "Compounds that enable alternative mitochondrial electron transfer."; A predoctoral trainee supported by National Institute of Health Grant T32 AG020494.	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Callaway NL, 2002, NEUROSCI LETT, V332, P83, DOI 10.1016/S0304-3940(02)00827-3; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; FRIEDMAN HS, 1988, CANCER RES, V48, P4189; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; McCarty MF, 2010, ALTERN MED REV, V15, P264; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Nieder C, 2006, REV RECENT CLIN TRIA, V1, P43, DOI 10.2174/157488706775246148; Oertel Joachim, 2005, Neurosurg Focus, V18, pe12; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Pepponi R, 2003, J PHARMACOL EXP THER, V304, P661, DOI 10.1124/jpet.102.043950; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarica EB, 2010, J NEUROSURG SCI, V54, P7; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Sontag EM, 2012, J NEUROSCI, V32, P11109, DOI 10.1523/JNEUROSCI.0895-12.2012; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEINSTEIN J, 1964, J BIOL CHEM, V239, P3031; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo_2011_06_482; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Youn SH, 2012, BIOL PHARM BULL, V35, P105, DOI 10.1248/bpb.35.105; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63	50	65	65	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9153	9164		10.1074/jbc.M112.440354	http://dx.doi.org/10.1074/jbc.M112.440354			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408428	Green Published, hybrid			2022-12-28	WOS:000316862200035
J	Clemente, P; Peralta, S; Cruz-Bermudez, A; Echevarria, L; Fontanesi, F; Barrientos, A; Fernandez-Moreno, MA; Garesse, R				Clemente, Paula; Peralta, Susana; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fontanesi, Flavia; Barrientos, Antoni; Fernandez-Moreno, Miguel A.; Garesse, Rafael			hCOA3 Stabilizes Cytochrome c Oxidase 1 (COX1) and Promotes Cytochrome c Oxidase Assembly in Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS; PROTEIN; DEFECTS; SUBUNIT; TRANSLATION; COMPLEX; EXPRESSION; C12ORF62; MSS51P; LRPPRC	Cytochrome c oxidase (COX) or complex IV of the mitochondrial respiratory chain plays a fundamental role in energy production of aerobic cells. In humans, COX deficiency is the most frequent cause of mitochondrial encephalomyopathies. Human COX is composed of 13 subunits of dual genetic origin, whose assembly requires an increasing number of nuclear-encoded accessory proteins known as assembly factors. Here, we have identified and characterized human CCDC56, an 11.7-kDa mitochondrial transmembrane protein, as a new factor essential for COX biogenesis. CCDC56 shares sequence similarity with the yeast COX assembly factor Coa3 and was termed hCOA3. hCOA3-silenced cells display a severe COX functional alteration owing to a decreased stability of newly synthesized COX1 and an impairment in the holoenzyme assembly process. We show that hCOA3 physically interacts with both the mitochondrial translation machinery and COX structural subunits. We conclude that hCOA3 stabilizes COX1 co-translationally and promotes its assembly with COX partner subunits. Finally, our results identify hCOA3 as a new candidate when screening for genes responsible for mitochondrial diseases associated with COX deficiency.	[Clemente, Paula; Peralta, Susana; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fernandez-Moreno, Miguel A.; Garesse, Rafael] Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols, UAM Consejo Super Invest Cient, Madrid 28029, Spain; [Clemente, Paula; Peralta, Susana; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fernandez-Moreno, Miguel A.; Garesse, Rafael] Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain; [Clemente, Paula; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fernandez-Moreno, Miguel A.; Garesse, Rafael] Hosp 12 Octubre I 12, Inst Invest Sanitaria, Madrid 28029, Spain; [Fontanesi, Flavia; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem, Miami, FL 33136 USA; [Fernandez-Moreno, Miguel A.; Garesse, Rafael] Comunidad Madrid, MITOLAB Consortium BMD 2402 P2010, Madrid 28029, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; University of Miami; University of Miami	Garesse, R (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Lab B19, C Arzobispo Morcillo 4, E-28029 Madrid, Spain.	rafael.garesse@uam.es	Clemente, Paula/AAA-5768-2021; Garesse, Rafael/F-3836-2012; Fernandez-Moreno, Miguel Angel/K-4425-2017; Bermúdez, Alberto Cruz/AAE-1341-2021	Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Bermúdez, Alberto Cruz/0000-0001-5136-7011; Garesse, Rafael/0000-0002-0338-2281; Echevarria, Lucia/0000-0001-9307-6992; Clemente, Paula/0000-0002-6885-3750; Fontanesi, Flavia/0000-0003-0509-3835	Instituto de Salud Carlos III [PI 10/0703]; Comunidad Autonoma de Madrid [S2010/BMD-2402]; Muscular Dystrophy Association [158547]; National Institutes of Health [GM071775A]; Ministerio de Ciencia e Innovacion grant (Spain); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion grant (Spain); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Instituto de Salud Carlos III Grant PI 10/0703 (to R. G.), Comunidad Autonoma de Madrid Grant S2010/BMD-2402 (to R. G.), Muscular Dystrophy Association Grants 158547 (to F. F). and 158547 (to A. B.), and National Institutes of Health Grant GM071775A (to A. B.).; Supported by Ministerio de Ciencia e Innovacion grant (Spain).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bratic A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002324; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016; MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Peralta S, 2012, J BIOL CHEM, V287, P24174, DOI 10.1074/jbc.M112.343764; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201	45	36	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8321	8331		10.1074/jbc.M112.422220	http://dx.doi.org/10.1074/jbc.M112.422220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362268	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000316564500032
J	Crona, M; Avesson, L; Sahlin, M; Lundin, D; Hinas, A; Klose, R; Soderbom, F; Sjoberg, BM				Crona, Mikael; Avesson, Lotta; Sahlin, Margareta; Lundin, Daniel; Hinas, Andrea; Klose, Ralph; Soderbom, Fredrik; Sjoberg, Britt-Marie			A Rare Combination of Ribonucleotide Reductases in the Social Amoeba Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ALLOSTERIC REGULATION; PSEUDOMONAS-AERUGINOSA; DIPHOSPHATE REDUCTASE; GENE-EXPRESSION; DNA; REVEALS; SUBUNIT; GENOME; GROWTH	Ribonucleotide reductases (RNRs) catalyze the only pathway for de novo synthesis of deoxyribonucleotides needed for DNA replication and repair. The vast majority of eukaryotes encodes only a class I RNR, but interestingly some eukaryotes, including the social amoeba Dictyostelium discoideum, encode both a class I and a class II RNR. The amino acid sequence of the D. discoideum class I RNR is similar to other eukaryotic RNRs, whereas that of its class IIRNRis most similar to the monomeric class II RNRs found in Lactobacillus spp. and a few other bacteria. Here we report the first study of RNRs in a eukaryotic organism that encodes class I and class II RNRs. Both classes of RNR genes were expressed in D. discoideum cells, although the class I transcripts were more abundant and strongly enriched during mid-development compared with the class II transcript. The quaternary structure, allosteric regulation, and properties of the diiron-oxo/radical cofactor of D. discoideum class I RNR are similar to those of the mammalian RNRs. Inhibition of D. discoideum class I RNR by hydroxyurea resulted in a 90% reduction in spore formation and decreased the germination viability of the surviving spores by 75%. Class II RNR could not compensate for class I inhibition during development, and an excess of vitamin B-12 coenzyme, which is essential for class II activity, did not improve spore formation. We suggest that class I is the principal RNR during D. discoideum development and growth and is important for spore formation, possibly by providing dNTPs for mitochondrial replication.	[Crona, Mikael; Sahlin, Margareta; Klose, Ralph; Sjoberg, Britt-Marie] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden; [Sahlin, Margareta; Lundin, Daniel; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Avesson, Lotta; Hinas, Andrea; Soderbom, Fredrik] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala Biomed Ctr, SE-75124 Uppsala, Sweden	Stockholm University; Stockholm University; Swedish University of Agricultural Sciences	Sjoberg, BM (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16, SE-10691 Stockholm, Sweden.	britt-marie.sjoberg@dbb.su.se		Sjoberg, Britt-Marie/0000-0001-5953-3360; Avesson, Lotta/0000-0002-5526-6768; Lundin, Daniel/0000-0002-8779-6464; Crona, Mikael/0000-0002-6420-6097	Swedish Research Council; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; European Community [EC005120]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Community(European Commission)	This work was supported by the Swedish Research Council (to B.M.S. and F.S.), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (the Swedish Research Council Formas) (to F.S.), and the European Community (Function of Small RNAs across Kingdoms (FOSRAK) Grant EC005120) (to F.S.).	ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Birgander PL, 2005, J BIOL CHEM, V280, P14997, DOI 10.1074/jbc.M500565200; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Chida J, 2004, J CELL SCI, V117, P3141, DOI 10.1242/jcs.01140; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Domkin V, 2002, J BIOL CHEM, V277, P18574, DOI 10.1074/jbc.M201553200; DURSTON AJ, 1978, EXP CELL RES, V115, P454, DOI 10.1016/0014-4827(78)90308-7; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Gaudet P, 2011, NUCLEIC ACIDS RES, V39, pD620, DOI 10.1093/nar/gkq1103; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kreppel L, 2004, NUCLEIC ACIDS RES, V32, pD332, DOI 10.1093/nar/gkh138; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; LARSSON A, 1966, J BIOL CHEM, V241, P2533; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; MATSUYAMA SI, 1995, DEV BIOL, V172, P182, DOI 10.1006/dbio.1995.0014; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Paps J, 2013, PROTIST, V164, P2, DOI 10.1016/j.protis.2012.09.002; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; SAHLIN M, 1986, J MAGN RESON, V67, P135, DOI 10.1016/0022-2364(86)90417-8; SANDONA D, 1995, J BIOL CHEM, V270, P5587, DOI 10.1074/jbc.270.10.5587; Sauge-Merle S, 1999, EUR J BIOCHEM, V266, P62, DOI 10.1046/j.1432-1327.1999.00814.x; SHAULSKY G, 1995, P NATL ACAD SCI USA, V92, P5660, DOI 10.1073/pnas.92.12.5660; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Srinivasan S, 2000, TRENDS CELL BIOL, V10, P215, DOI 10.1016/S0962-8924(00)01758-X; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; Thelander L, 1978, Methods Enzymol, V51, P227; Torrents E, 2006, J BIOL CHEM, V281, P5604, DOI 10.1074/jbc.M512962200; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Tsang A, 1996, BBA-GENE STRUCT EXPR, V1309, P100, DOI 10.1016/S0167-4781(96)00109-1; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288; ZADAHAMES IM, 1978, DEV BIOL, V63, P307, DOI 10.1016/0012-1606(78)90136-7; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746; ZIMMERMAN W, 1993, DEV BIOL, V160, P178, DOI 10.1006/dbio.1993.1296	58	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8198	8208		10.1074/jbc.M112.442434	http://dx.doi.org/10.1074/jbc.M112.442434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23372162	hybrid, Green Published			2022-12-28	WOS:000316564500020
J	Fillion, D; Cabana, J; Guillemette, G; Leduc, R; Lavigne, P; Escher, E				Fillion, Dany; Cabana, Jerome; Guillemette, Gaetan; Leduc, Richard; Lavigne, Pierre; Escher, Emanuel			Structure of the Human Angiotensin II Type 1 (AT1) Receptor Bound to Angiotensin II from Multiple Chemoselective Photoprobe Contacts Reveals a Unique Peptide Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD TRANSMEMBRANE DOMAIN; CONTAINING AMINO-ACIDS; AT(1) RECEPTOR; CRYSTAL-STRUCTURE; LIGAND-BINDING; 4-CARBOXYBENZOPHENONE-SENSITIZED PHOTOOXIDATION; EXTRACELLULAR DOMAINS; COVALENT ATTACHMENT; OPIOID RECEPTOR	Breakthroughs in G protein-coupled receptor structure determination based on crystallography have been mainly obtained from receptors occupied in their transmembrane domain core by low molecular weight ligands, and we have only recently begun to elucidate how the extracellular surface of G protein-coupled receptors (GPCRs) allows for the binding of larger peptide molecules. In the present study, we used a unique chemoselective photoaffinity labeling strategy, the methionine proximity assay, to directly identify at physiological conditions a total of 38 discrete ligand/receptor contact residues that form the extracellular peptide-binding site of an activated GPCR, the angiotensin II type 1 receptor. This experimental data set was used in homology modeling to guide the positioning of the angiotensin II (AngII) peptide within several GPCR crystal structure templates. We found that the CXC chemokine receptor type 4 accommodated the results better than the other templates evaluated; ligand/receptor contact residues were spatially grouped into defined interaction clusters with AngII. In the resulting receptor structure, a beta-hairpin fold in extracellular loop 2 in conjunction with two extracellular disulfide bridges appeared to open and shape the entrance of the ligand-binding site. The bound AngII adopted a somewhat vertical binding mode, allowing concomitant contacts across the extracellular surface and deep within the transmembrane domain core of the receptor. We propose that such a dualistic nature of GPCR interaction could be well suited for diffusible linear peptide ligands and a common feature of other peptidergic class A GPCRs.	[Fillion, Dany; Cabana, Jerome; Guillemette, Gaetan; Leduc, Richard; Lavigne, Pierre; Escher, Emanuel] Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Escher, E (corresponding author), Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Emanuel.Escher@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research [MOP-69019, MOP-13193]; Quebec Chapter of the Heart and Stroke Foundation of Canada [G-09-ES-3595]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Chapter of the Heart and Stroke Foundation of Canada	This work was supported in part by Canadian Institutes of Health Research Grants MOP-69019 and MOP-13193 as well as Quebec Chapter of the Heart and Stroke Foundation of Canada Grant G-09-ES-3595 (to E.E.).	Arsenault J, 2010, BIOCHEM PHARMACOL, V80, P990, DOI 10.1016/j.bcp.2010.06.004; Baker M, 2010, NAT METHODS, V7, P429, DOI 10.1038/nmeth0610-429; BOBROWSKI K, 1992, J AM CHEM SOC, V114, P10279, DOI 10.1021/ja00052a025; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Clement M, 2006, J RECEPT SIG TRANSD, V26, P417, DOI 10.1080/10799890600923195; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; Correa SAA, 2002, CAN J PHYSIOL PHARM, V80, P426, DOI 10.1139/y02-046; Correa SAA, 2002, REGUL PEPTIDES, V106, P33, DOI 10.1016/S0167-0115(02)00033-2; Costa-Neto CM, 2000, BRIT J PHARMACOL, V130, P1263, DOI 10.1038/sj.bjp.0703430; Costa-Neto CM, 2002, CAN J PHYSIOL PHARM, V80, P413, DOI 10.1139/y02-058; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Deseke E, 1998, EUR J ORG CHEM, V1998, P243, DOI 10.1002/(SICI)1099-0690(199802)1998:2<243::AID-EJOC243>3.0.CO;2-I; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Fillion D, 2010, J MED CHEM, V53, P2063, DOI 10.1021/jm9015747; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; GROBLEWSKI T, 1995, BIOCHEM BIOPH RES CO, V209, P153, DOI 10.1006/bbrc.1995.1483; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; Kaiser R, 1999, ANAL BIOCHEM, V266, P1, DOI 10.1006/abio.1998.2945; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MARCINIAK B, 1993, J PHYS CHEM-US, V97, P11937, DOI 10.1021/j100148a015; MARCINIAK B, 1995, J PHYS CHEM-US, V99, P13560, DOI 10.1021/j100036a037; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; OHYAMA K, 1995, REGUL PEPTIDES, V57, P141, DOI 10.1016/0167-0115(95)00030-F; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perlman S, 1997, MOL PHARMACOL, V51, P301, DOI 10.1124/mol.51.2.301; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rihakova L, 2002, J RECEPT SIGNAL TR R, V22, P297, DOI 10.1081/RRS-120014603; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Sachon E, 2002, J BIOL CHEM, V277, P50409, DOI 10.1074/jbc.M207242200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Takezako T, 2004, J BIOL CHEM, V279, P15248, DOI 10.1074/jbc.M312728200; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Tzakos AG, 2003, EUR J BIOCHEM, V270, P849, DOI 10.1046/j.1432-1033.2003.03441.x; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weber PJA, 1997, J PEPT RES, V49, P375; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; Yan LP, 2010, J BIOL CHEM, V285, P2227, DOI 10.1074/jbc.M109.077180; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zuscik MJ, 1998, J BIOL CHEM, V273, P3401, DOI 10.1074/jbc.273.6.3401	69	35	35	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8187	8197		10.1074/jbc.M112.442053	http://dx.doi.org/10.1074/jbc.M112.442053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386604	Green Published, hybrid			2022-12-28	WOS:000316564500019
J	Gao, N; Huang, J; He, WQ; Zhu, MS; Kamm, KE; Stull, JT				Gao, Ning; Huang, Jian; He, Weiqi; Zhu, Minsheng; Kamm, Kristine E.; Stull, James T.			Signaling through Myosin Light Chain Kinase in Smooth Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; CA2+ SENSITIZATION; OKADAIC ACID; CALYCULIN-A; RHO-KINASE; PHOSPHORYLATION; CONTRACTION; ACTIVATION; CALCIUM; BINDING	Ca2+/calmodulin-dependent myosin light chain kinase (MLCK) phosphorylates smooth muscle myosin regulatory light chain (RLC) to initiate contraction. We used a tamoxifen-activated, smooth muscle-specific inactivation of MLCK expression in adult mice to determine whether MLCK was differentially limiting in distinct smooth muscles. A 50% decrease in MLCK in urinary bladder smooth muscle had no effect on RLC phosphorylation or on contractile responses, whereas an 80% decrease resulted in only a 20% decrease in RLC phosphorylation and contractile responses to the muscarinic agonist carbachol. Phosphorylation of the myosin light chain phosphatase regulatory subunit MYPT1 at Thr-696 and Thr-853 and the inhibitor protein CPI-17 were also stimulated with carbachol. These results are consistent with the previous findings that activation of a small fraction of MLCK by limiting amounts of free Ca2+/calmodulin combined with myosin light chain phosphatase inhibition is sufficient for robust RLC phosphorylation and contractile responses in bladder smooth muscle. In contrast, a 50% decrease in MLCK in aortic smooth muscle resulted in 40% inhibition of RLC phosphorylation and aorta contractile responses, whereas a 90% decrease profoundly inhibited both responses. Thus, MLCK content is limiting for contraction in aortic smooth muscle. Phosphorylation of CPI-17 and MYPT1 at Thr-696 and Thr-853 were also stimulated with phenylephrine but significantly less than in bladder tissue. These results indicate differential contributions of MLCK to signaling. Limiting MLCK activity combined with modest Ca2+ sensitization responses provide insights into how haploinsufficiency of MLCK may result in contractile dysfunction in vivo, leading to dissections of human thoracic aorta.	[Gao, Ning; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [He, Weiqi; Zhu, Minsheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [He, Weiqi; Zhu, Minsheng] Nanjing Univ, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Nanjing University; Nanjing University	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu	He, Weiqi/I-7935-2013; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420	National Institutes of Health [HL26043, HL110869]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; National Basic Research Program of China (973) [2009CB942602, 2007CB947100]; National Natural Science of China Grant [30570911]; China Postdoctoral Science Foundation [20110491391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, P01HL110869, R37HL026043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science of China Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL26043 and HL110869, the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.), National Basic Research Program of China (973) Grants 2009CB942602 and 2007CB947100 (to M. S. Z), National Natural Science of China Grant 30570911 (to M. S. Z.), and China Postdoctoral Science Foundation Grant 20110491391 (to W. Q. H.).	[Anonymous], 2014, CELL SIGNAL BIOL; Arens WHJM, 2000, AM J PHYSIOL-REG I, V278, pR1305, DOI 10.1152/ajpregu.2000.278.5.R1305; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Cole WC, 2011, ARCH BIOCHEM BIOPHYS, V510, P160, DOI 10.1016/j.abb.2011.02.024; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Emmert DA, 2004, AM J PHYSIOL-CELL PH, V286, pC8, DOI 10.1152/ajpcell.00428.2002; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Geguchadze R, 2004, FEBS LETT, V557, P121, DOI 10.1016/S0014-5793(03)01456-X; GONG MC, 1992, J BIOL CHEM, V267, P14662; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; IKEBE M, 1985, J BIOL CHEM, V260, P27; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kim JH, 2011, J CELL PHYSIOL, V226, P2881, DOI 10.1002/jcp.22631; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; Kitazawa T, 2010, BIOCHEM BIOPH RES CO, V401, P75, DOI 10.1016/j.bbrc.2010.09.011; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; PATO MD, 1983, J BIOL CHEM, V258, P7047; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Raina H, 2009, J PHYSIOL-LONDON, V587, P2599, DOI 10.1113/jphysiol.2008.165258; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Stull JT, 2011, ARCH BIOCHEM BIOPHYS, V510, P120, DOI 10.1016/j.abb.2011.01.017; TAKAI A, 1995, BIOCHEM J, V306, P657, DOI 10.1042/bj3060657; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tsai MH, 2012, J PHYSIOL-LONDON, V590, P5107, DOI 10.1113/jphysiol.2012.235424; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Wang HB, 2012, J NEUROSCI RES, V90, P1547, DOI 10.1002/jnr.23036; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Yamawaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1040, DOI 10.1006/bbrc.2001.5290; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; ZIMMERMANN B, 1995, J BIOL CHEM, V270, P23966, DOI 10.1074/jbc.270.41.23966	61	45	51	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7596	7605		10.1074/jbc.M112.427112	http://dx.doi.org/10.1074/jbc.M112.427112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362260	hybrid, Green Published			2022-12-28	WOS:000316455300017
J	Lim, H; Kim, D; Lee, SJ				Lim, Hyoungsub; Kim, Donghoon; Lee, Sung Joong			Toll-like Receptor 2 Mediates Peripheral Nerve Injury-induced NADPH Oxidase 2 Expression in Spinal Cord Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPATHIC PAIN; MECHANICAL ALLODYNIA; PROTEIN-KINASE; RAT MODEL; HYPERSENSITIVITY; ACTIVATION; PATHWAYS; P38; PHOSPHORYLATION; INTERLEUKIN-6	We have previously reported that NADPH oxidase 2 (Nox2) is up-regulated in spinal cord microglia after spinal nerve injury, demonstrating that it is critical for microglia activation and subsequent pain hypersensitivity. However, the mechanisms and molecules involved in Nox2 induction have not been elucidated. Previous studies have shown that Toll-like receptors (TLRs) are involved in nerve injury-induced spinal cord microglia activation. In this study, we investigated the role of TLR in Nox2 expression in spinal cord microglia after peripheral nerve injury. Studies using TLR knock-out mice have shown that nerve injury-induced microglial Nox2 up-regulation is abrogated in TLR2 but not in TLR3 or -4 knock-out mice. Intrathecal injection of lipoteichoic acid, a TLR2 agonist, induced Nox2 expression in spinal cord microglia both at them RNA and protein levels. Similarly, lipoteichoic acid stimulation induced Nox2 expression and reactive oxygen species production in primary spinal cord glial cells in vitro. Studies on intracellular signaling pathways indicate that NF-kappa B and p38 MAP kinase activation is required for TLR2-induced Nox2 expression in glial cells. Conclusively, our data show that TLR2 mediates nerve injury-induced Nox2 gene expression in spinal cord microglia via NF-kappa B and p38 activation and thereby may contribute to spinal cord microglia activation.	[Lim, Hyoungsub; Kim, Donghoon; Lee, Sung Joong] Seoul Natl Univ, Dent Res Inst, Dept Neurosci & Physiol, Seoul 110799, South Korea; [Lim, Hyoungsub; Kim, Donghoon; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Seoul 110799, South Korea; [Lim, Hyoungsub; Lee, Sung Joong] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, SJ (corresponding author), Seoul Natl Univ, Sch Dent, Dept Neurosci & Physiol, 28 Yeongeon Dong, Seoul 110799, South Korea.	sjlee87@snu.ac.kr			National Research Foundation of Korea; Ministry of Education, Science, and Technology [2010-0002149, 2010-C00078, 2011-0000934, 2011-0027667]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grants 2010-0002149, 2010-C00078, 2011-0000934, and 2011-0027667).	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzi P, 2004, J IMMUNOL, V172, P4941, DOI 10.4049/jimmunol.172.8.4941; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Milligan ED, 2000, BRAIN RES, V861, P105, DOI 10.1016/S0006-8993(00)02050-3; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Schachtele SJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-35; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251	27	57	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7572	7579		10.1074/jbc.M112.414904	http://dx.doi.org/10.1074/jbc.M112.414904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23386616	Green Published, hybrid			2022-12-28	WOS:000316455300014
J	Rasheed, SAK; Teo, CR; Beillard, EJ; Voorhoeve, PM; Casey, PJ				Rasheed, Suhail Ahmed Kabeer; Teo, Cui Rong; Beillard, Emmanuel Jean; Voorhoeve, P. Mathijs; Casey, Patrick J.			MicroRNA-182 and MicroRNA-200a Control G-protein Subunit alpha-13 (GNA13) Expression and Cell Invasion Synergistically in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LYSOPHOSPHATIDIC ACID; TUMOR-SUPPRESSOR; MIR-200 FAMILY; G12 FAMILY; METASTASIS; MIGRATION; RECEPTORS; G-ALPHA(13); ACTIVATION	G protein-coupled receptors (GPCRs) and their ligands have been implicated in progression and metastasis of several cancers. GPCRs signal through heterotrimeric G proteins, and among the different types of G proteins, GNA12/13 have been most closely linked to tumor progression. In this study, we explored the role of GNA13 in prostate cancer cell invasion and the mechanism of up-regulation of GNA13 in these cells. An initial screen for GNA13 protein expression showed that GNA13 is highly expressed in the most aggressive cancer cell lines. Knockdown of GNA13 in highly invasive PC3 cells revealed that these cells depend on GNA13 expression for their invasion, migration, and Rho activation. As mRNA levels in these cells did not correlate with protein levels, we assessed the potential involvement of micro-RNAs (miRNAs) in post-transcriptional control of GNA13 expression. Expression analysis of miRNAs predicted to bind the 3'-UTR of GNA13 revealed that miR-182 and miR-141/200a showed an inverse correlation to the protein expression in LnCAP and PC3 cells. Ectopic expression of miR-182 and miR-141/200a in PC3 cells significantly reduced protein levels, GNA13-3'-UTR reporter activity and in vitro invasion of these cells. This effect was blocked by restoration of GNA13 expression in these cells. Importantly, inhibition of miR-182 and miR-141/200a in LnCAP cells using specific miRNA inhibitors elevated the expression of GNA13 and enhanced invasion of these cells. These data provide strong evidence that GNA13 is an important mediator of prostate cancer cell invasion, and that miR-182 and miR-200 family members regulate its expression post-transcriptionally.	[Rasheed, Suhail Ahmed Kabeer; Teo, Cui Rong; Beillard, Emmanuel Jean; Voorhoeve, P. Mathijs; Casey, Patrick J.] Duke NUS Grad Med Sch, Dept Canc & Stem Cell Biol, Singapore 169857, Singapore; [Voorhoeve, P. Mathijs] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Casey, PJ (corresponding author), Duke NUS Grad Med Sch, Dept Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	patrick.casey@duke-nus.edu.sg	Rasheed, Suhail Ahmed Kabeer/P-1257-2019	Rasheed, Suhail Ahmed Kabeer/0000-0002-7674-7560; Casey, Patrick/0000-0002-7366-9309				Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barshack I, 2010, PATHOL RES PRACT, V206, P578, DOI 10.1016/j.prp.2010.03.005; Beillard E, 2012, RNA, V18, P1091, DOI 10.1261/rna.031831.111; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Cheong SC, 2009, ORAL ONCOL, V45, P712, DOI 10.1016/j.oraloncology.2008.11.002; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kim ES, 2011, ONCOL RES, V19, P297, DOI 10.3727/096504011X13021877989919; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Lappano R, 2012, ACTA PHARMACOL SIN, V33, P351, DOI 10.1038/aps.2011.183; Li SY, 2005, INT J ONCOL, V27, P1329; Malchnkhuu E, 2008, BIOCHEM BIOPH RES CO, V366, P963, DOI 10.1016/j.bbrc.2007.12.054; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Rutnam ZJ, 2012, HISTOL HISTOPATHOL, V27, P1263, DOI 10.14670/HH-27.1263; Sayas CL, 2002, J NEUROSCI, V22, P6863; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shumay E, 2007, J BIOL CHEM, V282, P21529, DOI 10.1074/jbc.M701998200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhang ZJ, 2012, ONCOL REP, V27, P903, DOI 10.3892/or.2011.1611	39	65	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7986	7995		10.1074/jbc.M112.437749	http://dx.doi.org/10.1074/jbc.M112.437749			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23329838	Green Published, hybrid			2022-12-28	WOS:000316455300051
J	Burch, ML; Getachew, R; Osman, N; Febbraio, MA; Little, PJ				Burch, Micah L.; Getachew, Robel; Osman, Narin; Febbraio, Mark A.; Little, Peter J.			Thrombin-mediated Proteoglycan Synthesis Utilizes Both Protein-tyrosine Kinase and Serine/Threonine Kinase Receptor Transactivation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TO-RETENTION HYPOTHESIS; DELTA-OPIOID RECEPTORS; TRANSFORMING GROWTH-FACTOR-BETA-1; INCREASED BINDING; MAP KINASE; ACTIVATION; STIMULATION; ELONGATION; EXPRESSION	G protein-coupled receptor signaling is mediated by three main mechanisms of action; these are the classical pathway, beta-arrestin scaffold signaling, and the transactivation of protein-tyrosine kinase receptors such as those for EGF and PDGF. Recently, it has been demonstrated that G protein-coupled receptors can also mediate signals via transactivation of serine/threonine kinase receptors, most notably the transforming growth factor-beta receptor family. Atherosclerosis is characterized by the development of lipid-laden plaques in blood vessel walls. Initiation of plaque development occurs via low density lipoprotein retention in the neointima of vessels due to binding with modified proteoglycans secreted by vascular smooth muscle cells. Here we show that transactivation of protein-tyrosine kinase receptors is mediated by matrix metalloproteinase triple membrane bypass signaling. In contrast, serine/threonine kinase receptor transactivation is mediated by a cytoskeletal rearrangement-Rho kinase-integrin system, and both protein-tyrosine kinase and serine/threonine kinase receptor transactivation concomitantly account for the total proteoglycan synthesis stimulated by thrombin in vascular smooth muscle. This work provides evidence of thrombin-mediated proteoglycan synthesis and paves the way for a potential therapeutic target for plaque development and atherosclerosis.	[Burch, Micah L.; Getachew, Robel; Osman, Narin; Little, Peter J.] RMIT Univ, Hlth Innovat Inst, Diabet Complicat Lab, Bundoora, Vic 3004, Australia; [Burch, Micah L.; Febbraio, Mark A.] BakerIDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 3004, Australia; [Burch, Micah L.; Osman, Narin; Little, Peter J.] Monash Univ, Alfred Hosp, Dept Med, Cent & Eastern Clin Sch, Melbourne, Vic 3004, Australia	Royal Melbourne Institute of Technology (RMIT); Florey Institute of Neuroscience & Mental Health; Monash University	Little, PJ (corresponding author), RMIT Univ, Hlth Innovat Inst, Diabet Complicat Lab, Bundoora, Vic 3004, Australia.	peter.little@rmit.edu.au	Little, Peter J./F-9865-2015; Febbraio, Mark/AAE-9632-2019	Little, Peter J./0000-0002-0335-3835; Febbraio, Mark/0000-0002-9296-4418	National Health and Medical Research Council; National Heart Foundation of Australia [PB09M4769]; Diabetes Australia Research Trust; GlaxoSmithKline Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Diabetes Australia Research Trust; GlaxoSmithKline Australia(GlaxoSmithKline)	This work was supported by a National Health and Medical Research Council Fellowship (to P. J. L.) and a National Heart Foundation of Australia grant-in-aid (to P. J. L.) and Diabetes Australia Research Trust grants (to P. J. L. and N. O.). The Ph. D. Program of M. L. B. generously received support through a National Heart Foundation of Australia postgraduate scholarship (PB09M4769) and a postgraduate support award to the laboratory head from GlaxoSmithKline Australia.	Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Anggraeni VY, 2011, BIOCHEM BIOPH RES CO, V406, P36, DOI 10.1016/j.bbrc.2011.01.096; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P2897, DOI 10.1002/art.21246; Ballinger ML, 2009, ATHEROSCLEROSIS, V205, P451, DOI 10.1016/j.atherosclerosis.2009.01.024; Ballinger ML, 2004, CELL MOL LIFE SCI, V61, P1296, DOI 10.1007/s00018-004-3389-4; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Burch ML, 2010, J BIOL CHEM, V285, P26798, DOI 10.1074/jbc.M109.092767; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Eisinger DA, 2008, FEBS LETT, V582, P3325, DOI 10.1016/j.febslet.2008.08.021; Eisinger DA, 2008, CELL SIGNAL, V20, P2324, DOI 10.1016/j.cellsig.2008.09.002; Getachew R, 2010, ENDOCRINOLOGY, V151, P4356, DOI 10.1210/en.2010-0027; Ivey ME, 2008, THROMB RES, V123, P288, DOI 10.1016/j.thromres.2008.04.019; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lefkowitz RJ, 2007, BBA-BIOMEMBRANES, V1768, P748, DOI 10.1016/j.bbamem.2006.11.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Little PJ, 2010, J CARDIOVASC PHARM, V56, P360, DOI 10.1097/FJC.0b013e3181ee6811; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Neurohr C, 2006, AM J RESP CELL MOL, V35, P252, DOI 10.1165/rcmb.2006-0013OC; NEYLON CB, 1990, CIRC RES, V67, P814, DOI 10.1161/01.RES.67.4.814; Otani H, 2011, J PHARMACOL SCI, V115, P135, DOI 10.1254/jphs.10197FP; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160	37	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7410	7419		10.1074/jbc.M112.400259	http://dx.doi.org/10.1074/jbc.M112.400259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23335513	Green Published, hybrid			2022-12-28	WOS:000316002400059
J	Patwardhan, CA; Fauq, A; Peterson, LB; Miller, C; Blagg, BSJ; Chadli, A				Patwardhan, Chaitanya A.; Fauq, Abdul; Peterson, Laura B.; Miller, Charles; Blagg, Brian S. J.; Chadli, Ahmed			Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 COCHAPERONE P23; HEAT-SHOCK; MOLECULAR CHAPERONE; ANDROGEN RECEPTOR; CRYSTAL-STRUCTURE; BREAST-CANCER; CELASTROL; TRITERPENE; COMPLEX; ACTIVATION	Pharmacological inhibition of Hsp90 is an exciting option for cancer therapy. The clinical efficacy of Hsp90 inhibitors is, however, less than expected. Binding of the co-chaperone p23 to Hsp90 and induced overexpression of anti-apoptotic proteins Hsp70 and Hsp27 are thought to contribute to this outcome. Herein, we report that the natural product gedunin may provide a new alternative to inactivate the Hsp90 machine. We show that gedunin directly binds to p23 and inactivates it, without overexpression of Hsp27 and relatively modest induction of Hsp70. Using molecular docking and mutational analysis, we mapped the gedunin-binding site on p23. Functional analysis shows that gedunin inhibits the p23 chaperoning activity, blocks its cellular interaction with Hsp90, and interferes with p23-mediated gene regulation. Cell treatment with gedunin leads to cancer cell death by apoptosis through inactivation of p23 and activation of caspase 7, which cleaves p23 at the C terminus. These results provide important insight into the molecular mechanism of action of this promising lead compound.	[Patwardhan, Chaitanya A.; Chadli, Ahmed] Georgia Regents Univ, Canc Res Ctr, Mol Chaperones Program, Augusta, GA 30912 USA; [Fauq, Abdul] Mayo Clin, Coll Med, Organ Chem Lab, Jacksonville, FL 32224 USA; [Peterson, Laura B.; Blagg, Brian S. J.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Miller, Charles] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Environm Hlth Sci, New Orleans, LA 70112 USA	University System of Georgia; Augusta University; Mayo Clinic; University of Kansas; Tulane University	Chadli, A (corresponding author), Georgia Regents Univ, Canc Res Ctr, Mol Chaperones Program, 1410 Laney Walker Blvd,CN-3151, Augusta, GA 30912 USA.	achadli@georgiahealth.edu	blagg, brian s j/X-7770-2018; Miller, Charles A/I-3978-2019	blagg, brian s j/0000-0002-6200-3480; Miller, Charles A/0000-0003-0644-7455	National Institutes of Health [R01 GM102443-01]; American Heart Association [0930019N]; NATIONAL CANCER INSTITUTE [U01CA109265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM102443-01 (to A. C.). This work was also supported by Scientist Development Grant 0930019N from the American Heart Association (to A. C.).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Brandt GEL, 2008, J MED CHEM, V51, P6495, DOI 10.1021/jm8007486; Burlison JA, 2008, J ORG CHEM, V73, P2130, DOI 10.1021/jo702191a; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Felts SJ, 2007, CELL STRESS CHAPERON, V12, P353, DOI 10.1379/CSC-299.1; Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kamath SG, 2009, INT J GYNECOL CANCER, V19, P1564, DOI 10.1111/IGC.0b013e3181a83135; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Knoblauch R, 1999, MOL CELL BIOL, V19, P3748; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Oxelmark E, 2003, J BIOL CHEM, V278, P36547, DOI 10.1074/jbc.M305960200; Oxelmark E, 2006, MOL CELL BIOL, V26, P5205, DOI 10.1128/MCB.00009-06; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Poksay KS, 2012, J MOL NEUROSCI, V46, P303, DOI 10.1007/s12031-011-9574-7; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rao J, 2001, J BIOL CHEM, V276, P5814, DOI 10.1074/jbc.M007385200; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Simpson NE, 2012, MOL ENDOCRINOL, V26, P194, DOI 10.1210/me.2011-1068; Simpson NE, 2010, CANCER RES, V70, P8446, DOI 10.1158/0008-5472.CAN-10-1590; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Woo SH, 2009, J BIOL CHEM, V284, P30871, DOI 10.1074/jbc.M109.052720; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zelin E, 2012, MOL CELL, V48, P459, DOI 10.1016/j.molcel.2012.08.026; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484	61	85	88	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7313	7325		10.1074/jbc.M112.427328	http://dx.doi.org/10.1074/jbc.M112.427328			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23355466	Green Published, hybrid			2022-12-28	WOS:000316002400051
J	Lewis, WG; Robinson, LS; Gilbert, NM; Perry, JC; Lewis, AL				Lewis, Warren G.; Robinson, Lloyd S.; Gilbert, Nicole M.; Perry, Justin C.; Lewis, Amanda L.			Degradation, Foraging, and Depletion of Mucus Sialoglycans by the Vagina-adapted Actinobacterium Gardnerella vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; SIALIC-ACID TRANSPORT; LOW-BIRTH-WEIGHT; DIAGNOSING BACTERIAL VAGINOSIS; INFLAMMATORY-BOWEL-DISEASE; PRETERM DELIVERY; VIBRIO-CHOLERAE; PREGNANT-WOMEN; O-ACETYLATION; HAEMOPHILUS-INFLUENZAE	Bacterial vaginosis (BV) is a polymicrobial imbalance of the vaginal microbiota associated with reproductive infections, preterm birth, and other adverse health outcomes. Sialidase activity in vaginal fluids is diagnostic of BV and sialic acid-rich components of mucus have protective and immunological roles. However, whereas mucus degradation is believed to be important in the etiology and complications associated with BV, the role(s) of sialidases and the participation of individual bacterial species in the degradation of mucus barriers in BV have not been investigated. Here we demonstrate that the BV-associated bacterium Gardnerella vaginalis uses sialidase to break down and deplete sialic acid-containing mucus components in the vagina. Biochemical evidence using purified sialoglycan substrates supports a model in which 1) G. vaginalis extracellular sialidase hydrolyzes mucosal sialoglycans, 2) liberated sialic acid (N-acetylneuraminic acid) is transported into the bacterium, a process inhibited by excess N-glycolylneuraminic acid, and 3) sialic acid catabolism is initiated by an intracellular aldolase/lyase mechanism. G. vaginalis engaged in sialoglycan foraging in vitro, in the presence of human vaginal mucus, and in vivo, in a murine vaginal model, in each case leading to depletion of sialic acids. Comparison of sialic acid levels in human vaginal specimens also demonstrated significant depletion of mucus sialic acids in women with BV compared with women with a "normal" lactobacilli-dominated microbiota. Taken together, these studies show that G. vaginalis utilizes sialidase to support the degradation, foraging, and depletion of protective host mucus barriers, and that this process of mucus barrier degradation and depletion also occurs in the clinical setting of BV.	[Lewis, Warren G.] Washington Univ, Sch Med, Dept Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Robinson, Lloyd S.; Gilbert, Nicole M.; Perry, Justin C.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019	Lewis, Warren G/0000-0003-1210-6403; Gilbert, Nicole/0000-0003-4830-3257; Lewis, Amanda/0000-0001-6195-3030	National Institutes of Health [P50DK064540-11]; March of Dimes; Barnes-Jewish Hospital Foundation; American Heart Association; NCRR Grant [C06RR012466]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Barnes-Jewish Hospital Foundation; American Heart Association(American Heart Association); NCRR Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant P50DK064540-11, a Basil O' Connor award from the March of Dimes (to A. L. L.), a Translational Research Pilot Grant funded by the Barnes-Jewish Hospital Foundation (to A. L. L. and W. G. L.), and a postdoctoral fellowship from the American Heart Association (to N. M. G.).; We thank Jeffrey Peipert and Jennifer Allsworth for contributions of Contraceptive CHOICE project clinical specimens and confirmatory data. We also gratefully acknowledge Gina Secura and the CHOICE team of nurses and for logistical support in the collection of fresh vaginal specimens subsequently used for anaerobic culture and G. vaginalis isolation. We also thank Jenifer Bick for technical assistance and transport of fresh vaginal specimens from clinic to laboratory. We are grateful to Christy Marrs for helpful suggestions for G. vaginalis freezing media. The animal work described in this article was performed in a facility supported by NCRR Grant C06RR012466.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; BRISELDEN AM, 1990, J CLIN MICROBIOL, V28, P2761, DOI 10.1128/JCM.28.12.2761-2764.1990; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Byers HL, 1999, J MED MICROBIOL, V48, P375, DOI 10.1099/00222615-48-4-375; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Chowdhury Suchandra, 2009, Biotechnology Journal, V4, P361, DOI 10.1002/biot.200800253; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Donders GGG, 2000, AM J OBSTET GYNECOL, V182, P872, DOI 10.1016/S0002-9378(00)70338-3; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2011, ANAEROBE, V17, P191, DOI 10.1016/j.anaerobe.2011.01.001; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; GARDNER HL, 1954, SCIENCE, V120, P853, DOI 10.1126/science.120.3125.853; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hendler I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.073; Trinh HT, 2011, PLANTA MED, V77, P1996, DOI 10.1055/s-0031-1280094; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hitti J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7; HOLST E, 1994, J CLIN MICROBIOL, V32, P176, DOI 10.1128/JCM.32.1.176-186.1994; Homer KA, 1996, MICROBIOL-UK, V142, P1221, DOI 10.1099/13500872-142-5-1221; HOSKINS LC, 1981, J CLIN INVEST, V67, P163, DOI 10.1172/JCI110009; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; Jenkins GA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-48; Joo HM, 2011, INT IMMUNOPHARMACOL, V11, P1758, DOI 10.1016/j.intimp.2011.07.002; KROHN MA, 1989, J CLIN MICROBIOL, V27, P1266, DOI 10.1128/JCM.27.6.1266-1271.1989; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Lewis AL, 2011, APPL ENVIRON MICROB, V77, P5782, DOI 10.1128/AEM.00712-11; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Lubin JB, 2012, APPL ENVIRON MICROB, V78, P3407, DOI 10.1128/AEM.07395-11; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Marrs CN, 2012, MICROBES INFECT, V14, P500, DOI 10.1016/j.micinf.2011.12.009; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Mulligan C, 2012, J BIOL CHEM, V287, P3598, DOI 10.1074/jbc.M111.281030; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Myziuk L, 2003, J CLIN MICROBIOL, V41, P1925, DOI 10.1128/JCM.41.5.1925-1928.2003; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Pezzicoli A, 2012, J INFECT DIS, V206, P924, DOI 10.1093/infdis/jis451; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Rafay AM, 1996, J MED MICROBIOL, V44, P409, DOI 10.1099/00222615-44-6-409; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Roy S, 2011, MICROBIOL-SGM, V157, P3195, DOI 10.1099/mic.0.052498-0; Roy S, 2010, J BACTERIOL, V192, P2285, DOI 10.1128/JB.00079-10; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; SILVER HM, 1989, AM J OBSTET GYNECOL, V161, P808, DOI 10.1016/0002-9378(89)90406-7; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Slomiany BL, 1996, GEN PHARMACOL, V27, P761, DOI 10.1016/0306-3623(95)02050-0; Smayevsky J, 2001, Infect Dis Obstet Gynecol, V9, P17, DOI 10.1155/S1064744901000047; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Sumeksri Permsak, 2005, J Med Assoc Thai, V88 Suppl 3, pS7; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Thomas GH, 2011, MICROBIOL-SGM, V157, P3253, DOI 10.1099/mic.0.054692-0; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; VONNICOLAI H, 1984, ZBL BAKT-INT J MED M, V258, P20, DOI 10.1016/S0176-6724(84)80003-6; WATTS DH, 1990, OBSTET GYNECOL, V75, P52; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Wiggins R, 2000, J CLIN MICROBIOL, V38, P3096, DOI 10.1128/JCM.38.8.3096-3097.2000; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yoo EM, 2005, CLIN IMMUNOL, V116, P3, DOI 10.1016/j.clim.2005.03.010; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588	93	82	91	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12067	12079		10.1074/jbc.M113.453654	http://dx.doi.org/10.1074/jbc.M113.453654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479734	hybrid, Green Published			2022-12-28	WOS:000318157600040
J	Perez-Hernandez, D; Gutierrez-Vazquez, C; Jorge, I; Lopez-Martin, S; Ursa, A; Sanchez-Madrid, F; Vazquez, J; Yanez-Mo, M				Perez-Hernandez, Daniel; Gutierrez-Vazquez, Cristina; Jorge, Inmaculada; Lopez-Martin, Soraya; Ursa, Angeles; Sanchez-Madrid, Francisco; Vazquez, Jesus; Yanez-Mo, Maria			The Intracellular Interactome of Tetraspanin-enriched Microdomains Reveals Their Function as Sorting Machineries toward Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAP MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; PEPTIDE IDENTIFICATION; STATISTICAL-MODEL; MESSENGER-RNAS; CELL-MIGRATION; PROTEINS; CD81; ASSOCIATION; EWI-2	Extracellular vesicles are emerging as a potent mechanism of intercellular communication because they can systemically exchange genetic and protein material between cells. Tetraspanin molecules are commonly used as protein markers of extracellular vesicles, although their role in the unexplored mechanisms of cargo selection into exosomes has not been addressed. For that purpose, we have characterized the intracellular tetraspanin-enriched microdomain (TEM) interactome by high throughput mass spectrometry, in both human lymphoblasts and their derived exosomes, revealing a clear pattern of interaction networks. Proteins interacting with TEM receptors cytoplasmic regions presented a considerable degree of overlap, although some highly specific CD81 tetraspanin ligands, such as Rac GTPase, were detected. Quantitative proteomics showed that TEM ligands account for a great proportion of the exosome proteome and that a selective repertoire of CD81-associated molecules, including Rac, is not correctly routed to exosomes in cells from CD81-deficient animals. Our data provide evidence that insertion into TEM may be necessary for protein inclusion into the exosome structure.	[Perez-Hernandez, Daniel; Vazquez, Jesus] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Prot Chem & Prote, E-28049 Madrid, Spain; [Perez-Hernandez, Daniel; Gutierrez-Vazquez, Cristina; Jorge, Inmaculada; Sanchez-Madrid, Francisco; Vazquez, Jesus] Ctr Nacl Invest Cardiovasc, Dept Vasc Biol & Inflammat, E-28029 Madrid, Spain; [Lopez-Martin, Soraya; Yanez-Mo, Maria] Hosp Santa Cristina, Unidad Invest, E-28006 Madrid, Spain; [Ursa, Angeles; Sanchez-Madrid, Francisco] Inst Invest Sanitaria Princesa IIS IP, Hosp Princesa, Serv Inmunol, E-28006 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Vazquez, J (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Prot Chem & Prote, E-28049 Madrid, Spain.	jvazquez@cnic.es; myanez.hlpr@salud.madrid.org	Vazquez, Jesus/B-7697-2015; Yáñez-Mó, María/K-8577-2014; Sanchez-Madrid, Francisco/M-7889-2016; YÃÃez-MÃ, Maria/AAI-4544-2020	Vazquez, Jesus/0000-0003-1461-5092; Yáñez-Mó, María/0000-0001-7484-2866; Sanchez-Madrid, Francisco/0000-0001-5303-0762; YÃÃez-MÃ, Maria/0000-0001-7484-2866; Perez Hernandez, Daniel/0000-0003-0266-9050; Gutierrez-Vazquez, Cristina/0000-0002-3846-4631; Jorge, Inmaculada/0000-0001-8645-9477; Perez Hernandez, Daniel/0000-0003-4721-1203	Instituto de Salud Carlos III [PI080794, PI11/01645]; Ministerio de Ciencia e Innovacion (MCINN) [ERC-2011-AdG 294340-GEN-TRIS, SAF2011-25834]; Comunidad de Madrid (CAM) [INDISNET S2011/BMD-2332]; MCINN [BIO2009-07990]; CAM [BIO/0194/2006]; Fondo de Investigaciones Sanitarias (MCINN) [RECAVA RD06/0014]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (CAM)(Comunidad de Madrid); MCINN(European Commission); CAM; Fondo de Investigaciones Sanitarias (MCINN)	This work was supported by Grants PI080794 and PI11/01645 from the Instituto de Salud Carlos III (to M. Y.-M.); Grants ERC-2011-AdG 294340-GEN-TRIS, and SAF2011-25834 from the Ministerio de Ciencia e Innovacion (MCINN) and INDISNET S2011/BMD-2332 from the Comunidad de Madrid (CAM) (to F. S. M); Grants BIO2009-07990 from the MCINN and BIO/0194/2006 from the CAM(to J. V.); and Grant RECAVA RD06/0014 from the Fondo de Investigaciones Sanitarias (MCINN) (to J. V. and F. S. M.).	Abache T, 2007, J CELL BIOCHEM, V102, P650, DOI 10.1002/jcb.21318; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; BASSELL GJ, 1994, J CELL BIOL, V126, P863, DOI 10.1083/jcb.126.4.863; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bonzon-Kulichenko E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003335; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Clark KL, 2004, J BIOL CHEM, V279, P19401, DOI 10.1074/jbc.M312626200; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gordon-Alonso M, 2012, J IMMUNOL, V189, P689, DOI 10.4049/jimmunol.1103708; Gorrini C, 2005, P NATL ACAD SCI USA, V102, P9200, DOI 10.1073/pnas.0409513102; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jorge I, 2007, J MASS SPECTROM, V42, P1391, DOI 10.1002/jms.1314; Jorge I, 2009, MOL CELL PROTEOMICS, V8, P1130, DOI 10.1074/mcp.M800260-MCP200; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Miyado K, 2008, P NATL ACAD SCI USA, V105, P12921, DOI 10.1073/pnas.0710608105; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Ramos-Fernandez A, 2007, MOL CELL PROTEOMICS, V6, P1274, DOI 10.1074/mcp.T600029-MCP200; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Tejera E, 2013, MOL BIOL CELL, V24, P261, DOI 10.1091/mbc.E12-09-0642; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019; Yanez-Mo M, 2011, CELL MOL LIFE SCI, V68, P3323, DOI 10.1007/s00018-011-0746-y; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	59	295	308	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11649	11661		10.1074/jbc.M112.445304	http://dx.doi.org/10.1074/jbc.M112.445304			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23463506	Green Published, hybrid			2022-12-28	WOS:000318157600004
J	Zandarashvili, L; Sahu, D; Lee, K; Lee, YS; Singh, P; Rajarathnam, K; Iwahara, J				Zandarashvili, Levani; Sahu, Debashish; Lee, Kwanbok; Lee, Yong Sun; Singh, Pomila; Rajarathnam, Krishna; Iwahara, Junji			Real-time Kinetics of High-mobility Group Box 1 (HMGB1) Oxidation in Extracellular Fluids Studied by in Situ Protein NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX STATE; ENDOPLASMIC-RETICULUM; CELL RECRUITMENT; ACIDIC TAIL; CYSTEINE; CANCER; RAGE; GLUTATHIONE; RELAXATION; RESIDUES	Some extracellular proteins are initially secreted in reduced forms via a non-canonical pathway bypassing the endoplasmic reticulum and become oxidized in the extracellular space. One such protein is HMGB1 (high-mobility group box 1). Extracellular HMGB1 has different redox states that play distinct roles in inflammation. Using a unique NMR-based approach, we have investigated the kinetics of HMGB1 oxidation and the half-lives of all-thiol and disulfide HMGB1 species in serum, saliva, and cell culture medium. In this approach, salt-free lyophilized N-15-labeled all-thiol HMGB1 was dissolved in actual extracellular fluids, and the oxidation and clearance kinetics were monitored in situ by recording a series of heteronuclear H-1-N-15 correlation spectra. We found that the half-life depends significantly on the extracellular environment. For example, the half-life of all-thiol HMGB1 ranged from similar to 17 min (in human serum and saliva) to 3 h (in prostate cancer cell culture medium). Furthermore, the binding of ligands (glycyrrhizin and heparin) to HMGB1 significantly modulated the oxidation kinetics. Thus, the balance between the roles of all-thiol and disulfide HMGB1 proteins depends significantly on the extracellular environment and can also be artificially modulated by ligands. This is important because extracellular HMGB1 has been suggested as a therapeutic target for inflammatory diseases and cancer. Our work demonstrates that the in situ protein NMR approach is powerful for investigating the behavior of proteins in actual extracellular fluids containing an enormous number of different molecules.	[Zandarashvili, Levani; Sahu, Debashish; Lee, Kwanbok; Lee, Yong Sun; Rajarathnam, Krishna; Iwahara, Junji] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Singh, Pomila] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Zandarashvili, Levani; Sahu, Debashish; Rajarathnam, Krishna; Iwahara, Junji] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Iwahara, J (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 5-104B Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	j.iwahara@utmb.edu	Sahu, Debashish/G-8325-2018	Sahu, Debashish/0000-0002-5890-813X; Iwahara, Junji/0000-0003-4732-2173	National Institutes of Health [8UL1TR000071, 3R01 CA97959, 1P01 HL107152-01]; Institute for Translational Sciences at University of Texas Medical Branch; American Heart Association [12BGIA8960032]; NATIONAL CANCER INSTITUTE [R01CA097959] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Translational Sciences at University of Texas Medical Branch; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Clinical and Translational Science Award 8UL1TR000071, Grant 3R01 CA97959 (to P. S.), and Grant 1P01 HL107152-01 (to K. R.). This work was also supported by the Institute for Translational Sciences at University of Texas Medical Branch and American Heart Association Grant 12BGIA8960032 (to J. I.).	Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; Chaiswing L, 2010, ANTIOXID REDOX SIGN, V13, P449, DOI 10.1089/ars.2009.3020; Chimini Giovanna, 2005, P45, DOI 10.1017/CBO9780511546310.004; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Droge W, 2002, AGEING RES REV, V1, P257, DOI 10.1016/S1568-1637(01)00008-3; Ek M, 2006, ARTHRITIS RHEUM, V54, P2289, DOI 10.1002/art.21969; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Ellgaard L, 2004, BIOCHEM SOC T, V32, P663, DOI 10.1042/BST0320663; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Grek CL, 2010, CURR OPIN PHARMACOL, V10, P362, DOI 10.1016/j.coph.2010.05.003; Hildebrandt W, 2002, MECH AGEING DEV, V123, P1269, DOI 10.1016/S0047-6374(02)00013-1; Hildebrandt W, 2002, BLOOD, V99, P1552, DOI 10.1182/blood.V99.5.1552; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Liu AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035379; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Lotze Michael T, 2003, Curr Opin Investig Drugs, V4, P1405; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mollica L, 2008, CHEM PHYS LETT, V456, P236, DOI 10.1016/j.cplett.2008.03.022; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; Riuzzi F, 2006, J BIOL CHEM, V281, P8242, DOI 10.1074/jbc.M509436200; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Sahu D, 2008, FEBS LETT, V582, P3973, DOI 10.1016/j.febslet.2008.09.061; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tang DL, 2012, MOL MED, V18, P1360, DOI 10.2119/molmed.2012.00314; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wake H, 2009, EUR J PHARMACOL, V623, P89, DOI 10.1016/j.ejphar.2009.09.010; Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389	46	54	55	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11621	11627		10.1074/jbc.M113.449942	http://dx.doi.org/10.1074/jbc.M113.449942			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23447529	hybrid, Green Published			2022-12-28	WOS:000318157600001
J	Farrer, RG; Farrer, JR; DeVries, GH				Farrer, Robert G.; Farrer, Jason R.; DeVries, George H.			Platelet-derived Growth Factor-BB Activates Calcium/Calmodulin-dependent and -independent Mechanisms That Mediate Akt Phosphorylation in the Neurofibromin-deficient Human Schwann Cell Line ST88-14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE SHEATH TUMORS; PROTEIN-KINASE-B; TYPE-1 NEUROFIBROMATOSIS; SURVIVAL; RAS; EXPRESSION; HYPERACTIVATION; PROLIFERATION; APOPTOSIS; P21(RAS)	Neurofibromatosis type 1-derived Schwann cells isolated from malignant peripheral nerve sheath tumors (MPNSTs) overexpress PDGF receptor-beta and generate an aberrant intracellular calcium increase in response to PDGF-BB. Using the human MPNST Schwann cell line ST88-14, we demonstrate that, in addition to a transient phosphorylation of Akt, PDGF-BB stimulation produces an atypical sustained phosphorylation of Akt that is dependent on calcium and calmodulin (CaM). The sustained Akt phosphorylation did not occur in PDGF-BB-stimulated normal human Schwann cells or ST88-14 cells stimulated with stem cell factor, whose receptor is also overexpressed in ST88-14 cells. The sustained Akt phosphorylation induced by PDGF-BB was inhibited by pretreatment of the cells with either the intracellular calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N, N',N'-tetraacetic acid tetrakis(acetoxymethyl) ester (BAPTA-AM) or the CaM antagonist W7, whereas the transient portion was not inhibited. Akt also co-immunoprecipitated with CaM in a PDGF-BB-dependent manner, suggesting that direct interaction between Akt and CaM is involved in the sustained phosphorylation of Akt. Furthermore, we provide evidence that anti-apoptotic effects of PDGF-BB on serum-deprived ST88-14 cells can be inhibited by W7, implicating the PDGF-BB-induced activation of calcium/CaM in promoting cell survival, presumably through sustained Akt activation. We conclude that the activation of the calcium/CaM/Akt pathway resulting from stimulation of overexpressed PDGF receptor-beta may contribute to the survival and tumorigenicity of MPNST cells.	[Farrer, Robert G.; Farrer, Jason R.] Vet Affairs Edward Hines Jr Hosp, Res Serv, Hines, IL 60141 USA; [DeVries, George H.] Hunter Holmes McGuire Vet Adm Med Ctr, Res Serv, Richmond, VA 23249 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Hunter Holmes McGuire Veterinary Affairs Medical Center	Farrer, RG (corresponding author), Vet Affairs Edward Hines Jr Hosp, Res Serv 151, Bldg 1,Rm D4001,5000 5th Ave, Hines, IL 60141 USA.	robert.farrer@va.gov			Department of Veterans Affairs, Illinois Neurofibromatosis, Inc.; United States Army Medical Research and Materiel Command [DAMD17-98-8607]	Department of Veterans Affairs, Illinois Neurofibromatosis, Inc.(US Department of Veterans Affairs); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the Department of Veterans Affairs, Illinois Neurofibromatosis, Inc., and United States Army Medical Research and Materiel Command Contract Grant DAMD17-98-8607.	Badache A, 1998, ONCOGENE, V17, P795, DOI 10.1038/sj.onc.1201978; Badache A, 1998, J CELL PHYSIOL, V177, P334, DOI 10.1002/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO;2-9; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Carroll SL, 2005, J NEUROPATH EXP NEUR, V64, P1; Casella CTB, 1996, GLIA, V17, P327, DOI 10.1002/(SICI)1098-1136(199608)17:4<327::AID-GLIA7>3.0.CO;2-W; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Dang I, 2005, J NEUROSCI RES, V79, P318, DOI 10.1002/jnr.20334; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Donovan S, 2002, CANCER CELL, V2, P507, DOI 10.1016/S1535-6108(02)00214-3; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Liu XS, 2006, J BIOL CHEM, V281, P31380, DOI 10.1074/jbc.M606603200; Maiuri T, 2010, J BIOL CHEM, V285, P15038, DOI 10.1074/jbc.M110.121434; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; THOMAS SL, 2009, HDB NEUROCHEMISTRY M, P107; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yue YZ, 2004, J BIOL CHEM, V279, P12883, DOI 10.1074/jbc.M312308200; Zhang YY, 1998, J EXP MED, V187, P1893, DOI 10.1084/jem.187.11.1893	27	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11066	11073		10.1074/jbc.M112.442244	http://dx.doi.org/10.1074/jbc.M112.442244			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457304	Green Published, hybrid			2022-12-28	WOS:000317915500012
J	Ghodke, I; Muniyappa, K				Ghodke, Indrajeet; Muniyappa, K.			Processing of DNA Double-stranded Breaks and Intermediates of Recombination and Repair by Saccharomyces cerevisiae Mre11 and Its Stimulation by Rad50, Xrs2, and Sae2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE ACTIVITY; END-RESECTION; MRE11/RAD50/XRS2 COMPLEX; MEIOTIC RECOMBINATION; TELOMERE MAINTENANCE; FUNCTIONAL-ANALYSIS; REPLICATION FORKS; PATHWAY CHOICE; HAIRPIN DNA; CELL-CYCLE	Saccharomyces cerevisiae RAD50, MRE11, and XRS2 genes are essential for telomere length maintenance, cell cycle checkpoint signaling, meiotic recombination, and DNA double-stranded break (DSB) repair via nonhomologous end joining and homologous recombination. The DSB repair pathways that draw upon Mre11-Rad50-Xrs2 subunits are complex, so their mechanistic features remain poorly understood. Moreover, the molecular basis of DSB end resection in yeast mre11-nuclease deficient mutants and Mre11 nuclease-independent activation of ATM in mammals remains unknown and adds a new dimension to many unanswered questions about the mechanism of DSB repair. Here, we demonstrate that S. cerevisiae Mre11 (ScMre11) exhibits higher binding affinity for single-over double-stranded DNA and intermediates of recombination and repair and catalyzes robust unwinding of substrates possessing a 3' single-stranded DNA overhang but not of 5' overhangs or blunt-ended DNA fragments. Additional evidence disclosed that ScMre11 nuclease activity is dispensable for its DNA binding and unwinding activity, thus uncovering the molecular basis underlying DSB end processing in mre11 nuclease deficient mutants. Significantly, Rad50, Xrs2, and Sae2 potentiate the DNA unwinding activity of Mre11, thus underscoring functional interaction among the components of DSB end repair machinery. Our results also show that ScMre11 by itself binds to DSB ends, then promotes end bridging of duplex DNA, and directly interacts with Sae2. We discuss the implications of these results in the context of an alternative mechanism for DSB end processing and the generation of single-stranded DNA for DNA repair and homologous recombination.	[Ghodke, Indrajeet; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			Council of Scientific and Industrial Research, New Delhi; J. C. Bose National Fellowship from the Department of Science and Technology, Government of India, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose National Fellowship from the Department of Science and Technology, Government of India, New Delhi	This work was supported by a grant from the Council of Scientific and Industrial Research, New Delhi, and by a J. C. Bose National Fellowship from the Department of Science and Technology, Government of India, New Delhi (to K. M.).	Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bonetti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014142; Borde V, 2009, INT J BIOCHEM CELL B, V41, P1249, DOI 10.1016/j.biocel.2008.12.013; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bressan DA, 1998, GENETICS, V150, P591; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; Dong F, 2001, NUCLEIC ACIDS RES, V29, P3248, DOI 10.1093/nar/29.15.3248; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; Ghosal G, 2007, J MOL BIOL, V372, P864, DOI 10.1016/j.jmb.2007.07.013; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; JOHZUKA K, 1995, GENETICS, V139, P1521; KADYK LC, 1992, GENETICS, V132, P387; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Khanduja JS, 2012, J BIOL CHEM, V287, P1345, DOI 10.1074/jbc.M111.304741; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Kironmai KM, 1997, GENES CELLS, V2, P443; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lydeard JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000973; Majka J, 2012, J BIOL CHEM, V287, P2328, DOI 10.1074/jbc.M111.307041; Malmqvist M, 1997, CURR OPIN CHEM BIOL, V1, P378, DOI 10.1016/S1367-5931(97)80077-4; McKee AHZ, 1997, GENETICS, V146, P797; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Rattray AJ, 2001, GENETICS, V158, P109; Raynard S, 2008, GENE DEV, V22, P2903, DOI 10.1101/gad.1742408; Robison JG, 2005, J BIOL CHEM, V280, P12927, DOI 10.1074/jbc.M414391200; Sambrook J., 2002, MOL CLONING LAB MANU; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Tripathi P, 2006, J MOL BIOL, V364, P599, DOI 10.1016/j.jmb.2006.08.096; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	89	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11273	11286		10.1074/jbc.M112.439315	http://dx.doi.org/10.1074/jbc.M112.439315			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443654	Green Published, hybrid			2022-12-28	WOS:000317915500030
J	Xu, CL; Ren, GW; Cao, G; Chen, Q; Shou, PS; Zheng, CX; Du, LM; Han, XY; Jiang, MH; Yang, Q; Lin, LY; Wang, G; Yu, PF; Zhang, X; Cao, W; Brewer, G; Wang, Y; Shi, YF				Xu, Chunliang; Ren, Guangwen; Cao, Gang; Chen, Qing; Shou, Peishun; Zheng, Chunxing; Du, Liming; Han, Xiaoyan; Jiang, Menghui; Yang, Qian; Lin, Liangyu; Wang, Guan; Yu, Pengfei; Zhang, Xin; Cao, Wei; Brewer, Gary; Wang, Ying; Shi, Yufang			miR-155 Regulates Immune Modulatory Properties of Mesenchymal Stem Cells by Targeting TAK1-binding Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED IMMUNOSUPPRESSION; DENDRITIC CELLS; TISSUE; DIFFERENTIATION; MICRORNA-155; MECHANISMS; EXPRESSION; PATHWAY; MARROW	MSCs possess potent immunosuppressive capacity. We have reported that mouse MSCs inhibit T cell proliferation and function via nitric oxide. This immune regulatory capacity of MSCs is induced by the inflammatory cytokines IFN gamma together with either TNF alpha or IL-1 beta. This effect of inflammatory cytokines on MSCs is extraordinary; logarithmic increases in the expression of iNOS and chemokines are often observed. To investigate the molecular mechanisms underlying this robust effect of cytokines, we examined the expression of microRNAs in MSCs before and after cytokine treatment. We found that miR-155 is most significantly up-regulated. Furthermore, our results showed that miR-155 inhibits the immunosuppressive capacity of MSCs by reducing iNOS expression. We further demonstrated that miR-155 targets TAK1-binding protein 2 (TAB2) to regulate iNOS expression. Additionally, knockdown of TAB2 reduced iNOS expression. In summary, our study demonstrated that miR-155 inhibits the immunosuppressive capacity of MSCs by reducing iNOS expression by targeting TAB2. Our data revealed a novel role of miR-155 in regulating the immune modulatory activities of MSCs.	[Xu, Chunliang; Ren, Guangwen; Cao, Gang; Chen, Qing; Shou, Peishun; Zheng, Chunxing; Du, Liming; Han, Xiaoyan; Jiang, Menghui; Yang, Qian; Lin, Liangyu; Wang, Guan; Yu, Pengfei; Zhang, Xin; Cao, Wei; Brewer, Gary; Wang, Ying; Shi, Yufang] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Shanghai Inst Biol Sci, Inst Hlth Sci,Chinese Acad Sci,Sch Med, Shanghai 200025, Peoples R China; [Ren, Guangwen; Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Ren, Guangwen; Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ 08901 USA; [Brewer, Gary] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, Y (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China.	yingwang@sibs.ac.cn; yufangshi@sibs.ac.cn	han, xiao/HDN-9782-2022; Shou, Peishun/J-7985-2014; Shi, Yufang/AAE-4431-2020; Du, Liming/M-8227-2019; Yu, Pengfei/AHC-3497-2022; Xu, Chunliang/R-7065-2018	Shou, Peishun/0000-0001-7685-7471; Shi, Yufang/0000-0001-8964-319X; Yu, Pengfei/0000-0002-3894-5697; Du, Liming/0000-0002-0527-3556; Chen, Qing/0000-0002-2088-0370; wang, ying/0000-0002-2571-9367	Ministry of Science and Technology of China [2010CB945600, 2011DFA30630]; Scientific Innovation Project of the Chinese Academy of Science [XDA 01040107, XDA 01040110]; National Science and Technology Project of China [31010103908, 81273316]; Shanghai Municipal Key Projects of Basic Research [12JC1409200]; Shanghai Municipal Natural Science Foundation [12ZR1452600]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012KIP202]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Scientific Innovation Project of the Chinese Academy of Science; National Science and Technology Project of China; Shanghai Municipal Key Projects of Basic Research; Shanghai Municipal Natural Science Foundation; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the Ministry of Science and Technology of China (2010CB945600 and 2011DFA30630), Scientific Innovation Project of the Chinese Academy of Science (XDA 01040107 and XDA 01040110), the National Science and Technology Project of China (31010103908 and 81273316), Shanghai Municipal Key Projects of Basic Research (12JC1409200), Shanghai Municipal Natural Science Foundation (12ZR1452600), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, and the Chinese Academy of Sciences (2012KIP202).	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren G., 2001, J IMMUNOL, V184, P2321; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Xu GW, 2007, CELL RES, V17, P240, DOI 10.1038/cr.2007.4; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	25	68	79	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11074	11079		10.1074/jbc.M112.414862	http://dx.doi.org/10.1074/jbc.M112.414862			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449975	Green Published, hybrid			2022-12-28	WOS:000317915500013
J	Bublitz, M; Musgaard, M; Poulsen, H; Thogersen, L; Olesen, C; Schiott, B; Morth, JP; Moller, JV; Nissen, P				Bublitz, Maike; Musgaard, Maria; Poulsen, Hanne; Thogersen, Lea; Olesen, Claus; Schiott, Birgit; Morth, J. Preben; Moller, Jesper Vuust; Nissen, Poul			Ion Pathways in the Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; CALCIUM-PUMP; FUNCTIONAL CONSEQUENCES; TRANSMEMBRANE DOMAIN; CYCLOPIAZONIC ACID; CA2+ BINDING; AMINO-ACIDS; K+-ATPASE; TRANSPORT; NA+,K+-ATPASE	The sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) is a transmembrane ion transporter belonging to the P-II-type ATPase family. It performs the vital task of re-sequestering cytoplasmic Ca2+ to the sarco/endoplasmic reticulum store, thereby also terminating Ca2+-induced signaling such as in muscle contraction. This minireview focuses on the transport pathways of Ca2+ and H+ ions across the lipid bilayer through SERCA. The ion-binding sites of SERCA are accessible from either the cytoplasm or the sarco/endoplasmic reticulum lumen, and the Ca2+ entry and exit channels are both formed mainly by rearrangements of four N-terminal transmembrane alpha-helices. Recent improvements in the resolution of the crystal structures of rabbit SERCA1a have revealed a hydrated pathway in the C-terminal transmembrane region leading from the ion-binding sites to the cytosol. A comparison of different SERCA conformations reveals that this C-terminal pathway is exclusive to Ca2+-free E2 states, suggesting that it may play a functional role in proton release from the ion-binding sites. This is in agreement with molecular dynamics simulations and mutational studies and is in striking analogy to a similar pathway recently described for the related sodium pump. We therefore suggest a model for the ion exchange mechanism in P-II-ATPases including not one, but two cytoplasmic pathways working in concert.	[Bublitz, Maike; Musgaard, Maria; Poulsen, Hanne; Thogersen, Lea; Olesen, Claus; Morth, J. Preben; Moller, Jesper Vuust; Nissen, Poul] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark; [Schiott, Birgit] Aarhus Univ, Ctr Insoluble Prot Struct, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark; [Bublitz, Maike; Poulsen, Hanne; Morth, J. Preben; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Musgaard, Maria; Schiott, Birgit] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Olesen, Claus; Moller, Jesper Vuust] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Thogersen, Lea] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Schiott, Birgit] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Bublitz, M (corresponding author), Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark.	mbu@mb.au.dk	Schiott, Birgit/F-5067-2011; Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021; Nissen, Poul/D-5774-2014	Schiott, Birgit/0000-0001-9937-1562; Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Bublitz, Maike/0000-0003-3161-418X; Olesen, Claus/0000-0002-0462-1686; Musgaard, Maria/0000-0001-6096-9014	European Union FP7 Program EDICT; Danish Research Council Program DANSCATT; Danish Medical Research Council; Carlsberg fellowship; Danish Research Council; Novo-Nordisk Foundation; European Research Council	European Union FP7 Program EDICT; Danish Research Council Program DANSCATT; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carlsberg fellowship; Danish Research Council(Det Frie Forskningsrad (DFF)); Novo-Nordisk Foundation(Novo Nordisk Foundation); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Union FP7 Program EDICT and the Danish Research Council Program DANSCATT, a postdoctoral fellowship from the Danish Medical Research Council (to C. O.), a Carlsberg fellowship (to J. P. M.), an Eliteforsk travel stipend from the Danish Research Council (to M. M.), and a Hallas-Moller stipend from the Novo-Nordisk Foundation and the European Research Council Advanced Research Program BIOMEMOS (to P. N.). This article is part of the Thematic Minireview Series on the Ins and Outs of Calcium Transport.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; ANDERSEN JP, 1995, J BIOL CHEM, V270, P908, DOI 10.1074/jbc.270.2.908; ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BISHOP JE, 1988, J BIOL CHEM, V263, P1886; CLARK A, 1983, CELL CALCIUM, V4, P83, DOI 10.1016/0143-4160(83)90037-4; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2010, J BIOL CHEM, V285, P20780, DOI 10.1074/jbc.M110.116459; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Dode L, 2005, J BIOL CHEM, V280, P39124, DOI 10.1074/jbc.M506181200; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Ikeda S, 2003, J INVEST DERMATOL, V121, P475, DOI 10.1046/j.1523-1747.2003.12400.x; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JENCKS WP, 1989, J BIOL CHEM, V264, P18855; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Karjalainen EL, 2007, BBA-BIOENERGETICS, V1767, P1310, DOI 10.1016/j.bbabio.2007.07.010; LAUGER P, 1979, BIOCHIM BIOPHYS ACTA, V552, P143, DOI 10.1016/0005-2736(79)90253-0; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Lewis D, 2012, J BIOL CHEM, V287, P32717, DOI 10.1074/jbc.M112.373472; Menguy T, 2002, J BIOL CHEM, V277, P13016, DOI 10.1074/jbc.M108899200; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Musgaard M, 2012, BIOPHYS J, V102, P268, DOI 10.1016/j.bpj.2011.12.009; Musgaard M, 2011, BIOCHEMISTRY-US, V50, P11109, DOI 10.1021/bi201164b; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Till MS, 2010, J MOL MODEL, V16, P419, DOI 10.1007/s00894-009-0541-y; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; VIDAVER GA, 1966, J THEOR BIOL, V10, P301, DOI 10.1016/0022-5193(66)90128-7; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004	59	95	98	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10759	10765		10.1074/jbc.R112.436550	http://dx.doi.org/10.1074/jbc.R112.436550			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23400778	hybrid, Green Published			2022-12-28	WOS:000317565000054
J	Gilkes, DM; Bajpai, S; Chaturvedi, P; Wirtz, D; Semenza, GL				Gilkes, Daniele M.; Bajpai, Saumendra; Chaturvedi, Pallavi; Wirtz, Denis; Semenza, Gregg L.			Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by Inducing P4HA1, P4HA2, and PLOD2 Expression in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME TYPE-VI; BREAST-CANCER; LYSYL HYDROXYLASE; PROLYL 4-HYDROXYLASES; MAMMARY-TUMORS; FACTOR-I; COLLAGEN; METASTASIS; FIBROSIS; GROWTH	Extracellular matrix (ECM) composition, organization, and compliance provide both architectural and chemical cues that modulate tissue structure and function. ECM produced by stromal fibroblasts plays a key role in breast cancer invasion and metastasis, which are also stimulated by intratumoral hypoxia. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of ECM remodeling by fibroblasts under hypoxic conditions. HIF-1 activates expression of genes encoding collagen prolyl (P4HA1 and P4HA2) and lysyl (PLOD2) hydroxylases. P4HA1 and P4HA2 are required for collagen deposition, whereas PLOD2 is required for ECM stiffening and collagen fiber alignment. Together P4HA1, P4HA2, and PLOD2 mediate remodeling of ECM composition, alignment, and mechanical properties in response to hypoxia. HIF-1-dependent ECM remodeling by hypoxic fibroblasts induces changes in breast cancer cell morphology, adhesion, and motility that promote invasion and metastasis.	[Gilkes, Daniele M.; Chaturvedi, Pallavi; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Gilkes, Daniele M.; Chaturvedi, Pallavi; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Gilkes, Daniele M.; Bajpai, Saumendra; Wirtz, Denis; Semenza, Gregg L.] Johns Hopkins Univ, Ctr Oncol, Baltimore, MD 21218 USA; [Bajpai, Saumendra; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, 733 North Broadway,Suite 671, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Gilkes, Daniele M/AAI-8133-2020; Bajpai, Saumendra/B-8120-2014	Gilkes, Daniele M/0000-0003-3984-9338; Bajpai, Saumendra/0000-0002-9397-2102	National Institutes of Health through the NCI [U54-CA143868]; American Cancer Society [122437-RP-12-090-01-COUN]; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant U54-CA143868 through the NCI. This work was also supported by American Cancer Society Grant 122437-RP-12-090-01-COUN.; Recipient of a Susan G. Komen Breast Cancer Foundation postdoctoral fellowship award.	Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brinckmann J, 1996, J INVEST DERMATOL, V107, P589, DOI 10.1111/1523-1747.ep12582991; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Horino Y, 2002, LIFE SCI, V71, P3031, DOI 10.1016/S0024-3205(02)02142-2; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Luo WB, 2012, P NATL ACAD SCI USA, V109, pE3367, DOI 10.1073/pnas.1217394109; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2010, CELL TISSUE RES, V339, P19, DOI 10.1007/s00441-009-0841-7; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano P.P., 2010, CURR PROTOC CELL BIO; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Provenzano PP, 2009, CLIN EXP METASTAS, V26, P357, DOI 10.1007/s10585-008-9204-0; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; STEINMANN B, 1995, SCIENCE, V267, P258, DOI 10.1126/science.7809634; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang WG, 2002, CANCER RES, V62, P6278; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yeowell HN, 1997, ARCH BIOCHEM BIOPHYS, V347, P126, DOI 10.1006/abbi.1997.0319; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365	54	311	325	5	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10819	10829		10.1074/jbc.M112.442939	http://dx.doi.org/10.1074/jbc.M112.442939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23423382	hybrid, Green Published			2022-12-28	WOS:000317565000059
J	Watanabe, N; Mii, S; Asai, N; Asai, M; Niimi, K; Ushida, K; Kato, T; Enomoto, A; Ishii, H; Takahashi, M; Murakumo, Y				Watanabe, Naoki; Mii, Shinji; Asai, Naoya; Asai, Masato; Niimi, Kaoru; Ushida, Kaori; Kato, Takuya; Enomoto, Atsushi; Ishii, Hideshi; Takahashi, Masahide; Murakumo, Yoshiki			The REV7 Subunit of DNA Polymerase zeta Is Essential for Primordial Germ Cell Maintenance in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ELK-1; BINDING PROTEIN TIAR; EMBRYONIC STEM-CELLS; MICE LACKING; CATALYTIC SUBUNIT; REPAIR; COMPLEX; SPECIFICATION; MAD2L2; DISRUPTION	REV7 (also known as MAD2L2 and MAD2B) is involved in DNA repair, cell cycle regulation, gene expression, and carcinogenesis. In vitro studies show that REV7 interacts with several proteins and regulates their function. It has been reported that human REV7 is highly expressed in the adult testis by Northern blot analysis. However, the significance of REV7 in mammalian development has not been elucidated. Here, we present analyses of REV7-deficient (Rev7(-/-)) mice to clarify the significance of Rev7 in mouse development. In WT mice (Rev7(-/-)), Rev7 expression was ubiquitously observed in the embryo and confined to germ cells in the testes after birth. Rev7(-/-) mice exhibited growth retardation and a partial embryonic lethal phenotype. Mice that survived to adulthood were infertile in both sexes and showed germ cell aplasia in the testes and ovaries. Analyses of Rev7(-/-) embryos revealed that primordial germ cells (PGCs) were present at embryonic day 8.5 (E8.5). However, progressive loss of PGCs was observed during migration, and PGCs were absent in the genital ridges at E13.5. An increase of apoptotic cells was detected not only among PGCs but also in the forebrain of the Rev7(-/-) embryo, whereas cell proliferation was unaffected. Moreover, DNA damage accumulation and increased levels of histone methylation were detected in Rev7(-/-) embryos, and expression of Oct4 and Nanog was deregulated by REV7 deficiency at E8.5. These findings indicate that Rev7 is essential for PGC maintenance by prevention of apoptotic cell death in the mouse.	[Watanabe, Naoki; Mii, Shinji; Asai, Masato; Niimi, Kaoru; Ushida, Kaori; Kato, Takuya; Enomoto, Atsushi; Takahashi, Masahide; Murakumo, Yoshiki] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Dept Pathol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Niimi, Kaoru] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Dept Obstet & Gynecol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Pathol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Murakumo, Yoshiki] Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Nagoya University; Nagoya University; Nagoya University; Osaka University; Kitasato University	Murakumo, Y (corresponding author), Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	murakumo@med.kitasato-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; Mii, Shinji/I-7480-2014; asai, masato/I-7294-2014; Ishii, Hideshi/AAV-5317-2020; TAKAHASHI, Masahide/I-7244-2014; NIIMI, Kaoru/I-7509-2014; ASAI, Naoya/I-7377-2014; Enomoto, Atsushi/I-7272-2014	Takahashi, Masahide/0000-0002-2803-2683; Mii, Shinji/0000-0001-8266-3235; Enomoto, Atsushi/0000-0002-9206-6116	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Global Center of Excellence (GCOE) Research and for Scientific Research (A) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to M. T.), and by Grants-in-aid for Scientific Research (C) commissioned by MEXT of Japan (to Y. M.).	Anderson R, 1999, DEVELOPMENT, V126, P1655; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Burcham PC, 1999, MUTAT RES-GEN TOX EN, V443, P11, DOI 10.1016/S1383-5742(99)00008-3; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cesari F, 2004, MOL CELL BIOL, V24, P294, DOI 10.1128/MCB.24.1.294-305.2004; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Hsia KT, 2003, DEVELOPMENT, V130, P369, DOI 10.1242/dev.00221; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li L, 2007, MOL CELL BIOCHEM, V304, P297, DOI 10.1007/s11010-007-9512-8; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Matsui Y, 2010, J ANDROL, V31, P61, DOI 10.2164/jandrol.109.008094; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; McNally K, 2008, DNA REPAIR, V7, P597, DOI 10.1016/j.dnarep.2007.12.013; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nakane H, 2008, DNA REPAIR, V7, P1938, DOI 10.1016/j.dnarep.2008.08.003; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ng JMY, 2002, MOL CELL BIOL, V22, P1233, DOI 10.1128/MCB.22.4.1233-1245.2002; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Ombelet W, 2008, HUM REPROD UPDATE, V14, P605, DOI 10.1093/humupd/dmn042; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Rimkus C, 2007, INT J CANCER, V120, P207, DOI 10.1002/ijc.22155; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Saga Y, 2008, CURR OPIN GENET DEV, V18, P337, DOI 10.1016/j.gde.2008.06.003; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Schmahl J, 2000, DEVELOPMENT, V127, P65; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Sun JH, 2009, MECH DEVELOP, V126, P173, DOI 10.1016/j.mod.2008.11.004; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Van Sloun PPH, 2002, MOL CELL BIOL, V22, P2159, DOI 10.1128/MCB.22.7.2159-2169.2002; Vinson RK, 2002, MUTAT RES-FUND MOL M, V509, P79, DOI 10.1016/S0027-5107(02)00223-3; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06	64	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10459	10471		10.1074/jbc.M112.421966	http://dx.doi.org/10.1074/jbc.M112.421966			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23463509	Green Published, hybrid			2022-12-28	WOS:000317565000026
J	Tamai, T; Yamaguchi, O; Hikoso, S; Takeda, T; Taneike, M; Oka, T; Oyabu, J; Murakawa, T; Nakayama, H; Uno, Y; Horie, K; Nishida, K; Sonenberg, N; Shah, AM; Takeda, J; Komuro, I; Otsu, K				Tamai, Takahito; Yamaguchi, Osamu; Hikoso, Shungo; Takeda, Toshihiro; Taneike, Manabu; Oka, Takafumi; Oyabu, Jota; Murakawa, Tomokazu; Nakayama, Hiroyuki; Uno, Yoshihiro; Horie, Kyoji; Nishida, Kazuhiko; Sonenberg, Nahum; Shah, Ajay M.; Takeda, Junji; Komuro, Issei; Otsu, Kinya			Rheb (Ras Homologue Enriched in Brain)-dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation Becomes Indispensable for Cardiac Hypertrophic Growth after Early Postnatal Period	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION; DEPENDENT TRANSLATION; PRESSURE-OVERLOAD; GENE-EXPRESSION; PROTEIN-KINASE; CELL-GROWTH; AUTOPHAGY; MICE; SURVIVAL; DISEASE	Cardiomyocytes proliferate during fetal life but lose their ability to proliferate soon after birth and further increases in cardiac mass are achieved through an increase in cell size or hypertrophy. Mammalian target of rapamycin complex 1 (mTORC1) is critical for cell growth and proliferation. Rheb (Ras homologue enriched in brain) is one of the most important upstream regulators of mTORC1. Here, we attempted to clarify the role of Rheb in the heart using cardiac-specific Rheb-deficient mice (Rheb(-/-)). Rheb(-/-) mice died from postnatal day 8 to 10. The heart-to-body weight ratio, an index of cardiomyocyte hypertrophy, in Rheb(-/-) was lower than that in the control (Rheb(+/+)) at postnatal day 8. The cell surface area of cardiomyocytes isolated from the mouse hearts increased from postnatal days 5 to 8 in Rheb(+/+) mice but not in Rheb(-/-) mice. Ultrastructural analysis indicated that sarcomere maturation was impaired in Rheb(-/-) hearts during the neonatal period. Rheb(-/-) hearts exhibited no difference in the phosphorylation level of S6 or 4E-BP1, downstream of mTORC1 at postnatal day 3 but showed attenuation at postnatal day 5 or 8 compared with the control. Polysome analysis revealed that the mRNA translation activity decreased in Rheb(-/-) hearts at postnatal day 8. Furthermore, ablation of eukaryotic initiation factor 4E-binding protein 1 in Rheb(-/-) mice improved mRNA translation, cardiac hypertrophic growth, sarcomere maturation, and survival. Thus, Rheb-dependent mTORC1 activation becomes essential for cardiomyocyte hypertrophic growth after early postnatal period.	[Tamai, Takahito; Yamaguchi, Osamu; Hikoso, Shungo; Takeda, Toshihiro; Taneike, Manabu; Oka, Takafumi; Oyabu, Jota; Murakawa, Tomokazu; Nishida, Kazuhiko; Komuro, Issei; Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Taneike, Manabu; Nishida, Kazuhiko; Shah, Ajay M.; Otsu, Kinya] Kings Coll London, British Heart Fdn Ctr, Cardiovasc Div, London SE5 9NU, England; [Nakayama, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Pharmacogen, Suita, Osaka 5650871, Japan; [Uno, Yoshihiro] Osaka Univ, Lab Reprod Engn, Inst Expt Anim Sci, Suita, Osaka 5650871, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Sonenberg, Nahum] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	Osaka University; University of London; King's College London; Osaka University; Osaka University; Osaka University; McGill University; McGill University	Otsu, K (corresponding author), Kings Coll London, Cardiovasc Div, 125 Coldharbour Ln, London SE5 9NU, England.	kinya.otsu@kcl.ac.uk	Hikoso, Shungo/R-4281-2018	Shah, Ajay/0000-0002-6547-0631; Horie, Kyoji/0000-0001-9036-8180; Hikoso, Shungo/0000-0003-2284-1970; Yamaguchi, Osamu/0000-0002-7461-369X	Ministry of Education, Culture, Sports, and Science, Japan [CH/11/3/29051]; British Heart Foundation [RG/11/12/29052]	Ministry of Education, Culture, Sports, and Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Heart Foundation(British Heart Foundation)	This work was supported by Grant-in-aid for Scientific Research CH/11/3/29051 from the Ministry of Education, Culture, Sports, and Science, Japan to Osaka University and Grant RG/11/12/29052 from the British Heart Foundation to King's College London.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Gromov PS, 1995, FEBS LETT, V377, P221, DOI 10.1016/0014-5793(95)01349-0; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hikoso S, 2004, CIRCULATION, V110, P2631, DOI 10.1161/01.CIR.0000146798.70980.9A; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang YN, 2008, J MOL CELL CARDIOL, V45, P812, DOI 10.1016/j.yjmcc.2008.07.016; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yuan J, 2005, MOL BIOL REP, V32, P205, DOI 10.1007/s11033-005-0984-x; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	34	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10176	10187		10.1074/jbc.M112.423640	http://dx.doi.org/10.1074/jbc.M112.423640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426372	Green Published, hybrid			2022-12-28	WOS:000317114000058
J	Singh, D; Qi, RS; Jordan, JL; Mateo, LS; Kao, CC				Singh, Divyendu; Qi, Rongsu; Jordan, Jarrat L.; Mateo, Lani San; Kao, C. Cheng			The Human Antimicrobial Peptide LL-37, but Not the Mouse Ortholog, mCRAMP, Can Stimulate Signaling by Poly(I:C) through a FPRL1-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC PATHWAYS; DENDRITIC CELLS; SELF-DNA; INNATE; RECEPTOR; ACTIVATION; EXPRESSION; CLATHRIN; SURFACE; IL-8	LL-37 is an antimicrobial peptide produced by human cells that can down-regulate the lipopolysaccharide-induced innate immune responses and up-regulate double-stranded (ds) RNA-induced innate responses through Toll-like receptor 3 (TLR3). The murine LL-37 ortholog, mCRAMP, also inhibited lipopolysaccharide- induced responses, but unlike LL-37, it inhibited viral-induced responses in mouse cells. A fluorescence polarization assay showed that LL-37 was able to bind dsRNA better than mCRAMP. In the human lung epithelial cell line BEAS-2B, LL-37, but not mCRAMP, colocalized with TLR3, and the colocalization was increased in the presence of dsRNA. The presence of poly (I:C) increased the accumulation of LL-37 in Rab5 endosomes. Signaling by cells induced with both LL-37 and poly (I:C) was sensitive to inhibitors that affect clathrin-independent trafficking, whereas signaling by poly (I:C) alone was not, suggesting that the LL-37-poly (I:C) complex trafficked to signaling endosomes by a different mechanism than poly (I:C) alone. siRNA knockdown of known LL-37 receptors identified that FPRL1 was responsible for TLR3 signaling induced by LL-37-poly (I:C). These results show that LL-37 and mCRAMP have different activities in TLR3 signaling and that LL-37 can redirect trafficking of poly(I:C) to effect signaling by TLR3 in early endosomes in a mechanism that involves FPRL1.	[Singh, Divyendu; Qi, Rongsu; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Jordan, Jarrat L.; Mateo, Lani San] Janssen Pharmaceut Co Johnson & Johnson, Radnor, PA 19087 USA	Indiana University System; Indiana University Bloomington; Johnson & Johnson; Janssen Pharmaceuticals	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu		Jordan, Jarrat/0000-0002-0699-3774	Indiana Economic Development Corporation; Indiana METACyt Initiative through Lilly Endowment, Inc.	Indiana Economic Development Corporation; Indiana METACyt Initiative through Lilly Endowment, Inc.	This work was supported in part by a grant from the Indiana Economic Development Corporation (to C.K.).; We are grateful to Y. Lai and members of the Kao laboratory at Indiana University for numerous helpful discussions. We thank L. Kao for editing the manuscript and Jim Powers and the Indiana University Light Microscopy center for use of the confocal microscopy facility, which is supported by an Indiana METACyt Initiative funded in part through a grant from the Lilly Endowment, Inc.	Agerberth B., 2012, ANN RHEUM D IN PRESS; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Filewod NCJ, 2009, FEMS IMMUNOL MED MIC, V56, P233, DOI 10.1111/j.1574-695X.2009.00571.x; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Into T, 2010, CELL IMMUNOL, V264, P104, DOI 10.1016/j.cellimm.2010.05.005; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025837; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Limmongkon A, 2004, BIOCHEM BIOPH RES CO, V324, P382, DOI 10.1016/j.bbrc.2004.09.071; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Zhang XA, 2010, BBA-BIOMEMBRANES, V1798, P2201, DOI 10.1016/j.bbamem.2009.12.011	34	48	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8258	8268		10.1074/jbc.M112.440883	http://dx.doi.org/10.1074/jbc.M112.440883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386607	hybrid, Green Published			2022-12-28	WOS:000316564500026
J	Yang, HB; Li, GY; Wu, JJ; Wang, LD; Uhler, M; Simeone, DM				Yang, Huibin; Li, Gangyong; Wu, Jing-Jiang; Wang, Lidong; Uhler, Michael; Simeone, Diane M.			Protein Kinase A Modulates Transforming Growth Factor-beta Signaling through a Direct Interaction with Smad4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CANCER STEM-CELLS; TGF-BETA; E-CADHERIN; REGULATORY SUBUNIT; MOLECULAR-BASIS; BINDING-SITES; PROLINE-RICH; CAMP; ACTIVATION	Transforming growth factor beta (TGF beta) signaling normally functions to regulate embryonic development and cellular homeostasis. It is increasingly recognized that TGF beta signaling is regulated by cross-talk with other signaling pathways. We previously reported that TGF beta activates protein kinase A (PKA) independent of cAMP through an interaction of an activated Smad3-Smad4 complex and the regulatory subunit of the PKA holoenzyme (PKA-R). Here we define the interaction domains of Smad4 and PKA-R and the functional consequences of this interaction. Using a series of Smad4 and PKA-R truncation mutants, we identified amino acids 290-300 of the Smad4 linker region as critical for the specific interaction of Smad4 and PKA-R. Co-immunoprecipitation assays showed that the B cAMP binding domain of PKA-R was sufficient for interaction with Smad4. Targeting of B domain regions conserved among all PKA-R isoforms and exposed on the molecular surface demonstrated that amino acids 281-285 and 320-329 were required for complex formation with Smad4. Interactions of these specific regions of Smad4 and PKA-R were necessary for TGF beta-mediated increases in PKA activity, CREB (cAMP-response element-binding protein) phosphorylation, induction of p21, and growth inhibition. Moreover, this Smad4-PKA interaction was required for TGF beta-induced epithelial mesenchymal transition, invasion of pancreatic tumor cells, and regulation of tumor growth in vivo.	[Yang, Huibin; Li, Gangyong; Wu, Jing-Jiang; Wang, Lidong; Simeone, Diane M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Uhler, Michael] Univ Michigan, Dept Biochem, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Translat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Med Ctr, TC 2210B,Box 5343,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	simeone@umich.edu			National Institutes of Health [DK-061507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-061507 (to D. M. S.).	Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Attisano L., 2001, GENOME BIOL, V2, p3010.3011, DOI [DOI 10.1186/GB-2001-2-8-REVIEWS3010, 10.1186/gb-2001-2-8-reviews3010]; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; DOSKELAND SO, 1984, J BIOL CHEM, V259, P2291; Durand MK, 2004, THROMB HAEMOSTASIS, V91, P438, DOI 10.1160/TH03-12-0784; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Huang LJS, 1998, J BIOL CHEM, V273, P26739, DOI 10.1074/jbc.273.41.26739; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Makkar P, 2009, J MOL GRAPH MODEL, V27, P803, DOI 10.1016/j.jmgm.2008.12.003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Peng FF, 2008, AM J PHYSIOL-RENAL, V295, pF153, DOI 10.1152/ajprenal.00419.2007; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; ROBINSONSTEINER AM, 1983, J BIOL CHEM, V258, P1032; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; SHABB JB, 1995, PROTEIN SCI, V4, P2100, DOI 10.1002/pro.5560041015; Sharma K, 1997, J BIOL CHEM, V272, P14617, DOI 10.1074/jbc.272.23.14617; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Subramanian G, 2004, CANCER RES, V64, P5200, DOI 10.1158/0008-5472.CAN-04-0018; Takano S, 2007, J BIOCHEM, V141, P345, DOI 10.1093/jb/mvm039; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tsuchida K, 2003, KIDNEY INT, V63, P2000, DOI 10.1046/j.1523-1755.2003.00009.x; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wang LW, 1998, J BIOL CHEM, V273, P8522, DOI 10.1074/jbc.273.14.8522; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	58	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8737	8749		10.1074/jbc.M113.455675	http://dx.doi.org/10.1074/jbc.M113.455675			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362281	hybrid, Green Published			2022-12-28	WOS:000316564500073
J	Kirchner, P; Bug, M; Meyer, H				Kirchner, Philipp; Bug, Monika; Meyer, Hemmo			Ubiquitination of the N-terminal Region of Caveolin-1 Regulates Endosomal Sorting by the VCP/p97 AAA-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROTEIN; DEGRADATION; AUTOPHAGY; SYSTEM; P97; TRAFFICKING; BIOGENESIS; MUTATIONS; COMPLEXES	Caveolin-1 (CAV1) is the defining constituent of caveolae at the plasma membrane of many mammalian cells. For turnover, CAV1 is ubiquitinated and sorted to late endosomes and lysosomes. Sorting of CAV1 requires the AAA+-type ATPase VCP and its cofactor UBXD1. However, it is unclear in which region CAV1 is ubiquitinated and how ubiquitination is linked to sorting of CAV1 by VCP-UBXD1. Here, we show through site-directed mutagenesis that ubiquitination of CAV1 occurs at any of the six lysine residues, 5, 26, 30, 39, 47, and 57, that are clustered in the N-terminal region but not at lysines in the oligomerization, intramembrane, or C-terminal domains. Mutation of Lys-5-57 to arginines prevented binding of the VCP-UBXD1 complex and, importantly, strongly reduced recruitment of VCP-UBXD1 to endocytic compartments. Moreover, the Lys-5-57Arg mutation specifically interfered with trafficking of CAV1 from early to late endosomes. Conversely and consistently, depletion of VCP or UBXD1 led to accumulation of ubiquitinated CAV1, suggesting that VCP acts downstream of ubiquitination and is required for transport of the ubiquitinated form of CAV1 to late endosomes. These results define the N-terminal region of CAV1 as the critical ubiquitin conjugation site and, together with previous data, demonstrate the significance of this ubiquitination for binding to the VCP-UBXD1 complex and for sorting into lysosomes.	[Kirchner, Philipp; Bug, Monika; Meyer, Hemmo] Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, D-45117 Essen, Germany; [Kirchner, Philipp] BIOME, Grad Sch Biomed Sci, D-45147 Essen, Germany	University of Duisburg Essen	Meyer, H (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, Univ Str 5, D-45117 Essen, Germany.	hemmo.meyer@uni-due.de	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Kirchner, Philipp/0000-0002-7972-2318	Deutsche Forschungsgemeinschaft (DFG) [SPP1365/2, Me1626/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG) Priority Program SPP1365/2 Grant Me1626/2-1.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Galbiati F, 2000, J BIOL CHEM, V275, P37702, DOI 10.1074/jbc.M006657200; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062	39	36	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7363	7372		10.1074/jbc.M112.429076	http://dx.doi.org/10.1074/jbc.M112.429076			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23335559	hybrid, Green Published			2022-12-28	WOS:000316002400055
J	Alvarez-Dominguez, JR; Amosova, O; Fresco, JR				Alvarez-Dominguez, Juan R.; Amosova, Olga; Fresco, Jacques R.			Self-catalytic DNA Depurination Underlies Human beta-Globin Gene Mutations at Codon 6 That Cause Anemias and Thalassemias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROPHORETICALLY SILENT VARIANT; SITE-SPECIFIC DEPURINATION; BASE EXCISION-REPAIR; SICKLE-CELL MUTATION; CHAIN VARIANT; HEMOGLOBIN-VARIANTS; ORIGIN; DATABASE; HAPLOTYPES; RESISTANCE	The human beta-globin gene contains an 18-nucleotide coding strand sequence centered at codon 6 and capable of forming a stem-loop structure that can self-catalyze depurination of the 5' G residue of that codon. The resultant apurinic lesion is subject to error-prone repair, consistent with the occurrence about this codon of mutations responsible for 6 anemias and beta-thalassemias and additional substitutions without clinical consequences. The 4-residue loop of this stem-loop-forming sequence shows the highest incidence of mutation across the gene. The loop and first stem base pair-forming residues appeared early in the mammalian clade. The other stem-forming segments evolved more recently among primates, thereby conferring self-depurination capacity at codon 6. These observations indicate a conserved molecular mechanism leading to beta-globin variants underlying phenotypic diversity and disease.	[Alvarez-Dominguez, Juan R.; Amosova, Olga; Fresco, Jacques R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Alvarez-Dominguez, JR (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	juan.alvarez@mit.edu; olga.amosova@gmail.com; jrfresco@princeton.edu			Higgins Trust	Higgins Trust	This work was supported in part by a grant from the Higgins Trust.	Agarwal S, 1999, HEMOGLOBIN, V23, P263, DOI 10.3109/03630269909005707; Alanazi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025876; Allison AC, 2002, BIOCHEM MOL BIOL EDU, V30, P279, DOI 10.1002/bmb.2002.494030050108; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36316, DOI 10.1074/jbc.M111.272047; Amosova O, 2011, J BIOL CHEM, V286, P36322, DOI 10.1074/jbc.M111.272112; Bergman AC, 2009, HEMOGLOBIN, V33, P137, DOI 10.1080/03630260902861956; Bisse E, 2003, CLIN CHEM, V49, P137, DOI 10.1373/49.1.137; Bisse E, 2006, J CHROMATOGR A, V1115, P118, DOI 10.1016/j.chroma.2006.02.082; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Cai Y., 1982, CHINESE HEMATOL J, V3, P263; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Doss CGP, 2009, NEW BIOTECHNOL, V25, P214, DOI 10.1016/j.nbt.2009.01.004; Fresco JR, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P3, DOI 10.1007/978-3-642-20763-1_1; FRESCO JR, 1960, P NATL ACAD SCI USA, V46, P311, DOI 10.1073/pnas.46.3.311; Harano K, 1995, HEMOGLOBIN, V19, P397, DOI 10.3109/03630269509005831; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Ivaldi G., 2009, CLIN BIOCHEM, V42, P1851; Joly P, 2011, HEMOGLOBIN, V35, P147, DOI 10.3109/03630269.2010.550795; JURICIC D, 1983, HEMOGLOBIN, V7, P271, DOI 10.3109/03630268309048657; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KOLLIA P, 1989, HEMOGLOBIN, V13, P597, DOI 10.3109/03630268908993110; Korolev VG, 2005, RUSS J GENET+, V41, P1063, DOI 10.1007/s11177-005-0201-y; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; Kyrri A, 2001, HEMOGLOBIN, V25, P421, DOI 10.1081/HEM-100107880; Lacerra G, 2002, HEMOGLOBIN, V26, P59, DOI 10.1081/HEM-120002941; LANGDOWN JV, 1994, HEMOGLOBIN, V18, P333, DOI 10.3109/03630269408996199; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; LENARUSSO D, 1989, HEMOGLOBIN, V13, P743, DOI 10.3109/03630268908998848; MOOPENN WF, 1983, HEMOGLOBIN, V7, P91, DOI 10.3109/03630268309038405; ORKIN SH, 1981, J BIOL CHEM, V256, P9782; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Perea FJ, 1999, HEMOGLOBIN, V23, P231, DOI 10.3109/03630269909005703; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; PURRELLO R, 1993, J AM CHEM SOC, V115, P760, DOI 10.1021/ja00055a056; Sanguansermsri P., 2003, HAEMATOLOGICA, V88, pECR35; SCHROEDER WA, 1989, HEMOGLOBIN, V13, P325, DOI 10.3109/03630268909003397; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonelli V, 2005, NUCLEIC ACIDS RES, V33, P4404, DOI 10.1093/nar/gki749; SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P673, DOI 10.1021/tx00041a013; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; TUCHINDA S, 1965, BRIT MED J, V1, P1583, DOI 10.1136/bmj.1.5450.1583; Vichinsky Elliott, 2007, Hematology Am Soc Hematol Educ Program, P79; WAILOO K, 1991, B HIST MED, V65, P185; WILSON CID, 1984, FEBS LETT, V176, P331, DOI 10.1016/0014-5793(84)81190-4; Zhao X, 2010, J BIOINF COMPUT BIOL, V8, P101, DOI 10.1142/S021972001000518X	51	9	10	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11581	11589		10.1074/jbc.M113.454744	http://dx.doi.org/10.1074/jbc.M113.454744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23457306	Green Published, hybrid			2022-12-28	WOS:000317915500063
J	Mukundan, B; Ansari, A				Mukundan, Banupriya; Ansari, Athar			Srb5/Med18-mediated Termination of Transcription Is Dependent on Gene Looping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; MEDIATOR HEAD MODULE; PROCESSING FACTORS; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; INTERACTION MAP; ELONGATION; ACTIVATION; BINDING; DOMAIN	We have earlier demonstrated the involvement of Mediator subunit Srb5/Med18 in the termination of transcription for a subset of genes in yeast. Srb5/Med18 could affect termination either indirectly by modulating CTD-Ser(2) phosphorylation near the 3' end of a gene or directly by physically interacting with the cleavage and polyadenylation factor or cleavage factor 1 (CF1) complex and facilitating their recruitment to the terminator region. Here, we show that the CTD-Ser(2) phosphorylation pattern on Srb5/Med18-dependent genes remains unchanged in the absence of Srb5 in cells. Coimmunoprecipitation analysis revealed the physical interaction of Srb5/Med18 with the CF1 complex. No such interaction of Srb5/Med18 with the cleavage and polyadenylation factor complex, however, could be detected. The Srb5/Med18-CF1 interaction was not observed in the looping defective sua7-1 strain. Srb5/Med18 cross-linking to the 3' end of genes was also abolished in the sua7-1 strain. Chromosome conformation capture analysis revealed that the looped architecture of Srb5/Med18-dependent genes was abrogated in srb5(-) cells. Furthermore, Srb5-dependent termination of transcription was compromised in the looping defective sua7-1 cells. The overall conclusion of these results is that gene looping plays a crucial role in Srb5/Med18 facilitated termination of transcription, and the looped gene architecture may have a general role in termination of transcription in budding yeast.	[Mukundan, Banupriya; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	National Science Foundation [MCB1020911]; Department of Biology, Wayne State University	National Science Foundation(National Science Foundation (NSF)); Department of Biology, Wayne State University	This work was supported in part by National Science Foundation Grant MCB1020911 (to A. A.).; Supported by National Science Foundation Grant (MCB1020911) (to A. A.) and a graduate research fellowship from the Department of Biology, Wayne State University.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; [Anonymous], [No title captured]; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Ansari SA, 2012, TRANSCR-AUSTIN, V3, P110, DOI 10.4161/trns.19840; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Henriques T, 2012, TRANSCR-AUSTIN, V3, P198, DOI 10.4161/trns.21967; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; Hirose Y, 2000, GENE DEV, V14, P1415; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kremer SB, 2012, GENETICS, V191, P95, DOI 10.1534/genetics.111.135806; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lykke-Andersen S, 2011, CELL CYCLE, V10, P863, DOI 10.4161/cc.10.6.14931; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; Malik S, 2007, P NATL ACAD SCI USA, V104, P6182, DOI 10.1073/pnas.0608717104; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Moabbi AM, 2012, P NATL ACAD SCI USA, V109, P8505, DOI 10.1073/pnas.1112400109; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Proshkina G M, 2009, Bioorg Khim, V35, P572; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012	68	27	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11384	11394		10.1074/jbc.M112.446773	http://dx.doi.org/10.1074/jbc.M112.446773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476016	Green Published, hybrid			2022-12-28	WOS:000317915500041
J	Suginta, W; Chumjan, W; Mahendran, KR; Schulte, A; Winterhalter, M				Suginta, Wipa; Chumjan, Watcharin; Mahendran, Kozhinjampara R.; Schulte, Albert; Winterhalter, Mathias			Chitoporin from Vibrio harveyi, a Channel with Exceptional Sugar Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLACK LIPID-MEMBRANES; ESCHERICHIA-COLI; OUTER-MEMBRANE; CHITIN UTILIZATION; CURRENT NOISE; PSEUDOMONAS-AERUGINOSA; UTILIZATION PATHWAY; KLEBSIELLA-OXYTOCA; MARINE BACTERIUM; SINGLE-CHANNEL	Chitoporin (VhChiP) is a sugar-specific channel responsible for the transport of chitooligosaccharides through the outer membrane of the marine bacterium Vibrio harveyi. Single channel reconstitution into black lipid membrane allowed single chitosugar binding events in the channel to be resolved. VhChiP has an exceptionally high substrate affinity, with a binding constant of K = 5.0 x 10(6) M-1 for its best substrate (chitohexaose). The on-rates of chitosugars depend on applied voltages, as well as the side of the sugar addition, clearly indicating the inherent asymmetry of the VhChiP lumen. The binding affinity of VhChiP for chitohexaose is 1-5 orders of magnitude larger than that of other known sugar-specific porins for their preferred substrates. Thus, VhChiP is the most potent sugar-specific channel reported to date, with its high efficiency presumably reflecting the need for the bacterium to take up chitin-containing nutrients promptly under turbulent aquatic conditions to exploit them efficiently as its sole source of energy.	[Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Chem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Biochem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Mahendran, Kozhinjampara R.; Winterhalter, Mathias] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Suranaree University of Technology; Suranaree University of Technology; Jacobs University	Suginta, W (corresponding author), Suranaree Univ Technol, 111 Univ Ave, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		Winterhalter, Mathias/0000-0002-1604-3318	Alexander von Humboldt Fellowship for Experienced Researchers from the Alexander von Humboldt Foundation (Bonn, Germany); CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand) [60/2550]; Deutsche Forschungsgemeinschaft (DFG) [WI 2278/18-1]	Alexander von Humboldt Fellowship for Experienced Researchers from the Alexander von Humboldt Foundation (Bonn, Germany)(Alexander von Humboldt Foundation); CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Humboldt Fellow supported by an Alexander von Humboldt Fellowship for Experienced Researchers from the Alexander von Humboldt Foundation (Bonn, Germany). To whom correspondence should be addressed: Suranaree University of Technology, 111 University Ave., Nakhon Ratchasima 30000, Thailand. Fax: 66-44-226-187; E-mail: wipa@sut.ac.th.; Supported by CHE-PhD-SW Scholarship Contract 60/2550 from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand).; Supported by Deutsche Forschungsgemeinschaft (DFG) Grant WI 2278/18-1.	Actis LA, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P570, DOI 10.1079/9781845935542.0570; Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BENZ R, 1987, J GEN PHYSIOL, V89, P275, DOI 10.1085/jgp.89.2.275; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; Berkane E, 2005, J Nanobiotechnology, V3, P3, DOI 10.1186/1477-3155-3-3; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Hjerde E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-616; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Jung BO, 2008, MACROMOL RES, V16, P1, DOI 10.1007/BF03218953; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Klebba PE, 2002, RES MICROBIOL, V153, P417, DOI 10.1016/S0923-2508(02)01340-2; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Liuxy P. C., 1996, LETT APPL MICROBIOL, V22, P413; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; Mahendran KR, 2009, EUR BIOPHYS J BIOPHY, V38, P1141, DOI 10.1007/s00249-009-0495-0; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Orlik F, 2003, BIOPHYS J, V85, P876, DOI 10.1016/S0006-3495(03)74527-5; Pajatsch M, 1999, J BIOL CHEM, V274, P25159, DOI 10.1074/jbc.274.35.25159; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Suginta W, 2000, J APPL MICROBIOL, V89, P76, DOI 10.1046/j.1365-2672.2000.01076.x; Suginta W, 2007, ENZYME MICROB TECH, V41, P212, DOI 10.1016/j.enzmictec.2007.01.006; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Van Gelder P, 2000, BIOPHYS CHEM, V85, P153, DOI 10.1016/S0301-4622(99)00153-2; Van Gelder P, 2002, J BACTERIOL, V184, P2994, DOI 10.1128/JB.184.11.2994-2999.2002; Van Gelder P, 2001, PROTEIN ENG, V14, P943, DOI 10.1093/protein/14.11.943; Winterhalter M, 2000, CURR OPIN COLLOID IN, V5, P250, DOI 10.1016/S1359-0294(00)00063-7; WYLIE JL, 1993, J BIOENERG BIOMEMBR, V25, P547, DOI 10.1007/BF01108411; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200	40	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11038	11046		10.1074/jbc.M113.454108	http://dx.doi.org/10.1074/jbc.M113.454108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23447539	hybrid, Green Published			2022-12-28	WOS:000317915500010
J	Ingvarsen, S; Porse, A; Erpicum, C; Maertens, L; Jurgensen, HJ; Madsen, DH; Melander, MC; Gardsvoll, H; Hoyer-Hansen, G; Noel, A; Holmbeck, K; Engelholm, LH; Behrendt, N				Ingvarsen, Signe; Porse, Astrid; Erpicum, Charlotte; Maertens, Ludovic; Jurgensen, Henrik J.; Madsen, Daniel H.; Melander, Maria C.; Gardsvoll, Henrik; Hoyer-Hansen, Gunilla; Noel, Agnes; Holmbeck, Kenn; Engelholm, Lars H.; Behrendt, Niels			Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP IMPACT ON LYMPHANGIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TYPE-1 METALLOPROTEINASE; EXTRACELLULAR-MATRIX; GELATINASE-A; MT-MMP; MULTICENTRIC OSTEOLYSIS; COMPLEX-FORMATION; IV COLLAGENASE; CELL-SURFACE; TUMOR-GROWTH; ACTIVATION	The group of matrix metalloproteases (MMPs) is responsible for multiple processes of extracellular matrix remodeling in the healthy body but also for matrix and tissue destruction during cancer invasion and metastasis. The understanding of the contributions from each individual MMP, both in healthy and pathological events, has been complicated by the lack of specific inhibitors and the fact that some of the potent MMPs are multifunctional enzymes. These factors have also hampered the setup of therapeutic strategies targetingMMPactivity. A tempting target is the membrane-associated MT1-MMP, which has well-documented importance in matrix degradation but which takes part in more than one pathway in this regard. In this report, we describe the selective targeting of a single function of this enzyme by means of a specific monoclonal antibody against MT1-MMP, raised in an MT1-MMP knock-out mouse. The antibody blocks the enzyme ability to activate proMMP-2 without interfering with the collagenolytic function or the general proteolytic activity of MT1-MMP. Using this antibody, we have shown that the MT1-MMP-catalyzed activation of proMMP-2 is involved in the outgrowth of cultured lymphatic endothelial cells in a collagen matrix in vitro, as well as in lymphatic vessel sprouting assayed ex vivo. This is the first example of the complete inactivation of a single function of a multifunctional MMP and the use of this strategy to pursue its role.	[Madsen, Daniel H.; Melander, Maria C.; Gardsvoll, Henrik; Hoyer-Hansen, Gunilla; Engelholm, Lars H.; Behrendt, Niels] Rigshosp, Finsen Lab, BRIC, DK-2200 Copenhagen N, Denmark; [Ingvarsen, Signe] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Erpicum, Charlotte; Maertens, Ludovic; Noel, Agnes] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, B-4000 Liege, Belgium; [Holmbeck, Kenn] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	Rigshospitalet; University of Copenhagen; University of Liege; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Behrendt, N (corresponding author), Rigshosp, Finsen Lab, BRIC, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	niels.behrendt@finsenlab.dk	Ingvarsen, Signe Ziir/AAT-3296-2020	Madsen, Daniel Hargboel/0000-0002-3183-6201; Noel, Agnes/0000-0002-7670-6179; Engelholm, Lars/0000-0002-6616-1232; Ingvarsen, Signe Ziir/0000-0001-7800-6443; Behrendt, Niels/0000-0003-1833-3922	National Institutes of Health, NIDCR; Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium); Foundation against Cancer (Foundation of Public Interest, Belgium); Plan National Cancer (Service Public Federal, Belgium); European Community [201279]; "Grosserer Alfred Nielsen og Hustrus" Foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation [R118-2012-11578, R67-2010-6200] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002353] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000676] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Foundation against Cancer (Foundation of Public Interest, Belgium); Plan National Cancer (Service Public Federal, Belgium); European Community(European Commission); "Grosserer Alfred Nielsen og Hustrus" Foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NIDCR (to K. H.), the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer), the Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium), the Foundation against Cancer (Foundation of Public Interest, Belgium), the Plan National Cancer (Service Public Federal, Belgium), the European Community's Seventh Framework Programme FP7/2007-2011 under Grant Agreement n 201279 (to N.B., G. H.-H., and A.N.), and the "Grosserer Alfred Nielsen og Hustrus" Foundation (to L. H. E.). The work was also supported by personal grants from Copenhagen University Hospital (to A. P., D. H. M., and H.J.J.), from the Lundbeck Foundation (to D. H. M.) and from the University of Copenhagen, Faculty of Science (to S.I.).	Almholt K, 2008, MOL CANCER THER, V7, P2758, DOI 10.1158/1535-7163.MCT-08-0251; Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basu B, 2012, INT J BIOCHEM CELL B, V44, P393, DOI 10.1016/j.biocel.2011.11.015; Bigg HF, 2001, CANCER RES, V61, P3610; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Devy L, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/191670; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159; Evans BR, 2012, AM J HUM GENET, V91, P572, DOI 10.1016/j.ajhg.2012.07.022; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh T, 1998, CANCER RES, V58, P1048; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; List K, 1999, J IMMUNOL METHODS, V222, P125, DOI 10.1016/S0022-1759(98)00189-6; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Matsuo M, 2007, CANCER LETT, V251, P288, DOI 10.1016/j.canlet.2006.11.027; Mols J, 2005, IN VITRO CELL DEV-AN, V41, P83; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Naito S, 2012, BIOCHEMISTRY-US, V51, P8877, DOI 10.1021/bi301228d; Nakamura H, 1999, CANCER RES, V59, P467; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Polette M, 1996, VIRCHOWS ARCH, V428, P29; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Sounni NE, 2002, INT J CANCER, V98, P23, DOI 10.1002/ijc.10134; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Su JM, 2003, CANCER RES, V63, P600; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; TOKURAKU M, 1995, INT J CANCER, V64, P355, DOI 10.1002/ijc.2910640513; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; WINCHESTER P, 1969, AMER J ROENTGENOL RA, V106, P121, DOI 10.2214/ajr.106.1.121; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	53	44	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10195	10204		10.1074/jbc.M112.447169	http://dx.doi.org/10.1074/jbc.M112.447169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23413031	Green Published, hybrid			2022-12-28	WOS:000317565000002
J	Novoselova, TV; Rose, RS; Marks, HM; Sullivan, JA				Novoselova, Tatiana Vladislavovna; Rose, Ruth-Sarah; Marks, Helen Margaret; Sullivan, James Andrew			SUMOylation Regulates the Homologous to E6-AP Carboxyl Terminus (HECT) Ubiquitin Ligase Rsp5p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST METAL TRANSPORTER; PROSTATE-CANCER CELLS; RNA-POLYMERASE-II; SUMO MODIFICATION; PROTEIN LIGASE; PLASMA-MEMBRANE; IN-VITRO; SACCHAROMYCES-CEREVISIAE; ANDROGEN RECEPTOR; CHANNEL K2P1	The post-translational modifiers ubiquitin and small ubiquitin-related modifier (SUMO) regulate numerous critical signaling pathways and are key to controlling the cellular fate of proteins in eukaryotes. The attachment of ubiquitin and SUMO involves distinct, but related, machinery. However, it is now apparent that many substrates can be modified by both ubiquitin and SUMO and that some regulatory interaction takes place between the respective attachment machinery. Here, we demonstrate that the Saccharomyces cerevisiae ubiquitin ligase Rsp5p, a member of the highly conserved Nedd4 family of ubiquitin ligases, is SUMOylated in vivo. We further show that Rsp5p SUMOylation is mediated by the SUMO ligases Siz1p and Siz2p, members of the conserved family of PIAS SUMO ligases that are, in turn, substrates for Rsp5p-mediated ubiquitylation. Our experiments show that SUMOylated Rsp5p has reduced ubiquitin ligase activity, and similarly, ubiquitylated Siz1p demonstrates reduced SUMO ligase activity leading to respective changes in both ubiquitin-mediated sorting of the manganese transporter Smf1p and polySUMO chain formation. This reciprocal regulation of these highly conserved ligases represents an exciting and previously unidentified system of cross talk between the ubiquitin and SUMO systems.	[Novoselova, Tatiana Vladislavovna; Rose, Ruth-Sarah; Marks, Helen Margaret; Sullivan, James Andrew] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Sullivan, JA (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.a.sullivan@qmul.ac.uk	Rose, Ruth/AAW-3844-2020	Rose, Ruth/0000-0001-6406-137X; Sullivan, James/0000-0003-1457-2950	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/G004412/1] Funding Source: researchfish; BBSRC [BB/G004412/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council.	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Erdeniz N, 2000, MOL CELL BIOL, V20, P224, DOI 10.1128/MCB.20.1.224-232.2000; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hang LE, 2011, NAT STRUCT MOL BIOL, V18, P920, DOI 10.1038/nsmb.2100; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Wible BA, 2002, J BIOL CHEM, V277, P17852, DOI 10.1074/jbc.M201689200; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	60	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10308	10317		10.1074/jbc.M112.424234	http://dx.doi.org/10.1074/jbc.M112.424234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443663	Green Published, hybrid			2022-12-28	WOS:000317565000012
J	Haviv, H; Habeck, M; Kanai, R; Toyoshima, C; Karlish, SJD				Haviv, Haim; Habeck, Michael; Kanai, Ryuta; Toyoshima, Chikashi; Karlish, Steven J. D.			Neutral Phospholipids Stimulate Na,K-ATPase Activity A SPECIFIC LIPID-PROTEIN INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; SODIUM-POTASSIUM PUMP; MOLECULAR ACTIVITY; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; DIETARY SUPPLEMENTATION; BIOLOGICAL-MEMBRANES; FXYD PROTEINS; STEADY-STATE; NA+,K+-ATPASE	Membrane proteins interact with phospholipids either via an annular layer surrounding the transmembrane segments or by specific lipid-protein interactions. Although specifically bound phospholipids are observed in many crystal structures of membrane proteins, their roles are not well understood. Na,K-ATPase is highly dependent on acid phospholipids, especially phosphatidylserine, and previous work on purified detergent-soluble recombinant Na, K-ATPase showed that phosphatidylserine stabilizes and specifically interacts with the protein. Most recently the phosphatidylserine binding site has been located between transmembrane segments of alpha TM8-10 and the FXYD protein. This paper describes stimulation of Na, K-ATPase activity of the purified human alpha 1 beta 1 or alpha 1 beta 1FXYD1 complexes by neutral phospholipids, phosphatidylcholine, or phosphatidylethanolamine. In the presence of phosphatidylserine, soy phosphatidylcholine increases the Na, K-ATPase turnover rate from 5483 +/- 144 to 7552 +/- 105 (p < 0.0001). Analysis of alpha 1 beta 1FXYD1 complexes prepared with native or synthetic phospholipids shows that the stimulatory effect is structurally selective for neutral phospholipids with polyunsaturated fatty acyl chains, especially dilinoleoyl phosphatidylcholine or phosphatidylethanolamine. By contrast to phosphatidylserine, phosphatidylcholine or phosphatidylethanolamine destabilizes the Na, K-ATPase. Structural selectivity for stimulation of Na, K-ATPase activity and destabilization by neutral phospholipids distinguish these effects from the stabilizing effects of phosphatidylserine and imply that the phospholipids bind at distinct sites. A re-examination of electron densities of shark Na, K-ATPase is consistent with two bound phospholipids located between transmembrane segments alpha TM8-10 and TMFXYD(site A) and between TM2, -4, -6, -and 9 (site B). Comparison of the phospholipid binding pockets in E2 and E1 conformations suggests a possible mechanism of stimulation of Na, K-ATPase activity by the neutral phospholipid.	[Haviv, Haim; Habeck, Michael; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kanai, Ryuta; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bungkyo Ku, Tokyo 1130032, Japan	Weizmann Institute of Science; University of Tokyo	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il	Toyoshima, Chikashi/R-4153-2019	Habeck, Michael/0000-0002-4586-0499; Toyoshima, Chikashi/0000-0001-9640-0778	Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly, Weizmann Institute	Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly, Weizmann Institute	Supported by the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly, Weizmann Institute.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; DEPONT JJHHM, 1978, BIOCHIM BIOPHYS ACTA, V508, P464, DOI 10.1016/0005-2736(78)90092-5; Else PL, 2003, ANN NY ACAD SCI, V986, P525, DOI 10.1111/j.1749-6632.2003.tb07240.x; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gerbi A, 1997, DIABETOLOGIA, V40, P496, DOI 10.1007/s001250050707; GERBI A, 1993, BIOCHIM BIOPHYS ACTA, V1165, P291, DOI 10.1016/0005-2760(93)90139-Z; Gerbi A, 1998, J NEUROCHEM, V71, P732; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Hayashi Y, 1988, Prog Clin Biol Res, V268A, P205; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z; Turner N, 2006, PHYSIOL BIOCHEM ZOOL, V79, P522, DOI 10.1086/502815; WHEELER KP, 1970, J PHYSIOL-LONDON, V207, P303, DOI 10.1113/jphysiol.1970.sp009063; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037	49	35	39	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10073	10081		10.1074/jbc.M112.446997	http://dx.doi.org/10.1074/jbc.M112.446997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430748	Green Published, hybrid			2022-12-28	WOS:000317114000045
J	Liu, Y; Esser, L; Interlandi, G; Kisiela, DI; Tchesnokova, V; Thomas, WE; Sokurenko, E; Xia, D; Savarino, SJ				Liu, Yang; Esser, Lothar; Interlandi, Gianluca; Kisiela, Dagmara I.; Tchesnokova, Veronika; Thomas, Wendy E.; Sokurenko, Evgeni; Xia, Di; Savarino, Stephen J.			Tight Conformational Coupling between the Domains of the Enterotoxigenic Escherichia coli Fimbrial Adhesin CfaE Regulates Binding State Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ANTIGEN-I; STRUCTURAL BASIS; STRUCTURE VALIDATION; BACTERIAL ADHESION; CRYSTAL-STRUCTURE; FIMH; MOLPROBITY; DYNAMICS; PROTEIN	CfaE, the tip adhesin of enterotoxigenic Escherichia coli colonization factor antigen I fimbriae, initiates binding of this enteropathogen to the small intestine. It comprises stacked beta-sandwich adhesin (AD) and pilin (PD) domains, with the putative receptor-binding pocket at one pole and an equatorial interdomain interface. CfaE binding to erythrocytes is enhanced by application of moderate shear stress. A G168D replacement along the AD facing the CfaE interdomain region was previously shown to decrease the dependence on shear by increasing binding at lower shear forces. To elucidate the structural basis for this functional change, we studied the properties of CfaE G168D (with a self-complemented donor strand) and solved its crystal structure at 2.6 angstrom resolution. Compared with native CfaE, CfaE G168D showed a downward shift in peak erythrocyte binding under shear stress and greater binding under static conditions. The thermal melting transition of CfaE G168D occurred 10 C below that of CfaE. Compared with CfaE, the atomic structure of CfaE G168D revealed a 36% reduction in the buried surface area at the interdomain interface. Despite the location of this single modification in the AD, CfaE G168D exhibited structural derangements only in the adjoining PD compared with CfaE. In molecular dynamics simulations, the G168D mutation was associated with weakened interdomain interactions under tensile force. Taken together, these findings indicate that the AD and PD of CfaE are conformationally tightly coupled and support the hypothesis that opening of the interface plays a critical modulatory role in the allosteric activation of CfaE.	[Liu, Yang; Savarino, Stephen J.] USN, Enter Dis Dept, Infect Dis Directorate, Med Res Ctr, Silver Spring, MD 20910 USA; [Esser, Lothar; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Esser, Lothar; Thomas, Wendy E.] Univ Washington, Dept Engn, Seattle, WA 98195 USA; [Kisiela, Dagmara I.; Tchesnokova, Veronika; Sokurenko, Evgeni] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Savarino, Stephen J.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA	United States Department of Defense; United States Navy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Uniformed Services University of the Health Sciences - USA	Sokurenko, E (corresponding author), Univ Washington, Dept Microbiol, Hlth Sci Bldg,Rm E309, Seattle, WA 98195 USA.	evs@u.washington.edu; dixia@helix.nih.gov; stephen.savarino@med.navy.mil		Thomas, Wendy/0000-0001-8602-0819	National Institutes of Health [R01 AI050940]; National Cancer Institute Intramural Research Program; Trans-National Institutes of Health/Food and Drug Administration Intramural Biodefense Program; United States Army Military Infectious Diseases Research Program Work Unit [A1207]; Henry M. Jackson Foundation for the Advancement of Military Medicine; TeraGrid Grant [TG-MCB060069N]; National Science Foundation; NATIONAL CANCER INSTITUTE [ZIABC010735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Trans-National Institutes of Health/Food and Drug Administration Intramural Biodefense Program; United States Army Military Infectious Diseases Research Program Work Unit; Henry M. Jackson Foundation for the Advancement of Military Medicine; TeraGrid Grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI050940 (to E. S.) and by the National Cancer Institute Intramural Research Program and the Trans-National Institutes of Health/Food and Drug Administration Intramural Biodefense Program (to D. X.). This work was also supported by United States Army Military Infectious Diseases Research Program Work Unit A1207 and the Henry M. Jackson Foundation for the Advancement of Military Medicine (to S. J. S.). This work was prepared as part of the official duty of S. J. S.; We thank the staff of the Southeast Regional Collaborative Access Team for assistance for data collection. The molecular dynamics simulations were run on the Trestles supercomputer at the San Diego Supercomputer Center supported by TeraGrid Grant TG-MCB060069N with funding from the National Science Foundation. We are grateful to Daniel Isaac for critical reading of the manuscript.	ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Andersson M, 2012, J MOL BIOL, V415, P918, DOI 10.1016/j.jmb.2011.12.006; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker KK, 2009, CELL MICROBIOL, V11, P742, DOI 10.1111/j.1462-5822.2009.01287.x; BARTUS H, 1985, J CLIN MICROBIOL, V21, P951, DOI 10.1128/JCM.21.6.951-954.1985; Bjornham O, 2010, BIOPHYS J, V99, P1331, DOI 10.1016/j.bpj.2010.06.003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Li YF, 2007, J BIOL CHEM, V282, P23970, DOI 10.1074/jbc.M700921200; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poole ST, 2007, MOL MICROBIOL, V63, P1372, DOI 10.1111/j.1365-2958.2007.05612.x; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804	31	8	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9993	10001		10.1074/jbc.M112.413534	http://dx.doi.org/10.1074/jbc.M112.413534			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23393133	hybrid, Green Published			2022-12-28	WOS:000317114000038
J	Rushworth, JV; Griffiths, HH; Watt, NT; Hooper, NM				Rushworth, Jo V.; Griffiths, Heledd H.; Watt, Nicole T.; Hooper, Nigel M.			Prion Protein-mediated Toxicity of Amyloid-beta Oligomers Requires Lipid Rafts and the Transmembrane LRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; A-BETA; IN-VIVO; COGNITIVE IMPAIRMENTS; SYNAPTIC PLASTICITY; NEURONAL CELLS; N-TERMINUS; RECEPTOR; MEMORY; ENDOCYTOSIS	Soluble oligomers of the amyloid-beta (A beta) peptide cause neurotoxicity, synaptic dysfunction, and memory impairments that underlie Alzheimer disease (AD). The cellular prion protein (PrPC) was recently identified as a high affinity neuronal receptor for A beta oligomers. We report that fibrillar A beta oligomers recognized by the OC antibody, which have been shown to correlate with the onset and severity of AD, bind preferentially to cells and neurons expressing PrPC. The binding of A beta oligomers to cell surface PrPC, as well as their downstream activation of Fyn kinase, was dependent on the integrity of cholesterol-rich lipid rafts. In SH-SY5Y cells, fluorescence microscopy and co-localization with subcellular markers revealed that the A beta oligomers co-internalized with PrPC, accumulated in endosomes, and subsequently trafficked to lysosomes. The cell surface binding, internalization, and downstream toxicity of A beta oligomers was dependent on the transmembrane low density lipoprotein receptor-related protein-1 (LRP1). The binding of A beta oligomers to cell surface PrPC impaired its ability to inhibit the activity of the beta-secretase BACE1, which cleaves the amyloid precursor protein to produce A beta. The green tea polyphenol (-)-epigallo-catechin gallate and the red wine extract resveratrol both remodeled the fibrillar conformation of A beta oligomers. The resulting nonfibrillar oligomers displayed significantly reduced binding to PrPC-expressing cells and were no longer cytotoxic. These data indicate that soluble, fibrillar A beta oligomers bind to PrPC in a conformation-dependent manner and require the integrity of lipid rafts and the transmembrane LRP1 for their cytotoxicity, thus revealing potential targets to alleviate the neurotoxic properties of A beta oligomers in AD.	[Rushworth, Jo V.; Griffiths, Heledd H.; Watt, Nicole T.; Hooper, Nigel M.] Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Hooper, NM (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	N.M.Hooper@leeds.ac.uk	Rushworth, Jo/AAL-2555-2021	Rushworth, Jo/0000-0002-7134-2011; Hooper, Nigel/0000-0002-5811-3484; Jarosz-Griffiths, Heledd/0000-0001-5154-4815	Wellcome Trust; Alzheimer's Research UK; Medical Research Council; Alzheimers Research UK [ART-PG2010-2] Funding Source: researchfish; Medical Research Council [G0802189] Funding Source: researchfish; MRC [G0802189] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, Alzheimer's Research UK, and the Medical Research Council.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2009, NATURE, V457, P1090, DOI 10.1038/4571090a; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Dupiereux I, 2008, J NEUROSCI RES, V86, P653, DOI 10.1002/jnr.21506; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Paitel E, 2002, J NEUROCHEM, V83, P1208, DOI 10.1046/j.1471-4159.2002.01234.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Rees S, 1996, BIOTECHNIQUES, V20, P102; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Wimo A, 2010, WORLD ALZHEIMER REPO; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x	71	112	113	0	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8935	8951		10.1074/jbc.M112.400358	http://dx.doi.org/10.1074/jbc.M112.400358			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386614	hybrid, Green Published			2022-12-28	WOS:000316862200014
J	Yang, XF; Mei, S; Wang, XL; Li, X; Liu, R; Ma, Y; Hao, LP; Yao, P; Liu, LG; Sun, XF; Gu, HH; Liu, ZQ; Cao, WH				Yang, Xuefeng; Mei, Shuang; Wang, Xiaolei; Li, Xiang; Liu, Rui; Ma, Yan; Hao, Liping; Yao, Ping; Liu, Liegang; Sun, Xiufa; Gu, Haihua; Liu, Zhenqi; Cao, Wenhong			Leucine Facilitates Insulin Signaling through a G alpha(i) Protein-dependent Signaling Pathway in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; LOWERING AMINO-ACID; SKELETAL-MUSCLE; GLUCOSE DISPOSAL; KINASE PLAYS; RESISTANCE; MTOR; HYPERINSULINEMIA; GLUCONEOGENESIS; METABOLISM	In this study, we addressed the direct effect of leucine on insulin signaling. In investigating the associated mechanisms, we found that leucine itself does not activate the classical Akt- or ERK1/2 MAP kinase-dependent signaling pathways but can facilitate the insulin-induced phosphorylations of Akt(473) and ERK1/2 in a time- and dose-dependent manner in cultured hepatocytes. The leucine-facilitated insulin-induced phosphorylation of Akt at residue 473 was not affected by knocking down the key component of mTORC1 or -2 complexes but was blocked by inhibition of c-Src (PP2), PI3K (LY294002), G alpha(i) protein (pertussis toxin or siRNA against G alpha(i1) gene, or beta-arrestin 2 (siRNA)). Similarly, the leucine-facilitated insulin activation of ERK1/2 was also blunted by pertussis toxin. We further show that leucine facilitated the insulin-mediated suppression of glucose production and expression of key gluconeogenic genes in a G alpha(i1) protein-dependent manner in cultured primary hepatocytes. Together, these results show that leucine can directly facilitate insulin signaling through a G alpha(i) protein-dependent intracellular signaling pathway. This is the first evidence showing that macronutrients like amino acid leucine can facilitate insulin signaling through G proteins directly.	[Yang, Xuefeng; Wang, Xiaolei; Li, Xiang; Liu, Rui; Ma, Yan; Hao, Liping; Yao, Ping; Liu, Liegang; Sun, Xiufa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430030, Hubei, Peoples R China; [Yang, Xuefeng; Wang, Xiaolei; Li, Xiang; Liu, Rui; Ma, Yan; Hao, Liping; Yao, Ping; Liu, Liegang; Sun, Xiufa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430030, Hubei, Peoples R China; [Yang, Xuefeng; Mei, Shuang; Gu, Haihua; Cao, Wenhong] Univ N Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, Inst Nutr Res, Kannapolis, NC 28081 USA; [Yang, Xuefeng; Mei, Shuang; Gu, Haihua; Cao, Wenhong] Univ N Carolina Chapel Hill, Sch Med, Kannapolis, NC 28081 USA; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ, Sch Med, Dept Med Endocrinol & Metab, Durham, NC 27705 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; Duke University	Yang, XF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430030, Hubei, Peoples R China.	xuefengyang@gmail.com; caow@unc.edu	Yang, Xuefeng/AAB-7163-2019		National Natural Science Foundation of China [30800907]; Fundamental Research Funds for Central Universities Huazhong University of Science and Technology Grant [2011TS055]; American Diabetes Association Grant [7-09-BS-27]; National Institutes of Health Grant [R01DK076039]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities Huazhong University of Science and Technology Grant; American Diabetes Association Grant(American Diabetes Association); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grant 30800907 (to X. Y.), the Fundamental Research Funds for Central Universities Huazhong University of Science and Technology Grant 2011TS055 (to X. Y.), The American Diabetes Association Grant 7-09-BS-27 (to W. C.), and National Institutes of Health Grant R01DK076039 (to W. C.).	ABUMRAD NN, 1982, J SURG RES, V32, P453, DOI 10.1016/0022-4804(82)90126-3; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Cao Wenhong, 2011, Curr Mol Pharmacol, V4, P154; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Doi M, 2005, J NUTR, V135, P2103, DOI 10.1093/jn/135.9.2103; Doi M, 2003, BIOCHEM BIOPH RES CO, V312, P1111, DOI 10.1016/j.bbrc.2003.11.039; FELIG P, 1970, NEW ENGL J MED, V282, P166; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Feng XT, 2011, MOL BIOL REP, V38, P2517, DOI 10.1007/s11033-010-0389-3; Filiputti E, 2010, METABOLISM, V59, P635, DOI 10.1016/j.metabol.2009.09.007; FLAKOLL PJ, 1992, DIABETOLOGIA, V35, P357, DOI 10.1007/BF00401203; Guo KY, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-57; Hinault C, 2006, DIABETOLOGIA, V49, P1017, DOI 10.1007/s00125-006-0201-z; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Liu HY, 2009, J BIOL CHEM, V284, P27090, DOI 10.1074/jbc.M109.016675; Liu HY, 2009, J BIOL CHEM, V284, P14087, DOI 10.1074/jbc.M807992200; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; MORTIMORE GE, 1994, BIOCHEM BIOPH RES CO, V203, P200, DOI 10.1006/bbrc.1994.2168; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nishitani S, 2005, AM J PHYSIOL-GASTR L, V288, pG1292, DOI 10.1152/ajpgi.00510.2003; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; PISTERS PWT, 1991, METABOLISM, V40, P59, DOI 10.1016/0026-0495(91)90193-Z; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHWENK WF, 1987, DIABETES, V36, P199, DOI 10.2337/diabetes.36.2.199; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; TESSARI P, 1985, DIABETOLOGIA, V28, P870, DOI 10.1007/BF00291080; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	44	10	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9313	9320		10.1074/jbc.M112.409409	http://dx.doi.org/10.1074/jbc.M112.409409			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404499	Green Published, hybrid			2022-12-28	WOS:000316862200049
J	Downs, CA; Kumar, A; Kreiner, LH; Johnson, NM; Helms, MN				Downs, Charles A.; Kumar, Amrita; Kreiner, Lisa H.; Johnson, Nicholle M.; Helms, My N.			H2O2 Regulates Lung Epithelial Sodium Channel (ENaC) via Ubiquitin-like Protein Nedd8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; REDOX REGULATION; ALPHA-SUBUNIT; TRANSPORT; CELLS; SGK1; PHOSPHORYLATION; ARCHITECTURE; DEGRADATION; INHIBITION	Redundancies in both the ubiquitin and epithelial sodium transport pathways allude to their importance of proteolytic degradation and ion transport in maintaining normal cell function. The classical pathway implicated in ubiquitination of the epithelial sodium channel (ENaC) involves Nedd4-2 regulation of sodium channel subunit expression and has been studied extensively studied. However, less attention has been given to the role of the ubiquitin-like protein Nedd8. Here we show that Nedd8 plays an important role in the ubiquitination of ENaC in alveolar epithelial cells. We report that the Nedd8 pathway is redox-sensitive and that under oxidizing conditions Nedd8 conjugation to Cullin-1 is attenuated, resulting in greater surface expression of alpha-ENaC. This observation was confirmed in our electrophysiology studies in which we inhibited Nedd8-activating enzyme using MLN4924 (a specific Nedd8-activating enzyme inhibitor) and observed a marked increase in ENaC activity (measured as the product of the number of channels (N) and the open probability (Po) of a channel). These results suggest that ubiquitination of lung ENaC is redox-sensitive and may have significant implications for our understanding of the role of ENaC in pulmonary conditions where oxidative stress occurs, such as pulmonary edema and acute lung injury.	[Downs, Charles A.] Emory Univ, Sch Med, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Kreiner, Lisa H.; Johnson, Nicholle M.; Helms, My N.] Emory Univ, Sch Med, Dept Pediat, Ctr Dev Lung Biol, Atlanta, GA 30322 USA; [Downs, Charles A.; Kumar, Amrita; Kreiner, Lisa H.; Johnson, Nicholle M.; Helms, My N.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Helms, MN (corresponding author), Emory Univ, Sch Med, Dept Pediat, Ctr Dev Lung Biol, 2015 Uppergate Dr NE,316-K, Atlanta, GA 30322 USA.	mhelms@emory.edu						Asher C, 2003, BBA-BIOMEMBRANES, V1612, P59, DOI 10.1016/S0005-2736(03)00083-X; Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Gao DM, 2010, PROTEIN CELL, V1, P881, DOI 10.1007/s13238-010-0123-x; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Goodson P, 2012, AM J PHYSIOL-LUNG C, V302, pL410, DOI 10.1152/ajplung.00260.2011; Helms MN, 2008, J BIOL CHEM, V283, P22875, DOI 10.1074/jbc.M801363200; Helms My N, 2010, J Vis Exp, DOI 10.3791/1941; Hummler E, 1996, KIDNEY BLOOD PRESS R, V19, P160, DOI 10.1159/000174065; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kumar A., 2011, FASEB J, V22, P328; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Lazrak A, 2012, AM J RESP CELL MOL, V46, P342, DOI 10.1165/rcmb.2011-0309OC; Lazrak A, 2011, AM J PHYSIOL-LUNG C, V301, pL557, DOI 10.1152/ajplung.00094.2011; Li T, 2009, AM J PHYSIOL-LUNG C, V296, pL527, DOI 10.1152/ajplung.90506.2008; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Rafii B, 1998, AM J PHYSIOL-LUNG C, V275, pL764, DOI 10.1152/ajplung.1998.275.4.L764; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, CURR OPIN NEPHROL HY, V6, P447, DOI 10.1097/00041552-199709000-00007; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; Xu H, 2007, AM J PHYSIOL-LUNG C, V293, pL1454, DOI 10.1152/ajplung.00248.2007; Yu L, 2008, AM J PHYSIOL-RENAL, V295, pF1519, DOI 10.1152/ajprenal.00605.2007; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	43	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8136	8145		10.1074/jbc.M112.389536	http://dx.doi.org/10.1074/jbc.M112.389536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362276	Green Published, hybrid			2022-12-28	WOS:000316564500014
J	Eapen, A; Kulkarni, R; Ravindran, S; Ramachandran, A; Sundivakkam, P; Tiruppathi, C; George, A				Eapen, Asha; Kulkarni, Roma; Ravindran, Sriram; Ramachandran, Amsaveni; Sundivakkam, Premanand; Tiruppathi, Chinnaswammy; George, Anne			Dentin Phosphophoryn Activates Smad Protein Signaling through Ca2+-Calmodulin-dependent Protein Kinase II in Undifferentiated Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOPROTEIN; EXPRESSION; INHIBITOR; GENE; DPP; DIFFERENTIATION; SIALOPROTEIN; GROWTH; KN-62; BMP	Dentin phosphophoryn (DPP) is a major noncollagenous protein in the dentin matrix. In this study, we demonstrate that pluripotent stem cells such as C3H10T1/2 and human bone marrow cells can be committed to the osteogenic lineage by DPP. Treatment with DPP can stimulate the release of intracellular Ca2+. This calcium flux triggered the activation of Ca2+-calmodulin-dependent protein kinase II (CaMKII). Activated CaMKII induced the phosphorylation of Smad1 and promoted nuclear translocation of p-Smad1. Inhibition of store Ca2+ depletion by 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester) or down-regulation of CaMKII by KN-62, a selective cell-permeable pharmacological inhibitor or a dominant negative plasmid of CaMKII, blocked DPP-mediated Smad1 phosphorylation. Activation of Smad1 resulted in the expression of osteogenic markers such as Runx2, Osterix, DMP1, Bone sialoprotein, Osteocalcin, NFATc1, and Schnurri-2, which have been implicated in osteoblast differentiation. These findings suggest that DPP is capable of triggering commitment of pluripotent stem cells to the osteogenic lineage.	[Eapen, Asha; Kulkarni, Roma; Ravindran, Sriram; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Sundivakkam, Premanand; Tiruppathi, Chinnaswammy] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu		GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 19633]; Brodie Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brodie Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 19633. This work was also supported by The Brodie Endowment Fund.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931; Eapen A, 2012, CELL ADHES MIGR, V6, P307, DOI 10.4161/cam.20627; Eapen A, 2012, J BIOL CHEM, V287, P5211, DOI 10.1074/jbc.M111.290080; Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Fukuno N, 2011, BIOCHEM BIOPH RES CO, V408, P202, DOI 10.1016/j.bbrc.2011.02.127; George A, 2005, CELLS TISSUES ORGANS, V181, P232, DOI 10.1159/000091384; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026; LINDE A, 1980, J BIOL CHEM, V255, P5931; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Moustakas A, 2001, J CELL SCI, V114, P4359; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Praskova M, 2002, ARCH DERMATOL RES, V294, P198, DOI 10.1007/s00403-002-0312-4; RICHARDSON WS, 1978, J BIOL CHEM, V253, P8042; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; SCHWEITZER ES, 1995, J CELL SCI, V108, P2619; Sfeir C., 2000, CHEM BIOL MINERALIZE, P181; Souchelnytskyi S, 2002, TRENDS CELL BIOL, V12, P304, DOI 10.1016/S0962-8924(02)02300-0; Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200	36	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8585	8595		10.1074/jbc.M112.413997	http://dx.doi.org/10.1074/jbc.M112.413997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362283	hybrid, Green Published			2022-12-28	WOS:000316564500059
J	Malovichko, MV; Sabo, TM; Maurer, MC				Malovichko, Marina V.; Sabo, T. Michael; Maurer, Muriel C.			Ligand Binding to Anion-binding Exosites Regulates Conformational Properties of Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; ALLOSTERIC LINKAGE; SOLVENT ACCESSIBILITY; HYDROGEN-EXCHANGE; ALPHA-THROMBIN; PROTEIN-C; THROMBOMODULIN; ACTIVATION; SELECTION; COMPLEX	Thrombin participates in coagulation, anticoagulation, and initiation of platelet activation. To fulfill its diverse roles and maintain hemostasis, this serine protease is regulated via the extended active site region and anion-binding exosites (ABEs) I and II. For the current project, amide proton hydrogen-deuterium exchange coupled with MALDI-TOF mass spectrometry was used to characterize ligand binding to individual exosites and to investigate the presence of exosite-active site and exosite-exosite interactions. PAR3(44-56) and PAR1(49-62) were observed to bind to thrombin ABE I and then to exhibit long range effects over to ABE II. By contrast, Hirudin(54-65) focused more on ABE I and did not transmit influences over to ABE II. Although these three ligands were each directed to ABE I, they did not promote the same conformational consequences. D-Phe-Pro-Arg-chloromethyl ketone inhibition at the thrombin active site led to further local and long range consequences to thrombin-ABE I ligand complexes with the autolysis loop often most affected. When Hirudin(54-65) was bound to ABE I, it was still possible to bind GpIb alpha(269-286) or fibrinogen gamma'(410-427) to ABE II. Each ligand exerted its predominant influences on thrombin and also allowed interexosite communication. The results obtained support the proposal that thrombin is a highly dynamic protein. The transmission of ligand-specific local and long range conformational events is proposed to help regulate this multifunctional enzyme.	[Malovichko, Marina V.; Sabo, T. Michael; Maurer, Muriel C.] Univ Louisville, Dept Chem, Louisville, KY 40292 USA	University of Louisville	Maurer, MC (corresponding author), Univ Louisville, Dept Chem, 2320 South Brook St, Louisville, KY 40292 USA.	muriel.maurer@louisville.edu	Sabo, T./H-9681-2019	Sabo, T./0000-0002-9573-145X; Malovichko, Marina/0000-0003-2127-5858	National Institutes of Health [R01 HL68440]; Telemedicine and Advanced Technology Research Center of the United States Army [W81XWH]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telemedicine and Advanced Technology Research Center of the United States Army; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL68440. This work was also supported by Grant W81XWH from the Telemedicine and Advanced Technology Research Center of the United States Army.	Adams TE, 2009, J THROMB HAEMOST, V7, P1688, DOI 10.1111/j.1538-7836.2009.03563.x; Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Baerga-Ortiz A, 2002, PROTEIN SCI, V11, P1300, DOI 10.1110/ps.4670102; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Ban D, 2011, ANGEW CHEM INT EDIT, V50, P11437, DOI 10.1002/anie.201105086; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BODE W, 1992, PROTEIN SCI, V1, P426; Croy CH, 2004, BIOCHEMISTRY-US, V43, P5246, DOI 10.1021/bi0499718; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Fuglestad B, 2012, BIOPHYS J, V103, P79, DOI 10.1016/j.bpj.2012.05.047; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P2144, DOI 10.1021/bi00406a049; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Koeppe JR, 2005, BIOCHEMISTRY-US, V44, P14784, DOI 10.1021/bi0510577; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lancellotti S, 2008, J BIOL CHEM, V283, P30193, DOI 10.1074/jbc.M803659200; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Li W, 2010, J BIOL CHEM, V285, P38621, DOI 10.1074/jbc.M110.144964; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Mengwasser KE, 2005, J BIOL CHEM, V280, P26997, DOI 10.1074/jbc.M502678200; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Ng NMY, 2009, ARCH BIOCHEM BIOPHYS, V489, P48, DOI 10.1016/j.abb.2009.07.012; NI F, 1989, BIOCHEMISTRY-US, V28, P3094, DOI 10.1021/bi00433a053; NI F, 1992, BIOCHEMISTRY-US, V31, P11551, DOI 10.1021/bi00161a037; PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pineda AO, 2002, J BIOL CHEM, V277, P32015, DOI 10.1074/jbc.M205009200; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; Sabo TM, 2009, BIOCHEMISTRY-US, V48, P7110, DOI 10.1021/bi900745b; Sidhu PS, 2011, J MED CHEM, V54, P5522, DOI 10.1021/jm2005767; Trumbo TA, 2000, J BIOL CHEM, V275, P20627, DOI 10.1074/jbc.M000209200; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200; YE J, 1992, J BIOL CHEM, V267, P11023	53	32	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8667	8678		10.1074/jbc.M112.410829	http://dx.doi.org/10.1074/jbc.M112.410829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378535	Green Published, hybrid			2022-12-28	WOS:000316564500067
J	Hayama, R; Bahng, S; Karasu, ME; Marians, KJ				Hayama, Ryo; Bahng, Soon; Karasu, Mehmet E.; Marians, Kenneth J.			The MukB-ParC Interaction Affects the Intramolecular, Not Intermolecular, Activities of Topoisomerase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHROMOSOME CONDENSATION; DNA-REPLICATION; ELECTRON-MICROSCOPY; 13S CONDENSIN; IN-VITRO; SEGREGATION; PROTEIN; DECATENATION; DOMAIN	Proper chromosome organization is accomplished through binding of proteins such as condensins that shape the DNA and by modulation of chromosome topology by the action of topoisomerases. We found that the interaction between MukB, the bacterial condensin, and ParC, a subunit of topoisomerase IV, enhanced relaxation of negatively supercoiled DNA and knotting by topoisomerase IV, which are intramolecular DNA re-arrangements but not decatenation of multiply linked DNA dimers, which is an intermolecular DNA rearrangement required for proper segregation of daughter chromosomes. MukB DNA binding and a specific chiral arrangement of the DNA was required for topoisomerase IV stimulation because relaxation of positively supercoiled DNA was unaffected. This effect could be attributed to a more effective topological reconfiguration of the negatively supercoiled compared with positively supercoiled DNA by MukB. These data suggest that the MukB-ParC interaction may play a role in chromosome organization rather than in separation of daughter chromosomes.	[Hayama, Ryo] Weill Cornell Grad Sch Med Sci, Physiol Biophys & Syst Biol Grad Program, New York, NY 10065 USA; [Bahng, Soon; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Karasu, Mehmet E.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu		Hayama, Ryo/0000-0001-8706-213X; KARASU, MEHMET ERMAN/0000-0002-1918-9152	National Institutes of Health [GM34558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K. J. M.)	ADAMS DE, 1992, CELL, V71, P277, DOI 10.1016/0092-8674(92)90356-H; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Bigot S, 2010, NUCLEIC ACIDS RES, V38, P3031, DOI 10.1093/nar/gkp1243; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; Cuvier O, 2003, J CELL BIOL, V160, P645, DOI 10.1083/jcb.200209023; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HIASA H, 1994, J BIOL CHEM, V269, P26959; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; KAVENOFF R, 1976, CHROMOSOMA, V59, P89, DOI 10.1007/BF00328479; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Li YY, 2010, J MOL BIOL, V395, P11, DOI 10.1016/j.jmb.2009.10.040; Madabhushi R, 2009, MOL CELL, V33, P171, DOI 10.1016/j.molcel.2009.01.001; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; MARIANS KJ, 1987, J BIOL CHEM, V262, P10362; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Mossessova E, 2000, J BIOL CHEM, V275, P4099, DOI 10.1074/jbc.275.6.4099; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; PENG H, 1993, J BIOL CHEM, V268, P24481; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Petrushenko ZM, 2010, EMBO J, V29, P1126, DOI 10.1038/emboj.2009.414; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Stray JE, 2005, J BIOL CHEM, V280, P34723, DOI 10.1074/jbc.M506589200; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang Q, 2006, J BACTERIOL, V188, P4431, DOI 10.1128/JB.00313-06; WASSERMAN SA, 1988, NATURE, V334, P448, DOI 10.1038/334448a0; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241	38	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7653	7661		10.1074/jbc.M112.418087	http://dx.doi.org/10.1074/jbc.M112.418087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23349462	hybrid, Green Published			2022-12-28	WOS:000316455300022
J	Saha, S; Dey, SK; Biswas, A; Das, P; Das, MR; Jana, SS				Saha, Shekhar; Dey, Sumit K.; Biswas, Arunima; Das, Provas; Das, Mahua R.; Jana, Siddhartha S.			The Effect of Including the C2 Insert of Nonmuscle Myosin II-C on Neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; LIGHT-CHAIN; ARP2/3 COMPLEX; GROWTH CONES; PHOSPHORYLATION; DRIVES; FILOPODIA; ISOFORMS; KINASE; DIFFERENTIATION	The functional role of the C2 insert of nonmuscle myosin II-C (NM II-C) is poorly understood. Here, we report for the first time that the expression of the C2 insert-containing isoform, NM II-C1C2, is inducible in Neuro-2a cells during differentiation both at mRNA and protein levels. Immunoblot and RTPCR analysis reveal that expression of NM II-C1C2 peaks between days 3 and 6 of differentiation. Localization of NM II-C1C2 in Neuro-2a cells suggests that the C2 insert-containing isoform is localized in the cytosol and along the neurites, specifically at the adherence point to substratum. Inhibition of endogenous NM II-C1C2 using siRNA decreases the neurite length by 43% compared with control cells treated with nonspecific siRNA. Time lapse image analysis reveals that neurites of C2-siRNA-treated cells have a net negative change in neurite length per minute, leading to a reduction of overall neurite length. During neuritogenesis, NM II-C1C2 can interact and colocalize with beta 1-integrin in neurites. Altogether, these studies indicate thatNMII-C1C2 may be involved in stabilizing neurites by maintaining their structure at adhesion sites.	[Saha, Shekhar; Dey, Sumit K.; Das, Provas; Das, Mahua R.; Jana, Siddhartha S.] Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 32, India; [Biswas, Arunima] Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata 32, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Jana, SS (corresponding author), Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 32, India.	bcssj@iacs.res.in	saha, shekhar/P-8302-2017; BISWAS, ARUNIMA/AAY-8896-2021; Das, Provas/AAW-5814-2020	saha, shekhar/0000-0002-2797-3000; BISWAS, ARUNIMA/0000-0001-5099-6756; Dey, Sumit Kumar/0000-0001-5584-9704	Indian Association for the Cultivation of Science; Department of Biotechnology, Government of India	Indian Association for the Cultivation of Science(Department of Science & Technology (India)Indian Association for the Cultivation of Science (IACS) - Jadavpur); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Indian Association for the Cultivation of Science and the Department of Biotechnology, Government of India.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; ARREGUI CO, 1994, J NEUROSCI, V14, P6967; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966; Jing F, 2012, J CEREBR BLOOD F MET, V32, P248, DOI 10.1038/jcbfm.2011.133; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kim JH, 2011, J CELL PHYSIOL, V226, P2881, DOI 10.1002/jcp.22631; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Mar XF, 2006, MOL BIOL CELL, V17, P2138, DOI 10.1091/mbc.E05-10-0097; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Rosado LAR, 2011, J CELL SCI, V124, P483, DOI 10.1242/jcs.074211; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Seidman KJN, 1996, J NEUROCHEM, V66, P1011; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; Vervoort VS, 2002, SCIENCE, V296, P2401; Vicente-Manzanares M, 2010, BIOCHEM BIOPH RES CO, V402, P537, DOI 10.1016/j.bbrc.2010.10.071; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Wright JW, 2002, NEUROSCI BIOBEHAV R, V26, P529, DOI 10.1016/S0149-7634(02)00019-2; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Yang Q, 2012, J CELL BIOL, V197, P939, DOI 10.1083/jcb.201111052; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	56	8	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7815	7828		10.1074/jbc.M112.417196	http://dx.doi.org/10.1074/jbc.M112.417196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355468	hybrid, Green Published			2022-12-28	WOS:000316455300036
J	Fredrickson, EK; Gallagher, PS; Candadai, SVC; Gardner, RG				Fredrickson, Eric K.; Gallagher, Pamela S.; Candadai, Sarah V. Clowes; Gardner, Richard G.			Substrate Recognition in Nuclear Protein Quality Control Degradation Is Governed by Exposed Hydrophobicity That Correlates with Aggregation and Insolubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; POLYGLUTAMINE PROTEINS; SACCHAROMYCES-CEREVISIAE; CYTOSOLIC PROTEINS; MEMBRANE-PROTEIN; YEAST; PROTEASOME	Misfolded proteins present an escalating deleterious challenge to cells over the course of their lifetime. One mechanism the cell possesses to prevent misfolded protein accumulation is their destruction by protein quality control (PQC) degradation systems. In eukaryotes, PQC degradation typically proceeds via multiple ubiquitin-protein ligases that act throughout the cell to ubiquitinate misfolded proteins for proteasome degradation. What the exact feature of misfolding that each PQC ubiquitin-protein ligase recognizes in their substrates remains an open question. Our previous studies of the budding yeast nuclear ubiquitin-protein ligase San1 indicated that it recognizes exposed hydrophobicity within its substrates, with the threshold of hydrophobicity equivalent to that of 5 contiguous hydrophobic residues. Here, we uncover an additional parameter: the nature of the exposed hydrophobicity that confers San1-mediated degradation correlates with significant protein insolubility. San1 particularly targets exposed hydrophobicity that leads to insolubility and aggregation above a certain threshold. Our studies presented here provide additional insight into the details of misfolded nuclear protein recognition and demonstrate that there is selectivity for the type of exposed hydrophobicity.	[Fredrickson, Eric K.; Gallagher, Pamela S.; Candadai, Sarah V. Clowes; Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gardner, RG (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 NE Pacific St, Seattle, WA 98195 USA.	gardnerr@uw.edu		Gardner, Richard/0000-0003-2162-6275	National Institutes of Health through the NIGMS [5T32GM007750]; National Institutes of Health through the NIA [R01AG031136]; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031136] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health through the NIA; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This worked was supported, in whole or in part, by National Institutes of Health Training Grant 5T32GM007750 through the NIGMS (to E. K. F.) and Grant R01AG031136 through the NIA (to R. G. G.). This work was also supported by an Ellison Medical Foundation New Scholar Award in Aging (to R. G. G.) and a Marian E. Smith Junior Faculty Award (to R. G. G.).	Angeli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009053; [Anonymous], 1991, Methods Enzymol, V194, P1; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Beerten J, 2012, PROTEIN ENG DES SEL, V25, P357, DOI 10.1093/protein/gzs031; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brachmann CB, 1998, YEAST, V14, P115; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fredrickson EK, 2012, SEMIN CELL DEV BIOL, V23, P530, DOI 10.1016/j.semcdb.2011.12.006; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jung CH, 2004, PROTEIN SCI, V13, P694, DOI 10.1110/ps.03356604; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Lefebvre BG, 2004, PROTEIN SCI, V13, P1538, DOI 10.1110/ps.03579304; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Prasad R, 2012, BIOCHEM BIOPH RES CO, V425, P689, DOI 10.1016/j.bbrc.2012.07.080; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Siwach P, 2011, NEUROSCI RES, V70, P435, DOI 10.1016/j.neures.2011.05.001; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wang Steven S-S, 2008, Biotechnol J, V3, P165, DOI 10.1002/biot.200700065; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x	54	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6130	6139		10.1074/jbc.M112.406710	http://dx.doi.org/10.1074/jbc.M112.406710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23335508	Green Published, hybrid			2022-12-28	WOS:000315820700010
J	Capraro, BR; Shi, Z; Wu, TT; Chen, ZM; Dunn, JM; Rhoades, E; Baumgart, T				Capraro, Benjamin R.; Shi, Zheng; Wu, Tingting; Chen, Zhiming; Dunn, Joanna M.; Rhoades, Elizabeth; Baumgart, Tobias			Kinetics of Endophilin N-BAR Domain Dimerization and Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CURVATURE GENERATION; AMPHIPATHIC HELICES; BINDING; MECHANISM; DYNAMIN; SYNAPTOJANIN; VESICLES; MOLECULE; LIPIDS	The recruitment to plasma membrane invaginations of the protein endophilin is a temporally regulated step in clathrin-mediated endocytosis. Endophilin is believed to sense or stabilize membrane curvature, which in turn likely depends on the dimeric structure of the protein. The dynamic nature of the membrane association and dimerization of endophilin is thus functionally important and is illuminated herein. Using subunit exchange Forster resonance energy transfer (FRET), we determine dimer dissociation kinetics and find a dimerization equilibrium constant orders of magnitude lower than previously published values. We characterize N-BAR domain membrane association kinetics under conditions where the dimeric species predominates, by stopped flow, observing prominent electrostatic sensitivity of membrane interaction kinetics. Relative to membrane binding, we find that protein monomer/dimer species equilibrate with far slower kinetics. Complementary optical microscopy studies reveal strikingly slow membrane dissociation and an increase of dissociation rate constant for a construct lacking the amphipathic segment helix 0 (H0). We attribute the slow dissociation kinetics to higher-order protein oligomerization on the membrane. We incorporate our findings into a kinetic scheme for endophilin N-BAR membrane binding and find a significant separation of time scales for endophilin membrane binding and subsequent oligomerization. This separation may facilitate the regulation of membrane trafficking phenomena.	[Capraro, Benjamin R.; Shi, Zheng; Wu, Tingting; Chen, Zhiming; Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Dunn, Joanna M.; Rhoades, Elizabeth] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA	University of Pennsylvania; Yale University	Baumgart, T (corresponding author), Univ Penn, Dept Chem, 231 S 34th St, Philadelphia, PA 19104 USA.	baumgart@sas.upenn.edu	Capraro, Benjamin R/C-6090-2009	Shi, Zheng/0000-0002-5214-1871; Chen, Zhiming/0000-0002-2423-101X	National Institutes of Health/NIGMS [9P41GM104605]; National Institutes of Health [T32 GM08275, R01 GM097552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552, T32GM008275, P41GM104605, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. E. M. Ostap for generously providing access to the stopped-flow instrument. We thank Ken Chang for assisting with fluorescence measurements and for reading the manuscript. We thank Drs. J. Saven, P. Janmey, and T. Svitkina for additional access to instrumentation, Dr. T. Troxler for guidance with time-correlated single photon counting/lifetime measurements, and Drs. N. Mochizuki, P. De Camilli, and R. Langen for supplying plasmids. Time-correlated single photon counting measurements were collected at the Ultrafast Optical Processes Laboratory at the University of Pennsylvania supported through National Institutes of Health/NIGMS Grant 9P41GM104605.; Supported by National Institutes of Health Training Grant T32 GM08275.; This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM097552 (to T. B.).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Arbuzova A, 1997, J BIOL CHEM, V272, P27167, DOI 10.1074/jbc.272.43.27167; Ayton GS, 2009, BIOPHYS J, V97, P1616, DOI 10.1016/j.bpj.2009.06.036; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; BERG OG, 1978, BIOPHYS CHEM, V8, P271, DOI 10.1016/0301-4622(78)80010-6; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Cui HS, 2013, BIOPHYS J, V104, P404, DOI 10.1016/j.bpj.2012.12.006; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Cui HS, 2009, BIOPHYS J, V97, P2746, DOI 10.1016/j.bpj.2009.08.043; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dries DR, 2008, J BIOL CHEM, V283, P7885, DOI 10.1074/jbc.M709943200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Feeser EA, 2010, BIOCHEMISTRY-US, V49, P9353, DOI 10.1021/bi1012657; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frost A., 2009, POMBE CDC15 HOMOLOGY, P1; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Goldberg JM, 2012, J AM CHEM SOC, V134, P6088, DOI 10.1021/ja3005094; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Gregory SM, 2008, BIOPHYS J, V94, P1667, DOI 10.1529/biophysj.107.118760; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jia HF, 2005, J MOL BIOL, V350, P919, DOI 10.1016/j.jmb.2005.05.054; Jonsson T, 1996, BIOCHEMISTRY-US, V35, P4795, DOI 10.1021/bi953056s; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; KINGSLEY PB, 1979, CHEM PHYS LIPIDS, V24, P135, DOI 10.1016/0009-3084(79)90083-5; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Kreutzberger AJ, 2012, J PHYS CHEM B, V116, P951, DOI 10.1021/jp209080m; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; LOHMAN TM, 1978, BIOPHYS CHEM, V8, P281, DOI 10.1016/0301-4622(78)80011-8; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; McKenna JMD, 2009, J BIOL CHEM, V284, P28650, DOI 10.1074/jbc.M109.049791; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Merzlyakov M, 2007, J MEMBRANE BIOL, V215, P93, DOI 10.1007/s00232-007-9009-0; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Ross JA, 2011, BIOPHYS J, V100, P729, DOI 10.1016/j.bpj.2010.12.3717; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; SCHWARZ G, 1987, BIOPHYS CHEM, V26, P163, DOI 10.1016/0301-4622(87)80019-4; Sevcsik E, 2011, J AM CHEM SOC, V133, P7152, DOI 10.1021/ja2009554; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Subramanian M, 1998, BIOCHEMISTRY-US, V37, P1394, DOI 10.1021/bi9716581; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Suresh S, 2010, BIOCHEMISTRY-US, V49, P5766, DOI 10.1021/bi100760e; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang J, 2007, BIOCHEMISTRY-US, V46, P13856, DOI 10.1021/bi7018404; Tang J, 2009, J AM CHEM SOC, V131, P3816, DOI 10.1021/ja809007f; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; WENDT H, 1995, BIOCHEMISTRY-US, V34, P4097, DOI 10.1021/bi00012a028; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Yoon YD, 2012, J BIOL CHEM, V287, P34078, DOI 10.1074/jbc.M112.372789; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhu C, 2012, BIOPHYS J, V102, P1837, DOI 10.1016/j.bpj.2012.03.039	89	31	31	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12533	12543		10.1074/jbc.M112.435511	http://dx.doi.org/10.1074/jbc.M112.435511			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23482561	Green Published, hybrid			2022-12-28	WOS:000318555100012
J	Giardina, BJ; Dunton, D; Chiang, HL				Giardina, Bennett J.; Dunton, Danielle; Chiang, Hui-Ling			Vid28 Protein Is Required for the Association of Vacuole Import and Degradation (Vid) Vesicles with Actin Patches and the Retention of Vid Vesicle Proteins in the Intracellular Fraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CATABOLITE INACTIVATION; MALATE-DEHYDROGENASE; YEAST VACUOLE; GLUCONEOGENIC ENZYMES; MDH2 ISOZYME; FRUCTOSE-1,6-BISPHOSPHATASE; PATHWAY; AUTOPHAGY; MEMBRANE	Gluconeogenic enzymes are induced when Saccharomyces cerevisiae are starved of glucose. However, when glucose is added to prolonged starved cells, these enzymes are degraded in the vacuole via the vacuole import and degradation (Vid) pathway. The Vid pathway is linked to the nonclassical secretory and internalizing pathways. In prolonged starved cells, substantial amounts of the key gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) are in the extracellular fraction (periplasm). However, when glucose is added to glucose-starved cells, levels of extracellular FBPase decrease rapidly. Ultrastructural studies indicate that FBPase is in Vid/endosomes following glucose addition, suggesting that FBPase is internalized in response to glucose refeeding. Under the same conditions, the majority of Vid vesicle proteins are in the intracellular fraction. In yeast, actin polymerization is involved in endocytosis. Vid vesicles associate with actin patches initially, and they dissociate later. Here, we show that VID28 plays a critical role in the association of Vid vesicles with actin patches and the retention of Vid vesicle proteins in the intracellular fraction. Vid28p was distributed to Vid vesicles and interacted with other Vid vesicle proteins. Vid28p contains an Armadillo (ARM) domain required for FBPase degradation. When VID28 was deleted or when the ARM domain was mutated, Vid vesicles failed to co-localize with actin patches, and Vid vesicle proteins appeared in the extracellular fraction. We suggest that the ARM domain is required for the association of Vid vesicles with actin patches and the retention of Vid vesicle proteins in the intracellular fraction.	[Giardina, Bennett J.; Dunton, Danielle; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	hxc32@psu.edu			National Institutes of Health [R01 GM59480]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM59480 (to H. L. C.).	Alibhoy AA, 2012, J BIOL CHEM, V287, P33080, DOI 10.1074/jbc.M112.360412; Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2010, J BIOL CHEM, V285, P23357, DOI 10.1074/jbc.M109.075143; Brown C Randell, 2009, Commun Integr Biol, V2, P177; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bryant NJ, 1998, J CELL BIOL, V142, P651, DOI 10.1083/jcb.142.3.651; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; GAMO FJ, 1994, EUR J BIOCHEM, V222, P879, DOI 10.1111/j.1432-1033.1994.tb18935.x; GANCEDO C, 1971, J BACTERIOL, V107, P401, DOI 10.1128/JB.107.2.401-405.1971; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Hoffman M, 1996, GENETICS, V143, P1555; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lee HS, 2009, J PROTEOME RES, V8, P2851, DOI 10.1021/pr900009y; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Mijaljica D, 2007, AUTOPHAGY, V3, P417, DOI 10.4161/auto.4441; MINARD KI, 1994, ARCH BIOCHEM BIOPHYS, V315, P302, DOI 10.1006/abbi.1994.1504; MINARD KI, 1992, J BIOL CHEM, V267, P17458; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; TOYODA Y, 1987, BIOCHEM BIOPH RES CO, V143, P212, DOI 10.1016/0006-291X(87)90652-8; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	53	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11636	11648		10.1074/jbc.M112.419895	http://dx.doi.org/10.1074/jbc.M112.419895			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23393132	hybrid, Green Published			2022-12-28	WOS:000318157600003
J	Kim, JB; Kim, SY; Kim, BM; Lee, H; Kim, I; Yun, J; Jo, Y; Oh, T; Jo, Y; Chae, HD; Shin, DY				Kim, Jung-bin; Kim, So Youn; Kim, Byeong Mo; Lee, Hunjin; Kim, Insook; Yun, Jeanho; Jo, Yejin; Oh, Taeheun; Jo, Yongsam; Chae, Hee-Don; Shin, Deug Y.			Identification of a Novel Anti-apoptotic E3 Ubiquitin Ligase That Ubiquitinates Antagonists of Inhibitor of Apoptosis Proteins SMAC, HtrA2, and ARTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; PROMOTES APOPTOSIS; CASPASE ACTIVITY; ACTIN DAMAGE; CELL-DEATH; XIAP; IAP; FAMILY; MITOCHONDRIA; ACTIVATION	Identification of new anti-apoptotic genes is important for understanding the molecular mechanisms underlying apoptosis and tumorigenesis. The present study identified a novel anti-apoptotic gene named AREL1, which encodes a HECT(homologous to E6-AP carboxyl terminus) family E3 ubiquitin ligase. AREL1 interacted with and ubiquitinated IAP antagonists such as SMAC, HtrA2, and ARTS. However, AREL1 was cytosolic and did not localize to nuclei or mitochondria. The interactions between AREL1 and the IAP antagonists were specific for apoptosis-stimulated cells, in which the IAP antagonists were released into the cytosol from mitochondria. Furthermore, the ubiquitination and degradation of SMAC, HtrA2, and ARTS were significantly enhanced in AREL1-expressing cells following apoptotic stimulation, indicating that AREL1 binds to and ubiquitinates cytosolic but not mitochondria-associated forms of IAP antagonists. Furthermore, the anti-apoptotic role of AREL1-mediated degradation of SMAC, HtrA2, and ARTS was shown by simultaneous knockdown of three IAP antagonists, which caused the inhibition of caspase-3 cleavage, XIAP degradation, and induction of apoptosis. Therefore, the present study suggests that AREL1-mediated ubiquitination and degradation of cytosolic forms of three IAP antagonists plays an important role in the regulation of apoptosis.	[Kim, Jung-bin; Kim, So Youn; Kim, Byeong Mo; Lee, Hunjin; Kim, Insook; Yun, Jeanho; Jo, Yejin; Oh, Taeheun; Jo, Yongsam; Chae, Hee-Don; Shin, Deug Y.] Dankook Univ, Coll Med, Dept Microbiol & Immunol, Cheonan 330714, South Korea; [Kim, So Youn; Kim, Byeong Mo; Kim, Insook; Chae, Hee-Don; Shin, Deug Y.] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea	Dankook University; Seoul National University (SNU)	Shin, DY (corresponding author), Dankook Univ, Coll Med, Dept Microbiol & Immunol, Cheonan 330714, South Korea.	dyshin@dankook.ac.kr	Chae, Hee-Don/D-2620-2011		21C Frontier Functional Human Genome Project; Research Program for Regulation of Aging and Cancer; Basic Research Promotion Fund, Korean Research Foundation [KRF-2008-359-C00030, NRF-2009-353-C00070, 2012R1A1A3002027]; Korean Ministry of Education, Science, and Technology	21C Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Program for Regulation of Aging and Cancer; Basic Research Promotion Fund, Korean Research Foundation; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the 21C Frontier Functional Human Genome Project, the Research Program for Regulation of Aging and Cancer, and the Basic Research Promotion Fund (KRF-2008-359-C00030, NRF-2009-353-C00070, and 2012R1A1A3002027) from the Korean Research Foundation, which was funded by the Korean Ministry of Education, Science, and Technology.	Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Chae HD, 2008, ONCOGENE, V27, P4115, DOI 10.1038/onc.2008.46; Chae HD, 2012, EXP MOL MED, V44, P236, DOI 10.3858/emm.2012.44.3.018; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; LORENZI MV, 1995, ONCOGENE, V10, P2051; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Yoon K, 2004, BIOCHEM BIOPH RES CO, V319, P649, DOI 10.1016/j.bbrc.2004.05.043	30	32	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12014	12021		10.1074/jbc.M112.436113	http://dx.doi.org/10.1074/jbc.M112.436113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23479728	hybrid, Green Published			2022-12-28	WOS:000318157600035
J	Maldonado, EN; Sheldon, KL; DeHart, DN; Patnaik, J; Manevich, Y; Townsend, DM; Bezrukov, SM; Rostovtseva, TK; Lemasters, JJ				Maldonado, Eduardo N.; Sheldon, Kely L.; DeHart, David N.; Patnaik, Jyoti; Manevich, Yefim; Townsend, Danyelle M.; Bezrukov, Sergey M.; Rostovtseva, Tatiana K.; Lemasters, John J.			Voltage-dependent Anion Channels Modulate Mitochondrial Metabolism in Cancer Cells REGULATION BY FREE TUBULIN AND ERASTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; VDAC CHANNELS; WARBURG; ADP; PERMEABILITY; RESPIRATION; GLYCOLYSIS; ACTIVATION; ISOFORMS; RELEASE	Respiratory substrates and adenine nucleotides cross the mitochondrial outer membrane through the voltage-dependent anion channel (VDAC), comprising three isoforms - VDAC1, 2, and 3. We characterized the role of individual isoforms in mitochondrial metabolism by HepG2 human hepatoma cells using siRNA. With VDAC3 to the greatest extent, all VDAC isoforms contributed to the maintenance of mitochondrial membrane potential, but only VDAC3 knockdown decreased ATP, ADP, NAD(P)H, and mitochondrial redox state. Cells expressing predominantly VDAC3 were least sensitive to depolarization induced by increased free tubulin. In planar lipid bilayers, free tubulin inhibited VDAC1 and VDAC2 but not VDAC3. Erastin, a compound that interacts with VDAC, blocked and reversed mitochondrial depolarization after microtubule destabilizers in intact cells and antagonized tubulin-induced VDAC blockage in planar bilayers. In conclusion, free tubulin inhibits VDAC1/2 and limits mitochondrial metabolism in HepG2 cells, contributing to the Warburg phenomenon. Reversal of tubulin-VDAC interaction by erastin antagonizes Warburg metabolism and restores oxidative mitochondrial metabolism.	[Lemasters, John J.] Med Univ S Carolina, Ctr Cell Death Injury & Regenerat, Charleston, SC 29425 USA; [Maldonado, Eduardo N.; DeHart, David N.; Patnaik, Jyoti; Townsend, Danyelle M.; Lemasters, John J.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Maldonado, Eduardo N.; Townsend, Danyelle M.; Lemasters, John J.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Sheldon, Kely L.; Bezrukov, Sergey M.; Rostovtseva, Tatiana K.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Sheldon, Kely L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstein Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lemasters, JJ (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Ctr Cell Death Injury & Regenerat, DD504 Drug Discovery Bldg,70 President St,MSC 140, Charleston, SC 29425 USA.	JJLemasters@musc.edu		Maldonado, Eduardo/0000-0002-5285-3027	National Institutes of Health [DK37034, DK073336]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Specialized Program of Research Excellence Career Development Award [P50 CA058187]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA058187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK083262, R56DK037034, R01DK037034, R01DK073336, R37DK037034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Specialized Program of Research Excellence Career Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by Grants DK37034 and DK073336 from the National Institutes of Health. This work was also supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to K. L. S., S. M. B., and T. K. R).; Recipient of a Specialized Program of Research Excellence Career Development Award (Grant P50 CA058187).	Andre N, 2000, CANCER RES, V60, P5349; Andre N, 2002, FEBS LETT, V532, P256, DOI 10.1016/S0014-5793(02)03691-8; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 1980, Ann N Y Acad Sci, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; COLOMBINI M, 1987, BIOCHIM BIOPHYS ACTA, V905, P279, DOI 10.1016/0005-2736(87)90456-1; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P217, DOI 10.1016/0005-2728(93)90150-E; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; LEE AC, 1994, J BIOL CHEM, V269, P30974; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Lemasters JJ, 2012, BBA-BIOMEMBRANES, V1818, P1536, DOI 10.1016/j.bbamem.2011.11.034; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; MANNELLA CA, 1992, J BIOENERG BIOMEMBR, V24, P7, DOI 10.1007/BF00769525; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Prins JM, 2010, TOXICOL SCI, V113, P169, DOI 10.1093/toxsci/kfp249; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIES H, 1972, FEBS LETT, V27, P171, DOI 10.1016/0014-5793(72)80434-4; Song JM, 1996, J BIOENERG BIOMEMBR, V28, P153, DOI 10.1007/BF02110646; Timohhina N, 2009, J BIOENERG BIOMEMBR, V41, P259, DOI 10.1007/s10863-009-9224-8; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	50	158	161	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11920	11929		10.1074/jbc.M112.433847	http://dx.doi.org/10.1074/jbc.M112.433847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23471966	Green Published, hybrid			2022-12-28	WOS:000318157600027
J	Arora, K; Alfulaij, N; Higa, JK; Panee, J; Nichols, RA				Arora, Komal; Alfulaij, Naghum; Higa, Jason K.; Panee, Jun; Nichols, Robert A.			Impact of Sustained Exposure to beta-Amyloid on Calcium Homeostasis and Neuronal Integrity in Model Nerve Cell System Expressing alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT BASAL FOREBRAIN; A-BETA; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; UP-REGULATION; BINDING; HIPPOCAMPUS; DOPAMINE; SMOKERS; TAU	Although the interaction between beta-amyloid (A beta) and nicotinic acetylcholine receptors has been widely studied, the impact of prolonged exposure to A beta on nAChR expression and signaling is not known. In this study, we employed a neuronal culture model to better understand the impact of sustained exposure of A beta on the regulation of cellular and synaptic function. The differentiated rodent neuroblastoma cell line NG108-15 expressing exogenous high-affinity alpha 4 beta 2 nAChRs was exposed to soluble oligomeric A beta for several days. Ca2+ responses, expression levels of alpha 4 beta 2 nAChRs, rate of mitochondrial movement, mitochondrial fission, levels of reactive oxygen species, and nuclear integrity were compared between A beta-treated and untreated cells, transfected or not (mock-transfected) with alpha 4 beta 2 nAChRs. Sustained exposure of A beta(1-42) to alpha 4 beta 2 nAChR-transfected cells for several days led to increased Ca2+ responses on subsequent acute stimulation with A beta(1-42) or nicotine, paralleled by increased expression levels of alpha 4 beta 2 nAChRs, likely the result of enhanced receptor recycling. The rate of mitochondrial movement was sharply reduced, whereas the mitochondrial fission protein pDrp-1 was increased in alpha 4 beta 2 nAChR-transfected cells treated with A beta(1-42). In addition, the presence of alpha 4 beta 2 nAChRs dramatically enhanced A beta(1-42)-mediated increases in reactive oxygen species and nuclear fragmentation, eventually leading to apoptosis. Our data thus show disturbed calcium homeostasis coupled with mitochondrial dysfunction and loss of neuronal integrity on prolonged exposure of A beta in cells transfected with alpha 4 beta 2 nAChRs. Together, the results suggest that the presence of nAChRs sensitizes neurons to the toxic actions of soluble oligomeric A beta, perhaps contributing to the cholinergic deficit in Alzheimer disease.	[Arora, Komal; Alfulaij, Naghum; Higa, Jason K.; Panee, Jun; Nichols, Robert A.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa	Nichols, RA (corresponding author), 651 Ilalo St, Honolulu, HI 96813 USA.	robert.nichols@hawaii.edu		Higa, Jason Kenji/0000-0002-0429-6254	National Institutes of Health from the NIA [AG21586]; American Health Assistance Foundation [AHAF-A2007-409]; Hawaii Community Foundation [09ADVC-45413]; IDeA Networks of Biomedical Research Excellence II Grant from the National Center for Research Resources [P20RR016467]; National Center for Research Resources [G12RR003061]; National Institute on Minority Health and Health Disparities [G12MD007601]; COBRE Grant [P20RR016453]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453, P20RR016467, G12RR003061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health from the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation(BrightFocus Foundation); Hawaii Community Foundation; IDeA Networks of Biomedical Research Excellence II Grant from the National Center for Research Resources; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); COBRE Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant AG21586 from the NIA, American Health Assistance Foundation Grant AHAF-A2007-409, and Hawaii Community Foundation Grant 09ADVC-45413 (to R. A. N.).; Supported by IDeA Networks of Biomedical Research Excellence II Grant P20RR016467 from the National Center for Research Resources.; We thank Dr. Jerry Stitzel, University of Colorado, for kindly providing the mouse alpha 4 and beta 2 nAChR subunit sequences. We also thank Drs. Ghous Khan and Mei Tong for help with preliminary experiments examining expression of alpha 4 beta 2-nAChRs in differentiated NG108-15 cells. We thank Dr. Joe Ramos for advice on the endocytosis/recycling experiments and for providing anti-Rab5 antibody for preliminary experiments. We thank Dr. Marla Berry for valuable input. We also thank Drs. Peter Hoffmann and Frederick Bellinger for insightful comments on the manuscript. Additional support for the microscopy core at the University of Hawaii was provided by Research Center for Minority Institutions grants from the National Center for Research Resources (G12RR003061) and the National Institute on Minority Health and Health Disparities (G12MD007601), with additional funding from COBRE Grant P20RR016453.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BENCHERIF M, 1995, J PHARMACOL EXP THER, V275, P987; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Buisson B, 2002, TRENDS PHARMACOL SCI, V23, P130, DOI 10.1016/S0165-6147(00)01979-9; Chin JH, 2007, J NEUROSCI, V27, P9262, DOI 10.1523/JNEUROSCI.1843-07.2007; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Court JA, 1998, NEUROSCIENCE, V87, P63, DOI 10.1016/S0306-4522(98)00088-8; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; Dougherty JJ, 2008, NEUROCHEM RES, V33, P1106, DOI 10.1007/s11064-007-9557-9; FLORES CM, 1992, MOL PHARMACOL, V41, P31; FRIED G, 1995, SYNAPSE, V20, P44, DOI 10.1002/syn.890200108; Fu W, 2003, J NEUROPHYSIOL, V90, P3130, DOI 10.1152/jn.00616.2003; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hsu YN, 1996, J NEUROCHEM, V66, P667; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lukyanetz EA, 1998, NEUROSCIENCE, V87, P265, DOI 10.1016/S0306-4522(98)00057-8; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Valenzuela IMPY, 2010, J NEUROSCI, V30, P12455, DOI 10.1523/JNEUROSCI.3309-10.2010; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Mehta TK, 2009, J NEUROCHEM, V109, P1452, DOI 10.1111/j.1471-4159.2009.06070.x; Mohamed Amany, 2011, Int J Alzheimers Dis, V2011, P127984, DOI 10.4061/2011/127984; Mukhin AG, 2008, J NUCL MED, V49, P1628, DOI 10.2967/jnumed.108.050716; Nashmi R, 2003, J NEUROSCI, V23, P11554; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; Nichols RA, 2007, J BIOL CHEM, V282, P36102, DOI 10.1074/jbc.M706002200; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Patel AN, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002134; PENG X, 1994, MOL PHARMACOL, V46, P523; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Religa D, 2003, AM J PSYCHIAT, V160, P867, DOI 10.1176/appi.ajp.160.5.867; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Staley JK, 2006, J NEUROSCI, V26, P8707, DOI 10.1523/JNEUROSCI.0546-06.2006; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Tong M, 2011, J BIOL CHEM, V286, P34373, DOI 10.1074/jbc.M111.241299; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wu JL, 2007, BRAIN RES, V1182, P82, DOI 10.1016/j.brainres.2007.08.079; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; ZHANG X, 1994, BRAIN RES, V644, P32, DOI 10.1016/0006-8993(94)90343-3; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	57	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11175	11190		10.1074/jbc.M113.453746	http://dx.doi.org/10.1074/jbc.M113.453746			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479730	hybrid, Green Published			2022-12-28	WOS:000317915500022
J	Heiss, C; Skowyra, ML; Liu, H; Klutts, JS; Wang, ZR; Williams, M; Srikanta, D; Beverley, SM; Azadi, P; Doering, TL				Heiss, Christian; Skowyra, Michael L.; Liu, Hong; Klutts, J. Stacey; Wang, Zhirui; Williams, Matthew; Srikanta, Deepa; Beverley, Stephen M.; Azadi, Parastoo; Doering, Tamara L.			Unusual Galactofuranose Modification of a Capsule Polysaccharide in the Pathogenic Yeast Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-ANALYSIS; O-ANTIGEN; GALACTOXYLOMANNAN; GENE; GLUCURONOXYLOMANNAN; LIPOPOLYSACCHARIDE; VIRULENCE; METABOLISM; EXPRESSION; APOPTOSIS	Galactofuranose (Galf) is the five-membered ring form of galactose. Although it is absent from mammalian glycans, it occurs as a structural and antigenic component of important cell surface molecules in a variety of microbes, ranging from bacteria to parasites and fungi. One such organism is Cryptococcus neoformans, a pathogenic yeast that causes lethal meningoencephalitis in immunocompromised individuals, particularly AIDS patients. C. neoformans is unique among fungal pathogens in bearing a complex polysaccharide capsule, a critical virulence factor reported to include Galf. Notably, how Galf modification contributes to the structure and function of the cryptococcal capsule is not known. We have determined that Galf is beta 1,2-linked to an unusual tetrasubstituted galactopyranose of the glucuronoxylomannogalactan (GXMGal) capsule polysaccharide. This discovery fills a longstanding gap in our understanding of a major polymer of the cryptococcal capsule. We also engineered a C. neoformans strain that lacks UDP-galactopyranose mutase; this enzyme forms UDP-Galf, the nucleotide sugar donor required for Galf addition. Mutase activity was required for the incorporation of Galf into glucuronoxylomannogalactan but was dispensable for vegetative growth, cell integrity, and virulence in a mouse model.	[Heiss, Christian; Wang, Zhirui; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Skowyra, Michael L.; Liu, Hong; Klutts, J. Stacey; Williams, Matthew; Srikanta, Deepa; Beverley, Stephen M.; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University System of Georgia; University of Georgia; Washington University (WUSTL)	Doering, TL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	doering@borcim.wustl.edu	Skowyra, Michal Leszek/AAS-4850-2020; Heiss, Christian/GPX-7678-2022	Skowyra, Michal Leszek/0000-0002-1365-034X; Heiss, Christian/0000-0003-1118-8953; Beverley, Stephen/0000-0001-5319-0811; Klutts, James/0000-0003-3788-1940	National Institutes of Health [R01 GM071007, R01 AI031078]; United States Department of Energy [DE-FG02-09ER20097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM071007 (to T. L. D.) and R01 AI031078 (to S. M. B.). This work was also supported by United States Department of Energy Grant DE-FG02-09ER20097 (to P. A.).	BERST M, 1969, EUR J BIOCHEM, V11, P353, DOI 10.1111/j.1432-1033.1969.tb00779.x; Bertozzi C. R., 2009, ESSENTIALS GLYCOBIOL, P23; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; CHERNIAK R, 1988, CARBOHYD RES, V172, P113, DOI 10.1016/S0008-6215(00)90846-2; CHERNIAK R, 1982, CARBOHYD RES, V103, P239, DOI 10.1016/S0008-6215(00)80686-2; Cordeiro LMC, 2008, INT J BIOL MACROMOL, V42, P436, DOI 10.1016/j.ijbiomac.2008.02.002; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; De Jesus M, 2009, J IMMUNOL, V183, P3885, DOI 10.4049/jimmunol.0900449; Delfino D, 1997, INFECT IMMUN, V65, P2454, DOI 10.1128/IAI.65.6.2454-2456.1997; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; EVANS EE, 1950, J IMMUNOL, V64, P423; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Fries BC, 1999, INFECT IMMUN, V67, P6076, DOI 10.1128/IAI.67.11.6076-6083.1999; Gates-Hollingsworth MA, 2009, MOL MICROBIOL, V74, P126, DOI 10.1111/j.1365-2958.2009.06855.x; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Heitman J, 1999, FUNGAL GENET BIOL, V28, P1, DOI 10.1006/fgbi.1999.1155; HEUSER J, 1981, TRENDS BIOCHEM SCI, V6, P64, DOI 10.1016/0968-0004(81)90024-4; Ingavale SS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000155; JACOBSON ES, 1982, J BACTERIOL, V150, P1292, DOI 10.1128/JB.150.3.1292-1296.1982; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kumar CPG, 2010, MYCOSES, V53, P262, DOI 10.1111/j.1439-0507.2009.01699.x; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; Lee SHC, 1995, LAB INVEST, V73, P871; Leone MR, 2010, ANGEW CHEM INT EDIT, V49, P7476, DOI 10.1002/anie.201003301; Levery SB, 1998, BIOCHEMISTRY-US, V37, P8764, DOI 10.1021/bi9730083; LIPKIND GM, 1988, CARBOHYD RES, V175, P59, DOI 10.1016/0008-6215(88)80156-3; Ma N, 2010, J NAT PROD, V73, P590, DOI 10.1021/np9007188; Marino C., 2012, GLYCANS BIOCH CHARAC, P207; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Oppenheimer M, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/415976; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; Raso TF, 2004, MED MYCOL, V42, P355, DOI 10.1080/13693780410001712061; Rivera J, 1998, INFECT IMMUN, V66, P5027, DOI 10.1128/IAI.66.10.5027-5030.1998; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; Sassaki GL, 2005, AN ACAD BRAS CIENC, V77, P223, DOI 10.1590/S0001-37652005000200003; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; SETHI KK, 1968, J INFECT DIS, V118, P135, DOI 10.1093/infdis/118.2.135; Slavikova Elzbieta, 1995, Acta Microbiologica Polonica, V44, P181; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Srikanta D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022773; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Suzuki E, 2002, INFECT IMMUN, V70, P6592, DOI 10.1128/IAI.70.12.6592-6596.2002; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; ToneShimokawa Y, 1996, J BACTERIOL, V178, P317, DOI 10.1128/jb.178.1.317-320.1996; Toukach FV, 1996, CARBOHYD RES, V295, P117, DOI 10.1016/S0008-6215(96)90130-5; Trivedi SR, 2011, JAVMA-J AM VET MED A, V239, P357, DOI 10.2460/javma.239.3.357; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005	77	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10994	11003		10.1074/jbc.M112.441998	http://dx.doi.org/10.1074/jbc.M112.441998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23408430	hybrid, Green Published			2022-12-28	WOS:000317915500006
J	Li, Y; Wang, YQ				Li, Yang; Wang, Yuqi			Ras Protein/cAMP-dependent Protein Kinase Signaling Is Negatively Regulated by a Deubiquitinating Enzyme, Ubp3, in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; RAS/CAMP PATHWAY; UBIQUITIN; BINDING; METABOLISM; STARVATION; RESISTANCE; RECEPTOR; ELEMENTS	Ras proteins and cAMP-dependent protein kinase (protein kinase A, PKA) are important components of a nutrient signaling pathway that mediates cellular responses to glucose in yeast. The molecular mechanisms that regulate Ras/PKA-mediated signaling remain to be fully understood. Here, we provide evidence that Ras/PKA signaling is negatively regulated by a deubiquitinating enzyme, Ubp3. Disrupting the activity of Ubp3 leads to hyperactivation of PKA, as evidenced by much enhanced phosphorylation of PKA substrates, decreased accumulation of glycogen, larger cell size, and increased sensitivity to heat shock. Levels of intracellular cAMP and the active forms of Ras proteins are also elevated in the ubp3 Delta mutant. Consistent with a possibility that the increased cAMP is responsible for the abnormal signaling behavior of the ubp3 Delta mutant, overexpressing PDE2, which encodes a phosphodiesterase that hydrolyzes cAMP, significantly relieves the cell size increase and heat shock sensitivity of the mutant. Further analysis reveals that Ubp3 interacts with a Ras GTPase-accelerating protein, Ira2, and regulates its level of ubiquitination. Together, our data indicate that Ubp3 is a new regulator of the Ras/PKA signaling pathway and suggest that Ubp3 regulates this pathway by controlling the ubiquitination of Ras GTPase-accelerating protein Ira2.	[Li, Yang; Wang, Yuqi] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu		Li, Yang/0000-0001-5714-0416	National Institutes of Health [R15GM093313-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM093313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15GM093313-01 (to Y. W.).	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Broach JR, 1991, CURR OPIN GENET DEV, V1, P370, DOI 10.1016/S0959-437X(05)80302-8; BROSTROM CO, 1971, P NATL ACAD SCI USA, V68, P2444, DOI 10.1073/pnas.68.10.2444; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Burrows JF, 2012, FRONT BIOSCI-LANDMRK, V17, P1184, DOI 10.2741/3980; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Chautard H, 2004, EUKARYOT CELL, V3, P459, DOI 10.1128/EC.3.2.459-470.2004; Cherkasova VA, 2003, CURR BIOL, V13, P1220, DOI 10.1016/S0960-9822(03)00490-1; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Esch RK, 2006, EUKARYOT CELL, V5, P2147, DOI 10.1128/EC.00270-06; Feldkamp MM, 1999, SURG NEUROL, V51, P211, DOI 10.1016/S0090-3019(97)00356-X; Grewal Thomas, 2011, Genes Cancer, V2, P288, DOI 10.1177/1947601911407330; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Petkova MI, 2010, J BIOL CHEM, V285, P19521, DOI 10.1074/jbc.M109.085282; JOHNSTON C, 1991, BIOCHEM SOC T, V19, P296, DOI 10.1042/bst0190296; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kvint K, 2008, MOL CELL, V30, P498, DOI 10.1016/j.molcel.2008.04.018; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Phan VT, 2010, MOL CELL BIOL, V30, P2264, DOI 10.1128/MCB.01450-08; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Powers S, 1992, Semin Cancer Biol, V3, P209; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Riccardi V M, 1992, Curr Probl Pediatr, V22, P66, DOI 10.1016/0045-9380(92)90053-2; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rudoni S, 2001, BBA-MOL CELL RES, V1538, P181, DOI 10.1016/S0167-4889(01)00067-2; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sole C, 2011, EMBO J, V30, P3274, DOI 10.1038/emboj.2011.227; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; Thevelein JM, 2000, ENZYME MICROB TECH, V26, P819, DOI 10.1016/S0141-0229(00)00177-0; Toda T, 1986, Princess Takamatsu Symp, V17, P253; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhu M, 2011, J BIOL CHEM, V286, P27147, DOI 10.1074/jbc.M111.254193	60	20	21	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11358	11365		10.1074/jbc.M112.449751	http://dx.doi.org/10.1074/jbc.M112.449751			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476013	Green Published, hybrid			2022-12-28	WOS:000317915500038
J	Lin, HL; Trejo, J				Lin, Huilan; Trejo, JoAnn			Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits beta-Arrestin-mediated Endosomal Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; HUMAN ENDOTHELIAL-CELLS; OPIOID RECEPTOR; DEPENDENT INTERNALIZATION; DOWN-REGULATION; TRAFFICKING; PAR1; RESENSITIZATION; COMPLEX; GPCR	Thrombin cleaves the N terminus of PAR1, generating a new N-terminal domain that functions as a tethered ligand that binds intermolecularly to activate PAR2 in trans. The mechanisms that regulate PAR1-PAR2 heterodimer signaling and trafficking are not known. We now report that PAR1 and PAR2 form a heterodimer that exhibits unique trafficking and signaling behaviors compared with receptor protomers. Using bioluminescence resonance energy transfer, immunofluorescence microscopy, co-immunoprecipitation, and cells expressing receptors exogenously and endogenously, we show that PAR1 and PAR2 specifically interact and form stable dimers. Intriguingly, the PAR1-PAR2 heterodimer displays constitutive internalization that is driven by PAR1 C-terminal tail sorting motifs and is a process that enhances dimer formation. Upon thrombin activation, PAR1-PAR2 dimers co-internalize and recruit beta-arrestins to endosomes. Remarkably, PAR1-PAR2 heterodimers appear to utilize a distinct interface for beta-arrestin interaction compared with receptor protomers. Moreover, thrombin-activated PAR1-PAR2 heterodimers enhance beta-arrestin-mediated ERK1/2 activation in the cytoplasm, whereas activated ERK1/2 induced by the thrombin-activated PAR1 protomer redistributes to the nucleus. Thus, the formation of PAR1-PAR2 heterodimers provides additional modes of thrombin-stimulated signaling responses that appear to be distinctly regulated compared with the receptor protomer.	[Lin, Huilan; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Sch Med, BSB Rm 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Lin, Huilan/B-7671-2013	TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [GM090689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090689 (to J. T.).	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lidington EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1437, DOI 10.1152/ajpcell.00502.2004; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sambrano GR, 1999, J BIOL CHEM, V274, P20178, DOI 10.1074/jbc.274.29.20178; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Suzuki H, 2009, HYPERTENSION, V53, P182, DOI 10.1161/HYPERTENSIONAHA.108.125229; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1996, J BIOL CHEM, V271, P21536, DOI 10.1074/jbc.271.35.21536; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	47	67	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11203	11215		10.1074/jbc.M112.439950	http://dx.doi.org/10.1074/jbc.M112.439950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23476015	Green Published, hybrid			2022-12-28	WOS:000317915500024
J	Liu, YQ; Sanchez-Tillo, E; Lu, XQ; Huang, L; Clem, B; Telang, S; Jenson, AB; Cuatrecasas, M; Chesney, J; Postigo, A; Dean, DC				Liu, Yongqing; Sanchez-Tillo, Ester; Lu, Xiaoqin; Huang, Li; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Cuatrecasas, Miriam; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.			Sequential Inductions of the ZEB1 Transcription Factor Caused by Mutation of Rb and Then Ras Proteins Are Required for Tumor Initiation and Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RETINOBLASTOMA GENE; CELL-CYCLE; SIGNALING PATHWAY; DOWN-REGULATION; FEEDBACK LOOP; CANCER-CELLS; G(1) CONTROL; IN-VIVO; K-RAS	Rb1 restricts cell cycle progression, and it imposes cell contact inhibition to suppress tumor outgrowth. It also triggers oncogene-induced senescence to block Ras mutation. Loss of the Rb1 pathway, which is a hallmark of cancer cells, then provides a permissive environment for Ras mutation, and Ras is sufficient for invasive tumor formation in Rb1 family mutant mouse embryo fibroblasts (MEFs). These results demonstrate that sequential mutation of the Rb1 and Ras pathways comprises a tumor initiation axis. Both Rb1 and Ras regulate expression of the transcription factor ZEB1, thereby linking tumor initiation to the subsequent invasion and metastasis, which is induced by ZEB1. ZEB1 acts in a negative feedback loop to block expression of miR-200, which is thought to facilitate tumor invasion and metastasis. However, ZEB1 also represses cyclin-dependent kinase (cdk) inhibitors to control the cell cycle; its mutation in MEFs leads to induction of these inhibitors and premature senescence. Here, we provide evidence for two sequential inductions of ZEB1 during Ras transformation of MEFs. Rb1 constitutively represses cdk inhibitors, and induction of ZEB1 when the Rb1 pathway is lost is required to maintain this repression, allowing for the classic immortalization and loss of cell contact inhibition seen when the Rb1 pathway is lost. In vivo, we show that this induction of ZEB1 is required for Ras-initiated tumor formation. ZEB1 is then further induced by Ras, beyond the level seen with Rb1 mutation, and this Ras superinduction is required to reach a threshold of ZEB1 sufficient for repression of miR-200 and tumor invasion.	[Liu, Yongqing; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Mol Targets Program, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Liu, Yongqing; Lu, Xiaoqin; Huang, Li; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Liu, Yongqing; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Birth Defects Ctr, Louisville, KY 40202 USA; [Sanchez-Tillo, Ester; Postigo, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Grp Transcript Regulat Gene Express, CIBERehd, Barcelona 08036, Spain; [Postigo, Antonio] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain; [Cuatrecasas, Miriam] Univ Barcelona, Dept Pathol, Ctr Diagnost Biomed CDB Hosp Clin, E-08036 Barcelona, Spain; [Cuatrecasas, Miriam] Univ Barcelona, Tumor Bank Biobank, IDIBAPS, Hosp Clin, E-08036 Barcelona, Spain; [Huang, Li] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	University of Louisville; University of Louisville; University of Louisville; University of Louisville; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Zhejiang University	Postigo, A (corresponding author), IDIBAPS, Grp Transcript Regulat Gene Express, Villarroel 170, Barcelona 08036, Spain.	idib412@clinic.ub.es; dcdean01@louisville.edu	Cuatrecasas, Miriam/C-9156-2019	Cuatrecasas, Miriam/0000-0003-3063-0110; Postigo, Antonio/0000-0003-4605-2634	National Institutes of Health [EY019113, EY018603, EY015636]; National Institutes of Health through the NIGMS [P20GM103453]; Olga Torres Foundation (FOT); Spanish Association Against Cancer (AECC); Avon Breast Cancer Campaign (AVON-SAU); Ministry of Economy and Competitiveness (MEC) [MICINN-BFU2010-15163]; NATIONAL CANCER INSTITUTE [R01CA149438] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY015636, R01EY018603, R21EY019113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103453, P30GM106396] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Olga Torres Foundation (FOT); Spanish Association Against Cancer (AECC); Avon Breast Cancer Campaign (AVON-SAU); Ministry of Economy and Competitiveness (MEC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grants EY019113 and EY018603 (to D.C.D.), National Institutes of Health Institutional Development Award P20GM103453 through the NIGMS (to Y.L.), and National Institutes of Health Core Grant EY015636 (to A.P.). This work was also supported by the Olga Torres Foundation (FOT), Spanish Association Against Cancer (AECC), Avon Breast Cancer Campaign (AVON-SAU), and Ministry of Economy and Competitiveness (MEC)/MICINN-BFU2010-15163 (to A.P.).	Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chassot AA, 2008, CELL CYCLE, V7, P2038, DOI 10.4161/cc.7.13.6233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; El-Naggar S, 2009, MOL CELL BIOL, V29, P5710, DOI 10.1128/MCB.00197-09; Foijer F, 2005, CANCER CELL, V8, P455, DOI 10.1016/j.ccr.2005.10.021; Foijer F, 2007, CANCER RES, V67, P9244, DOI 10.1158/0008-5472.CAN-07-1650; Geryk-Hall M, 2009, CURR ONCOL REP, V11, P446, DOI 10.1007/s11912-009-0061-z; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li W, 2009, P NATL ACAD SCI USA, V106, P486, DOI 10.1073/pnas.0804177106; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mora J, 2012, PEDIATR BLOOD CANCER, V58, P532, DOI 10.1002/pbc.23348; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen AD, 2012, J SURG ONCOL, V105, P830, DOI 10.1002/jso.23012; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yoo JY, 1999, MODERN PATHOL, V12, P775; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X	42	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11572	11580		10.1074/jbc.M112.434951	http://dx.doi.org/10.1074/jbc.M112.434951			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443660	hybrid, Green Published			2022-12-28	WOS:000317915500062
J	Yu, JW; Farias, A; Hwang, I; Fernandes-Alnemri, T; Alnemri, ES				Yu, Je-Wook; Farias, Andrew; Hwang, Inhwa; Fernandes-Alnemri, Teresa; Alnemri, Emad S.			Ribotoxic Stress through p38 Mitogen-activated Protein Kinase Activates in Vitro the Human Pyrin Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL MEDITERRANEAN FEVER; NLRP3 INFLAMMASOME; CELL-DEATH; CASPASE-1; PYROPTOSOME; INHIBITORS; DISEASES	Human pyrin with gain-of-function mutations in its B30.2/SPRY domain causes the autoinflammatory disease familial Mediterranean fever by assembling an ASC-dependent inflammasome that activates caspase-1. Wild-type human pyrin can also form an inflammasome complex with ASC after engagement by autoinflammatory PSTPIP1 mutants. How the pyrin inflammasome is activated in the absence of disease-associated mutations is not yet known. We report here that ribotoxic stress triggers the assembly of the human pyrin inflammasome, leading to ASC oligomerization and caspase-1 activation in THP-1 macrophages and in a 293T cell line stably reconstituted with components of the pyrin inflammasome. Knockdown of pyrin and selective inhibition of p38 MAPK greatly attenuated caspase-1 activation by ribotoxic stress, whereas expression of the conditional mutant Delta MEKK3:ER* allowed the activation of caspase-1 without ribotoxic stress. Disruption of microtubules by colchicine also inhibited pyrin inflammasome activation by ribotoxic stress. Together, our results indicate that ribotoxic stress activates the human pyrin inflammasome through a mechanism that requires p38 MAPK signaling and microtubule stability.	[Yu, Je-Wook; Farias, Andrew; Fernandes-Alnemri, Teresa; Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Yu, Je-Wook; Farias, Andrew; Fernandes-Alnemri, Teresa; Alnemri, Emad S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Yu, Je-Wook; Hwang, Inhwa] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul 120752, South Korea	Jefferson University; Jefferson University; Yonsei University; Yonsei University Health System	Yu, JW (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul 120752, South Korea.	jewookyu@yuhs.ac; emad.alnemri@jefferson.edu		Yu, Je-Wook/0000-0001-5943-4071	National Research Foundation Basic Science Research Program Grant from the Ministry of Education, Science and Technology (MEST) [2010-10849]; National R&D Program for Cancer Control Grant from the Ministry of Health, Welfare and Family Affairs, Korea [1020190]; National Institutes of Health [AG14357, AR055398]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	National Research Foundation Basic Science Research Program Grant from the Ministry of Education, Science and Technology (MEST); National R&D Program for Cancer Control Grant from the Ministry of Health, Welfare and Family Affairs, Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14357 and AR055398 (to E. S. A).; Supported by National Research Foundation Basic Science Research Program Grant 2010-10849 from the Ministry of Education, Science and Technology (MEST) and National R&D Program for Cancer Control Grant 1020190 from the Ministry of Health, Welfare and Family Affairs, Korea. To whom correspondence may be addressed: Dept. of Microbiology and Immunology, Yonsei University College of Medicine, Seoul 120-752, Korea. E-mail: jewookyu@yuhs.ac.	Aksentijevich I, 1997, CELL, V90, P797; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bernot A, 1997, NAT GENET, V17, P25; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Garner AP, 2002, ONCOGENE, V21, P8089, DOI 10.1038/sj.onc.1206000; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kataoka T, 2012, EUR J PHARMACOL, V676, P1, DOI 10.1016/j.ejphar.2011.11.044; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Laskin JD, 2002, TOXICOL SCI, V69, P289, DOI 10.1093/toxsci/69.2.289; Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Ozturk MA, 2011, CLIN EXP RHEUMATOL, V29, pS77; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wang DH, 2013, J BIOL CHEM, V288, P4594, DOI 10.1074/jbc.M112.443077; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	31	25	27	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11378	11383		10.1074/jbc.M112.448795	http://dx.doi.org/10.1074/jbc.M112.448795			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479736	Green Published, hybrid			2022-12-28	WOS:000317915500040
J	Asai, T; Morrison, SL				Asai, Tsuneaki; Morrison, Sherie L.			The SRC Family Tyrosine Kinase HCK and the ETS Family Transcription Factors SPIB and EHF Regulate Transcytosis across a Human Follicle-associated Epithelium Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATCH M-CELLS; SECRETORY IGA; IN-VITRO; GM-CSF; HUMAN ENTEROCYTES; CACO-2 CELLS; DIFFERENTIATION; TRANSPORT; EXPRESSION; RECEPTOR	A critical step in the induction of adaptive mucosal immunity is antigen transcytosis, in which luminal antigens are transported to organized lymphoid tissues across the follicle-associated epithelium (FAE) of Peyer's patches. However, virtually nothing is known about intracellular signaling proteins and transcription factors that regulate apical-to-basolateral transcytosis. The FAE can transcytose a variety of luminal contents, including inert particles, in the absence of specific opsonins. Furthermore, it expresses receptors for secretory immunoglobulin A(SIgA), the main antibody in mucosal secretions, and uses them to efficiently transcytose SIgA-opsonized particles present in the lumen. Using a human FAE model, we show that the tyrosine kinase HCK regulates apical-to-basolateral transcytosis of non-opsonized and SIgA-opsonized particles. We also show that, in cultured intestinal epithelial cells, ectopic expression of the transcription factor SPIB or EHF is sufficient to activate HCK-dependent apical-to-basolateral transcytosis of these particles. Our results provide the first molecular insights into the intracellular regulation of antigen sampling at mucosal surfaces.	[Asai, Tsuneaki; Morrison, Sherie L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Asai, T (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 615 Charles Young Dr, Los Angeles, CA 90095 USA.	tsuneaki.asai@ucla.edu			National Institutes of Health [R21AI092386]; California HIV/AIDS Research Program [ID10-LA-012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AI092386. This work was also supported by California HIV/AIDS Research Program Grant ID10-LA-012 (to S. L. M.).	Baumann J, 2010, IMMUNOL LETT, V131, P59, DOI 10.1016/j.imlet.2010.03.005; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Blanco LP, 2006, INFECT IMMUN, V74, P6957, DOI 10.1128/IAI.00905-06; Brandtzaeg P, 2010, IMMUNOL INVEST, V39, P303, DOI 10.3109/08820131003680369; BROWN D, 1990, J PHYSIOL-LONDON, V427, P81, DOI 10.1113/jphysiol.1990.sp018162; Carreno S, 2002, J BIOL CHEM, V277, P21007, DOI 10.1074/jbc.M201212200; CHANTRET I, 1994, J CELL SCI, V107, P213; Corthesy B, 2009, IMMUNOPHARM IMMUNOT, V31, P174, DOI 10.1080/08923970802438441; Crottet P, 1998, J IMMUNOL, V161, P5445; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; des Rieux A, 2007, EUR J PHARM SCI, V30, P380, DOI 10.1016/j.ejps.2006.12.006; Ferruzza S, 2012, TOXICOL IN VITRO, V26, P1252, DOI 10.1016/j.tiv.2012.01.008; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Harper LV, 2003, MOL CELL PROBE, V17, P261, DOI 10.1016/S0890-8508(03)00063-X; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Innes NPT, 1999, ARCH ORAL BIOL, V44, P519, DOI 10.1016/S0003-9969(99)00027-8; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kerneis S, 2000, MICROBES INFECT, V2, P1119, DOI 10.1016/S1286-4579(00)01266-1; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kesisoglou F, 2010, MOL PHARMACEUT, V7, P619, DOI 10.1021/mp9001377; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Kunisawa J, 2012, ADV DRUG DELIVER REV, V64, P523, DOI 10.1016/j.addr.2011.07.003; Le Ferrec E, 2001, ATLA-ALTERN LAB ANIM, V29, P649, DOI 10.1177/026119290102900604; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; LINNEKIN D, 1994, BLOOD, V84, P94, DOI 10.1182/blood.V84.1.94.bloodjournal84194; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mantis NJ, 2004, J IMMUNOL, V172, P6838, DOI 10.4049/jimmunol.172.11.6838; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Munera J, 2011, STEM CELLS, V29, P430, DOI 10.1002/stem.599; Murthy AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016847; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Pagel JM, 2007, CANCER RES, V67, P5921, DOI 10.1158/0008-5472.CAN-07-0080; PORTA C, 1992, EXP PHYSIOL, V77, P929, DOI 10.1113/expphysiol.1992.sp003662; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz O., 2013, TRENDS IMMU IN PRESS; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Sui LL, 2004, BIOCHEM BIOPH RES CO, V319, P920, DOI 10.1016/j.bbrc.2004.05.065; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Tyrer P, 2006, INFECT IMMUN, V74, P625, DOI 10.1128/IAI.74.1.625-631.2006; van Spriel AB, 2002, J IMMUNOL, V169, P3831, DOI 10.4049/jimmunol.169.7.3831; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Zucco F, 2005, ATLA-ALTERN LAB ANIM, V33, P603, DOI 10.1177/026119290503300618	55	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10395	10405		10.1074/jbc.M112.437475	http://dx.doi.org/10.1074/jbc.M112.437475			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439650	Green Published, hybrid			2022-12-28	WOS:000317565000020
J	Conibear, AC; Rosengren, KJ; Daly, NL; Henriques, ST; Craik, DJ				Conibear, Anne C.; Rosengren, K. Johan; Daly, Norelle L.; Henriques, Sonia Troeira; Craik, David J.			The Cyclic Cystine Ladder in theta-Defensins Is Important for Structure and Stability, but Not Antibacterial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOTIDE KALATA B1; ANTIMICROBIAL PEPTIDE RTD-1; CIRCULAR PROTEINS; BETA; ALPHA; MUTAGENESIS; RETROCYCLIN; LIGATION; BINDING; VIRUS	theta-Defensins are ribosomally synthesized cyclic peptides found in the leukocytes of some primate species and have promising applications as antimicrobial agents and scaffolds for peptide drugs. The cyclic cystine ladder motif, comprising a cyclic peptide backbone and three parallel disulfide bonds, is characteristic of theta-defensins. In this study, we explore the role of the cyclic peptide backbone and cystine ladder in the structure, stability, and activity of theta-defensins. theta-Defensin analogues with different numbers and combinations of disulfide bonds were synthesized and characterized in terms of their NMR solution structures, serum and thermal stabilities, and their antibacterial and membrane-binding activities. Whereas the structures and stabilities of the peptides were primarily dependent on the number and position of the disulfide bonds, their antibacterial and membrane-binding properties were dependent on the cyclic backbone. The results provide insights into the mechanism of action of theta-defensins and illustrate the potential of theta-defensin analogues as scaffolds for peptide drug design.	[Conibear, Anne C.; Rosengren, K. Johan; Daly, Norelle L.; Henriques, Sonia Troeira; Craik, David J.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Conibear, Anne/AFO-0979-2022; Craik, David/B-1695-2010; Rosengren, K. Johan/P-4450-2016; Henriques, Sonia Troeira/J-3500-2016; Conibear, Anne/AAL-3855-2020; Daly, Norelle L/D-4302-2013; Conibear, Anne/C-5246-2014	Conibear, Anne/0000-0002-5482-6225; Craik, David/0000-0003-0007-6796; Rosengren, K. Johan/0000-0002-5007-8434; Henriques, Sonia Troeira/0000-0001-9564-9651; Conibear, Anne/0000-0002-5482-6225; Daly, Norelle L/0000-0002-4697-6602; Conibear, Anne/0000-0002-5482-6225	Australian Research Council [DP0984390, DE120103152]; University of Queensland; National Health and Medical Research Council [APP631420, APP1026501]; Queensland Government	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government	This work was supported by Australian Research Council Grant DP0984390.; Supported by a University of Queensland International scholarship.; Supported by National Health and Medical Research Council Career Development Award Grant APP631420.; Supported by a Queensland Government smart state fellowship. Present address: Queensland Tropical Health Alliance, School of Pharmacy and Molecular Sciences and Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Cairns, QLD 4878, Australia.; Supported by a Discovery Early Career Research Award DE120103152 from the Australian Research Council.; Recipient of National Health and Medical Research Council Professorial Fellow Grant APP1026501. To whom correspondence should be addressed. Tel.: 61( 0)7-3346-2019; E-mail: d.craik@imb.uq.edu.au.	Abuja PM, 2004, FEBS LETT, V566, P301, DOI 10.1016/j.febslet.2004.03.112; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakraborty K, 2005, BIOCHEMISTRY-US, V44, P14638, DOI 10.1021/bi050921s; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Conibear AC, 2012, BIOPOLYMERS, V98, P518, DOI 10.1002/bip.22121; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 2007, BIOCHEMISTRY-US, V46, P9920, DOI 10.1021/bi700720e; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Gibbs AC, 1998, NAT STRUCT BIOL, V5, P284, DOI 10.1038/nsb0498-284; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2010, BIOPOLYMERS, V94, P314, DOI 10.1002/bip.21367; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Korsinczky MLJ, 2005, BIOCHEMISTRY-US, V44, P1145, DOI 10.1021/bi048297r; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Montalban-Lopez M, 2012, J BIOL CHEM, V287, P27007, DOI 10.1074/jbc.R112.354688; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Schaal JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051337; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tang M, 2006, BIOPHYS J, V90, P3616, DOI 10.1529/biophysj.105.062075; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Trabi M, 2001, BIOCHEMISTRY-US, V40, P4211, DOI 10.1021/bi002028t; Vermeer LS, 2012, J BIOL CHEM, V287, P34120, DOI 10.1074/jbc.M112.359067; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Weiss TM, 2002, BIOCHEMISTRY-US, V41, P10070, DOI 10.1021/bi025853d; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Wu CL, 2012, NAT CHEM, V4, P1045, DOI [10.1038/NCHEM.1487, 10.1038/nchem.1487]; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004	54	57	60	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10830	10840		10.1074/jbc.M113.451047	http://dx.doi.org/10.1074/jbc.M113.451047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430740	Green Published, hybrid			2022-12-28	WOS:000317565000060
J	Lorenz, MA; El Azzouny, MA; Kennedy, RT; Burant, CF				Lorenz, Matthew A.; El Azzouny, Mahmoud A.; Kennedy, Robert T.; Burant, Charles F.			Metabolome Response to Glucose in the beta-Cell Line INS-1 832/13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; ACYL-COA ESTERS; MOUSE PANCREATIC-ISLETS; SENSITIVE K+ CHANNEL; MALONYL-COA; MECHANISMS; EXOCYTOSIS; PYRUVATE; NUCLEOTIDES; CARBOXYLASE	Glucose-stimulated insulin secretion (GSIS) from pancreatic beta-cells is triggered by metabolism of the sugar to increase ATP/ADP ratio that blocks the K-ATP channel leading to membrane depolarization and insulin exocytosis. Other metabolic pathways believed to augment insulin secretion have yet to be fully elucidated. To study metabolic changes during GSIS, liquid chromatography with mass spectrometry was used to determine levels of 87 metabolites temporally following a change in glucose from 3 to 10 mM glucose and in response to increasing concentrations of glucose in the INS-1 832/13 beta-cell line. U-[C-13]Glucose was used to probe flux in specific metabolic pathways. Results include a rapid increase in ATP/ADP, anaplerotic tricarboxylic acid cycle flux, and increases in the malonyl CoA pathway, support prevailing theories of GSIS. Novel findings include that aspartate used for anaplerosis does not derive from the glucose fuel added to stimulate insulin secretion, glucose flux into glycerol-3-phosphate, and esterification of long chain CoAs resulting in rapid consumption of long chain CoAs and de novo generation of phosphatidic acid and diacylglycerol. Further, novel metabolites with potential roles in GSIS such as 5-aminoimidazole-4-carboxamide ribotide (ZMP), GDP-mannose, and farnesyl pyrophosphate were found to be rapidly altered following glucose exposure.	[Lorenz, Matthew A.; El Azzouny, Mahmoud A.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA; [Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Burant, CF (corresponding author), Univ Michigan, Dept Internal Med, 6309 Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	burantc@umich.edu	Kennedy, Robert/G-9095-2016; ElAzzouny, Mahmoud/G-5748-2013; Burant, Charles/GPC-5690-2022	Kennedy, Robert/0000-0003-2447-7471; Burant, Charles/0000-0001-9189-5003	National Institutes of Health [DK046960, DK079084]; MI Nutrition Obesity Research Center [P30 DK089503]; Michigan Diabetes Research and Training Center [P60 DK20572]; Michigan Regional Comprehensive Metabolomics Resource Core [U24 DK097153]; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960, R37DK046960, R01DK079084, P30DK089503, U24DK097153, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MI Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; Michigan Regional Comprehensive Metabolomics Resource Core; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part or in whole, by National Institutes of Health Grants DK046960 (to R. T. K.), DK079084 (to C. F. B. and R. T. K.), MI Nutrition Obesity Research Center (P30 DK089503), the Michigan Diabetes Research and Training Center (P60 DK20572), the Michigan Regional Comprehensive Metabolomics Resource Core (U24 DK097153), and the Robert C. and Veronica Atkins Foundation, and the A. Alfred Taubman Institute (to C. F. B.).	Akkan A G, 1994, Diabetes Res, V25, P13; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bender K, 2006, BIOCHEM SOC T, V34, P811, DOI 10.1042/BST0340811; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; HALL ML, 1960, BIOCHEM BIOPH RES CO, V3, P239, DOI 10.1016/0006-291X(60)90231-X; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; HASHIMOTO T, 1971, EUR J BIOCHEM, V24, P128, DOI 10.1111/j.1432-1033.1971.tb19663.x; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Krippeit-Drews P, 2003, PFLUG ARCH EUR J PHY, V445, P556, DOI 10.1007/s00424-002-0975-x; Kwan EP, 2007, DIABETES OBES METAB, V9, P99, DOI 10.1111/j.1463-1326.2007.00788.x; LIANG Y, 1991, DIABETES, V40, P327, DOI 10.2337/diabetes.40.3.327; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Odegaard ML, 2010, J BIOL CHEM, V285, P16530, DOI 10.1074/jbc.M109.092593; Poitout V, 2008, AM J PHYSIOL-ENDOC M, V294, pE214, DOI 10.1152/ajpendo.00638.2007; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Sato Y, 2010, ANAL CHEM, V82, P9858, DOI 10.1021/ac102211r; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Straub SG, 2004, AM J PHYSIOL-CELL PH, V287, pC565, DOI 10.1152/ajpcell.00079.2004; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; WILCOCK AR, 1972, BIOCHEM MED METAB B, V6, P116, DOI 10.1016/0006-2944(72)90029-4; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232; ZHANG S, 1995, J ENDOCRINOL, V147, P33, DOI 10.1677/joe.0.1470033	57	60	60	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10923	10935		10.1074/jbc.M112.414961	http://dx.doi.org/10.1074/jbc.M112.414961			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426361	hybrid, Green Published			2022-12-28	WOS:000317565000069
J	Yan, JP; Kaur, S; DeLucia, M; Hao, CL; Mehrens, J; Wang, CP; Golczak, M; Palczewski, K; Gronenborn, AM; Ahn, J; Skowronski, J				Yan, Junpeng; Kaur, Sarabpreet; DeLucia, Maria; Hao, Caili; Mehrens, Jennifer; Wang, Chuanping; Golczak, Marcin; Palczewski, Krzysztof; Gronenborn, Angela M.; Ahn, Jinwoo; Skowronski, Jacek			Tetramerization of SAMHD1 Is Required for Biological Activity and Inhibition of HIV Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; AICARDI-GOUTIERES SYNDROME; IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; VPX; REPLICATION; PROTEIN; GENE; DEGRADATION; MACROPHAGES	SAMHD1 is a dGTP-activated dNTPase that has been implicated as a modulator of the innate immune response. In monocytes and their differentiated derivatives, as well as in quiescent cells, SAMHD1strongly inhibits HIV-1 infection and, to a lesser extent, HIV-2 and simian immunodeficiency virus (SIV) because of their virion-associated virulence factor Vpx, which directs SAMHD1 for proteasomal degradation. Here, we used a combination of biochemical and virologic approaches to gain insights into the functional organization of human SAMHD1. We found that the catalytically active recombinant dNTPase is a dGTP-induced tetramer. Chemical cross-linking studies revealed SAMHD1 tetramers in human monocytic cells, in which it strongly restricts HIV-1 infection. The propensity of SAMHD1 to maintain the tetrameric state in vitro is regulated by its C terminus, located outside of the catalytic domain. Accordingly, we show that the C terminus is required for the full ability of SAMHD1 to deplete dNTP pools and to inhibit HIV-1 infection in U937 monocytes. Interestingly, the human SAMHD1 C terminus contains a docking site for HIV-2/SIVmac Vpx and is known to have evolved under positive selection. This evidence indicates that Vpx targets a functionally important element in SAMHD1. Together, our findings imply that SAMHD1 tetramers are the biologically active form of this dNTPase and provide new insights into the functional organization of SAMHD1.	[Yan, Junpeng; Kaur, Sarabpreet; Hao, Caili; Wang, Chuanping; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [DeLucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [DeLucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.; Ahn, Jinwoo; Skowronski, Jacek] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Case Western Reserve University; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jahn@structbio.pitt.edu; jacek.skowronski@case.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [AI077459, AI100673, P50GM082251]; CWRU/UH Center for AIDS Research Grant [P30AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100673, P30AI036219, R01AI077459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CWRU/UH Center for AIDS Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077459 and AI100673 (to J. S.), P50GM082251 (to A. M. G., J. A., and J. S.), and CWRU/UH Center for AIDS Research Grant P30AI036219.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Fromentin E, 2010, ANAL CHEM, V82, P1982, DOI 10.1021/ac902737j; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Jepps H, 2008, EARLY HUM DEV, V84, P783, DOI 10.1016/j.earlhumdev.2008.09.001; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; KAWAMURA M, 1994, MICROBIOL IMMUNOL, V38, P871, DOI 10.1111/j.1348-0421.1994.tb02140.x; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Suzuki K, 2007, INT J HEMATOL, V85, P384, DOI 10.1532/IJH97.06213; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Wei W, 2012, CELL MICROBIOL, V14, P1745, DOI 10.1111/j.1462-5822.2012.01835.x; Xin BZ, 2011, P NATL ACAD SCI USA, V108, P5372, DOI 10.1073/pnas.1014265108; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991	38	110	116	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10406	10417		10.1074/jbc.M112.443796	http://dx.doi.org/10.1074/jbc.M112.443796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426366	Green Published, hybrid			2022-12-28	WOS:000317565000021
J	Reddy, K; Zamiri, B; Stanley, SYR; Macgregor, RB; Pearson, CE				Reddy, Kaalak; Zamiri, Bita; Stanley, Sabrina Y. R.; Macgregor, Robert B., Jr.; Pearson, Christopher E.			The Disease-associated r(GGGGCC)(n) Repeat from the C9orf72 Gene Forms Tract Length-dependent Uni- and Multimolecular RNA G-quadruplex Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXANUCLEOTIDE REPEAT; MESSENGER-RNA; TRANSLATION; INSTABILITY; BINDING; 5'-UTR; EXPANSIONS; STABILITY; PROTEIN; REGION	Certain DNA and RNA sequences can form G-quadruplexes, which can affect promoter activity, genetic instability, RNA splicing, translation, and neurite mRNA localization. Amyotrophic lateral sclerosis and frontotemporal dementia were recently shown to be caused by expansion of a (GGGGCC)(n). (GGCCCC)(n) repeat in the C9orf72 gene. Mutant r(GGGGCC)(n)-containing transcripts aggregate in nuclear foci possibly sequestering repeat-binding proteins, suggesting a toxic RNA pathogenesis. We demonstrate that the r(GGGGCC)(n) RNA but not the C-rich r(GGCCCC)(n) RNA forms extremely stable uni- and multimolecular parallel G-quadruplex structures (up to 95 degrees C). Multimolecular G-quadruplex formation is influenced by repeat number and RNA concentration. MBNL1, a splicing factor that is sequestered in myotonic dystrophy patients by binding to expanded r(CUG)n repeat hairpins, does not bind the C9orf72 repeats, but the splicing factor ASF/SF2 can bind the r(GGGGCC)(n) repeat. Because multimolecular G-quadruplexes are enhanced by repeat length, RNA-RNA interactions facilitated by G-quadruplex formation at expanded repeats might influence transcript aggregation and foci formation in amyotrophic lateral sclerosis-frontotemporal dementia cells. Tract length-dependent G-quadruplex formation by the C9orf72RNA should be considered when assessing the role of this repeat in C9orf72 gene activity, protein binding, transcript foci formation, and translation of the C9orf72 product, including the non-canonical repeat-associated non-ATG translation (RAN translation) into pathologic dipeptide repeats, as well as any oligonucleotide repeat-based therapy.	[Reddy, Kaalak; Pearson, Christopher E.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Reddy, Kaalak; Stanley, Sabrina Y. R.; Pearson, Christopher E.] Univ Toronto, Program Mol Genet, Toronto, ON M5G 1L7, Canada; [Zamiri, Bita; Macgregor, Robert B., Jr.] Univ Toronto, Leslie Dan Fac Pharm, Grad Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Pearson, CE (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, 101 Coll St,East Tower,15-312 TMDT, Toronto, ON M5G 1L7, Canada.	cepearson.sickkids@gmail.com		Pearson, Christopher/0000-0001-9545-4205	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR); Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship (OGS)	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	This work was supported by grants from the Amyotrophic Lateral Sclerosis Association of America (to C. E. P.), the Canadian Institutes of Health Research (CIHR) to (C. E. P.), and the Natural Science and Engineering Research Council of Canada (to R. B. M.).; supported by an Ontario Graduate Scholarship (OGS).	Abu-Ghazalah RM, 2009, BIOPHYS CHEM, V141, P180, DOI 10.1016/j.bpc.2009.01.013; Arora A, 2009, FEBS J, V276, P3628, DOI 10.1111/j.1742-4658.2009.07082.x; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Faudale M, 2012, CHEM COMMUN, V48, P874, DOI 10.1039/c1cc15850c; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gomez-Tortosa E, 2013, NEUROLOGY, V80, P366, DOI 10.1212/WNL.0b013e31827f08ea; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Melko M, 2010, BIOCHIMIE, V92, P919, DOI 10.1016/j.biochi.2010.05.018; Merkina EE, 2005, BIOPHYS J, V89, P365, DOI 10.1529/biophysj.105.061259; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Pedroso IA, 2007, BIOPOLYMERS, V87, P74, DOI 10.1002/bip.20790; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shin J, 2009, NEUROSCI LETT, V466, P99, DOI 10.1016/j.neulet.2009.07.079; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Willemsen R, 2011, CLIN GENET, V80, P214, DOI 10.1111/j.1399-0004.2011.01723.x; Wojciechowska M, 2011, RNA BIOL, V8, P565, DOI 10.4161/rna.8.4.15397; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhai QQ, 2012, BIOORG MED CHEM LETT, V22, P1142, DOI 10.1016/j.bmcl.2011.11.099; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	46	227	230	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9860	9866		10.1074/jbc.C113.452532	http://dx.doi.org/10.1074/jbc.C113.452532			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23423380	hybrid, Green Published			2022-12-28	WOS:000317114000026
J	Sand, R; Sharmin, N; Morgan, C; Gallin, WJ				Sand, Rheanna; Sharmin, Nazlee; Morgan, Carla; Gallin, Warren J.			Fine-tuning of Voltage Sensitivity of the K(v)1.2 Potassium Channel by Interhelix Loop Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNEL; ELECTROSTATIC INTERACTIONS; POLYORCHIS PENICILLATUS; GATING KINETICS; XENOPUS OOCYTES; LIPID-MEMBRANE; S3-S4 LINKER; SENSOR; KV1.2; ACTIVATION	Many proteins function by changing conformation in response to ligand binding or changes in other factors in their environment. Any change in the sequence of a protein, for example during evolution, which alters the relative free energies of the different functional conformations changes the conditions under which the protein will function. Voltage-gated ion channels are membrane proteins that open and close an ion-selective pore in response to changes in transmembrane voltage. The charged S4 transmembrane helix transduces changes in transmembrane voltage into a change in protein internal energy by interacting with the rest of the channel protein through a combination of non-covalent interactions between adjacent helices and covalent interactions along the peptide backbone. However, the structural basis for the wide variation in the V-50 value between different voltage-gated potassium channels is not well defined. To test the role of the loop linking the S3 helix and the S4 helix in voltage sensitivity, we have constructed a set of mutants of the rat K(v)1.2 channel that vary solely in the length and composition of the extracellular loop that connects S4 to S3. We evaluated the effect of these different loop substitutions on the voltage sensitivity of the channel and compared these experimental results with molecular dynamics simulations of the loop structures. Here, we show that this loop has a significant role in setting the precise V-50 of activation in K(v)1 family channels.	[Sand, Rheanna; Sharmin, Nazlee; Morgan, Carla; Gallin, Warren J.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Gallin, Warren J.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Gallin, WJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	wgallin@ualberta.ca		Sharmin, Nazlee/0000-0002-2408-2333; Sand, Rheanna/0000-0002-8936-0234	Canadian Institutes for Health Research; National Science and Engineering Research Council of Canada; National Science and Engineering Research Council	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by grants from The Canadian Institutes for Health Research and the National Science and Engineering Research Council of Canada (to W. J. G.); Supported by an National Science and Engineering Research Council postgraduate scholarship.	Baumgartner W, 1999, BIOPHYS J, V77, P1980, DOI 10.1016/S0006-3495(99)77039-6; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Gonzalez C, 2000, J GEN PHYSIOL, V115, P193, DOI 10.1085/jgp.115.2.193; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Grigoriev NG, 1999, J NEUROPHYSIOL, V82, P1728, DOI 10.1152/jn.1999.82.4.1728; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; HUANG QQ, 1993, J BIOL CHEM, V268, P20613; Jegla T, 1995, J NEUROSCI, V15, P7989; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kim M, 1997, J NEUROSCI, V17, P8213; Klassen TL, 2008, J EXP BIOL, V211, P3442, DOI 10.1242/jeb.022608; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Radley TL, 2003, J MOL BIOL, V332, P529, DOI 10.1016/S0022-2836(03)00925-2; RAMASWAMI M, 1990, Molecular and Cellular Neuroscience, V1, P214, DOI 10.1016/1044-7431(90)90004-N; Sand RM, 2011, J EXP BIOL, V214, P3124, DOI 10.1242/jeb.057000; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Vargas E, 2012, J GEN PHYSIOL, V140, P587, DOI 10.1085/jgp.201210873; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Xu YP, 2010, CELL, V142, P580, DOI 10.1016/j.cell.2010.07.013; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	47	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9686	9695		10.1074/jbc.M112.437483	http://dx.doi.org/10.1074/jbc.M112.437483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413033	hybrid, Green Published			2022-12-28	WOS:000317114000011
J	De Lay, N; Schu, DJ; Gottesman, S				De Lay, Nicholas; Schu, Daniel J.; Gottesman, Susan			Bacterial Small RNA-based Negative Regulation: Hfq and Its Accomplices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI HFQ; MESSENGER-RNA; POLYNUCLEOTIDE PHOSPHORYLASE; SOLUBLE-RNAS; CRUCIAL ROLE; BINDING; DEGRADATION; REGION; COMPETITION; PROTEINS	A large group of bacterial small regulatory RNAs (sRNAs) use the Hfq chaperone to mediate pairing with and regulation of mRNAs. Recent findings help to clarify how Hfq acts and highlight the role of the endonuclease RNase E and its associated proteins (the degradosome) in negative regulation by these sRNAs. sRNAs frequently uncouple transcription and translation by blocking ribosome access to the mRNA, allowing other proteins access to the mRNA. As more examples of sRNA-mediated regulation are studied, more variations on how Hfq, RNase E, and other proteins collaborate to bring about sRNA-based regulation are being found.	[De Lay, Nicholas; Schu, Daniel J.; Gottesman, Susan] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gottesman, S (corresponding author), NCI, Mol Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	gottesms@helix.nih.gov		De Lay, Nicholas/0000-0003-2249-7073	National Cancer Institute Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008714] Funding Source: NIH RePORTER	National Cancer Institute Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The preparation of this review was supported in whole by the National Institutes of Health Intramural Research Program of the National Cancer Institute Center for Cancer Research.	Andrade JM, 2008, RNA, V14, P543, DOI 10.1261/rna.683308; Andrade JM, 2012, RNA, V18, P844, DOI 10.1261/rna.029413.111; Balbontin R, 2010, MOL MICROBIOL, V78, P380, DOI 10.1111/j.1365-2958.2010.07342.x; Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015; Beisel CL, 2012, EMBO J, V31, P1961, DOI 10.1038/emboj.2012.52; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brescia CC, 2003, RNA, V9, P33, DOI 10.1261/rna.2570803; Briani F, 2008, RNA, V14, P2417, DOI 10.1261/rna.1123908; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CARMICHAEL GG, 1975, J BIOL CHEM, V250, P3607; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Corcoran CP, 2012, MOL MICROBIOL, V84, P428, DOI 10.1111/j.1365-2958.2012.08031.x; De Lay N, 2011, RNA, V17, P1172, DOI 10.1261/rna.2531211; Desnoyers G, 2012, GENE DEV, V26, P726, DOI 10.1101/gad.182493.111; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Gottesman S, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P59; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hussein R, 2011, P NATL ACAD SCI USA, V108, P1110, DOI 10.1073/pnas.1010082108; Ikeda Y, 2011, MOL MICROBIOL, V79, P419, DOI 10.1111/j.1365-2958.2010.07454.x; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; KUSHNER SR, 2007, ESCHERICHIA COLI SAL; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Maki K, 2008, P NATL ACAD SCI USA, V105, P10332, DOI 10.1073/pnas.0803106105; Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x; Mohanty BK, 2003, MOL MICROBIOL, V50, P645, DOI 10.1046/j.1365-2958.2003.03724.x; Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Olejniczak M, 2011, BIOCHEMISTRY-US, V50, P4427, DOI 10.1021/bi102043f; Otaka H, 2011, P NATL ACAD SCI USA, V108, P13059, DOI 10.1073/pnas.1107050108; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Salim NN, 2012, NUCLEIC ACIDS RES, V40, P8021, DOI 10.1093/nar/gks392; Salim NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013028; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sittka A, 2009, RNA BIOL, V6, P266, DOI 10.4161/rna.6.3.8332; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Updegrove TB, 2011, RNA, V17, P489, DOI 10.1261/rna.2452111; Urban Johannes H., 2009, V540, P301, DOI 10.1007/978-1-59745-558-9_22; Viegas SC, 2007, NUCLEIC ACIDS RES, V35, P7651, DOI 10.1093/nar/gkm916; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang WW, 2011, GENE DEV, V25, P2106, DOI 10.1101/gad.16746011; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Windbichler N, 2008, RNA BIOL, V5, P30, DOI 10.4161/rna.5.1.5694; Worrall JAR, 2008, J MOL BIOL, V382, P870, DOI 10.1016/j.jmb.2008.07.059; Zhang AX, 2013, J MOL BIOL, V425, P3678, DOI 10.1016/j.jmb.2013.01.006; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	65	194	195	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					7996	8003		10.1074/jbc.R112.441386	http://dx.doi.org/10.1074/jbc.R112.441386			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362267	Green Published, hybrid			2022-12-28	WOS:000316564500001
J	Spurny, R; Billen, B; Howard, RJ; Brams, M; Debaveye, S; Price, KL; Weston, DA; Strelkov, SV; Tytgat, J; Bertrand, S; Bertrand, D; Lummis, SCR; Ulens, C				Spurny, Radovan; Billen, Bert; Howard, Rebecca J.; Brams, Marijke; Debaveye, Sarah; Price, Kerry L.; Weston, David A.; Strelkov, Sergei V.; Tytgat, Jan; Bertrand, Sonia; Bertrand, Daniel; Lummis, Sarah C. R.; Ulens, Chris			Multisite Binding of a General Anesthetic to the Prokaryotic Pentameric Erwinia chrysanthemi Ligand-gated Ion Channel (ELIC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; ACID TYPE-A; VOLATILE ANESTHETICS; GLYCINE RECEPTORS; MECHANISMS; GABA(A); ALCOHOL; MODULATION; SUBUNIT	Pentameric ligand-gated ion channels (pLGICs), such as nicotinic acetylcholine, glycine, gamma-aminobutyric acid GABA(A/C) receptors, and the Gloeobacter violaceus ligand-gated ion channel (GLIC), are receptors that contain multiple allosteric binding sites for a variety of therapeutics, including general anesthetics. Here, we report the x-ray crystal structure of the Erwinia chrysanthemi ligand-gated ion channel (ELIC) in complex with a derivative of chloroform, which reveals important features of anesthetic recognition, involving multiple binding at three different sites. One site is located in the channel pore and equates with a noncompetitive inhibitor site found in many pLGICs. A second transmembrane site is novel and is located in the lower part of the transmembrane domain, at an interface formed between adjacent subunits. A third site is also novel and is located in the extracellular domain in a hydrophobic pocket between the beta 7-beta 10 strands. Together, these results extend our understanding of pLGIC modulation and reveal several specific binding interactions that may contribute to modulator recognition, further substantiating a multisite model of allosteric modulation in this family of ion channels.	[Spurny, Radovan; Billen, Bert; Brams, Marijke; Debaveye, Sarah; Ulens, Chris] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, B-3000 Louvain, Belgium; [Howard, Rebecca J.] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Price, Kerry L.; Weston, David A.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB 1QW, England; [Strelkov, Sergei V.] Katholieke Univ Leuven, Lab Biocrystallog, B-3000 Louvain, Belgium; [Tytgat, Jan] Katholieke Univ Leuven, Toxicol Lab, B-3000 Louvain, Belgium; [Bertrand, Sonia; Bertrand, Daniel] HiQScreen Sarl, CH-1211 Geneva 12, Switzerland	KU Leuven; University of Texas System; University of Texas Austin; University of Cambridge; KU Leuven; KU Leuven	Ulens, C (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, Herestr 49,PB 601, B-3000 Louvain, Belgium.	chris.ulens@med.kuleuven.be	Strelkov, Sergei V/G-7425-2014	Strelkov, Sergei V/0000-0001-7189-4652; Price, Kerry/0000-0002-5563-4567; Tytgat, Jan/0000-0003-1778-6022; Howard, Rebecca/0000-0003-2049-3378	KU Leuven [OT/08/048]; FWO-Vlaanderen [G.0739.09, G.0743.10, G.0939.11]; European Union [HEALTH-F2-2007-202088]; Wellcome Trust; Medical Research Council (MRC)	KU Leuven(KU Leuven); FWO-Vlaanderen(FWO); European Union(European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grants KU Leuven OT/08/048 and FWO-Vlaanderen G.0739.09, G.0743.10, and G.0939.11 (to C. U.), the European Union Seventh Framework Programme under grant agreement HEALTH-F2-2007-202088 (to C. U., D. B., and S. C. R. L.), and the Wellcome Trust (to S. C. R. L. and K. L. P.).; Recipient of a Medical Research Council (MRC) studentship.	Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Beckstead MJ, 2000, MOL PHARMACOL, V57, P1199; Beckstead MJ, 2002, J NEUROCHEM, V82, P1343, DOI 10.1046/j.1471-4159.2002.01086.x; Beckstead MJ, 2001, J BIOL CHEM, V276, P24959, DOI 10.1074/jbc.M011627200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Daniels S, 1998, TOXICOL LETT, V101, P71, DOI 10.1016/S0378-4274(98)00167-2; FORMAN SA, 1995, MOL PHARMACOL, V48, P574; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Gumilar F, 2003, NEUROPHARMACOLOGY, V45, P964, DOI 10.1016/S0028-3908(03)00247-8; HARRIS RA, 1995, FASEB J, V9, P1454, DOI 10.1096/fasebj.9.14.7589987; HARRISON NL, 1993, MOL PHARMACOL, V44, P628; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jenkins A, 2008, ANESTH ANALG, V107, P486, DOI 10.1213/ane.0b013e31817b70c1; Kash TL, 2003, BRAIN RES, V960, P36, DOI 10.1016/S0006-8993(02)03748-4; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; LENA C, 1993, TRENDS NEUROSCI, V16, P181, DOI 10.1016/0166-2236(93)90150-K; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lopes CMB, 1998, BRIT J PHARMACOL, V125, P309, DOI 10.1038/sj.bjp.0702069; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Nakahiro M, 1996, NEUROSCI LETT, V205, P127, DOI 10.1016/0304-3940(96)12397-1; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Pascual JM, 1998, J GEN PHYSIOL, V112, P611, DOI 10.1085/jgp.112.5.611; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; Sear JW, 2009, BRIT J ANAESTH, V103, P50, DOI 10.1093/bja/aep092; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; WACHTEL RE, 1995, J PHARMACOL EXP THER, V274, P1355; Wallner M, 2008, BRIT J PHARMACOL, V154, P288, DOI 10.1038/bjp.2008.32; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; Yu Y, 2003, P NATL ACAD SCI USA, V100, P3907, DOI 10.1073/pnas.0730718100; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	49	80	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8355	8364		10.1074/jbc.M112.424507	http://dx.doi.org/10.1074/jbc.M112.424507			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364792	Green Published, hybrid			2022-12-28	WOS:000316564500035
J	Chen, Y; Sawada, O; Kohno, H; Le, YZ; Subauste, C; Maeda, T; Maeda, A				Chen, Yu; Sawada, Osamu; Kohno, Hideo; Le, Yun-Zheng; Subauste, Carlos; Maeda, Tadao; Maeda, Akiko			Autophagy Protects the Retina from Light-induced Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACULAR DEGENERATION; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; MOUSE RETINA; IN-VIVO; MICE; BECLIN-1; PARKIN; CELLS; GENE	Autophagy is a conserved feature of lysosome-mediated intracellular degradation. Dysregulated autophagy is implicated as a contributor in neurodegenerative diseases; however, the role of autophagy in retinal degeneration remains largely unknown. Here, we report that the photo-activated visual chromophore, all-trans-retinal, modulated autophagosome formation in ARPE19 retinal cells. Increased formation of autophagosomes in these cells was observed when incubated with 2.5 mu M all-trans-retinal, a condition that did not cause cell death after 24 h in culture. However, autophagosome formation was decreased at concentrations, which caused cell death. Increased expression of activating transcription factor 4 (Atf4), which indicates the activation of oxidative stress, was recorded in response to light illumination in retinas of Abca4(-/-) Rdh8(-/-) mice, which showed delayed clearance of all-trans-retinal after light exposure. Expression of autophagosome marker LC3B-II and mitochondria-specific autophagy, mitophagy, regulator Park2, were significantly increased in the retinas of Abca4(-/-) Rdh8(-/-) mice after light exposure, suggesting involvement of autophagy and mitophagy in the pathogenesis of light-induced retinal degeneration. Deletion of essential genes required for autophagy, including Beclin1 systemically or Atg7 in only rod photoreceptors resulted in increased susceptibility to light-induced retinal damage. Increased photoreceptor cell death was observed when retinas lacking the rod photoreceptor-specific Atg7 gene were coincubated with 20 mu M all-trans-retinal. Park2(-/-) mice also displayed light-induced retinal degeneration. Ultra-structural analyses showed mitochondrial and endoplasmic reticulum impairment in retinas of these model animals after light exposure. Taken together, these observations provide novel evidence implicating an important role of autophagy and mitophagy in protecting the retina from all-trans-retinal- and light-induced degeneration.	[Chen, Yu; Kohno, Hideo; Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Sawada, Osamu; Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Subauste, Carlos] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Chen, Yu] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Shanghai 200437, Peoples R China; [Chen, Yu] Shanghai Univ Tradit Chinese Med, Clin Res Inst Integrat Med, Shanghai 200437, Peoples R China; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center	Maeda, A (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu		Subauste, Carlos/0000-0002-5602-1439	National Institutes of Health [K08EY019031, K08EY019880, R01EY022658, R01EY018341, R24EY021126, P30EY011373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Fight for Sight; Ohio Lions Eye Research Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL EYE INSTITUTE [R01EY018341, K08EY019880, K08EY019031, P30EY011373, R24EY021126, R01EY022658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Fight for Sight; Ohio Lions Eye Research Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019031, K08EY019880, R01EY022658, R01EY018341, R24EY021126, and P30EY011373. This work was also supported by the Research to Prevent Blindness Foundation, Foundation Fighting Blindness, Fight for Sight, Ohio Lions Eye Research Foundation, and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holz F G, 1995, Ger J Ophthalmol, V4, P336; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Le YZ, 2006, MOL VIS, V12, P389; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okano K, 2012, J NEUROCHEM, V121, P146, DOI 10.1111/j.1471-4159.2012.07647.x; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Portillo JAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014472; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; REME CE, 1977, INVEST OPHTH VIS SCI, V16, P815; Shelley EJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P483, DOI 10.1001/archophthalmol.2008.622; Sparrow JR, 2010, ADV EXP MED BIOL, V703, P63, DOI 10.1007/978-1-4419-5635-4_5; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	41	106	110	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7506	7518		10.1074/jbc.M112.439935	http://dx.doi.org/10.1074/jbc.M112.439935			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23341467	Green Published, hybrid			2022-12-28	WOS:000316455300007
J	Agarwal, V; Kuchipudi, A; Fulde, M; Riesbeck, K; Bergmann, S; Blom, AM				Agarwal, Vaibhav; Kuchipudi, Arunakar; Fulde, Marcus; Riesbeck, Kristian; Bergmann, Simone; Blom, Anna M.			Streptococcus pneumoniae Endopeptidase O (PepO) Is a Multifunctional Plasminogen- and Fibronectin-binding Protein, Facilitating Evasion of Innate Immunity and Invasion of Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; FACTOR-H; EXTRACELLULAR-MATRIX; SURFACE PROTEIN; MEDIATED INTERNALIZATION; SECRETORY COMPONENT; VIRULENCE FACTORS; ADHERENCE; ADHESIN; DISEASE	Streptococcus pneumoniae infections remain a major cause of morbidity and mortality worldwide. Therefore a detailed understanding and characterization of the mechanism of host cell colonization and dissemination is critical to gain control over this versatile pathogen. Here we identified a novel 72-kDa pneumococcal protein endopeptidase O (PepO), as a plasminogen-and fibronectin-binding protein. Using a collection of clinical isolates, representing different serotypes, we found PepO to be ubiquitously present both at the gene and protein level. In addition, PepO protein was secreted in a growth phase-dependent manner to the culture supernatants of the pneumococcal isolates. Recombinant PepO bound human plasminogen and fibronectin in a dose-dependent manner and plasminogen did not compete with fibronectin for binding PepO. PepO bound plasminogen via lysine residues and the interaction was influenced by ionic strength. Moreover, upon activation of PepO-bound plasminogen by urokinase-type plasminogen activator, generated plasmin cleaved complement protein C3b thus assisting in complement control. Furthermore, direct binding assays demonstrated the interaction of PepO with epithelial and endothelial cells that in turn blocked pneumococcal adherence. Moreover, a pepO-mutant strain showed impaired adherence to and invasion of host cells compared with their isogenic wildtype strains. Taken together, the results demonstrated that PepO is a ubiquitously expressed plasminogen-and fibronectin-binding protein, which plays role in pneumococcal invasion of host cells and aids in immune evasion.	[Agarwal, Vaibhav; Kuchipudi, Arunakar; Riesbeck, Kristian; Blom, Anna M.] Lund Univ, Dept Lab Med, S-20502 Malmo, Sweden; [Fulde, Marcus] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Bergmann, Simone] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	Lund University; Hannover Medical School; Braunschweig University of Technology	Blom, AM (corresponding author), Wallenberg Inst & Labs, Dept Lab Med, Floor 4, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Riesbeck, Kristian/0000-0001-6274-6965	Swedish Research Council [K2012-66X-14928-09-5]; National Board of Health and Welfare; Foundations of Osterlund; Greta and Johan Kock; King Gustav V's 80th Anniversary; Inga-Britt and Arne Lundberg; Torsten and Ragnar Soderbergs; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Board of Health and Welfare; Foundations of Osterlund; Greta and Johan Kock; King Gustav V's 80th Anniversary; Inga-Britt and Arne Lundberg; Torsten and Ragnar Soderbergs; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	This work was supported in part by Swedish Research Council Grant K2012-66X-14928-09-5 and grants from the National Board of Health and Welfare, Foundations of Osterlund, Greta and Johan Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, Torsten and Ragnar Soderbergs, Royal Physiographic Society in Lund, and the Skane University Hospital. Recipient of a postdoctoral stipend from the Swedish Society for Medical Research.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bernardo-Garcia N, 2011, ACTA CRYSTALLOGR F, V67, P1285, DOI 10.1107/S1744309111030922; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; COLLEN D, 1975, THROMB DIATH HAEMOST, V34, P403, DOI 10.1055/s-0038-1651399; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Talay Susanne R., 2005, V12, P90, DOI 10.1159/000081691; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner AJ, 2000, ADV EXP MED BIOL, V477, P229; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wiles KG, 2010, J BIOL CHEM, V285, P21153, DOI 10.1074/jbc.M110.107730; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	52	72	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6849	6863		10.1074/jbc.M112.405530	http://dx.doi.org/10.1074/jbc.M112.405530			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341464	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000316002400007
J	Rass, E; Chandramouly, G; Zha, S; Alt, FW; Xie, AY				Rass, Emilie; Chandramouly, Gurushankar; Zha, Shan; Alt, Frederick W.; Xie, Anyong			Ataxia Telangiectasia Mutated (ATM) Is Dispensable for Endonuclease I-Scel-induced Homologous Recombination in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; GENOMIC INSTABILITY; IONIZING-RADIATION; HISTONE H2AX; FUNCTIONAL SYNERGY; KINASE-ACTIVITY; REPAIR PATHWAY; MDC1; PHOSPHORYLATION	Ataxia telangiectasia mutated (ATM) is activated upon DNA double strand breaks (DSBs) and phosphorylates numerous DSB response proteins, including histone H2AX on serine 139 (Ser-139) to form gamma-H2AX. Through interaction with MDC1, gamma-H2AX promotes DSB repair by homologous recombination (HR). H2AX Ser-139 can also be phosphorylated by DNA-dependent protein kinase catalytic subunit and ataxia telangiectasia- and Rad3-related kinase. Thus, we tested whether ATM functions in HR, particularly that controlled by gamma-H2AX, by comparing HR occurring at the euchromatic ROSA26 locus between mouse embryonic stem cells lacking either ATM, H2AX, or both. We show here that loss of ATM does not impair HR, including H2AX-dependent HR, but confers sensitivity to inhibition of poly(ADP-ribose) polymerases. Loss of ATM or H2AX has independent contributions to cellular sensitivity to ionizing radiation. The ATM-independent HR function of H2AX requires both Ser-139 phosphorylation and gamma-H2AX/MDC1 interaction. Our data suggest that ATM is dispensable for HR, including that controlled by H2AX, in the context of euchromatin, excluding the implication of such an HR function in genomic instability, hypersensitivity to DNA damage, and poly(ADP-ribose) polymerase inhibition associated with ATM deficiency.	[Rass, Emilie; Chandramouly, Gurushankar; Xie, Anyong] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Rass, Emilie; Chandramouly, Gurushankar; Xie, Anyong] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zha, Shan; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Zha, Shan; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Xie, AY (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, 330 Brookline Ave, Boston, MA 02215 USA.	axie@bidmc.harvard.edu		Zha, Shan/0000-0002-6568-1818	National Institutes of Health [R01GM073894]; NATIONAL CANCER INSTITUTE [R01CA158073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073894.	Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choi S, 2010, CELL CYCLE, V9, P4052, DOI 10.4161/cc.9.20.13471; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Daniel JA, 2012, J CELL BIOL, V198, P295, DOI 10.1083/jcb.201204035; Dar I, 2011, J BIOL CHEM, V286, P15361, DOI 10.1074/jbc.M110.204172; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2012, INT J MOL SCI, V13, P11844, DOI 10.3390/ijms130911844; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kocher S, 2012, NUCLEIC ACIDS RES, V40, P8336, DOI 10.1093/nar/gks604; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu CG, 2008, FEBS LETT, V582, P2703, DOI 10.1016/j.febslet.2008.06.051; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Menissier-de Murcia J, 2001, MOL CELL BIOL, V21, P1828; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Orsburn B, 2010, MOL CELL BIOL, V30, P2341, DOI 10.1128/MCB.00091-10; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Serrano MA, 2013, ONCOGENE, V32, P2452, DOI 10.1038/onc.2012.257; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang JD, 2011, J CELL BIOL, V193, P267, DOI 10.1083/jcb.201010026; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wen WH, 2010, J BIOL CHEM, V285, P39108, DOI 10.1074/jbc.M110.151753; White JS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000758; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xie AY, 2010, CELL CYCLE, V9, P3602, DOI 10.4161/cc.9.17.12884; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yamamoto K, 2012, J CELL BIOL, V198, P305, DOI 10.1083/jcb.201204098; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105	54	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7086	7095		10.1074/jbc.M112.445825	http://dx.doi.org/10.1074/jbc.M112.445825			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23355489	Green Published, hybrid			2022-12-28	WOS:000316002400030
J	Mikelis, CM; Palmby, TR; Simaan, M; Li, WL; Szabo, R; Lyons, R; Martin, D; Yagi, H; Fukuhara, S; Chikumi, H; Galisteo, R; Mukouyama, YS; Bugge, TH; Gutkind, JS				Mikelis, Constantinos M.; Palmby, Todd R.; Simaan, May; Li, Wenling; Szabo, Roman; Lyons, Ruth; Martin, Daniel; Yagi, Hiroshi; Fukuhara, Shigetomo; Chikumi, Hiroki; Galisteo, Rebeca; Mukouyama, Yoh-suke; Bugge, Thomas H.; Gutkind, J. Silvio			PDZ-RhoGEF and LARG Are Essential for Embryonic Development and Provide a Link between Thrombin and LPA Receptors and Rho Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; LEUKEMIA-ASSOCIATED RHO; HETEROTRIMERIC G-PROTEINS; VASCULAR SMOOTH-MUSCLE; GTPASES; GROWTH; G-ALPHA(13); MIGRATION; CROSSTALK; PLEXIN-B1	G protein-coupled receptors (GPCRs) linked to both members of the G alpha(12) family of heterotrimeric G proteins alpha subunits, G alpha(12) and G alpha(13), regulate the activation of Rho GTPases, thereby contributing to many key biological processes. Multiple Rho GEFs have been proposed to link G alpha(12/13) GPCRs to Rho activation, including PDZ-RhoGEF (PRG), leukemia-associated Rho GEF (LARG), p115-RhoGEF (p115), lymphoid blast crisis (Lbc), and Dbl. PRG, LARG, and p115 share the presence of a regulator of G protein signaling homology (RGS) domain. There is limited information on the biological roles of this RGS-containing family of RhoGEFs in vivo. p115-deficient mice are viable with some defects in the immune system and gastrointestinal motor dysfunctions, whereas in an initial study we showed that mice deficient for Larg are viable and resistant to salt-induced hypertension. Here, we generated knock-out mice for Prg and observed that these mice do not display any overt phenotype. However, deficiency in Prg and Larg leads to complex developmental defects and early embryonic lethality. Signaling from G alpha(11/q)-linked GPCRs to Rho was not impaired in mouse embryonic fibroblasts defective in all three RGS-containing RhoGEFs. However, a combined lack of Prg, Larg, and p115 expression	[Mikelis, Constantinos M.; Palmby, Todd R.; Simaan, May; Szabo, Roman; Lyons, Ruth; Martin, Daniel; Yagi, Hiroshi; Fukuhara, Shigetomo; Chikumi, Hiroki; Galisteo, Rebeca; Bugge, Thomas H.; Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Li, Wenling; Mukouyama, Yoh-suke] NHLBI, Lab Stem Cell & Neurovasc Biol, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gutkind, JS (corresponding author), NIDCR, NIH, 30 Convent Dr,Bldg 30,Rm 211, Bethesda, MD 20892 USA.	sg39v@nih.gov	Mikelis, Constantinos/AGF-9423-2022; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Mukouyama, Yoh-suke/0000-0002-9084-4922; Martin Izquierdo, Daniel/0000-0002-8880-9087	National Institutes of Health Grant [Z01DE00551]; Intramural Research Program of the NIDCR, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551, ZIADE000699] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22113009, 22390040] Funding Source: KAKEN	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIDCR, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01DE00551 and the Intramural Research Program of the NIDCR, National Institutes of Health.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin SH, 2000, BIOCHEM BIOPH RES CO, V277, P718, DOI 10.1006/bbrc.2000.3744; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kuner R, 2002, EUR J NEUROSCI, V16, P2333, DOI 10.1046/j.1460-9568.2002.02402.x; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Swiercz JM, 2009, MOL CELL BIOL, V29, P6321, DOI 10.1128/MCB.00103-09; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Vanni C, 2007, CELL CYCLE, V6, P2058, DOI 10.4161/cc.6.16.4574; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Ying ZK, 2006, MOL PHARMACOL, V69, P932, DOI 10.1124/mol.105.017830	43	42	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12232	12243		10.1074/jbc.M112.428599	http://dx.doi.org/10.1074/jbc.M112.428599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23467409	Green Published, hybrid			2022-12-28	WOS:000318157600055
J	Cebotaru, L; Woodward, O; Cebotaru, V; Guggino, WB				Cebotaru, Liudmila; Woodward, Owen; Cebotaru, Valeriu; Guggino, William B.			Transcomplementation by a Truncation Mutant of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Enhances Delta F508 Processing through a Biomolecular Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNELS; GENE-TRANSFER; EXPRESSION; IDENTIFICATION; PROTEIN; VECTOR; DOMAIN; TRAFFICKING; SEROTYPE-2; TRANSPORT	We previously showed that a truncation mutant of CFTR missing the first four transmembrane segments of TMD1, Delta 264 CFTR, binds to key elements in the ER quality control mechanism to increase the amounts of the mature C band of both wt and Delta F508 CFTR through transcomplementation. Here, we created a new construct, Delta 27-264 CFTR. Even though Delta 27-264 CFTR is rapidly degraded in the proteasome, steady state protein can be detected by Western blot. Delta 27-264 CFTR can also increase the amounts of the mature C band of both wt and Delta F508 CFTR through transcomplementation. Electrophysiology experiments show that Delta 27-264 CFTR can restore chloride channel currents. Further experiments with the conduction mutant S341A show conclusively that currents are indeed generated by rescued channel function of Delta F508 CFTR. Immunoprecipitation studies show that Delta 27-264 binds to Delta F508-CFTR, suggesting a bimolecular interaction. Thus the adeno-associated viral vector, rAAV-Delta 27-264 CFTR, is a highly promising CF gene therapy vector, because it increases the amount of mature band C protein both from wt and Delta F508 CFTR, and rescues channel activity of Delta F508 CFTR.	[Cebotaru, Liudmila] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila; Woodward, Owen; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Cebotaru, Valeriu] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Wood Basic Sci Bldg 214A,725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institutes of Health [NIH P01 HL51811]; Cystic Fibrosis Foundation [GUGGINO5X0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or in part by National Institutes of Health Grant NIH P01 HL51811 and Cystic Fibrosis Foundation Grant GUGGINO5X0.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; CARROLL TP, 1995, J BIOL CHEM, V270, P11941, DOI 10.1074/jbc.270.20.11941; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; COLLINS FS, 1990, HOSP PRACT, V25, P47; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; Devidas S, 1998, J BIOL CHEM, V273, P29373, DOI 10.1074/jbc.273.45.29373; Fischer AC, 2007, MOL THER, V15, P756, DOI 10.1038/sj.mt.6300059; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Kirk KL, 2000, CELL MOL LIFE SCI, V57, P623, DOI 10.1007/PL00000724; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; McCarty NA, 2000, J EXP BIOL, V203, P1947; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mueller C, 2008, J GENE MED, V10, P51, DOI 10.1002/jgm.1119; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Sirninger J, 2004, HUM GENE THER, V15, P832, DOI 10.1089/1043034041839262; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	41	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10505	10512		10.1074/jbc.M112.420489	http://dx.doi.org/10.1074/jbc.M112.420489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23463513	Green Published, hybrid			2022-12-28	WOS:000317565000030
J	Hossain, MI; Roulston, CL; Kamaruddin, MA; Chu, PWY; Ng, DCH; Dusting, GJ; Bjorge, JD; Williamson, NA; Fujita, DJ; Cheung, SN; Chan, TO; Hill, AF; Cheng, HC				Hossain, M. Iqbal; Roulston, Carli L.; Kamaruddin, M. Aizuddin; Chu, Percy W. Y.; Ng, Dominic C. H.; Dusting, Gregory J.; Bjorge, Jeffrey D.; Williamson, Nicholas A.; Fujita, Donald J.; Cheung, Steve N.; Chan, Tung O.; Hill, Andrew F.; Cheng, Heung-Chin			A Truncated Fragment of Src Protein Kinase Generated by Calpain-mediated Cleavage Is a Mediator of Neuronal Death in Excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-INDUCED INJURY; C-SRC; BRAIN ISCHEMIA; CELL-DEATH; CEREBRAL-ISCHEMIA; NMDA RECEPTORS; ACTIVATED SRC; STROKE; NEURODEGENERATION; CALCINEURIN	Excitotoxicity resulting from overstimulation of glutamate receptors is a major cause of neuronal death in cerebral ischemic stroke. The overstimulated ionotropic glutamate receptors exert their neurotoxic effects in part by overactivation of calpains, which induce neuronal death by catalyzing limited proteolysis of specific cellular proteins. Here, we report that in cultured cortical neurons and in vivo in a rat model of focal ischemic stroke, the tyrosine kinase Src is cleaved by calpains at a site in the N-terminal unique domain. This generates a truncated Src fragment of similar to 52 kDa, which we localized predominantly to the cytosol. A cell membrane-permeable fusion peptide derived from the unique domain of Src prevents calpain from cleaving Src in neurons and protects against excitotoxic neuronal death. To explore the role of the truncated Src fragment in neuronal death, we expressed a recombinant truncated Src fragment in cultured neurons and examined how it affects neuronal survival. Expression of this fragment, which lacks the myristoylation motif and unique domain, was sufficient to induce neuronal death. Furthermore, inactivation of the prosurvival kinase Akt is a key step in its neurotoxic signaling pathway. Because Src maintains neuronal survival, our results implicate calpain cleavage as a molecular switch converting Src from a promoter of cell survival to a mediator of neuronal death in excitotoxicity. Besides unveiling a new pathological action of Src, our discovery of the neurotoxic action of the truncated Src fragment suggests new therapeutic strategies with the potential to minimize brain damage in ischemic stroke.	[Hossain, M. Iqbal; Kamaruddin, M. Aizuddin; Chu, Percy W. Y.; Ng, Dominic C. H.; Williamson, Nicholas A.; Hill, Andrew F.; Cheng, Heung-Chin] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Roulston, Carli L.; Dusting, Gregory J.] OBrien Inst, Fitzroy, Vic 3065, Australia; [Roulston, Carli L.; Dusting, Gregory J.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Bjorge, Jeffrey D.; Fujita, Donald J.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Hlth Sci Ctr, Calgary, AB T2N 4N1, Canada; [Cheung, Steve N.] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Chan, Tung O.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Melbourne; Centre for Eye Research Australia; University of Melbourne; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Deakin University; Jefferson University	Cheng, HC (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	heung@unimelb.edu.au	Ng, Dominic/C-7291-2015; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020; Williamson, Nicholas A/O-9812-2016	Ng, Dominic/0000-0003-4657-159X; Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Williamson, Nicholas A/0000-0002-2173-3452; Cheng, Heung-Chin/0000-0002-4965-7148	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by project grants from the National Health and Medical Research Council of Australia.; Supported by Future Fellowships of the Australian Research Council.	Ardizzone TD, 2007, STROKE, V38, P1621, DOI 10.1161/STROKEAHA.106.478966; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bernocco S, 2008, PROTEOMICS, V8, P930, DOI 10.1002/pmic.200700738; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Cao X, 2009, BIOCHEM J, V424, P201, DOI 10.1042/BJ20090643; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Du WL, 2010, J CLIN INVEST, V120, P3480, DOI 10.1172/JCI43165; Dutta S, 2002, BIOL CHEM, V383, P785, DOI 10.1515/BC.2002.082; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; FEDER D, 1990, J BIOL CHEM, V265, P8205; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hou XY, 2007, NEUROSCI LETT, V420, P235, DOI 10.1016/j.neulet.2007.03.048; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Jiang XN, 2008, ANN NEUROL, V63, P632, DOI 10.1002/ana.21365; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Lennmyr F, 2004, ACTA NEUROL SCAND, V110, P175, DOI 10.1111/j.1600-0404.2004.00306.x; Liang S, 2009, J PHARMACOL EXP THER, V331, P827, DOI 10.1124/jpet.109.156562; Liu DZ, 2008, NEUROBIOL DIS, V30, P201, DOI 10.1016/j.nbd.2008.01.006; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Markowitz Alison J B, 2007, Cellscience, V4, P111; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Mukalyama H, 2008, BIOORGAN MED CHEM, V16, P909, DOI 10.1016/j.bmc.2007.10.068; Mukherjee A, 2011, CURR OPIN CELL BIOL, V23, P223, DOI 10.1016/j.ceb.2010.12.006; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Roulston CL, 2008, EUR J PHARMACOL, V584, P100, DOI 10.1016/j.ejphar.2008.01.046; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Takadera T, 2012, NEUROTOX RES, V21, P309, DOI 10.1007/s12640-011-9284-5; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8	58	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9696	9709		10.1074/jbc.M112.419713	http://dx.doi.org/10.1074/jbc.M112.419713			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23400779	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000317114000012
J	Fields, GB				Fields, Gregg B.			Interstitial Collagen Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN CATHEPSIN-K; MATRIX-METALLOPROTEINASE ACTIVITIES; NATIVE TYPE-I; NEUTROPHIL COLLAGENASE; SUBSTRATE-SPECIFICITY; GELATINASE-A; FIBROBLAST COLLAGENASE; MOLECULAR-MECHANISM; THERMAL-STABILITY; CATALYTIC DOMAIN	Interstitial collagen mechanical and biological properties are altered by proteases that catalyze the hydrolysis of the collagen triple-helical structure. Collagenolysis is critical in development and homeostasis but also contributes to numerous pathologies. Mammalian collagenolytic enzymes include matrix metalloproteinases, cathepsin K, and neutrophil elastase, and a variety of invertebrates and pathogens possess collagenolytic enzymes. Components of the mechanism of action for the collagenolytic enzyme MMP-1 have been defined experimentally, and insights into other collagenolytic mechanisms have been provided. Ancillary biomolecules may modulate the action of collagenolytic enzymes.	Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	Torrey Pines Institute for Molecular Studies, Florida	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA.	gfields@tpims.org			National Institutes of Health [CA98799, MH78948]; NHLBI [268201000036C]; Multiple Sclerosis National Research Institute; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Multiple Sclerosis National Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98799 and MH78948 and Contract 268201000036C from NHLBI. This work was also supported by the Multiple Sclerosis National Research Institute.	Adhikari AS, 2012, J AM CHEM SOC, V134, P13259, DOI 10.1021/ja212170b; Adhikari AS, 2011, J AM CHEM SOC, V133, P1686, DOI 10.1021/ja109972p; Amar S., 2012, PEPTIDES 2012, P102; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Atkinson SJ, 2001, FEBS LETT, V491, P222, DOI 10.1016/S0014-5793(01)02204-9; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; BIRKEDALHANSEN H, 1985, J BIOL CHEM, V260, P6411; Camp RJ, 2011, J AM CHEM SOC, V133, P4073, DOI 10.1021/ja110098b; Chang SW, 2012, BIOMATERIALS, V33, P3852, DOI 10.1016/j.biomaterials.2012.02.001; Cherney MM, 2011, J BIOL CHEM, V286, P8988, DOI 10.1074/jbc.M110.126706; Christiansen VJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P177, DOI 10.1016/j.abb.2006.11.006; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Collier IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024029; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Duarte Ana S, 2005, Curr Drug Discov Technol, V2, P37, DOI 10.2174/1570163053175448; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; Eckhard U, 2011, BIOL CHEM, V392, P1039, DOI 10.1515/BC.2011.099; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Fasciglione GF, 2012, J BIOL INORG CHEM, V17, P663, DOI 10.1007/s00775-012-0886-z; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Flynn BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012337; FRENCH MF, 1992, J PROTEIN CHEM, V11, P83, DOI 10.1007/BF01025095; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gioia M, 2002, J BIOL CHEM, V277, P23123, DOI 10.1074/jbc.M110873200; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; HIROSE T, 1993, P NATL ACAD SCI USA, V90, P2569, DOI 10.1073/pnas.90.7.2569; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Kim M, 2007, BBA-GEN SUBJECTS, V1770, P1627, DOI 10.1016/j.bbagen.2007.08.003; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Knauper V, 2001, EUR J BIOCHEM, V268, P1888, DOI 10.1046/j.1432-1033.2001.02062.x; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; LECROISEY A, 1987, J BIOL CHEM, V262, P7546; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; MAINARDI CL, 1980, J BIOL CHEM, V255, P2006; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; McGrath ME, 1997, NAT STRUCT BIOL, V4, P105, DOI 10.1038/nsb0297-105; Miles CA, 2002, J MOL BIOL, V321, P797, DOI 10.1016/S0022-2836(02)00703-9; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Philominathan STL, 2012, PROTEIN SCI, V21, P1554, DOI 10.1002/pro.2145; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; Ravikumar KM, 2007, J MECH MATER STRUCT, V2, P999, DOI 10.2140/jomms.2007.2.999; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Robinson MW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001012; Rosenblum G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011043; RYHANEN L, 1983, ARCH BIOCHEM BIOPHYS, V223, P562, DOI 10.1016/0003-9861(83)90621-5; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Salsas-Escat R, 2010, BIOCHEMISTRY-US, V49, P4147, DOI 10.1021/bi9021473; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Shuo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043751; Song F, 2006, BBA-GEN SUBJECTS, V1760, P1521, DOI 10.1016/j.bbagen.2006.05.002; Starr AE, 2012, J BIOL CHEM, V287, P13382, DOI 10.1074/jbc.M111.314179; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Suarez E, 2008, J PHYS CHEM B, V112, P15248, DOI 10.1021/jp8074699; Sun HB, 2000, ANAL BIOCHEM, V283, P153, DOI 10.1006/abio.2000.4629; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; TSU CA, 1994, J BIOL CHEM, V269, P19565; Tsuruoka N, 2003, APPL ENVIRON MICROB, V69, P162, DOI 10.1128/AEM.69.1.162-169.2003; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wang YK, 2010, J BIOL CHEM, V285, P14285, DOI 10.1074/jbc.M109.087023; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; WELGUS HG, 1985, J BIOL CHEM, V260, P1052; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h; Yanez-Mo M, 2008, BLOOD, V112, P3217, DOI 10.1182/blood-2008-02-139394; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979; Zareian R, 2010, LANGMUIR, V26, P9917, DOI 10.1021/la100384e; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	98	118	124	5	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8785	8793		10.1074/jbc.R113.451211	http://dx.doi.org/10.1074/jbc.R113.451211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430258	hybrid, Green Published			2022-12-28	WOS:000316862200001
J	Sayegh, J; Cao, J; Zou, MR; Morales, A; Blair, LP; Norcia, M; Hoyer, D; Tackett, AJ; Merkel, JS; Yan, Q				Sayegh, Joyce; Cao, Jian; Zou, Mike Ran; Morales, Alfonso; Blair, Lauren P.; Norcia, Michael; Hoyer, Denton; Tackett, Alan J.; Merkel, Jane S.; Yan, Qin			Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; LYSINE DEMETHYLASES; CELL-PROLIFERATION; TUMOR-GROWTH; BINDING; TUMORIGENESIS; PROMOTE; ASSAYS; PLU-1	JARID1B (also known as KDM5B or PLU1) is a member of the JARID1 family of histone lysine demethylases responsible for the demethylation of trimethylated lysine 27 in histone H3 (H3K4me3), a mark for actively transcribed genes. JARID1B is overexpressed in several cancers, including breast cancer, prostate cancer, and lung cancer. In addition, JARID1B is required for mammary tumor formation in syngeneic or xenograft mouse models. JARID1B-expressing melanoma cells are associated with increased self-renewal character. Therefore, JARID1B represents an attractive target for cancer therapy. Here we characterized JARID1B using a homogeneous luminescence-based demethylase assay. We then conducted a high throughput screen of over 15,000 small molecules to identify inhibitors of JARID1B. From this screen, we identified several known JmjC histone demethylase inhibitors, including 2,4-pyridinedicarboxylic acid and catechols. More importantly, we identified several novel inhibitors, including 2-4(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one (PBIT), which inhibits JARID1B with an IC50 of about 3 mu M in vitro. Consistent with this, PBIT treatment inhibited removal of H3K4me3 by JARID1B in cells. Furthermore, this compound inhibited proliferation of cells expressing higher levels of JARID1B. These results suggest that this novel small molecule inhibitor is a lead compound that can be further optimized for cancer therapy.	[Sayegh, Joyce; Cao, Jian; Zou, Mike Ran; Morales, Alfonso; Blair, Lauren P.; Yan, Qin] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Norcia, Michael; Hoyer, Denton; Merkel, Jane S.] Yale Univ, Yale Ctr Mol Discovery, West Haven, CT 06516 USA; [Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Yale University; Yale University; University of Arkansas System; University of Arkansas Medical Sciences	Yan, Q (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St,BML 348C,POB 208023, New Haven, CT 06510 USA.	qin.yan@yale.edu	Yan, Qin/E-8893-2012; Cao, Jian/K-2440-2014	Yan, Qin/0000-0003-4077-453X; Cao, Jian/0000-0003-3424-6802; Morales, Alfonso/0000-0002-8713-7100	Yale Center for Molecular Discovery; Alexander and Margaret Stewart Trust Fellowship; Breast Cancer Alliance Young Investigator Grant; Melanoma Research Foundation Career Development Award; Developmental Research Award from Yale Specialized Programs of Research Excellence (YSPORE) in Skin Cancer; National Institutes of Health [CA16359, R01 DA025755]; CTSA Grant from the National Center for Advancing Translational Sciences [UL1 RR024139]; Clinical and Translational Science Award (CTSA) Scholar Award from Yale Center for Clinical Investigation; NATIONAL CANCER INSTITUTE [P30CA016359, P50CA121974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025755] Funding Source: NIH RePORTER	Yale Center for Molecular Discovery; Alexander and Margaret Stewart Trust Fellowship; Breast Cancer Alliance Young Investigator Grant; Melanoma Research Foundation Career Development Award; Developmental Research Award from Yale Specialized Programs of Research Excellence (YSPORE) in Skin Cancer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA Grant from the National Center for Advancing Translational Sciences; Clinical and Translational Science Award (CTSA) Scholar Award from Yale Center for Clinical Investigation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by a pilot grant from the Yale Center for Molecular Discovery, Clinical and Translational Science Award (CTSA) Scholar Award from Yale Center for Clinical Investigation, the Alexander and Margaret Stewart Trust Fellowship, Breast Cancer Alliance Young Investigator Grant, Melanoma Research Foundation Career Development Award, a Developmental Research Award from Yale Specialized Programs of Research Excellence (YSPORE) in Skin Cancer (all to Q. Y.) and by National Institutes of Health Grants CA16359 (to the Yale Comprehensive Cancer Center) and R01 DA025755 (to A. J. T.). This work was made possible by CTSA Grant UL1 RR024139 from the National Center for Advancing Translational Sciences.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Blair LP, 2012, DNA CELL BIOL, V31, pS49, DOI 10.1089/dna.2012.1654; Blair Lauren P, 2011, Cancers (Basel), V3, P1383, DOI 10.3390/cancers3011383; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dou DF, 2011, BIOORGAN MED CHEM, V19, P5782, DOI 10.1016/j.bmc.2011.08.029; Gauthier N, 2012, J BIOMOL SCREEN, V17, P49, DOI 10.1177/1087057111416659; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Hou JL, 2012, AM J TRANSL RES, V4, P247; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jorgensen WL, 2011, BIOORG MED CHEM LETT, V21, P4545, DOI 10.1016/j.bmcl.2011.05.127; Kawamura A, 2010, ANAL BIOCHEM, V404, P86, DOI 10.1016/j.ab.2010.04.030; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kristensen LH, 2012, FEBS J, V279, P1905, DOI 10.1111/j.1742-4658.2012.08567.x; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Nielsen AL, 2012, FEBS LETT, V586, P1190, DOI 10.1016/j.febslet.2012.03.001; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Suzuki T, 2011, J MED CHEM, V54, P8236, DOI 10.1021/jm201048w; Thalhammer A, 2011, ORG BIOMOL CHEM, V9, P127, DOI 10.1039/c0ob00592d; Vasan M, 2010, CHEMMEDCHEM, V5, P2079, DOI 10.1002/cmdc.201000275; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010	38	91	95	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9408	9417		10.1074/jbc.M112.419861	http://dx.doi.org/10.1074/jbc.M112.419861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408432	hybrid, Green Published			2022-12-28	WOS:000316862200057
J	Beloglazova, N; Flick, R; Tchigvintsev, A; Brown, G; Popovic, A; Nocek, B; Yakunin, AF				Beloglazova, Natalia; Flick, Robert; Tchigvintsev, Anatoli; Brown, Greg; Popovic, Ana; Nocek, Boguslaw; Yakunin, Alexander F.			Nuclease Activity of the Human SAMHD1 Protein Implicated in the Aicardi-Goutieres Syndrome and HIV-1 Restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 1.2 PROTEIN; HD-DOMAIN; TRIPHOSPHATE TRIPHOSPHOHYDROLASE; DEOXYGUANOSINE TRIPHOSPHATE; TREX1; ACID; REPLICATION; MUTATIONS; INFECTION; FAMILY	The human HD domain protein SAMHD1 is implicated in the Aicardi-Goutieres autoimmune syndrome and in the restriction of HIV-1 replication in myeloid cells. Recently, this protein has been shown to possess dNTP triphosphatase activity, which is proposed to inhibit HIV-1 replication and the autoimmune response by hydrolyzing cellular dNTPs. Here, we show that the purified full-length human SAMHD1 protein also possesses metal-dependent 3' -> 5' exonuclease activity against single-stranded DNAs and RNAs in vitro. In double-stranded substrates, this protein preferentially cleaved 3'-overhangs and RNA in blunt-ended DNA/RNA duplexes. Full-length SAMHD1 also exhibited strong DNA and RNA binding to substrates with complex secondary structures. Both nuclease and dNTP triphosphatase activities of SAMHD1 are associated with its HD domain, but the SAM domain is required for maximal activity and nucleic acid binding. The nuclease activity of SAMHD1 could represent an additional mechanism contributing to HIV-1 restriction and suppression of the autoimmune response through direct cleavage of viral and endogenous nucleic acids. In addition, we demonstrated the presence of dGTP triphosphohydrolase and nuclease activities in several microbial HD domain proteins, suggesting that these proteins might contribute to anti-viral defense in prokaryotes.	[Beloglazova, Natalia; Flick, Robert; Tchigvintsev, Anatoli; Brown, Greg; Popovic, Ana; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Banting & Best Dept Med Res, Toronto, ON M5S 3E5, Canada; [Nocek, Boguslaw] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory	Yakunin, AF (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Banting & Best Dept Med Res, Toronto, ON M5S 3E5, Canada.	a.iakounine@utoronto.ca	Popovic, Ana/AAF-8508-2021; Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490	Government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; Ontario Research Fund Grant [ORF-GL2-01-004]; Natural Sciences and Engineering Research Council (NSERC)	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Research Fund Grant; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Government of Canada through Genome Canada and Ontario Genomics Institute Grant 2009-OGI-ABC-1405, Ontario Research Fund Grant ORF-GL2-01-004, and a Natural Sciences and Engineering Research Council (NSERC) Discovery team grant (to A.F.Y.).	Alarcon-Riquelme ME, 2006, NAT GENET, V38, P866, DOI 10.1038/ng0806-866; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HUBER HE, 1988, J BIOL CHEM, V263, P13549; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mouland AJ, 2001, MOL CELL BIOL, V21, P2133, DOI 10.1128/MCB.21.6.2133-2143.2001; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; MYERS JA, 1987, J BIOL CHEM, V262, P5288; Oganesyan V, 2007, ACTA CRYSTALLOGR F, V63, P369, DOI 10.1107/S1744309107018945; Oussenko IA, 2002, J BACTERIOL, V184, P6250, DOI 10.1128/JB.184.22.6250-6259.2002; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Schultz J, 1997, PROTEIN SCI, V6, P249; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; WURGLER SM, 1993, J BIOL CHEM, V268, P20046; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	39	163	170	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8101	8110		10.1074/jbc.M112.431148	http://dx.doi.org/10.1074/jbc.M112.431148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364794	Green Published, hybrid			2022-12-28	WOS:000316564500011
J	Mailloux, RJ; Xuan, JY; Beauchamp, B; Jui, LD; Lou, M; Harper, ME				Mailloux, Ryan J.; Xuan, Jian Ying; Beauchamp, Brittany; Jui, Linda; Lou, Marjorie; Harper, Mary-Ellen			Glutaredoxin-2 Is Required to Control Proton Leak through Uncoupling Protein-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES PRODUCTION; SKELETAL-MUSCLE; S-GLUTATHIONYLATION; REDOX STATE; COMPLEX-I; THIOLTRANSFERASE GLUTAREDOXIN; REVERSIBLE GLUTATHIONYLATION; MITOCHONDRIAL CA2+; DEPENDENT CONTROL; OXIDATIVE STRESS	Glutathionylation has emerged as a key modification required for controlling protein function in response to changes in cell redox status. Recently, we showed that the glutathionylation state of uncoupling protein-3 (UCP3) modulates the leak of protons back into the mitochondrial matrix, thus controlling reactive oxygen species production. However, whether or not UCP3 glutathionylation is mediated enzymatically has remained unknown because previous work relied on the use of pharmacological agents, such as diamide, to alter the UCP3 glutathionylation state. Here, we demonstrate that glutaredoxin-2 (Grx2), a matrix oxidoreductase, is required to glutathionylate and inhibit UCP3. Analysis of bioenergetics in skeletal muscle mitochondria revealed that knock-out of Grx2 (Grx2(-/-)) increased proton leak in a UCP3-dependent manner. These effects were reversed using diamide, a glutathionylation catalyst. Importantly, the increased leak did not compromise coupled respiration. Knockdown of Grx2 augmented proton leak-dependent respiration in primary myotubes from wild type mice, an effect that was absent in UCP3(-/-) cells. These results confirm that Grx2 deactivates UCP3 by glutathionylation. To our knowledge, this is the first enzyme identified to regulate UCP3 by glutathionylation and is the first study on the role of Grx2 in the regulation of energy metabolism.	[Mailloux, Ryan J.; Xuan, Jian Ying; Beauchamp, Brittany; Jui, Linda; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Immunol & Microbiol, Ottawa, ON K1H 8M5, Canada; [Lou, Marjorie] Univ Nebraska, Ctr Redox Biol, Lincoln, NE 68583 USA; [Lou, Marjorie] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	University of Ottawa; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Immunol & Microbiol, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca		Harper, Mary-Ellen/0000-0003-3864-5886; Mailloux, Ryan/0000-0003-3986-9830	Canadian Institutes of Health Research, Institute of Nutrition, Metabolism, and Diabetes; Canadian Institutes of Health Research	Canadian Institutes of Health Research, Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research, Institute of Nutrition, Metabolism, and Diabetes (to M.E.H.), and a postdoctoral fellowship from Canadian Institutes of Health Research (to R.J.M.).	Adams SH, 2000, J NUTR, V130, P711, DOI 10.1093/jn/130.4.711; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bevilacqua L, 2010, BBA-BIOENERGETICS, V1797, P1389, DOI 10.1016/j.bbabio.2010.02.018; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001; Harper ME, 2002, DIABETES, V51, P2459, DOI 10.2337/diabetes.51.8.2459; Himms-Hagen J, 1999, INT J OBESITY, V23, pS30, DOI 10.1038/sj.ijo.0800940; Hirasaka K, 2011, ANTIOXID REDOX SIGN, V15, P2645, DOI 10.1089/ars.2011.3888; Huppertz C, 2001, J BIOL CHEM, V276, P12520, DOI 10.1074/jbc.M011708200; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; ISAACS J, 1977, BIOCHIM BIOPHYS ACTA, V497, P192, DOI 10.1016/0304-4165(77)90152-0; ISAACS JT, 1977, BIOCHIM BIOPHYS ACTA, V498, P29, DOI 10.1016/0304-4165(77)90084-8; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Liedhegner EAS, 2012, ANTIOXID REDOX SIGN, V16, P543, DOI 10.1089/ars.2011.4119; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Mailloux RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393538; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mailloux RJ, 2011, BIOCHEM J, V437, P301, DOI 10.1042/BJ20110571; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mookerjee SA, 2011, BBA-BIOENERGETICS, V1807, P1474, DOI 10.1016/j.bbabio.2011.07.011; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; PAPOV VV, 1994, PROTEIN SCI, V3, P428; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Pfefferle A, 2013, BBA-MOL CELL RES, V1833, P80, DOI 10.1016/j.bbamcr.2012.10.006; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Zaffagnini M, 2012, PLANT SCI, V185, P86, DOI 10.1016/j.plantsci.2012.01.005; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	65	54	54	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8365	8379		10.1074/jbc.M112.442905	http://dx.doi.org/10.1074/jbc.M112.442905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23335511	hybrid, Green Published			2022-12-28	WOS:000316564500036
J	Fang, ZY; Luna, EJ				Fang, Zhiyou; Luna, Elizabeth J.			Supervillin-mediated Suppression of p53 Protein Enhances Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SMOOTH-MUSCLE; NUCLEAR-LOCALIZATION; ACTIN; PROLIFERATION; ARCHVILLIN; INHIBITOR; REVEALS; PATHWAY; CANCER	Integrin-based adhesions promote cell survival as well as cell motility and invasion. We show here that the adhesion regulatory protein supervillin increases cell survival by decreasing levels of the tumor suppressor protein p53 and downstream target genes. RNAi-mediated knockdown of a new splice form of supervillin (isoform 4) or both isoforms 1 and 4 increases the amount of p53 and cell death, whereas p53 levels decrease after overexpression of either supervillin isoform. Cellular responses to DNA damage induced by etoposide or doxorubicin include down-regulation of endogenous supervillin coincident with increases in p53. In DNA-damaged supervillin knockdown cells, p53 knockdown or inhibition partially rescues the loss of cell metabolic activity, a measure of cell proliferation. Knockdown of the p53 deubiquitinating enzyme USP7/HAUSP also reverses the supervillin phenotype, blocking the increase in p53 levels seen after supervillin knockdown and accentuating the decrease in p53 levels triggered by supervillin overexpression. Conversely, supervillin overexpression decreases the association of USP7 and p53 and attenuates USP7-mediated p53 deubiquitination. USP7 binds directly to the supervillin N terminus and can deubiquitinate and stabilize supervillin. Supervillin also is stabilized by derivatization with the ubiquitin-like protein SUMO1. These results show that supervillin regulates cell survival through control of p53 levels and suggest that supervillin and its interaction partners at sites of cell-substrate adhesion constitute a locus for cross-talk between survival signaling and cell motility pathways.	[Fang, Zhiyou; Luna, Elizabeth J.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fang, ZY (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, 377 Plantat St, Worcester, MA 01605 USA.	zhiyou.fang@umassmed.edu; elizabeth.luna@umassmed.edu	Fang, Zhiyou/GQY-6875-2022		National Institutes of Health [GM033048-26S1]; Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM033048-26S1. This work was also supported by the Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA.	Andoh T, 2000, CELL BIOCHEM BIOPHYS, V33, P181, DOI 10.1385/CBB:33:2:181; Bhuwania R, 2012, J CELL SCI, V125, P2300, DOI 10.1242/jcs.100032; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Edelstein LC, 2012, CIRCULATION, V125, P2762, DOI 10.1161/CIRCULATIONAHA.112.091462; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fang ZY, 2010, TRAFFIC, V11, P782, DOI 10.1111/j.1600-0854.2010.01062.x; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gangopadhyay SS, 2009, J BIOL CHEM, V284, P17607, DOI 10.1074/jbc.M109.002386; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Golubovskaya VM, 2011, ANTI-CANCER AGENT ME, V11, P617; Hall CL, 2002, CELL COMMUN ADHES, V9, P273, DOI 10.1080/15419060216306; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Ilic D, 1998, J CELL BIOL, V143, P547; Iqbal MS, 2010, BIOCHEM BIOPH RES CO, V392, P415, DOI 10.1016/j.bbrc.2010.01.038; Janouskova H, 2012, CANCER RES, V72, P3463, DOI 10.1158/0008-5472.CAN-11-4199; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Mak AS, 2011, CELL ADHES MIGR, V5, P144, DOI 10.4161/cam.5.2.14375; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Nagano M, 2012, INT J CELL BIOL; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Oh SW, 2003, J CELL SCI, V116, P2261, DOI 10.1242/jcs.00422; Pestonjamasp KN, 1997, J CELL BIOL, V139, P1255, DOI 10.1083/jcb.139.5.1255; Pope RK, 1998, GENOMICS, V52, P342, DOI 10.1006/geno.1998.5466; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ren XP, 2002, CANCER BIOL THER, V1, P703, DOI 10.4161/cbt.323; Schaefer A, 2012, BIOCHEM J, V442, P13, DOI 10.1042/BJ20111815; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith TC, 2010, CYTOSKELETON, V67, P346, DOI 10.1002/cm.20449; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125	64	26	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7918	7929		10.1074/jbc.M112.416842	http://dx.doi.org/10.1074/jbc.M112.416842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382381	hybrid, Green Published			2022-12-28	WOS:000316455300045
J	Nelson, JW; Subrahmanyan, RM; Summers, SA; Xiao, XS; Alkayed, NJ				Nelson, Jonathan W.; Subrahmanyan, Rishi M.; Summers, Sol A.; Xiao, Xiangshu; Alkayed, Nabil J.			Soluble Epoxide Hydrolase Dimerization Is Required for Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC TARGET; GENETIC-VARIATION; COMPLEMENTATION; POLYMORPHISMS; PHOSPHATASE; PROTEINS; ENZYME; STROKE; CELLS; EPHX2	Soluble epoxide hydrolase (sEH) plays a key role in the metabolic conversion of the protective eicosanoid 14,15-epoxyeicosatrienoic acid to 14,15-dihydroxyeicosatrienoic acid. Accordingly, inhibition of sEH hydrolase activity has been shown to be beneficial in multiple models of cardiovascular diseases, thus identifying sEH as a valuable therapeutic target. Recently, a common human polymorphism (R287Q) was identified that reduces sEH hydrolase activity and is localized to the dimerization interface of the protein, suggesting a relationship between sEH dimerization and activity. To directly test the hypothesis that dimerization is essential for the proper function of sEH, we generated mutations within the sEH protein that would either disrupt or stabilize dimerization. We quantified the dimerization state of each mutant using a split firefly luciferase protein fragment-assisted complementation system. The hydrolase activity of each mutant was determined using a fluorescence-based substrate conversion assay. We found that mutations that disrupted dimerization also eliminated hydrolase enzymatic activity. In contrast, a mutation that stabilized dimerization restored hydrolase activity. Finally, we investigated the kinetics of sEH dimerization and found that the human R287Q polymorphism was metastable and capable of swapping dimer partners faster than the WT enzyme. These results indicate that dimerization is required for sEH hydrolase activity. Disrupting sEH dimerization may therefore serve as a novel therapeutic strategy for reducing sEH hydrolase activity.	[Nelson, Jonathan W.; Subrahmanyan, Rishi M.; Summers, Sol A.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA; [Nelson, Jonathan W.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Xiao, Xiangshu] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Alkayed, NJ (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, 3181 SW Sam Jackson Pk Rd,UHN 2, Portland, OR 97239 USA.	alkayedn@ohsu.edu		Nelson, Jonathan/0000-0003-1456-9399	National Institutes of Health [R01 NS44313]; American Heart Association [11PRE5710008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044313, P30NS061800, R01NS070837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS44313 (to N.J.A.). This work was also supported by American Heart Association Predoctoral Fellowship 11PRE5710008 (to J.W.N.).	Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Burdon KP, 2008, DIABETES VASC DIS RE, V5, P128, DOI 10.3132/dvdr.2008.021; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Iliff JJ, 2009, FUTUR NEUROL, V4, P179, DOI 10.2217/14796708.4.2.179; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jester BW, 2010, J AM CHEM SOC, V132, P11727, DOI 10.1021/ja104491h; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Jones PD, 2005, ANAL BIOCHEM, V343, P66, DOI 10.1016/j.ab.2005.03.041; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Lee CR, 2011, HYPERTENSION, V57, P116, DOI 10.1161/HYPERTENSIONAHA.110.161695; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Ohtoshi K, 2005, BIOCHEM BIOPH RES CO, V331, P347, DOI 10.1016/j.bbrc.2005.03.171; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Srivastava PK, 2004, ARCH BIOCHEM BIOPHYS, V427, P164, DOI 10.1016/j.abb.2004.05.003; Zhang L, 2008, PHARMACOGENET GENOM, V18, P45, DOI 10.1097/FPC.0b013e3282f313e8; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	20	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7697	7703		10.1074/jbc.M112.429258	http://dx.doi.org/10.1074/jbc.M112.429258			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362272	Green Published, hybrid			2022-12-28	WOS:000316455300026
J	Schofield, AV; Gamell, C; Suryadinata, R; Sarcevic, B; Bernard, O				Schofield, Alice V.; Gamell, Cristina; Suryadinata, Randy; Sarcevic, Boris; Bernard, Ora			Tubulin Polymerization Promoting Protein 1 (Tppp1) Phosphorylation by Rho-associated Coiled-coil Kinase (Rock) and Cyclin-dependent Kinase 1 (Cdk1) Inhibits Microtubule Dynamics to Increase Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; IDENTIFICATION; TPPP/P25; PROGRESSION; SUBSTRATE; ASSEMBLIES; ACTIVATION; TRANSITION; EXPRESSION; MITOSIS	Tubulin polymerization promoting protein 1 (Tppp1) regulates microtubule (MT) dynamics via promoting MT polymerization and inhibiting histone deacetylase 6 (Hdac6) activity to increase MT acetylation. Our results reveal that as a consequence, Tppp1 inhibits cell proliferation by delaying the G(1)/S-phase and the mitosis to G(1)-phase transitions. We show that phosphorylation of Tppp1 by Rho-associated coiled-coil kinase (Rock) prevents its Hdac6 inhibitory activity to enable cells to enter S-phase. Whereas, our analysis of the role of Tppp1 during mitosis revealed that inhibition of its MT polymerizing and Hdac6 regulatory activities were necessary for cells to re-enter the G(1)-phase. During this investigation, we also discovered that Tppp1 is a novel Cyclin B/Cdk1 (cyclin-dependent kinase) substrate and that Cdk phosphorylation of Tppp1 inhibits its MT polymerizing activity. Overall, our results show that dual Rock and Cdk phosphorylation of Tppp1 inhibits its regulation of the cell cycle to increase cell proliferation.	[Schofield, Alice V.; Gamell, Cristina; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Cytoskeleton & Canc Unit, Fitzroy, Vic 3065, Australia; [Suryadinata, Randy; Sarcevic, Boris] Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Cell Cycle & Canc Unit, Fitzroy, Vic 3065, Australia; [Schofield, Alice V.; Sarcevic, Boris; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Bernard, O (corresponding author), 9 Princes St, Fitzroy, Vic 3065, Australia.	obernard@svi.edu.au	Suryadinata, Randy/C-2819-2013	Sarcevic, Boris/0000-0002-8063-1050; Gamell, Cristina/0000-0003-0720-2652	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Cancer Council of Victoria; Victorian Government's Operational Infrastructure Support Program; Australian Postgraduate Award; NHMRC	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government's Operational Infrastructure Support Program; Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), the Cancer Council of Victoria, and the Victorian Government's Operational Infrastructure Support Program.; Recipient of an Australian Postgraduate Award.; Supported by a Fellowship from the NHMRC.	Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charrasse S, 2000, EXP CELL RES, V254, P249, DOI 10.1006/excr.1999.4740; Chen J, 2008, INVEST OPHTH VIS SCI, V49, P175, DOI 10.1167/iovs.07-0488; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; Harvey SAK, 2004, INVEST OPHTH VIS SCI, V45, P2168, DOI 10.1167/iovs.03-1218; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kim S, 2011, NAT CELL BIOL, V13, P351, DOI 10.1038/ncb2183; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Li AQ, 2011, NAT CELL BIOL, V13, P402, DOI 10.1038/ncb2218; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; MASSON D, 1995, J CELL BIOL, V131, P1015, DOI 10.1083/jcb.131.4.1015; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Schofield AV, 2012, J BIOL CHEM, V287, P43620, DOI 10.1074/jbc.M112.394965; Skorobogatko YV, 2011, AMINO ACIDS, V40, P765, DOI 10.1007/s00726-010-0645-9; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	35	31	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7907	7917		10.1074/jbc.M112.441048	http://dx.doi.org/10.1074/jbc.M112.441048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355470	Green Published, hybrid			2022-12-28	WOS:000316455300044
J	Cohen-Katsenelson, K; Wasserman, T; Darlyuk-Saadon, I; Rabner, A; Glaser, F; Aronheim, A				Cohen-Katsenelson, Ksenya; Wasserman, Tanya; Darlyuk-Saadon, Ilona; Rabner, Alona; Glaser, Fabian; Aronheim, Ami			Identification and Analysis of a Novel Dimerization Domain Shared by Various Members of c-Jun N-terminal Kinase (JNK) Scaffold Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOCKING INTERACTIONS; SPINDLE POLE; WDR62; MUTATIONS; ACTIVATION; SEQUENCE; JIP; FAMILIES; MODULE	Mitogen-activated protein kinases (MAPKs) form a kinase tier module in which MAPK, MAP2K, and MAP3K are held by scaffold proteins. The scaffold proteins serve as a protein platform for selective and spatial kinase activation. The precise mechanism by which the scaffold proteins function has not yet been fully explained. WDR62 is a novel scaffold protein of the c-Jun N-terminal kinase (JNK) pathway. Recessive mutations within WDR62 result in severe cerebral cortical malformations. One of the WDR62 mutant proteins found in a patient with microcephaly encodes a C-terminal truncated protein that fails to associate efficiently with JNK and MKK7 beta 1. The present article shows that the WDR62 C-terminal region harbors a novel dimerization domain composed of a putative loop-helix domain that is necessary and sufficient for WDR62 dimerization and is critical for its scaffolding function. The loop-helix domain is highly conserved between orthologues and is also shared by the JNK scaffold protein, JNKBP1/MAPKBP1. Based on the high sequence conservation of the loop-helix domain, our article shows that MAPKBP1 homodimerizes and heterodimerizes with WDR62. Endogenous WDR62 and MAPKBP1 co-localize to stress granules following arsenite treatment, but not during mitosis. This study proposes another layer of complexity, in which coordinated activation of signaling pathways is mediated by the association between the different JNK scaffold proteins depending on their biological function.	[Cohen-Katsenelson, Ksenya; Wasserman, Tanya; Darlyuk-Saadon, Ilona; Aronheim, Ami] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Mol Genet, IL-31096 Haifa, Israel; [Rabner, Alona; Glaser, Fabian] Technion Israel Inst Technol, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Bioinformat Knowledge Unit, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Aronheim, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Mol Genet, 1 Efron St, IL-31096 Haifa, Israel.	aronheim@tx.technion.ac.il		Aronheim, Ami/0000-0002-8575-4092	Israeli Science Foundation [573/11]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Israeli Science Foundation Grant 573/11 (to A. A.).	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bhat V, 2011, CLIN GENET, V80, P532, DOI 10.1111/j.1399-0004.2011.01686.x; Biesecker LG, 2011, AM J MED GENET A, V155A, P2069, DOI 10.1002/ajmg.a.34183; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bogoyevitch MA, 2012, J CELL SCI, V125, P5096, DOI 10.1242/jcs.107326; Borsello T, 2007, J NEUROSCI RES, V85, P3632, DOI 10.1002/jnr.21435; Cohen-Katsenelson K, 2011, BIOCHEM J, V439, P381, DOI 10.1042/BJ20110284; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kousar R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-119; Koyano S, 1999, FEBS LETT, V457, P385, DOI 10.1016/S0014-5793(99)01084-4; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Mooney LM, 2004, J BIOL CHEM, V279, P11843, DOI 10.1074/jbc.M311841200; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Wasserman T, 2010, MOL BIOL CELL, V21, P117, DOI 10.1091/mbc.E09-06-0512; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Yablonski D, 1996, P NATL ACAD SCI USA, V93, P13864, DOI 10.1073/pnas.93.24.13864; Yamaguchi T, 2009, CELL BIOL INT, V33, P364, DOI 10.1016/j.cellbi.2009.01.003; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zaki MS, 2011, AM J MED GENET A, V155A, P3035, DOI 10.1002/ajmg.a.34078	43	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7294	7304		10.1074/jbc.M112.422055	http://dx.doi.org/10.1074/jbc.M112.422055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23341463	Green Published, hybrid			2022-12-28	WOS:000316002400049
J	Lee, LK; Bryant, KJ; Bouveret, R; Lei, PW; Duff, AP; Harrop, SJ; Huang, EP; Harvey, RP; Gelb, MH; Gray, PP; Curmi, PM; Cunningham, AM; Church, WB; Scott, KF				Lee, Lawrence K.; Bryant, Katherine J.; Bouveret, Romaric; Lei, Pei-Wen; Duff, Anthony P.; Harrop, Stephen J.; Huang, Edwin P.; Harvey, Richard P.; Gelb, Michael H.; Gray, Peter P.; Curmi, Paul M.; Cunningham, Anne M.; Church, W. Bret; Scott, Kieran F.			Selective Inhibition of Human Group IIA-secreted Phospholipase A(2) (hGIIA) Signaling Reveals Arachidonic Acid Metabolism Is Associated with Colocalization of hGIIA to Vimentin in Rheumatoid Synoviocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNOVIAL-FLUID PHOSPHOLIPASE-A2; CRYSTAL-STRUCTURE; ACTIVE-SITE; BINDING; SUBSTRATE; ENZYMES; DESIGN; POTENT; ROLES	Human group IIA secreted phospholipase A(2) (hGIIA) promotes tumor growth and inflammation and can act independently of its well described catalytic lipase activity via an alternative poorly understood signaling pathway. With six chemically diverse inhibitors we show that it is possible to selectively inhibit hGIIA signaling over catalysis, and x-ray crystal structures illustrate that signaling involves a pharmacologically distinct surface to the catalytic site. We demonstrate in rheumatoid fibroblast-like synoviocytes that non-catalytic signaling is associated with rapid internalization of the enzyme and colocalization with vimentin. Trafficking of exogenous hGIIA was monitored with immunofluorescence studies, which revealed that vimentin localization is disrupted by inhibitors of signaling that belong to a rare class of small molecule inhibitors that modulate protein-protein interactions. This study provides structural and pharmacological evidence for an association between vimentin, hGIIA, and arachidonic acid metabolism in synovial inflammation, avenues for selective interrogation of hGIIA signaling, and new strategies for therapeutic hGIIA inhibitor design.	[Lee, Lawrence K.; Church, W. Bret] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Lee, Lawrence K.; Church, W. Bret] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; Bouveret, Romaric; Lei, Pei-Wen; Harvey, Richard P.; Scott, Kieran F.] Univ New S Wales, St Vincents Hosp, Sch Clin, Sydney, NSW 2052, Australia; [Cunningham, Anne M.] Univ New S Wales, Fac Med, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; Huang, Edwin P.; Gray, Peter P.] Univ New S Wales, Dept Biotechnol, Sydney, NSW 2052, Australia; [Curmi, Paul M.] Univ New S Wales, Fac Sci, Sch Phys, Sydney, NSW 2052, Australia; [Bouveret, Romaric; Harvey, Richard P.] Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Duff, Anthony P.] Australian Nucl Sci & Technol Org, Menai, NSW 2234, Australia; [Curmi, Paul M.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; Australian Nuclear Science & Technology Organisation; St Vincents Hospital Sydney; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scott, KF (corresponding author), Univ Western Sydney, Sch Med, Ingham Inst Appl Med Res, POB 3151 Westfields Liverpool, Liverpool, NSW 2170, Australia.	kieran.scott@unsw.edu.au	Curmi, Paul/G-7185-2011; Church, William/H-6040-2013; Gray, Peter/AAC-3737-2019; Bouveret, Romaric/K-4540-2015; Bryant, Katherine/E-8574-2010	Curmi, Paul/0000-0001-5762-7638; Church, William/0000-0002-8033-5518; Bryant, Katherine/0000-0002-8686-623X; Lee, Lawrence/0000-0002-4453-4886; Duff, Anthony/0000-0003-3586-360X; gelb, michael/0000-0001-7000-5219; Bouveret, Romaric/0000-0002-3141-5167; Scott, Kieran/0000-0002-6012-4107; Harvey, Richard/0000-0002-9950-9792	United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Center for Research Resources [RR007707]; Australian Synchrotron Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER	United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Australian Synchrotron Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the staff at beamline 14-BMC (BioCARS) at the Advanced Photon Source for support. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science (Contract DE-AC02-06CH11357), and use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Center for Research Resources (Grant RR007707) and the Australian Synchrotron Research Program.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; Bidgood MJ, 2000, J IMMUNOL, V165, P2790, DOI 10.4049/jimmunol.165.5.2790; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Bradley JD, 2005, J RHEUMATOL, V32, P417; Bryant KJ, 2011, J BIOL CHEM, V286, P2492, DOI 10.1074/jbc.M110.123927; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; DeLano W.L, PYMOL MOL GRAPHICS S; Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gadek TR, 2003, BIOCHEM PHARMACOL, V65, P1, DOI 10.1016/S0006-2952(02)01479-X; Hansford KA, 2003, CHEMBIOCHEM, V4, P181, DOI 10.1002/cbic.200390029; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7306, DOI 10.1021/bi00243a036; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; LAMBEAU G, 1995, J BIOL CHEM, V270, P5534, DOI 10.1074/jbc.270.10.5534; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Magro AJ, 2005, ACTA CRYSTALLOGR D, V61, P1670, DOI 10.1107/S0907444905029598; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RENETSEDER R, 1988, J MOL BIOL, V200, P181, DOI 10.1016/0022-2836(88)90342-7; REYNOLDS LJ, 1992, ANAL BIOCHEM, V204, P190, DOI 10.1016/0003-2697(92)90160-9; Rosenson RS, 2010, CURR OPIN LIPIDOL, V21, P473, DOI 10.1097/MOL.0b013e32833eb581; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; Scott KF, 2003, EXPERT OPIN THER TAR, V7, P427, DOI 10.1517/14728222.7.3.427; Scott KF, 2010, BIOCHIMIE, V92, P601, DOI 10.1016/j.biochi.2010.03.019; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; SMITH GM, 1992, BRIT J RHEUMATOL, V31, P175; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tseng A, 1996, J BIOL CHEM, V271, P23992, DOI 10.1074/jbc.271.39.23992; VOLWERK JJ, 1974, BIOCHEMISTRY-US, V13, P1446, DOI 10.1021/bi00704a020; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yokota Y, 1999, BBA-MOL CELL BIOL L, V1438, P213, DOI 10.1016/S1388-1981(99)00053-0; Zeiher BG, 2005, CRIT CARE MED, V33, P1741, DOI 10.1097/01.CCM.0000171540.54520.69; Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4	45	16	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15269	15279		10.1074/jbc.M112.397893	http://dx.doi.org/10.1074/jbc.M112.397893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23482564	Green Published, hybrid			2022-12-28	WOS:000319452100053
J	Kim, S; Gross, DS				Kim, Sunyoung; Gross, David S.			Mediator Recruitment to Heat Shock Genes Requires Dual Hsf1 Activation Domains and Mediator Tail Subunits Med15 and Med16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR HSF1; GENOME-WIDE ANALYSIS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; INDEPENDENT RECRUITMENT; NUCLEOSOME DISPLACEMENT; PREINITIATION COMPLEX; NEGATIVE REGULATION; YEAST MEDIATOR	The evolutionarily conserved Mediator complex is central to the regulation of gene transcription in eukaryotes because it serves as a physical and functional interface between upstream regulators and the Pol II transcriptional machinery. Nonetheless, its role appears to be context-dependent, and the detailed mechanism by which it governs the expression of most genes remains unknown. Here we investigate Mediator involvement in HSP (heat shock protein) gene regulation in the yeast Saccharomyces cerevisiae. We find that in response to thermal upshift, subunits representative of each of the four Mediator modules (Head, Middle, Tail, and Kinase) are rapidly, robustly, and selectively recruited to the promoter regions of HSP genes. Their residence is transient, returning to near-background levels within 90 min. Hsf1 (heat shock factor 1) plays a central role in recruiting Mediator, as indicated by the fact that truncation of either its N- or C-terminal activation domain significantly reduces Mediator occupancy, whereas removal of both activation domains abolishes it. Likewise, ablation of either of two Mediator Tail subunits, Med15 or Med16, reduces Mediator recruitment to HSP promoters, whereas deletion of both abolishes it. Accompanying the loss of Mediator, recruitment of RNA polymerase II is substantially diminished. Interestingly, Mediator antagonizes Hsf1 occupancy of non-induced promoters yet facilitates enhanced Hsf1 association with activated ones. Collectively, our observations indicate that Hsf1, via its dual activation domains, recruits holo-Mediator to HSP promoters in response to acute heat stress through cooperative physical and/or functional interactions with the Tail module.	[Kim, Sunyoung; Gross, David S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Gross, DS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Hwy, Shreveport, LA 71130 USA.	dgross@lsuhsc.edu			National Science Foundation [MCB-0747227, MCB-1025025]; Direct For Biological Sciences [1025025] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0747227 and MCB-1025025 (to D. S. G.).	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Ansari S. A., 2013, CELL MOL LI IN PRESS; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Erkina TY, 2008, MOL CELL BIOL, V28, P1207, DOI 10.1128/MCB.01069-07; Erkine AM, 1996, MOL CELL BIOL, V16, P7004; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Galdieri L, 2012, J MOL BIOL, V415, P464, DOI 10.1016/j.jmb.2011.11.020; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghosh S, 2011, MOL CELL BIOL, V31, P190, DOI 10.1128/MCB.00317-10; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Gromoller A, 2000, FEBS LETT, V484, P48, DOI 10.1016/S0014-5793(00)02123-2; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; Hashimoto S, 2011, SCIENCE, V333, P1161, DOI 10.1126/science.1206638; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jedidi I, 2010, J BIOL CHEM, V285, P2438, DOI 10.1074/jbc.M109.071589; Kim S., 2012, THESIS LOUISIANA STA; Kremer SB, 2012, GENETICS, V191, P95, DOI 10.1534/genetics.111.135806; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Larschan E, 2005, MOL CELL BIOL, V25, P114, DOI 10.1128/MCB.25.1.114-123.2005; Lee DK, 1999, GENE DEV, V13, P2934, DOI 10.1101/gad.13.22.2934; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mehta S, 2009, FEBS LETT, V583, P3115, DOI 10.1016/j.febslet.2009.08.036; Miller C, 2012, J BIOL CHEM, V287, P44017, DOI 10.1074/jbc.M112.430140; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Tabtiang RK, 1998, MOL CELL BIOL, V18, P4707, DOI 10.1128/MCB.18.8.4707; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005; Zhu XF, 2011, NUCLEIC ACIDS RES, V39, P8342, DOI 10.1093/nar/gkr551; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	75	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12197	12213		10.1074/jbc.M112.449553	http://dx.doi.org/10.1074/jbc.M112.449553			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23447536	Green Published, hybrid			2022-12-28	WOS:000318157600051
J	Pal, M; Koul, S; Koul, HK				Pal, Mintu; Koul, Sweaty; Koul, Hari K.			The Transcription Factor Sterile Alpha Motif (SAM) Pointed Domain-containing ETS Transcription Factor (SPDEF) Is Required for E-cadherin Expression in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; AGGRESSIVE PHENOTYPE; ANOIKIS RESISTANCE; PROGNOSTIC VALUE; GENE-EXPRESSION; BREAST-CANCER; FACTOR SNAIL; FACTOR PDEF; TGF-BETA	Loss of E-cadherin is one of the key steps in tumor progression. Our previous studies demonstrate that SAM pointed domain-containing ETS transcription factor (SPDEF) inhibited prostate cancer metastasis in vitro and in vivo. In the present study, we evaluated the relationship between SPDEF and E-cadherin expression in an effort to better understand the mechanism of action of SPDEF in prostate tumor cell invasion and metastasis. The results presented here demonstrate a direct correlation between expression of E-cadherin and SPDEF in prostate cancer cells. Additional data demonstrate that modulation of E-cadherin and SPDEF had similar effects on cell migration/invasion. In addition, siRNA-mediated knockdown of E-cadherin was sufficient to block the effects of SPDEF on cell migration and invasion. We also show that stable forced expression of SPDEF results in increased expression of E-cadherin, whereas down-regulation of SPDEF decreased E-cadherin expression. In addition, we demonstrate that SPDEF expression is not regulated by E-cadherin. Moreover, our chromatin immunoprecipitation and luciferase reporter assay revealed that SPDEF occupies E-cadherin promoter site and acts as a direct transcriptional inducer of E-cadherin in prostate cancer cells. Taken together, to the best of our knowledge, these studies are the first demonstrating requirement of SPDEF for expression of E-cadherin, an essential epithelial cell junction protein. Given that loss of E-cadherin is a central tenant in tumor metastasis, the results of our studies, by providing a new mechanism for regulation of E-cadherin expression, could have far reaching impact.	[Pal, Mintu; Koul, Sweaty; Koul, Hari K.] Univ Colorado, Dept Surg, Sch Med, Program Urosci,Div Urol, Aurora, CO 80045 USA; [Koul, Hari K.] Univ Colorado, Ctr Comprehens Canc, Aurora, CO 80045 USA; [Koul, Sweaty; Koul, Hari K.] Denver Vet Adm Med Ctr, Denver, CO 80220 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Koul, HK (corresponding author), 12700 E 19th Ave,RC2-6001,MS C317, Aurora, CO 80045 USA.	Hari.koul@ucdenver.edu			Chair Commitment; Department of Surgery, School of Medicine Academic Enrichment Funds; Veterans Affairs Merit Award [01BX001258]; National Institutes of Health [R01 DK54084, R01CA161880]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA161880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054084] Funding Source: NIH RePORTER	Chair Commitment; Department of Surgery, School of Medicine Academic Enrichment Funds; Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Chair Commitment (to H. K. K.) and the Department of Surgery, School of Medicine Academic Enrichment Funds (to H. K. K.).; Supported in part by Veterans Affairs Merit Award 01BX001258 and National Institutes of Health Grants R01 DK54084 and R01CA161880. To whom correspondence should be addressed: 12700 E. 19th Ave, RC2-6001; MS-C317, Aurora, CO 80045. Tel.: 303-724-6300; Fax: 303-724-6330; E-mail: Hari.koul@ucdenver.edu.	Bankfalvi A, 2002, J PATHOL, V198, P343, DOI 10.1002/path.1204; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cheng L, 1996, AM J PATHOL, V148, P1375; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; del Muro XG, 2000, EUR J CANCER, V36, P357; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; Fan LS, 2012, ONCOL LETT, V4, P1225, DOI 10.3892/ol.2012.934; Feldman RJ, 2003, CANCER RES, V63, P4626; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gabbert HE, 1996, INT J CANCER, V69, P184, DOI 10.1002/(SICI)1097-0215(19960621)69:3<184::AID-IJC6>3.0.CO;2-W; Ghadersohi A, 2011, PROSTATE, V71, P1178, DOI 10.1002/pros.21333; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Johnson TR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-148; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KATAGIRI A, 1995, BRIT J CANCER, V71, P376, DOI 10.1038/bjc.1995.76; Krishnadath KK, 1997, J PATHOL, V182, P331; Li G, 2001, CANCER RES, V61, P3819; MATTIJSSEN V, 1993, INT J CANCER, V55, P580, DOI 10.1002/ijc.2910550411; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Pal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025377; PIGNATELLI M, 1994, J PATHOL, V174, P243, DOI 10.1002/path.1711740403; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Richmond PJM, 1997, CANCER RES, V57, P3189; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Sood AK, 2012, PROSTATE, V72, P592, DOI 10.1002/pros.21461; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396; Steffan JJ, 2011, CANCER LETT, V310, P109, DOI 10.1016/j.canlet.2011.06.011; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Turner DP, 2011, PROSTATE, V71, P1723, DOI 10.1002/pros.21389; vonWasielewski R, 1997, CANCER RES, V57, P2501; Wang GY, 2008, AM J EPIDEMIOL, V167, P7, DOI 10.1093/aje/kwm264; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yoshida R, 2001, INT J ONCOL, V18, P513; Yu Q, 2000, GENE DEV, V14, P163; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	53	12	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12222	12231		10.1074/jbc.M112.434225	http://dx.doi.org/10.1074/jbc.M112.434225			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23449978	hybrid, Green Published			2022-12-28	WOS:000318157600054
J	Alzayady, KJ; Chandrasekhar, R; Yule, DI				Alzayady, Kamil J.; Chandrasekhar, Rahul; Yule, David I.			Fragmented Inositol 1,4,5-Trisphosphate Receptors Retain Tetrameric Architecture and Form Functional Ca2+ Release Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; TRISPHOSPHATE RECEPTOR; SIGNAL-TRANSDUCTION; IP3 RECEPTORS; TYPE-1; APOPTOSIS; CLEAVAGE; DOMAIN; CALCINEURIN; ACTIVATION	Inositol 1,4,5-trisphosphate receptor isoforms are a family of ubiquitously expressed ligand-gated channels encoded by three individual genes. The proteins are localized to membranes of intracellular Ca2+ stores and play pivotal roles in Ca2+ homeostasis. Previous studies have demonstrated that IP(3)R1 is cleaved by the intracellular proteases calpain and caspase both in vivo and in vitro. However, the resultant cleavage products are poorly defined, and the functional consequences of these proteolytic events are not fully understood. We demonstrate that IP(3)R1 is cleaved during staurosporine-induced apoptosis, yielding N-terminal fragments encompassing the ligand-binding domain and the majority of the central modulatory domain together with a C-terminal fragment containing the channel domain and cytosolic tail. Notably, these fragments remain associated with the membrane after initiation of apoptotic cleavage. Furthermore, when recombinant IP(3)R1 fragments, corresponding to those predicted to be generated by caspase or calpain cleavage, are stably coexpressed in cells, they physically associate and form functional channels. These data provide novel insights regarding the regulation of I(P)3R1 during proteolysis and provide direct evidence that polypeptide continuity is not required for IP3R activation and Ca2+ release.	[Alzayady, Kamil J.; Chandrasekhar, Rahul; Yule, David I.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	david_Yule@urmc.rochester.edu			National Institutes of Health [R01 DE014756, DK54568]; NIDCR, National Institutes of Health [T90 DE021985-02]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756, T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568, R56DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE014756 and DK54568 (to D. I. Y.) and by NIDCR, National Institutes of Health Training Grant T90 DE021985-02 (to K. J. A.).	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bhanumathy C, 2012, J BIOL CHEM, V287, P43674, DOI 10.1074/jbc.M112.415786; Blackshaw S, 2000, FASEB J, V14, P1375, DOI 10.1096/fj.14.10.1375; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; Elkoreh G, 2012, J CELL BIOCHEM, V113, P2775, DOI 10.1002/jcb.24155; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Hang LS, 2000, J NEUROCHEM, V75, P1852; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; How PC, 2011, J BIOL CHEM, V286, P8565, DOI 10.1074/jbc.M110.175174; Igwe OJ, 1997, MOL BRAIN RES, V46, P39, DOI 10.1016/S0169-328X(96)00269-0; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Kopil CM, 2012, J NEUROCHEM, V123, P147, DOI 10.1111/j.1471-4159.2012.07859.x; Kopil CM, 2011, J BIOL CHEM, V286, P35998, DOI 10.1074/jbc.M111.254177; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; MAGNUSSON A, 1993, FEBS LETT, V323, P229, DOI 10.1016/0014-5793(93)81345-Z; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mukerjee N, 2000, ARCH BIOCHEM BIOPHYS, V379, P337, DOI 10.1006/abbi.2000.1889; Mukerjee N, 2001, BIOCHEM BIOPH RES CO, V285, P1192, DOI 10.1006/bbrc.2001.5278; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Orrenius S, 1991, Adv Exp Med Biol, V283, P419; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Shimbo K, 2012, P NATL ACAD SCI USA, V109, P12432, DOI 10.1073/pnas.1208616109; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szlufcik K, 2006, BIOL CELL, V98, P1, DOI 10.1042/BC20050031; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Verbert L, 2008, BIOL CELL, V100, P39, DOI 10.1042/BC20070086; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yim H, 2003, MOL BIOL CELL, V14, P4250, DOI 10.1091/mbc.E03-01-0029; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	54	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11122	11134		10.1074/jbc.M113.453241	http://dx.doi.org/10.1074/jbc.M113.453241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479737	Green Published, hybrid			2022-12-28	WOS:000317915500017
J	Bertsch, J; Parthasarathy, A; Buckel, W; Muller, V				Bertsch, Johannes; Parthasarathy, Anutthaman; Buckel, Wolfgang; Mueller, Volker			An Electron-bifurcating Caffeyl-CoA Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETOBACTERIUM-WOODII; TRANSFER FLAVOPROTEIN; COENZYME-A; TRANSFERRING FLAVOPROTEIN; ENERGY-CONSERVATION; INTERMEDIATE STEP; CRYSTAL-STRUCTURE; ENZYME COMPLEX; FERREDOXIN; IRON	A low potential electron carrier ferredoxin (E-0' approximate to -500 mV) is used to fuel the only bioenergetic coupling site, a sodium-motive ferredoxin: NAD(+) oxidoreductase (Rnf) in the acetogenic bacterium Acetobacterium woodii. Because ferredoxin reduction with physiological electron donors is highly endergonic, it must be coupled to an exergonic reaction. One candidate is NADH-dependent caffeyl-CoA reduction. We have purified a complex from A. woodii that contains a caffeyl-CoA reductase and an electron transfer flavoprotein. The enzyme contains three subunits encoded by the carCDE genes and is predicted to have, in addition to FAD, two [4Fe-4S] clusters as cofactor, which is consistent with the experimental determination of 4 mol of FAD, 9 mol of iron, and 9 mol of acid-labile sulfur. The enzyme complex catalyzed caffeyl-CoA-dependent oxidation of reduced methyl viologen. With NADH as donor, it catalyzed caffeyl-CoA reduction, but this reaction was highly stimulated by the addition of ferredoxin. Spectroscopic analyses revealed that ferredoxin and caffeyl-CoA were reduced simultaneously, and a stoichiometry of 1.3:1 was determined. Apparently, the caffeyl-CoA reductase-Etf complex of A. woodii uses the novel mechanism of flavin-dependent electron bifurcation to drive the endergonic ferredoxin reduction with NADH as reductant by coupling it to the exergonic NADH-dependent reduction of caffeyl-CoA.	[Bertsch, Johannes; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60438 Frankfurt, Germany; [Parthasarathy, Anutthaman; Buckel, Wolfgang] Univ Marburg, Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany; [Buckel, Wolfgang] Univ Marburg, Fachbereich Biol, D-35043 Marburg, Germany	Goethe University Frankfurt; Max Planck Society; Philipps University Marburg; Philipps University Marburg	Muller, V (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Parthasarathy, Anutthaman/L-5490-2019; Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508; Parthasarathy, Anutthaman/0000-0003-1830-5948; Parthasarathy, Anutthaman/0000-0003-4750-6335	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Aufurth S, 2000, J BIOL CHEM, V275, P33297, DOI 10.1074/jbc.M005134200; BACHE R, 1981, ARCH MICROBIOL, V130, P255, DOI 10.1007/BF00459530; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BERTINI I, 1995, EUR J BIOCHEM, V232, P192, DOI 10.1111/j.1432-1033.1995.tb20799.x; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; Boiangiu CD, 2005, J MOL MICROB BIOTECH, V10, P105, DOI 10.1159/000091558; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt K, 2013, J BIOENERG BIOMEMBR, V45, P15, DOI 10.1007/s10863-012-9474-8; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; CRANE FL, 1956, J BIOL CHEM, V218, P717; Dimroth Peter, 2008, V45, P153, DOI 10.1007/400_2007_045; DUEE ED, 1994, J MOL BIOL, V243, P683, DOI 10.1016/0022-2836(94)90041-8; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fritz M, 2008, FEBS J, V275, P1999, DOI 10.1111/j.1742-4658.2008.06354.x; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; Gottschalk G, 2001, BBA-BIOENERGETICS, V1505, P28, DOI 10.1016/S0005-2728(00)00274-7; HEISE R, 1991, FEBS LETT, V295, P119, DOI 10.1016/0014-5793(91)81400-3; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess V, 2013, APPL ENVIRON MICROB, V79, P1942, DOI 10.1128/AEM.03604-12; Hess V, 2011, J BACTERIOL, V193, P971, DOI 10.1128/JB.01126-10; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Huang HY, 2012, J BACTERIOL, V194, P3689, DOI 10.1128/JB.00385-12; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Mueller V., 2008, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0001415.pub2, DOI 10.1002/9780470015902.A0001415.PUB2]; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; REIDLINGER J, 1994, FEBS LETT, V356, P17, DOI 10.1016/0014-5793(94)01222-9; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Schlegel K, 2012, FEBS J, V279, P4444, DOI 10.1111/febs.12031; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Schmitz RA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P86, DOI 10.1007/0-387-30742-7_4; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Swanson MA, 2008, BIOCHEMISTRY-US, V47, P8894, DOI 10.1021/bi800507p; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; TSAI MH, 1995, RES MICROBIOL, V146, P397, DOI 10.1016/0923-2508(96)80285-3; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007	51	55	59	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11304	11311		10.1074/jbc.M112.444919	http://dx.doi.org/10.1074/jbc.M112.444919			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23479729	hybrid, Green Published			2022-12-28	WOS:000317915500033
J	Nordholm, J; da Silva, DV; Damjanovic, J; Dou, D; Daniels, R				Nordholm, Johan; da Silva, Diogo V.; Damjanovic, Justina; Dou, Dan; Daniels, Robert			Polar Residues and Their Positional Context Dictate the Transmembrane Domain Interactions of Influenza A Neuraminidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX INTERACTIONS; VIRUS NEURAMINIDASE; DRIVE ASSOCIATION; MEMBRANE-PROTEINS; MOTIFS; SEQUENCE; SIGNAL; OLIGOMERIZATION; RECOGNITION; MATURATION	Interactions that facilitate transmembrane domain (TMD) dimerization have been identified mainly using synthetic TMDs. Here, we investigated how inherent properties within natural TMDs modulate their interaction strength by exploiting the sequence variation in the nine neuraminidase subtypes (N1-N9) and the prior knowledge that a N1 TMD oligomerizes. Initially, consensus TMDs were created from the influenza A virus database, and their interaction strengths were measured in a biological membrane system. The TMD interactions increased with respect to decreasing hydrophobicity across the subtypes (N1-N9) and within the human N1 subtype where the N1 TMDs from the pandemic H1N1 strain of swine origin were found to be significantly less hydrophobic. The hydrophobicity correlation was attributed to the conserved amphipathicity within the TMDs as the interactions were abolished by mutating residues on the polar faces that are unfavorably positioned in the membrane. Similarly, local changes enhanced the interactions only when a larger polar residue existed on the appropriate face in an unfavorable membrane position. Together, the analysis of this unique natural TMD data set demonstrates how polar-mediated TMD interactions from bitopic proteins depend on which polar residues are involved and their positioning with respect to the helix and the membrane bilayer.	[Nordholm, Johan; da Silva, Diogo V.; Damjanovic, Justina; Dou, Dan; Daniels, Robert] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Daniels, R (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	robertd@dbb.su.se		nordholm, johan/0000-0002-5864-8489; daniels, Robert/0000-0002-5988-2920	Swedish Research Council; Swedish Foundation for Strategic Research; Carl Trygger Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Trygger Foundation	This work was supported by grants from the Swedish Research Council, Swedish Foundation for Strategic Research, and the Carl Trygger Foundation (to R. D.).	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; BOS TJ, 1984, P NATL ACAD SCI-BIOL, V81, P2327, DOI 10.1073/pnas.81.8.2327; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; da Silva DV, 2013, J BIOL CHEM, V288, P644, DOI 10.1074/jbc.M112.424150; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Hubert P, 2010, CELL ADHES MIGR, V4, P313, DOI 10.4161/cam.4.2.12430; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mellroth P, 2012, J BIOL CHEM, V287, P11018, DOI 10.1074/jbc.M111.318584; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Oates J, 2010, BBA-BIOMEMBRANES, V1798, P605, DOI 10.1016/j.bbamem.2009.12.016; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Partridge AW, 2002, BIOPOLYMERS, V66, P350, DOI 10.1002/bip.10313; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Rath A, 2012, ANNU REV BIOPHYS, V41, P135, DOI [10.1146/annurev-biophys-050511-102310, 10.1146/annurev-biophys-050591-102310]; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; SAITO T, 1995, J VIROL, V69, P5011, DOI 10.1128/JVI.69.8.5011-5017.1995; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Wang N, 2008, J BIOL CHEM, V283, P33826, DOI 10.1074/jbc.M806897200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	51	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10652	10660		10.1074/jbc.M112.440230	http://dx.doi.org/10.1074/jbc.M112.440230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447533	hybrid, Green Published			2022-12-28	WOS:000317565000043
J	Wei, ZK; Seldin, MM; Natarajan, N; Djemal, DC; Peterson, JM; Wong, GW				Wei, Zhikui; Seldin, Marcus M.; Natarajan, Niranjana; Djemal, David C.; Peterson, Jonathan M.; Wong, G. William			C1q/Tumor Necrosis Factor-related Protein 11 (CTRP11), a Novel Adipose Stroma-derived Regulator of Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; SHORT-CHAIN COLLAGEN; INSULIN SENSITIVITY; FAMILY; OBESITY; CLONING; GLUCOSE; EXPRESSION; TISSUE; BRAIN	C1q/TNF-related proteins (CTRPs) are a family of secreted regulators of glucose and lipid metabolism. Here, we describe CTRP11, a novel and phylogenetically conserved member of the C1q family. Our studies revealed that white and brown adipose are major tissues that express CTRP11, and its expression is acutely regulated by changes in metabolic state. Within white adipose tissue, CTRP11 is primarily expressed by stromal vascular cells. As a secreted multimeric protein, CTRP11 forms disulfide-linked oligomers. Although the conserved N-terminal Cys-28 and Cys-32 are dispensable for the assembly of higher-order oligomeric structures, they are unexpectedly involved in modulating protein secretion. When co-expressed, CTRP11 forms heteromeric complexes with closely related CTRP10, CTRP13, and CRF (CTRP14) via the C-terminal globular domains, combinatorial associations that potentially generate functionally distinct complexes. Functional studies revealed a role for CTRP11 in regulating adipogenesis. Ectopic expression of CTRP11 or exposure to recombinant protein inhibited differentiation of 3T3-L1 adipocytes. The expression of peroxisome proliferator-activated receptor-gamma and CAAT/enhancer binding protein-alpha, which drive the adipogenic gene program, was markedly suppressed by CTRP11. Impaired adipogenesis was caused by a CTRP11-mediated decrease in p42/44-MAPK signaling and inhibition of mitotic clonal expansion, a process essential for adipocyte differentiation in culture. These results implicate CTRP11 as a novel secreted regulator of adipogenesis and highlight the potential paracrine cross-talk between adipocytes and cells of the stromal vascular compartment in maintaining adipose tissue homeostasis.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association [SDG2260721, PRE3790034]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, P30DK079637, R01DK084171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.) and American Heart Association Grant SDG2260721.; Supported by American Heart Association Fellowship PRE3790034.; Supported by National Institutes of Health National Research Service Award F32DK084607. Present address: Dept. of Health Sciences, School of Public Health, East Tennessee State University, Johnson City, TN 37614.	Aerbajinai W, 2004, J BIOL CHEM, V279, P1916, DOI 10.1074/jbc.M305634200; BALL EG, 1960, J BIOL CHEM, V235, P584; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BERNARD M, 1988, J BIOL CHEM, V263, P17159; Berube NG, 1999, MOL BRAIN RES, V63, P233, DOI 10.1016/S0169-328X(98)00278-2; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; GERSHONI JM, 1985, ANAL BIOCHEM, V146, P59, DOI 10.1016/0003-2697(85)90395-1; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; GRIES FA, 1967, J CLIN INVEST, V46, P1413, DOI 10.1172/JCI105633; Hayward C P, 1995, Curr Opin Hematol, V2, P339; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huang HY, 2005, BIOCHEM BIOPH RES CO, V338, P1185, DOI 10.1016/j.bbrc.2005.10.057; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shiratsuchi T, 1997, CYTOGENET CELL GENET, V79, P103, DOI 10.1159/000134693; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolfing B, 2008, OBESITY, V16, P1481, DOI 10.1038/oby.2008.206; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3	64	55	63	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10214	10229		10.1074/jbc.M113.458711	http://dx.doi.org/10.1074/jbc.M113.458711			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23449976	Green Published, hybrid			2022-12-28	WOS:000317565000004
J	Bradley, EW; Carpio, LR; Westendorf, JJ				Bradley, Elizabeth W.; Carpio, Lomeli R.; Westendorf, Jennifer J.			Histone Deacetylase 3 Suppression Increases PH Domain and Leucine-rich Repeat Phosphatase (Phlpp)1 Expression in Chondrocytes to Suppress Akt Signaling and Matrix Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; ENDOCHONDRAL OSSIFICATION; MURINE CHONDROCYTES; GROWTH-PLATE; DIFFERENTIATION; RAPAMYCIN; PATHWAYS; CELLS; CHONDROGENESIS; MAINTENANCE	HDACs epigenetically regulate cellular processes by modifying chromatin and influencing gene expression. We previously reported that conditional deletion of Hdac3 in osteo-chondroprogenitor cells with Osx1-Cre caused severe osteopenia due to abnormal maturation of osteoblasts. The mice were also smaller. To address the abnormal longitudinal growth in these animals, the role of Hdac3 in chondrocyte differentiation was evaluated. We found that Hdac3 is highly expressed in resting and prehypertrophic growth plate chondrocytes, as well as in articular chondrocytes. Hdac3-deficient chondrocytes entered hypertrophy sooner and were smaller than normal chondrocytes. Extracellular matrix production was suppressed as glycosaminoglycan secretion and production of aggrecan, osteopontin, and matrix extracellular phosphoglycoprotein were reduced in Hdac3-deficient chondrocytes. These phenotypes led to the hypothesis that the Akt/mTOR pathway was repressed in these Hdac3-deficient chondrocytes because Akt promotes hypertrophy and matrix production in many tissues. The phosphorylation and activation of Akt, its substrate mTOR, and the mTOR substrate, p70 S6 kinase, were indeed reduced in Hdac3-deficient primary chondrocytes as well as in chondrocytes exposed to HDAC inhibitors. Expression of constitutively active Akt restored phosphorylation of mTOR and p70 S6K and matrix gene expression levels. Reduced phosphorylation of Akt and its substrates in Hdac3-deficient or HDAC inhibitors treated chondrocytes correlated with increased expression of the phosphatase Phlpp1. Hdac3 associated with a Phlpp1 promoter region containing Smad binding elements and was released after TGF beta was added to the culture. These data demonstrate that Hdac3 controls chondrocyte hypertrophy and matrix content by repressing Phlpp1 expression and facilitating Akt activity.	[Bradley, Elizabeth W.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Carpio, Lomeli R.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Westendorf, JJ (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		Shull, Lomeli/0000-0001-7537-8516; Bradley, Elizabeth/0000-0002-8814-5524	National Institutes of Health [AR48147, AR61873, AR56950, GM055252]; Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048147, T32AR056950, F32AR061873, R01AR068103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research and training grants from the National Institutes of Health (AR48147, AR61873, AR56950, and GM055252), Mayo Clinic, and the Mayo Graduate School.	Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Alvarez-Garcia O, 2007, PEDIATR NEPHROL, V22, P954, DOI 10.1007/s00467-007-0456-8; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bradley EW, 2011, CRIT REV EUKAR GENE, V21, P101; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chen WP, 2010, MOL BIOL REP, V37, P3967, DOI 10.1007/s11033-010-0055-9; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Jin EJ, 2007, J CELL BIOCHEM, V102, P252, DOI 10.1002/jcb.21430; Joosten LAB, 2011, MOL MED, V17, P391, DOI 10.2119/molmed.2011.00058; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Karp SJ, 2000, DEVELOPMENT, V127, P543; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Lambert Jr, 2001, METH MOL B, V176, P273; Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nasu Y, 2008, OSTEOARTHR CARTILAGE, V16, P723, DOI 10.1016/j.joca.2007.10.014; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Oh CD, 2001, EUR J PHARMACOL, V427, P175, DOI 10.1016/S0014-2999(01)01241-9; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Sun Z, 2011, J BIOL CHEM, V286, P33301, DOI 10.1074/jbc.M111.277707; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603	55	63	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9572	9582		10.1074/jbc.M112.423723	http://dx.doi.org/10.1074/jbc.M112.423723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408427	Green Published, hybrid			2022-12-28	WOS:000317114000001
J	Zhang, N; Wang, XL; Huo, Q; Li, XY; Wang, HY; Schneider, P; Hu, GH; Yang, QF				Zhang, Ning; Wang, Xiaolong; Huo, Qiang; Li, Xiaoyan; Wang, Huiyun; Schneider, Pascal; Hu, Guohong; Yang, Qifeng			The Oncogene Metadherin Modulates the Apoptotic Pathway Based on the Tumor Necrosis Factor Superfamily Member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE-ELEVATED GENE-1; NATIVE TRAIL; CELLS; RESISTANCE; SURVIVIN; CHEMORESISTANCE; IDENTIFICATION; PROGRESSION; METASTASIS; EXPRESSION	Metadherin (MTDH), the newly discovered gene, is overexpressed in more than 40% of breast cancers. Recent studies have revealed that MTDH favors an oncogenic course and chemoresistance. With a number of breast cancer cell lines and breast tumor samples, we found that the relative expression of MTDH correlated with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity in breast cancer. In this study, we found that knockdown of endogenous MTDH cells sensitized the MDA-MB-231 cells to TRAIL-induced apoptosis both in vitro and in vivo. Conversely, stable overexpression of MTDH in MCF-7 cells enhanced cell survival with TRAIL treatment. Mechanically, MTDH down-regulated caspase-8, decreased caspase-8 recruitment into the TRAIL death-inducing signaling complex, decreased caspase-3 and poly(ADP-ribose) polymerase-2 processing, increased Bcl-2 expression, and stimulated TRAIL-induced Akt phosphorylation, without altering death receptor status. In MDA-MB-231 breast cancer cells, sensitization to TRAIL upon MTDH down-regulation was inhibited by the caspase inhibitor Z-VAD-fmk (benzyloxycarbonyl-VAD-fluoromethyl ketone), suggesting that MTDH depletion stimulates activation of caspases. In MCF-7 breast cancer cells, resistance to TRAIL upon MTDH overexpression was abrogated by depletion of Bcl-2, suggesting that MTDH-induced Bcl-2 expression contributes to TRAIL resistance. We further confirmed that MTDH may control Bcl-2 expression partly by suppressing miR-16. Collectively, our results point to a protective function of MTDH against TRAIL-induced death, whereby it inhibits the intrinsic apoptosis pathway through miR-16-mediated Bcl-2 up-regulation and the extrinsic apoptosis pathway through caspase-8 down-regulation.	[Zhang, Ning; Wang, Xiaolong; Huo, Qiang; Li, Xiaoyan; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250012, Shandong, Peoples R China; [Wang, Huiyun] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Hu, Guohong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Hu, Guohong] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China	Shandong University; State Key Lab Oncology South China; Sun Yat Sen University; University of Lausanne; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Hu, GH (corresponding author), Inst Hlth Sci, 225 South Chongqing Rd, Shanghai 200025, Peoples R China.	ghhu@sibs.ac.cn; qifengy@gmail.com	yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022; Zhang, Ning/GNP-1966-2022	Zhang, Ning/0000-0002-6430-4236; Hu, Guohong/0000-0002-2980-5166; Schneider, Pascal/0000-0003-0677-9409; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81072150, 81172529, 81272903]; Swiss National Science Foundation [31003A_138065]; Shandong Science and Technology Development Plan [2012GZC22115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Shandong Science and Technology Development Plan	This work was supported by National Natural Science Foundation of China (Grants 81072150, 81172529, and 81272903), the Swiss National Science Foundation (Grant 31003A_138065), and Shandong Science and Technology Development Plan (Grant 2012GZC22115).	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Keane MM, 1999, CANCER RES, V59, P734; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim EH, 2004, ONCOGENE, V23, P446, DOI 10.1038/sj.onc.1207025; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Li C, 2011, J SURG ONCOL, V103, P184, DOI 10.1002/jso.21788; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li XA, 2011, CANCER SCI, V102, P1151, DOI 10.1111/j.1349-7006.2011.01919.x; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Maksimovic-Ivanic D, 2012, IMMUNOL RES, V52, P157, DOI 10.1007/s12026-012-8284-8; Mehta K, 2002, J NATL CANCER I, V94, P1652; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Seol DW, 2001, CANCER RES, V61, P1138; Shankar S, 2009, MOL CANCER THER, V8, P1596, DOI 10.1158/1535-7163.MCT-08-1004; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak Henning, 2008, V414, P221; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205; Wei Y, 2009, CELL CYCLE, V8, P2132; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang QF, 2000, BREAST CANCER RES TR, V61, P211, DOI 10.1023/A:1006474307180; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yoon MJ, 2012, CARCINOGENESIS, V33, P492, DOI 10.1093/carcin/bgr298; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhou ZM, 2012, INT J CANCER, V130, P1504, DOI 10.1002/ijc.26122	44	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9396	9407		10.1074/jbc.M112.395913	http://dx.doi.org/10.1074/jbc.M112.395913			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408429	Green Published, hybrid			2022-12-28	WOS:000316862200056
J	Das, F; Ghosh-Choudhury, N; Bera, A; Dey, N; Abboud, HE; Kasinath, BS; Choudhury, GG				Das, Falguni; Ghosh-Choudhury, Nandini; Bera, Amit; Dey, Nirmalya; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			Transforming Growth Factor beta Integrates Smad 3 to Mechanistic Target of Rapamycin Complexes to Arrest Deptor Abundance for Glomerular Mesangial Cell Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SMOOTH-MUSCLE-CELLS; RICTOR-MTOR COMPLEX; HIGH GLUCOSE; DIABETIC-NEPHROPATHY; SIGNAL-TRANSDUCTION; MAMMALIAN TARGET; FIBRONECTIN EXPRESSION; MESENCHYMAL TRANSITION	In many renal diseases, transforming growth factor beta (TGF beta)-stimulated canonical Smad 3 and noncanonical mechanistic target of rapamycin (mTOR) promote increased protein synthesis and mesangial cell hypertrophy. The cellular underpinnings involving these signaling molecules to regulate mesangial cell hypertrophy are not fully understood. Deptor has recently been identified as an mTOR interacting protein and functions as an endogenous inhibitor of the kinase activity for both TORC1 and TORC2. Prolonged incubation of mesangial cells with TGF beta reduced the levels of deptor concomitant with an increase in TORC1 and TORC2 activity. Sustained TGF beta activation was required to inhibit association of deptor with mTOR, whereas rapid activation had no effect. Using the mTOR inhibitor PP242, we found that TGF beta-induced both early and sustained activation of TORC1 and TORC2 was necessary for deptor suppression. PP242-induced reversal of deptor suppression by TGF beta was associated with a significant inhibition of TGF beta-stimulated protein synthesis and hypertrophy. Interestingly, expression of siRNA against Smad 3 or Smad 7, which blocks TGF beta receptor-specific Smad 3 signaling, prevented TGF beta-induced suppression of deptor abundance and TORC1/2 activities. Furthermore, overexpression of Smad 3 decreased deptor expression similar to TGF beta stimulation concomitant with increased TORC1 and TORC2 activities. Finally, knockdown of deptor reversed Smad 7-mediated inhibition of protein synthesis and mesangial cell hypertrophy induced by TGF beta. These data reveal the requirement of both early and late activation of mTOR for TGF beta-induced protein synthesis. Our results support that TGF beta-stimulated Smad 3 acts as a key node to instill a feedback loop between deptor down-regulation and TORC1/2 activation in driving mesangial cell hypertrophy.	[Ghosh-Choudhury, Nandini; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Das, Falguni; Bera, Amit; Dey, Nirmalya; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			National Institutes of Health [RO1 DK50190, RO1 AR 52425, RO1 DK 78971, RO1 DK 077295, RC2A 036613]; Veterans Affairs Merit Review grants; Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio; Juvenile Diabetes Research Foundation; Veterans Affairs Research Service; Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation [1-2008-185]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078971, R01DK050190, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grants(US Department of Veterans Affairs); Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Research Service(US Department of Veterans Affairs); Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK50190 and Veterans Affairs Merit Review grants (to G. G. C.).; Supported by National Institutes of Health Grant RO1 AR 52425, Veterans Affairs Merit Review grants, and a Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio.; Supported by National Institutes of Health Grant RO1 DK 78971 and Veterans Affairs Merit Review and Juvenile Diabetes Research Foundation grants.; Supported by National Institutes of Health Grants RO1 DK 077295 and RC2A 036613 and the Veterans Affairs Research Service.; Recipient of Veterans Affairs Senior Research Career Scientist Award and supported by Juvenile Diabetes Research Foundation Grant 1-2008-185.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Chen S, 2004, KIDNEY INT, V65, P1191, DOI 10.1111/j.1523-1755.2004.00492.x; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; CHOUDHURY GG, 1993, AM J PHYSIOL, V265, pF634, DOI 10.1152/ajprenal.1993.265.5.F634; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Das F, 2007, FEBS LETT, V581, P5259, DOI 10.1016/j.febslet.2007.10.014; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim HW, 2004, KIDNEY INT, V66, P1859, DOI 10.1111/j.1523-1755.2004.00959.x; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mavrakis M, 2007, AUTOPHAGY, V3, P151, DOI 10.4161/auto.3632; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7756	7768		10.1074/jbc.M113.455782	http://dx.doi.org/10.1074/jbc.M113.455782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362262	Green Published, hybrid			2022-12-28	WOS:000316455300031
J	Dong, NZ; Fang, CD; Jiang, YZ; Zhou, TT; Liu, M; Zhou, JP; Shen, JZ; Fukuda, K; Qin, J; Wu, QY				Dong, Ningzheng; Fang, Chaodong; Jiang, Yizhi; Zhou, Tiantian; Liu, Meng; Zhou, Jianping; Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu			Corin Mutation R539C from Hypertensive Patients Impairs Zymogen Activation and Generates an Inactive Alternative Ectodomain Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; SALT-SENSITIVE HYPERTENSION; ANCHORED SERINE PROTEASES; IRON-DEFICIENCY ANEMIA; PLASMA SOLUBLE CORIN; CARDIAC-HYPERTROPHY; RECEPTOR GENE; ASSOCIATION; BLOOD; CELL	Corin is a cardiac transmembrane serine protease that regulates blood pressure by activating natriuretic peptides. Corin variants have been associated with African Americans with hypertension and heart disease. Here, we report a new mutation in exon 12 of the CORIN gene identified in a family of patients with hypertension. The mutation resulted in R539C substitution in the Fz2 (Frizzled-2) domain of the corin propeptide region. We expressed and characterized the corin R539C mutant in HEK293 cells. As determined by Western blot analysis, the R539C mutation did not alter corin expression in transfected cells but impaired corin zymogen activation. In a proatrial natriuretic peptide processing assay, the corin mutant had reduced activity and exhibited a dominant-negative effect on wild-type corin. In addition, the R539C mutation altered corin ectodomain shedding, producing an alternative similar to 75-kDa fragment that was biologically inactive. Using protease inhibitors and the catalytically inactive corin mutant S985A, we showed that the similar to 75-kDa fragment was generated by corin autocleavage. We constructed a series of mutants by replacing single or double Arg residues in the corin propeptide and identified Arg-530 in the Fz2 domain as the alternative autocleavage site. Our results show that the corin mutation R539C identified in hypertensive patients impairs corin zymogen activation and causes an alternative autocleavage that reduces corin activity. These data support that human CORIN gene mutations causing impaired corin activity may be an underlying mechanism in hypertension.	[Dong, Ningzheng; Fang, Chaodong; Jiang, Yizhi; Zhou, Tiantian; Liu, Meng; Wu, Qingyu] Soochow Univ, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Dong, Ningzheng; Jiang, Yizhi] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Thrombosis & Hemostasis Key Lab,Minist Hlth, Suzhou 215123, Peoples R China; [Zhou, Jianping] First Hosp Yancheng, Dept Gerontol, Yancheng 224001, Peoples R China; [Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Dept Nephrol, Cleveland, OH 44195 USA; [Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Dept Hypertens, Cleveland, OH 44195 USA	Soochow University - China; Soochow University - China; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Wu, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org	Shen, Jianzhong/AAH-8184-2019	Qin, Jun/0000-0002-2647-9270; Wu, Qingyu/0000-0003-0561-9315	National Institutes of Health [HL089298]; National Natural Science Foundation of China [31070716, 81170247, 31161130356]; Natural Science Foundation of the Jiangsu Higher Education Institutions [10KJB320017]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Proteases and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions; Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Proteases and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL089298. This work was also supported by National Natural Science Foundation of China Grants 31070716, 81170247, and 31161130356; Natural Science Foundation of the Jiangsu Higher Education Institutions Grant 10KJB320017; the Priority Academic Program Development of Jiangsu Higher Education Institutions; and the Danish-Chinese Center for Proteases and Cancer.	Ambrosius WT, 1999, HYPERTENSION, V34, P631, DOI 10.1161/01.HYP.34.4.631; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Becherer JD, 2003, CURR TOP DEV BIOL, V54, P101, DOI 10.1016/S0070-2153(03)54006-6; Buckley CL, 2011, REGUL PEPTIDES, V172, P44, DOI 10.1016/j.regpep.2011.08.006; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chen SH, 2010, AM J PHYSIOL-HEART C, V299, pH1687, DOI 10.1152/ajpheart.00399.2010; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Cui YJ, 2009, KIDNEY INT, V76, P1137, DOI 10.1038/ki.2009.357; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dong NZ, 2012, CLIN CHIM ACTA, V413, P378, DOI 10.1016/j.cca.2011.10.032; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Guipponi M, 2008, FRONT BIOSCI-LANDMRK, V13, P1557, DOI 10.2741/2780; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; Mullins LJ, 2006, PHYSIOL REV, V86, P709, DOI 10.1152/physrev.00016.2005; Nakayama T, 2000, CIRC RES, V86, P841, DOI 10.1161/01.RES.86.8.841; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Pan JL, 2002, J BIOL CHEM, V277, P38390, DOI 10.1074/jbc.M205686200; Peleg A, 2009, CLIN CHIM ACTA, V409, P85, DOI 10.1016/j.cca.2009.09.004; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Tran KL, 2004, AM J PHYSIOL-HEART C, V287, pH1625, DOI 10.1152/ajpheart.00298.2004; Wang W, 2012, HYPERTENSION, V60, P1352, DOI 10.1161/HYPERTENSIONAHA.112.201244; Wang W, 2012, KIDNEY INT, V82, P26, DOI 10.1038/ki.2012.41; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P4179, DOI 10.2741/2379; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Zhou YQ, 2009, NEPHROL DIAL TRANSPL, V24, P1071, DOI 10.1093/ndt/gfn727	49	50	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7867	7874		10.1074/jbc.M112.411512	http://dx.doi.org/10.1074/jbc.M112.411512			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23372161	hybrid, Green Published			2022-12-28	WOS:000316455300040
J	Jung, HY; Wang, X; Jun, S; Park, JI				Jung, Hae-Yun; Wang, Xin; Jun, Sohee; Park, Jae-Il			Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE HTERT; REGULATES TELOMERASE; UBIQUITIN LIGASE; APOPTOTIC RESPONSE; PROTEIN-KINASES; DYRK FAMILY; DNA; END; PHOSPHORYLATION; CHROMOSOMES	Telomerase maintains the telomere, a specialized chromosomal end structure that is essential for genomic stability and cell immortalization. Telomerase is not active in most somatic cells, but its reactivation is one of the hallmarks of cancer. In this study, we found that dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (Dyrk2) negatively regulates telomerase activity. Dyrk2 phosphorylates TERT protein, a catalytic subunit of telomerase. Phosphorylated TERT is then associated with the EDD-DDB1-VprBP E3 ligase complex for subsequent ubiquitin-mediated TERT protein degradation. During the cell cycle, Dyrk2 interacts with TERT at the G2/M phase and induces degradation. In contrast, depletion of endogenous Dyrk2 disrupts the cell cycle-dependent regulation of TERT and elicits the constitutive activation of telomerase. Similarly, a Dyrk2 nonsense mutation identified in breast cancer compromises ubiquitination-mediated TERT protein degradation. Our findings suggest the novel molecular mechanism of kinase-associated telomerase regulation.	[Jung, Hae-Yun; Wang, Xin; Jun, Sohee; Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Program Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Park, JI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jaeil@mdanderson.org	park, jaeil/AAS-5894-2021	PARK, JAE-IL/0000-0002-0737-2654; Jung, Hae-Yun/0000-0001-9467-2219	University Cancer Foundation [IRG-08-061-01]; Center for Stem Cell and Developmental Biology Transformative Pilot Grant; Institutional Research Grant; New Faculty Award (M.D. Anderson Cancer Center Support Grant); Metastasis Research Center Grant; National Institutes of Health through M.D. Anderson's Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	University Cancer Foundation; Center for Stem Cell and Developmental Biology Transformative Pilot Grant; Institutional Research Grant; New Faculty Award (M.D. Anderson Cancer Center Support Grant); Metastasis Research Center Grant; National Institutes of Health through M.D. Anderson's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University Cancer Foundation (IRG-08-061-01), a Center for Stem Cell and Developmental Biology Transformative Pilot Grant (M.D. Anderson), an Institutional Research Grant (M.D. Anderson), a New Faculty Award (M.D. Anderson Cancer Center Support Grant), and a Metastasis Research Center Grant (M.D. Anderson).; We thank Pierre McCrea, Lei Li, and Junjie Chen for helpful comments on the manuscript and Junjie Chen and Sub-bareddy Maddika for providing reagents. The DNA Analysis Core Facility was supported by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant, CA016672.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Blackburn EH, 2000, NAT STRUCT BIOL, V7, P847, DOI 10.1038/79594; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonifaci N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014078; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Oh W, 2010, ONCOGENE, V29, P4101, DOI 10.1038/onc.2010.160; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; RHYU MS, 1995, J NATL CANCER I, V87, P884, DOI 10.1093/jnci/87.12.884; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452	57	45	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7252	7262		10.1074/jbc.M112.416792	http://dx.doi.org/10.1074/jbc.M112.416792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23362280	hybrid, Green Published			2022-12-28	WOS:000316002400045
